Citrus Sinensis ID: 001952
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 992 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LFA2 | 934 | Serine/threonine-protein | yes | no | 0.622 | 0.661 | 0.630 | 0.0 | |
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.435 | 0.733 | 0.607 | 1e-163 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.435 | 0.733 | 0.607 | 1e-163 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.405 | 0.660 | 0.650 | 1e-159 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.375 | 0.643 | 0.645 | 1e-146 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.420 | 0.794 | 0.446 | 1e-110 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.369 | 0.744 | 0.495 | 1e-108 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.388 | 0.878 | 0.503 | 1e-107 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.352 | 0.723 | 0.503 | 1e-105 | |
| P93025 | 915 | Phototropin-2 OS=Arabidop | no | no | 0.332 | 0.360 | 0.458 | 2e-96 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 824 bits (2129), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/676 (63%), Positives = 504/676 (74%), Gaps = 58/676 (8%)
Query: 365 THA-VKVEIAQKEKHVPAHPS-SSDTVDLPEQEKNVSAPSKLANRTSTVKSGRKGRLHAV 422
THA V+ ++ + +KHV + PS SS V+ E +KN+S +S V S +KG+L
Sbjct: 269 THAFVEDDVIEIDKHVTSLPSHSSKKVNATELDKNIS--------SSAVDSEQKGKLDDA 320
Query: 423 PSSSSSNGSRVTKISRNSPRVAKQVLRKKGAVKKKVKQDSASSPCSSNFYSEVRSQLEPS 482
P+S + NG V K++R PR + + K K+ SA+ P + E+ L+ S
Sbjct: 321 PNSGTENGKTVRKVTRMIPRPKQPKKKILLKKKLKIGVVSATYPTKDD--EEIVPSLDSS 378
Query: 483 STQLICQRCHCALKNAS---NLPYQDST------VSNLTSVS---AEVISTSVTTG---- 526
+ QL+CQRCHC+LK+ S N P S+ +L+SVS A S ++G
Sbjct: 379 ANQLLCQRCHCSLKSTSIDDNPPSYTSSHNPKICTDSLSSVSNKEAHQGSDENSSGSCNV 438
Query: 527 ---------IIEPDFIPNDSDRSQPIVGK------TKSKGEFSQSSKSSLGDYSSSTSNS 571
I++ D +++ +V K + K EFS SSK SLGDYS STS S
Sbjct: 439 SQSSEADIVIMKQDVSSSNNSGIGAMVEKETENPTSSEKFEFSLSSKDSLGDYSRSTSIS 498
Query: 572 DDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELI 631
++SNLS SCGN+PHMS DVRWEAI+H+++QYGS+GLRHFNLL+KLGCGDIGTVYLAELI
Sbjct: 499 EESNLSRFSCGNKPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELI 558
Query: 632 GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYC 691
GTNCLFAIKVMDNEFLARRKK PRAQ EREIL+MLDHPFLPTLY+QFTSDNLSCLVMEYC
Sbjct: 559 GTNCLFAIKVMDNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYC 618
Query: 692 PGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751
PGGDLHVLRQKQLG+CF EPAARFYVAE+LLALEYLHMLG+IYRDLKPENILVREDGHIM
Sbjct: 619 PGGDLHVLRQKQLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIM 678
Query: 752 LTDFDLSLRCSVSPTLLKSSS--NMDPARVSGPCTESNCIQPFCI-EPTCQVPCFSPRFL 808
LTDFDLSLRC+V+PTL++S+S DPAR+SGP SNCIQPFCI EP+CQV CFSPR
Sbjct: 679 LTDFDLSLRCAVNPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLS 738
Query: 809 PATAKTRKPK-ADPAAQI-----RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGA 862
+ RKPK D ++ RSLPQLVAEPT+ARSNSFVGTHEYLAPEIIKGEGHGA
Sbjct: 739 SNQQQGRKPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGA 798
Query: 863 AVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922
AVDWWTFG+ LYELLYG+TPFKG N+ETLANVV+Q+LKFPDSPL+SFQA+DLIRGLL+K
Sbjct: 799 AVDWWTFGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVK 858
Query: 923 EPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKS------K 976
EPENRLGS+KG+ EIK+HPFFEGLNWALIRCAIPPELPDFY+YG S +
Sbjct: 859 EPENRLGSEKGSVEIKRHPFFEGLNWALIRCAIPPELPDFYEYGGGPEAAADSPGGSNNR 918
Query: 977 YLECKATGEQLEFELF 992
YLECKA G+ LEFELF
Sbjct: 919 YLECKAIGDHLEFELF 934
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 577 bits (1488), Expect = e-163, Method: Compositional matrix adjust.
Identities = 277/456 (60%), Positives = 338/456 (74%), Gaps = 24/456 (5%)
Query: 526 GIIEPDFIPNDSDRSQPIVGKTKSKGEFSQSSK-------------SSLGDYSSSTSNSD 572
G++E D I N S +S +GK S S++ SS S+S+ SD
Sbjct: 98 GVVE-DGIANGSLKSSSALGKEHGIASASGSARLVGRSETGERGFSSSRCRPSTSSDVSD 156
Query: 573 DSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG 632
+S S S +PH + D RWEAI+ +R + G +GL HF LL+KLGCGDIG+VYL+EL G
Sbjct: 157 ESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELSG 216
Query: 633 TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCP 692
T FA+KVMD LA RKK+ RAQTE+EIL+ LDHPFLPTLY+ F +D SCLVME+CP
Sbjct: 217 TKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCP 276
Query: 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML 752
GGDLH LRQ+Q GK F E A +FYVAE+LLA+EYLHMLG+IYRDLKPEN+LVREDGHIML
Sbjct: 277 GGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVLVREDGHIML 336
Query: 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQV--------PCFS 804
+DFDLSLRC+VSPTL++ SSN D A ++ C+QP C+EP+C + CF
Sbjct: 337 SDFDLSLRCAVSPTLIR-SSNPD-AEALRKNNQAYCVQPACVEPSCMIQPSCATPTTCFG 394
Query: 805 PRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAV 864
PRF + K RKPK + Q+ P+L+AEP+DARS SFVGTHEYLAPEIIKGEGHG+AV
Sbjct: 395 PRFFSKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAV 454
Query: 865 DWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924
DWWTFGIFLYELL+G+TPFKGSGN TL NV+ Q L+FP+ P++SF ARDLIRGLL+KEP
Sbjct: 455 DWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEP 514
Query: 925 ENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960
+ RLG ++GA EIKQHPFFEG+NWALIRCA PPE+P
Sbjct: 515 QQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 577 bits (1487), Expect = e-163, Method: Compositional matrix adjust.
Identities = 277/456 (60%), Positives = 338/456 (74%), Gaps = 24/456 (5%)
Query: 526 GIIEPDFIPNDSDRSQPIVGKTKSKGEFSQSSK-------------SSLGDYSSSTSNSD 572
G++E D I N S +S +GK S S++ SS S+S+ SD
Sbjct: 98 GVVE-DGIANGSLKSSSALGKEHGIASASGSARLVGRSETGERGFSSSRCRPSTSSDVSD 156
Query: 573 DSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG 632
+S S S +PH + D RWEAI+ +R + G +GL HF LL+KLGCGDIG+VYL+EL G
Sbjct: 157 ESACSSISSVTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIGSVYLSELNG 216
Query: 633 TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCP 692
T FA+KVMD LA RKK+ RAQTE+EIL+ LDHPFLPTLY+ F +D SCLVME+CP
Sbjct: 217 TKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKFSCLVMEFCP 276
Query: 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML 752
GGDLH LRQ+Q GK F E A +FYVAE+LLA+EYLHMLG+IYRDLKPEN+LVREDGHIML
Sbjct: 277 GGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVLVREDGHIML 336
Query: 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQV--------PCFS 804
+DFDLSLRC+VSPTL++ SSN D A ++ C+QP C+EP+C + CF
Sbjct: 337 SDFDLSLRCAVSPTLIR-SSNPD-AEALRKNNQAYCVQPACVEPSCMIQPSCATPTTCFG 394
Query: 805 PRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAV 864
PRF + K RKPK + Q+ P+L+AEP+DARS SFVGTHEYLAPEIIKGEGHG+AV
Sbjct: 395 PRFFSKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGHGSAV 454
Query: 865 DWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924
DWWTFGIFLYELL+G+TPFKGSGN TL NV+ Q L+FP+ P++SF ARDLIRGLL+KEP
Sbjct: 455 DWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLIRGLLVKEP 514
Query: 925 ENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960
+ RLG ++GA EIKQHPFFEG+NWALIRCA PPE+P
Sbjct: 515 QQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVP 550
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 564 bits (1453), Expect = e-159, Method: Compositional matrix adjust.
Identities = 270/415 (65%), Positives = 326/415 (78%), Gaps = 13/415 (3%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PH + D+RWEAI+ VR + G + +RHF LL+KLGCGDIG+VYLAEL GT FA+KVM+
Sbjct: 202 KPHKANDIRWEAIQAVRTRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMN 261
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
LA RKK+ RAQTEREIL+ LDHPFLPTLY+ F ++ SCLVME+CPGGDLH LRQ+Q
Sbjct: 262 KTELANRKKLLRAQTEREILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQ 321
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
GK FSE A RFYVAEVLL+LEYLHMLG+IYRDLKPEN+LVREDGHIML+DFDLSLRCSV
Sbjct: 322 PGKYFSEHAVRFYVAEVLLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSV 381
Query: 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCI-EPTCQVP-CFSPRFLPATAKTRKPKA-- 819
SPTL+KSS+N+ + SG C + +CI+P C+ +P C P CF+PRFL +K K
Sbjct: 382 SPTLVKSSNNLQ-TKSSGYCVQPSCIEPTCVMQPDCIKPSCFTPRFLSGKSKKDKKSKPK 440
Query: 820 -DPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY 878
D Q+ LP+L+AEPT+ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFLYELL+
Sbjct: 441 NDMHNQVTPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 500
Query: 879 GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938
GRTPFKGS N TL NV+ Q L+FP+SP +SF ARDLIRGLL+KEP++RL ++GA EIK
Sbjct: 501 GRTPFKGSANRATLFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIK 560
Query: 939 QHPFFEGLNWALIRCAIPPELPDFYDYGIQDM-VPQKSKYLECKATGEQLEFELF 992
QHPFF+ +NWALIRCA PPE+P Q + +PQ K L K +G L+ + F
Sbjct: 561 QHPFFQNVNWALIRCATPPEVPR------QVINLPQTEKDLGVKPSGNYLDIDFF 609
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 519 bits (1337), Expect = e-146, Method: Compositional matrix adjust.
Identities = 249/386 (64%), Positives = 300/386 (77%), Gaps = 14/386 (3%)
Query: 584 RPHM-SADVRWEAIRHVRLQYGS-IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV 641
+PH + D RW AI+ VR + GS + + F L++KLG GDIG VYLAELIGT FA+KV
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 642 MDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQ 701
M+ +A RKK+ RAQTE+EIL+ LDHPFLPTLYS F ++ SCLVME+CPGGDLH LRQ
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 702 KQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761
KQ GK F E AARFYVAEVLLA+EYLHMLG+IYRDLKPEN+LVREDGHIML+DFDLSLRC
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 762 SVSPTLLKSSSNMDPARVSGPCTESNC-------IQPFCIEPTCQVPCFSPRFLPATAKT 814
+VSPTL++ ++ ++ S C + C +QP CI+P CF+PRFL + K
Sbjct: 333 AVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPV----CFTPRFL-SKGKH 387
Query: 815 RKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLY 874
RK D + QIR LP+L+AEPT ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFLY
Sbjct: 388 RKKSNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLY 447
Query: 875 ELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934
ELL+G TPF+G N TL NVV Q L+FP+ P +SF ARDLIRGLL+KEP++RL ++GA
Sbjct: 448 ELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGA 507
Query: 935 AEIKQHPFFEGLNWALIRCAIPPELP 960
EIKQHPFF+ +NWALIRC PP++P
Sbjct: 508 TEIKQHPFFQSVNWALIRCTSPPQIP 533
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1024), Expect = e-110, Method: Compositional matrix adjust.
Identities = 215/481 (44%), Positives = 290/481 (60%), Gaps = 64/481 (13%)
Query: 535 NDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWE 594
N+SD VG S+ SS + SS S+ + L+ S ++PH + V WE
Sbjct: 11 NESDYESSTVGPDSSRRTSWLSSSFTASPSCSSISHLSNHGLN-SYNQSKPHKANQVAWE 69
Query: 595 AIRHVRLQYG-SIGLRHFNLLQKLGCGDIGTVYLAELIGT--NCLFAIKVMDNEFLARRK 651
A+ +R G ++GL HF LL++LG GDIG+VYL ++ G+ +A+KV+D E +A +K
Sbjct: 70 AMARLRRCCGRAVGLEHFRLLKRLGSGDIGSVYLCQIRGSPETAFYAMKVVDKEAVAVKK 129
Query: 652 KMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEP 711
K+ RA+ E++IL MLDHPF PTLY+ F + + S LVMEYCPGGDL+ +R +Q K F+
Sbjct: 130 KLGRAEMEKKILGMLDHPFCPTLYAAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTIS 189
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSS 771
+ RFY AE L+ALEYLHM+G++YRDLKPEN+L+REDGH+ML+DFDLS +C V P L
Sbjct: 190 STRFYAAETLVALEYLHMMGIVYRDLKPENVLIREDGHVMLSDFDLSFKCDVVPQFL--- 246
Query: 772 SNMDPARVSGPCTESNCIQPFCIEPTCQ-------VPCFSPRFLPATAKTRKPK------ 818
S+ D R + I+ C P+C + CFSP T+ R+ K
Sbjct: 247 SDNDRDRGHQEDDDDISIRRKCSTPSCTTTPLNPVISCFSP-----TSSRRRKKNVVTTT 301
Query: 819 -----ADPAAQIRS---------------------------LPQLVAEPTDARSNSFVGT 846
A + ++S P + AEP +ARS SFVGT
Sbjct: 302 IHENAAGTSDSVKSNDVSRTFSRSPSSCSRVSNGLRDISGGCPSIFAEPINARSKSFVGT 361
Query: 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSP 906
HEYLAPE+I G+GHG+AVDWWT+GIFLYE+++GRTPFKG NE+TL N++ L FP
Sbjct: 362 HEYLAPEVISGQGHGSAVDWWTYGIFLYEMIFGRTPFKGDNNEKTLVNILKAPLTFPKVI 421
Query: 907 LIS-------FQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPEL 959
+ S A+DLI LL+K P+ RLGS KG+ EIK+H FFEG+NWALIR PP +
Sbjct: 422 VNSPKEYEDMVNAQDLIIKLLVKNPKKRLGSLKGSIEIKRHEFFEGVNWALIRSIKPPWV 481
Query: 960 P 960
P
Sbjct: 482 P 482
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 392 bits (1007), Expect = e-108, Method: Compositional matrix adjust.
Identities = 205/414 (49%), Positives = 262/414 (63%), Gaps = 47/414 (11%)
Query: 578 GSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAEL------- 630
SSC +PH + WEAIR +R G +GL HF L+++LG GD+G VYL L
Sbjct: 47 ASSCRYKPHKANQAEWEAIRRLRAGAGRVGLEHFRLVRRLGSGDLGNVYLCRLREPWSSS 106
Query: 631 ----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686
CL+A+KV+D + LA RKK+ RA+ ER+ILR LDHPFLPTLY+ F + + +CL
Sbjct: 107 SMTTTAGGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEASHYACL 166
Query: 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746
VME+CPGGDLHV RQ+Q G+ F+ + RFYVAE +LALEYLHM+GV+YRDLKPEN+LVR
Sbjct: 167 VMEFCPGGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPENVLVRG 226
Query: 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQP-FCIEPTCQVPCFSP 805
DGHIML+DFDLSL+C V P LL+ PAR + + P C+ PT Q P S
Sbjct: 227 DGHIMLSDFDLSLKCDVVPKLLR------PARSAAAGGKPPLPPPSSCVPPTIQ-PVLSC 279
Query: 806 RFLPATAKTRKPK-------------------ADPAAQIRSLPQLVAEPTDARSNSFVGT 846
F K K + + +V EP ARS SFVGT
Sbjct: 280 IFR-GVHKCHHAKECAGGGAAAGNNGDGDGNDEEAETETAEPEVVVVEPVAARSKSFVGT 338
Query: 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSP 906
HEYLAPE+I G+GHG+AVDWWT G+F+YE+LYGRTPFKG NE+TL N++ Q + FP
Sbjct: 339 HEYLAPEVISGQGHGSAVDWWTLGVFMYEMLYGRTPFKGESNEKTLINIIKQPVTFPRLA 398
Query: 907 LISFQ--------ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952
+ A+DL+ LL K P+ RLGS G+AE+K+HPFF+G+NWAL+R
Sbjct: 399 GAAAAGEWEEMKTAQDLMLQLLAKNPKKRLGSTMGSAEVKRHPFFKGVNWALVR 452
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (1000), Expect = e-107, Method: Compositional matrix adjust.
Identities = 216/429 (50%), Positives = 274/429 (63%), Gaps = 44/429 (10%)
Query: 542 PIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRL 601
PI T+S FS+ S D ST ++S LS +PH S+D + IR +
Sbjct: 17 PISSGTESCSSFSRLS----FDAPPSTIPEEESFLS-----LKPHRSSDFAYAEIRRRKK 67
Query: 602 QYGSIGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVMDNEFLARRKKMPRA 656
Q + R F L++++G GDIGTVYL L G + FA+KV+D E LA +KKM RA
Sbjct: 68 Q--GLTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESRSSYFAMKVVDKEALALKKKMHRA 125
Query: 657 QTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFY 716
+ E+ IL+MLDHPFLPTLY++F + + SC+VMEYC GGDLH LR +Q + FS +ARFY
Sbjct: 126 EMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLRHRQPHRRFSLSSARFY 185
Query: 717 VAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776
AEVL+ALEYLHMLG+IYRDLKPENILVR DGHIML+DFDLSL CS S ++SSS
Sbjct: 186 AAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSL-CSDSIAAVESSS---- 240
Query: 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKT--RKPKADPAAQIRSLPQLVAE 834
S P E+ ++ SPR A+ R ++ + VAE
Sbjct: 241 ---SSP--ENQQLR-------------SPRRFTRLARLFQRVLRSKKVQTLEPTRLFVAE 282
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
P ARS SFVGTHEY+APE+ G HG AVDWW FG+FLYE++YG+TPF N+ L N
Sbjct: 283 PVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVFLYEMIYGKTPFVAPTNDVILRN 342
Query: 895 VVMQSLKFP-DSPLISFQ--ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951
+V + L FP DSP F+ AR+LI GLL K+P RLGS++GAAE+K HPFF+GLN+ALI
Sbjct: 343 IVKRQLSFPTDSPATMFELHARNLISGLLNKDPTKRLGSRRGAAEVKVHPFFKGLNFALI 402
Query: 952 RCAIPPELP 960
R PPE+P
Sbjct: 403 RTLTPPEIP 411
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 385 bits (988), Expect = e-105, Method: Compositional matrix adjust.
Identities = 196/389 (50%), Positives = 251/389 (64%), Gaps = 39/389 (10%)
Query: 584 RPHMSADVRWEAIRHVRLQYGS-IGLRHFNLLQKLGCGDIGTVYLAELIGTN-----CLF 637
RPH S DV W AIR + +G R F L++++G GDIGTVYL L + C++
Sbjct: 83 RPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRLRSSPERESPCMY 142
Query: 638 AIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL 696
A+KV+D +AR++K+ RA E+ ILR LDHPFLPTL++ F + + SC VME+CPGGDL
Sbjct: 143 AMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFSCAVMEFCPGGDL 202
Query: 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756
H LR + + F P+ARFY AEVLLA+EYLHM+G++YRDLKPEN+L+R DGHIMLTDFD
Sbjct: 203 HSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLIRADGHIMLTDFD 262
Query: 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRK 816
LSL+ + SP+L + D E + CF P L + R
Sbjct: 263 LSLQSTTSPSLDGDTDTDD-------------------EASGGASCF-PDHLLRFKRRRN 302
Query: 817 PKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYEL 876
A P P+ VAEP DARS SFVGTHEY+APE+ G HGAAVDWW +G+FLYEL
Sbjct: 303 AVAAPR------PRFVAEPVDARSCSFVGTHEYVAPEVASGGAHGAAVDWWAYGVFLYEL 356
Query: 877 LYGRTPFKGSGNEETLANVVMQSLKFPD-----SPLISFQARDLIRGLLIKEPENRLGSQ 931
+YGRTPF G+ NE TL N+V + L FP P + ARDLI LL K+P RLGS+
Sbjct: 357 IYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADA-DARDLIARLLAKDPAARLGSR 415
Query: 932 KGAAEIKQHPFFEGLNWALIRCAIPPELP 960
+GAA++K HPFF+ LN AL+R + PP +P
Sbjct: 416 RGAADVKSHPFFKSLNLALLRSSRPPVVP 444
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93025|PHOT2_ARATH Phototropin-2 OS=Arabidopsis thaliana GN=PHOT2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 354 bits (909), Expect = 2e-96, Method: Compositional matrix adjust.
Identities = 172/375 (45%), Positives = 230/375 (61%), Gaps = 45/375 (12%)
Query: 585 PHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDN 644
PH W+AI+ ++ ++GL HF ++ LG GD G+V+L EL GT L+A+K M+
Sbjct: 551 PHNKESTSWKAIKKIQASGETVGLHHFKPIKPLGSGDTGSVHLVELKGTGELYAMKAMEK 610
Query: 645 EFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQL 704
+ R K RA EREI+ +LDHPFLPTLY+ F + CL+ ++CPGG+L L +Q
Sbjct: 611 TMMLNRNKAHRACIEREIISLLDHPFLPTLYASFQTSTHVCLITDFCPGGELFALLDRQP 670
Query: 705 GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764
K +E +ARFY AEV++ LEYLH LG++YRDLKPENIL+++DGHI+L DFDLS + +
Sbjct: 671 MKILTEDSARFYAAEVVIGLEYLHCLGIVYRDLKPENILLKKDGHIVLADFDLSFMTTCT 730
Query: 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQ 824
P L+ +P A +K R+ K+ P
Sbjct: 731 PQLI-------------------------------IPA-------APSKRRRSKSQP--- 749
Query: 825 IRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFK 884
LP VAEP+ +SNSFVGT EY+APEII G GH +A+DWW GI LYE+LYGRTPF+
Sbjct: 750 ---LPTFVAEPS-TQSNSFVGTEEYIAPEIITGAGHTSAIDWWALGILLYEMLYGRTPFR 805
Query: 885 GSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
G ++T AN++ + L FP S +S R LI LL ++P +RLGS+ GA EIKQH FF
Sbjct: 806 GKNRQKTFANILHKDLTFPSSIPVSLVGRQLINTLLNRDPSSRLGSKGGANEIKQHAFFR 865
Query: 945 GLNWALIRCAIPPEL 959
G+NW LIR PP L
Sbjct: 866 GINWPLIRGMSPPPL 880
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for photo-induced movements. Mediates calcium spiking of extra- and intracellular origins in response to blue light. Involved in hypocotyl phototropism. Contributes to the chloroplast accumulation in low blue light and mediates their translocation (avoidance response) at high fluence. Regulates stomata opening and photomorphogenesis response of leaf tissue. Not involved in hypocotyl elongation inhibition, anthocyanin accumulation or cotyledon opening. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 992 | ||||||
| 255586764 | 956 | serine/threonine protein kinase, putativ | 0.948 | 0.984 | 0.614 | 0.0 | |
| 356537061 | 863 | PREDICTED: serine/threonine-protein kina | 0.640 | 0.735 | 0.683 | 0.0 | |
| 357510983 | 876 | Protein kinase-like protein [Medicago tr | 0.703 | 0.796 | 0.630 | 0.0 | |
| 356548337 | 866 | PREDICTED: serine/threonine-protein kina | 0.640 | 0.733 | 0.681 | 0.0 | |
| 356570839 | 868 | PREDICTED: serine/threonine-protein kina | 0.660 | 0.754 | 0.660 | 0.0 | |
| 449511846 | 867 | PREDICTED: serine/threonine-protein kina | 0.661 | 0.756 | 0.666 | 0.0 | |
| 449451116 | 867 | PREDICTED: serine/threonine-protein kina | 0.658 | 0.753 | 0.663 | 0.0 | |
| 356503796 | 871 | PREDICTED: serine/threonine-protein kina | 0.674 | 0.768 | 0.644 | 0.0 | |
| 225440934 | 864 | PREDICTED: serine/threonine-protein kina | 0.649 | 0.745 | 0.684 | 0.0 | |
| 30693719 | 934 | KCBP-interacting protein kinase [Arabido | 0.622 | 0.661 | 0.630 | 0.0 |
| >gi|255586764|ref|XP_002534001.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223526003|gb|EEF28382.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1108 bits (2866), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 619/1007 (61%), Positives = 747/1007 (74%), Gaps = 66/1007 (6%)
Query: 1 MGSFPGSCEIVEAGEEVNSVQNSRRTYRPSSGSSVMDKDQKPRVLKLAYNESLEDDINQL 60
MGS+ +CEIVEA EEV S +S+R Y+ SG V D +P VLKL Y +SLEDDINQL
Sbjct: 1 MGSYSRTCEIVEAREEVISANHSKRVYQSHSGLRVGGNDGEPSVLKLGYRDSLEDDINQL 60
Query: 61 FEAISLKNSTKGWGLSHEVGTSMSPVRKSDLKKPISV--PHSPRLGTSQPVSLKQALREL 118
FEAISLKNS+KG GLS++ TS SP+RK+ +K+PI+V P+SPR+ +S+ VSLKQALR+L
Sbjct: 61 FEAISLKNSSKGLGLSNQASTSSSPLRKNAMKRPITVGVPNSPRIVSSEQVSLKQALRDL 120
Query: 119 SITKASEMAAMKRISKSTSSSVMSEAGRIKNLYNTKVVEPASGSGLLMDEGKGNMVEISL 178
I+KASEMAAMKR SK S +SEAGRIK+LYN+ VVE S SG +DEGK +VEISL
Sbjct: 121 CISKASEMAAMKRSSKPIGSPRVSEAGRIKSLYNSVVVE-TSRSGHSIDEGKRALVEISL 179
Query: 179 VPEESQLTSSQKMPPSLQVPKMKLINQSDNSSPQFTIPTLQNAMGISQSANSSPLFAVPK 238
VPEE++ SS+K+P + NQS SSPQ + N SA SSP FAV
Sbjct: 180 VPEETKSNSSEKVP-------CQSSNQSVCSSPQSHLSKSSN-----HSAYSSPQFAV-- 225
Query: 239 RQNFSGTSKSAHSSPQYAIPKMKNAAGTNQSVHYAPQFSVPTIQ--NAAVTNQS--AHSS 294
+ S+ +S Q AI T Q++ Q ++ Q N + QS ++
Sbjct: 226 ---LTAKSEFDTTSMQDAIASASQKVQT-QALKLPDQSTLSKKQSGNGTILMQSELGSAT 281
Query: 295 PRFASSTIQNSTGTNKGAQSSSRLTVPTTDGSTGTNQRAHSSPRLAVPTQSGPQTARMQD 354
+ S +++ + + AQSS R VP T+ STGT P QS
Sbjct: 282 RKVGSQAVKSPSQS---AQSSPRFGVPFTNISTGT-----------TPVQS--------- 318
Query: 355 EIISTSTNVGTHAVKVEIAQKEKHVPAHP-SSSDTVD-LPEQEKNVSAPSKLANRTSTVK 412
++IS ST VG+ E+AQKE + A S SD+VD +P+++ ++ K+A + S +
Sbjct: 319 KVISASTKVGSQGSTTEMAQKETCMNATSLSHSDSVDNMPDEDTIIATSKKVARKASAPR 378
Query: 413 SGRKGRLHAVPSSSSSNGSRVTKISRNSPRVAKQVLRKKGAVKKKVKQDSASSPCSSNFY 472
SGRKGRL PSSS N SRV+K +RN+PR+AK ++ K +VKKKV Q +AS+ +
Sbjct: 379 SGRKGRLFYSPSSSI-NISRVSKFTRNAPRLAKPGIKNKSSVKKKVNQGTASA---ARIP 434
Query: 473 SEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSNLTSVSAEVISTSVTTGIIEPDF 532
+E + L P++ QL+C +C CAL+N S ++S S +AEV ST+V +G + DF
Sbjct: 435 NEGNNSLAPTTGQLVCHKCQCALRNVS----EESNQGISASFTAEVSSTNVDSGASKSDF 490
Query: 533 IPNDSDRSQPIV-----GKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHM 587
++ +RS+ I K++ KGEFSQSSKSSLG+YS+STSNSD+SN S SC NRPHM
Sbjct: 491 SSSNCNRSRSIGKAKKNSKSREKGEFSQSSKSSLGEYSTSTSNSDESNASRPSCCNRPHM 550
Query: 588 SADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL 647
S D+RWEAIRHV++Q + LRHFN+L+KLGCGDIGTVYLAELIG+NCLFAIKVMDNEFL
Sbjct: 551 SKDIRWEAIRHVKMQDKVLSLRHFNILKKLGCGDIGTVYLAELIGSNCLFAIKVMDNEFL 610
Query: 648 ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC 707
ARRKKMPRAQTEREILRMLDHPFLPTLY+QFTSDNLSCLVMEYCPGGDLHVLRQKQLG
Sbjct: 611 ARRKKMPRAQTEREILRMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGGS 670
Query: 708 FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767
FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC+VSPTL
Sbjct: 671 FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCNVSPTL 730
Query: 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827
LK S++ DP + SGPCTES+CI+PFCIEP+CQVPCFSPRFLPA AK RK KA+ AA ++S
Sbjct: 731 LK-STDADPMKASGPCTESSCIEPFCIEPSCQVPCFSPRFLPAAAKARKLKAEMAAHLKS 789
Query: 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG 887
LPQLVAEPTDARSNSFVGTHEYLAPEIIKG+GHGAAVDWWTFGIFLYELLYGRTPFKGS
Sbjct: 790 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGKGHGAAVDWWTFGIFLYELLYGRTPFKGSC 849
Query: 888 NEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947
NEETL NVV+Q+L+FPDSPL+SFQARDLI GLL K+PENRLG++KGAAEIKQHPFFEGLN
Sbjct: 850 NEETLDNVVLQNLRFPDSPLVSFQARDLIWGLLSKDPENRLGTEKGAAEIKQHPFFEGLN 909
Query: 948 WALIRCAIPPELPDFYDYGIQDMVPQK--SKYLECKATGEQLEFELF 992
WALIRCAIPPELPD+Y++G+ + SKYLE +ATGE LEFELF
Sbjct: 910 WALIRCAIPPELPDYYEFGVPYASSHETSSKYLEYEATGEHLEFELF 956
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537061|ref|XP_003537049.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 901 bits (2328), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/664 (68%), Positives = 523/664 (78%), Gaps = 29/664 (4%)
Query: 343 TQSGPQTARMQDEIISTSTNVGTHAVKVEIAQKEKHVPAHP-----SSSDTVDLPEQEKN 397
TQ+ + M ++ S+S+ VG + E AQ EK ++ ++LPE N
Sbjct: 215 TQNDTGASLMPSDLASSSSKVGVLSPSSEPAQIEKQTSESSSSSCNTNGSKLELPE---N 271
Query: 398 VSAPSKLANRTSTVKSGRKGRLHAVPSSSSS-NGSRVTKISRNSPRVAKQVLRKKGAVKK 456
S+P K+ N+ S K+GRKGRL V SSS+S NG+RV K+SRN+PR K +++ K KK
Sbjct: 272 ASSPKKIGNKASASKNGRKGRLQTVSSSSTSVNGNRVCKLSRNAPRTVKSIIKNKNFGKK 331
Query: 457 KVKQDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSNLTSVS- 515
KVKQDS S+ SEV + +TQL+C+RC CA++N + +++L S+S
Sbjct: 332 KVKQDSVSALFDPT-CSEVNDKSVSGTTQLVCERCWCAIEN-------NKGITSLDSISP 383
Query: 516 AEVISTSVTTGIIEPDFIPNDSDRSQPIVGKT---KSKGEFSQSSKSSLGDYSSSTSNSD 572
E I++ +G +S R V K K + EFSQSSKSS GDYSSSTS SD
Sbjct: 384 GEGINSVNNSGAASAGC---NSSREVTKVKKNTVLKEQLEFSQSSKSSQGDYSSSTSTSD 440
Query: 573 DSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG 632
+SNLSGSSCGNRPHMS DVRW+AIRH ++Q G +GLRHFNLL+KLGCGDIGTVYLAELIG
Sbjct: 441 ESNLSGSSCGNRPHMSKDVRWKAIRHAQIQNGVLGLRHFNLLKKLGCGDIGTVYLAELIG 500
Query: 633 TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCP 692
+CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY+QFTSDNLSCLVMEYCP
Sbjct: 501 KSCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYAQFTSDNLSCLVMEYCP 560
Query: 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML 752
GGDLHVLRQKQLG+ FSEPAARFYVAEVLLALEYLHMLGV+YRDLKPENILVREDGHIML
Sbjct: 561 GGDLHVLRQKQLGRSFSEPAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHIML 620
Query: 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATA 812
TDFDLSLRC VSPTLLKSS +DPA++SGPC +S+CI+PFCIEP CQVPCFSPR LP A
Sbjct: 621 TDFDLSLRCDVSPTLLKSSY-VDPAKISGPCAQSSCIEPFCIEPACQVPCFSPRLLPPAA 679
Query: 813 KTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIF 872
K RK K D AQ+RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFG+F
Sbjct: 680 KARKLKNDLGAQLRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVF 739
Query: 873 LYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932
LYELLYGRTPFKGS NEETLANVV+Q L+FPD+P +S QARDLIRGLL+KEPENRLGS+K
Sbjct: 740 LYELLYGRTPFKGSNNEETLANVVLQGLRFPDTPFVSIQARDLIRGLLVKEPENRLGSEK 799
Query: 933 GAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKS----KYLECKATGEQLE 988
GAAEIKQHPFFEGLNWALIRCAIPPELPD ++G+ +M PQ KY+EC A GE +E
Sbjct: 800 GAAEIKQHPFFEGLNWALIRCAIPPELPDLCEFGVSEMTPQSQGKGVKYVECNAAGELVE 859
Query: 989 FELF 992
FELF
Sbjct: 860 FELF 863
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357510983|ref|XP_003625780.1| Protein kinase-like protein [Medicago truncatula] gi|355500795|gb|AES81998.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 896 bits (2315), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/736 (63%), Positives = 546/736 (74%), Gaps = 38/736 (5%)
Query: 284 AAVTNQSAHSSPRFASSTIQ-----------NSTGTNKGAQSSSRLTVPTTDGSTGTNQR 332
++V ++++HS P A S + S NK +QS + T ++Q
Sbjct: 152 SSVVDEASHSGPHIAESKGRRMEISLVPEKSQSLSFNKTSQSHQTTQI------TSSSQA 205
Query: 333 AHSSPRLAVPT---QSGPQTARMQDEIISTSTNVGTHAVKVEIAQKEKHVPAH-PSSSDT 388
+S+ +AV T SG ++R + S+ VG+ + +V Q EK PA PS S+T
Sbjct: 206 INSAWEIAVATNQLHSGTSSSR--SDAACLSSRVGSQSQRVVPVQPEKQTPASSPSLSNT 263
Query: 389 VDLP-EQEKNVSAPSKLANRTSTVKSGRKGRLHAVPSSSSS-NGSRVTKISRNSPRVAKQ 446
+ E N S+P KL N+ + SGRKGRL SSS+S NGSRV K ++ R K
Sbjct: 264 AESKLELSVNASSPKKLGNKVAVSNSGRKGRLQTSSSSSTSVNGSRVNKQPHHTSRTIKM 323
Query: 447 VLRKKGAVKKKVKQDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDS 506
V++ K KKKVK+DS S+ C S S+ P + QL+C+RC CAL++ Q+
Sbjct: 324 VIKNKSPSKKKVKEDSGSASCDPT--SNEVSKSVPGTAQLVCERCRCALEDTKEEKNQEV 381
Query: 507 TVSNLTSVSAEVISTSVTTGIIEPDFIPNDSDRSQPIVG--------KTKSKGEFSQSSK 558
+ TS V ++V + +P N + + + K K + EFSQSSK
Sbjct: 382 MALDSTSPGNGVNFSNVHSSSYKPYSASNSGNIGKAVAKVEKIQKNTKLKEQLEFSQSSK 441
Query: 559 SSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLG 618
SS G+YSSSTS SD+SN+SGSSCG+RPHMS DVRWEAIRH ++Q+G +GLRHFNLL+KLG
Sbjct: 442 SSQGEYSSSTSTSDESNMSGSSCGSRPHMSKDVRWEAIRHAQMQHGVLGLRHFNLLKKLG 501
Query: 619 CGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678
CGDIGTVYLAELIGT+CLFAIKVMD EFLARRKKMPRAQTEREILRMLDHPFLPTLY QF
Sbjct: 502 CGDIGTVYLAELIGTSCLFAIKVMDIEFLARRKKMPRAQTEREILRMLDHPFLPTLYVQF 561
Query: 679 TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLK 738
TSDNLSCLVMEYCPGGDLHVLRQKQLG+CFSE AARFYVAEVLLALEYLHMLGV+YRDLK
Sbjct: 562 TSDNLSCLVMEYCPGGDLHVLRQKQLGRCFSELAARFYVAEVLLALEYLHMLGVVYRDLK 621
Query: 739 PENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTC 798
PENILVREDGHIMLTDFDLSLRC+VSPTLLKSSSN+DPA+VSG +S+CI+P CI+P+C
Sbjct: 622 PENILVREDGHIMLTDFDLSLRCAVSPTLLKSSSNIDPAKVSGLGAQSSCIEPLCIQPSC 681
Query: 799 QVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE 858
QV CFSPRFLPA AK RK K DP A IRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK E
Sbjct: 682 QVSCFSPRFLPAAAKARKLKVDPLAHIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKEE 741
Query: 859 GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRG 918
GHGAAVDWWTFG+FLYELLYGRTPFKGS NEETLANVV+QSL FPD P +SF+A+DLIRG
Sbjct: 742 GHGAAVDWWTFGVFLYELLYGRTPFKGSNNEETLANVVLQSLGFPDDPFVSFEAKDLIRG 801
Query: 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVP--QKSK 976
LL+KEPENRLGSQKGAAEIKQHPFFEGLNWALIRC IPPELP+F D+G+ DM + +K
Sbjct: 802 LLVKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCTIPPELPEFCDFGVLDMASHGKGAK 861
Query: 977 YLECKATGEQLEFELF 992
YLEC G+ +EFELF
Sbjct: 862 YLECN-VGQHVEFELF 876
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356548337|ref|XP_003542559.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 892 bits (2305), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/666 (68%), Positives = 519/666 (77%), Gaps = 31/666 (4%)
Query: 343 TQSGPQTARMQDEIISTSTNVGTHAVKVEIAQKEKHVPAHP-----SSSDTVDLPEQEKN 397
TQ+ + M ++ S+S+ VG + E AQ EK ++ ++ PE N
Sbjct: 216 TQNDTGASLMPSDLASSSSKVGVLSQSSEPAQIEKQTSESSSSSCNTNGSKLEFPE---N 272
Query: 398 VSAPSKLANRTSTVKSGRKGRLHAVPSSSSS-NGSRVTKISRNSPRVAKQVLRKKGAVKK 456
S+P K+ N+ S SGRKGRL V SSS+S NG+RV K+SRN+PR K ++ K KK
Sbjct: 273 ASSPKKIGNKASASNSGRKGRLQTVSSSSTSVNGNRVCKLSRNAPRTVKSFIKNKKFGKK 332
Query: 457 KVKQDSASS---PCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSNLTS 513
KVKQDS S+ P S+ EV ++ +TQL+C+RC CA++N + DS
Sbjct: 333 KVKQDSVSALFDPTSN----EVNNKSVSGTTQLVCERCWCAIENNEGVTSLDSLSPGEGI 388
Query: 514 VSAEVISTSVTTGIIEPDFIPNDSDRSQPIVGKT---KSKGEFSQSSKSSLGDYSSSTSN 570
S V S + + G +S R V K K + EFSQSSKSS GDYSSSTS
Sbjct: 389 NSVNVHSGAASAGC--------NSSREVTKVKKNTVLKEQLEFSQSSKSSQGDYSSSTST 440
Query: 571 SDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAEL 630
SD+SNLSGSSCGNRPHMS DVRW+AIRH ++Q+G +GLRHFNLL+KLGCGDIGTVYLAEL
Sbjct: 441 SDESNLSGSSCGNRPHMSKDVRWKAIRHAQMQHGVLGLRHFNLLKKLGCGDIGTVYLAEL 500
Query: 631 IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690
IG NCLFAIKVMDNEFLARRKK PRAQTEREILRMLDHPFLPTLY+QFTSDNLSCLVMEY
Sbjct: 501 IGKNCLFAIKVMDNEFLARRKKTPRAQTEREILRMLDHPFLPTLYAQFTSDNLSCLVMEY 560
Query: 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHI 750
CPGGDLHVLRQKQLG+ FSEPAARFYVAEVLLALEYLHMLGV+YRDLKPENILVREDGHI
Sbjct: 561 CPGGDLHVLRQKQLGRSFSEPAARFYVAEVLLALEYLHMLGVVYRDLKPENILVREDGHI 620
Query: 751 MLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPA 810
MLTDFDLSLRC VSPTLLKSSS++DPA++SGPC +S+CI+PFCIEP CQVPCFSPR LP
Sbjct: 621 MLTDFDLSLRCDVSPTLLKSSSDVDPAKISGPCAQSSCIEPFCIEPACQVPCFSPRILPP 680
Query: 811 TAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFG 870
AK RK K D AAQ+RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFG
Sbjct: 681 AAKARKLKTDLAAQLRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFG 740
Query: 871 IFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS 930
+FLYELLYGRTPFKGS NEETLANVV+Q L+FPD+P +S Q RDLIRGLL+KEPENRLGS
Sbjct: 741 VFLYELLYGRTPFKGSNNEETLANVVLQGLRFPDTPFVSIQGRDLIRGLLVKEPENRLGS 800
Query: 931 QKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKS----KYLECKATGEQ 986
+KGAAEIKQHPFFEGLNWALIRCAIPPELPD ++G+ +M Q KY+EC A GE
Sbjct: 801 EKGAAEIKQHPFFEGLNWALIRCAIPPELPDLREFGVSEMTLQSQGKGVKYVECNAAGEL 860
Query: 987 LEFELF 992
+EFELF
Sbjct: 861 VEFELF 866
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356570839|ref|XP_003553591.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2297), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/669 (66%), Positives = 527/669 (78%), Gaps = 14/669 (2%)
Query: 334 HSSPRLAVPT-QSGPQTARMQDEIISTSTNVGTHAVKVEIAQKEKHVPAH-PSSSDTVDL 391
HSS +AV T + T+ +Q ++ +S+ VG + +V + E+ A PS +T
Sbjct: 204 HSSREIAVATTKYDAGTSLIQSDLAGSSSKVGIQSQRVVPVETEEQASASSPSLYNTSGC 263
Query: 392 P-EQEKNVSAPSKLANRTSTVKSGRKGRLHAVPSSSSSNGSRVTKISRNSPRVAKQVLRK 450
E KN S+P KL N+TS +G+KGRL V SS++ NG+RV K R++P K V++
Sbjct: 264 KSEVPKNASSPKKLGNKTSVSNTGKKGRLQTVSSSNAVNGNRVNKPPRHAPWTVKSVIKN 323
Query: 451 KGAVKKKVKQDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSN 510
K KKK K+DS S+ C +EV + P + +LIC+RC CAL+N S QD +
Sbjct: 324 KNLSKKKQKEDSCSTLCGPT-PNEVNKPV-PGTPRLICERCRCALENTSEEKNQDIVALD 381
Query: 511 LTSVSAEVISTSVTTGIIEPDFIPNDSDRSQPIVG----KTKSKGEFSQSSKSSLGDYSS 566
TS V ++V +G +P + + ++S+ + K K + EFSQSSKSS G+YSS
Sbjct: 382 STSPENGVNLSNVHSGSNKPGLVSSSVNKSKTVAKVKNTKLKEQIEFSQSSKSSQGEYSS 441
Query: 567 STSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVY 626
STS SD+SN+SGSS RPHMS DVRW AIRH ++Q+G +GLRHFNLL+KLGCGDIGTVY
Sbjct: 442 STSTSDESNVSGSSRSTRPHMSKDVRWAAIRHAQVQHGVLGLRHFNLLKKLGCGDIGTVY 501
Query: 627 LAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686
LAELIGT+CLFAIKVMDNEFL RRKKMPRAQTEREILR+LDHPFLPT+Y+QFTSDNLSCL
Sbjct: 502 LAELIGTSCLFAIKVMDNEFLERRKKMPRAQTEREILRILDHPFLPTMYAQFTSDNLSCL 561
Query: 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746
VMEYCPGGDLHVLRQKQLG+ FSEPAARFYVAEVLLALEYLHMLGV+YRDLKPENILVRE
Sbjct: 562 VMEYCPGGDLHVLRQKQLGRYFSEPAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRE 621
Query: 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPR 806
DGHIMLTDFDLSLRC+V+P LLK SS++DPA++SG +++CI+PFCIEP+CQVPCFSPR
Sbjct: 622 DGHIMLTDFDLSLRCAVNPMLLK-SSDVDPAKISGLSAQASCIEPFCIEPSCQVPCFSPR 680
Query: 807 FLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDW 866
LP AK RK K D AAQ+RSLPQLVAEPTDARSNSFVGTHEYLAPEIIK EGHGAAVDW
Sbjct: 681 LLPTAAKARKLKVDLAAQVRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKEEGHGAAVDW 740
Query: 867 WTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926
WTFG+FLYELLYGRTPFKGS NEETLANVV+ L+FP+ P +SFQA+DLIRGLL+KEPEN
Sbjct: 741 WTFGVFLYELLYGRTPFKGSNNEETLANVVLLGLRFPEHPNVSFQAKDLIRGLLVKEPEN 800
Query: 927 RLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQK---SKYLECKAT 983
RLGS+KGAAEIKQHPFFEGLNWALIRCA+PPELPDFYD+G+ DM+ + +KYLECK
Sbjct: 801 RLGSEKGAAEIKQHPFFEGLNWALIRCAMPPELPDFYDFGVSDMMNSQCKGAKYLECK-V 859
Query: 984 GEQLEFELF 992
GE +EFELF
Sbjct: 860 GEHVEFELF 868
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449511846|ref|XP_004164070.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/672 (66%), Positives = 522/672 (77%), Gaps = 16/672 (2%)
Query: 333 AHSSPRLAVPTQSGPQTARMQDEIIST-STNVGTHAVKVEIAQKEKHV-PAHPSSSDTVD 390
AHSS TQ + A ++ I T VG+ +K E+ ++E+ + P SS
Sbjct: 200 AHSSQLPVAKTQKHIEVATVESNIKPTLPKKVGSQTLKAELEKEEESITPPSISSCTIGK 259
Query: 391 LPEQEKNVSAPSKLANRTSTVKSGRKGRLHAVPSSSSSNGSRVTKISRNSPRVAKQVLRK 450
+ E+EK + A S++AN+ ++ K+GRKGRL SS +G++VTK+SR++ R K V+R
Sbjct: 260 VLEKEKKILAGSRVANKVTSSKAGRKGRLQTASSSKLGSGNKVTKLSRSASRSVKPVIRN 319
Query: 451 KGAVKKKVKQDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSN 510
KG KKKVKQD +S CSS+ Y+ V +PS +LIC+RCHCAL +A+ +DS +
Sbjct: 320 KGLAKKKVKQDLSSPTCSSSTYNAVNGDNDPSKKKLICERCHCALNSAA----KDSKKGS 375
Query: 511 LTSVSAEVISTSVTT--GIIEPDFIPNDSDRSQPIVGK---TKSKGEFSQSSKSSLGDYS 565
+ SA ++T + I DS S V + + KGEFSQSSKSS G+YS
Sbjct: 376 ASQFSAFSSDVNITNPKSGVNKTGINVDSKASDVKVKRNTRVRDKGEFSQSSKSSQGEYS 435
Query: 566 SSTSNSDDS--NLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIG 623
SST++ N GSS GNRPHMS D RWEAIR+ +LQ+G + LRHFNLL+KLGCGDIG
Sbjct: 436 SSTTSIISDDSNGHGSSTGNRPHMSKDFRWEAIRNAQLQHGVLSLRHFNLLKKLGCGDIG 495
Query: 624 TVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683
TVYLAEL T CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY QFT+DNL
Sbjct: 496 TVYLAELTDTQCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYVQFTTDNL 555
Query: 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743
SCLVMEYCPGGDLHVLRQKQLG+ F EPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL
Sbjct: 556 SCLVMEYCPGGDLHVLRQKQLGRVFPEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 615
Query: 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSS-NMDPARVSGPCTESNCIQPFCIEPTCQVPC 802
VREDGHIMLTDFDLSLRC+V+PTLLKSSS N D + SGPCT+S+C +PFCIEP+CQVPC
Sbjct: 616 VREDGHIMLTDFDLSLRCTVNPTLLKSSSFNADLVKTSGPCTDSSCAEPFCIEPSCQVPC 675
Query: 803 FSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGA 862
FSPRFLPA AKTRK K D QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGA
Sbjct: 676 FSPRFLPAAAKTRKSKPDLTTQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGA 735
Query: 863 AVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922
AVDWWTFG+FLYELLYGRTPFKGS N+ETL+NV+MQ L FPD+P++SFQARDLIRGLL+K
Sbjct: 736 AVDWWTFGVFLYELLYGRTPFKGSNNDETLSNVIMQGLSFPDTPIVSFQARDLIRGLLVK 795
Query: 923 EPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKSK--YLEC 980
EPENR G++KGAAEIKQHPFFEGLNWALIRCA+PPELPD D I M+ Q++K YLE
Sbjct: 796 EPENRFGTEKGAAEIKQHPFFEGLNWALIRCAVPPELPDLCDVDITSMIAQQNKFRYLES 855
Query: 981 KATGEQLEFELF 992
K+TGE LEFELF
Sbjct: 856 KSTGEHLEFELF 867
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451116|ref|XP_004143308.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 886 bits (2290), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/675 (66%), Positives = 522/675 (77%), Gaps = 22/675 (3%)
Query: 333 AHSSPRLAVPTQSGPQTARMQDEIIST-STNVGTHAVKVEIAQKEKHV-PAHPSSSDTVD 390
AHSS TQ + A ++ I T VG+ +K E+ ++E+ + P SS
Sbjct: 200 AHSSQLPVAKTQKHIEVATVESNIKPTLPKKVGSQTLKAELEKEEESITPPSISSCTIGK 259
Query: 391 LPEQEKNVSAPSKLANRTSTVKSGRKGRLHAVPSSSSSNGSRVTKISRNSPRVAKQVLRK 450
+ E+EK + A S++AN+ ++ K+GRKGRL SS +G++VTK+SR++ R K V+R
Sbjct: 260 VLEKEKKILAGSRVANKVTSSKAGRKGRLQTASSSKLGSGNKVTKLSRSASRSVKPVIRN 319
Query: 451 KGAVKKKVKQDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSN 510
KG KKKVKQD +S CSS+ Y+ V +PS +LIC+RCHCAL +A+ +DS +
Sbjct: 320 KGLAKKKVKQDLSSPTCSSSTYNAVNGDNDPSKKKLICERCHCALNSAA----KDSKKGS 375
Query: 511 LTSVSAEVISTSVT--------TGIIEPDFIPNDSDRSQPIVGKTKSKGEFSQSSKSSLG 562
+ SA ++T TGI + SD + + KGEFSQSSKSS G
Sbjct: 376 ASQFSAFSSDVNITNPKSGGNKTGI---NVDSKASDVKVKRNARVRDKGEFSQSSKSSQG 432
Query: 563 DYSSSTSNSDDS--NLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCG 620
+YSSST++ N GSS GNRPHMS D RWEAIR+ +LQ+G + LRHFNLL+KLGCG
Sbjct: 433 EYSSSTTSIISDDSNGHGSSTGNRPHMSKDFRWEAIRNAQLQHGVLSLRHFNLLKKLGCG 492
Query: 621 DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680
DIGTVYLAEL T CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY QFT+
Sbjct: 493 DIGTVYLAELTDTQCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYVQFTT 552
Query: 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPE 740
DNLSCLVMEYCPGGDLHVLRQKQLG+ F EPAARFYVAEVLLALEYLHMLGVIYRDLKPE
Sbjct: 553 DNLSCLVMEYCPGGDLHVLRQKQLGRVFPEPAARFYVAEVLLALEYLHMLGVIYRDLKPE 612
Query: 741 NILVREDGHIMLTDFDLSLRCSVSPTLLKSSS-NMDPARVSGPCTESNCIQPFCIEPTCQ 799
NILVREDGHIMLTDFDLSLRC+V+PTLLKSSS N D + SGPCT+S+C +PFCIEP+CQ
Sbjct: 613 NILVREDGHIMLTDFDLSLRCTVNPTLLKSSSFNADLVKTSGPCTDSSCAEPFCIEPSCQ 672
Query: 800 VPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG 859
VPCFSPRFLPA AKTRK K D QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG
Sbjct: 673 VPCFSPRFLPAAAKTRKSKPDLTTQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG 732
Query: 860 HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGL 919
HGAAVDWWTFG+FLYELLYGRTPFKGS N+ETL+NV+MQ L FPD+P++SFQARDLIRGL
Sbjct: 733 HGAAVDWWTFGVFLYELLYGRTPFKGSNNDETLSNVIMQGLSFPDTPIVSFQARDLIRGL 792
Query: 920 LIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKSK--Y 977
L+KEPENR G++KGAAEIKQHPFFEGLNWALIRCA+PPELPD D I M+ Q++K Y
Sbjct: 793 LVKEPENRFGTEKGAAEIKQHPFFEGLNWALIRCAVPPELPDLCDVDITSMIAQQNKFRY 852
Query: 978 LECKATGEQLEFELF 992
LE K+TGE LEFELF
Sbjct: 853 LESKSTGEHLEFELF 867
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503796|ref|XP_003520689.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2279), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/694 (64%), Positives = 532/694 (76%), Gaps = 25/694 (3%)
Query: 318 LTVPTTDGSTGTNQRA------HSSPRLAVPT-QSGPQTARMQDEIISTSTNVGTHAVKV 370
L++ T S T+Q A HSS +AV T + ++ +Q ++ +S+ VG + +V
Sbjct: 184 LSLEKTSQSYQTSQIASSSRNIHSSWEIAVATTKYDAGSSLIQSDLACSSSKVGIQSQRV 243
Query: 371 EIAQKEKHVPAH-PSSSDTV-DLPEQEKNVSAPSKLANRTSTVKSGRKGRLHAVPSSSSS 428
+ E+ A PS +T E KN S+P KL N+ +G+KGRL V SS+S
Sbjct: 244 VPVETEEQASASSPSLYNTFGSKSEVPKNASSPKKLGNKAYMSNTGKKGRLQTVSSSTSV 303
Query: 429 NGSRVTKISRNSPRVAKQVLRKKGAVKKKVKQDSASS---PCSSNFYSEVRSQLEPSSTQ 485
N +RV K ++PR K V++ K KKK K+DS S+ P + V P + +
Sbjct: 304 NDNRVNKPPCHAPRTVKSVIKNKNLSKKKQKEDSGSALHGPTPNEVNKPV-----PGTPR 358
Query: 486 LICQRCHCALKNASNLPYQDSTVSNLTSVSAEVISTSVTTGIIEPDFIPNDSDRSQPIVG 545
LIC+RC CAL+N QD + S V ++V +G +P + + ++S+
Sbjct: 359 LICERCRCALENTCEEKNQDIVALDSISPGDGVNLSNVHSGSNKPGLVSSSVNKSKTGAK 418
Query: 546 ----KTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRL 601
K K + +FSQSSKSS G+YSSSTS SD+SN+SGSS RPHMS DVRW AIRH ++
Sbjct: 419 VKNTKLKEQIDFSQSSKSSQGEYSSSTSTSDESNVSGSSRSTRPHMSKDVRWAAIRHAQM 478
Query: 602 QYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE 661
Q+G +GLRHFNLL+KLGCGDIGTVYLAELIGT+CLFAIKVMDNEFL RR+KMPRAQTERE
Sbjct: 479 QHGVLGLRHFNLLKKLGCGDIGTVYLAELIGTSCLFAIKVMDNEFLERREKMPRAQTERE 538
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
ILR+LDHPFLPT+Y+QFTSDNLSCLVMEYCPGGDLHVLRQKQLG+ FSEPAARFYVAEVL
Sbjct: 539 ILRILDHPFLPTMYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRYFSEPAARFYVAEVL 598
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSG 781
LALEYLHMLGV+YRDLKPENILVREDGHIMLTDFDLSLRC+V+PTLLKSSS++DPA++SG
Sbjct: 599 LALEYLHMLGVVYRDLKPENILVREDGHIMLTDFDLSLRCAVNPTLLKSSSDVDPAKISG 658
Query: 782 PCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841
+++CI+PFCIEP+CQVPCFSPR LPA AK RK K D AAQ+RSLPQLVAEPTDARSN
Sbjct: 659 LSAQASCIEPFCIEPSCQVPCFSPRLLPAAAKARKLKVDLAAQVRSLPQLVAEPTDARSN 718
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
SFVGTHEYLAPEIIK EGHGAAVDWWTFG+FLYELLYGRTPFKGS NEETLANVV+Q L+
Sbjct: 719 SFVGTHEYLAPEIIKEEGHGAAVDWWTFGVFLYELLYGRTPFKGSNNEETLANVVLQGLR 778
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961
FP P +SFQA+DLIRGLL+KEPENRLGS+KGAAEIKQHPFFEGLNWALIRCA+PPELPD
Sbjct: 779 FPKHPNVSFQAKDLIRGLLVKEPENRLGSEKGAAEIKQHPFFEGLNWALIRCAVPPELPD 838
Query: 962 FYDYGIQDMV-PQ--KSKYLECKATGEQLEFELF 992
FYD+G+ DMV PQ +KYLECK GE +EFELF
Sbjct: 839 FYDFGVSDMVNPQGKGAKYLECK-VGEHVEFELF 871
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440934|ref|XP_002277025.1| PREDICTED: serine/threonine-protein kinase KIPK-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2262), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 458/669 (68%), Positives = 528/669 (78%), Gaps = 25/669 (3%)
Query: 337 PRLAV-PTQSGPQTARMQDEIISTSTNVGTHAVKVEIAQKEKHVPAHPSSSDTVD--LPE 393
PR AV TQ G Q EI+ ST + K QKEKH S D + E
Sbjct: 208 PRFAVGATQLGTTARSPQSEIVPVSTEISNQTSKT--VQKEKHTSVTALSGANTDDNMLE 265
Query: 394 QEKNVSAPSKLANRTSTVKSGRKGRLHAVPSSSSSNGSRVTKISRNSPRVAKQVLRKKGA 453
A +K ANR S +K GRKGRL V SSS N S+ +K ++N+ RV K +LR K
Sbjct: 266 LGTTGHASTKSANRASALKPGRKGRLQNV-PSSSVNSSKASKSTKNTQRVVKPILRNKNF 324
Query: 454 VKKKVKQDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSNLTS 513
VKKKVKQDS S+ +SN SEV +++PS++QL+CQRCHCALK+A QDS SNL S
Sbjct: 325 VKKKVKQDSNSATSTSNTCSEVNDEMDPSTSQLVCQRCHCALKDARKELSQDSPTSNLKS 384
Query: 514 VSAEVISTSVTTGIIEPDFIPNDSDRSQPIV------GKTKSKGEFSQSSKSSLGDYSSS 567
+S E +++ + +P N +R + I K++ KGE SQSSKSS G+YSSS
Sbjct: 385 LSTEASFSNMNSVANKPGISSNSYNRHKAIFVKANKNAKSREKGELSQSSKSSRGEYSSS 444
Query: 568 TSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYL 627
TS S++S LSGSSCGNRPHMS D+RWEAIR V++Q G +GLRHFNLL+KLG GDIGTVYL
Sbjct: 445 TSISEESILSGSSCGNRPHMSKDLRWEAIRQVQMQQGVLGLRHFNLLKKLGGGDIGTVYL 504
Query: 628 AELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687
AELIGT CLFAIKVMDN+FLARRKKMPRAQTEREILRMLDHPFLPTLY+QFTSDNLSCLV
Sbjct: 505 AELIGTCCLFAIKVMDNDFLARRKKMPRAQTEREILRMLDHPFLPTLYAQFTSDNLSCLV 564
Query: 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747
MEYCPGGDLHVLRQKQ G+ F E AARFYVAEVLLALEYLHMLGV+YRDLKPENILVRED
Sbjct: 565 MEYCPGGDLHVLRQKQPGRNFPEQAARFYVAEVLLALEYLHMLGVVYRDLKPENILVRED 624
Query: 748 GHIMLTDFDLSLRCSVSPTLLKSSSN-MDPAR-VSGPCTESNCIQPFCIEPTCQVPCFSP 805
GHIMLTDFDLSLRC+V+PTLLKSSS+ M+P R +SGPC ES+CI P CIEP+C+VPCFSP
Sbjct: 625 GHIMLTDFDLSLRCNVNPTLLKSSSSTMEPTRMMSGPCKESSCIDPLCIEPSCEVPCFSP 684
Query: 806 RFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVD 865
RFLPA A+TRK K++ AAQ+RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHG+AVD
Sbjct: 685 RFLPAAARTRKLKSELAAQVRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGSAVD 744
Query: 866 WWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925
WWTFG+FLYELLYG+TPFKGSGN+ETLANVV+QSLKFPD+P+ISFQARDLIRGLL+KEPE
Sbjct: 745 WWTFGVFLYELLYGKTPFKGSGNDETLANVVLQSLKFPDNPIISFQARDLIRGLLMKEPE 804
Query: 926 NRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQK--SKYLECKAT 983
NRLGS++GAAEIKQHPFFEGLNWALIRC IPPELP+F ++G+ + Q+ SKY
Sbjct: 805 NRLGSERGAAEIKQHPFFEGLNWALIRCTIPPELPEFGEFGLMTVASQQKESKY------ 858
Query: 984 GEQLEFELF 992
LEFELF
Sbjct: 859 ---LEFELF 864
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30693719|ref|NP_566973.2| KCBP-interacting protein kinase [Arabidopsis thaliana] gi|30693721|ref|NP_850687.1| KCBP-interacting protein kinase [Arabidopsis thaliana] gi|75263849|sp|Q9LFA2.1|KIPK_ARATH RecName: Full=Serine/threonine-protein kinase KIPK; AltName: Full=KCBP-interacting protein kinase gi|7529713|emb|CAB86893.1| protein kinase-like [Arabidopsis thaliana] gi|21703143|gb|AAM74511.1| AT3g52890/F8J2_60 [Arabidopsis thaliana] gi|25054838|gb|AAN71909.1| putative protein kinase [Arabidopsis thaliana] gi|25090422|gb|AAN72297.1| At3g52890/F8J2_60 [Arabidopsis thaliana] gi|332645484|gb|AEE79005.1| KCBP-interacting protein kinase [Arabidopsis thaliana] gi|332645485|gb|AEE79006.1| KCBP-interacting protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 824 bits (2129), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/676 (63%), Positives = 504/676 (74%), Gaps = 58/676 (8%)
Query: 365 THA-VKVEIAQKEKHVPAHPS-SSDTVDLPEQEKNVSAPSKLANRTSTVKSGRKGRLHAV 422
THA V+ ++ + +KHV + PS SS V+ E +KN+S +S V S +KG+L
Sbjct: 269 THAFVEDDVIEIDKHVTSLPSHSSKKVNATELDKNIS--------SSAVDSEQKGKLDDA 320
Query: 423 PSSSSSNGSRVTKISRNSPRVAKQVLRKKGAVKKKVKQDSASSPCSSNFYSEVRSQLEPS 482
P+S + NG V K++R PR + + K K+ SA+ P + E+ L+ S
Sbjct: 321 PNSGTENGKTVRKVTRMIPRPKQPKKKILLKKKLKIGVVSATYPTKDD--EEIVPSLDSS 378
Query: 483 STQLICQRCHCALKNAS---NLPYQDST------VSNLTSVS---AEVISTSVTTG---- 526
+ QL+CQRCHC+LK+ S N P S+ +L+SVS A S ++G
Sbjct: 379 ANQLLCQRCHCSLKSTSIDDNPPSYTSSHNPKICTDSLSSVSNKEAHQGSDENSSGSCNV 438
Query: 527 ---------IIEPDFIPNDSDRSQPIVGK------TKSKGEFSQSSKSSLGDYSSSTSNS 571
I++ D +++ +V K + K EFS SSK SLGDYS STS S
Sbjct: 439 SQSSEADIVIMKQDVSSSNNSGIGAMVEKETENPTSSEKFEFSLSSKDSLGDYSRSTSIS 498
Query: 572 DDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELI 631
++SNLS SCGN+PHMS DVRWEAI+H+++QYGS+GLRHFNLL+KLGCGDIGTVYLAELI
Sbjct: 499 EESNLSRFSCGNKPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELI 558
Query: 632 GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYC 691
GTNCLFAIKVMDNEFLARRKK PRAQ EREIL+MLDHPFLPTLY+QFTSDNLSCLVMEYC
Sbjct: 559 GTNCLFAIKVMDNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYC 618
Query: 692 PGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751
PGGDLHVLRQKQLG+CF EPAARFYVAE+LLALEYLHMLG+IYRDLKPENILVREDGHIM
Sbjct: 619 PGGDLHVLRQKQLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIM 678
Query: 752 LTDFDLSLRCSVSPTLLKSSS--NMDPARVSGPCTESNCIQPFCI-EPTCQVPCFSPRFL 808
LTDFDLSLRC+V+PTL++S+S DPAR+SGP SNCIQPFCI EP+CQV CFSPR
Sbjct: 679 LTDFDLSLRCAVNPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLS 738
Query: 809 PATAKTRKPK-ADPAAQI-----RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGA 862
+ RKPK D ++ RSLPQLVAEPT+ARSNSFVGTHEYLAPEIIKGEGHGA
Sbjct: 739 SNQQQGRKPKRGDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGA 798
Query: 863 AVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922
AVDWWTFG+ LYELLYG+TPFKG N+ETLANVV+Q+LKFPDSPL+SFQA+DLIRGLL+K
Sbjct: 799 AVDWWTFGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVK 858
Query: 923 EPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKS------K 976
EPENRLGS+KG+ EIK+HPFFEGLNWALIRCAIPPELPDFY+YG S +
Sbjct: 859 EPENRLGSEKGSVEIKRHPFFEGLNWALIRCAIPPELPDFYEYGGGPEAAADSPGGSNNR 918
Query: 977 YLECKATGEQLEFELF 992
YLECKA G+ LEFELF
Sbjct: 919 YLECKAIGDHLEFELF 934
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 992 | ||||||
| TAIR|locus:2049485 | 949 | AT2G36350 [Arabidopsis thalian | 0.412 | 0.430 | 0.803 | 1.4e-225 | |
| TAIR|locus:2085191 | 934 | KIPK "KCBP-interacting protein | 0.412 | 0.437 | 0.792 | 7.6e-220 | |
| TAIR|locus:2144598 | 926 | AT5G03640 [Arabidopsis thalian | 0.410 | 0.439 | 0.774 | 2.1e-204 | |
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.380 | 0.643 | 0.706 | 8.3e-151 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.407 | 0.577 | 0.656 | 1.9e-145 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.409 | 0.802 | 0.644 | 2.3e-144 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.411 | 0.819 | 0.626 | 4.4e-141 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.372 | 0.483 | 0.663 | 1.7e-137 | |
| TAIR|locus:2091443 | 578 | ATPK7 [Arabidopsis thaliana (t | 0.379 | 0.650 | 0.654 | 5.2e-134 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.401 | 0.797 | 0.614 | 3.9e-131 |
| TAIR|locus:2049485 AT2G36350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1795 (636.9 bits), Expect = 1.4e-225, Sum P(3) = 1.4e-225
Identities = 336/418 (80%), Positives = 373/418 (89%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PHMS DVRWEA++HV+LQYGS+GLRHFNLL+KLGCGDIGTVYLAEL+GTNCLFAIKVMD
Sbjct: 532 KPHMSMDVRWEAVKHVKLQYGSLGLRHFNLLKKLGCGDIGTVYLAELVGTNCLFAIKVMD 591
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
NEFLARRKK PRAQ ER IL+MLDHPFLPTLY+QFTSDNLSCLVMEYCPGGDLHVLRQKQ
Sbjct: 592 NEFLARRKKTPRAQAERAILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 651
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
L +CFSEPA RFYVAE+LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC+V
Sbjct: 652 LSRCFSEPATRFYVAEILLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCAV 711
Query: 764 SPTLLKSSS--NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATA---KTRKPK 818
+PTLL+S+S DPAR+SGP + SNCIQP CIEP+C+VPCFSPR L A K RKPK
Sbjct: 712 NPTLLRSTSPPEKDPARMSGPYSTSNCIQPLCIEPSCRVPCFSPRLLSTQARNQKPRKPK 771
Query: 819 ADP--AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYEL 876
Q RSLPQLVAEPT+ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFG+ LYEL
Sbjct: 772 RPDLLTQQFRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYEL 831
Query: 877 LYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAE 936
LYG+TPFKG NEETL+NVV Q+LKFPDSPL+SFQA++LIR LL+K+PE+RLGS+KGAAE
Sbjct: 832 LYGKTPFKGYDNEETLSNVVYQNLKFPDSPLVSFQAKELIRRLLVKDPESRLGSEKGAAE 891
Query: 937 IKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMV-PQ-KSKYLECKATGEQLEFELF 992
IK+HPFFEGLNWALIRCAIPPELPD YD G + P+ ++YLECKA G+ LEFELF
Sbjct: 892 IKRHPFFEGLNWALIRCAIPPELPDIYDNGATEATSPEGNNRYLECKAIGDHLEFELF 949
|
|
| TAIR|locus:2085191 KIPK "KCBP-interacting protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1788 (634.5 bits), Expect = 7.6e-220, Sum P(2) = 7.6e-220
Identities = 336/424 (79%), Positives = 374/424 (88%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PHMS DVRWEAI+H+++QYGS+GLRHFNLL+KLGCGDIGTVYLAELIGTNCLFAIKVMD
Sbjct: 511 KPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMD 570
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
NEFLARRKK PRAQ EREIL+MLDHPFLPTLY+QFTSDNLSCLVMEYCPGGDLHVLRQKQ
Sbjct: 571 NEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQ 630
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
LG+CF EPAARFYVAE+LLALEYLHMLG+IYRDLKPENILVREDGHIMLTDFDLSLRC+V
Sbjct: 631 LGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAV 690
Query: 764 SPTLLKSSS--NMDPARVSGPCTESNCIQPFCI-EPTCQVPCFSPRFLPATAKTRKPK-A 819
+PTL++S+S DPAR+SGP SNCIQPFCI EP+CQV CFSPR + RKPK
Sbjct: 691 NPTLVRSNSPPGKDPARISGPYNTSNCIQPFCITEPSCQVSCFSPRLSSNQQQGRKPKRG 750
Query: 820 DPAAQI-----RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLY 874
D ++ RSLPQLVAEPT+ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFG+ LY
Sbjct: 751 DHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLY 810
Query: 875 ELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934
ELLYG+TPFKG N+ETLANVV+Q+LKFPDSPL+SFQA+DLIRGLL+KEPENRLGS+KG+
Sbjct: 811 ELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGS 870
Query: 935 AEIKQHPFFEGLNWALIRCAIPPELPDFYDYG------IQDMVPQKSKYLECKATGEQLE 988
EIK+HPFFEGLNWALIRCAIPPELPDFY+YG ++YLECKA G+ LE
Sbjct: 871 VEIKRHPFFEGLNWALIRCAIPPELPDFYEYGGGPEAAADSPGGSNNRYLECKAIGDHLE 930
Query: 989 FELF 992
FELF
Sbjct: 931 FELF 934
|
|
| TAIR|locus:2144598 AT5G03640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1659 (589.1 bits), Expect = 2.1e-204, Sum P(2) = 2.1e-204
Identities = 323/417 (77%), Positives = 357/417 (85%)
Query: 584 RPHMSADVRWEAIRHVRLQYG--SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV 641
RPHMS DVRWEAI+H+R Q+G S+GLRHFNLL+KLGCGDIGTVYLAEL GTNCLFAIKV
Sbjct: 512 RPHMSKDVRWEAIQHIRAQHGLGSLGLRHFNLLKKLGCGDIGTVYLAELTGTNCLFAIKV 571
Query: 642 MDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQ 701
MDNEFL RR KM RAQTE++IL+MLDHPFLPTLY+ FTSDNLSCLVME CPGGDLHVLRQ
Sbjct: 572 MDNEFLERRNKMSRAQTEKDILKMLDHPFLPTLYAHFTSDNLSCLVMECCPGGDLHVLRQ 631
Query: 702 KQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761
KQ G+ F EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR+DGHIM+TDFDLSLRC
Sbjct: 632 KQPGRWFPEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRDDGHIMVTDFDLSLRC 691
Query: 762 SVSPTLLKSSSNM--DPARVS-GPCTESNCIQPFCIEPTCQV---PCFSPRFLPATAKTR 815
+VSPTLL SSS + D R+S G T SNCI+P C P P + K
Sbjct: 692 TVSPTLLNSSSPLHADAMRLSSGSRTGSNCIEPSCFRPKLSRGSGPKKKGKQHRMMMKKL 751
Query: 816 KPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYE 875
K K+D A+ +SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYE
Sbjct: 752 K-KSDLIARFKSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYE 810
Query: 876 LLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAA 935
LLYG+TPFKG+ NEET+ANVV+QSLKFPD+P +SFQA+DLIRGLL+KEPENRLG++KGAA
Sbjct: 811 LLYGKTPFKGATNEETIANVVLQSLKFPDNPNVSFQAKDLIRGLLVKEPENRLGTEKGAA 870
Query: 936 EIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKSKYLECKATGEQLEFELF 992
EIK+H FFEGLNWALIRCAIPPELPDFYDYG+ + KS YL+CKA GE LEFELF
Sbjct: 871 EIKRHAFFEGLNWALIRCAIPPELPDFYDYGVPNQ-EGKSNYLDCKAVGEHLEFELF 926
|
|
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1454 (516.9 bits), Expect = 8.3e-151, Sum P(2) = 8.3e-151
Identities = 269/381 (70%), Positives = 320/381 (83%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PH + D+RWEAI+ VR++ G +GL HF LL++LGCGDIG+VYL+EL GT C FA+KVMD
Sbjct: 164 KPHKANDLRWEAIQAVRVRDGLLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMD 223
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
LA RKK+ RAQTEREIL+ LDHPFLPTLY+ F ++ SCLVME+CPGGDLH LRQ+Q
Sbjct: 224 KTSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQRQ 283
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
GK FSE A +FY+AE LLALEYLHMLG++YRDLKPEN+LVREDGHIML+DFDLSLRC V
Sbjct: 284 PGKHFSEQAVKFYIAESLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCLV 343
Query: 764 SPTLLKSSS-NMDPARVSGPCTESNCIQPFCIEPTCQVP--CFSPR-FLPATAKTRKPKA 819
SPTL+KS++ DP R + C + CI+P CI+P+C VP CFSPR F + K RKPK
Sbjct: 344 SPTLVKSAAIESDPLRKNVYCVQPACIEPSCIQPSCTVPTTCFSPRLFSSKSKKDRKPKN 403
Query: 820 DPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYG 879
D A Q+R LP+LVAEPTDARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFLYELL+G
Sbjct: 404 DTANQVRPLPELVAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 463
Query: 880 RTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939
RTPFKGSGN +TL NVV Q L+FP++P++SF ARDLIRGLL+KEP+ RLG ++GA E+KQ
Sbjct: 464 RTPFKGSGNRQTLFNVVGQPLRFPETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVKQ 523
Query: 940 HPFFEGLNWALIRCAIPPELP 960
HPFFEG+NWALIRCA PPE+P
Sbjct: 524 HPFFEGVNWALIRCATPPEIP 544
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1421 (505.3 bits), Expect = 1.9e-145, P = 1.9e-145
Identities = 279/425 (65%), Positives = 332/425 (78%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PH D RW+AI +R + G +G+ HF LL++LGCGDIG+VYL+EL GT C FA+KVMD
Sbjct: 281 KPHKGNDPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGTRCYFAMKVMD 340
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
LA RKK+ RAQTEREIL++LDHPFLPTLY+ F +D SCLVMEYCPGGDLH LRQ+Q
Sbjct: 341 KASLASRKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQ 400
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
GK FSE AARFY AEVLLALEYLHMLGV+YRDLKPEN+LVR+DGHIML+DFDLSLRC+V
Sbjct: 401 PGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAV 460
Query: 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPT--CQVP-CFSPRFLPATAK--TRKPK 818
SPTL++ SS+ DP++ + C+QP CIEPT C P CF PR P +K T KP+
Sbjct: 461 SPTLIRISSD-DPSKRGA----AFCVQPACIEPTTVCMQPACFLPRLFPQKSKKKTPKPR 515
Query: 819 ADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY 878
AD Q S+P+LVAEPT ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFL+ELLY
Sbjct: 516 ADSGFQANSMPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLHELLY 575
Query: 879 GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938
G+TPFKGSGN TL NVV Q LKFPDSP S+ +RDLIRGLL+KEP+NRLG ++GA EIK
Sbjct: 576 GKTPFKGSGNRATLFNVVGQQLKFPDSPATSYASRDLIRGLLVKEPQNRLGVKRGATEIK 635
Query: 939 QHPFFEGLNWALIRCAIPPELP-----DF-YDYG-IQDM-VPQKSKYL---ECKATGEQL 987
QHPFFEG+NWALIRC+ PPE+P D+ YG + + V SK + + K+ G+ L
Sbjct: 636 QHPFFEGVNWALIRCSTPPEVPRPVEPDYPAKYGQVNPVGVGNTSKRVVGADAKSGGKYL 695
Query: 988 EFELF 992
+FE F
Sbjct: 696 DFEFF 700
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1395 (496.1 bits), Expect = 2.3e-144, Sum P(2) = 2.3e-144
Identities = 267/414 (64%), Positives = 324/414 (78%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PH + DVRWEAI+ VR ++G +GL HF LL++LGCGDIGTV+LAEL GT C FA+KVMD
Sbjct: 96 KPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVMD 155
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
LA RKK+ RAQTEREIL+ LDHPFLPTLYS F ++ SCLVME+CPGGDLH LRQ+Q
Sbjct: 156 KGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 215
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
GK FSE AA+FYVAEVLLA+EYLHMLG+IYRDLKPEN+LVR+DGH+ML+DFDLSLRC+V
Sbjct: 216 PGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 275
Query: 764 SPTLLKSSS-NMDPARVSGPCTESNCIQ-PFCIE-PTCQVPCFSPRFLPATAKT-RKPKA 819
SPT+++S+ + + SG C + CIQ P CI PT CFSPR+ + +K +K K
Sbjct: 276 SPTVVRSTVLASEGQKNSGYCAQPACIQQPSCISAPTT---CFSPRYFSSKSKKDKKMKN 332
Query: 820 DPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYG 879
+ Q+ LP+LVAEPT ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFLYELL+G
Sbjct: 333 ETGNQVSPLPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 392
Query: 880 RTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939
+TPFKGSGN TL NVV Q L+FP+SP++SF ARDLIR LL+KEP++RL ++GA E+KQ
Sbjct: 393 KTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEMKQ 452
Query: 940 HPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKSKYLECKAT-GEQLEFELF 992
HPFFEG+NWAL+RCA PPE+P DY P + K+ LEF+ F
Sbjct: 453 HPFFEGVNWALVRCASPPEIPKPVDYESAPATPAAATSTSVKSDQSNYLEFDFF 506
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1357 (482.7 bits), Expect = 4.4e-141, Sum P(2) = 4.4e-141
Identities = 262/418 (62%), Positives = 322/418 (77%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PH + DVRWEAI+ VR ++G +GL HF LL++LGCGDIGTV+LAEL GT C FA+KVMD
Sbjct: 82 KPHKANDVRWEAIQAVRTKHGGLGLNHFRLLKRLGCGDIGTVHLAELNGTRCYFAMKVMD 141
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
LA RKK+ RAQTEREIL+ LDHPFLPTLYS F ++ SCLVME+CPGGDLH LRQ+Q
Sbjct: 142 KTALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQRQ 201
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
GK F+E AA+FYVAEVLLA+EYLHMLG+IYRDLKPEN+LVR+DGH+ML+DFDLSLRC+V
Sbjct: 202 PGKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCTV 261
Query: 764 SPTLLKSSS--NMDPARVSGPCTESN-CIQ-PFCIEPTCQVPCFSPRFLPATAKT-RKPK 818
S ++++S++ + ++ S C++ CIQ P CI CF PRF + +K +KPK
Sbjct: 262 SLSIVRSANVGSEGLSKNSVSCSQQPACIQQPSCIS-MAPTSCFGPRFFSSKSKKDKKPK 320
Query: 819 ADPAA-QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL 877
+ Q+ LP+LVAEPT ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFLYELL
Sbjct: 321 TENGNHQVTPLPELVAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL 380
Query: 878 YGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEI 937
+G+TPFKGSGN TL NVV Q L+FP+SP++SF ARDLIR LL+KEP++RL ++GA EI
Sbjct: 381 FGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATEI 440
Query: 938 KQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQKSKYLECKATGEQ---LEFELF 992
KQHPFFEG+NWAL+RCA PPE+P D + P +Q LEF+ F
Sbjct: 441 KQHPFFEGVNWALVRCASPPEIPKPVDLEALNPTPTVPAAASSSVRSDQSNYLEFDFF 498
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1311 (466.6 bits), Expect = 1.7e-137, Sum P(2) = 1.7e-137
Identities = 256/386 (66%), Positives = 307/386 (79%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+PH D W AI +R + G +G+ HF LL++LGCGDIG+VYLAEL GT C FA+KVMD
Sbjct: 336 KPHKGNDPWWNAILAIRTRDGILGMSHFKLLKRLGCGDIGSVYLAELSGTRCHFAVKVMD 395
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
L RKK+ RAQTER+IL++LDHPFLPTLY+ F +D SCLVMEYCPGGDLH LRQ+Q
Sbjct: 396 KASLEDRKKLNRAQTERDILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQ 455
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
GK FSE AARFY AEVLLALEYLHMLGV+YRDLKPEN+LVR+DGHIML+DFDLSLRC+V
Sbjct: 456 PGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAV 515
Query: 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPT--C--QVPCFSPRFL-P---ATAKTR 815
SPTL+K+ + DP+R G + C+QP C+EPT C Q CF PR + P K+R
Sbjct: 516 SPTLIKTFDS-DPSR-RG----AFCVQPACMEPTSACIIQPSCFLPRSIFPNKNKKNKSR 569
Query: 816 KPKADP-AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLY 874
K +AD + SLP+LVAEP + RS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIF++
Sbjct: 570 KTQADFFKSHSGSLPELVAEP-NTRSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFVH 628
Query: 875 ELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934
ELLYG+TPFKGSGN TL NVV + LKFP+SP S+ RDLI+ LL+K+P+NRLG+++GA
Sbjct: 629 ELLYGKTPFKGSGNRATLFNVVGEQLKFPESPATSYAGRDLIQALLVKDPKNRLGTKRGA 688
Query: 935 AEIKQHPFFEGLNWALIRCAIPPELP 960
EIKQHPFFEG+NWALIRC+ PPE+P
Sbjct: 689 TEIKQHPFFEGVNWALIRCSTPPEVP 714
|
|
| TAIR|locus:2091443 ATPK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1291 (459.5 bits), Expect = 5.2e-134, Sum P(2) = 5.2e-134
Identities = 250/382 (65%), Positives = 301/382 (78%)
Query: 584 RPHM-SADVRWEAIRHVRLQYGS-IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV 641
+PH + D RW AI+ VR + GS + + F L++KLG GDIG VYLAELIGT FA+KV
Sbjct: 153 KPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSFAVKV 212
Query: 642 MDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQ 701
M+ +A RKK+ RAQTE+EIL+ LDHPFLPTLYS F ++ SCLVME+CPGGDLH LRQ
Sbjct: 213 MEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQ 272
Query: 702 KQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761
KQ GK F E AARFYVAEVLLA+EYLHMLG+IYRDLKPEN+LVREDGHIML+DFDLSLRC
Sbjct: 273 KQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRC 332
Query: 762 SVSPTLLKSSSNMDPARVSGPCTESNCI-QPFCI-EPTCQVP-CFSPRFLPATAKTRKPK 818
+VSPTL++ ++ ++ S C + C+ Q CI +P C P CF+PRFL + K RK
Sbjct: 333 AVSPTLVRFAAITLESKSSSYCIQPTCVDQSSCIVQPDCIQPVCFTPRFL-SKGKHRKKS 391
Query: 819 ADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY 878
D + QIR LP+L+AEPT ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFGIFLYELL+
Sbjct: 392 NDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 451
Query: 879 GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938
G TPF+G N TL NVV Q L+FP+ P +SF ARDLIRGLL+KEP++RL ++GA EIK
Sbjct: 452 GITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIK 511
Query: 939 QHPFFEGLNWALIRCAIPPELP 960
QHPFF+ +NWALIRC PP++P
Sbjct: 512 QHPFFQSVNWALIRCTSPPQIP 533
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
Identities = 261/425 (61%), Positives = 315/425 (74%)
Query: 584 RPHMSADVRWEAIRHVRLQYGS-IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM 642
+PH D+RW+AI++V+ +GL HF LL+KLGCGDIG+VYLAEL C FA+KVM
Sbjct: 86 KPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVYLAELREMGCFFAMKVM 145
Query: 643 DNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQK 702
D L RKK+ RAQTEREIL +LDHPFLPTLYS F ++ SCL+ME+C GGDLH+LRQK
Sbjct: 146 DKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCLLMEFCSGGDLHILRQK 205
Query: 703 QLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762
Q GK FSE AARFY +EVLLALEYLHM+GV+YRDLKPEN++VREDGHIML+DFDLSL+
Sbjct: 206 QPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVREDGHIMLSDFDLSLQSF 265
Query: 763 VSPTLLKSSSNMDPARVSGPC-TESNCIQPFCIEPTCQVP-------CFSPRFLPATAKT 814
VSPTL++S+S P+ C S CIQP CI+P+C++P CF PRFL K
Sbjct: 266 VSPTLIQSTSQ--PS-----CHIASYCIQPPCIDPSCKLPVACIQPSCFKPRFL--NNKP 316
Query: 815 RKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLY 874
RK K + A SLP L+AEPT ARS SFVGTHEYLAPEII+G+GHG++VDWWTFGIFLY
Sbjct: 317 RKAKTEKAGS-DSLPMLIAEPTAARSMSFVGTHEYLAPEIIRGDGHGSSVDWWTFGIFLY 375
Query: 875 ELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934
ELL G+TPFKG+GN ETL NVV Q LKFP+ ISF A+DLIRGLL K+P+ RLG +KGA
Sbjct: 376 ELLTGKTPFKGNGNRETLFNVVGQPLKFPEGS-ISFAAKDLIRGLLTKDPKKRLGFKKGA 434
Query: 935 AEIKQHPFFEGLNWALIRCAIPPELPDFYDYGI-----QDMVPQKSKYLECK--ATGEQL 987
EIKQHPFF +NWALIR PPE+P D I + V Q+ K+ + ++G L
Sbjct: 435 TEIKQHPFFNNVNWALIRSTTPPEIPKPIDLSILNETLKSSVQQQGKHSKQSDSSSGPYL 494
Query: 988 EFELF 992
+FE F
Sbjct: 495 DFEFF 499
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q9LFA2 | KIPK_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6301 | 0.6229 | 0.6616 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00021642001 | SubName- Full=Chromosome chr8 scaffold_23, whole genome shotgun sequence; (857 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 992 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-168 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-83 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-76 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-61 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-57 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-55 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-54 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-45 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-45 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-44 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-44 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-43 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-43 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-43 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-39 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-37 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-36 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-35 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-35 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-34 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-34 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-34 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-33 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-33 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-33 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-32 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-32 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-31 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-31 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-31 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-31 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-31 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-30 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-30 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-30 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-30 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-30 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-30 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-30 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-29 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-28 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-28 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-28 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-28 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-28 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-28 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-27 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-27 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-27 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-27 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-27 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-27 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-27 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-27 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-27 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-27 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-26 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-26 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-26 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-26 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-26 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-25 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-25 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-25 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-25 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-25 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-25 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-24 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-24 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-24 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-24 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-24 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-24 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-23 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-22 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-22 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-22 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-22 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-22 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-21 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-21 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-21 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-21 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-19 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 9e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-13 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-13 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-12 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-09 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-09 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-07 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-06 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-06 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-06 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-05 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-05 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-05 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 1e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 2e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-04 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-04 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-04 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 7e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 0.001 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 0.001 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.001 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 0.002 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.002 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.002 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.002 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 0.002 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.003 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 0.003 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.003 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 0.004 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.004 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 494 bits (1275), Expect = e-168
Identities = 179/353 (50%), Positives = 226/353 (64%), Gaps = 43/353 (12%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+HF ++ LG GD+G V+L L GT LFA+KV+D + + +R K+ R TE+EIL LDH
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
PFLPTLY+ F ++ CLVM+YCPGG+L L Q+Q GKC SE ARFY AEVLLALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNC 788
+LG++YRDLKPENIL+ E GHIML+DFDLS + V P + +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKAL---------------- 164
Query: 789 IQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848
RK + + +E RSNSFVGT E
Sbjct: 165 --------------------------RKGSRRS-SVNSIPSETFSEEPSFRSNSFVGTEE 197
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLI 908
Y+APE+I G+GHG+AVDWWT GI LYE+LYG TPFKGS +ET +N++ + + FP SP +
Sbjct: 198 YIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPV 257
Query: 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961
S ARDLIR LL+K+P RLGS++GAAEIKQHPFF G+NWALIR PP +P
Sbjct: 258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPR 310
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 268 bits (688), Expect = 9e-83
Identities = 110/337 (32%), Positives = 159/337 (47%), Gaps = 63/337 (18%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HP 669
F + +G G TV LA+ TN +AIK++D L + KK+ + E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 670 FLPTLYSQFTSDNLSCL--VMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+ LY F + L V+EY P G+L +R+ E RFY AE+LLALEY
Sbjct: 63 GIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEY 117
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTES 786
LH G+I+RDLKPENIL+ +D HI +TDF ++ + ES
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFG--------------TAKVLD---PNSSPES 160
Query: 787 NCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846
N I+ + R SFVGT
Sbjct: 161 NKGDATNIDSQIEKN-----------------------------------RRRFASFVGT 185
Query: 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSP 906
EY++PE++ + G + D W G +Y++L G+ PF+GS T ++ FP P
Sbjct: 186 AEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP--P 243
Query: 907 LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
A+DLI LL+ +P++RLG +G E+K HPFF
Sbjct: 244 NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 5e-76
Identities = 118/354 (33%), Positives = 184/354 (51%), Gaps = 51/354 (14%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F +++ +G G G V+L T ++A+KV+ + +R ++ + ER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ LY F + LVMEY PGGDL L ++ F E ARFY+AE++LAL+ +H L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQ 790
G I+RD+KP+NIL+ DGHI L DF L + + + + +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKK-------MNKAKD----------------R 157
Query: 791 PFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850
+ + + + + ++ R+NS VGT +Y+
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRV--------------------RANSTVGTPDYI 197
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSLKFPDSPLI 908
APE+++G +G DWW+ G+ LYE+LYG PF +ET ++ +SL+FP P +
Sbjct: 198 APEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPV 257
Query: 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF 962
S +A DLI LL +PE+RLGS EIK HPFF+G++W +R PP +P+
Sbjct: 258 SPEAIDLICRLLC-DPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFVPEL 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 213 bits (545), Expect = 1e-61
Identities = 118/359 (32%), Positives = 182/359 (50%), Gaps = 43/359 (11%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F ++ +G G G V L + T ++A+K + + ++++ + ER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ LY F +N L+MEY PGGD+ L K+ F+E RFY+AE +LA++ +H L
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQ 790
G I+RD+KP+N+L+ GHI L+DF L T LK S + R+
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLC-------TGLKKSHRTEFYRILS--------- 164
Query: 791 PFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850
+ + + K KA+ + R A + S VGT +Y+
Sbjct: 165 --------HALPSNFLDFISKPMSSKRKAETWKRNRR----------ALAYSTVGTPDYI 206
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSLKFPDSPLI 908
APE+ G+ DWW+ G+ +YE+L G PF +ET ++ ++L+FPD +
Sbjct: 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPL 266
Query: 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR---CAIPPELPDFYD 964
S +A+DLI+ L E E RLG+ G EIK HPFF+G++W IR I PEL D
Sbjct: 267 SPEAKDLIKRLCC-EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPELKSITD 323
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 2e-57
Identities = 118/354 (33%), Positives = 176/354 (49%), Gaps = 36/354 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F ++ +G G G V L + TN L+A+K + + R + + ER+IL D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
++ LY F + VM+Y PGGD+ L + F E ARFY+AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCI 789
+G I+RD+KP+NIL+ DGHI LTDF L C T + + + S + +
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGL---C----TGFRWTHD------SKYYQKGDHH 166
Query: 790 QPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849
+ +EP+ + L + RK + R L ++S VGT Y
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQ-----HQRCL-----------AHSLVGTPNY 210
Query: 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSLKFPDSPL 907
+APE++ G+ DWW+ G+ LYE+L G+ PF ET V+ +L P
Sbjct: 211 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAK 270
Query: 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA-LIRCAIPPELP 960
+S +A DLI L E+RLG GA EIK HPFF+G+++A LIR P +P
Sbjct: 271 LSREASDLILR-LCCGAEDRLGKN-GADEIKAHPFFKGIDFASLIRRQKAPYIP 322
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 6e-55
Identities = 72/143 (50%), Positives = 93/143 (65%), Gaps = 4/143 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V L T L+A+KV+ + + +RK++ TER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 677 QF-TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
F T + L LV+EY PGG+L K+ FSE ARFY AE++LALEYLH LG+IYR
Sbjct: 61 AFQTEEKL-YLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 736 DLKPENILVREDGHIMLTDFDLS 758
DLKPENIL+ DGHI LTDF L+
Sbjct: 118 DLKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 4e-54
Identities = 121/360 (33%), Positives = 178/360 (49%), Gaps = 47/360 (13%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F+ ++ +G G G V L + T ++A+K + + ++ ++ + ER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ +LY F L+ME+ PGGDL + K FSE RFY+AE +LA+E +H L
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT--------LLKSSSNMDPARVSGP 782
G I+RD+KP+NIL+ GHI L+ D L LL+ SN +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLS--DFGLSTGFHKQHDSAYYQKLLQGKSNKNRI----- 173
Query: 783 CTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842
N + I T S + AT K + +L+A T
Sbjct: 174 -DNRNSVAVDSINLT-----MSSKDQIATWKKNR-------------RLMAYST------ 208
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSL 900
VGT +Y+APEI +G+G DWW+ G ++E L G PF + ET ++ ++L
Sbjct: 209 -VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETL 267
Query: 901 KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960
FPD +S +A DLIR LI ENRLG + GA EIK HPFF G++W IR P +P
Sbjct: 268 YFPDDIHLSVEAEDLIRR-LITNAENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIP 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 7e-54
Identities = 70/148 (47%), Positives = 93/148 (62%), Gaps = 4/148 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ +L+KLG G G VYLA T L AIKV+ + + +K R E +IL+ L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ LY F ++ LVMEYC GGDL L +K+ SE ARFY+ ++L ALEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK 116
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLS 758
G+++RDLKPENIL+ EDGH+ L DF L+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 8e-48
Identities = 65/147 (44%), Positives = 91/147 (61%), Gaps = 6/147 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F ++ LG G G V L G+ +A+K++ + + K++ E+ IL+ + HPF
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 671 LPTLYSQFTSDNLSC-LVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
L LY F D+ + LVMEY PGG+L LR+ F EP ARFY A+V+LALEYLH
Sbjct: 63 LVNLYGSF-QDDSNLYLVMEYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLH 118
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
L ++YRDLKPEN+L+ DG+I +TDF
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 65/161 (40%), Positives = 90/161 (55%), Gaps = 5/161 (3%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ LL+KLG G GTVY A+ GT + A+K++ + KK A+ E ILR L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L F + LVMEYC GGDL L + SE A+ ++L LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHS 116
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770
G+I+RDLKPENIL+ E+G + + DF L+ + S + L +
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
|
Length = 260 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 8e-45
Identities = 117/368 (31%), Positives = 179/368 (48%), Gaps = 46/368 (12%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L+ +G G G V L + T ++A+K++ + ++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ ++ F L+ME+ PGGD+ L K+ SE A +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQ 790
G I+RD+KP+N+L+ GH+ L+DF L T LK + + R
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLC-------TGLKKAHRTEFYR------------ 161
Query: 791 PFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850
+ P K KA+ + R QL + S VGT +Y+
Sbjct: 162 --------NLTHNPPSDFSFQNMNSKRKAETWKKNRR--QL--------AYSTVGTPDYI 203
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSLKFPDSPLI 908
APE+ G+ DWW+ G+ +YE+L G PF +ET V+ ++L FP I
Sbjct: 204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPI 263
Query: 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR---CAIPPELPDFYDY 965
S +A+DLI + ENR+GS G EIK HPFFEG++W IR AIP E+ D
Sbjct: 264 SEKAKDLILRFCT-DSENRIGSN-GVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDT 321
Query: 966 GIQDMVPQ 973
D P+
Sbjct: 322 SNFDEFPE 329
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 66/163 (40%), Positives = 95/163 (58%), Gaps = 4/163 (2%)
Query: 620 GDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679
G G V+LA+ T ++AIKV+ + R+ ++ + TER+IL P++ LY F
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 680 SDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLK 738
LVMEY PGGDL +L + +G E AR Y+AE++LALEYLH G+I+RDLK
Sbjct: 64 GKKNLYLVMEYLPGGDLASLL--ENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 739 PENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSG 781
P+NIL+ +GH+ LTDF LS V + + + R+ G
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-44
Identities = 118/353 (33%), Positives = 180/353 (50%), Gaps = 32/353 (9%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F ++ LG G G V LA + T+ L+A+K + + + R ++ + ER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ LY F + VM+Y PGGD+ L + + F E ARFY+AE+ LA+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQ 790
G I+RD+KP+NIL+ DGHI LTDF L T + + N S + + I+
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLC-------TGFRWTHN------SKYYQKGSHIR 167
Query: 791 PFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850
+EP+ S KT + +A Q R L ++S VGT Y+
Sbjct: 168 QDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQ-RCL-----------AHSLVGTPNYI 215
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSLKFPDSPLI 908
APE++ +G+ DWW+ G+ L+E+L G+ PF ET V+ +L P +
Sbjct: 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKL 275
Query: 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL-IRCAIPPELP 960
S +A DLI L E RLG + GA +IK HPFF ++++ IR P +P
Sbjct: 276 SPEAVDLI-TKLCCSAEERLG-RNGADDIKAHPFFSEVDFSSDIRTQPAPYVP 326
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 108/333 (32%), Positives = 150/333 (45%), Gaps = 77/333 (23%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLY 675
+G G G V LA+ +A+KV+ + + ++K+ ER +L + L HPFL L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 676 SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
F + V++Y GG+L Q++ +CF EP ARFY AEV A+ YLH L +IYR
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 736 DLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIE 795
DLKPENIL+ GH++LTDF L C E ++P E
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL-------------------------CKEG--VEP---E 150
Query: 796 PTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEII 855
T C +P +L A RK EP D
Sbjct: 151 ETTSTFCGTPEYL-APEVLRK-----------------EPYD------------------ 174
Query: 856 KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDL 915
VDWW G LYE+LYG PF + N++ + L+ P ++ A DL
Sbjct: 175 ------RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVA--ACDL 226
Query: 916 IRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
+ GLL K+ RLG++ EIK H FF +NW
Sbjct: 227 LVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 55/108 (50%), Positives = 74/108 (68%), Gaps = 3/108 (2%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+R+N+F GT EYLAPE++ G+G+G AVDWW+ G+ LYE+L G+ PF +E +
Sbjct: 146 EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ L+FP+ +S +ARDLI GLL K+P RLGS GA EIK HPFF
Sbjct: 206 LKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGS-GGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 9e-43
Identities = 115/349 (32%), Positives = 167/349 (47%), Gaps = 47/349 (13%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F ++ LG G G V LA + T L+A+K + + + R ++ + ER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 671 LPTLYSQFT-SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ LY F DNL VM+Y PGGD+ L + F E ARFY+AE+ A+E +H
Sbjct: 63 VVRLYYSFQDKDNLY-FVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDL--SLRCSVSPTLLKS-----SSNMDPARVSGP 782
+G I+RD+KP+NIL+ DGHI LTDF L R + +S +MD + G
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 783 CTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842
C R P + + A LV P
Sbjct: 180 PANCRC---------------GDRLKPLERRAARQHQRCLAH-----SLVGTPN------ 213
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSL 900
Y+APE++ G+ DWW+ G+ LYE+L G+ PF ET V+ SL
Sbjct: 214 ------YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
Query: 901 KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949
P +S +A DLI L + PE+RLG + GA EIK HPFF+ ++++
Sbjct: 268 HIPPQAKLSPEASDLIIK-LCRGPEDRLG-KNGADEIKAHPFFKTIDFS 314
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 4e-41
Identities = 113/368 (30%), Positives = 180/368 (48%), Gaps = 46/368 (12%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L+ +G G G V L + T ++A+K++ + ++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ ++ F L+ME+ PGGD+ L K+ +E +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQ 790
G I+RD+KP+N+L+ GH+ L+DF L T LK + + R S+
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLC-------TGLKKAHRTEFYRNLNHSLPSD--- 170
Query: 791 PFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850
F+ + + + K K R+ QL + S VGT +Y+
Sbjct: 171 ------------FTFQNMNSKRKAETWK-------RNRRQL--------AFSTVGTPDYI 203
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSLKFPDSPLI 908
APE+ G+ DWW+ G+ +YE+L G PF +ET V+ ++L FP I
Sbjct: 204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPI 263
Query: 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR---CAIPPELPDFYDY 965
S +A+DLI E E+R+G+ G EIK +PFFEG++W IR AIP E+ D
Sbjct: 264 SEKAKDLILRFCC-EWEHRIGA-PGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDT 321
Query: 966 GIQDMVPQ 973
D P
Sbjct: 322 SNFDEFPD 329
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 7e-39
Identities = 65/155 (41%), Positives = 87/155 (56%), Gaps = 4/155 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G GTVYLA T AIK++ E + + E EIL+ L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE--ELLREIEILKKLNHPNIVKLYG 58
Query: 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736
F +N LVMEYC GG L L ++ GK SE + ++L LEYLH G+I+RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 737 LKPENILV-REDGHIMLTDFDLSLRCSVSPTLLKS 770
LKPENIL+ ++G + L DF LS + +LLK+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT 152
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 65/146 (44%), Positives = 90/146 (61%), Gaps = 9/146 (6%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLY 675
LG G G V LAEL GT+ L+A+KV+ + + + + TE+ +L + HPFL L+
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 676 SQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
S F T D L VMEY GGDL H+ R + F EP ARFY AE++L L++LH G+
Sbjct: 63 SCFQTKDRL-FFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERGI 117
Query: 733 IYRDLKPENILVREDGHIMLTDFDLS 758
IYRDLK +N+L+ +GHI + DF +
Sbjct: 118 IYRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 6e-36
Identities = 51/119 (42%), Positives = 72/119 (60%), Gaps = 1/119 (0%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889
Q+ + VGT +Y+APE+I G+GH VDWW+ G LYE L G PF G E
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 890 ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
E N++ +++P+ +S +A DLI LL+ +PE RLG+ K EIK HPFF+G++W
Sbjct: 208 EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 59/152 (38%), Positives = 82/152 (53%), Gaps = 10/152 (6%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD--- 667
F L LG G G V LAE T L+AIK + + R ++ E+ I +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HPFL L++ F +++ C VMEY GGDL H+ FSEP A FY A V+L L+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQ 115
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
YLH ++YRDLK +N+L+ +G + + DF L
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 59/140 (42%), Positives = 82/140 (58%), Gaps = 4/140 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V L ++ N FA+K + + + +E+EIL +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 677 QFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
F ++MEYC GG+L +LR + L F E ARFY+A V+LA EYLH G+IYR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL---FDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 736 DLKPENILVREDGHIMLTDF 755
DLKPEN+L+ +G++ L DF
Sbjct: 118 DLKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 58/151 (38%), Positives = 93/151 (61%), Gaps = 6/151 (3%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
HF LL+ +G G G V + + T +FA+K M+ + + + ER IL+ L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
FL L+ F + LV++ GGDL H+ ++ + FSE +F++ E++LALEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLALEYL 116
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H G+I+RD+KP+NIL+ E GH+ +TDF+++
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 50/115 (43%), Positives = 68/115 (59%), Gaps = 4/115 (3%)
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
GT EYLAPEII +G+G AVDWW GI +YE+L G PF + ++ ++FP
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP- 218
Query: 905 SPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNW-ALIRCAIPP 957
S A+DLIR LL + RLG+ K G +IK HP+F G++W AL++ I
Sbjct: 219 -SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEA 272
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 49/110 (44%), Positives = 65/110 (59%), Gaps = 6/110 (5%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+ +FVGT EY+APE++ G+G+G AVD W+ G+ LYELL G+ PF G L
Sbjct: 149 PGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
Query: 896 VMQSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ + P IS +A+DLIR LL+K+PE RL A E QHPFF
Sbjct: 209 IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 48/127 (37%), Positives = 77/127 (60%), Gaps = 5/127 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+++F GT +Y+APEI+ + +G AVDWW G+ LYE+L G++PF+G +E +++
Sbjct: 150 GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLG-SQKGAAEIKQHPFFEGLNW-ALIRCA 954
+++P +S +A+ +++ L K PE RLG G +IK HPFF ++W L R
Sbjct: 210 EDEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKE 267
Query: 955 I-PPELP 960
I PP P
Sbjct: 268 IKPPFKP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 49/115 (42%), Positives = 72/115 (62%), Gaps = 7/115 (6%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE--ETLANVV 896
++ +F GT EY+APEII +G+ +VD+W+ GI LYELL GR PF + E +++
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 897 MQS--LKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNW 948
+ L+FP I A+DLI+ LL + PE RLG+ K G +IK+H +F G +W
Sbjct: 208 KGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 63/154 (40%), Positives = 95/154 (61%), Gaps = 9/154 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDN-EFLARRKKMPRAQTEREILRML 666
F LL+ LG G G V+L +G L+A+KV+ + + K +TER++L +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 667 DH-PFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLAL 724
PFL TL+ F +D L+++Y GG+L L Q++ F+E R Y+AE++LAL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH---FTESEVRVYIAEIVLAL 118
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++LH LG+IYRD+K ENIL+ +GH++LTDF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 7e-33
Identities = 63/137 (45%), Positives = 87/137 (63%), Gaps = 9/137 (6%)
Query: 839 RSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM 897
R+ SF GT EY+APEII+G+ GHG AVDWW+ GI ++ELL G +PF G T + V
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 898 QSLKF--PDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRC 953
+ LK P I +A+DL+ LL K+P+ RLG+ +GA+EIK+HPFF+GL+W AL
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALR 281
Query: 954 AIP----PELPDFYDYG 966
+ P + + D G
Sbjct: 282 KVNPPFRPSIRNELDVG 298
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 55/146 (37%), Positives = 82/146 (56%), Gaps = 4/146 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
++ +G G G V+L + +A+KVM + R K+ E+ +L+ + HPF
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L+ ++MEY PGG+L LR G+ FS FY +E++ ALEYLH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GR-FSNSTGLFYASEIVCALEYLHS 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDF 755
++YRDLKPENIL+ ++GHI LTDF
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 58/137 (42%), Positives = 83/137 (60%), Gaps = 10/137 (7%)
Query: 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKG 885
L + + R+ SF GT EY+APE+I+G GH AVDWW+ G+ +ELL G +PF
Sbjct: 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
Query: 886 SGNEETLANVVMQSLK----FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
G + + + + + LK FP + +S +ARD I+ LL K+P+ RLG+ GA EIK HP
Sbjct: 211 DGEQNSQSEISRRILKSKPPFPKT--MSAEARDFIQKLLEKDPKKRLGA-NGADEIKNHP 267
Query: 942 FFEGLNW-ALIRCAIPP 957
FF+G++W L IP
Sbjct: 268 FFQGIDWDDLAAKRIPA 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 65/140 (46%), Positives = 85/140 (60%), Gaps = 3/140 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM-LDHPFLPTLY 675
LG G G V LAEL GT+ ++AIKV+ + + + + TE+ IL + HPFL L+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 676 SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
F + + VMEY GGDL + Q Q + F EP +RFY AEV LAL +LH GVIYR
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 736 DLKPENILVREDGHIMLTDF 755
DLK +NIL+ +GH L DF
Sbjct: 121 DLKLDNILLDAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 64/149 (42%), Positives = 82/149 (55%), Gaps = 2/149 (1%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F +L ++G G G V+LA+ T + A+K M L + ++ TER+IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+L L F D L MEY PGGD L LG SE ARFY+AE+ A++ LH
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-NLG-VLSEDHARFYMAEMFEAVDALHE 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
LG I+RDLKPEN L+ GHI LTDF LS
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 50/151 (33%), Positives = 85/151 (56%), Gaps = 3/151 (1%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ +++++G G G VYL L+ +K +D ++ +++ A E +IL+ L+HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-EDALNEVKILKKLNHP 59
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
+ Y F C+VMEY GGDL + +QK+ GK F E + ++ LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H +++RD+KP+NI + +G + L DF +S
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 52/150 (34%), Positives = 74/150 (49%), Gaps = 9/150 (6%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLDHPFLP 672
+ LG G G+VYLA T L A+K ++ L+ + EREI L L HP +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 673 T-LYSQFTSDNLS-CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
S+ + + + +EY GG L L +K EP R Y ++L L YLH
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLR 760
G+++RD+K NILV DG + L DF + R
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKR 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 60/146 (41%), Positives = 87/146 (59%), Gaps = 3/146 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP- 669
FN L LG G G V LAE GT+ L+AIK++ + + + + E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
FL L+S F + + VMEY GGDL + +Q+GK F EP A FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGK-FKEPHAVFYAAEIAIGLFFLHS 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDF 755
G+IYRDLK +N+++ +GHI + DF
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADF 145
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 47/122 (38%), Positives = 78/122 (63%), Gaps = 6/122 (4%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ ++++F GT +Y+APEI+KG+ + +VDWW+FG+ LYE+L G++PF G +E +++
Sbjct: 150 EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI-RCAI 955
FP IS +A+D + L ++P RLG +I+QHPFF G++W + + I
Sbjct: 210 NDRPHFPRW--ISKEAKDCLSKLFERDPTKRLGV---DGDIRQHPFFRGIDWERLEKREI 264
Query: 956 PP 957
PP
Sbjct: 265 PP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 61/169 (36%), Positives = 94/169 (55%), Gaps = 3/169 (1%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLP 672
L+ + G G+VYLA+ T FAIKV+ + + ++ + ER I+ + + P++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
LY F S + LVMEY GGD L + LG E A+ Y+AEV+L +E LH G+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGG-LPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 733 IYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSG 781
I+RD+KPEN+L+ + GH+ LTDF LS + + + + P + G
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILG 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 63/144 (43%), Positives = 85/144 (59%), Gaps = 8/144 (5%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTL-Y 675
LG G G V L T +A+K++ E + + ++ TE +L+ HPFL L Y
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 676 SQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
S T D L C VMEY GG+L H+ R++ FSE ARFY AE++ AL YLH V+
Sbjct: 63 SFQTHDRL-CFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCDVV 117
Query: 734 YRDLKPENILVREDGHIMLTDFDL 757
YRDLK EN+++ +DGHI +TDF L
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 59/148 (39%), Positives = 87/148 (58%), Gaps = 2/148 (1%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F ++ + G G VYL T FA+K ++ + L R ++ + ER+IL ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ +++ F + C+VMEY GGD L K +G + AR Y AE +LALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATL-LKNIGALPVD-MARMYFAETVLALEYLHNY 120
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLS 758
G+++RDLKP+N+L+ GHI LTDF LS
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 64/148 (43%), Positives = 97/148 (65%), Gaps = 6/148 (4%)
Query: 614 LQKLGCGDIGTVYLA-ELIGTNC--LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
L+ LG G G V+L ++ G + L+A+KV+ L R ++ R + ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ L+ F ++ L++++ GGDL K++ F+E +FY+AE+ LAL++LH L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL 117
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLS 758
G+IYRDLKPENIL+ E+GHI LTDF LS
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 57/154 (37%), Positives = 87/154 (56%), Gaps = 4/154 (2%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L F + + LG G G V +A+ GT +AIK + + + K++ E+ IL L
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLALEY 726
HPF+ + F +N ++E+ GG+L LR+ G+ F A+FY AE++LA EY
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA--GR-FPNDVAKFYHAELVLAFEY 133
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760
LH +IYRDLKPEN+L+ GH+ +TDF + +
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 62/145 (42%), Positives = 88/145 (60%), Gaps = 9/145 (6%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLY 675
+G G G V LA+ +A+KV+ + + ++K+ ER +L + + HPFL L+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 676 SQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
F T+D L V++Y GG+L H+ R++ F EP ARFY AE+ AL YLH L +
Sbjct: 63 YSFQTADKLY-FVLDYVNGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSLNI 117
Query: 733 IYRDLKPENILVREDGHIMLTDFDL 757
IYRDLKPENIL+ GH++LTDF L
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 63/154 (40%), Positives = 94/154 (61%), Gaps = 9/154 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFLARRKK-MPRAQTEREILRML 666
F LL+ LG G G V+L + T L+A+KV+ L ++ K + +TER +L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 667 -DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLAL 724
PFL TL+ F ++ L+++Y GG++ L Q+ FSE RFY E++LAL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILAL 118
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
E+LH LG++YRD+K ENIL+ +GH++LTDF LS
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 53/124 (42%), Positives = 72/124 (58%), Gaps = 4/124 (3%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
R+ + GT EYLAPE+I+ +GHG AVDWWT G+ LYE + G PF ++
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNW-ALIRCAIP 956
LKFP+ +ARDL++GLL + RLG+ K G A++K HP+F G NW L P
Sbjct: 231 RLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288
Query: 957 PELP 960
+P
Sbjct: 289 APIP 292
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 57/126 (45%), Positives = 76/126 (60%), Gaps = 5/126 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
D ++N+F GT EYLAPE++ G G+ AVDWWT G+ LYE+L G PF E ++
Sbjct: 147 DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA--LIRCA 954
+ L+FPD A+DL+ GLL ++P RLG GA EIK HPFF L+W L++
Sbjct: 207 QEPLRFPDG--FDRDAKDLLIGLLSRDPTRRLGYN-GAQEIKNHPFFSQLSWKKLLMKGI 263
Query: 955 IPPELP 960
PP P
Sbjct: 264 QPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 54/132 (40%), Positives = 80/132 (60%), Gaps = 10/132 (7%)
Query: 839 RSNSFVGTHEYLAPEIIK----GEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
+SN VGT +Y++PEI++ G+G G DWW+ G+ +YE+LYG TPF ET
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 894 NVV--MQSLKFP-DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950
++ + +FP D +S +A+DLIR L+ PE RLG + G + K HPFFEG++W
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLG-RNGLQDFKDHPFFEGIDWDN 276
Query: 951 IRCAIPPELPDF 962
IR + P +P+
Sbjct: 277 IRNSTAPYVPEV 288
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 54/155 (34%), Positives = 80/155 (51%), Gaps = 8/155 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F +L+K+G G G VY A T AIKV+ E +++K+ E +IL+ HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI---INEIQILKKCKHP 57
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQ--KQLGKCFSEPAARFYVAEVLLALEYL 727
+ Y + + +VME+C GG L + K + +E + E+L LEYL
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSL---KDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762
H G+I+RD+K NIL+ DG + L DF LS + S
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 49/126 (38%), Positives = 82/126 (65%), Gaps = 7/126 (5%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
DA++ +F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L G++PF G EE ++
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI--RCA 954
M + +P ++ +A+D++ L ++EPE RLG + +I+QHPFF ++W+ + R
Sbjct: 210 MDNPCYPR--WLTREAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREI 264
Query: 955 IPPELP 960
PP P
Sbjct: 265 EPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 61/150 (40%), Positives = 86/150 (57%), Gaps = 10/150 (6%)
Query: 614 LQKLGCGDIGTVYLAE-LIGTNC--LFAIKVMDNEFLARRKK-MPRAQTEREILRMLDHP 669
L+ LG G G V+ + G + +FA+KV+ + R +K + ER IL + HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
F+ L F + L++EY GG+L H+ R+ F E A FY++E+ LALE+L
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHL 116
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDL 757
H G+IYRDLKPENIL+ GH+ LTDF L
Sbjct: 117 HQQGIIYRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 55/158 (34%), Positives = 90/158 (56%), Gaps = 1/158 (0%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F++ +G G G V + T ++A+KVM L ++ + + ER+IL + + P+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+P L F + LVMEY PGGDL L + + F E A+FY+AE++LA+ +H +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQM 121
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768
G ++RD+KPEN+L+ GHI L DF + R + + +
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 61/142 (42%), Positives = 83/142 (58%), Gaps = 7/142 (4%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM-LDHPFLPTLY 675
LG G G V LAEL GTN FAIK + + + + ER +L + +HPFL L+
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 676 SQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
F + VMEY GGDL H+ + G+ F E ARFY AE++ L++LH G+I
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHI---QSSGR-FDEARARFYAAEIICGLQFLHKKGII 118
Query: 734 YRDLKPENILVREDGHIMLTDF 755
YRDLK +N+L+ +DGHI + DF
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-28
Identities = 51/110 (46%), Positives = 67/110 (60%), Gaps = 3/110 (2%)
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
GT EY+APE+I +G+G VDWW GI LYE L G PF G EE V+ +++P+
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 905 S-PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW-ALIR 952
+ A+DLI LL + P RLG+ GA E+KQH FF GL+W L+R
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGT-GGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-28
Identities = 53/131 (40%), Positives = 75/131 (57%), Gaps = 10/131 (7%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGH----GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
R ++ VGT +Y++PE++K +G G DWW+ G+FLYE+L G TPF T +
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 895 VV--MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF--EGLNWAL 950
++ SL FPD IS QA+DLI L + E RLG + G EIK HPFF + +
Sbjct: 259 IMDHKNSLTFPDDIEISKQAKDLICAFL-TDREVRLG-RNGVDEIKSHPFFKNDQWTFDN 316
Query: 951 IRCAIPPELPD 961
IR + P +P+
Sbjct: 317 IRETVAPVVPE 327
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-28
Identities = 62/152 (40%), Positives = 88/152 (57%), Gaps = 6/152 (3%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ +L+KLG G G VYLA L A+KV+ + ++ K++ R E +IL L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 670 -FLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
+ LY F + LVMEY GG L +L++ SE A F +A++L ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 728 HMLGVIYRDLKPENILVREDGH-IMLTDFDLS 758
H G+I+RD+KPENIL+ DG + L DF L+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 9e-28
Identities = 48/121 (39%), Positives = 75/121 (61%), Gaps = 4/121 (3%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
R+++F GT E+LAPE++ + AVDWW G+ +YE+L G +PF G EE ++V
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCAIP 956
+++P +S +A ++R LL + PE RLGS +K A ++K+ PFF +NW L+ I
Sbjct: 217 EVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
Query: 957 P 957
P
Sbjct: 275 P 275
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 49/131 (37%), Positives = 73/131 (55%), Gaps = 5/131 (3%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
R+ + GT EYLAPE+I+ +GH AVDWW GI +YE+L G PF ++
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNWALI--RCAI 955
L+FP + A+DLI+ LL+ + RLG+ K GA ++K H +F+ ++W + R
Sbjct: 214 KLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLK 271
Query: 956 PPELPDFYDYG 966
PP +P G
Sbjct: 272 PPIVPKVSHDG 282
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 58/142 (40%), Positives = 86/142 (60%), Gaps = 7/142 (4%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLY 675
+G G V L EL T ++A+KV+ E + + + QTE+ + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 676 SQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
S F +++ V+E+ GGDL H+ RQ++L E ARFY AE+ LAL +LH G+I
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKL----PEEHARFYSAEISLALNFLHERGII 118
Query: 734 YRDLKPENILVREDGHIMLTDF 755
YRDLK +N+L+ +GHI LTD+
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 62/143 (43%), Positives = 83/143 (58%), Gaps = 5/143 (3%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLY 675
LG G G V+LAEL GTN FAIK + + + + E+ +L + +HPFL LY
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 676 SQF-TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
F T +NL VMEY GGDL + Q F P A FY AE++ L++LH G++Y
Sbjct: 63 CTFQTKENLF-FVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVY 119
Query: 735 RDLKPENILVREDGHIMLTDFDL 757
RDLK +NIL+ DGHI + DF +
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 58/143 (40%), Positives = 84/143 (58%), Gaps = 6/143 (4%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V L T +A+K++ E + + ++ TE +L+ HPFL L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 677 QFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
F + + C VMEY GG+L H+ R++ F+E ARFY AE++ ALEYLH V+Y
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRDVVY 118
Query: 735 RDLKPENILVREDGHIMLTDFDL 757
RD+K EN+++ +DGHI +TDF L
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 60/145 (41%), Positives = 87/145 (60%), Gaps = 5/145 (3%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR---MLDHPFLPT 673
+G G G VY T ++A+KV+ + + +K++ ER IL + + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
L F +D+ LV +Y GG+L QK+ G+ FSE A+FY+AE++LALE+LH ++
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GR-FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 734 YRDLKPENILVREDGHIMLTDFDLS 758
YRDLKPENIL+ GHI L DF LS
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 47/122 (38%), Positives = 77/122 (63%), Gaps = 4/122 (3%)
Query: 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM 897
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ GR PF +E+ ++M
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 898 QSLKFPDSPLISFQARDLIRGLLIKEPENRL-GSQKGAAEIKQHPFFEGLNW-ALIRCAI 955
+ ++FP + +S +A+ L+ GLL K+P+ RL G + A EI +H FF +NW +++ +
Sbjct: 210 EEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL 267
Query: 956 PP 957
P
Sbjct: 268 EP 269
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 51/144 (35%), Positives = 81/144 (56%), Gaps = 4/144 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V ++ T ++A K +D + L +RK A E++IL + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 677 QFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
F + + CLVM GGDL H+ + G F E A FY A+++ LE+LH ++Y
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 735 RDLKPENILVREDGHIMLTDFDLS 758
RDLKPEN+L+ + G++ ++D L+
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 57/162 (35%), Positives = 87/162 (53%), Gaps = 13/162 (8%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ ++ SF GT EY+APE++ GH + DWW+FG+ ++E+L G PF+G +ET+ ++
Sbjct: 152 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
L P +S +A+ L+R L + P NRLG+ G EIK+HPFF ++W L R
Sbjct: 212 KAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRRE 269
Query: 955 IPPEL------PD---FYDYGIQDMVPQKSKYLECKATGEQL 987
I P PD ++D P+ S + A QL
Sbjct: 270 IKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANAHQL 311
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 59/142 (41%), Positives = 86/142 (60%), Gaps = 3/142 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLY 675
+G G G V LA +A+KV+ + + ++K+ +ER +L + + HPFL L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 676 SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
F + + V++Y GG+L Q++ +CF EP ARFY AE+ AL YLH L ++YR
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 736 DLKPENILVREDGHIMLTDFDL 757
DLKPENIL+ GHI+LTDF L
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 4e-27
Identities = 52/117 (44%), Positives = 76/117 (64%), Gaps = 9/117 (7%)
Query: 839 RSNSFVGTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
R+ SF GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF G + + A +
Sbjct: 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS 221
Query: 897 MQSLK----FPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW 948
+ LK +P +S A+D+I+ LL+K+P+ RLG A EIK+HPFF+ +NW
Sbjct: 222 RRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 5e-27
Identities = 60/156 (38%), Positives = 96/156 (61%), Gaps = 11/156 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFLARRKKMPR-AQTEREILRM 665
+F LL+ LG G G V+L + + L+A+KV+ + ++ K +TER++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 666 LDH-PFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLL 722
+ PFL TL+ F +D L+++Y GG+L H+ ++++ F E + Y E++L
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVL 116
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
ALE+LH LG+IYRD+K ENIL+ +GH++LTDF LS
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 52/127 (40%), Positives = 77/127 (60%), Gaps = 5/127 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+++F GT EY+APEI+ GHG AVDWW+ G +Y++L G PF ++T+ ++
Sbjct: 154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG-AAEIKQHPFFEGLNW--ALIRC 953
L P P ++ +ARDL++ LL + P +RLG+ G AAE++ HPFF +NW L R
Sbjct: 214 KGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARK 271
Query: 954 AIPPELP 960
PP P
Sbjct: 272 VEPPFKP 278
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 44/108 (40%), Positives = 61/108 (56%), Gaps = 3/108 (2%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
FVGT +YLAPE I G G DWW+ G ++E L+G PF + N++ + + +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
Query: 903 PD--SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
P+ S +A DLI LL +P RLG+ G EIK HPFF+ +NW
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGA-NGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 47/123 (38%), Positives = 73/123 (59%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF G +E +++
Sbjct: 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
++ +P S +S +A + +GLL K P RLG G +I++H FF ++W L R
Sbjct: 215 EHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERRE 272
Query: 955 IPP 957
I P
Sbjct: 273 IQP 275
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 48/125 (38%), Positives = 76/125 (60%), Gaps = 9/125 (7%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG----NEETLANVVMQS 899
GT Y+APE+++GE + +VDW+ G LYE++ GR+PF+ EE + +
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA 214
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAA-EIKQHPFFEGLNWALIRCAI--P 956
+++PD S +A+DL LL K+PE RLG + G+A E+++HP F+ LNW + + P
Sbjct: 215 VEYPDK--FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272
Query: 957 PELPD 961
P +PD
Sbjct: 273 PFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 58/144 (40%), Positives = 82/144 (56%), Gaps = 3/144 (2%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPT 673
+ LG G G V LA L + L+A+KV+ + + + + TE+ IL + +HPFL
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
LY F + + VME+ GGDL QK + F E ARFY AE+ AL +LH G+I
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGII 118
Query: 734 YRDLKPENILVREDGHIMLTDFDL 757
YRDLK +N+L+ +GH L DF +
Sbjct: 119 YRDLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 50/130 (38%), Positives = 76/130 (58%), Gaps = 10/130 (7%)
Query: 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV- 896
+NS VG+ +Y+APE+++G+G+ VD+W+ G LYE L G PF GS ET N+
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
Query: 897 -MQSLKFPD----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951
++L+ P +S +A DLI LI +P R GS + +IK HPFF+ ++W +
Sbjct: 213 WKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFGSLE---DIKNHPFFKEVDWNEL 268
Query: 952 RCAIPPELPD 961
R PP +P+
Sbjct: 269 RELKPPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 70/189 (37%), Positives = 100/189 (52%), Gaps = 23/189 (12%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP- 669
FN L LG G G V LAE GT+ L+AIK++ + + + + E+ +L + D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
FL L+S F + + VMEY GGDL H+ +Q+GK F EP A FY AE+ + L +L
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGK-FKEPQAVFYAAEISVGLFFL 117
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESN 787
H G+IYRDLK +N+++ +GHI + DF + +M V G T +
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGM------------CKEHM----VDGVTTRTF 161
Query: 788 CIQPFCIEP 796
C P I P
Sbjct: 162 CGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 51/125 (40%), Positives = 69/125 (55%), Gaps = 4/125 (3%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
E + S +F GT EYLAPE+++ + + VDWW G LYE+LYG PF E
Sbjct: 148 EHSKTTS-TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD 206
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA-LIR 952
N++ + L+ P IS AR L+ GLL K+ RLG++ EIK H FF +NW L+
Sbjct: 207 NILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVN 264
Query: 953 CAIPP 957
I P
Sbjct: 265 KKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVM---DNEFLARRKKMPRAQTEREILRMLDHP 669
K+G G G VY A + T L A+K + DN K + E ++L +L HP
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN----DPKTIKEIADEMKVLELLKHP 59
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
L Y + MEYC GG L +L G+ E R Y ++L L YLH
Sbjct: 60 NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768
G+++RD+KP NI + +G I L DF +++ + T +
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 56/142 (39%), Positives = 83/142 (58%), Gaps = 3/142 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLY 675
+G G G V LA+ +A+KV+ + + RK+ ER +L + + HPFL L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 676 SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
F + V+++ GG+L Q++ + F EP ARFY AE+ AL YLH + ++YR
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 736 DLKPENILVREDGHIMLTDFDL 757
DLKPENIL+ GH++LTDF L
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 1e-25
Identities = 54/129 (41%), Positives = 80/129 (62%), Gaps = 6/129 (4%)
Query: 836 TDARS-NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
TDA + +F GT EYLAPE+++ +G AVDWW G+ +YE++ GR PF +E+
Sbjct: 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 895 VVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL-GSQKGAAEIKQHPFFEGLNWALI-- 951
++M+ +KFP + +S A+ L+ GLLIK+P RL G A EI +H FF G+NW +
Sbjct: 207 ILMEDIKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYD 264
Query: 952 RCAIPPELP 960
+ +PP P
Sbjct: 265 KKLVPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 1e-25
Identities = 59/148 (39%), Positives = 85/148 (57%), Gaps = 2/148 (1%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F +++ + G G VYL + L+A+KV+ + + + + Q ER+ L + PF
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ LY S N LVMEY GGD+ L + F E A Y++EV LAL+YLH
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLH--IYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLS 758
G+I+RDLKP+N+L+ +GHI LTDF LS
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 59/148 (39%), Positives = 89/148 (60%), Gaps = 3/148 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP- 669
FN L LG G G V LAE GT+ L+AIK++ + + + + E+ +L + P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
FL L+S F + + VMEY GGDL + + +Q+G+ F EP A FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL-MYQIQQVGR-FKEPHAVFYAAEIAIGLFFLHS 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDL 757
G+IYRDLK +N+++ +GHI + DF +
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 79/345 (22%), Positives = 125/345 (36%), Gaps = 100/345 (28%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV----MDNEFLARRKKMPRAQTEREILRM 665
++ LG G G VY T ++A+K D EF RK++ R E + LR
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF---RKQLLR---ELKTLRS 55
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
+ P++ Y F + +V+EY GG L L +K EP + ++L L+
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLD 113
Query: 726 YLH-MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN------MDPAR 778
YLH +I+RD+KP N+L+ G + + DF +S + TL + ++ M P R
Sbjct: 114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGIS--KVLENTLDQCNTFVGTVTYMSPER 171
Query: 779 VSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP-AAQIRSLPQLVAEPTD 837
+ G ++ AA I SL + E
Sbjct: 172 IQG------------------------------------ESYSYAADIWSLGLTLLE--- 192
Query: 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM 897
+G +L P ++ EL+ +
Sbjct: 193 ----CALGKFPFLPPG---------QPSFF-------ELMQ---------------AICD 217
Query: 898 QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ S + RD I L K+P+ R AAE+ QHPF
Sbjct: 218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRP----SAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 44/127 (34%), Positives = 79/127 (62%), Gaps = 4/127 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+ +N+F GT EYLAPE++ E G+ VD+W+ G+ ++E+ G +PF ++ N+
Sbjct: 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI--RC 953
++FP + ++S + R ++GLL + P++RLG+ + A E+K+HPFF ++W L+ +
Sbjct: 210 AFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQ 268
Query: 954 AIPPELP 960
PP P
Sbjct: 269 ITPPFKP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 4e-25
Identities = 59/144 (40%), Positives = 85/144 (59%), Gaps = 7/144 (4%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V L + T +A+K++ E + + ++ TE +L+ HPFL L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 677 QFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVI 733
F + + C VMEY GG+L H+ R+ + FSE ARFY AE++ AL+YLH V+
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKNVV 118
Query: 734 YRDLKPENILVREDGHIMLTDFDL 757
YRDLK EN+++ +DGHI +TDF L
Sbjct: 119 YRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 50/147 (34%), Positives = 71/147 (48%), Gaps = 7/147 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L+K+G G G VY A T AIK M R++ E I++ HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHP 75
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ Y + + +VMEY GG L ++ Q +EP + EVL LEYLH
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH 133
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
VI+RD+K +NIL+ +DG + L DF
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 5e-25
Identities = 56/143 (39%), Positives = 84/143 (58%), Gaps = 6/143 (4%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V L + +A+K++ E + + ++ TE +L+ HPFL +L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 677 QFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
F + + C VMEY GG+L H+ R++ FSE RFY AE++ AL+YLH ++Y
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 735 RDLKPENILVREDGHIMLTDFDL 757
RDLK EN+++ +DGHI +TDF L
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 9e-25
Identities = 48/127 (37%), Positives = 76/127 (59%), Gaps = 5/127 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ GR PF +E ++
Sbjct: 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRL-GSQKGAAEIKQHPFFEGLNW--ALIRC 953
M+ ++FP + +S +A+ L+ GLL K+P+ RL G A E+ +H FF +NW + +
Sbjct: 209 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 266
Query: 954 AIPPELP 960
+PP P
Sbjct: 267 LLPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 53/150 (35%), Positives = 90/150 (60%), Gaps = 1/150 (0%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F +L+ +G G G V + ++ T ++A+K+++ + +R + + ER++L D +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ L+ F +N LVM+Y GGDL L K E ARFY+AE++LA++ +H L
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK-FEDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLR 760
G ++RD+KP+N+L+ ++GHI L DF LR
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 42/113 (37%), Positives = 61/113 (53%), Gaps = 10/113 (8%)
Query: 837 DARSNSFVGTHEYLAPEIIK-GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---ETL 892
+ +FVGT Y+APE++ G G+G VD W+ G+ LYELL G+ PF G + +
Sbjct: 152 SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
Query: 893 ANVVMQSLKFPDSPLISFQ--ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
++ L+F + S A+DLI+ L K+P R A EI QHP+F
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 59/144 (40%), Positives = 86/144 (59%), Gaps = 7/144 (4%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLY 675
+G G V L L T ++A+KV+ E + + + QTE+ + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 676 SQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
S F +++ V+EY GGDL H+ RQ++L E ARFY AE+ LAL YLH G+I
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKL----PEEHARFYSAEISLALNYLHERGII 118
Query: 734 YRDLKPENILVREDGHIMLTDFDL 757
YRDLK +N+L+ +GHI LTD+ +
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 45/126 (35%), Positives = 77/126 (61%), Gaps = 7/126 (5%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
D R+++F GT +Y+APEI++G + +VDWW+FG+ LYE+L G++PF G +E ++
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI--RCA 954
+ + +P I+ +++D++ L ++P RLG I+ HPFF+ +NW + R
Sbjct: 210 VDTPHYPR--WITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKREL 264
Query: 955 IPPELP 960
PP P
Sbjct: 265 DPPFKP 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 37/110 (33%), Positives = 55/110 (50%), Gaps = 3/110 (2%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
D + S GT Y+APE++ +G+ AVDWW+ G+ YE L G+ P++G
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 895 VVMQSLKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
Q P S +A D I LL ++P+ RLG ++K HP+F
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 3/151 (1%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
++ L +G G G VY + T AIK + E + + + + E ++L+ L HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHP 59
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ + + +++EY G L + K+ G F E YV +VL L YLH
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQI-IKKFGP-FPESLVAVYVYQVLQGLAYLHE 117
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLR 760
GVI+RD+K NIL +DG + L DF ++ +
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATK 148
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 50/126 (39%), Positives = 77/126 (61%), Gaps = 5/126 (3%)
Query: 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM 897
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ GR PF +E+ ++M
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
Query: 898 QSLKFPDSPLISFQARDLIRGLLIKEPENRL-GSQKGAAEIKQHPFFEGLNWALI--RCA 954
+ ++FP + +S +A+ L+ GLL K+P+ RL G A EI QH FF G+ W + +
Sbjct: 211 EEIRFPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKL 268
Query: 955 IPPELP 960
+PP P
Sbjct: 269 VPPFKP 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 53/149 (35%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCL-FAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
FN ++ LG G G V LA + AIK + + ++K++ +ER+IL ++HP
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
F LY F ++ LV+E+ GG+ ++ K F FY A+++L EYL
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQS 149
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
L ++YRDLKPEN+L+ +DG I +TDF +
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFA 178
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 47/125 (37%), Positives = 74/125 (59%), Gaps = 13/125 (10%)
Query: 844 VGTHEYLAPEI---IKGEG---HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV- 896
VGT +Y+APE+ + G+G +G DWW+ G+ YE++YGR+PF + +T N++
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223
Query: 897 -MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAI 955
+ LKFP+ P +S DLI+ LL + RLG + + HPFF ++W IR ++
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLLCG-QKERLGYEG----LCCHPFFSKIDWNNIRNSL 278
Query: 956 PPELP 960
PP +P
Sbjct: 279 PPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 55/153 (35%), Positives = 89/153 (58%), Gaps = 17/153 (11%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN------ 888
P D S +F GT Y+APEI++GE +G +VDWW G+ ++E++ GR+PF G
Sbjct: 149 PGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
Query: 889 --EETLANVVMQ-SLKFPDSPLISFQARDLIRGLLIKEPENRLG--SQKGAAEIKQHPFF 943
E+ L V+++ ++ P S +S +A +++G L K+P+ RLG Q G +IK HPFF
Sbjct: 208 NTEDYLFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
Query: 944 EGLNWALI--RCAIPPELPDFY-DYGIQDMVPQ 973
++W L+ + +PP P+ D + + PQ
Sbjct: 266 RNIDWDLLEQKQVLPPYKPNIESDRDLDNFDPQ 298
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/141 (38%), Positives = 73/141 (51%), Gaps = 2/141 (1%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
+G G G V T ++A+K + + R ++ ER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736
F S LV+ + GG+L Q++ F ARFY AE+L ALE LH VIYRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 737 LKPENILVREDGHIMLTDFDL 757
LKPENIL+ GHI L DF L
Sbjct: 119 LKPENILLDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 57/144 (39%), Positives = 85/144 (59%), Gaps = 7/144 (4%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLY 675
+G G V L L + ++A+KV+ E + + + QTE+ + +PFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 676 SQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
S F + + LV+EY GGDL H+ RQ++L E ARFY AE+ +AL +LH G+I
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKL----PEEHARFYAAEICIALNFLHERGII 118
Query: 734 YRDLKPENILVREDGHIMLTDFDL 757
YRDLK +N+L+ DGHI LTD+ +
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/145 (36%), Positives = 80/145 (55%), Gaps = 2/145 (1%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V ++ T L+A K ++ + L +RK A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 677 QFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
F + CLVM GGDL H+ + F EP A FY A+++ LE+LH +IY
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 735 RDLKPENILVREDGHIMLTDFDLSL 759
RDLKPEN+L+ DG++ ++D L++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 53/151 (35%), Positives = 87/151 (57%), Gaps = 15/151 (9%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFK------GSGN 888
P D S +F GT Y+APEI++GE +G +VDWW G+ ++E++ GR+PF
Sbjct: 149 PGDTTS-TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207
Query: 889 EETLANVVMQS-LKFPDSPLISFQARDLIRGLLIKEPENRLGS--QKGAAEIKQHPFFEG 945
E+ L V+++ ++ P +S +A +++G L K+P+ RLG Q G ++IK H FF
Sbjct: 208 EDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265
Query: 946 LNWALI--RCAIPPELPDFY-DYGIQDMVPQ 973
++W L+ + PP P DYG+++ Q
Sbjct: 266 IDWDLLEKKQVTPPFKPQITDDYGLENFDTQ 296
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 56/182 (30%), Positives = 79/182 (43%), Gaps = 20/182 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE--REILRM-- 665
+ L++ +G G VY A + N AIK +D E K + E +E+ M
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLE------KCQTSVDELRKEVQAMSQ 55
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGD-LHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
+HP + Y+ F + LVM Y GG L +++ E + EVL L
Sbjct: 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPAR---VSG 781
EYLH G I+RD+K NIL+ EDG + + DF VS +L R V
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADF------GVSASLADGGDRTRKVRKTFVGT 169
Query: 782 PC 783
PC
Sbjct: 170 PC 171
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 1e-22
Identities = 57/170 (33%), Positives = 98/170 (57%), Gaps = 1/170 (0%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F +L+ +G G G V + +L + +FA+K+++ + +R + + ER++L D+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ TL+ F +N LVM+Y GGDL L K + E ARFY+AE+++A++ +H L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQL 121
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVS 780
++RD+KP+NIL+ +GHI L DF L+ T+ S + P +S
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 44/123 (35%), Positives = 66/123 (53%), Gaps = 5/123 (4%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
VGT Y+APE++K E + + DWW G +YE++ G++PF+ + V + +
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 904 D--SPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNWALIRCAI--PPE 958
+ S S AR + R LL K+P RLG + GA E+K HPFF N+ + + PP
Sbjct: 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281
Query: 959 LPD 961
PD
Sbjct: 282 CPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 43/125 (34%), Positives = 70/125 (56%), Gaps = 6/125 (4%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+++F GT +Y+APEI++ +G +VDWW G+ LYE+L G PF+ ++ ++
Sbjct: 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENRLGS--QKGAAEIKQHPFFEGLNWALI--RCAI 955
+ +P +S A D+++ + K P RLGS G I +HPFF+ L+W + R
Sbjct: 213 VVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIE 270
Query: 956 PPELP 960
PP P
Sbjct: 271 PPFRP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-22
Identities = 43/110 (39%), Positives = 71/110 (64%), Gaps = 3/110 (2%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G +E +++ +
Sbjct: 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENRLG-SQKGAAEIKQHPFFEGLNW 948
+ +P S +S +A + +GL+ K P RLG +G +IK+H FF ++W
Sbjct: 218 VAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 265
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 3e-22
Identities = 49/151 (32%), Positives = 77/151 (50%), Gaps = 8/151 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE---ILRMLD 667
+ ++++LG G G+VYLA T L AIK M +F RE + ++ +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKF----YSWEECMNLREVKSLRKLNE 56
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
HP + L F ++ V EY G +L+ L + + GK FSE R + ++L L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H G +RDLKPEN+LV + + DF L+
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-22
Identities = 53/152 (34%), Positives = 82/152 (53%), Gaps = 4/152 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F + LG G G V ++ T ++A K ++ + + +RK A E++IL ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ L + + + CLV+ GGDL H+ G F E A FY AE+L LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLH 119
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760
+YRDLKPENIL+ + GHI ++D L+++
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 4e-22
Identities = 41/110 (37%), Positives = 70/110 (63%), Gaps = 3/110 (2%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+ +F GT +Y+APEII + +G +VDWW +G+ LYE+L G+ PF G +E +++ +
Sbjct: 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENRLG-SQKGAAEIKQHPFFEGLNW 948
+ +P S +S +A + +GL+ K P RLG +G +I++H FF ++W
Sbjct: 218 VSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 4e-22
Identities = 53/153 (34%), Positives = 90/153 (58%), Gaps = 17/153 (11%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN------ 888
P D S F GT Y+APEI++GE +G +VDWW G+ ++E++ GR+PF G+
Sbjct: 149 PGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
Query: 889 --EETLANVVMQ-SLKFPDSPLISFQARDLIRGLLIKEPENRLG--SQKGAAEIKQHPFF 943
E+ L V+++ ++ P S +S +A +++ L K+P+ RLG Q G A+I+ HPFF
Sbjct: 208 NTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265
Query: 944 EGLNWALI--RCAIPPELPDFY-DYGIQDMVPQ 973
++W L+ + +PP P+ ++G+ + Q
Sbjct: 266 RNVDWDLMEQKQVVPPFKPNISGEFGLDNFDAQ 298
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 56/158 (35%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHP 669
F L++ +G G G VY A T L AIK+MD ++ + E ILR +HP
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII--EDEEE--EIKEEYNILRKYSNHP 63
Query: 670 FLPTLYSQFTSDNLSC------LVMEYCPGG---DLHVLRQKQLGKCFSEPAARFYVAEV 720
+ T Y F N LVME C GG DL V ++ GK E + + E
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL-VKGLRKKGKRLKEEWIAYILRET 122
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L L YLH VI+RD+K +NIL+ ++ + L DF +S
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 5e-22
Identities = 53/142 (37%), Positives = 78/142 (54%), Gaps = 3/142 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLY 675
LG G G V LAEL G FA+K + + + + E+ +L + ++PFL LY
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 676 SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
F + VME+ GGDL Q + G+ F A FY AE++ L++LH G+IYR
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDK-GR-FDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 736 DLKPENILVREDGHIMLTDFDL 757
DLK +N+++ DGHI + DF +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 56/153 (36%), Positives = 84/153 (54%), Gaps = 6/153 (3%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F + LG G G V ++ T ++A K ++ + + +RK A E++IL ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 671 LPTL-YSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
+ +L Y+ T D L CLV+ GGDL H+ G F E A FY AE+ LE L
Sbjct: 62 VVSLAYAYETKDAL-CLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDL 118
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760
H ++YRDLKPENIL+ + GHI ++D L++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 6e-22
Identities = 55/170 (32%), Positives = 96/170 (56%), Gaps = 1/170 (0%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F +++ +G G G V + ++ T ++A+K+++ + +R + + ER +L D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ TL+ F +N LVM+Y GGDL L K + E ARFY+AE++LA+ +H L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVS 780
++RD+KP+N+L+ +GHI L DF L+ + T+ S + P +S
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYIS 171
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 50/154 (32%), Positives = 69/154 (44%), Gaps = 14/154 (9%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF----AIKVMDNEFLARRKKMPRAQTE--RE--ILR 664
L +KLG G G VY L G A+K + + + E RE I+R
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED------ASEQQIEEFLREARIMR 56
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
LDHP + L T + +VMEY PGGDL +K K S + ++ +
Sbjct: 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
EYL I+RDL N LV E+ + ++DF LS
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 150
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 8e-22
Identities = 52/151 (34%), Positives = 83/151 (54%), Gaps = 4/151 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F + LG G G V ++ T ++A K ++ + + +RK A E++IL ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ +L + + + CLV+ GGDL H+ + G F E A FY AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSL 759
++YRDLKPENIL+ + GHI ++D L++
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAV 150
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 9e-22
Identities = 48/119 (40%), Positives = 69/119 (57%), Gaps = 3/119 (2%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+ +F GT EYLAPE+I+ + + VDWW G LYE+LYG PF E N++ +
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA-LIRCAIPP 957
L P S A ++ LL K+ + RLG+++ EI++HPFFE L+W L + IPP
Sbjct: 213 LVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-21
Identities = 43/129 (33%), Positives = 74/129 (57%), Gaps = 7/129 (5%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ +F GT +Y+APEI++ +G +VDWW G+ +YE++ G+ PF+ ++ +++
Sbjct: 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLG---SQKGAAEIKQHPFFEGLNWALI-- 951
+ +P +S +A +++ + K P RLG SQ G IKQHPFF+ ++W L+
Sbjct: 210 HDDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ 267
Query: 952 RCAIPPELP 960
R PP P
Sbjct: 268 RKIKPPFKP 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 46/140 (32%), Positives = 76/140 (54%), Gaps = 11/140 (7%)
Query: 831 LVAEPTDARSNS--FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG- 887
L E D +S + + GT ++APE+++GE + +VD++ G+ LYE++ R PF+ G
Sbjct: 143 LAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 202
Query: 888 ---NEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA-AEIKQHPFF 943
N+E ++ S+ +PD S ++ LL K+PE RLG + G ++ HP F
Sbjct: 203 KVENKELKQRILNDSVTYPDK--FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
Query: 944 EGLNWALIRCAI--PPELPD 961
LNW + + PP +PD
Sbjct: 261 RDLNWRQLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 57/156 (36%), Positives = 85/156 (54%), Gaps = 17/156 (10%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQT----EREILRML---DHP 669
+G G G VY T ++A+K +D +R KM + +T ER +L ++ D P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK----KRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
F+ + F + + +++ GGDLH L Q + FSE RFY AE++L LE++H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEAEMRFYAAEIILGLEHMH 114
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764
V+YRDLKP NIL+ E GH+ ++ DL L C S
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRIS--DLGLACDFS 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 55/155 (35%), Positives = 75/155 (48%), Gaps = 16/155 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREIL 663
+ L+Q++G G G VY A I T L AIKV+ D E + Q E +L
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII---------QQEISML 54
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
+ HP + + + + +VMEYC GG L + Q G SE + E L
Sbjct: 55 KECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPL-SELQIAYVCRETLKG 113
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L YLH G I+RD+K NIL+ EDG + L DF +S
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-21
Identities = 51/131 (38%), Positives = 77/131 (58%), Gaps = 10/131 (7%)
Query: 839 RSNSFVGTHEYLAPEIIK----GEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
+S+ VGT +Y++PEI++ G G +G DWW+ G+ +YE+LYG TPF ET
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 894 NVV--MQSLKFPDSPL-ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950
++ + +FP +S +A+DLI+ L+ E RLG Q G + K+H FFEG++W
Sbjct: 219 KIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLG-QNGIEDFKKHAFFEGIDWEN 276
Query: 951 IRCAIPPELPD 961
IR P +PD
Sbjct: 277 IRNLEAPYIPD 287
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-21
Identities = 61/193 (31%), Positives = 99/193 (51%), Gaps = 28/193 (14%)
Query: 596 IRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR 655
IR +R++ + +++ +G G G V L T ++A+K++ + +R
Sbjct: 35 IRDLRMK-----AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 89
Query: 656 AQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA--A 713
ER+I+ + P++ L+ F D +VMEY PGGDL L + P A
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWA 144
Query: 714 RFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF--------DLSLRCS--- 762
RFY AEV+LAL+ +H +G I+RD+KP+N+L+ + GH+ L DF + +RC
Sbjct: 145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 204
Query: 763 -----VSPTLLKS 770
+SP +LKS
Sbjct: 205 GTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 5e-21
Identities = 52/132 (39%), Positives = 77/132 (58%), Gaps = 10/132 (7%)
Query: 839 RSNSFVGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
R ++ VGT +Y++PE++K +G +G DWW+ G+FLYE+L G TPF T +
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 895 VV--MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL-- 950
++ SL FPD IS +A++LI L + E RLG + G EIK+H FF+ WA
Sbjct: 259 IMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLG-RNGVEEIKRHLFFKNDQWAWET 316
Query: 951 IRCAIPPELPDF 962
+R + P +PD
Sbjct: 317 LRDTVAPVVPDL 328
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 7e-21
Identities = 57/176 (32%), Positives = 92/176 (52%), Gaps = 19/176 (10%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F++++ +G G G V L + ++A+K++ + +R ER+I+ + +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ L+ F D +VMEY PGGDL L E ARFY AEV+LAL+ +H +
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIHSM 161
Query: 731 GVIYRDLKPENILVREDGHIMLTDF--------DLSLRCS--------VSPTLLKS 770
G I+RD+KP+N+L+ + GH+ L DF + +RC +SP +LKS
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-20
Identities = 53/136 (38%), Positives = 79/136 (58%), Gaps = 10/136 (7%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIK----GEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGN 888
E +S+ VGT +Y++PEI++ G+G +G DWW+ G+ +YE+LYG TPF
Sbjct: 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213
Query: 889 EETLANVV--MQSLKFPDSPL-ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
ET ++ + +FP +S A+DLIR L+ E+RLG Q G + KQHPFF G
Sbjct: 214 VETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLG-QNGIEDFKQHPFFTG 271
Query: 946 LNWALIRCAIPPELPD 961
++W IR P +P+
Sbjct: 272 IDWDNIRNCEAPYIPE 287
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 1e-20
Identities = 54/159 (33%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
+ L+KLG G G VY A T + A+K +DNE + +P + REI L+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE----EEGIP-STALREISLLKEL 55
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
HP + L ++ LV EYC DL K+ G S + + ++L L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAY 113
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765
H +++RDLKP+NIL+ DG + L DF L+ R P
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLA-RAFGIP 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-20
Identities = 46/115 (40%), Positives = 65/115 (56%), Gaps = 3/115 (2%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
E + +++F GT EYLAPE++ + + VDWW G LYE+LYG PF E
Sbjct: 148 EH-NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD 206
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
N++ + L+ P I+ AR L+ GLL K+ RLG++ EIK H FF +NW
Sbjct: 207 NILNKPLQL--KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-20
Identities = 52/132 (39%), Positives = 76/132 (57%), Gaps = 10/132 (7%)
Query: 839 RSNSFVGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
R ++ VGT +Y++PE++K +G +G DWW+ G+FL+E+L G TPF T +
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSK 258
Query: 895 VV--MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG--LNWAL 950
++ SL FP+ IS A++LI L + E RLG + G EIKQHPFF+ NW
Sbjct: 259 IMDHKNSLNFPEDVEISKHAKNLICAFL-TDREVRLG-RNGVEEIKQHPFFKNDQWNWDN 316
Query: 951 IRCAIPPELPDF 962
IR P +P+
Sbjct: 317 IRETAAPVVPEL 328
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-20
Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 24/197 (12%)
Query: 592 RWEAI-RHVR-LQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR 649
R+E I R +R LQ + +++++ +G G G V L + ++A+K++ + +
Sbjct: 27 RYEKIVRKIRKLQMKA---EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIK 83
Query: 650 RKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFS 709
R ER+I+ + P++ L+ F D +VMEY PGGDL L
Sbjct: 84 RSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVP 140
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL--------RC 761
E A+FY AEV+LAL+ +H +G+I+RD+KP+N+L+ + GH+ L DF + RC
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200
Query: 762 S--------VSPTLLKS 770
+SP +LKS
Sbjct: 201 DTAVGTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 54/152 (35%), Positives = 83/152 (54%), Gaps = 9/152 (5%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPT 673
+G G G VY T ++A+K +D + + ++ A ER +L ++ D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
+ F + + C +++ GGDLH L Q + FSE RFY E++L LE++H V
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMHNRFV 118
Query: 733 IYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764
+YRDLKP NIL+ E GH+ ++ DL L C S
Sbjct: 119 VYRDLKPANILLDEHGHVRIS--DLGLACDFS 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/149 (38%), Positives = 79/149 (53%), Gaps = 7/149 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F LL+ +G G G VY A TN + AIKV+D E ++ Q E + L P+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSPY 60
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGD-LHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ Y F + ++MEYC GG L +L+ GK E F + EVLL LEYLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK---PGK-LDETYIAFILREVLLGLEYLHE 116
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
G I+RD+K NIL+ E+G + L DF +S
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 49/155 (31%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF----AIKVMDNEFLARRKKMPRAQTE--RE--ILR 664
L +KLG G G VY +L G A+K + + + E RE I+R
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED------ASEQQIEEFLREARIMR 56
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLA 723
LDHP + L T + +VMEY GGDL LR+ + S + ++
Sbjct: 57 KLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNR--PKLSLSDLLSFALQIARG 114
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EYL I+RDL N LV E+ + ++DF LS
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLS 149
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 16/153 (10%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREILRMLDH 668
F++L+KLG G G+VY A T + AIKV ++ + K E IL+ D
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-------EISILKQCDS 57
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGG---DLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
P++ Y + + +VMEYC G D+ + K L +E + + L LE
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL----TEEEIAAILYQTLKGLE 113
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
YLH I+RD+K NIL+ E+G L DF +S
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMPRAQTEREI--LRML 666
+ + ++G G G VY A T L A+K M+NE ++ P REI L+ L
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE----KEGFPI-TAIREIKLLQKL 55
Query: 667 DHPFLPTLYSQFTSDNLSC--LVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLA 723
HP + L TS +V EY DL +L ++ F+E + Y+ ++L
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVK--FTESQIKCYMKQLLEG 112
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
L+YLH G+++RD+K NIL+ DG + L DF L
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 57/173 (32%), Positives = 84/173 (48%), Gaps = 8/173 (4%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF-LARRKKMPRAQTEREILRMLDHPFLP 672
L +LG G+ G V T + A+K + E A +K++ R E +IL + P++
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSPYIV 62
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH-MLG 731
Y F ++ + MEY GG L + K++ E VL L YLH
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKIL-KEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSGP 782
+I+RD+KP NILV G I L DF +S L S++ T + +SS M P R+ G
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGN 174
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 17/157 (10%)
Query: 611 FNLLQKLGCGDIGTVYLAELIG----TNCLFAIKVMDNEFLARRKKMPRAQTE--RE--I 662
L +KLG G G VY L G T A+K + + + E E I
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL------KEGASEEEREEFLEEASI 54
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVL 721
++ L HP + L T +V EY PGGDL LR+ G+ + ++
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH--GEKLTLKDLLQMALQIA 112
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EYL ++RDL N LV E+ + ++DF LS
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 44/124 (35%), Positives = 74/124 (59%), Gaps = 9/124 (7%)
Query: 844 VGTHEYLAPEII-KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA---NVVMQS 899
VGTH Y+APE++ KG + ++ DW++ G L++LL G +PF+ ++ + +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIP 956
++ PDS S + R L+ GLL ++ RLG +GA E+K+HPFF L+W ++ + P
Sbjct: 216 VELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273
Query: 957 PELP 960
P +P
Sbjct: 274 PLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 41/123 (33%), Positives = 72/123 (58%), Gaps = 5/123 (4%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
VGT Y+APE++ + + + D+W G +YE++ G++PF+G + V + L+
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
Query: 904 DSPLISF--QARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNWALIRCAI--PPE 958
+ F +A+ + + LL K+P+ RLG Q+ GA E+K+HPFF +N+ + + PP
Sbjct: 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281
Query: 959 LPD 961
+PD
Sbjct: 282 VPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F +L+KLG G G+VY + + N +A+K +D ++++++ A E IL ++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVNEIRILASVNHPN 60
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLH--VLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ + F N C+VMEY P GDL + ++K+ K E ++L L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+++RDLK NIL+ + + + D +S
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-19
Identities = 46/119 (38%), Positives = 68/119 (57%), Gaps = 7/119 (5%)
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL 892
A+ D R+ + GT EY+APEI+ GHG A DWWT GIF+YE+L G PF NE L
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF--YANEPLL 235
Query: 893 --ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW 948
++ + FP + + L++ LL + R G+ +KGA +K+HP+F ++W
Sbjct: 236 IYQKILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292
|
Length = 340 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 5e-19
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F +L K+G G G V+ ++A+K +D + RR++ A E +L LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRER-EEAIDEARVLAKLDSSY 60
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAA-RFYVAEVLLALEYLHM 729
+ Y F +VMEY GDLH L + Q G+ E RF++ ++LL L +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLHS 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDF 755
+++RD+K N+ + ++ + D
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDL 145
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 7e-19
Identities = 50/151 (33%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK--KMPRAQTEREI--LRMLDH 668
+L ++G G G V+ A+ T A+K + RR +P Q REI L+ H
Sbjct: 4 ILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPN-QALREIKALQACQH 58
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
P++ L F + LVMEY P DL VLR ++ + E + Y+ +L + Y+
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYM 115
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H G+++RDLKP N+L+ DG + + DF L+
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 7e-19
Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 7/155 (4%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
RH+ +L K G G V ++ T ++A K ++ + + +RK A E+ IL ++
Sbjct: 2 FRHYRVLGK---GGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN 58
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
F+ +L + + + CLV+ GGDL H+ G F E A FY AE+ LE
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLE 116
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760
L ++YRDLKPENIL+ + GHI ++D L+++
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 47/173 (27%), Positives = 70/173 (40%), Gaps = 12/173 (6%)
Query: 616 KLGCGDIGTVYLAEL---IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
KLG G G VY +L G A+K + + +K E +++ L HP +
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD--FLKEARVMKKLGHPNVV 59
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQL------GKCFSEPAARFYVAEVLLALE 725
L T + LV+EY GGDL LR+ + S + ++ +E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPAR 778
YL ++RDL N LV ED + ++DF LS K + P R
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 50/147 (34%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLDHPFLP 672
+ LG G G+VY + FA+K + + + Q E+EI L L HP +
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 673 TLY-SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
++ DNL + +E PGG L L +K F EP R Y ++LL LEYLH
Sbjct: 66 QYLGTEREEDNL-YIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLS 758
++RD+K NILV +G + L DF ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-18
Identities = 43/123 (34%), Positives = 70/123 (56%), Gaps = 7/123 (5%)
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS----GNEETLANVVMQSL 900
GT+ Y+APEI+K E + VDW+ G +YE++ GRTPFK EE + +
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 901 KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAI--PPE 958
KF +++D+ R L K+PE+RLGS++ + ++H FF+ +N+ + + PP
Sbjct: 216 KFEHQNFTE-ESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPF 274
Query: 959 LPD 961
+PD
Sbjct: 275 VPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 48/149 (32%), Positives = 78/149 (52%), Gaps = 4/149 (2%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ ++ +LG G G VY A+ T A K++ E +++ E +IL HP
Sbjct: 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHP 62
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ LY + +N +++E+C GG L + + L + +EP R+ ++L AL +LH
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
VI+RDLK NIL+ DG + L DF +S
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 48/145 (33%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPF 883
+I L V P VGT Y+APE+I E + + DWW G +YE++ G++PF
Sbjct: 142 RISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
Query: 884 KGSGN----EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG-SQKGAAEIK 938
+ EE V ++ + S A+ + R LL K P+ RLG GAA +K
Sbjct: 202 RKRKERVKREEVDRRVKEDQEEYSEK--FSEDAKSICRMLLTKNPKERLGCRGNGAAGVK 259
Query: 939 QHPFFEGLNWALIRCAI--PPELPD 961
QHP F+ +N+ + + PP PD
Sbjct: 260 QHPIFKNINFKRLEANMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 51/147 (34%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPF 883
+I L V P VGT Y+APE++K E + + DWW G LYE++ G++PF
Sbjct: 142 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
Query: 884 KGSGNE------ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-KGAAE 936
+ + E L V + SP AR L + LL K+P+ RLG Q GA E
Sbjct: 202 QQRKKKIKREEVERLVKEVQEEYSEKFSP----DARSLCKMLLCKDPKERLGCQGGGARE 257
Query: 937 IKQHPFFEGLNWALIRCAI--PPELPD 961
+K+HP F+ +N+ + + PP PD
Sbjct: 258 VKEHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQ---TEREILRML 666
+ +L+ +G G GTV + K +D + ++K Q +E ILR L
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK----QQLVSEVNILREL 56
Query: 667 DHPFLPTLYSQF--TSDNLSCLVMEYCPGGDLHVL--RQKQLGKCFSEPAARFYVAEVLL 722
HP + Y + S+ +VMEYC GGDL L + K+ K E + ++LL
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 723 ALEYLHMLG-----VIYRDLKPENILVREDGHIMLTDFDLS 758
AL H V++RDLKP NI + + ++ L DF L+
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 7e-18
Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 4/146 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G V ++ T ++A K +D + L ++ A E+EIL ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 677 QFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
F S CLVM GGDL H+ + G Y A++ + +LH + ++Y
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER--VIHYSAQITCGILHLHSMDIVY 118
Query: 735 RDLKPENILVREDGHIMLTDFDLSLR 760
RD+KPEN+L+ + G+ L+D L++
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVE 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 57/178 (32%), Positives = 86/178 (48%), Gaps = 16/178 (8%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLDHPFL 671
L +LG G G+V L T +FA+K + + Q RE I + P++
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 672 PTLYSQFTSDNLSCL--VMEYCPGGDLHVLRQ---KQLGKCFSEPAARFYVAE-VLLALE 725
Y F ++ S + MEYC GG L + + K+ G+ + + +AE VL L
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK--IAESVLKGLS 119
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
YLH +I+RD+KP NIL+ G + L DF +S L S++ T +S M P R+ G
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQG 177
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 1e-17
Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 23/161 (14%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI--L 663
+ LL+ +G G G V A T AIK V D+ A+R REI L
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-------ILREIKLL 53
Query: 664 RMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYV 717
R L H + L + +V E DLH V++ Q ++ ++++
Sbjct: 54 RHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP---LTDDHIQYFL 109
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++L L+YLH VI+RDLKP NILV + + + DF L+
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 49/150 (32%), Positives = 83/150 (55%), Gaps = 4/150 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ ++ +LG G G VY A+ T L A KV++ + +++ E EIL +HP+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPY 70
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ L F D +++E+CPGG + + +L + +EP + ++L AL+YLH +
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLR 760
+I+RDLK N+L+ DG I L DF +S +
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 2/143 (1%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
+G G G V+L L IK + E + + +++ AQ E ++L++L HP + Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHPNIIEYYE 66
Query: 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736
F D +VMEY PGG L QK+ E + ++LLAL ++H +++RD
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRD 126
Query: 737 LKPENILVREDGHIM-LTDFDLS 758
LK +NIL+ + ++ + DF +S
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGIS 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 52/161 (32%), Positives = 76/161 (47%), Gaps = 13/161 (8%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKM-----PRAQTEREILRM 665
+ +KLG G VY A T + AIK + L RK+ A E ++L+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQE 58
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLAL 724
L HP + L F + LV E+ DL V++ K + + + Y+ L L
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSI--VLTPADIKSYMLMTLRGL 115
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765
EYLH +++RDLKP N+L+ DG + L DF L+ R SP
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-RSFGSP 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 57/171 (33%), Positives = 88/171 (51%), Gaps = 12/171 (7%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT 673
+ LG G+ GTVY A + T + A+KV+ + +K + +E EIL D P++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK--QIMSELEILYKCDSPYIIG 63
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA-ARFYVAEVLLALEYLHMLGV 732
Y F +N + E+ GG L V R+ E R VA V+ L YL L +
Sbjct: 64 FYGAFFVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVA-VVKGLTYLWSLKI 116
Query: 733 IYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
++RD+KP N+LV G + L DF +S L S++ T + +++ M P R+SG
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISG 167
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 45/139 (32%), Positives = 79/139 (56%), Gaps = 9/139 (6%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEII-KGEGHGAAVDWWTFGIFLYELLYGRTPF---KGS 886
L + + + ++ VGTH Y+APE++ KG + ++ DW++ G L++LL G +PF K
Sbjct: 143 LACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202
Query: 887 GNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-KGAAEIKQHPFFEG 945
E + +++ PDS S + + L+ GLL ++ RLG +GA E+K+H FF+G
Sbjct: 203 DKHEIDRMTLTVNVELPDS--FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260
Query: 946 LNW--ALIRCAIPPELPDF 962
++W ++ PP +P
Sbjct: 261 IDWQQVYLQKYPPPLIPPR 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 53/183 (28%), Positives = 72/183 (39%), Gaps = 25/183 (13%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK-KMPRAQTEREI--LRMLDHPF 670
L +G G G V T + AIK +F + + RE+ LR L H
Sbjct: 6 LGVVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ L F LV EY L +L G A R Y+ ++L A+ Y H
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LPPDAVRSYIWQLLQAIAYCHSH 119
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDL--SLRCSV--------------SPTLLKSSSNM 774
+I+RD+KPENILV E G + L DF +LR +P LL +N
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179
Query: 775 DPA 777
Sbjct: 180 GKP 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 52/180 (28%), Positives = 85/180 (47%), Gaps = 25/180 (13%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP----------RAQTEREI 662
L Q+LG G GTVYL + K + E L K++P +A E ++
Sbjct: 4 LQQRLGKGSFGTVYLVK--------DKKAVAEERLKVLKEIPVGELNPNETVQANQEAQL 55
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEV 720
L LDHP + ++ F + C++ EYC G DL + K GK SE + ++
Sbjct: 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL----RCSVSPTLLKSSSNMDP 776
LL + Y+H +++RDLK +NI ++ + + + DF +S C ++ T + M P
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 55/173 (31%), Positives = 89/173 (51%), Gaps = 11/173 (6%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLDHPFL 671
+ LG G+ G+V + I T + A KV+ + + + R Q RE I+ P++
Sbjct: 10 ISDLGAGNGGSVSKVKHIPTGTVMAKKVV---HIGAKSSV-RKQILRELQIMHECRSPYI 65
Query: 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH-ML 730
+ Y F ++N C+ ME+ G L + K+ G E + VA V+ L YL+ +
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSLDRI-YKKGGPIPVEILGKIAVA-VVEGLTYLYNVH 123
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
+++RD+KP NILV G I L DF +S L S++ T + +S+ M P R+ G
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQG 176
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 43/146 (29%), Positives = 80/146 (54%), Gaps = 2/146 (1%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ +++K+G G G +YLA+ + IK +D + ++K ++ E +L + HP
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ T ++ F + +VMEYC GGDL +Q G FSE + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 731 GVIYRDLKPENILVREDGHIM-LTDF 755
+++RD+K +NI + ++G + L DF
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDF 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLDHPFL 671
L K+G G G VY A T + AIK + L + REI L+ L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIK---LRFESEGIPKTALREIKLLKELNHPNI 60
Query: 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
L F LV E+ +++ +Q G E + Y+ ++L L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHG 118
Query: 732 VIYRDLKPENILVREDGHIMLTDFDL 757
+++RDLKPEN+L+ +G + L DF L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGL 144
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 22/155 (14%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM-----DNEFLARRKKMPRAQTEREI--- 662
+ L+ +G G G VY + + T + A+K++ D++ + +RE+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV---------SDIQREVALL 53
Query: 663 --LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
LR P + Y + ++MEY GG + L + +E + EV
Sbjct: 54 SQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREV 110
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
L+AL+Y+H +GVI+RD+K NILV G++ L DF
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDF 145
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-16
Identities = 68/242 (28%), Positives = 102/242 (42%), Gaps = 46/242 (19%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIK-----VMDNEFLARRKKMPRA-QTEREILRMLDHP- 669
+G G G+VYL + L A+K + R++ M A E +L+ L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L S +D+L+ + +EY PGG + L G F E R +V ++L L YLH
Sbjct: 68 IVQYLGSSLDADHLN-IFLEYVPGGSVAALLN-NYG-AFEETLVRNFVRQILKGLNYLHN 124
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCI 789
G+I+RD+K NILV G I ++DF +S + + K++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA---------------- 168
Query: 790 QPFCIEPTCQVPCF--SPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847
P+ Q F +P + T+ TRK A I SL LV E G H
Sbjct: 169 -----RPSLQGSVFWMAPEVVKQTSYTRK------ADIWSLGCLVVE-------MLTGKH 210
Query: 848 EY 849
+
Sbjct: 211 PF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-15
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 5/118 (4%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
+GT +YLAPE++ G+ HG AVDWW G+ L+E L G PF ++ N++ + + +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 904 D-SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960
+ +S A++ I LL +P R G E+KQHP F G++W ++ P +P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKR----AGLKELKQHPLFHGVDWENLQNQTMPFIP 654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM---QSLK 901
GT +Y +PE IKG + + DWW G+ YELL G+ PFK +E L + Q K
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED-EDEELDLESLLKRQQKK 226
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
P +S A D ++ +L RL + EI +HPF
Sbjct: 227 LPFIKNVSKNANDFVQSMLKYNINYRLTNYN---EIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 25/162 (15%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF----LARRKKMPRAQTEREI--L 663
+ L +G G G V A T AIK + F A+R T RE+ L
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR-------TYRELRLL 68
Query: 664 RMLDHPFLPTLYSQFTSD-NLS-----CLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFY 716
+ +DH + L FT +L LV G DL+ +++ ++L S+ +F
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKL----SDDHIQFL 123
Query: 717 VAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
V ++L L+Y+H G+I+RDLKP NI V ED + + DF L+
Sbjct: 124 VYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 4/151 (2%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ ++ +LG G G VY A+ T L A KV+D + +++ E +IL DHP
Sbjct: 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 62
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L F +N +++E+C GG + + +L + +EP R + L AL YLH
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAV-MLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLR 760
+I+RDLK NIL DG I L DF +S +
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 11/164 (6%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD--H 668
F L+Q++G G G VY A + T L AIKV+ E A ++EI+ M D H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE-----PGEDFAVVQQEIIMMKDCKH 65
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ + + + + ME+C GG L + + SE + E L L YLH
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLH 123
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
G ++RD+K NIL+ ++GH+ L DF +S + ++ T+ K S
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKS 165
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L++ +G G G VY + T L AIKVMD + + E +L+ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 671 -LPTLYSQFTS------DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
+ T Y F D+ LVME+C G + L + G E + E+L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L +LH VI+RD+K +N+L+ E+ + L DF +S
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 5/151 (3%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR--RKKMPRAQTEREILRMLD 667
H+ ++ LG G G L + L K ++ L R K+ A E IL +L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN---LTRLSEKERRDALNEIVILSLLQ 57
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
HP + Y+ F DN + MEY GG L+ +Q G+ F E +Y+ +++ A+ Y+
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H G+++RD+K NI + + G I L DF +S
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 22/148 (14%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE-------ILRMLDH 668
K+G G G V +A T A+K MD R Q RE I+R H
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMD----------LRKQQRRELLFNEVVIMRDYQH 75
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
P + +YS + + +VME+ GG L ++ ++ +E VL AL +L
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRM----NEEQIATVCLAVLKALSFL 131
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDF 755
H GVI+RD+K ++IL+ DG + L+DF
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 53/148 (35%), Positives = 73/148 (49%), Gaps = 8/148 (5%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+ + +K+G G GTVY A + T AIK M+ L ++ K E ++R H
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRENKH 75
Query: 669 P-FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
P + L S D L +VMEY GG L + + C E E L ALE+L
Sbjct: 76 PNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFL 131
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDF 755
H VI+RD+K +NIL+ DG + LTDF
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDF 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 90/386 (23%), Positives = 129/386 (33%), Gaps = 121/386 (31%)
Query: 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMP-RAQTE 659
YG LR + +L KLG G G VY A I T + A+K +M NE + P A E
Sbjct: 2 YGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE----KDGFPITALRE 57
Query: 660 REILRMLDHP-FLPTL-----YSQFTSDNLSC--LVMEYCP---GGDLHVLRQKQLGKCF 708
+IL+ L HP +P + + +V Y G L K
Sbjct: 58 IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----L 112
Query: 709 SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768
+E + Y+ ++L + YLH +++RD+K NIL+ G + + DF L
Sbjct: 113 TESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL----------- 161
Query: 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828
AR P PK R
Sbjct: 162 --------AR------------------------------PYDGPPPNPKGGGGGGTRKY 183
Query: 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSG 887
LV T Y PE++ GE + AVD W G E+ R +G
Sbjct: 184 TNLVV------------TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS 231
Query: 888 ---------------NEETLANVVMQSL-------KFPDSPLISFQA--------RDLIR 917
EET +SL F + P + DL+
Sbjct: 232 DIDQLHLIFKLCGTPTEETWPG--WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLS 289
Query: 918 GLLIKEPENRLGSQKGAAEIKQHPFF 943
LL +P RL A++ +HP+F
Sbjct: 290 KLLSLDPYKRL----TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 53/167 (31%), Positives = 87/167 (52%), Gaps = 12/167 (7%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMD------NEFLARRKKMPRA-QTEREILRMLD 667
+ +G G G VYLA + T + A+K ++ +R+K M +A ++E E L+ LD
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
H + T++ + +EY PGG + + G+ F E RF+ +VL L YL
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GR-FEEQLVRFFTEQVLEGLAYL 124
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774
H G+++RDLK +N+LV DG ++DF +S + S + + NM
Sbjct: 125 HSKGILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNM 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 55/175 (31%), Positives = 83/175 (47%), Gaps = 13/175 (7%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVM--DNEFLARRKKMPRAQTEREILRMLDHPFLPTL 674
LG G G VYL + T A+K + D + +K++ + E ++L+ L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 675 YSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
Y D + MEY PGG + Q + +E R Y ++L +EYLH +++
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVK--DQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 735 RDLKPENILVREDGHIMLTDFDLSLR----CSVSPTLLKSSSN----MDPARVSG 781
RD+K NIL G++ L DF S R CS S T +KS + M P +SG
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICS-SGTGMKSVTGTPYWMSPEVISG 181
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
T + + VGT YL+PE+ + + + D W+ G LYEL + PF+G N LA
Sbjct: 154 SSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELA 212
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
+++ P S + R+L+ LL K+PE R
Sbjct: 213 LKILKGQYPPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLD- 667
+ L ++G G GTVY A + T A+K + + +P + T REI L+ L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLS-TLREIALLKQLES 57
Query: 668 --HPFLPTLYSQF-TSDNLSC----LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
HP + L LV E+ DL K + + ++
Sbjct: 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L +++LH +++RDLKP+NILV DG + + DF L+
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 5/104 (4%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
N+ VGT ++APE+I G+ + D W+ GI EL G+ P+ + L +
Sbjct: 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG 213
Query: 900 L-KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ S + +D ++ L K PE R A ++ +HPF
Sbjct: 214 PPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 48/183 (26%), Positives = 85/183 (46%), Gaps = 12/183 (6%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L +F + +K+G G VY A + + A+K + + K E ++L+ LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-----HVLRQKQLGKCFSEPAARFYVAEVLL 722
HP + + F +N +V+E GDL H +QK+L E Y ++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTIWKYFVQLCS 117
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL----SLRCSVSPTLLKSSSNMDPAR 778
ALE++H +++RD+KP N+ + G + L D L S + + + +L+ + M P R
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 779 VSG 781
+
Sbjct: 178 IHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 45/162 (27%), Positives = 83/162 (51%), Gaps = 17/162 (10%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRA----QTERE---IL 663
+N+L+ +G G G L + + ++ +A+K + ++P++ + R+ +L
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI---------RLPKSSSAVEDSRKEAVLL 52
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
+ HP + F +D +VMEYC GGDL + Q GK F E + ++ L
Sbjct: 53 AKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG 112
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765
++++H V++RD+K +NI + ++G + L DF S R SP
Sbjct: 113 VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSP 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 40/147 (27%), Positives = 75/147 (51%), Gaps = 5/147 (3%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLDHPFL 671
++K+G G G L + + IK ++ +++ R ++ +E+ L + HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEIN---ISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
F + +VM+YC GGDL+ Q G F E + ++ LAL+++H
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK 121
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLS 758
+++RD+K +NI + +DG I L DF ++
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 38/138 (27%), Positives = 65/138 (47%), Gaps = 1/138 (0%)
Query: 618 GCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQ 677
D+ V+LA+ TN L A+K ++ + ++ + Q E R L HP + +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLD-SCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 678 FTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737
F D+ +V G L + + E A F + +VL AL+Y+H G I+R +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127
Query: 738 KPENILVREDGHIMLTDF 755
K +IL+ DG ++L+
Sbjct: 128 KASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 12/181 (6%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L +F + +K+G G VY A + A+K + L K E ++L+ L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-----HVLRQKQLGKCFSEPAARFYVAEVLL 722
HP + Y+ F DN +V+E GDL H +QK+L E Y ++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL---IPEKTVWKYFVQLCS 117
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL----SLRCSVSPTLLKSSSNMDPAR 778
ALE++H V++RD+KP N+ + G + L D L S + + + +L+ + M P R
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 779 V 779
+
Sbjct: 178 I 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 9/162 (5%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIK--VMD-NEFLARRKKMPRAQTEREILRMLDHPFLPT 673
LG G GTVY L L A+K +D + LA K+ + Q E ++L+ L H +
Sbjct: 8 LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
DN + ME+ PGG + + + G EP Y ++L + YLH V+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSI-LNRFGP-LPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 734 YRDLKPENILVREDGHIMLTDFDLSLR-CSVSPTLLKSSSNM 774
+RD+K N+++ +G I L DF + R V L + SNM
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG--LHGTHSNM 164
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 48/147 (32%), Positives = 67/147 (45%), Gaps = 13/147 (8%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR-----KKMPRAQTEREILRMLDH 668
L K+G G G V+ T + AIK +F+ KK+ A E +L+ L H
Sbjct: 6 LSKIGEGSYGVVFKCRNRETGQIVAIK----KFVESEDDPVIKKI--ALREIRMLKQLKH 59
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
P L L F LV EYC L+ L + G E + + + L A+ + H
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCH 117
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
I+RD+KPENIL+ + G I L DF
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 35/105 (33%), Positives = 57/105 (54%), Gaps = 5/105 (4%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+ S GT ++APE+I+GE +G A D W+ G + E+ G+ P+ GN + S
Sbjct: 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS 219
Query: 900 LKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ P+ P +S +A+D +R L ++P+ R A E+ QHPF
Sbjct: 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRP----TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 9/156 (5%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELI----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
RH +++LG G G V L T A+K +++ + + E EILR
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEILR 61
Query: 665 MLDHPFLPTL--YSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
LDH + + L+MEY P G L Q+ + + + +++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQICK 120
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++YL I+RDL NILV + + ++DF L+
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 50/147 (34%), Positives = 69/147 (46%), Gaps = 6/147 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L+++G G G VY A + TN + AIK M +K E L+ L HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 671 LPTLYSQFTSDNLSCLVMEYCPG--GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ ++ + LVMEYC G D+ + +K L + E AA L L YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--VEIAA--ICHGALQGLAYLH 132
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
I+RD+K NIL+ E G + L DF
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 57/177 (32%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLDH 668
F L +LG G+ G V + + A K++ E K R Q RE +L +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI----KPAIRNQIIRELKVLHECNS 58
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
P++ Y F SD + ME+ GG L VL K+ G+ + +A VL L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPENILGKISIA-VLRGLTYL 115
Query: 728 H-MLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
+++RD+KP NILV G I L DF +S L S++ + + + S M P R+ G
Sbjct: 116 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 36/107 (33%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 841 NSFVGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV- 896
S GT Y+APE+I G +GHG A D W+ G + E+ G+ P+ NE + V
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG 220
Query: 897 -MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
PDS +S + +D + L +P+ R A+E+ QHPF
Sbjct: 221 AGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP----TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 9/154 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L++ +G G G VY + T L AIKVMD + ++ Q + + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRN 64
Query: 671 LPTLYSQFTS------DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
+ T Y F D+ LVME+C G + L + G E + E+L L
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+LH VI+RD+K +N+L+ E+ + L DF +S
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 6/169 (3%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
++ +G G G V L + IK ++ +RR++ A+ E ++L L HP +
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA-AEQEAQLLSQLKHPNIV 62
Query: 673 TLYSQFT-SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
+ D L +VM +C GGDL+ ++Q GK E + ++ +AL+YLH
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 732 VIYRDLKPENILVREDGHIMLTDFD----LSLRCSVSPTLLKSSSNMDP 776
+++RDLK +N+ + I + D L +C ++ TL+ + M P
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-11
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 614 LQKLGCGDIGTVYLAELIGTNC--LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL 671
L+ LGCG G V+ A + ++C A+K + L + + A E +I+R LDH +
Sbjct: 10 LRPLGCGSNGLVFSA--VDSDCDKRVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 672 PTLY-------SQFTSD-------NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYV 717
+Y S T D N +V EY +VL Q L SE AR ++
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPL----SEEHARLFM 120
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIMLTDFDLS 758
++L L+Y+H V++RDLKP N+ + ED + + DF L+
Sbjct: 121 YQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 53/165 (32%), Positives = 79/165 (47%), Gaps = 6/165 (3%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT 673
L ++G G G VY A TN + A+K M +K E + L+ L HP
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 674 LYSQFTSDNLSCLVMEYCPGG--DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
+ ++ + LVMEYC G DL + +K L + E AA + A L L YLH
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEV--EIAAITHGA--LQGLAYLHSHN 141
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776
+I+RD+K NIL+ E G + L DF + + S + + + + M P
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 49/167 (29%), Positives = 77/167 (46%), Gaps = 22/167 (13%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF----LARRKKMPRAQTERE--ILR 664
+ ++ +G G G V A + AIK + + F LA+R T RE ILR
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKR-------TLRELKILR 59
Query: 665 MLDHPFLPTLYSQF-TSDNLS---CLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAE 719
H + + +VM+ DLH ++ Q +E R+++ +
Sbjct: 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQ---PLTEEHIRYFLYQ 115
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766
+L L+Y+H VI+RDLKP N+LV ED + + DF ++ S SPT
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 3e-11
Identities = 59/164 (35%), Positives = 84/164 (51%), Gaps = 23/164 (14%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK-VMD---NEFLARRKKMPRAQTEREIL 663
LR + +LQKLG G G V+ A T + A+K + D N A+R T REI+
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR-------TFREIM 58
Query: 664 ---RMLDHPFLPTLYSQFTSDNLS--CLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYV 717
+ DHP + L + ++N LV EY DLH V+R L + R+ +
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANIL----EDVHKRYIM 113
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761
++L AL+Y+H VI+RDLKP NIL+ D + L DF L+ R
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA-RS 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNC--LFAIKVMDNEFLARRKKMPRAQTEREI--LRM 665
+ L+++LG G G V A T+ AIK + N F KK+ + RE+ LR
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF---SKKILAKRALRELKLLRH 57
Query: 666 L-DHPFLPTLYSQ--FTSDNLSCL-----VMEYCPGGDLH-VLRQKQLGKCFSEPAARFY 716
H + LY N + L +ME DLH ++R Q ++ + +
Sbjct: 58 FRGHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQP---LTDAHFQSF 110
Query: 717 VAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765
+ ++L L+Y+H V++RDLKP N+LV D + + DF L+ S +P
Sbjct: 111 IYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 49/172 (28%), Positives = 75/172 (43%), Gaps = 6/172 (3%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT 673
L +LG G+ G+VY T A+K + E K + E +IL P++
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVD 63
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC-FSEPAARFYVAEVLLALEYL-HMLG 731
Y F + + MEY G L L + E R V+ L++L
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
+I+RD+KP N+LV +G + L DF +S L S++ T + S M P R+
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKS 175
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 7/162 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ L+Q++G G G VY A + T L A+K++ L Q E +++ H
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCN 67
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ + + S + MEYC GG L + + SE + E L L YLH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
G ++RD+K NIL+ ++G + L DF ++ + ++ T+ K S
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKS 165
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L+K+G G G V+ T + AIK++D E ++ Q E +L D P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 63
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGD-LHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ Y + D ++MEY GG L +L L E + E+L L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPL----DETQIATILREILKGLDYLHS 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
I+RD+K N+L+ E G + L DF ++
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 16/150 (10%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRML-DHP 669
+L K+G G V A+ T +AIK M F K + + REI LR L HP
Sbjct: 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSPHP 58
Query: 670 ----FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
+ L+ + + L+ LV E +L+ L + + + E + Y+ ++L +L+
Sbjct: 59 NILRLIEVLFDR-KTGRLA-LVFELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLD 114
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDF 755
++H G+ +RD+KPENIL+++D + L DF
Sbjct: 115 HMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 65.1 bits (157), Expect = 7e-11
Identities = 40/124 (32%), Positives = 57/124 (45%), Gaps = 18/124 (14%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGH---GAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
A ++ VGT Y+APE++ G ++ D W+ GI LYELL G PF+G N
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 892 LANVVMQSLKFPDS-----------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ + L+ P LIS A DL++ LL K+P+NRL S + H
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS----SSDLSH 275
Query: 941 PFFE 944
Sbjct: 276 DLLA 279
|
Length = 384 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 8e-11
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 3/95 (3%)
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
M D+P LY T+ L+M+Y GDL L +K+ SE + + +++ AL
Sbjct: 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEAL 122
Query: 725 EYLHMLGVIYRDLKPENIL-VREDGHIMLTDFDLS 758
LH +I+ D+K EN+L R I L D+ L
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 40/150 (26%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMD---NEFLARRKKMPRAQTEREILRMLDHPFL 671
Q+LG G + Y A + T L A+K + N + + + + E ++ L+HP +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
+ D+ L +E+ GG + L K F E Y ++L L YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQ 123
Query: 732 VIYRDLKPENILVREDGHIM-LTDFDLSLR 760
+I+RD+K N+L+ G + + DF + R
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
F L+++G G G VY T + AIK++D E ++ Q E +L D
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDS 61
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGD-LHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
P++ Y + ++MEY GG L +L+ L + + R E+L L+YL
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR----EILKGLDYL 117
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H I+RD+K N+L+ E G + L DF ++
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMP-RAQTEREILRMLD 667
+ L K+G G G V+ A T + A+K +M+NE ++ P A E +IL++L
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE----KEGFPITALREIKILQLLK 69
Query: 668 HP----------FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYV 717
H T Y+++ LV E+C DL L + K F+ + +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFY--LVFEFCEH-DLAGLLSNKNVK-FTLSEIKKVM 125
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+L L Y+H +++RD+K NIL+ +DG + L DF L+
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 45/149 (30%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L+++G G G V+ T + AIK++D E ++ Q E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 63
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGD-LHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ Y + ++MEY GG L +LR F E + E+L L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHS 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
I+RD+K N+L+ E G + L DF ++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 25/190 (13%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G GTV A+ + FA+KV+D E ++ K RAQ E L D + +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAEVCCLLNCDFFSIVKCHE 98
Query: 677 QFTSDN--------LSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
F + + LV++Y GDL + + + + F E A +VLLA+ +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHH 158
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTES 786
+H +I+RD+K NIL+ +G + L DF S M A VS +
Sbjct: 159 VHSKHMIHRDIKSANILLCSNGLVKLGDFGF--------------SKMYAATVSDDVGRT 204
Query: 787 NCIQPFCIEP 796
C P+ + P
Sbjct: 205 FCGTPYYVAP 214
|
Length = 496 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
F ++K+G G G VY A T + A+K +D E + +P REI L+ L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPSTAI-REISLLKEL 56
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+HP + L ++N LV E+ DL P + Y+ ++L L +
Sbjct: 57 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H V++RDLKP+N+L+ +G I L DF L+
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 53/154 (34%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
F L ++G G G VY A + + A+K MDNE R +P + REI L L
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE----RDGIP-ISSLREITLLLNL 63
Query: 667 DHPFLPTLYSQFTSDNLSC--LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
HP + L +L LVMEYC DL L + FSE + + ++L L
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLD-NMPTPFSESQVKCLMLQLLRGL 121
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+YLH +I+RDLK N+L+ + G + + DF L+
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 50/147 (34%), Positives = 72/147 (48%), Gaps = 6/147 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F+ L+++G G G VY A + + + AIK M +K E L+ L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 671 LPTLYSQFTSDNLSCLVMEYCPG--GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ ++ + LVMEYC G DL + +K L + E AA + A L L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV--EIAAVTHGA--LQGLAYLH 132
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
+I+RD+K NIL+ E G + L DF
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 51/147 (34%), Positives = 73/147 (49%), Gaps = 6/147 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L+++G G G VY A + TN + AIK M +K E + L+ + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGG--DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ ++ + LVMEYC G DL + +K L + E AA + A L L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV--EIAAITHGA--LQGLAYLH 142
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
+I+RD+K NIL+ E G + L DF
Sbjct: 143 SHNMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF----LARRKKMPRAQTEREI--LR 664
+ LQ +G G G V A T AIK + F LA+R T RE+ L+
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-------TYRELKLLK 64
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLA 723
L H + +L F S + G DLH +L + L K F ++++ ++L
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF----IQYFLYQILRG 120
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L+Y+H GV++RDLKP NIL+ E+ + + DF L+
Sbjct: 121 LKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/154 (31%), Positives = 79/154 (51%), Gaps = 21/154 (13%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVM----DNEFLARRKKMPRAQTEREI--LRMLD 667
L+K+G G GTV+ A+ T+ + A+K + D+E +P + REI L+ L
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVP-SSALREICLLKELK 57
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEP---AARFYVAEVLLAL 724
H + LY SD LV EYC DL +K C + + ++ ++L L
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYC-DQDL----KKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ H V++RDLKP+N+L+ ++G + L DF L+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 38/99 (38%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG--SG-NEETLANVVMQSLKFPDS 905
Y APE+ A DWW+ G L+ELL G+T + SG N T +L P+
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHT-------TLNIPE- 199
Query: 906 PLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFF 943
+S +AR L++ LL P RLG+ G +IK HPFF
Sbjct: 200 -WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 6/147 (4%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+ + +K+G G GTVY A + T AI+ M+ L ++ K E ++R +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKN 76
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
P + + + +VMEY GG L + + C E E L ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH 133
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
VI+RD+K +NIL+ DG + LTDF
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 4e-10
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+ + +K+G G GTVY A I T AIK M+ L ++ K E ++R +
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKN 75
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
P + + + +VMEY GG L + + C E E L AL++LH
Sbjct: 76 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH 132
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
VI+RD+K +NIL+ DG + LTDF + ++P K S+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRST 174
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 6/150 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-AQTEREILRMLDHP 669
F L+KLG G TVY T + A+K + L + P A E +++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH---LDAEEGTPSTAIREISLMKELKHE 58
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA-ARFYVAEVLLALEYLH 728
+ L+ ++N LV EY DL + +P + + ++L + + H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLS 758
V++RDLKP+N+L+ + G + L DF L+
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 12/181 (6%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L +F + +K+G G VY A + A+K + + K E ++L+ L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-----HVLRQKQLGKCFSEPAARFYVAEVLL 722
HP + F DN +V+E GDL + +QK+L E Y ++
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL---IPERTVWKYFVQLCS 117
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL----SLRCSVSPTLLKSSSNMDPAR 778
A+E++H V++RD+KP N+ + G + L D L S + + + +L+ + M P R
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 779 V 779
+
Sbjct: 178 I 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 35/110 (31%), Positives = 61/110 (55%), Gaps = 9/110 (8%)
Query: 651 KKMPRA-QTEREILRMLDH--PFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLG 705
K + ++ + RE L ++ H P + L+ S++ LV+++ GG L H+ + +
Sbjct: 24 KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI- 82
Query: 706 KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
E + + AE+++AL+ LH G++ RDL P NIL+ + GHI LT F
Sbjct: 83 ---PEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 55/196 (28%), Positives = 80/196 (40%), Gaps = 37/196 (18%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
L L ++G G G VY T + A+K +M R + E R+
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVK-----------QMRRTGNKEENKRI 60
Query: 666 L----------DHPFLPTLYSQFT--SDNLSCL-VMEYCPGGDLHVLRQKQLGKCFSEPA 712
L D P++ Y F SD C+ +M C L L K++ E
Sbjct: 61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTC----LDKLL-KRIQGPIPEDI 115
Query: 713 ARFYVAEVLLALEYL---HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769
++ AL YL H GVI+RD+KP NIL+ G++ L DF +S R S +
Sbjct: 116 LGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTR 173
Query: 770 S---SSNMDPARVSGP 782
S ++ M P R+ P
Sbjct: 174 SAGCAAYMAPERIDPP 189
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHP 669
+ +++ +G G G VY L A+K++D + E IL+ L +HP
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD----PISDVDEEIEAEYNILQSLPNHP 79
Query: 670 FLPTLYSQF-TSDNLS----CLVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLL 722
+ Y F +D L LV+E C GG + L + L G+ E + + LL
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776
L++LH +I+RD+K NIL+ +G + L DF +S + + S L +++S P
Sbjct: 140 GLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRRNTSVGTP 192
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 9/113 (7%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
++ + +FVGT Y+APE I+G + D W+ G+ L EL GR P+ +
Sbjct: 152 VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 896 VMQSLKFPDSPLI-----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
++Q + P + S +D + LIK+P R E+ +HPF
Sbjct: 212 LLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER----PSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 41/173 (23%), Positives = 64/173 (36%), Gaps = 14/173 (8%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQ---------TERE--ILRM 665
LG G G V A T + AIK + ++ R T RE I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
+ H + L + + LVM+ V+ +K +E + + ++L L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIR---LTESQVKCILLQILNGLN 133
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPAR 778
LH ++RDL P NI + G + DF L+ R P S + R
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 19/169 (11%)
Query: 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMP-RAQTE 659
+G + F+++ ++G G G VY A T L A+K +DNE ++ P A E
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE----KEGFPITAIRE 56
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSC----------LVMEYCPGGDLHVLRQKQLGKCFS 709
+ILR L+H + L T + LV EY DL L + L FS
Sbjct: 57 IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVH-FS 114
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
E + ++ ++L L Y H ++RD+K NIL+ G I L DF L+
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 21/156 (13%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVM----DNEFLARRKKMPRAQTEREILRMLDHP 669
L+++G G GTV A T AIK + +E A+R A E +L+ + H
Sbjct: 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR-----AYRELRLLKHMKHE 74
Query: 670 FLPTLYSQFTSD-NLS-----CLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLL 722
+ L FT D +L LVM + G DL +++ ++L SE +F V ++L
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKL----SEDRIQFLVYQMLK 129
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L+Y+H G+I+RDLKP N+ V ED + + DF L+
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/163 (32%), Positives = 77/163 (47%), Gaps = 13/163 (7%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP-RAQTEREILRMLDHPFLP 672
L+KLG G TV+ T L A+K + L + P A E +L+ L H +
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQ--KQLGKCFSEPAARFYVAEVLLALEYLHML 730
TL+ +D LV EY L+Q G S + ++ ++L L Y H
Sbjct: 68 TLHDIVHTDKSLTLVFEYLDKD----LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773
V++RDLKP+N+L+ E G + L DF L+ R PT K+ SN
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPT--KTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV-VM 897
R S VGT ++APE+I +G VD W+ GI + E++ G P+ + + +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 898 QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
K + +S + R + +L+++P R AAE+ HPF
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQR----ATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 50/160 (31%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM----DNEFLARRKKMPRAQTEREILR 664
+ L+++G G G+V A T AIK + +E A+R A E +L+
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR-----AYRELTLLK 69
Query: 665 MLDHPFLPTLYSQFTS----DNLS--CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVA 718
+ H + L FTS D LVM Y + QK +G SE ++ V
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVY 124
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++L L+Y+H G+I+RDLKP N+ V ED + + DF L+
Sbjct: 125 QMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 46/169 (27%), Positives = 67/169 (39%), Gaps = 29/169 (17%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNC-----LFAIKVMDNEFLARRKKMPRAQTE--REILRM 665
L++LG G G VY EL G N AIK + + P+ Q E +E M
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL------KENAEPKVQQEFRQEAELM 62
Query: 666 --LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLR-----------QKQLGKCFS 709
L HP + L T + +C++ EY GDLH V + +
Sbjct: 63 SDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++ +EYL ++RDL N LV E + ++DF LS
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 22/116 (18%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
T ++ N+FVGT ++APE+IK G+ D W+ GI EL G P L+++
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP---------LSDL 201
Query: 896 -VMQSL-----KFPDS---PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
M+ L P S S +D + L K+P+ R A E+ +H F
Sbjct: 202 HPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP----SAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 9/161 (5%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP-RAQTEREILRMLDHPFLP 672
L KLG G TV+ T L A+K + L + P A E +L+ L H +
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIR---LEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
TL+ ++ LV EY L G S + ++ ++L L Y H +
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLKQYL--DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 733 IYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773
++RDLKP+N+L+ E G + L DF L+ SV PT K+ SN
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSV-PT--KTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY 675
K+G G G V +A T A+K MD L ++++ E I+R H + +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 676 SQFTSDNLSCLVMEYCPGGDL-----HV-LRQKQLGK-CFSEPAARFYVAEVLLALEYLH 728
+ + + +VME+ GG L H + ++Q+ C S VL AL YLH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS----------VLRALSYLH 135
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762
GVI+RD+K ++IL+ DG I L+DF + S
Sbjct: 136 NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 34/106 (32%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 842 SFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
SF G+ ++APE+I +G +G A D W+ G + E+ G+ P+ E +A V +
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVA-AVFKIG 215
Query: 901 KFPDSPLI----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ + P I S +A+D I L ++P R AAE+ +HPF
Sbjct: 216 RSKELPPIPDHLSDEAKDFILKCLQRDPSLRP----TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 14/161 (8%)
Query: 611 FNLLQKLGCGDIGTVY-LAELIGTNCLFAIKVMDNEFLARRK-KMPRAQTEREIL----- 663
+ +L+ LG G G VY + + L A+K ++ A K K R ++ +I+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 664 --RMLDHPFLPTLYSQFTSDNLSCLVMEY---CPGGDLHVLRQKQLGKCFSEPAARFYVA 718
L HP + Y F ++ +VM+ P G+ H K+ + F+E
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIFV 120
Query: 719 EVLLALEYLHMLG-VIYRDLKPENILVREDGHIMLTDFDLS 758
+++LAL YLH +++RDL P NI++ ED + +TDF L+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 45/141 (31%), Positives = 75/141 (53%), Gaps = 8/141 (5%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY 675
K+G G G V +A + + L A+K MD L ++++ E I+R H + +Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 676 SQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
+ + + +VME+ GG L ++ ++ + E A +A VL AL LH GVI+
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLA-VLKALSVLHAQGVIH 139
Query: 735 RDLKPENILVREDGHIMLTDF 755
RD+K ++IL+ DG + L+DF
Sbjct: 140 RDIKSDSILLTHDGRVKLSDF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 10/111 (9%)
Query: 657 QTEREILRML-DHPFLPTLYSQF------TSDNLSCLVMEYCPGGDLHVLRQKQL--GKC 707
+ E IL+ L DHP + Y + D L LV+E C GG + L + L G+
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL-WLVLELCNGGSVTDLVKGFLKRGER 120
Query: 708 FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
EP + + E L+ L++LH+ I+RD+K NIL+ +G + L DF +S
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 48/145 (33%), Positives = 66/145 (45%), Gaps = 9/145 (6%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK-KMPRAQTEREI--LRMLDHPF 670
L +G G G V + T + AIK +FL KM + REI L+ L H
Sbjct: 6 LGLVGEGSYGMVMKCKHKETGQIVAIK----KFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
L L F LV E+ L L + G E R Y+ ++L +E+ H
Sbjct: 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSH 119
Query: 731 GVIYRDLKPENILVREDGHIMLTDF 755
+I+RD+KPENILV + G + L DF
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 49/164 (29%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+ + +K+G G GTV+ A + T AIK ++ L ++ K E +++ L +
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKN 75
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
P + F + +VMEY GG L + + C E E L ALE+LH
Sbjct: 76 PNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH 132
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
VI+RD+K +N+L+ DG + LTDF + ++P K S+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ--ITPEQSKRST 174
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 11/176 (6%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLDH 668
F + +LG G+ G V+ + + A K++ E K R Q RE +L +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNS 62
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL- 727
P++ Y F SD + ME+ GG L + +K G+ + + +A V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIA-VIKGLTYLR 120
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
+++RD+KP NILV G I L DF +S L S++ + + + S M P R+ G
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 176
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 13/163 (7%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP-RAQTEREILRMLDHPFLP 672
L KLG G TVY T+ L A+K + L + P A E +L+ L H +
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQ--KQLGKCFSEPAARFYVAEVLLALEYLHML 730
TL+ ++ LV EY L+Q G + + ++ ++L L Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDKD----LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773
V++RDLKP+N+L+ E G + L DF L+ R PT K+ SN
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPT--KTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 29/103 (28%), Positives = 42/103 (40%), Gaps = 38/103 (36%)
Query: 840 SNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
+ VGT Y+APE++ G+G+ D W+ G+ LYEL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
+ +DLIR +L K+PE R A EI +H
Sbjct: 188 -----------PELKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 35/123 (28%), Positives = 54/123 (43%), Gaps = 20/123 (16%)
Query: 833 AEPTDARS---NSFVGTHEYLAPEIIK-GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN 888
A+ D +FVGT ++APE+++ G+ D W+FGI EL G P+ +
Sbjct: 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY----S 208
Query: 889 EETLANVVMQSLKFPDSPL--------ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ V+M +L+ L S R +I L K+P R A E+ +H
Sbjct: 209 KYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKR----PTAEELLKH 264
Query: 941 PFF 943
FF
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 4/90 (4%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQSL 900
S VGT Y++PE I G+ D W+ G LYE+ ++PF G N +L + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC- 223
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRL 928
+P P S + RDL+ + +PE R
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 55/177 (31%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLDH 668
F + +LG G+ G V + + + A K++ E K R Q RE +L +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI----KPAIRNQIIRELQVLHECNS 62
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
P++ Y F SD + ME+ GG L VL++ + + E + +A VL L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIA-VLRGLAYL 119
Query: 728 -HMLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
+++RD+KP NILV G I L DF +S L S++ + + + S M P R+ G
Sbjct: 120 REKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG 176
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY 675
K+G G G V +A + A+K+MD L ++++ E I+R H + +Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 676 SQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
+ ++ME+ GG L ++ Q +L +E VL AL YLH GVI+
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTRL----NEEQIATVCESVLQALCYLHSQGVIH 140
Query: 735 RDLKPENILVREDGHIMLTDF 755
RD+K ++IL+ DG + L+DF
Sbjct: 141 RDIKSDSILLTLDGRVKLSDF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-08
Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 33/189 (17%)
Query: 611 FNLLQKLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTE-------RE 661
+ + +G G G VY A+ +AIK K + Q RE
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF---------KGDKEQYTGISQSACRE 52
Query: 662 I--LRMLDHPFLPTLYSQFTSDNLSC--LVMEYCPGGDLHVL---RQKQLGKCFSEPAAR 714
I LR L H + +L F L+ +Y ++ RQ + +
Sbjct: 53 IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAK-RVSIPPSMVK 111
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILV----REDGHIMLTDFDLSLRCSVSPTLLKS 770
+ ++L + YLH V++RDLKP NILV E G + + D L+ R +P LK
Sbjct: 112 SLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFNAP--LKP 168
Query: 771 SSNMDPARV 779
+++DP V
Sbjct: 169 LADLDPVVV 177
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 25/103 (24%), Positives = 45/103 (43%), Gaps = 7/103 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
++VGT Y++PE + + D W+ G +YEL PF + + + +
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI--KEG 225
Query: 901 KFPDSPLI-SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
KF P S + ++I+ +L +P+ R E+ Q P
Sbjct: 226 KFRRIPYRYSSELNEVIKSMLNVDPDKR----PSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 20/152 (13%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTL 674
+K+G G+ G VY L N A+K + K+ + E EIL+ DHP + L
Sbjct: 1 EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKL 57
Query: 675 YSQFTSDNLSCLVMEYCPGGDL--------HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+VME PGG L + L K+L + + AA +EY
Sbjct: 58 IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA---------GMEY 108
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L I+RDL N LV E+ + ++DF +S
Sbjct: 109 LESKNCIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 32/159 (20%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE---------REI-- 662
++K+G G G VY A T + A+K + R +TE REI
Sbjct: 4 VEKIGEGTYGVVYKARDKLTGEIVALKKI------------RLETEDEGVPSTAIREISL 51
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC----FSEPAARFYVA 718
L+ L+HP + L S+N LV E+ L + +K + P + Y+
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
++L + Y H V++RDLKP+N+L+ +G + L DF L
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 6/172 (3%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F L +KLG G G V+ L AIK++ ++ L +++ Q E + L+ L H
Sbjct: 8 FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDF---QKEVQALKRLRHKH 63
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
L +L++ + ++ E G L + G+ + +V + YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGP 782
I+RDL NILV ED + DF L+ R L S + P + + P
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLA-RLIKEDVYLSSDKKI-PYKWTAP 173
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 609 RHFNLLQKLGCGDIGTVYLA--ELIGTNC--LFAIKVMDNEFLARRKKMPRAQTEREILR 664
RH +Q+LG G+ G+V L + + N + A+K + + + + + + E EIL+
Sbjct: 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH---STAEHLRDFEREIEILK 60
Query: 665 MLDHPFL----PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
L H + YS NL LVMEY P G L QK + Y +++
Sbjct: 61 SLQHDNIVKYKGVCYSA-GRRNLR-LVMEYLPYGSLRDYLQKHRERLDH-RKLLLYASQI 117
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EYL ++RDL NILV + + + DF L+
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-08
Identities = 31/132 (23%), Positives = 62/132 (46%), Gaps = 12/132 (9%)
Query: 633 TNCLFAIKVMDNEFLARRK----KMPRAQTEREILRMLDH--PFLPTLYSQFTSDNLSCL 686
TN ++ + D +++ + K + E IL++L +P + + SD S L
Sbjct: 11 TNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYL 70
Query: 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746
+ME+ G L + +++ + +AE+L L L +L + + DL P NILV +
Sbjct: 71 LMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLVLCHGDLHPGNILVDD 124
Query: 747 DGHIMLTDFDLS 758
+ + D++ +
Sbjct: 125 GKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 11/101 (10%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
+GT Y+APE+ KG + D W+ G LYE+ PF+ ++ +Q K+P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--RYKVQRGKYP 219
Query: 904 DSPLISFQARDL---IRGLLIKEPENRLGSQKGAAEIKQHP 941
P+ ++DL IR +L +P+ R K I P
Sbjct: 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDK----ILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 39/127 (30%), Positives = 61/127 (48%), Gaps = 23/127 (18%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
+ S VGT ++APE+I +G VD W+ GI + E++ G P+ ++ +Q
Sbjct: 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY--------FSDSPVQ 224
Query: 899 SLK-FPDSP--------LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949
++K DSP IS RD + +L +EP+ R +Q E+ HPF L
Sbjct: 225 AMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQ----ELLDHPFL--LQTG 278
Query: 950 LIRCAIP 956
L C +P
Sbjct: 279 LPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 15/104 (14%)
Query: 658 TEREILRMLDHPFLPTLYSQFTSDNLSCLVME------YCPGGDLHVLRQKQLGKCFSEP 711
TE ILR ++HP + L FT + +CL++ YC ++ ++ + C
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYC-----YLAAKRNIAICDILA 186
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
R VL A++YLH +I+RD+K ENI + G + L DF
Sbjct: 187 IER----SVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 43/169 (25%), Positives = 62/169 (36%), Gaps = 38/169 (22%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNE------FLARRKKMPRAQTE 659
I + L +G G+ G V L + G A+K + ++ FLA M
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKV--AVKCLKDDSTAAQAFLAEASVMTT---- 56
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL----------HVLRQKQLGKCFS 709
L HP L L N +V EY G L + +QLG
Sbjct: 57 ------LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL- 109
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+V +EYL ++RDL N+LV ED ++DF L+
Sbjct: 110 ---------DVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 4e-08
Identities = 41/142 (28%), Positives = 57/142 (40%), Gaps = 34/142 (23%)
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG---- 887
A TD +V T Y APEI+ H VD W+ G + ELL G+T F GS
Sbjct: 165 ARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ 224
Query: 888 -----------NEETLANVVMQSLK-----FPDSPLISF---------QARDLIRGLLIK 922
+EE L + +S + P P F A DL+ +L+
Sbjct: 225 LKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVL 284
Query: 923 EPENRLGSQKGAAEIKQHPFFE 944
+P+ R+ AAE HP+
Sbjct: 285 DPDKRI----TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 6/154 (3%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP-RAQTEREILRMLDHP 669
+ L+KLG G TVY + L A+KV+ L + P A E +L+ L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHA 63
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L+ + LV EY DL K G E + ++ ++L L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE-NVKLFLFQLLRGLSYIHQ 121
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
+++RDLKP+N+L+ + G + L DF L+ SV
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 37/198 (18%)
Query: 565 SSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGT 624
SSS+S+S S+ SGS+ +S R + ++G G GT
Sbjct: 51 SSSSSSSSSSSASGSAPSAAKSLSELER---------------------VNRIGSGAGGT 89
Query: 625 VYLAELIGTNCLFAIKVM-DNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683
VY T L+A+KV+ N R+++ R E EILR ++HP + + F +
Sbjct: 90 VYKVIHRPTGRLYALKVIYGNHEDTVRRQICR---EIEILRDVNHPNVVKCHDMFDHNGE 146
Query: 684 SCLVMEYCPGGDL---HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPE 740
+++E+ GG L H+ ++ L AR ++L + YLH +++RD+KP
Sbjct: 147 IQVLLEFMDGGSLEGTHIADEQFLAD-----VAR----QILSGIAYLHRRHIVHRDIKPS 197
Query: 741 NILVREDGHIMLTDFDLS 758
N+L+ ++ + DF +S
Sbjct: 198 NLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 7/106 (6%)
Query: 840 SNSFVGTHEYLAPEII-KG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM 897
+ +F GT +Y+APE+I KG G+GA D W+ G + E+ G+ PF G + V
Sbjct: 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 898 QSLKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
P+ P +S +A++ I +P+ R A ++ Q PF
Sbjct: 226 MFKIHPEIPESLSAEAKNFILRCFEPDPDKR----ASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 20/159 (12%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREILRMLDH- 668
L+K+G G G VY A T L A+K MD E + P A E +L+ML
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-----PTALREISLLQMLSES 60
Query: 669 PFLPTLYSQFTSDNLS-----CLVMEYCPGGDLH---VLRQKQLGKCFSEPAARFYVAEV 720
++ L + + LV EY DL + G+ + ++ ++
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIM-LTDFDLS 758
L + + H GV++RDLKP+N+LV + ++ + D L
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 5/101 (4%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
+ VGT Y++PE+ +G + D W G LYELL + F + N L ++Q
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNY 218
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
P + S + L+ LL ++PE R A E+ P
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKR----PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 7/170 (4%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
L+Q++G G G V+L + + AIK + ++ + AQ ++ L HP L
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFIEEAQ----VMMKLSHPKLV 62
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
LY T + CLV E+ G L + Q GK FS+ +V + YL V
Sbjct: 63 QLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSNV 121
Query: 733 IYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGP 782
I+RDL N LV E+ + ++DF ++ R + S+ P + S P
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMT-RFVLDDQYTSSTGTKFPVKWSSP 170
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 52/176 (29%), Positives = 80/176 (45%), Gaps = 13/176 (7%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVM--DNEFLARRKKMPRAQTEREILRMLDHPFLPTL 674
LG G G VYL + T A K + D E K++ + E ++L+ L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 675 YSQFT--SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
Y ++ + MEY PGG V Q + +E R Y ++L + YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGS--VKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 733 IYRDLKPENILVREDGHIMLTDFDLSLRCS---VSPTLLKSSSN----MDPARVSG 781
++RD+K NIL G++ L DF S R +S T ++S + M P +SG
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 55/178 (30%), Positives = 76/178 (42%), Gaps = 43/178 (24%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNE------FLARRKKMPRAQTEREILRMLD 667
L KLG G TVY T L A+K + E F A R E +L+ L
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR--------EASLLKDLK 61
Query: 668 HPFLPTLYSQFTSDNLSCLVMEY-----------CPGG-DLHVLRQKQLGKCFSEPAARF 715
H + TL+ + LV EY C GG +H R
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH--------------NVRL 107
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773
++ ++L L Y H V++RDLKP+N+L+ E G + L DF L+ SV P+ K+ SN
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV-PS--KTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 8e-08
Identities = 41/128 (32%), Positives = 66/128 (51%), Gaps = 2/128 (1%)
Query: 647 LARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGK 706
L ++ A++E L DH + + F SD+ L+MEY GGDL+ +++L +
Sbjct: 103 LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE 162
Query: 707 --CFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764
F E +++LAL+ +H +++RDLK NI + G I L DF S + S S
Sbjct: 163 HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222
Query: 765 PTLLKSSS 772
+L +SS
Sbjct: 223 VSLDVASS 230
|
Length = 478 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 43/152 (28%), Positives = 61/152 (40%), Gaps = 16/152 (10%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLF---AIKVMDNEFLARRKKMPRAQTE--REILRM--LD 667
+KLG G G V E + A+K + + K+ + +E M LD
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL------KSDKLSDIMDDFLKEAAIMHSLD 54
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
H L LY + L +V E P G L LR+ LG F Y ++ + Y
Sbjct: 55 HENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRY 112
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L I+RDL NIL+ D + + DF L
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 13/176 (7%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVM--DNEFLARRKKMPRAQTEREILRMLDHPFLPTL 674
LG G G VYL T A+K + D E K++ + E ++L+ L H +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 675 YS--QFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
Y + + + ME+ PGG + Q + +E R Y ++L + YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIK--DQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 733 IYRDLKPENILVREDGHIMLTDFDLSLRCS---VSPTLLKSSSN----MDPARVSG 781
++RD+K NIL G++ L DF S R +S T +KS + M P +SG
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-08
Identities = 42/147 (28%), Positives = 64/147 (43%), Gaps = 13/147 (8%)
Query: 638 AIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY-SQFTSDNLSCLVMEYCPGGDL 696
AIK++ + + R + E + L HP + L S L V EY PG L
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTL 66
Query: 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLT 753
+ G + R + +VL AL H G+++RDLKP+NI+V + G H +
Sbjct: 67 REVLAAD-GALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
Query: 754 DFDLSLRCSVSPTLLKSSSNMDPARVS 780
DF + TLL + D A ++
Sbjct: 125 DFGIG-------TLLPGVRDADVATLT 144
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 44/146 (30%), Positives = 66/146 (45%), Gaps = 5/146 (3%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G G VY A + T AIK + R P + E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHE-EIALHSYLKHRNIVQYLG 72
Query: 677 QFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
+ + + ME PGG L +LR K +E FY ++L L+YLH +++R
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 736 DLKPENILVRE-DGHIMLTDFDLSLR 760
D+K +N+LV G + ++DF S R
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKR 158
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 34/131 (25%), Positives = 49/131 (37%), Gaps = 37/131 (28%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------ 887
THE Y APEI+ G H AVD W+ G E++ G+ F G
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215
Query: 888 ---NEET---LANVVMQSLKFPDS---------PLISFQARDLIRGLLIKEPENRLGSQK 932
EE+ + + FP P + + DL+ +L P R+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---- 271
Query: 933 GAAEIKQHPFF 943
A E +HP+F
Sbjct: 272 SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 11/99 (11%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+++FVGT Y++PE I+G + D W+ GI + EL G+ PF S ++ + M
Sbjct: 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 900 LKF---------PDSPLISF--QARDLIRGLLIKEPENR 927
L P P F RD + L+K+P R
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 15/177 (8%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVM--DNEFLARRKKMPRAQTEREILRMLDHPFLPTL 674
LG G G VYL T A+K + D + K++ + E ++L+ L H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 675 YSQF---TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
Y LS V EY PGG + Q + +E R Y ++L + YLH
Sbjct: 70 YGCLRDPEEKKLSIFV-EYMPGGS--IKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLSLRCS---VSPTLLKSSSN----MDPARVSG 781
+++RD+K NIL G++ L DF S R +S T +KS + M P +SG
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 43/129 (33%), Positives = 55/129 (42%), Gaps = 33/129 (25%)
Query: 844 VGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV------ 896
V T Y APE++ G VD W G ELL G F G + E LA V
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 897 -------MQSL------KFPDSPLI---------SFQARDLIRGLLIKEPENRLGSQKGA 934
+ SL FP+S I S +A DL++GLL+ +P RL A
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL----SA 276
Query: 935 AEIKQHPFF 943
AE +HP+F
Sbjct: 277 AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 33/111 (29%), Positives = 52/111 (46%), Gaps = 14/111 (12%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-----ETLANVV 896
+F GT Y+APE I+G+ + D W+ G+ L E+ R PF G E L+ +V
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV 221
Query: 897 -MQSLKFPDSPLI----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
M + + D P S + +D I+ L K+P R + +HP+
Sbjct: 222 NMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD----MLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-07
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 3/94 (3%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
++SF GT YLAPE+ + + + D W+ G+ LYELL PFKG E + V+
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG- 286
Query: 900 LKFPDSPL-ISFQARDLIRGLLIKEPENRLGSQK 932
K+ P +S + L+ LL K P R +Q+
Sbjct: 287 -KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQ 319
|
Length = 478 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 5e-07
Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 29/157 (18%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI--LRMLDHPF 670
+G G G V A+ TN AIK DN A+R T REI LR LDH
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKR-------TLREIKLLRHLDHEN 65
Query: 671 L--------PTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVL 721
+ P F + +M+ DLH ++R Q S+ ++++ ++L
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQ---TLSDDHCQYFLYQLL 118
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L+Y+H V++RDLKP N+L+ + + + DF L+
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 3/149 (2%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-AQTEREILRMLDHP 669
+ ++K+G G G VY T + A+K + E + + +P A E +L+ L HP
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIREISLLKELQHP 59
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L ++ L+ E+ L G+ + Y+ ++L + + H
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
V++RDLKP+N+L+ G I L DF L+
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 7e-07
Identities = 33/105 (31%), Positives = 52/105 (49%), Gaps = 5/105 (4%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
NS VGT ++APE+IK + +G VD W+ GI E+ G P+ L + + +
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI 233
Query: 901 -KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
+ S + +D + L+K+PE R A E+ QHPF +
Sbjct: 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKR----PSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 34/109 (31%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
R S VGT ++APE+I +G VD W+ GI + E++ G P+ NE L + M
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF---NEPPLKAMKMI 228
Query: 899 SLKFPDSPLISFQARDLIRG----LLIKEPENRLGSQKGAAEIKQHPFF 943
P + ++G LL+++P R AAE+ +HPF
Sbjct: 229 RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR----ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 34/160 (21%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREILRML 666
L++LG G G V+L + G + AIK++ +++F+ E +++ L
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----------EAKVMMKL 56
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL---- 722
HP L LY T +V EY G L +++ GK E LL
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK---------LGTEWLLDMCS 107
Query: 723 ----ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A+EYL G I+RDL N LV ED + ++DF L+
Sbjct: 108 DVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 10/105 (9%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA---NVVMQ 898
S GT +++PE+I GEG+G D W+ G + E+L + P+ E +A + Q
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQ 222
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+S AR+ +R ++ + R A E+ +H F
Sbjct: 223 PTNPQLPSHVSPDARNFLRRTFVENAKKR----PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 2/92 (2%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+++ S VGT Y PEI+K E +G D W FG LY++ + PF S N +LA +
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY-STNMLSLATKI 225
Query: 897 MQSLKFP-DSPLISFQARDLIRGLLIKEPENR 927
++++ P + S D+I L + E R
Sbjct: 226 VEAVYEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 28/88 (31%), Positives = 45/88 (51%), Gaps = 1/88 (1%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+N+ VGT YL+PE+ + + + D W G+ LYE G+ PF + N+ L +++
Sbjct: 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRG 216
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENR 927
+ P S + S Q LI L K+ R
Sbjct: 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPF-KGSGNEETLANV-VM 897
+ ++VGT+ Y+APE I GE +G D W+ GI EL GR P+ + N+ +L + ++
Sbjct: 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209
Query: 898 QSLKFPDSPLI-----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
Q + D P++ S + I + K+P+ R + + HPF
Sbjct: 210 QCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPE----NLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--- 898
+F GT Y+APEI + + + D ++ G+ LYELL + PF G EE VM
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE-----VMHKTL 258
Query: 899 SLKF-PDSPLISFQARDLIRGLLIKEPENRLGSQK 932
+ ++ P P IS + ++++ LL +P+ R S K
Sbjct: 259 AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSK 293
|
Length = 496 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 37/145 (25%), Positives = 62/145 (42%), Gaps = 34/145 (23%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+A TD+ +V T Y APE+I H VD W+ G + E+L G+ FKG + +
Sbjct: 164 LARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223
Query: 891 TLANVV----------MQSLKFPDS-------------------PLISFQARDLIRGLLI 921
L ++ +Q L+ D+ P + A +++ +L+
Sbjct: 224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLV 283
Query: 922 KEPENRLGSQKGAAEIKQHPFFEGL 946
+ E+R+ AAE HP+FE
Sbjct: 284 LDAESRI----TAAEALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 35/110 (31%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV--V 896
+ S VGT ++APE+I +G VD W+ GI + E++ G P+ NE L + +
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF---NEPPLQAMRRI 230
Query: 897 MQSL--KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
+L + DS +S R + +L++EP R +Q E+ QHPF +
Sbjct: 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQ----ELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 5/101 (4%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
S GT +++PE+I GEG+G D W+ G + E+L + P+ + + Q
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
IS ARD + + ++ + A E+ +HPF
Sbjct: 228 PQLPSHISEHARDFLGCIFVEARH-----RPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-06
Identities = 39/160 (24%), Positives = 71/160 (44%), Gaps = 23/160 (14%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM---DNEFLARRKKMPRAQTEREI--LR 664
+ L +G G G V A T AIK + +++ +R T REI LR
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR-------TLREIKILR 58
Query: 665 MLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA 718
H + + + +V E DL+ +++ + L S ++++
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHL----SNDHIQYFLY 113
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++L L+Y+H V++RDLKP N+L+ + + + DF L+
Sbjct: 114 QILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 39/161 (24%), Positives = 62/161 (38%), Gaps = 21/161 (13%)
Query: 616 KLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+LG G G V+LAE L A+K + + R+ Q E E+L +L H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELLTVLQHQH 68
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDL-----------HVLRQKQLGKC--FSEPAARFYV 717
+ Y T +V EY GDL +L + +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+++ + YL L ++RDL N LV + + + DF +S
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 12/157 (7%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L+ + L+ +G G G V A T AIK + F RA E ++++++
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVN 73
Query: 668 HPFLPTLYSQFTSD-NLS-----CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
H + L + FT +L LVME +L + Q L + + ++L
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDL----DHERMSYLLYQML 128
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+++LH G+I+RDLKP NI+V+ D + + DF L+
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 35/143 (24%), Positives = 55/143 (38%), Gaps = 35/143 (24%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+ + +V T Y APE++ G+ +G VD W G + ELL G F G + +
Sbjct: 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209
Query: 891 TL-------------------ANVVMQSLKFPD-SPLISFQAR----------DLIRGLL 920
L +N + FP+ S S + R D ++ L
Sbjct: 210 QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACL 269
Query: 921 IKEPENRLGSQKGAAEIKQHPFF 943
+P+ RL E+ QHP+F
Sbjct: 270 RMDPKERL----TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 10/147 (6%)
Query: 616 KLGCGDIGTVY--LAELIGTNCLFAIKVM--DNEFLARRKKMPRAQTEREILRMLDHPFL 671
+LG G+ G V + ++ AIKV+ +NE R + M E EI+ LD+P++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM----REAEIMHQLDNPYI 57
Query: 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
+ ++ L LVME GG L+ + + + +V + ++YL
Sbjct: 58 VRMIGVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYLEGKN 115
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLS 758
++RDL N+L+ + ++DF LS
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 27/66 (40%), Positives = 40/66 (60%), Gaps = 4/66 (6%)
Query: 720 VLLALEYLH-MLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTL-LKSSSNMD 775
++ ALEYLH L VI+RD+KP N+L+ +G + L DF +S L SV+ T+ M
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMA 171
Query: 776 PARVSG 781
P R++
Sbjct: 172 PERINP 177
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 32/122 (26%), Positives = 56/122 (45%), Gaps = 31/122 (25%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
T A+ N+ +GT ++APE+I+ G+ D W+ GI E+ G+ P +++
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP---------YSDI 202
Query: 896 ----VM--------QSLKFPD--SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
+ +L P+ SP + D ++ L+K+PE R A ++ QHP
Sbjct: 203 HPMRAIFMIPNKPPPTLSDPEKWSPEFN----DFVKKCLVKDPEER----PSAIQLLQHP 254
Query: 942 FF 943
F
Sbjct: 255 FI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 33/121 (27%), Positives = 53/121 (43%), Gaps = 24/121 (19%)
Query: 836 TDARSNSFVGTHEYLAPEII-----KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
T + ++F+GT ++APE++ K + D W+ GI L EL P + E
Sbjct: 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP-----HHE 210
Query: 891 TLANVVMQSLKFPDSP--------LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
N + LK S S D ++ L+K+P++R AAE+ +HPF
Sbjct: 211 L--NPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP----TAAELLKHPF 264
Query: 943 F 943
Sbjct: 265 V 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 836 TDARSNSFVGTHEYLAPEII-KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
++ ++FVGT ++APE+I +G+ + D W+ GI +YE+ G P+ S + A
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY--SDVDAFRAM 211
Query: 895 VVMQSLKFPDSPLISFQA--RDLIRGLLIKEPENRLGSQKGAAE--IKQH 940
+++ K P + R+ + L +EP+ RL +++ IK H
Sbjct: 212 MLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 28/104 (26%), Positives = 52/104 (50%), Gaps = 7/104 (6%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV--VMQSL 900
+GT ++APE+++GE +G + D W+ G + E+ + P+ + LA + + +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 901 KFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
P P +S RD+ L +PE+R + E+ +HP F
Sbjct: 228 TAPSIPEHLSPGLRDVTLRCLELQPEDR----PPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 12/147 (8%)
Query: 617 LGCGDIGTV---YLAELIGTNCLFAIKVM-DNEFLARRKKMPRAQTEREILRMLDHPFLP 672
LG G+ G+V G A+K + A +K+ R E ++ LDHP +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPCIV 59
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
L + L LVME P G L L++++ + +V + + YL
Sbjct: 60 RLIGVCKGEPL-MLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLESKH 115
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLS 758
++RDL N+L+ ++DF +S
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 47/152 (30%), Positives = 66/152 (43%), Gaps = 17/152 (11%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKV-----MD-NEFLARRKKMPRAQTEREILRML 666
LL+KLG G G V+ T + A+K MD +FLA E +I++ L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPKDFLA----------EAQIMKKL 58
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
HP L LY+ T + +V E G L Q G+ P A+V + Y
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L I+RDL N+LV E+ + DF L+
Sbjct: 119 LEAQNYIHRDLAARNVLVGENNICKVADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 20/175 (11%)
Query: 614 LQKLGCGDIGTVYLAELI---GTNCL-FAIKVMDNEFLARRKKMPRAQTE--REILRM-- 665
++ LG G GTVY I + AIKV+ R + P+A E E M
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL------REETSPKANKEILDEAYVMAS 65
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLA 723
+DHP + L S + L+ + P G L +V R + S+ + V ++
Sbjct: 66 VDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYV-RNHK-DNIGSQYLLNWCV-QIAKG 121
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPAR 778
+ YL +++RDL N+LV+ H+ +TDF L+ V + P +
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK 176
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 43/153 (28%), Positives = 64/153 (41%), Gaps = 15/153 (9%)
Query: 613 LLQKLGCGDIGTVYLA---ELIGTNCLFAIKVMDNEF-LARRKKMPRAQTEREILRMLDH 668
L + +G G G VY A+K N + R+K E I+R DH
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKF---LQEAYIMRQFDH 66
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARF--YVAEVLLALE 725
P + L ++N +VME P G+L L+ + +S A Y ++ AL
Sbjct: 67 PHIVKLIG-VITENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALA 121
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
YL ++RD+ N+LV + L DF LS
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 41/151 (27%), Positives = 63/151 (41%), Gaps = 20/151 (13%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVMD------NEFLARRKKMPRAQTEREILRMLDHP 669
KLG G G VY + A+K + EFL E +++ + HP
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----------EAAVMKEIKHP 62
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVA-EVLLALEYL 727
L L T + ++ E+ G+L LR+ + Y+A ++ A+EYL
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYL 120
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
I+RDL N LV E+ + + DF LS
Sbjct: 121 EKKNFIHRDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-06
Identities = 44/168 (26%), Positives = 82/168 (48%), Gaps = 19/168 (11%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK-----VMDNEFLARRKKMPRAQTEREI 662
++ +++++ +G G +G VYLA + A+K + +N L +K+ R E +I
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL--KKRFLR---EAKI 55
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLR--------QKQLGKCFSEPAA 713
L HP + +YS + + M Y G L +L+ K+L + S A
Sbjct: 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 714 RFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761
++ +EY+H GV++RDLKP+NIL+ G +++ D+ ++
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
|
Length = 932 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 40/163 (24%), Positives = 60/163 (36%), Gaps = 19/163 (11%)
Query: 613 LLQKLGCGDIGTVYLAEL-----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L ++LG G G V+L E L A+K + +K + E E+L
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK--DFEREAELLTNFQ 66
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQ--KQLGKCFSEPAARFYVAEVLL-- 722
H + Y T + +V EY GDL+ LR S + + L
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ 126
Query: 723 -------ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ YL ++RDL N LV D + + DF +S
Sbjct: 127 IAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 44/182 (24%), Positives = 70/182 (38%), Gaps = 35/182 (19%)
Query: 610 HFNLLQKLGCGDIGTVYLAELI----------------GTNCLFAIKVMDNEFLARRKKM 653
H +KLG G G V+L E++ G L A+K++ + A +
Sbjct: 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD--ANKNAR 63
Query: 654 PRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL------HVLRQKQ---- 703
E +IL L P + L ++ C++ EY GDL H L K+
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 704 -------LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756
S + ++ ++YL L ++RDL N LV E+ I + DF
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 757 LS 758
+S
Sbjct: 184 MS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 44/172 (25%), Positives = 72/172 (41%), Gaps = 23/172 (13%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVM-DNEFLARRKKMPRAQTE 659
I L +++LG G VY L GT AIK + D R++ + E
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEF---KHE 58
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLR--QKQLG--------K 706
+ L HP + L T + ++ YC DLH V+R +G K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 707 CFSEPAARFY-VAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
EPA + V ++ +E+L V+++DL N+LV + ++ ++D L
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 6e-06
Identities = 30/108 (27%), Positives = 47/108 (43%), Gaps = 7/108 (6%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
S VGT ++APE+I+ G A D W+ G + ELL G P+ L +V
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 897 M-QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
P+ IS + +D + K+P R A ++ +HP+
Sbjct: 213 QDDHPPLPEG--ISPELKDFLMQCFQKDPNLR----PTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 6e-06
Identities = 35/130 (26%), Positives = 49/130 (37%), Gaps = 34/130 (26%)
Query: 844 VGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG--------------- 887
V T Y PE++ G G VD W+ G L EL G+ F+GS
Sbjct: 162 VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 888 NEETLANVV----MQSLKFPDSP----------LISFQARDLIRGLLIKEPENRLGSQKG 933
+E V ++LK LI A DL+ LL +P+ R+
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI----S 277
Query: 934 AAEIKQHPFF 943
A + QH +F
Sbjct: 278 ADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 31/84 (36%), Positives = 40/84 (47%), Gaps = 1/84 (1%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
VGT YL+PEI + + D W+ G LYEL + PF+G+ N L + Q P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP 221
Query: 904 DSPLISFQARDLIRGLLIKEPENR 927
SP S R LI L P +R
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 46/182 (25%), Positives = 68/182 (37%), Gaps = 43/182 (23%)
Query: 610 HFNLLQKLGCGDIGTVYLAE---LIGTNC-------------LFAIKVMD--------NE 645
N ++KLG G G V+L E L + L A+KV+ +
Sbjct: 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 646 FLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQL 704
FL K + R L P + L T D C++MEY GDL L++
Sbjct: 66 FLKEVKILSR----------LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVA 115
Query: 705 GKCFSEPAARFYVAEVLL--------ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756
++ LL + YL L ++RDL N LV ++ I + DF
Sbjct: 116 ETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG 175
Query: 757 LS 758
+S
Sbjct: 176 MS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTP 882
D+ +NSFVGT Y++PE ++G + D W+ G+ L E+ GR P
Sbjct: 152 DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.6 bits (115), Expect = 7e-06
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 13/115 (11%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 895 VVMQ---SLKFPD--SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
+ L+ P+ SP+ RD + L + E R GS K E+ QHPF +
Sbjct: 227 IATNGTPELQNPEKLSPIF----RDFLNRCLEMDVEKR-GSAK---ELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 33/130 (25%), Positives = 54/130 (41%), Gaps = 24/130 (18%)
Query: 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEII---KGEGHGAAVDWWTFGIFLYELLY 878
+AQ+ + T A+ SF+GT ++APE+ + G+ D W GI EL
Sbjct: 148 SAQLTA--------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE 199
Query: 879 GRTPFKGSGNEETLANVVMQSLKFPDSPLI------SFQARDLIRGLLIKEPENRLGSQK 932
+ P + + + + S P + S D I+ L K+P+ R
Sbjct: 200 LQPPMF---DLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR----P 252
Query: 933 GAAEIKQHPF 942
A ++ QHPF
Sbjct: 253 TATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 41/145 (28%), Positives = 61/145 (42%), Gaps = 34/145 (23%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+A DA +V T Y APE+I H VD W+ G + E+L G+T FKG +
Sbjct: 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 891 TLANVV----------------------MQSL-KFPDS------PLISFQARDLIRGLLI 921
L ++ ++SL K+P P S QA DL+ +L
Sbjct: 223 QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLE 282
Query: 922 KEPENRLGSQKGAAEIKQHPFFEGL 946
+ + RL A E +HP+F+
Sbjct: 283 LDVDKRL----TATEALEHPYFDSF 303
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 8e-06
Identities = 49/161 (30%), Positives = 71/161 (44%), Gaps = 31/161 (19%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL----ARRKKMPRAQTEREILRMLDH- 668
L +G G G+V A A+K + F ARR T RE LR+L H
Sbjct: 20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR-------TYRE-LRLLKHM 71
Query: 669 ----------PFLP-TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYV 717
F P T F L +M G DL+ + + Q S+ +F +
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLM----GADLNNIVKCQK---LSDEHVQFLI 124
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++L L+Y+H G+I+RDLKP N+ V ED + + DF L+
Sbjct: 125 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 6/146 (4%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
L++KLG G G V++ G + A+K + ++ + AQ I++ L H L
Sbjct: 10 LIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLEEAQ----IMKKLRHDKLV 64
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
LY+ + + + +V EY G L + G+ P A+V + Y+ +
Sbjct: 65 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123
Query: 733 IYRDLKPENILVREDGHIMLTDFDLS 758
I+RDL+ NILV + + DF L+
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 15/134 (11%)
Query: 659 EREILRMLDHPFLPTLYSQFTS--DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA---- 712
E +LR L HP + +L F S D L+ +Y H+++ + K +P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 107
Query: 713 --ARFYVAEVLLALEYLHMLGVIYRDLKPENILVR----EDGHIMLTDFDLSLRCSVSPT 766
+ + ++L + YLH V++RDLKP NILV E G + + D + R SP
Sbjct: 108 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSP- 165
Query: 767 LLKSSSNMDPARVS 780
LK +++DP V+
Sbjct: 166 -LKPLADLDPVVVT 178
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 35/128 (27%), Positives = 58/128 (45%), Gaps = 23/128 (17%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ NE L
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL---NENPLRA 223
Query: 895 VVM------QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
+ + L+ P+ F RD + L + E R A E+ QHPF
Sbjct: 224 LYLIATNGTPELQNPEKLSAIF--RDFLNRCLEMDVEKR----GSAKELLQHPF------ 271
Query: 949 ALIRCAIP 956
++ A P
Sbjct: 272 --LKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 16/112 (14%)
Query: 840 SNSFVGTHEYLAPEII--KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV-- 895
+ S G+ ++APE+I +G+ A VD W+ G + E+ GR P+ +EE +A +
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW---SDEEAIAAMFK 223
Query: 896 VMQSLKFPD-----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ P S +S A D + P+NR A E+ QHPF
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNR----PTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 37/111 (33%), Positives = 51/111 (45%), Gaps = 15/111 (13%)
Query: 841 NSFVGTHEYLAPEII-----KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
NS VGT Y++PE I G G A D W+ G+ + E GR PF G G + A+
Sbjct: 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF-GVGRQGDWAS- 283
Query: 896 VMQSLKFPDSP----LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+M ++ P S + R I L +EP R A ++ QHPF
Sbjct: 284 LMCAICMSQPPEAPATASREFRHFISCCLQREPAKRW----SAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP- 669
+ + + +G G G V A T AIK +++ F R E ++LR+L HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPD 60
Query: 670 -------FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC---FSEPAARFYVAE 719
LP +F + +ME DLH Q+ K + +F++ +
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELME----SDLH-----QVIKANDDLTPEHHQFFLYQ 111
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+L AL+Y+H V +RDLKP+NIL D + + DF L+
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 4/142 (2%)
Query: 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS 676
LG G+ G V+ L + A+K E L + K+ + +E IL+ DHP + L
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV-AVKTC-KEDLPQELKI-KFLSEARILKQYDHPNIVKLIG 59
Query: 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736
T +VME PGGD +K+ + ++ +F + + + YL I+RD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCIHRD 118
Query: 737 LKPENILVREDGHIMLTDFDLS 758
L N LV E+ + ++DF +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 27/159 (16%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH----- 668
L +G G G+V A T A+K + F + + +T RE LR+L H
Sbjct: 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF---QSIIHAKRTYRE-LRLLKHMKHEN 77
Query: 669 ------PFLP-TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC--FSEPAARFYVAE 719
F P +F L +M G DL+ + KC ++ +F + +
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLM----GADLN-----NIVKCQKLTDDHVQFLIYQ 128
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+L L+Y+H +I+RDLKP N+ V ED + + DF L+
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 29/157 (18%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP-----RAQTEREILRMLDHP 669
+++G G+ G V+ L N A+K + R+ +P + E IL+ HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVK-------SCRETLPPDLKAKFLQEARILKQYSHP 53
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHV--------LRQKQLGKCFSEPAARFYVAEVL 721
+ L T +VME GGD L+ K+L + AA
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAA-------- 105
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EYL I+RDL N LV E + ++DF +S
Sbjct: 106 -GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 2e-05
Identities = 35/130 (26%), Positives = 48/130 (36%), Gaps = 33/130 (25%)
Query: 843 FVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE----------T 891
+V T Y APE++ G +G+ VD W+ G ELL R F G + T
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT 217
Query: 892 LANVVMQSL------------KFPDSPL------ISFQARDLIRGLLIKEPENRLGSQKG 933
V K PL S QA DL+ +L +P R+
Sbjct: 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI----T 273
Query: 934 AAEIKQHPFF 943
A + HP+F
Sbjct: 274 AEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 5/111 (4%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 895 VVMQSLKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
+ +P +S RD + L + + R GS K E+ QHPF +
Sbjct: 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRR-GSAK---ELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 33/106 (31%), Positives = 46/106 (43%), Gaps = 11/106 (10%)
Query: 845 GTHEYLAPEIIKGEGHGAAV----DWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQ- 898
G Y+APE I E + D W+ GI + EL GR P+ + L VV +
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP 224
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
S + P S + +D + L K + R E+ QHPFFE
Sbjct: 225 SPQLPAEKF-SPEFQDFVNKCLKKNYKER----PNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L+ + L+ +G G G V A + AIK + F + RA E +++ ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 74
Query: 668 HPFLPTLYSQFTSDNL------SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
H + +L + FT LVME V++ + + + ++L
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQML 129
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+++LH G+I+RDLKP NI+V+ D + + DF L+
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 48/181 (26%), Positives = 74/181 (40%), Gaps = 21/181 (11%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREI 662
+ L++LG G G V + G + AIK++ ++EF+ E ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFI----------EEAKV 52
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVL 721
+ L H L LY T +V EY G L + LR+ S+ +V
Sbjct: 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK--DVC 110
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSG 781
+ YL I+RDL N LV + G + ++DF LS R + S + P R S
Sbjct: 111 EGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLS-RYVLDDEYTSSVGSKFPVRWSP 169
Query: 782 P 782
P
Sbjct: 170 P 170
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-05
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 10/101 (9%)
Query: 659 EREILRMLDHPFLPTLYSQFTSDNLSCLVM-EYCPGGDLHVL---RQKQLGKCFSEPAAR 714
E +LR L HP + L L+CLV+ +Y DL+ R + LG AR
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVAR 267
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
++L A++Y+H G+I+RD+K EN+LV I L DF
Sbjct: 268 ----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 2e-05
Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 35/170 (20%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQ------TEREI-- 662
+ L ++ G G VY A T + A+K + KM + + + REI
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALK---------KLKMEKEKEGFPITSLREINI 57
Query: 663 LRMLDHPFLPTLYSQFTSDNLS--CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
L L HP + T+ NL +VMEY H L K L + +P F +EV
Sbjct: 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE----HDL--KSLMETMKQP---FLQSEV 108
Query: 721 -------LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
L + +LH +++RDLK N+L+ G + + DF L+
Sbjct: 109 KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 47/156 (30%), Positives = 68/156 (43%), Gaps = 20/156 (12%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIK---VMDNEFLARRKKMPRAQTEREI-----LRMLD 667
++G G GTVY A + A+K V NE +P + T RE+ L D
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-----DGLPLS-TVREVALLKRLEAFD 60
Query: 668 HPFLPTLY-----SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
HP + L S+ + LV E+ DL K + + + L
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L++LH +++RDLKPENILV G + L DF L+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 26/170 (15%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK----KMPRAQT---------- 658
L +KLG G G V+L E G + EF + KM RA
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGL--AEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66
Query: 659 EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGK---------CF 708
E +I+ L +P + L SD+ C++ EY GDL+ L Q+++
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 709 SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
S + ++ ++YL L ++RDL N LV I + DF +S
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 608 LRHFNLLQKLGCGDIGTVYLA--ELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
L+ + L+ +G G G V A ++G N A+K + F + RA E +L+
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINV--AVKKLSRPF-QNQTHAKRAYRELVLLKC 76
Query: 666 LDHPFLPTLYSQFTSDNL------SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAE 719
++H + +L + FT LVME V+ + + + +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----LDHERMSYLLYQ 131
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+L +++LH G+I+RDLKP NI+V+ D + + DF L+
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 43/154 (27%), Positives = 64/154 (41%), Gaps = 17/154 (11%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD------NEFLARRKKMPRAQTEREILR 664
L +KLG G G V++ GT + A+K + FL E +I++
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTMSPEAFLQ----------EAQIMK 56
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
L H L LY+ + + +V EY G L + GK P A++ +
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
YL I+RDL NILV E+ + DF L+
Sbjct: 117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 10/148 (6%)
Query: 614 LQKLGCGDIGTVY--LAELIGTNCLFAIKVMDNEFLARRKKMP-RAQTEREILRMLDHPF 670
L+KLG G TVY ++ + G L A+KV+ + + +P A E +L+ L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQ--LVALKVIS---MKTEEGVPFTAIREASLLKGLKHAN 64
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ L+ + V EY + Q G R ++ ++L L Y+H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGG--LHPYNVRLFMFQLLRGLAYIHGQ 122
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLS 758
+++RDLKP+N+L+ G + L DF L+
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 1/92 (1%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+ +++ + VGT Y++PE+ +G+ + D W G LYEL + F+ + N L
Sbjct: 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA-NLPALVLK 212
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
+M P S S R LI +L +P R
Sbjct: 213 IMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-05
Identities = 20/46 (43%), Positives = 29/46 (63%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTP 882
D+ +NSFVGT Y++PE ++G + D W+ G+ L EL GR P
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 3/143 (2%)
Query: 613 LLQKLGCG--DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
LL +G G D+ TV LA T ++ ++ E + + Q E + ++ +HP
Sbjct: 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPN 60
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ + F +DN +V + G L SE A + + VL AL+Y+H +
Sbjct: 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120
Query: 731 GVIYRDLKPENILVREDGHIMLT 753
G ++R +K +IL+ DG + L+
Sbjct: 121 GYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 40/134 (29%), Positives = 63/134 (47%), Gaps = 15/134 (11%)
Query: 659 EREILRMLDHPFLPTLYSQFTS--DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA---- 712
E +LR L HP + L F S D L+ +Y H+++ + K +P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPR 107
Query: 713 --ARFYVAEVLLALEYLHMLGVIYRDLKPENILVR----EDGHIMLTDFDLSLRCSVSPT 766
+ + ++L + YLH V++RDLKP NILV E G + + D + R SP
Sbjct: 108 SMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSP- 165
Query: 767 LLKSSSNMDPARVS 780
LK +++DP V+
Sbjct: 166 -LKPLADLDPVVVT 178
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 8/146 (5%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT 673
+++LG G G V+L + AIK ++ ++ + A+ ++ L HP L
Sbjct: 9 MKELGSGQFGVVHLGKW-RAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQ 63
Query: 674 LYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
LY T +V E+ G L + LRQ+Q GK S+ +V +EYL
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GK-LSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 733 IYRDLKPENILVREDGHIMLTDFDLS 758
I+RDL N LV G + ++DF ++
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 24/166 (14%)
Query: 611 FNLLQKLGCGDIGTVYLAEL---IGTNCLFAIKVMDNEFLARRKKMPRAQTE---REILR 664
L + LG G+ G+V +L G+ A+K M + + E E
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS------EIEEFLSEAAC 54
Query: 665 M--LDHPFLPTLYS-QFTSDNLSCL-----VMEYCPGGDLH--VLRQKQLGKCFSEPAAR 714
M DHP + L F + +L + ++ + GDLH +L + G P
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 715 F--YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++ ++ L +EYL I+RDL N ++RED + + DF LS
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 39/144 (27%), Positives = 58/144 (40%), Gaps = 38/144 (26%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+A TD +V T Y APEI+ H VD W+ G + ELL GRT F G+ + +
Sbjct: 166 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225
Query: 891 TL----------------------ANVVMQSLKFPDSPLISF---------QARDLIRGL 919
L A +QSL P ++F A DL+ +
Sbjct: 226 QLKLILRLVGTPGAELLKKISSESARNYIQSL--TQMPKMNFANVFIGANPLAVDLLEKM 283
Query: 920 LIKEPENRLGSQKGAAEIKQHPFF 943
L+ + + R+ AA+ H +F
Sbjct: 284 LVLDSDKRI----TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 18/152 (11%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMD------NEFLARRKKMPRAQTEREILRML 666
L++KLG G G V++ + AIK + FLA E +++ L
Sbjct: 10 LVKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLA----------EANLMKQL 58
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
HP L LY+ T + + ++ EY G L + G + A++ + +
Sbjct: 59 QHPRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAF 117
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ I+RDL+ NILV E + DF L+
Sbjct: 118 IERKNYIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 10/160 (6%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
++ ++ LLQ +G G+ G V L + G A+K + N+ A+ E ++
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQA-----FLAEASVMT 54
Query: 665 MLDHPFLPTLYSQFTSDNLSC-LVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLL 722
L H L L + +V EY G L LR + + +F + +V
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCE 113
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762
A+EYL ++RDL N+LV ED ++DF L+ S
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 153
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-05
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 20/156 (12%)
Query: 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL 663
G L + +++K+G G G V+L + T F K + L R+K + E ++
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNVM 66
Query: 664 RMLDHPFLPTLYSQF--TSDNLSCLVMEYCPGGDLHVLRQKQLGKCF------SEPAARF 715
R L H + +F ++ ++ME+C GDL + + KC+ E A
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL----SRNIQKCYKMFGKIEEHAIVD 122
Query: 716 YVAEVLLALEYLHMLG-------VIYRDLKPENILV 744
++L AL Y H L V++RDLKP+NI +
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
|
Length = 1021 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 6e-05
Identities = 34/136 (25%), Positives = 51/136 (37%), Gaps = 38/136 (27%)
Query: 843 FVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG-------------- 887
+V T Y APE++ A+D W+ G ELL + F G
Sbjct: 166 YVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGT 225
Query: 888 -NEETL-------ANVVMQSLKFPDSPLISF---------QARDLIRGLLIKEPENRLGS 930
+EE L A ++SL P P +A DL+ +L+ +P+ R+
Sbjct: 226 PSEEDLKFITSEKARNYLKSL--PKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT- 282
Query: 931 QKGAAEIKQHPFFEGL 946
A E HP+ L
Sbjct: 283 ---ADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 6e-05
Identities = 40/152 (26%), Positives = 58/152 (38%), Gaps = 40/152 (26%)
Query: 826 RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFK 884
RSL +L P + +V T Y APEI+ G VD W+ G L E+L G+ F
Sbjct: 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214
Query: 885 GSG---------------NEETL-------ANVVMQSL----------KFPDSPLISFQA 912
G+ + E + A ++ SL P + A
Sbjct: 215 GTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASD---DA 271
Query: 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
DL++ LL+ P RL A E +HP+
Sbjct: 272 LDLLKKLLVFNPNKRL----TAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 29/87 (33%), Positives = 38/87 (43%), Gaps = 15/87 (17%)
Query: 865 DWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923
D W+FGI L E++ YGR P+ G N E L V + + P P + DL+ K+
Sbjct: 186 DVWSFGILLTEIVTYGRVPYPGMTNREVLEQ-VERGYRMPRPPNCPEELYDLMLQCWDKD 244
Query: 924 PENRLGSQKGAAEIKQHPFFEGLNWAL 950
PE R P FE L L
Sbjct: 245 PEER-------------PTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-05
Identities = 18/37 (48%), Positives = 27/37 (72%)
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
+VL L LH +G+++RD+KPEN+LV DG + + DF
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 35/194 (18%)
Query: 587 MSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-------CLFAI 639
+ D RWE R RL G + LG G G V +AE IG + A+
Sbjct: 7 LPEDPRWEVPRD-RLVLG----------KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV 55
Query: 640 KVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-- 696
K++ ++ A K + +E E+++M+ H + L T D +++EY G+L
Sbjct: 56 KMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 113
Query: 697 --HVLRQKQLGKCFSE---PAARFYVA-------EVLLALEYLHMLGVIYRDLKPENILV 744
R + C++ P + +V +EYL I+RDL N+LV
Sbjct: 114 YLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173
Query: 745 REDGHIMLTDFDLS 758
ED + + DF L+
Sbjct: 174 TEDNVMKIADFGLA 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 6/143 (4%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY 675
KLG G G V++ GT + AIK + ++ + AQ +++ L H L LY
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQ----VMKKLRHEKLVQLY 67
Query: 676 SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
+ + + + +V EY G L + ++GK P A++ + Y+ + ++R
Sbjct: 68 AVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126
Query: 736 DLKPENILVREDGHIMLTDFDLS 758
DL+ NILV E+ + DF L+
Sbjct: 127 DLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 44/159 (27%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ---- 898
+V T Y APE+I G G+ VD W+ G + EL+ G F+G+ + + V+ Q
Sbjct: 182 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241
Query: 899 SLKF---------------PDSPLISF---------------------QARDLIRGLLIK 922
S +F P P ISF QARDL+ +L+
Sbjct: 242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI 301
Query: 923 EPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961
+P+ R+ E +HP+ A PP++ D
Sbjct: 302 DPDKRISVD----EALRHPYITVWYDPAEAEAPPPQIYD 336
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 9/149 (6%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-AQTEREILRMLDHPFLP 672
++K+G G G VY A TN A+K + E + +P A E +L+ + H +
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA--ARFYVAEVLLALEYLHML 730
L S+ LV EY DL + + F++ + Y+ ++L + Y H
Sbjct: 65 RLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH 121
Query: 731 GVIYRDLKPENILV-REDGHIMLTDFDLS 758
V++RDLKP+N+L+ R + L DF L+
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 7/147 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLDH 668
F +L +G G G V T + AIK + + + + T RE+ LR L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKD---SEENEEVKETTLRELKMLRTLKQ 59
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ L F LV EY L +L + G R Y+ +++ A+ + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCH 117
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
+++RD+KPEN+L+ + + L DF
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889
+L+ P A + ++VGT Y+ PEI + + D W+ G LYEL + PF+ +
Sbjct: 148 RLLTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN--- 203
Query: 890 ETLANVVMQSLKFPDSPL---ISFQARDLIRGLLIKEPENR 927
+ N++++ + PL S++ R LI+ + + P +R
Sbjct: 204 -SWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 31/111 (27%), Positives = 52/111 (46%), Gaps = 5/111 (4%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 895 VVMQSLKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
+ +P +S RD + L + E R GS K E+ QH F +
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKR-GSAK---ELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 19/46 (41%), Positives = 29/46 (63%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTP 882
D+ +NSFVGT Y++PE ++G + D W+ G+ L E+ GR P
Sbjct: 156 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 43/168 (25%), Positives = 66/168 (39%), Gaps = 48/168 (28%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-------------- 888
+V T Y APE+I G G+ VD W+ G + E++ G F G+ +
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236
Query: 889 --------EETLANVVMQSLK---------FPDS----------PLISFQARDLIRGLLI 921
+ T+ N V K FPD L + QARDL+ +L+
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296
Query: 922 KEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQD 969
+PE R+ + QHP+ + + PP P YD+ I +
Sbjct: 297 IDPEKRI----SVDDALQHPYIN-VWYDPSEVEAPPPAP--YDHSIDE 337
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 1e-04
Identities = 32/120 (26%), Positives = 49/120 (40%), Gaps = 21/120 (17%)
Query: 645 EFLARRKKMPR-------AQTEREILRML-DHPF-LPTLYSQFTSDNLSCLVMEYCPGGD 695
++L RK AQ E L+ L + F +P N +VMEY G +
Sbjct: 62 DYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVE 117
Query: 696 LHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
L+ +R E E+L + + G+I+ DL NILV +D I + D+
Sbjct: 118 LYRVRV-------LEDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 47/204 (23%), Positives = 77/204 (37%), Gaps = 45/204 (22%)
Query: 565 SSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGT 624
+ ++ + + C ++ + VR+QY N+L L G G
Sbjct: 58 TDYDADEESLSPQTDVCQEPCETTSSS--DPASVVRMQY--------NILSSLTPGSEGE 107
Query: 625 VYLAELIGTNCLFAIKVMDNEFLARRKKMPRA-------QTEREILRMLDHPFLPTLYSQ 677
V++ G R+K + +A E +IL+ + H + L
Sbjct: 108 VFVCTKHGDE-------------QRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHA 154
Query: 678 FTSDNLSCLVMEY--CPGGDLHVLRQKQLGKCFSEPAA---RFYVAEVLL-ALEYLHMLG 731
+ + C+VM C DL + S P + LL AL YLH G
Sbjct: 155 YRWKSTVCMVMPKYKC---DLFTYVDR------SGPLPLEQAITIQRRLLEALAYLHGRG 205
Query: 732 VIYRDLKPENILVREDGHIMLTDF 755
+I+RD+K ENI + E + +L DF
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDF 229
|
Length = 392 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 35/146 (23%), Positives = 64/146 (43%), Gaps = 5/146 (3%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
L++KLG G G V++ + A+K + ++ + + A +++ L H L
Sbjct: 10 LVKKLGAGQFGEVWMG-YYNNSTKVAVKTLKPGTMSVQAFLEEAN----LMKTLQHDKLV 64
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
LY+ T + ++ EY G L + G P + A++ + Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 733 IYRDLKPENILVREDGHIMLTDFDLS 758
I+RDL+ N+LV E + DF L+
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 20/40 (50%), Positives = 28/40 (70%)
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++L L++LH V++RDLKP+NILV G I L DF L+
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 44/190 (23%), Positives = 79/190 (41%), Gaps = 23/190 (12%)
Query: 613 LLQKLGCGDIGTVYLAEL----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+++LG G +Y L + L AIK + + + ++ Q E ++ L H
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHH 66
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLR--QKQLGKCFSEPAAR--------- 714
P + L T + C++ EY GDLH ++R +G C S+
Sbjct: 67 PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVG-CSSDEDGTVKSSLDHGD 125
Query: 715 -FYVA-EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
++A ++ +EYL +++DL NIL+ E H+ ++D LS +
Sbjct: 126 FLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 773 NMDPARVSGP 782
++ P R P
Sbjct: 186 SLLPIRWMPP 195
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 31/113 (27%), Positives = 52/113 (46%), Gaps = 19/113 (16%)
Query: 646 FLARRKKMPRAQTEREILRMLDHPF---LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQK 702
+++R A+ E E L+ L +P +P + N +VMEY G +L+ LR
Sbjct: 150 YVSRLA----AEREFEALQRL-YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRLD 200
Query: 703 QLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
P ++L + + G+++ DL NILV EDG I++ D+
Sbjct: 201 V-----ENPDEILD--KILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 8/144 (5%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRA-QTEREILRMLDHPFLPTL 674
KLG G G V++ GT + AIK + + MP A E +I++ L H L L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPL 66
Query: 675 YSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734
Y+ + + + +V E+ G L ++ GK P A++ + Y+ + I+
Sbjct: 67 YAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 735 RDLKPENILVREDGHIMLTDFDLS 758
RDL+ NILV ++ + DF L+
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 38/147 (25%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 616 KLGCGDIGTVY--LAELIGTNCLFAIKVMDNEF--LARRKKMPRAQTEREILRMLDHPFL 671
+LG G+ GTV + ++ + A+K++ N+ A + ++ R E +++ LD+P++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---EANVMQQLDNPYI 58
Query: 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
+ +++ LVME G L+ QK K +E V +V + ++YL
Sbjct: 59 VRMIGICEAESW-MLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETN 115
Query: 732 VIYRDLKPENILVREDGHIMLTDFDLS 758
++RDL N+L+ + ++DF LS
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 35/132 (26%), Positives = 52/132 (39%), Gaps = 34/132 (25%)
Query: 843 FVGTHEYLAPEI-IKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-------------- 887
+V T Y APEI + + + A+D W+ G L ELL + FKG
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 888 -NEETLANVVMQSL-----KFPDSPLISF---------QARDLIRGLLIKEPENRLGSQK 932
+EETL+ + P+ P F A DL+ LL +P R+ +
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE- 287
Query: 933 GAAEIKQHPFFE 944
E +HP+
Sbjct: 288 ---EALEHPYLA 296
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 27/101 (26%), Positives = 48/101 (47%), Gaps = 5/101 (4%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
S GT +++PE+I GEG+G D W+ G + E+L + P+ + + Q
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 227
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
P +S RD ++ + + E +L + A E+ +H F
Sbjct: 228 PVLPPHVSDHCRDFLKRIFV---EAKL--RPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 31/101 (30%), Positives = 43/101 (42%), Gaps = 15/101 (14%)
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQSLKFPDSPLIS 909
APE D W+FGI L E++ YGR P+ G N E L V Q + P P
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-VDQGYRMPCPPGCP 230
Query: 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950
+ D++ ++P++R P FE L W L
Sbjct: 231 KELYDIMLDCWKEDPDDR-------------PTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 21/61 (34%), Positives = 33/61 (54%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
++E ++A +V T Y +PE++ G +G AVD W+ G L EL G+ F G +
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
Query: 892 L 892
L
Sbjct: 210 L 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 33/172 (19%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK---------KMPRAQT------- 658
+KLG G G V+L E G K MD +F KM R
Sbjct: 11 EKLGEGQFGEVHLCEAEGME-----KFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 659 ---EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH--VLRQKQLGKCFSEPAA 713
E +I+ L P + L + + + C++ EY GDL+ + R +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 714 -------RFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
F ++ ++YL L ++RDL N LV ++ I + DF +S
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 12/157 (7%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L+ + L+ +G G G V A AIK + F + RA E +++ ++
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVN 81
Query: 668 HPFLPTLYSQFTSDNL------SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
H + L + FT +VME V++ + + + ++L
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME-----LDHERMSYLLYQML 136
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+++LH G+I+RDLKP NI+V+ D + + DF L+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 19/37 (51%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 723 ALEYL-HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
AL YL L +I+RD+KP NIL+ +G+I L DF +S
Sbjct: 119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 1/136 (0%)
Query: 618 GCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQ 677
G ++ +VYLA T L +++ D E + + Q E + HP + T ++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLEN-CTEEHLKALQNEVVLSHFFRHPNIMTSWTV 67
Query: 678 FTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737
FT+ + ++ + G + L + + SE + L L YLH G I+R++
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNI 127
Query: 738 KPENILVREDGHIMLT 753
K +IL+ DG + L+
Sbjct: 128 KASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 4/91 (4%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQ 898
++S VGT Y++PE I G+ D W+ G LYE+ ++PF G N +L + Q
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 222
Query: 899 SLKFPDSPL--ISFQARDLIRGLLIKEPENR 927
+P P S + R L+ + +PE R
Sbjct: 223 C-DYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQ 898
++S VGT Y++PE I G+ D W+ G LYE+ ++PF G N +L + Q
Sbjct: 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ 222
Query: 899 SLKFPDSPL--ISFQARDLIRGLLIKEPENR 927
+P P S + R+L+ + +P+ R
Sbjct: 223 C-DYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 39/141 (27%), Positives = 53/141 (37%), Gaps = 34/141 (24%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL- 892
PT SN V T Y P+I+ G + +D W G YE+ GR F GS EE L
Sbjct: 157 PTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215
Query: 893 ------------------ANVVMQSLKFPD---SPLISFQAR------DLIRGLLIKEPE 925
+N +S +P L + R +L+ LL E
Sbjct: 216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGR 275
Query: 926 NRLGSQKGAAEIKQHPFFEGL 946
R+ A E +HP+F L
Sbjct: 276 KRI----SAEEAMKHPYFHCL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 40/159 (25%), Positives = 63/159 (39%), Gaps = 44/159 (27%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV------ 896
+V T Y APE+I G G+ VD W+ G + E++ G F G+ + + V+
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 897 ----MQSLK---------------------FPD---------SPLISFQARDLIRGLLIK 922
M+ L+ FPD + L + QARDL+ +L+
Sbjct: 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 923 EPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961
+ R+ E QHP+ A PP++PD
Sbjct: 305 DASKRI----SVDEALQHPYINVWYDPSEAEAPPPKIPD 339
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 27/174 (15%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK-----VMDNEFLARRKKMPRAQTER 660
+ L+ L + +G G+ G V E G A+K V FL M + +
Sbjct: 3 LNLQKLTLGEIIGEGEFGAVLQGEYTGQKV--AVKNIKCDVTAQAFLEETAVMTKLHHK- 59
Query: 661 EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARF--YV 717
++R+L LY +VME G+L + LR + G+ + +
Sbjct: 60 NLVRLLGVILHNGLY----------IVMELMSKGNLVNFLRTR--GR-ALVSVIQLLQFS 106
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSS 771
+V +EYL +++RDL NILV EDG ++DF L+ V + +S
Sbjct: 107 LDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNS 157
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 35/194 (18%)
Query: 587 MSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-------CLFAI 639
+ AD +WE R RL G + LG G G V +AE IG + A+
Sbjct: 1 LPADPKWELSR-TRLTLG----------KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAV 49
Query: 640 KVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-H 697
K++ ++ A K + +E E+++M+ H + L T D +++EY G+L
Sbjct: 50 KMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLRE 107
Query: 698 VLRQKQL-GKCFSEPAARF------------YVAEVLLALEYLHMLGVIYRDLKPENILV 744
LR ++ G +S + +V +EYL I+RDL N+LV
Sbjct: 108 YLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167
Query: 745 REDGHIMLTDFDLS 758
ED + + DF L+
Sbjct: 168 TEDNVMKIADFGLA 181
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 25/84 (29%), Positives = 42/84 (50%), Gaps = 1/84 (1%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
+GT YL+PEI + + D W G LYE+ + F+ +GN + L +++ P
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE-AGNMKNLVLKIIRGSYPP 220
Query: 904 DSPLISFQARDLIRGLLIKEPENR 927
S S+ R+L+ L + P +R
Sbjct: 221 VSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 36/125 (28%), Positives = 53/125 (42%), Gaps = 24/125 (19%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAV------DWWTFGIFLYELLYGRTPF 883
LVA + A++N +G Y+APE IK G D W+ G+ + E+ GR P+
Sbjct: 152 NLVA--SLAKTN--IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207
Query: 884 KGSGNEETLANVVMQSLKFPDS------PLISFQARDLIRGLLIKEPENRLGSQKGAAEI 937
ET AN+ Q D S A+D + L K P R A++
Sbjct: 208 P----PETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR----PTYAQL 259
Query: 938 KQHPF 942
+HP+
Sbjct: 260 LEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 27/103 (26%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
S GT +++PE+I GEG+G D W+ + E+L + P+ + + Q K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227
Query: 902 --FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
PD +S RD ++ + ++E A + +HPF
Sbjct: 228 PMLPDG--VSDACRDFLKQIFVEEKRRPT-----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 32/118 (27%), Positives = 49/118 (41%), Gaps = 10/118 (8%)
Query: 836 TDARSNSFVGTHEYLAPEII-----KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
T R +SF+GT ++APE++ K + D W+ GI L E+ P
Sbjct: 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
Query: 891 TLANVVMQSLKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947
L + P S + RD ++ L K PE R AA++ +HPF +
Sbjct: 223 VLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR----PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 31/110 (28%), Positives = 48/110 (43%), Gaps = 11/110 (10%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
T + N+FVGT ++APE+I+ + + D W+ GI EL G P ++ V
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP----NSDMHPMRV 209
Query: 896 VMQSLKFPDSPLI---SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ K L S ++ I L K+P R A E+ +H F
Sbjct: 210 LFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFR----PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 6e-04
Identities = 39/193 (20%), Positives = 75/193 (38%), Gaps = 30/193 (15%)
Query: 563 DYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDI 622
D +S + + DD L + + R V G + +++ L G
Sbjct: 39 DSASESDDDDDDGLIPTK-------------QKAREVVASLG------YTVIKTLTPGSE 79
Query: 623 GTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682
G V++A G +K+ + E +L+ ++HP + + S
Sbjct: 80 GRVFVATKPGQPDPVVLKI---------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA 130
Query: 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742
++C+V+ + DL+ K+ A ++L L YLH +I+RD+K ENI
Sbjct: 131 ITCMVLPHY-SSDLYTYLTKRSRP-LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI 188
Query: 743 LVREDGHIMLTDF 755
+ + + + D
Sbjct: 189 FINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 50/191 (26%), Positives = 81/191 (42%), Gaps = 35/191 (18%)
Query: 590 DVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-------CLFAIKVM 642
D RWE R L + LG G G V +AE +G + A+K++
Sbjct: 7 DPRWEFSRD-----------KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML 55
Query: 643 DNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLR 700
++ A K + +E E+++M+ H + L T D +++EY G+L LR
Sbjct: 56 KDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 113
Query: 701 QKQ-LGKCFSEPAARF------------YVAEVLLALEYLHMLGVIYRDLKPENILVRED 747
++ G +S AR +V +EYL I+RDL N+LV E+
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173
Query: 748 GHIMLTDFDLS 758
+ + DF L+
Sbjct: 174 NVMKIADFGLA 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 7e-04
Identities = 35/143 (24%), Positives = 57/143 (39%), Gaps = 23/143 (16%)
Query: 624 TVYLAELIGTNCLFAIKV----MDNEFLARRKKMPRAQTE-REILRMLDH--PFLPTLYS 676
+YL + +G + +V E L R + R + E R + R P +Y
Sbjct: 9 IIYLGDFLGLKAVIKERVPKSYRHPE-LDERIRRERTRNEARLLSRARKAGVN-TPVVY- 65
Query: 677 QFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735
+ +VMEY G L V+ + + E+ + LH G+++
Sbjct: 66 -DVDPDNKTIVMEYIEGKPLKDVIEEGNDE----------LLREIGRLVGKLHKAGIVHG 114
Query: 736 DLKPENILVREDGHIMLTDFDLS 758
DL NI+VR+D + L DF L
Sbjct: 115 DLTTSNIIVRDDK-LYLIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 8e-04
Identities = 42/152 (27%), Positives = 59/152 (38%), Gaps = 44/152 (28%)
Query: 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEII-KGEGHGAAVDWWTFGIFLYELLYGR 880
A +IRS P TD +V T Y APEI+ + + + VD W G + EL R
Sbjct: 146 AREIRSRPPY----TD-----YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
Query: 881 TPFKGSGNE--------ETLAN----------VVMQSL--KFPDSPLISFQ--------- 911
F GS +E L + L +FP S
Sbjct: 197 PLFPGS-SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPE 255
Query: 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
A DLI+ +L +P+ R A++ QHP+F
Sbjct: 256 AIDLIKDMLRWDPKKRP----TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 8e-04
Identities = 32/106 (30%), Positives = 55/106 (51%), Gaps = 11/106 (10%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
+ +F GT Y++PE +K +G+ + D W+ G LYE+ F+G +VV++
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLRI 217
Query: 900 LKFPDSPL---ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
++ P L S Q +++ +L K+P R AAEI ++PF
Sbjct: 218 VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRP----SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-04
Identities = 19/48 (39%), Positives = 26/48 (54%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPF 883
T + N+FVGT ++APE+IK + D W+ GI EL G P
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 35/128 (27%), Positives = 50/128 (39%), Gaps = 31/128 (24%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTP-FKGSGNEETL-------- 892
S V T Y APE++ + VD W+ G E L+ R P F+G+ + L
Sbjct: 165 SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRPLFRGTSEADQLDKIFDVIG 223
Query: 893 --------ANVVMQSLKFPDSPLISFQ---------ARDLIRGLLIKEPENRLGSQKGAA 935
NV + FP SF+ DL++ +L P R+ A
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI----SAF 279
Query: 936 EIKQHPFF 943
E QHP+F
Sbjct: 280 EALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 34/111 (30%), Positives = 49/111 (44%), Gaps = 17/111 (15%)
Query: 840 SNSFVGTHEYLAPEIIKG--EGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+NSFVGT ++APE+I EG VD W+ GI EL + P L ++
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227
Query: 897 MQSLKFPDSPLI-----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
DSP + S R+ + L K P++R S E+ +H F
Sbjct: 228 QN-----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSS----EELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 19/47 (40%), Positives = 27/47 (57%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTP 882
T + N+FVGT ++APE+IK + + D W+ GI EL G P
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 21/66 (31%), Positives = 39/66 (59%), Gaps = 6/66 (9%)
Query: 695 DLH--VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML 752
DLH ++ + L S + ++ ++L L+YLH G+++RD+KP N+LV + + +
Sbjct: 89 DLHKIIVSPQPL----SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKI 144
Query: 753 TDFDLS 758
DF L+
Sbjct: 145 CDFGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 32/141 (22%), Positives = 55/141 (39%), Gaps = 18/141 (12%)
Query: 625 VYLAELIGTNCLFAIKV----MDNEFLARRKKMPRAQTEREIL---RMLDHPFLPTLYSQ 677
+YL + +G + ++ E L R + R + E I+ R +P +Y
Sbjct: 12 IYLGDFLGIKAVIKWRIPKRYRHPE-LDERIRRERTRREARIMSRARKAGVN-VPAVYFV 69
Query: 678 FTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737
+ + +VMEY G L L + E+ + LH G+I+ DL
Sbjct: 70 DPENFI--IVMEYIEGEPLKDLINS------NGMEELELSREIGRLVGKLHSAGIIHGDL 121
Query: 738 KPENILVREDGHIMLTDFDLS 758
N+++ I L DF L+
Sbjct: 122 TTSNMILSGGK-IYLIDFGLA 141
|
Length = 211 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 41/166 (24%), Positives = 74/166 (44%), Gaps = 22/166 (13%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCL-----FAIKVMDNEFLARRKKMPRAQTEREILRML- 666
L + LG G G V AE +G + A+K++ ++ A K + +E E+++M+
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIG 73
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQ-------------LGKCFSEPA 712
H + L T + +V+EY G+L LR ++ + ++
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 713 ARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ +V +E+L I+RDL N+LV ED + + DF L+
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 30/110 (27%), Positives = 45/110 (40%), Gaps = 21/110 (19%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS---------GNEETL 892
S GT ++APE+I G+G D W+ G ++E+ G+ P G L
Sbjct: 167 SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL 226
Query: 893 ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
M L PDS S A D + L ++ R A ++ +H F
Sbjct: 227 ----MPRL--PDS--FSAAAIDFVTSCLTRDQHER----PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 37/137 (27%), Positives = 56/137 (40%), Gaps = 33/137 (24%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
P + SN V T Y AP+++ G + ++D W+ G + E++ GR F G+ NE+ L
Sbjct: 153 PVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
Query: 894 NV--------------VMQS----LKFPDSPLISFQ---------ARDLIRGLLIKEPEN 926
+ + Q FP P Q DL+ LL PE
Sbjct: 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPEL 271
Query: 927 RLGSQKGAAEIKQHPFF 943
R+ A + QHP+F
Sbjct: 272 RI----SAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 38/138 (27%), Positives = 57/138 (41%), Gaps = 34/138 (24%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL- 892
PT SN V T Y P+++ G + +D W G LYE+ GR F GS +E L
Sbjct: 156 PTKTYSNEVV-TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214
Query: 893 ------------------ANVVMQSLKFPD---SPLISFQAR------DLIRGLLIKEPE 925
+N +S FP PLI+ R DL+ LL+ E +
Sbjct: 215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETK 274
Query: 926 NRLGSQKGAAEIKQHPFF 943
+R+ ++ +H +F
Sbjct: 275 SRISAEAAL----RHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 16/50 (32%), Positives = 30/50 (60%)
Query: 706 KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
KC ++ + + ++L LEY+H G+ + D+KPENI+V + + D+
Sbjct: 121 KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170
|
Length = 294 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 43/163 (26%), Positives = 66/163 (40%), Gaps = 25/163 (15%)
Query: 609 RHFNLLQKLGCGDIGTV----YLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
R+ ++ LG G G V Y GT + A+K + E ++ + E IL+
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE--CGQQNTSGWKKEINILK 61
Query: 665 MLDHPFLPTLYSQFTSD---NLSCLVMEYCPGGDL------HVLRQKQLGKCFSEPAARF 715
L H + Y S+ L+MEY P G L H L QL
Sbjct: 62 TLYHENI-VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL---------LL 111
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ ++ + YLH I+RDL N+L+ D + + DF L+
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 9/156 (5%)
Query: 609 RHFNLLQKLGCGDIGTV----YLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
R ++ LG G G V Y E T A+K + E + + + E EILR
Sbjct: 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILR 61
Query: 665 MLDHPFLPTLYSQFTSDNLSC--LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
L H + T D + L+ME+ P G L + K + + Y ++
Sbjct: 62 NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICK 120
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++YL ++RDL N+LV + + + DF L+
Sbjct: 121 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 22/172 (12%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAE---LIGTN--CLFAIKVMDNEFLARRKKMPRAQTER 660
I R L ++LG G G V+LAE L T L A+K + + LA RK Q E
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREA 58
Query: 661 EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-----------VLRQKQLGKCFS 709
E+L L H + Y + +V EY GDL+ +L Q +
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 710 E--PAARFYVA-EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
E + ++A ++ + YL ++RDL N LV + + + DF +S
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 34/141 (24%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEI-IKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS---- 886
+A D + +V T Y APEI + + + VD W+ G E+L G+ F G
Sbjct: 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213
Query: 887 ---------GN--EETLANVVMQ-SLKFPDS-------PLISF------QARDLIRGLLI 921
G ++ + + + +L+F S P A DL+ +L+
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLV 273
Query: 922 KEPENRLGSQKGAAEIKQHPF 942
+P+ R+ AAE HP+
Sbjct: 274 FDPQKRI----SAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 33/142 (23%), Positives = 60/142 (42%), Gaps = 35/142 (24%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+A P + ++ +V T Y APE++ G+ +G AVD W G + E+L G F G + +
Sbjct: 150 LAAPGEVYTD-YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID 208
Query: 891 TLANVVM-------------------QSLKFPDS----------PLISFQARDLIRGLLI 921
L +++ ++ P+ P +S DL + L
Sbjct: 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLR 268
Query: 922 KEPENRLGSQKGAAEIKQHPFF 943
+P++R S +++ H FF
Sbjct: 269 IDPDDRPSS----SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 22/78 (28%), Positives = 33/78 (42%), Gaps = 2/78 (2%)
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQSLKFPDSPLIS 909
APE D W+FGI LYE+ YG+ P+ G N E + + + P
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY-DQITAGYRMPCPAKCP 230
Query: 910 FQARDLIRGLLIKEPENR 927
+ ++ EPE+R
Sbjct: 231 QEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.003
Identities = 31/133 (23%), Positives = 45/133 (33%), Gaps = 39/133 (29%)
Query: 844 VGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG--------------- 887
V T Y APE++ G A+D W+ G ELL + F G
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTP 226
Query: 888 NEET------LANVVMQSLKFPDSP-----------LISFQARDLIRGLLIKEPENRLGS 930
E+ L + F P +S DL+ LL +P R+
Sbjct: 227 TEKIWPGFSELPGA--KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI-- 282
Query: 931 QKGAAEIKQHPFF 943
A + +HP+F
Sbjct: 283 --SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 25/81 (30%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQSLKFPDSP 906
++ APE I D W+FGI L E++ YGR P+ G N E + N + + + P
Sbjct: 168 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN-LERGYRMPRPD 226
Query: 907 LISFQARDLIRGLLIKEPENR 927
+ +L+R ++PE R
Sbjct: 227 NCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 28/104 (26%), Positives = 41/104 (39%), Gaps = 3/104 (2%)
Query: 659 EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARF--- 715
E + R L+HP + Q LV+E+CP GDL + G
Sbjct: 45 EVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR 104
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759
EV L +LH I+ DL N + D + + D+ L+L
Sbjct: 105 MACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL 148
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 17/160 (10%)
Query: 613 LLQKLGCGDIGTVY--LAELIGTNCLF---AIK-VMDNEFLARRKKMPRAQTEREILRML 666
L+++LG G G VY LA+ + AIK V +N + R + E +++
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF---LNEASVMKEF 66
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQK-----QLGKCFSEPAARFY--VA 718
+ + L ++ + +VME GDL LR + +F A
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
E+ + YL ++RDL N +V ED + + DF ++
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 7/152 (4%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMPRAQTEREILRML 666
+ + L +G G G VY A I T+ AIK + D ++ R + + I+ +
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLK 125
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA--ARFYVAEVLLAL 724
D+ + + L+ +VME+ P +H + + P + Y ++ AL
Sbjct: 126 DYYYTECFKKNEKNIFLN-VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIM-LTDF 755
Y+H + +RDLKP+N+L+ + H + L DF
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 21/81 (25%), Positives = 40/81 (49%), Gaps = 2/81 (2%)
Query: 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQSLKFPDSP 906
++ APE I D W+FGI LYE++ YG+ P+ G N + ++ + + + P
Sbjct: 169 KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-ALQRGYRMPRME 227
Query: 907 LISFQARDLIRGLLIKEPENR 927
+ D+++ ++ E R
Sbjct: 228 NCPDELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.004
Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 13/138 (9%)
Query: 624 TVYLAELIGTNCLFAI---KVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680
+YL + +G + K + L + + R + E IL +P
Sbjct: 11 IIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD 70
Query: 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPE 740
+ +VMEY G L K E A + EV + LH G+++ DL
Sbjct: 71 PDNGLIVMEYIEGELL---------KDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTS 121
Query: 741 NILVREDGHIMLTDFDLS 758
NI++ I DF L
Sbjct: 122 NIILSGGR-IYFIDFGLG 138
|
Length = 204 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 8/146 (5%)
Query: 617 LGCGDIGTVY----LAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
LG G GTVY + E AIK++ NE + + E I+ +DHP L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKIL-NETTGPKANV-EFMDEALIMASMDHPHLV 72
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
L S + LV + P G L + S+ + V ++ + YL +
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV-QIAKGMMYLEERRL 130
Query: 733 IYRDLKPENILVREDGHIMLTDFDLS 758
++RDL N+LV+ H+ +TDF L+
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 992 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.8 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.33 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.28 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.17 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.15 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.12 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.96 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.95 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.59 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.43 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.39 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.36 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.27 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.2 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.15 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.01 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.93 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.84 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.64 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.07 | |
| PLN02236 | 344 | choline kinase | 96.03 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.98 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.8 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.64 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.16 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.05 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.79 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.79 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.61 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.15 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.92 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.74 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.22 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 92.87 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.73 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.54 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 91.85 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 91.82 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-66 Score=572.23 Aligned_cols=372 Identities=73% Similarity=1.220 Sum_probs=335.2
Q ss_pred CCCCCCCCCcchhhhHhhhee-eecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHH
Q 001952 580 SCGNRPHMSADVRWEAIRHVR-LQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQT 658 (992)
Q Consensus 580 s~~~~~~~s~d~~~e~~~~~~-~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~ 658 (992)
++...++...+..|+.+...+ ...+.+..++|++++.||+|.-|+||+|++.+++..+|+|++.+..+..++...+++.
T Consensus 47 ~~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~t 126 (459)
T KOG0610|consen 47 SSGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQT 126 (459)
T ss_pred cccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHH
Confidence 456788999999999998777 6788899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecC
Q 001952 659 EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLK 738 (992)
Q Consensus 659 EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIK 738 (992)
|.+||..++||+++.||..|+.++..|||||||+||+|+.+++++.++.|++..++.|+.+|+.||+|||.+||||||||
T Consensus 127 E~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLK 206 (459)
T KOG0610|consen 127 EREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLK 206 (459)
T ss_pred HHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCC
Q 001952 739 PENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPK 818 (992)
Q Consensus 739 PeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~ 818 (992)
|+||||.++|+++|+||.|+.+|...+.+........ . ...|.|.. ++..|++|+......+..+
T Consensus 207 PENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~---------~--~~~~~~~~--~~~s~f~~r~~~~~~~~~k-- 271 (459)
T KOG0610|consen 207 PENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRS---------S--GSQPSCRS--RQPSCFSPRCLSSSKKRKK-- 271 (459)
T ss_pred cceeEEecCCcEEeeeccccccCCCCCeeeccCCCCC---------C--CCCccccc--ccccccccchhcccccccc--
Confidence 9999999999999999999999977776654321110 0 01233332 4567888886555443333
Q ss_pred CChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh
Q 001952 819 ADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898 (992)
Q Consensus 819 ~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~ 898 (992)
.+...+ +..+.+.+++.+.++++++||.+|+|||++.|.+++.++|||+|||+|||||+|..||+|.++.+++.+|+.+
T Consensus 272 ~~~~~~-~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~ 350 (459)
T KOG0610|consen 272 KDESAS-RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ 350 (459)
T ss_pred cccccc-ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC
Confidence 222233 7788899999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCCCCCC
Q 001952 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGI 967 (992)
Q Consensus 899 ~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~d~~~ 967 (992)
.+.||..+.++..++|||+++|.+||.+|+...++|.||.+||||+++||+++|+..||++|+..+...
T Consensus 351 ~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 351 PLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred CCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccCc
Confidence 999999999999999999999999999999999999999999999999999999999999998888754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-54 Score=488.61 Aligned_cols=341 Identities=37% Similarity=0.646 Sum_probs=273.5
Q ss_pred heeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeee
Q 001952 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQ 677 (992)
Q Consensus 598 ~~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~ 677 (992)
..+.+...+..++|+++..||+|+||.||+|+.+.+|..||+|++++.......++..+..|..+|...++++||+||..
T Consensus 130 ~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs 209 (550)
T KOG0605|consen 130 YLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS 209 (550)
T ss_pred HHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence 34445556788999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred eccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccc
Q 001952 678 FTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757 (992)
Q Consensus 678 f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGL 757 (992)
|.+.+++||||||++||++..+|.+. ..|++..++.|+.+++.|++.||++|+|||||||+|+|||..|++||+||||
T Consensus 210 FQD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 210 FQDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred ecCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999999999999875 7899999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccC-CC-CCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 758 SLRCSVSPTLLKS-SS-NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 758 A~~l~~~~~~~~~-~s-~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
+.-+......... .. .++.. .+. ..+.-.+.. .+.....+...+... ....
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~-~~~---------------------~~~~~~~~~-~~~~~~~~~~~~~~~----w~~n 340 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQIN-LSE---------------------AKPSDFPKF-NTPRSTMSRREQLQT----WKRN 340 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhh-hcc---------------------CCCcccccc-ccccchhhHHHHHHH----HHhh
Confidence 8433211100000 00 00000 000 000000000 000011111111111 1111
Q ss_pred CCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHH
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQAR 913 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~ 913 (992)
......+.+|||.|||||++.+.+|+..+|+|||||||||||.|.+||.+.+..+++++|+.-. +.+|....++.+++
T Consensus 341 rr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~ 420 (550)
T KOG0605|consen 341 RRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAK 420 (550)
T ss_pred hhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHH
Confidence 2223345799999999999999999999999999999999999999999999999999998755 78888888999999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCC---CCCCCCCcc
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP---DFYDYGIQD 969 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp---~~~d~~~~~ 969 (992)
|||.+||+ ||++|+. ..+++||..||||++++|..|+...+|++| ...|+..+|
T Consensus 421 DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFd 477 (550)
T KOG0605|consen 421 DLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFD 477 (550)
T ss_pred HHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccc
Confidence 99999999 9999999 789999999999999999999999999988 344444443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-54 Score=469.79 Aligned_cols=280 Identities=41% Similarity=0.776 Sum_probs=253.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|+++++||+|+||+||+++.+.+++.||+|++++..............|..||..++||+||.|+..|++.+.+|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34679999999999999999999999999999999999988888888899999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
||+||+.||.|..++++. +.|++..++.|+.+|+.||.|||++|||||||||+||||+.+|+++|+||||++..-
T Consensus 102 lVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--- 176 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--- 176 (357)
T ss_pred EEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc---
Confidence 999999999999999875 789999999999999999999999999999999999999999999999999974210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.......+++|
T Consensus 177 ---------------------------------------------------------------------~~~~~t~tfcG 187 (357)
T KOG0598|consen 177 ---------------------------------------------------------------------KDGDATRTFCG 187 (357)
T ss_pred ---------------------------------------------------------------------cCCCccccccC
Confidence 01122345899
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|||||++.+.+|+.++||||||+++|||++|.+||.+.+..+++.+|+......+. ..++.++++||+++|..||+
T Consensus 188 T~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~LL~rdp~ 266 (357)
T KOG0598|consen 188 TPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKKLLKRDPR 266 (357)
T ss_pred CccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHHHhccCHH
Confidence 99999999999999999999999999999999999999999999999999888744333 25899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCchhhh--hcCCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLNWALI--RCAIPPELP 960 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp 960 (992)
+|++....+++|.+||||.++||..+ +...||+.|
T Consensus 267 ~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P 303 (357)
T KOG0598|consen 267 QRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKP 303 (357)
T ss_pred HhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeec
Confidence 99975567999999999999999966 567788777
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-52 Score=443.81 Aligned_cols=290 Identities=41% Similarity=0.747 Sum_probs=265.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
..+++|++++.||.|+||+|.+++.+.+|..||+|++++..+-+-+.++...+|..+|+.+.||++++|++.|.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66789999999999999999999999999999999999998888888999999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||||++||.|..++++. ++|++..++.|+.||+.||+|||.++||||||||+|||||.+|.+||.|||+|+++..
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 999999999999999985 7899999999999999999999999999999999999999999999999999866421
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
+..+.+|
T Consensus 197 -------------------------------------------------------------------------rT~TlCG 203 (355)
T KOG0616|consen 197 -------------------------------------------------------------------------RTWTLCG 203 (355)
T ss_pred -------------------------------------------------------------------------cEEEecC
Confidence 2345789
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++...+|+.++|+|+|||++|||+.|.+||...+...++.+|+...+.+|.. ++.++++||+++|+.|-.
T Consensus 204 TPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~vD~t 281 (355)
T KOG0616|consen 204 TPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY--FSSDAKDLLKKLLQVDLT 281 (355)
T ss_pred CccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc--cCHHHHHHHHHHHhhhhH
Confidence 999999999999999999999999999999999999999999999999999999999874 999999999999999999
Q ss_pred CcCCChH-hHHHHHcCCCCCCCchhhh--hcCCCCCCC----CCCCCCCccccccc
Q 001952 926 NRLGSQK-GAAEIKQHPFFEGLNWALI--RCAIPPELP----DFYDYGIQDMVPQK 974 (992)
Q Consensus 926 kRPT~~~-~aeEILkHPfF~~lnw~~l--r~~~pp~lp----~~~d~~~~~~~~q~ 974 (992)
+|.+..+ +..+|..||||++++|..+ |...+|..| ...|.+.++.....
T Consensus 282 ~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gdtsnfd~y~e~ 337 (355)
T KOG0616|consen 282 KRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGDTSNFDDYEEE 337 (355)
T ss_pred hhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcccccccccccc
Confidence 9976554 8999999999999999876 556777666 45566666554433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=472.75 Aligned_cols=281 Identities=42% Similarity=0.788 Sum_probs=257.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCC
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDN 682 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~ 682 (992)
+.+..++|.++++||+|+||+|+++.++++++.||||+++++.+..++.+...+.|..|+.... ||+++.|+..|...+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4567899999999999999999999999999999999999998888899999999999998885 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
++|+||||+.||++..+.+ ...|++..++.|++.|+.||+|||++||||||||.+|||||.+|++||+|||+++..
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~- 518 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG- 518 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc-
Confidence 9999999999999544433 367999999999999999999999999999999999999999999999999997321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
-..+.+..+
T Consensus 519 -----------------------------------------------------------------------m~~g~~TsT 527 (694)
T KOG0694|consen 519 -----------------------------------------------------------------------MGQGDRTST 527 (694)
T ss_pred -----------------------------------------------------------------------CCCCCcccc
Confidence 112345678
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
++||+.|||||+|.+..|+.++|||+|||+|||||.|..||.|.+.++.+..|+.....+|.. ++.++.++++++|.+
T Consensus 528 fCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~--ls~ea~~il~~ll~k 605 (694)
T KOG0694|consen 528 FCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--LSKEAIAIMRRLLRK 605 (694)
T ss_pred ccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc--ccHHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999999999999999999999998875 999999999999999
Q ss_pred CcCCcCCC-hHhHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 923 EPENRLGS-QKGAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 923 DPekRPT~-~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
+|++|+++ .+.+++|..||||+++||..+ |...||+.|.
T Consensus 606 ~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~ 647 (694)
T KOG0694|consen 606 NPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPT 647 (694)
T ss_pred CcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcc
Confidence 99999997 357899999999999999977 6788888883
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=461.78 Aligned_cols=288 Identities=39% Similarity=0.675 Sum_probs=258.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
....||.+++.||+|+|++||+|....+++.||||++.+..+.+...+..+.+|.++|.+| +||.|++|+..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3467999999999999999999999999999999999999999999999999999999999 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+|+||+++|+|.+++++. +.|++.-++.|+.||+.||+|||++|||||||||+||||+.+|+++|.|||-|+.+...
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999986 78999999999999999999999999999999999999999999999999998665321
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.... . .|.. ......+..+++
T Consensus 228 ~~~~------~-------------------------~~~~----------------------------~~~a~s~~~SFV 248 (604)
T KOG0592|consen 228 QKSQ------E-------------------------NPVD----------------------------PNQASSRRSSFV 248 (604)
T ss_pred hccc------c-------------------------CccC----------------------------cccccCccccee
Confidence 1100 0 0000 000111136799
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||-.|.+||+|.....+..+|||+|||+||.|+.|.+||.+.++..++.+|+.-.+.||.. +++.++|||+++|..||
T Consensus 249 GTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~--fp~~a~dLv~KLLv~dp 326 (604)
T KOG0592|consen 249 GTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG--FPEDARDLIKKLLVRDP 326 (604)
T ss_pred eeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC--CCHHHHHHHHHHHccCc
Confidence 9999999999999999999999999999999999999999999999999999888888764 99999999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp 960 (992)
.+|+| +.+|.+||||.++||..+..-.||.+-
T Consensus 327 ~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 327 SDRLT----SQQIKAHPFFEGVDWENLWQQTPPKLQ 358 (604)
T ss_pred ccccc----HHHHhhCcccccCChhhhhhcCCCccc
Confidence 99999 999999999999999999888888664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=457.59 Aligned_cols=255 Identities=34% Similarity=0.618 Sum_probs=240.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
.+|+..++||+|||+.||++++..+|+.||+|++.+..+........+.+|++|.+.|+|||||+|+++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|+|+.++|..++++. +.++|..++.+++||+.||.|||+++|||||||..||||+++.++||+|||||.++.
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le------ 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE------ 169 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec------
Confidence 999999999999854 789999999999999999999999999999999999999999999999999985542
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
..+++..+.+|||.
T Consensus 170 ------------------------------------------------------------------~~~Erk~TlCGTPN 183 (592)
T KOG0575|consen 170 ------------------------------------------------------------------YDGERKKTLCGTPN 183 (592)
T ss_pred ------------------------------------------------------------------CcccccceecCCCc
Confidence 12345567899999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++...+++..+||||+||+||.||.|++||...+-.+++.+|....+.+|. .++.++++||.+||..||.+||
T Consensus 184 YIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rp 261 (592)
T KOG0575|consen 184 YIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLRPNPSERP 261 (592)
T ss_pred ccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhcCCcccCC
Confidence 99999999999999999999999999999999999999999999999999999887 5999999999999999999999
Q ss_pred CChHhHHHHHcCCCC
Q 001952 929 GSQKGAAEIKQHPFF 943 (992)
Q Consensus 929 T~~~~aeEILkHPfF 943 (992)
+ +++||.|+||
T Consensus 262 s----l~~vL~h~Ff 272 (592)
T KOG0575|consen 262 S----LDEVLDHPFF 272 (592)
T ss_pred C----HHHHhcCHhh
Confidence 9 9999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-49 Score=435.96 Aligned_cols=261 Identities=32% Similarity=0.484 Sum_probs=225.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh----cchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR----KKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~----~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++++...... .......+|+++|++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4678899999999999999999999999999999987765442 233446799999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC---CcEEEEecccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED---GHIMLTDFDLSLR 760 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d---g~VKLsDFGLA~~ 760 (992)
.||||||+.||.|.+.+-.+ +.+.+..-+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999988775 678888899999999999999999999999999999999866 6799999999844
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.+ .....
T Consensus 329 ~g-------------------------------------------------------------------------~~sfm 335 (475)
T KOG0615|consen 329 SG-------------------------------------------------------------------------EGSFM 335 (475)
T ss_pred cc-------------------------------------------------------------------------cceeh
Confidence 22 11223
Q ss_pred CccccCCCccChhhhcCCCC---CccceeeehhhhhhhhccCCCCCCCCCchH-HHHHHHhhccCC--CCCccchHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGH---GAAVDWWTFGIFLYELLYGRTPFKGSGNEE-TLANVVMQSLKF--PDSPLISFQARD 914 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~---s~kSDIWSLGVlLyELLTGr~PF~g~s~~e-~L~~Iv~~~lk~--P~~~~vs~el~d 914 (992)
.+++||+.|.|||++.+.++ ..++|||||||+||-+|+|.+||.+..... ....|..+.+.+ +.+..+++++.+
T Consensus 336 ~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~d 415 (475)
T KOG0615|consen 336 KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALD 415 (475)
T ss_pred hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHH
Confidence 46799999999999998764 458899999999999999999999877666 556666666654 344568999999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
||.+||..||++||+ ++|+|+||||+-..
T Consensus 416 lI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 416 LINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred HHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 999999999999999 99999999999665
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=429.10 Aligned_cols=260 Identities=32% Similarity=0.501 Sum_probs=227.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-eE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN-LS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~-~l 684 (992)
+..++.+.++.||+|..|+||+|+|+.+++.+|+|++... ........+.+|+++|+.++|||||.+||.|...+ .+
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 3456777888999999999999999999999999999533 23445577899999999999999999999999988 59
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|+||||.+|+|..++... +.+++...-.++.+|++||.|||+ ++||||||||+|||++..|.+||||||.+..+..
T Consensus 154 sI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999998875 679999999999999999999995 8999999999999999999999999998744310
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
...+++
T Consensus 232 --------------------------------------------------------------------------S~a~tf 237 (364)
T KOG0581|consen 232 --------------------------------------------------------------------------SIANTF 237 (364)
T ss_pred --------------------------------------------------------------------------hhcccc
Confidence 023568
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCC-----CchHHHHHHHhhcc-CCCCCccchHHHHHHHH
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS-----GNEETLANVVMQSL-KFPDSPLISFQARDLIR 917 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~-----s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~ 917 (992)
+||..|||||.+.+..|+.++||||||++|+||++|++||... +-.+.+..|+.+.. .+|.. .+++++++||.
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~FV~ 316 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSFVS 316 (364)
T ss_pred cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHHHH
Confidence 9999999999999999999999999999999999999999874 44577777776443 34433 69999999999
Q ss_pred HhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 918 GLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
.||++||.+|++ +.|+++|||+.....
T Consensus 317 ~CL~Kdp~~R~s----~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 317 CCLRKDPSERPS----AKQLLQHPFIKKFED 343 (364)
T ss_pred HHhcCCcccCCC----HHHHhcCHHHhhccc
Confidence 999999999999 999999999987654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-48 Score=412.01 Aligned_cols=262 Identities=29% Similarity=0.459 Sum_probs=223.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
+.|+.+.++|+|+||+||+|+++.+|+.||||.+.... ++.....-..+|+.+|++++|+|+|.|+++|.....++|||
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 56888999999999999999999999999999996431 11223345689999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|||+..-|+++-+ . ...++...++.|++|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 81 E~~dhTvL~eLe~-~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~----- 153 (396)
T KOG0593|consen 81 EYCDHTVLHELER-Y-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA----- 153 (396)
T ss_pred eecchHHHHHHHh-c-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC-----
Confidence 9998777776643 3 36789999999999999999999999999999999999999999999999999854321
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
..+.++.++.|++
T Consensus 154 -------------------------------------------------------------------pgd~YTDYVATRW 166 (396)
T KOG0593|consen 154 -------------------------------------------------------------------PGDNYTDYVATRW 166 (396)
T ss_pred -------------------------------------------------------------------Ccchhhhhhhhhh
Confidence 2345778899999
Q ss_pred ccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh-------------------ccCCCCC---
Q 001952 849 YLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-------------------SLKFPDS--- 905 (992)
Q Consensus 849 Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~-------------------~lk~P~~--- 905 (992)
|+|||++.| ..|+..+|||++||++.||++|.+.|+|.++.+++..|... ++.+|.+
T Consensus 167 YRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~ 246 (396)
T KOG0593|consen 167 YRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHP 246 (396)
T ss_pred ccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCc
Confidence 999999999 57999999999999999999999999999999999877541 2233333
Q ss_pred -------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 906 -------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 906 -------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
+.++.-+.||+.+||..||++|++ .+++|.|+||+++--.
T Consensus 247 epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~~~er 293 (396)
T KOG0593|consen 247 EPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDGFIER 293 (396)
T ss_pred cchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHHHHHHHH
Confidence 224556789999999999999999 9999999999665433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=401.64 Aligned_cols=265 Identities=36% Similarity=0.697 Sum_probs=232.3
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+++|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+..
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999998764 5689999999999999999999999999999999999999999999999998632110
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
......||+.
T Consensus 154 ----------------------------------------------------------------------~~~~~~gt~~ 163 (291)
T cd05612 154 ----------------------------------------------------------------------RTWTLCGTPE 163 (291)
T ss_pred ----------------------------------------------------------------------CcccccCChh
Confidence 0112358999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++. .++..+++||.+||..||.+|+
T Consensus 164 y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~ 241 (291)
T cd05612 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR--HLDLYAKDLIKKLLVVDRTRRL 241 (291)
T ss_pred hcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc--cCCHHHHHHHHHHcCCCHHHcc
Confidence 99999999999999999999999999999999999998888888888777666654 4788999999999999999999
Q ss_pred CC-hHhHHHHHcCCCCCCCchhhhh
Q 001952 929 GS-QKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 929 T~-~~~aeEILkHPfF~~lnw~~lr 952 (992)
+. ...++++++||||..++|..+.
T Consensus 242 ~~~~~~~~~~l~h~~~~~~~~~~~~ 266 (291)
T cd05612 242 GNMKNGADDVKNHRWFKSVDWDDVP 266 (291)
T ss_pred CCccCCHHHHhcCccccCCCHHHHh
Confidence 52 2349999999999999998764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=410.79 Aligned_cols=281 Identities=34% Similarity=0.698 Sum_probs=240.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCC-eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTN-CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg-~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++.+.||+|+||.||+|.+..++ ..||+|++.............+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~ 106 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYL 106 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEE
Confidence 45678999999999999999999876654 68999999876544455567788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+..
T Consensus 107 ~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999999998764 5689999999999999999999999999999999999999999999999998732110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
......
T Consensus 184 --------------------------------------------------------------------------~~~~~~ 189 (340)
T PTZ00426 184 --------------------------------------------------------------------------RTYTLC 189 (340)
T ss_pred --------------------------------------------------------------------------Ccceec
Confidence 011246
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+......+|. .++..+.+||++||..||
T Consensus 190 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~dp 267 (340)
T PTZ00426 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK--FLDNNCKHLMKKLLSHDL 267 (340)
T ss_pred CChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCH
Confidence 899999999999999999999999999999999999999988877777777766665554 488999999999999999
Q ss_pred CCcCCC-hHhHHHHHcCCCCCCCchhhhh--cCCCCCCCCCCCC
Q 001952 925 ENRLGS-QKGAAEIKQHPFFEGLNWALIR--CAIPPELPDFYDY 965 (992)
Q Consensus 925 ekRPT~-~~~aeEILkHPfF~~lnw~~lr--~~~pp~lp~~~d~ 965 (992)
++|++. ...++++++||||.+++|..+. ...+|..|+..+.
T Consensus 268 ~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~~ 311 (340)
T PTZ00426 268 TKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNV 311 (340)
T ss_pred HHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCC
Confidence 999731 1239999999999999998764 4566777765544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=406.43 Aligned_cols=268 Identities=39% Similarity=0.748 Sum_probs=235.6
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++||||+++++++..++.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34678999999999999999999999999999999998765444455677889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~-- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC--
Confidence 999999999999988764 5689999999999999999999999999999999999999999999999998733210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
......|
T Consensus 171 -------------------------------------------------------------------------~~~~~~g 177 (329)
T PTZ00263 171 -------------------------------------------------------------------------RTFTLCG 177 (329)
T ss_pred -------------------------------------------------------------------------CcceecC
Confidence 0112468
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.+..+....+.+|. .++.++++||.+||..||.
T Consensus 178 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~ 255 (329)
T PTZ00263 178 TPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--WFDGRARDLVKGLLQTDHT 255 (329)
T ss_pred ChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC--CCCHHHHHHHHHHhhcCHH
Confidence 99999999999999999999999999999999999999988877888777776665554 4889999999999999999
Q ss_pred CcCCC-hHhHHHHHcCCCCCCCchhhhh
Q 001952 926 NRLGS-QKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 926 kRPT~-~~~aeEILkHPfF~~lnw~~lr 952 (992)
+|++. ...+++|+.||||.+.+|..+.
T Consensus 256 ~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 256 KRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred HcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 99973 2348999999999999999764
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=412.78 Aligned_cols=325 Identities=34% Similarity=0.597 Sum_probs=241.6
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|.+++.||+|+||.||+|.+..+++.||||++.+...........+.+|+++|+.++||||++++++|.+.+++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997665444455677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++||+|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999988764 568999999999999999999999999999999999999999999999999985432110000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
...+... ...+..+. ................ ....+.. ............+||+.
T Consensus 159 ------~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~~~~---~~~~~~~----~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 159 ------YYQKLLQ---GKSNKNRI---------DNRNSVAVDSINLTMS---SKDQIAT----WKKNRRLMAYSTVGTPD 213 (377)
T ss_pred ------ccccccc---cccccccc---------cccccccccccccccc---chhhhhh----hhhcccccccccCCCcc
Confidence 0000000 00000000 0000000000000000 0000000 00000111224679999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh--hccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM--QSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~--~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
|+|||++.+..++.++|||||||+||||++|..||.+....+.+..+.. ..+.+|....++.++.+||.+||. +|.+
T Consensus 214 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~ 292 (377)
T cd05629 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAEN 292 (377)
T ss_pred ccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 9999999999999999999999999999999999998877777776664 334555555688999999999997 7887
Q ss_pred cCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF 962 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~ 962 (992)
|+. +..+.|++.||||.+++|+.++...+|.+|..
T Consensus 293 r~~-r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~ 327 (377)
T cd05629 293 RLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327 (377)
T ss_pred cCC-CCCHHHHhcCCCcCCCCHHHHccCCCCcccCC
Confidence 752 11299999999999999999988888777743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=404.61 Aligned_cols=262 Identities=39% Similarity=0.740 Sum_probs=226.4
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGG 694 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GG 694 (992)
+.||+|+||.||+|.+..+++.||||+++............+.+|+.+|+.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765444455667788999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCC
Q 001952 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774 (992)
Q Consensus 695 SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~ 774 (992)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----------- 147 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----------- 147 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----------
Confidence 999888764 5789999999999999999999999999999999999999999999999998632100
Q ss_pred CCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhh
Q 001952 775 DPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEI 854 (992)
Q Consensus 775 ~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEv 854 (992)
........+||+.|+|||+
T Consensus 148 -------------------------------------------------------------~~~~~~~~~gt~~y~aPE~ 166 (323)
T cd05571 148 -------------------------------------------------------------DGATMKTFCGTPEYLAPEV 166 (323)
T ss_pred -------------------------------------------------------------CCCcccceecCccccChhh
Confidence 0001123569999999999
Q ss_pred hcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH-h
Q 001952 855 IKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-G 933 (992)
Q Consensus 855 L~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~-~ 933 (992)
+.+..++.++|||||||+||||++|+.||.+.+....+..+......+|. .++.++.+||.+||..||++||+... .
T Consensus 167 ~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05571 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPED 244 (323)
T ss_pred hcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCC
Confidence 99999999999999999999999999999988777777777666666654 48999999999999999999993111 2
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
+.+|++||||.+++|..+.
T Consensus 245 ~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 245 AKEIMEHRFFASINWQDVV 263 (323)
T ss_pred HHHHHcCCCcCCCCHHHHH
Confidence 9999999999999998774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=406.69 Aligned_cols=315 Identities=35% Similarity=0.630 Sum_probs=241.5
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||+||+|.+..+++.||||++.............+.+|+++|..++|+||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444455567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998764 568999999999999999999999999999999999999999999999999985542111000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
. ..... ...+... +. .+..+....... ..............+||+.
T Consensus 159 ~-------~~~~~------~~~~~~~---~~-~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~gt~~ 204 (364)
T cd05599 159 F-------YRILS------HALPSNF---LD-FISKPMSSKRKA-----------------ETWKRNRRALAYSTVGTPD 204 (364)
T ss_pred c-------ccccc------ccccccc---cc-cccccccccccc-----------------cchhhcccccccccccCcc
Confidence 0 00000 0000000 00 000000000000 0000001111234579999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..++... +.++....++.++.+||.+||. +|.+
T Consensus 205 y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 205 YIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred ccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhh
Confidence 999999999999999999999999999999999999888777777665433 3444444578999999999996 9999
Q ss_pred cCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~ 961 (992)
|++. ..++|+|.||||.+++|..++...++.+|.
T Consensus 284 R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 284 RLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred cCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 9973 459999999999999999887766666663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=408.33 Aligned_cols=305 Identities=32% Similarity=0.578 Sum_probs=234.4
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||+||+|.+..+++.||||++.+...........+..|+.++..++|+||+++++.+.+.+.+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++||+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.++|+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~- 157 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT- 157 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc-
Confidence 999999999998764 57899999999999999999999999999999999999999999999999998554211000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
...+... . .....+.-.... .... ...............+||+.
T Consensus 158 ------~~~~~~~------~-------------~~~~~~~~~~~~-~~~~----------~~~~~~~~~~~~~~~~Gt~~ 201 (363)
T cd05628 158 ------EFYRNLN------H-------------SLPSDFTFQNMN-SKRK----------AETWKRNRRQLAFSTVGTPD 201 (363)
T ss_pred ------ccccccc------c-------------cccccccccccc-cccc----------cchhhhccccccccccCCcc
Confidence 0000000 0 000000000000 0000 00000001112235689999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh--hccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM--QSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~--~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++. ..+.+|....++.++++||.+|+. +|.+
T Consensus 202 Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~ 280 (363)
T cd05628 202 YIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEH 280 (363)
T ss_pred ccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Chhh
Confidence 9999999999999999999999999999999999998888888877765 334555555578999999999875 5665
Q ss_pred cCCChHhHHHHHcCCCCCCCchhhhhcC
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWALIRCA 954 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~~lr~~ 954 (992)
|++ +..++||++||||++++|..++..
T Consensus 281 r~~-r~~~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 281 RIG-APGVEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred cCC-CCCHHHHhCCCCCCCCCHHHHHhC
Confidence 532 112999999999999999998654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=401.74 Aligned_cols=273 Identities=39% Similarity=0.652 Sum_probs=236.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+..+++.||||++.............+..|+++|..++||||+++++++...+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444455667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999998764 5689999999999999999999999999999999999999999999999998732100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
......||+.
T Consensus 154 ----------------------------------------------------------------------~~~~~~gt~~ 163 (333)
T cd05600 154 ----------------------------------------------------------------------YANSVVGSPD 163 (333)
T ss_pred ----------------------------------------------------------------------ccCCcccCcc
Confidence 1123468999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCC----ccchHHHHHHHHHhccC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDS----PLISFQARDLIRGLLIK 922 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~----~~vs~el~dLI~kcL~~ 922 (992)
|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..+.... +..+.. ..++.++.+||.+||..
T Consensus 164 y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 243 (333)
T cd05600 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIND 243 (333)
T ss_pred ccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhC
Confidence 999999999999999999999999999999999999887777666554322 222222 14688999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF 962 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~ 962 (992)
+|.+|++ +.++++||||..++|..++...++.+|+.
T Consensus 244 ~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 279 (333)
T cd05600 244 PSRRFGS----LEDIKNHPFFKEVDWNELRELKPPFVPEL 279 (333)
T ss_pred hhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCCCC
Confidence 9999999 99999999999999999987777777743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=394.07 Aligned_cols=279 Identities=33% Similarity=0.560 Sum_probs=230.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+|..++|+||+++++++.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37889999999999999999999999999999986544443444567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++|+|..++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999998887654445689999999999999999999999999999999999999999999999998733210
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........||..|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~g~~~y 167 (285)
T cd05631 155 -------------------------------------------------------------------GETVRGRVGTVGY 167 (285)
T ss_pred -------------------------------------------------------------------CCeecCCCCCCCc
Confidence 0001234689999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh--hccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM--QSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~--~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
+|||++.+..++.++|||||||+||||++|+.||.+.........+.. ..........++.++.+||++||..||.+|
T Consensus 168 ~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R 247 (285)
T cd05631 168 MAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKER 247 (285)
T ss_pred cCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHh
Confidence 999999999999999999999999999999999987654332222211 111222233588999999999999999999
Q ss_pred CCCh-HhHHHHHcCCCCCCCchhhhhcC--CCCCCCC
Q 001952 928 LGSQ-KGAAEIKQHPFFEGLNWALIRCA--IPPELPD 961 (992)
Q Consensus 928 PT~~-~~aeEILkHPfF~~lnw~~lr~~--~pp~lp~ 961 (992)
|+.. ..++++++||||.+++|..+... .||..|+
T Consensus 248 ~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 248 LGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred cCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 9743 24899999999999999988654 5666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=401.85 Aligned_cols=304 Identities=39% Similarity=0.711 Sum_probs=245.0
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|.+++.||+|+||.||+|.+..+++.||||++.............+..|+++|..++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544456677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++... ..+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++..+.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998875 678999999999999999999999999999999999999999999999999985543211000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
. .. .. .....+........ ..............||+.
T Consensus 159 ~-------~~-~~---------------~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~gt~~ 195 (350)
T cd05573 159 Y-------YL-ND---------------SHNLLFRDNVLVRR--------------------RDHKQRRVRANSTVGTPD 195 (350)
T ss_pred c-------cc-cc---------------cccccccccccccc--------------------cccccccccccccccCcc
Confidence 0 00 00 00000000000000 000001112334579999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh--hccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM--QSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~--~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+.. ..+.+|....++.++.+||.+||. ||.+
T Consensus 196 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~ 274 (350)
T cd05573 196 YIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPED 274 (350)
T ss_pred ccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-Chhh
Confidence 9999999999999999999999999999999999999887777777776 555666666679999999999997 9999
Q ss_pred cCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~ 961 (992)
|++. ++++|+||||+.++|..+....++.+|.
T Consensus 275 R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~~~~ 306 (350)
T cd05573 275 RLGS---FEEIKSHPFFKGIDWENLRETKPPFVPE 306 (350)
T ss_pred cCCC---HHHHhcCCCcCCCCHHHHhhCCCCcCCC
Confidence 9995 8999999999999999888777776663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=398.25 Aligned_cols=276 Identities=37% Similarity=0.691 Sum_probs=237.5
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|.+.+.||+|+||.||+|.+..+++.||||+++............+.+|+.+++.++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+....
T Consensus 81 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~--- 156 (330)
T cd05601 81 EYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK--- 156 (330)
T ss_pred CCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC---
Confidence 999999999998765 3568999999999999999999999999999999999999999999999999974321100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........||+.
T Consensus 157 --------------------------------------------------------------------~~~~~~~~gt~~ 168 (330)
T cd05601 157 --------------------------------------------------------------------MVNSKLPVGTPD 168 (330)
T ss_pred --------------------------------------------------------------------ceeeecccCCcc
Confidence 000112368999
Q ss_pred ccChhhhc------CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh--ccCCCCCccchHHHHHHHHHhc
Q 001952 849 YLAPEIIK------GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--SLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 849 Y~APEvL~------g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~--~lk~P~~~~vs~el~dLI~kcL 920 (992)
|+|||++. +..++.++|||||||++|||++|+.||......+.+..++.. ...+|....++.++.+||.+||
T Consensus 169 y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll 248 (330)
T cd05601 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLL 248 (330)
T ss_pred ccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHc
Confidence 99999997 456789999999999999999999999988777777776543 2455665568999999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~ 961 (992)
. +|.+||+ +++++.||||..++|..++...++.+|.
T Consensus 249 ~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~~ 284 (330)
T cd05601 249 C-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFVPT 284 (330)
T ss_pred c-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCc
Confidence 8 9999999 9999999999999999998877777663
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=403.51 Aligned_cols=315 Identities=35% Similarity=0.584 Sum_probs=235.9
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+++|+.++|+||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544555677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998764 568999999999999999999999999999999999999999999999999975432110000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCc-cccCCCCCCcCccccCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQ-LVAEPTDARSNSFVGTH 847 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~-~~a~~~~~~s~s~vGT~ 847 (992)
.. ......+... ... . ........ ........ .............+||+
T Consensus 159 ~~-~~~~~~~~~~-----~~~--------------~-~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~gt~ 208 (376)
T cd05598 159 YY-QKGDHHRQDS-----MEP--------------S-EEWSEIDR---------CRLKPLERRRKRQHQRCLAHSLVGTP 208 (376)
T ss_pred cc-cccccccccc-----ccc--------------c-cccccccc---------ccccchhhhhhhhcccccccccCCCc
Confidence 00 0000000000 000 0 00000000 00000000 00000111223568999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh--ccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--SLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~--~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
.|+|||++.+..++.++|||||||+||||++|+.||.+....+.+..+... .+.++....++.++.+||.+|+ .+|.
T Consensus 209 ~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~ 287 (376)
T cd05598 209 NYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAE 287 (376)
T ss_pred cccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHh
Confidence 999999999999999999999999999999999999988776666655432 2334444468899999999976 5999
Q ss_pred CcC---CChHhHHHHHcCCCCCCCchhhh-hcCCCCCCC
Q 001952 926 NRL---GSQKGAAEIKQHPFFEGLNWALI-RCAIPPELP 960 (992)
Q Consensus 926 kRP---T~~~~aeEILkHPfF~~lnw~~l-r~~~pp~lp 960 (992)
+|+ + +.++++||||..++|..+ +...++.+|
T Consensus 288 ~R~~~~t----~~ell~h~~~~~~~~~~~~~~~~~~~~~ 322 (376)
T cd05598 288 DRLGKNG----ADEIKAHPFFKGIDFASLIRRQKAPYIP 322 (376)
T ss_pred hcCCCCC----HHHHhCCCCcCCCCHHHHhhcCCCCCCC
Confidence 999 7 999999999999999877 344344444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-47 Score=451.84 Aligned_cols=298 Identities=37% Similarity=0.671 Sum_probs=265.5
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
..++..++|+++++||.|+||.|.+++++.+++.||+|++++-....+.....|+.|.++|...+.+-|+.|+..|.+++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34556789999999999999999999999999999999999866666777788999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
++||||||++||+|-.++.+. ..+++..+++|+..|+.||+-||+.|+|||||||+|||||..|++||+|||-+.++.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999999999986 379999999999999999999999999999999999999999999999999875542
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. ...++..
T Consensus 227 ~d-----------------------------------------------------------------------G~V~s~~ 235 (1317)
T KOG0612|consen 227 AD-----------------------------------------------------------------------GTVRSSV 235 (1317)
T ss_pred CC-----------------------------------------------------------------------CcEEecc
Confidence 11 1223455
Q ss_pred cccCCCccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh--ccCCCCCccchHHHHHH
Q 001952 843 FVGTHEYLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--SLKFPDSPLISFQARDL 915 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~--~lk~P~~~~vs~el~dL 915 (992)
.+|||.|++||+|.. +.|+..+||||+||++||||+|..||...+-.++|.+|+.. .+.||....++.++++|
T Consensus 236 aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdL 315 (1317)
T KOG0612|consen 236 AVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDL 315 (1317)
T ss_pred ccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHH
Confidence 689999999999973 46899999999999999999999999999999999999876 78888777899999999
Q ss_pred HHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCC---CCCCCCCccccccch
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP---DFYDYGIQDMVPQKS 975 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp---~~~d~~~~~~~~q~~ 975 (992)
|.++++ +|+.|++ +.++++|..||||.+++|..||...||.+| -.-|+++||....-.
T Consensus 316 I~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~ 376 (1317)
T KOG0612|consen 316 IEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDL 376 (1317)
T ss_pred HHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCcCCCCCcccccccccccc
Confidence 999876 8999998 789999999999999999999999999999 456777776654443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=404.07 Aligned_cols=322 Identities=35% Similarity=0.589 Sum_probs=237.4
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++|+||+++++.|.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 68999999999999999999999999999999987654445566778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
||++|+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.++|+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~ 159 (382)
T cd05625 82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (382)
T ss_pred CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccc
Confidence 99999999988764 5689999999999999999999999999999999999999999999999999743321000000
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
. ...+..+.. . ............|....... .... ..............+||+.|
T Consensus 160 ~-~~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~--------------~~~~--~~~~~~~~~~~~~~~gt~~Y 214 (382)
T cd05625 160 Y-QSGDHVRQD-------S-MDFSNEWGDPANCRCGDRLK--------------PLER--RAARQHQRCLAHSLVGTPNY 214 (382)
T ss_pred c-ccccccccc-------c-cccccccccccccccccccc--------------chhh--hhccccccccccccccCccc
Confidence 0 000000000 0 00000000000000000000 0000 00000011122356899999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh--ccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--SLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~--~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
+|||++.+..++.++|||||||+||||++|+.||.+.+..+....+... .+.+|....+++++.+||.+|+ .+|.+|
T Consensus 215 ~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R 293 (382)
T cd05625 215 IAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDR 293 (382)
T ss_pred CCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHc
Confidence 9999999999999999999999999999999999988777777666542 3445555568999999999976 599999
Q ss_pred CCChHhHHHHHcCCCCCCCchhh-hhcCCCCCCC
Q 001952 928 LGSQKGAAEIKQHPFFEGLNWAL-IRCAIPPELP 960 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~lnw~~-lr~~~pp~lp 960 (992)
++ ...++++++||||+.++|.. ++...+|.+|
T Consensus 294 ~~-~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 326 (382)
T cd05625 294 LG-KNGADEIKAHPFFKTIDFSSDLRQQSAPYIP 326 (382)
T ss_pred CC-CCCHHHHhcCCCcCCcChHHHHhcCCCCccC
Confidence 97 34589999999999999985 4444444444
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=401.01 Aligned_cols=305 Identities=34% Similarity=0.609 Sum_probs=236.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+..+++.||||+++............+..|+.++..++|+||++++++|.+.+.+||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998665444556677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.++|+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998764 568999999999999999999999999999999999999999999999999985442110000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.. .... ..+... .+..... ... ................+||+.
T Consensus 159 ~~------~~~~-------------~~~~~~---~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~gt~~ 201 (360)
T cd05627 159 FY------RNLT-------------HNPPSD---FSFQNMN--SKR-------------KAETWKKNRRQLAYSTVGTPD 201 (360)
T ss_pred cc------cccc-------------cCCccc---ccccccc--ccc-------------ccccccccccccccccCCCcc
Confidence 00 0000 000000 0000000 000 000000111122335689999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh--ccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--SLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~--~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
|+|||++.+..++.++|||||||+||||++|+.||.+....+.+..+... .+.+|....++.++++||.+|+ .||.+
T Consensus 202 Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~ 280 (360)
T cd05627 202 YIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSEN 280 (360)
T ss_pred ccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhh
Confidence 99999999999999999999999999999999999988887777776642 3445544457899999999987 59999
Q ss_pred cCCChHhHHHHHcCCCCCCCchhhhhcC
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWALIRCA 954 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~~lr~~ 954 (992)
|++. ..++|+++||||++++|..++..
T Consensus 281 R~~~-~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 281 RIGS-NGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred cCCC-CCHHHHhcCCCCCCCCHHHHhcC
Confidence 9962 34899999999999999988654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=422.01 Aligned_cols=261 Identities=31% Similarity=0.472 Sum_probs=226.0
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCC-eE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDN-LS 684 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~-~l 684 (992)
..++|.++++||.|+||.||+|+...++..||||.+++......+. .-.+|+..|++|+ ||||++|.+++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 3578999999999999999999999999999999998765443322 2368999999998 999999999999887 99
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||| ..+|+++++.+ +..|++..++.|+.||+.||+|||.+|++||||||+|||+.....+||+|||||+.....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999 88999999987 789999999999999999999999999999999999999999999999999998554211
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
..++.++
T Consensus 164 -------------------------------------------------------------------------pPYTeYV 170 (538)
T KOG0661|consen 164 -------------------------------------------------------------------------PPYTEYV 170 (538)
T ss_pred -------------------------------------------------------------------------CCcchhh
Confidence 1246688
Q ss_pred cCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh-------------------ccCCCC
Q 001952 845 GTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-------------------SLKFPD 904 (992)
Q Consensus 845 GT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~-------------------~lk~P~ 904 (992)
.|++|+|||+|+.. .|+.++|||++||+++|+++-+++|.|.++.+++.+|..- ++.+|.
T Consensus 171 STRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~ 250 (538)
T KOG0661|consen 171 STRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQ 250 (538)
T ss_pred hcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCc
Confidence 99999999998765 5799999999999999999999999999999998877531 122222
Q ss_pred C---------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 905 S---------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 905 ~---------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
. +..+.++.+||.+||.+||++||| |.++|+||||+.-..
T Consensus 251 ~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 251 VKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQVGRA 299 (538)
T ss_pred CCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCcccccccc
Confidence 1 225678999999999999999999 999999999997543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=405.93 Aligned_cols=319 Identities=34% Similarity=0.569 Sum_probs=235.3
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|++++.||+|+||+||+|.+..+++.||||++.............+..|+++|+.++|+||+++++++.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999987655555566778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|++||+|.+++... ..+++..++.++.||+.||+|||..||+||||||+||||+.++.++|+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999998764 5689999999999999999999999999999999999999999999999999754321100000
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCc-cccCCCCCCcCccccCCC
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQ-LVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~-~~a~~~~~~s~s~vGT~~ 848 (992)
.. .....+.. ...+...-.. ...|.... ....... .............+||+.
T Consensus 160 ~~-~~~~~~~~-------~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (381)
T cd05626 160 YQ-KGSHIRQD-------SMEPSDLWDD-VSNCRCGD-----------------RLKTLEQRATKQHQRCLAHSLVGTPN 213 (381)
T ss_pred cc-cccccccc-------ccCccccccc-cccccccc-----------------ccchhhccccccccccccccccCCcc
Confidence 00 00000000 0000000000 00000000 0000000 000011112345689999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh--hccCCCCCccchHHHHHHHHHhccC--Cc
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM--QSLKFPDSPLISFQARDLIRGLLIK--EP 924 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~--~~lk~P~~~~vs~el~dLI~kcL~~--DP 924 (992)
|+|||++.+..++.++|||||||+||||++|+.||...+..+....++. ..+.++....++.++.+||.+||.. ++
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~ 293 (381)
T cd05626 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEER 293 (381)
T ss_pred ccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence 9999999999999999999999999999999999998777666666653 3345555556899999999996654 45
Q ss_pred CCcCCChHhHHHHHcCCCCCCCchhhh-hcCCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLNWALI-RCAIPPELP 960 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~lnw~~l-r~~~pp~lp 960 (992)
..|++ +++|+.||||.+++|... +...+|.+|
T Consensus 294 ~~R~~----~~~~l~hp~f~~~~~~~~~~~~~~~~~p 326 (381)
T cd05626 294 LGRNG----ADDIKAHPFFSEVDFSSDIRTQPAPYVP 326 (381)
T ss_pred cCCCC----HHHHhcCcccCCCChhHHhhcCCCCccC
Confidence 55999 999999999999999764 444344454
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=394.58 Aligned_cols=262 Identities=39% Similarity=0.763 Sum_probs=225.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||||++.............+..|.+++..+ +||||++++++|...+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876544445556677889998876 799999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~---------- 148 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL---------- 148 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc----------
Confidence 9999888764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (321)
T cd05591 149 --------------------------------------------------------------NGVTTTTFCGTPDYIAPE 166 (321)
T ss_pred --------------------------------------------------------------CCccccccccCccccCHH
Confidence 000112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH-
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK- 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~- 932 (992)
++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||++|++...
T Consensus 167 ~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~ 244 (321)
T cd05591 167 ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVAS 244 (321)
T ss_pred HHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 999999999999999999999999999999998888888887766655554 48899999999999999999994322
Q ss_pred --hHHHHHcCCCCCCCchhhhh
Q 001952 933 --GAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 933 --~aeEILkHPfF~~lnw~~lr 952 (992)
.+.++++||||..++|..+.
T Consensus 245 ~~~~~~~~~hp~~~~~~~~~~~ 266 (321)
T cd05591 245 QGGEDAIKQHPFFKEIDWVLLE 266 (321)
T ss_pred CCCHHHHhcCCccCCCCHHHHH
Confidence 39999999999999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=395.19 Aligned_cols=273 Identities=38% Similarity=0.732 Sum_probs=230.3
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHH---HHcCCCCccceeeeeccCCeEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL---RMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieIL---k~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
|++++.||+|+||.||+|.+..+++.||||+++............+..|+.++ +.++||||+++++++...+.+|||
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999999999999999999876544444556677776665 456799999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~---- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG---- 153 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC----
Confidence 999999999887764 4689999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.........|++
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~g~~ 165 (324)
T cd05589 154 --------------------------------------------------------------------FGDRTSTFCGTP 165 (324)
T ss_pred --------------------------------------------------------------------CCCcccccccCc
Confidence 000112356899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||.+|
T Consensus 166 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R 243 (324)
T cd05589 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLRRNPERR 243 (324)
T ss_pred cccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHhHc
Confidence 999999999999999999999999999999999999988877777777776666554 489999999999999999999
Q ss_pred CCChH-hHHHHHcCCCCCCCchhhhh--cCCCCCCC
Q 001952 928 LGSQK-GAAEIKQHPFFEGLNWALIR--CAIPPELP 960 (992)
Q Consensus 928 PT~~~-~aeEILkHPfF~~lnw~~lr--~~~pp~lp 960 (992)
|++.. .+.++++||||..++|..+. ...++.+|
T Consensus 244 ~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~ 279 (324)
T cd05589 244 LGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVP 279 (324)
T ss_pred CCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccC
Confidence 96433 49999999999999998763 33344444
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=394.35 Aligned_cols=267 Identities=37% Similarity=0.730 Sum_probs=228.9
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC-CccceeeeeccCCeEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP-FLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP-NIVkL~g~f~~~~~lyLVm 688 (992)
+|++++.||+|+||.||+|.+.++++.||||++.+...........+..|++++..+.|+ +|+.+++++...+.+||||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544445566778899999999765 5888999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~----- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF----- 153 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-----
Confidence 999999999888764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.........||+.
T Consensus 154 -------------------------------------------------------------------~~~~~~~~~gt~~ 166 (324)
T cd05587 154 -------------------------------------------------------------------GGKTTRTFCGTPD 166 (324)
T ss_pred -------------------------------------------------------------------CCCceeeecCCcc
Confidence 0001123468999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||.+|+
T Consensus 167 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~ 244 (324)
T cd05587 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTKHPAKRL 244 (324)
T ss_pred ccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHcC
Confidence 99999999999999999999999999999999999988887888777766555554 4889999999999999999999
Q ss_pred CCh-HhHHHHHcCCCCCCCchhhhh
Q 001952 929 GSQ-KGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 929 T~~-~~aeEILkHPfF~~lnw~~lr 952 (992)
+.. ....++++||||..++|..+.
T Consensus 245 ~~~~~~~~~~~~hp~~~~~~~~~~~ 269 (324)
T cd05587 245 GCGPTGERDIREHAFFRRIDWEKLE 269 (324)
T ss_pred CCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 842 235899999999999998663
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=393.71 Aligned_cols=276 Identities=37% Similarity=0.717 Sum_probs=234.6
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVm 688 (992)
+|.+++.||+|+||.||+|.+..+++.||||++.+...........+..|..++..+ +|++|+++++++...+.+||||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876544444455667788888877 5899999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~----- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW----- 153 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-----
Confidence 999999999888764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.........||+.
T Consensus 154 -------------------------------------------------------------------~~~~~~~~~gt~~ 166 (323)
T cd05616 154 -------------------------------------------------------------------DGVTTKTFCGTPD 166 (323)
T ss_pred -------------------------------------------------------------------CCCccccCCCChh
Confidence 0001123468999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||.+|+
T Consensus 167 y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p~~R~ 244 (323)
T cd05616 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGKRL 244 (323)
T ss_pred hcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHcccCHHhcC
Confidence 99999999999999999999999999999999999998888888888776666654 4899999999999999999999
Q ss_pred CCh-HhHHHHHcCCCCCCCchhhhh--cCCCCCCCC
Q 001952 929 GSQ-KGAAEIKQHPFFEGLNWALIR--CAIPPELPD 961 (992)
Q Consensus 929 T~~-~~aeEILkHPfF~~lnw~~lr--~~~pp~lp~ 961 (992)
+.. ....++++||||..++|..+. ...+|..|+
T Consensus 245 ~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~ 280 (323)
T cd05616 245 GCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPK 280 (323)
T ss_pred CCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 853 246899999999999998774 344555554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=410.81 Aligned_cols=261 Identities=36% Similarity=0.599 Sum_probs=232.0
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh--cchhHHHHHHHHHHHcC-CCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR--KKMPRAQTEREILRMLD-HPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~--~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~ 682 (992)
...+.|.+.+.||+|+||+|++|.+..+++.||||++++...... .....+.+|+.+++.++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 346789999999999999999999999999999998876522211 23456678999999999 999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-CcEEEEeccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLSLRC 761 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-g~VKLsDFGLA~~l 761 (992)
.+|+||||+.||+|.+++.. .+++.+..++.+++||+.||+|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 99999999999999999987 3789999999999999999999999999999999999999999 99999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ..+....
T Consensus 172 ~------------------------------------------------------------------------~~~~~l~ 179 (370)
T KOG0583|consen 172 P------------------------------------------------------------------------GEDGLLK 179 (370)
T ss_pred C------------------------------------------------------------------------CCCCccc
Confidence 1 0122345
Q ss_pred ccccCCCccChhhhcCCC-C-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccc-hHHHHHHHHH
Q 001952 842 SFVGTHEYLAPEIIKGEG-H-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLI-SFQARDLIRG 918 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~-~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~v-s~el~dLI~k 918 (992)
.++||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+...++..|....+.+|.. + +.++++||++
T Consensus 180 t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~--~~S~~~~~Li~~ 257 (370)
T KOG0583|consen 180 TFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSY--LLSPEARSLIEK 257 (370)
T ss_pred CCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCC--cCCHHHHHHHHH
Confidence 678999999999999977 7 689999999999999999999999988888898988888888875 5 9999999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||..||.+|++ +.+|++||||+..
T Consensus 258 mL~~~P~~R~t----~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 258 MLVPDPSTRIT----LLEILEHPWFQKE 281 (370)
T ss_pred HcCCCcccCCC----HHHHhhChhhccC
Confidence 99999999999 9999999999974
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=394.66 Aligned_cols=263 Identities=37% Similarity=0.742 Sum_probs=220.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||||+++............+..|..++..+ +||||++++++|...+.+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999999999999999876554455566788899999888 799999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 9999887654 5799999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (329)
T cd05588 149 --------------------------------------------------------------PGDTTSTFCGTPNYIAPE 166 (329)
T ss_pred --------------------------------------------------------------CCCccccccCCccccCHH
Confidence 000112356899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCC--------ch-HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG--------NE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s--------~~-e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
++.+..++.++|||||||++|||++|+.||.... .. .....+......+|. .++.++.+||.+||..||
T Consensus 167 ~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP 244 (329)
T cd05588 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGFLNKDP 244 (329)
T ss_pred HHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCH
Confidence 9999999999999999999999999999996321 11 223334444444443 488999999999999999
Q ss_pred CCcCCCh--HhHHHHHcCCCCCCCchhhhhc
Q 001952 925 ENRLGSQ--KGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 925 ekRPT~~--~~aeEILkHPfF~~lnw~~lr~ 953 (992)
.+|++.. ..++++++||||..++|..+..
T Consensus 245 ~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 245 KERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275 (329)
T ss_pred HHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence 9999843 3489999999999999987753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=395.80 Aligned_cols=262 Identities=39% Similarity=0.757 Sum_probs=224.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGG 694 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GG 694 (992)
+.||+|+||.||++.+..+++.||||++.............+.+|+.+|+.++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765444455677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCC
Q 001952 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774 (992)
Q Consensus 695 SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~ 774 (992)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~----------- 147 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT----------- 147 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-----------
Confidence 998887654 5689999999999999999999999999999999999999999999999998632100
Q ss_pred CCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhh
Q 001952 775 DPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEI 854 (992)
Q Consensus 775 ~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEv 854 (992)
.........||+.|+|||+
T Consensus 148 -------------------------------------------------------------~~~~~~~~~gt~~y~aPE~ 166 (328)
T cd05593 148 -------------------------------------------------------------DAATMKTFCGTPEYLAPEV 166 (328)
T ss_pred -------------------------------------------------------------cccccccccCCcCccChhh
Confidence 0000123468999999999
Q ss_pred hcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh-Hh
Q 001952 855 IKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-KG 933 (992)
Q Consensus 855 L~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~-~~ 933 (992)
+.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||.+|++.. ..
T Consensus 167 ~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (328)
T cd05593 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDD 244 (328)
T ss_pred hcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 99999999999999999999999999999887777777666655555554 4899999999999999999998311 12
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
+.+|++||||.+.+|..+.
T Consensus 245 ~~~il~h~~~~~~~~~~~~ 263 (328)
T cd05593 245 AKEIMRHSFFTGVNWQDVY 263 (328)
T ss_pred HHHHhcCCCcCCCCHHHHH
Confidence 9999999999999998664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=391.27 Aligned_cols=258 Identities=41% Similarity=0.733 Sum_probs=224.4
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||+|+||.||+|.+..+++.||+|++.............+..|+.+|+.++||||+++++++...+.+||||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865444445566788899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCC
Q 001952 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776 (992)
Q Consensus 697 ~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~ 776 (992)
..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~------------- 145 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK------------- 145 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc-------------
Confidence 9988764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred CccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhc
Q 001952 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK 856 (992)
Q Consensus 777 ~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~ 856 (992)
.........||+.|+|||++.
T Consensus 146 -----------------------------------------------------------~~~~~~~~~gt~~y~aPE~~~ 166 (312)
T cd05585 146 -----------------------------------------------------------DDDKTNTFCGTPEYLAPELLL 166 (312)
T ss_pred -----------------------------------------------------------CCCccccccCCcccCCHHHHc
Confidence 000112346899999999999
Q ss_pred CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHH
Q 001952 857 GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAE 936 (992)
Q Consensus 857 g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeE 936 (992)
+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||..||.+||+. ..+.|
T Consensus 167 ~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~-~~~~e 243 (312)
T cd05585 167 GHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGY-NGAQE 243 (312)
T ss_pred CCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCC-CCHHH
Confidence 999999999999999999999999999988777777777766666554 488999999999999999999862 23899
Q ss_pred HHcCCCCCCCchhhh
Q 001952 937 IKQHPFFEGLNWALI 951 (992)
Q Consensus 937 ILkHPfF~~lnw~~l 951 (992)
+|.||||...+|..+
T Consensus 244 ~l~hp~~~~~~~~~~ 258 (312)
T cd05585 244 IKNHPFFSQLSWKKL 258 (312)
T ss_pred HHcCCCcCCCCHHHH
Confidence 999999999999765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=395.17 Aligned_cols=262 Identities=39% Similarity=0.737 Sum_probs=225.8
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGG 694 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GG 694 (992)
+.||+|+||.||++.+..++..||+|++.............+.+|+.+|+.++||||++++++|...+.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765444455667788999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCC
Q 001952 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774 (992)
Q Consensus 695 SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~ 774 (992)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~----------- 147 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----------- 147 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-----------
Confidence 998887764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred CCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhh
Q 001952 775 DPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEI 854 (992)
Q Consensus 775 ~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEv 854 (992)
.........||+.|+|||+
T Consensus 148 -------------------------------------------------------------~~~~~~~~~gt~~y~aPE~ 166 (323)
T cd05595 148 -------------------------------------------------------------DGATMKTFCGTPEYLAPEV 166 (323)
T ss_pred -------------------------------------------------------------CCCccccccCCcCcCCccc
Confidence 0000123468999999999
Q ss_pred hcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh-Hh
Q 001952 855 IKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-KG 933 (992)
Q Consensus 855 L~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~-~~ 933 (992)
+.+..++.++|||||||+||||++|+.||.+.+....+..+......+|. .++.++.+||.+||..||++|++.. ..
T Consensus 167 ~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~ 244 (323)
T cd05595 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSD 244 (323)
T ss_pred ccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCC
Confidence 99999999999999999999999999999988777777777766666654 4899999999999999999998321 12
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
+.++++|+||.+.+|..+.
T Consensus 245 ~~~~l~h~~~~~~~~~~~~ 263 (323)
T cd05595 245 AKEVMEHRFFLSINWQDVV 263 (323)
T ss_pred HHHHHcCCCcCCCCHHHHH
Confidence 9999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=386.93 Aligned_cols=312 Identities=57% Similarity=1.003 Sum_probs=254.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||||.+.............+..|+++|+.++|+||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999997654443345567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+.+++|.+++....+..+++..++.++.||+.||+|||..||+|+||||+|||++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999887656779999999999999999999999999999999999999999999999999975432110000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.. ... ..+... . . ...................+||..
T Consensus 161 ~~--------~~~--------------------~~~~~~--~-------~------~~~~~~~~~~~~~~~~~~~~g~~~ 197 (316)
T cd05574 161 SK--------ALR--------------------KGSRRS--S-------V------NSIPSETFSEEPSFRSNSFVGTEE 197 (316)
T ss_pred cc--------ccc--------------------cccccc--c-------c------cccchhhhcccccCCCCCCcCccC
Confidence 00 000 000000 0 0 000001111122223445689999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|||||||++|+|++|..||.+.+....+..+......++....++.++.+||.+||..||++||
T Consensus 198 y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~ 277 (316)
T cd05574 198 YIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL 277 (316)
T ss_pred CcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCC
Confidence 99999999999999999999999999999999999988888888888777777766655789999999999999999999
Q ss_pred CChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCC
Q 001952 929 GSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFY 963 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~ 963 (992)
++...++|+|.||||++.+|+.++-..+|.+|...
T Consensus 278 s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 278 GSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred CchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 99999999999999999999999999898887544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=393.66 Aligned_cols=270 Identities=37% Similarity=0.721 Sum_probs=228.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..+ +||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999876544445566778888888876 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~---------- 148 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF---------- 148 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc----------
Confidence 9999888764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (320)
T cd05590 149 --------------------------------------------------------------NGKTTSTFCGTPDYIAPE 166 (320)
T ss_pred --------------------------------------------------------------CCCcccccccCccccCHH
Confidence 000112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH-
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK- 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~- 932 (992)
++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++.+||.+||..||++|++...
T Consensus 167 ~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (320)
T cd05590 167 ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTL 244 (320)
T ss_pred HHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 999999999999999999999999999999988887877777766555544 48899999999999999999999421
Q ss_pred -hHHHHHcCCCCCCCchhhhh--cCCCCCCC
Q 001952 933 -GAAEIKQHPFFEGLNWALIR--CAIPPELP 960 (992)
Q Consensus 933 -~aeEILkHPfF~~lnw~~lr--~~~pp~lp 960 (992)
..+++++||||..++|..+. ...|+..|
T Consensus 245 ~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 275 (320)
T cd05590 245 GGEEAILRHPFFKELDWEKLNRRQIEPPFRP 275 (320)
T ss_pred CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 23899999999999998763 34444444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=404.15 Aligned_cols=258 Identities=29% Similarity=0.516 Sum_probs=225.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|.+.+.||.|+||+||+|+++.++..||||.+.+..+ ..+..+.+..|+.+|+.++|||||.|++++..++.+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999987654 234556788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC------CcEEEEeccccccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED------GHIMLTDFDLSLRC 761 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d------g~VKLsDFGLA~~l 761 (992)
||||.||+|..|++.. +.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999985 579999999999999999999999999999999999999864 35899999998665
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... ....
T Consensus 166 ~~~-------------------------------------------------------------------------~~a~ 172 (429)
T KOG0595|consen 166 QPG-------------------------------------------------------------------------SMAE 172 (429)
T ss_pred Cch-------------------------------------------------------------------------hHHH
Confidence 311 1123
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC-ccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS-PLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~-~~vs~el~dLI~kcL 920 (992)
+.+|++.|||||++....|+.++|+||+|++||+|++|+.||...+..+.+..+-.+....+.. ..++..+.+|+..+|
T Consensus 173 tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll 252 (429)
T KOG0595|consen 173 TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLL 252 (429)
T ss_pred HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHH
Confidence 5689999999999999999999999999999999999999999998888888766554443332 345667789999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
..+|..|.+ ..+-+.|+|+..
T Consensus 253 ~~~~~~~~~----~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 253 QRNPKDRIS----FEDFFDHPFLAA 273 (429)
T ss_pred hcCccccCc----hHHhhhhhhccc
Confidence 999999999 788888887765
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=399.96 Aligned_cols=281 Identities=35% Similarity=0.633 Sum_probs=237.2
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
...+..++|++++.||+|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 34456789999999999999999999999999999999998654444445556788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||++||+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999999998875 358899999999999999999999999999999999999999999999999874321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .......
T Consensus 194 ~~-----------------------------------------------------------------------~~~~~~~ 202 (370)
T cd05596 194 AN-----------------------------------------------------------------------GMVRCDT 202 (370)
T ss_pred CC-----------------------------------------------------------------------CcccCCC
Confidence 00 0001123
Q ss_pred cccCCCccChhhhcCC----CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGE----GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQARDLI 916 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~----~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~dLI 916 (992)
.+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+....+..++... +.+|....++.++.+||
T Consensus 203 ~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 282 (370)
T cd05596 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLI 282 (370)
T ss_pred CCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHH
Confidence 4699999999999764 37899999999999999999999999988777777776543 45566556899999999
Q ss_pred HHhccCCcCC--cCCChHhHHHHHcCCCCCCCchh--hhhcCCCCCCCC
Q 001952 917 RGLLIKEPEN--RLGSQKGAAEIKQHPFFEGLNWA--LIRCAIPPELPD 961 (992)
Q Consensus 917 ~kcL~~DPek--RPT~~~~aeEILkHPfF~~lnw~--~lr~~~pp~lp~ 961 (992)
.+||..+|.+ |++ ++||++||||+..+|. .++...++.+|+
T Consensus 283 ~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 283 CAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred HHHccChhhccCCCC----HHHHhcCcccCCCChhhHHhcCCCcCccCc
Confidence 9999999988 999 9999999999998876 345555666653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=390.29 Aligned_cols=262 Identities=40% Similarity=0.749 Sum_probs=224.0
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGG 694 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GG 694 (992)
+.||+|+||.||+|.+..+++.||+|++.............+..|++++..++||||+++++++...+.+||||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 695 SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
+|..++... ..+++..++.++.||+.||+|||+ .||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~---------- 148 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK---------- 148 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC----------
Confidence 999887754 568999999999999999999997 7999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (325)
T cd05594 149 --------------------------------------------------------------DGATMKTFCGTPEYLAPE 166 (325)
T ss_pred --------------------------------------------------------------CCcccccccCCcccCCHH
Confidence 000012346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh-H
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-K 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~-~ 932 (992)
++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||++|++.. .
T Consensus 167 ~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~ 244 (325)
T cd05594 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPD 244 (325)
T ss_pred HHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCC
Confidence 999999999999999999999999999999988777777776666666554 4889999999999999999998211 1
Q ss_pred hHHHHHcCCCCCCCchhhhh
Q 001952 933 GAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 933 ~aeEILkHPfF~~lnw~~lr 952 (992)
.+.++++||||.++.|....
T Consensus 245 ~~~~il~h~~~~~~~~~~~~ 264 (325)
T cd05594 245 DAKEIMQHKFFAGIVWQDVY 264 (325)
T ss_pred CHHHHhcCCCcCCCCHHHHH
Confidence 29999999999999998663
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=390.46 Aligned_cols=262 Identities=40% Similarity=0.738 Sum_probs=223.5
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHH-HHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE-ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~Eie-ILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||+||+|.+..+++.||||++.............+..|.. +++.++||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999999999999999998665444344445555555 56789999999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---------- 148 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc----------
Confidence 9999888764 5789999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (323)
T cd05575 149 --------------------------------------------------------------HSKTTSTFCGTPEYLAPE 166 (323)
T ss_pred --------------------------------------------------------------CCCccccccCChhhcChh
Confidence 000112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
++.+..++.++|||||||+||||++|..||.+.+..+.+..+......++ +.++.++.+||.+||..||.+||+....
T Consensus 167 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK--PNISVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred hhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 99999999999999999999999999999998877777777766655544 3478999999999999999999997777
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
+.++++||||..++|..+.
T Consensus 245 ~~~il~~~~~~~~~~~~~~ 263 (323)
T cd05575 245 FLEIKNHVFFSSINWDDLV 263 (323)
T ss_pred HHHHHcCCCcCCCCHHHHh
Confidence 8999999999999998774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=398.89 Aligned_cols=279 Identities=34% Similarity=0.654 Sum_probs=232.6
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.....++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 44556899999999999999999999999999999999976544444445567889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|+||||++||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 9999999999999999875 3588999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
. ........
T Consensus 195 ~-----------------------------------------------------------------------~~~~~~~~ 203 (370)
T cd05621 195 T-----------------------------------------------------------------------GMVRCDTA 203 (370)
T ss_pred C-----------------------------------------------------------------------CceecccC
Confidence 0 00011234
Q ss_pred ccCCCccChhhhcCCC----CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHHHHHH
Q 001952 844 VGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQARDLIR 917 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~----~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~dLI~ 917 (992)
+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+..++... +.+|....++..+++||.
T Consensus 204 ~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~ 283 (370)
T cd05621 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLIC 283 (370)
T ss_pred CCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHH
Confidence 6999999999998643 7889999999999999999999999888777887777643 455555567999999999
Q ss_pred HhccCCcCC--cCCChHhHHHHHcCCCCCCCch--hhhhcCCCCCCC
Q 001952 918 GLLIKEPEN--RLGSQKGAAEIKQHPFFEGLNW--ALIRCAIPPELP 960 (992)
Q Consensus 918 kcL~~DPek--RPT~~~~aeEILkHPfF~~lnw--~~lr~~~pp~lp 960 (992)
.||..++.+ |++ +.|+++||||+...| ..++...++.+|
T Consensus 284 ~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p 326 (370)
T cd05621 284 AFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVP 326 (370)
T ss_pred HHccCchhccCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCC
Confidence 999855543 778 999999999998554 555555555555
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=389.06 Aligned_cols=279 Identities=37% Similarity=0.720 Sum_probs=235.3
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyLVm 688 (992)
+|++.+.||+|+||.||+|.+..+++.||||++.+...........+..|+.++..+. |++|+++++++...+.+||||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765444455566788899998885 577888999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~----- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV----- 153 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-----
Confidence 999999999888764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.........||+.
T Consensus 154 -------------------------------------------------------------------~~~~~~~~~gt~~ 166 (323)
T cd05615 154 -------------------------------------------------------------------DGVTTRTFCGTPD 166 (323)
T ss_pred -------------------------------------------------------------------CCccccCccCCcc
Confidence 0000123468999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......+|. .++.++.+||.+||..||.+|+
T Consensus 167 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~p~~R~ 244 (323)
T cd05615 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTKHPSKRL 244 (323)
T ss_pred ccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccCHhhCC
Confidence 99999999999999999999999999999999999988877778787776666554 4889999999999999999999
Q ss_pred CCh-HhHHHHHcCCCCCCCchhhhhc--CCCCCCCCCCC
Q 001952 929 GSQ-KGAAEIKQHPFFEGLNWALIRC--AIPPELPDFYD 964 (992)
Q Consensus 929 T~~-~~aeEILkHPfF~~lnw~~lr~--~~pp~lp~~~d 964 (992)
+.. ....++++||||..++|..+.. ..+|..|+...
T Consensus 245 ~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~ 283 (323)
T cd05615 245 GCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCG 283 (323)
T ss_pred CCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCC
Confidence 853 3478999999999999987743 44555554333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=387.82 Aligned_cols=259 Identities=36% Similarity=0.745 Sum_probs=220.0
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||+|+++............+..|..++..+ +||||+++++++...+++||||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3699999999999999999999999999876443334455667788888754 899999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---------- 148 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------
Confidence 9999888764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (316)
T cd05620 149 --------------------------------------------------------------GDNRASTFCGTPDYIAPE 166 (316)
T ss_pred --------------------------------------------------------------CCCceeccCCCcCccCHH
Confidence 000112356899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||..||++|++.
T Consensus 167 ~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~--- 241 (316)
T cd05620 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLGV--- 241 (316)
T ss_pred HHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC---
Confidence 999999999999999999999999999999988777766666555444443 488999999999999999999992
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
.+++++||||+.++|..+.
T Consensus 242 ~~~~~~h~~f~~~~~~~~~ 260 (316)
T cd05620 242 VGNIRGHPFFKTINWTALE 260 (316)
T ss_pred hHHHHcCCCcCCCCHHHHH
Confidence 3689999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=387.84 Aligned_cols=277 Identities=35% Similarity=0.656 Sum_probs=231.4
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||++.+..+++.||+|++.+...........+..|+.++..++|+||+++++++.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444445566788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~---- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED---- 155 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC----
Confidence 999999999998764 356899999999999999999999999999999999999999999999999987332100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........+||+.
T Consensus 156 -------------------------------------------------------------------~~~~~~~~~gt~~ 168 (332)
T cd05623 156 -------------------------------------------------------------------GTVQSSVAVGTPD 168 (332)
T ss_pred -------------------------------------------------------------------CcceecccccCcc
Confidence 0000122469999
Q ss_pred ccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC--CCC-CccchHHHHHHHHHhc
Q 001952 849 YLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK--FPD-SPLISFQARDLIRGLL 920 (992)
Q Consensus 849 Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk--~P~-~~~vs~el~dLI~kcL 920 (992)
|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+...... +|. ...++.++++||.+||
T Consensus 169 y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll 248 (332)
T cd05623 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLI 248 (332)
T ss_pred ccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHc
Confidence 999999973 45789999999999999999999999988887888777654433 222 2347899999999999
Q ss_pred cCCcCC--cCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC
Q 001952 921 IKEPEN--RLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961 (992)
Q Consensus 921 ~~DPek--RPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~ 961 (992)
..++.+ |++ ++|+++||||.+++|..++....+.+|.
T Consensus 249 ~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 287 (332)
T cd05623 249 CSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYIPE 287 (332)
T ss_pred cChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCC
Confidence 765544 566 9999999999999999998766666663
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=408.22 Aligned_cols=275 Identities=32% Similarity=0.434 Sum_probs=229.3
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--C
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--N 682 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~ 682 (992)
....+.|+.+++||+|.||.||+|++..+|+.||+|.++.+. ..........+||.||++|+||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 344678999999999999999999999999999999998653 2345566778999999999999999999988766 6
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||| .-+|..++.. .+-.|++.+++.|+.||+.||+|||.+||+|||||.+||||+.+|++||+|||||+.+.
T Consensus 192 siYlVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 192 SIYLVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred eEEEEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 899999999 5567666664 34679999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. ....+++
T Consensus 270 ~~-----------------------------------------------------------------------~~~~~T~ 278 (560)
T KOG0600|consen 270 PS-----------------------------------------------------------------------GSAPYTS 278 (560)
T ss_pred CC-----------------------------------------------------------------------CCccccc
Confidence 11 1122567
Q ss_pred cccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh----------ccCCCC-------
Q 001952 843 FVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ----------SLKFPD------- 904 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~----------~lk~P~------- 904 (992)
.+-|++|+|||+|+|. .|+.++|+||.||||.||++|++.|+|.++.+++..|..- ..++|.
T Consensus 279 rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~ 358 (560)
T KOG0600|consen 279 RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQ 358 (560)
T ss_pred ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCC
Confidence 7899999999999997 5899999999999999999999999999999999988641 112221
Q ss_pred ----------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC
Q 001952 905 ----------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961 (992)
Q Consensus 905 ----------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~ 961 (992)
...++..+.+|+..||..||++|.| |.++|+|+||..- -....|..||.
T Consensus 359 ~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~t~----p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 359 QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFTTE----PLPCDPSSLPK 417 (560)
T ss_pred CcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCcccccC----CCCCCcccCCC
Confidence 0235678889999999999999999 9999999999432 22333445665
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=378.99 Aligned_cols=271 Identities=33% Similarity=0.560 Sum_probs=223.5
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|++.+.||+|+||.||++.+..+++.||||++.............+.+|+.+++.++|+||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999999976544433344556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|..++.......+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999887665445689999999999999999999999999999999999999999999999998632110
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~~~y 167 (285)
T cd05605 155 -------------------------------------------------------------------GETIRGRVGTVGY 167 (285)
T ss_pred -------------------------------------------------------------------CCccccccCCCCc
Confidence 0001124689999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh--ccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--SLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~--~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
+|||++.+..++.++|||||||++|||++|+.||.+.........+... .........++..+.+||.+||..||++|
T Consensus 168 ~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05605 168 MAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFR 247 (285)
T ss_pred cCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHh
Confidence 9999999988999999999999999999999999876554333222211 11112223488899999999999999999
Q ss_pred CCCh-HhHHHHHcCCCCCCCchhhhhc
Q 001952 928 LGSQ-KGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 928 PT~~-~~aeEILkHPfF~~lnw~~lr~ 953 (992)
|++. ..++++++||||...+|..+..
T Consensus 248 ~~~~~~~~~~l~~~~~~~~~~~~~~~~ 274 (285)
T cd05605 248 LGCRGEGAEEVKAHPFFRTANFKRLEA 274 (285)
T ss_pred cCCCCCCHHHHhcCcCccCCCHHHHhh
Confidence 9321 1299999999999999997753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=387.72 Aligned_cols=279 Identities=35% Similarity=0.651 Sum_probs=232.1
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||++++..+++.||+|++.+...........+..|+.++..++|+||+++++++...+..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998654344444566788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++||+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 156 (331)
T cd05624 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--- 156 (331)
T ss_pred eCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC---
Confidence 999999999998764 3568999999999999999999999999999999999999999999999999974321000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........||+.
T Consensus 157 --------------------------------------------------------------------~~~~~~~~gt~~ 168 (331)
T cd05624 157 --------------------------------------------------------------------TVQSSVAVGTPD 168 (331)
T ss_pred --------------------------------------------------------------------ceeeccccCCcc
Confidence 000112468999
Q ss_pred ccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC---ccchHHHHHHHHHhc
Q 001952 849 YLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS---PLISFQARDLIRGLL 920 (992)
Q Consensus 849 Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~---~~vs~el~dLI~kcL 920 (992)
|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+......++.+ ..++.++++||.+||
T Consensus 169 y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll 248 (331)
T cd05624 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLI 248 (331)
T ss_pred cCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHc
Confidence 999999986 457889999999999999999999999887777777776544333222 246889999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~ 961 (992)
..++. |+. ...++++++||||+.++|..++...++.+|.
T Consensus 249 ~~~~~-~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~ 287 (331)
T cd05624 249 CSRER-RLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYIPD 287 (331)
T ss_pred cCchh-hcC-CCCHHHHhcCCCcCCCCHHHHhhCCCCccCC
Confidence 97654 432 1239999999999999999999888777774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=386.54 Aligned_cols=277 Identities=36% Similarity=0.674 Sum_probs=230.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||++.+..+++.||||++.+...........+.+|+.++..++|+||++++++|..++++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444455667889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++|++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 156 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--- 156 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC---
Confidence 999999999998753 3568999999999999999999999999999999999999999999999999874321000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........||+.
T Consensus 157 --------------------------------------------------------------------~~~~~~~~gt~~ 168 (331)
T cd05597 157 --------------------------------------------------------------------TVQSNVAVGTPD 168 (331)
T ss_pred --------------------------------------------------------------------Cccccceecccc
Confidence 000112368999
Q ss_pred ccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc--CCCC-CccchHHHHHHHHHhc
Q 001952 849 YLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL--KFPD-SPLISFQARDLIRGLL 920 (992)
Q Consensus 849 Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l--k~P~-~~~vs~el~dLI~kcL 920 (992)
|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.... .++. ...++.++++||++||
T Consensus 169 y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll 248 (331)
T cd05597 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLI 248 (331)
T ss_pred ccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHc
Confidence 999999974 3478899999999999999999999998877777777665432 2222 2347899999999999
Q ss_pred cCCcCC--cCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC
Q 001952 921 IKEPEN--RLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD 961 (992)
Q Consensus 921 ~~DPek--RPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~ 961 (992)
..++.. |++ +.++++||||.+++|..+....++.+|+
T Consensus 249 ~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~~ 287 (331)
T cd05597 249 CSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAPYVPE 287 (331)
T ss_pred cCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCCccCc
Confidence 764433 667 9999999999999999998777766663
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=386.09 Aligned_cols=262 Identities=39% Similarity=0.793 Sum_probs=223.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||+||+|.+..+++.||||++++...........+..|.+++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999876554455566778899999888 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---------- 148 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---------- 148 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc----------
Confidence 9999888764 5799999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........+||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~g~~~y~aPE 166 (318)
T cd05570 149 --------------------------------------------------------------GGVTTSTFCGTPDYIAPE 166 (318)
T ss_pred --------------------------------------------------------------CCCcccceecCccccCHH
Confidence 000112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh-H
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-K 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~-~ 932 (992)
++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++.+||.+||..||.+||+.. .
T Consensus 167 ~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~ 244 (318)
T cd05570 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPT 244 (318)
T ss_pred HhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCC
Confidence 999999999999999999999999999999988777777777666555554 4889999999999999999999921 1
Q ss_pred hHHHHHcCCCCCCCchhhhh
Q 001952 933 GAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 933 ~aeEILkHPfF~~lnw~~lr 952 (992)
.+.+++.||||...+|....
T Consensus 245 ~~~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 245 GEQDIKGHPFFREIDWDKLE 264 (318)
T ss_pred CHHHHhcCCCcCCCCHHHHH
Confidence 12999999999999997553
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=385.81 Aligned_cols=259 Identities=40% Similarity=0.803 Sum_probs=220.0
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||||+++............+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999876544444455566677777654 899999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
|+|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999888764 56899999999999999999999999999999999999999999999999997321100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........||+.|+|||
T Consensus 150 ---------------------------------------------------------------~~~~~~~~gt~~y~aPE 166 (316)
T cd05592 150 ---------------------------------------------------------------EGKASTFCGTPDYIAPE 166 (316)
T ss_pred ---------------------------------------------------------------CCccccccCCccccCHH
Confidence 00112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+| ..++.++.+||.+||..||.+||++
T Consensus 167 ~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~ll~~~l~~~P~~R~~~--- 241 (316)
T cd05592 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP--RWISKEAKDCLSKLFERDPTKRLGV--- 241 (316)
T ss_pred HHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHccCCHHHcCCC---
Confidence 99999999999999999999999999999998887777776655444444 3588999999999999999999983
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
..++++||||..++|..+.
T Consensus 242 ~~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05592 242 DGDIRQHPFFRGIDWERLE 260 (316)
T ss_pred hHHHHcCcccCCCCHHHHH
Confidence 4688999999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=406.75 Aligned_cols=284 Identities=35% Similarity=0.635 Sum_probs=251.1
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..+..+.|...++||+||||.||-|+.+.+|+.||+|.+.+..+..+.......+|..||.++..++||.|-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34556789999999999999999999999999999999998888888888889999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||..|.||+|..+|.+..+..|++..++.|+.+|+.||++||+.+||+|||||+|||||+.|++.|+|+|||..+..
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999888876667899999999999999999999999999999999999999999999999999854321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.......
T Consensus 340 -------------------------------------------------------------------------g~~~~~r 346 (591)
T KOG0986|consen 340 -------------------------------------------------------------------------GKPIRGR 346 (591)
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 1122345
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
+||.+|||||++.+..|+...|+|+|||+||||+.|+.||...... +.-+.++.....+++ .+++++++|.+.+
T Consensus 347 vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~--kFS~eakslc~~L 424 (591)
T KOG0986|consen 347 VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSD--KFSEEAKSLCEGL 424 (591)
T ss_pred cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccc--ccCHHHHHHHHHH
Confidence 8999999999999999999999999999999999999999865432 333444445556664 4999999999999
Q ss_pred ccCCcCCcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCCCC
Q 001952 920 LIKEPENRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELPDF 962 (992)
Q Consensus 920 L~~DPekRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~~ 962 (992)
|++||.+|++.+ .++.++.+||||+.+||..+ .+..||.+|+.
T Consensus 425 L~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp 470 (591)
T KOG0986|consen 425 LTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDP 470 (591)
T ss_pred HccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCc
Confidence 999999999997 68999999999999999977 56889999943
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=385.60 Aligned_cols=258 Identities=40% Similarity=0.812 Sum_probs=219.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||||+++............+..|..++..+ +||||+++++++.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999876443334455667788888764 899999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999988764 56899999999999999999999999999999999999999999999999986321000
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........||+.|+|||
T Consensus 150 ---------------------------------------------------------------~~~~~~~~gt~~y~aPE 166 (316)
T cd05619 150 ---------------------------------------------------------------DAKTCTFCGTPDYIAPE 166 (316)
T ss_pred ---------------------------------------------------------------CCceeeecCCccccCHH
Confidence 00112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||..||++||+
T Consensus 167 ~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~---- 240 (316)
T cd05619 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRLG---- 240 (316)
T ss_pred HHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCC----
Confidence 999999999999999999999999999999988777777666554444443 48889999999999999999999
Q ss_pred H-HHHHcCCCCCCCchhhhh
Q 001952 934 A-AEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 a-eEILkHPfF~~lnw~~lr 952 (992)
+ ++++.||||..++|..+.
T Consensus 241 ~~~~l~~h~~~~~~~~~~~~ 260 (316)
T cd05619 241 VKGDIRQHPFFREIDWSALE 260 (316)
T ss_pred ChHHHHcCcccCCCCHHHHH
Confidence 6 489999999999998774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=413.97 Aligned_cols=256 Identities=30% Similarity=0.521 Sum_probs=230.9
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|.+.+.||+|+||+||+|+.+.+.+.||||.+.+.. ...+....+.+|++|++.++|||||.++++|+...++|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 57888999999999999999999999999999997653 22345667899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+.| +|+.++... +.++++.++.++.|++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.+....
T Consensus 81 e~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--- 154 (808)
T ss_pred hhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc---
Confidence 99966 999998874 789999999999999999999999999999999999999999999999999985543211
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
...+.+.||+.
T Consensus 155 ---------------------------------------------------------------------~vltsikGtPl 165 (808)
T KOG0597|consen 155 ---------------------------------------------------------------------SVLTSIKGTPL 165 (808)
T ss_pred ---------------------------------------------------------------------eeeeeccCccc
Confidence 11245679999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|||||++.+..|+..+|+|||||++|||++|++||....-.+....|+....++|. ..+..+++||.++|.+||.+|+
T Consensus 166 YmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rl 243 (808)
T KOG0597|consen 166 YMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDPAQRL 243 (808)
T ss_pred ccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcChhhcc
Confidence 99999999999999999999999999999999999998888888888888888876 4899999999999999999999
Q ss_pred CChHhHHHHHcCCCCCCC
Q 001952 929 GSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~l 946 (992)
+ +.+++.|||.++.
T Consensus 244 t----W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 244 T----WTDLLGHPFWKGK 257 (808)
T ss_pred c----HHHHhcChHHhhh
Confidence 9 9999999998764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=385.83 Aligned_cols=263 Identities=38% Similarity=0.704 Sum_probs=223.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHH-HHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE-ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~Eie-ILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||+||+|.+..+++.||||++.............+..|.. +++.++||||+++++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999999999999999998654433334445555654 46779999999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---------- 148 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---------- 148 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC----------
Confidence 9998887754 5789999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (325)
T cd05604 149 --------------------------------------------------------------QSDTTTTFCGTPEYLAPE 166 (325)
T ss_pred --------------------------------------------------------------CCCCcccccCChhhCCHH
Confidence 000112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
++.+..++.++|||||||+||||++|..||.+.+..+.+..+......++ +.++..+.+||.+||..||.+||+....
T Consensus 167 ~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 167 VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR--PGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred HHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC--CCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 99999999999999999999999999999998877777777766554443 3478899999999999999999998778
Q ss_pred HHHHHcCCCCCCCchhhhhc
Q 001952 934 AAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr~ 953 (992)
+.++++||||..++|..+..
T Consensus 245 ~~~i~~h~~f~~~~~~~~~~ 264 (325)
T cd05604 245 FLEIQEHPFFESLSWTDLEQ 264 (325)
T ss_pred HHHHhcCCCcCCCCHHHHHh
Confidence 89999999999999987754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=393.77 Aligned_cols=280 Identities=35% Similarity=0.653 Sum_probs=234.5
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
...+..++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++..++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34566789999999999999999999999999999999997654444444566788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|+||||++||+|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 99999999999999998875 358899999999999999999999999999999999999999999999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .......
T Consensus 194 ~~-----------------------------------------------------------------------~~~~~~~ 202 (371)
T cd05622 194 KE-----------------------------------------------------------------------GMVRCDT 202 (371)
T ss_pred cC-----------------------------------------------------------------------CcccccC
Confidence 00 0001123
Q ss_pred cccCCCccChhhhcCCC----CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQARDLI 916 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~----~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~dLI 916 (992)
.+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+..++... +.+|....++..+++||
T Consensus 203 ~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 282 (371)
T cd05622 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 282 (371)
T ss_pred cccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHH
Confidence 56999999999998643 7899999999999999999999999887777777776543 45666667899999999
Q ss_pred HHhccCCcCC---cCCChHhHHHHHcCCCCCCCc--hhhhhcCCCCCCCC
Q 001952 917 RGLLIKEPEN---RLGSQKGAAEIKQHPFFEGLN--WALIRCAIPPELPD 961 (992)
Q Consensus 917 ~kcL~~DPek---RPT~~~~aeEILkHPfF~~ln--w~~lr~~~pp~lp~ 961 (992)
.+||. +|.. |++ ++||++|+||+... |..++...+|.+|.
T Consensus 283 ~~~L~-~~~~r~~r~~----~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~ 327 (371)
T cd05622 283 CAFLT-DREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPD 327 (371)
T ss_pred HHHcC-ChhhhcCCCC----HHHHhcCcccCCCChhHHhcCCCCCCCCCC
Confidence 99998 5555 556 99999999999855 55667766666664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=386.97 Aligned_cols=262 Identities=37% Similarity=0.731 Sum_probs=217.4
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..+ +||||+++++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999876544444556678888888776 899999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~---------- 148 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC----------
Confidence 9998887654 5789999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (329)
T cd05618 149 --------------------------------------------------------------PGDTTSTFCGTPNYIAPE 166 (329)
T ss_pred --------------------------------------------------------------CCCccccccCCccccCHH
Confidence 000112356899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCC--------Cch-HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS--------GNE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~--------s~~-e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
++.+..++.++|||||||++|||++|+.||... ... .....+......+|. .++.++.+||.+||..||
T Consensus 167 ~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dP 244 (329)
T cd05618 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLNKDP 244 (329)
T ss_pred HHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhcCCH
Confidence 999999999999999999999999999999521 111 223334444444543 588999999999999999
Q ss_pred CCcCCCh--HhHHHHHcCCCCCCCchhhhh
Q 001952 925 ENRLGSQ--KGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 925 ekRPT~~--~~aeEILkHPfF~~lnw~~lr 952 (992)
++|++.. .++.++++||||..++|..+.
T Consensus 245 ~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~ 274 (329)
T cd05618 245 KERLGCHPQTGFADIQGHPFFRNVDWDLME 274 (329)
T ss_pred HHcCCCCCCCCHHHHhcCCCCCCCCHHHHH
Confidence 9999842 246899999999999998664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=393.59 Aligned_cols=262 Identities=31% Similarity=0.478 Sum_probs=217.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC--eEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN--LSCL 686 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~--~lyL 686 (992)
.+|...+.||+|+||.||++.+..+|+.+|||.+.... ....+.+.+|+.+|.+++|||||+++|...... .++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 45677788999999999999999989999999987541 111566899999999999999999999754444 6999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-CCcEEEEeccccccccCCc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-DGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-dg~VKLsDFGLA~~l~~~~ 765 (992)
+|||+++|+|.+++.+..+ .+++..++.+.+||+.||+|||++|||||||||+|||++. +|.+||+|||++......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~- 171 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK- 171 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccc-
Confidence 9999999999999998755 7999999999999999999999999999999999999999 799999999997543210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.........+.|
T Consensus 172 --------------------------------------------------------------------~~~~~~~~~~~G 183 (313)
T KOG0198|consen 172 --------------------------------------------------------------------GTKSDSELSVQG 183 (313)
T ss_pred --------------------------------------------------------------------cccccccccccC
Confidence 000111234679
Q ss_pred CCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCC-CCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 846 THEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKG-SGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 846 T~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g-~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
|+.|||||++..+ ..+.++|||||||++.||+||..||.. ....+.+..+.........+..++.++++||.+||..|
T Consensus 184 tp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~ 263 (313)
T KOG0198|consen 184 TPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRD 263 (313)
T ss_pred CccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcC
Confidence 9999999999963 334599999999999999999999987 44455555555554333444569999999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCCCc
Q 001952 924 PENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~ln 947 (992)
|++||| |+++|+|||.....
T Consensus 264 p~~Rpt----a~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 264 PEKRPT----AEELLEHPFLKQNS 283 (313)
T ss_pred cccCcC----HHHHhhChhhhccc
Confidence 999999 99999999997643
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=384.11 Aligned_cols=262 Identities=40% Similarity=0.768 Sum_probs=221.5
Q ss_pred EEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHh-hcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 615 QKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLAR-RKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~-~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
+.||+|+||.||+|++. .+++.||||++....... ......+..|+++|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999864 468899999998654322 23345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+++++|..++... ..+.+..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~------- 152 (323)
T cd05584 82 LSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH------- 152 (323)
T ss_pred CCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc-------
Confidence 9999999988764 5688999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
.........||+.|+
T Consensus 153 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 167 (323)
T cd05584 153 -----------------------------------------------------------------EGTVTHTFCGTIEYM 167 (323)
T ss_pred -----------------------------------------------------------------CCCcccccCCCcccc
Confidence 000112346899999
Q ss_pred ChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCC
Q 001952 851 APEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 851 APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......++ ..++.++.+||.+||..||++||+.
T Consensus 168 aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~ 245 (323)
T cd05584 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGA 245 (323)
T ss_pred ChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--CCCCHHHHHHHHHHcccCHhHcCCC
Confidence 99999999999999999999999999999999998887777777776655544 3588999999999999999999921
Q ss_pred h-HhHHHHHcCCCCCCCchhhhh
Q 001952 931 Q-KGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 931 ~-~~aeEILkHPfF~~lnw~~lr 952 (992)
. ..+++++.||||...+|..+.
T Consensus 246 ~~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 246 GPGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHh
Confidence 1 129999999999999998774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=414.45 Aligned_cols=264 Identities=30% Similarity=0.511 Sum_probs=232.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+-|++.+.||.|+.|.|-+|++..+|+.+|||++.+...........+.+|+-||+.+.|||+++||++|++..++|||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 35688899999999999999999999999999999865323334456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
.||++||.|.+++-.. +++++..+..+++||+.|+.|+|..+|+||||||+|+||+..+++||+|||+|..-
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------ 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------ 162 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc------
Confidence 9999999999988775 78999999999999999999999999999999999999999999999999997321
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
..| --..+.||.+
T Consensus 163 -----------~~g--------------------------------------------------------klLeTSCGSP 175 (786)
T KOG0588|consen 163 -----------VPG--------------------------------------------------------KLLETSCGSP 175 (786)
T ss_pred -----------cCC--------------------------------------------------------ccccccCCCc
Confidence 011 1123457999
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+|.+||++.|..| +.++||||-|||||.||||+.||.+.+-...|.++..+.+..|. .++.++++||++||..||++
T Consensus 176 HYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~VDp~~ 253 (786)
T KOG0588|consen 176 HYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDVDPST 253 (786)
T ss_pred ccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhccCccc
Confidence 9999999999998 89999999999999999999999988777777787777777774 59999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCchhhhh
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~~lr 952 (992)
|+| .+||++|||+.+..-....
T Consensus 254 RiT----~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 254 RIT----TEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ccc----HHHHhhCchhhcCCCCChh
Confidence 999 9999999999988655443
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=404.06 Aligned_cols=269 Identities=35% Similarity=0.609 Sum_probs=229.9
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhc-----------chhHHHHHHHHHHHcCCCCcc
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK-----------KMPRAQTEREILRMLDHPFLP 672 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~-----------~~~~~~~EieILk~L~HPNIV 672 (992)
+...+++|++++.||+|.||.|-+|++..+++.||||++.+..+.... ..+...+|+.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 455678999999999999999999999999999999999865543221 134788999999999999999
Q ss_pred ceeeeecc--CCeEEEEEEecCCCChHHHHHhhcCCC-CCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc
Q 001952 673 TLYSQFTS--DNLSCLVMEYCPGGDLHVLRQKQLGKC-FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH 749 (992)
Q Consensus 673 kL~g~f~~--~~~lyLVmEy~~GGSL~~lLkk~~~~~-Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~ 749 (992)
+|+++..+ .+.+|||+|||..|.+...-. ... +.+.+++.|+++++.||+|||.+|||||||||+|+||+.+|+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc
Confidence 99999875 468999999999888755422 244 899999999999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCC
Q 001952 750 IMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLP 829 (992)
Q Consensus 750 VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~ 829 (992)
+||+|||.+..+....
T Consensus 249 VKIsDFGVs~~~~~~~---------------------------------------------------------------- 264 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGS---------------------------------------------------------------- 264 (576)
T ss_pred EEeeccceeeecccCC----------------------------------------------------------------
Confidence 9999999874321100
Q ss_pred ccccCCCCCCcCccccCCCccChhhhcCCC----CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC
Q 001952 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS 905 (992)
Q Consensus 830 ~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~----~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~ 905 (992)
....++.....+||+.|+|||++.++. .+.+.|||||||+||.|+.|+.||.+....+.+.+|+...+.+|..
T Consensus 265 ---~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~ 341 (576)
T KOG0585|consen 265 ---DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN 341 (576)
T ss_pred ---ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc
Confidence 000011112258999999999998743 3788999999999999999999999999999999999999999999
Q ss_pred ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+.+.++++|||.+||++||++|++ +.+|..|||...-
T Consensus 342 pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 342 PEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVTRD 378 (576)
T ss_pred ccccHHHHHHHHHHhhcChhheee----hhhheecceeccC
Confidence 999999999999999999999999 9999999998653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=392.32 Aligned_cols=279 Identities=39% Similarity=0.742 Sum_probs=253.0
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|..+++||+|.||+|.+|+-+.+++.||||+++++.+..+..+..-..|-.+|+..+||++..|...|...+++|
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence 45688999999999999999999999999999999999998888888888899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||..||.|..++... ..|++...+.|-.+|+.||.|||+++||+||||.+|+|+|++|++||.||||++.-
T Consensus 245 FVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~---- 318 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE---- 318 (516)
T ss_pred EEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc----
Confidence 999999999998777764 67999999999999999999999999999999999999999999999999996220
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
...+.....++|
T Consensus 319 --------------------------------------------------------------------I~~g~t~kTFCG 330 (516)
T KOG0690|consen 319 --------------------------------------------------------------------IKYGDTTKTFCG 330 (516)
T ss_pred --------------------------------------------------------------------ccccceeccccC
Confidence 012233457899
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||+|....|+.++|+|.+||++|||+.|+.||...++...+..|+...++||.. ++++++.|+.++|.+||.
T Consensus 331 TPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~kdP~ 408 (516)
T KOG0690|consen 331 TPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT--LSPEAKTLLSGLLKKDPK 408 (516)
T ss_pred ChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc--CCHHHHHHHHHHhhcChH
Confidence 999999999999999999999999999999999999999999999999999999999985 999999999999999999
Q ss_pred CcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCC
Q 001952 926 NRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELP 960 (992)
Q Consensus 926 kRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp 960 (992)
+|++.. ..+.||.+|+||.++||... +...||.-|
T Consensus 409 kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKP 446 (516)
T KOG0690|consen 409 KRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKP 446 (516)
T ss_pred hhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCC
Confidence 999864 36999999999999999855 345666666
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=385.04 Aligned_cols=261 Identities=38% Similarity=0.735 Sum_probs=222.1
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc---CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L---~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
||+|+||+||+|.+..+++.||||++.+...........+..|..++..+ +||||+++++++...+.+||||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765444444445556677777665 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---------- 148 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT---------- 148 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC----------
Confidence 9999888764 5689999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (330)
T cd05586 149 --------------------------------------------------------------DNKTTNTFCGTTEYLAPE 166 (330)
T ss_pred --------------------------------------------------------------CCCCccCccCCccccCHH
Confidence 000112346999999999
Q ss_pred hhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 854 IIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 854 vL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
++.+. .++.++|||||||+||||++|+.||.+.+..+.+..+......++.. .++.++.+||.+||..||.+||+...
T Consensus 167 ~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~~~~~ 245 (330)
T cd05586 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHR 245 (330)
T ss_pred HHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHcCCCHHHCCCCCC
Confidence 99865 47999999999999999999999999887777777777666666543 47899999999999999999997666
Q ss_pred hHHHHHcCCCCCCCchhhhh
Q 001952 933 GAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 933 ~aeEILkHPfF~~lnw~~lr 952 (992)
.+.++++||||...+|..+.
T Consensus 246 ~~~~ll~h~~~~~~~~~~~~ 265 (330)
T cd05586 246 DAVELKEHPFFADIDWDLLS 265 (330)
T ss_pred CHHHHhcCccccCCCHHHHH
Confidence 79999999999999998774
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=375.83 Aligned_cols=263 Identities=31% Similarity=0.544 Sum_probs=218.0
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||+|+||.||++.+..+|+.||+|++.............+..|+++|+.++||||+++++++..+.++|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344556799999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCC
Q 001952 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776 (992)
Q Consensus 697 ~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~ 776 (992)
..++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~------------ 148 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG------------ 148 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC------------
Confidence 98876654456889999999999999999999999999999999999999999999999987432100
Q ss_pred CccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhc
Q 001952 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK 856 (992)
Q Consensus 777 ~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~ 856 (992)
.......|+..|+|||++.
T Consensus 149 -------------------------------------------------------------~~~~~~~~~~~y~aPE~~~ 167 (277)
T cd05607 149 -------------------------------------------------------------KTITQRAGTNGYMAPEILK 167 (277)
T ss_pred -------------------------------------------------------------ceeeccCCCCCccCHHHHc
Confidence 0001235888999999999
Q ss_pred CCCCCccceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 857 GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 857 g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
+..++.++|||||||++|||++|+.||.+.... +...........++ ...++.++++||.+||..||++||++..
T Consensus 168 ~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred cCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 999999999999999999999999999764332 22233332232222 2357899999999999999999999666
Q ss_pred hHHHHHcCCCCCCCchhhhhc
Q 001952 933 GAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 933 ~aeEILkHPfF~~lnw~~lr~ 953 (992)
.+.++++|+||++++|..+..
T Consensus 247 ~~~~~~~h~~f~~~~~~~~~~ 267 (277)
T cd05607 247 KNDDPRKHEFFKTINFPRLEA 267 (277)
T ss_pred chhhhhcChhhcCCCHHHHhc
Confidence 668999999999999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=375.95 Aligned_cols=263 Identities=32% Similarity=0.608 Sum_probs=216.9
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||+|+||+||+|.+..+++.||+|++.............+..|+.+|+.++|+||+++++++...+.+||||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999866544444456678899999999999999999999999999999999999999
Q ss_pred HHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCC
Q 001952 697 HVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774 (992)
Q Consensus 697 ~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~ 774 (992)
..++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~---------- 150 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG---------- 150 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC----------
Confidence 8876532 2356899999999999999999999999999999999999999999999999987332100
Q ss_pred CCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhh
Q 001952 775 DPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEI 854 (992)
Q Consensus 775 ~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEv 854 (992)
........||+.|+|||+
T Consensus 151 --------------------------------------------------------------~~~~~~~~g~~~y~aPE~ 168 (280)
T cd05608 151 --------------------------------------------------------------QSKTKGYAGTPGFMAPEL 168 (280)
T ss_pred --------------------------------------------------------------CccccccCCCcCccCHHH
Confidence 000123468999999999
Q ss_pred hcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHH----HHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCC
Q 001952 855 IKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL----ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 855 L~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L----~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
+.+..++.++|||||||++|||++|+.||......... ..+......+ +..++.++.+|+.+||..||++||+.
T Consensus 169 ~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 169 LQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTY--PDKFSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred hcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCC--cccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 99999999999999999999999999999865433222 2222222222 23588999999999999999999954
Q ss_pred hH-hHHHHHcCCCCCCCchhhhhc
Q 001952 931 QK-GAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 931 ~~-~aeEILkHPfF~~lnw~~lr~ 953 (992)
.. .++++++||||++++|..+..
T Consensus 247 ~~~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 247 RDGNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred CCCCHHHHhcChhhhcCCHhHHhh
Confidence 32 389999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=384.26 Aligned_cols=262 Identities=40% Similarity=0.733 Sum_probs=222.1
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHH-HHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTER-EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~Ei-eILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||+|++.............+..|. .+++.++|+||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999865433333333444444 457889999999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+.+..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---------- 148 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---------- 148 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc----------
Confidence 9999988764 5688999999999999999999999999999999999999999999999998732100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........+||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (325)
T cd05602 149 --------------------------------------------------------------HNGTTSTFCGTPEYLAPE 166 (325)
T ss_pred --------------------------------------------------------------CCCCcccccCCccccCHH
Confidence 000112346999999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
++.+..++.++|||||||++|||++|..||.+.+..+.+..+......++ +.++..+.+||.+||..||.+|++....
T Consensus 167 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred HHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 99999999999999999999999999999998887777777765544433 3588999999999999999999998777
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
+.++++|+||..++|..+.
T Consensus 245 ~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 245 FMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred HHHHhcCcccCCCCHHHHH
Confidence 8899999999999998774
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=382.73 Aligned_cols=262 Identities=40% Similarity=0.734 Sum_probs=221.8
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHH-HHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE-ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~Eie-ILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|.. +++.++||||+++++++...+.+||||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999998665444344445555554 67889999999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---------- 148 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC----------
Confidence 9998887653 5688999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (321)
T cd05603 149 --------------------------------------------------------------PEETTSTFCGTPEYLAPE 166 (321)
T ss_pred --------------------------------------------------------------CCCccccccCCcccCCHH
Confidence 000112346899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
++.+..++.++|||||||++|||++|..||.+.+....+..+......++. ..+.++.+||.+||..||.+|++....
T Consensus 167 ~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (321)
T cd05603 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKAD 244 (321)
T ss_pred HhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCC
Confidence 999999999999999999999999999999988777777777665555443 478899999999999999999997666
Q ss_pred HHHHHcCCCCCCCchhhhh
Q 001952 934 AAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr 952 (992)
+.++++|+||..++|..+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 245 FLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred HHHHhCCCCcCCCCHHHHh
Confidence 7899999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=383.58 Aligned_cols=263 Identities=37% Similarity=0.723 Sum_probs=220.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|+.++..+ +|+||+.+++++...+.+||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999876555555567788999999888 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---------- 148 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---------- 148 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC----------
Confidence 9999887754 5699999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........+||+.|+|||
T Consensus 149 --------------------------------------------------------------~~~~~~~~~gt~~y~aPE 166 (327)
T cd05617 149 --------------------------------------------------------------PGDTTSTFCGTPNYIAPE 166 (327)
T ss_pred --------------------------------------------------------------CCCceecccCCcccCCHH
Confidence 000112356899999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCC------chH-HHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG------NEE-TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s------~~e-~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
++.+..++.++|||||||+||||++|+.||.... ..+ .+..+......+| ..++..+.+||.+||..||.+
T Consensus 167 ~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~~L~~dP~~ 244 (327)
T cd05617 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLKGFLNKDPKE 244 (327)
T ss_pred HHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHHHHHHHHHHhccCHHH
Confidence 9999999999999999999999999999996421 222 2333333333443 358899999999999999999
Q ss_pred cCCCh--HhHHHHHcCCCCCCCchhhhhc
Q 001952 927 RLGSQ--KGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 927 RPT~~--~~aeEILkHPfF~~lnw~~lr~ 953 (992)
|++.+ ..+++++.||||..++|..+..
T Consensus 245 R~~~~~~~~~~~i~~h~~f~~~~~~~~~~ 273 (327)
T cd05617 245 RLGCQPQTGFSDIKSHTFFRSIDWDLLEK 273 (327)
T ss_pred cCCCCCCCCHHHHHcCCCCCCCCHHHHHh
Confidence 99853 3578999999999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=381.12 Aligned_cols=269 Identities=43% Similarity=0.802 Sum_probs=217.9
Q ss_pred CceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHH-hhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLA-RRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~-~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+|++++.||+|+||.||++++. .+++.||+|++.+.... .......+..|+.+|+.+ +|+||+++++++..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999764 46889999999765432 223345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+++|+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999888764 56899999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.........
T Consensus 159 -----------------------------------------------------------------------~~~~~~~~~ 167 (332)
T cd05614 159 -----------------------------------------------------------------------EKERTYSFC 167 (332)
T ss_pred -----------------------------------------------------------------------CCCcccccc
Confidence 000112356
Q ss_pred cCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 845 GTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 845 GT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
||+.|+|||++.+.. ++.++|||||||+||||++|+.||...... .....+.... .+.+..++..+.+||.+|
T Consensus 168 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~ 245 (332)
T cd05614 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--PPFPSFIGPEAQDLLHKL 245 (332)
T ss_pred CCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCHHHHHHHHHH
Confidence 999999999998754 789999999999999999999999754322 2222233222 233345889999999999
Q ss_pred ccCCcCCcCCCh-HhHHHHHcCCCCCCCchhhhhc
Q 001952 920 LIKEPENRLGSQ-KGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 920 L~~DPekRPT~~-~~aeEILkHPfF~~lnw~~lr~ 953 (992)
|..||++||+.. ..++++++||||+..+|..+..
T Consensus 246 l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 280 (332)
T cd05614 246 LRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL 280 (332)
T ss_pred cCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 999999999421 1389999999999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=374.51 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=211.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+++++.++|+||+++++++..++.+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 379999999999999999999999999999999975421 1233456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++++.|..+... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~---- 153 (287)
T cd07848 80 EYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG---- 153 (287)
T ss_pred ecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc----
Confidence 99998877665443 356899999999999999999999999999999999999999999999999997432100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.........||+.
T Consensus 154 -------------------------------------------------------------------~~~~~~~~~~~~~ 166 (287)
T cd07848 154 -------------------------------------------------------------------SNANYTEYVATRW 166 (287)
T ss_pred -------------------------------------------------------------------ccccccccccccc
Confidence 0001123468999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------cCCCC-----
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------------LKFPD----- 904 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------------lk~P~----- 904 (992)
|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.... ..++.
T Consensus 167 y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07848 167 YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQ 246 (287)
T ss_pred cCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcc
Confidence 999999999999999999999999999999999999876655544332211 01111
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...++.++.+||.+||..||++||+ ++++|+||||
T Consensus 247 ~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred cHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 0126778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.26 Aligned_cols=262 Identities=41% Similarity=0.789 Sum_probs=223.0
Q ss_pred EEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEec
Q 001952 615 QKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~ 691 (992)
+.||+|+||.||++++. .+++.||+|++....... .....+..|+++|+.++||||+++++++...+.+||||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 57999999999999763 578899999998654322 23345678999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCC
Q 001952 692 PGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSS 771 (992)
Q Consensus 692 ~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~ 771 (992)
++++|..++.+. ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------- 151 (318)
T cd05582 81 RGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------- 151 (318)
T ss_pred CCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-------
Confidence 999999988764 56899999999999999999999999999999999999999999999999986321100
Q ss_pred CCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccC
Q 001952 772 SNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLA 851 (992)
Q Consensus 772 s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~A 851 (992)
........||+.|+|
T Consensus 152 -----------------------------------------------------------------~~~~~~~~g~~~y~a 166 (318)
T cd05582 152 -----------------------------------------------------------------EKKAYSFCGTVEYMA 166 (318)
T ss_pred -----------------------------------------------------------------CCceecccCChhhcC
Confidence 001123468999999
Q ss_pred hhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh
Q 001952 852 PEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ 931 (992)
Q Consensus 852 PEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~ 931 (992)
||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||++||..||++||++.
T Consensus 167 PE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~ 244 (318)
T cd05582 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAG 244 (318)
T ss_pred HHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 99999988999999999999999999999999988777777777666555543 4889999999999999999999964
Q ss_pred H-hHHHHHcCCCCCCCchhhhhc
Q 001952 932 K-GAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 932 ~-~aeEILkHPfF~~lnw~~lr~ 953 (992)
. .+++++.||||..++|..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T cd05582 245 PDGVEEIKRHPFFSTIDWNKLYR 267 (318)
T ss_pred CCCHHHHhCCCCcCCCCHHHHHh
Confidence 3 478899999999999987653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=375.30 Aligned_cols=262 Identities=27% Similarity=0.386 Sum_probs=209.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc--ccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999987532 122234567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 156 (303)
T cd07869 82 FEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--- 156 (303)
T ss_pred EECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC---
Confidence 99994 6777776654 356889999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (303)
T cd07869 157 ---------------------------------------------------------------------SHTYSNEVVTL 167 (303)
T ss_pred ---------------------------------------------------------------------CccCCCCcccC
Confidence 00012235789
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccC-----CC----------------C
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLK-----FP----------------D 904 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk-----~P----------------~ 904 (992)
.|+|||++.+. .++.++|||||||+||||++|..||.+..+. +.+..+...... ++ .
T Consensus 168 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (303)
T cd07869 168 WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYS 247 (303)
T ss_pred CCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccC
Confidence 99999998764 5789999999999999999999999876543 233222211000 00 0
Q ss_pred C---------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 905 S---------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 905 ~---------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
+ ..++.++.+||.+||+.||.+||+ +.|+|+||||..+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 248 PKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPPR 297 (303)
T ss_pred CccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCChh
Confidence 0 013467889999999999999999 9999999999988753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=372.87 Aligned_cols=256 Identities=30% Similarity=0.448 Sum_probs=211.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||.|+||.||+|.+..+++.||+|+++... .......+.+|+.+|+.++||||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 568999999999999999999999999999999987532 122334677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||++ ++|..++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~--- 156 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP--- 156 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC---
Confidence 99996 5888887654 345789999999999999999999999999999999999999999999999987321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|++
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (288)
T cd07871 157 ---------------------------------------------------------------------TKTYSNEVVTL 167 (288)
T ss_pred ---------------------------------------------------------------------CccccCceecc
Confidence 00012235789
Q ss_pred CccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-------------------CCCC---
Q 001952 848 EYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------KFPD--- 904 (992)
Q Consensus 848 ~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------k~P~--- 904 (992)
.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+..... .++.
T Consensus 168 ~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (288)
T cd07871 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRA 247 (288)
T ss_pred cccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCC
Confidence 9999999876 4589999999999999999999999998777666655432110 1111
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...++.++++||.+||..||.+||| ++|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 248 QPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred CchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 1235778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=402.91 Aligned_cols=255 Identities=30% Similarity=0.498 Sum_probs=226.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
...|....+||+|..|.||.|....+++.||||.+... .....+.+.+|+.+|+..+|+|||.+++.|..++.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~---~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR---KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec---cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 56788889999999999999999999999999999764 333445678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|.+.+... .+++.++..||++++.||+|||.+||||||||.+|||++.+|.+||+|||++..+...
T Consensus 349 MEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--- 422 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--- 422 (550)
T ss_pred EeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc---
Confidence 9999999999998874 5999999999999999999999999999999999999999999999999997443210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+||+
T Consensus 423 ---------------------------------------------------------------------~~KR~TmVGTP 433 (550)
T KOG0578|consen 423 ---------------------------------------------------------------------QSKRSTMVGTP 433 (550)
T ss_pred ---------------------------------------------------------------------cCccccccCCC
Confidence 01234568999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh-hccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM-QSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~-~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+|||||++....|+.++||||||++++||+-|++||...+....+..|-. +.+.+..+..++..+++||.+||+.|+++
T Consensus 434 YWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~ 513 (550)
T KOG0578|consen 434 YWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQ 513 (550)
T ss_pred CccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhc
Confidence 99999999999999999999999999999999999998777766666654 44566677789999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~ 944 (992)
|++ |.|||+||||+
T Consensus 514 Ras----A~eLL~HpFl~ 527 (550)
T KOG0578|consen 514 RAS----AKELLEHPFLK 527 (550)
T ss_pred CCC----HHHHhcChhhh
Confidence 999 99999999994
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=392.14 Aligned_cols=254 Identities=30% Similarity=0.462 Sum_probs=216.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-eE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN-LS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~-~l 684 (992)
+...++.+.+.||.|+||+||+|.++++. .||||++......... ...|.+|+.+|.+++|||||+|+|++.+.. .+
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSL 115 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence 44555666677999999999999996553 2999999865433333 678999999999999999999999999887 79
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-eeeeecCCceEEEccCC-cEEEEecccccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG-VIYRDLKPENILVREDG-HIMLTDFDLSLRCS 762 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G-IIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~ 762 (992)
+|||||+++|+|..++.......+++..+..|+.||+.||.|||+++ ||||||||+||||+.++ ++||+|||+++...
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999999998744578999999999999999999999999 99999999999999998 99999999974432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
... ...+.
T Consensus 196 ~~~------------------------------------------------------------------------~~~~~ 203 (362)
T KOG0192|consen 196 ISK------------------------------------------------------------------------TSMTS 203 (362)
T ss_pred ccc------------------------------------------------------------------------ccccC
Confidence 100 01122
Q ss_pred cccCCCccChhhhc--CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 843 FVGTHEYLAPEIIK--GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 843 ~vGT~~Y~APEvL~--g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
..||+.|||||++. ...|+.++||||||++||||+||+.||.+.........++....+.+.+..++..+..||..||
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW 283 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCW 283 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhC
Confidence 56999999999999 5689999999999999999999999999998866666766677666666669999999999999
Q ss_pred cCCcCCcCCChHh
Q 001952 921 IKEPENRLGSQKG 933 (992)
Q Consensus 921 ~~DPekRPT~~~~ 933 (992)
..||..||++...
T Consensus 284 ~~dp~~RP~f~ei 296 (362)
T KOG0192|consen 284 LVDPSRRPSFLEI 296 (362)
T ss_pred CCCCCcCCCHHHH
Confidence 9999999996543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=381.41 Aligned_cols=285 Identities=26% Similarity=0.355 Sum_probs=234.5
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--C
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--D 681 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~ 681 (992)
+....++|+.+.+|++|+||.||+|+++.+++.||+|.++.+. .....--...+|+.+|.+++|||||.+.++... -
T Consensus 71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 4455788999999999999999999999999999999998664 222333456789999999999999999998763 4
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+||||||| .-+|..++... ..+|....++.++.|++.||+|||.+.|+||||||+|+|+.+.|.+||+|||||+.+
T Consensus 150 d~iy~VMe~~-EhDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 150 DKIYIVMEYV-EHDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred ceeeeeHHHH-HhhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 5799999999 67888888875 368999999999999999999999999999999999999999999999999999665
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
+.. .-.++
T Consensus 228 gsp------------------------------------------------------------------------~k~~T 235 (419)
T KOG0663|consen 228 GSP------------------------------------------------------------------------LKPYT 235 (419)
T ss_pred cCC------------------------------------------------------------------------cccCc
Confidence 321 01134
Q ss_pred ccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------cC
Q 001952 842 SFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------------LK 901 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------------lk 901 (992)
..+-|.+|+|||+|.|.. |+.++|+||+|||+.||+++++.|.|.+..+++.+|..-. ..
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 568899999999999875 8999999999999999999999999999999998886421 11
Q ss_pred CCCC----------cc-chHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCCCCCCccc
Q 001952 902 FPDS----------PL-ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDM 970 (992)
Q Consensus 902 ~P~~----------~~-vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~d~~~~~~ 970 (992)
++.. .. +++...+|+..+|.+||.+|.| |+|.|+|+||.+.-. ...|.++|.+-.+.+.+.
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~P~----p~~P~~~Pt~P~k~~~~~ 387 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRETPL----PIDPSMFPTWPAKSEQQR 387 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccCCC----CCChhhcCCCcccccccc
Confidence 1110 00 4577889999999999999999 999999999998532 223445665555555554
Q ss_pred c
Q 001952 971 V 971 (992)
Q Consensus 971 ~ 971 (992)
.
T Consensus 388 ~ 388 (419)
T KOG0663|consen 388 V 388 (419)
T ss_pred C
Confidence 3
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=392.46 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=202.8
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC------CCccceeeeecc
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH------PFLPTLYSQFTS 680 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H------PNIVkL~g~f~~ 680 (992)
..++|++++.||+|+||+||+|.+..+++.||||+++... .....+..|+++++.++| .+|++++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4578999999999999999999999999999999996421 122344567777777654 458889998875
Q ss_pred C-CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCC----------
Q 001952 681 D-NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDG---------- 748 (992)
Q Consensus 681 ~-~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg---------- 748 (992)
. +++|||||++ |++|.+++.+. ..+++..++.|+.||+.||+|||. .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 5789999998 78888887654 578999999999999999999997 5999999999999998765
Q ss_pred ------cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 749 ------HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 749 ------~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
.+||+|||++....
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------------------------------------ 299 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------------------------------------ 299 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------------------------------------
Confidence 49999999752100
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......+
T Consensus 300 ---------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 300 ---------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ---------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 01123579999999999999999999999999999999999999999877766555443221111
Q ss_pred CC----------------------------------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCC
Q 001952 903 PD----------------------------------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942 (992)
Q Consensus 903 P~----------------------------------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPf 942 (992)
|. ....+..+.|||.+||.+||++||+ ++|||+|||
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~ 440 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQMTTHPY 440 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHHHhcCcc
Confidence 10 0011345779999999999999999 999999999
Q ss_pred CCCC
Q 001952 943 FEGL 946 (992)
Q Consensus 943 F~~l 946 (992)
|..+
T Consensus 441 ~~~~ 444 (467)
T PTZ00284 441 VLKY 444 (467)
T ss_pred cccc
Confidence 9864
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.98 Aligned_cols=265 Identities=28% Similarity=0.401 Sum_probs=210.9
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----CeE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-----NLS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-----~~l 684 (992)
+|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+++|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987432 1122334678899999999999999999987533 358
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 57888887754 56899999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. .........+
T Consensus 157 ~---------------------------------------------------------------------~~~~~~~~~~ 167 (338)
T cd07859 157 T---------------------------------------------------------------------PTAIFWTDYV 167 (338)
T ss_pred c---------------------------------------------------------------------CccccccCCC
Confidence 0 0000112356
Q ss_pred cCCCccChhhhcC--CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh------------------------
Q 001952 845 GTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ------------------------ 898 (992)
Q Consensus 845 GT~~Y~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~------------------------ 898 (992)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+...
T Consensus 168 ~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (338)
T cd07859 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSM 247 (338)
T ss_pred CCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhh
Confidence 8999999999976 56899999999999999999999999876654433322110
Q ss_pred --ccCCC---CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 899 --SLKFP---DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 899 --~lk~P---~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
....+ ..+.++.++.+||.+||..||++||+ ++|+|+||||+++....-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~~~~ 301 (338)
T cd07859 248 RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAKVER 301 (338)
T ss_pred cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCcccc
Confidence 00000 01235678899999999999999999 999999999998876543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=368.58 Aligned_cols=278 Identities=35% Similarity=0.598 Sum_probs=226.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|++.+.||+|+||.||+|.+..+++.||||.+.............+..|+.+|+.++|+||+.+++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876533333334556789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 99999999888665445689999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~g~~~y 167 (285)
T cd05630 155 -------------------------------------------------------------------GQTIKGRVGTVGY 167 (285)
T ss_pred -------------------------------------------------------------------CccccCCCCCccc
Confidence 0001123689999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch---HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~---e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+|||++.+..++.++|||||||++|||++|+.||...... +....++.. ........++.++.+||.+||..||++
T Consensus 168 ~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (285)
T cd05630 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKMLLCKDPKE 246 (285)
T ss_pred cChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHHhhcCHHH
Confidence 9999999999999999999999999999999999875432 222222211 111223457889999999999999999
Q ss_pred cCCCh-HhHHHHHcCCCCCCCchhhhhc--CCCCCCCC
Q 001952 927 RLGSQ-KGAAEIKQHPFFEGLNWALIRC--AIPPELPD 961 (992)
Q Consensus 927 RPT~~-~~aeEILkHPfF~~lnw~~lr~--~~pp~lp~ 961 (992)
||+.. ..++|+++||||.+++|..+.. ..|+..|+
T Consensus 247 R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 247 RLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred ccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 99842 2478999999999999997754 44555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=388.25 Aligned_cols=269 Identities=31% Similarity=0.466 Sum_probs=234.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++..+||.|..++||+|+....++.||||+++.+... ..+..+.+|+..|..++||||++++..|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 34578999999999999999999999999999999999977544 3478899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||.||.+|++.++++......|++..+..|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+..
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~- 178 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD- 178 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc-
Confidence 9999999999999999988888899999999999999999999999999999999999999999999999998632210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
+| .....+.+.++
T Consensus 179 ---------------~G----------------------------------------------------~R~~~rf~tfv 191 (516)
T KOG0582|consen 179 ---------------SG----------------------------------------------------DRQVTRFNTFV 191 (516)
T ss_pred ---------------cC----------------------------------------------------ceeeEeecccc
Confidence 00 00011125679
Q ss_pred cCCCccChhhhcC--CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--------ccchHHHHH
Q 001952 845 GTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--------PLISFQARD 914 (992)
Q Consensus 845 GT~~Y~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--------~~vs~el~d 914 (992)
||+.|||||++.. .+|+.++||||||++..||.+|..||......++|..-+.+....+.. ..++..++.
T Consensus 192 gtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e 271 (516)
T KOG0582|consen 192 GTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFRE 271 (516)
T ss_pred CcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHH
Confidence 9999999999764 468999999999999999999999999999999888877776643322 235567999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
+|..||.+||.+||+ ++++|+|+||+...
T Consensus 272 ~i~~CL~kDP~kRpt----AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 272 MIALCLVKDPSKRPT----ASKLLKHAFFKKAK 300 (516)
T ss_pred HHHHHhhcCcccCCC----HHHHhccHHHhhcc
Confidence 999999999999999 99999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=382.32 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=215.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceee-eeccCCe
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYS-QFTSDNL 683 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g-~f~~~~~ 683 (992)
...+.+|+++++||.|.||+||++.+..+|..+|.|.++-+.. .....+.+..|+.+|++|+|||||++++ .|.+++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3446789999999999999999999999999999999985543 3455677889999999999999999999 4555555
Q ss_pred -EEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhh--cC--eeeeecCCceEEEccCCcEEEEecc
Q 001952 684 -SCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHM--LG--VIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 684 -lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs--~G--IIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
++||||||.+|+|..+++.. ..+.+++..+|.++.|++.||..+|. .. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 89999999999999888743 34679999999999999999999998 34 9999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
|++.+....
T Consensus 174 L~r~l~s~~----------------------------------------------------------------------- 182 (375)
T KOG0591|consen 174 LGRFLSSKT----------------------------------------------------------------------- 182 (375)
T ss_pred hHhHhcchh-----------------------------------------------------------------------
Confidence 986653211
Q ss_pred CCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC-ccchHHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS-PLISFQARDL 915 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~-~~vs~el~dL 915 (992)
....+++|||.||+||.+.+.+|+.++|||||||+||||+.-+.||.|.+-.+...+|-...+. |.+ ..++.++..|
T Consensus 183 -tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~-~~p~~~YS~~l~~l 260 (375)
T KOG0591|consen 183 -TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP-PLPDEHYSTDLREL 260 (375)
T ss_pred -HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC-CCcHHHhhhHHHHH
Confidence 1134679999999999999999999999999999999999999999999666666666555443 233 5789999999
Q ss_pred HHHhccCCcCCcCCC
Q 001952 916 IRGLLIKEPENRLGS 930 (992)
Q Consensus 916 I~kcL~~DPekRPT~ 930 (992)
|..|+..||+.||+.
T Consensus 261 i~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 261 INMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHccCCcccCCCc
Confidence 999999999999994
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=401.83 Aligned_cols=265 Identities=31% Similarity=0.442 Sum_probs=223.5
Q ss_pred eeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-C-----CCcc
Q 001952 599 VRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-H-----PFLP 672 (992)
Q Consensus 599 ~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-H-----PNIV 672 (992)
+.+...+....+|++++.||+|+||.|.+|++.++++.||||++++. .........|+.+|..|+ | -|||
T Consensus 176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~V 251 (586)
T KOG0667|consen 176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIV 251 (586)
T ss_pred eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEE
Confidence 33444444445999999999999999999999999999999999864 344566778999999996 3 3799
Q ss_pred ceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC--cE
Q 001952 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG--HI 750 (992)
Q Consensus 673 kL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg--~V 750 (992)
+++++|...+++|||+|.+ ..+|+++++.+.-.+|+...++.|+.||+.||.+||++||||+|||||||||...+ .+
T Consensus 252 rm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~v 330 (586)
T KOG0667|consen 252 RMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRI 330 (586)
T ss_pred Eeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCce
Confidence 9999999999999999999 89999999998778899999999999999999999999999999999999998544 69
Q ss_pred EEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCc
Q 001952 751 MLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQ 830 (992)
Q Consensus 751 KLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~ 830 (992)
||+|||.+...
T Consensus 331 KVIDFGSSc~~--------------------------------------------------------------------- 341 (586)
T KOG0667|consen 331 KVIDFGSSCFE--------------------------------------------------------------------- 341 (586)
T ss_pred eEEeccccccc---------------------------------------------------------------------
Confidence 99999986221
Q ss_pred cccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC---------
Q 001952 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK--------- 901 (992)
Q Consensus 831 ~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk--------- 901 (992)
......++.++.|+|||+|+|.+|+.+.||||||||++||++|.++|.|.+..+++..|+.-...
T Consensus 342 ------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 ------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred ------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 11122578999999999999999999999999999999999999999999999999888641100
Q ss_pred -------------------------------------------CC-CC-------c-cchHHHHHHHHHhccCCcCCcCC
Q 001952 902 -------------------------------------------FP-DS-------P-LISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 902 -------------------------------------------~P-~~-------~-~vs~el~dLI~kcL~~DPekRPT 929 (992)
.| .. . .-...+.|||.+||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00 00 0 01235789999999999999999
Q ss_pred ChHhHHHHHcCCCCCCCc
Q 001952 930 SQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 930 ~~~~aeEILkHPfF~~ln 947 (992)
..++|+||||.+..
T Consensus 496 ----p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 496 ----PAQALNHPFLTGTS 509 (586)
T ss_pred ----HHHHhcCccccccc
Confidence 99999999999653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=368.79 Aligned_cols=259 Identities=30% Similarity=0.445 Sum_probs=221.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
.+|..+++||+|.||.||+|++..+|+.||||.++.....+ .......+|+.+|+.++|+||+.|+++|-+.+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 47888899999999999999999999999999998653322 23356789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+ ..+|+..++.. ...+....++.|+.++++||+|||.+.|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p---- 154 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP---- 154 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC----
Confidence 999 68899888765 467899999999999999999999999999999999999999999999999998554210
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
....+..+-|++
T Consensus 155 --------------------------------------------------------------------~~~~~~~V~TRW 166 (318)
T KOG0659|consen 155 --------------------------------------------------------------------NRIQTHQVVTRW 166 (318)
T ss_pred --------------------------------------------------------------------Ccccccceeeee
Confidence 111223378999
Q ss_pred ccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-----CC---------------CCC--
Q 001952 849 YLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-----KF---------------PDS-- 905 (992)
Q Consensus 849 Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-----k~---------------P~~-- 905 (992)
|+|||++.|.. |+..+||||.||++.||+-|.+.|.|.++.+++..|..... .+ |.+
T Consensus 167 YRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~ 246 (318)
T KOG0659|consen 167 YRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPL 246 (318)
T ss_pred ccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcc
Confidence 99999999975 89999999999999999999999999999999988864211 11 111
Q ss_pred ----ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 906 ----PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 906 ----~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+..+.++.||+.+||.+||.+|++ +.|+|+|+||...
T Consensus 247 ~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 247 NNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKSL 287 (318)
T ss_pred ccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhcC
Confidence 224567899999999999999999 9999999999975
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=364.73 Aligned_cols=278 Identities=33% Similarity=0.578 Sum_probs=227.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|+..+.||+|+||+||+|.+..+++.||+|++.............+.+|+++|+.++|+||+.+++++..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37788999999999999999999999999999976544433344557789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|..++.......+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998877654457999999999999999999999999999999999999999999999999986321100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
.......|+..|
T Consensus 156 --------------------------------------------------------------------~~~~~~~g~~~~ 167 (285)
T cd05632 156 --------------------------------------------------------------------ESIRGRVGTVGY 167 (285)
T ss_pred --------------------------------------------------------------------CcccCCCCCcCc
Confidence 001123689999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc--CCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL--KFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l--k~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
+|||++.+..++.++|||||||++|||++|..||.+.........+..... .......++.++.+||..||..||++|
T Consensus 168 ~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 247 (285)
T cd05632 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247 (285)
T ss_pred cChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHc
Confidence 999999999999999999999999999999999987665444333322111 112223478899999999999999999
Q ss_pred CCChH-hHHHHHcCCCCCCCchhhhh--cCCCCCCC
Q 001952 928 LGSQK-GAAEIKQHPFFEGLNWALIR--CAIPPELP 960 (992)
Q Consensus 928 PT~~~-~aeEILkHPfF~~lnw~~lr--~~~pp~lp 960 (992)
|++.+ .+.+++.|+||...+|..+. ...|+.+|
T Consensus 248 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05632 248 LGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVP 283 (285)
T ss_pred CCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCC
Confidence 99654 48899999999999998764 23344444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=376.15 Aligned_cols=261 Identities=27% Similarity=0.401 Sum_probs=215.6
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++++.||+|+||.||++.+..++..||+|++.... .......+.+|+++|+.++||||+++++++..++.++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 34679999999999999999999999999999999987542 1233456889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~- 156 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (331)
T ss_pred EEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc-
Confidence 999999999999998764 5689999999999999999999986 699999999999999999999999998632110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (331)
T cd06649 157 -------------------------------------------------------------------------SMANSFV 163 (331)
T ss_pred -------------------------------------------------------------------------cccccCC
Confidence 0011246
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH-----------------------------
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV----------------------------- 895 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I----------------------------- 895 (992)
||+.|+|||++.+..++.++|||||||+||||++|+.||......+....+
T Consensus 164 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (331)
T cd06649 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGH 243 (331)
T ss_pred CCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccccc
Confidence 899999999999999999999999999999999999999765433322111
Q ss_pred -----------------HhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 896 -----------------VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 896 -----------------v~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
+...........++.++++||.+||..||++||+ +.||++||||+..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~~~ 309 (331)
T cd06649 244 GMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRSEV 309 (331)
T ss_pred ccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhccc
Confidence 0000000011236789999999999999999999 999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=364.78 Aligned_cols=256 Identities=27% Similarity=0.391 Sum_probs=208.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcC-CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc---CCCCccceeeeec-----
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIG-TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPTLYSQFT----- 679 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~-tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L---~HPNIVkL~g~f~----- 679 (992)
.+|++++.||+|+||.||+|.+.. +++.||||+++..... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 4688999998754211 12223456677777765 6999999999875
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
....+++||||+. ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999995 689888876655668999999999999999999999999999999999999999999999999874
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
..... ..
T Consensus 159 ~~~~~-------------------------------------------------------------------------~~ 165 (290)
T cd07862 159 IYSFQ-------------------------------------------------------------------------MA 165 (290)
T ss_pred eccCC-------------------------------------------------------------------------cc
Confidence 32100 01
Q ss_pred cCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-----CCC----------
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-----FPD---------- 904 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-----~P~---------- 904 (992)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..++..... ++.
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 245 (290)
T cd07862 166 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFH 245 (290)
T ss_pred cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhcc
Confidence 12346899999999999999999999999999999999999999998888877776542110 000
Q ss_pred ----------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ----------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ----------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+.++..+.+||.+||..||++||+ +.|+|+||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 246 SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred CCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 0236678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=401.43 Aligned_cols=298 Identities=36% Similarity=0.644 Sum_probs=266.4
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
+..+.+.+++++..||-|+||.|-++........+|+|++++..+-+.....++..|..||..++.|+||+||..|.+.+
T Consensus 414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 44566788999999999999999999987777679999999888877788889999999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
++|++||-|-||.|+..++.. +.|++..++.|+..++.|++|||++|||+|||||+|+||+.+|.+||.|||+|+.+.
T Consensus 494 yvYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred hhhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999999999875 789999999999999999999999999999999999999999999999999986653
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
. .....+
T Consensus 572 ~-------------------------------------------------------------------------g~KTwT 578 (732)
T KOG0614|consen 572 S-------------------------------------------------------------------------GRKTWT 578 (732)
T ss_pred c-------------------------------------------------------------------------CCceee
Confidence 2 123456
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
++||+.|.|||++.+.+++.++|.|+||+++||||+|.+||.+.+.+.++..|+.+--.+..+..+...+.+||++++..
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~ 658 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRD 658 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhc
Confidence 89999999999999999999999999999999999999999999999999999987666666677999999999999999
Q ss_pred CcCCcCCCh-HhHHHHHcCCCCCCCchhhhhc--CCCCCCC---CCCCCCCccccccch
Q 001952 923 EPENRLGSQ-KGAAEIKQHPFFEGLNWALIRC--AIPPELP---DFYDYGIQDMVPQKS 975 (992)
Q Consensus 923 DPekRPT~~-~~aeEILkHPfF~~lnw~~lr~--~~pp~lp---~~~d~~~~~~~~q~~ 975 (992)
+|.+|++.+ .++.+|.+|.||.++||..++. ..||.+| ...|.+++|-..--+
T Consensus 659 ~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~Fd~~p~dn 717 (732)
T KOG0614|consen 659 NPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNFDNFPPDN 717 (732)
T ss_pred CcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhccCCCccc
Confidence 999999975 5899999999999999998864 5566666 666777776654433
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=382.70 Aligned_cols=281 Identities=28% Similarity=0.451 Sum_probs=232.4
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CC---eE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DN---LS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~---~l 684 (992)
.|...+++|.|+||.||+|....+++.||||.+-.+. . .-.+|+++|+.++|||||+|+.+|.. ++ ++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r---~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----R---YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----C---cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 5778899999999999999999999999999886431 1 12469999999999999999998853 22 45
Q ss_pred EEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-CcEEEEeccccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLSLRC 761 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-g~VKLsDFGLA~~l 761 (992)
.|||||| ..+|..+++.. .+..++...++.|.+||++||.|||..||+||||||.|||+|.+ |.+||||||.|+.+
T Consensus 98 nlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 6899999 57787777642 23678888999999999999999999999999999999999955 99999999998654
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. ++...
T Consensus 177 ~~-------------------------------------------------------------------------~epni 183 (364)
T KOG0658|consen 177 VK-------------------------------------------------------------------------GEPNI 183 (364)
T ss_pred cc-------------------------------------------------------------------------CCCce
Confidence 21 11234
Q ss_pred ccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh-----------------ccCCC
Q 001952 842 SFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-----------------SLKFP 903 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~-----------------~lk~P 903 (992)
+++.|+.|+|||.+.|. .|+.+.||||.||+++||+-|++.|.|.+..+++..|+.- ..++|
T Consensus 184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p 263 (364)
T KOG0658|consen 184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFP 263 (364)
T ss_pred eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCc
Confidence 57889999999999987 5899999999999999999999999999999998887641 11111
Q ss_pred ----------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCCCCCCcccccc
Q 001952 904 ----------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQ 973 (992)
Q Consensus 904 ----------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~d~~~~~~~~q 973 (992)
....+++++.+|+.++|.++|.+|.+ +.|+|.||||+++.-...+......+|..|++...++...
T Consensus 264 ~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdelr~~~~~l~~g~~lp~lf~f~~~e~~~~ 339 (364)
T KOG0658|consen 264 QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDELRDPNTKLPNGRPLPPLFNFKRAELGIS 339 (364)
T ss_pred ccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHhhCcCccCcCCCcCCCccCchHHHhccc
Confidence 11236789999999999999999999 9999999999999877666666668999999987766555
Q ss_pred ch
Q 001952 974 KS 975 (992)
Q Consensus 974 ~~ 975 (992)
++
T Consensus 340 ~~ 341 (364)
T KOG0658|consen 340 PE 341 (364)
T ss_pred hH
Confidence 44
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=366.61 Aligned_cols=260 Identities=35% Similarity=0.585 Sum_probs=240.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|++.+.||.|.||.||+|+.+.++-.||+|++.+..+........+.+|++|-..|+||||+++|+||.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 35689999999999999999999999999999999999888777777788899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|++||..+|.|...++......+++.....|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+..-.
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 99999999999999997777889999999999999999999999999999999999999999999999999863210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
..+....+|
T Consensus 176 -----------------------------------------------------------------------~~kR~tlcg 184 (281)
T KOG0580|consen 176 -----------------------------------------------------------------------SNKRKTLCG 184 (281)
T ss_pred -----------------------------------------------------------------------CCCceeeec
Confidence 112345689
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|..|.+||...+..++..+|+|++|++.||++.|.+||......+.+.+|..-.+.+| ..++.++.|||.+||.++|.
T Consensus 185 t~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p--~~is~~a~dlI~~ll~~~p~ 262 (281)
T KOG0580|consen 185 TLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP--STISGGAADLISRLLVKNPI 262 (281)
T ss_pred ccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC--cccChhHHHHHHHHhccCcc
Confidence 9999999999999999999999999999999999999999999999999998888888 46999999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ 945 (992)
+|+. +.|++.|||+..
T Consensus 263 ~r~~----l~~v~~hpwI~a 278 (281)
T KOG0580|consen 263 ERLA----LTEVMDHPWIVA 278 (281)
T ss_pred cccc----HHHHhhhHHHHh
Confidence 9999 999999999865
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=392.15 Aligned_cols=280 Identities=26% Similarity=0.413 Sum_probs=218.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-----
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS----- 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~----- 680 (992)
....+|++++.||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++|+||++++++|..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 3457899999999999999999999999999999988542 1234579999999999999999988742
Q ss_pred ---CCeEEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEe
Q 001952 681 ---DNLSCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTD 754 (992)
Q Consensus 681 ---~~~lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsD 754 (992)
...+++||||++ ++|..++... ....+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 125779999996 4676665432 245789999999999999999999999999999999999999655 799999
Q ss_pred ccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccC
Q 001952 755 FDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834 (992)
Q Consensus 755 FGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~ 834 (992)
||++..+..
T Consensus 215 FGla~~~~~----------------------------------------------------------------------- 223 (440)
T PTZ00036 215 FGSAKNLLA----------------------------------------------------------------------- 223 (440)
T ss_pred cccchhccC-----------------------------------------------------------------------
Confidence 999743210
Q ss_pred CCCCCcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--------------
Q 001952 835 PTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------- 899 (992)
Q Consensus 835 ~~~~~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------- 899 (992)
.......+||+.|+|||++.+. .++.++|||||||+||||++|.+||.+....+.+..++...
T Consensus 224 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~ 301 (440)
T PTZ00036 224 --GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPN 301 (440)
T ss_pred --CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchh
Confidence 0011234689999999998775 68999999999999999999999999988777776654321
Q ss_pred ---cCCCC----------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcC-CCCCCCCCCCC
Q 001952 900 ---LKFPD----------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCA-IPPELPDFYDY 965 (992)
Q Consensus 900 ---lk~P~----------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~-~pp~lp~~~d~ 965 (992)
..++. +...+.++.+||.+||.+||.+||+ +.|+|+||||+.+.+...... .-..+|..+.+
T Consensus 302 ~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 377 (440)
T PTZ00036 302 YADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRDPCIKLPKYIDKLPDLFNF 377 (440)
T ss_pred hhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhcccccCCCCCCCCCCCcCC
Confidence 11111 1235678999999999999999999 999999999998876543321 12345666666
Q ss_pred CCccc
Q 001952 966 GIQDM 970 (992)
Q Consensus 966 ~~~~~ 970 (992)
...++
T Consensus 378 ~~~~~ 382 (440)
T PTZ00036 378 CDAEI 382 (440)
T ss_pred CHHHH
Confidence 55444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=395.41 Aligned_cols=336 Identities=34% Similarity=0.583 Sum_probs=263.9
Q ss_pred eeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 600 RLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 600 ~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
++.....+..-|..++.||-|+||.|.++...++...||+|.+++..+..+..+...+.|.+||...+.+.||+||..|.
T Consensus 620 RLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 620 RLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred HHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 33334445677889999999999999999999999999999999988888889999999999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
+.+.+|+||+|++||++-.+|-+. +-|.+..+++|+.+|.+|+++.|..|+|||||||+|||||.+|++||.||||+.
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCT 777 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 777 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccc
Confidence 999999999999999998887764 679999999999999999999999999999999999999999999999999974
Q ss_pred cccCC--cccccCCCCCCCCccCC--CCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 760 RCSVS--PTLLKSSSNMDPARVSG--PCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 760 ~l~~~--~~~~~~~s~~~~~r~sg--p~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
-+... ..+.. +.++.|-.. +..++... .+|+.. + ....+ ...
T Consensus 778 GfRWTHdskYYq---~gdH~RqDSmep~~e~~d~----------~~~lkv--L------------~~ra~-------~~h 823 (1034)
T KOG0608|consen 778 GFRWTHDSKYYQ---EGDHHRQDSMEPSPEWADI----------SKCLKV--L------------ERRAM-------RQH 823 (1034)
T ss_pred cceecccccccc---CCCccccccCCCchhhccc----------cccchH--H------------HHHHH-------hhh
Confidence 43211 11110 111111100 00010000 001000 0 00000 011
Q ss_pred CCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHH--hhccCCCCCccchHHHH
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--MQSLKFPDSPLISFQAR 913 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv--~~~lk~P~~~~vs~el~ 913 (992)
........+||+.|+|||+|...+|+..+|+||.|||||||+.|+.||......+...+++ ...+.++....++.++.
T Consensus 824 ~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~ 903 (1034)
T KOG0608|consen 824 QRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEAL 903 (1034)
T ss_pred hhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHH
Confidence 2223446789999999999999999999999999999999999999999877766655443 34566777777999999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCC---CCCCCCCcccccc
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP---DFYDYGIQDMVPQ 973 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp---~~~d~~~~~~~~q 973 (992)
+||.+++ .+++.|++ ..+++++..||||++|||..+|.-..+.+| ..-|++++|-+.-
T Consensus 904 ~li~kLc-~sad~RLG-kng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdp 964 (1034)
T KOG0608|consen 904 DLIQKLC-CSADSRLG-KNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDP 964 (1034)
T ss_pred HHHHHHh-cChhhhhc-ccchhhhhcCccccccchHhhhhccCCcCccccCCCccccCCcCCc
Confidence 9999874 58999998 567889999999999999999987666666 6778888887654
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=361.25 Aligned_cols=265 Identities=42% Similarity=0.805 Sum_probs=229.5
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||++.+..+++.||+|++.............+.+|+++|+.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998665444455677889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~----- 153 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----- 153 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC-----
Confidence 999999999998765 5789999999999999999999999999999999999999999999999998632210
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
......|++.
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~~~ 163 (290)
T cd05580 154 ----------------------------------------------------------------------RTYTLCGTPE 163 (290)
T ss_pred ----------------------------------------------------------------------CCCCCCCCcc
Confidence 0112357889
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||.+.+..++.++||||||+++|+|++|+.||......+.+..+......++. .++..++++|.+||..||.+|+
T Consensus 164 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred ccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--cCCHHHHHHHHHHccCCHHHcc
Confidence 99999999888899999999999999999999999887766666666655544443 4789999999999999999999
Q ss_pred CC-hHhHHHHHcCCCCCCCchhhhh
Q 001952 929 GS-QKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 929 T~-~~~aeEILkHPfF~~lnw~~lr 952 (992)
+. ...++|+++||||..++|..+.
T Consensus 242 ~~~~~~~~~l~~~~~~~~~~~~~~~ 266 (290)
T cd05580 242 GNLKNGVNDIKNHPWFAGIDWIALL 266 (290)
T ss_pred CcccCCHHHHHcCcccccCCHHHHh
Confidence 32 1239999999999999998774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=373.94 Aligned_cols=255 Identities=28% Similarity=0.401 Sum_probs=206.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+++|+.++|+||+++++++...+.+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 467788899999999999999999999999999986432 122345678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+.+++|... ..+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 151 ~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--- 221 (353)
T PLN00034 151 LEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--- 221 (353)
T ss_pred EecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc---
Confidence 999999998643 23567788899999999999999999999999999999999999999999997432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+||.
T Consensus 222 ---------------------------------------------------------------------~~~~~~~~gt~ 232 (353)
T PLN00034 222 ---------------------------------------------------------------------MDPCNSSVGTI 232 (353)
T ss_pred ---------------------------------------------------------------------cccccccccCc
Confidence 00012346899
Q ss_pred CccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCc--hHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 848 EYLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN--EETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 848 ~Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~--~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
.|+|||++.. ..++.++|||||||+||||++|+.||..... +..+...+...........++.++++||.+||
T Consensus 233 ~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 312 (353)
T PLN00034 233 AYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCL 312 (353)
T ss_pred cccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHc
Confidence 9999999853 2346789999999999999999999974332 22222222222223333457899999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
..||++||+ +.|||+||||.+.
T Consensus 313 ~~~P~~Rpt----~~ell~hp~~~~~ 334 (353)
T PLN00034 313 QREPAKRWS----AMQLLQHPFILRA 334 (353)
T ss_pred cCChhhCcC----HHHHhcCcccccC
Confidence 999999999 9999999999885
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=379.62 Aligned_cols=263 Identities=29% Similarity=0.429 Sum_probs=222.5
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-----CCe
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-----DNL 683 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-----~~~ 683 (992)
..|..++.||.|+||.|+.+.+..+|+.||||.+...+ .......+..+|+.+|+.++|+||+.+++++.. .+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 45666899999999999999999999999999997543 344566788999999999999999999999865 457
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|+|+|+| +.+|+..++.+ ..+++..++.+++||+.||+|+|+.+|+||||||.|+|++.++.+||||||+|+....
T Consensus 101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 89999999 88999999875 5599999999999999999999999999999999999999999999999999854321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
. ......+.+
T Consensus 178 ~----------------------------------------------------------------------~~~~~mTeY 187 (359)
T KOG0660|consen 178 F----------------------------------------------------------------------FEDGFMTEY 187 (359)
T ss_pred c----------------------------------------------------------------------Ccccchhcc
Confidence 0 112234567
Q ss_pred ccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-----------------------
Q 001952 844 VGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS----------------------- 899 (992)
Q Consensus 844 vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~----------------------- 899 (992)
+.|++|+|||++.. ..|+.+.||||+||+|.||++|++.|.|.+..+++..|+.-.
T Consensus 188 VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~sl 267 (359)
T KOG0660|consen 188 VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSL 267 (359)
T ss_pred eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhC
Confidence 89999999999865 468999999999999999999999999998888887665311
Q ss_pred cCCCC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 900 LKFPD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 900 lk~P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
...|. .+..++.+.||+++||..||.+|+| ++|+|.||||..+-..
T Consensus 268 p~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 268 PQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAPYHDP 319 (359)
T ss_pred CCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHhcChhhhhhcCC
Confidence 11111 1346778999999999999999999 9999999999987543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=383.99 Aligned_cols=280 Identities=38% Similarity=0.718 Sum_probs=251.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ly 685 (992)
...+|.++.+||+|+||.|.+|..+++++.||||+++++.+.....++.-..|..+|... +-|++++|+..|..-+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 457899999999999999999999999999999999998877777777778888888877 4678999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+.||+|-..++.. +.|.+..+..|+.+|+.||=|||++|||+||||.+||||+.+|++||.|||+++.-
T Consensus 427 FVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn---- 500 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN---- 500 (683)
T ss_pred eEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc----
Confidence 999999999999888875 67999999999999999999999999999999999999999999999999996321
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
...+.....++|
T Consensus 501 --------------------------------------------------------------------i~~~~TTkTFCG 512 (683)
T KOG0696|consen 501 --------------------------------------------------------------------IFDGVTTKTFCG 512 (683)
T ss_pred --------------------------------------------------------------------ccCCcceeeecC
Confidence 011223457899
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++...+|+.++|+|||||+|||||.|++||.|.+..+.+..|+.....+|.. ++.++.+++..+|.+.|.
T Consensus 513 TPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--lSkEAv~ickg~ltK~P~ 590 (683)
T KOG0696|consen 513 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--LSKEAVAICKGLLTKHPG 590 (683)
T ss_pred CCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc--ccHHHHHHHHHHhhcCCc
Confidence 999999999999999999999999999999999999999999999999999999999875 999999999999999999
Q ss_pred CcCCChH-hHHHHHcCCCCCCCchhhh--hcCCCCCCCCC
Q 001952 926 NRLGSQK-GAAEIKQHPFFEGLNWALI--RCAIPPELPDF 962 (992)
Q Consensus 926 kRPT~~~-~aeEILkHPfF~~lnw~~l--r~~~pp~lp~~ 962 (992)
+|++... +-.+|..||||+.+||..+ +...||.-|+.
T Consensus 591 kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 591 KRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred cccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 9999754 5678999999999999977 45778877754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=357.15 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=206.3
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc---CCCCccceeeeecc-----C
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPTLYSQFTS-----D 681 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L---~HPNIVkL~g~f~~-----~ 681 (992)
+|++++.||+|+||.||+|.+..+++.||+|.++.... .......+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875321 112223455677777665 79999999998864 3
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+++||||+. ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999996 58888887654556899999999999999999999999999999999999999999999999986332
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... ....
T Consensus 159 ~~~-------------------------------------------------------------------------~~~~ 165 (288)
T cd07863 159 SCQ-------------------------------------------------------------------------MALT 165 (288)
T ss_pred cCc-------------------------------------------------------------------------ccCC
Confidence 100 0011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-----CCC-------------
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-----KFP------------- 903 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-----k~P------------- 903 (992)
...||..|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+..... .++
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07863 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPR 245 (288)
T ss_pred CccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCC
Confidence 23578899999999999999999999999999999999999988777666655543110 000
Q ss_pred -------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 904 -------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 904 -------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
..+.++.++.+||.+||..||++||+ +.|++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 246 GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred CCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 01236778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=382.67 Aligned_cols=261 Identities=37% Similarity=0.569 Sum_probs=233.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~ly 685 (992)
....|++.+.||.|.||.||+|..+.+|+.+|+|++.+...........+.+|+.+|+++. |||||.++++|+....+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3567999999999999999999999999999999998876555455678899999999998 999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC----CcEEEEeccccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED----GHIMLTDFDLSLRC 761 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d----g~VKLsDFGLA~~l 761 (992)
||||+|.||.|.+.+... .+++..+..++.||+.++.|||+.||+||||||+|||+... +.++++|||++...
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 999999999999988876 39999999999999999999999999999999999999733 47999999998543
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. .....
T Consensus 190 ~~-------------------------------------------------------------------------~~~~~ 196 (382)
T KOG0032|consen 190 KP-------------------------------------------------------------------------GERLH 196 (382)
T ss_pred cC-------------------------------------------------------------------------CceEe
Confidence 21 12344
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHh
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGL 919 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kc 919 (992)
..+||+.|+|||++....|+..+||||+||++|.|+.|..||.+....+....+....+.++.. +.++..+++||+.|
T Consensus 197 ~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~l 276 (382)
T KOG0032|consen 197 TIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKL 276 (382)
T ss_pred eecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHh
Confidence 5789999999999999999999999999999999999999999999999999999888766544 45789999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
|..||.+|++ +.++|+|||+.+..
T Consensus 277 l~~dp~~R~t----a~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 277 LEFDPRKRLT----AAQALQHPWIKSIG 300 (382)
T ss_pred cccCcccCCC----HHHHhcCccccCCc
Confidence 9999999999 99999999988764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=371.63 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=206.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD----- 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~----- 681 (992)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35799999999999999999999999999999999965421 223345677899999999999999999998644
Q ss_pred -CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 682 -NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 682 -~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
..+|+||||+.+ +|...+.. .+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++..
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 357999999965 56555442 478899999999999999999999999999999999999999999999998732
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
... ....
T Consensus 173 ~~~-------------------------------------------------------------------------~~~~ 179 (359)
T cd07876 173 ACT-------------------------------------------------------------------------NFMM 179 (359)
T ss_pred ccc-------------------------------------------------------------------------CccC
Confidence 100 0001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh----------------------
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ---------------------- 898 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~---------------------- 898 (992)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 180 ~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (359)
T cd07876 180 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVEN 259 (359)
T ss_pred CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhh
Confidence 2246899999999999999999999999999999999999999887655444332211
Q ss_pred ccCCC------------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 899 SLKFP------------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 899 ~lk~P------------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
...++ .....+.++++||.+||..||++||+ +.|+|+||||..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 260 RPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred CCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 11111 00123567899999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=357.99 Aligned_cols=294 Identities=37% Similarity=0.667 Sum_probs=236.9
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||++.+..+++.|++|.+.............+.+|+++++.++|+||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 37899999999999999999999999999999998664433444567789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++|++|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~- 157 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT- 157 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc-
Confidence 999999999998764 56899999999999999999999999999999999999999999999999986421100000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
......... ...........|+..
T Consensus 158 -------------------------------------~~~~~~~~~-------------------~~~~~~~~~~~~~~~ 181 (305)
T cd05609 158 -------------------------------------NLYEGHIEK-------------------DTREFLDKQVCGTPE 181 (305)
T ss_pred -------------------------------------ccccccccc-------------------chhhccccCCccCcc
Confidence 000000000 000000112457889
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC-ccchHHHHHHHHHhccCCcCCc
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS-PLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~-~~vs~el~dLI~kcL~~DPekR 927 (992)
|+|||.+.+..++.++|||||||++|||++|..||.+....+.+..+......++.. ..++.++.+||.+||..||++|
T Consensus 182 y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 261 (305)
T cd05609 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261 (305)
T ss_pred ccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhc
Confidence 999999999889999999999999999999999999887777777766655544443 2478899999999999999999
Q ss_pred CCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCC
Q 001952 928 LGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF 962 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~ 962 (992)
|++ ..+.++|+||||...+|+.......+.+|.+
T Consensus 262 ~~~-~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 295 (305)
T cd05609 262 LGT-GGAFEVKQHRFFLGLDWNGLLRQKAEFIPQL 295 (305)
T ss_pred cCc-cCHHHHHhCccccCCCHHHHhhcCCCCCCCC
Confidence 984 3478999999999999998766555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=362.10 Aligned_cols=259 Identities=29% Similarity=0.446 Sum_probs=211.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... .......+.+|+++++.++|+||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc--cCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 468999999999999999999999999999999987542 122334567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||++ ++|..++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--- 157 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--- 157 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC---
Confidence 99996 4777776654 345889999999999999999999999999999999999999999999999987321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........+|+
T Consensus 158 ---------------------------------------------------------------------~~~~~~~~~~~ 168 (309)
T cd07872 158 ---------------------------------------------------------------------TKTYSNEVVTL 168 (309)
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00011235788
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------cCCC----
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------------LKFP---- 903 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------------lk~P---- 903 (992)
.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.... ..++
T Consensus 169 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (309)
T cd07872 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKP 248 (309)
T ss_pred cccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCC
Confidence 99999998764 57999999999999999999999998877665554443210 1111
Q ss_pred -----CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 904 -----DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 904 -----~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
..+.++.++++||.+||..||.+||+ +.|+|+||||+.+
T Consensus 249 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 292 (309)
T cd07872 249 QPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSL 292 (309)
T ss_pred CchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhc
Confidence 11236788999999999999999999 9999999999876
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=379.77 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=206.2
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+...+|++++.||+|+||.||+|.+..+++.||||.... ..+.+|+++|+.++||||++++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 345789999999999999999999999999999997542 23568999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+|||++ +++|..++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 160 lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~-- 234 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD-- 234 (391)
T ss_pred EEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc--
Confidence 999999 57888777654 5689999999999999999999999999999999999999999999999999732100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
..........|
T Consensus 235 ---------------------------------------------------------------------~~~~~~~~~~g 245 (391)
T PHA03212 235 ---------------------------------------------------------------------INANKYYGWAG 245 (391)
T ss_pred ---------------------------------------------------------------------ccccccccccC
Confidence 00001123579
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc-------hHHHHHHHhhcc------------------
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-------EETLANVVMQSL------------------ 900 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-------~e~L~~Iv~~~l------------------ 900 (992)
|+.|+|||++.+..++.++|||||||+||||++|..||.+... ...+..++....
T Consensus 246 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~ 325 (391)
T PHA03212 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY 325 (391)
T ss_pred ccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHH
Confidence 9999999999999999999999999999999999988764321 122222221110
Q ss_pred --------CCCCC-------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 901 --------KFPDS-------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 901 --------k~P~~-------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
..+.. ..++.++.+||.+||..||.+||+ +.|+|+||||+.+
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~ 382 (391)
T PHA03212 326 IGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQDI 382 (391)
T ss_pred HHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhccC
Confidence 00000 124568899999999999999999 9999999999875
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=348.42 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=219.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH--HhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL--ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l--~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ........+.+|+++++.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 468899999999999999999988999999999864321 112234568889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+....
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 158 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc-
Confidence 99999999999988764 568899999999999999999999999999999999999999999999999874321000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
..........|+
T Consensus 159 --------------------------------------------------------------------~~~~~~~~~~~~ 170 (263)
T cd06625 159 --------------------------------------------------------------------SSGTGMKSVTGT 170 (263)
T ss_pred --------------------------------------------------------------------cccccccCCCcC
Confidence 000001234578
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
..|+|||++.+..++.++|||||||++|||++|+.||......+....+.........+..++..+.+||.+||..+|.+
T Consensus 171 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 250 (263)
T cd06625 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKK 250 (263)
T ss_pred ccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCccc
Confidence 88999999999989999999999999999999999998877766666655544444444568899999999999999999
Q ss_pred cCCChHhHHHHHcCCCC
Q 001952 927 RLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF 943 (992)
||+ +.++++|+||
T Consensus 251 Rpt----~~~ll~~~~~ 263 (263)
T cd06625 251 RPS----AEELLRHFFV 263 (263)
T ss_pred CCC----HHHHhhCCCC
Confidence 999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=370.46 Aligned_cols=256 Identities=28% Similarity=0.429 Sum_probs=208.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999987532 1223345677899999999999999999987643
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+|+||||+. ++|..++.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 35799999995 567666643 3788999999999999999999999999999999999999999999999997321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. .....
T Consensus 177 ~~-------------------------------------------------------------------------~~~~~ 183 (364)
T cd07875 177 GT-------------------------------------------------------------------------SFMMT 183 (364)
T ss_pred CC-------------------------------------------------------------------------CCccc
Confidence 10 00012
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC--------------------
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-------------------- 901 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-------------------- 901 (992)
...||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.....
T Consensus 184 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (364)
T cd07875 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENR 263 (364)
T ss_pred CCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhC
Confidence 246899999999999999999999999999999999999999988776666555431110
Q ss_pred --CC------------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 902 --FP------------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 902 --~P------------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+. .....+.++++||.+||..||.+||| +.|+|+||||...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~~ 324 (364)
T cd07875 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVW 324 (364)
T ss_pred CCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCcccccc
Confidence 00 00113457899999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=372.22 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=212.6
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC--CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG--TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~--tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
...+|++++.||+|+||.||+|...+ .++.||+|.+... ....+|+++|+.++|+||++++++|...+.+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34689999999999999999997643 4678999988642 2245799999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+|||++ +++|..++.. ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.++|+|||++..+...
T Consensus 162 ~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 162 CMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999 5678887744 367899999999999999999999999999999999999999999999999997432110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. .........
T Consensus 239 ~----------------------------------------------------------------------~~~~~~~~~ 248 (392)
T PHA03207 239 P----------------------------------------------------------------------DTPQCYGWS 248 (392)
T ss_pred c----------------------------------------------------------------------ccccccccc
Confidence 0 000112356
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc---hHHHHHHHhhc----cCC---------------
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---EETLANVVMQS----LKF--------------- 902 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---~e~L~~Iv~~~----lk~--------------- 902 (992)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..++... ..+
T Consensus 249 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (392)
T PHA03207 249 GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQY 328 (392)
T ss_pred cccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhh
Confidence 99999999999999999999999999999999999999987543 23333322110 000
Q ss_pred --------CC-----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcC
Q 001952 903 --------PD-----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCA 954 (992)
Q Consensus 903 --------P~-----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~ 954 (992)
+. ...++.++.+||.+||..||++||+ +.|+|.||||....|+.++..
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~~~ 389 (392)
T PHA03207 329 AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLNIT 389 (392)
T ss_pred cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhcCc
Confidence 00 0124568899999999999999999 999999999999999888754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=369.57 Aligned_cols=259 Identities=27% Similarity=0.411 Sum_probs=212.6
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++.+.||+|+||.||++.+..++..+|+|++.... .......+.+|+++|+.++|+||++++++|..++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 34578999999999999999999999999999999987532 1223456789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|||||+++++|.+++... ..+++..+..++.||+.||.|||.. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 80 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~- 156 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 156 (333)
T ss_pred EEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh-
Confidence 999999999999998764 5688999999999999999999975 799999999999999999999999998632210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (333)
T cd06650 157 -------------------------------------------------------------------------SMANSFV 163 (333)
T ss_pred -------------------------------------------------------------------------hccccCC
Confidence 0011235
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH-----------------------------
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV----------------------------- 895 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I----------------------------- 895 (992)
|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (333)
T cd06650 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243 (333)
T ss_pred CCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcc
Confidence 889999999999988999999999999999999999999765432221110
Q ss_pred ---------------HhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 896 ---------------VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 896 ---------------v~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+...........++.++++||.+||..||++||+ ++||+.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 244 DSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred cccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 0000000001135678999999999999999999 9999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=367.85 Aligned_cols=261 Identities=28% Similarity=0.500 Sum_probs=230.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+.|++.+.||+|.|+.||++.+..+|+.+|+|+++...+... ..+.+.+|+.|-+.|+||||++|.+.+.+....|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4678888899999999999999999999999999986655543 678899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA~~l~~~ 764 (992)
||++.|++|..-+-.. ..+++..+-.+++||+.+|+|+|.+||||||+||+|+|+-. .--+||+|||++..+..
T Consensus 89 Fe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred EecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 9999999996443332 34789999999999999999999999999999999999963 33589999999855421
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
......++
T Consensus 166 ------------------------------------------------------------------------g~~~~G~~ 173 (355)
T KOG0033|consen 166 ------------------------------------------------------------------------GEAWHGFA 173 (355)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 11123568
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~ 922 (992)
|||+|||||++...+|+..+|||+-||+||-||.|.+||.+.+....++.|+.+.+.++. .+.+++++++||++||..
T Consensus 174 GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~ 253 (355)
T KOG0033|consen 174 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTV 253 (355)
T ss_pred CCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhcc
Confidence 999999999999999999999999999999999999999999999999999988877654 567999999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
||.+|+| +.|+|+|||+...+-
T Consensus 254 dP~kRIt----a~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 254 NPKKRIT----ADEALKHPWICNRER 275 (355)
T ss_pred Chhhhcc----HHHHhCCchhcchHH
Confidence 9999999 999999999988653
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=372.32 Aligned_cols=261 Identities=25% Similarity=0.350 Sum_probs=211.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----eE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN-----LS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~-----~l 684 (992)
+|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+++|+.++|+||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4788999999999999999998899999999986431 11223456788999999999999999999998776 88
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 99999995 6777776543 56899999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.........
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (372)
T cd07853 157 -----------------------------------------------------------------------ESKHMTQEV 165 (372)
T ss_pred -----------------------------------------------------------------------ccccCCCCC
Confidence 000011235
Q ss_pred cCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh-----------------------cc
Q 001952 845 GTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-----------------------SL 900 (992)
Q Consensus 845 GT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~-----------------------~l 900 (992)
+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+... ..
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 245 (372)
T cd07853 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPH 245 (372)
T ss_pred cCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCC
Confidence 78899999999885 4789999999999999999999999988776665554321 01
Q ss_pred CC-------CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 901 KF-------PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 901 k~-------P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
.. .....++.++.+||.+||..||.+||+ +.|+|+||||.+..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~ 297 (372)
T cd07853 246 KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRLR 297 (372)
T ss_pred CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcch
Confidence 11 111235778999999999999999999 9999999999986543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=367.40 Aligned_cols=259 Identities=20% Similarity=0.307 Sum_probs=206.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
.+..++|++.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 455679999999999999999999753 345689999987432 122345678999999999 899999999988
Q ss_pred ccC-CeEEEEEEecCCCChHHHHHhhc-----------------------------------------------------
Q 001952 679 TSD-NLSCLVMEYCPGGDLHVLRQKQL----------------------------------------------------- 704 (992)
Q Consensus 679 ~~~-~~lyLVmEy~~GGSL~~lLkk~~----------------------------------------------------- 704 (992)
... +.+|+||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 754 46899999999999999887531
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCC
Q 001952 705 -------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPA 777 (992)
Q Consensus 705 -------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~ 777 (992)
...+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~----------- 229 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD----------- 229 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcc-----------
Confidence 12477888999999999999999999999999999999999999999999999743210000
Q ss_pred ccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcC
Q 001952 778 RVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKG 857 (992)
Q Consensus 778 r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g 857 (992)
........+++.|+|||++.+
T Consensus 230 -----------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~ 250 (338)
T cd05102 230 -----------------------------------------------------------YVRKGSARLPLKWMAPESIFD 250 (338)
T ss_pred -----------------------------------------------------------hhcccCCCCCccccCcHHhhc
Confidence 000112346788999999999
Q ss_pred CCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHH
Q 001952 858 EGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAE 936 (992)
Q Consensus 858 ~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeE 936 (992)
..++.++|||||||+||||++ |..||.+....+.+...+........+..++.++.+||.+||..||++||+ +.|
T Consensus 251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~e 326 (338)
T cd05102 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT----FSA 326 (338)
T ss_pred CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC----HHH
Confidence 999999999999999999997 999998866555554544444444444568899999999999999999999 666
Q ss_pred HHc
Q 001952 937 IKQ 939 (992)
Q Consensus 937 ILk 939 (992)
|++
T Consensus 327 l~~ 329 (338)
T cd05102 327 LVE 329 (338)
T ss_pred HHH
Confidence 654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=377.05 Aligned_cols=253 Identities=30% Similarity=0.532 Sum_probs=230.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|++.+.||+|.||+|-+|.....|+.||||.|+++.+.....+-++.+|++||..|+||||+.+|++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999999999999999999999888888899999999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||..+|.|++|+... +.+++..++.+++||+.|+.|+|.++++|||||.+|||||.++++||+||||+-.+..
T Consensus 132 MEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~---- 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD---- 205 (668)
T ss_pred EEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc----
Confidence 9999999999999886 7799999999999999999999999999999999999999999999999999743321
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
......|+|++
T Consensus 206 ---------------------------------------------------------------------~kfLqTFCGSP 216 (668)
T KOG0611|consen 206 ---------------------------------------------------------------------KKFLQTFCGSP 216 (668)
T ss_pred ---------------------------------------------------------------------ccHHHHhcCCc
Confidence 11234689999
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|.+||++.|.+| ++.+|-|||||+||.|++|..||.|.+.....+.|-.+.+..|. -+.++.-||++||..+|++
T Consensus 217 LYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP~R 293 (668)
T KOG0611|consen 217 LYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVNPER 293 (668)
T ss_pred ccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcCccc
Confidence 9999999999998 89999999999999999999999999887777777766666554 4667889999999999999
Q ss_pred cCCChHhHHHHHcCCC
Q 001952 927 RLGSQKGAAEIKQHPF 942 (992)
Q Consensus 927 RPT~~~~aeEILkHPf 942 (992)
|.| +++|..|=|
T Consensus 294 RAT----ieDiAsHWW 305 (668)
T KOG0611|consen 294 RAT----IEDIASHWW 305 (668)
T ss_pred chh----HHHHhhhhe
Confidence 999 999999954
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.06 Aligned_cols=264 Identities=33% Similarity=0.593 Sum_probs=217.5
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||+|+||+||+|.+..+++.||+|++.............+..|+++|+.++||||+++++++...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999765443344455667899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCC
Q 001952 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776 (992)
Q Consensus 697 ~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~ 776 (992)
.+++.......+++..++.++.||+.||.|||..||+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 9998876445789999999999999999999999999999999999999999999999998633210
Q ss_pred CccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhc
Q 001952 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK 856 (992)
Q Consensus 777 ~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~ 856 (992)
........++..|++||++.
T Consensus 148 ------------------------------------------------------------~~~~~~~~~~~~y~~PE~~~ 167 (277)
T cd05577 148 ------------------------------------------------------------GKKIKGRAGTPGYMAPEVLQ 167 (277)
T ss_pred ------------------------------------------------------------CCccccccCCCCcCCHHHhc
Confidence 00011234678899999999
Q ss_pred CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHHHHHHHhccCCcCCcCCChH-h
Q 001952 857 GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-G 933 (992)
Q Consensus 857 g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~-~ 933 (992)
+..++.++|||||||++|+|++|+.||...........+.... .....+..+++++.+||.+||..||.+||+... .
T Consensus 168 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 247 (277)
T cd05577 168 GEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGS 247 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCccc
Confidence 8889999999999999999999999998765422222222111 122223347899999999999999999996554 5
Q ss_pred HHHHHcCCCCCCCchhhhhc
Q 001952 934 AAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 934 aeEILkHPfF~~lnw~~lr~ 953 (992)
+.+++.||||..++|..+..
T Consensus 248 ~~~ll~h~~~~~~~~~~~~~ 267 (277)
T cd05577 248 ADEVREHPLFKDLNWRRLEA 267 (277)
T ss_pred HHHHHhChhhhcCChhhhhc
Confidence 99999999999999988754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.89 Aligned_cols=258 Identities=40% Similarity=0.736 Sum_probs=219.0
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||.|+||.||+|.+..+++.|++|++.............+.+|+.+++.++|+||+++++++.+++.+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999988999999999765443334456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCC
Q 001952 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776 (992)
Q Consensus 697 ~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~ 776 (992)
.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~------------ 146 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG------------ 146 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc------------
Confidence 9998764 45899999999999999999999999999999999999999999999999986332100
Q ss_pred CccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhc
Q 001952 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK 856 (992)
Q Consensus 777 ~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~ 856 (992)
.......|+..|++||.+.
T Consensus 147 -------------------------------------------------------------~~~~~~~~~~~~~~PE~~~ 165 (262)
T cd05572 147 -------------------------------------------------------------QKTWTFCGTPEYVAPEIIL 165 (262)
T ss_pred -------------------------------------------------------------cccccccCCcCccChhHhc
Confidence 0011235788899999999
Q ss_pred CCCCCccceeeehhhhhhhhccCCCCCCCCC--chHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCC-hHh
Q 001952 857 GEGHGAAVDWWTFGIFLYELLYGRTPFKGSG--NEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKG 933 (992)
Q Consensus 857 g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s--~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~-~~~ 933 (992)
+..++.++|+|||||++|+|++|..||.... ..+.+..+.........+..++.++.+||.+||..+|++|+++ ...
T Consensus 166 ~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~ 245 (262)
T cd05572 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGG 245 (262)
T ss_pred CCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccC
Confidence 8889999999999999999999999998776 5556666653333333334468899999999999999999995 345
Q ss_pred HHHHHcCCCCCCCchh
Q 001952 934 AAEIKQHPFFEGLNWA 949 (992)
Q Consensus 934 aeEILkHPfF~~lnw~ 949 (992)
++|+++||||.+++|.
T Consensus 246 ~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 246 IKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHhcChhhhCCCCC
Confidence 8999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=368.21 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=220.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC-ccceeeeeccCC----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF-LPTLYSQFTSDN---- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN-IVkL~g~f~~~~---- 682 (992)
...|..+++||+|+||+||+|+.+.+|+.||+|.++.+.-. +..-....+|+.+|+.++|+| |+.|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45677788899999999999999999999999999865321 224456789999999999999 999999998777
Q ss_pred --eEEEEEEecCCCChHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 683 --LSCLVMEYCPGGDLHVLRQKQLG--KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 683 --~lyLVmEy~~GGSL~~lLkk~~~--~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.++|||||+ ..+|..++..... ..++...++.+++||+.||+|||++||+||||||.||||+..|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 7899999887643 35777899999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
+.+... ..
T Consensus 168 ra~~ip------------------------------------------------------------------------~~ 175 (323)
T KOG0594|consen 168 RAFSIP------------------------------------------------------------------------MR 175 (323)
T ss_pred HHhcCC------------------------------------------------------------------------cc
Confidence 533210 01
Q ss_pred CcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-----------------
Q 001952 839 RSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL----------------- 900 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l----------------- 900 (992)
.++.-++|.+|+|||++.|. .|+..+||||+||+++||++++..|.+..+.+++..|..-..
T Consensus 176 ~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k 255 (323)
T KOG0594|consen 176 TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYK 255 (323)
T ss_pred cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccccccc
Confidence 13455799999999999998 689999999999999999999999999999988888754110
Q ss_pred -CCCCC----------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 901 -KFPDS----------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 901 -k~P~~----------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.++.. +..+.+..+|+.+||+.+|.+|.+ ++.+|.||||..+.
T Consensus 256 ~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 256 APFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSELP 309 (323)
T ss_pred ccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhcccc
Confidence 11111 112347889999999999999999 99999999999984
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.57 Aligned_cols=256 Identities=27% Similarity=0.451 Sum_probs=217.9
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|.+.+.||+|+||.||+|.+..+++.|++|.+...... ......+..|+++++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588899999999999999999999999999998754322 2334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++....+..+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~----- 154 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN----- 154 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc-----
Confidence 999999999998765677899999999999999999999999999999999999999999999999986432100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~~~y 167 (256)
T cd08529 155 -------------------------------------------------------------------TNFANTIVGTPYY 167 (256)
T ss_pred -------------------------------------------------------------------cchhhccccCccc
Confidence 0001123578889
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
+|||++.+..++.++|||||||++|||++|+.||...+..+....+...... +....++.++.++|.+||..+|++||+
T Consensus 168 ~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 246 (256)
T cd08529 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPD 246 (256)
T ss_pred cCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHHHHHHHHHHccCCcccCcC
Confidence 9999999999999999999999999999999999887766666555543322 222357889999999999999999999
Q ss_pred ChHhHHHHHcCCCC
Q 001952 930 SQKGAAEIKQHPFF 943 (992)
Q Consensus 930 ~~~~aeEILkHPfF 943 (992)
+.++++|||+
T Consensus 247 ----~~~ll~~~~~ 256 (256)
T cd08529 247 ----TFQLLRNPSL 256 (256)
T ss_pred ----HHHHhhCCCC
Confidence 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=366.13 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=206.8
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD----- 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~----- 681 (992)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35799999999999999999999998999999999875321 122345677899999999999999999988643
Q ss_pred -CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 682 -NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 682 -~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
..+|+||||+.+ +|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccccc
Confidence 357999999954 56655543 478899999999999999999999999999999999999999999999999732
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.... ...
T Consensus 169 ~~~~-------------------------------------------------------------------------~~~ 175 (355)
T cd07874 169 AGTS-------------------------------------------------------------------------FMM 175 (355)
T ss_pred CCCc-------------------------------------------------------------------------ccc
Confidence 1100 001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc---------------------
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--------------------- 899 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--------------------- 899 (992)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++...
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (355)
T cd07874 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVEN 255 (355)
T ss_pred CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhc
Confidence 22468999999999999999999999999999999999999998876555544332210
Q ss_pred -cCC-----C-------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 900 -LKF-----P-------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 900 -lk~-----P-------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
..+ + .....+.++++||.+||..||++||+ +.|+|+||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~~ 317 (355)
T cd07874 256 RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINVW 317 (355)
T ss_pred CCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhcc
Confidence 000 0 01123567899999999999999999 9999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=353.29 Aligned_cols=265 Identities=29% Similarity=0.486 Sum_probs=220.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+.|++++.||+|+||.||+|.+..++..|++|++... .......+..|+.+++.++|+||+++++++..++.+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 46799999999999999999999999999999998753 223456678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred EecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 9999999998877654 356899999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 164 ---------------------------------------------------------------------~~~~~~~~~~~ 174 (292)
T cd06644 164 ---------------------------------------------------------------------LQRRDSFIGTP 174 (292)
T ss_pred ---------------------------------------------------------------------ccccceecCCc
Confidence 00012245788
Q ss_pred CccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhcc
Q 001952 848 EYLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 848 ~Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~ 921 (992)
.|+|||++.+ ..++.++|||||||++|||++|..||...+....+..+..... .......++.++.+||.+||.
T Consensus 175 ~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 254 (292)
T cd06644 175 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALD 254 (292)
T ss_pred cccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhc
Confidence 9999999853 4468899999999999999999999987665555555433222 223334577899999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCCCchhhhh
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~lnw~~lr 952 (992)
.||++||+ ++++++||||..++|+...
T Consensus 255 ~~p~~Rp~----~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 255 KHPETRPS----AAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred CCcccCcC----HHHHhcCccccccccchhH
Confidence 99999999 9999999999999997644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=363.36 Aligned_cols=312 Identities=37% Similarity=0.697 Sum_probs=260.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCe
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ 683 (992)
.+.+.+|.++++||.|+|.+|.++++..+++.||+|+++++.+...+...-.+.|..+.... +||++|-|...|..+..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 45688999999999999999999999999999999999999888878777788888887766 79999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+++|.||++||+|...++++ ..++++.++.|..+|..||.|||+.|||+||||.+|+|++..|++||.|+|+++.-
T Consensus 326 lffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~-- 401 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-- 401 (593)
T ss_pred EEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC--
Confidence 99999999999998877776 67999999999999999999999999999999999999999999999999986220
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
-........+
T Consensus 402 ----------------------------------------------------------------------l~~gd~tstf 411 (593)
T KOG0695|consen 402 ----------------------------------------------------------------------LGPGDTTSTF 411 (593)
T ss_pred ----------------------------------------------------------------------CCCCcccccc
Confidence 0012334578
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCC-------CCCchHHH-HHHHhhccCCCCCccchHHHHHH
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFK-------GSGNEETL-ANVVMQSLKFPDSPLISFQARDL 915 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~-------g~s~~e~L-~~Iv~~~lk~P~~~~vs~el~dL 915 (992)
+||+.|+|||++.|..|+..+|+|+|||++|||+.|+.||. ..+.++.+ .-|+...++.|.. ++-.+..+
T Consensus 412 cgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs--lsvkas~v 489 (593)
T KOG0695|consen 412 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS--LSVKASHV 489 (593)
T ss_pred cCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce--eehhhHHH
Confidence 99999999999999999999999999999999999999996 12233333 4456677788775 77888899
Q ss_pred HHHhccCCcCCcCCCh--HhHHHHHcCCCCCCCchhhhh--cCCCCCCC---CCCCCCCccc-----cccch-hhhhhhc
Q 001952 916 IRGLLIKEPENRLGSQ--KGAAEIKQHPFFEGLNWALIR--CAIPPELP---DFYDYGIQDM-----VPQKS-KYLECKA 982 (992)
Q Consensus 916 I~kcL~~DPekRPT~~--~~aeEILkHPfF~~lnw~~lr--~~~pp~lp---~~~d~~~~~~-----~~q~~-~~~~~~~ 982 (992)
++..|.+||.+|++.. -++.++..|+||+.++|..+. ...||.-| ..++..++|. ..|.. .--...+
T Consensus 490 lkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~d~i~ 569 (593)
T KOG0695|consen 490 LKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIK 569 (593)
T ss_pred HHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCHHHHH
Confidence 9999999999999874 478999999999999999774 57788777 3333333333 23332 2224566
Q ss_pred cccccccCCC
Q 001952 983 TGEQLEFELF 992 (992)
Q Consensus 983 ~~~~~~~~~~ 992 (992)
+=|+.|||=|
T Consensus 570 ridqsefegf 579 (593)
T KOG0695|consen 570 RIDQSEFEGF 579 (593)
T ss_pred hcchhhcCcc
Confidence 7788888866
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.96 Aligned_cols=254 Identities=39% Similarity=0.660 Sum_probs=209.9
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
|++++.||+|+||+||++.+..+++.||+|++......... .....+|+.+++.++|+||+++++++...+..++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78899999999999999999999999999999865433222 22345599999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+.+++|.+++... ..+++..++.++.||+.||+|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999998843 6789999999999999999999999999999999999999999999999998743200
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
.........++..|+
T Consensus 151 -----------------------------------------------------------------~~~~~~~~~~~~~y~ 165 (260)
T PF00069_consen 151 -----------------------------------------------------------------NNENFNPFVGTPEYM 165 (260)
T ss_dssp -----------------------------------------------------------------TTSEBSSSSSSGGGS
T ss_pred -----------------------------------------------------------------ccccccccccccccc
Confidence 001122346888999
Q ss_pred Chhhhc-CCCCCccceeeehhhhhhhhccCCCCCCCCCch---HHHHHHHhhccCCCCC--ccchHHHHHHHHHhccCCc
Q 001952 851 APEIIK-GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---ETLANVVMQSLKFPDS--PLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 851 APEvL~-g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~---e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~DP 924 (992)
|||++. +..++.++||||||+++|+|++|..||...... ..+............. ......+.+||.+||..||
T Consensus 166 aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 245 (260)
T PF00069_consen 166 APEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDP 245 (260)
T ss_dssp CHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSG
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCCh
Confidence 999998 778899999999999999999999999987322 3333333222211111 1234799999999999999
Q ss_pred CCcCCChHhHHHHHcCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF 943 (992)
++||+ +.++++||||
T Consensus 246 ~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 246 EQRPS----AEELLKHPWF 260 (260)
T ss_dssp GGSTT----HHHHHTSGGG
T ss_pred hHCcC----HHHHhcCCCC
Confidence 99999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=353.06 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=212.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc--ccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 578999999999999999999999999999999986432 122334567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. ++|..++... ...+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--- 157 (301)
T cd07873 83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--- 157 (301)
T ss_pred Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC---
Confidence 99996 6888877654 356889999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........+++
T Consensus 158 ---------------------------------------------------------------------~~~~~~~~~~~ 168 (301)
T cd07873 158 ---------------------------------------------------------------------TKTYSNEVVTL 168 (301)
T ss_pred ---------------------------------------------------------------------CCcccccceee
Confidence 00011234688
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------cCCCC---
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------------LKFPD--- 904 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------------lk~P~--- 904 (992)
.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.... ..++.
T Consensus 169 ~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (301)
T cd07873 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRA 248 (301)
T ss_pred cccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCcccc
Confidence 99999998764 47889999999999999999999998877655554433210 01111
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
...++.++.+||.+||..||.+||+ +.|+|+||||+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~ 293 (301)
T cd07873 249 DCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLG 293 (301)
T ss_pred ccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccc
Confidence 1246778999999999999999999 99999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=341.59 Aligned_cols=265 Identities=43% Similarity=0.784 Sum_probs=222.0
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||.|+||.||+|.+..+++.|++|++.............+.+|+++++.++|+||+++++.+..++..|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999988999999999766544445667889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCC
Q 001952 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776 (992)
Q Consensus 697 ~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~ 776 (992)
..++... ..+++..+..++.||+.||.|||.+||+|+||+|+|||++.++.++|+|||++.........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--------- 149 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI--------- 149 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc---------
Confidence 9998864 46899999999999999999999999999999999999999999999999986432110000
Q ss_pred CccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhc
Q 001952 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK 856 (992)
Q Consensus 777 ~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~ 856 (992)
.. ...........++..|++||.+.
T Consensus 150 ----------------------~~---------------------------------~~~~~~~~~~~~~~~~~~Pe~~~ 174 (265)
T cd05579 150 ----------------------NL---------------------------------NDDEKEDKRIVGTPDYIAPEVIL 174 (265)
T ss_pred ----------------------cc---------------------------------ccccccccCcccCccccCHHHhc
Confidence 00 00001122345788899999999
Q ss_pred CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHH
Q 001952 857 GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAE 936 (992)
Q Consensus 857 g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeE 936 (992)
+..++.++|||||||++|||++|..||......+.+..+......++....++..+.+||.+||+.+|++||++ ..+.+
T Consensus 175 ~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~-~~~~~ 253 (265)
T cd05579 175 GQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEE 253 (265)
T ss_pred CCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCC-ccHHH
Confidence 88899999999999999999999999988877777777666555555544458999999999999999999991 22399
Q ss_pred HHcCCCCCCCch
Q 001952 937 IKQHPFFEGLNW 948 (992)
Q Consensus 937 ILkHPfF~~lnw 948 (992)
+|+||||.+++|
T Consensus 254 ~l~~~~~~~~~~ 265 (265)
T cd05579 254 IKNHPFFKGIDW 265 (265)
T ss_pred HhcCccccCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.13 Aligned_cols=256 Identities=28% Similarity=0.435 Sum_probs=209.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
.++|.+++.||.|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++|+||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4689999999999999999999999999999999975432 223345577899999999999999999988533
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
...|++||++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 8899887764 46899999999999999999999999999999999999999999999999997331
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ....
T Consensus 169 ~---------------------------------------------------------------------------~~~~ 173 (343)
T cd07878 169 D---------------------------------------------------------------------------DEMT 173 (343)
T ss_pred C---------------------------------------------------------------------------CCcC
Confidence 1 0012
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc--------------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------- 900 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------- 900 (992)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 174 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (343)
T cd07878 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQ 253 (343)
T ss_pred CccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhh
Confidence 3468999999999987 4689999999999999999999999988766555544432110
Q ss_pred ---CCCC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 901 ---KFPD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 901 ---k~P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..+. ...+++.+.+||.+||..||.+||+ +.|+|.||||..+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~~ 305 (343)
T cd07878 254 SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQYH 305 (343)
T ss_pred ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhccC
Confidence 0010 0124556889999999999999999 99999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=346.27 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=210.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeecc------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTS------ 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~------ 680 (992)
.+.|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.++..+ +|+||++++++|..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC----CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 45788889999999999999999999999999998643 22335678899999998 79999999999864
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
...+|+||||+.+++|..++.......+++..+..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 24689999999999999998875556789999999999999999999999999999999999999999999999999743
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.... ....
T Consensus 161 ~~~~------------------------------------------------------------------------~~~~ 168 (272)
T cd06637 161 LDRT------------------------------------------------------------------------VGRR 168 (272)
T ss_pred cccc------------------------------------------------------------------------cccC
Confidence 2100 0011
Q ss_pred CccccCCCccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDL 915 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dL 915 (992)
....|+..|+|||++.+ ..++.++|||||||++|||++|..||...........+............++.++.+|
T Consensus 169 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (272)
T cd06637 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSF 248 (272)
T ss_pred CcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHH
Confidence 23468899999999873 3578899999999999999999999976655444444333322222233577899999
Q ss_pred HHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
|.+||..||.+||+ +.++++||||
T Consensus 249 i~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 249 IESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred HHHHcCCChhhCCC----HHHHhhCCCC
Confidence 99999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.51 Aligned_cols=256 Identities=24% Similarity=0.415 Sum_probs=214.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-CCeEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-DNLSCLVM 688 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-~~~lyLVm 688 (992)
+|++++.||.|+||.||++.+..+++.||+|.+...... ......+.+|+++++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 489999999999999999999989999999998754322 2334567889999999999999999998864 45689999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++.......+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~---- 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ---- 155 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc----
Confidence 9999999999988765567899999999999999999999999999999999999999999999999986332100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........|++.
T Consensus 156 --------------------------------------------------------------------~~~~~~~~~~~~ 167 (257)
T cd08223 156 --------------------------------------------------------------------CDMASTLIGTPY 167 (257)
T ss_pred --------------------------------------------------------------------CCccccccCCcC
Confidence 000112357889
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..... .+....++.++.+||.+||..||++||
T Consensus 168 y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp 246 (257)
T cd08223 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRP 246 (257)
T ss_pred ccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-CCCccccCHHHHHHHHHHhccCcccCC
Confidence 9999999999999999999999999999999999987665555555444332 223345889999999999999999999
Q ss_pred CChHhHHHHHcCCCC
Q 001952 929 GSQKGAAEIKQHPFF 943 (992)
Q Consensus 929 T~~~~aeEILkHPfF 943 (992)
+ +.++++||||
T Consensus 247 ~----~~~~l~~~~~ 257 (257)
T cd08223 247 S----VKSILRQPYI 257 (257)
T ss_pred C----HHHHhcCCCC
Confidence 9 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=363.36 Aligned_cols=251 Identities=23% Similarity=0.362 Sum_probs=200.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+|+.++|+||+++++++...+..|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999986432 224689999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+ .++|..++... ...+++..++.|+.||+.||.|||.+|||||||||+|||++.++.++|+|||++.....
T Consensus 136 ~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 209 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---- 209 (357)
T ss_pred EEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc----
Confidence 9999 56787777653 35789999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 210 ---------------------------------------------------------------------~~~~~~~~gt~ 220 (357)
T PHA03209 210 ---------------------------------------------------------------------APAFLGLAGTV 220 (357)
T ss_pred ---------------------------------------------------------------------Ccccccccccc
Confidence 00012345899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCC-CCCCc---------hHHHHHHHhhc----cCCC----------
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPF-KGSGN---------EETLANVVMQS----LKFP---------- 903 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF-~g~s~---------~e~L~~Iv~~~----lk~P---------- 903 (992)
.|+|||++.+..++.++|||||||++|||+++..++ ..... ...+..++... ..++
T Consensus 221 ~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (357)
T PHA03209 221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRG 300 (357)
T ss_pred cccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHH
Confidence 999999999999999999999999999999855444 33211 11122222110 0111
Q ss_pred ------------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 904 ------------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 904 ------------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
....++.++.+||.+||..||.+||+ +.|+|+||||+.+
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~~ 357 (357)
T PHA03209 301 FIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQL 357 (357)
T ss_pred HHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhccC
Confidence 00124567788999999999999999 9999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=378.74 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=216.3
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..+.+.+++.||+|.||.||+|.+.++. .||+|.++.. ......|.+|+++|++|+|+|||+|++++..++.+
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi 276 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI 276 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCC-cccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence 445566778899999999999999996653 5999999754 22335677999999999999999999999998899
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|||||||+.|+|.++++...+..+.....+.|+.||+.|++||+++++|||||...||||+++..+||+|||||+.....
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999999999999866788999999999999999999999999999999999999999999999999998633211
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.+... ....
T Consensus 357 ~Y~~~-----------------------------------------------------------------------~~~k 365 (468)
T KOG0197|consen 357 EYTAS-----------------------------------------------------------------------EGGK 365 (468)
T ss_pred ceeec-----------------------------------------------------------------------CCCC
Confidence 11100 0011
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
-+..|.|||.+....++.++|||||||+||||+| |+.||.+..+.+.+.. +.++.++|.+..+++++.+|+..||+.+
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~CP~~vY~lM~~CW~~~ 444 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEGCPDEVYELMKSCWHED 444 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCCCCHHHHHHHHHHhhCC
Confidence 2456999999999999999999999999999999 9999999988887755 6788999999999999999999999999
Q ss_pred cCCcCCCh
Q 001952 924 PENRLGSQ 931 (992)
Q Consensus 924 PekRPT~~ 931 (992)
|++|||+.
T Consensus 445 P~~RPtF~ 452 (468)
T KOG0197|consen 445 PEDRPTFE 452 (468)
T ss_pred cccCCCHH
Confidence 99999943
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=360.05 Aligned_cols=265 Identities=24% Similarity=0.367 Sum_probs=208.9
Q ss_pred EEEEEccC--CceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 613 LLQKLGCG--DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 613 ilr~LGsG--~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
++++||+| +|++||++.+..+++.||||+++..... ......+.+|+++++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 7899999999999999999999754321 23345677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+++++|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.++++||+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~----- 155 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG----- 155 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc-----
Confidence 999999999876555568999999999999999999999999999999999999999999999998642210000
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
... ...........++..|+
T Consensus 156 ----~~~--------------------------------------------------------~~~~~~~~~~~~~~~y~ 175 (327)
T cd08227 156 ----QRL--------------------------------------------------------RVVHDFPKYSVKVLPWL 175 (327)
T ss_pred ----ccc--------------------------------------------------------cccccccccccceeccc
Confidence 000 00000011234677899
Q ss_pred ChhhhcC--CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC---------------------------
Q 001952 851 APEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK--------------------------- 901 (992)
Q Consensus 851 APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk--------------------------- 901 (992)
|||++.+ ..++.++|||||||++|||++|+.||........+.........
T Consensus 176 aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T cd08227 176 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLG 255 (327)
T ss_pred ChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCC
Confidence 9999986 45899999999999999999999999876544433333221110
Q ss_pred -----------------CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 902 -----------------FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 902 -----------------~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.+....++.++.+||.+||..||++||+ ++|+++||||+.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 256 ESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred cccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 0011234678999999999999999999 99999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=379.54 Aligned_cols=260 Identities=31% Similarity=0.499 Sum_probs=231.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe-EEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL-SCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~-lyL 686 (992)
.++|..+++||.|+||.+++++++.++..|++|.+.......+. .+....|+.+++++.|||||.+++.|+.++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 56899999999999999999999999999999999865443332 2367889999999999999999999998888 999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||+||+||+|.+.+.++.+..|+++.+..|+.||+.||.|||++.|+|||||+.|||++.++.|+|+|||+|+.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 999999999999999888888999999999999999999999999999999999999999999999999998664310
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.....+.+||
T Consensus 160 ----------------------------------------------------------------------~~~a~tvvGT 169 (426)
T KOG0589|consen 160 ----------------------------------------------------------------------DSLASTVVGT 169 (426)
T ss_pred ----------------------------------------------------------------------hhhhheecCC
Confidence 0123457899
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+.||.||++.+.+|+.++|||||||++|||++-+.+|.+.+-.....+|.... -.|.+..++.+++.||..||..+|+.
T Consensus 170 p~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~~P~~ 248 (426)
T KOG0589|consen 170 PYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRKNPEH 248 (426)
T ss_pred CcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhcCCcc
Confidence 99999999999999999999999999999999999999987766666666544 56666779999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ 945 (992)
||+ +.+||.+|.++.
T Consensus 249 RPs----a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 249 RPS----ALELLRRPHLLR 263 (426)
T ss_pred CCC----HHHHhhChhhhh
Confidence 999 999999988774
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=348.77 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=209.1
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++|+.++||||+++++++...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36888999999999999999999999999999986532 1223356788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|..+ ..+++..+..++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..+..
T Consensus 79 e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----- 147 (279)
T cd06619 79 EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----- 147 (279)
T ss_pred ecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc-----
Confidence 99999999654 2468889999999999999999999999999999999999999999999998632100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.......||..
T Consensus 148 ---------------------------------------------------------------------~~~~~~~~~~~ 158 (279)
T cd06619 148 ---------------------------------------------------------------------SIAKTYVGTNA 158 (279)
T ss_pred ---------------------------------------------------------------------ccccCCCCChh
Confidence 00112468899
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch-------HHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-------ETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-------e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
|+|||++.+..++.++|||||||++|+|++|+.||...... +....+............++.++.+||.+||.
T Consensus 159 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (279)
T cd06619 159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMR 238 (279)
T ss_pred hcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhh
Confidence 99999999999999999999999999999999999653221 11222222211111123477899999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
.||++||+ ++|+++||||..++-.
T Consensus 239 ~~P~~Rp~----~~eil~~~~~~~~~~~ 262 (279)
T cd06619 239 KQPKERPA----PENLMDHPFIVQYNDG 262 (279)
T ss_pred CChhhCCC----HHHHhcCcccccccCc
Confidence 99999999 9999999999887643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=380.18 Aligned_cols=260 Identities=28% Similarity=0.389 Sum_probs=218.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCC-CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGT-NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~t-g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..|.+.+.||.|+||.||+|....+ ++.||+|.+... .......+..|+.+|+.++||||++++++|...+.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 4599999999999999999988777 788999977533 223335677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||++||+|.+++... ....+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++..+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999887643 23468899999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+|
T Consensus 224 ----------------------------------------------------------------------~~~~~~~~~g 233 (478)
T PTZ00267 224 ----------------------------------------------------------------------SLDVASSFCG 233 (478)
T ss_pred ----------------------------------------------------------------------ccccccccCC
Confidence 0001223569
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+...... +.+..++.++.+||.+||..||+
T Consensus 234 t~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~ 312 (478)
T PTZ00267 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPA 312 (478)
T ss_pred CccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhccChh
Confidence 99999999999999999999999999999999999999988777777776654433 33345889999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~l 946 (992)
+||+ +++++.|+|++.+
T Consensus 313 ~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 313 LRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred hCcC----HHHHHhCHHHHHH
Confidence 9999 9999999998654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=345.50 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=207.4
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++++.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58899999999999999999998999999999865321 12234567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 690 YCPGGDLHVLRQKQL-GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 690 y~~GGSL~~lLkk~~-~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|++ ++|..++.... +..+++..++.++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 154 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP---- 154 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC----
Confidence 996 68887776533 256899999999999999999999999999999999999999999999999986332100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........+++.
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~~~~ 166 (285)
T cd07861 155 --------------------------------------------------------------------VRVYTHEVVTLW 166 (285)
T ss_pred --------------------------------------------------------------------cccccCCccccc
Confidence 000112256888
Q ss_pred ccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc------------------CCC------
Q 001952 849 YLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL------------------KFP------ 903 (992)
Q Consensus 849 Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l------------------k~P------ 903 (992)
|+|||++.+. .++.++|||||||++|||+||+.||.+....+.+..+..... .++
T Consensus 167 y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (285)
T cd07861 167 YRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGS 246 (285)
T ss_pred ccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcch
Confidence 9999998765 468999999999999999999999987665444433221100 000
Q ss_pred ---CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 904 ---DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 904 ---~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
....++.++.+||.+||..||++||+ +.+|++||||
T Consensus 247 ~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 247 LRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred hHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 01236788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.26 Aligned_cols=256 Identities=36% Similarity=0.670 Sum_probs=216.3
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|+++++.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999987654444556788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+.|++|..++... ..+++..+..|+.||+.||.|||.+||+|+||+|+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~----- 153 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD----- 153 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC-----
Confidence 99999999998764 57899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
.......|+..|
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~~~y 165 (258)
T cd05578 154 --------------------------------------------------------------------TLTTSTSGTPGY 165 (258)
T ss_pred --------------------------------------------------------------------ccccccCCChhh
Confidence 001123477889
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc--hHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN--EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~--~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
+|||++.+..++.++|+|||||++|+|++|..||..... .+.+...... .....+..++.++.++|.+||..||.+|
T Consensus 166 ~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R 244 (258)
T cd05578 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKR 244 (258)
T ss_pred cCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHc
Confidence 999999998899999999999999999999999987764 3333333221 2233334578999999999999999999
Q ss_pred CCChHhHHHHHcCCCC
Q 001952 928 LGSQKGAAEIKQHPFF 943 (992)
Q Consensus 928 PT~~~~aeEILkHPfF 943 (992)
|+.. +.|++.||||
T Consensus 245 ~~~~--~~~l~~~~~~ 258 (258)
T cd05578 245 LGDN--LKDLKNHPYF 258 (258)
T ss_pred CCcc--HHHHhcCCCC
Confidence 9922 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.42 Aligned_cols=260 Identities=32% Similarity=0.632 Sum_probs=204.6
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHH---HcCCCCccceeeeeccCCeEEEEEEecC
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR---MLDHPFLPTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk---~L~HPNIVkL~g~f~~~~~lyLVmEy~~ 692 (992)
.||+|+||.||++.+..+++.+|+|++.............+.+|..+++ ..+|+||+.+++++...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999999999999999987543322222223344444443 3479999999999999999999999999
Q ss_pred CCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCC
Q 001952 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772 (992)
Q Consensus 693 GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s 772 (992)
+++|..++... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~--------- 149 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--------- 149 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc---------
Confidence 99999888764 5699999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccCh
Q 001952 773 NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAP 852 (992)
Q Consensus 773 ~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~AP 852 (992)
.......|+..|+||
T Consensus 150 -----------------------------------------------------------------~~~~~~~~~~~y~aP 164 (279)
T cd05633 150 -----------------------------------------------------------------KKPHASVGTHGYMAP 164 (279)
T ss_pred -----------------------------------------------------------------cCccCcCCCcCccCH
Confidence 000123588999999
Q ss_pred hhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCc--hHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 853 EIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN--EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 853 EvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~--~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
|.+.+ ..++.++|||||||++|||++|..||..... ...+.... .......+..++.++.+||.+||..||.+|++
T Consensus 165 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTVNVELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred HHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh-hcCCcCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 99874 5679999999999999999999999975432 22222221 11222233458899999999999999999993
Q ss_pred C-hHhHHHHHcCCCCCCCchhhhh
Q 001952 930 S-QKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 930 ~-~~~aeEILkHPfF~~lnw~~lr 952 (992)
. ...+.|+++||||++++|..+.
T Consensus 244 ~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 244 CLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred CCCCCHHHHHhCccccCCCHhHHh
Confidence 1 1229999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=388.59 Aligned_cols=152 Identities=39% Similarity=0.638 Sum_probs=138.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|.+++.||+|+||.||+|.+..+++.||||+++............+..|+.+++.++|+||+++++++...+++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999765433344456788899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
|||+.|++|..++... ..+++..++.|+.||+.||+|||.+|||||||||+||||+.++.++|+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999998764 56889999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=352.85 Aligned_cols=254 Identities=29% Similarity=0.444 Sum_probs=210.5
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||++.+..++..+|+|.+.... .......+.+|+++++.++||||++++++|..++.+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999986532 1223456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||+++++|.+++... ..+++..++.++.||+.||.|||+ ++|+|+||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999998765 568999999999999999999997 6999999999999999999999999998622100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......|+.
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~~~ 162 (308)
T cd06615 153 ----------------------------------------------------------------------SMANSFVGTR 162 (308)
T ss_pred ----------------------------------------------------------------------cccccCCCCc
Confidence 0012246888
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc---------------------------
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL--------------------------- 900 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l--------------------------- 900 (992)
.|+|||++.+..++.++|||||||++|||++|+.||...+..... .+.....
T Consensus 163 ~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (308)
T cd06615 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFE 241 (308)
T ss_pred CccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchhhHHH
Confidence 999999999888999999999999999999999999765432222 2111100
Q ss_pred -----------CCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 901 -----------KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 901 -----------k~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
..|. ..++.++++||.+||..||++||+ +.++++||||...
T Consensus 242 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~ 293 (308)
T cd06615 242 LLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKRA 293 (308)
T ss_pred HHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhhc
Confidence 0111 136778999999999999999999 9999999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=380.98 Aligned_cols=257 Identities=30% Similarity=0.435 Sum_probs=224.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
..|..++.||.|.||.||+|.+..+++.||||++..+. .......++.|+.+|..++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45777799999999999999999999999999998763 4455678899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|||.||++.++++.. ..+.+..+..++++++.||.|||.++.||||||+.|||+..+|.+||+|||.+..+..
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~----- 163 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN----- 163 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeec-----
Confidence 999999999998863 4558888889999999999999999999999999999999999999999999744321
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
...+...++||+.
T Consensus 164 -------------------------------------------------------------------~~~rr~tfvGTPf 176 (467)
T KOG0201|consen 164 -------------------------------------------------------------------TVKRRKTFVGTPF 176 (467)
T ss_pred -------------------------------------------------------------------hhhcccccccccc
Confidence 0112256899999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|||||++.+..|+.++||||||++.+||++|.+||.....+..+..|-...+..-+. .++..+++||..||.+||+.||
T Consensus 177 wMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P~~Rp 255 (467)
T KOG0201|consen 177 WMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKEFVEACLDKNPEFRP 255 (467)
T ss_pred ccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHHHHHHHhhcCcccCc
Confidence 999999999999999999999999999999999999887765555544443332232 6889999999999999999999
Q ss_pred CChHhHHHHHcCCCCCCC
Q 001952 929 GSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~l 946 (992)
+ |.+||+|+|++..
T Consensus 256 s----A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 256 S----AKELLKHKFIKRA 269 (467)
T ss_pred C----HHHHhhhHHHHhc
Confidence 9 9999999999874
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.22 Aligned_cols=250 Identities=28% Similarity=0.383 Sum_probs=191.3
Q ss_pred EEEccCCceEEEEEEEc--CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CCeEEEEEEe
Q 001952 615 QKLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DNLSCLVMEY 690 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~--~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~~lyLVmEy 690 (992)
++||+|+||.||+|.+. .+++.||+|.+... .....+.+|+.+|+.++||||++++++|.. +..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC-----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 57999999999999875 46788999998643 223456789999999999999999998853 5678999999
Q ss_pred cCCCChHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE----ccCCcEEEEeccccc
Q 001952 691 CPGGDLHVLRQKQL-------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV----REDGHIMLTDFDLSL 759 (992)
Q Consensus 691 ~~GGSL~~lLkk~~-------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL----d~dg~VKLsDFGLA~ 759 (992)
+ +++|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||++.
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 A-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred c-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 9 567877765321 2358899999999999999999999999999999999999 456789999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..... ....
T Consensus 161 ~~~~~~~---------------------------------------------------------------------~~~~ 171 (317)
T cd07868 161 LFNSPLK---------------------------------------------------------------------PLAD 171 (317)
T ss_pred ccCCCCc---------------------------------------------------------------------cccc
Confidence 3210000 0001
Q ss_pred cCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCc---------hHHHHHHHhhcc---------
Q 001952 840 SNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGN---------EETLANVVMQSL--------- 900 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---------~e~L~~Iv~~~l--------- 900 (992)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+... .+.+..++....
T Consensus 172 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T cd07868 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWED 251 (317)
T ss_pred cCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHH
Confidence 1235689999999999875 579999999999999999999999975432 122222211000
Q ss_pred --CCCC-------------------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 901 --KFPD-------------------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 901 --k~P~-------------------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
..+. ....+.++.+||.+||..||.+||| ++|+|+||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 252 IKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 0000 0112456889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=381.99 Aligned_cols=265 Identities=29% Similarity=0.441 Sum_probs=220.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN---- 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~---- 682 (992)
..++|.+.+.||+|+||+||+|.+..+++.||||++...... ......+.+|+.+|..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 457999999999999999999999999999999999754322 233456788999999999999999998775332
Q ss_pred ----eEEEEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecc
Q 001952 683 ----LSCLVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 683 ----~lyLVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
.+++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+.|||||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3789999999999999886532 3568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++..+.... .
T Consensus 189 ls~~~~~~~----------------------------------------------------------------------~ 198 (496)
T PTZ00283 189 FSKMYAATV----------------------------------------------------------------------S 198 (496)
T ss_pred cCeeccccc----------------------------------------------------------------------c
Confidence 974431000 0
Q ss_pred CCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+..... .+.+..++.++.+||
T Consensus 199 ~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 277 (496)
T PTZ00283 199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-DPLPPSISPEMQEIV 277 (496)
T ss_pred ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCCHHHHHHH
Confidence 0011235799999999999999999999999999999999999999998776666666654433 234456889999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.+||..||.+||+ +.++++|||++.+-
T Consensus 278 ~~~L~~dP~~RPs----~~ell~~p~~~~~~ 304 (496)
T PTZ00283 278 TALLSSDPKRRPS----SSKLLNMPICKLFI 304 (496)
T ss_pred HHHcccChhhCcC----HHHHHhCHHHHHhh
Confidence 9999999999999 99999999987643
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.59 Aligned_cols=261 Identities=30% Similarity=0.437 Sum_probs=217.6
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||.|+||+||+|.+..++..+++|++...... .....+.+|+++|+.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4799999999999999999999889999999998654222 24567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 689 EYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 99999999999876533 5689999999999999999999999999999999999999999999999998743321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
..........|+.
T Consensus 158 -------------------------------------------------------------------~~~~~~~~~~~~~ 170 (267)
T cd06610 158 -------------------------------------------------------------------RTRKVRKTFVGTP 170 (267)
T ss_pred -------------------------------------------------------------------ccccccccccCCh
Confidence 0000112346889
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-CCCC---ccchHHHHHHHHHhccC
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-FPDS---PLISFQARDLIRGLLIK 922 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-~P~~---~~vs~el~dLI~kcL~~ 922 (992)
.|++||++... .++.++|+|||||++|||++|+.||...+..+.+..++..... ++.. ..++.++.+||.+||..
T Consensus 171 ~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 250 (267)
T cd06610 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQK 250 (267)
T ss_pred hhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCC
Confidence 99999999877 7899999999999999999999999887776666665544221 1111 24678899999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF 943 (992)
||++||+ +.+|++||||
T Consensus 251 ~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 251 DPSKRPT----AEELLKHKFF 267 (267)
T ss_pred ChhhCcC----HHHHhhCCCC
Confidence 9999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.16 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=204.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||.|+||.||+|.+..+|+.||+|.+..... .......+.+|+++++.++|+||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58899999999999999999999999999999875321 12233566789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+. ++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~----- 152 (284)
T cd07839 80 YCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP----- 152 (284)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-----
Confidence 996 5777766543 356899999999999999999999999999999999999999999999999987432100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........++..|
T Consensus 153 -------------------------------------------------------------------~~~~~~~~~~~~y 165 (284)
T cd07839 153 -------------------------------------------------------------------VRCYSAEVVTLWY 165 (284)
T ss_pred -------------------------------------------------------------------CCCcCCCccccCC
Confidence 0001123467889
Q ss_pred cChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCC-CCchHHHHHHHhhc--------------cC---CC-------
Q 001952 850 LAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKG-SGNEETLANVVMQS--------------LK---FP------- 903 (992)
Q Consensus 850 ~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g-~s~~e~L~~Iv~~~--------------lk---~P------- 903 (992)
+|||++.+.. ++.++|||||||++|||++|..||.. .+..+.+..+.... .. ++
T Consensus 166 ~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
T cd07839 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTS 245 (284)
T ss_pred cChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcch
Confidence 9999998754 68999999999999999999888644 33334443332110 00 00
Q ss_pred ---CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 904 ---DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 904 ---~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
..+.++.++++||.+||..||.+||+ ++++++||||
T Consensus 246 ~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 246 LVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred hhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 01236788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.03 Aligned_cols=257 Identities=29% Similarity=0.462 Sum_probs=214.3
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
|++++.||+|+||.||+|.+..++..+++|.+.... ......+.+|+++++.++|+||+++++++..++..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 677889999999999999999999999999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+++++|..++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~------ 156 (282)
T cd06643 84 CAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT------ 156 (282)
T ss_pred cCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc------
Confidence 9999998877653 356899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
........|+..|+
T Consensus 157 ------------------------------------------------------------------~~~~~~~~~~~~y~ 170 (282)
T cd06643 157 ------------------------------------------------------------------IQRRDSFIGTPYWM 170 (282)
T ss_pred ------------------------------------------------------------------cccccccccccccc
Confidence 00012245888999
Q ss_pred Chhhhc-----CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCc
Q 001952 851 APEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 851 APEvL~-----g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DP 924 (992)
|||++. +..++.++|||||||++|||++|+.||...+..+.+..+..... ..+.+..++.++.+||.+||..||
T Consensus 171 aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 250 (282)
T cd06643 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNV 250 (282)
T ss_pred CHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCCh
Confidence 999984 34578899999999999999999999988776666655544322 233344578899999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCCc
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~ln 947 (992)
.+||+ ++++++||||....
T Consensus 251 ~~Rp~----~~~il~~~~~~~~~ 269 (282)
T cd06643 251 DARWT----TTQLLQHPFVTVNS 269 (282)
T ss_pred hhCcC----HHHHhcCCCEeccC
Confidence 99999 99999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.16 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=209.9
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++|+||+++++++...+.+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 478999999999999999999998999999999864321 1122345678999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++++.|..++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---- 153 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP---- 153 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCC----
Confidence 999999888776543 46899999999999999999999999999999999999999999999999987432100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........++..
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~~~~ 165 (286)
T cd07847 154 --------------------------------------------------------------------GDDYTDYVATRW 165 (286)
T ss_pred --------------------------------------------------------------------cccccCcccccc
Confidence 001122357788
Q ss_pred ccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------cCCCC----
Q 001952 849 YLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------------LKFPD---- 904 (992)
Q Consensus 849 Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------------lk~P~---- 904 (992)
|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+.... ...+.
T Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07847 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETR 245 (286)
T ss_pred cCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccc
Confidence 999999887 457899999999999999999999999877665554433211 01111
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...++..+.+||.+||..||++||+ +.|++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 246 EPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred cCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 1235778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=343.84 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=211.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 467888999999999999999999999999999987542 22334577899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--- 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--- 159 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc---
Confidence 9999999999988764 56899999999999999999999999999999999999999999999999986432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|+.
T Consensus 160 ---------------------------------------------------------------------~~~~~~~~~~~ 170 (267)
T cd06645 160 ---------------------------------------------------------------------IAKRKSFIGTP 170 (267)
T ss_pred ---------------------------------------------------------------------ccccccccCcc
Confidence 00011235889
Q ss_pred CccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC---CccchHHHHHHHHHhcc
Q 001952 848 EYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD---SPLISFQARDLIRGLLI 921 (992)
Q Consensus 848 ~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~---~~~vs~el~dLI~kcL~ 921 (992)
.|+|||++. ...++.++|||||||++|||++|..||........+..........+. ...++..+.+||.+||.
T Consensus 171 ~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 250 (267)
T cd06645 171 YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALT 250 (267)
T ss_pred cccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHcc
Confidence 999999985 445789999999999999999999999776655544444333332221 12367789999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCC
Q 001952 922 KEPENRLGSQKGAAEIKQHPF 942 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPf 942 (992)
.+|++||+ +++|+.|||
T Consensus 251 ~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 251 KNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred CCchhCcC----HHHHhcCCC
Confidence 99999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.31 Aligned_cols=256 Identities=39% Similarity=0.714 Sum_probs=212.9
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHH-HHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieIL-k~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||.|+||.||+|.+..+++.||||++.+...........+..|..++ ...+|+||+++++++..++.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999999999999999999765433323333445555444 455899999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|..++... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999998764 5689999999999999999999999999999999999999999999999998622100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.....|+..|++||
T Consensus 150 ------------------------------------------------------------------~~~~~~~~~y~~pe 163 (260)
T cd05611 150 ------------------------------------------------------------------NKKFVGTPDYLAPE 163 (260)
T ss_pred ------------------------------------------------------------------cccCCCCcCccChh
Confidence 11235778899999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccCCcCCcCCCh
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIKEPENRLGSQ 931 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~DPekRPT~~ 931 (992)
.+.+..++.++||||||+++|||++|..||...+..+.+..+......++. ...++.++.++|.+||..+|++||++
T Consensus 164 ~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~- 242 (260)
T cd05611 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGA- 242 (260)
T ss_pred hhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCC-
Confidence 999888899999999999999999999999988777776666655544432 23478999999999999999999962
Q ss_pred HhHHHHHcCCCCCCCchh
Q 001952 932 KGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 932 ~~aeEILkHPfF~~lnw~ 949 (992)
..++|+|.||||..++|.
T Consensus 243 ~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 243 NGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CcHHHHHcChHhhcCCCC
Confidence 226899999999999994
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.59 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=218.4
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 588999999999999999999999999999998754322 2234577889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+.+++|..++.......+++..++.|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~----- 154 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST----- 154 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc-----
Confidence 999999999887654556889999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~~~~ 167 (256)
T cd08218 155 -------------------------------------------------------------------VELARTCIGTPYY 167 (256)
T ss_pred -------------------------------------------------------------------hhhhhhccCCccc
Confidence 0001123578889
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
+|||++.+..++.++|+|||||++|+|++|+.||...+..+.+..++.+.. .+....++.++.+||.+||..+|++||+
T Consensus 168 ~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (256)
T cd08218 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPS 246 (256)
T ss_pred cCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC-CCCcccCCHHHHHHHHHHhhCChhhCcC
Confidence 999999998899999999999999999999999988777777766654443 2233457889999999999999999999
Q ss_pred ChHhHHHHHcCCCC
Q 001952 930 SQKGAAEIKQHPFF 943 (992)
Q Consensus 930 ~~~~aeEILkHPfF 943 (992)
+.++++||||
T Consensus 247 ----~~~vl~~~~~ 256 (256)
T cd08218 247 ----VNSILEKNFI 256 (256)
T ss_pred ----HHHHhhCcCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=377.45 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=216.5
Q ss_pred ecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 602 QYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 602 ~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
.++++..+++.+...||+|.||+||+|.|.++ ||||+++.+.... +.++.|++|+.+|++-+|.||+-+.||+..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 55677788889999999999999999999765 9999998765443 4788999999999999999999999999988
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
.. .||+-+|+|-+|+.+++... ..|.....+.|++||+.|+.|||.++|||||||..||+|.+++.|||+||||+..-
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 87 99999999999999998764 66899999999999999999999999999999999999999999999999997321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. .+. ......
T Consensus 539 ~----------------------------------------------------~w~------------------g~~q~~ 548 (678)
T KOG0193|consen 539 T----------------------------------------------------RWS------------------GEQQLE 548 (678)
T ss_pred e----------------------------------------------------eec------------------cccccC
Confidence 1 000 001112
Q ss_pred ccccCCCccChhhhcC---CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC----ccchHHHHH
Q 001952 842 SFVGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS----PLISFQARD 914 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g---~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~----~~vs~el~d 914 (992)
...|...|||||+++. .+|+..+|||||||++|||++|.+||. .++.+++..++.+++..|+. ..++.++++
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~ 627 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKR 627 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCccchhhhccCHHHHHH
Confidence 2347788999999974 368999999999999999999999999 56666666666666555543 336679999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHc
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILk 939 (992)
|+..||.+++++||.+...+..|+.
T Consensus 628 Ll~~C~~~~~~eRP~F~~il~~l~~ 652 (678)
T KOG0193|consen 628 LLSDCWKFDREERPLFPQLLSKLEE 652 (678)
T ss_pred HHHHHHhcCcccCccHHHHHHHHHH
Confidence 9999999999999995555444443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=346.61 Aligned_cols=261 Identities=29% Similarity=0.479 Sum_probs=218.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||.|+||.||+|.+..++..||+|++... .......+..|+++++.++|+||+++++++..++.+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 45799999999999999999999889999999998643 223345678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|..++... ...+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~---- 155 (280)
T cd06611 81 IEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS---- 155 (280)
T ss_pred eeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc----
Confidence 9999999999988764 35689999999999999999999999999999999999999999999999998632110
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.........|+.
T Consensus 156 --------------------------------------------------------------------~~~~~~~~~~~~ 167 (280)
T cd06611 156 --------------------------------------------------------------------TLQKRDTFIGTP 167 (280)
T ss_pred --------------------------------------------------------------------cccccceeecch
Confidence 000112345888
Q ss_pred CccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhcc
Q 001952 848 EYLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 848 ~Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~ 921 (992)
.|++||++.. ..++.++|||||||++|||++|+.||.+.+....+..+..... .+..+..++.++.+||.+||.
T Consensus 168 ~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 247 (280)
T cd06611 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLV 247 (280)
T ss_pred hhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhc
Confidence 9999999863 3467899999999999999999999988776666655544322 223334578899999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
.+|.+||+ ++++|+||||....+
T Consensus 248 ~~p~~Rps----~~~il~~~~~~~~~~ 270 (280)
T cd06611 248 KDPDDRPT----AAELLKHPFVSDQSD 270 (280)
T ss_pred cChhhCcC----HHHHhcChhhcccch
Confidence 99999999 999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.44 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=214.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH------hhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA------RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~------~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
+|.+...||+|+||.||+|.+..++..||+|.+...... .......+.+|+++++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467778999999999999999888999999988643211 12234567889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
.++||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||+|+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999998764 5688999999999999999999999999999999999999999999999999744321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... . ..........
T Consensus 159 ~~~---------~---------------------------------------------------------~~~~~~~~~~ 172 (267)
T cd06628 159 NSL---------S---------------------------------------------------------TKTNGARPSL 172 (267)
T ss_pred ccc---------c---------------------------------------------------------CCcccccccc
Confidence 000 0 0000011234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
.|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+......+..+.. ......+..++.++.+||.+||..|
T Consensus 173 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 251 (267)
T cd06628 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISSEAIDFLEKTFEID 251 (267)
T ss_pred CCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcccCHHHHHHHHHHccCC
Confidence 588899999999998899999999999999999999999988766555544433 2222233457889999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCC
Q 001952 924 PENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF 943 (992)
|.+||+ +.+|++||||
T Consensus 252 p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 252 HNKRPT----AAELLKHPFL 267 (267)
T ss_pred chhCcC----HHHHhhCCCC
Confidence 999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.72 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=210.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH--HhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CCeEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL--ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DNLSC 685 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l--~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~~ly 685 (992)
+|+..+.||+|+||.||+|.+..++..|++|++..... ........+.+|+.+++.++|+||+++++++.. .+.++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68889999999999999999999999999998864321 112334567889999999999999999998865 46789
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
++|||+++++|.+++... ..+++..++.++.||+.||+|||+++|+|+||+|+||+++.++.++|+|||++..+....
T Consensus 83 l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 999999999999988764 458899999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
. .........+
T Consensus 161 ~---------------------------------------------------------------------~~~~~~~~~~ 171 (266)
T cd06651 161 M---------------------------------------------------------------------SGTGIRSVTG 171 (266)
T ss_pred c---------------------------------------------------------------------cCCccccCCc
Confidence 0 0000112357
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.........+..++..+.+|| .||..+|+
T Consensus 172 ~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~ 250 (266)
T cd06651 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEAR 250 (266)
T ss_pred cccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChh
Confidence 88999999999988999999999999999999999999877665555544333222222345778899999 67778999
Q ss_pred CcCCChHhHHHHHcCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~ 944 (992)
+||+ ++||++||||+
T Consensus 251 ~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 251 HRPS----AEELLRHPFAQ 265 (266)
T ss_pred hCcC----HHHHhcCcccc
Confidence 9999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=343.72 Aligned_cols=257 Identities=30% Similarity=0.433 Sum_probs=210.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeec------
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFT------ 679 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~------ 679 (992)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||++++++|.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3468899999999999999999999999999999986532 2234577889999888 7999999999985
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
..+.+|++|||+++++|..++.......+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 35678999999999999999887656678899999999999999999999999999999999999999999999999863
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
..... ...
T Consensus 170 ~~~~~------------------------------------------------------------------------~~~ 177 (282)
T cd06636 170 QLDRT------------------------------------------------------------------------VGR 177 (282)
T ss_pred hhhcc------------------------------------------------------------------------ccC
Confidence 22100 001
Q ss_pred cCccccCCCccChhhhc-----CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHH
Q 001952 840 SNSFVGTHEYLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~-----g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
.....|+..|+|||++. +..++.++|||||||++|||++|..||......+.+..+............++.++.+
T Consensus 178 ~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (282)
T cd06636 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFID 257 (282)
T ss_pred CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHH
Confidence 12345888999999986 3457889999999999999999999997765544444333222222222347889999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
||.+||..||.+||+ +.|||+||||
T Consensus 258 li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 258 FIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred HHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 999999999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=371.28 Aligned_cols=261 Identities=31% Similarity=0.514 Sum_probs=232.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
.-|.+.+.||+|.|..|-+|++.-+|+.||||++.+..+.. .....++.|+..|+.++|||||+||++......+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 45888899999999999999999999999999998876554 33457788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE-ccCCcEEEEeccccccccCCccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV-REDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL-d~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|+-.+|+|++|+-+.. ..+.++.+++|++||+.|+.|+|+..+|||||||+|+.+ .+-|.+||.|||++-.+..
T Consensus 97 ELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---- 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---- 171 (864)
T ss_pred EecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC----
Confidence 9999999999998764 679999999999999999999999999999999999766 5788999999999633211
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
+...+.++|..
T Consensus 172 ---------------------------------------------------------------------G~kL~TsCGSL 182 (864)
T KOG4717|consen 172 ---------------------------------------------------------------------GKKLTTSCGSL 182 (864)
T ss_pred ---------------------------------------------------------------------cchhhcccchh
Confidence 12345678999
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|-|||+|+|..| .+++|||||||+||-|+.|+.||+..++-+.+..|++=.+..|. .++.+++|||..||..||.+
T Consensus 183 AYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs--hvS~eCrdLI~sMLvRdPkk 260 (864)
T KOG4717|consen 183 AYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS--HVSKECRDLIQSMLVRDPKK 260 (864)
T ss_pred hccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch--hhhHHHHHHHHHHHhcCchh
Confidence 9999999999998 47899999999999999999999999999999999876666554 69999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCchhh
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
|.+ ++||..|+|++..|-..
T Consensus 261 RAs----lEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 261 RAS----LEEIVSTSWLQAGDRGL 280 (864)
T ss_pred hcc----HHHHhccccccCCCCCc
Confidence 999 99999999999998643
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.37 Aligned_cols=270 Identities=30% Similarity=0.453 Sum_probs=233.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH-----hhcchhHHHHHHHHHHHc-CCCCccceeeeeccC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA-----RRKKMPRAQTEREILRML-DHPFLPTLYSQFTSD 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~-----~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~ 681 (992)
...|...+.||.|..+.|-+|.++.++..+|+|++...... .......-..|+.||+++ .||+|++|.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677788999999999999999999999999998643211 112234456899999998 799999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+++|+|.|+.|.|.+++... -.+++...+.|++||+.|++|||.++||||||||+|||++++.+++|+|||++.++
T Consensus 96 sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999999999875 56899999999999999999999999999999999999999999999999998554
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. ++...
T Consensus 174 ~~-------------------------------------------------------------------------GekLr 180 (411)
T KOG0599|consen 174 EP-------------------------------------------------------------------------GEKLR 180 (411)
T ss_pred CC-------------------------------------------------------------------------chhHH
Confidence 22 22334
Q ss_pred ccccCCCccChhhhcCC------CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC--CCccchHHHH
Q 001952 842 SFVGTHEYLAPEIIKGE------GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP--DSPLISFQAR 913 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~------~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P--~~~~vs~el~ 913 (992)
..+||++|+|||.+.+. +|+..+|+|++||+||.||.|.+||.......+++.|+.+.+.|. .+..++...+
T Consensus 181 elCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~K 260 (411)
T KOG0599|consen 181 ELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVK 260 (411)
T ss_pred HhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHH
Confidence 56899999999999763 578899999999999999999999999888999999999888764 4566889999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCC
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIP 956 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~p 956 (992)
|||.+||..||.+|+| ++|+|.||||..+-...-|...|
T Consensus 261 dLIsrlLqVdp~~Rit----ake~LaHpff~q~~~~~~r~msP 299 (411)
T KOG0599|consen 261 DLISRLLQVDPTKRIT----AKEALAHPFFIQIAQQQARQMSP 299 (411)
T ss_pred HHHHHHHeeCchhccc----HHHHhcChHHHHHHHhcccccCC
Confidence 9999999999999999 99999999998766555554444
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.69 Aligned_cols=256 Identities=33% Similarity=0.620 Sum_probs=204.8
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHH---HHHHHcCCCCccceeeeeccCCeEEEEEEecC
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTER---EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~Ei---eILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~ 692 (992)
.||+|+||.||+|.+..+++.||||++.+...........+..|. .+++...||||+.+++++...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999999999999999998754322211112223333 34455689999999999999999999999999
Q ss_pred CCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCC
Q 001952 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772 (992)
Q Consensus 693 GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s 772 (992)
|++|..++... ..+++..++.|+.|++.||.|||+.+|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~--------- 149 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--------- 149 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc---------
Confidence 99999888754 5689999999999999999999999999999999999999999999999998632110
Q ss_pred CCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccCh
Q 001952 773 NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAP 852 (992)
Q Consensus 773 ~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~AP 852 (992)
.......|+..|+||
T Consensus 150 -----------------------------------------------------------------~~~~~~~~~~~y~aP 164 (278)
T cd05606 150 -----------------------------------------------------------------KKPHASVGTHGYMAP 164 (278)
T ss_pred -----------------------------------------------------------------cCCcCcCCCcCCcCc
Confidence 000123588999999
Q ss_pred hhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCc---hHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 853 EIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGN---EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 853 EvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|++.+. .++.++|||||||++|||++|+.||.+... ......+...... .+..++.++.+||.+||..+|.+|+
T Consensus 165 E~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPDSFSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred HHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC--CCCcCCHHHHHHHHHHhhcCHHhcc
Confidence 999754 689999999999999999999999986532 2222222222222 2334789999999999999999999
Q ss_pred -----CChHhHHHHHcCCCCCCCchhhhhc
Q 001952 929 -----GSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 929 -----T~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
+ +.++++||||..++|+.+..
T Consensus 243 ~~~~~~----~~~ll~~~~~~~~~~~~~~~ 268 (278)
T cd05606 243 GCLGRG----AQEVKEHPFFRSLDWQMVFL 268 (278)
T ss_pred CCCCCC----HHHHHhCccccCCCchHhhh
Confidence 7 99999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=338.77 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=213.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhH---HHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF---LARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~---l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
+|.+.+.||+|+||.||+|.. .+++.+|+|.+.... .........+.+|+++|+.++|+||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 477889999999999999976 477889999886431 1122334568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+|||++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998764 4688999999999999999999999999999999999999999999999998743210000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
. ...........|+
T Consensus 158 -------------~-----------------------------------------------------~~~~~~~~~~~~~ 171 (265)
T cd06631 158 -------------H-----------------------------------------------------GTHSNMLKSMHGT 171 (265)
T ss_pred -------------c-----------------------------------------------------ccccccccccCCC
Confidence 0 0000011234589
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-cCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-LKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... ...+....++.++.+||++||..+|+
T Consensus 172 ~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 251 (265)
T cd06631 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQH 251 (265)
T ss_pred ccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcc
Confidence 99999999999889999999999999999999999998766555544443332 22223345889999999999999999
Q ss_pred CcCCChHhHHHHHcCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF 943 (992)
+||+ +.++|.||||
T Consensus 252 ~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 252 ERPS----ALQLLRHDFL 265 (265)
T ss_pred cCCC----HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=333.58 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=216.3
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||+|+||.||+|.+..++..+|||.+...... ......+..|+++|+.++|+||+++++.+..++.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 588999999999999999999999999999998754322 2335678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-CcEEEEeccccccccCCcccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-g~VKLsDFGLA~~l~~~~~~~ 768 (992)
|+++++|.+++....+..+++..++.++.|++.||.|||++||+|+||+|+|||++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999987655668999999999999999999999999999999999999854 46899999987432100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.......|+..
T Consensus 156 ---------------------------------------------------------------------~~~~~~~~~~~ 166 (256)
T cd08220 156 ---------------------------------------------------------------------SKAYTVVGTPC 166 (256)
T ss_pred ---------------------------------------------------------------------ccccccccCCc
Confidence 00112357889
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......+..... .+....++.++.+||.+||..+|++||
T Consensus 167 y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp 245 (256)
T cd08220 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLILSMLNLDPSKRP 245 (256)
T ss_pred ccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHHccCChhhCC
Confidence 9999999988889999999999999999999999988776666655554332 233345788999999999999999999
Q ss_pred CChHhHHHHHcCCCC
Q 001952 929 GSQKGAAEIKQHPFF 943 (992)
Q Consensus 929 T~~~~aeEILkHPfF 943 (992)
+ +.|++.||||
T Consensus 246 t----~~~ll~~p~~ 256 (256)
T cd08220 246 Q----LSQIMAQPIC 256 (256)
T ss_pred C----HHHHhhCCCC
Confidence 9 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.11 Aligned_cols=242 Identities=17% Similarity=0.200 Sum_probs=204.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc----CCeEEEEEEe
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS----DNLSCLVMEY 690 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~----~~~lyLVmEy 690 (992)
..||+|++|.||+|.+ +|+.||||+++............+.+|+.+|++++||||+++++++.+ ...++|||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5699999999999998 678999999976533333335677899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
+++|+|.+++... ..+++.....++.|++.||.|||. .+++||||||+|||++.++.+||+|||++..+..
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~------ 175 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS------ 175 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc------
Confidence 9999999998864 568899999999999999999998 5999999999999999999999999998743210
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
......|+..|
T Consensus 176 ---------------------------------------------------------------------~~~~~~~~~~y 186 (283)
T PHA02988 176 ---------------------------------------------------------------------PPFKNVNFMVY 186 (283)
T ss_pred ---------------------------------------------------------------------ccccccCcccc
Confidence 00123578899
Q ss_pred cChhhhcC--CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 850 LAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 850 ~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.....++.+..++.++.+||.+||+.||++|
T Consensus 187 ~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 266 (283)
T PHA02988 187 FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKR 266 (283)
T ss_pred cCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccC
Confidence 99999987 6789999999999999999999999998877777777766655555555688999999999999999999
Q ss_pred CCChHhHHHHHc
Q 001952 928 LGSQKGAAEIKQ 939 (992)
Q Consensus 928 PT~~~~aeEILk 939 (992)
|+ +.|+++
T Consensus 267 ps----~~ell~ 274 (283)
T PHA02988 267 PN----IKEILY 274 (283)
T ss_pred cC----HHHHHH
Confidence 99 566553
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.25 Aligned_cols=255 Identities=27% Similarity=0.421 Sum_probs=210.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++|+||+++++++...+.+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3568999999999999999999999999999999986431 2233467789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+|||++.++.++|+|||++..+...
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-- 159 (267)
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc--
Confidence 99999999999988754 56899999999999999999999999999999999999999999999999997432100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........|+
T Consensus 160 ----------------------------------------------------------------------~~~~~~~~~~ 169 (267)
T cd06646 160 ----------------------------------------------------------------------IAKRKSFIGT 169 (267)
T ss_pred ----------------------------------------------------------------------ccccCccccC
Confidence 0001123578
Q ss_pred CCccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC---CccchHHHHHHHHHhc
Q 001952 847 HEYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD---SPLISFQARDLIRGLL 920 (992)
Q Consensus 847 ~~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~---~~~vs~el~dLI~kcL 920 (992)
..|+|||.+. ...++.++|||||||++|||++|+.||......+....+....+..+. ...++..+.+||.+||
T Consensus 170 ~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 249 (267)
T cd06646 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISL 249 (267)
T ss_pred ccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHh
Confidence 8999999985 344788999999999999999999999766544443333333322222 2346789999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPF 942 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPf 942 (992)
..||++||+ +++||+|+|
T Consensus 250 ~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 250 TKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred hCChhhCcC----HHHHhcCCC
Confidence 999999999 999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.00 Aligned_cols=258 Identities=33% Similarity=0.493 Sum_probs=216.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+++++.++|+||+++++++..+..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 36888999999999999999999999999999987542 1233456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++... .+++..++.++.||+.||.|||..+|+|+||+|+||+++.++.++|+|||++..+....
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999998763 68999999999999999999999999999999999999999999999999974431100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.......|+..
T Consensus 153 ---------------------------------------------------------------------~~~~~~~~~~~ 163 (274)
T cd06609 153 ---------------------------------------------------------------------SKRNTFVGTPF 163 (274)
T ss_pred ---------------------------------------------------------------------cccccccCCcc
Confidence 00122457888
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|||||||++|+|++|+.||...+.......+............++.++.++|.+||..||++||
T Consensus 164 y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rp 243 (274)
T cd06609 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERP 243 (274)
T ss_pred ccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCc
Confidence 99999999988999999999999999999999999876655554444333221111112788999999999999999999
Q ss_pred CChHhHHHHHcCCCCCCCc
Q 001952 929 GSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~ln 947 (992)
+ ++++++||||....
T Consensus 244 t----~~~il~~~~~~~~~ 258 (274)
T cd06609 244 S----AKELLKHKFIKKAK 258 (274)
T ss_pred C----HHHHhhChhhcCCC
Confidence 9 99999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.44 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=219.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++++.||.|+||.||.+++..+++.+++|.+...... ......+.+|+++|++++|+||+++++++.+.+.++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 589999999999999999999999999999998654322 2334567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++....+..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999887655678999999999999999999999999999999999999999999999999863321000
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
.......|++.|
T Consensus 156 --------------------------------------------------------------------~~~~~~~~~~~y 167 (256)
T cd08221 156 --------------------------------------------------------------------SMAETVVGTPYY 167 (256)
T ss_pred --------------------------------------------------------------------ccccccCCCccc
Confidence 001224578899
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
+|||++.+..++.++|||||||++|||++|..||......+....+....... ....++.++.++|.+||..+|++||+
T Consensus 168 ~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~s 246 (256)
T cd08221 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP-VVSVYSSELISLVHSLLQQDPEKRPT 246 (256)
T ss_pred cCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHcccCcccCCC
Confidence 99999999889999999999999999999999998877777777766544432 23457889999999999999999999
Q ss_pred ChHhHHHHHcCCCC
Q 001952 930 SQKGAAEIKQHPFF 943 (992)
Q Consensus 930 ~~~~aeEILkHPfF 943 (992)
+.++|+|+|+
T Consensus 247 ----~~~ll~~~~l 256 (256)
T cd08221 247 ----ADEVLDQPLL 256 (256)
T ss_pred ----HHHHhhCcCC
Confidence 9999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.18 Aligned_cols=260 Identities=26% Similarity=0.403 Sum_probs=211.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH--HhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CCeE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL--ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DNLS 684 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l--~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~~l 684 (992)
.+|++.+.||+|+||.||+|.+..+++.||||++..... ........+.+|+.+++.++|+||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478999999999999999999999999999998863211 112334678889999999999999999998876 3568
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..+...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999988764 45788999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ..........
T Consensus 160 ~---------------------------------------------------------------------~~~~~~~~~~ 170 (265)
T cd06652 160 C---------------------------------------------------------------------LSGTGMKSVT 170 (265)
T ss_pred c---------------------------------------------------------------------ccccccccCC
Confidence 0 0000012235
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
|+..|+|||++.+..++.++|||||||++|||++|+.||........+..+.........+..++..+.++|.+||. +|
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p 249 (265)
T cd06652 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EA 249 (265)
T ss_pred CCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-Ch
Confidence 88899999999998899999999999999999999999987665555554443332222334577889999999995 99
Q ss_pred CCcCCChHhHHHHHcCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~ 944 (992)
++||+ ++||++|||+.
T Consensus 250 ~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 250 KLRPS----ADELLRHTFVH 265 (265)
T ss_pred hhCCC----HHHHhcCcccC
Confidence 99999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=347.08 Aligned_cols=257 Identities=28% Similarity=0.443 Sum_probs=216.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|++++.||+|+||.||+|.+..+++.|++|.+.... ......+.+|+.+++.++|+||+++++.|......|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 368999999999999999999998999999999987542 22345678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++.. ..+++..+..++.||+.||.|||..||+||||||+|||++.++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--- 169 (296)
T cd06654 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (296)
T ss_pred ecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc---
Confidence 999999999998865 35789999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|++
T Consensus 170 ---------------------------------------------------------------------~~~~~~~~~~~ 180 (296)
T cd06654 170 ---------------------------------------------------------------------QSKRSTMVGTP 180 (296)
T ss_pred ---------------------------------------------------------------------ccccCcccCCc
Confidence 00011235788
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-cCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-LKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||.+.+..++.++|||||||++|+|++|+.||........+..+.... ...+....++..+.+||.+||..||++
T Consensus 181 ~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 260 (296)
T cd06654 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260 (296)
T ss_pred cccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCccc
Confidence 9999999999889999999999999999999999998776654444333222 222334457889999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~l 946 (992)
||+ +.+|+.||||...
T Consensus 261 Rpt----~~eil~~~~~~~~ 276 (296)
T cd06654 261 RGS----AKELLQHQFLKIA 276 (296)
T ss_pred CcC----HHHHhhChhhhcc
Confidence 999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=343.88 Aligned_cols=271 Identities=20% Similarity=0.282 Sum_probs=216.1
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
++..++|++.+.||+|+||.||+|.+.. .+..||+|.+..... ......+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3456799999999999999999997652 355799998864321 122345678999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLG--------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~--------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
..+..|+||||+++|+|.+++..... ..+....++.++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999999875321 2345678889999999999999999999999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++..+.....
T Consensus 160 L~Dfg~~~~~~~~~~----------------------------------------------------------------- 174 (288)
T cd05061 160 IGDFGMTRDIYETDY----------------------------------------------------------------- 174 (288)
T ss_pred ECcCCcccccccccc-----------------------------------------------------------------
Confidence 999998743210000
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....++.
T Consensus 175 -----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 248 (288)
T cd05061 175 -----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG-YLDQPDNCPE 248 (288)
T ss_pred -----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCH
Confidence 000011235677999999999889999999999999999998 899998877666665554432 2233345688
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHc--CCCCCCCch
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQ--HPFFEGLNW 948 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILk--HPfF~~lnw 948 (992)
.+.+||.+||..||++||++...++.+.+ ||||.+++|
T Consensus 249 ~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 249 RVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 99999999999999999996655555554 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=334.22 Aligned_cols=255 Identities=33% Similarity=0.496 Sum_probs=214.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||.|+||.||+|.+..+++.+++|++.... ......+.+|+++++.++||||+++++++...+.+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999998889999999997542 22456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 79 ~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--- 154 (262)
T cd06613 79 MEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--- 154 (262)
T ss_pred EeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh---
Confidence 9999999999988764 256899999999999999999999999999999999999999999999999986332100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|+.
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (262)
T cd06613 155 ---------------------------------------------------------------------IAKRKSFIGTP 165 (262)
T ss_pred ---------------------------------------------------------------------hhccccccCCc
Confidence 00012245788
Q ss_pred CccChhhhcCC---CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC---CCccchHHHHHHHHHhcc
Q 001952 848 EYLAPEIIKGE---GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP---DSPLISFQARDLIRGLLI 921 (992)
Q Consensus 848 ~Y~APEvL~g~---~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P---~~~~vs~el~dLI~kcL~ 921 (992)
.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+....+..+ ....++.++.+||.+||.
T Consensus 166 ~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 245 (262)
T cd06613 166 YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLT 245 (262)
T ss_pred cccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcC
Confidence 89999999877 789999999999999999999999988766655554444322221 123357789999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCC
Q 001952 922 KEPENRLGSQKGAAEIKQHPF 942 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPf 942 (992)
.+|.+||+ +.+|+.|+|
T Consensus 246 ~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 246 KDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred CChhhCCC----HHHHhcCCC
Confidence 99999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=360.06 Aligned_cols=289 Identities=27% Similarity=0.335 Sum_probs=230.4
Q ss_pred hHhhheeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC--CC--
Q 001952 594 EAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD--HP-- 669 (992)
Q Consensus 594 e~~~~~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~--HP-- 669 (992)
+...++-++.+.....+|.++..||+|.||.|..|++..++..||||+++.- .........|+++|.++. -|
T Consensus 74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g 149 (415)
T KOG0671|consen 74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNG 149 (415)
T ss_pred CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCC
Confidence 3445678888888899999999999999999999999999999999999853 233345678999999993 22
Q ss_pred --CccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC
Q 001952 670 --FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747 (992)
Q Consensus 670 --NIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d 747 (992)
-+|++.+||...++.|||+|.+ |-++.+++..+...+++...++.|++||+.+++|||+.+|+|.||||+|||+...
T Consensus 150 ~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 150 KFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSS 228 (415)
T ss_pred ceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEecc
Confidence 2789999999999999999999 8899999999877899999999999999999999999999999999999999766
Q ss_pred CcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhcc
Q 001952 748 GHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827 (992)
Q Consensus 748 g~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~ 827 (992)
...++-+-+.... . ........|+.
T Consensus 229 ~~~~~~~~k~~~~-~------------------------------------------------------~r~~ks~~I~v 253 (415)
T KOG0671|consen 229 EYFKTYNPKKKVC-F------------------------------------------------------IRPLKSTAIKV 253 (415)
T ss_pred ceEEEeccCCccc-e------------------------------------------------------eccCCCcceEE
Confidence 5555444432100 0 00001123444
Q ss_pred CCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH---Hh-------
Q 001952 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV---VM------- 897 (992)
Q Consensus 828 ~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I---v~------- 897 (992)
++++.+....+....++.|+.|+|||++++.+|+..+||||+||||+||+||..+|++.++.|.|..+ +.
T Consensus 254 IDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi 333 (415)
T KOG0671|consen 254 IDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMI 333 (415)
T ss_pred EecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHh
Confidence 55555566667778889999999999999999999999999999999999999999999988866433 11
Q ss_pred -----------hccCCCCC-----------------------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 898 -----------QSLKFPDS-----------------------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 898 -----------~~lk~P~~-----------------------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
+.+.++.. ..-..++.|||++||.+||.+|+| +.|+|.||||
T Consensus 334 ~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT----l~EAL~HpFF 409 (415)
T KOG0671|consen 334 KKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT----LREALSHPFF 409 (415)
T ss_pred hhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc----HHHHhcCHHh
Confidence 01111100 001125789999999999999999 9999999999
Q ss_pred CCC
Q 001952 944 EGL 946 (992)
Q Consensus 944 ~~l 946 (992)
..+
T Consensus 410 ~~~ 412 (415)
T KOG0671|consen 410 ARL 412 (415)
T ss_pred hcC
Confidence 875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=340.05 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=209.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
+...+|++.+.||+|+||.||+|.+. ..+..||+|.++.... ......+.+|+.+|+.++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34578999999999999999999875 4567899999875421 223356789999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..||||||+++++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999999998764 2468999999999999999999999999999999999999999999999999752110
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
... ......
T Consensus 159 ~~~-----------------------------------------------------------------------~~~~~~ 167 (266)
T cd05064 159 SEA-----------------------------------------------------------------------IYTTMS 167 (266)
T ss_pred ccc-----------------------------------------------------------------------hhcccC
Confidence 000 000011
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+ ......+.+..++..+.+++.+||.
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~c~~ 246 (266)
T cd05064 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCPNLLHQLMLDCWQ 246 (266)
T ss_pred CCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcC
Confidence 235678999999999999999999999999999775 99999887776665554 3444556666789999999999999
Q ss_pred CCcCCcCCChHhHHHHHc
Q 001952 922 KEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILk 939 (992)
.+|++||+ +++|++
T Consensus 247 ~~p~~RP~----~~~i~~ 260 (266)
T cd05064 247 KERGERPR----FSQIHS 260 (266)
T ss_pred CCchhCCC----HHHHHH
Confidence 99999999 666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=336.03 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=211.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH---HhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL---ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l---~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
+|+..+.||+|+||.||++.+..+++.||+|++..... ........+..|+.+|++++|+||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999999999999999999864321 112235678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEeccccccccCCc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~~~~ 765 (992)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998764 5689999999999999999999999999999999999998766 69999999874431100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
. ..........|
T Consensus 159 ~--------------------------------------------------------------------~~~~~~~~~~~ 170 (268)
T cd06630 159 T--------------------------------------------------------------------GAGEFQGQLLG 170 (268)
T ss_pred c--------------------------------------------------------------------cCCcccccccc
Confidence 0 00000123458
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHH---hhccCCCCCccchHHHHHHHHHhccC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV---MQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv---~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
+..|+|||++.+..++.++|||||||++|+|++|..||...........+. ........+..++.++.++|.+||..
T Consensus 171 ~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 250 (268)
T cd06630 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLEL 250 (268)
T ss_pred ccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCC
Confidence 899999999998889999999999999999999999997654333222221 12222223345788999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~ 944 (992)
+|++||+ +.++++||||+
T Consensus 251 ~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 251 QPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred CcccCcC----HHHHhcCcccC
Confidence 9999999 99999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=341.15 Aligned_cols=256 Identities=30% Similarity=0.443 Sum_probs=209.6
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++++.||.|+||.||+|.+..++..||||.+.... ........+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5889999999999999999999999999999986432 122233567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+. ++|..++.......+++..++.++.||+.||+|||+.||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~----- 153 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP----- 153 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC-----
Confidence 995 68888887655567899999999999999999999999999999999999999999999999986322100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........++..|
T Consensus 154 -------------------------------------------------------------------~~~~~~~~~~~~y 166 (284)
T cd07860 154 -------------------------------------------------------------------VRTYTHEVVTLWY 166 (284)
T ss_pred -------------------------------------------------------------------ccccccccccccc
Confidence 0001122467889
Q ss_pred cChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc------------------CCCC------
Q 001952 850 LAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL------------------KFPD------ 904 (992)
Q Consensus 850 ~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l------------------k~P~------ 904 (992)
+|||++.+.. ++.++|||||||++|||+||+.||.+.+..+.+..++.... .++.
T Consensus 167 ~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd07860 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDF 246 (284)
T ss_pred cCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCH
Confidence 9999987755 58899999999999999999999988766555544432111 0110
Q ss_pred ---CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ---SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ---~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+.++.++++||.+||..||.+||+ ++++++||||
T Consensus 247 ~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 247 SKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred HHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 1236778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=335.89 Aligned_cols=279 Identities=38% Similarity=0.634 Sum_probs=225.0
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyLV 687 (992)
++|.+.+.||+|+||.||+|.+..++..|++|++.............+..|+++++.+. |+||+++++++...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998754434444567888999999998 99999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ..+++..++.|+.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999998875 47999999999999999999999999999999999999999999999999997543211000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
. ......+. ................|+.
T Consensus 159 ~---------------------------~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~ 186 (280)
T cd05581 159 E---------------------------SNKGDATN-------------------------IDSQIEKNRRRFASFVGTA 186 (280)
T ss_pred c---------------------------cCCCCCcc-------------------------ccccccccccccccccCCc
Confidence 0 00000000 0000001112234557899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|++||++.+..++.++|||||||++|+|++|+.||........+..+......++ ..++..+.+||.+||..+|.+|
T Consensus 187 ~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R 264 (280)
T cd05581 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDR 264 (280)
T ss_pred cccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCC--CccCHHHHHHHHHHhcCCHhhC
Confidence 99999999988899999999999999999999999998877666666665444444 3478999999999999999999
Q ss_pred CCChHhHHHHHcCCCC
Q 001952 928 LGSQKGAAEIKQHPFF 943 (992)
Q Consensus 928 PT~~~~aeEILkHPfF 943 (992)
|++....+++|+||||
T Consensus 265 ~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 265 LGVNEGYDELKAHPFF 280 (280)
T ss_pred CCcccCHHHHhcCCCC
Confidence 9922222999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=333.25 Aligned_cols=253 Identities=31% Similarity=0.489 Sum_probs=213.9
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..++..|++|.+..... ...+.+|+++++.++|+||+++++++.....+|++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 578999999999999999999988899999999975421 567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++... ...+++..++.++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 999999999998753 357899999999999999999999999999999999999999999999999986332100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........|+..
T Consensus 153 --------------------------------------------------------------------~~~~~~~~~~~~ 164 (256)
T cd06612 153 --------------------------------------------------------------------MAKRNTVIGTPF 164 (256)
T ss_pred --------------------------------------------------------------------ccccccccCCcc
Confidence 000112347888
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .+.....++.++.+||.+||..||++|
T Consensus 165 y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 244 (256)
T cd06612 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER 244 (256)
T ss_pred ccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhC
Confidence 9999999999999999999999999999999999987665544433322211 222233467899999999999999999
Q ss_pred CCChHhHHHHHcCCCC
Q 001952 928 LGSQKGAAEIKQHPFF 943 (992)
Q Consensus 928 PT~~~~aeEILkHPfF 943 (992)
|+ +.|+|.||||
T Consensus 245 ps----~~~il~~~~~ 256 (256)
T cd06612 245 PS----AIQLLQHPFI 256 (256)
T ss_pred cC----HHHHhcCCCC
Confidence 99 9999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.65 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=209.3
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++|+.++|+||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4689999999999999999999888999999998653211 123345778999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++++.|..+.... ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~---- 153 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---- 153 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC----
Confidence 999999998876543 45899999999999999999999999999999999999999999999999986332100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........++..
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~~~~ 165 (286)
T cd07846 154 --------------------------------------------------------------------GEVYTDYVATRW 165 (286)
T ss_pred --------------------------------------------------------------------ccccCcccceee
Confidence 000122457889
Q ss_pred ccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------cCCCC----
Q 001952 849 YLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------------LKFPD---- 904 (992)
Q Consensus 849 Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------------lk~P~---- 904 (992)
|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+.... ...+.
T Consensus 166 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07846 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245 (286)
T ss_pred ccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCc
Confidence 9999998764 46889999999999999999999998766555444433211 01111
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+.++..+.+||.+||..+|++||+ +.+|++||||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 246 EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred chHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 1236788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=338.19 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=208.0
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHH-HHHcCCCCccceeeeeccCCeEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI-LRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieI-Lk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
++|++.+.||+|+||.||+|.+..+++.||||+++...... ....+..|+.+ ++.++|+||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987542111 12234445554 6777999999999999999999999
Q ss_pred EEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|||++ ++|..++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||++..+..
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99995 7887776643 234689999999999999999999997 999999999999999999999999998633210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (283)
T cd06617 157 ------------------------------------------------------------------------SVAKTIDA 164 (283)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011235
Q ss_pred cCCCccChhhhcC----CCCCccceeeehhhhhhhhccCCCCCCCC-CchHHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 845 GTHEYLAPEIIKG----EGHGAAVDWWTFGIFLYELLYGRTPFKGS-GNEETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 845 GT~~Y~APEvL~g----~~~s~kSDIWSLGVlLyELLTGr~PF~g~-s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
|+..|+|||++.+ ..++.++|+|||||++|||++|+.||... ...+.+..+............++.++.+||.+|
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 244 (283)
T cd06617 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKC 244 (283)
T ss_pred CCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHH
Confidence 7888999999875 44688999999999999999999999753 334555554433222111234788999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
|..+|++||+ +.++++||||...++.
T Consensus 245 l~~~p~~Rp~----~~~il~~~~~~~~~~~ 270 (283)
T cd06617 245 LKKNYKERPN----YPELLQHPFFELHLSK 270 (283)
T ss_pred ccCChhhCcC----HHHHhcCchhhhcccc
Confidence 9999999999 9999999999987655
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=346.85 Aligned_cols=257 Identities=29% Similarity=0.453 Sum_probs=214.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|.+++.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||++++++|..++..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 378999999999999999999998899999999986432 22235578899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 95 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~--- 168 (297)
T cd06656 95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 168 (297)
T ss_pred ecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC---
Confidence 999999999999865 45789999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|++
T Consensus 169 ---------------------------------------------------------------------~~~~~~~~~~~ 179 (297)
T cd06656 169 ---------------------------------------------------------------------QSKRSTMVGTP 179 (297)
T ss_pred ---------------------------------------------------------------------ccCcCcccCCc
Confidence 00011235788
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh-ccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-SLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~-~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||.+.+..++.++|||||||++|+|++|..||.+.+....+..+... ......+..++..+++||.+||..||++
T Consensus 180 ~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 259 (297)
T cd06656 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDR 259 (297)
T ss_pred cccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 999999999998999999999999999999999999876554443332222 1222233457788999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~l 946 (992)
||+ ++++++||||+..
T Consensus 260 Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 260 RGS----AKELLQHPFLKLA 275 (297)
T ss_pred CcC----HHHHhcCchhccc
Confidence 999 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.22 Aligned_cols=256 Identities=33% Similarity=0.474 Sum_probs=210.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCC----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDN---- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~---- 682 (992)
.++|++.+.||+|+||.||+|.+..+++.+++|++.... .....+.+|+++++.+ +|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 578999999999999999999999889999999987542 2235678999999998 7999999999996544
Q ss_pred --eEEEEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 683 --LSCLVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 683 --~lyLVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.+|+||||+++++|.+++.... +..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 5899999999999999887543 467899999999999999999999999999999999999999999999999986
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
...... ..
T Consensus 161 ~~~~~~------------------------------------------------------------------------~~ 168 (275)
T cd06608 161 AQLDST------------------------------------------------------------------------LG 168 (275)
T ss_pred eecccc------------------------------------------------------------------------hh
Confidence 332100 00
Q ss_pred CcCccccCCCccChhhhcCC-----CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGE-----GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQA 912 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~-----~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el 912 (992)
......|+..|+|||++.+. .++.++|||||||+||+|++|..||........+..+..... .......++.++
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (275)
T cd06608 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKF 248 (275)
T ss_pred hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHH
Confidence 01223588899999998643 467889999999999999999999987666555555543322 122222367789
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+||.+||..||++||+ +.++++|||+
T Consensus 249 ~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 249 NDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred HHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 99999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=340.36 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=211.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCC-----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTN-----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg-----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
+..++|++++.||+|+||.||+|.+...+ ..|++|.++... .......+.+|+.+|..++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34568999999999999999999886655 689999986432 12234567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLG--------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~--------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~ 746 (992)
.+..|++|||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 9999999999999999999876421 45788899999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhc
Q 001952 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIR 826 (992)
Q Consensus 747 dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~ 826 (992)
++.++|+|||++.......
T Consensus 160 ~~~~~L~dfg~~~~~~~~~------------------------------------------------------------- 178 (283)
T cd05048 160 GLTVKISDFGLSRDIYSAD------------------------------------------------------------- 178 (283)
T ss_pred CCcEEECCCcceeeccccc-------------------------------------------------------------
Confidence 9999999999974321000
Q ss_pred cCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCC
Q 001952 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDS 905 (992)
Q Consensus 827 ~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~ 905 (992)
.........+++.|+|||.+.+..++.++|||||||+||||++ |..||.+....+....+. .....+.+
T Consensus 179 ---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~ 248 (283)
T cd05048 179 ---------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-SRQLLPCP 248 (283)
T ss_pred ---------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCcCCCc
Confidence 0000112346788999999999889999999999999999998 999999877766655544 33334444
Q ss_pred ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
..++.++.+|+.+||..||.+||+ +.||+++
T Consensus 249 ~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 249 EDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred ccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 568999999999999999999999 7787764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.35 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=209.3
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeec----
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFT---- 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~---- 679 (992)
....++|++++.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|+||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 345689999999999999999999999999999999986421 1224567899999999 7999999999873
Q ss_pred -cCCeEEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecc
Q 001952 680 -SDNLSCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 680 -~~~~lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
.++.+|+||||+++++|..++... ....+++..++.++.||+.||.|||+++|+||||||+||+++.++.++|+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 456789999999999999887642 23568899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++......
T Consensus 170 ~~~~~~~~------------------------------------------------------------------------ 177 (286)
T cd06638 170 VSAQLTST------------------------------------------------------------------------ 177 (286)
T ss_pred ceeecccC------------------------------------------------------------------------
Confidence 87432100
Q ss_pred CCCcCccccCCCccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-cCCCCCccchH
Q 001952 837 DARSNSFVGTHEYLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-LKFPDSPLISF 910 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-lk~P~~~~vs~ 910 (992)
........|++.|+|||++.+ ..++.++|||||||++|||++|+.||........+..+.... .....+..++.
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (286)
T cd06638 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSN 257 (286)
T ss_pred CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCH
Confidence 000112358899999999863 447889999999999999999999998766555444332221 12223334678
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
++.+||.+||..||++||+ +.||++|+||
T Consensus 258 ~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 258 EFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 8999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=344.65 Aligned_cols=258 Identities=28% Similarity=0.464 Sum_probs=218.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|++++.||.|+||.||+|.+..+++.|+||.+... .......+.+|+.+++.++|+||+++++++...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc---cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 36799999999999999999999999999999998643 223345678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|..++.. ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..+...
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--- 168 (296)
T cd06655 95 MEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--- 168 (296)
T ss_pred EEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc---
Confidence 999999999998865 35899999999999999999999999999999999999999999999999986322100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|+.
T Consensus 169 ---------------------------------------------------------------------~~~~~~~~~~~ 179 (296)
T cd06655 169 ---------------------------------------------------------------------QSKRSTMVGTP 179 (296)
T ss_pred ---------------------------------------------------------------------cccCCCcCCCc
Confidence 00011235788
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+....+..+..... .+..+..++..+.+||.+||..||.+
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 259 (296)
T cd06655 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEK 259 (296)
T ss_pred cccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhh
Confidence 99999999998899999999999999999999999988776655554433222 22334457889999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCc
Q 001952 927 RLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ln 947 (992)
||+ +.+|+.||||....
T Consensus 260 Rpt----~~~il~~~~~~~~~ 276 (296)
T cd06655 260 RGS----AKELLQHPFLKLAK 276 (296)
T ss_pred CCC----HHHHhhChHhhhcc
Confidence 999 99999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=378.12 Aligned_cols=261 Identities=30% Similarity=0.480 Sum_probs=228.1
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
+.|+++..||.|+||.||+|..+.++...|-|+|.-. ..+....+..|++||..++||+||+|++.|..++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4578888999999999999999999888899988643 4556778889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|||.||-...++-.. +..+.+.++.-+|+|++.||.|||+++|||||||..|||++.+|.++|+|||.+....
T Consensus 109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------ 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------ 181 (1187)
T ss_pred eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch------
Confidence 999999998776654 6789999999999999999999999999999999999999999999999999862210
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.+.....+|+||++
T Consensus 182 ------------------------------------------------------------------~t~qkRDsFIGTPY 195 (1187)
T KOG0579|consen 182 ------------------------------------------------------------------STRQKRDSFIGTPY 195 (1187)
T ss_pred ------------------------------------------------------------------hHHhhhccccCCcc
Confidence 01223457899999
Q ss_pred ccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccC
Q 001952 849 YLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 849 Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~ 922 (992)
|||||+..+ .+|++++||||||++|.||..+.+|....+.+..+.+|..... .+..+...+..+.|||.+||.+
T Consensus 196 WMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~K 275 (1187)
T KOG0579|consen 196 WMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVK 275 (1187)
T ss_pred cccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhc
Confidence 999999875 4789999999999999999999999999999988888866543 4555667888999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
||..||+ +++||+||||+...-+
T Consensus 276 np~~Rp~----aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 276 NPRNRPP----AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred CCccCCC----HHHHhhCcccccCCcc
Confidence 9999999 9999999999977543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.61 Aligned_cols=257 Identities=32% Similarity=0.490 Sum_probs=211.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+++.++|+||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 588999999999999999999989999999998754321 2234567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~----- 152 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE----- 152 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC-----
Confidence 99 999999887543 66899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
.........|+..|
T Consensus 153 ------------------------------------------------------------------~~~~~~~~~~~~~y 166 (286)
T cd07832 153 ------------------------------------------------------------------EPRLYSHQVATRWY 166 (286)
T ss_pred ------------------------------------------------------------------CCCccccccCcccc
Confidence 00001223588899
Q ss_pred cChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-------------------CCCC-----
Q 001952 850 LAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------KFPD----- 904 (992)
Q Consensus 850 ~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------k~P~----- 904 (992)
+|||++.+.. ++.++|||||||++|||++|.+||.+....+.+..++.... .++.
T Consensus 167 ~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (286)
T cd07832 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIP 246 (286)
T ss_pred cCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcch
Confidence 9999987654 58999999999999999999988988776666555443110 0110
Q ss_pred ----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 905 ----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 905 ----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
.+.++.++.+||.+||..||.+||+ ++++|+||||.
T Consensus 247 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 247 LEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred HHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 0235678999999999999999999 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=330.46 Aligned_cols=252 Identities=27% Similarity=0.467 Sum_probs=212.1
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||.|+||.||++.+..+++.||+|.++... .......+..|+.+++.++|+||+++++.+..++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5889999999999999999999999999999986432 12334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++....+..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~----- 153 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----- 153 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc-----
Confidence 999999999887665667899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 154 -------------------------------------------------------------------~~~~~~~~~~~~~ 166 (255)
T cd08219 154 -------------------------------------------------------------------GAYACTYVGTPYY 166 (255)
T ss_pred -------------------------------------------------------------------ccccccccCCccc
Confidence 0001224588899
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
+|||++.+..++.++|+||||+++|+|++|..||...+....+..+..... .+.+..++..+.+||.+||..||++||+
T Consensus 167 ~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 245 (255)
T cd08219 167 VPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY-KPLPSHYSYELRSLIKQMFKRNPRSRPS 245 (255)
T ss_pred cCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC-CCCCcccCHHHHHHHHHHHhCCcccCCC
Confidence 999999999899999999999999999999999987665555555443332 2334457889999999999999999999
Q ss_pred ChHhHHHHHcC
Q 001952 930 SQKGAAEIKQH 940 (992)
Q Consensus 930 ~~~~aeEILkH 940 (992)
+.+|+.-
T Consensus 246 ----~~~il~~ 252 (255)
T cd08219 246 ----ATTILSR 252 (255)
T ss_pred ----HHHHhhc
Confidence 8888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=331.27 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=218.4
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||.|++|.||+|.+..+++.|+||++...... .....+..|+.++..++|+||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998754221 33567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||+++++|.+++... ..+++..++.++.||+.||.|||. .|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~--- 153 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT--- 153 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccC---
Confidence 999999999998764 678999999999999999999999 99999999999999999999999999986332100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 154 ---------------------------------------------------------------------~~~~~~~~~~~ 164 (264)
T cd06623 154 ---------------------------------------------------------------------LDQCNTFVGTV 164 (264)
T ss_pred ---------------------------------------------------------------------CCcccceeecc
Confidence 00011335788
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC--chHHHHHHHhhccCCCCCcc-chHHHHHHHHHhccCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG--NEETLANVVMQSLKFPDSPL-ISFQARDLIRGLLIKEP 924 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s--~~e~L~~Iv~~~lk~P~~~~-vs~el~dLI~kcL~~DP 924 (992)
.|+|||.+.+..++.++||||||+++|+|++|+.||.... ....+...+........... ++..+.++|.+||..+|
T Consensus 165 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 244 (264)
T cd06623 165 TYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDP 244 (264)
T ss_pred cccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCCh
Confidence 8999999999989999999999999999999999998774 33333333333333333444 78899999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCCc
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~ln 947 (992)
++||+ +.++++||||+..+
T Consensus 245 ~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 245 KKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred hhCCC----HHHHHhCHHHHhcc
Confidence 99999 99999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=339.95 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=211.1
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++|+.++|+||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46889999999999999999999899999999886431 2223456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 689 EYCPGGDLHVLRQKQL-GKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~-~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||+++++|..++.... ...+++..++.++.||+.||.|||. .||+|+||||+|||++.++.++|+|||++..+..
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 9999999998887531 2368999999999999999999996 5999999999999999999999999998632100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.......|+
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (286)
T cd06622 156 -----------------------------------------------------------------------SLAKTNIGC 164 (286)
T ss_pred -----------------------------------------------------------------------CccccCCCc
Confidence 001123477
Q ss_pred CCccChhhhcCCC------CCccceeeehhhhhhhhccCCCCCCCCCchHHHHH---HHhhccCCCCCccchHHHHHHHH
Q 001952 847 HEYLAPEIIKGEG------HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN---VVMQSLKFPDSPLISFQARDLIR 917 (992)
Q Consensus 847 ~~Y~APEvL~g~~------~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~---Iv~~~lk~P~~~~vs~el~dLI~ 917 (992)
+.|+|||++.+.. ++.++|||||||++|||++|+.||........+.. +.. ......+..++.++.+||.
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 243 (286)
T cd06622 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTLPSGYSDDAQDFVA 243 (286)
T ss_pred cCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-cCCCCCCcccCHHHHHHHH
Confidence 8899999986543 47899999999999999999999976544333322 222 1222233448899999999
Q ss_pred HhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 918 GLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
+||..+|++||+ +.+++.||||....
T Consensus 244 ~~l~~~p~~Rp~----~~~l~~~~~~~~~~ 269 (286)
T cd06622 244 KCLNKIPNRRPT----YAQLLEHPWLVKYK 269 (286)
T ss_pred HHcccCcccCCC----HHHHhcChhhhhcc
Confidence 999999999999 99999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.00 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=212.5
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH--HhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL--ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l--~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+|+..+.||+|+||.||+|.+..+++.|++|.+..... ........+..|+++++.++|+||+++++++..++.+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 46777899999999999999988899999999864321 1123446788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~--- 155 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF--- 155 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc---
Confidence 9999999999998764 46889999999999999999999999999999999999999999999999986332100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......|+.
T Consensus 156 ----------------------------------------------------------------------~~~~~~~~~~ 165 (258)
T cd06632 156 ----------------------------------------------------------------------SFAKSFKGSP 165 (258)
T ss_pred ----------------------------------------------------------------------ccccccCCCc
Confidence 0012245788
Q ss_pred CccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|++||.+.... ++.++|+|||||++|+|++|+.||......+....+.........+..++.++.+||.+||..+|++
T Consensus 166 ~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 245 (258)
T cd06632 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSL 245 (258)
T ss_pred ceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCccc
Confidence 899999998776 8999999999999999999999998776555554444322222223457889999999999999999
Q ss_pred cCCChHhHHHHHcCCCC
Q 001952 927 RLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF 943 (992)
||+ +.+++.||||
T Consensus 246 Rp~----~~~~l~~~~~ 258 (258)
T cd06632 246 RPT----AAELLEHPFV 258 (258)
T ss_pred CcC----HHHHhcCCCC
Confidence 999 9999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.24 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=210.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccC----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSD---- 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~---- 681 (992)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +|+||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4678999999999999999999999999999999986431 2234567889999988 899999999998643
Q ss_pred -CeEEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 682 -NLSCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 682 -~~lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+.+|+||||+++++|.++++.. .+..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 4689999999999999887642 2356899999999999999999999999999999999999999999999999986
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+... ..
T Consensus 176 ~~~~~~------------------------------------------------------------------------~~ 183 (291)
T cd06639 176 AQLTST------------------------------------------------------------------------RL 183 (291)
T ss_pred hhcccc------------------------------------------------------------------------cc
Confidence 332100 00
Q ss_pred CcCccccCCCccChhhhcCCC-----CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEG-----HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQA 912 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~-----~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el 912 (992)
......|+..|+|||++.... ++.++|||||||++|||++|+.||......+.+..+..... .......+...+
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 263 (291)
T cd06639 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSF 263 (291)
T ss_pred cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHH
Confidence 011235788899999986543 68899999999999999999999988766666555443322 222233466789
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
.+||.+||..+|++||+ +.||+.||||+
T Consensus 264 ~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 264 NHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 99999999999999999 99999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=335.99 Aligned_cols=256 Identities=30% Similarity=0.446 Sum_probs=212.4
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||.|+||.||+|.+..+++.|++|++..... ......+.+|+++++.++||||+++++++...+.+||+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 367888899999999999999999999999999876432 233456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||+++++|.+++.... ..+++..+..++.||+.||+|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999987643 578999999999999999999999 99999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
......|+.
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (265)
T cd06605 155 -----------------------------------------------------------------------LAKTFVGTS 163 (265)
T ss_pred -----------------------------------------------------------------------HhhcccCCh
Confidence 000145788
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC-----chHHHHHHHhhccCCCCCc-cchHHHHHHHHHhcc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-----NEETLANVVMQSLKFPDSP-LISFQARDLIRGLLI 921 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s-----~~e~L~~Iv~~~lk~P~~~-~vs~el~dLI~kcL~ 921 (992)
.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..++... ...... .++.++.+||.+||.
T Consensus 164 ~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 242 (265)
T cd06605 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLPSGKFSPDFQDFVNLCLI 242 (265)
T ss_pred hccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCChhhcCHHHHHHHHHHcC
Confidence 8999999999999999999999999999999999997542 223333333221 111112 278899999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.||++||+ +.+++.||||+..
T Consensus 243 ~~p~~Rpt----~~~ll~~~~~~~~ 263 (265)
T cd06605 243 KDPRERPS----YKELLEHPFIKKY 263 (265)
T ss_pred CCchhCcC----HHHHhhCchhhcc
Confidence 99999999 9999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=341.35 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=213.0
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||+||++.+..+++.||+|++.... .......+.+|+++++.++|+||+++++++...+.+||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4568999999999999999999999899999999886432 22334678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
||||+++++|..++... +.+++..++.++.|++.||.|||+ .||+||||+|+|||++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~-- 156 (284)
T cd06620 81 CMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN-- 156 (284)
T ss_pred EEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh--
Confidence 99999999999888764 568999999999999999999997 6999999999999999999999999998632100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.......|
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (284)
T cd06620 157 ------------------------------------------------------------------------SIADTFVG 164 (284)
T ss_pred ------------------------------------------------------------------------hccCcccc
Confidence 00012358
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch-----------HHHHHHHhhccCCCCCccchHHHHH
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-----------ETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-----------e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
+..|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+............++.++.+
T Consensus 165 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (284)
T cd06620 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244 (284)
T ss_pred CcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHH
Confidence 89999999999888999999999999999999999999865442 2222222222111111237788999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||.+||..||++||+ +.|+++|+||...
T Consensus 245 li~~~l~~dp~~Rpt----~~e~~~~~~~~~~ 272 (284)
T cd06620 245 FVDACLLKDPTERPT----PQQLCAMPPFIQA 272 (284)
T ss_pred HHHHHhcCCcccCcC----HHHHhcCcccccc
Confidence 999999999999999 9999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=392.72 Aligned_cols=269 Identities=27% Similarity=0.393 Sum_probs=221.1
Q ss_pred eecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 601 LQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 601 ~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
+..++....+|++++.||+|+||+||+|.+..++..||+|++...... ......+..|+.+|+.|+|||||+++++|..
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 345666788999999999999999999999999999999998754322 2234567889999999999999999998854
Q ss_pred --CCeEEEEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhc-------CeeeeecCCceEEEcc---
Q 001952 681 --DNLSCLVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHML-------GVIYRDLKPENILVRE--- 746 (992)
Q Consensus 681 --~~~lyLVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~-------GIIHRDIKPeNILLd~--- 746 (992)
...+||||||+++++|..++.... ...+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 467899999999999999887532 25689999999999999999999985 4999999999999964
Q ss_pred --------------CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCcccc
Q 001952 747 --------------DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATA 812 (992)
Q Consensus 747 --------------dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~ 812 (992)
.+.+||+|||++..+...
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~------------------------------------------------ 195 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE------------------------------------------------ 195 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccc------------------------------------------------
Confidence 234899999997332100
Q ss_pred ccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC--CCCccceeeehhhhhhhhccCCCCCCCCCchH
Q 001952 813 KTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE--GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890 (992)
Q Consensus 813 kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~--~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e 890 (992)
......+||+.|+|||++.+. .++.++||||||||||||++|..||.......
T Consensus 196 -------------------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~ 250 (1021)
T PTZ00266 196 -------------------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS 250 (1021)
T ss_pred -------------------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH
Confidence 001234689999999999753 47899999999999999999999998877776
Q ss_pred HHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 891 TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 891 ~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
.+...+.....++. ..++.++.+||..||..+|.+||+ +.++|.|+||..+..
T Consensus 251 qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 251 QLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCC
Confidence 66666655544443 246889999999999999999999 999999999987654
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.48 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=202.7
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC----------------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG----------------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~----------------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN 670 (992)
..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35689999999999999999997632 34579999987532 1223456789999999999999
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChHHHHHhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCee
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLG-----------------KCFSEPAARFYVAEVLLALEYLHMLGVI 733 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~-----------------~~Lse~~i~~Ia~QIL~GL~YLHs~GII 733 (992)
|+++++++...+..||||||+++++|.+++..... ..+++..++.++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999999999999999999999999998865321 2367788999999999999999999999
Q ss_pred eeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccc
Q 001952 734 YRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAK 813 (992)
Q Consensus 734 HRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~k 813 (992)
||||||+|||++.++.+||+|||++..+.....
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~----------------------------------------------- 193 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDY----------------------------------------------- 193 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCce-----------------------------------------------
Confidence 999999999999999999999999743211000
Q ss_pred cCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc--CCCCCCCCCchHH
Q 001952 814 TRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY--GRTPFKGSGNEET 891 (992)
Q Consensus 814 t~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT--Gr~PF~g~s~~e~ 891 (992)
........++..|+|||++.+..++.++|||||||++|||++ +..||.+....+.
T Consensus 194 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 250 (304)
T cd05096 194 -----------------------YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQV 250 (304)
T ss_pred -----------------------eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHH
Confidence 000112346788999999999899999999999999999986 6788887666555
Q ss_pred HHHHHhh------ccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 892 LANVVMQ------SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 892 L~~Iv~~------~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
+..+... ......++.++..+.+||.+||..||++||+ +.+|.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~ 299 (304)
T cd05096 251 IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS----FSDIH 299 (304)
T ss_pred HHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC----HHHHH
Confidence 4443221 1112233457889999999999999999999 77764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.19 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=189.4
Q ss_pred EEEccCCceEEEEEEEcC--CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec--cCCeEEEEEEe
Q 001952 615 QKLGCGDIGTVYLAELIG--TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT--SDNLSCLVMEY 690 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~--tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~--~~~~lyLVmEy 690 (992)
.+||+|+||.||+|.+.. ++..||+|.+... .....+.+|+++|+.++||||+++++++. .+..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC-----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999998754 5678999998643 22345678999999999999999999885 45678999999
Q ss_pred cCCCChHHHHHhh-------cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE----ccCCcEEEEeccccc
Q 001952 691 CPGGDLHVLRQKQ-------LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV----REDGHIMLTDFDLSL 759 (992)
Q Consensus 691 ~~GGSL~~lLkk~-------~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL----d~dg~VKLsDFGLA~ 759 (992)
+. ++|..++... ....+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.++|+|||++.
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5776665422 12357889999999999999999999999999999999999 466789999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..... ....
T Consensus 161 ~~~~~~~---------------------------------------------------------------------~~~~ 171 (317)
T cd07867 161 LFNSPLK---------------------------------------------------------------------PLAD 171 (317)
T ss_pred ccCCCcc---------------------------------------------------------------------cccc
Confidence 3210000 0001
Q ss_pred cCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCch---------HHHHHHHhhc----------
Q 001952 840 SNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---------ETLANVVMQS---------- 899 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~---------e~L~~Iv~~~---------- 899 (992)
.....||+.|+|||++.+. .++.++|||||||++|||+||+.||...... ..+..+....
T Consensus 172 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (317)
T cd07867 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWED 251 (317)
T ss_pred cCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhh
Confidence 1234689999999999875 4799999999999999999999999754321 1111111100
Q ss_pred ----cCCC----------------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 900 ----LKFP----------------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 900 ----lk~P----------------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
..++ .....+..+.+||.+||..||.+||| +.|+|+||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 252 IRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 0000 00113456889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=328.71 Aligned_cols=256 Identities=29% Similarity=0.491 Sum_probs=215.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|.+.+.||.|+||.||+|.+..++..||+|.+....... .....+.+|+++++.++|+||+++++.+...+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5889999999999999999999999999999997643221 234567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEeccccccccCCcccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~~~~~~~ 768 (992)
|+++++|.+++....+..+++..++.++.||+.||.|||..+|+|+||||+|||++.++ .++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---- 155 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC----
Confidence 99999999998776555689999999999999999999999999999999999999876 4699999986332100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........|++.
T Consensus 156 --------------------------------------------------------------------~~~~~~~~~~~~ 167 (257)
T cd08225 156 --------------------------------------------------------------------MELAYTCVGTPY 167 (257)
T ss_pred --------------------------------------------------------------------cccccccCCCcc
Confidence 000112347889
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|+|||||++|||++|..||...+..+....+..... .+..+.++.++.++|.+||..+|++||
T Consensus 168 ~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp 246 (257)
T cd08225 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRP 246 (257)
T ss_pred ccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCc
Confidence 9999999988899999999999999999999999987766655555443332 233345788999999999999999999
Q ss_pred CChHhHHHHHcCCCC
Q 001952 929 GSQKGAAEIKQHPFF 943 (992)
Q Consensus 929 T~~~~aeEILkHPfF 943 (992)
+ +.|+++||||
T Consensus 247 t----~~~ll~~~~~ 257 (257)
T cd08225 247 S----ITSILKRPFL 257 (257)
T ss_pred C----HHHHhhCCCC
Confidence 9 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=358.59 Aligned_cols=258 Identities=19% Similarity=0.286 Sum_probs=209.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEE-----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeec
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAEL-----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFT 679 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~-----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~ 679 (992)
+..++|++.+.||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|..+ +||||++++++|.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4456899999999999999999975 3456789999986432 122335678899999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhc-------------------------------------------------------
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQL------------------------------------------------------- 704 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~------------------------------------------------------- 704 (992)
..+..|+|||||++|+|..++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999998886431
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 705 ------------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 705 ------------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 12467888999999999999999999999999999999999999999999999743211000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........++
T Consensus 270 ----------------------------------------------------------------------~~~~~~~~~~ 279 (375)
T cd05104 270 ----------------------------------------------------------------------YVVKGNARLP 279 (375)
T ss_pred ----------------------------------------------------------------------ccccCCCCCC
Confidence 0000112356
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|+|||++.+..++.++|||||||+||||++ |..||.+......+..++........+...+.++.+||.+||..||+
T Consensus 280 ~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 359 (375)
T cd05104 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPL 359 (375)
T ss_pred cceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChh
Confidence 78999999999999999999999999999998 89999887666666666665555544456788999999999999999
Q ss_pred CcCCChHhHHHHHc
Q 001952 926 NRLGSQKGAAEIKQ 939 (992)
Q Consensus 926 kRPT~~~~aeEILk 939 (992)
+||+ +.||++
T Consensus 360 ~RPs----~~eil~ 369 (375)
T cd05104 360 KRPT----FKQIVQ 369 (375)
T ss_pred HCcC----HHHHHH
Confidence 9999 777664
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.79 Aligned_cols=258 Identities=29% Similarity=0.454 Sum_probs=210.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh-------hcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR-------RKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~-------~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
+|.+.+.||+|+||.||+|....+++.||+|.++...... ......+..|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778889999999999999998899999999886432111 112346788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998775 568999999999999999999999999999999999999999999999999863211
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. ........
T Consensus 160 ~~----------------------------------------------------------------------~~~~~~~~ 169 (272)
T cd06629 160 DI----------------------------------------------------------------------YDNDQNMS 169 (272)
T ss_pred cc----------------------------------------------------------------------cccccccc
Confidence 00 00000122
Q ss_pred cccCCCccChhhhcCCC--CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC--CCC--CccchHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK--FPD--SPLISFQARDLI 916 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~--~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk--~P~--~~~vs~el~dLI 916 (992)
..|+..|+|||++.+.. ++.++|+||||+++|||++|..||......+.+..+...... ++. ...++.++.+||
T Consensus 170 ~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 249 (272)
T cd06629 170 MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL 249 (272)
T ss_pred ccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHH
Confidence 45788999999998765 789999999999999999999999766555544443322222 221 124678999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+||..||++||+ ++++|+||||
T Consensus 250 ~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 250 NACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred HHHhcCChhhCCC----HHHHhhCCCC
Confidence 9999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=359.31 Aligned_cols=258 Identities=20% Similarity=0.290 Sum_probs=209.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCC-----CeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeec
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFT 679 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~t-----g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~ 679 (992)
+..++|++.+.||+|+||.||+|.+... +..||||+++.... ......+.+|+++|+.+ +|+||++++++|.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 4567899999999999999999986543 35799999975321 22345678899999999 8999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhc-------------------------------------------------------
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQL------------------------------------------------------- 704 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~------------------------------------------------------- 704 (992)
..+.+||||||+++|+|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 9999999999999999998886431
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCC
Q 001952 705 -------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSS 771 (992)
Q Consensus 705 -------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~ 771 (992)
...+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~----- 267 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN----- 267 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-----
Confidence 12477888999999999999999999999999999999999999999999999743210000
Q ss_pred CCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccC
Q 001952 772 SNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLA 851 (992)
Q Consensus 772 s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~A 851 (992)
........++..|+|
T Consensus 268 -----------------------------------------------------------------~~~~~~~~~~~~y~a 282 (374)
T cd05106 268 -----------------------------------------------------------------YVVKGNARLPVKWMA 282 (374)
T ss_pred -----------------------------------------------------------------eeeccCCCCccceeC
Confidence 000011235678999
Q ss_pred hhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCC
Q 001952 852 PEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 852 PEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
||++.+..++.++|||||||+||||++ |+.||........+..++......+.+..++.++.+||.+||..||++||+
T Consensus 283 PE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs- 361 (374)
T cd05106 283 PESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT- 361 (374)
T ss_pred HHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcC-
Confidence 999999899999999999999999997 999998876655566666655555555567899999999999999999999
Q ss_pred hHhHHHHHc
Q 001952 931 QKGAAEIKQ 939 (992)
Q Consensus 931 ~~~aeEILk 939 (992)
+.+|++
T Consensus 362 ---~~~l~~ 367 (374)
T cd05106 362 ---FSQISQ 367 (374)
T ss_pred ---HHHHHH
Confidence 666543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=331.98 Aligned_cols=254 Identities=21% Similarity=0.302 Sum_probs=211.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+...+|.+.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+++|+.++|+||+++++++..++.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 44567999999999999999999999999999999987532 22456788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999999999876555668999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+
T Consensus 159 -----------------------------------------------------------------------~~~~~~~~~ 167 (263)
T cd05052 159 -----------------------------------------------------------------------YTAHAGAKF 167 (263)
T ss_pred -----------------------------------------------------------------------eeccCCCCC
Confidence 000011234
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ ........+..++.++.+||.+||..||
T Consensus 168 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p 246 (263)
T cd05052 168 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKGYRMERPEGCPPKVYELMRACWQWNP 246 (263)
T ss_pred ccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 567999999999999999999999999999998 99999887655554444 3444445555688999999999999999
Q ss_pred CCcCCChHhHHHHHc
Q 001952 925 ENRLGSQKGAAEIKQ 939 (992)
Q Consensus 925 ekRPT~~~~aeEILk 939 (992)
++||+ +.++++
T Consensus 247 ~~Rp~----~~~l~~ 257 (263)
T cd05052 247 SDRPS----FAEIHQ 257 (263)
T ss_pred ccCCC----HHHHHH
Confidence 99999 555543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=349.62 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=206.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 5789999999999999999999999999999999864321 122334567899999999999999999988643
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
...||||||+. ++|..++... +++..+..++.||+.||+|||.+||+||||||+|||++.++.++|+|||++...
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 35799999994 5787776542 889999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... ....
T Consensus 169 ~~~-------------------------------------------------------------------------~~~~ 175 (353)
T cd07850 169 GTS-------------------------------------------------------------------------FMMT 175 (353)
T ss_pred CCC-------------------------------------------------------------------------CCCC
Confidence 100 0011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC--------------------
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-------------------- 901 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-------------------- 901 (992)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++.....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (353)
T cd07850 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENR 255 (353)
T ss_pred CCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcC
Confidence 235788999999999999999999999999999999999999877655554444321000
Q ss_pred ----------------CCC-----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 902 ----------------FPD-----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 902 ----------------~P~-----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
++. ....+.++++||.+||..||.+||+ +.|+|.||||+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~~ 316 (353)
T cd07850 256 PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYINV 316 (353)
T ss_pred CCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHhh
Confidence 000 1124567899999999999999999 999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=335.92 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=207.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCe----
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNL---- 683 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~---- 683 (992)
++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46899999999999999999999999999999986542 12223456788999999995 6999999999876665
Q ss_pred -EEEEEEecCCCChHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-CCcEEEEecccc
Q 001952 684 -SCLVMEYCPGGDLHVLRQKQL---GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-DGHIMLTDFDLS 758 (992)
Q Consensus 684 -lyLVmEy~~GGSL~~lLkk~~---~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-dg~VKLsDFGLA 758 (992)
.|+||||+++ +|..++.... ...+++..++.++.||+.||.|||.+||+||||+|+|||++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 7877776542 245899999999999999999999999999999999999998 889999999987
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+... ..
T Consensus 159 ~~~~~~------------------------------------------------------------------------~~ 166 (295)
T cd07837 159 RAFSIP------------------------------------------------------------------------VK 166 (295)
T ss_pred eecCCC------------------------------------------------------------------------cc
Confidence 432100 00
Q ss_pred CcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC----------------
Q 001952 839 RSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK---------------- 901 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk---------------- 901 (992)
......+++.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..+......
T Consensus 167 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T cd07837 167 SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH 246 (295)
T ss_pred ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchh
Confidence 01122467889999998764 5789999999999999999999999987776666554431100
Q ss_pred -CCC---------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 902 -FPD---------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 902 -~P~---------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
++. .+.++.++.+||.+||..||.+||+ +.|++.||||+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 247 EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 000 1236788999999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.55 Aligned_cols=256 Identities=28% Similarity=0.419 Sum_probs=211.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec--cCCeEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT--SDNLSCLV 687 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~--~~~~lyLV 687 (992)
+|++++.||.|+||.||+|.+..++..||+|++...... ......+..|+++++.++|+||+++++++. .+..+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 588999999999999999999999999999998754322 233456788999999999999999999875 35578999
Q ss_pred EEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHh-----hcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 688 MEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLH-----MLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLH-----s~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
|||+++++|..++... ....+++..++.++.||+.||+||| ..+|+|+||+|+|||++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999888653 2357899999999999999999999 88999999999999999999999999998633
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.... ....
T Consensus 160 ~~~~------------------------------------------------------------------------~~~~ 167 (265)
T cd08217 160 LGHD------------------------------------------------------------------------SSFA 167 (265)
T ss_pred ccCC------------------------------------------------------------------------cccc
Confidence 2100 0001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
....|+..|+|||++.+..++.++|+||||+++|+|++|+.||...+..+....+.. ......+..++.++.+||.+||
T Consensus 168 ~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~l 246 (265)
T cd08217 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE-GKFRRIPYRYSSELNEVIKSML 246 (265)
T ss_pred cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc-CCCCCCccccCHHHHHHHHHHc
Confidence 123578899999999998899999999999999999999999988765444444333 2222333457889999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF 943 (992)
..+|++||+ +.+|++|||+
T Consensus 247 ~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 247 NVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred cCCcccCCC----HHHHhhCCCC
Confidence 999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=367.23 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=203.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++++|+|||++++++..++..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2346799999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||++ .++|..++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++..+....
T Consensus 239 ~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 9999 57888777654 2468999999999999999999999999999999999999999999999999974321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.........||+
T Consensus 315 --------------------------------------------------------------------~~~~~~~~~GT~ 326 (461)
T PHA03211 315 --------------------------------------------------------------------STPFHYGIAGTV 326 (461)
T ss_pred --------------------------------------------------------------------ccccccccCCCc
Confidence 000012346999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC-------chHHHHHHHhh-cc---CCC-------------
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-------NEETLANVVMQ-SL---KFP------------- 903 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s-------~~e~L~~Iv~~-~l---k~P------------- 903 (992)
.|+|||++.+..++.++|||||||+||||++|..++.... ....+..++.. .. .++
T Consensus 327 ~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~ 406 (461)
T PHA03211 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH 406 (461)
T ss_pred CCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHh
Confidence 9999999999999999999999999999999876654321 12233333221 11 011
Q ss_pred ----------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 904 ----------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 904 ----------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
....++.++.+||.+||..||.+||+ +.|||+||||+.
T Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 407 RAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred hhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 00124557899999999999999999 999999999975
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.73 Aligned_cols=257 Identities=31% Similarity=0.459 Sum_probs=210.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+++|+.++|+||+++++++..++.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 379999999999999999999999999999999875422 2234467889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++++.|..+.... ..+++..++.++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 154 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP--- 154 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc---
Confidence 999887777665543 558999999999999999999999999999999999999999999999999874321000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........++..
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~~~~ 166 (288)
T cd07833 155 --------------------------------------------------------------------ASPLTDYVATRW 166 (288)
T ss_pred --------------------------------------------------------------------cccccCcccccC
Confidence 001123467889
Q ss_pred ccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-------------------CCC-----
Q 001952 849 YLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------KFP----- 903 (992)
Q Consensus 849 Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------k~P----- 903 (992)
|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+..... .++
T Consensus 167 ~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (288)
T cd07833 167 YRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQP 246 (288)
T ss_pred CcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCc
Confidence 9999999988 789999999999999999999999987665554433321000 000
Q ss_pred ------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 904 ------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 904 ------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
....++.++.+||.+||..+|++||+ +.++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 247 ESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred HHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 01124788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.26 Aligned_cols=259 Identities=29% Similarity=0.392 Sum_probs=211.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH--hhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA--RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~--~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+|++.+.||+|+||.||+|.+..+++.||||.+...... .......+..|+++++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999989999999999754322 112234567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+ +++|..++.... ..+++..++.++.||+.||.|||.+||+|+||+|+|||++.++.++|+|||++..+...
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--- 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--- 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC---
Confidence 9999 999999987642 36899999999999999999999999999999999999999999999999997432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........+++
T Consensus 156 ---------------------------------------------------------------------~~~~~~~~~~~ 166 (298)
T cd07841 156 ---------------------------------------------------------------------NRKMTHQVVTR 166 (298)
T ss_pred ---------------------------------------------------------------------Cccccccccce
Confidence 00011224677
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC--------------------C---
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF--------------------P--- 903 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~--------------------P--- 903 (992)
.|+|||.+.+. .++.++|||||||++|||++|..+|.+....+.+..+....... +
T Consensus 167 ~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T cd07841 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTP 246 (298)
T ss_pred eeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcc
Confidence 89999998654 56899999999999999999988888877766655543211000 0
Q ss_pred ---CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 904 ---DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 904 ---~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
....++.++.+||.+||..||++||+ +.|+++|+||++.
T Consensus 247 ~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~~ 288 (298)
T cd07841 247 LKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSND 288 (298)
T ss_pred hhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccCC
Confidence 00234678999999999999999999 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=336.22 Aligned_cols=256 Identities=31% Similarity=0.458 Sum_probs=204.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||+|.+..+++.||||.+.... .......+.+|+++++.++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEH--EEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccc--ccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 468999999999999999999998899999999987532 122234567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. ++|..++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 156 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--- 156 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC---
Confidence 99996 58988877543 46899999999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (291)
T cd07844 157 ---------------------------------------------------------------------SKTYSNEVVTL 167 (291)
T ss_pred ---------------------------------------------------------------------Ccccccccccc
Confidence 00011124678
Q ss_pred CccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhc-------------------cCCCC--
Q 001952 848 EYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQS-------------------LKFPD-- 904 (992)
Q Consensus 848 ~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~-------------------lk~P~-- 904 (992)
.|+|||++.+ ..++.++|||||||++|||++|+.||.+... .+.+..+.... ..++.
T Consensus 168 ~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T cd07844 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYP 247 (291)
T ss_pred ccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccC
Confidence 8999999876 4578999999999999999999999976652 22222221100 00000
Q ss_pred -------Cccch--HHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 -------SPLIS--FQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 -------~~~vs--~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...++ .++.+||.+||..+|++||+ +.|++.||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 248 PRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred ChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 01133 77889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.13 Aligned_cols=262 Identities=28% Similarity=0.400 Sum_probs=211.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--CeE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--NLS 684 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~~l 684 (992)
..++|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999864321 112233456799999999999999999998754 568
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+. ++|..++... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999995 5788877654 256899999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. .......
T Consensus 162 ~------------------------------------------------------------------------~~~~~~~ 169 (309)
T cd07845 162 A------------------------------------------------------------------------KPMTPKV 169 (309)
T ss_pred c------------------------------------------------------------------------CCCCccc
Confidence 0 0011123
Q ss_pred cCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-------------------CCCC
Q 001952 845 GTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------KFPD 904 (992)
Q Consensus 845 GT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------k~P~ 904 (992)
++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+..... ..+.
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (309)
T cd07845 170 VTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPK 249 (309)
T ss_pred ccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccC
Confidence 5778999999876 4578999999999999999999999998887777766554210 0110
Q ss_pred C---------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 905 S---------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 905 ~---------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
. ..++.++.+||.+||..||++||+ +.++|.||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~~~ 297 (309)
T cd07845 250 QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKEKP 297 (309)
T ss_pred CCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhccCC
Confidence 0 125778899999999999999999 99999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=327.94 Aligned_cols=259 Identities=32% Similarity=0.537 Sum_probs=213.1
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|.+.+.||+|+||.||+|.+..+++.|++|+++..... ......+..|+++++.++|+||+++++++...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 588899999999999999999889999999998765322 3456788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~--- 154 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT--- 154 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC---
Confidence 99999999998764 4578999999999999999999999999999999999999999999999998743211000
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
. .........++..|
T Consensus 155 -------------------------------~----------------------------------~~~~~~~~~~~~~~ 169 (264)
T cd06626 155 -------------------------------T----------------------------------MGEEVQSLAGTPAY 169 (264)
T ss_pred -------------------------------c----------------------------------ccccccCCcCCcCc
Confidence 0 00001123578889
Q ss_pred cChhhhcCCC---CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh--ccCCCCCccchHHHHHHHHHhccCCc
Q 001952 850 LAPEIIKGEG---HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ--SLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 850 ~APEvL~g~~---~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~--~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
++||++.+.. ++.++|||||||++|||++|+.||............+.. ...+|....++..+.+||.+||..+|
T Consensus 170 ~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 249 (264)
T cd06626 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDP 249 (264)
T ss_pred cChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCc
Confidence 9999998876 789999999999999999999999765433333222222 22344444458899999999999999
Q ss_pred CCcCCChHhHHHHHcCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF 943 (992)
.+||+ +.+++.|||+
T Consensus 250 ~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 250 KKRPT----ASELLQHPFV 264 (264)
T ss_pred ccCCC----HHHHhcCCCC
Confidence 99999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=334.69 Aligned_cols=268 Identities=40% Similarity=0.749 Sum_probs=215.0
Q ss_pred CceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHh-hcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLAR-RKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~-~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+|++.+.||.|+||.||+|.+. .+|+.||+|++....... ......+.+|+.+|+.+ +|+||+.+++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4888999999999999999875 478899999997643322 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999988764 56889999999999999999999999999999999999999999999999987332100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ........
T Consensus 159 ~-----------------------------------------------------------------------~~~~~~~~ 167 (290)
T cd05613 159 E-----------------------------------------------------------------------VERAYSFC 167 (290)
T ss_pred c-----------------------------------------------------------------------cccccccc
Confidence 0 00011245
Q ss_pred cCCCccChhhhcCC--CCCccceeeehhhhhhhhccCCCCCCCCCchH----HHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 845 GTHEYLAPEIIKGE--GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE----TLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 845 GT~~Y~APEvL~g~--~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e----~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
|+..|+|||.+.+. .++.++|||||||++|+|++|..||....... ....+...... .+..++..+.+||.+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~ 245 (290)
T cd05613 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP--YPQEMSALAKDIIQR 245 (290)
T ss_pred CCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC--CCccCCHHHHHHHHH
Confidence 88899999999764 46789999999999999999999997543322 22222222222 234578899999999
Q ss_pred hccCCcCCcCCC-hHhHHHHHcCCCCCCCchhhhh
Q 001952 919 LLIKEPENRLGS-QKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 919 cL~~DPekRPT~-~~~aeEILkHPfF~~lnw~~lr 952 (992)
||..||++|++. ...+++++.||||+.++|..+.
T Consensus 246 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 246 LLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred HhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 999999999842 1239999999999999998774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.44 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=210.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||.|++|.||+|.+..+++.||||.+..... .......+.+|+++++.++|+||+++++++...+.+|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999998999999999865421 1233456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-CCcEEEEeccccccccCCccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-DGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||+. ++|..++.......+++..++.++.||+.||+|||++||+|+||+|+|||++. ++.+||+|||++......
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--- 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--- 156 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC---
Confidence 9995 57877776554455788899999999999999999999999999999999985 557999999987332100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|++
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (294)
T PLN00009 157 ---------------------------------------------------------------------VRTFTHEVVTL 167 (294)
T ss_pred ---------------------------------------------------------------------ccccccCceee
Confidence 00011235788
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc---------------------CCC--
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL---------------------KFP-- 903 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l---------------------k~P-- 903 (992)
.|+|||++.+. .++.++|||||||++|+|+||+.||.+....+.+.++..... .++
T Consensus 168 ~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (294)
T PLN00009 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPK 247 (294)
T ss_pred cccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCC
Confidence 99999998774 578999999999999999999999988766655554432100 000
Q ss_pred ----CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 904 ----DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 904 ----~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..+.++.+++++|.+||..+|++||+ +.++++||||..++
T Consensus 248 ~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~ 291 (294)
T PLN00009 248 DLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLG 291 (294)
T ss_pred CHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHh
Confidence 01236788999999999999999999 99999999998765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.27 Aligned_cols=253 Identities=22% Similarity=0.351 Sum_probs=210.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|+++++||+|+||.||+|.+. ++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45688999999999999999999874 45679999886432 22456788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
++|||+++++|.+++....+..+++..++.++.||+.||+|||..+++||||||+|||++.++.++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999999999887666678999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+
T Consensus 158 -----------------------------------------------------------------------~~~~~~~~~ 166 (261)
T cd05072 158 -----------------------------------------------------------------------YTAREGAKF 166 (261)
T ss_pred -----------------------------------------------------------------------eeccCCCcc
Confidence 000012235
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ .....++....++.++.+||.+||..+|
T Consensus 167 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p 245 (261)
T cd05072 167 PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYRMPRMENCPDELYDIMKTCWKEKA 245 (261)
T ss_pred ceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCCc
Confidence 678999999999889999999999999999998 99999887665555444 3445555555688999999999999999
Q ss_pred CCcCCChHhHHHHHc
Q 001952 925 ENRLGSQKGAAEIKQ 939 (992)
Q Consensus 925 ekRPT~~~~aeEILk 939 (992)
++||+ ++++++
T Consensus 246 ~~Rp~----~~~i~~ 256 (261)
T cd05072 246 EERPT----FDYLQS 256 (261)
T ss_pred ccCcC----HHHHHH
Confidence 99999 666653
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=335.59 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=201.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|.+++.||+|+||.||+|.+..++..||||++.... .......+.+|+++|+.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC--cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999999999999999986542 122233567899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. ++|..++... ...+.+..++.++.||+.||.|||..||+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 156 (291)
T cd07870 82 FEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--- 156 (291)
T ss_pred Eeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC---
Confidence 99995 6676665543 245788889999999999999999999999999999999999999999999986321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (291)
T cd07870 157 ---------------------------------------------------------------------SQTYSSEVVTL 167 (291)
T ss_pred ---------------------------------------------------------------------CCCCCCccccc
Confidence 00011234688
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhcc-----------CCC-----------
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSL-----------KFP----------- 903 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~l-----------k~P----------- 903 (992)
.|+|||++.+. .++.++|||||||+||||++|..||.+.... +.+..+..... ..+
T Consensus 168 ~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T cd07870 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCK 247 (291)
T ss_pred cccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccC
Confidence 89999998764 5788999999999999999999999865432 22222211000 000
Q ss_pred -C-------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 904 -D-------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 904 -~-------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
. ....+.++.+||.+||..||.+||+ +.|++.||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 248 PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred CcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 0 0012467889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=368.51 Aligned_cols=271 Identities=23% Similarity=0.306 Sum_probs=199.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCe-EEEEE--------------EechhHHHhhcchhHHHHHHHHHHHcCCCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNC-LFAIK--------------VMDNEFLARRKKMPRAQTEREILRMLDHPF 670 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~-~VAIK--------------vIkk~~l~~~~~~~~~~~EieILk~L~HPN 670 (992)
...++|++++.||+|+||+||+|.++.... .+++| ++.+...........+.+|+.+|+.++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 346789999999999999999997654322 22222 111111111223456789999999999999
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQL---GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~---~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d 747 (992)
|+++++++...+..|+|+|++ +++|..++.... ........++.|+.||+.||+|||++|||||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999999 556666654321 1223456788899999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhcc
Q 001952 748 GHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827 (992)
Q Consensus 748 g~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~ 827 (992)
+.+||+|||++..+...
T Consensus 304 ~~vkL~DFGla~~~~~~--------------------------------------------------------------- 320 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKE--------------------------------------------------------------- 320 (501)
T ss_pred CCEEEEeCCCceecCcc---------------------------------------------------------------
Confidence 99999999997432100
Q ss_pred CCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCC-C--CchHHHHHHHhhc----c
Q 001952 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG-S--GNEETLANVVMQS----L 900 (992)
Q Consensus 828 ~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g-~--s~~e~L~~Iv~~~----l 900 (992)
........+||+.|+|||++.+..++.++|||||||+||||++|..++.+ . .....+..++... .
T Consensus 321 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 392 (501)
T PHA03210 321 --------REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDE 392 (501)
T ss_pred --------cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChh
Confidence 00011235799999999999999999999999999999999998765432 2 2223333322210 0
Q ss_pred CCCC--------------------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhh
Q 001952 901 KFPD--------------------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 901 k~P~--------------------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr 952 (992)
.++. ...++.++.++|.+||..||.+||+ +.|+|.||||...++..+.
T Consensus 393 ~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~~~~~~~ 466 (501)
T PHA03210 393 EFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAEEEEEIL 466 (501)
T ss_pred hcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcCCchHHH
Confidence 0110 0124567788999999999999999 9999999999988766543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.98 Aligned_cols=256 Identities=22% Similarity=0.330 Sum_probs=209.7
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
..++|.+.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+++|+.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35678999999999999999998753 35789999987542 122346788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQL------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH 749 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~ 749 (992)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||.+||+||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999987542 134788899999999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCC
Q 001952 750 IMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLP 829 (992)
Q Consensus 750 VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~ 829 (992)
++|+|||++........
T Consensus 161 ~kl~d~g~~~~~~~~~~--------------------------------------------------------------- 177 (280)
T cd05049 161 VKIGDFGMSRDVYTTDY--------------------------------------------------------------- 177 (280)
T ss_pred EEECCcccceecccCcc---------------------------------------------------------------
Confidence 99999998733210000
Q ss_pred ccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccc
Q 001952 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLI 908 (992)
Q Consensus 830 ~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~v 908 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+....... ....+
T Consensus 178 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 249 (280)
T cd05049 178 -------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ-RPRTC 249 (280)
T ss_pred -------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC-CCCCC
Confidence 000112245788999999999999999999999999999998 999998887777666655443332 23458
Q ss_pred hHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
+..+.+||.+||..||++||+ +.|+++
T Consensus 250 ~~~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 250 PSEVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred CHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.47 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=207.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyL 686 (992)
.++|+..+.||+|+||.||++.+..+++.||||.+...... .....+..|+.++.++. |+||+++++++..++..++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 34677778899999999999999999999999998754222 33456788999999996 9999999999999999999
Q ss_pred EEEecCCCChHHHHH---hhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 687 VMEYCPGGDLHVLRQ---KQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 687 VmEy~~GGSL~~lLk---k~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
+|||+. ++|..+.. ......+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999984 56554432 22235689999999999999999999974 99999999999999999999999999874321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 160 ~~-------------------------------------------------------------------------~~~~~ 166 (288)
T cd06616 160 DS-------------------------------------------------------------------------IAKTR 166 (288)
T ss_pred cC-------------------------------------------------------------------------Ccccc
Confidence 00 00112
Q ss_pred cccCCCccChhhhcCC---CCCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhcc-CCC--CCccchHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGE---GHGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQSL-KFP--DSPLISFQARDL 915 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~---~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~l-k~P--~~~~vs~el~dL 915 (992)
..|+..|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+..+..... .++ ....++.++.+|
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 246 (288)
T cd06616 167 DAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNF 246 (288)
T ss_pred ccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHH
Confidence 2478889999999876 689999999999999999999999976542 122223222211 111 112478899999
Q ss_pred HHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
|.+||..||++||+ +++|++||||+...|.
T Consensus 247 i~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 247 INLCLIKDESKRPK----YKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHccCChhhCcC----HHHHhcChhhhchhhc
Confidence 99999999999999 9999999999987654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=328.90 Aligned_cols=257 Identities=27% Similarity=0.423 Sum_probs=204.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..+.+.....||+|+||.||+|.+..++..|++|.+.... ......+.+|+.+++.++|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445555568999999999999999899999999886542 2234567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-CCcEEEEeccccccccC
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCF--SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-DGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~L--se~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-dg~VKLsDFGLA~~l~~ 763 (992)
||||+++++|..++.... ..+ ++..+..++.||+.||.|||+.||+||||||+|||++. ++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999887642 334 78889999999999999999999999999999999986 67999999998633210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
. .......
T Consensus 162 ~------------------------------------------------------------------------~~~~~~~ 169 (268)
T cd06624 162 I------------------------------------------------------------------------NPCTETF 169 (268)
T ss_pred C------------------------------------------------------------------------CCccccC
Confidence 0 0001112
Q ss_pred ccCCCccChhhhcCCC--CCccceeeehhhhhhhhccCCCCCCCCCchHHH-HHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 844 VGTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL-ANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~--~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L-~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
.|+..|+|||++.+.. ++.++||||||+++|+|++|+.||......... ............+..++.++.+||.+||
T Consensus 170 ~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 249 (268)
T cd06624 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCF 249 (268)
T ss_pred CCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHc
Confidence 4788999999997654 788999999999999999999999765432221 1111111122223457889999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF 943 (992)
..+|.+||+ +.|++.||||
T Consensus 250 ~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 250 EPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred CCCchhCCC----HHHHHhCCCC
Confidence 999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=342.31 Aligned_cols=253 Identities=19% Similarity=0.307 Sum_probs=205.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeE----EEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCL----FAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~----VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
+...+|++.+.||+|+||.||+|.+..++.. ||||+++... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3457899999999999999999988666553 8999986431 123345678899999999999999999998765
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..++|+||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 5789999999999999887642 45888999999999999999999999999999999999999999999999997543
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
..... .....
T Consensus 160 ~~~~~----------------------------------------------------------------------~~~~~ 169 (316)
T cd05108 160 GADEK----------------------------------------------------------------------EYHAE 169 (316)
T ss_pred cCCCc----------------------------------------------------------------------ceecc
Confidence 21000 00001
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ +..++.....++.+..++.++.+||.+||
T Consensus 170 ~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl 248 (316)
T cd05108 170 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCW 248 (316)
T ss_pred CCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 1234678999999999999999999999999999997 999998765443 45556666666666778899999999999
Q ss_pred cCCcCCcCCChHh
Q 001952 921 IKEPENRLGSQKG 933 (992)
Q Consensus 921 ~~DPekRPT~~~~ 933 (992)
..||++||++...
T Consensus 249 ~~~p~~Rps~~~l 261 (316)
T cd05108 249 MIDADSRPKFREL 261 (316)
T ss_pred cCChhhCcCHHHH
Confidence 9999999994433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=368.98 Aligned_cols=255 Identities=30% Similarity=0.387 Sum_probs=227.0
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
..|.-++.||.|+||.||.|++..+.+.||||.+........+..+.+..|+.+|+.++|||++.+.|.|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 34677789999999999999999999999999998766566677788999999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||| -|+-.+++... .+++-+..+..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|...
T Consensus 106 EYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------- 176 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------- 176 (948)
T ss_pred HHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-------
Confidence 999 67777777654 367899999999999999999999999999999999999999999999999986221
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
...++|+|||.
T Consensus 177 ---------------------------------------------------------------------~PAnsFvGTPy 187 (948)
T KOG0577|consen 177 ---------------------------------------------------------------------APANSFVGTPY 187 (948)
T ss_pred ---------------------------------------------------------------------CchhcccCCcc
Confidence 11356899999
Q ss_pred ccChhhhcC---CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 849 YLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 849 Y~APEvL~g---~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|||||+|.. +.|+-++||||||++..||.-.++|++.++.+-.+.-|..+....-.....++.++.|+..||.+-|.
T Consensus 188 wMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipq 267 (948)
T KOG0577|consen 188 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQ 267 (948)
T ss_pred ccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcc
Confidence 999999974 56899999999999999999999999999999888888776655555567899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ 945 (992)
+||| .+++|+|+|...
T Consensus 268 eRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 268 ERPT----SEELLKHRFVLR 283 (948)
T ss_pred cCCc----HHHHhhcchhcc
Confidence 9999 999999999865
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.81 Aligned_cols=257 Identities=30% Similarity=0.448 Sum_probs=213.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
+.|.....||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 34555677999999999999998899999999986532 223456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---- 171 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---- 171 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc----
Confidence 99999999998754 45889999999999999999999999999999999999999999999999986321100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........|+..
T Consensus 172 --------------------------------------------------------------------~~~~~~~~~~~~ 183 (292)
T cd06658 172 --------------------------------------------------------------------VPKRKSLVGTPY 183 (292)
T ss_pred --------------------------------------------------------------------cccCceeecCcc
Confidence 000112458899
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-cCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-LKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
|+|||++.+..++.++|||||||++|||++|+.||.+......+..+.... ..++....++..+.+||.+||..||.+|
T Consensus 184 y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 263 (292)
T cd06658 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQR 263 (292)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHC
Confidence 999999999889999999999999999999999998876665554433221 1222333477889999999999999999
Q ss_pred CCChHhHHHHHcCCCCCCCc
Q 001952 928 LGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~ln 947 (992)
|+ ++++++||||....
T Consensus 264 pt----~~~il~~~~~~~~~ 279 (292)
T cd06658 264 AT----AQELLQHPFLKLAG 279 (292)
T ss_pred cC----HHHHhhChhhhccC
Confidence 99 99999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.04 Aligned_cols=247 Identities=29% Similarity=0.457 Sum_probs=216.8
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.+++.++...-++-||.|+.|.||+|++ .++.||||.++.- -..+|..|++|+|+||+.|.|+|....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCc
Confidence 4556666667778899999999999998 5678999988632 134788899999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|||||||..|-|..+++.. ..+.......|..+|+.|+.|||.++|||||||.-||||..+..|||+|||-++.+.
T Consensus 186 cyCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 999999999999999999874 778999999999999999999999999999999999999999999999999864321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
. ......
T Consensus 264 ~-------------------------------------------------------------------------~STkMS 270 (904)
T KOG4721|consen 264 D-------------------------------------------------------------------------KSTKMS 270 (904)
T ss_pred h-------------------------------------------------------------------------hhhhhh
Confidence 0 001235
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
|.||..|||||+|...+.+.++|||||||+|||||||..||.+.+...++--+-.+.+.+|.+..+++.++-||+.||.-
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 78999999999999999999999999999999999999999987776666566667788898889999999999999999
Q ss_pred CcCCcCCChHhHHHHHcC
Q 001952 923 EPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 923 DPekRPT~~~~aeEILkH 940 (992)
.|.+||+ +.+||.|
T Consensus 351 KpRNRPS----Frqil~H 364 (904)
T KOG4721|consen 351 KPRNRPS----FRQILLH 364 (904)
T ss_pred CCCCCcc----HHHHHHH
Confidence 9999999 8888887
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=329.63 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=206.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||||.+.............+.+|+++|+.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999886432222334456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 689 EYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||+++++|..++.... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-- 159 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch--
Confidence 9999999998876422 245789999999999999999999999999999999999999999999999986432100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........|+
T Consensus 160 ----------------------------------------------------------------------~~~~~~~~~~ 169 (267)
T cd08228 160 ----------------------------------------------------------------------TTAAHSLVGT 169 (267)
T ss_pred ----------------------------------------------------------------------hHHHhcCCCC
Confidence 0001123578
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhccCCCC-CccchHHHHHHHHHhccCCc
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQSLKFPD-SPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~lk~P~-~~~vs~el~dLI~kcL~~DP 924 (992)
..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+...+......+. ...++.++.+||.+||..+|
T Consensus 170 ~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 249 (267)
T cd08228 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDP 249 (267)
T ss_pred ccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCc
Confidence 889999999998899999999999999999999999975432 2223232222222221 12467889999999999999
Q ss_pred CCcCCChHhHHHHHc
Q 001952 925 ENRLGSQKGAAEIKQ 939 (992)
Q Consensus 925 ekRPT~~~~aeEILk 939 (992)
++||+ +.++++
T Consensus 250 ~~Rp~----~~~vl~ 260 (267)
T cd08228 250 DQRPD----IGYVHQ 260 (267)
T ss_pred ccCcC----HHHHHH
Confidence 99999 888876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=329.72 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=201.1
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccC--CeEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSD--NLSCLV 687 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~--~~lyLV 687 (992)
|++++.||+|+||.||+|.+..++..||+|+++.... ........+|+.++.++. |+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999875421 112223457888888885 99999999999877 899999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. ++|.+++... ...+++..++.++.||+.||+|||..||+||||+|+|||++. +.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 79 FELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred EecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 99996 5777776653 246899999999999999999999999999999999999999 99999999986332100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......++.
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~~~ 162 (282)
T cd07831 153 ----------------------------------------------------------------------PPYTEYISTR 162 (282)
T ss_pred ----------------------------------------------------------------------CCcCCCCCCc
Confidence 0011234788
Q ss_pred CccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc------------------cCCCC----
Q 001952 848 EYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS------------------LKFPD---- 904 (992)
Q Consensus 848 ~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~------------------lk~P~---- 904 (992)
.|+|||++.. ..++.++|||||||++|||++|..||.+.+..+.+..+.... ..++.
T Consensus 163 ~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (282)
T cd07831 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGT 242 (282)
T ss_pred ccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccc
Confidence 8999998755 456889999999999999999999998877665554443211 01111
Q ss_pred -----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 -----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 -----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...++.++.+||.+||..+|++||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 243 GLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred cHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 1235789999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=330.91 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=207.9
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||.|++|.||+|.+..++..||||+++... .......+.+|+++++.++|+||+++++++...+..|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccc--cccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 5899999999999999999999999999999987542 12234566789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 690 YCPGGDLHVLRQKQL-GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 690 y~~GGSL~~lLkk~~-~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|+++ +|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~---- 153 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP---- 153 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC----
Confidence 9975 7877776532 245899999999999999999999999999999999999999999999999986322100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........++..
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~~~~ 165 (284)
T cd07836 154 --------------------------------------------------------------------VNTFSNEVVTLW 165 (284)
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 000112346788
Q ss_pred ccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc------------------CCCC-----
Q 001952 849 YLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL------------------KFPD----- 904 (992)
Q Consensus 849 Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l------------------k~P~----- 904 (992)
|++||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+..... .++.
T Consensus 166 y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (284)
T cd07836 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQD 245 (284)
T ss_pred ccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHH
Confidence 9999998765 468999999999999999999999998777666555432110 0000
Q ss_pred ----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+.++.++.++|.+||+.||++||+ +.++++||||
T Consensus 246 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 246 LQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred HHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 0134678899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.45 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=212.8
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
...+|++++.||.|+||.||+|.+.. +..+++|++.... ......+..|+.+|+.++|+||+++++++...+..|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34679999999999999999999977 8889999987542 2234567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++....+..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 9999999999999987666778999999999999999999999999999999999999999999999999873321000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.......++
T Consensus 159 -----------------------------------------------------------------------~~~~~~~~~ 167 (261)
T cd05148 159 -----------------------------------------------------------------------YLSSDKKIP 167 (261)
T ss_pred -----------------------------------------------------------------------ccccCCCCc
Confidence 000112356
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|++||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+. .....+.+..++..+.++|.+||..||.
T Consensus 168 ~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 246 (261)
T cd05148 168 YKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIYKIMLECWAAEPE 246 (261)
T ss_pred eEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHHHHHHHHcCCCch
Confidence 78999999998889999999999999999998 899998877777766655 4445555567889999999999999999
Q ss_pred CcCCChHhHHHHHc
Q 001952 926 NRLGSQKGAAEIKQ 939 (992)
Q Consensus 926 kRPT~~~~aeEILk 939 (992)
+||+ +.+|++
T Consensus 247 ~Rpt----~~~l~~ 256 (261)
T cd05148 247 DRPS----FKALRE 256 (261)
T ss_pred hCcC----HHHHHH
Confidence 9999 555553
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=335.79 Aligned_cols=260 Identities=27% Similarity=0.368 Sum_probs=202.8
Q ss_pred CceEEEEEccCCceEEEEEEEcC--CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--CeEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIG--TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--NLSC 685 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~--tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~~ly 685 (992)
+|.+.+.||+|+||.||+|.+.. +++.||||++.............+.+|+.+++.++||||+++++++... +.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 7899999999764322233446678899999999999999999999887 8899
Q ss_pred EEEEecCCCChHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc----CCcEEEEecccc
Q 001952 686 LVMEYCPGGDLHVLRQKQL---GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE----DGHIMLTDFDLS 758 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~---~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~----dg~VKLsDFGLA 758 (992)
|||||+++ +|..++.... ...+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 6666554322 236889999999999999999999999999999999999999 899999999987
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+..... ...
T Consensus 160 ~~~~~~~~---------------------------------------------------------------------~~~ 170 (316)
T cd07842 160 RLFNAPLK---------------------------------------------------------------------PLA 170 (316)
T ss_pred cccCCCcc---------------------------------------------------------------------ccc
Confidence 43211000 000
Q ss_pred CcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchH---------HHHHHHhh----------
Q 001952 839 RSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE---------TLANVVMQ---------- 898 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e---------~L~~Iv~~---------- 898 (992)
......++..|+|||++.+. .++.++|||||||+||||++|+.||.+..... .+..++..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 250 (316)
T cd07842 171 DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWP 250 (316)
T ss_pred ccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHH
Confidence 11234678899999998774 57899999999999999999999998654322 11111110
Q ss_pred ----------------ccCCCC---------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 899 ----------------SLKFPD---------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 899 ----------------~lk~P~---------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...++. ....+.++.++|.+||..||++||+ +.|+++||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 251 DIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred HHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 001110 0035567899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=335.01 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=214.5
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
..|+.++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++|+||+++++++..++.+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357788899999999999999998999999999874321 233467888999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++|++|.+++.. ..+++..+..++.|++.||+|||..+++|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~---- 154 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---- 154 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC----
Confidence 99999999998865 45889999999999999999999999999999999999999999999999987332100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........++..
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~~~~ 166 (277)
T cd06640 155 --------------------------------------------------------------------QIKRNTFVGTPF 166 (277)
T ss_pred --------------------------------------------------------------------ccccccccCccc
Confidence 000112357888
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|+|||++.+..++.++|+|||||++|||++|..||...........+. ..........++..+.+||.+||..+|++||
T Consensus 167 y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 245 (277)
T cd06640 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTLTGEFSKPFKEFIDACLNKDPSFRP 245 (277)
T ss_pred ccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-cCCCCCCchhhhHHHHHHHHHHcccCcccCc
Confidence 999999999889999999999999999999999998766554443332 2222222334778899999999999999999
Q ss_pred CChHhHHHHHcCCCCCCCc
Q 001952 929 GSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~ln 947 (992)
+ +.+++.|+||....
T Consensus 246 ~----~~~il~~~~~~~~~ 260 (277)
T cd06640 246 T----AKELLKHKFIVKNA 260 (277)
T ss_pred C----HHHHHhChHhhhcc
Confidence 9 99999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=326.84 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=206.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+++|+.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4679999999999999999998754 4579999886432 2234678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc--
Confidence 99999999999887543 458899999999999999999999999999999999999999999999999863321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (256)
T cd05114 155 ---------------------------------------------------------------------YTSSSGAKFPV 165 (256)
T ss_pred ---------------------------------------------------------------------eeccCCCCCch
Confidence 00001123566
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+... .....+...+.++.+||.+||..+|++
T Consensus 166 ~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~li~~c~~~~p~~ 244 (256)
T cd05114 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG-FRLYRPKLASMTVYEVMYSCWHEKPEG 244 (256)
T ss_pred hhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHccCCccc
Confidence 7999999998889999999999999999999 99999888777776666543 233334457889999999999999999
Q ss_pred cCCChHhHHHHHc
Q 001952 927 RLGSQKGAAEIKQ 939 (992)
Q Consensus 927 RPT~~~~aeEILk 939 (992)
||+ +.+|++
T Consensus 245 Rps----~~~l~~ 253 (256)
T cd05114 245 RPT----FAELLR 253 (256)
T ss_pred CcC----HHHHHH
Confidence 999 777764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=343.61 Aligned_cols=261 Identities=27% Similarity=0.389 Sum_probs=206.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----C
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-----N 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-----~ 682 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++... ........+..|+.+|+.++|+||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 36899999999999999999999999999999998642 1223345677899999999999999999986543 4
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 6899999995 577777654 468999999999999999999999999999999999999999999999999874321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... .......
T Consensus 158 ~~~~---------------------------------------------------------------------~~~~~~~ 168 (336)
T cd07849 158 PEHD---------------------------------------------------------------------HTGFLTE 168 (336)
T ss_pred cccc---------------------------------------------------------------------ccCCcCC
Confidence 0000 0001122
Q ss_pred cccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc----------------------
Q 001952 843 FVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS---------------------- 899 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~---------------------- 899 (992)
..||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (336)
T cd07849 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKS 248 (336)
T ss_pred cCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhh
Confidence 468899999998765 468999999999999999999999998765443333221100
Q ss_pred cCC----C---CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 900 LKF----P---DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 900 lk~----P---~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
... + ..+.++.++.+||.+||..||++||+ +.|+++||||..+-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~~ 299 (336)
T cd07849 249 LPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQYH 299 (336)
T ss_pred cCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHHhcCccccccC
Confidence 000 0 01235678999999999999999999 99999999999763
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=349.36 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=209.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
++..++|++.+.||+|+||.||+|.+.+ +++.||+|+++... .......+..|++++.++ +|+||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3456789999999999999999997544 35789999987432 122345677899999999 899999999987
Q ss_pred cc-CCeEEEEEEecCCCChHHHHHhhcC----------------------------------------------------
Q 001952 679 TS-DNLSCLVMEYCPGGDLHVLRQKQLG---------------------------------------------------- 705 (992)
Q Consensus 679 ~~-~~~lyLVmEy~~GGSL~~lLkk~~~---------------------------------------------------- 705 (992)
.. +..++++|||+++++|..++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 5678999999999999988764321
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCc
Q 001952 706 -------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPAR 778 (992)
Q Consensus 706 -------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r 778 (992)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~------------ 228 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------------ 228 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcc------------
Confidence 2578999999999999999999999999999999999999999999999999744311000
Q ss_pred cCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC
Q 001952 779 VSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE 858 (992)
Q Consensus 779 ~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~ 858 (992)
........++..|+|||++.+.
T Consensus 229 ----------------------------------------------------------~~~~~~~~~~~~y~aPE~~~~~ 250 (337)
T cd05054 229 ----------------------------------------------------------YVRKGDARLPLKWMAPESIFDK 250 (337)
T ss_pred ----------------------------------------------------------hhhccCCCCCccccCcHHhcCC
Confidence 0001123456789999999999
Q ss_pred CCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHH
Q 001952 859 GHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEI 937 (992)
Q Consensus 859 ~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEI 937 (992)
.++.++|||||||+||||++ |..||.+....+.+...+........+..++.++.+|+.+||+.+|++||+ +.||
T Consensus 251 ~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~el 326 (337)
T cd05054 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT----FSEL 326 (337)
T ss_pred CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC----HHHH
Confidence 99999999999999999997 999998866656665555555444444567889999999999999999999 8888
Q ss_pred HcC
Q 001952 938 KQH 940 (992)
Q Consensus 938 LkH 940 (992)
++|
T Consensus 327 l~~ 329 (337)
T cd05054 327 VEI 329 (337)
T ss_pred HHH
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=333.41 Aligned_cols=261 Identities=28% Similarity=0.398 Sum_probs=203.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----- 682 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+++++.++||||+++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4689999999999999999999999999999999864321 1122334567999999999999999999886543
Q ss_pred ---eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 683 ---LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 683 ---~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
..|+||||+. ++|..++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999995 5787776653 3468999999999999999999999999999999999999999999999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+...... ....
T Consensus 168 ~~~~~~~~--------------------------------------------------------------------~~~~ 179 (310)
T cd07865 168 AFSLSKNS--------------------------------------------------------------------KPNR 179 (310)
T ss_pred cccCCccc--------------------------------------------------------------------CCCC
Confidence 33110000 0000
Q ss_pred cCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------
Q 001952 840 SNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS------------------- 899 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~------------------- 899 (992)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+..-.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (310)
T cd07865 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKK 259 (310)
T ss_pred ccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhh
Confidence 12245788999999987754 6889999999999999999999998776554433222110
Q ss_pred cCCCCC-----------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 900 LKFPDS-----------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 900 lk~P~~-----------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
..++.. ...+..+.+||.+||..||++||+ ++|+|+||||
T Consensus 260 ~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 260 MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred ccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 001110 012456789999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=338.84 Aligned_cols=258 Identities=28% Similarity=0.402 Sum_probs=213.4
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|...+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+++++.++|+||+++++++...+.+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4666778999999999999998899999999987442 12234578899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|..++.. ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT----- 154 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc-----
Confidence 9999999988764 46899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~~~y 167 (277)
T cd06642 155 -------------------------------------------------------------------QIKRNTFVGTPFW 167 (277)
T ss_pred -------------------------------------------------------------------chhhhcccCcccc
Confidence 0001123578889
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
+|||++.+..++.++|||||||++|||++|+.||...........+.... .......++.++.+||.+||..+|++||+
T Consensus 168 ~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 246 (277)
T cd06642 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS-PPTLEGQYSKPFKEFVEACLNKDPRFRPT 246 (277)
T ss_pred cCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC-CCCCCcccCHHHHHHHHHHccCCcccCcC
Confidence 99999999989999999999999999999999997665554444332222 11122346788999999999999999999
Q ss_pred ChHhHHHHHcCCCCCCCchh
Q 001952 930 SQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 930 ~~~~aeEILkHPfF~~lnw~ 949 (992)
+.++++||||..+.+.
T Consensus 247 ----~~~il~~~~~~~~~~~ 262 (277)
T cd06642 247 ----AKELLKHKFITRYTKK 262 (277)
T ss_pred ----HHHHHHhHHHHHHhhh
Confidence 9999999999876543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=327.05 Aligned_cols=259 Identities=26% Similarity=0.396 Sum_probs=213.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhH--HHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--CeE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF--LARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--NLS 684 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~--l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~~l 684 (992)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... .........+.+|+++++.++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47899999999999999999999999999999875321 11223456788999999999999999999998653 568
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999988764 45889999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ..........
T Consensus 160 ~---------------------------------------------------------------------~~~~~~~~~~ 170 (264)
T cd06653 160 C---------------------------------------------------------------------MSGTGIKSVT 170 (264)
T ss_pred c---------------------------------------------------------------------ccCccccccC
Confidence 0 0000112345
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.........+..++..+.++|.+||. +|
T Consensus 171 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~ 249 (264)
T cd06653 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EE 249 (264)
T ss_pred CcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-Cc
Confidence 88999999999998899999999999999999999999988766666655554433333445688999999999999 57
Q ss_pred CCcCCChHhHHHHHcCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF 943 (992)
..||+ +.+++.|||.
T Consensus 250 ~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 250 KRRPT----AEFLLRHPFV 264 (264)
T ss_pred ccCcc----HHHHhcCCCC
Confidence 99999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.35 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=208.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--CeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--NLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~~ly 685 (992)
.++|++.+.||.|+||.||+|.+..+++.+++|.++..... ......+.+|+++++.++||||+++++++... +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 45799999999999999999999989999999999754322 22334567899999999999999999998877 8999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||||+. ++|..++.... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999996 58988877642 468999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.......+
T Consensus 161 ------------------------------------------------------------------------~~~~~~~~ 168 (293)
T cd07843 161 ------------------------------------------------------------------------KPYTQLVV 168 (293)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00112346
Q ss_pred CCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-----------------------
Q 001952 846 THEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK----------------------- 901 (992)
Q Consensus 846 T~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk----------------------- 901 (992)
++.|+|||++.+.. ++.++|||||||++|||++|..||......+.+..+......
T Consensus 169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (293)
T cd07843 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248 (293)
T ss_pred cccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccc
Confidence 78899999987654 689999999999999999999999887766655544321100
Q ss_pred ------CCCCcc-chHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 902 ------FPDSPL-ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 902 ------~P~~~~-vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...... ++..+.+||.+||..||++||+ +.|+|.||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred cchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 000111 4778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=329.23 Aligned_cols=258 Identities=21% Similarity=0.278 Sum_probs=209.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC-----CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t-----g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
++..++|.+.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|+.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 34567899999999999999999988643 3789999986442 1122346788999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQL--------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~--------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
.....|+||||+++++|..++.... ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999886532 12467889999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++..+.....
T Consensus 160 l~dfg~~~~~~~~~~----------------------------------------------------------------- 174 (277)
T cd05032 160 IGDFGMTRDIYETDY----------------------------------------------------------------- 174 (277)
T ss_pred ECCcccchhhccCcc-----------------------------------------------------------------
Confidence 999998743210000
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.+..+. .....+.+..++.
T Consensus 175 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 248 (277)
T cd05032 175 -----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGGHLDLPENCPD 248 (277)
T ss_pred -----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCCCCCCCCCCCH
Confidence 000112346778999999998889999999999999999998 999998876666555554 3333334445789
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
++.+||.+||..+|++||+ +.+|+.
T Consensus 249 ~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 249 KLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred HHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 9999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=320.62 Aligned_cols=256 Identities=33% Similarity=0.548 Sum_probs=217.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|.+.+.||.|+||.||++.+..++..|++|++...... ......+..|+++++.++|+|++++++.+...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 588999999999999999999988999999999754321 2344567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 690 YCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 690 y~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|+++++|.+++.... +..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999887653 4678999999999999999999999999999999999999999999999999863321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......|++
T Consensus 158 ----------------------------------------------------------------------~~~~~~~~~~ 167 (258)
T cd08215 158 ----------------------------------------------------------------------DLAKTVVGTP 167 (258)
T ss_pred ----------------------------------------------------------------------ceecceeeee
Confidence 0011235788
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+.... ..+.+..++.++.++|.+||..+|++|
T Consensus 168 ~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R 246 (258)
T cd08215 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEER 246 (258)
T ss_pred cccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 8999999999889999999999999999999999998776655555554433 223334688899999999999999999
Q ss_pred CCChHhHHHHHcCCCC
Q 001952 928 LGSQKGAAEIKQHPFF 943 (992)
Q Consensus 928 PT~~~~aeEILkHPfF 943 (992)
|+ +.++|+||||
T Consensus 247 p~----~~~ll~~~~~ 258 (258)
T cd08215 247 PS----IAQILQSPFI 258 (258)
T ss_pred cC----HHHHhcCCCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=332.10 Aligned_cols=258 Identities=20% Similarity=0.273 Sum_probs=207.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
+..++|++.+.||+|+||.||+|.+.+ .+..||||++.... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998753 35679999986431 11223457889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcC--------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEE
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLG--------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML 752 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~--------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKL 752 (992)
....++||||+++++|.+++..... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999999875321 23567889999999999999999999999999999999999999999
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++..+......
T Consensus 161 ~dfg~~~~~~~~~~~----------------------------------------------------------------- 175 (277)
T cd05062 161 GDFGMTRDIYETDYY----------------------------------------------------------------- 175 (277)
T ss_pred CCCCCccccCCccee-----------------------------------------------------------------
Confidence 999987432110000
Q ss_pred cCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHH
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQ 911 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~e 911 (992)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+..... .+....++..
T Consensus 176 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 249 (277)
T cd05062 176 -----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL-LDKPDNCPDM 249 (277)
T ss_pred -----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCCHH
Confidence 00011245678999999999889999999999999999999 7899988776666655554432 2333457889
Q ss_pred HHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.+||.+||..||++||+ +.|++++
T Consensus 250 ~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 250 LFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred HHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 999999999999999999 7777754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.64 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=210.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC---CCCccceeeeeccCCeEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD---HPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~---HPNIVkL~g~f~~~~~lyL 686 (992)
.|++.+.||+|+||.||+|.+..+++.||+|+++... .......+.+|+.+++.++ |+||+++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4778889999999999999999999999999986532 2233456788999999986 9999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 80 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 154 (277)
T cd06917 80 IMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-- 154 (277)
T ss_pred EEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC--
Confidence 9999999999998865 36899999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........|+
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (277)
T cd06917 155 ----------------------------------------------------------------------SSKRSTFVGT 164 (277)
T ss_pred ----------------------------------------------------------------------ccccccccCC
Confidence 0001123588
Q ss_pred CCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|+|||++.+. .++.++|+|||||++|+|++|..||.+.........+............++.++.+||.+||..||+
T Consensus 165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 244 (277)
T cd06917 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPK 244 (277)
T ss_pred cceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcc
Confidence 899999998754 4689999999999999999999999876554433322211111111112678999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCc
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ln 947 (992)
+||+ +.+++.|+||+...
T Consensus 245 ~R~~----~~~il~~~~~~~~~ 262 (277)
T cd06917 245 ERLS----AEELLKSKWIKAHS 262 (277)
T ss_pred cCcC----HHHHhhChHhhccc
Confidence 9999 99999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.68 Aligned_cols=258 Identities=29% Similarity=0.463 Sum_probs=215.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|.+.+.||+|+||.||++.+..++..|++|.+... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 46899999999999999999998888899999998643 222345678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|..++.. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 95 ~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--- 168 (293)
T cd06647 95 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 168 (293)
T ss_pred EecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc---
Confidence 999999999999875 35789999999999999999999999999999999999999999999999986322100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|++
T Consensus 169 ---------------------------------------------------------------------~~~~~~~~~~~ 179 (293)
T cd06647 169 ---------------------------------------------------------------------QSKRSTMVGTP 179 (293)
T ss_pred ---------------------------------------------------------------------ccccccccCCh
Confidence 00011235888
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh-hccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM-QSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~-~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|++||++.+..++.++|||||||++|+|++|+.||...+..+.+..+.. ....++....++..+.+||.+||..+|++
T Consensus 180 ~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~ 259 (293)
T cd06647 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 259 (293)
T ss_pred hhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 99999999988899999999999999999999999987665544433322 22233334457788999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCc
Q 001952 927 RLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ln 947 (992)
||+ +.+++.|+||+..+
T Consensus 260 Rp~----~~~il~h~~~~~~~ 276 (293)
T cd06647 260 RGS----AKELLQHPFLKIAK 276 (293)
T ss_pred CcC----HHHHhcCHHHhcCc
Confidence 999 99999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.95 Aligned_cols=268 Identities=41% Similarity=0.780 Sum_probs=215.6
Q ss_pred CceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHH-hhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLA-RRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~-~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+|++.+.||+|+||.||++.+. .+++.||||++++.... .......+..|+.++..+ +|+||+++++.+..++.+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4888999999999999999864 35688999999754332 223345678899999999 699999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+.+++|..++... ..+++..++.++.|++.||.|||..|++||||+|+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999887754 56889999999999999999999999999999999999999999999999986332100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.........
T Consensus 159 -----------------------------------------------------------------------~~~~~~~~~ 167 (288)
T cd05583 159 -----------------------------------------------------------------------EEERAYSFC 167 (288)
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 000011235
Q ss_pred cCCCccChhhhcCCC--CCccceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 845 GTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 845 GT~~Y~APEvL~g~~--~s~kSDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
|+..|++||.+.+.. ++.++||||||+++|||++|..||...... +....+.... .+.+..++..+.+||.+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 245 (288)
T cd05583 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK--PPFPKTMSAEARDFIQK 245 (288)
T ss_pred CCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--CCCCcccCHHHHHHHHH
Confidence 788999999998765 688999999999999999999999654322 2222222222 23334578899999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhc
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
||..||++||++ ..+.++|+||||+.++|+.+..
T Consensus 246 ~l~~~p~~R~t~-~~~~~~l~~~~~~~~~~~~~~~ 279 (288)
T cd05583 246 LLEKDPKKRLGA-NGADEIKNHPFFQGIDWDDLAA 279 (288)
T ss_pred HhcCCHhhccCc-chHHHHhcCcccccCCHHHHhh
Confidence 999999999983 4578899999999999987743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=332.51 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=207.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEc----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELI----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.+++|++.+.||+|+||.||+|.+. ..+..|++|.+.... .......+.+|+++++.++|+||+++++++..++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 355789999987432 2233456788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhc---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQL---------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~---------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d 747 (992)
..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999885321 1247788899999999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhcc
Q 001952 748 GHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827 (992)
Q Consensus 748 g~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~ 827 (992)
+.++|+|||++........
T Consensus 161 ~~~kl~dfg~~~~~~~~~~------------------------------------------------------------- 179 (283)
T cd05090 161 LHVKISDLGLSREIYSADY------------------------------------------------------------- 179 (283)
T ss_pred CcEEeccccccccccCCcc-------------------------------------------------------------
Confidence 9999999999743211000
Q ss_pred CCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCc
Q 001952 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSP 906 (992)
Q Consensus 828 ~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~ 906 (992)
........++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.... +.....++.+.
T Consensus 180 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~ 249 (283)
T cd05090 180 ---------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-VRKRQLLPCSE 249 (283)
T ss_pred ---------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCcCCCCC
Confidence 000112335678999999998889999999999999999998 9999988765444443 33444445555
Q ss_pred cchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 907 LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 907 ~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.++.++.+||.+||..||++||+ +.+|+++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 250 DCPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred CCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 68899999999999999999999 6776654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=331.08 Aligned_cols=255 Identities=29% Similarity=0.431 Sum_probs=208.7
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
|++.+.||.|++|.||+|.+..+|..||||++..... .......+.+|+++++.++|+||+++++++..++..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6778899999999999999998999999999875421 122335678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+ +++|..++.......+++..++.++.||+.||+|||+++++|+||+|+|||++.++.++|+|||++..+...
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~------ 152 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP------ 152 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC------
Confidence 9 578998887764456899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
........++..|+
T Consensus 153 ------------------------------------------------------------------~~~~~~~~~~~~~~ 166 (283)
T cd07835 153 ------------------------------------------------------------------VRTYTHEVVTLWYR 166 (283)
T ss_pred ------------------------------------------------------------------ccccCccccccCCC
Confidence 00011224678899
Q ss_pred ChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC------------------CC--------
Q 001952 851 APEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK------------------FP-------- 903 (992)
Q Consensus 851 APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk------------------~P-------- 903 (992)
|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..++..... ++
T Consensus 167 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T cd07835 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS 246 (283)
T ss_pred CCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchh
Confidence 99988765 4688999999999999999999999887766555544332100 00
Q ss_pred -CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 904 -DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 904 -~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
....++.++.+||.+||+.||.+||+ +.|++.||||
T Consensus 247 ~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 247 KVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred hhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 11346688999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=356.49 Aligned_cols=259 Identities=28% Similarity=0.311 Sum_probs=201.6
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.....+++|...+.||+|+||.||+|...++ ..||||.+...... . ..+|.+|+++|.+++|||+|+|+|||.+.+
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~ 144 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQ--G-EREFLNEVEILSRLRHPNLVKLLGYCLEGG 144 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCc--c-hhHHHHHHHHHhcCCCcCcccEEEEEecCC
Confidence 3344568899889999999999999988544 88999988754211 1 455999999999999999999999999988
Q ss_pred -eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeeeecCCceEEEccCCcEEEEecccc
Q 001952 683 -LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG---VIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 683 -~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G---IIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+.+||||||++|+|.+++.......++|..+++|+.+++.||+|||... |||||||++|||||.+..+||+|||+|
T Consensus 145 ~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa 224 (361)
T KOG1187|consen 145 EHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLA 224 (361)
T ss_pred ceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCc
Confidence 5999999999999999988754328899999999999999999999854 999999999999999999999999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
+..... ..
T Consensus 225 ~~~~~~------------------------------------------------------------------------~~ 232 (361)
T KOG1187|consen 225 KLGPEG------------------------------------------------------------------------DT 232 (361)
T ss_pred ccCCcc------------------------------------------------------------------------cc
Confidence 321100 00
Q ss_pred CcCcc-ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC--chHHHHHH-------------HhhccCC
Q 001952 839 RSNSF-VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG--NEETLANV-------------VMQSLKF 902 (992)
Q Consensus 839 ~s~s~-vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s--~~e~L~~I-------------v~~~lk~ 902 (992)
..... .||.+|++||++..+..+.++|||||||+|+||+||+.+..... ....+..+ ++..+..
T Consensus 233 ~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~ 312 (361)
T KOG1187|consen 233 SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE 312 (361)
T ss_pred ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC
Confidence 00111 69999999999999889999999999999999999998887432 11112221 1111110
Q ss_pred CCCc--cchHHHHHHHHHhccCCcCCcCCChHhHHHH
Q 001952 903 PDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEI 937 (992)
Q Consensus 903 P~~~--~vs~el~dLI~kcL~~DPekRPT~~~~aeEI 937 (992)
.... ..-..+..+...|+..+|.+||+|.+++.++
T Consensus 313 ~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 313 GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 0100 1122466899999999999999987766555
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=338.73 Aligned_cols=257 Identities=30% Similarity=0.380 Sum_probs=210.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
...|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+++++.++||||+++++++..++..|||
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45699999999999999999999989999999998643222233345678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. |+|.+++... ...+++..+..++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 94 MEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred HHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 99996 5666665533 24689999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.....|++
T Consensus 168 ------------------------------------------------------------------------~~~~~~~~ 175 (307)
T cd06607 168 ------------------------------------------------------------------------ANSFVGTP 175 (307)
T ss_pred ------------------------------------------------------------------------CCCccCCc
Confidence 01234778
Q ss_pred CccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 848 EYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 848 ~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
.|+|||++. ...++.++||||||+++|||++|..||.+.+.......+............++.++.+||.+||..||
T Consensus 176 ~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 255 (307)
T cd06607 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIP 255 (307)
T ss_pred cccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCCh
Confidence 899999985 34578899999999999999999999987766555544433322221223467889999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~l 946 (992)
++||+ +.+|+.||||...
T Consensus 256 ~~Rp~----~~~il~~~~~~~~ 273 (307)
T cd06607 256 QDRPS----SEELLKHRFVLRE 273 (307)
T ss_pred hhCcC----HHHHhcChhhccc
Confidence 99999 9999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=331.15 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=209.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC-----CeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t-----g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
.+..++|++.+.||+|+||.||++.+... ...+|+|.+..... ......+.+|+++++.+ +|+||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34567899999999999999999988644 37899999875421 22345678899999999 899999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQ--------------LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV 744 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~--------------~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL 744 (992)
..++.+|++|||+++++|..++... ....+++..++.++.||+.||+|||+.||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999998652 23568899999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhh
Q 001952 745 REDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQ 824 (992)
Q Consensus 745 d~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~ 824 (992)
+.++.++|+|||++..+.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~---------------------------------------------------------- 187 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDY---------------------------------------------------------- 187 (293)
T ss_pred cCCCeEEeCccccccccccccc----------------------------------------------------------
Confidence 9999999999999743211000
Q ss_pred hccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCC
Q 001952 825 IRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFP 903 (992)
Q Consensus 825 i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P 903 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+ .......
T Consensus 188 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~ 254 (293)
T cd05053 188 ------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-KEGYRME 254 (293)
T ss_pred ------------eeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCC
Confidence 000001124567999999999999999999999999999997 99999887665555444 3444444
Q ss_pred CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 904 DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 904 ~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+..++.++.+||.+||..||++||+ +.|++++
T Consensus 255 ~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 255 KPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 44567889999999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=327.85 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=205.3
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||.|+||.||+|.+..+++.|+||.+.............+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57888999999999999999998899999999886543333344567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 689 EYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||+++++|..++.... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 9999999999886422 346899999999999999999999999999999999999999999999999986322100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........|+
T Consensus 160 ----------------------------------------------------------------------~~~~~~~~~~ 169 (267)
T cd08229 160 ----------------------------------------------------------------------TTAAHSLVGT 169 (267)
T ss_pred ----------------------------------------------------------------------CcccccccCC
Confidence 0001123578
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch--HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE--ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~--e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
..|+|||++.+..++.++||||||+++|||++|..||.+.... .....+............++..+.+||.+||..||
T Consensus 170 ~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 249 (267)
T cd08229 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP 249 (267)
T ss_pred cCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCc
Confidence 8999999999988999999999999999999999999765432 22222222111111123478899999999999999
Q ss_pred CCcCCChHhHHHHH
Q 001952 925 ENRLGSQKGAAEIK 938 (992)
Q Consensus 925 ekRPT~~~~aeEIL 938 (992)
++||+ +.+|+
T Consensus 250 ~~Rpt----~~~i~ 259 (267)
T cd08229 250 EKRPD----ITYVY 259 (267)
T ss_pred ccCCC----HHHHH
Confidence 99999 55544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.59 Aligned_cols=257 Identities=33% Similarity=0.496 Sum_probs=213.3
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--CeEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--NLSCLV 687 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~~lyLV 687 (992)
+|.+.+.||+|++|.||+|.+..++..|++|++...... ......+.+|++++++++|+||+++++.+... +.+++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 478889999999999999999989999999998754321 24467788999999999999999999999988 899999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET- 156 (260)
T ss_pred EEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc-
Confidence 9999999999998875 3789999999999999999999999999999999999999999999999998743311000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~~~~ 167 (260)
T cd06606 157 ---------------------------------------------------------------------GEGTGSVRGTP 167 (260)
T ss_pred ---------------------------------------------------------------------cccccCCCCCc
Confidence 00012235788
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHH-HHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET-LANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~-L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|++||.+.+..++.++||||||+++|+|++|..||........ +..+.........+..++..+.+||.+||..||++
T Consensus 168 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~ 247 (260)
T cd06606 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKK 247 (260)
T ss_pred cccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhh
Confidence 89999999998899999999999999999999999987663222 22222112222233456889999999999999999
Q ss_pred cCCChHhHHHHHcCCCC
Q 001952 927 RLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF 943 (992)
||+ +.+++.||||
T Consensus 248 Rp~----~~~ll~~~~~ 260 (260)
T cd06606 248 RPT----ADELLQHPFL 260 (260)
T ss_pred CCC----HHHHhhCCCC
Confidence 999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.74 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=213.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|...+.||.|++|.||++.+..+++.+++|++.... ......+.+|+.+++.++|+||+++++++...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4555678999999999999998899999999986432 2233557889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999998876 45899999999999999999999999999999999999999999999999985321100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 169 -------------------------------------------------------------------~~~~~~~~~~~~y 181 (285)
T cd06648 169 -------------------------------------------------------------------VPRRKSLVGTPYW 181 (285)
T ss_pred -------------------------------------------------------------------CcccccccCCccc
Confidence 0001123578899
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-CCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-FPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
+|||.+.+..++.++|||||||++|||++|+.||.+.+....+..+...... ......++..+.+||.+||..+|++||
T Consensus 182 ~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 261 (285)
T cd06648 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA 261 (285)
T ss_pred cCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCc
Confidence 9999999988999999999999999999999999887666666555443221 122233778999999999999999999
Q ss_pred CChHhHHHHHcCCCCCCCc
Q 001952 929 GSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~ln 947 (992)
+ +.++++||||....
T Consensus 262 t----~~~il~~~~~~~~~ 276 (285)
T cd06648 262 T----AAELLNHPFLAKAG 276 (285)
T ss_pred C----HHHHccCcccccCC
Confidence 9 99999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.37 Aligned_cols=258 Identities=30% Similarity=0.466 Sum_probs=208.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CCeEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DNLSCL 686 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~~lyL 686 (992)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+++++.++|+||++++++|.. .+.+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 46899999999999999999999999999999987532 12334668899999999999999999998854 457899
Q ss_pred EEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 687 VMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||+++++|.+++... ....+++..+..++.||+.||.|||..|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999999998876542 2356889999999999999999999999999999999999999999999999986321100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (287)
T cd06621 159 --------------------------------------------------------------------------LAGTFT 164 (287)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001124
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC-----chHHHHHHHhhc-cCCCCC----ccchHHHHH
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-----NEETLANVVMQS-LKFPDS----PLISFQARD 914 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s-----~~e~L~~Iv~~~-lk~P~~----~~vs~el~d 914 (992)
++..|++||.+.+..++.++|||||||++|+|++|..||.... ..+....+.... ..++.. ..++..+.+
T Consensus 165 ~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd06621 165 GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKD 244 (287)
T ss_pred CCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHH
Confidence 6778999999999999999999999999999999999998652 223333322211 111111 124678999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||.+||..+|.+||+ +.|+++||||...
T Consensus 245 li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 272 (287)
T cd06621 245 FIKQCLEKDPTRRPT----PWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHcCCCcccCCC----HHHHHhCcccccc
Confidence 999999999999999 9999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.89 Aligned_cols=250 Identities=50% Similarity=0.866 Sum_probs=213.1
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||.|+||.||++.+..+++.|++|++.............+..|+++++.++|+||+++++.+..++.+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999876544444566788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCC
Q 001952 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776 (992)
Q Consensus 697 ~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~ 776 (992)
.+++... ..+++..+..++.||+.||.|||..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9998764 468999999999999999999999999999999999999999999999999863321000
Q ss_pred CccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhc
Q 001952 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK 856 (992)
Q Consensus 777 ~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~ 856 (992)
.......|+..|++||.+.
T Consensus 148 -------------------------------------------------------------~~~~~~~~~~~~~~Pe~~~ 166 (250)
T cd05123 148 -------------------------------------------------------------SRTNTFCGTPEYLAPEVLL 166 (250)
T ss_pred -------------------------------------------------------------CcccCCcCCccccChHHhC
Confidence 0112345788899999999
Q ss_pred CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHH
Q 001952 857 GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAE 936 (992)
Q Consensus 857 g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeE 936 (992)
+..++.++|+||||+++|+|++|..||...+..+.+..+......+ +..++.++.+||.+||..||++||++.. +++
T Consensus 167 ~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~R~~~~~-~~~ 243 (250)
T cd05123 167 GKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF--PEFLSPEARDLISGLLQKDPTKRLGSGG-AEE 243 (250)
T ss_pred CCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCHHHHHHHHHHhcCCHhhCCCccc-HHH
Confidence 8888999999999999999999999998776666666665544333 3447899999999999999999999322 399
Q ss_pred HHcCCCC
Q 001952 937 IKQHPFF 943 (992)
Q Consensus 937 ILkHPfF 943 (992)
+++||||
T Consensus 244 l~~~~~f 250 (250)
T cd05123 244 IKAHPFF 250 (250)
T ss_pred HHhCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.38 Aligned_cols=252 Identities=26% Similarity=0.352 Sum_probs=209.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++.+.||+|+||.||+|.+. +++.||||.++... .....+.+|+.+++.++|+||+++++++...+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999875 45679999987532 22356788999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+++++|.+++....+..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999999999887655678999999999999999999999999999999999999999999999999974432000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
. .......+
T Consensus 158 ~-----------------------------------------------------------------------~~~~~~~~ 166 (261)
T cd05068 158 Y-----------------------------------------------------------------------EAREGAKF 166 (261)
T ss_pred c-----------------------------------------------------------------------cccCCCcC
Confidence 0 00001123
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
+..|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+ ......+....++..+.+||.+||..+|
T Consensus 167 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P 245 (261)
T cd05068 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-DQGYRMPCPPGCPKELYDIMLDCWKEDP 245 (261)
T ss_pred ceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCHHHHHHHHHHhhcCc
Confidence 467999999999899999999999999999999 99999887666666554 3444445555688999999999999999
Q ss_pred CCcCCChHhHHHHH
Q 001952 925 ENRLGSQKGAAEIK 938 (992)
Q Consensus 925 ekRPT~~~~aeEIL 938 (992)
++||+ +.+|+
T Consensus 246 ~~Rp~----~~~l~ 255 (261)
T cd05068 246 DDRPT----FETLQ 255 (261)
T ss_pred ccCCC----HHHHH
Confidence 99999 66654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=364.76 Aligned_cols=251 Identities=31% Similarity=0.514 Sum_probs=215.9
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCC
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGD 695 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGS 695 (992)
+||+|.||+||-|++..+...+|||-+... .....+-+..|+.+-++|+|.|||+++|.+.+++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 599999999999999999999999998643 34566788999999999999999999999999999999999999999
Q ss_pred hHHHHHhhcCCCC--CHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-cCCcEEEEeccccccccCCcccccCCC
Q 001952 696 LHVLRQKQLGKCF--SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIMLTDFDLSLRCSVSPTLLKSSS 772 (992)
Q Consensus 696 L~~lLkk~~~~~L--se~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-~dg~VKLsDFGLA~~l~~~~~~~~~~s 772 (992)
|..+++... +++ .+.++-.|.+||+.||.|||++.|||||||-+|+|++ -.|.+||+|||-++++..
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--------- 728 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--------- 728 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc---------
Confidence 999998764 456 7889999999999999999999999999999999997 788999999999877631
Q ss_pred CCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccCh
Q 001952 773 NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAP 852 (992)
Q Consensus 773 ~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~AP 852 (992)
..||+ ..+.||..||||
T Consensus 729 -------inP~T--------------------------------------------------------ETFTGTLQYMAP 745 (1226)
T KOG4279|consen 729 -------INPCT--------------------------------------------------------ETFTGTLQYMAP 745 (1226)
T ss_pred -------CCccc--------------------------------------------------------cccccchhhhCh
Confidence 11221 346799999999
Q ss_pred hhhcCC--CCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 853 EIIKGE--GHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 853 EvL~g~--~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
|+|..+ +|+.++|||||||++.||.||++||...... ..+.++.......|-+..++.+++.||.+|+..||..||+
T Consensus 746 EvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~s 825 (1226)
T KOG4279|consen 746 EVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPS 825 (1226)
T ss_pred HhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCcc
Confidence 999876 4899999999999999999999999865443 3333333333445555678999999999999999999999
Q ss_pred ChHhHHHHHcCCCCCCC
Q 001952 930 SQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 930 ~~~~aeEILkHPfF~~l 946 (992)
|.++|..||++.-
T Consensus 826 ----A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 826 ----AKDLLQDPFLQHN 838 (1226)
T ss_pred ----HHHhccCcccccC
Confidence 9999999999875
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=341.83 Aligned_cols=267 Identities=28% Similarity=0.397 Sum_probs=211.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc----CCeE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS----DNLS 684 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~----~~~l 684 (992)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+|+.++|+||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875421 22344567789999999999999999998863 4578
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+ +++|..++... ..+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 56888887654 55899999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. ..........
T Consensus 161 ~~--------------------------------------------------------------------~~~~~~~~~~ 172 (334)
T cd07855 161 PT--------------------------------------------------------------------EHKYFMTEYV 172 (334)
T ss_pred Cc--------------------------------------------------------------------CCCccccccc
Confidence 00 0000112346
Q ss_pred cCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc--------------------CCC
Q 001952 845 GTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL--------------------KFP 903 (992)
Q Consensus 845 GT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l--------------------k~P 903 (992)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+..... .++
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 252 (334)
T cd07855 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLP 252 (334)
T ss_pred ccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcc
Confidence 8889999999876 4578999999999999999999999987665444332221100 000
Q ss_pred C---------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 904 D---------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 904 ~---------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
. .+.++.++.+||.+||+.+|++||+ +++++.||||++..-...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 253 RKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQYHDPDD 305 (334)
T ss_pred cCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhccCCcc
Confidence 0 1235788999999999999999999 999999999997765444
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.14 Aligned_cols=257 Identities=20% Similarity=0.290 Sum_probs=208.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
..++|.+.+.||+|+||.||+|.+.. .+..|++|.+.... .......+..|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45689999999999999999999977 67889999886432 112234578899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEEEE
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLG-----KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLT 753 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~-----~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VKLs 753 (992)
+..|+||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999999876532 2588999999999999999999999999999999999998655 59999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|||++..+.....
T Consensus 162 dfg~~~~~~~~~~------------------------------------------------------------------- 174 (277)
T cd05036 162 DFGMARDIYRASY------------------------------------------------------------------- 174 (277)
T ss_pred cCccccccCCccc-------------------------------------------------------------------
Confidence 9999743310000
Q ss_pred CCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHH
Q 001952 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQA 912 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el 912 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+ ........+..++..+
T Consensus 175 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 250 (277)
T cd05036 175 ---YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV-TGGGRLDPPKGCPGPV 250 (277)
T ss_pred ---eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHH
Confidence 000011223567999999999999999999999999999997 99999887666555443 3333344445688999
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+||.+||..+|++||+ +.++++|
T Consensus 251 ~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 251 YRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred HHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999999999999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=315.29 Aligned_cols=252 Identities=33% Similarity=0.530 Sum_probs=212.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|.+.+.||+|++|.||++.+..++..+++|++..... .....+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58888999999999999999988899999999976432 345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++.... ..+++..+..++.||+.||.|||..|++|+||+|+||+++.++.++|+|||++......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~----- 151 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT----- 151 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccc-----
Confidence 999999999887642 56899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
.......|+..|
T Consensus 152 --------------------------------------------------------------------~~~~~~~~~~~~ 163 (253)
T cd05122 152 --------------------------------------------------------------------KARNTMVGTPYW 163 (253)
T ss_pred --------------------------------------------------------------------ccccceecCCcc
Confidence 001224578889
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-cCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-LKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
++||++.+..++.++||||||+++|+|++|+.||...+....+..+.... ...+....++..+.++|.+||..||.+||
T Consensus 164 ~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 243 (253)
T cd05122 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP 243 (253)
T ss_pred cCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCC
Confidence 99999998889999999999999999999999998775554444433321 22333333478999999999999999999
Q ss_pred CChHhHHHHHcCCC
Q 001952 929 GSQKGAAEIKQHPF 942 (992)
Q Consensus 929 T~~~~aeEILkHPf 942 (992)
+ +.++++|||
T Consensus 244 t----~~~~l~~~~ 253 (253)
T cd05122 244 T----AEQLLKHPF 253 (253)
T ss_pred C----HHHHhcCCC
Confidence 9 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=322.49 Aligned_cols=254 Identities=26% Similarity=0.379 Sum_probs=205.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||+|.++............+.+|+++++.++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999986433233334567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 689 EYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||+++++|..++.... ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 9999999998886532 345889999999999999999999999999999999999999999999999986332100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........|+
T Consensus 160 ----------------------------------------------------------------------~~~~~~~~~~ 169 (267)
T cd08224 160 ----------------------------------------------------------------------TTAAHSLVGT 169 (267)
T ss_pred ----------------------------------------------------------------------CcccceecCC
Confidence 0001123477
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc-h-HHHHHHHhhccCCCCCc-cchHHHHHHHHHhccCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-E-ETLANVVMQSLKFPDSP-LISFQARDLIRGLLIKE 923 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~-e~L~~Iv~~~lk~P~~~-~vs~el~dLI~kcL~~D 923 (992)
..|+|||.+.+..++.++|||||||++|+|++|+.||..... . +....+. .....+.+. .++..+.++|.+||..+
T Consensus 170 ~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~cl~~~ 248 (267)
T cd08224 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYSEELRDLVSRCINPD 248 (267)
T ss_pred ccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-cCCCCCCChhhcCHHHHHHHHHHcCCC
Confidence 889999999998899999999999999999999999965432 1 2222222 222222222 57789999999999999
Q ss_pred cCCcCCChHhHHHHHc
Q 001952 924 PENRLGSQKGAAEIKQ 939 (992)
Q Consensus 924 PekRPT~~~~aeEILk 939 (992)
|++||+ +.+|++
T Consensus 249 p~~Rp~----~~~il~ 260 (267)
T cd08224 249 PEKRPD----ISYVLQ 260 (267)
T ss_pred cccCCC----HHHHHH
Confidence 999999 666653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=338.01 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=212.6
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
..|.....||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 34555567999999999999998889999999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---- 170 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---- 170 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc----
Confidence 99999999988764 45899999999999999999999999999999999999999999999999986321100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........|+..
T Consensus 171 --------------------------------------------------------------------~~~~~~~~~~~~ 182 (297)
T cd06659 171 --------------------------------------------------------------------VPKRKSLVGTPY 182 (297)
T ss_pred --------------------------------------------------------------------cccccceecCcc
Confidence 000122458899
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
|+|||++.+..++.++|||||||++|||++|+.||......+.+..+..... .+.....++..+.++|.+||..+|++|
T Consensus 183 y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~R 262 (297)
T cd06659 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262 (297)
T ss_pred ccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccC
Confidence 9999999998899999999999999999999999987766666554432211 112223467889999999999999999
Q ss_pred CCChHhHHHHHcCCCCCCC
Q 001952 928 LGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~l 946 (992)
|+ +.+++.||||...
T Consensus 263 ps----~~~ll~~~~~~~~ 277 (297)
T cd06659 263 AT----AQELLDHPFLLQT 277 (297)
T ss_pred cC----HHHHhhChhhccC
Confidence 99 9999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=336.60 Aligned_cols=255 Identities=24% Similarity=0.317 Sum_probs=205.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeE--EEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCL--FAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~--VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~ 682 (992)
+.+++|++.+.||+|+||.||+|.+..++.. +++|.+.... .......+.+|+++|.++ +|+||+++++++..++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 3467899999999999999999998777654 5777765321 223345678899999999 8999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG 748 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg 748 (992)
.+|+||||+++++|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999987542 13578999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccC
Q 001952 749 HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828 (992)
Q Consensus 749 ~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~ 828 (992)
.++|+|||++.....
T Consensus 162 ~~kl~dfg~~~~~~~----------------------------------------------------------------- 176 (303)
T cd05088 162 VAKIADFGLSRGQEV----------------------------------------------------------------- 176 (303)
T ss_pred cEEeCccccCcccch-----------------------------------------------------------------
Confidence 999999998621100
Q ss_pred CccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCcc
Q 001952 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPL 907 (992)
Q Consensus 829 ~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~ 907 (992)
........++..|+|||++.+..++.++|||||||+||||+| |..||.+....+....+ ........+..
T Consensus 177 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~ 247 (303)
T cd05088 177 --------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLN 247 (303)
T ss_pred --------hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCcCCCCCC
Confidence 000001123567999999998889999999999999999998 99999877666655544 23333333345
Q ss_pred chHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 908 vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
++.++.+||.+||..+|++||+ ++++|.+
T Consensus 248 ~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 248 CDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred CCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 7889999999999999999999 6666654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.89 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=213.0
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
.+..++|.+.+.||+|+||.||++.+. ..+..||||+++... .......+.+|+++++++ +|+||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345678999999999999999999753 345689999987532 122345678899999999 799999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
...+.+|+||||+.+++|..++.......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999987654445899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+..... ..
T Consensus 189 ~~~~~~~~----------------------------------------------------------------------~~ 198 (302)
T cd05055 189 RDIMNDSN----------------------------------------------------------------------YV 198 (302)
T ss_pred ccccCCCc----------------------------------------------------------------------ee
Confidence 33210000 00
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIR 917 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~ 917 (992)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+......+....++.++.+||.
T Consensus 199 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 278 (302)
T cd05055 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMK 278 (302)
T ss_pred ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 0011246778999999999999999999999999999998 999998877766666666655555555567899999999
Q ss_pred HhccCCcCCcCCChHhHHHHHc
Q 001952 918 GLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEILk 939 (992)
+||..+|++||+ +.|+++
T Consensus 279 ~cl~~~p~~Rpt----~~ell~ 296 (302)
T cd05055 279 TCWDADPLKRPT----FKQIVQ 296 (302)
T ss_pred HHcCCCchhCcC----HHHHHH
Confidence 999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=325.49 Aligned_cols=254 Identities=28% Similarity=0.431 Sum_probs=206.6
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc---CCCCccceeeeeccCCe----
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPTLYSQFTSDNL---- 683 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L---~HPNIVkL~g~f~~~~~---- 683 (992)
|++.+.||+|+||.||+|.+..++..||+|+++.... .......+.+|+++++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6788999999999999999988899999999974322 112223456788777666 59999999999987776
Q ss_pred -EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 684 -SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 684 -lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
++++|||+. ++|..++.......+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++..+.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 588888876544568999999999999999999999999999999999999999999999999863321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 159 ~~-------------------------------------------------------------------------~~~~~ 165 (287)
T cd07838 159 FE-------------------------------------------------------------------------MALTS 165 (287)
T ss_pred CC-------------------------------------------------------------------------ccccc
Confidence 00 00112
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-----CCCC-------------
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-----KFPD------------- 904 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-----k~P~------------- 904 (992)
..++..|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+..... .++.
T Consensus 166 ~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (287)
T cd07838 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYT 245 (287)
T ss_pred ccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhccccc
Confidence 2467889999999999999999999999999999999999998877777766654211 0000
Q ss_pred -------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 -------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 -------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+.++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 246 PRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred ccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 0124567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=325.52 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=209.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.++|++.+.||+|+||.||+|.+... ...||||+++... .......+.+|+.+++.++|+||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999988643 4579999987542 222345678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987653 46899999999999999999999999999999999999999999999999997443100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. ........
T Consensus 160 ~~----------------------------------------------------------------------~~~~~~~~ 169 (266)
T cd05033 160 EA----------------------------------------------------------------------TYTTKGGK 169 (266)
T ss_pred cc----------------------------------------------------------------------ceeccCCC
Confidence 00 00000123
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+. .....+....++..+.+|+.+||..+
T Consensus 170 ~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~ 248 (266)
T cd05033 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCPSALYQLMLDCWQKD 248 (266)
T ss_pred CCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 4678999999999899999999999999999998 999998776655554443 33444555568899999999999999
Q ss_pred cCCcCCChHhHHHHHcC
Q 001952 924 PENRLGSQKGAAEIKQH 940 (992)
Q Consensus 924 PekRPT~~~~aeEILkH 940 (992)
|++||+ +.||+++
T Consensus 249 p~~Rp~----~~ei~~~ 261 (266)
T cd05033 249 RNERPT----FSQIVST 261 (266)
T ss_pred cccCcC----HHHHHHH
Confidence 999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=353.56 Aligned_cols=255 Identities=22% Similarity=0.302 Sum_probs=207.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCC-----CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeec
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFT 679 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~t-----g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~ 679 (992)
+..++|.+++.||+|+||.||+|.+... +..||||++.... .......+.+|+++|+.+. ||||++++++|.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 4567899999999999999999987543 3469999996532 2223456889999999996 999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhc-------------------------------------------------------
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQL------------------------------------------------------- 704 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~------------------------------------------------------- 704 (992)
..+.+|||||||++|+|.+++..+.
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999998876531
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc
Q 001952 705 ---------------------------------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR 745 (992)
Q Consensus 705 ---------------------------------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd 745 (992)
...+++..++.++.||+.||+|||..||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 12477888899999999999999999999999999999999
Q ss_pred cCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhh
Q 001952 746 EDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQI 825 (992)
Q Consensus 746 ~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i 825 (992)
.++.++|+|||++..+.....
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~----------------------------------------------------------- 292 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSN----------------------------------------------------------- 292 (400)
T ss_pred CCCEEEEEeCCcceecccccc-----------------------------------------------------------
Confidence 999999999999743210000
Q ss_pred ccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCC
Q 001952 826 RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPD 904 (992)
Q Consensus 826 ~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~ 904 (992)
........++..|+|||++.+..++.++|||||||+||||++ |..||........+...+.....++.
T Consensus 293 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~ 361 (400)
T cd05105 293 -----------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAK 361 (400)
T ss_pred -----------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCC
Confidence 000112356788999999999999999999999999999997 99999876655555555555555555
Q ss_pred CccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 905 SPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 905 ~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
...++.++.+||.+||..||++||++..
T Consensus 362 ~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 362 PDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred CccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 6678899999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=329.95 Aligned_cols=270 Identities=27% Similarity=0.388 Sum_probs=208.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC----
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD---- 681 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~---- 681 (992)
...++|++.+.||.|+||.||+|.+..+++.||||++..... .......+.+|+++++.++|+||+++++++...
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence 346899999999999999999999999999999999864321 112233567899999999999999999987543
Q ss_pred ----CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccc
Q 001952 682 ----NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757 (992)
Q Consensus 682 ----~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGL 757 (992)
..+|+||||+. ++|..++... ...+++..++.++.||+.||+|||.+||+|+||||+|||++.++.++|+|||+
T Consensus 84 ~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 84 KRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 35799999995 5666665543 35699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+........... . ......
T Consensus 162 ~~~~~~~~~~~~----------~---------------------------------------------------~~~~~~ 180 (311)
T cd07866 162 ARPYDGPPPNPK----------G---------------------------------------------------GGGGGT 180 (311)
T ss_pred chhccCCCcccc----------c---------------------------------------------------CCcccc
Confidence 744321000000 0 000011
Q ss_pred CCcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC-----------CC-
Q 001952 838 ARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF-----------PD- 904 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~-----------P~- 904 (992)
.......|++.|+|||++.+. .++.++|||||||++|||++|+.||.+.+....+..+....... +.
T Consensus 181 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (311)
T cd07866 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGC 260 (311)
T ss_pred cccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccc
Confidence 123445789999999998765 47899999999999999999999998877766655543311100 00
Q ss_pred ----------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ----------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ----------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...+..++.+||.+||..||.+||+ +.|++.||||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 261 EGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred cccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 0123467889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.35 Aligned_cols=255 Identities=29% Similarity=0.424 Sum_probs=212.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
-|++++.||.|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++..++.+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 4777889999999999999998899999999986432 12334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|..++.. ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----- 154 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-----
Confidence 9999999988864 46899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 155 -------------------------------------------------------------------~~~~~~~~~~~~y 167 (277)
T cd06641 155 -------------------------------------------------------------------QIKRNTFVGTPFW 167 (277)
T ss_pred -------------------------------------------------------------------hhhhccccCCccc
Confidence 0001123578889
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
+|||.+.+..++.++|+|||||++|+|++|..||...........+.... .......++.++.++|.+||..+|.+||+
T Consensus 168 ~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 246 (277)
T cd06641 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPT 246 (277)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC-CCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence 99999998888999999999999999999999998766555544433222 22223347889999999999999999999
Q ss_pred ChHhHHHHHcCCCCCCC
Q 001952 930 SQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 930 ~~~~aeEILkHPfF~~l 946 (992)
+.++++||||...
T Consensus 247 ----~~~~l~~~~~~~~ 259 (277)
T cd06641 247 ----AKELLKHKFIVRF 259 (277)
T ss_pred ----HHHHHhCHHHhhh
Confidence 9999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.44 Aligned_cols=261 Identities=31% Similarity=0.472 Sum_probs=219.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..+.|++.+.||+|+||.||+|.+..++..|++|++..... ....+..|+++++.++|+||+++++++...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 35678889999999999999999988899999999975421 34567889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++.... ..+++..+..++.||+.||.|||..||+|+||+|+||+++.++.++|+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~-- 169 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE-- 169 (286)
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence 999999999999988752 37899999999999999999999999999999999999999999999999986322100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........++
T Consensus 170 ----------------------------------------------------------------------~~~~~~~~~~ 179 (286)
T cd06614 170 ----------------------------------------------------------------------KSKRNSVVGT 179 (286)
T ss_pred ----------------------------------------------------------------------hhhhccccCC
Confidence 0001123477
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|++||++.+..++.++|+|||||++|+|++|+.||...........+..... .......++.++.+||.+||..+|.
T Consensus 180 ~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 259 (286)
T cd06614 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259 (286)
T ss_pred cccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChh
Confidence 889999999988899999999999999999999999987766655555443332 2223333788999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCch
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~lnw 948 (992)
+||+ +.++++|+||....|
T Consensus 260 ~Rpt----~~~il~~~~~~~~~~ 278 (286)
T cd06614 260 KRPS----AEELLQHPFLKKACP 278 (286)
T ss_pred hCcC----HHHHhhChHhhccCc
Confidence 9999 999999999998554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=317.51 Aligned_cols=254 Identities=30% Similarity=0.469 Sum_probs=215.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||+|++|.||++.+..+++.|++|.+...... ......+.+|+++++.++|+|++++++++...+..|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588899999999999999999889999999999765322 2345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++... ..+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS---- 153 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc----
Confidence 99999999998765 578999999999999999999999999999999999999999999999999974431100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
.......|+..|
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~~~y 165 (254)
T cd06627 154 --------------------------------------------------------------------KDDASVVGTPYW 165 (254)
T ss_pred --------------------------------------------------------------------ccccccccchhh
Confidence 001223578889
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
+|||.+.+..++.++|||+||+++|+|++|..||........+..+... ...+.+..++..+.++|.+||..+|++||+
T Consensus 166 ~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~ 244 (254)
T cd06627 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-DHPPLPEGISPELKDFLMQCFQKDPNLRPT 244 (254)
T ss_pred cCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc-CCCCCCCCCCHHHHHHHHHHHhCChhhCcC
Confidence 9999998888899999999999999999999999876655555444422 222333457889999999999999999999
Q ss_pred ChHhHHHHHcCCCC
Q 001952 930 SQKGAAEIKQHPFF 943 (992)
Q Consensus 930 ~~~~aeEILkHPfF 943 (992)
+.+++.||||
T Consensus 245 ----~~~~l~~~~~ 254 (254)
T cd06627 245 ----AKQLLKHPWI 254 (254)
T ss_pred ----HHHHhcCCCC
Confidence 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=331.79 Aligned_cols=257 Identities=20% Similarity=0.322 Sum_probs=208.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCC-----CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~t-----g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
+...+|++.+.||+|+||.||+|.+..+ +..||||+++... .......+..|+.++..++||||+++++++..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456788899999999999999987543 5789999997532 11223567889999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~ 746 (992)
.+..++++||+.+++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 999999999999999999875321 134788889999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhc
Q 001952 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIR 826 (992)
Q Consensus 747 dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~ 826 (992)
++.+||+|||++..+.....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~------------------------------------------------------------ 179 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY------------------------------------------------------------ 179 (283)
T ss_pred CCceEecccccccccccchh------------------------------------------------------------
Confidence 99999999998743210000
Q ss_pred cCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCC
Q 001952 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDS 905 (992)
Q Consensus 827 ~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~ 905 (992)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+..... .+..
T Consensus 180 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~~~ 248 (283)
T cd05091 180 ----------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPCP 248 (283)
T ss_pred ----------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCC
Confidence 000112345778999999998889999999999999999998 8899988777766666554433 2334
Q ss_pred ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..++..+.+|+.+||+.+|++||+ +.+|+.
T Consensus 249 ~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~ 278 (283)
T cd05091 249 DDCPAWVYTLMLECWNEFPSRRPR----FKDIHS 278 (283)
T ss_pred CCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 468899999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.40 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=208.8
Q ss_pred EEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEec
Q 001952 615 QKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~ 691 (992)
+.||+|+||.||+|.+... +..|++|++....... ....+..|+++++.++|+||+++++++.....+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3699999999999999866 8899999997653221 3567889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 692 PGGDLHVLRQKQL-------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 692 ~GGSL~~lLkk~~-------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
++++|.+++.... ...+++..++.++.||+.||+|||++||+|+||+|+|||++.++.++|+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999988642 356899999999999999999999999999999999999999999999999987433210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. ........
T Consensus 159 ~~----------------------------------------------------------------------~~~~~~~~ 168 (262)
T cd00192 159 DY----------------------------------------------------------------------YRKKTGGK 168 (262)
T ss_pred cc----------------------------------------------------------------------cccccCCC
Confidence 00 00112234
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|+|||.+.+..++.++|||||||++|||++ |..||......+.+..+.. ......+..++.++.++|.+||..+
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~ 247 (262)
T cd00192 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSCWQLD 247 (262)
T ss_pred cCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHHccCC
Confidence 6788999999998889999999999999999999 6999988866666555543 4444555568899999999999999
Q ss_pred cCCcCCChHhHHHHHcC
Q 001952 924 PENRLGSQKGAAEIKQH 940 (992)
Q Consensus 924 PekRPT~~~~aeEILkH 940 (992)
|.+||+ +.+++++
T Consensus 248 p~~Rps----~~~l~~~ 260 (262)
T cd00192 248 PEDRPT----FSELVER 260 (262)
T ss_pred cccCcC----HHHHHHh
Confidence 999999 8888875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=342.90 Aligned_cols=262 Identities=24% Similarity=0.361 Sum_probs=205.7
Q ss_pred EEccC--CceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 616 KLGCG--DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 616 ~LGsG--~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
.||.| +||+||++.+..+++.||||++...... ......+.+|+.+++.++||||++++++|..++..|+||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 9999999999999999999998754221 23346788899999999999999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|.+++.......+++..++.++.||+.||+|||+.||+||||||+|||++.++.++++||+.+......
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~--------- 154 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRN--------- 154 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhcc---------
Confidence 99999988765566899999999999999999999999999999999999999999999999864221100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
....+ ..........++..|++||
T Consensus 155 ~~~~~--------------------------------------------------------~~~~~~~~~~~~~~y~aPE 178 (328)
T cd08226 155 GQKAK--------------------------------------------------------VVYDFPQFSTSVLPWLSPE 178 (328)
T ss_pred Ccccc--------------------------------------------------------ccccccccccCccCccChh
Confidence 00000 0000001123566799999
Q ss_pred hhcCC--CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-------------------------------
Q 001952 854 IIKGE--GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL------------------------------- 900 (992)
Q Consensus 854 vL~g~--~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l------------------------------- 900 (992)
++.+. .++.++|||||||++|||++|..||.+......+...+....
T Consensus 179 ~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (328)
T cd08226 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESV 258 (328)
T ss_pred hhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccch
Confidence 99874 478999999999999999999999987665554443332211
Q ss_pred --------------CCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 901 --------------KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 901 --------------k~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..+....++..+.+||++||..||++||+ +.|+|+||||..+.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~~ 315 (328)
T cd08226 259 VAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQVK 315 (328)
T ss_pred hccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHHH
Confidence 11112235678999999999999999999 99999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=330.18 Aligned_cols=254 Identities=22% Similarity=0.344 Sum_probs=207.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
...+|.+.+.||+|+||.||++.+. .++..+|+|.+... .......+.+|+++|+.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3568999999999999999999752 34567999998653 123345678999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhc-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcE
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQL-----------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHI 750 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~-----------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~V 750 (992)
+.+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999987542 1248999999999999999999999999999999999999999999
Q ss_pred EEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCc
Q 001952 751 MLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQ 830 (992)
Q Consensus 751 KLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~ 830 (992)
+|+|||++..+.....
T Consensus 160 kl~dfg~~~~~~~~~~---------------------------------------------------------------- 175 (288)
T cd05093 160 KIGDFGMSRDVYSTDY---------------------------------------------------------------- 175 (288)
T ss_pred EeccCCccccccCCce----------------------------------------------------------------
Confidence 9999998743210000
Q ss_pred cccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccch
Q 001952 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLIS 909 (992)
Q Consensus 831 ~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs 909 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+..... .+....++
T Consensus 176 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~ 248 (288)
T cd05093 176 ------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV-LQRPRTCP 248 (288)
T ss_pred ------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-CCCCCCCC
Confidence 000112235778999999999989999999999999999998 9999988777666666654432 23334578
Q ss_pred HHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 910 FQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 910 ~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
.++.+||.+||..||.+||+ +.+++
T Consensus 249 ~~l~~li~~~l~~~p~~Rpt----~~~v~ 273 (288)
T cd05093 249 KEVYDLMLGCWQREPHMRLN----IKEIH 273 (288)
T ss_pred HHHHHHHHHHccCChhhCCC----HHHHH
Confidence 89999999999999999999 55553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=323.84 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=206.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++++.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.+++.++|+||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 44678999999999999999999875 456799999875322 2345789999999999999999999885 45689
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
++|||+++++|.+++.......+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 99999999999999887655668999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (260)
T cd05070 157 -----------------------------------------------------------------------YTARQGAKF 165 (260)
T ss_pred -----------------------------------------------------------------------cccccCCCC
Confidence 000011235
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+. .....+.+..++..+.+||.+||..+|
T Consensus 166 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05070 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPISLHELMLQCWKKDP 244 (260)
T ss_pred CccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcccCc
Confidence 667999999998889999999999999999999 999998877666665554 344445555688899999999999999
Q ss_pred CCcCCChHhHHHHH
Q 001952 925 ENRLGSQKGAAEIK 938 (992)
Q Consensus 925 ekRPT~~~~aeEIL 938 (992)
++||+ +++++
T Consensus 245 ~~Rpt----~~~l~ 254 (260)
T cd05070 245 EERPT----FEYLQ 254 (260)
T ss_pred ccCcC----HHHHH
Confidence 99999 66654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.89 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=199.9
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCC
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGD 695 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGS 695 (992)
.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+++|+.++|+||+++++++...+.+||||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 5999999999999999899999999886432 12334567899999999999999999999999999999999999999
Q ss_pred hHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCC
Q 001952 696 LHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMD 775 (992)
Q Consensus 696 L~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~ 775 (992)
|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 80 L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--------- 149 (252)
T cd05084 80 FLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--------- 149 (252)
T ss_pred HHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc---------
Confidence 99998754 34688999999999999999999999999999999999999999999999998632210000
Q ss_pred CCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhh
Q 001952 776 PARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEII 855 (992)
Q Consensus 776 ~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL 855 (992)
........++..|+|||.+
T Consensus 150 -------------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 168 (252)
T cd05084 150 -------------------------------------------------------------ASTGGMKQIPVKWTAPEAL 168 (252)
T ss_pred -------------------------------------------------------------cccCCCCCCceeecCchhh
Confidence 0000011234579999999
Q ss_pred cCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhH
Q 001952 856 KGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934 (992)
Q Consensus 856 ~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~a 934 (992)
.+..++.++|||||||++|||++ |..||...........+ ......+.+..++..+.+||.+||..+|++||+ +
T Consensus 169 ~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~ 243 (252)
T cd05084 169 NYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLMERCWEYDPGQRPS----F 243 (252)
T ss_pred cCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-HcCCCCCCcccCCHHHHHHHHHHcCCChhhCcC----H
Confidence 99989999999999999999998 99999776555444433 334444555567899999999999999999999 6
Q ss_pred HHHH
Q 001952 935 AEIK 938 (992)
Q Consensus 935 eEIL 938 (992)
.+++
T Consensus 244 ~~~~ 247 (252)
T cd05084 244 STVH 247 (252)
T ss_pred HHHH
Confidence 6665
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.49 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=207.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|.+++.||+|+||.||+|.+.+ +..+|||.+.... .....+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS----MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc----ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 4469999887532 2235678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+.+++|.+++.... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--
Confidence 99999999999987643 368999999999999999999999999999999999999999999999999863321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (256)
T cd05113 155 ---------------------------------------------------------------------YTSSVGSKFPV 165 (256)
T ss_pred ---------------------------------------------------------------------eeecCCCccCh
Confidence 00011123567
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|++||++.+..++.++|||||||++|||++ |..||...+..+....+... ...+.....+..+.++|.+||..||++
T Consensus 166 ~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~ 244 (256)
T cd05113 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG-LRLYRPHLASEKVYAIMYSCWHEKAEE 244 (256)
T ss_pred hhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCCccc
Confidence 8999999998889999999999999999998 99999877766665555443 333344457889999999999999999
Q ss_pred cCCChHhHHHHHcC
Q 001952 927 RLGSQKGAAEIKQH 940 (992)
Q Consensus 927 RPT~~~~aeEILkH 940 (992)
||+ +.+|+.+
T Consensus 245 Rp~----~~~ll~~ 254 (256)
T cd05113 245 RPT----FQQLLSS 254 (256)
T ss_pred CCC----HHHHHHh
Confidence 999 8888754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.01 Aligned_cols=262 Identities=28% Similarity=0.362 Sum_probs=209.5
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN- 682 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~- 682 (992)
|+...++|++.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+++++.++||||+++++++....
T Consensus 2 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~ 80 (302)
T cd07864 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD 80 (302)
T ss_pred chhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch
Confidence 44567899999999999999999999998999999999975421 1223345678999999999999999999987654
Q ss_pred ---------eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEE
Q 001952 683 ---------LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLT 753 (992)
Q Consensus 683 ---------~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLs 753 (992)
.+||||||+++ +|..++... ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+
T Consensus 81 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 81 ALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred hhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeC
Confidence 79999999965 666666543 3468999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|||++..+....
T Consensus 159 dfg~~~~~~~~~-------------------------------------------------------------------- 170 (302)
T cd07864 159 DFGLARLYNSEE-------------------------------------------------------------------- 170 (302)
T ss_pred cccccccccCCc--------------------------------------------------------------------
Confidence 999874321000
Q ss_pred CCCCCCcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC----------
Q 001952 834 EPTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF---------- 902 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~---------- 902 (992)
........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+..+.+..+.......
T Consensus 171 ---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (302)
T cd07864 171 ---SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIK 247 (302)
T ss_pred ---ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccc
Confidence 0001122457789999998754 47899999999999999999999998877666665544321100
Q ss_pred ------------------CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 903 ------------------PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 903 ------------------P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.....++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 248 LPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred cccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 011236789999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.67 Aligned_cols=251 Identities=27% Similarity=0.359 Sum_probs=205.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+...+|++.+.||+|+||.||+|.+..+. .||+|++.... .....+.+|+++++.++|+||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCc----cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 34568999999999999999999886654 59999987532 12346788999999999999999999875 45689
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+++++|.+++....+..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999999987555568899999999999999999999999999999999999999999999999874321100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
. .......+
T Consensus 157 ~-----------------------------------------------------------------------~~~~~~~~ 165 (262)
T cd05071 157 Y-----------------------------------------------------------------------TARQGAKF 165 (262)
T ss_pred c-----------------------------------------------------------------------ccccCCcc
Confidence 0 00011236
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.. ....+....++..+.+||.+||..||
T Consensus 166 ~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p 244 (262)
T cd05071 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEP 244 (262)
T ss_pred cceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-CCCCCCccccCHHHHHHHHHHccCCc
Confidence 678999999999899999999999999999999 8999988776666655433 33444455688999999999999999
Q ss_pred CCcCCChHhHHHHH
Q 001952 925 ENRLGSQKGAAEIK 938 (992)
Q Consensus 925 ekRPT~~~~aeEIL 938 (992)
++||+ +.+++
T Consensus 245 ~~Rp~----~~~~~ 254 (262)
T cd05071 245 EERPT----FEYLQ 254 (262)
T ss_pred ccCCC----HHHHH
Confidence 99999 55554
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.61 Aligned_cols=250 Identities=23% Similarity=0.338 Sum_probs=205.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|+++++.++|+||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA----MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 456888999999999999999885 45679999986432 1234577899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-- 154 (256)
T ss_pred EecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc--
Confidence 99999999999987643 368999999999999999999999999999999999999999999999999863321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (256)
T cd05059 155 ---------------------------------------------------------------------YTSSQGTKFPV 165 (256)
T ss_pred ---------------------------------------------------------------------ccccCCCCCCc
Confidence 00001112456
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||++.+..++.++|||||||+||||++ |+.||......+....+. .....+.+..++.++.+|+.+||..+|++
T Consensus 166 ~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 244 (256)
T cd05059 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS-AGYRLYRPKLAPTEVYTIMYSCWHEKPED 244 (256)
T ss_pred cccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhh
Confidence 7999999999999999999999999999999 899998776666555443 34444445568999999999999999999
Q ss_pred cCCChHhHHHHHc
Q 001952 927 RLGSQKGAAEIKQ 939 (992)
Q Consensus 927 RPT~~~~aeEILk 939 (992)
||+ +.|+++
T Consensus 245 Rpt----~~~~l~ 253 (256)
T cd05059 245 RPA----FKKLLS 253 (256)
T ss_pred CcC----HHHHHH
Confidence 999 777765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=323.23 Aligned_cols=254 Identities=20% Similarity=0.307 Sum_probs=203.0
Q ss_pred ceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe----
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL---- 683 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~---- 683 (992)
|.+.+.||+|+||.||+|.+..+ +..||||+++..... ......+..|+++|+.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56788999999999999987653 478999998753221 2234568899999999999999999998865544
Q ss_pred --EEEEEEecCCCChHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccc
Q 001952 684 --SCLVMEYCPGGDLHVLRQKQL----GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757 (992)
Q Consensus 684 --lyLVmEy~~GGSL~~lLkk~~----~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGL 757 (992)
.+++|||+++++|..++.... ...+++..++.++.||+.||+|||+.||+||||||+|||+++++.++|+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 799999999999998875432 23688999999999999999999999999999999999999999999999999
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+........ .
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------~ 169 (273)
T cd05035 160 SKKIYSGDY----------------------------------------------------------------------Y 169 (273)
T ss_pred eeecccccc----------------------------------------------------------------------c
Confidence 743311000 0
Q ss_pred CCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.. ......+..++.++.+||
T Consensus 170 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li 248 (273)
T cd05035 170 RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRH-GNRLKQPEDCLDELYDLM 248 (273)
T ss_pred cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCcCCCHHHHHHH
Confidence 00011224567999999998889999999999999999999 9999988776666655443 333444456889999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHcC
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+||..||.+||+ +.|++++
T Consensus 249 ~~~l~~~p~~Rp~----~~e~~~~ 268 (273)
T cd05035 249 YSCWRADPKDRPT----FTKLREV 268 (273)
T ss_pred HHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999 6666653
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=329.00 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=208.1
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCC----------------eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTN----------------CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg----------------~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN 670 (992)
...+|++++.||+|+||.||+|.+...+ ..||+|++..... ......+.+|+++|+.++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876533 5689999875421 133456788999999999999
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCce
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLG---------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPEN 741 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~---------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeN 741 (992)
|+++++++..++..++||||+.+++|..++..... ..+++..++.++.||+.||+|||++||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999999999999999999999999999876431 258899999999999999999999999999999999
Q ss_pred EEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCCh
Q 001952 742 ILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP 821 (992)
Q Consensus 742 ILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~ 821 (992)
||++.++.++|+|||++........
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------------- 185 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDY------------------------------------------------------- 185 (296)
T ss_pred eeecCCCceEEccccceeecccCcc-------------------------------------------------------
Confidence 9999999999999998743210000
Q ss_pred hhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc--CCCCCCCCCchHHHHHHHhh-
Q 001952 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY--GRTPFKGSGNEETLANVVMQ- 898 (992)
Q Consensus 822 ~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT--Gr~PF~g~s~~e~L~~Iv~~- 898 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||......+.+......
T Consensus 186 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~ 250 (296)
T cd05051 186 ---------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFF 250 (296)
T ss_pred ---------------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcc
Confidence 000112346788999999999889999999999999999998 78899877666666555432
Q ss_pred -----ccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 899 -----SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 899 -----~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
....+....++.++.+||.+||..||++||+ +.||++
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 251 RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred ccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHHH
Confidence 2223334457789999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.65 Aligned_cols=251 Identities=32% Similarity=0.471 Sum_probs=201.6
Q ss_pred eEEEEEccCCceEEEEEEEc----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 612 NLLQKLGCGDIGTVYLAELI----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
++.+.||.|.||.||+|.+. ..+..|+||.++... .......+.+|+++|+.++||||++++|++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 46788999999999999997 456789999996431 223367788999999999999999999999988889999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++|+|.+++.......+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~- 158 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK- 158 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-
Confidence 9999999999999986556799999999999999999999999999999999999999999999999999743210000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........+..
T Consensus 159 ---------------------------------------------------------------------~~~~~~~~~~~ 169 (259)
T PF07714_consen 159 ---------------------------------------------------------------------YKNDSSQQLPL 169 (259)
T ss_dssp ---------------------------------------------------------------------EEESTTSESGG
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00011223567
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||.+.+..++.++||||||++||||++ |+.||.+....+....+ ......+.+..++..+.+||..||..||++
T Consensus 170 ~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~ 248 (259)
T PF07714_consen 170 RYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEK 248 (259)
T ss_dssp GGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHHHHHHHHHcCCChhh
Confidence 8999999999989999999999999999999 78999888776666666 444445555568999999999999999999
Q ss_pred cCCChHhHHHHHc
Q 001952 927 RLGSQKGAAEIKQ 939 (992)
Q Consensus 927 RPT~~~~aeEILk 939 (992)
||+ +.+|++
T Consensus 249 RPs----~~~i~~ 257 (259)
T PF07714_consen 249 RPS----FQEILQ 257 (259)
T ss_dssp S------HHHHHH
T ss_pred CcC----HHHHHh
Confidence 999 666653
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=343.26 Aligned_cols=338 Identities=24% Similarity=0.327 Sum_probs=228.0
Q ss_pred eeecccccc-cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-----C---CC
Q 001952 600 RLQYGSIGL-RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-----H---PF 670 (992)
Q Consensus 600 ~~~~gei~~-~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-----H---PN 670 (992)
.+..|.... .+|.+.++||+|.|++||+|++..+.+.||+|+.+... ...+....|+.+|+.++ | .+
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~ 143 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKC 143 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence 445565444 89999999999999999999999999999999998643 33455678999999883 3 36
Q ss_pred ccceeeeec----cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEc
Q 001952 671 LPTLYSQFT----SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVR 745 (992)
Q Consensus 671 IVkL~g~f~----~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd 745 (992)
||+|+++|. .+.++|||+|++ |.+|..+|.....+.++...++.|++|||.||+|||+ +||||.||||+|||+.
T Consensus 144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999997 467999999999 9999999998888899999999999999999999996 5999999999999996
Q ss_pred cCCcEEEEecccccccc-C----CcccccCCC-----------------------------------CCCCCccCCCCCC
Q 001952 746 EDGHIMLTDFDLSLRCS-V----SPTLLKSSS-----------------------------------NMDPARVSGPCTE 785 (992)
Q Consensus 746 ~dg~VKLsDFGLA~~l~-~----~~~~~~~~s-----------------------------------~~~~~r~sgp~~~ 785 (992)
.+..--..|-.-|..+. . .+....+.. ..+..... +..+
T Consensus 223 ~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~-~~~~ 301 (590)
T KOG1290|consen 223 STEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEE-PNQE 301 (590)
T ss_pred ccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccc-cccc
Confidence 54210000111000000 0 000000000 00000000 0000
Q ss_pred CCCCCCc-----------cCCCCC-------CCCCCCC-----------------CcCccc--ccc--------------
Q 001952 786 SNCIQPF-----------CIEPTC-------QVPCFSP-----------------RFLPAT--AKT-------------- 814 (992)
Q Consensus 786 s~~~~p~-----------~~~~~~-------~~~~~sp-----------------r~~~~~--~kt-------------- 814 (992)
+....+. .++... .....+| ++.... ..+
T Consensus 302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~ 381 (590)
T KOG1290|consen 302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN 381 (590)
T ss_pred ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence 0000000 000000 0000000 000000 000
Q ss_pred -CCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCC------C
Q 001952 815 -RKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS------G 887 (992)
Q Consensus 815 -~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~------s 887 (992)
-........+++..+.+.++|...+.+.-+.|+.|+|||+|.|.+|++.+||||++|++|||+||.++|... .
T Consensus 382 p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~r 461 (590)
T KOG1290|consen 382 PDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSR 461 (590)
T ss_pred CCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCc
Confidence 001234455667788889999999999999999999999999999999999999999999999999999742 2
Q ss_pred chHHHHHHHhhccCCCC----------------------------------------CccchHHHHHHHHHhccCCcCCc
Q 001952 888 NEETLANVVMQSLKFPD----------------------------------------SPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 888 ~~e~L~~Iv~~~lk~P~----------------------------------------~~~vs~el~dLI~kcL~~DPekR 927 (992)
+++.++.|+.-...+|. +..-..++.+||.-||+.+|++|
T Consensus 462 DEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR 541 (590)
T KOG1290|consen 462 DEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKR 541 (590)
T ss_pred cHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccc
Confidence 34556555432111110 00112367899999999999999
Q ss_pred CCChHhHHHHHcCCCCCCCc
Q 001952 928 LGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~ln 947 (992)
++ |.++|+|||+..+-
T Consensus 542 ~t----A~~cl~hPwLn~~~ 557 (590)
T KOG1290|consen 542 PT----AAQCLKHPWLNPVA 557 (590)
T ss_pred cc----HHHHhcCccccCCC
Confidence 99 99999999998753
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.22 Aligned_cols=255 Identities=20% Similarity=0.327 Sum_probs=205.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCe----EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNC----LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
+...+|++++.||+|+||+||+|.+..++. .||+|++.... .......+.+|+.++..++|+||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345789999999999999999999877765 48999986432 122345678899999999999999999998754
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+++|||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 578999999999999988764 246899999999999999999999999999999999999999999999999997443
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
..... .....
T Consensus 160 ~~~~~----------------------------------------------------------------------~~~~~ 169 (279)
T cd05109 160 DIDET----------------------------------------------------------------------EYHAD 169 (279)
T ss_pred ccccc----------------------------------------------------------------------eeecC
Confidence 21000 00001
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...++..|++||.+.+..++.++|||||||+||||++ |..||......... ..+......+....++.++.++|.+||
T Consensus 170 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l 248 (279)
T cd05109 170 GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPICTIDVYMIMVKCW 248 (279)
T ss_pred CCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCccCCHHHHHHHHHHc
Confidence 1234678999999999999999999999999999998 99999776544433 444444444555568899999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||++||+ +.+++.
T Consensus 249 ~~dp~~Rp~----~~~l~~ 263 (279)
T cd05109 249 MIDSECRPR----FRELVD 263 (279)
T ss_pred CCChhhCcC----HHHHHH
Confidence 999999999 667663
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=321.46 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=207.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|+++++||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++|+||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999864 56789999987532 22356788999999999999999999874 55789
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
++|||+.+++|.+++....+..+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 99999999999999877656678999999999999999999999999999999999999999999999999863321000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (260)
T cd05067 157 -----------------------------------------------------------------------YTAREGAKF 165 (260)
T ss_pred -----------------------------------------------------------------------cccccCCcc
Confidence 000011235
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
+..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+ ......+....++.++.+||.+||..+|
T Consensus 166 ~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p 244 (260)
T cd05067 166 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMPRPDNCPEELYELMRLCWKEKP 244 (260)
T ss_pred cccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCCh
Confidence 678999999999989999999999999999999 99999887666555544 3444455555678899999999999999
Q ss_pred CCcCCChHhHHHHHc
Q 001952 925 ENRLGSQKGAAEIKQ 939 (992)
Q Consensus 925 ekRPT~~~~aeEILk 939 (992)
++||+ +++++.
T Consensus 245 ~~Rp~----~~~l~~ 255 (260)
T cd05067 245 EERPT----FEYLRS 255 (260)
T ss_pred hhCCC----HHHHHH
Confidence 99999 776654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=327.19 Aligned_cols=245 Identities=31% Similarity=0.498 Sum_probs=198.7
Q ss_pred cCceEEEEE--ccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEE
Q 001952 609 RHFNLLQKL--GCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 609 ~~Yeilr~L--GsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ly 685 (992)
++|++.+.+ |+|+||.||++....+++.+|+|++...... . .|+.....+ +|+||++++++|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN------A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc------h--hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666665 9999999999999999999999998754211 1 122222222 7999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEeccccccccCC
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLRCSVS 764 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~~~ 764 (992)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999998765 4789999999999999999999999999999999999999888 999999998632110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.....
T Consensus 163 ---------------------------------------------------------------------------~~~~~ 167 (267)
T PHA03390 163 ---------------------------------------------------------------------------PSCYD 167 (267)
T ss_pred ---------------------------------------------------------------------------CccCC
Confidence 01124
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHH----HHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET----LANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~----L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
|+..|+|||++.+..++.++|||||||++|||++|..||......+. +.... ....+....++..+.+||.+||
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l 245 (267)
T PHA03390 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSML 245 (267)
T ss_pred CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHHh
Confidence 78899999999999999999999999999999999999986543322 22222 1222333458899999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
+.||.+|++. +++||+||||.
T Consensus 246 ~~~p~~R~~~---~~~~l~h~~~~ 266 (267)
T PHA03390 246 KYNINYRLTN---YNEIIKHPFLK 266 (267)
T ss_pred ccChhhCCch---HHHHhcCCccc
Confidence 9999999961 59999999996
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=332.01 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=203.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCe--EEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNC--LFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~--~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ly 685 (992)
++|++.+.||+|+||.||+|.+..++. .+++|.++... .......+..|++++.++ +||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999998877664 46888876321 122345678899999999 7999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 686 LVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999987532 13478899999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++......
T Consensus 160 l~dfg~~~~~~~~------------------------------------------------------------------- 172 (297)
T cd05089 160 IADFGLSRGEEVY------------------------------------------------------------------- 172 (297)
T ss_pred ECCcCCCccccce-------------------------------------------------------------------
Confidence 9999986211000
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
........+..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+. .....+.+..++.
T Consensus 173 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~ 245 (297)
T cd05089 173 ------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRMEKPRNCDD 245 (297)
T ss_pred ------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCCH
Confidence 00001123457999999999989999999999999999997 999998877666665544 3334444456889
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
++.+||.+||..+|.+||+ ++++++.
T Consensus 246 ~~~~li~~~l~~~p~~Rp~----~~~i~~~ 271 (297)
T cd05089 246 EVYELMRQCWRDRPYERPP----FAQISVQ 271 (297)
T ss_pred HHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999999999 6666543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=332.93 Aligned_cols=256 Identities=30% Similarity=0.389 Sum_probs=211.5
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|...+.||+|+||.||+|.+..++..|+||++.............+..|+++++.++|+||+++++++.+.+..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 36777889999999999999999999999999865432223344567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+. ++|..++... ...+++..++.++.||+.||.|||.+||+|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------- 172 (313)
T cd06633 102 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------- 172 (313)
T ss_pred cCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-------
Confidence 995 5676666543 3568999999999999999999999999999999999999999999999999852100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
......|+..|
T Consensus 173 ---------------------------------------------------------------------~~~~~~~~~~y 183 (313)
T cd06633 173 ---------------------------------------------------------------------PANSFVGTPYW 183 (313)
T ss_pred ---------------------------------------------------------------------CCCCccccccc
Confidence 00123578889
Q ss_pred cChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 850 LAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 850 ~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+|||++. ...++.++|||||||++|||++|..||...+....+..+............++..+.+||.+||..+|.+
T Consensus 184 ~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 263 (313)
T cd06633 184 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQE 263 (313)
T ss_pred cChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhh
Confidence 9999985 3557889999999999999999999998877666666554443332223346778999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCc
Q 001952 927 RLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ln 947 (992)
||+ +.+++.||||...+
T Consensus 264 Rp~----~~~~l~~~~~~~~~ 280 (313)
T cd06633 264 RPA----SAELLRHDFVRRDR 280 (313)
T ss_pred CcC----HHHHhcCcccCCCc
Confidence 999 99999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=316.80 Aligned_cols=254 Identities=29% Similarity=0.448 Sum_probs=213.9
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+|++.+.||.|+||.||++.+..+++.+++|.+...... ......+..|+++++.++|+||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 588999999999999999999999999999998764322 2334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 690 YCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 690 y~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|+++++|..++.... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 999999998876532 356889999999999999999999999999999999999999999999999987332100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
......|+.
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (256)
T cd08530 157 -----------------------------------------------------------------------MAKTQIGTP 165 (256)
T ss_pred -----------------------------------------------------------------------CcccccCCc
Confidence 001124678
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|++||.+.+..++.++|+||||+++|||++|+.||...+..+....+.... ..+....++.+++++|.+||..+|++|
T Consensus 166 ~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 244 (256)
T cd08530 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK-YPPIPPIYSQDLQNFIRSMLQVKPKLR 244 (256)
T ss_pred cccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCchhhCHHHHHHHHHHcCCCcccC
Confidence 8999999999889999999999999999999999998876655554443332 223334578899999999999999999
Q ss_pred CCChHhHHHHHcCCCC
Q 001952 928 LGSQKGAAEIKQHPFF 943 (992)
Q Consensus 928 PT~~~~aeEILkHPfF 943 (992)
|+ +.++++||++
T Consensus 245 p~----~~~~l~~p~~ 256 (256)
T cd08530 245 PN----CDKILASPAV 256 (256)
T ss_pred CC----HHHHhcCCCC
Confidence 99 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=320.17 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=211.9
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..++|.+.+.||.|+||.||+|.+. ++..||||.+.... .....+.+|+.+++.++|+||+++++++.....+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356789999999999999999999875 45779999987532 2235678899999999999999999999998999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
++||||+++++|.+++....+..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999999998765567899999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. .......
T Consensus 157 ~~-----------------------------------------------------------------------~~~~~~~ 165 (261)
T cd05034 157 EY-----------------------------------------------------------------------TAREGAK 165 (261)
T ss_pred hh-----------------------------------------------------------------------hhhhccC
Confidence 00 0000112
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|+|||.+.+..++.++|||||||++|||++ |+.||.+......+..+. .....+.+..++.++.+++.+||..+
T Consensus 166 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~ 244 (261)
T cd05034 166 FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPEELYDLMLQCWDKD 244 (261)
T ss_pred CCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 4567999999999889999999999999999998 999998877766666654 34444555567889999999999999
Q ss_pred cCCcCCChHhHHHHHc
Q 001952 924 PENRLGSQKGAAEIKQ 939 (992)
Q Consensus 924 PekRPT~~~~aeEILk 939 (992)
|++||+ +++++.
T Consensus 245 p~~Rp~----~~~l~~ 256 (261)
T cd05034 245 PEERPT----FEYLQS 256 (261)
T ss_pred cccCCC----HHHHHH
Confidence 999999 777653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=337.69 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=206.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
..+|.+.+.||.|+||.||+|.+..++..||+|.+.... ......+.+|+++|+.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999986532 23446678899999999999999999876543
Q ss_pred --------CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-cCCcEEE
Q 001952 682 --------NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIML 752 (992)
Q Consensus 682 --------~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-~dg~VKL 752 (992)
...|+||||+. ++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEE
Confidence 35799999995 688877754 4689999999999999999999999999999999999998 4567899
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++..+.....
T Consensus 157 ~dfg~~~~~~~~~~------------------------------------------------------------------ 170 (342)
T cd07854 157 GDFGLARIVDPHYS------------------------------------------------------------------ 170 (342)
T ss_pred CCcccceecCCccc------------------------------------------------------------------
Confidence 99998743210000
Q ss_pred cCCCCCCcCccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-----------
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL----------- 900 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l----------- 900 (992)
.........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.....
T Consensus 171 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07854 171 ---HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELL 247 (342)
T ss_pred ---cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 0000112357888999998765 4578899999999999999999999987766555444332110
Q ss_pred -----------CCC------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 901 -----------KFP------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 901 -----------k~P------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
..+ ....++.++.+||.+||..||++||+ +.|+|.||||+.+.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~~~~ 308 (342)
T cd07854 248 NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSCYSC 308 (342)
T ss_pred hhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCccccccC
Confidence 000 01236778999999999999999999 999999999987644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.50 Aligned_cols=257 Identities=31% Similarity=0.436 Sum_probs=209.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----- 682 (992)
.++|++++.||+|+||.||+|.+..++..||||++.... ........+.+|+++|+.++|+||+++++++..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 568999999999999999999999999999999986431 12223346778999999999999999999987553
Q ss_pred -eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 683 -LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 683 -~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
.+|+||||+ +++|..++.. ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899888764 46899999999999999999999999999999999999999999999999986321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. ...
T Consensus 169 ~~---------------------------------------------------------------------------~~~ 173 (343)
T cd07880 169 DS---------------------------------------------------------------------------EMT 173 (343)
T ss_pred cc---------------------------------------------------------------------------Ccc
Confidence 10 011
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-----------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP----------------- 903 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P----------------- 903 (992)
...+++.|++||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..++......+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (343)
T cd07880 174 GYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253 (343)
T ss_pred ccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHH
Confidence 2346788999999986 4578999999999999999999999987766555544432111100
Q ss_pred ------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 904 ------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 904 ------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
....++.++.+||.+||+.||.+||+ +.+++.||||+...-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~~~ 306 (343)
T cd07880 254 KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEFHD 306 (343)
T ss_pred hccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhhcC
Confidence 01236778999999999999999999 999999999997643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=327.91 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=204.7
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
...+|.+.+.||+|+||.||+|.+.. ++..+++|.+..... .....+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 35679999999999999999998643 456789999865422 2235678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d 747 (992)
+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999987542 1347899999999999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhcc
Q 001952 748 GHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827 (992)
Q Consensus 748 g~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~ 827 (992)
+.++|+|||++.......
T Consensus 160 ~~~~l~dfg~a~~~~~~~-------------------------------------------------------------- 177 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTD-------------------------------------------------------------- 177 (291)
T ss_pred CcEEECCCCcccccCCCc--------------------------------------------------------------
Confidence 999999999873321000
Q ss_pred CCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCc
Q 001952 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSP 906 (992)
Q Consensus 828 ~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~ 906 (992)
.........|+..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+.... ......
T Consensus 178 --------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 248 (291)
T cd05094 178 --------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLERPR 248 (291)
T ss_pred --------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCCCc
Confidence 0000112346788999999999999999999999999999998 999998877666665544332 223334
Q ss_pred cchHHHHHHHHHhccCCcCCcCCChH
Q 001952 907 LISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 907 ~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
.++..+.+||.+||..||.+||++..
T Consensus 249 ~~~~~~~~li~~~l~~~P~~Rpt~~~ 274 (291)
T cd05094 249 VCPKEVYDIMLGCWQREPQQRLNIKE 274 (291)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHH
Confidence 57889999999999999999999433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=336.59 Aligned_cols=261 Identities=28% Similarity=0.398 Sum_probs=214.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----eE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN-----LS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~-----~l 684 (992)
+|++.+.||.|+||.||+|.+..++..||||++.... ........+.+|+++++.++|+||+++++++...+ .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999998889999999987542 12334467888999999999999999999998765 78
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+. ++|..++... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999996 5888887654 47899999999999999999999999999999999999999999999999997442110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. .........
T Consensus 157 ~~---------------------------------------------------------------------~~~~~~~~~ 167 (330)
T cd07834 157 ED---------------------------------------------------------------------EKGFLTEYV 167 (330)
T ss_pred cc---------------------------------------------------------------------ccccccccc
Confidence 00 000112345
Q ss_pred cCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC--------------------
Q 001952 845 GTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP-------------------- 903 (992)
Q Consensus 845 GT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P-------------------- 903 (992)
++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..++......+
T Consensus 168 ~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (330)
T cd07834 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLP 247 (330)
T ss_pred cccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcc
Confidence 78899999999988 789999999999999999999999998877666655543211110
Q ss_pred ---------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 904 ---------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 904 ---------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..+.++.++.+||.+||..+|++||+ +++++.||||+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~~ 296 (330)
T cd07834 248 KKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQLH 296 (330)
T ss_pred cCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHhhc
Confidence 01225678999999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=319.87 Aligned_cols=247 Identities=22% Similarity=0.354 Sum_probs=203.0
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec-cCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT-SDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~-~~~~l 684 (992)
+...+|++.+.||+|+||.||++... +..|++|.++.. .....+.+|+.+++.++|+||+++++++. .++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999774 667999998643 22356788999999999999999999754 55678
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++.......+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 9999999999999998876545688999999999999999999999999999999999999999999999998632110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (256)
T cd05082 155 --------------------------------------------------------------------------TQDTGK 160 (256)
T ss_pred --------------------------------------------------------------------------cCCCCc
Confidence 000112
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|+|||++.+..++.++|||||||++|||++ |+.||......+.... +...........++..+.+||.+||..+
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~ 239 (256)
T cd05082 161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPVVYDVMKQCWHLD 239 (256)
T ss_pred cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCCHHHHHHHHHHhcCC
Confidence 3457999999999889999999999999999997 9999987654444433 3344444444568899999999999999
Q ss_pred cCCcCCChHhHHHHHc
Q 001952 924 PENRLGSQKGAAEIKQ 939 (992)
Q Consensus 924 PekRPT~~~~aeEILk 939 (992)
|++||+ +.++++
T Consensus 240 p~~Rpt----~~~l~~ 251 (256)
T cd05082 240 AATRPS----FLQLRE 251 (256)
T ss_pred hhhCcC----HHHHHH
Confidence 999999 666654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.41 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=200.7
Q ss_pred CceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCChHHHH
Q 001952 621 DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLR 700 (992)
Q Consensus 621 ~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lL 700 (992)
++|.||.++...+++.||||++..... .......+..|+++|+.++|+||++++++|...+..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 445566666666899999999975421 2334567899999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccC
Q 001952 701 QKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVS 780 (992)
Q Consensus 701 kk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~s 780 (992)
.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||.+..+...... .
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~---------~--- 158 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR---------Q--- 158 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc---------c---
Confidence 8765667899999999999999999999999999999999999999999999999986432110000 0
Q ss_pred CCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC--
Q 001952 781 GPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE-- 858 (992)
Q Consensus 781 gp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~-- 858 (992)
...........++..|+|||++.+.
T Consensus 159 -----------------------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~ 185 (314)
T cd08216 159 -----------------------------------------------------RVVHDFPKSSVKNLPWLSPEVLQQNLQ 185 (314)
T ss_pred -----------------------------------------------------cccccccccccccccccCHHHhcCCCC
Confidence 0000011234577889999999764
Q ss_pred CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC--------------------------------CCCCc
Q 001952 859 GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK--------------------------------FPDSP 906 (992)
Q Consensus 859 ~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk--------------------------------~P~~~ 906 (992)
.++.++|||||||++|||++|..||........+...+.+... .+...
T Consensus 186 ~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (314)
T cd08216 186 GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265 (314)
T ss_pred CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhh
Confidence 5789999999999999999999999876554443322221100 01112
Q ss_pred cchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 907 LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 907 ~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.++.++.+||..||..||++||+ +.++|+||||..+
T Consensus 266 ~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~ 301 (314)
T cd08216 266 TFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQC 301 (314)
T ss_pred HHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhh
Confidence 24567899999999999999999 9999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=337.43 Aligned_cols=263 Identities=27% Similarity=0.391 Sum_probs=209.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----C
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-----N 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-----~ 682 (992)
..+|.+.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.+|+.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3579999999999999999999999999999999875321 223345667899999999999999999988643 3
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 83 DVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred cEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 589999999 57888887654 569999999999999999999999999999999999999999999999999873321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. ......
T Consensus 160 ~~------------------------------------------------------------------------~~~~~~ 167 (337)
T cd07858 160 EK------------------------------------------------------------------------GDFMTE 167 (337)
T ss_pred CC------------------------------------------------------------------------cccccc
Confidence 00 001122
Q ss_pred cccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh-----------------------h
Q 001952 843 FVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM-----------------------Q 898 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~-----------------------~ 898 (992)
..|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+.. .
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (337)
T cd07858 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRS 247 (337)
T ss_pred cccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHh
Confidence 357888999999875 4588999999999999999999999987654333322211 0
Q ss_pred ccCCC------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 899 SLKFP------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 899 ~lk~P------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
....+ ..+.++.++.+||++||..+|++||+ +.++|+||||..+.-..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 248 LPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASLHDPS 301 (337)
T ss_pred cCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhhcCcc
Confidence 00000 11347788999999999999999999 99999999998875443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=373.99 Aligned_cols=262 Identities=29% Similarity=0.423 Sum_probs=212.8
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeee-ecc--
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQ-FTS-- 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~-f~~-- 680 (992)
.++..++++.+.|.+|||+.||+|.+.+.|..||+|++-.. +......+.+|+++|+.|. |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 34566789999999999999999999988899999988643 4566788899999999996 9999999993 221
Q ss_pred ----CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCcEEEEe
Q 001952 681 ----DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLTD 754 (992)
Q Consensus 681 ----~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~VKLsD 754 (992)
.-.++|+||||.||.|-+++..+....|++..+++|+.|++.|+.+||.+. |||||||-|||||..+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 135789999999999999999877778999999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccC
Q 001952 755 FDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834 (992)
Q Consensus 755 FGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~ 834 (992)
||-+.-.. +.|+ .+... .-.
T Consensus 190 FGSatt~~----------------------------------------~~~~----~~~e~---~~v------------- 209 (738)
T KOG1989|consen 190 FGSATTKI----------------------------------------LSPT----SAQEV---NYV------------- 209 (738)
T ss_pred cccccccc----------------------------------------CCCc----cHHHH---HHH-------------
Confidence 99862110 0000 00000 000
Q ss_pred CCCCCcCccccCCCccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHH
Q 001952 835 PTDARSNSFVGTHEYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQ 911 (992)
Q Consensus 835 ~~~~~s~s~vGT~~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~e 911 (992)
+..-....|+.|+|||+|. +...+.++|||+|||+||-|++...||.+... ..|+.+.+.+|..+.++..
T Consensus 210 ---e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~ 282 (738)
T KOG1989|consen 210 ---EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDR 282 (738)
T ss_pred ---HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHH
Confidence 0011124689999999875 66789999999999999999999999987643 3567788999998889999
Q ss_pred HHHHHHHhccCCcCCcCCChHhHHH
Q 001952 912 ARDLIRGLLIKEPENRLGSQKGAAE 936 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~~~aeE 936 (992)
+++||+.||+.||++||+.-+++.+
T Consensus 283 l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 283 LKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHHhccCcccCCCHHHHHHH
Confidence 9999999999999999994433333
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=323.87 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=212.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.++|++++.||.|+||.||+|+... ..+.|++|.+.... .......+.+|+++|++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999998753 35679999886431 1223467889999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcC-------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEec
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLG-------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~-------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDF 755 (992)
..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999999876531 15899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 756 DLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 756 GLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
|++......
T Consensus 162 ~~~~~~~~~----------------------------------------------------------------------- 170 (275)
T cd05046 162 SLSKDVYNS----------------------------------------------------------------------- 170 (275)
T ss_pred ccccccCcc-----------------------------------------------------------------------
Confidence 986321000
Q ss_pred CCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHH
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
.........++..|++||.+.+..++.++|||||||++|+|++ |..||.+......+..+......++....++..+.+
T Consensus 171 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 250 (275)
T cd05046 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYK 250 (275)
T ss_pred cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHH
Confidence 0001122346778999999998889999999999999999998 899998777766666666556556555668899999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+|.+||..+|++||+ +.|++.+
T Consensus 251 ~i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 251 LMTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred HHHHHcCCCcccCCC----HHHHHHH
Confidence 999999999999999 8887754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=326.20 Aligned_cols=254 Identities=17% Similarity=0.258 Sum_probs=203.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCe----EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNC----LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
..++|++++.||+|+||.||+|.+..+++ .+++|.+... ........+..|+.+++.++||||+++++++. +.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 45689999999999999999999877665 4777777532 11233456777888899999999999999875 45
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..++++||+++|+|.+++... ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 578999999999999998764 3568999999999999999999999999999999999999999999999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
... .......
T Consensus 161 ~~~----------------------------------------------------------------------~~~~~~~ 170 (279)
T cd05111 161 PDD----------------------------------------------------------------------KKYFYSE 170 (279)
T ss_pred CCC----------------------------------------------------------------------cccccCC
Confidence 000 0001122
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..++..|++||++.+..++.++|||||||++|||++ |..||.+..... +..++......+....++.++.+++.+||.
T Consensus 171 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~ 249 (279)
T cd05111 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDLLEKGERLAQPQICTIDVYMVMVKCWM 249 (279)
T ss_pred CCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHHCCCcCCCCCCCCHHHHHHHHHHcC
Confidence 346778999999999889999999999999999998 999998765443 344445444445555677889999999999
Q ss_pred CCcCCcCCChHhHHHHHc
Q 001952 922 KEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILk 939 (992)
.||++||+ +.|+++
T Consensus 250 ~~p~~Rps----~~el~~ 263 (279)
T cd05111 250 IDENVRPT----FKELAN 263 (279)
T ss_pred CCcccCcC----HHHHHH
Confidence 99999999 556544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=323.06 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=206.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCC---eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTN---CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg---~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.++.... ......+.+|+.+|+.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 468999999999999999999886443 4799999865321 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999998765 346899999999999999999999999999999999999999999999999987432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. . ........
T Consensus 160 ~~----------~-----------------------------------------------------------~~~~~~~~ 170 (267)
T cd05066 160 PE----------A-----------------------------------------------------------AYTTRGGK 170 (267)
T ss_pred cc----------e-----------------------------------------------------------eeecCCCc
Confidence 00 0 00001122
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|++||.+.+..++.++|+|||||++|||++ |..||.+....+.+..+. .....+....++..+.+|+.+||+.+
T Consensus 171 ~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~ 249 (267)
T cd05066 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQKD 249 (267)
T ss_pred cceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccC
Confidence 3567999999999889999999999999999886 999998876666555544 33455555568889999999999999
Q ss_pred cCCcCCChHhHHHHH
Q 001952 924 PENRLGSQKGAAEIK 938 (992)
Q Consensus 924 PekRPT~~~~aeEIL 938 (992)
|.+||+ +.+++
T Consensus 250 p~~Rp~----~~~i~ 260 (267)
T cd05066 250 RNERPK----FEQIV 260 (267)
T ss_pred chhCCC----HHHHH
Confidence 999999 55554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=321.57 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=208.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCe---EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNC---LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~---~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
..+|++.+.||+|+||.||+|.+..+++ .||||++.... .......+..|+.+++.++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4578999999999999999999876654 69999987532 223346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
++||||+++++|..++... ...+++..++.++.|++.||.|||++|++|+||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999988764 356899999999999999999999999999999999999999999999999986332100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. . + .........
T Consensus 160 ~~--------~-----------------------------~------------------------------~~~~~~~~~ 172 (269)
T cd05065 160 TS--------D-----------------------------P------------------------------TYTSSLGGK 172 (269)
T ss_pred cc--------c-----------------------------c------------------------------ccccccCCC
Confidence 00 0 0 000000111
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+ ......+....++..+.+++.+||..+
T Consensus 173 ~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~~l~~~ 251 (269)
T cd05065 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMDCPTALHQLMLDCWQKD 251 (269)
T ss_pred cceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCcccCCHHHHHHHHHHcCCC
Confidence 2457999999999999999999999999999886 99999887666655554 344555555668889999999999999
Q ss_pred cCCcCCChHhHHHHHc
Q 001952 924 PENRLGSQKGAAEIKQ 939 (992)
Q Consensus 924 PekRPT~~~~aeEILk 939 (992)
|++||+ +.+|+.
T Consensus 252 p~~Rp~----~~~i~~ 263 (269)
T cd05065 252 RNARPK----FGQIVS 263 (269)
T ss_pred hhhCcC----HHHHHH
Confidence 999999 666664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=358.62 Aligned_cols=261 Identities=31% Similarity=0.500 Sum_probs=233.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
....|.+...||+|.|++|.+|.+..++..||||++.+..+.... .+.+.+|+++|+.++|||||+|+.+.+....+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 456899999999999999999999999999999999987655433 3458999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+.+|.+++++.+. +.+.+..++.++.|++.|++|||.++|||||||.+||||+.+.++||+|||++..+...
T Consensus 133 V~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred EEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc--
Confidence 99999999999999986 56778999999999999999999999999999999999999999999999998554321
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
....+++|+
T Consensus 209 -----------------------------------------------------------------------~~lqt~cgs 217 (596)
T KOG0586|consen 209 -----------------------------------------------------------------------LMLQTFCGS 217 (596)
T ss_pred -----------------------------------------------------------------------ccccccCCC
Confidence 112356799
Q ss_pred CCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+.|.|||++.|..| ++.+|+||||++||.|+.|..||.+.+-.+.....+.+.++.|.. ++.++.+||+++|..+|.
T Consensus 218 ppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl~Ps 295 (596)
T KOG0586|consen 218 PPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVLNPS 295 (596)
T ss_pred CCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce--eechhHHHHHHhhccCcc
Confidence 99999999999887 799999999999999999999999988777777888888888775 899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCchh
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
+|++ +++|.+|.|.....-.
T Consensus 296 kr~~----~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 296 KRGP----CDQIMKDRWRNDLLEA 315 (596)
T ss_pred ccCC----HHHhhhhcccchhhhh
Confidence 9999 9999999998765433
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=319.21 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=205.4
Q ss_pred EEEccCCceEEEEEEEcC-CC--eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEec
Q 001952 615 QKLGCGDIGTVYLAELIG-TN--CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~-tg--~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~ 691 (992)
+.||+|+||.||+|.+.. .+ ..||||++...... .....+.+|+.++++++|+||+++++++.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999998855 33 36999999865432 445678899999999999999999999988 8999999999
Q ss_pred CCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCC
Q 001952 692 PGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSS 771 (992)
Q Consensus 692 ~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~ 771 (992)
++++|..++.......+++..++.++.||+.||.|||..||+|+||+|+|||++.++.++|+|||++..+.....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~----- 152 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED----- 152 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc-----
Confidence 999999998875435689999999999999999999999999999999999999999999999999744311000
Q ss_pred CCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccC
Q 001952 772 SNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLA 851 (992)
Q Consensus 772 s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~A 851 (992)
.........++..|+|
T Consensus 153 ----------------------------------------------------------------~~~~~~~~~~~~~y~~ 168 (257)
T cd05040 153 ----------------------------------------------------------------HYVMEEHLKVPFAWCA 168 (257)
T ss_pred ----------------------------------------------------------------ceecccCCCCCceecC
Confidence 0000012346788999
Q ss_pred hhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCC
Q 001952 852 PEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 852 PEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
||++.+..++.++|||||||++|||++ |+.||......+.+..+......++.+..++..+.+|+.+||..+|++||+
T Consensus 169 pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 247 (257)
T cd05040 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPT- 247 (257)
T ss_pred HHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCC-
Confidence 999999899999999999999999998 999998877777666665444444455567889999999999999999999
Q ss_pred hHhHHHHHc
Q 001952 931 QKGAAEIKQ 939 (992)
Q Consensus 931 ~~~aeEILk 939 (992)
+.++++
T Consensus 248 ---~~~~~~ 253 (257)
T cd05040 248 ---FAALRE 253 (257)
T ss_pred ---HHHHHH
Confidence 666654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=320.12 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=205.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++.+.||+|+||.||+|.+..+. .+|+|.+.... .....+.+|+.+++.++|+||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 4467999999999999999999886554 58999886432 22356788999999999999999999875 456899
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+.+++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 99999999999998876555688999999999999999999999999999999999999999999999998743210000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.......++
T Consensus 158 -----------------------------------------------------------------------~~~~~~~~~ 166 (260)
T cd05069 158 -----------------------------------------------------------------------TARQGAKFP 166 (260)
T ss_pred -----------------------------------------------------------------------cccCCCccc
Confidence 000112356
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+. .....+....++..+.+||.+||..||+
T Consensus 167 ~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~ 245 (260)
T cd05069 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRMPCPQGCPESLHELMKLCWKKDPD 245 (260)
T ss_pred hhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCcccCHHHHHHHHHHccCCcc
Confidence 78999999998889999999999999999999 999998877666665543 3444444556889999999999999999
Q ss_pred CcCCChHhHHHHHc
Q 001952 926 NRLGSQKGAAEIKQ 939 (992)
Q Consensus 926 kRPT~~~~aeEILk 939 (992)
+||+ ++++++
T Consensus 246 ~Rp~----~~~i~~ 255 (260)
T cd05069 246 ERPT----FEYIQS 255 (260)
T ss_pred cCcC----HHHHHH
Confidence 9999 666654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=333.57 Aligned_cols=255 Identities=30% Similarity=0.398 Sum_probs=213.4
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
..|...+.||+|+||.||++.+..++..||+|++.............+..|+++++.++|+|++++++++..++..||||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 45888899999999999999999899999999987542222334456788999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+. |+|.+++... ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------ 176 (317)
T cd06635 105 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------ 176 (317)
T ss_pred eCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC------
Confidence 9996 4676665543 3568999999999999999999999999999999999999999999999999852110
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
......|+..
T Consensus 177 ----------------------------------------------------------------------~~~~~~~~~~ 186 (317)
T cd06635 177 ----------------------------------------------------------------------PANSFVGTPY 186 (317)
T ss_pred ----------------------------------------------------------------------CcccccCCcc
Confidence 0012347788
Q ss_pred ccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 849 YLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 849 Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+|||++. ...++.++|||||||++|||++|..||........+..+............++..+++||.+||..+|.
T Consensus 187 y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 266 (317)
T cd06635 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQ 266 (317)
T ss_pred ccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcc
Confidence 99999984 345789999999999999999999999887766666666655544444456788999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ 945 (992)
+||+ +.++++|+|+..
T Consensus 267 ~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 267 DRPT----SEELLKHMFVLR 282 (317)
T ss_pred cCcC----HHHHHhChhhhc
Confidence 9999 999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=320.97 Aligned_cols=255 Identities=21% Similarity=0.287 Sum_probs=207.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCe---EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNC---LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~---~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..++|+..+.||+|+||.||+|.+..++. .+++|.+..... ......+..|+++++.++|+||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 45678899999999999999999875543 799999865421 2234567889999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
.|+||||+++++|..++... ...+++..+..++.|++.||+|||+.||+|+||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 99999999999999998754 35689999999999999999999999999999999999999999999999998743211
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.... .......
T Consensus 160 ~~~~---------------------------------------------------------------------~~~~~~~ 170 (268)
T cd05063 160 DPEG---------------------------------------------------------------------TYTTSGG 170 (268)
T ss_pred cccc---------------------------------------------------------------------ceeccCC
Confidence 0000 0000011
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
..+..|+|||++.+..++.++|||||||++|||++ |+.||...+..+....+. .....+....++.++.+||.+||..
T Consensus 171 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~c~~~ 249 (268)
T cd05063 171 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMDCPSAVYQLMLQCWQQ 249 (268)
T ss_pred CcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23467999999998889999999999999999997 999998877666665554 3445555556889999999999999
Q ss_pred CcCCcCCChHhHHHHH
Q 001952 923 EPENRLGSQKGAAEIK 938 (992)
Q Consensus 923 DPekRPT~~~~aeEIL 938 (992)
+|++||+ +.+++
T Consensus 250 ~p~~Rp~----~~~i~ 261 (268)
T cd05063 250 DRARRPR----FVDIV 261 (268)
T ss_pred CcccCcC----HHHHH
Confidence 9999999 55554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=322.20 Aligned_cols=255 Identities=32% Similarity=0.472 Sum_probs=206.5
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--CeEEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--NLSCLVM 688 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~~lyLVm 688 (992)
|++++.||.|+||.||+|.+..+++.+|+|++.... ........+.+|+++++.++|+||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678899999999999999999999999999998643 1223345678899999999999999999999887 8999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||++ ++|..++... ...+++..++.++.||+.||+|||..|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~--- 154 (287)
T cd07840 80 EYMD-HDLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN--- 154 (287)
T ss_pred cccc-ccHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC---
Confidence 9996 5888877653 2468999999999999999999999999999999999999999999999999874321000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........++..
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~~~~ 166 (287)
T cd07840 155 --------------------------------------------------------------------SADYTNRVITLW 166 (287)
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 000112246778
Q ss_pred ccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-----CCCC------------------
Q 001952 849 YLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-----KFPD------------------ 904 (992)
Q Consensus 849 Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-----k~P~------------------ 904 (992)
|+|||.+.+. .++.++|||||||++|||++|+.||...+..+.+..+..... .++.
T Consensus 167 y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (287)
T cd07840 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKR 246 (287)
T ss_pred cCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchh
Confidence 9999988764 578999999999999999999999988776665555433110 0000
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
...++.++.++|.+||..+|.+||+ +.++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 247 RLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred HHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 0112778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=320.60 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=198.6
Q ss_pred EEccCCceEEEEEEE--cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 616 KLGCGDIGTVYLAEL--IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~--~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
.||+|+||.||+|.+ .+++..+|+|+++.... .......+..|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 45678999999864421 1233467888999999999999999999875 4567999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.++|+|||++..+......
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~------ 151 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY------ 151 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe------
Confidence 9999998754 56899999999999999999999999999999999999999999999999997432110000
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........++..|+|||
T Consensus 152 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 168 (257)
T cd05116 152 ---------------------------------------------------------------YKAKTHGKWPVKWYAPE 168 (257)
T ss_pred ---------------------------------------------------------------eeecCCCCCCccccCHh
Confidence 00001123467899999
Q ss_pred hhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
.+.+..++.++|||||||++|||++ |..||.+....+....+ ......+.+..++.++.+||.+||..||++||++..
T Consensus 169 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~ 247 (257)
T cd05116 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAV 247 (257)
T ss_pred HhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHH
Confidence 9988889999999999999999998 99999877665555544 344444455568999999999999999999999544
Q ss_pred hHHHHH
Q 001952 933 GAAEIK 938 (992)
Q Consensus 933 ~aeEIL 938 (992)
....+.
T Consensus 248 i~~~l~ 253 (257)
T cd05116 248 VELRLR 253 (257)
T ss_pred HHHHHh
Confidence 444433
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=322.15 Aligned_cols=253 Identities=34% Similarity=0.501 Sum_probs=205.1
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyLVmE 689 (992)
|.+.+.||+|+||.||+|.+..+++.|+||.+...... .......+|+..++.++ |+||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999888999999998654211 12223456889999998 9999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+ +++|.+++....+..+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 88998888765445789999999999999999999999999999999999999999999999998632210
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........|+..|
T Consensus 152 -------------------------------------------------------------------~~~~~~~~~~~~~ 164 (283)
T cd07830 152 -------------------------------------------------------------------RPPYTDYVSTRWY 164 (283)
T ss_pred -------------------------------------------------------------------CCCcCCCCCcccc
Confidence 0001123578899
Q ss_pred cChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-------------------CCCC-----
Q 001952 850 LAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------KFPD----- 904 (992)
Q Consensus 850 ~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------k~P~----- 904 (992)
+|||++.+ ..++.++|+||||+++|||++|+.||.+....+.+..+..... .++.
T Consensus 165 ~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd07830 165 RAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTS 244 (283)
T ss_pred cCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccccccc
Confidence 99998864 4578999999999999999999999988776655544332100 0000
Q ss_pred ----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 ----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 ----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
....+.++.+||++||..||++||+ +.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 245 LHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred HHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 0113578999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=326.20 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=207.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
...+|.+.++||+|+||.||++... .++..+++|.+... .......+.+|+++++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4568889999999999999999753 35678999988643 223345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcC-------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLG-------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG 748 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~-------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg 748 (992)
+..|++|||+++++|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 999999999999999999875421 3478899999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccC
Q 001952 749 HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828 (992)
Q Consensus 749 ~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~ 828 (992)
.++|+|||++..+.....
T Consensus 160 ~~kL~dfg~~~~~~~~~~-------------------------------------------------------------- 177 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-------------------------------------------------------------- 177 (280)
T ss_pred CEEECCCCceeEcCCCce--------------------------------------------------------------
Confidence 999999998743210000
Q ss_pred CccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCcc
Q 001952 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPL 907 (992)
Q Consensus 829 ~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~ 907 (992)
........+++.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+... .....+..
T Consensus 178 --------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 248 (280)
T cd05092 178 --------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG-RELERPRT 248 (280)
T ss_pred --------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC-ccCCCCCC
Confidence 000112345678999999999999999999999999999998 99999877766666555443 23334456
Q ss_pred chHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 908 vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
++..+.+||.+||..||.+||+ +.||+.
T Consensus 249 ~~~~~~~li~~cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 249 CPPEVYAIMQGCWQREPQQRMV----IKDIHS 276 (280)
T ss_pred CCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 8899999999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=371.18 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=220.9
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
.++...+.++.+.||+|.||+||+|+..+ ....||||.++... ..+....|++|+++|..++|||||+|+|+|
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVC 558 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence 34556778888999999999999997753 45689999998653 334567899999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcC--------C----CCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLG--------K----CFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~--------~----~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~ 746 (992)
..++.+|||||||..|+|.+||+...+ . +++..+.+.|+.||+.|++||-++.+|||||..+|+||.+
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 999999999999999999999985432 2 2788899999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhc
Q 001952 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIR 826 (992)
Q Consensus 747 dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~ 826 (992)
+-.|||+||||++..+...++-
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk---------------------------------------------------------- 660 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYK---------------------------------------------------------- 660 (774)
T ss_pred ceEEEecccccchhhhhhhhhc----------------------------------------------------------
Confidence 9999999999986655332211
Q ss_pred cCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCC
Q 001952 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDS 905 (992)
Q Consensus 827 ~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~ 905 (992)
......-+..||+||.|..+.|+.++|||||||+|||+++ |+.||.+..+.+.+..+-.+.+ ++.+
T Consensus 661 ------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~P 727 (774)
T KOG1026|consen 661 ------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCP 727 (774)
T ss_pred ------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCC
Confidence 0112245678999999999999999999999999999998 9999999999999999888887 8888
Q ss_pred ccchHHHHHHHHHhccCCcCCcCC
Q 001952 906 PLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT 929 (992)
..++.++.+|+..||+.+|.+||+
T Consensus 728 e~CP~~vY~LM~~CW~~~P~~RPs 751 (774)
T KOG1026|consen 728 ENCPTEVYSLMLECWNENPKRRPS 751 (774)
T ss_pred CCCCHHHHHHHHHHhhcCcccCCC
Confidence 999999999999999999999999
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=321.68 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=200.2
Q ss_pred eEEEEEccCCceEEEEEEEcCCCe--EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc------CCe
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNC--LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------DNL 683 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~--~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------~~~ 683 (992)
.+.+.||+|+||.||+|.+..++. .||+|.++... ........+..|+++|+.++|+||+++++++.. ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 456789999999999999877664 68999886532 122345677889999999999999999998743 235
Q ss_pred EEEEEEecCCCChHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQ----LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~----~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
.+++|||+.+|+|..++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 78999999999998876432 12457899999999999999999999999999999999999999999999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..... ...
T Consensus 161 ~~~~~~~----------------------------------------------------------------------~~~ 170 (272)
T cd05075 161 KIYNGDY----------------------------------------------------------------------YRQ 170 (272)
T ss_pred ccCcccc----------------------------------------------------------------------eec
Confidence 3211000 000
Q ss_pred cCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
.....+++.|++||++.+..++.++|||||||++|||++ |+.||.+....+.+..+.. ....+....++..+.+||.+
T Consensus 171 ~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 249 (272)
T cd05075 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ-GNRLKQPPDCLDGLYSLMSS 249 (272)
T ss_pred CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHH
Confidence 011235678999999999999999999999999999999 8999988766655554433 33334445688899999999
Q ss_pred hccCCcCCcCCChHhHHHHHcC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkH 940 (992)
||..||++||+ +.+|+++
T Consensus 250 ~l~~~p~~Rps----~~~l~~~ 267 (272)
T cd05075 250 CWLLNPKDRPS----FETLRCE 267 (272)
T ss_pred HcCCCcccCcC----HHHHHHH
Confidence 99999999999 7776653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.03 Aligned_cols=247 Identities=21% Similarity=0.329 Sum_probs=206.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++.+.||.|+||.||+|... ++.||||.+..... ....+.+|+.+++.++|+||+++++++...+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 4578999999999999999999874 67899999975422 35678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++.......+++..++.++.|++.||.|||..||+|+||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999999988764457899999999999999999999999999999999999999999999999987332100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.....++
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd05039 156 -------------------------------------------------------------------------QDSGKLP 162 (256)
T ss_pred -------------------------------------------------------------------------cccCCCc
Confidence 0011234
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|+|||++.+..++.++|||||||++|||++ |..||......+... .+........+..++.++.+||.+||..+|+
T Consensus 163 ~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05039 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEVYKVMKDCWELDPA 241 (256)
T ss_pred ccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCCccCCCHHHHHHHHHHhccChh
Confidence 57999999998889999999999999999997 999998765444443 3333334444455789999999999999999
Q ss_pred CcCCChHhHHHHHc
Q 001952 926 NRLGSQKGAAEIKQ 939 (992)
Q Consensus 926 kRPT~~~~aeEILk 939 (992)
+||+ +.|+++
T Consensus 242 ~Rp~----~~~l~~ 251 (256)
T cd05039 242 KRPT----FKQLRE 251 (256)
T ss_pred hCcC----HHHHHH
Confidence 9999 777664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=333.41 Aligned_cols=274 Identities=26% Similarity=0.327 Sum_probs=211.4
Q ss_pred cCce-EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhc-----------chhHHHHHHHHHHHcCCCCccceee
Q 001952 609 RHFN-LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK-----------KMPRAQTEREILRMLDHPFLPTLYS 676 (992)
Q Consensus 609 ~~Ye-ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~-----------~~~~~~~EieILk~L~HPNIVkL~g 676 (992)
++|. +.+.||.|+||.||+|.+..+++.||||++......... ....+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 456799999999999999989999999998654221100 1124678999999999999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecc
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
++..++..|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999995 6888887653 568999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++..+...... . ..... .....
T Consensus 165 ~~~~~~~~~~~-~-------~~~~~--------------------------------------------------~~~~~ 186 (335)
T PTZ00024 165 LARRYGYPPYS-D-------TLSKD--------------------------------------------------ETMQR 186 (335)
T ss_pred ceeeccccccc-c-------ccccc--------------------------------------------------ccccc
Confidence 97543211000 0 00000 00000
Q ss_pred CCCcCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-----CCC------
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-----FPD------ 904 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-----~P~------ 904 (992)
........++..|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+...... ++.
T Consensus 187 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 266 (335)
T PTZ00024 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPL 266 (335)
T ss_pred cccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccc
Confidence 11122335788999999998754 689999999999999999999999988877776655432110 000
Q ss_pred ---------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 905 ---------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 905 ---------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
...++.++.+||.+||..+|++||+ ++|+|.||||+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 267 YTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKSDP 320 (335)
T ss_pred ccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCCCC
Confidence 1234678999999999999999999 99999999998653
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=326.94 Aligned_cols=262 Identities=27% Similarity=0.390 Sum_probs=209.1
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCe
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ 683 (992)
.+..++|++.+.||+|+||.||+|.+..++..||||+++.... ......+..|+.++..+ +|+||+++++++..+..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3457889999999999999999999988899999999975321 12234456677766666 59999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
+|+||||+ +++|..++... ...+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.++|+|||++..+.
T Consensus 89 ~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 89 VFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99999998 56777776653 3578999999999999999999997 699999999999999999999999999863321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 167 ~~-------------------------------------------------------------------------~~~~~ 173 (296)
T cd06618 167 DS-------------------------------------------------------------------------KAKTR 173 (296)
T ss_pred CC-------------------------------------------------------------------------CcccC
Confidence 00 00011
Q ss_pred cccCCCccChhhhcCCC----CCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhcc-CCCCCccchHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQSL-KFPDSPLISFQARDLI 916 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~----~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~l-k~P~~~~vs~el~dLI 916 (992)
..++..|+|||++.+.. ++.++|||||||++|||++|+.||..... .+.+..++.... ..+....++.++.+||
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 253 (296)
T cd06618 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV 253 (296)
T ss_pred CCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Confidence 24678899999997654 78899999999999999999999976433 344555444432 2333334788999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.+||..||.+||+ ++++++||||+...
T Consensus 254 ~~~l~~~p~~Rp~----~~~il~~~~~~~~~ 280 (296)
T cd06618 254 DLCLTKDHRKRPK----YRELLQHPFIRRYE 280 (296)
T ss_pred HHHccCChhhCCC----HHHHhcChhhhccc
Confidence 9999999999999 99999999998643
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=362.31 Aligned_cols=253 Identities=26% Similarity=0.400 Sum_probs=215.3
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH-HhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe--EEEEE
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL--SCLVM 688 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l-~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~--lyLVm 688 (992)
+...+||+|+|-+||+|.+..+|..||+-.++...+ ......++|..|+.+|+.|+|+||+++|.+|.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 344679999999999999999999999877764443 334556889999999999999999999999987554 88999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEc-cCCcEEEEeccccccccCCc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVR-EDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd-~dg~VKLsDFGLA~~l~~~~ 765 (992)
|++..|+|..|+++. +.++...++.|++||+.||.|||++. |||||||.+||+|+ .-|.|||+|+|||..+.
T Consensus 123 EL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r--- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR--- 197 (632)
T ss_pred ecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh---
Confidence 999999999999986 67889999999999999999999996 99999999999998 56889999999985431
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
..+....+|
T Consensus 198 -----------------------------------------------------------------------~s~aksvIG 206 (632)
T KOG0584|consen 198 -----------------------------------------------------------------------KSHAKSVIG 206 (632)
T ss_pred -----------------------------------------------------------------------ccccceecc
Confidence 112334789
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-CCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP-DSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P-~~~~vs~el~dLI~kcL~~DP 924 (992)
||.|||||++. ..|+..+||||||++|+||+|+.+||....+..++.+-|..+.+.. ....-++++++||.+||.. .
T Consensus 207 TPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~ 284 (632)
T KOG0584|consen 207 TPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-K 284 (632)
T ss_pred CccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-c
Confidence 99999999998 6799999999999999999999999998877655555555554432 2333467999999999999 9
Q ss_pred CCcCCChHhHHHHHcCCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~l 946 (992)
..|++ +.|||+||||+.-
T Consensus 285 ~~R~s----a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 285 SERLS----AKELLKDPFFDED 302 (632)
T ss_pred hhccC----HHHHhhChhhccc
Confidence 99999 9999999999985
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=338.59 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=206.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeec
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFT 679 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~ 679 (992)
+..++|++.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.+|..+ +|+||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45678999999999999999999853 357889999997532 122345678899999999 6899999999876
Q ss_pred c-CCeEEEEEEecCCCChHHHHHhhc------------------------------------------------------
Q 001952 680 S-DNLSCLVMEYCPGGDLHVLRQKQL------------------------------------------------------ 704 (992)
Q Consensus 680 ~-~~~lyLVmEy~~GGSL~~lLkk~~------------------------------------------------------ 704 (992)
. +..+++||||+++|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 456899999999999999886431
Q ss_pred -----------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 705 -----------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 705 -----------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~------- 234 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD------- 234 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc-------
Confidence 12367788899999999999999999999999999999999999999999998743210000
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........++..|+|||
T Consensus 235 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 235 ---------------------------------------------------------------YVRKGDARLPLKWMAPE 251 (343)
T ss_pred ---------------------------------------------------------------hhhcCCCCCCcceECcH
Confidence 00001123567799999
Q ss_pred hhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
++.+..++.++|||||||++|||++ |..||.+......+...+......+.+..++.++.+++..||..||++||+
T Consensus 252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps--- 328 (343)
T cd05103 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT--- 328 (343)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcC---
Confidence 9999999999999999999999997 999998765555555555554444444557889999999999999999999
Q ss_pred hHHHHHcC
Q 001952 933 GAAEIKQH 940 (992)
Q Consensus 933 ~aeEILkH 940 (992)
+.||++|
T Consensus 329 -~~eil~~ 335 (343)
T cd05103 329 -FSELVEH 335 (343)
T ss_pred -HHHHHHH
Confidence 8888775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=328.15 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=207.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcC-------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeee
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIG-------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQ 677 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~-------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~ 677 (992)
+...+|.+.+.||+|+||.||+|.+.. .+..||+|++.... .......+.+|+.+++.+ +|+||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 456789999999999999999997632 34579999987532 123346788999999999 89999999999
Q ss_pred eccCCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 678 FTSDNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 678 f~~~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
+...+..|+||||+++++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 999999999999999999999987642 134778889999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 744 Ld~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
++.++.++|+|||++..+.....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~--------------------------------------------------------- 192 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDY--------------------------------------------------------- 192 (304)
T ss_pred EcCCCcEEECCCccceecccccc---------------------------------------------------------
Confidence 99999999999999744311000
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCC
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
........+++.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+ ......
T Consensus 193 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~ 258 (304)
T cd05101 193 -------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL-KEGHRM 258 (304)
T ss_pred -------------cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HcCCcC
Confidence 000111235678999999999889999999999999999998 88999887665555544 333444
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.....++.++.+||.+||..+|.+||+ +.|+++
T Consensus 259 ~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~l~ 291 (304)
T cd05101 259 DKPANCTNELYMMMRDCWHAIPSHRPT----FKQLVE 291 (304)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHH
Confidence 444568899999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=329.99 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=204.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCC-------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeee
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT-------NCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQ 677 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~t-------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~ 677 (992)
+..++|.+.+.||+|+||.||++.+.+. ...+|+|++.... .......+..|+++++.+ +|+||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 3357899999999999999999987542 3469999997542 122345678899999999 79999999999
Q ss_pred eccCCeEEEEEEecCCCChHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 678 FTSDNLSCLVMEYCPGGDLHVLRQKQLG--------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 678 f~~~~~lyLVmEy~~GGSL~~lLkk~~~--------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
+...+.+|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 9999999999999999999999876421 34788999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 744 Ld~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
++.++.++|+|||++..+.....
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~--------------------------------------------------------- 195 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDY--------------------------------------------------------- 195 (307)
T ss_pred EcCCCcEEECCCcccccccccch---------------------------------------------------------
Confidence 99999999999998743210000
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCC
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+... .+......
T Consensus 196 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~ 261 (307)
T cd05098 196 -------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-LLKEGHRM 261 (307)
T ss_pred -------------hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH-HHHcCCCC
Confidence 000011124567999999999889999999999999999998 889997765444443 34444444
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..+..++.++.+||.+||..+|.+||+ +.++++
T Consensus 262 ~~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~ 294 (307)
T cd05098 262 DKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 294 (307)
T ss_pred CCCCcCCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 445568899999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=336.54 Aligned_cols=266 Identities=33% Similarity=0.464 Sum_probs=210.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeecc--CCe
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTS--DNL 683 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~--~~~ 683 (992)
..++|++.+.||+|+||.||+|.+..+++.+|||.+..... .......+.+|+.+++.+ +|+||++++++|.. ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 35789999999999999999999988899999998854321 122334567899999999 99999999998864 346
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||+. ++|..++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 899999996 5888887653 678899999999999999999999999999999999999999999999998744311
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.... .........
T Consensus 160 ~~~~-------------------------------------------------------------------~~~~~~~~~ 172 (337)
T cd07852 160 LEEN-------------------------------------------------------------------PENPVLTDY 172 (337)
T ss_pred cccc-------------------------------------------------------------------ccCcchhcc
Confidence 0000 000011234
Q ss_pred ccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC--------------------
Q 001952 844 VGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF-------------------- 902 (992)
Q Consensus 844 vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~-------------------- 902 (992)
.|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+.......
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (337)
T cd07852 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSL 252 (337)
T ss_pred cccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhc
Confidence 68999999998865 457899999999999999999999998776655554433221110
Q ss_pred ---------CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 903 ---------PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 903 ---------P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
...+.++.++.+||.+||..||++||+ +.++++||||+.++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~~~ 303 (337)
T cd07852 253 PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQFHN 303 (337)
T ss_pred ccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhhcc
Confidence 001225788999999999999999999 999999999988753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=336.72 Aligned_cols=256 Identities=30% Similarity=0.423 Sum_probs=211.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL---- 683 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~---- 683 (992)
.++|++.+.||+|+||.||+|.+..++..||||++..... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 5689999999999999999999999999999999865321 12233556789999999999999999998876654
Q ss_pred --EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 684 --SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 684 --lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+|+|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899988875 46899999999999999999999999999999999999999999999999986321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. ...
T Consensus 169 ~~---------------------------------------------------------------------------~~~ 173 (343)
T cd07851 169 DD---------------------------------------------------------------------------EMT 173 (343)
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 10 011
Q ss_pred ccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-----------------
Q 001952 842 SFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP----------------- 903 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P----------------- 903 (992)
...++..|+|||.+.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......+
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (343)
T cd07851 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ 253 (343)
T ss_pred CCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHH
Confidence 23577889999998764 578999999999999999999999988777666655443211000
Q ss_pred ------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 904 ------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 904 ------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
....++.++.+||.+||..||++||+ +.||+.||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~~~ 305 (343)
T cd07851 254 SLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAEYH 305 (343)
T ss_pred hccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCccccC
Confidence 00125788999999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.37 Aligned_cols=247 Identities=22% Similarity=0.306 Sum_probs=196.6
Q ss_pred EEccCCceEEEEEEEc--CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 616 KLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~--~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
.||+|+||.||+|.+. ..+..||+|++.... .......+.+|+.++++++|+||+++++++. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999775 445679999987542 2233456889999999999999999999886 4578999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~------ 151 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY------ 151 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc------
Confidence 9999988753 356899999999999999999999999999999999999999999999999987432110000
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........++..|+|||
T Consensus 152 ---------------------------------------------------------------~~~~~~~~~~~~y~aPE 168 (257)
T cd05115 152 ---------------------------------------------------------------YKARSAGKWPLKWYAPE 168 (257)
T ss_pred ---------------------------------------------------------------eeccCCCCCCcccCCHH
Confidence 00001112457899999
Q ss_pred hhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
++.+..++.++|||||||++|||++ |..||.+....+....+ ......+.+..++.++.+||.+||..||++||++..
T Consensus 169 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~ 247 (257)
T cd05115 169 CINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI-EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAK 247 (257)
T ss_pred HHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 9998889999999999999999996 99999887766655444 333444444567899999999999999999999544
Q ss_pred hHHH
Q 001952 933 GAAE 936 (992)
Q Consensus 933 ~aeE 936 (992)
.+..
T Consensus 248 i~~~ 251 (257)
T cd05115 248 VEER 251 (257)
T ss_pred HHHH
Confidence 4333
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=321.54 Aligned_cols=254 Identities=31% Similarity=0.476 Sum_probs=208.0
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+..|+++|+.++|+||+++++++..++.+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56788999999999999999889999999998754322 12345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+++ +|..++.... ..+++..++.++.||+.||.|||..||+|+||+|+|||++.++.++|+|||++..+....
T Consensus 80 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 965 7777766532 578999999999999999999999999999999999999999999999999863321000
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
.......++..|+
T Consensus 153 -------------------------------------------------------------------~~~~~~~~~~~~~ 165 (283)
T cd05118 153 -------------------------------------------------------------------RPYTHYVVTRWYR 165 (283)
T ss_pred -------------------------------------------------------------------ccccCccCccccc
Confidence 0011235778899
Q ss_pred ChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-------------------CC-------
Q 001952 851 APEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-------------------FP------- 903 (992)
Q Consensus 851 APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-------------------~P------- 903 (992)
|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...... ++
T Consensus 166 ~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (283)
T cd05118 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL 245 (283)
T ss_pred CcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCH
Confidence 99999887 6899999999999999999999999887776665554322110 00
Q ss_pred --CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 904 --DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 904 --~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
..+.++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 246 PKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred HHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 01235778999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.60 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=198.2
Q ss_pred EEEccCCceEEEEEEEcCCC---eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEec
Q 001952 615 QKLGCGDIGTVYLAELIGTN---CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg---~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~ 691 (992)
++||+|+||.||+|.+...+ ..||+|.+...... .....+..|+.+++.++|+||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 36999999999999876555 78999999755322 23456788999999999999999999876 45689999999
Q ss_pred CCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCC
Q 001952 692 PGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSS 771 (992)
Q Consensus 692 ~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~ 771 (992)
++++|.+++... ..+++..++.++.||+.||+|||..||+|+||||+|||++.++.++|+|||++..+......
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~---- 151 (257)
T cd05060 78 PLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---- 151 (257)
T ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc----
Confidence 999999998865 46899999999999999999999999999999999999999999999999997443210000
Q ss_pred CCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccC
Q 001952 772 SNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLA 851 (992)
Q Consensus 772 s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~A 851 (992)
........++..|+|
T Consensus 152 -----------------------------------------------------------------~~~~~~~~~~~~y~a 166 (257)
T cd05060 152 -----------------------------------------------------------------YRATTAGRWPLKWYA 166 (257)
T ss_pred -----------------------------------------------------------------cccccCccccccccC
Confidence 000001124567999
Q ss_pred hhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCC
Q 001952 852 PEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 852 PEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
||.+.+..++.++|||||||++|||++ |..||...+..+.... +......+.+..++..+++||.+||..+|++||+
T Consensus 167 PE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~- 244 (257)
T cd05060 167 PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIMLSCWKYRPEDRPT- 244 (257)
T ss_pred HHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcC-
Confidence 999999999999999999999999998 9999987766554444 3344444555668899999999999999999999
Q ss_pred hHhHHHHH
Q 001952 931 QKGAAEIK 938 (992)
Q Consensus 931 ~~~aeEIL 938 (992)
+.+++
T Consensus 245 ---~~~l~ 249 (257)
T cd05060 245 ---FSELE 249 (257)
T ss_pred ---HHHHH
Confidence 55554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=330.66 Aligned_cols=257 Identities=28% Similarity=0.366 Sum_probs=211.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
...|...+.||+|+||.||+|.+..++..++||.+.............+.+|+++++.++|+|++++++++......|+|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34577888999999999999999999999999998643222223345677899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. ++|..++... ...+++..++.++.||+.||.|||..|++||||+|+|||++.++.++|+|||++.....
T Consensus 94 ~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 94 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 99996 5777665543 35689999999999999999999999999999999999999999999999998632100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.....|+.
T Consensus 168 ------------------------------------------------------------------------~~~~~~~~ 175 (308)
T cd06634 168 ------------------------------------------------------------------------ANXFVGTP 175 (308)
T ss_pred ------------------------------------------------------------------------cccccCCc
Confidence 01234788
Q ss_pred CccChhhhcC---CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 848 EYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 848 ~Y~APEvL~g---~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
.|+|||.+.+ ..++.++|||||||++|||++|..||......+.+..+............++..+.+||.+||..+|
T Consensus 176 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P 255 (308)
T cd06634 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 255 (308)
T ss_pred cccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCc
Confidence 8999999853 4578899999999999999999999987766555555544433333334578889999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~l 946 (992)
++||+ +.++++||||...
T Consensus 256 ~~Rp~----~~~ll~~~~~~~~ 273 (308)
T cd06634 256 QDRPT----SEVLLKHRFVLRE 273 (308)
T ss_pred ccCCC----HHHHhhCcccccc
Confidence 99999 9999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=353.71 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=223.1
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCC----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTN----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
.+++..++..+.++||+|.||.||+|.+...+ ..||||..+......+....++.+|.++|+.++|||||+|||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34556677777899999999999999887542 23899998753334456778899999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.....+|||||+|.||+|.+++++.. ..++......++.+.+.||+|||.+++|||||..+|+|++.++.+||+||||+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999999874 36999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
+... .+..
T Consensus 310 ~~~~--~~~~---------------------------------------------------------------------- 317 (474)
T KOG0194|consen 310 RAGS--QYVM---------------------------------------------------------------------- 317 (474)
T ss_pred cCCc--ceee----------------------------------------------------------------------
Confidence 4321 0000
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIR 917 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~ 917 (992)
....-.-+..|+|||.+....|+.++|||||||++||+++ |..||.+....+....++...++.+.+...+.++..++.
T Consensus 318 ~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~ 397 (474)
T KOG0194|consen 318 KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMK 397 (474)
T ss_pred ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHH
Confidence 0000123567999999999999999999999999999999 899999999999999998888888888889999999999
Q ss_pred HhccCCcCCcCCChHhHHH
Q 001952 918 GLLIKEPENRLGSQKGAAE 936 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeE 936 (992)
+||..||+.||+|......
T Consensus 398 ~c~~~~p~~R~tm~~i~~~ 416 (474)
T KOG0194|consen 398 QCWKKDPEDRPTMSTIKKK 416 (474)
T ss_pred HhccCChhhccCHHHHHHH
Confidence 9999999999997655443
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.10 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=203.6
Q ss_pred CceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... ......+.+|+.+|+.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 47888999999999999998753 235789998864321 12345678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 685 CLVMEYCPGGDLHVLRQKQL----------------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~----------------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
|+||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999876421 13478889999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|++.++.++|+|||++..+......
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------------------- 183 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------------- 183 (290)
T ss_pred EEcCCCcEEeccccccccccCccch-------------------------------------------------------
Confidence 9999999999999997432110000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+ ..+.....
T Consensus 184 ---------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~ 247 (290)
T cd05045 184 ---------------VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF-NLLKTGYR 247 (290)
T ss_pred ---------------hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHhCCCC
Confidence 00011234667999999998889999999999999999998 99999876555444 44445555
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.+.+..++.++.+||..||+.+|++||+ +.++++
T Consensus 248 ~~~~~~~~~~~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 248 MERPENCSEEMYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCC----HHHHHH
Confidence 5555668899999999999999999999 666553
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=327.53 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=203.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCC--------------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCcc
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGT--------------NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~t--------------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIV 672 (992)
..++|++.+.||+|+||.||+|.+.+. ...||+|.++... .......+.+|+++|+.++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456899999999999999999987543 2358999987542 122345678899999999999999
Q ss_pred ceeeeeccCCeEEEEEEecCCCChHHHHHhhcC----------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLG----------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 673 kL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~----------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
++++++...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|+||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999999999999999999999999998865321 2367888999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|++.++.++|+|||++..+.....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~-------------------------------------------------------- 184 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDY-------------------------------------------------------- 184 (295)
T ss_pred EEcCCCcEEecccccccccccCcc--------------------------------------------------------
Confidence 999999999999998743210000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc--CCCCCCCCCchHHHHHHHh---
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY--GRTPFKGSGNEETLANVVM--- 897 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT--Gr~PF~g~s~~e~L~~Iv~--- 897 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||......+....+..
T Consensus 185 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~ 250 (295)
T cd05097 185 --------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFR 250 (295)
T ss_pred --------------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhh
Confidence 000112345678999999999889999999999999999988 6788887766555544322
Q ss_pred ---hccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 898 ---QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 898 ---~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..........++..+.+||.+||..||++||+ +++|++
T Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 251 NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 11122334457889999999999999999999 666643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.73 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=207.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4789999999999999999999988999999999875321 122345677899999999999999999987532
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
...|++++++ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 4578899987 8899888764 45899999999999999999999999999999999999999999999999986321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ....
T Consensus 171 ~---------------------------------------------------------------------------~~~~ 175 (345)
T cd07877 171 D---------------------------------------------------------------------------DEMT 175 (345)
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0011
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc--------------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------- 900 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------- 900 (992)
...|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (345)
T cd07877 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 255 (345)
T ss_pred ccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHH
Confidence 2357888999999877 4678999999999999999999999987666555444332111
Q ss_pred ---CCCC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 901 ---KFPD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 901 ---k~P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..+. ....+.++.+||.+||..||.+||+ +.+++.||||.++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~~~ 307 (345)
T cd07877 256 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYH 307 (345)
T ss_pred HhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhhcC
Confidence 0110 0124678899999999999999999 99999999999753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=336.52 Aligned_cols=257 Identities=33% Similarity=0.474 Sum_probs=207.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
..+|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3589999999999999999999988999999999875321 122334578899999999999999999998754
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+|+||||+. .+|..++. ..+++..++.++.||+.||+|||.+||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred ceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 34699999994 56765542 45899999999999999999999999999999999999999999999999986321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ....
T Consensus 168 ~---------------------------------------------------------------------------~~~~ 172 (342)
T cd07879 168 D---------------------------------------------------------------------------AEMT 172 (342)
T ss_pred C---------------------------------------------------------------------------CCCC
Confidence 0 0011
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc---------------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--------------------- 899 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--------------------- 899 (992)
...|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++...
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (342)
T cd07879 173 GYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252 (342)
T ss_pred CceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHh
Confidence 2357888999999877 457899999999999999999999999876655554443311
Q ss_pred --cCCCC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 900 --LKFPD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 900 --lk~P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
...+. .+.++.++.+||.+||..||++||+ +.+++.||||+.+.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 253 SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRDA 306 (342)
T ss_pred hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhcccc
Confidence 00010 1235678899999999999999999 9999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.72 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=207.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH--hhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA--RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~--~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+|.+.+.||+|+||.||++.+...+..+++|+++..... .......+..|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 588999999999999999999877777777776542211 112233466789999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||+++++|..++... ....+++..++.++.||+.||.|||+.||+|+||+|+||+++. +.++|+|||++..+...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 9999999999887642 2356899999999999999999999999999999999999975 56999999986432100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........|
T Consensus 159 -----------------------------------------------------------------------~~~~~~~~~ 167 (260)
T cd08222 159 -----------------------------------------------------------------------CDLATTFTG 167 (260)
T ss_pred -----------------------------------------------------------------------cccccCCCC
Confidence 000112347
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+..|+|||.+.+..++.++|+||||+++|+|++|..||...........+.... .......++.++.+||.+||..+|+
T Consensus 168 ~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~ 246 (260)
T cd08222 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP-TPSLPETYSRQLNSIMQSMLNKDPS 246 (260)
T ss_pred CcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC-CCCCcchhcHHHHHHHHHHhcCChh
Confidence 788999999988888999999999999999999999998766555555544322 2222345788999999999999999
Q ss_pred CcCCChHhHHHHHcCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF 943 (992)
+||+ +.|+++||||
T Consensus 247 ~Rp~----~~~il~~~~~ 260 (260)
T cd08222 247 LRPS----AAEILRNPFI 260 (260)
T ss_pred hCcC----HHHHhhCCCC
Confidence 9999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.19 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=206.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
..++|++.+.||+|+||.||+|.+.+ ++..||+|++.... .......+.+|+.+++.++||||+++++++..+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998753 57889999987532 122335678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcC--------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCce
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLG--------------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPEN 741 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~--------------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeN 741 (992)
+..|+||||+++++|.+++..... ..+++..++.++.||+.||+|||..||+||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 999999999999999999875321 246788899999999999999999999999999999
Q ss_pred EEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCCh
Q 001952 742 ILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP 821 (992)
Q Consensus 742 ILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~ 821 (992)
||++.++.++|+|||++..+..... +
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~-----------------------------------~------------------- 186 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADY-----------------------------------Y------------------- 186 (288)
T ss_pred eEecCCCceEECccccceecccCcc-----------------------------------c-------------------
Confidence 9999999999999998643211000 0
Q ss_pred hhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhcc
Q 001952 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSL 900 (992)
Q Consensus 822 ~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~l 900 (992)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+.....
T Consensus 187 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~ 250 (288)
T cd05050 187 ----------------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV 250 (288)
T ss_pred ----------------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence 00011124567999999999999999999999999999997 8899988777666665543332
Q ss_pred CCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 901 KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 901 k~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
++.+..++.++.+||.+||..||++||+ +.||+
T Consensus 251 -~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~el~ 283 (288)
T cd05050 251 -LSCPDNCPLELYNLMRLCWSKLPSDRPS----FASIN 283 (288)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHH
Confidence 3334457889999999999999999999 66665
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.55 Aligned_cols=256 Identities=23% Similarity=0.309 Sum_probs=201.6
Q ss_pred cCceEEEEEccCCceEEEEEEE----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--C
Q 001952 609 RHFNLLQKLGCGDIGTVYLAEL----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD--N 682 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~--~ 682 (992)
..|++++.||+|+||.||+|.+ ..++..||+|.++... .......+.+|+++|+.++|+||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4578899999999999999975 3567889999987442 223345788999999999999999999998765 6
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..++||||++|++|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 789999999999999998764 2458999999999999999999999999999999999999999999999999874321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... .......
T Consensus 161 ~~~~---------------------------------------------------------------------~~~~~~~ 171 (284)
T cd05079 161 TDKE---------------------------------------------------------------------YYTVKDD 171 (284)
T ss_pred cCcc---------------------------------------------------------------------ceeecCC
Confidence 0000 0000112
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCC--------------CchHHHHHHHhhccCCCCCccc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS--------------GNEETLANVVMQSLKFPDSPLI 908 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~--------------s~~e~L~~Iv~~~lk~P~~~~v 908 (992)
..|+..|+|||++.+..++.++|||||||++|||+++..|+... .........+......+....+
T Consensus 172 ~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (284)
T cd05079 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNC 251 (284)
T ss_pred CCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCC
Confidence 34677899999999988999999999999999999987664321 1112222223333344445568
Q ss_pred hHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.++.+||.+||..||++||+ +.+++++
T Consensus 252 ~~~~~~li~~~l~~~p~~Rpt----~~~il~~ 279 (284)
T cd05079 252 PEEVYQLMRKCWEFQPSKRTT----FQNLIEG 279 (284)
T ss_pred CHHHHHHHHHHccCCcccCcC----HHHHHHH
Confidence 899999999999999999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.99 Aligned_cols=254 Identities=30% Similarity=0.458 Sum_probs=208.6
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
|++.+.||+|+||.||+|.+..+++.||+|++.... ........+..|+.+++.++|+||+++++++...+.+++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 567788999999999999999999999999997643 1233445678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+. ++|.+++.... ..+++..++.++.||+.||.|||.+||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~------ 151 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP------ 151 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC------
Confidence 96 58999888642 46899999999999999999999999999999999999999999999999986332100
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
........++..|+
T Consensus 152 ------------------------------------------------------------------~~~~~~~~~~~~~~ 165 (282)
T cd07829 152 ------------------------------------------------------------------LRTYTHEVVTLWYR 165 (282)
T ss_pred ------------------------------------------------------------------ccccCccccCcCcC
Confidence 00011224567899
Q ss_pred ChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc------------------cCCCC-------
Q 001952 851 APEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS------------------LKFPD------- 904 (992)
Q Consensus 851 APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~------------------lk~P~------- 904 (992)
|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+.... ..++.
T Consensus 166 aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (282)
T cd07829 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLE 245 (282)
T ss_pred ChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchH
Confidence 99999877 78999999999999999999999998877666655443210 00110
Q ss_pred --CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 905 --SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 905 --~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
.+.++.++.++|.+||..||++||+ +++++.||||
T Consensus 246 ~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 246 KVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred HhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 0124678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=315.32 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=206.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..++|++.+.||+|+||.||++.+. .+..+++|.+.... .....+.+|+++++.++|+||+++++++.. ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 345688999999999999999999865 44569999887532 223567889999999999999999999887 778
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|++|||+++++|.+++....+..+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999999998765567888999999999999999999999999999999999999999999999987332100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. .......
T Consensus 156 ~~-----------------------------------------------------------------------~~~~~~~ 164 (260)
T cd05073 156 EY-----------------------------------------------------------------------TAREGAK 164 (260)
T ss_pred Cc-----------------------------------------------------------------------ccccCCc
Confidence 00 0001123
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+....+ ......+....++.++.+++.+||..+
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~ 243 (260)
T cd05073 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPEELYNIMMRCWKNR 243 (260)
T ss_pred ccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCcccCCHHHHHHHHHHcccC
Confidence 5677999999998889999999999999999998 99999887665555443 344455555568889999999999999
Q ss_pred cCCcCCChHhHHHHH
Q 001952 924 PENRLGSQKGAAEIK 938 (992)
Q Consensus 924 PekRPT~~~~aeEIL 938 (992)
|++||+ +.+++
T Consensus 244 p~~Rp~----~~~l~ 254 (260)
T cd05073 244 PEERPT----FEYIQ 254 (260)
T ss_pred cccCcC----HHHHH
Confidence 999999 55554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.50 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=202.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC----------------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG----------------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~----------------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN 670 (992)
..++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+++|+.++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence 45689999999999999999986532 34579999987431 1223456789999999999999
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCce
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLG---------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPEN 741 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~---------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeN 741 (992)
|+++++++...+..|+||||+++++|..++..... ..+++..++.++.||+.||+|||+.||+|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99999999999999999999999999998876421 236678899999999999999999999999999999
Q ss_pred EEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCCh
Q 001952 742 ILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP 821 (992)
Q Consensus 742 ILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~ 821 (992)
||++.++.++|+|||++..+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~------------------------------------------------------- 185 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDY------------------------------------------------------- 185 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcc-------------------------------------------------------
Confidence 9999999999999999743211000
Q ss_pred hhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc--CCCCCCCCCchHHHHHHHh--
Q 001952 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY--GRTPFKGSGNEETLANVVM-- 897 (992)
Q Consensus 822 ~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT--Gr~PF~g~s~~e~L~~Iv~-- 897 (992)
........++..|++||++.+..++.++|||||||++|||++ |..||......+.+.....
T Consensus 186 ---------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~ 250 (296)
T cd05095 186 ---------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF 250 (296)
T ss_pred ---------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHH
Confidence 000112235678999999998889999999999999999998 7899987665555443221
Q ss_pred ----hccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 898 ----QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 898 ----~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
....++.+..++..+.+||.+||..||.+||+ +.+|+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~ 291 (296)
T cd05095 251 RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS----FQEIH 291 (296)
T ss_pred hhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHH
Confidence 12223444567889999999999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=320.13 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=200.2
Q ss_pred ccCceEEEEEccCCceEEEEEEE----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--C
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAEL----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--D 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~ 681 (992)
..+|++++.||+|+||.||+|.. ..+++.||||.+.... ......+.+|+++|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35789999999999999999974 3568899999986532 2334567899999999999999999998653 4
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 5689999999999999998754 245899999999999999999999999999999999999999999999999997433
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
...... .....
T Consensus 159 ~~~~~~---------------------------------------------------------------------~~~~~ 169 (284)
T cd05081 159 PQDKEY---------------------------------------------------------------------YKVRE 169 (284)
T ss_pred cCCCcc---------------------------------------------------------------------eeecC
Confidence 110000 00000
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch---------------HHHHHHHhhccCCCCCc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---------------ETLANVVMQSLKFPDSP 906 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~---------------e~L~~Iv~~~lk~P~~~ 906 (992)
...++..|+|||++.+..++.++|||||||++|||++|..++...... ..+..++.....++...
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (284)
T cd05081 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPP 249 (284)
T ss_pred CCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCC
Confidence 112345699999999988999999999999999999987765432111 11223344444555556
Q ss_pred cchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 907 LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 907 ~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.++.++.+||.+||..+|++||+ +.||++
T Consensus 250 ~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 250 GCPAEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred CCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 68899999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.97 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=208.9
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
...||+|+||.||++.+..++..||||.+.... ......+.+|+.+++.++|+||+++++++...+..|+||||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 457999999999999999999999999985431 22345678899999999999999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
++|.+++.. ..+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 102 ~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--------- 169 (292)
T cd06657 102 GALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--------- 169 (292)
T ss_pred CcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc---------
Confidence 999988754 45899999999999999999999999999999999999999999999999986321100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
........|+..|++||
T Consensus 170 ---------------------------------------------------------------~~~~~~~~~~~~y~~pE 186 (292)
T cd06657 170 ---------------------------------------------------------------VPRRKSLVGTPYWMAPE 186 (292)
T ss_pred ---------------------------------------------------------------cccccccccCccccCHH
Confidence 00011235788999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-cCCCCCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-LKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
.+.+..++.++|+|||||++|+|++|..||.+....+.+..+.... ..+.....++..+.++|.+||..||.+||+
T Consensus 187 ~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~--- 263 (292)
T cd06657 187 LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT--- 263 (292)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcC---
Confidence 9988888999999999999999999999998776655554443221 122233347889999999999999999999
Q ss_pred hHHHHHcCCCCCCC
Q 001952 933 GAAEIKQHPFFEGL 946 (992)
Q Consensus 933 ~aeEILkHPfF~~l 946 (992)
+.+++.||||...
T Consensus 264 -~~~ll~~~~~~~~ 276 (292)
T cd06657 264 -AAELLKHPFLAKA 276 (292)
T ss_pred -HHHHhcChHHhcc
Confidence 9999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=347.74 Aligned_cols=261 Identities=27% Similarity=0.442 Sum_probs=206.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+....|+++++||+||.+.||++...+. +.||+|.+.... .+.....-+.+|+++|.+| .|.+||+||+|-..++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 4567899999999999999999977554 456666554322 2345667889999999999 599999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||- ..+|..++++... .++...++.|..|+|.++.++|.+||||.||||.|+||- .|.+||+|||+|..+...
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9999986 7899999887643 344458899999999999999999999999999999997 578999999998432110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. +.......+
T Consensus 513 T----------------------------------------------------------------------TsI~kdsQv 522 (677)
T KOG0596|consen 513 T----------------------------------------------------------------------TSIVKDSQV 522 (677)
T ss_pred c----------------------------------------------------------------------cceeecccc
Confidence 0 011123458
Q ss_pred cCCCccChhhhcCCC-----------CCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhhcc--CCCCCccchH
Q 001952 845 GTHEYLAPEIIKGEG-----------HGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQSL--KFPDSPLISF 910 (992)
Q Consensus 845 GT~~Y~APEvL~g~~-----------~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~~l--k~P~~~~vs~ 910 (992)
||+.||+||.+.... .+.++|||||||+||+|++|++||...- .+..+..|..-.. .||..+. .+
T Consensus 523 GT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~ 601 (677)
T KOG0596|consen 523 GTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-ND 601 (677)
T ss_pred CcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-ch
Confidence 999999999997543 3678999999999999999999997543 3444555554433 4444322 23
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
++.++++.||.+||.+||+ +.|+|+|||++-+
T Consensus 602 ~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 602 ELIDVMKCCLARDPKKRWS----IPELLQHPFLQIQ 633 (677)
T ss_pred HHHHHHHHHHhcCcccCCC----cHHHhcCcccccc
Confidence 4999999999999999999 9999999999874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=329.83 Aligned_cols=262 Identities=29% Similarity=0.429 Sum_probs=205.4
Q ss_pred CceEEEEEccCCceEEEEEEEcCC--CeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeecc----CC
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGT--NCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTS----DN 682 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~t--g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~----~~ 682 (992)
+|++.+.||+|+||.||++.+..+ +..||||++.... ........+.+|+++++.+ +|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 588999999999999999999887 8899999986432 1122345677899999999 59999999987542 35
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|++|||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678999998 57888887653 568999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... ........
T Consensus 157 ~~~~--------------------------------------------------------------------~~~~~~~~ 168 (332)
T cd07857 157 ENPG--------------------------------------------------------------------ENAGFMTE 168 (332)
T ss_pred cccc--------------------------------------------------------------------cccccccC
Confidence 1000 00011123
Q ss_pred cccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc---------------------
Q 001952 843 FVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL--------------------- 900 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l--------------------- 900 (992)
..||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..++....
T Consensus 169 ~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (332)
T cd07857 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRS 248 (332)
T ss_pred cccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHh
Confidence 568999999998876 4689999999999999999999999987665444433322100
Q ss_pred --CCC------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 901 --KFP------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 901 --k~P------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..+ ..+.++..+.+||.+||..||.+||+ +.+++.||||.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~~~~ 299 (332)
T cd07857 249 LPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLAIWH 299 (332)
T ss_pred ccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhhhhc
Confidence 000 01235678999999999999999999 99999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.94 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=204.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcC-------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeee
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIG-------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQ 677 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~-------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~ 677 (992)
+..++|.+.+.||+|+||.||+|.+.+ ....+|+|+++... .......+..|+.+++.+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 345689999999999999999997642 34579999987432 123345678899999999 69999999999
Q ss_pred eccCCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 678 FTSDNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 678 f~~~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
+...+.+|+||||+++++|..++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 999999999999999999999987642 134788899999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 744 Ld~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
++.++.++|+|||++..+.....
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~--------------------------------------------------------- 189 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDY--------------------------------------------------------- 189 (314)
T ss_pred EcCCCcEEEcccccccccccccc---------------------------------------------------------
Confidence 99999999999999743210000
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCC
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.. ....
T Consensus 190 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~ 255 (314)
T cd05099 190 -------------YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE-GHRM 255 (314)
T ss_pred -------------ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 000001123457999999999889999999999999999999 8999988766665555443 3333
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..+..++.++++||.+||..||++||+ +.++++
T Consensus 256 ~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 256 DKPSNCTHELYMLMRECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 334457889999999999999999999 566554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.90 Aligned_cols=257 Identities=19% Similarity=0.252 Sum_probs=207.6
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcC----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIG----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS- 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~- 680 (992)
+..++|++.+.||+|+||.||+|.+.. .+..|++|.+.... .......+.+|+.+|+.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 346789999999999999999999875 35789999886431 22335667889999999999999999998765
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEe
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLG------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTD 754 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsD 754 (992)
....++++||+++++|..++..... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 5778999999999999999876422 4588999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccC
Q 001952 755 FDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834 (992)
Q Consensus 755 FGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~ 834 (992)
||+++.+......
T Consensus 161 ~g~~~~~~~~~~~------------------------------------------------------------------- 173 (280)
T cd05043 161 NALSRDLFPMDYH------------------------------------------------------------------- 173 (280)
T ss_pred CCCcccccCCceE-------------------------------------------------------------------
Confidence 9997433110000
Q ss_pred CCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHH
Q 001952 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQAR 913 (992)
Q Consensus 835 ~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~ 913 (992)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.. ..+.....++....++.++.
T Consensus 174 ---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 249 (280)
T cd05043 174 ---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPDELF 249 (280)
T ss_pred ---EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCCCCCCCCcCCHHHH
Confidence 00011235677999999999989999999999999999999 99999877555544 34444555555556789999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
++|.+||..||++||+ +.++++
T Consensus 250 ~li~~~l~~~p~~Rps----~~~~~~ 271 (280)
T cd05043 250 AVMACCWALDPEERPS----FSQLVQ 271 (280)
T ss_pred HHHHHHcCCChhhCCC----HHHHHH
Confidence 9999999999999999 666653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=313.46 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=205.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
..+|++.+.||+|+||.||+|.+. .+..+|+|++..... ....+..|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 457899999999999999999875 466899999874321 234578899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 154 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-- 154 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc--
Confidence 99999999999887542 458899999999999999999999999999999999999999999999999863321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........++.
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (256)
T cd05112 155 ---------------------------------------------------------------------YTSSTGTKFPV 165 (256)
T ss_pred ---------------------------------------------------------------------ccccCCCccch
Confidence 00001123567
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+. .......+...+..+.+|+.+||..+|++
T Consensus 166 ~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~l~~~p~~ 244 (256)
T cd05112 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYELMQHCWKERPED 244 (256)
T ss_pred hhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHHHHcccChhh
Confidence 8999999998889999999999999999998 999998776655555543 23333334457889999999999999999
Q ss_pred cCCChHhHHHHHcC
Q 001952 927 RLGSQKGAAEIKQH 940 (992)
Q Consensus 927 RPT~~~~aeEILkH 940 (992)
||+ +.|++++
T Consensus 245 Rp~----~~~~l~~ 254 (256)
T cd05112 245 RPS----FSLLLHQ 254 (256)
T ss_pred CCC----HHHHHHh
Confidence 999 7777753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=316.02 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=202.1
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++|+||+++++++... ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 356899999999999999999875 67789999986532 234678899999999999999999998765 4799
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|.+++.......+++..++.++.||+.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999988765556899999999999999999999999999999999999999999999999986321100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
......+
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (254)
T cd05083 154 -------------------------------------------------------------------------VDNSKLP 160 (254)
T ss_pred -------------------------------------------------------------------------CCCCCCC
Confidence 0011234
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|+|||++.+..++.++|||||||++|||++ |+.||......+....+ ...........++..+.+||.+||..+|+
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 239 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-EKGYRMEPPEGCPADVYVLMTSCWETEPK 239 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-hCCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 57999999998889999999999999999997 99999887665554443 34444444456889999999999999999
Q ss_pred CcCCChHhHHHHHc
Q 001952 926 NRLGSQKGAAEIKQ 939 (992)
Q Consensus 926 kRPT~~~~aeEILk 939 (992)
+||+ +.++++
T Consensus 240 ~Rp~----~~~l~~ 249 (254)
T cd05083 240 KRPS----FHKLRE 249 (254)
T ss_pred hCcC----HHHHHH
Confidence 9999 666654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=342.94 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=222.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
-|.++.+||+|+||.||+|.++.+|..+|||.+..+ ...+++..|+.|+.+++.+++|++||.|.....++||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 366778999999999999999999999999998743 567888999999999999999999999988889999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
||.-|++.++++.+ .+++.+..+..+++..+.||+|||...-||||||..||||+-+|++||+|||.+-.+.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999998865 5789999999999999999999999999999999999999999999999999873321
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
.+-...+..+||+.|
T Consensus 181 -----------------------------------------------------------------DTMAKRNTVIGTPFW 195 (502)
T KOG0574|consen 181 -----------------------------------------------------------------DTMAKRNTVIGTPFW 195 (502)
T ss_pred -----------------------------------------------------------------hhHHhhCccccCccc
Confidence 011224567999999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-cCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-LKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
||||++..-+|+..+||||||++..||.-|++||.+...+..+..|-... ..|..+...+.++.|||+.||.+.|++|.
T Consensus 196 MAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~ 275 (502)
T KOG0574|consen 196 MAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERK 275 (502)
T ss_pred ccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHH
Confidence 99999999999999999999999999999999998876655544443332 23444556788999999999999999999
Q ss_pred CChHhHHHHHcCCCCCCC
Q 001952 929 GSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~l 946 (992)
| +.++++|||++..
T Consensus 276 T----A~~L~~H~FiknA 289 (502)
T KOG0574|consen 276 T----ALRLCEHTFIKNA 289 (502)
T ss_pred H----HHHHhhhhhhcCC
Confidence 9 9999999999874
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.18 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=196.2
Q ss_pred Cc-eEEEEEccCCceEEEEEEE----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CC
Q 001952 610 HF-NLLQKLGCGDIGTVYLAEL----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DN 682 (992)
Q Consensus 610 ~Y-eilr~LGsG~FGtVYlA~~----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~ 682 (992)
+| ++++.||+|+||+||++.. ..++..||+|++..... ......+.+|+++|+.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 44 8999999999999988653 35678899999875321 1234567789999999999999999998765 34
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 68999999999999999875 358999999999999999999999999999999999999999999999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
..... ......
T Consensus 159 ~~~~~---------------------------------------------------------------------~~~~~~ 169 (283)
T cd05080 159 EGHEY---------------------------------------------------------------------YRVRED 169 (283)
T ss_pred Ccchh---------------------------------------------------------------------hccCCC
Confidence 10000 000011
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch--------------HHHHHHHhhccCCCCCccc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE--------------ETLANVVMQSLKFPDSPLI 908 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~--------------e~L~~Iv~~~lk~P~~~~v 908 (992)
..++..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+.+..+
T Consensus 170 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (283)
T cd05080 170 GDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNC 249 (283)
T ss_pred CCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCC
Confidence 23556799999999888999999999999999999999998643211 1111222223333444557
Q ss_pred hHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
+.++.+|+.+||..||++||+ +.+++.
T Consensus 250 ~~~~~~li~~cl~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 250 PQEVYILMKNCWETEAKFRPT----FRSLIP 276 (283)
T ss_pred CHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 889999999999999999999 666553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=330.83 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=206.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC-------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT-------NCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYS 676 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t-------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g 676 (992)
++...+|++.+.||+|+||.||+|.+.+. +..||+|++.... .......+.+|+++++++ +|+||+++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 34456899999999999999999986532 2368999887431 123346788999999999 7999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
++...+.+|++|||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 9999999999999999999999987532 13477888999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|++.++.++|+|||++........
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~-------------------------------------------------------- 189 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDY-------------------------------------------------------- 189 (334)
T ss_pred EEcCCCcEEECCcccceecccccc--------------------------------------------------------
Confidence 999999999999998743211000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
........++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+. ....
T Consensus 190 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~ 254 (334)
T cd05100 190 --------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-EGHR 254 (334)
T ss_pred --------------cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCC
Confidence 000011234567999999999999999999999999999998 899998876666555543 3334
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+....++.++.+||.+||..+|++||+ +.||+++
T Consensus 255 ~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 255 MDKPANCTHELYMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 4444557889999999999999999999 6666554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=346.88 Aligned_cols=260 Identities=30% Similarity=0.475 Sum_probs=218.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGG 694 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GG 694 (992)
++||+|-||+||-|+++.+|+.||||+|.+..+... ....+.+|+.||..++||.||.|...|+..+.+++|||-+.|.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 679999999999999999999999999987655443 3367899999999999999999999999999999999999555
Q ss_pred ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEEEEeccccccccCCcccccCC
Q 001952 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLTDFDLSLRCSVSPTLLKSS 771 (992)
Q Consensus 695 SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VKLsDFGLA~~l~~~~~~~~~~ 771 (992)
-|+ ++-....+.+++...+.++.||+.||.|||-++|+|+||||+|||+.... .+||||||+|+.....
T Consensus 649 MLE-MILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk------- 720 (888)
T KOG4236|consen 649 MLE-MILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK------- 720 (888)
T ss_pred HHH-HHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-------
Confidence 554 44444567899999999999999999999999999999999999997544 6999999998654310
Q ss_pred CCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccC
Q 001952 772 SNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLA 851 (992)
Q Consensus 772 s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~A 851 (992)
....+.+||+.|+|
T Consensus 721 ------------------------------------------------------------------sFRrsVVGTPAYLa 734 (888)
T KOG4236|consen 721 ------------------------------------------------------------------SFRRSVVGTPAYLA 734 (888)
T ss_pred ------------------------------------------------------------------hhhhhhcCCccccC
Confidence 11245789999999
Q ss_pred hhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccCCcCCcCC
Q 001952 852 PEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 852 PEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
||+|...+|...-|+||.||++|--|.|.+||... +++-..|....+-+|. +..++.++.|||..+|+..-.+|.+
T Consensus 735 PEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys 812 (888)
T KOG4236|consen 735 PEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS 812 (888)
T ss_pred HHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc
Confidence 99999999999999999999999999999999653 3333344334444443 2468999999999999999999999
Q ss_pred ChHhHHHHHcCCCCCCCc-hhhhhcCC
Q 001952 930 SQKGAAEIKQHPFFEGLN-WALIRCAI 955 (992)
Q Consensus 930 ~~~~aeEILkHPfF~~ln-w~~lr~~~ 955 (992)
++..|.|||+++.. |..+|...
T Consensus 813 ----vdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 813 ----VDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred ----hHhhccchhhhcchHHHHHHHHH
Confidence 99999999999976 77666543
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=344.47 Aligned_cols=259 Identities=22% Similarity=0.296 Sum_probs=211.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f 678 (992)
++..++|.+.+.||+|+||.||+|.+.+ .++.||||+++... .......+..|+.+|..+. ||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 4556788899999999999999998643 45689999997542 1223346789999999997 99999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcC-----------------------------------------------------
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLG----------------------------------------------------- 705 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~----------------------------------------------------- 705 (992)
...+.+||||||+.+|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999998875321
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 706 -------------------------------------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 706 -------------------------------------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
..+++..++.|+.||+.||+|||..+|+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 2356777889999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|++.++.++|+|||++..+.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~-------------------------------------------------------- 294 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSN-------------------------------------------------------- 294 (401)
T ss_pred EEeCCCEEEEEecCcceecccccc--------------------------------------------------------
Confidence 999999999999999743210000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
........++..|+|||++.+..++.++|||||||+||||++ |..||......+.+...+.....
T Consensus 295 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~ 360 (401)
T cd05107 295 --------------YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYR 360 (401)
T ss_pred --------------cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCC
Confidence 000112346788999999999889999999999999999998 89999887777766666666665
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
++.+..++.++.+||.+||..+|.+||+ +.+|++
T Consensus 361 ~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~ 394 (401)
T cd05107 361 MAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVH 394 (401)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 5555668899999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=315.93 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=204.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcC----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--C
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIG----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--D 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~ 681 (992)
.++|++.+.||+|+||.||+|.+.. ++..||||++...... .....+.+|+++++.+.|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578888999999999999998653 4789999999754321 245678899999999999999999999877 6
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
...++||||+++++|.+++.... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.++|+|||++...
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 68999999999999999987652 35899999999999999999999999999999999999999999999999997433
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
...... .....
T Consensus 160 ~~~~~~---------------------------------------------------------------------~~~~~ 170 (284)
T cd05038 160 PEDKDY---------------------------------------------------------------------YYVKE 170 (284)
T ss_pred ccCCcc---------------------------------------------------------------------eeccC
Confidence 100000 00000
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc--------------hHHHHHHHhhccCCCCCcc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN--------------EETLANVVMQSLKFPDSPL 907 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~--------------~e~L~~Iv~~~lk~P~~~~ 907 (992)
...++..|++||.+.+..++.++|||||||++|||++|..||..... ...+...+.....++....
T Consensus 171 ~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (284)
T cd05038 171 PGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPS 250 (284)
T ss_pred CCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCcc
Confidence 12345679999999988899999999999999999999999865322 2223344444555555556
Q ss_pred chHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 908 vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
++.++.+|+.+||..+|++||+ +.||++
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 251 CPDEVYDLMKLCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred CCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 7889999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=310.93 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=197.8
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCC
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGD 695 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGS 695 (992)
.||+|+||.||+|.+. ++..+|+|++..... ......+.+|+++++.++|+||+++++++...+..++||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 6899999999999864 678899999875421 1223457889999999999999999999999999999999999999
Q ss_pred hHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCC
Q 001952 696 LHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMD 775 (992)
Q Consensus 696 L~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~ 775 (992)
|.+++... ...+++..++.++.|++.||.|||.+|++|+||||+||+++.++.++|+|||++.......
T Consensus 79 L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---------- 147 (250)
T cd05085 79 FLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---------- 147 (250)
T ss_pred HHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc----------
Confidence 99988754 2457899999999999999999999999999999999999999999999999863211000
Q ss_pred CCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhh
Q 001952 776 PARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEII 855 (992)
Q Consensus 776 ~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL 855 (992)
........++..|+|||++
T Consensus 148 -------------------------------------------------------------~~~~~~~~~~~~y~aPE~~ 166 (250)
T cd05085 148 -------------------------------------------------------------YSSSGLKQIPIKWTAPEAL 166 (250)
T ss_pred -------------------------------------------------------------cccCCCCCCcccccCHHHh
Confidence 0000011245679999999
Q ss_pred cCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhH
Q 001952 856 KGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934 (992)
Q Consensus 856 ~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~a 934 (992)
.+..++.++|||||||++|||++ |..||.+.........+. ..........++.++.+|+.+||..+|++||+ +
T Consensus 167 ~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~ 241 (250)
T cd05085 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK----F 241 (250)
T ss_pred ccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCC----H
Confidence 98889999999999999999998 999998876655554443 33333334458899999999999999999999 6
Q ss_pred HHHHc
Q 001952 935 AEIKQ 939 (992)
Q Consensus 935 eEILk 939 (992)
.|+++
T Consensus 242 ~~l~~ 246 (250)
T cd05085 242 SELQK 246 (250)
T ss_pred HHHHH
Confidence 66654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.03 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=204.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCe----EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNC----LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
...+|++.+.||+|+||.||+|.+..+++ .+|+|.+..... ......+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45689999999999999999999876654 589998865421 2334567889999999999999999999887 7
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..++||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8899999999999999987653 458999999999999999999999999999999999999999999999999974432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
..... .....
T Consensus 161 ~~~~~----------------------------------------------------------------------~~~~~ 170 (279)
T cd05057 161 VDEKE----------------------------------------------------------------------YHAEG 170 (279)
T ss_pred Ccccc----------------------------------------------------------------------eecCC
Confidence 10000 00001
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..++..|+|||.+....++.++|||||||++|||++ |+.||.+....+.... +.....++.+...+.++.++|.+||.
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~ 249 (279)
T cd05057 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LEKGERLPQPPICTIDVYMVLVKCWM 249 (279)
T ss_pred CcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhCCCCCCCCCCCCHHHHHHHHHHcC
Confidence 123567999999998889999999999999999998 9999988765554443 44444555556688899999999999
Q ss_pred CCcCCcCCChH
Q 001952 922 KEPENRLGSQK 932 (992)
Q Consensus 922 ~DPekRPT~~~ 932 (992)
.||.+||++..
T Consensus 250 ~~p~~Rp~~~~ 260 (279)
T cd05057 250 IDAESRPTFKE 260 (279)
T ss_pred CChhhCCCHHH
Confidence 99999999443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=309.40 Aligned_cols=251 Identities=28% Similarity=0.412 Sum_probs=207.3
Q ss_pred ceEEEEEccCCceEEEEEEEcCCC----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTN----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
|++.+.||.|+||.||+|.+...+ ..||+|++..... ......+..|+.+|+.++|+||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 356788999999999999998766 8999999975421 1145678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
+|||+++++|.+++.......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998865433389999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.. .....++
T Consensus 159 ---------------------------------------------------------------------~~--~~~~~~~ 167 (258)
T smart00219 159 ---------------------------------------------------------------------YK--KKGGKLP 167 (258)
T ss_pred ---------------------------------------------------------------------cc--cccCCCc
Confidence 00 0011267
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+.. ....+....++.++.++|.+||..||+
T Consensus 168 ~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~ 246 (258)
T smart00219 168 IRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKK-GYRLPKPENCPPEIYKLMLQCWAEDPE 246 (258)
T ss_pred ccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-CCCCCCCCcCCHHHHHHHHHHCcCChh
Confidence 88999999988889999999999999999998 8899987666666555443 333444455889999999999999999
Q ss_pred CcCCChHhHHHHHc
Q 001952 926 NRLGSQKGAAEIKQ 939 (992)
Q Consensus 926 kRPT~~~~aeEILk 939 (992)
+||+ +.++++
T Consensus 247 ~Rpt----~~~ll~ 256 (258)
T smart00219 247 DRPT----FSELVE 256 (258)
T ss_pred hCcC----HHHHHh
Confidence 9999 888875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=380.78 Aligned_cols=261 Identities=31% Similarity=0.507 Sum_probs=219.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
++....+||.|.||.||-|....+|+..|+|-++..... ...+..+.+|+.+|..++|||+|++||+-.+.+..+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 445566899999999999999999999999988754333 5667788899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
||.||+|.++++. +.-.++...+.+..|++.||.|||++|||||||||.||||+.+|.+|++|||.|..+....
T Consensus 1315 yC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~---- 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA---- 1388 (1509)
T ss_pred HhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch----
Confidence 9999999999875 3556777788889999999999999999999999999999999999999999985542110
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
..++ ..-...+||+.|
T Consensus 1389 --------------------------------------------------------~~~~--------~el~~~~GT~~Y 1404 (1509)
T KOG4645|consen 1389 --------------------------------------------------------QTMP--------GELQSMMGTPMY 1404 (1509)
T ss_pred --------------------------------------------------------hcCC--------HHHHhhcCCchh
Confidence 0000 112246899999
Q ss_pred cChhhhcCC---CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 850 LAPEIIKGE---GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 850 ~APEvL~g~---~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
||||++.+. ++.-+.|||||||+++||+||+.||...++.-.+...|..+-+.+.+..++.+.+|||.+||..||.+
T Consensus 1405 MAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~ 1484 (1509)
T KOG4645|consen 1405 MAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKM 1484 (1509)
T ss_pred cCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchh
Confidence 999999864 57889999999999999999999998876665555555555555555559999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ 945 (992)
|.+ +.|||+|-|-+.
T Consensus 1485 Rw~----~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1485 RWT----ASQLLEHAFGKS 1499 (1509)
T ss_pred hhH----HHHHHHhhcccc
Confidence 988 999999987654
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=367.30 Aligned_cols=273 Identities=22% Similarity=0.317 Sum_probs=207.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++.+.||+|+||.||+|.+..+++.||||++............++.+|+++++.++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997543222333457889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhc---------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 689 EYCPGGDLHVLRQKQL---------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~---------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
||++|++|.+++.... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999886421 1235567788999999999999999999999999999999999999999999985
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.......... ...... ...+ ......
T Consensus 162 ~i~~~~~~~~------~l~~~~-----------------~~s~-------------------------------~s~~t~ 187 (932)
T PRK13184 162 FKKLEEEDLL------DIDVDE-----------------RNIC-------------------------------YSSMTI 187 (932)
T ss_pred eccccccccc------cccccc-----------------cccc-------------------------------cccccc
Confidence 5421100000 000000 0000 000011
Q ss_pred cCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH-HhhccCCCCCccchHHHHHHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV-VMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I-v~~~lk~P~~~~vs~el~dLI~k 918 (992)
....+||+.|+|||++.+..++.++|||||||++|||+||+.||......+..... +...........++..+.+++.+
T Consensus 188 ~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~r 267 (932)
T PRK13184 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMK 267 (932)
T ss_pred CCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHH
Confidence 12357999999999999999999999999999999999999999875544332221 11111112223578899999999
Q ss_pred hccCCcCCcCCChHhHH
Q 001952 919 LLIKEPENRLGSQKGAA 935 (992)
Q Consensus 919 cL~~DPekRPT~~~~ae 935 (992)
||..||++|++....+.
T Consensus 268 cL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 268 ALAVDPAERYSSVQELK 284 (932)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999998544333
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=331.48 Aligned_cols=259 Identities=32% Similarity=0.512 Sum_probs=216.0
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
+.||+|+|+.|--|....+|..||||++.+. ......++.+|++++.++ .|+||++|+++|+++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 4699999999999999999999999999875 344556789999999999 599999999999999999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc---EEEEeccccccccCCcccccC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~---VKLsDFGLA~~l~~~~~~~~~ 770 (992)
|.|...+++. ..|++..+..++.+|+.||+|||.+||.||||||+|||....+. +|||||.|..-...
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~------- 231 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL------- 231 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc-------
Confidence 9999888876 67999999999999999999999999999999999999987665 79999999622111
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
+++|. | .-+ -...+-+|+-.||
T Consensus 232 ---------~~~~s------p----------ast---------------------------------P~L~tPvGSAEfM 253 (463)
T KOG0607|consen 232 ---------NNDCS------P----------AST---------------------------------PELLTPVGSAEFM 253 (463)
T ss_pred ---------CCCCC------C----------CCC---------------------------------ccccCcccchhhc
Confidence 11110 0 000 0122457999999
Q ss_pred Chhhhc---C--CCCCccceeeehhhhhhhhccCCCCCCCCCc---------------hHHHHHHHhhccCCCCC--ccc
Q 001952 851 APEIIK---G--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---------------EETLANVVMQSLKFPDS--PLI 908 (992)
Q Consensus 851 APEvL~---g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---------------~e~L~~Iv~~~lk~P~~--~~v 908 (992)
|||+.. + ..|+.++|.|||||+||-||.|.+||.|.-. ...+..|..+.+.||+. ..+
T Consensus 254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahI 333 (463)
T KOG0607|consen 254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHI 333 (463)
T ss_pred chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHh
Confidence 999864 2 3579999999999999999999999986421 24456666777888865 458
Q ss_pred hHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
+.+.+|||..+|..|+.+|++ +..+++|||++...
T Consensus 334 S~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~ 368 (463)
T KOG0607|consen 334 SSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCA 368 (463)
T ss_pred hHHHHHHHHHHHhccHHhhhh----hhhccCCccccccc
Confidence 999999999999999999999 99999999999764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=314.98 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=204.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
...+|.+.+.||+|+||.||+|.+... ...|+||...... .......+.+|+.+++.++|+||+++++++.. +.
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 456789999999999999999987543 3468999886542 12334577889999999999999999998875 55
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
.|+||||+++++|.+++... ...+++..++.++.||+.||+|||+.|++|+||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 78999999999999998764 24589999999999999999999999999999999999999999999999998743211
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ......
T Consensus 160 ~~~-----------------------------------------------------------------------~~~~~~ 168 (270)
T cd05056 160 ESY-----------------------------------------------------------------------YKASKG 168 (270)
T ss_pred ccc-----------------------------------------------------------------------eecCCC
Confidence 000 000111
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+. .....+.+..++.++.+||.+||..
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~ 247 (270)
T cd05056 169 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCPPTLYSLMTKCWAY 247 (270)
T ss_pred CccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHcCC
Confidence 24567999999998889999999999999999996 999998877666654443 3334444556889999999999999
Q ss_pred CcCCcCCChHhHHHHHc
Q 001952 923 EPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 923 DPekRPT~~~~aeEILk 939 (992)
+|++||+ +.+++.
T Consensus 248 ~P~~Rpt----~~~~~~ 260 (270)
T cd05056 248 DPSKRPR----FTELKA 260 (270)
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 666654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=311.00 Aligned_cols=246 Identities=26% Similarity=0.383 Sum_probs=201.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGG 694 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GG 694 (992)
++||+|+||.||+|.+.. ++.|++|++...... .....+..|+++++.++|+||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999877 899999998754322 23456788999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCC
Q 001952 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774 (992)
Q Consensus 695 SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~ 774 (992)
+|.+++... ...+++..+..++.|++.||+|||++||+||||+|+|||++.++.++|+|||++........
T Consensus 78 ~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (251)
T cd05041 78 SLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-------- 148 (251)
T ss_pred cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcc--------
Confidence 999988754 24678999999999999999999999999999999999999999999999998743210000
Q ss_pred CCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhh
Q 001952 775 DPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEI 854 (992)
Q Consensus 775 ~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEv 854 (992)
........++..|+|||+
T Consensus 149 --------------------------------------------------------------~~~~~~~~~~~~y~~PE~ 166 (251)
T cd05041 149 --------------------------------------------------------------TVSDGLKQIPIKWTAPEA 166 (251)
T ss_pred --------------------------------------------------------------eeccccCcceeccCChHh
Confidence 000001123567999999
Q ss_pred hcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHh
Q 001952 855 IKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKG 933 (992)
Q Consensus 855 L~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~ 933 (992)
+.+..++.++|||||||++|||++ |..||.+.........+ ......+.+..++.++.+||.+||..+|++||+
T Consensus 167 ~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---- 241 (251)
T cd05041 167 LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPS---- 241 (251)
T ss_pred hccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHHhccChhhCcC----
Confidence 998889999999999999999999 89999877655444443 333444445568899999999999999999999
Q ss_pred HHHHHc
Q 001952 934 AAEIKQ 939 (992)
Q Consensus 934 aeEILk 939 (992)
+.|+++
T Consensus 242 ~~ell~ 247 (251)
T cd05041 242 FSEIYN 247 (251)
T ss_pred HHHHHH
Confidence 888775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=328.51 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=205.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-CCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-DNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-~~~lyL 686 (992)
.++|++++.||.|+||.||+|.+..+++.||||++..... .......+..|+++++.++||||++++++|.. ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence 5689999999999999999999999999999998864321 12334567789999999999999999998865 567899
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+ +++|..++.. ..+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++....
T Consensus 88 v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~---- 159 (328)
T cd07856 88 VTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD---- 159 (328)
T ss_pred Eeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC----
Confidence 99999 6789888764 457888999999999999999999999999999999999999999999999862210
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.......++
T Consensus 160 -----------------------------------------------------------------------~~~~~~~~~ 168 (328)
T cd07856 160 -----------------------------------------------------------------------PQMTGYVST 168 (328)
T ss_pred -----------------------------------------------------------------------CCcCCCccc
Confidence 001123567
Q ss_pred CCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh----------------------cc---
Q 001952 847 HEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ----------------------SL--- 900 (992)
Q Consensus 847 ~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~----------------------~l--- 900 (992)
..|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+... ..
T Consensus 169 ~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (328)
T cd07856 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKR 248 (328)
T ss_pred ccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcccc
Confidence 88999999876 56899999999999999999999999876543222211110 00
Q ss_pred -CCCC---CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 901 -KFPD---SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 901 -k~P~---~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..+. .+.++.++.++|.+||..+|++||+ +++++.||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~~~~ 295 (328)
T cd07856 249 EPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLAPYH 295 (328)
T ss_pred CCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCcccccc
Confidence 0110 1235788999999999999999999 99999999997654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=314.92 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=191.8
Q ss_pred EEccCCceEEEEEEEcC--CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 616 KLGCGDIGTVYLAELIG--TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~--tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
.||+|+||.||+|.... ....+++|.+.... .......+.+|+++++.++|+||+++++++...+.+||||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999996533 34578888876432 122345678899999999999999999999999999999999999
Q ss_pred CChHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 694 GDLHVLRQKQLG---KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 694 GSL~~lLkk~~~---~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
|+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---- 155 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY---- 155 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh----
Confidence 999999876432 2346778899999999999999999999999999999999999999999998632110000
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
........++..|+
T Consensus 156 ------------------------------------------------------------------~~~~~~~~~~~~y~ 169 (269)
T cd05042 156 ------------------------------------------------------------------YITKDCHAVPLRWL 169 (269)
T ss_pred ------------------------------------------------------------------eeccCCCCCccccc
Confidence 00001224567899
Q ss_pred ChhhhcC-------CCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhcc-CCCC---CccchHHHHHHHHH
Q 001952 851 APEIIKG-------EGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSL-KFPD---SPLISFQARDLIRG 918 (992)
Q Consensus 851 APEvL~g-------~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~l-k~P~---~~~vs~el~dLI~k 918 (992)
|||++.. ..++.++|||||||++|||++ |..||....+.+.+..++.... .++. ...++..+.+++..
T Consensus 170 aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (269)
T cd05042 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQF 249 (269)
T ss_pred CHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHH
Confidence 9999753 346889999999999999999 8899988777776666554332 2222 22467888999999
Q ss_pred hccCCcCCcCCChHhHHHHHc
Q 001952 919 LLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILk 939 (992)
|| .||++||+ +++|++
T Consensus 250 ~~-~dp~~Rpt----~~~v~~ 265 (269)
T cd05042 250 CW-LDPETRPT----AEEVHE 265 (269)
T ss_pred Hh-cCcccccC----HHHHHH
Confidence 98 59999999 666654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=315.62 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=198.7
Q ss_pred EEccCCceEEEEEEEcCCC------eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 616 KLGCGDIGTVYLAELIGTN------CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg------~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.||+|+||.||+|.+.... ..+|||.+.... .......+.+|+++|+.++||||+++++++...+..|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5999999999999886543 689999886432 12334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-----cEEEEeccccc
Q 001952 690 YCPGGDLHVLRQKQL-----GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-----HIMLTDFDLSL 759 (992)
Q Consensus 690 y~~GGSL~~lLkk~~-----~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-----~VKLsDFGLA~ 759 (992)
|+++++|.+++.... ...+++..++.++.||+.||.|||+.+|+|+||||+|||++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 999999999887532 23478899999999999999999999999999999999999877 89999999874
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..... ...
T Consensus 160 ~~~~~~~----------------------------------------------------------------------~~~ 169 (269)
T cd05044 160 DIYKSDY----------------------------------------------------------------------YRK 169 (269)
T ss_pred ccccccc----------------------------------------------------------------------ccc
Confidence 3210000 000
Q ss_pred cCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+ .....+.....++..+.+||.+
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ 248 (269)
T cd05044 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQKPENCPDKIYQLMTN 248 (269)
T ss_pred CcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccCCcccchHHHHHHHHH
Confidence 011235678999999999999999999999999999998 99999877666655444 3333444445688999999999
Q ss_pred hccCCcCCcCCChHhHHHHHc
Q 001952 919 LLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILk 939 (992)
||..+|.+||+ +.++++
T Consensus 249 ~l~~~p~~Rp~----~~~i~~ 265 (269)
T cd05044 249 CWAQDPSERPT----FDRIQE 265 (269)
T ss_pred HcCCCcccCCC----HHHHHH
Confidence 99999999999 666653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=316.40 Aligned_cols=243 Identities=26% Similarity=0.327 Sum_probs=195.4
Q ss_pred EEccCCceEEEEEEEcCCCe--EEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEEecC
Q 001952 616 KLGCGDIGTVYLAELIGTNC--LFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~--~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmEy~~ 692 (992)
.||+|+||.||+|.+..++. .+++|.++... .......+..|++++.++ +||||+++++++...+.+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999999987765 46888876321 122345678899999999 89999999999999999999999999
Q ss_pred CCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 693 GGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 693 GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+++|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999987542 124788999999999999999999999999999999999999999999999986
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..... . .
T Consensus 160 ~~~~~--~-----------------------------------------------------------------------~ 166 (270)
T cd05047 160 RGQEV--Y-----------------------------------------------------------------------V 166 (270)
T ss_pred cccch--h-----------------------------------------------------------------------h
Confidence 21000 0 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIR 917 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~ 917 (992)
.......+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+. .....+....++.++.+||.
T Consensus 167 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~ 245 (270)
T cd05047 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPLNCDDEVYDLMR 245 (270)
T ss_pred hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHh-CCCCCCCCCcCCHHHHHHHH
Confidence 0001123567999999998889999999999999999997 999998776655555443 33333344457889999999
Q ss_pred HhccCCcCCcCCChHhHHHHH
Q 001952 918 GLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEIL 938 (992)
+||..||.+||+ +.+++
T Consensus 246 ~~l~~~p~~Rps----~~~il 262 (270)
T cd05047 246 QCWREKPYERPS----FAQIL 262 (270)
T ss_pred HHcccChhhCCC----HHHHH
Confidence 999999999999 55554
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=311.91 Aligned_cols=249 Identities=19% Similarity=0.279 Sum_probs=193.5
Q ss_pred EEEccCCceEEEEEEEcC---CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec-cCCeEEEEEEe
Q 001952 615 QKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT-SDNLSCLVMEY 690 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~---tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~-~~~~lyLVmEy 690 (992)
+.||+|+||.||+|.+.. ....||||.+.... .......+..|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 358999999999998753 34679999885321 1233456788999999999999999999765 45668999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+.+++|..++.... ..+.+..+..++.||+.||.|||+.+|+||||||+|||++.++.++|+|||++..+......
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 99999999987642 34677788899999999999999999999999999999999999999999987432110000
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
.........++..|+
T Consensus 155 -----------------------------------------------------------------~~~~~~~~~~~~~y~ 169 (262)
T cd05058 155 -----------------------------------------------------------------SVHNHTGAKLPVKWM 169 (262)
T ss_pred -----------------------------------------------------------------eecccccCcCCcccc
Confidence 000011223567899
Q ss_pred ChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCC
Q 001952 851 APEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 851 APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT 929 (992)
|||++.+..++.++|||||||++|||++ |.+||...+..+....+ .....++....++..+.+|+.+||..+|++||+
T Consensus 170 aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 248 (262)
T cd05058 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPT 248 (262)
T ss_pred ChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCC
Confidence 9999998889999999999999999999 56677666555544443 333334444557889999999999999999999
Q ss_pred ChHhHHHHHc
Q 001952 930 SQKGAAEIKQ 939 (992)
Q Consensus 930 ~~~~aeEILk 939 (992)
+.++++
T Consensus 249 ----~~~il~ 254 (262)
T cd05058 249 ----FSELVS 254 (262)
T ss_pred ----HHHHHH
Confidence 666654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=329.26 Aligned_cols=255 Identities=30% Similarity=0.483 Sum_probs=216.4
Q ss_pred ccCceEE-EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeecc----C
Q 001952 608 LRHFNLL-QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTS----D 681 (992)
Q Consensus 608 ~~~Yeil-r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~----~ 681 (992)
+++|.+- ++||-|-.|.|..|.++.+++.+|+|++... ....+|+++--+. .|||||.++++|++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 5667664 5799999999999999999999999998643 3456788875444 79999999999864 4
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEecccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLS 758 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA 758 (992)
..+.+|||+|+||.|...++.+....|++..+-.|++||..|+.|||+.+|.||||||+|+|+.. +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 67889999999999999999887788999999999999999999999999999999999999974 446999999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
++-... .
T Consensus 212 K~t~~~-------------------------------------------------------------------------~ 218 (400)
T KOG0604|consen 212 KETQEP-------------------------------------------------------------------------G 218 (400)
T ss_pred cccCCC-------------------------------------------------------------------------c
Confidence 542110 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc----hHHHHHHHhhccCCCCC--ccchHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN----EETLANVVMQSLKFPDS--PLISFQA 912 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~----~e~L~~Iv~~~lk~P~~--~~vs~el 912 (992)
...+-+-|+.|.|||++....|+..+|+|||||++|-||.|.+||..+.. ..+-.+|..+.+.||.+ ..++++.
T Consensus 219 ~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~a 298 (400)
T KOG0604|consen 219 DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAA 298 (400)
T ss_pred cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHH
Confidence 01123468999999999999999999999999999999999999986543 35667788888888765 4589999
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
+|+|+++|..+|.+|+| +++++.|||+.+.+
T Consensus 299 KdlIR~LLkt~PteRlT----I~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 299 KDLIRKLLKTEPTERLT----IEEVMDHPWINQYE 329 (400)
T ss_pred HHHHHHHhcCCchhhee----HHHhhcCchhcccc
Confidence 99999999999999999 99999999998753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=342.18 Aligned_cols=272 Identities=31% Similarity=0.430 Sum_probs=226.5
Q ss_pred hhhh-HhhheeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC--
Q 001952 591 VRWE-AIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-- 667 (992)
Q Consensus 591 ~~~e-~~~~~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-- 667 (992)
..|+ .-.+|.+..|++.-.+|.+....|+|-|++|.+|.+..-|..||||+|.+..+.. ..-+.|++||++|.
T Consensus 413 DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 413 DNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDA 488 (752)
T ss_pred cCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhcc
Confidence 4454 3467899999999999999999999999999999999989999999998764433 23367999999994
Q ss_pred ----CCCccceeeeeccCCeEEEEEEecCCCChHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 668 ----HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQL-GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 668 ----HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~-~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
.-|+++|+..|.+.+++|||||.+ ..+|.+++++.. +-.|....++.|+.||..||..|..+||+|.||||+||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNI 567 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccce
Confidence 458999999999999999999998 789999998753 24577889999999999999999999999999999999
Q ss_pred EEccCC-cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCCh
Q 001952 743 LVREDG-HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP 821 (992)
Q Consensus 743 LLd~dg-~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~ 821 (992)
||++.. .+||||||.|.....
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~e---------------------------------------------------------- 589 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASE---------------------------------------------------------- 589 (752)
T ss_pred EeccCcceeeeccCcccccccc----------------------------------------------------------
Confidence 999654 589999998733211
Q ss_pred hhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC
Q 001952 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 822 ~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
...+-+.-++.|+|||+|+|..|++..|+||.||+||||+||+..|+|..+.++|...+.-..+
T Consensus 590 ----------------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 590 ----------------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred ----------------ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 0112234567799999999999999999999999999999999999999998888776653333
Q ss_pred CCCC----------------------------------------------------------ccchHHHHHHHHHhccCC
Q 001952 902 FPDS----------------------------------------------------------PLISFQARDLIRGLLIKE 923 (992)
Q Consensus 902 ~P~~----------------------------------------------------------~~vs~el~dLI~kcL~~D 923 (992)
||.. ..+-..+++||.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 3310 001236789999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCC
Q 001952 924 PENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~ 945 (992)
|++|++ +.++|.||||.+
T Consensus 734 P~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRIT----VNQALKHPFITE 751 (752)
T ss_pred hhhcCC----HHHHhcCCcccC
Confidence 999999 999999999975
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.80 Aligned_cols=238 Identities=20% Similarity=0.280 Sum_probs=189.8
Q ss_pred EEccCCceEEEEEEEcCCCe-------EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 616 KLGCGDIGTVYLAELIGTNC-------LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~-------~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
.||.|+||.||+|.+...+. .+++|.+... .......+..|+.+++.++||||+++++++..++..++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 59999999999998865443 3888887543 2233456788999999999999999999999989999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc--------EEEEecccccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH--------IMLTDFDLSLR 760 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~--------VKLsDFGLA~~ 760 (992)
||+++|+|..++.... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++. ++++|||++..
T Consensus 79 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 79 EYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred ecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999987642 46889999999999999999999999999999999999987765 58888887521
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.. ..
T Consensus 158 ~~----------------------------------------------------------------------------~~ 161 (258)
T cd05078 158 VL----------------------------------------------------------------------------PK 161 (258)
T ss_pred cC----------------------------------------------------------------------------Cc
Confidence 10 00
Q ss_pred CccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCC-CCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGR-TPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr-~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
....++..|+|||++.+. .++.++|||||||++|||++|. .||......... ........+|. ..+.++.+||.+
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~li~~ 238 (258)
T cd05078 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPA--PKWTELANLINQ 238 (258)
T ss_pred hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCC--CCcHHHHHHHHH
Confidence 123467889999999874 4789999999999999999984 666554443332 33333444443 366789999999
Q ss_pred hccCCcCCcCCChHhHHHHHcC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkH 940 (992)
||+.||++||+ +++|++.
T Consensus 239 ~l~~~p~~Rps----~~~il~~ 256 (258)
T cd05078 239 CMDYEPDFRPS----FRAIIRD 256 (258)
T ss_pred HhccChhhCCC----HHHHHHh
Confidence 99999999999 8887753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=367.89 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=217.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCC-----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTN-----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg-----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
+.....++.+.||+|.||.||.|...+.. ..||||.++.. ........|.+|..+|+.++|||||+|+|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 44567788899999999999999886543 34899988754 345567789999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEec
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQL-----GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~-----~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDF 755 (992)
....+|++|||+||+|..++++.. ...+.....+.++.||+.|+.||+++++|||||..+|+||+....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999999998752 245788899999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 756 DLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 756 GLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
|+|+..+-..++...
T Consensus 847 GlArDiy~~~yyr~~----------------------------------------------------------------- 861 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKH----------------------------------------------------------------- 861 (1025)
T ss_pred chhHhhhhchheecc-----------------------------------------------------------------
Confidence 999644322221100
Q ss_pred CCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHH
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
....-...|||||.+....++.++|||||||+|||++| |..||.+.++.+.+..++.+. +++.+..+++.+.+
T Consensus 862 -----~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~ly~ 935 (1025)
T KOG1095|consen 862 -----GEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKLYQ 935 (1025)
T ss_pred -----CccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHHHH
Confidence 00123467999999999999999999999999999999 999999999999998777776 88888899999999
Q ss_pred HHHHhccCCcCCcCCCh
Q 001952 915 LIRGLLIKEPENRLGSQ 931 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~ 931 (992)
||..||..+|++||++.
T Consensus 936 lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 936 LMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred HHHHHccCChhhCccHH
Confidence 99999999999999943
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=321.03 Aligned_cols=254 Identities=20% Similarity=0.326 Sum_probs=203.7
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCe----EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNC----LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
...+|+..+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45788999999999999999999877665 47888886432 122234578899999999999999999988754
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..++++||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 468999999999999988764 2458899999999999999999999999999999999999999999999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... ......
T Consensus 161 ~~~~----------------------------------------------------------------------~~~~~~ 170 (303)
T cd05110 161 GDEK----------------------------------------------------------------------EYNADG 170 (303)
T ss_pred Cccc----------------------------------------------------------------------ccccCC
Confidence 0000 000111
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..++..|+|||++.+..++.++|||||||++|||++ |..||.+... ..+..++.....++....++.++.++|..||.
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~ 249 (303)
T cd05110 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLLEKGERLPQPPICTIDVYMVMVKCWM 249 (303)
T ss_pred CccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcC
Confidence 235678999999999999999999999999999997 9999977643 33445555555566566678899999999999
Q ss_pred CCcCCcCCChHhHHHHHc
Q 001952 922 KEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILk 939 (992)
.+|++||+ ++++++
T Consensus 250 ~~p~~Rp~----~~~l~~ 263 (303)
T cd05110 250 IDADSRPK----FKELAA 263 (303)
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 555544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.45 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=214.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ly 685 (992)
+.++.+.+..||.|+.|.||++.++.+|..+|||.+.... ..+...++...+.++... +.|+||+++|||..+..++
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence 4556677888999999999999999999999999997653 334456667777776555 4899999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|.||.| ..-++.+++.. .+++++..+-.+...++.||.||.+ +||||||+||+|||+|..|++||||||++-++-.
T Consensus 168 IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd- 244 (391)
T KOG0983|consen 168 ICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD- 244 (391)
T ss_pred HHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec-
Confidence 999998 55566666654 4679999999999999999999985 5899999999999999999999999999744311
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
..+ .+...
T Consensus 245 ---------------------------------------------SkA---------------------------htrsA 252 (391)
T KOG0983|consen 245 ---------------------------------------------SKA---------------------------HTRSA 252 (391)
T ss_pred ---------------------------------------------ccc---------------------------ccccc
Confidence 011 12345
Q ss_pred cCCCccChhhhcCC---CCCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhhccC-CCCCccchHHHHHHHHHh
Q 001952 845 GTHEYLAPEIIKGE---GHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQSLK-FPDSPLISFQARDLIRGL 919 (992)
Q Consensus 845 GT~~Y~APEvL~g~---~~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~~lk-~P~~~~vs~el~dLI~kc 919 (992)
|.+.|||||.|.-. .|+.++||||||++|+||.||+.||.+.+ +.+.+.+++..... ++....+++++.+|+..|
T Consensus 253 GC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~C 332 (391)
T KOG0983|consen 253 GCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDC 332 (391)
T ss_pred CCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHH
Confidence 88999999999754 58999999999999999999999999854 56777777765442 333344899999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
|.+|+.+||. -.++|+|||+...+
T Consensus 333 L~kd~r~RP~----Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 333 LTKDHRKRPK----YNKLLEHPFIKRYE 356 (391)
T ss_pred hhcCcccCcc----hHHHhcCcceeecc
Confidence 9999999999 89999999997664
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.31 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=190.8
Q ss_pred EEccCCceEEEEEEEcC--CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 616 KLGCGDIGTVYLAELIG--TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~--tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
.||+|+||.||+|.+.. ++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+|+||||+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 58999999999998643 456799998865421 12234678899999999999999999999999999999999999
Q ss_pred CChHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 694 GDLHVLRQKQLG---KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 694 GSL~~lLkk~~~---~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
++|.+++..... ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~----- 154 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED----- 154 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc-----
Confidence 999999875321 245677888999999999999999999999999999999999999999999863210000
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
.........|+..|+
T Consensus 155 -----------------------------------------------------------------~~~~~~~~~~~~~y~ 169 (269)
T cd05087 155 -----------------------------------------------------------------YYVTPDQLWVPLRWI 169 (269)
T ss_pred -----------------------------------------------------------------eeecCCCcCCccccc
Confidence 000011245778899
Q ss_pred ChhhhcCC-------CCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhh-ccCCCCC---ccchHHHHHHHHH
Q 001952 851 APEIIKGE-------GHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQ-SLKFPDS---PLISFQARDLIRG 918 (992)
Q Consensus 851 APEvL~g~-------~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~-~lk~P~~---~~vs~el~dLI~k 918 (992)
|||++.+. .++.++|||||||++|||++ |+.||......+.+...+.. ...++.+ ..++..+.+||..
T Consensus 170 aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 249 (269)
T cd05087 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQF 249 (269)
T ss_pred CHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHH
Confidence 99998643 35789999999999999996 99999877666554443332 2223222 1356789999999
Q ss_pred hccCCcCCcCCChHhHHHHH
Q 001952 919 LLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEIL 938 (992)
|| .+|++||+ ++||+
T Consensus 250 c~-~~P~~Rpt----~~~l~ 264 (269)
T cd05087 250 CW-LQPEQRPS----AEEVH 264 (269)
T ss_pred Hh-cCcccCCC----HHHHH
Confidence 99 68999999 77765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.74 Aligned_cols=253 Identities=27% Similarity=0.426 Sum_probs=203.8
Q ss_pred CceEEEEEccCCceEEEEEEEcC-CCeEEEEEEechhHH-------HhhcchhHHHHHHHHHHH-cCCCCccceeeeecc
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIG-TNCLFAIKVMDNEFL-------ARRKKMPRAQTEREILRM-LDHPFLPTLYSQFTS 680 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~-tg~~VAIKvIkk~~l-------~~~~~~~~~~~EieILk~-L~HPNIVkL~g~f~~ 680 (992)
+|++.+.||+|+||.||+|.+.. .++.+|+|.+..... ........+..|+.++.. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999987 678999998864321 112234456778887765 799999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDL 757 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGL 757 (992)
++..|+||||+++++|.+++... ....+++..++.++.||+.||.|||. .||+|+||+|+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999999887542 23568999999999999999999996 7899999999999999999999999998
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (269)
T cd08528 161 AKQKQPE------------------------------------------------------------------------- 167 (269)
T ss_pred eeecccc-------------------------------------------------------------------------
Confidence 7332100
Q ss_pred CCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHH
Q 001952 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIR 917 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~ 917 (992)
.......|+..|++||++.+..++.++||||||+++|||++|+.||...........+............++.++.+||.
T Consensus 168 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 247 (269)
T cd08528 168 SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVIT 247 (269)
T ss_pred cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHH
Confidence 00122357888999999999889999999999999999999999998776655555555444332222357889999999
Q ss_pred HhccCCcCCcCCChHhHHHHHc
Q 001952 918 GLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEILk 939 (992)
+||..||++||+ +.|+..
T Consensus 248 ~cl~~~p~~Rp~----~~e~~~ 265 (269)
T cd08528 248 SCLTPDAEARPD----IIQVSA 265 (269)
T ss_pred HHCCCCCccCCC----HHHHHH
Confidence 999999999999 555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.39 Aligned_cols=238 Identities=21% Similarity=0.296 Sum_probs=189.1
Q ss_pred EEccCCceEEEEEEEcCC------------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 616 KLGCGDIGTVYLAELIGT------------NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~t------------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.||+|+||.||+|.+... ...+++|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 589999999999986432 235899988654 22334567888999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc-------EEEEecc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH-------IMLTDFD 756 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~-------VKLsDFG 756 (992)
.++||||+++++|..++... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++. ++++|||
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999998887653 356899999999999999999999999999999999999987664 8999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++..+..
T Consensus 158 ~~~~~~~------------------------------------------------------------------------- 164 (262)
T cd05077 158 IPITVLS------------------------------------------------------------------------- 164 (262)
T ss_pred CCccccC-------------------------------------------------------------------------
Confidence 8632100
Q ss_pred CCCcCccccCCCccChhhhc-CCCCCccceeeehhhhhhhhc-cCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIK-GEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~-g~~~s~kSDIWSLGVlLyELL-TGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
.....|+..|+|||++. +..++.++|||||||+||||+ +|..||......+.. ......... ....+.++.+
T Consensus 165 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~ 238 (262)
T cd05077 165 ---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCML--VTPSCKELAD 238 (262)
T ss_pred ---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccC--CCCChHHHHH
Confidence 01134678899999987 456899999999999999998 588888765443332 222222222 2225678999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
||.+||..||.+||+ +.+|+++
T Consensus 239 li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 239 LMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred HHHHHcCCChhhCcC----HHHHHHh
Confidence 999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=316.49 Aligned_cols=238 Identities=22% Similarity=0.282 Sum_probs=189.7
Q ss_pred EEccCCceEEEEEEEcC------------------------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc
Q 001952 616 KLGCGDIGTVYLAELIG------------------------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL 671 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~------------------------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI 671 (992)
.||+|+||.||+|.+.. ....|++|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 59999999999997532 12458999987542 2334567889999999999999
Q ss_pred cceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---
Q 001952 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG--- 748 (992)
Q Consensus 672 VkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg--- 748 (992)
+++++++......||||||+++++|..++... ...+++..+..++.||+.||+|||+.||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888653 35688999999999999999999999999999999999998654
Q ss_pred ----cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhh
Q 001952 749 ----HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQ 824 (992)
Q Consensus 749 ----~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~ 824 (992)
.++|+|||++....
T Consensus 158 ~~~~~~kl~d~g~~~~~~-------------------------------------------------------------- 175 (274)
T cd05076 158 GTSPFIKLSDPGVSFTAL-------------------------------------------------------------- 175 (274)
T ss_pred CccceeeecCCccccccc--------------------------------------------------------------
Confidence 37999999852110
Q ss_pred hccCCccccCCCCCCcCccccCCCccChhhhcC-CCCCccceeeehhhhhhhhc-cCCCCCCCCCchHHHHHHHhhccCC
Q 001952 825 IRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 825 i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELL-TGr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
......++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.+....+.. ........+
T Consensus 176 --------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~ 240 (274)
T cd05076 176 --------------SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-RFYEKKHRL 240 (274)
T ss_pred --------------cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-HHHHhccCC
Confidence 0001246677999999876 45799999999999999995 699999876554433 333333334
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+. ....++.+||.+||..+|++||+ +.+||++
T Consensus 241 ~~--~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 241 PE--PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred CC--CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 33 25678999999999999999999 7887764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.23 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=189.9
Q ss_pred EEEccCCceEEEEEEEcCCC----------eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 615 QKLGCGDIGTVYLAELIGTN----------CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg----------~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+|+.++|+||+++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36999999999999998766 357888876432 115677889999999999999999999888 778
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-------cEEEEeccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-------HIMLTDFDL 757 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-------~VKLsDFGL 757 (992)
++||||+++++|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999988653 3689999999999999999999999999999999999999887 799999998
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+.....
T Consensus 155 a~~~~~-------------------------------------------------------------------------- 160 (259)
T cd05037 155 PITVLS-------------------------------------------------------------------------- 160 (259)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 632110
Q ss_pred CCcCccccCCCccChhhhcCC--CCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHH
Q 001952 838 ARSNSFVGTHEYLAPEIIKGE--GHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~--~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||......+...... .....+.. ....+.+
T Consensus 161 --~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~ 235 (259)
T cd05037 161 --REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP--DCAELAN 235 (259)
T ss_pred --ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC--CchHHHH
Confidence 0112356679999999887 78999999999999999999 688887765433333222 22222222 2378999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHc
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILk 939 (992)
||.+||..+|.+||+ +.++++
T Consensus 236 li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 236 LINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred HHHHHhccChhhCCC----HHHHHH
Confidence 999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.23 Aligned_cols=233 Identities=30% Similarity=0.433 Sum_probs=189.5
Q ss_pred CCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCChHHH
Q 001952 620 GDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVL 699 (992)
Q Consensus 620 G~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~l 699 (992)
|.||.||++.+..+++.||+|.+.... ....|...+....||||+++++++...+..||||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997542 122344445556799999999999999999999999999999998
Q ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCcc
Q 001952 700 RQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARV 779 (992)
Q Consensus 700 Lkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~ 779 (992)
+... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..+..
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~---------------- 137 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---------------- 137 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc----------------
Confidence 8764 4589999999999999999999999999999999999999999999999997532110
Q ss_pred CCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCC
Q 001952 780 SGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG 859 (992)
Q Consensus 780 sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~ 859 (992)
......++..|+|||.+.+..
T Consensus 138 -----------------------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 158 (237)
T cd05576 138 -----------------------------------------------------------SCDGEAVENMYCAPEVGGISE 158 (237)
T ss_pred -----------------------------------------------------------ccccCCcCccccCCcccCCCC
Confidence 001123456799999998888
Q ss_pred CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh-HhHHHHH
Q 001952 860 HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ-KGAAEIK 938 (992)
Q Consensus 860 ~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~-~~aeEIL 938 (992)
++.++|||||||++|||++|+.||...... ......+..+..++..+++||.+||..||++|+++. ..+++++
T Consensus 159 ~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 232 (237)
T cd05576 159 ETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232 (237)
T ss_pred CCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHH
Confidence 999999999999999999999887643211 111111222345888999999999999999999943 2369999
Q ss_pred cCCCC
Q 001952 939 QHPFF 943 (992)
Q Consensus 939 kHPfF 943 (992)
.||||
T Consensus 233 ~h~~~ 237 (237)
T cd05576 233 SHPFF 237 (237)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=304.35 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=216.9
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|...++||+|.||+||+|+...+++.||+|.++.+. ..+..-....+|+-+|+.++|.|||+++++...++.+-||+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 4666788999999999999999999999999997653 223344677899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|| ..+|..+.... ++.++.+.++.++.|++.||.|+|+++++||||||.|+||+.+|.+||+|||+++.++..
T Consensus 82 ~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip----- 154 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP----- 154 (292)
T ss_pred Hh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc-----
Confidence 99 78888887654 577999999999999999999999999999999999999999999999999998665321
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
+.|+ ..-+-|.+|
T Consensus 155 ------------------------------vrcy-------------------------------------saevvtlwy 167 (292)
T KOG0662|consen 155 ------------------------------VRCY-------------------------------------SAEVVTLWY 167 (292)
T ss_pred ------------------------------eEee-------------------------------------eceeeeeec
Confidence 1121 223578999
Q ss_pred cChhhhcCCC-CCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhcc-----CCC------CC-----------
Q 001952 850 LAPEIIKGEG-HGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSL-----KFP------DS----------- 905 (992)
Q Consensus 850 ~APEvL~g~~-~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~l-----k~P------~~----------- 905 (992)
++|.++.|.. |+...|+||.||++.||.. |++.|+|.+..+++..|..... .+| +.
T Consensus 168 rppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypatts 247 (292)
T KOG0662|consen 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTS 247 (292)
T ss_pred cCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccch
Confidence 9999999976 6899999999999999996 9999999999999988864211 111 11
Q ss_pred -----ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 906 -----PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 906 -----~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+.++...+||++++|..+|.+|++ ++++|+||||...
T Consensus 248 wsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 248 WSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSDF 289 (292)
T ss_pred HHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCcccccc
Confidence 112335689999999999999999 9999999999764
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=313.43 Aligned_cols=260 Identities=18% Similarity=0.236 Sum_probs=188.9
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHH--hh------cchhHHHHHHHHHHHcCCCCccc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLA--RR------KKMPRAQTEREILRMLDHPFLPT 673 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~--~~------~~~~~~~~EieILk~L~HPNIVk 673 (992)
.+...+|++.+.||+|+||.||+|.+..+ +..+|+|+....... .. ........+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 45567899999999999999999998877 667788864321100 00 00011122333455668999999
Q ss_pred eeeeeccCC----eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc
Q 001952 674 LYSQFTSDN----LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH 749 (992)
Q Consensus 674 L~g~f~~~~----~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~ 749 (992)
+++.+.... ..+++||++ ..++..++... ..+++..++.|+.||+.||+|||+.+|+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR 164 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence 998765433 457888887 55676666543 34678889999999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCC
Q 001952 750 IMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLP 829 (992)
Q Consensus 750 VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~ 829 (992)
++|+|||++..+.......
T Consensus 165 ~~l~DFGla~~~~~~~~~~------------------------------------------------------------- 183 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHI------------------------------------------------------------- 183 (294)
T ss_pred EEEEEcCCceeeccCCccc-------------------------------------------------------------
Confidence 9999999985542100000
Q ss_pred ccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHH---------HHHhhcc
Q 001952 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA---------NVVMQSL 900 (992)
Q Consensus 830 ~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~---------~Iv~~~l 900 (992)
...........||+.|+|||++.+..++.++|||||||+||||++|..||.+......+. .+.....
T Consensus 184 ----~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (294)
T PHA02882 184 ----EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI 259 (294)
T ss_pred ----ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh
Confidence 000011123469999999999999999999999999999999999999998774322211 1111112
Q ss_pred CCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 901 KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 901 k~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.+ ...+.++.+++..||..+|++||+ ..+|++
T Consensus 260 ~~---~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 260 KI---KNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred cc---CCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 22 236788999999999999999999 677664
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=307.51 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=198.3
Q ss_pred ceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----
Q 001952 611 FNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----- 682 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----- 682 (992)
|.+.+.||+|+||.||+|.+. ++++.||||++..... .......+.+|+.+|+.++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567789999999999999865 3578999999875421 1223456788999999999999999999886432
Q ss_pred -eEEEEEEecCCCChHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccc
Q 001952 683 -LSCLVMEYCPGGDLHVLRQKQL----GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757 (992)
Q Consensus 683 -~lyLVmEy~~GGSL~~lLkk~~----~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGL 757 (992)
..++++||+.+++|..++.... ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3478999999999988765321 12478889999999999999999999999999999999999999999999998
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+..+..... .
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------~ 169 (273)
T cd05074 160 SKKIYSGDY----------------------------------------------------------------------Y 169 (273)
T ss_pred cccccCCcc----------------------------------------------------------------------e
Confidence 744311000 0
Q ss_pred CCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
.......++..|++||.+.+..++.++|||||||++|||++ |+.||.+.+..+.+..+... ..+.....++..+.+|+
T Consensus 170 ~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~ 248 (273)
T cd05074 170 RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLKQPPDCLEDVYELM 248 (273)
T ss_pred ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHH
Confidence 00112235677999999999989999999999999999999 89999877665555544432 22333345788999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHc
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILk 939 (992)
.+||..+|++||+ +.+++.
T Consensus 249 ~~~l~~~p~~Rps----~~~~~~ 267 (273)
T cd05074 249 CQCWSPEPKCRPS----FQHLRD 267 (273)
T ss_pred HHHcCCChhhCcC----HHHHHH
Confidence 9999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=307.92 Aligned_cols=247 Identities=19% Similarity=0.268 Sum_probs=190.4
Q ss_pred EEccCCceEEEEEEEcCC--CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCC
Q 001952 616 KLGCGDIGTVYLAELIGT--NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~t--g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
.||+|+||.||+|.+... ...+++|.+.... .......+.+|+.+++.++||||+++++++......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999976433 3356777765432 122346788999999999999999999999999999999999999
Q ss_pred CChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCC
Q 001952 694 GDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSS 771 (992)
Q Consensus 694 GSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~ 771 (992)
++|..++.... ...+++..++.++.||+.||+|||+.+|+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~------ 153 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED------ 153 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch------
Confidence 99999887642 2345677788999999999999999999999999999999999999999999862210000
Q ss_pred CCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccC
Q 001952 772 SNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLA 851 (992)
Q Consensus 772 s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~A 851 (992)
.........|+..|+|
T Consensus 154 ----------------------------------------------------------------~~~~~~~~~~~~~y~a 169 (268)
T cd05086 154 ----------------------------------------------------------------YIETEDDKCVPLRWLA 169 (268)
T ss_pred ----------------------------------------------------------------hhhcccCCcCcccccC
Confidence 0000113457889999
Q ss_pred hhhhcC-------CCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhcc-CCC---CCccchHHHHHHHHHh
Q 001952 852 PEIIKG-------EGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSL-KFP---DSPLISFQARDLIRGL 919 (992)
Q Consensus 852 PEvL~g-------~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~l-k~P---~~~~vs~el~dLI~kc 919 (992)
||++.. ..++.++|||||||++|||++ |..||......+.+..++.... ..+ ....++..+.++|..|
T Consensus 170 PE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 249 (268)
T cd05086 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFC 249 (268)
T ss_pred chhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHH
Confidence 999853 235789999999999999997 6778887777666666554432 111 1234678899999999
Q ss_pred ccCCcCCcCCChHhHHHHHc
Q 001952 920 LIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILk 939 (992)
| .+|++||+ +.+|++
T Consensus 250 ~-~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 250 W-LSPEKRAT----AEEVHR 264 (268)
T ss_pred h-hCcccCCC----HHHHHH
Confidence 9 68999999 777654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=337.90 Aligned_cols=244 Identities=33% Similarity=0.492 Sum_probs=202.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyL 686 (992)
.+.|++...||.|+|+.|-.|.+..+++.+++|++.+. .....+|+.++... +||||+++.+.+.+..+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-------~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-------ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc-------ccccccccchhhhhcCCCcceeecceecCCceeee
Confidence 57788888899999999999999999999999999754 12234567665554 79999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE-ccCCcEEEEeccccccccCCc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV-REDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL-d~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||++.|+.|.+.+... . .....+..|+++|+.|+.|||.+|||||||||+|||+ +..|+++|+|||.+.....
T Consensus 394 v~e~l~g~ell~ri~~~--~-~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~-- 468 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK--P-EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER-- 468 (612)
T ss_pred eehhccccHHHHHHHhc--c-hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch--
Confidence 99999999887776654 2 2236777899999999999999999999999999999 5999999999998743210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.|.. -+-
T Consensus 469 -------------------------------~~~t------------------------------------------p~~ 475 (612)
T KOG0603|consen 469 -------------------------------SCDT------------------------------------------PAL 475 (612)
T ss_pred -------------------------------hhcc------------------------------------------cch
Confidence 0111 135
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|..|.|||++....|+.++||||||++||+||+|+.||........+...+. ..+ ....+++.+++||++||+.||.
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~-~~~--~s~~vS~~AKdLl~~LL~~dP~ 552 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ-MPK--FSECVSDEAKDLLQQLLQVDPA 552 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc-CCc--cccccCHHHHHHHHHhccCChh
Confidence 7789999999999999999999999999999999999988766633322221 122 2256999999999999999999
Q ss_pred CcCCChHhHHHHHcCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF 943 (992)
+||+ +.+|+.||||
T Consensus 553 ~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 553 LRLG----ADEIGAHPWF 566 (612)
T ss_pred hCcC----hhhhccCcch
Confidence 9999 9999999999
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=309.20 Aligned_cols=265 Identities=23% Similarity=0.346 Sum_probs=211.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC---
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN--- 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~--- 682 (992)
+..++|++.+.||+|||+-||+++...++..||+|.+.... .+......+|++..++++|||+++++++...+.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 56789999999999999999999999999999999997653 345567889999999999999999999886443
Q ss_pred --eEEEEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCcEEEEecc
Q 001952 683 --LSCLVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 683 --~lyLVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
..||++.|...|+|.+.++... +..+++..++.|+.+|+.||++||... +.||||||.|||+.+.+.++|.|||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence 4899999999999998877543 457999999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
.+...... +.+ ....-++++ |.
T Consensus 175 S~~~a~i~--------------i~~-------------------------------------~~~a~~lQe-------~a 196 (302)
T KOG2345|consen 175 SATQAPIQ--------------IEG-------------------------------------SRQALRLQE-------WA 196 (302)
T ss_pred CccccceE--------------eec-------------------------------------hHHHHHHHH-------HH
Confidence 86332100 000 000111111 11
Q ss_pred CCCcCccccCCCccChhhhcCC---CCCccceeeehhhhhhhhccCCCCCCCCCc--hHHHHHHHhhccCCCCCccchHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGE---GHGAAVDWWTFGIFLYELLYGRTPFKGSGN--EETLANVVMQSLKFPDSPLISFQ 911 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~---~~s~kSDIWSLGVlLyELLTGr~PF~g~s~--~e~L~~Iv~~~lk~P~~~~vs~e 911 (992)
.-..|..|+|||.+... ..+.++|||||||+||+|++|.-||..... .-....+....+.+|....+++.
T Consensus 197 -----~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~ 271 (302)
T KOG2345|consen 197 -----EERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEA 271 (302)
T ss_pred -----HHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHH
Confidence 12367889999999754 358999999999999999999999963211 01112334457788888889999
Q ss_pred HHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.+||+.||+.||.+||+ +.+++.+
T Consensus 272 l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 272 LHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred HHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 999999999999999999 8887754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=355.94 Aligned_cols=271 Identities=28% Similarity=0.403 Sum_probs=205.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------- 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------- 680 (992)
..+|+.++.||+||||.||+++.+-+|+.||||.|.... .......+.+|+.+|.+|+|||||++|..|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 467888899999999999999999999999999998654 44566788999999999999999999976511
Q ss_pred ------------------------------------------------C-------------------------------
Q 001952 681 ------------------------------------------------D------------------------------- 681 (992)
Q Consensus 681 ------------------------------------------------~------------------------------- 681 (992)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Q 001952 682 ---------------------------------NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728 (992)
Q Consensus 682 ---------------------------------~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH 728 (992)
-.+||-||||+..+|.++++.+.... .....+.++++|+.||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 12689999999999999988753111 46788999999999999999
Q ss_pred hcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcC
Q 001952 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFL 808 (992)
Q Consensus 729 s~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~ 808 (992)
++|||||||||.||+|+.++.|||+|||+|............
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~-------------------------------------- 756 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQ-------------------------------------- 756 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhh--------------------------------------
Confidence 999999999999999999999999999998442110000000
Q ss_pred ccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCC---CCccceeeehhhhhhhhccCCCCCCC
Q 001952 809 PATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG---HGAAVDWWTFGIFLYELLYGRTPFKG 885 (992)
Q Consensus 809 ~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~---~s~kSDIWSLGVlLyELLTGr~PF~g 885 (992)
................+..+||.-|+|||++.+.. |+.++|+||||++||||++ ||..
T Consensus 757 ----------------~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T 817 (1351)
T KOG1035|consen 757 ----------------DLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT 817 (1351)
T ss_pred ----------------ccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc
Confidence 00000111222334567889999999999998765 9999999999999999994 4643
Q ss_pred C-CchHHHHHHHhhccCCCCCccc----hHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 886 S-GNEETLANVVMQSLKFPDSPLI----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 886 ~-s~~e~L~~Iv~~~lk~P~~~~v----s~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
. .....+.++-...+.++ ..+ -..-..+|++||..||.+||| |.|+|++.||-
T Consensus 818 sMERa~iL~~LR~g~iP~~--~~f~~~~~~~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 818 SMERASILTNLRKGSIPEP--ADFFDPEHPEEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred hHHHHHHHHhcccCCCCCC--cccccccchHHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 2 22223333322333333 111 124468999999999999999 99999999997
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.41 Aligned_cols=265 Identities=31% Similarity=0.417 Sum_probs=205.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCC----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-CC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTN----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-DN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-~~ 682 (992)
+..|+++..||+|.||.||+|....++ +.+|||.++.+.- .........+|+.+++.++||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 457899999999999999999554432 3689998864421 22334567899999999999999999999987 88
Q ss_pred eEEEEEEecCCCChHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC----CcEEEEec
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQ---LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED----GHIMLTDF 755 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~---~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d----g~VKLsDF 755 (992)
.++|+|||.+. +|..+++-. ..+.++...++.|++||+.|+.|||++-|+||||||.|||+..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999954 555555432 23568899999999999999999999999999999999999987 89999999
Q ss_pred cccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 756 DLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 756 GLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
|+++.+... + .|.
T Consensus 181 GlaR~~~~p--l----------------------kpl------------------------------------------- 193 (438)
T KOG0666|consen 181 GLARLFNNP--L----------------------KPL------------------------------------------- 193 (438)
T ss_pred cHHHHhhcc--c----------------------ccc-------------------------------------------
Confidence 998765310 0 000
Q ss_pred CCCCcCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCC---------chHHHHHHHhhc-----c
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSG---------NEETLANVVMQS-----L 900 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s---------~~e~L~~Iv~~~-----l 900 (992)
......+-|.+|+|||+|.|.. |+.+.|||+.||++.||||-.+.|.+.. ..+++.+|+.-. .
T Consensus 194 --~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~ 271 (438)
T KOG0666|consen 194 --ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDK 271 (438)
T ss_pred --ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccc
Confidence 0123457899999999999985 6999999999999999999999998632 234455543210 0
Q ss_pred CC------CCC------------------------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 901 KF------PDS------------------------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 901 k~------P~~------------------------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.+ |.. ..-++...+|+.+||.+||.+|++ ++++|+|+||.+-+
T Consensus 272 ~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 272 DWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTEDP 344 (438)
T ss_pred cchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhcccccccCC
Confidence 11 111 001234679999999999999999 99999999998764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=338.98 Aligned_cols=250 Identities=21% Similarity=0.314 Sum_probs=215.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcC---CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~---tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.++..+.++||+|+||.||+|.|.. +-..||||+++.+.+.. .+..|.+|+.+|.+|+|+|+++|||+..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 3455666789999999999998864 33468999998764332 67889999999999999999999999887 778
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
.||||+++.|+|.+.+++-....|.......|+.||+.||.||..+++|||||...||||-....||||||||.+-+..+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999999999999866677889999999999999999999999999999999999999999999999998666543
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
..... ......
T Consensus 266 ed~Yv---------------------------------------------------------------------m~p~rk 276 (1039)
T KOG0199|consen 266 EDMYV---------------------------------------------------------------------MAPQRK 276 (1039)
T ss_pred CcceE---------------------------------------------------------------------ecCCCc
Confidence 22110 011122
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
-...|||||.|....++.++|||+|||+||||+| |..||.|.....+|.+|- .+-.++.+..++.++.+++..||..+
T Consensus 277 vPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~ 355 (1039)
T KOG0199|consen 277 VPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHN 355 (1039)
T ss_pred CcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCC
Confidence 4567999999999999999999999999999998 999999999999998876 77788888899999999999999999
Q ss_pred cCCcCCC
Q 001952 924 PENRLGS 930 (992)
Q Consensus 924 PekRPT~ 930 (992)
|++||++
T Consensus 356 paDRptF 362 (1039)
T KOG0199|consen 356 PADRPTF 362 (1039)
T ss_pred ccccccH
Confidence 9999994
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=338.31 Aligned_cols=260 Identities=30% Similarity=0.467 Sum_probs=224.6
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeec-----c
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFT-----S 680 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~-----~ 680 (992)
..+-|++.+.||.|.+|.||+++.+.+++.+|+|++... .....++..|.++|+.. +|||++.+||+|. .
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 356799999999999999999999999999999998754 33445677888998887 6999999999985 4
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
++.+|||||||.||+.-+++++..+..+.|+.+..|++.++.||.+||.+.+||||||-.|||++.+|.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 67899999999999999999998889999999999999999999999999999999999999999999999999999754
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+.. +..+.
T Consensus 173 lds------------------------------------------------------------------------T~grR 180 (953)
T KOG0587|consen 173 LDS------------------------------------------------------------------------TVGRR 180 (953)
T ss_pred eec------------------------------------------------------------------------ccccc
Confidence 421 22345
Q ss_pred CccccCCCccChhhhcCC-----CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGE-----GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARD 914 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~-----~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~d 914 (992)
+.++||+.|||||++.+. .|+.++|+||||++..||--|.+|+-+.-....|..|-.... ++..+...+.++.+
T Consensus 181 nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~Fnd 260 (953)
T KOG0587|consen 181 NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFND 260 (953)
T ss_pred cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHH
Confidence 678999999999999865 478899999999999999999999998877766665543322 22234457889999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||..||.+|-++||+ ..++|+|||+.+.
T Consensus 261 FIs~cL~Kd~e~RP~----~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 261 FISTCLVKDYEQRPS----TEELLKHPFITEQ 288 (953)
T ss_pred HHHHHHhhccccCcc----hhhhccCCccccc
Confidence 999999999999999 9999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=286.35 Aligned_cols=242 Identities=48% Similarity=0.748 Sum_probs=201.6
Q ss_pred CceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCChHHHH
Q 001952 621 DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLR 700 (992)
Q Consensus 621 ~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lL 700 (992)
+||.||+|.+.++++.+++|++....... ....+.+|++.++.++|+||+++++++......+++|||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999999889999999997542211 1567889999999999999999999999999999999999999999998
Q ss_pred HhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccC
Q 001952 701 QKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVS 780 (992)
Q Consensus 701 kk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~s 780 (992)
... ..+++..++.++.+++.+|.|||..||+|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred Hhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 764 238899999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCC
Q 001952 781 GPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGH 860 (992)
Q Consensus 781 gp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~ 860 (992)
......++..|++||.+.+..+
T Consensus 142 ----------------------------------------------------------~~~~~~~~~~~~~pE~~~~~~~ 163 (244)
T smart00220 142 ----------------------------------------------------------LLTTFVGTPEYMAPEVLLGKGY 163 (244)
T ss_pred ----------------------------------------------------------ccccccCCcCCCCHHHHccCCC
Confidence 1122357788999999998889
Q ss_pred CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCcc--chHHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 861 GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPL--ISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 861 s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~--vs~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
+.++|||+||+++|+|++|..||......+.....+........... ++.++.+++.+||..+|++||+ +.+++
T Consensus 164 ~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~~~~~ 239 (244)
T smart00220 164 GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT----AEEAL 239 (244)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC----HHHHh
Confidence 99999999999999999999999874444444444433332222212 7889999999999999999999 99999
Q ss_pred cCCCC
Q 001952 939 QHPFF 943 (992)
Q Consensus 939 kHPfF 943 (992)
+||||
T Consensus 240 ~~~~~ 244 (244)
T smart00220 240 QHPFF 244 (244)
T ss_pred hCCCC
Confidence 99997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.54 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=214.0
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc------
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------ 680 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------ 680 (992)
..+.|+.+.+||+|.||.||+|+...+++.||+|++-.+. +....-....+|+.+|..++|+|++.|++.|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence 3567888889999999999999999999999998764331 122333556889999999999999999998853
Q ss_pred --CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 681 --DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 681 --~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
...+||||.+| .-+|..++... ...|+...+..++.+++.||.|+|+..|+|||+|++|+||+.+|.+||+|||++
T Consensus 94 r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 94 RDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 23589999999 56777776643 357899999999999999999999999999999999999999999999999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
+.+...... ...
T Consensus 172 r~fs~~~n~--------------------------------------------------------------------~kp 183 (376)
T KOG0669|consen 172 RAFSTSKNV--------------------------------------------------------------------VKP 183 (376)
T ss_pred cceeccccc--------------------------------------------------------------------CCC
Confidence 655322111 112
Q ss_pred CcCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh--hccC---CC---------
Q 001952 839 RSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM--QSLK---FP--------- 903 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~--~~lk---~P--------- 903 (992)
++++.+-|.+|++||.+.|.. |+...|||..||++.||+||.+.|.++.+..++..|-. +... +|
T Consensus 184 rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~ 263 (376)
T KOG0669|consen 184 RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQ 263 (376)
T ss_pred CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHH
Confidence 367788999999999999875 89999999999999999999999999988887766532 1110 11
Q ss_pred --------CC----------c-cchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 904 --------DS----------P-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 904 --------~~----------~-~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.. + .-++++.||+.+||..||.+|++ +.++|.|.||..-
T Consensus 264 sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~kd 321 (376)
T KOG0669|consen 264 SIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFWKD 321 (376)
T ss_pred hccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhhcC
Confidence 00 0 02347789999999999999999 9999999999753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=333.12 Aligned_cols=262 Identities=19% Similarity=0.229 Sum_probs=180.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCC----CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeee----
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT----NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQ---- 677 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~t----g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~---- 677 (992)
+..++|++.+.||+|+||.||+|.+..+ +..||||.+.... ....... +.+....+.+++.++..
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~--e~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMN--ERVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHH--HHHHhhchhhHHHHHHhhhcc
Confidence 4568999999999999999999999888 8999999886421 1111111 11222233333333322
Q ss_pred --eccCCeEEEEEEecCCCChHHHHHhhcC------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeec
Q 001952 678 --FTSDNLSCLVMEYCPGGDLHVLRQKQLG------------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737 (992)
Q Consensus 678 --f~~~~~lyLVmEy~~GGSL~~lLkk~~~------------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDI 737 (992)
...+..++|||||+.+++|.+++..... .......+..|+.||+.||+|||++|||||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 2456789999999999999988875311 01123446689999999999999999999999
Q ss_pred CCceEEEcc-CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCC
Q 001952 738 KPENILVRE-DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRK 816 (992)
Q Consensus 738 KPeNILLd~-dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~ 816 (992)
||+|||++. ++.+||+|||++..+....
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~--------------------------------------------------- 310 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI--------------------------------------------------- 310 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc---------------------------------------------------
Confidence 999999985 5799999999974321100
Q ss_pred CCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC----------------------CCCccceeeehhhhhh
Q 001952 817 PKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE----------------------GHGAAVDWWTFGIFLY 874 (992)
Q Consensus 817 ~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~----------------------~~s~kSDIWSLGVlLy 874 (992)
......++|++.|+|||.+... .++.++|||||||+||
T Consensus 311 --------------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~ 370 (566)
T PLN03225 311 --------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370 (566)
T ss_pred --------------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence 0011235688899999976432 2345679999999999
Q ss_pred hhccCCCCCCCCCchHHHHHHHhhc-c-----------CC--------CCCccchHHHHHHHHHhccCCcCCcCCChHhH
Q 001952 875 ELLYGRTPFKGSGNEETLANVVMQS-L-----------KF--------PDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934 (992)
Q Consensus 875 ELLTGr~PF~g~s~~e~L~~Iv~~~-l-----------k~--------P~~~~vs~el~dLI~kcL~~DPekRPT~~~~a 934 (992)
||+++..++.. ....+..++... . .. .........+++||.+||..||.+||+ +
T Consensus 371 el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t----a 444 (566)
T PLN03225 371 QMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS----A 444 (566)
T ss_pred HHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC----H
Confidence 99997766532 222222222110 0 00 000112234569999999999999999 9
Q ss_pred HHHHcCCCCCCCchhhh
Q 001952 935 AEIKQHPFFEGLNWALI 951 (992)
Q Consensus 935 eEILkHPfF~~lnw~~l 951 (992)
.++|+||||.+.++..+
T Consensus 445 ~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 445 KAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHhCCcCcCCCCcccc
Confidence 99999999999887644
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=330.69 Aligned_cols=256 Identities=21% Similarity=0.292 Sum_probs=220.6
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCC---eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTN---CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg---~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
.+++.....+.++||.|.||.||+|+++..+ ..||||.++... ..+....|..|..||.+++||||++|.|+...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 4566778889999999999999999998655 479999998764 33456788999999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
...++||+|||++|+|..||+.+. +.|...+...+++.|+.|++||-+.|+|||||...|||++.+-.+|++||||++.
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999886 4599999999999999999999999999999999999999999999999999864
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+...+ .+. ...
T Consensus 781 ledd~-----------------~~~----------------------------------------------------ytt 791 (996)
T KOG0196|consen 781 LEDDP-----------------EAA----------------------------------------------------YTT 791 (996)
T ss_pred cccCC-----------------Ccc----------------------------------------------------ccc
Confidence 42110 000 000
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
..-.-+..|.|||.|....++.++||||||++|||.++ |..||.+.++.+.+.. +..++++|.+..++..+..|+..|
T Consensus 792 ~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpPmDCP~aL~qLMldC 870 (996)
T KOG0196|consen 792 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPPMDCPAALYQLMLDC 870 (996)
T ss_pred cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCCCCCcHHHHHHHHHH
Confidence 11123467999999999999999999999999999886 9999999999988866 457788888889999999999999
Q ss_pred ccCCcCCcCCChH
Q 001952 920 LIKEPENRLGSQK 932 (992)
Q Consensus 920 L~~DPekRPT~~~ 932 (992)
|++|-.+||.+.+
T Consensus 871 WqkdR~~RP~F~q 883 (996)
T KOG0196|consen 871 WQKDRNRRPKFAQ 883 (996)
T ss_pred HHHHhhcCCCHHH
Confidence 9999999999543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=319.90 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=217.0
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
+....+..+.++||-|-||.||.|.|+.....||||.++.+ .-.+.+|..|..+|+.++|||+|+|+|+|..+..+
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 34456778889999999999999999999999999999754 45568899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|||+|||..|+|.+|++......++.-..+.++.||..|++||...++|||||...|.|+.++..+|++||||++.+...
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGD 418 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCC
Confidence 99999999999999999876566777788889999999999999999999999999999999999999999998765432
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.+-.. ....
T Consensus 419 TYTAH-----------------------------------------------------------------------AGAK 427 (1157)
T KOG4278|consen 419 TYTAH-----------------------------------------------------------------------AGAK 427 (1157)
T ss_pred ceecc-----------------------------------------------------------------------cCcc
Confidence 11100 0011
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
-...|.|||-|....++.++|||+|||+|||+.| |-.||.|.+-- +...++...++...+..+++.+.+|++.||.+.
T Consensus 428 FPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~Ws 506 (1157)
T KOG4278|consen 428 FPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYGLLEKGYRMDGPEGCPPKVYELMRACWNWS 506 (1157)
T ss_pred CcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHhccccccCCCCCCHHHHHHHHHHhcCC
Confidence 2456999999999999999999999999999998 99999998544 444667788888888889999999999999999
Q ss_pred cCCcCCCh
Q 001952 924 PENRLGSQ 931 (992)
Q Consensus 924 PekRPT~~ 931 (992)
|..||++.
T Consensus 507 PsDRPsFa 514 (1157)
T KOG4278|consen 507 PSDRPSFA 514 (1157)
T ss_pred cccCccHH
Confidence 99999943
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=307.73 Aligned_cols=276 Identities=28% Similarity=0.415 Sum_probs=220.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
..+|.-++.+|.|.- .|.-+.+.-.++.||+|.+... ........+..+|+.++..+.|+||++++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 357888889999998 7888888889999999988765 33345567889999999999999999999999643
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
...|+||||| ..+|...+.. .++...+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+++.-
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 3579999999 8899888773 3788999999999999999999999999999999999999999999999997331
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. .+-+.+
T Consensus 169 ~-------------------------------------------------------------------------~~~~mt 175 (369)
T KOG0665|consen 169 D-------------------------------------------------------------------------TDFMMT 175 (369)
T ss_pred C-------------------------------------------------------------------------cccccC
Confidence 1 011234
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc---------------------
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL--------------------- 900 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l--------------------- 900 (992)
.++.|+.|+|||++.+..|...+||||+||++.||++|+..|.|.+..+++.+++....
T Consensus 176 pyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~ 255 (369)
T KOG0665|consen 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENR 255 (369)
T ss_pred chhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcC
Confidence 57899999999999999999999999999999999999999999888888776653111
Q ss_pred ----------CCCCC---------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh---hhhcCCCCC
Q 001952 901 ----------KFPDS---------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA---LIRCAIPPE 958 (992)
Q Consensus 901 ----------k~P~~---------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~---~lr~~~pp~ 958 (992)
.+|+. ..-...+++|+.+||..||++|.+ ++++|+||||+ -|= .+....|+.
T Consensus 256 ~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~--vw~~~~ev~ap~pe~ 329 (369)
T KOG0665|consen 256 PQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK--VWYDPDEVEAPPPEI 329 (369)
T ss_pred hHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee--eecccccccCCCCch
Confidence 11111 112235789999999999999999 99999999998 352 223333332
Q ss_pred CCCCCCCCCcc
Q 001952 959 LPDFYDYGIQD 969 (992)
Q Consensus 959 lp~~~d~~~~~ 969 (992)
.-+++|+...+
T Consensus 330 ~d~~~d~~~~t 340 (369)
T KOG0665|consen 330 YDKQLDEREHT 340 (369)
T ss_pred hhhhcccccCC
Confidence 33566665444
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=315.72 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=213.0
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.++..+...+.++||+|-||.|.+|+..+ +..||+|.++.+. .......|.+|+.+|.+|+||||++|+|+|..++.
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 34556677888999999999999998844 6899999998653 23345788999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||+||+++|+|..++.+.....+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++-++.
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999999999887433344555667999999999999999999999999999999999999999999865543
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.++. .-....
T Consensus 690 g~yy----------------------------------------------------------------------~vqgr~ 699 (807)
T KOG1094|consen 690 GDYY----------------------------------------------------------------------RVQGRA 699 (807)
T ss_pred CCce----------------------------------------------------------------------eeecce
Confidence 3221 111234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc--CCCCCCCCCchHHHHHHHh------hccCCCCCccchHHHHHH
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY--GRTPFKGSGNEETLANVVM------QSLKFPDSPLISFQARDL 915 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT--Gr~PF~g~s~~e~L~~Iv~------~~lk~P~~~~vs~el~dL 915 (992)
+-+..|||+|.|..+.++.++|+|+||++|||+++ ...||....+++..++.-. ...-++.++.++..+.+|
T Consensus 700 vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyel 779 (807)
T KOG1094|consen 700 VLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYEL 779 (807)
T ss_pred eeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHH
Confidence 56788999999999999999999999999999986 7889988777666554421 111234556789999999
Q ss_pred HHHhccCCcCCcCCChHhHHHHH
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEIL 938 (992)
|..||..|-++||+ .++|-
T Consensus 780 ml~Cw~~es~~RPs----Fe~lh 798 (807)
T KOG1094|consen 780 MLRCWRRESEQRPS----FEQLH 798 (807)
T ss_pred HHHHhchhhhcCCC----HHHHH
Confidence 99999999999999 55553
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=318.27 Aligned_cols=264 Identities=20% Similarity=0.233 Sum_probs=191.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEc----------------CCCeEEEEEEechhHHHh-----------hcchhHHHH
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELI----------------GTNCLFAIKVMDNEFLAR-----------RKKMPRAQT 658 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~----------------~tg~~VAIKvIkk~~l~~-----------~~~~~~~~~ 658 (992)
+..++|++.++||+|+||.||+|.+. ..++.||||.+....... .........
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 45679999999999999999999752 235679999986431110 011223445
Q ss_pred HHHHHHHcCCCCc-----cceeeeecc--------CCeEEEEEEecCCCChHHHHHhhcC--------------------
Q 001952 659 EREILRMLDHPFL-----PTLYSQFTS--------DNLSCLVMEYCPGGDLHVLRQKQLG-------------------- 705 (992)
Q Consensus 659 EieILk~L~HPNI-----VkL~g~f~~--------~~~lyLVmEy~~GGSL~~lLkk~~~-------------------- 705 (992)
|+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++...+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777766654 777887753 3568999999999999998874211
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCC
Q 001952 706 --KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPC 783 (992)
Q Consensus 706 --~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~ 783 (992)
..+++..++.++.||+.||.|||..+|+||||||+|||++.++.++|+|||++..+....
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~------------------ 363 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI------------------ 363 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC------------------
Confidence 124567788999999999999999999999999999999999999999999973321000
Q ss_pred CCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCC----
Q 001952 784 TESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG---- 859 (992)
Q Consensus 784 ~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~---- 859 (992)
........+|+.|+|||.+....
T Consensus 364 -----------------------------------------------------~~~~~~g~~tp~Y~aPE~l~~~~~~~~ 390 (507)
T PLN03224 364 -----------------------------------------------------NFNPLYGMLDPRYSPPEELVMPQSCPR 390 (507)
T ss_pred -----------------------------------------------------ccCccccCCCcceeChhhhcCCCCCCc
Confidence 00001123578899999886432
Q ss_pred ----------------C--CccceeeehhhhhhhhccCCC-CCCCCCc-----------hHHHHHHHhhccCCCCCccch
Q 001952 860 ----------------H--GAAVDWWTFGIFLYELLYGRT-PFKGSGN-----------EETLANVVMQSLKFPDSPLIS 909 (992)
Q Consensus 860 ----------------~--s~kSDIWSLGVlLyELLTGr~-PF~g~s~-----------~e~L~~Iv~~~lk~P~~~~vs 909 (992)
+ ....||||+||+||+|++|.. ||.+... ...++.+....+.++....++
T Consensus 391 ~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s 470 (507)
T PLN03224 391 APAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNK 470 (507)
T ss_pred cchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccC
Confidence 1 134799999999999999875 7753211 111222223344555555678
Q ss_pred HHHHHHHHHhccCCc---CCcCCChHhHHHHHcCCCCC
Q 001952 910 FQARDLIRGLLIKEP---ENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 910 ~el~dLI~kcL~~DP---ekRPT~~~~aeEILkHPfF~ 944 (992)
..++|||.+||..+| .+|++ +.|+|.||||.
T Consensus 471 ~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~ 504 (507)
T PLN03224 471 EAGWDLACKLITKRDQANRGRLS----VGQALSHRFFL 504 (507)
T ss_pred hHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcC
Confidence 999999999999876 68999 99999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=304.32 Aligned_cols=268 Identities=26% Similarity=0.358 Sum_probs=213.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHH-HcCCCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR-MLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk-~L~HPNIVkL~g~f~~~~~lyL 686 (992)
.++.+-+..||.|+||+|++..++.+|+.+|||.++.... .....++..|.+... .-+.||||++||+...++..||
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceee
Confidence 4455666789999999999999999999999999986543 344566777777644 4479999999999999999999
Q ss_pred EEEecCCCChHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 687 VMEYCPGGDLHVLRQK---QLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk---~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.||+| ..+|..+.+. -....+++..+-.|....+.||+||.+ +.||||||||+||||+..|.+||||||++-.+-
T Consensus 141 CMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 141 CMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred eHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 99999 6777654332 223568888888888899999999985 589999999999999999999999999863321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
...++ +.
T Consensus 220 ----------------------------------------------~SiAk---------------------------T~ 226 (361)
T KOG1006|consen 220 ----------------------------------------------DSIAK---------------------------TV 226 (361)
T ss_pred ----------------------------------------------HHHHh---------------------------hh
Confidence 00111 12
Q ss_pred cccCCCccChhhhcC--CCCCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhccCCCC----CccchHHHHHH
Q 001952 843 FVGTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQSLKFPD----SPLISFQARDL 915 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~lk~P~----~~~vs~el~dL 915 (992)
-.|.+.|||||.+.. .+|+.++|+||||++|||+.||++||.+.+. .+++..++.+..+.-. ...++..+..+
T Consensus 227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~f 306 (361)
T KOG1006|consen 227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRF 306 (361)
T ss_pred ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHH
Confidence 358889999999974 4589999999999999999999999998654 5777777776543322 13478899999
Q ss_pred HHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCC
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAI 955 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~ 955 (992)
|.-||.+|-..||. -.+++++||++-.....-++..
T Consensus 307 intCl~Kd~~~Rpk----y~~Lk~~~fyr~y~~~~~~v~v 342 (361)
T KOG1006|consen 307 INTCLIKDRSDRPK----YDDLKKFPFYRMYAVEGPDVEV 342 (361)
T ss_pred HHHHhhcccccCcc----hhhhhcCchhhhhhhcCCceeh
Confidence 99999999999999 8999999999876555444433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.13 Aligned_cols=269 Identities=30% Similarity=0.480 Sum_probs=217.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEech--hHHH--hhcchhHHHHHHHHHHHcCCCCccceeeeec-c
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDN--EFLA--RRKKMPRAQTEREILRMLDHPFLPTLYSQFT-S 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk--~~l~--~~~~~~~~~~EieILk~L~HPNIVkL~g~f~-~ 680 (992)
...++|-++..||.|||+.||+|.+....++||||+-.. .+-. .........+|..|-+.|+||-||++|+||. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345688899999999999999999999999999998642 2211 1233467789999999999999999999997 5
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEcc---CCcEEEEec
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVRE---DGHIMLTDF 755 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~---dg~VKLsDF 755 (992)
.+.+|-|+|||+|.+|..+++.. +.+++..++.|+.||+.||.||.+.. |||-||||.||||.. -|.+||.||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 56789999999999999999875 67999999999999999999999874 999999999999964 457999999
Q ss_pred cccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 756 DLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 756 GLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
||++.+....+.. ..
T Consensus 618 GLSKIMdddSy~~-----------------------------------------------------------------vd 632 (775)
T KOG1151|consen 618 GLSKIMDDDSYNS-----------------------------------------------------------------VD 632 (775)
T ss_pred chhhhccCCccCc-----------------------------------------------------------------cc
Confidence 9986653211100 00
Q ss_pred CCCCcCccccCCCccChhhhcCC----CCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHH--HH-hhccCCCCCcc
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGE----GHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLAN--VV-MQSLKFPDSPL 907 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~----~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~--Iv-~~~lk~P~~~~ 907 (992)
.-+......||.+|++||.+.-+ ..+.++||||+||++|..++|+.||..+-.. +++.. |+ .....||..+.
T Consensus 633 GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPv 712 (775)
T KOG1151|consen 633 GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPV 712 (775)
T ss_pred ceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCc
Confidence 11223446799999999988643 3589999999999999999999999764332 33321 22 24568888899
Q ss_pred chHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 908 vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
++.++++||++||++.-+.|.. +-+|..||||.-
T Consensus 713 VsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyllP 746 (775)
T KOG1151|consen 713 VSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLLP 746 (775)
T ss_pred cCHHHHHHHHHHHHhhhhhhhh----HHHHccCccccc
Confidence 9999999999999999999999 999999999964
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=325.84 Aligned_cols=254 Identities=31% Similarity=0.466 Sum_probs=197.8
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC------eE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN------LS 684 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~------~l 684 (992)
|..-+.||+|+||.||+++++.+|+.||||.++... .....+...+|+++|++++|+|||+++++=+... ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 455578999999999999999999999999998753 2334566789999999999999999999765443 45
Q ss_pred EEEEEecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc--CC--cEEEEeccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE--DG--HIMLTDFDLSL 759 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~--dg--~VKLsDFGLA~ 759 (992)
.+|||||.||+|+..++...+ .++++...+.++.++..||.|||++|||||||||.||++-. +| ..||+|||.|+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 899999999999999886443 56999999999999999999999999999999999999963 34 36999999985
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..+ ..
T Consensus 173 el~d~-------------------------------------------------------------------------s~ 179 (732)
T KOG4250|consen 173 ELDDN-------------------------------------------------------------------------SL 179 (732)
T ss_pred cCCCC-------------------------------------------------------------------------Ce
Confidence 54211 12
Q ss_pred cCccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhhc---------------
Q 001952 840 SNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQS--------------- 899 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~~--------------- 899 (992)
..+++||..|.+||++-. ..|+..+|.|||||++|+.+||..||...... +....+..+.
T Consensus 180 ~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgp 259 (732)
T KOG4250|consen 180 FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGP 259 (732)
T ss_pred eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCc
Confidence 356799999999999994 78899999999999999999999999754333 3333332211
Q ss_pred ----cCCCCCccch----HHHHHHHHHhccCCcCCcC--CC---hHhHHHHHc
Q 001952 900 ----LKFPDSPLIS----FQARDLIRGLLIKEPENRL--GS---QKGAAEIKQ 939 (992)
Q Consensus 900 ----lk~P~~~~vs----~el~dLI~kcL~~DPekRP--T~---~~~aeEILk 939 (992)
..+|.+...+ ..+...+..+|..+|.+|. .+ ....++||+
T Consensus 260 v~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 260 VEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1222222222 3456788899999999998 32 223555554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=291.09 Aligned_cols=268 Identities=25% Similarity=0.445 Sum_probs=217.2
Q ss_pred hhhHhhheeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCC
Q 001952 592 RWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPF 670 (992)
Q Consensus 592 ~~e~~~~~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPN 670 (992)
..+..+...+.+| ..++|++++++|.|.|+.||.|....+++.++||+++.- ....+.+|+.||..|. |||
T Consensus 23 eYWdYE~~~i~wg--~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~N 94 (338)
T KOG0668|consen 23 EYWDYESLVIDWG--NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPN 94 (338)
T ss_pred hhcchhheeeecc--ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCC
Confidence 3344555666677 457999999999999999999999899999999999753 3356789999999996 999
Q ss_pred ccceeeeeccC--CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-C
Q 001952 671 LPTLYSQFTSD--NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-D 747 (992)
Q Consensus 671 IVkL~g~f~~~--~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-d 747 (992)
|++|+++..+. ....|||||+.+.+...+.. .++...++.++.+|+.||+|+|++||+|||+||.|++|+. .
T Consensus 95 Ii~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~ 169 (338)
T KOG0668|consen 95 IIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL 169 (338)
T ss_pred eeehhhhhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh
Confidence 99999998764 45689999998888776643 4788899999999999999999999999999999999995 4
Q ss_pred CcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhcc
Q 001952 748 GHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827 (992)
Q Consensus 748 g~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~ 827 (992)
..++|+|||||+.+...
T Consensus 170 rkLrlIDWGLAEFYHp~--------------------------------------------------------------- 186 (338)
T KOG0668|consen 170 RKLRLIDWGLAEFYHPG--------------------------------------------------------------- 186 (338)
T ss_pred ceeeeeecchHhhcCCC---------------------------------------------------------------
Confidence 46999999998654321
Q ss_pred CCccccCCCCCCcCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCC-CCCchHHHHHHHh--------
Q 001952 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFK-GSGNEETLANVVM-------- 897 (992)
Q Consensus 828 ~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~-g~s~~e~L~~Iv~-------- 897 (992)
..++-.+.++.|--||+|.... |+.+-|+|||||+|..|+..+.||. |.++.+++.+|..
T Consensus 187 ----------~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 187 ----------KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred ----------ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 1234557788899999998764 7999999999999999999888865 6777777766632
Q ss_pred -----hccCC---------------------CCC-ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 898 -----QSLKF---------------------PDS-PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 898 -----~~lk~---------------------P~~-~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
..+.+ +.. -.+++++.|||.++|..|..+|+| |.|++.||||..+.-+
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVREA 331 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHHHH
Confidence 00000 011 225689999999999999999999 9999999999876443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=312.58 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=207.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcC----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIG----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.+...+.+.||.|-||.||.|.+.. ..-.||||.-+.+. ..+..+.|..|.-+|+.++||||++|+|+|.+ ..
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3344556789999999999997643 34468999887642 23346778999999999999999999999875 46
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
.+||||+++-|.|+.|++.+. ..++......|+.||+.||.|||+..+|||||..+|||+.....+||+||||++.+..
T Consensus 465 ~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 899999999999999999763 6788999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
..++- ....
T Consensus 544 ~~yYk-----------------------------------------------------------------------aS~~ 552 (974)
T KOG4257|consen 544 DAYYK-----------------------------------------------------------------------ASRG 552 (974)
T ss_pred cchhh-----------------------------------------------------------------------cccc
Confidence 11110 0011
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.-+..|||||-+.-..++.++|||-|||+|||++. |..||.+-.+.+.+-. +.++-++|.++.+++.+..|+.+||++
T Consensus 553 kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-iEnGeRlP~P~nCPp~LYslmskcWay 631 (974)
T KOG4257|consen 553 KLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-IENGERLPCPPNCPPALYSLMSKCWAY 631 (974)
T ss_pred ccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-ecCCCCCCCCCCCChHHHHHHHHHhcc
Confidence 23457999999999999999999999999999997 9999999777666544 456678888889999999999999999
Q ss_pred CcCCcCCChH
Q 001952 923 EPENRLGSQK 932 (992)
Q Consensus 923 DPekRPT~~~ 932 (992)
||.+||.+.+
T Consensus 632 eP~kRPrfte 641 (974)
T KOG4257|consen 632 EPSKRPRFTE 641 (974)
T ss_pred CcccCCcHHH
Confidence 9999999654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=331.62 Aligned_cols=238 Identities=20% Similarity=0.276 Sum_probs=184.0
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
..|...+.||+|+||.||+|.+..++..||||.+.... .....|++++++++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-------SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-------cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 34666778999999999999998899999999986421 11234688999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH---MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH---s~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
||+++|+|.++++. +++..+..|+.||+.||+||| ..+|+||||||+|||++.++..++. ||......
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 99999999999863 789999999999999999999 6699999999999999988887765 55421000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
......|
T Consensus 834 -------------------------------------------------------------------------~~~~~~~ 840 (968)
T PLN00113 834 -------------------------------------------------------------------------TDTKCFI 840 (968)
T ss_pred -------------------------------------------------------------------------cCCCccc
Confidence 0011257
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhh-------------ccC--CCCCccch
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQ-------------SLK--FPDSPLIS 909 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~-------------~lk--~P~~~~vs 909 (992)
|+.|+|||++.+..++.++|||||||++|||+||+.||..... ...+..+... ... .+......
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHH
Confidence 8899999999999999999999999999999999999854221 1111111110 000 01111123
Q ss_pred HHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 910 ~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.++.+++.+||..||++||+ +.|+++
T Consensus 921 ~~~~~l~~~Cl~~~P~~RPt----~~evl~ 946 (968)
T PLN00113 921 VEVMNLALHCTATDPTARPC----ANDVLK 946 (968)
T ss_pred HHHHHHHHhhCcCCchhCcC----HHHHHH
Confidence 45778999999999999999 555544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=316.08 Aligned_cols=251 Identities=29% Similarity=0.429 Sum_probs=199.3
Q ss_pred eEEEEEccCCceE-EEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEEEE
Q 001952 612 NLLQKLGCGDIGT-VYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 612 eilr~LGsG~FGt-VYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.-.+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ....+.+|+..|+.. +|||||++|+.-.+...+||+.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3345699999886 899988 6779999988543 345678999999998 59999999999889999999999
Q ss_pred ecCCCChHHHHHhh-cC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CC--cEEEEecccccccc
Q 001952 690 YCPGGDLHVLRQKQ-LG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DG--HIMLTDFDLSLRCS 762 (992)
Q Consensus 690 y~~GGSL~~lLkk~-~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg--~VKLsDFGLA~~l~ 762 (992)
.| ..+|.++++.. .. ........+.++.|++.||++||..+||||||||.||||.. ++ .++|+|||+++++.
T Consensus 584 LC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred Hh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 99 89999999873 11 11111456788899999999999999999999999999986 34 58999999997765
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
..+.-. .+...
T Consensus 663 ~~~sS~---------------------------------------------------------------------~r~s~ 673 (903)
T KOG1027|consen 663 GGKSSF---------------------------------------------------------------------SRLSG 673 (903)
T ss_pred CCcchh---------------------------------------------------------------------hcccC
Confidence 322110 01234
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCC-ccchHHHHHHHHHhc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDS-PLISFQARDLIRGLL 920 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~-~~vs~el~dLI~kcL 920 (992)
..||-+|+|||++....-+.++|||||||++|+.++ |..||... .+.-.+|+.+...+-.- +.-..+++|||.+||
T Consensus 674 ~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml 751 (903)
T KOG1027|consen 674 GSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPLPDCEAKDLISRML 751 (903)
T ss_pred CCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccCchHHHHHHHHHhc
Confidence 469999999999999999999999999999999999 49999653 44455666655433221 112238999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+.||..||+ |.++|.||||...
T Consensus 752 ~~dP~~RPs----a~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 752 NPDPQLRPS----ATDVLNHPLFWDS 773 (903)
T ss_pred CCCcccCCC----HHHHhCCCccCCh
Confidence 999999999 9999999999654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=290.94 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=210.3
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----CeE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-----NLS 684 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-----~~l 684 (992)
+.+.-+.||.|+||.||-+.+..+|+.||+|.+..-. ..-....++.+|+.+|..++|.|++..+++..-. ..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3445578999999999999999999999999986532 3334456788999999999999999999876533 346
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+++|+| ..+|+.++-. ...++.+.++-+++||++||+|||+.+|+||||||.|+|++.+..+||||||+++.....
T Consensus 133 YV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh
Confidence 8889988 6777777654 367888999999999999999999999999999999999999999999999998432110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
...+.+.-+
T Consensus 210 -----------------------------------------------------------------------~~~hMTqEV 218 (449)
T KOG0664|consen 210 -----------------------------------------------------------------------DRLNMTHEV 218 (449)
T ss_pred -----------------------------------------------------------------------hhhhhHHHH
Confidence 001123346
Q ss_pred cCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh-----------------------hcc
Q 001952 845 GTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM-----------------------QSL 900 (992)
Q Consensus 845 GT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~-----------------------~~l 900 (992)
-|..|+|||++.|.. |+.++||||.||++.||+-.+.+|...+..+++..|.+ +..
T Consensus 219 VTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~ 298 (449)
T KOG0664|consen 219 VTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGL 298 (449)
T ss_pred HHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCC
Confidence 788999999999975 79999999999999999999999999988888876643 112
Q ss_pred CCCCC---------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 901 KFPDS---------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 901 k~P~~---------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
+.|.. ..-..+..+++.++|..||++|.+ .++++.|+|..+..+.
T Consensus 299 k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~r 352 (449)
T KOG0664|consen 299 RAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRLR 352 (449)
T ss_pred CCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhccccccccccee
Confidence 22211 122346778999999999999999 9999999999987654
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=308.28 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=212.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYS 676 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g 676 (992)
++..++..+.+.||+|.||.||+|...+ ....||||.++.... ......+..|+++|+.+ .|+||+.++|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3445555666799999999999997542 145799999976532 25567889999999999 5999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhc------C--------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQL------G--------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~------~--------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
++...+.+++|+||+..|+|..+++... . ..++......++.||+.|++||++..+|||||..+||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNV 449 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNV 449 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhE
Confidence 9999999999999999999999988764 0 1388899999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|+..+..+||+|||+++.........
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~------------------------------------------------------ 475 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYR------------------------------------------------------ 475 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceE------------------------------------------------------
Confidence 99999999999999985432111000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
.......-...|||||.+....|+.++||||||++||||+| |..||.+......+...+..+.+
T Consensus 476 ---------------~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r 540 (609)
T KOG0200|consen 476 ---------------TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNR 540 (609)
T ss_pred ---------------ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCC
Confidence 00000002345999999999999999999999999999998 99999986634444557778888
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
...+..++.++.++++.||+.+|++||++....+.+-.
T Consensus 541 ~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 541 MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 88888899999999999999999999995444444333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=293.15 Aligned_cols=300 Identities=25% Similarity=0.364 Sum_probs=212.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcC---CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSD 681 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~---tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~ 681 (992)
.....|..+++||+|.|++||++.+.. .++.||+|.+... ....++.+|+++|..+ .+.||+++.+.+...
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc-----cCchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 345678999999999999999998877 7889999998643 4567789999999998 599999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-cCCcEEEEecccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIMLTDFDLSLR 760 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-~dg~VKLsDFGLA~~ 760 (992)
+..++||||++.....++... ++...++.|++.++.||.++|.+|||||||||.|+|++ ..+.-.|+|||||.+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999999999888765 67889999999999999999999999999999999998 566789999999964
Q ss_pred ccCCcccccCCCCCCCCcc-CCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 761 CSVSPTLLKSSSNMDPARV-SGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~-sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
..... ..+.++. .++ ... + .-+......+..... ... .............
T Consensus 183 ~d~~~-------~~~~s~~~~~~-~~~----~-----~~g~~~~~~~~~~~~-----~p~-------g~~~~~~~~r~~~ 233 (418)
T KOG1167|consen 183 YDGYQ-------QTEHSRSYSGR-HAT----P-----AMGKDVHCQSVATAS-----KPA-------GYYRRCNDGRPSE 233 (418)
T ss_pred HHhhh-------hhhhhhhhhcc-cCC----c-----cccCccccccccccc-----CCC-------CceeccCCCccce
Confidence 22111 0111110 000 000 0 000000000000000 000 0000001122233
Q ss_pred cCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHh--------------hc--cC
Q 001952 840 SNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVM--------------QS--LK 901 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~--------------~~--lk 901 (992)
.....||++|+|||++...+ .+.++||||.||+++.+++++.||.... +.+.+..++. +. +.
T Consensus 234 ~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~ 313 (418)
T KOG1167|consen 234 RANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW 313 (418)
T ss_pred ecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence 45678999999999998654 5899999999999999999999987432 2222222210 00 00
Q ss_pred ---------------------------------CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 902 ---------------------------------FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 902 ---------------------------------~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
......++..+.||+.+||+.||.+|++ ++++|+||||...+-
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPFFDEADR 389 (418)
T ss_pred ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcCCcchhh
Confidence 0001224457889999999999999999 999999999996653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=304.60 Aligned_cols=252 Identities=22% Similarity=0.295 Sum_probs=210.2
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCe----EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNC----LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
.+..++||+|+||+||+|.|...|+ .||||++... ...+...++..|.-+|..++|||+++|++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3445789999999999998876655 5788888654 23445678899999999999999999999998776 889
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
|++|+++|.|.++++... ..+.....+.|+.||++||.|||.++++||||-.+||||....++||.|||+++.+.....
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999998763 5688889999999999999999999999999999999999999999999999865432111
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.. ......-.
T Consensus 854 ey----------------------------------------------------------------------~~~~gK~p 863 (1177)
T KOG1025|consen 854 EY----------------------------------------------------------------------SAPGGKVP 863 (1177)
T ss_pred cc----------------------------------------------------------------------cccccccC
Confidence 00 01111234
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+.|||-|.+....|+.++|||||||++|||+| |..||.+....++ ...+..+.+++.++.++.++.-++.+||..|+.
T Consensus 864 ikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~ 942 (1177)
T KOG1025|consen 864 IKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-PDLLEKGERLSQPPICTIDVYMVMVKCWMIDAD 942 (1177)
T ss_pred cHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-hHHHhccccCCCCCCccHHHHHHHHHHhccCcc
Confidence 67999999999999999999999999999999 9999999866554 455666777999999999999999999999999
Q ss_pred CcCCChHhHHHH
Q 001952 926 NRLGSQKGAAEI 937 (992)
Q Consensus 926 kRPT~~~~aeEI 937 (992)
.||++...++++
T Consensus 943 ~rp~fkel~~~f 954 (1177)
T KOG1025|consen 943 SRPTFKELAEEF 954 (1177)
T ss_pred cCccHHHHHHHH
Confidence 999965554444
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=282.14 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=187.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHH--cCCCCccceeeeeccCC---
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM--LDHPFLPTLYSQFTSDN--- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~--L~HPNIVkL~g~f~~~~--- 682 (992)
.++..+.+.||+|.||.||+|.|++ +.||||+|... ....+++|.+|+.. |+|+||+.|++.-..++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRG--EDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hheeEEEEEecCccccceeeccccC--CceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4677889999999999999999965 56999999642 22445677777754 59999999998765443
Q ss_pred -eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc--------CeeeeecCCceEEEccCCcEEEE
Q 001952 683 -LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML--------GVIYRDLKPENILVREDGHIMLT 753 (992)
Q Consensus 683 -~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~--------GIIHRDIKPeNILLd~dg~VKLs 753 (992)
.++||++|.+.|+|++|+.. ..++....++++.-++.||++||.. .|.|||||..|||+.++|.+.|+
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 58999999999999999997 4689999999999999999999964 39999999999999999999999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|+|||.+......
T Consensus 359 DLGLAv~h~~~t~------------------------------------------------------------------- 371 (513)
T KOG2052|consen 359 DLGLAVRHDSDTD------------------------------------------------------------------- 371 (513)
T ss_pred eceeeEEecccCC-------------------------------------------------------------------
Confidence 9999966432110
Q ss_pred CCCCCCcCccccCCCccChhhhcCCC----C--Cccceeeehhhhhhhhcc----C------CCCCCC----CCchHHHH
Q 001952 834 EPTDARSNSFVGTHEYLAPEIIKGEG----H--GAAVDWWTFGIFLYELLY----G------RTPFKG----SGNEETLA 893 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL~g~~----~--s~kSDIWSLGVlLyELLT----G------r~PF~g----~s~~e~L~ 893 (992)
.-+...+..+||..|||||+|...- + -..+||||||.++||+.- | ++||.+ ....+.++
T Consensus 372 -~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMr 450 (513)
T KOG2052|consen 372 -TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMR 450 (513)
T ss_pred -cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHh
Confidence 0122345568999999999997642 1 256899999999999873 2 578864 33456666
Q ss_pred HHHhhc-cC--CCCCccchH---HHHHHHHHhccCCcCCcCC
Q 001952 894 NVVMQS-LK--FPDSPLISF---QARDLIRGLLIKEPENRLG 929 (992)
Q Consensus 894 ~Iv~~~-lk--~P~~~~vs~---el~dLI~kcL~~DPekRPT 929 (992)
+++.-. ++ +|....-.+ .+-.|++.||..+|.-|+|
T Consensus 451 kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 451 KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 665432 22 222221222 4567999999999999999
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=285.42 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=187.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHH--cCCCCccceeeeeccCC----
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM--LDHPFLPTLYSQFTSDN---- 682 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~--L~HPNIVkL~g~f~~~~---- 682 (992)
...++++.||+|.||.||+|.+ +++.||||++... ..+.+.+|.+|... ++|+||++++++-....
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 4456678899999999999999 4589999999743 34567788888765 47999999999876544
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc---------CeeeeecCCceEEEccCCcEEEE
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML---------GVIYRDLKPENILVREDGHIMLT 753 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~---------GIIHRDIKPeNILLd~dg~VKLs 753 (992)
.++||++|.+.|+|.+|++. ..++|....+|+.-+++||+|||+. .|+|||||..||||..|+.+.|+
T Consensus 282 eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 78999999999999999997 4689999999999999999999964 39999999999999999999999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|||||.++.....
T Consensus 359 DFGLAl~~~p~~~------------------------------------------------------------------- 371 (534)
T KOG3653|consen 359 DFGLALRLEPGKP------------------------------------------------------------------- 371 (534)
T ss_pred ccceeEEecCCCC-------------------------------------------------------------------
Confidence 9999977642110
Q ss_pred CCCCCCcCccccCCCccChhhhcCCC-CC-----ccceeeehhhhhhhhccCCC------------CCC----CCCchHH
Q 001952 834 EPTDARSNSFVGTHEYLAPEIIKGEG-HG-----AAVDWWTFGIFLYELLYGRT------------PFK----GSGNEET 891 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL~g~~-~s-----~kSDIWSLGVlLyELLTGr~------------PF~----g~s~~e~ 891 (992)
......-+||..|||||+|.|.- +. .+.||||+|.+||||++.-. ||. .....+.
T Consensus 372 ---~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~ 448 (534)
T KOG3653|consen 372 ---QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEE 448 (534)
T ss_pred ---CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHH
Confidence 01112358999999999998763 22 46899999999999997432 332 1122333
Q ss_pred HHHHH-hh--ccCCCCCcc---chHHHHHHHHHhccCCcCCcCCChHhHHHH
Q 001952 892 LANVV-MQ--SLKFPDSPL---ISFQARDLIRGLLIKEPENRLGSQKGAAEI 937 (992)
Q Consensus 892 L~~Iv-~~--~lk~P~~~~---vs~el~dLI~kcL~~DPekRPT~~~~aeEI 937 (992)
+...+ .. +..+|+... -..-+++.|+.||..|++-|+|+.=+.+.+
T Consensus 449 mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 449 MQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred HHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 33333 32 223332211 224578999999999999999965343333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=300.31 Aligned_cols=259 Identities=31% Similarity=0.463 Sum_probs=222.6
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|+++.++|.|.||.||++++..+++..|+|+++.+ ....+.-++.|+-+++.++|+|||.+++.+...+.+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 357899999999999999999999999999999999854 45566777889999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
+||||.||+|.+..+. .+++++.++..+++..+.||+|||..|=+|||||-.|||+++.|.+||.|||.+-.+..
T Consensus 90 cMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--- 164 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--- 164 (829)
T ss_pred EEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh---
Confidence 9999999999887554 37899999999999999999999999999999999999999999999999998633210
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.-.....++||
T Consensus 165 ---------------------------------------------------------------------ti~KrksfiGt 175 (829)
T KOG0576|consen 165 ---------------------------------------------------------------------TIAKRKSFIGT 175 (829)
T ss_pred ---------------------------------------------------------------------hhhhhhcccCC
Confidence 11223568999
Q ss_pred CCccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC---CCccchHHHHHHHHHhc
Q 001952 847 HEYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP---DSPLISFQARDLIRGLL 920 (992)
Q Consensus 847 ~~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P---~~~~vs~el~dLI~kcL 920 (992)
+.|||||+-. .+.|...+|||++|++..||---++|....-.+..+..+....+..| +....++.+.+|++.+|
T Consensus 176 pywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~al 255 (829)
T KOG0576|consen 176 PYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGAL 255 (829)
T ss_pred ccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHh
Confidence 9999999864 56789999999999999999988888777666666666655555443 44457788999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.++|.+||+ ++.+|.|||...-
T Consensus 256 tknpKkRpt----aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 256 TKNPKKRPT----AEKLLQHPFVSQT 277 (829)
T ss_pred cCCCccCCC----hhhheeceeeccc
Confidence 999999999 9999999998754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=239.53 Aligned_cols=213 Identities=41% Similarity=0.627 Sum_probs=182.8
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCCh
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL 696 (992)
||+|.+|.||++.+..+++.+++|++....... ....+.+|+.+++.+.|++|+++++++......+++|||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997542211 246788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-CCcEEEEeccccccccCCcccccCCCCCC
Q 001952 697 HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-DGHIMLTDFDLSLRCSVSPTLLKSSSNMD 775 (992)
Q Consensus 697 ~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-dg~VKLsDFGLA~~l~~~~~~~~~~s~~~ 775 (992)
..++.... ..+++..++.++.+++.+|.|||..|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 35889999999999999999999999999999999999999 89999999998643211000
Q ss_pred CCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhh
Q 001952 776 PARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEII 855 (992)
Q Consensus 776 ~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL 855 (992)
......+...|++||.+
T Consensus 149 ---------------------------------------------------------------~~~~~~~~~~~~~pe~~ 165 (215)
T cd00180 149 ---------------------------------------------------------------LLKTIVGTPAYMAPEVL 165 (215)
T ss_pred ---------------------------------------------------------------hhhcccCCCCccChhHh
Confidence 01123467789999999
Q ss_pred cCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhH
Q 001952 856 KGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGA 934 (992)
Q Consensus 856 ~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~a 934 (992)
... .++.+.|+|+||+++++| ..+.++|.+||..||++||+ +
T Consensus 166 ~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~----~ 208 (215)
T cd00180 166 LGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS----A 208 (215)
T ss_pred cccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC----H
Confidence 887 788999999999999999 57889999999999999999 9
Q ss_pred HHHHcCC
Q 001952 935 AEIKQHP 941 (992)
Q Consensus 935 eEILkHP 941 (992)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=261.06 Aligned_cols=219 Identities=27% Similarity=0.403 Sum_probs=176.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHH-cCCCCccceeeeeccCCe
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM-LDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~-L~HPNIVkL~g~f~~~~~ 683 (992)
++..++...+..||.|++|.|-+.++..+|...|+|.+.... ..+...++..|+++..+ ..+|++|.+||.+..+..
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 344556666778999999999999999999999999997543 23445566778877554 479999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
++|.||.| ..+|..+.++- .+..+++..+-+|+..+++||.|||++ .|||||+||+|||++.+|++|+||||++-.
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999999 77887665432 257789999999999999999999976 899999999999999999999999998633
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+. ...+++
T Consensus 199 L~----------------------------------------------dSiAkt-------------------------- 206 (282)
T KOG0984|consen 199 LV----------------------------------------------DSIAKT-------------------------- 206 (282)
T ss_pred eh----------------------------------------------hhhHHH--------------------------
Confidence 21 011111
Q ss_pred CccccCCCccChhhhcC----CCCCccceeeehhhhhhhhccCCCCCCCC-CchHHHHHHHhhc
Q 001952 841 NSFVGTHEYLAPEIIKG----EGHGAAVDWWTFGIFLYELLYGRTPFKGS-GNEETLANVVMQS 899 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g----~~~s~kSDIWSLGVlLyELLTGr~PF~g~-s~~e~L~~Iv~~~ 899 (992)
...|...|||||.+.. ..|+.++||||||++++||.++++||... ...+++..++...
T Consensus 207 -~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 207 -MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred -HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 1247778999999864 36899999999999999999999999864 4567777777654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=283.30 Aligned_cols=203 Identities=33% Similarity=0.529 Sum_probs=176.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH-----hhcchhHHHHHHHHHHHcC---CCCccceeeee
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA-----RRKKMPRAQTEREILRMLD---HPFLPTLYSQF 678 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~-----~~~~~~~~~~EieILk~L~---HPNIVkL~g~f 678 (992)
.+.+|..++.||+|+||.||+|.++.+...|+||.+.++.+- +....-.+--|+.||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 357899999999999999999999999999999999876532 2333445667999999997 99999999999
Q ss_pred ccCCeEEEEEEec-CCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccc
Q 001952 679 TSDNLSCLVMEYC-PGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757 (992)
Q Consensus 679 ~~~~~lyLVmEy~-~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGL 757 (992)
++++++||+||-. +|.+|.++++.. ..+++..+..|++||+.|+++||++||||||||-+|+.++.+|-+||+|||.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999975 456889998875 6799999999999999999999999999999999999999999999999998
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+.... +|
T Consensus 717 aa~~k-----------------sg-------------------------------------------------------- 723 (772)
T KOG1152|consen 717 AAYTK-----------------SG-------------------------------------------------------- 723 (772)
T ss_pred hhhhc-----------------CC--------------------------------------------------------
Confidence 63321 11
Q ss_pred CCcCccccCCCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCC
Q 001952 838 ARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKG 885 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g 885 (992)
....++||..|.|||+|.|..| +..-|||+||++||.+++...||.+
T Consensus 724 -pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 724 -PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred -CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 1235789999999999999988 8889999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=241.98 Aligned_cols=212 Identities=45% Similarity=0.707 Sum_probs=175.4
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
|.+.+.||.|++|.||++.+.++++.+++|.+...... .....+.+|++.++.++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999888899999999764322 1456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+++++|..++..... .+++..++.++.+++.+|.|||.++++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999887521 17899999999999999999999999999999999999999999999999864321000
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
........++..|+
T Consensus 153 ------------------------------------------------------------------~~~~~~~~~~~~~~ 166 (225)
T smart00221 153 ------------------------------------------------------------------AALLKTVKGTPFYL 166 (225)
T ss_pred ------------------------------------------------------------------cccccceeccCCcC
Confidence 00112235677899
Q ss_pred Chhhh-cCCCCCccceeeehhhhhhhhccCCCCCCC-CCchHHHHHHH
Q 001952 851 APEII-KGEGHGAAVDWWTFGIFLYELLYGRTPFKG-SGNEETLANVV 896 (992)
Q Consensus 851 APEvL-~g~~~s~kSDIWSLGVlLyELLTGr~PF~g-~s~~e~L~~Iv 896 (992)
+||.+ ....++.++|||+||+++|||++|+.||.. .++...+.+.+
T Consensus 167 ~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 167 APEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred CHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 99999 666778899999999999999999999977 44543443333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=295.32 Aligned_cols=237 Identities=15% Similarity=0.202 Sum_probs=158.1
Q ss_pred HHcCC-CCccceeeee-------ccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeee
Q 001952 664 RMLDH-PFLPTLYSQF-------TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYR 735 (992)
Q Consensus 664 k~L~H-PNIVkL~g~f-------~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHR 735 (992)
+.+.| .||+.++++| .+...++++|||+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 34455 5888888887 3345678889988 77999999753 3569999999999999999999999999999
Q ss_pred ecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccC
Q 001952 736 DLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTR 815 (992)
Q Consensus 736 DIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~ 815 (992)
||||+||||+..|.++++|||++........ ...+..+.... +...... .
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~--------~~~ki~DfG~a--------------------~~~~~~~-~- 154 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDED--------ATTKSREIGSS--------------------RREEILS-E- 154 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCccccccc--------Ccccccccccc--------------------ccccccc-c-
Confidence 9999999999999999999998633211000 00000000000 0000000 0
Q ss_pred CCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH
Q 001952 816 KPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895 (992)
Q Consensus 816 ~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I 895 (992)
.....................+||+.|||||++.+..|+.++|||||||+||||++|..||.... ..+..+
T Consensus 155 -------~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~ 225 (793)
T PLN00181 155 -------RRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSL 225 (793)
T ss_pred -------cchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHH
Confidence 00000000000000111223579999999999999999999999999999999999988875421 122222
Q ss_pred HhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 896 v~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
... ...+.......+..+++.+||..||.+||+ +.|||+||||...
T Consensus 226 ~~~-~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~~ 271 (793)
T PLN00181 226 RHR-VLPPQILLNWPKEASFCLWLLHPEPSCRPS----MSELLQSEFINEP 271 (793)
T ss_pred HHh-hcChhhhhcCHHHHHHHHHhCCCChhhCcC----hHHHhhchhhhhh
Confidence 211 111111112345678999999999999999 9999999999874
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=255.01 Aligned_cols=254 Identities=18% Similarity=0.227 Sum_probs=203.6
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCC-----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg-----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
..+...++++...+-+|.||.||+|.|++.+ +.|.+|.++.. ....++..+..|--+|..+.|||++.+.+++
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3344567888888999999999999887543 23555655443 2344566778888888889999999999987
Q ss_pred cc-CCeEEEEEEecCCCChHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 679 TS-DNLSCLVMEYCPGGDLHVLRQKQLG------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 679 ~~-~~~lyLVmEy~~GGSL~~lLkk~~~------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
.+ ....+++|.++.-|+|..++....+ ..+...+...++.||+.|++|||++||||.||..+|.+|++.-.+|
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk 436 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK 436 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence 54 5677899999999999999883322 3456677888999999999999999999999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|-.|++.+-... +. |+
T Consensus 437 ltDsaLSRDLFP~D--------------------Yh--------------cL---------------------------- 454 (563)
T KOG1024|consen 437 LTDSALSRDLFPGD--------------------YH--------------CL---------------------------- 454 (563)
T ss_pred eccchhccccCccc--------------------cc--------------cc----------------------------
Confidence 99999975442111 00 10
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
..+-.-+..||+||.+....|+.++|+|||||+||||+| |+.||-..++.|+...+ ..++++.++-.+++
T Consensus 455 --------GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-kdGyRlaQP~NCPD 525 (563)
T KOG1024|consen 455 --------GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-KDGYRLAQPFNCPD 525 (563)
T ss_pred --------CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-hccceecCCCCCcH
Confidence 001113567999999999999999999999999999998 99999999888877654 56677777778999
Q ss_pred HHHHHHHHhccCCcCCcCCC
Q 001952 911 QARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~ 930 (992)
++..++..||+.+|++||++
T Consensus 526 eLf~vMacCWallpeeRPsf 545 (563)
T KOG1024|consen 526 ELFTVMACCWALLPEERPSF 545 (563)
T ss_pred HHHHHHHHHHhcCcccCCCH
Confidence 99999999999999999994
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-27 Score=275.50 Aligned_cols=253 Identities=42% Similarity=0.729 Sum_probs=214.8
Q ss_pred EccCCceEEEEEEE---cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEEEEEecC
Q 001952 617 LGCGDIGTVYLAEL---IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 617 LGsG~FGtVYlA~~---~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyLVmEy~~ 692 (992)
+|+|+||.|++++. .+.+..||+|++++.....+... ....|..++..++ ||++|++...|+.+..++++++|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 79999999998743 34577899999987655444443 5667888899887 9999999999999999999999999
Q ss_pred CCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCC
Q 001952 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772 (992)
Q Consensus 693 GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s 772 (992)
||.|...+... ..+.+.....+...++.+|+++|..||||||+|++||+++.+|++++.|||+++..-.
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~--------- 149 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK--------- 149 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh---------
Confidence 99998776654 5688889999999999999999999999999999999999999999999999743210
Q ss_pred CCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccCh
Q 001952 773 NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAP 852 (992)
Q Consensus 773 ~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~AP 852 (992)
....+||..||||
T Consensus 150 -------------------------------------------------------------------~~~~cgt~eymAp 162 (612)
T KOG0603|consen 150 -------------------------------------------------------------------EKIACGTYEYRAP 162 (612)
T ss_pred -------------------------------------------------------------------hhhcccchhhhhh
Confidence 0011799999999
Q ss_pred hhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh-
Q 001952 853 EIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ- 931 (992)
Q Consensus 853 EvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~- 931 (992)
|++. ++..++|+||||+++|||+||..||.+ +.+..|....+.+|. .++..+++++..++..+|.+|+...
T Consensus 163 EI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~ 234 (612)
T KOG0603|consen 163 EIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRLGAGP 234 (612)
T ss_pred Hhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHhccCc
Confidence 9999 678899999999999999999999988 777777776666665 4899999999999999999999964
Q ss_pred HhHHHHHcCCCCCCCchhhhhcCCC
Q 001952 932 KGAAEIKQHPFFEGLNWALIRCAIP 956 (992)
Q Consensus 932 ~~aeEILkHPfF~~lnw~~lr~~~p 956 (992)
.++.||++|+||+.++|..+.....
T Consensus 235 ~~~~eik~h~f~~~i~~~~l~~r~~ 259 (612)
T KOG0603|consen 235 DGVDEIKQHEFFQSIDWNELEARSR 259 (612)
T ss_pred chhHHHhccchheeeeHhhHhhcCC
Confidence 5799999999999999997754333
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=221.66 Aligned_cols=262 Identities=39% Similarity=0.588 Sum_probs=203.3
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC-CccceeeeeccCCeEEEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP-FLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP-NIVkL~g~f~~~~~lyLVmE 689 (992)
|.+.+.||.|+||.||++.+. ..+++|.+.............+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999987 67899999876433333467788999999999988 79999999988888899999
Q ss_pred ecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEeccccccccCCccc
Q 001952 690 YCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~~~~~~ 767 (992)
|+.+++|..++..... ..+.......++.|++.+|.|+|..|++||||||+|||++..+ .++++|||++..+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977665421 2688999999999999999999999999999999999999988 7999999997422110000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC-CCcCccccC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD-ARSNSFVGT 846 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~-~~s~s~vGT 846 (992)
... .......||
T Consensus 159 -------------------------------------------------------------------~~~~~~~~~~~~t 171 (384)
T COG0515 159 -------------------------------------------------------------------SSIPALPSTSVGT 171 (384)
T ss_pred -------------------------------------------------------------------ccccccccccccc
Confidence 000 123456799
Q ss_pred CCccChhhhcC---CCCCccceeeehhhhhhhhccCCCCCCCCCc----hHHHHHHHhhccC-CC--CCccc----hHHH
Q 001952 847 HEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN----EETLANVVMQSLK-FP--DSPLI----SFQA 912 (992)
Q Consensus 847 ~~Y~APEvL~g---~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~----~e~L~~Iv~~~lk-~P--~~~~v----s~el 912 (992)
..|++||.+.+ ..+....|+|++|++++++++|..||..... ......+...... .. ..... ...+
T Consensus 172 ~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (384)
T COG0515 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAA 251 (384)
T ss_pred cccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHH
Confidence 99999999998 5778999999999999999999999887664 2333333322222 11 11111 2578
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.+++..++..+|..|.+ ..+...++|+...
T Consensus 252 ~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~~ 281 (384)
T COG0515 252 SDLLKKLLAKDPKNRLS----SSSDLSHDLLAHL 281 (384)
T ss_pred HHHHHHHHhcCchhcCC----HHHHhhchHhhCc
Confidence 89999999999999999 6666666554443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=243.51 Aligned_cols=254 Identities=22% Similarity=0.327 Sum_probs=188.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceee-eeccCCeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYS-QFTSDNLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g-~f~~~~~ly 685 (992)
.+.|.+.+.||+|.||.+.+|+++++...+++|.+.... .....|.+|...--.| .|.||+.-|+ .|+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 467999999999999999999999999999999998653 2345567776553333 5999998886 567788999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc--cCCcEEEEeccccccccC
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR--EDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd--~dg~VKLsDFGLA~~l~~ 763 (992)
+++||++.|+|..-+.. ..+.+...+.++.|++.||+|||+.++||||||.+||||- +...+||||||+....+.
T Consensus 99 F~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred EeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999999876654 4688999999999999999999999999999999999996 344799999998633211
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.- ...
T Consensus 176 tV---------------------------------------------------------------------------~~~ 180 (378)
T KOG1345|consen 176 TV---------------------------------------------------------------------------KYL 180 (378)
T ss_pred ee---------------------------------------------------------------------------hhh
Confidence 00 001
Q ss_pred ccCCCccChhhhcCC---C--CCccceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhh-ccCCCC-CccchHHH
Q 001952 844 VGTHEYLAPEIIKGE---G--HGAAVDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQ-SLKFPD-SPLISFQA 912 (992)
Q Consensus 844 vGT~~Y~APEvL~g~---~--~s~kSDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~-~lk~P~-~~~vs~el 912 (992)
.-+..|.+||++... . ..+..|||.||+++|.+|||.+||+..... ..+..+..+ ....|. ...+++.+
T Consensus 181 ~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a 260 (378)
T KOG1345|consen 181 EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKA 260 (378)
T ss_pred hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHH
Confidence 123458999987643 2 367899999999999999999999853221 222222222 223332 13478889
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
..+.++-|..+++.|-. .+.+....+..|.+
T Consensus 261 ~r~Fkk~lt~~~~drck-i~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 261 LRLFKKSLTPRFKDRCK-IWTAKKMRKCLWKE 291 (378)
T ss_pred HHHHHHhcCCcccccch-hHHHHHHHHHHHHH
Confidence 99999999999999932 12255555554543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=222.28 Aligned_cols=161 Identities=22% Similarity=0.204 Sum_probs=128.0
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
|+|.+++... +..+++..++.|+.||+.||.|||+++ ||+|||++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6889988764 456999999999999999999999998 999999999999999 998632100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
....||+.|+|||
T Consensus 62 -------------------------------------------------------------------~~~~g~~~y~aPE 74 (176)
T smart00750 62 -------------------------------------------------------------------EQSRVDPYFMAPE 74 (176)
T ss_pred -------------------------------------------------------------------ccCCCcccccChH
Confidence 0114789999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccCC-----CCCccchH--HHHHHHHHhccCCcC
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLKF-----PDSPLISF--QARDLIRGLLIKEPE 925 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk~-----P~~~~vs~--el~dLI~kcL~~DPe 925 (992)
++.+..++.++|||||||++|||+||+.||...... ..+..+....... +....++. ++.+||.+||..||+
T Consensus 75 ~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~ 154 (176)
T smart00750 75 VIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQ 154 (176)
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccc
Confidence 999999999999999999999999999999765443 2333333222211 11122333 689999999999999
Q ss_pred CcCCChHhHHHHHcCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~ 944 (992)
+||+ +.|+++|+|+.
T Consensus 155 ~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 155 RREA----ANHYLAHCRAL 169 (176)
T ss_pred cccC----HHHHHHHHHHH
Confidence 9999 99999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=266.55 Aligned_cols=252 Identities=38% Similarity=0.666 Sum_probs=188.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
-.+|+.++.|..|+||.||+++++.+.+.+|+| +++..+.-+ .+|.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilR----------nilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILR----------NILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhh----------ccccccCCccee---------------
Confidence 357889999999999999999999999999995 443322111 144455556555
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|+-..+++.. +.++.. ++.+++|||+-||+|||+||+|+||+.=|++|+.|||+.+..-...
T Consensus 136 ------gDc~tllk~~--g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~-- 197 (1205)
T KOG0606|consen 136 ------GDCATLLKNI--GPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL-- 197 (1205)
T ss_pred ------chhhhhcccC--CCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc--
Confidence 3333443432 334332 2789999999999999999999999999999999999974321000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
..+ .+ + ..|. .....-.....+||+
T Consensus 198 ------------------atn----l~---------------e------------g~I~------k~t~Ef~dKqvcgTP 222 (1205)
T KOG0606|consen 198 ------------------ATN----LK---------------E------------GHIE------KDTHEFQDKQVCGTP 222 (1205)
T ss_pred ------------------cch----hh---------------h------------cchH------HHHHHhhhccccCCc
Confidence 000 00 0 0000 000011123458999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC-ccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS-PLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~-~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||++.-.+|+..+|||++|+++||++-|..||.+...++.+..++...+.+|.. +.++.++++||.++|..+|..
T Consensus 223 eyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~ 302 (1205)
T KOG0606|consen 223 EYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLC 302 (1205)
T ss_pred cccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHh
Confidence 9999999999999999999999999999999999999999999999988888877765 347789999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCchh-hhhcCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNWA-LIRCAIPPELP 960 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw~-~lr~~~pp~lp 960 (992)
|.... ++.++.+|+||+.+||. ++|..+. ++|
T Consensus 303 Rlgt~-ga~evk~h~ff~~LDw~~llRqkae-fvp 335 (1205)
T KOG0606|consen 303 RLGTG-GALEVKQHGFFQLLDWKSLLRQKAE-FVP 335 (1205)
T ss_pred hcccc-hhhhhhhccceeecccchhhhhhcc-ccc
Confidence 99855 89999999999999999 4455433 444
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-23 Score=229.12 Aligned_cols=257 Identities=25% Similarity=0.320 Sum_probs=196.2
Q ss_pred CceEEEEEccCCceEEEEEEEcCCC-eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC----CCccceeeee-ccCCe
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTN-CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH----PFLPTLYSQF-TSDNL 683 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg-~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H----PNIVkL~g~f-~~~~~ 683 (992)
+|.+.+.||+|+||.||+|.+...+ ..+|+|+..... ......+..|..+|..+.. .++..+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~---~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKEL---GSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecc---cCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 679999876531 1111256788999888863 6899999999 58889
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-----CcEEEEecccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-----GHIMLTDFDLS 758 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-----g~VKLsDFGLA 758 (992)
.||||+.+ |.+|.++......+.|+..++..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999877766789999999999999999999999999999999999999865 36999999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
+++...... + +. . .....
T Consensus 175 r~~~~~~~~-------------~-----------------~~-~-------------------------------~~~r~ 192 (322)
T KOG1164|consen 175 RRFKYVGDS-------------G-----------------GN-L-------------------------------RPPRP 192 (322)
T ss_pred ccccccCCC-------------C-----------------cc-c-------------------------------ccCCC
Confidence 643211000 0 00 0 00001
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh---ccCCCCCccchHHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ---SLKFPDSPLISFQARDL 915 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~---~lk~P~~~~vs~el~dL 915 (992)
....+.||..|+++.+..+...+.+.|+||++.++.||+.|..||.+............. ..........+.++..+
T Consensus 193 ~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (322)
T KOG1164|consen 193 QKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKI 272 (322)
T ss_pred CccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHH
Confidence 113456999999999999999999999999999999999999999876543333222221 11111223356778888
Q ss_pred HHHhccCCcCCcCCChH
Q 001952 916 IRGLLIKEPENRLGSQK 932 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~ 932 (992)
...+-..+...+|....
T Consensus 273 ~~~~~~~~~~~~Pdy~~ 289 (322)
T KOG1164|consen 273 LEYIDSLDYEDKPDYEK 289 (322)
T ss_pred HHHhhccCCcCCCCHHH
Confidence 88888889999998443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-24 Score=259.63 Aligned_cols=260 Identities=26% Similarity=0.356 Sum_probs=196.5
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEech---hHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDN---EFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk---~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
....+|.|.+|.|+.+......+.++.|.+.. .....+.....+..|+-+-..+.|+|++..+..+.+....+.+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45679999999888887766665566665431 111112222225566667777899999999888887777777799
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
||++ +|..++... ..+....+..++.||+.||+|||..||.|||||++|+|++.+|.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~---- 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW---- 474 (601)
T ss_pred cccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc----
Confidence 9999 999888764 468888999999999999999999999999999999999999999999999864321100
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
+........++|.-.|
T Consensus 475 ----------------------------------------------------------------e~~~~~~~g~~gS~pY 490 (601)
T KOG0590|consen 475 ----------------------------------------------------------------EKNIHESSGIVGSDPY 490 (601)
T ss_pred ----------------------------------------------------------------chhhhhhcCcccCCcC
Confidence 0000223457899999
Q ss_pred cChhhhcCCCCC-ccceeeehhhhhhhhccCCCCCCCCCchHHH-HHHH-hhccCC-----CCCccchHHHHHHHHHhcc
Q 001952 850 LAPEIIKGEGHG-AAVDWWTFGIFLYELLYGRTPFKGSGNEETL-ANVV-MQSLKF-----PDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 850 ~APEvL~g~~~s-~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L-~~Iv-~~~lk~-----P~~~~vs~el~dLI~kcL~ 921 (992)
+|||++.+..|+ ..+||||.|++++.|++|+.||......+.. .... ...... .....++.+.+.+|.+||+
T Consensus 491 ~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~ 570 (601)
T KOG0590|consen 491 LAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQ 570 (601)
T ss_pred cCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHcc
Confidence 999999999995 5689999999999999999999865444332 1111 111111 1112367788999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.||.+|.+ +++|++.+||++++
T Consensus 571 ~~P~~R~t----i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 571 LDPTKRIT----IEQILNDEWIRSIE 592 (601)
T ss_pred CChhheec----HHHHhhChHhhhcc
Confidence 99999999 99999999999886
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.7e-22 Score=208.80 Aligned_cols=281 Identities=20% Similarity=0.267 Sum_probs=211.6
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~l 684 (992)
+....|.++++||+|+||.+|+|....+|+.||||+-... .....+.-|..+.+.|+ ...|..+..|+.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 3467899999999999999999999999999999987532 23345667888888886 46788899899999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEEEEeccccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLTDFDLSLRC 761 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VKLsDFGLA~~l 761 (992)
.|||+++ |.+|+++..-. ...|+..+++.++-|++.-|+|+|.+++|||||||+|+|+.-+- .+.|+||||++++
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999 99999987754 36799999999999999999999999999999999999997543 5889999999776
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
....+.. + + .-....
T Consensus 165 ~d~~t~~-------------------H-----------I-----------------------------------pyre~r 179 (341)
T KOG1163|consen 165 RDIRTRQ-------------------H-----------I-----------------------------------PYREDR 179 (341)
T ss_pred ccccccc-------------------c-----------C-----------------------------------ccccCC
Confidence 4211100 0 0 011223
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc---hHHHHHHHhhccCCCCC---ccchHHHHHH
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---EETLANVVMQSLKFPDS---PLISFQARDL 915 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---~e~L~~Iv~~~lk~P~~---~~vs~el~dL 915 (992)
+..||..|.+--...+...+.+-|+-|+|.+|.++.-|..||++... ...+++|.......+.. ..++.++.-.
T Consensus 180 ~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~my 259 (341)
T KOG1163|consen 180 NLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMY 259 (341)
T ss_pred ccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHH
Confidence 45799999998888888889999999999999999999999998543 35556665555544422 2366777777
Q ss_pred HHHhccCCcCCcCCCh------HhHHHHHcCCCCCCCchhhhhcCCCCC
Q 001952 916 IRGLLIKEPENRLGSQ------KGAAEIKQHPFFEGLNWALIRCAIPPE 958 (992)
Q Consensus 916 I~kcL~~DPekRPT~~------~~aeEILkHPfF~~lnw~~lr~~~pp~ 958 (992)
|..|-..-=++-|... ..+---|+|-|=--.||..+.......
T Consensus 260 l~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~~q~ 308 (341)
T KOG1163|consen 260 LNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKSQQS 308 (341)
T ss_pred HHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHhhcc
Confidence 7777665555555521 112222345444446888776554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=228.35 Aligned_cols=142 Identities=23% Similarity=0.201 Sum_probs=114.0
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC-CCeEEEEEEechhHH--HhhcchhHHHHHHHHHHHcCCCCccc-eeeeeccCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG-TNCLFAIKVMDNEFL--ARRKKMPRAQTEREILRMLDHPFLPT-LYSQFTSDN 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~-tg~~VAIKvIkk~~l--~~~~~~~~~~~EieILk~L~HPNIVk-L~g~f~~~~ 682 (992)
..++|.+.+.||+|+||+||+|.+.. +++.||||++..... ........+.+|+++|+.++|+||+. ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 35789999999999999999998876 677889998753210 11123456889999999999999985 4432 4
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeec-CCceEEEccCCcEEEEeccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDL-KPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDI-KPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..||||||++|++|... .. .. ...++.|++.+|.|||++||||||| ||+|||++.++.++|+|||++..+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 57999999999999632 11 11 1467899999999999999999999 999999999999999999998554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=211.67 Aligned_cols=249 Identities=22% Similarity=0.326 Sum_probs=194.3
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyLV 687 (992)
-.|++.++||+|+||.+++|...-+++.||||.-.. ......+..|....+.| ..++|...|.+..++.+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-----kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-----KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc-----cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 479999999999999999999999999999997542 34455677888888888 578999999888899999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-----cEEEEecccccccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-----HIMLTDFDLSLRCS 762 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-----~VKLsDFGLA~~l~ 762 (992)
||++ |.+|+++..-. +..|+..++..++.|++.-++|+|++.+|+|||||+|+||...+ .+.|+|||+|+.+.
T Consensus 103 idLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9999 99999998765 67899999999999999999999999999999999999998554 58999999986542
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. ...+ . .++ ....+
T Consensus 181 Dp---------------------------~Tkq---H----------------------------------IPY-rE~KS 195 (449)
T KOG1165|consen 181 DP---------------------------KTKQ---H----------------------------------IPY-REHKS 195 (449)
T ss_pred Cc---------------------------cccc---c----------------------------------Ccc-ccccc
Confidence 10 0000 0 001 11234
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCC---CchHHHHHHHhhccCCCCC---ccchHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS---GNEETLANVVMQSLKFPDS---PLISFQARDLI 916 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~---s~~e~L~~Iv~~~lk~P~~---~~vs~el~dLI 916 (992)
..||-.||+-...+|...+.+-|+-|||-+++++|-|..||.|. ++.+.+++|-...-..|.. ..++.++..-+
T Consensus 196 LsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl 275 (449)
T KOG1165|consen 196 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYL 275 (449)
T ss_pred cccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHH
Confidence 56999999999899999999999999999999999999999874 4556677765433222211 22555665555
Q ss_pred HHhccCCcCCcCC
Q 001952 917 RGLLIKEPENRLG 929 (992)
Q Consensus 917 ~kcL~~DPekRPT 929 (992)
+-.-..+=++-|.
T Consensus 276 ~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 276 RYVRRLDFFETPD 288 (449)
T ss_pred HHHHhcCcccCCC
Confidence 5555555555555
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=236.25 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=174.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHH---HHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQ---TEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~---~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
+|...+.||.+.|=+|.+|++.+ | .|+||++-+.. .......+. .|+. ...++|||++.+.-+.+.+...||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~--p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQD--PTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccC--CCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence 67888999999999999998854 4 38999985432 112222233 3333 555689999999998888888999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
|-+|+ .-+|++.+.-+ ..+...+.+-|+.||+.||..+|+.||+|+|||.+||||+.-+++.|+||.-.+ +.
T Consensus 99 vRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK-----Pt 170 (1431)
T KOG1240|consen 99 VRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK-----PT 170 (1431)
T ss_pred HHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC-----Cc
Confidence 99998 67888877653 345666777889999999999999999999999999999999999999998532 22
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
++..++..+.. ....+. ..-
T Consensus 171 YLPeDNPadf~------------------------------------------------------fFFDTS------rRR 190 (1431)
T KOG1240|consen 171 YLPEDNPADFT------------------------------------------------------FFFDTS------RRR 190 (1431)
T ss_pred cCCCCCcccce------------------------------------------------------EEEecC------Cce
Confidence 22211111100 000000 112
Q ss_pred CCccChhhhcCC----------C-CCccceeeehhhhhhhhcc-CCCCCCCC-------CchHHHHHHHhhccCCCCCcc
Q 001952 847 HEYLAPEIIKGE----------G-HGAAVDWWTFGIFLYELLY-GRTPFKGS-------GNEETLANVVMQSLKFPDSPL 907 (992)
Q Consensus 847 ~~Y~APEvL~g~----------~-~s~kSDIWSLGVlLyELLT-Gr~PF~g~-------s~~e~L~~Iv~~~lk~P~~~~ 907 (992)
..|+|||.+... . .+++.||||+||+++||++ |++||.-. .+.......+ +.+
T Consensus 191 tCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~L-e~I------- 262 (1431)
T KOG1240|consen 191 TCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLL-EKI------- 262 (1431)
T ss_pred eeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHH-HhC-------
Confidence 359999987642 2 5788999999999999998 89998521 0011111111 111
Q ss_pred chHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 908 vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
-+..+++||..|++.||.+|++ |++.|+.
T Consensus 263 ed~~~Rnlil~Mi~rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 263 EDVSLRNLILSMIQRDPSKRLS----AEDYLQK 291 (1431)
T ss_pred cCccHHHHHHHHHccCchhccC----HHHHHHh
Confidence 1236899999999999999999 9999875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=194.56 Aligned_cols=140 Identities=24% Similarity=0.264 Sum_probs=108.1
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhc---------c--------------hhHHHHHHHHHHHcCCCCc
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK---------K--------------MPRAQTEREILRMLDHPFL 671 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~---------~--------------~~~~~~EieILk~L~HPNI 671 (992)
..||+|+||.||+|.+. +|+.||||+++........ . ......|+.+|..+.++++
T Consensus 3 ~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 57999999999999986 8999999999754221111 0 0122458999999988877
Q ss_pred cceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcCeeeeecCCceEEEccCCcE
Q 001952 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL-HMLGVIYRDLKPENILVREDGHI 750 (992)
Q Consensus 672 VkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YL-Hs~GIIHRDIKPeNILLd~dg~V 750 (992)
.....+.. .+ .+|||||++|++|...+.. ...+++..+..++.||+.+|.|| |..|||||||||+|||++ ++.+
T Consensus 82 ~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v 156 (190)
T cd05147 82 PCPEPILL-KS-HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL 156 (190)
T ss_pred CCCcEEEe-cC-CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence 54433322 22 3899999988877654322 25688999999999999999999 799999999999999998 5789
Q ss_pred EEEecccccc
Q 001952 751 MLTDFDLSLR 760 (992)
Q Consensus 751 KLsDFGLA~~ 760 (992)
+|+|||++..
T Consensus 157 ~LiDFG~a~~ 166 (190)
T cd05147 157 YIIDVSQSVE 166 (190)
T ss_pred EEEEcccccc
Confidence 9999999843
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.4e-20 Score=196.90 Aligned_cols=140 Identities=16% Similarity=0.182 Sum_probs=114.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhH------HHHHHHHHHHcCCCCccceeeeec
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR------AQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~------~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
+...+|++++.||.|+||.||++.. ++..+|||+++............ +.+|+..+.++.|++|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3468999999999999999999766 35579999997654333333333 578999999999999999998865
Q ss_pred cC--------CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 680 SD--------NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 680 ~~--------~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
.. +..+|||||++|.+|.++.. +++ ....+|+.+|..||..||+||||||.|||++.+| ++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence 32 35799999999999987632 232 2456999999999999999999999999999988 99
Q ss_pred EEecccc
Q 001952 752 LTDFDLS 758 (992)
Q Consensus 752 LsDFGLA 758 (992)
|+|||..
T Consensus 175 liDfg~~ 181 (232)
T PRK10359 175 IIDLSGK 181 (232)
T ss_pred EEECCCc
Confidence 9999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=186.70 Aligned_cols=141 Identities=21% Similarity=0.197 Sum_probs=110.6
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh-----------------------cchhHHHHHHHHHHHcCCCC
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR-----------------------KKMPRAQTEREILRMLDHPF 670 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~-----------------------~~~~~~~~EieILk~L~HPN 670 (992)
.+.||+|+||.||+|.+. +|+.||||+++....... .....+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999986 899999999975421100 00122357889999999998
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChHHH-HHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCC
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVL-RQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDG 748 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~~l-Lkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg 748 (992)
|.....+.... .||||||++|+++... +.. ..++...+..++.|++.+|.|||. .||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 86555444332 4899999988865433 332 457888999999999999999999 9999999999999999 88
Q ss_pred cEEEEeccccccc
Q 001952 749 HIMLTDFDLSLRC 761 (992)
Q Consensus 749 ~VKLsDFGLA~~l 761 (992)
.++|+|||++...
T Consensus 155 ~~~liDFG~a~~~ 167 (190)
T cd05145 155 KPYIIDVSQAVEL 167 (190)
T ss_pred CEEEEEcccceec
Confidence 9999999998554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=8e-20 Score=200.27 Aligned_cols=236 Identities=25% Similarity=0.321 Sum_probs=150.7
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC----------CCCccceeeeec
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD----------HPFLPTLYSQFT 679 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~----------HPNIVkL~g~f~ 679 (992)
.+...+.||.|+++.||.+.+..+++.+|+|++.............+.+|.-....+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567788999999999999999999999999986443333444555666654444432 212222222221
Q ss_pred ---------cC---C-----eEEEEEEecCCCChHHHHHh---hcCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeeeec
Q 001952 680 ---------SD---N-----LSCLVMEYCPGGDLHVLRQK---QLGK--CFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737 (992)
Q Consensus 680 ---------~~---~-----~lyLVmEy~~GGSL~~lLkk---~~~~--~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDI 737 (992)
.. . ..+++|+-+ -++|..++.. .... .+.......+..|++..+++||..||||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 1 236788887 7788777553 1111 1223344556689999999999999999999
Q ss_pred CCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCC
Q 001952 738 KPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKP 817 (992)
Q Consensus 738 KPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~ 817 (992)
+|+|+|++.+|.+.|+||+...+.+..
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~----------------------------------------------------- 198 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR----------------------------------------------------- 198 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE-----------------------------------------------------
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce-----------------------------------------------------
Confidence 999999999999999999976442100
Q ss_pred CCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC--------CCCccceeeehhhhhhhhccCCCCCCCCCch
Q 001952 818 KADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE--------GHGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889 (992)
Q Consensus 818 ~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~--------~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~ 889 (992)
......+..|.+||..... .++.+.|.|+||++||.|++|+.||......
T Consensus 199 ----------------------~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~ 256 (288)
T PF14531_consen 199 ----------------------YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPE 256 (288)
T ss_dssp ----------------------EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGG
T ss_pred ----------------------eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcc
Confidence 0001234679999987543 4688999999999999999999999865332
Q ss_pred HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 890 ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 890 e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
..... .|.....+++.++.||..+|..+|.+|
T Consensus 257 ~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 257 ADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 11111 333334689999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-20 Score=199.08 Aligned_cols=243 Identities=20% Similarity=0.320 Sum_probs=199.6
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
++..+..++.+|.+...|..|+|+|.+++ ++.|+++......+ ....|..|.-.|+.+.||||+.+++.|.....+.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 44556667778999999999999997775 67788875544332 3356788888899999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCcEEEE--eccccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLT--DFDLSLRC 761 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~VKLs--DFGLA~~l 761 (992)
++..||+.|+|+.+++...+-..+..++..++.+|+.|++|||+.. |.---|....+++|++-..+|. |--++.+
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999999999999876666788899999999999999999985 4445678888999887765543 2222100
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
..
T Consensus 343 ------------------------------------------------------------------------------e~ 344 (448)
T KOG0195|consen 343 ------------------------------------------------------------------------------EV 344 (448)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred ccccCCCccChhhhcCCCC---CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 842 SFVGTHEYLAPEIIKGEGH---GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~---s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
.....+.||+||.+...+- -.++|+|||+++||||.|...||....+++.-.++..++++..-++.++..+..|+.-
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~i 424 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNI 424 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHH
Confidence 1234678999999987754 3679999999999999999999999999999889888888888888899999999999
Q ss_pred hccCCcCCcCCC
Q 001952 919 LLIKEPENRLGS 930 (992)
Q Consensus 919 cL~~DPekRPT~ 930 (992)
|+..||.+||.+
T Consensus 425 cmnedpgkrpkf 436 (448)
T KOG0195|consen 425 CMNEDPGKRPKF 436 (448)
T ss_pred HhcCCCCcCCCc
Confidence 999999999993
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8e-20 Score=202.67 Aligned_cols=211 Identities=25% Similarity=0.313 Sum_probs=152.5
Q ss_pred CCCCccceeeeecc---------------------------CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHH
Q 001952 667 DHPFLPTLYSQFTS---------------------------DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAE 719 (992)
Q Consensus 667 ~HPNIVkL~g~f~~---------------------------~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~Q 719 (992)
+|||||++.++|.+ ...+||||... ..+|+.++..+ ..+....+.++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence 59999999998843 23579999988 78999998864 4677788899999
Q ss_pred HHHHHHHHhhcCeeeeecCCceEEEccCC----cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCC
Q 001952 720 VLLALEYLHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIE 795 (992)
Q Consensus 720 IL~GL~YLHs~GIIHRDIKPeNILLd~dg----~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~ 795 (992)
++.|+.|||++||.|||+|.+|||+.-+. .+.|+|||.+..... .|
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~----------------hG-------------- 399 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN----------------HG-------------- 399 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccc----------------cc--------------
Confidence 99999999999999999999999996333 479999998622110 00
Q ss_pred CCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCC------CCccceeeeh
Q 001952 796 PTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG------HGAAVDWWTF 869 (992)
Q Consensus 796 ~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~------~s~kSDIWSL 869 (992)
.+ -++..+....-|.-..||||+....+ --.++|.|+.
T Consensus 400 --lq----------------------------------lpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~ 443 (598)
T KOG4158|consen 400 --LQ----------------------------------LPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAA 443 (598)
T ss_pred --cc----------------------------------cccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhh
Confidence 01 11112223334667789999987542 1368999999
Q ss_pred hhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 870 GIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 870 GVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
|.+.||+++...||.+......-..-..+....+.+..+++.+++|+..+|..||.+|++ -.+++.+|+.-.|..-+|
T Consensus 444 GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvs-p~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 444 GALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVS-PNIAANVLNLSLWRMGED 521 (598)
T ss_pred hhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCC-ccHHHhHHHHHHhcCchH
Confidence 999999999999998854432111112222223344569999999999999999999999 356666776544444444
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=181.29 Aligned_cols=202 Identities=23% Similarity=0.225 Sum_probs=140.7
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH-hhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEEEEE
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA-RRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~-~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.+...|+.|+||+||++.. .+..++.+.+...... .......+.+|+++|++|. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3457899999999998766 5667777766543221 1112235789999999995 5889999986 44699999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeec-CCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDL-KPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDI-KPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|+.|.+|...+.. . ...++.|++.+|+|||.+||+|||| ||+|||++.+|.++|+|||++.........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~- 148 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW- 148 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH-
Confidence 9999998654321 1 1347789999999999999999999 799999999999999999998432110000
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.+++ ..+++..+... ...+++.
T Consensus 149 ------------------------------------~r~L---------------~~rDl~~llk~-------~~~y~~~ 170 (218)
T PRK12274 149 ------------------------------------MRLL---------------AREDLRHLLKH-------KRMYCPA 170 (218)
T ss_pred ------------------------------------HHHH---------------HHHHHHHHHHH-------HHhcCCC
Confidence 0000 00011111000 1236788
Q ss_pred ccChhhhcCC-CCC-ccceeeehhhhhhhhccCCCCCCCCC
Q 001952 849 YLAPEIIKGE-GHG-AAVDWWTFGIFLYELLYGRTPFKGSG 887 (992)
Q Consensus 849 Y~APEvL~g~-~~s-~kSDIWSLGVlLyELLTGr~PF~g~s 887 (992)
|+.|+...-. ..+ .+.++++.|+-+|.++|++.++.+.+
T Consensus 171 ~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 171 ALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred CCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 9999865543 223 67899999999999999999876543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.6e-18 Score=179.88 Aligned_cols=134 Identities=19% Similarity=0.209 Sum_probs=105.6
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-----CCCCccceeeeeccCC---eEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-----DHPFLPTLYSQFTSDN---LSC 685 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-----~HPNIVkL~g~f~~~~---~ly 685 (992)
.+.||+|+||.||. +..++.. +||++.... ......+.+|+.+++.+ +||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46799999999995 6556554 699886532 22345689999999999 6799999999998763 434
Q ss_pred -EEEEe--cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHH-HHHhhcCeeeeecCCceEEEccC----CcEEEEeccc
Q 001952 686 -LVMEY--CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL-EYLHMLGVIYRDLKPENILVRED----GHIMLTDFDL 757 (992)
Q Consensus 686 -LVmEy--~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL-~YLHs~GIIHRDIKPeNILLd~d----g~VKLsDFGL 757 (992)
+|||| +.+++|.+++.+. .+++. ..++.|++.++ +|||+++||||||||+|||++.. +.++|+||+.
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5579999999752 36555 35688888888 99999999999999999999743 3799999544
Q ss_pred c
Q 001952 758 S 758 (992)
Q Consensus 758 A 758 (992)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-18 Score=208.89 Aligned_cols=198 Identities=26% Similarity=0.389 Sum_probs=158.3
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC---CCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD---HPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~---HPNIVkL~g~f~~~ 681 (992)
++....|.|-+.||+|+||.||+|.... |+.||+|+=+... ..+|..-.+++.+|+ -+.|+.+...+.-.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~------~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN------PWEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC------ceeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4556789999999999999999998876 9999999875431 222333344555555 34566666666677
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-------CcEEEEe
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-------GHIMLTD 754 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-------g~VKLsD 754 (992)
+.-+||+||.+.|+|.+++.. .+.+++..+..++.|++.-++.||..||||+||||+|+||... -.++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 778999999999999999884 4779999999999999999999999999999999999999632 2489999
Q ss_pred ccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccC
Q 001952 755 FDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834 (992)
Q Consensus 755 FGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~ 834 (992)
||-+..+..-+
T Consensus 845 fG~siDm~lfp--------------------------------------------------------------------- 855 (974)
T KOG1166|consen 845 FGRSIDMKLFP--------------------------------------------------------------------- 855 (974)
T ss_pred cccceeeeEcC---------------------------------------------------------------------
Confidence 99874332111
Q ss_pred CCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCC
Q 001952 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRT 881 (992)
Q Consensus 835 ~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~ 881 (992)
........++|-.+-.+|+..|..|++..|.|.|+-+++-||.|++
T Consensus 856 -~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 856 -DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred -CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 0112345678889999999999999999999999999999999965
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.8e-17 Score=167.82 Aligned_cols=136 Identities=24% Similarity=0.268 Sum_probs=112.6
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhH-----HHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF-----LARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~-----l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
+.||+|++|.||+|.+ .+..+++|+..... .........+.+|+.++..+.|++|+....++...+..+||||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 55678999765321 1111223457789999999999999887777777788899999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
|++|++|.+++... .. ....++.+|+.+|.+||..||+|+|++|.|||++ ++.++|+|||++.
T Consensus 80 ~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 99999999987653 12 7888999999999999999999999999999999 7889999999863
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=177.53 Aligned_cols=144 Identities=24% Similarity=0.222 Sum_probs=111.5
Q ss_pred CceEEEEEccCCceEEEEEE-EcCCCeEEEEEEechhHHHhh---------------------cchhHHHHHHHHHHHcC
Q 001952 610 HFNLLQKLGCGDIGTVYLAE-LIGTNCLFAIKVMDNEFLARR---------------------KKMPRAQTEREILRMLD 667 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~-~~~tg~~VAIKvIkk~~l~~~---------------------~~~~~~~~EieILk~L~ 667 (992)
.|.+.+.||+|+||.||+|. +..+|+.||||+++....... .....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999998 667899999999875321100 01123568999999997
Q ss_pred CCC--ccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC-eeeeecCCceEEE
Q 001952 668 HPF--LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG-VIYRDLKPENILV 744 (992)
Q Consensus 668 HPN--IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G-IIHRDIKPeNILL 744 (992)
+.+ +++++++ ...+|||||+.|.+|..+.... ..+....+..++.||+.+|.|||..| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 533 3444442 2358999999998886654222 34566677899999999999999999 9999999999999
Q ss_pred ccCCcEEEEecccccc
Q 001952 745 REDGHIMLTDFDLSLR 760 (992)
Q Consensus 745 d~dg~VKLsDFGLA~~ 760 (992)
+ ++.++|+|||++..
T Consensus 183 ~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 183 H-DGKVVIIDVSQSVE 197 (237)
T ss_pred E-CCCEEEEEChhhhc
Confidence 9 88999999999754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=163.58 Aligned_cols=133 Identities=24% Similarity=0.268 Sum_probs=106.3
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhH-----HHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEF-----LARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~-----l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
.||+|+||.||+|.+ .+..+++|+..... ........++.+|++++..+.|+++.....++...+..+|||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999986 45678999864321 11122235677899999999988766555555666677999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
++|++|.+++.... . .++.+|+.+|.+||..||+|+|++|.|||++ ++.++|.|||++..
T Consensus 79 ~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998865421 0 7899999999999999999999999999999 88999999998743
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=187.30 Aligned_cols=139 Identities=25% Similarity=0.280 Sum_probs=111.5
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEec-h----hHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD-N----EFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIk-k----~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..|...+.||+|+||+||+|.+.+.+ +++|+.. + ..........++.+|+++++.++|++|+..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 44566788999999999999886554 3444321 1 111122233567899999999999999988887777778
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+|||||++|++|.+++. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||++..
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998775 246789999999999999999999999999999 678899999999844
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-17 Score=202.61 Aligned_cols=310 Identities=33% Similarity=0.534 Sum_probs=232.8
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..+.|.+.+-+-+|.++.++.+.-..++-..++|+..............+..+-.++-...+|.++....-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 35678888889999999999998877776777777654433334444444455555545567888877766777888999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
+++|+.|++|...++.. ++.+.+..+.++..+..+++|||...++|+|++|.|+|...+|+.++.|||........+.
T Consensus 882 ~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred hhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999888875 4677788888999999999999999999999999999999999999999996544332222
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.... +| ......++........ +.+... .........||
T Consensus 960 ~~~~---------sg-----------------~~~~~~~~~~~~~~~~--------------~~l~~~-~~~~~~~~~~t 998 (1205)
T KOG0606|consen 960 TTDL---------SG-----------------PSSSGTPRRLSRSERR--------------PQLSAD-EARRKHAVVGT 998 (1205)
T ss_pred cCCc---------cc-----------------ccccCccccccccccc--------------cccccc-hhhccccccCC
Confidence 1110 00 0001111111100000 000011 12334567899
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCc-cchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSP-LISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~-~vs~el~dLI~kcL~~DPe 925 (992)
+.|.+||.+.+..++..+|+|++|++++|.++|..||........+.++..+...+|..+ ..+.++++++..+|..+|.
T Consensus 999 ~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~ 1078 (1205)
T KOG0606|consen 999 PDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPT 1078 (1205)
T ss_pred CcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCch
Confidence 999999999999999999999999999999999999999999999999999888887654 4788999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp 960 (992)
+|.++ .++.+...|+||+..+|..+..-...++|
T Consensus 1079 qr~~a-~~~~e~k~~~~~~~~~~~~l~~q~~~~~p 1112 (1205)
T KOG0606|consen 1079 QRLGA-KGAAEVKGHPFFQDVDWENLALQKAEFVP 1112 (1205)
T ss_pred hccCc-ccccccccCCccCCCCccccccccCccCC
Confidence 99993 34558999999999999988654444555
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.5e-18 Score=195.04 Aligned_cols=184 Identities=29% Similarity=0.407 Sum_probs=136.3
Q ss_pred CeEEEEEEecCCCChHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQ-LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~-~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.++||.|++|.-.+|.+|+... .....++...+.|+.|++.|++| +|.||+|+||.||++..++.+||+||||...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 4689999999999999999743 34556788899999999999999 9999999999999999999999999999633
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
...... ........
T Consensus 406 ~~~~~~------------------------------------------------------------------~~~~~a~~ 419 (516)
T KOG1033|consen 406 QDKDET------------------------------------------------------------------VAPAAASH 419 (516)
T ss_pred cccCCc------------------------------------------------------------------ccchhhhh
Confidence 211100 00011234
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCC-CCccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFP-DSPLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P-~~~~vs~el~dLI~k 918 (992)
+..+||+.||+||.|.+..|+.++|||+||++|+||++ -...|.-. ..+..+-.+ .+| ....-.++-.+|+.+
T Consensus 420 t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g--~ip~~~~~d~p~e~~ll~~ 494 (516)
T KOG1033|consen 420 TQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDG--IIPPEFLQDYPEEYTLLQQ 494 (516)
T ss_pred hhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcC--CCChHHhhcCcHHHHHHHH
Confidence 45689999999999999999999999999999999997 34444221 222222112 222 111112344689999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF 943 (992)
||...|.+||+ +.+.-.|+|.
T Consensus 495 lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 495 LLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred hcCCCcccCch----HHHHhhhhhc
Confidence 99999999997 7776667664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-16 Score=163.62 Aligned_cols=138 Identities=27% Similarity=0.238 Sum_probs=107.2
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh-------------------cchhHHHHHHHHHHHcCCCC-
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR-------------------KKMPRAQTEREILRMLDHPF- 670 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~-------------------~~~~~~~~EieILk~L~HPN- 670 (992)
|.+.+.||+|+||.||++.+. +|+.||||+++....... .....+..|..++..+.|.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777889999999999999874 789999998764320000 01123567888888887774
Q ss_pred -ccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc
Q 001952 671 -LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH 749 (992)
Q Consensus 671 -IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~ 749 (992)
++.+++. ...++||||++|++|..+... .....++.+|+.+|.++|..||+||||||+|||++.++.
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 4444432 345899999999998765321 345678899999999999999999999999999999999
Q ss_pred EEEEeccccccc
Q 001952 750 IMLTDFDLSLRC 761 (992)
Q Consensus 750 VKLsDFGLA~~l 761 (992)
++|+|||++..+
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999998554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=7e-16 Score=155.62 Aligned_cols=138 Identities=23% Similarity=0.235 Sum_probs=97.8
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchh---------------------HHHHHHHHHHHcCCCC--
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP---------------------RAQTEREILRMLDHPF-- 670 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~---------------------~~~~EieILk~L~HPN-- 670 (992)
.+.||+|+||.||+|.+. +++.||||+++........... ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 457999999999999886 7889999998753211111111 1134555666664433
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChH-HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCC
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDG 748 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~-~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg 748 (992)
+.++++. ...+|||||++++.+. ..+.... . ...++.++.+++.+|.++|. .||+|+||||+|||++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444443 2358999999985442 1112110 1 15678899999999999999 9999999999999999 89
Q ss_pred cEEEEeccccccc
Q 001952 749 HIMLTDFDLSLRC 761 (992)
Q Consensus 749 ~VKLsDFGLA~~l 761 (992)
.++|+|||.+...
T Consensus 152 ~~~liDfg~a~~~ 164 (187)
T cd05119 152 KVYIIDVPQAVEI 164 (187)
T ss_pred cEEEEECcccccc
Confidence 9999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.4e-17 Score=197.09 Aligned_cols=263 Identities=26% Similarity=0.361 Sum_probs=199.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcC-CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIG-TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~-tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyL 686 (992)
..|.+.+.||+|+|+.|-++.... ....+|+|.+.... ........+..|..+-+.+. |.|++.+++...+.+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 457777889999999998886643 34456777665432 12233344455776666666 9999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh-hcCeeeeecCCceEEEccCC-cEEEEeccccccccCC
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH-MLGVIYRDLKPENILVREDG-HIMLTDFDLSLRCSVS 764 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH-s~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~~~ 764 (992)
+++|..|+++...+........+...+..++.|+..+|.|+| ..++.|+||||+|.+++..+ .+++.|||+|..+..-
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999988773222225677888899999999999999 99999999999999999999 9999999998443210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.| ........+
T Consensus 179 ---------------~g------------------------------------------------------~~~~~~~~~ 189 (601)
T KOG0590|consen 179 ---------------NG------------------------------------------------------AERSLKDRC 189 (601)
T ss_pred ---------------CC------------------------------------------------------cceeeeccc
Confidence 00 011122345
Q ss_pred c-CCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHH-HHHHHhhcc--CCCCCccchHHHHHHHHHh
Q 001952 845 G-THEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET-LANVVMQSL--KFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 845 G-T~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~-L~~Iv~~~l--k~P~~~~vs~el~dLI~kc 919 (992)
| ++.|+|||.+.+. ......|+||.|+++.-+++|..|+......+. +..+..... .......++....+++.++
T Consensus 190 g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~ 269 (601)
T KOG0590|consen 190 GSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKI 269 (601)
T ss_pred CCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhccccc
Confidence 6 9999999999995 447889999999999999999999875433322 122222211 2223345778899999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
|..+|..|.+ .+++..++|+..
T Consensus 270 l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 270 LKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccCCchhccc----cccccccccccc
Confidence 9999999999 999999999998
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.4e-15 Score=139.59 Aligned_cols=131 Identities=25% Similarity=0.285 Sum_probs=110.8
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC--CCccceeeeeccCCeEEEEEEe
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH--PFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H--PNIVkL~g~f~~~~~lyLVmEy 690 (992)
+++.||.|.++.||++...+ ..+++|++..... ...+..|+.+++.+.| .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 35789999999999998844 6799999865421 3467889999999976 5899999998888899999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML---GVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~---GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
+.|+.+..+ +......++.+++.+|++||.. +++|+||+|.|||++..+.++|.|||++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 988877543 4456677889999999999985 79999999999999998999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.9e-15 Score=173.96 Aligned_cols=197 Identities=22% Similarity=0.272 Sum_probs=148.7
Q ss_pred HHHcCCCCccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCe-eeeecCCce
Q 001952 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV-IYRDLKPEN 741 (992)
Q Consensus 663 Lk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GI-IHRDIKPeN 741 (992)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++.-...++++|+.||.|||.--| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 45688999999999999999999999999999999998873 4668888888999999999999997754 999999999
Q ss_pred EEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCCh
Q 001952 742 ILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP 821 (992)
Q Consensus 742 ILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~ 821 (992)
.+++..+.+||.|||+...... ..
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~---------~~----------------------------------------------- 103 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEE---------TA----------------------------------------------- 103 (484)
T ss_pred ceeeeeEEEEechhhhcccccc---------cc-----------------------------------------------
Confidence 9999999999999999532210 00
Q ss_pred hhhhccCCccccCCCCCCcCccccCCCccChhhhcCCC-------CCccceeeehhhhhhhhccCCCCCCCCCc----hH
Q 001952 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG-------HGAAVDWWTFGIFLYELLYGRTPFKGSGN----EE 890 (992)
Q Consensus 822 ~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~-------~s~kSDIWSLGVlLyELLTGr~PF~g~s~----~e 890 (992)
.........-...|.|||.+.+.. .+.+.||||||++++|+++...||..... .+
T Consensus 104 --------------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~e 169 (484)
T KOG1023|consen 104 --------------EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDE 169 (484)
T ss_pred --------------cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHH
Confidence 000001111234699999998742 36679999999999999999999975322 22
Q ss_pred HHHHHHhhccCCCCC-----ccchHHHHHHHHHhccCCcCCcCCC
Q 001952 891 TLANVVMQSLKFPDS-----PLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 891 ~L~~Iv~~~lk~P~~-----~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
....+.........+ ..+.+++..+++.||..+|++||++
T Consensus 170 ii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 170 IILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred HHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 333322212211111 1345578999999999999999993
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=155.13 Aligned_cols=136 Identities=25% Similarity=0.282 Sum_probs=104.0
Q ss_pred EEEc-cCCceEEEEEEEcCCCeEEEEEEechhHH-----H-----hhcchhHHHHHHHHHHHcCCCCc--cceeeeeccC
Q 001952 615 QKLG-CGDIGTVYLAELIGTNCLFAIKVMDNEFL-----A-----RRKKMPRAQTEREILRMLDHPFL--PTLYSQFTSD 681 (992)
Q Consensus 615 r~LG-sG~FGtVYlA~~~~tg~~VAIKvIkk~~l-----~-----~~~~~~~~~~EieILk~L~HPNI--VkL~g~f~~~ 681 (992)
..|| .||.|+||.+... +..++||.+....+ . .......+.+|++++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 8889999998773 66799998854221 1 11223567889999999998875 6777765432
Q ss_pred C-e---EEEEEEecCC-CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecc
Q 001952 682 N-L---SCLVMEYCPG-GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 682 ~-~---lyLVmEy~~G-GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
. . .+|||||++| .+|.+++.. ..+++. .+.+|+.+|.+||..||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 2 2599999997 689888764 335543 35689999999999999999999999999998999999999
Q ss_pred ccc
Q 001952 757 LSL 759 (992)
Q Consensus 757 LA~ 759 (992)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-13 Score=160.02 Aligned_cols=261 Identities=21% Similarity=0.212 Sum_probs=193.9
Q ss_pred cCceEEEEEcc--CCceEEEEEEE--cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCe
Q 001952 609 RHFNLLQKLGC--GDIGTVYLAEL--IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNL 683 (992)
Q Consensus 609 ~~Yeilr~LGs--G~FGtVYlA~~--~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~ 683 (992)
..|.+...+|. |.+|.||.+.. ..++..+|+|.-+...- ....-.+-.+|+...+.++ |+|.++.+..|+..+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCc
Confidence 45667788999 99999999988 88888999997432211 1111122245666666664 9999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHH----HHHHHhhcCeeeeecCCceEEEccC-CcEEEEecccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL----ALEYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLS 758 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~----GL~YLHs~GIIHRDIKPeNILLd~d-g~VKLsDFGLA 758 (992)
+|+-+|+| +.+|..+.... ...++...++.+..+... ||..+|..+|+|-|+||+||++..+ ..++++|||+.
T Consensus 193 lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred ceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 99999999 68887776643 345788889999999999 9999999999999999999999999 78999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+...... . +. .
T Consensus 271 ~~i~~~~~~-------------~------------------~~-----------------------------------~- 283 (524)
T KOG0601|consen 271 SKISDGNFS-------------S------------------VF-----------------------------------K- 283 (524)
T ss_pred EEccCCccc-------------c------------------ce-----------------------------------e-
Confidence 554321100 0 00 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCC--CchHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS--GNEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~--s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
..-...|...|++||.+.+. ++...|||+||.++++..+|-.++... +.+..++.+. +........+.++...+
T Consensus 284 ~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e~~~~~s~~l~~~~ 359 (524)
T KOG0601|consen 284 VSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY---IPLEFCEGGSSSLRSVT 359 (524)
T ss_pred eeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc---CchhhhcCcchhhhhHH
Confidence 00011355679999999876 788999999999999999987776655 5555554432 11111122455677799
Q ss_pred HHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
..|+..+|-.|++ +..++.|+|+.+..
T Consensus 360 ~~~~d~~~~~~~~----~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 360 SQMLDEDPRLRLT----AQILTALNVIHSKL 386 (524)
T ss_pred HHhcCcchhhhhH----HHHHhccccccchh
Confidence 9999999999999 99999999988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=6e-12 Score=146.09 Aligned_cols=143 Identities=21% Similarity=0.191 Sum_probs=95.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh-------------------------------cchh------HHH
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR-------------------------------KKMP------RAQ 657 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~-------------------------------~~~~------~~~ 657 (992)
+.||.|++|.||+|.+. +|+.||||+.+......- +... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999874 688999999864311000 0000 133
Q ss_pred HHHHHHHHc----CCCCccceeeee-ccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHH-HHHHHhhcC
Q 001952 658 TEREILRML----DHPFLPTLYSQF-TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL-ALEYLHMLG 731 (992)
Q Consensus 658 ~EieILk~L----~HPNIVkL~g~f-~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~-GL~YLHs~G 731 (992)
+|...+.++ .|.+-+.+-.++ ......+|||||++|++|.++..... ..+. ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 344444444 222222222222 23445799999999999987765321 1122 3445555555 478899999
Q ss_pred eeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 732 VIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 732 IIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
++|+|++|.||+++.+|.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999986653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=153.31 Aligned_cols=145 Identities=19% Similarity=0.260 Sum_probs=94.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh-------------------------------hcchhHH
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR-------------------------------RKKMPRA 656 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~-------------------------------~~~~~~~ 656 (992)
+.+|+. +.||.|++|.||+|.++.+|+.||||+++...... .+....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 78999999999999998889999999997542100 0111223
Q ss_pred HHHHHHHHHcCCCCccceeeeecc-------------CCeEEEEEEecCCCChHHHHHhhcCC----CCCHHHHHHHHHH
Q 001952 657 QTEREILRMLDHPFLPTLYSQFTS-------------DNLSCLVMEYCPGGDLHVLRQKQLGK----CFSEPAARFYVAE 719 (992)
Q Consensus 657 ~~EieILk~L~HPNIVkL~g~f~~-------------~~~lyLVmEy~~GGSL~~lLkk~~~~----~Lse~~i~~Ia~Q 719 (992)
.+|+++.+.. .|+.++...|.+ ....+|||||+.|+.|.++..-...+ .+.+..+..++.|
T Consensus 198 ~~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 198 HDELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 3444443333 233333333322 33457999999999997652211111 1223333334444
Q ss_pred HHHHHHHHhhcCeeeeecCCceEEEccCC----cEEEEecccccccc
Q 001952 720 VLLALEYLHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLRCS 762 (992)
Q Consensus 720 IL~GL~YLHs~GIIHRDIKPeNILLd~dg----~VKLsDFGLA~~l~ 762 (992)
++..|++|+|+||.||+++.+| .++++|||+...+.
T Consensus 276 -------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 -------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 3468999999999999999888 99999999986653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.4e-11 Score=121.80 Aligned_cols=127 Identities=21% Similarity=0.298 Sum_probs=95.3
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeeccCCeEEEEEEecC
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~~~~lyLVmEy~~ 692 (992)
++.|+.|.++.||++... +..|++|+..... .....+..|+.+++.+.+.++ .+++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGT----ELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCc----ccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999874 6789999976431 112245788999998865554 45555433 33579999999
Q ss_pred CCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCe-----eeeecCCceEEEccCCcEEEEeccccc
Q 001952 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV-----IYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 693 GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GI-----IHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
|..+... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 75 G~~l~~~--~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE--D--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc--c--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887543 0 1123456789999999999874 9999999999999 6789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.9e-12 Score=147.14 Aligned_cols=253 Identities=21% Similarity=0.283 Sum_probs=184.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc-CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI-GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDN 682 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~-~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~ 682 (992)
.....+|..+..||.|.|+.|+.+..+ .++..|++|-+.+......... .-..|+.+...+ -|.+++.++..|....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCccccc
Confidence 344678999999999999999998765 6788899998765432221211 223455555555 4999999999898888
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-CcEEEEeccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLSLRC 761 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-g~VKLsDFGLA~~l 761 (992)
..||--|||.++++...+.- ...+.+...+.+..|++.+|.++|+..++|+|+||+||++..+ +..++.|||...++
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 88999999999988755422 2457888899999999999999999999999999999999986 77889999986432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.....+
T Consensus 418 ~~~~~~-------------------------------------------------------------------------- 423 (524)
T KOG0601|consen 418 AFSSGV-------------------------------------------------------------------------- 423 (524)
T ss_pred ceeccc--------------------------------------------------------------------------
Confidence 211000
Q ss_pred ccccCCCc-cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEY-LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y-~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...++..| .+++.+....+..+.|++|||..+.|.++|...-..... +..+..+ ..+..+....++..+.+.++
T Consensus 424 ~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~~--~~p~~~~~~~~~q~~~kv~~ 498 (524)
T KOG0601|consen 424 FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRSG--DTPNLPGLKLQLQVLLKVMI 498 (524)
T ss_pred ccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeecc--cccCCCchHHhhhhhhhhhc
Confidence 01122334 355566667788999999999999999999765443322 2222222 22333335578889999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF 943 (992)
..++..|+. +.++..|.=|
T Consensus 499 ~~~~~~~~l----~~~l~~~~~~ 517 (524)
T KOG0601|consen 499 NPDRKRRPS----AVELSLHSEF 517 (524)
T ss_pred CCccccchh----hhhhcccchh
Confidence 999999999 7787777544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1e-12 Score=144.42 Aligned_cols=244 Identities=21% Similarity=0.252 Sum_probs=161.3
Q ss_pred eEEEEEEEcCCCeEEEEEEechhHHHhhcch-hHHHHHHHHHHHcCCCCccceeeeeccCC-----eEEEEEEecCCCCh
Q 001952 623 GTVYLAELIGTNCLFAIKVMDNEFLARRKKM-PRAQTEREILRMLDHPFLPTLYSQFTSDN-----LSCLVMEYCPGGDL 696 (992)
Q Consensus 623 GtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~-~~~~~EieILk~L~HPNIVkL~g~f~~~~-----~lyLVmEy~~GGSL 696 (992)
-.||++.+...|..|..-.++.......... .....-..-|-.+.|.|||+++.||.+.+ ...++.||+..|+|
T Consensus 80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 3578887777776665544432211111111 11111122344557999999999997543 47899999999999
Q ss_pred HHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCC
Q 001952 697 HVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772 (992)
Q Consensus 697 ~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s 772 (992)
..++++.. ...+.....++|+.||+.||.|||... |||+++..+-|++..+|.+|+.---..
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~-------------- 225 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPD-------------- 225 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcc--------------
Confidence 99887543 356788889999999999999999985 999999999999999998886522110
Q ss_pred CCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccCh
Q 001952 773 NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAP 852 (992)
Q Consensus 773 ~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~AP 852 (992)
...+ . ... ....+ ...-.+-++|.+|
T Consensus 226 --------------------s~h~---------s----~~~--------------------~~~~E-k~~~~~~~g~~a~ 251 (458)
T KOG1266|consen 226 --------------------STHP---------S----VNS--------------------TREAE-KSVNTSLPGFSAP 251 (458)
T ss_pred --------------------ccch---------h----hhh--------------------hhHhh-hhccccCCccccC
Confidence 0000 0 000 00000 0111356789999
Q ss_pred hhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc----hHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 853 EIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN----EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 853 EvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~----~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
|.-.....+-++|||+||...+||..|..--..... ++...+.+. .+. ...-+++|.+||+-.|..||
T Consensus 252 ~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~---~le-----n~lqr~~i~kcl~~eP~~rp 323 (458)
T KOG1266|consen 252 ESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII---GLE-----NGLQRGSITKCLEGEPNGRP 323 (458)
T ss_pred CcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee---ecc-----CccccCcCcccccCCCCCCc
Confidence 987777778899999999999999988765332211 122222111 111 11235799999999999999
Q ss_pred CChHhHHHHHcCCCCCCC
Q 001952 929 GSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~l 946 (992)
+ +.++|.||.+-++
T Consensus 324 ~----ar~llfHpllfeV 337 (458)
T KOG1266|consen 324 D----ARLLLFHPLLFEV 337 (458)
T ss_pred c----hhhhhcCceeeec
Confidence 9 9999999986554
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-10 Score=137.31 Aligned_cols=121 Identities=16% Similarity=0.202 Sum_probs=99.2
Q ss_pred EEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCC
Q 001952 628 AELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC 707 (992)
Q Consensus 628 A~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~ 707 (992)
|..+.++..|.|.+.+... ......+.+-+..|+.++||||+++++.++.++.+|||+|.+ .-|..++++.
T Consensus 31 ~t~k~~~~~vsVF~~~~~~---~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l---- 101 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSN---GEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL---- 101 (690)
T ss_pred cceeccCCceEEEEEeCCC---chhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh----
Confidence 5556677778888776432 133455677788899999999999999999999999999998 4566666653
Q ss_pred CCHHHHHHHHHHHHHHHHHHh-hcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 708 FSEPAARFYVAEVLLALEYLH-MLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 708 Lse~~i~~Ia~QIL~GL~YLH-s~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
....+.-.++||+.||.||| +.+++|++|.-.-|+|+..|..||++|.++
T Consensus 102 -~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 102 -GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 35666677899999999998 568999999999999999999999999986
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.4e-10 Score=119.92 Aligned_cols=138 Identities=17% Similarity=0.166 Sum_probs=98.5
Q ss_pred EEEccCCceEEEEEEEcC------CCeEEEEEEechhHH---------Hhh----------cchhHHH----HHHHHHHH
Q 001952 615 QKLGCGDIGTVYLAELIG------TNCLFAIKVMDNEFL---------ARR----------KKMPRAQ----TEREILRM 665 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~------tg~~VAIKvIkk~~l---------~~~----------~~~~~~~----~EieILk~ 665 (992)
..||.|--+.||.|...+ .+..+|||+.+-... ..+ .....+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997643 357899998752111 000 0112233 78888888
Q ss_pred cCC--CCccceeeeeccCCeEEEEEEecCCCChHH-HHHhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcCeeeeecCCce
Q 001952 666 LDH--PFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLALEYL-HMLGVIYRDLKPEN 741 (992)
Q Consensus 666 L~H--PNIVkL~g~f~~~~~lyLVmEy~~GGSL~~-lLkk~~~~~Lse~~i~~Ia~QIL~GL~YL-Hs~GIIHRDIKPeN 741 (992)
+.. -++.+++++ ..-+|||||+.+..+.. .++. ..++......+..+++.+|.+| |..||||+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 456677764 44689999996654422 2222 2345566777889999999999 89999999999999
Q ss_pred EEEccCCcEEEEecccccc
Q 001952 742 ILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 742 ILLd~dg~VKLsDFGLA~~ 760 (992)
||+. ++.+.|+|||.+..
T Consensus 156 IL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEEE-CCcEEEEECCCcee
Confidence 9997 56799999998744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.6e-10 Score=113.98 Aligned_cols=144 Identities=21% Similarity=0.208 Sum_probs=110.2
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEE-----echhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKV-----MDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKv-----Ikk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+..|-+|+-+.|+++.+ .|+.++||. .+...++..-...+..+|..+|.++.--.|.-..-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567788999999999988 556667763 3444445555556778899999988755665444456666667899
Q ss_pred EEecCC-CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc---EEEEecccc
Q 001952 688 MEYCPG-GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLS 758 (992)
Q Consensus 688 mEy~~G-GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~---VKLsDFGLA 758 (992)
|||++| .++.+++...............++.+|-..|.-||..+|||+||..+||||..+|. +.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 999977 37788877654444444445788899999999999999999999999999986653 589999996
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.6e-10 Score=113.41 Aligned_cols=138 Identities=20% Similarity=0.223 Sum_probs=102.0
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC--CccceeeeeccC---CeEEEEEE
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP--FLPTLYSQFTSD---NLSCLVME 689 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP--NIVkL~g~f~~~---~~lyLVmE 689 (992)
+.||.|.++.||++...+ |+.+++|+....... .....+..|.++++.+.+. .+.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 568999999999998743 578999998653211 1345678899999999753 467788777654 36789999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM---------------------------------------- 729 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs---------------------------------------- 729 (992)
|++|.+|...+.. ..++......++.+++..|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999888654321 235555666666666666666663
Q ss_pred ----------------cCeeeeecCCceEEEcc--CCcEEEEecccc
Q 001952 730 ----------------LGVIYRDLKPENILVRE--DGHIMLTDFDLS 758 (992)
Q Consensus 730 ----------------~GIIHRDIKPeNILLd~--dg~VKLsDFGLA 758 (992)
..+||+|+.|.|||++. ++.+.|+||+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~ 204 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA 204 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence 24799999999999998 677899999986
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.5e-09 Score=112.73 Aligned_cols=132 Identities=23% Similarity=0.273 Sum_probs=101.3
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEe-----chhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVM-----DNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvI-----kk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
.|++|+-+.+|++.+.+ ..+++|.= +...++.+-...+..+|..+|..+.--.|.-.+=++.+.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 57899999999997743 34666642 333444444556678899999988765665555556677778899999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
++|..|.+++... ...++..|-.-+.-||..||||+||.++||++..++ +.++||||+.
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 9999999887763 244667777778889999999999999999998665 9999999973
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.3e-09 Score=129.76 Aligned_cols=169 Identities=23% Similarity=0.355 Sum_probs=120.8
Q ss_pred HHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCC
Q 001952 719 EVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPT 797 (992)
Q Consensus 719 QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~ 797 (992)
+++.||.|+|+. ++||++|.|++|.++.+|..||+.|+++.... ++ +++
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~------------------~~-~~~----------- 156 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNAN------------------GP-TEY----------- 156 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccC------------------CC-Ccc-----------
Confidence 344899999976 89999999999999999999999999863211 00 000
Q ss_pred CCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhc
Q 001952 798 CQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL 877 (992)
Q Consensus 798 ~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELL 877 (992)
+|. .+.........-...|.|||++.+...+.++|+|||||++|.+.
T Consensus 157 ---p~~------------------------------~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~ 203 (700)
T KOG2137|consen 157 ---PFS------------------------------EYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIY 203 (700)
T ss_pred ---ccc------------------------------cCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEe
Confidence 000 00000001112345699999999988899999999999999999
Q ss_pred -cCCCCCCCCCchHHHHHHHh--hccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcC
Q 001952 878 -YGRTPFKGSGNEETLANVVM--QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCA 954 (992)
Q Consensus 878 -TGr~PF~g~s~~e~L~~Iv~--~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~ 954 (992)
.|+..+...+....+..... +-..+-....++.++++=|.++|..++..||+ +.+++.-|||..---..+|..
T Consensus 204 ~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~~aLrfL 279 (700)
T KOG2137|consen 204 NGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGLKALRFL 279 (700)
T ss_pred cCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchhhhhhhc
Confidence 57777766655444332221 11122223468899999999999999999998 999999999998776666654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.8e-08 Score=107.12 Aligned_cols=135 Identities=14% Similarity=0.024 Sum_probs=96.5
Q ss_pred ceEEEEEEEcCCCeEEEEEEechhHHHh---h-----cchhHHHHHHHHHHHcCCCCc--cceeeeecc-----CCeEEE
Q 001952 622 IGTVYLAELIGTNCLFAIKVMDNEFLAR---R-----KKMPRAQTEREILRMLDHPFL--PTLYSQFTS-----DNLSCL 686 (992)
Q Consensus 622 FGtVYlA~~~~tg~~VAIKvIkk~~l~~---~-----~~~~~~~~EieILk~L~HPNI--VkL~g~f~~-----~~~lyL 686 (992)
...|+++.+ .|+.|.||......... . .-...+.+|...+..|..-+| +.++++++. ...-+|
T Consensus 35 ~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 35 GRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 344666655 56689999764322110 0 111246788888888854443 455556543 234689
Q ss_pred EEEecCCC-ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-------CCcEEEEecccc
Q 001952 687 VMEYCPGG-DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-------DGHIMLTDFDLS 758 (992)
Q Consensus 687 VmEy~~GG-SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-------dg~VKLsDFGLA 758 (992)
|||++++. +|.+++........+......++.+|+..+.-||..||+|+|+++.|||++. ++.+.|+||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999886 8988876432244566778899999999999999999999999999999985 457999999986
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.6e-08 Score=112.30 Aligned_cols=134 Identities=19% Similarity=0.181 Sum_probs=106.6
Q ss_pred ceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec----cCCeEEEEEEecCCC-Ch
Q 001952 622 IGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT----SDNLSCLVMEYCPGG-DL 696 (992)
Q Consensus 622 FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~----~~~~lyLVmEy~~GG-SL 696 (992)
-.+.|+|...-+|..|++|+++-.... .......-+++++++.|.|||+|.++|. .+..++|||+|.++. +|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~---~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQ---STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeecccccc---CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 357899999999999999999432211 1122345678999999999999999987 356789999998874 67
Q ss_pred HHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 697 HVLRQKQL-------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 697 ~~lLkk~~-------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.++.-... +...++..+|.|+.||..||.+||+.|+.-+-|.|.+||++.+-.++|..-|+.
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 66543221 234678999999999999999999999999999999999998888888877764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.3e-08 Score=102.33 Aligned_cols=127 Identities=26% Similarity=0.287 Sum_probs=82.8
Q ss_pred EEEEEEEcCCCeEEEEEEechhHH-----------------------HhhcchhHHHHHHHHHHHcCCC--Cccceeeee
Q 001952 624 TVYLAELIGTNCLFAIKVMDNEFL-----------------------ARRKKMPRAQTEREILRMLDHP--FLPTLYSQF 678 (992)
Q Consensus 624 tVYlA~~~~tg~~VAIKvIkk~~l-----------------------~~~~~~~~~~~EieILk~L~HP--NIVkL~g~f 678 (992)
.||.|.. .+|..+|||+.+.... ..........+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888877 5677899998753210 0001123567899999999755 466776553
Q ss_pred ccCCeEEEEEEecC--CCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH-HhhcCeeeeecCCceEEEccCCcEEEEec
Q 001952 679 TSDNLSCLVMEYCP--GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY-LHMLGVIYRDLKPENILVREDGHIMLTDF 755 (992)
Q Consensus 679 ~~~~~lyLVmEy~~--GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~Y-LHs~GIIHRDIKPeNILLd~dg~VKLsDF 755 (992)
..+|||||++ |..+..+.... ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2379999998 66665554432 2244566778888886665 579999999999999999977 8999999
Q ss_pred ccccc
Q 001952 756 DLSLR 760 (992)
Q Consensus 756 GLA~~ 760 (992)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98743
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.4e-07 Score=93.52 Aligned_cols=106 Identities=28% Similarity=0.304 Sum_probs=84.4
Q ss_pred chhHHHHHHHHHHHcCCC--CccceeeeeccCC----eEEEEEEecCCC-ChHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Q 001952 652 KMPRAQTEREILRMLDHP--FLPTLYSQFTSDN----LSCLVMEYCPGG-DLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724 (992)
Q Consensus 652 ~~~~~~~EieILk~L~HP--NIVkL~g~f~~~~----~lyLVmEy~~GG-SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL 724 (992)
....+.+|...+..|..- .+++.+++.+... ..+||+|++++. +|.+++.... .++......++.+++..+
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLI 131 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHH
Confidence 345678888888777533 3567777665422 358999999885 7999887642 256677888999999999
Q ss_pred HHHhhcCeeeeecCCceEEEccCC---cEEEEeccccc
Q 001952 725 EYLHMLGVIYRDLKPENILVREDG---HIMLTDFDLSL 759 (992)
Q Consensus 725 ~YLHs~GIIHRDIKPeNILLd~dg---~VKLsDFGLA~ 759 (992)
.-||..||+|+|+++.|||++.++ .+.|+||+.+.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 999999999999999999999887 89999999763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.4e-07 Score=97.63 Aligned_cols=135 Identities=27% Similarity=0.289 Sum_probs=98.0
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH------------Hhh-------cchhHHHHHHHHHHHcCCC--C
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL------------ARR-------KKMPRAQTEREILRMLDHP--F 670 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l------------~~~-------~~~~~~~~EieILk~L~HP--N 670 (992)
.+...||-|--+.||.|.+. .|..+|||.-+.... ... .....+.+|.++|.+|.-. .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999884 678899997532110 000 0123467899999998544 5
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcE
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHI 750 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~V 750 (992)
+.+.+++ +..++||||++|..|.... ++......++..|+.-+.-+-..||||+|+.+-|||++.+|.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCE
Confidence 6777664 4567999999998876542 1233344556666666666668999999999999999999999
Q ss_pred EEEecccc
Q 001952 751 MLTDFDLS 758 (992)
Q Consensus 751 KLsDFGLA 758 (992)
.++||--+
T Consensus 242 ~vIDwPQ~ 249 (304)
T COG0478 242 VVIDWPQA 249 (304)
T ss_pred EEEeCccc
Confidence 99999754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.9e-06 Score=88.15 Aligned_cols=141 Identities=17% Similarity=0.157 Sum_probs=100.7
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHH---HhhcchhHHHHHHHHHHHcCCCC--ccceeeeec-c----CCeEEE
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFL---ARRKKMPRAQTEREILRMLDHPF--LPTLYSQFT-S----DNLSCL 686 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l---~~~~~~~~~~~EieILk~L~HPN--IVkL~g~f~-~----~~~lyL 686 (992)
-|.||-+-|++..+.+. .|-+|.-..... ........|.+|+..|..+..-+ ++++. ++. . .-.-+|
T Consensus 26 ~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 35688888998877433 678886541110 10224467889999988885332 44554 332 1 123579
Q ss_pred EEEecCC-CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc--EEEEecccccc
Q 001952 687 VMEYCPG-GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH--IMLTDFDLSLR 760 (992)
Q Consensus 687 VmEy~~G-GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~--VKLsDFGLA~~ 760 (992)
|+|-+.| .+|.+++....-...+......++.+|+..|.-||..|+.|+|+-+.|||++.+|. +.++||..++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9998854 48888876543345577778899999999999999999999999999999987777 99999997643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.6e-06 Score=96.29 Aligned_cols=236 Identities=19% Similarity=0.231 Sum_probs=149.8
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeee------ecc-CCeE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQ------FTS-DNLS 684 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~------f~~-~~~l 684 (992)
..+.||+|+-+.+|-..--. ..+-|++........ ...++.|... .||-+-.-+.| .-. ...+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 34679999999999653322 235577764321111 1123333333 56643321111 112 2337
Q ss_pred EEEEEecCCCC-hHHHHH----hhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 685 CLVMEYCPGGD-LHVLRQ----KQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 685 yLVmEy~~GGS-L~~lLk----k~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
.++|..+.|.. +..+.. ++....+.|......++.|+.+.+.||..|.+-+|+.++|||+.+++.+.|.|=.-..
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 78888887652 222221 1222457789999999999999999999999999999999999999999999865321
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+ ..+..
T Consensus 166 i~-------------------------------------------------------------------------~ng~~ 172 (637)
T COG4248 166 IN-------------------------------------------------------------------------ANGTL 172 (637)
T ss_pred ec-------------------------------------------------------------------------cCCce
Confidence 11 01122
Q ss_pred cCccccCCCccChhhhc-----CCCCCccceeeehhhhhhhhccC-CCCCCCC-------CchHHHHHHHhh--------
Q 001952 840 SNSFVGTHEYLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYG-RTPFKGS-------GNEETLANVVMQ-------- 898 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~-----g~~~s~kSDIWSLGVlLyELLTG-r~PF~g~-------s~~e~L~~Iv~~-------- 898 (992)
+..-+|..+|.+||... +..-+...|.|.||++||+||.| +.||.|. +..|. .|..+
T Consensus 173 ~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~ 250 (637)
T COG4248 173 HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQ 250 (637)
T ss_pred EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhc
Confidence 33447889999999876 33447789999999999999985 9999863 22221 11111
Q ss_pred -ccCCCCC-----ccchHHHHHHHHHhccCC--cCCcCCChH
Q 001952 899 -SLKFPDS-----PLISFQARDLIRGLLIKE--PENRLGSQK 932 (992)
Q Consensus 899 -~lk~P~~-----~~vs~el~dLI~kcL~~D--PekRPT~~~ 932 (992)
....|-+ ..+++++..|..+|+..- +.-||+.+.
T Consensus 251 ~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 251 RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1111111 235678889999999854 568999654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.28 E-value=1e-05 Score=86.89 Aligned_cols=140 Identities=19% Similarity=0.205 Sum_probs=92.0
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhH------HHHHHHHHHHc---CCCCccceee
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR------AQTEREILRML---DHPFLPTLYS 676 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~------~~~EieILk~L---~HPNIVkL~g 676 (992)
+...+|..++++-......|.+... ++..+++|..+.........+.. ..+++..+..+ .-..+..++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3457889999988877777777655 56789999987543222222211 22333333333 3333344333
Q ss_pred eec-----cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 677 QFT-----SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 677 ~f~-----~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
+.+ -....+|+|||++|..|.++.. +++ .+...|..+|.-||..|++|+|+.|.|++++.++ ++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~ 174 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IR 174 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EE
Confidence 332 2234569999999998876532 222 2345577788999999999999999999999655 89
Q ss_pred EEecccc
Q 001952 752 LTDFDLS 758 (992)
Q Consensus 752 LsDFGLA 758 (992)
+.||+..
T Consensus 175 iID~~~k 181 (229)
T PF06176_consen 175 IIDTQGK 181 (229)
T ss_pred EEECccc
Confidence 9999864
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=9e-06 Score=96.77 Aligned_cols=143 Identities=23% Similarity=0.223 Sum_probs=88.8
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh-------------------------------hcchhHHHH-----
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR-------------------------------RKKMPRAQT----- 658 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~-------------------------------~~~~~~~~~----- 658 (992)
..|+.++-|.||+|.+. +|+.||||+.+...... .+....+..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56999999999999995 48999999986431100 000111222
Q ss_pred -HHHHHHHc-----CCCCccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCe
Q 001952 659 -EREILRML-----DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732 (992)
Q Consensus 659 -EieILk~L-----~HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GI 732 (992)
|...+.++ +.++|.--.=|++-.....|+|||++|..+.++..-.. ..++...+.....++ -+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 22222222 13332222223333456689999999999887743221 345533332222222 1233445899
Q ss_pred eeeecCCceEEEccCCcEEEEeccccccc
Q 001952 733 IYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 733 IHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+|.|..|.||++..+|.+.+.|||+..++
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecC
Confidence 99999999999999999999999997554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-05 Score=101.15 Aligned_cols=244 Identities=23% Similarity=0.252 Sum_probs=154.5
Q ss_pred hhHHHHHHHHHHHcCCCCccceeeeeccCCeE----EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Q 001952 653 MPRAQTEREILRMLDHPFLPTLYSQFTSDNLS----CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728 (992)
Q Consensus 653 ~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l----yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH 728 (992)
......|++.+..+.|+|++.++.|....... .+..++|...++...++.- ..++....+.+..+++.||+|+|
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH
Confidence 34445677778888999999999987654333 3556788888888877754 66888999999999999999999
Q ss_pred hcCeeeeecCCc---eEEEccCCcEEEE--eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCC
Q 001952 729 MLGVIYRDLKPE---NILVREDGHIMLT--DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCF 803 (992)
Q Consensus 729 s~GIIHRDIKPe---NILLd~dg~VKLs--DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~ 803 (992)
...+.|.-|... +..++.++.+.++ ||+....+..
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---------------------------------------- 343 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---------------------------------------- 343 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCC----------------------------------------
Confidence 985555544443 3333444444444 5554322110
Q ss_pred CCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCcc--ceeeehhhhhhhhccCCC
Q 001952 804 SPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAA--VDWWTFGIFLYELLYGRT 881 (992)
Q Consensus 804 spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~k--SDIWSLGVlLyELLTGr~ 881 (992)
........-+..|.++|.+....+..+ .|+|.+|.++..+..|..
T Consensus 344 ---------------------------------~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~ 390 (1351)
T KOG1035|consen 344 ---------------------------------NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGED 390 (1351)
T ss_pred ---------------------------------cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCc
Confidence 011112234455778888777666444 699999999999988755
Q ss_pred CCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCC---CC
Q 001952 882 PFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIP---PE 958 (992)
Q Consensus 882 PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~p---p~ 958 (992)
+-.... .....+. ........+++.+|+..++++|+. +.+++.|+|...-.........+ ..
T Consensus 391 i~~~~~---~~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~~~~~~~~~~~~~~~~~~ 455 (1351)
T KOG1035|consen 391 ISEKSA---VPVSLLD--------VLSTSELLDALPKCLDEDSEERLS----ALELLTHPFLRFPTDNESSEFAPNDETS 455 (1351)
T ss_pred cccccc---chhhhhc--------cccchhhhhhhhhhcchhhhhccc----hhhhhhchhcccccccccccccCccccc
Confidence 432211 1111110 011125778999999999999999 99999999987655443322221 12
Q ss_pred CC---CCCCCCCccccccchhhhhhhccccccccCC
Q 001952 959 LP---DFYDYGIQDMVPQKSKYLECKATGEQLEFEL 991 (992)
Q Consensus 959 lp---~~~d~~~~~~~~q~~~~~~~~~~~~~~~~~~ 991 (992)
.| -.++......+.|..+|+. |+||.++
T Consensus 456 ~~~~~~r~~~~~s~~~r~~SRY~~-----DFEEL~l 486 (1351)
T KOG1035|consen 456 VPQFRLRFSGAMSPLQRQFSRYLN-----DFEELEL 486 (1351)
T ss_pred cCccCCCCccccCccccchhhHhh-----hhHHHHH
Confidence 22 1222233334455568888 8777654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.12 E-value=2e-05 Score=84.39 Aligned_cols=134 Identities=13% Similarity=0.122 Sum_probs=83.2
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeeeeccCCeEEEEEEecC
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~f~~~~~lyLVmEy~~ 692 (992)
..||+|..+.||+. . +..+++|+..... ....+.+|.++++.+..-. +.+.+++....+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999984 2 3357889876421 2234678999998886443 4678888877888899999998
Q ss_pred CCC-hHHH------------------HHhhcC---CCCCHHHHH-HHHH----------HHHHH-HHHHhh----cCeee
Q 001952 693 GGD-LHVL------------------RQKQLG---KCFSEPAAR-FYVA----------EVLLA-LEYLHM----LGVIY 734 (992)
Q Consensus 693 GGS-L~~l------------------Lkk~~~---~~Lse~~i~-~Ia~----------QIL~G-L~YLHs----~GIIH 734 (992)
|.. +... +.+-.. ......... .+.. .+... ..+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 1111 010000 011111100 0100 01111 222221 24899
Q ss_pred eecCCceEEEccCCcEEEEecccc
Q 001952 735 RDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 735 RDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+|+.|.||+++.++ +.|+||+.+
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhc
Confidence 99999999999888 999999986
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=6.2e-05 Score=77.23 Aligned_cols=138 Identities=26% Similarity=0.315 Sum_probs=81.2
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC--Cccceeeeec---cCCeEEEEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP--FLPTLYSQFT---SDNLSCLVM 688 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP--NIVkL~g~f~---~~~~lyLVm 688 (992)
++.|+.|..+.||++...+ ..+++|+.... .....+..|..+++.+... -+.+++.+.. .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4679999999999998855 47999998654 2234566788888887533 3567776442 234579999
Q ss_pred EecCCCChHH----------------HHH---hhc--CCCCCHHH---------HHHH------------HHHHHH-HHH
Q 001952 689 EYCPGGDLHV----------------LRQ---KQL--GKCFSEPA---------ARFY------------VAEVLL-ALE 725 (992)
Q Consensus 689 Ey~~GGSL~~----------------lLk---k~~--~~~Lse~~---------i~~I------------a~QIL~-GL~ 725 (992)
++++|..+.. ++. ... ...+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988776 111 110 01111100 0000 111222 333
Q ss_pred HHhh-------cCeeeeecCCceEEEc-cCCcEEEEecccc
Q 001952 726 YLHM-------LGVIYRDLKPENILVR-EDGHIMLTDFDLS 758 (992)
Q Consensus 726 YLHs-------~GIIHRDIKPeNILLd-~dg~VKLsDFGLA 758 (992)
.++. ..+||+|+.|.|||++ .++.+-|+||+.+
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 3332 3599999999999999 6666689999986
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.98 E-value=5.4e-05 Score=82.51 Aligned_cols=135 Identities=23% Similarity=0.228 Sum_probs=86.4
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcc-------------------hh--HHHHHHHHHHHcC--CCCcc
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKK-------------------MP--RAQTEREILRMLD--HPFLP 672 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~-------------------~~--~~~~EieILk~L~--HPNIV 672 (992)
.|+.|--+.||+|.. +++..+|+|+++......+.. .. =..+|..-|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566777778999966 668899999987543322110 00 0123444444442 33334
Q ss_pred ceeeeeccCCeEEEEEEecCCCChH-HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcE
Q 001952 673 TLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHI 750 (992)
Q Consensus 673 kL~g~f~~~~~lyLVmEy~~GGSL~-~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~V 750 (992)
+.+.+. .-.|||||+....+. -.|.. .++.......+..+++..+.-|-. .|+||+||..=|||+. ++.+
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 444432 236999999544211 01111 223333577778888888888876 8999999999999999 8899
Q ss_pred EEEeccccc
Q 001952 751 MLTDFDLSL 759 (992)
Q Consensus 751 KLsDFGLA~ 759 (992)
.|+|||-+.
T Consensus 206 ~iID~~QaV 214 (268)
T COG1718 206 YIIDVSQAV 214 (268)
T ss_pred EEEECcccc
Confidence 999999763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=6.8e-07 Score=106.11 Aligned_cols=242 Identities=16% Similarity=0.147 Sum_probs=157.5
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC-ccceeeeeccCCeEEEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF-LPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN-IVkL~g~f~~~~~lyLVmE 689 (992)
|...+.+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+..+++.+++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 344455789999999998886665544 6666432 23456889999999999 7777777778889999999
Q ss_pred ecCCC-ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 690 YCPGG-DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 690 y~~GG-SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
++.++ +-...+... ...+.+-....+++.-+++|+|||+.-=+|+| |||..+ +..++.||+....+.-
T Consensus 315 i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~----- 383 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR----- 383 (829)
T ss_pred hhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc-----
Confidence 99777 221111100 01233334455666778899999988668998 887765 5678888886422110
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
....+.+.+|+.
T Consensus 384 --------------------------------------------------------------------~~~~~t~~~~~~ 395 (829)
T KOG0576|consen 384 --------------------------------------------------------------------TMKPRTAIGTPE 395 (829)
T ss_pred --------------------------------------------------------------------ccccccCCCCCC
Confidence 001345679999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCc--cch-HHHHHHHHHhccCCcC
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSP--LIS-FQARDLIRGLLIKEPE 925 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~--~vs-~el~dLI~kcL~~DPe 925 (992)
++|||+.....+....|.|++|+--.+|--|-+|-... ...+..+-.+.-.+.... ..+ ..-+++...|+...|.
T Consensus 396 ~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~ 473 (829)
T KOG0576|consen 396 PLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPP 473 (829)
T ss_pred CCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCC
Confidence 99999999999999999999998666666665554320 000000000000000000 000 0112577889999999
Q ss_pred CcCCChHhHHHHHcCCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~l 946 (992)
.|+. ...++.|.+|.+-
T Consensus 474 ~pkv----~mgacfsKvfngC 490 (829)
T KOG0576|consen 474 TPKV----HMGACFSKVFNGC 490 (829)
T ss_pred CCcc----hhhHHHHHHhccC
Confidence 9988 8889999888863
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.9e-05 Score=80.18 Aligned_cols=134 Identities=21% Similarity=0.124 Sum_probs=82.5
Q ss_pred EccCCc-eEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEEEEEecCCC
Q 001952 617 LGCGDI-GTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLVMEYCPGG 694 (992)
Q Consensus 617 LGsG~F-GtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyLVmEy~~GG 694 (992)
|-.|.. ..||++... +..++||+..... ...+.+|+++++.+. +--+.+++++....+..+||||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444554 779998653 3578889876431 234567888888873 444668888777667789999999998
Q ss_pred ChHHHH----------------HhhcC-----CCCCHH--HHHHH-----------------------HHHHHHHHHHH-
Q 001952 695 DLHVLR----------------QKQLG-----KCFSEP--AARFY-----------------------VAEVLLALEYL- 727 (992)
Q Consensus 695 SL~~lL----------------kk~~~-----~~Lse~--~i~~I-----------------------a~QIL~GL~YL- 727 (992)
.|.... ..... .++... ..... +.+++..|...
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 775331 00000 011100 00000 11111111111
Q ss_pred ---hhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 728 ---HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 728 ---Hs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
....++|+|+.|.|||++.++.+.|+||+.+
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 1224999999999999999888899999976
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=4.3e-05 Score=91.20 Aligned_cols=139 Identities=24% Similarity=0.264 Sum_probs=86.7
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh----------------------------hcchhHHHHHHHHH---
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR----------------------------RKKMPRAQTEREIL--- 663 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~----------------------------~~~~~~~~~EieIL--- 663 (992)
+.||.-+.|.||+|+++. |+.||||+-+...... ++....+..|++.+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999976 9999999865321100 00111122222222
Q ss_pred -------HHcCCCC------ccceeeeeccCCeEEEEEEecCCCChHHH--HHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Q 001952 664 -------RMLDHPF------LPTLYSQFTSDNLSCLVMEYCPGGDLHVL--RQKQLGKCFSEPAARFYVAEVLLALEYLH 728 (992)
Q Consensus 664 -------k~L~HPN------IVkL~g~f~~~~~lyLVmEy~~GGSL~~l--Lkk~~~~~Lse~~i~~Ia~QIL~GL~YLH 728 (992)
+.+.|-+ |.++| +.-.....|+||||+|.-+.++ +.+ ..++...+...+.++.. +-|=
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~i~~~l~~~~~--~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDK---RGISPHDILNKLVEAYL--EQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHH---cCCCHHHHHHHHHHHHH--HHHH
Confidence 2233444 33333 2233457899999999877644 333 34555544333333321 2333
Q ss_pred hcCeeeeecCCceEEEcc----CCcEEEEeccccccc
Q 001952 729 MLGVIYRDLKPENILVRE----DGHIMLTDFDLSLRC 761 (992)
Q Consensus 729 s~GIIHRDIKPeNILLd~----dg~VKLsDFGLA~~l 761 (992)
..|++|+|-.|.|||++. ++.+.+.|||+....
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 568999999999999993 668999999997543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.94 E-value=9.1e-05 Score=78.73 Aligned_cols=128 Identities=23% Similarity=0.305 Sum_probs=91.3
Q ss_pred cCceEEEEEccCCc-eEEEEEEEcCCCeEEEEEEechhH----------HHh-h-------cchhHHHHHHHHHHHc---
Q 001952 609 RHFNLLQKLGCGDI-GTVYLAELIGTNCLFAIKVMDNEF----------LAR-R-------KKMPRAQTEREILRML--- 666 (992)
Q Consensus 609 ~~Yeilr~LGsG~F-GtVYlA~~~~tg~~VAIKvIkk~~----------l~~-~-------~~~~~~~~EieILk~L--- 666 (992)
.+++.++.||.|.- |.||+++. .|+.||+|++..-. ... . ....-|..|.....+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999988 56689999943100 000 0 2234577788776666
Q ss_pred CCCCc--cceeeeeccC------------------CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Q 001952 667 DHPFL--PTLYSQFTSD------------------NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726 (992)
Q Consensus 667 ~HPNI--VkL~g~f~~~------------------~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~Y 726 (992)
.+.++ |+++||..=. ....||.||++... .+.. .-+.+|+.-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHH
Confidence 45566 9999987211 12468888886544 1222 234567778889
Q ss_pred HhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 727 LHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999987 3489999853
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0001 Score=92.49 Aligned_cols=81 Identities=21% Similarity=0.338 Sum_probs=57.2
Q ss_pred EEEEEccCCceEEEEEEEcCCC--eEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCc--cceeeeeccC---CeE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTN--CLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFL--PTLYSQFTSD---NLS 684 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg--~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNI--VkL~g~f~~~---~~l 684 (992)
.++.|+.|.+..+|+..+...+ ..+++|+....... .....+.+|..+|+.+. |.+| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998775432 35777876432111 11235778999999995 6665 7878777654 467
Q ss_pred EEEEEecCCCC
Q 001952 685 CLVMEYCPGGD 695 (992)
Q Consensus 685 yLVmEy~~GGS 695 (992)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998865
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00025 Score=75.45 Aligned_cols=72 Identities=10% Similarity=0.105 Sum_probs=45.8
Q ss_pred EEEccCCce-EEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC---CccceeeeeccC---CeEEEE
Q 001952 615 QKLGCGDIG-TVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP---FLPTLYSQFTSD---NLSCLV 687 (992)
Q Consensus 615 r~LGsG~FG-tVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP---NIVkL~g~f~~~---~~lyLV 687 (992)
+.|+.|+.. .||+.. ..+++|+.... .....+.+|.++|..+... -+.++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 467777766 589762 24778876532 1234678899999888532 345555544332 235889
Q ss_pred EEecCCCCh
Q 001952 688 MEYCPGGDL 696 (992)
Q Consensus 688 mEy~~GGSL 696 (992)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999776
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00085 Score=71.11 Aligned_cols=133 Identities=20% Similarity=0.248 Sum_probs=92.3
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHH-------------HhhcchhHHHHHHHHHHHcC------CCCcccee
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-------------ARRKKMPRAQTEREILRMLD------HPFLPTLY 675 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l-------------~~~~~~~~~~~EieILk~L~------HPNIVkL~ 675 (992)
..||+|+.-.||.- ..+...+||++..... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999964 3344578999876540 00112345566776665554 88999999
Q ss_pred eeeccCCeEEEEEEecCC------CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-
Q 001952 676 SQFTSDNLSCLVMEYCPG------GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG- 748 (992)
Q Consensus 676 g~f~~~~~lyLVmEy~~G------GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg- 748 (992)
|+.+++-.+.+|+|.+.+ .+|.+++.. ..++. . +...+-.-.+||-+++|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999998643 357777754 34554 3 233344445688899999999999999997433
Q ss_pred ---cEEEEe-ccc
Q 001952 749 ---HIMLTD-FDL 757 (992)
Q Consensus 749 ---~VKLsD-FGL 757 (992)
.+.|+| ||-
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 467777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0016 Score=68.68 Aligned_cols=75 Identities=21% Similarity=0.380 Sum_probs=49.1
Q ss_pred EEEEccCCceEEEEEEEcC-CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC-CccceeeeeccCCeEEEEEEec
Q 001952 614 LQKLGCGDIGTVYLAELIG-TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP-FLPTLYSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~-tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP-NIVkL~g~f~~~~~lyLVmEy~ 691 (992)
++.|..|-...+|++.... .+..|++|+.... ........+|+.+++.+... -.+++++.+. + .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~----~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK----TELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC----ccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567788888999997643 3567889987532 11112335788888888533 3455555433 2 3899999
Q ss_pred CCCCh
Q 001952 692 PGGDL 696 (992)
Q Consensus 692 ~GGSL 696 (992)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.00055 Score=71.68 Aligned_cols=96 Identities=24% Similarity=0.249 Sum_probs=77.1
Q ss_pred HHHHHHHHHcCC-CCccceeeeeccCCeEEEEEEecCCCChHHH---HHhhcCCCCCHHHHHHHHHHHHHHHHHHhh---
Q 001952 657 QTEREILRMLDH-PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVL---RQKQLGKCFSEPAARFYVAEVLLALEYLHM--- 729 (992)
Q Consensus 657 ~~EieILk~L~H-PNIVkL~g~f~~~~~lyLVmEy~~GGSL~~l---Lkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs--- 729 (992)
..|.-+|+.+.+ +++++++|+|- .++|.||+..+++... +... ...+|..+.+|+.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 347778888865 69999999982 3679999977765421 1111 235899999999999999999987
Q ss_pred cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 730 ~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
..+.-.|++++||-++.+|.+|+.|.+.+
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhc
Confidence 34888999999999999999999999975
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00082 Score=70.37 Aligned_cols=129 Identities=25% Similarity=0.298 Sum_probs=90.4
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeeccCCeEEEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~~~~lyLVmE 689 (992)
.+..+.||+|.+|.||+|.+. |..+|+|+-+.+ .....+..|.++|..+.-.++ .++|.|..+ ++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 345677999999999999995 447999987643 445678889999999876665 466655443 35599
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecC-CceEEEccCCcEEEEeccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLK-PENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIK-PeNILLd~dg~VKLsDFGLA~ 759 (992)
|+.|-.|.++-.. .+... +..++..---|-..||-|..|. |..++|..++.+.|+||.-|.
T Consensus 93 ~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 93 YIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9998888766432 12222 2334444334556799999885 555666666699999999874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0032 Score=70.22 Aligned_cols=79 Identities=16% Similarity=0.090 Sum_probs=56.3
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC---CCccceeeeecc---CCeE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH---PFLPTLYSQFTS---DNLS 684 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H---PNIVkL~g~f~~---~~~l 684 (992)
..-.+.||.|..+.||+....+ + .+++|..+. ......+..|.+.|+.+.- -.+.++++++.. .+..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~-----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARS-----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecc-----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 3445679999999999986533 3 477787532 1122467889999998853 357888887754 4668
Q ss_pred EEEEEecCCCCh
Q 001952 685 CLVMEYCPGGDL 696 (992)
Q Consensus 685 yLVmEy~~GGSL 696 (992)
+||||+++|.++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0032 Score=69.83 Aligned_cols=143 Identities=18% Similarity=0.180 Sum_probs=82.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeeee------cc
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQF------TS 680 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~f------~~ 680 (992)
+....++.|+.|....+|++.. .++ .+++|+.... .....+..|++++..|.... +.+++... ..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~-----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKR-----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-CCC-cEEEEEecCC-----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 3445567788888889999865 333 5788987532 11233455677777763222 34444321 22
Q ss_pred CCeEEEEEEecCCCChH-----H------H---HHhh-cC--CC------CC-HHHH--H----------HHHHHHHHHH
Q 001952 681 DNLSCLVMEYCPGGDLH-----V------L---RQKQ-LG--KC------FS-EPAA--R----------FYVAEVLLAL 724 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~-----~------l---Lkk~-~~--~~------Ls-e~~i--~----------~Ia~QIL~GL 724 (992)
.+..+++|+|++|..+. . . ++.. .+ .. +. |... . .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999885431 0 0 1110 00 00 00 0000 0 0011233445
Q ss_pred HHHhh-------cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 725 EYLHM-------LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 725 ~YLHs-------~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+++.. .++||+|+.+.||+++.++.+.|+||+.+
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 55542 57999999999999998887789999986
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.002 Score=70.46 Aligned_cols=139 Identities=15% Similarity=0.112 Sum_probs=82.3
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeee------eccCCe
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQ------FTSDNL 683 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~------f~~~~~ 683 (992)
.-++.|..|....+|+.... +..+++|+.... ....+..|+.++..+.+.+ +.+++.. ....+.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTD--SGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEeC--CCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 33567888888899998653 336889987631 1234556777777774332 4454432 123456
Q ss_pred EEEEEEecCCCChHH--------H------HHhhc-C--CC------CCHHHH--H--------HHHHHHHHHHHHHhh-
Q 001952 684 SCLVMEYCPGGDLHV--------L------RQKQL-G--KC------FSEPAA--R--------FYVAEVLLALEYLHM- 729 (992)
Q Consensus 684 lyLVmEy~~GGSL~~--------l------Lkk~~-~--~~------Lse~~i--~--------~Ia~QIL~GL~YLHs- 729 (992)
.++||+|++|..+.. + ++... + .. ..+... . .....+...+.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999876521 0 01100 0 00 011000 0 011112334444443
Q ss_pred ------cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 730 ------LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 730 ------~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.++||+|+.|.|||++.++.+.|.||+.+
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 36999999999999998877899999986
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.003 Score=69.45 Aligned_cols=76 Identities=20% Similarity=0.281 Sum_probs=49.4
Q ss_pred EEEEccCCceEEEEEEEcC------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC-ccceeeeeccCCeEEE
Q 001952 614 LQKLGCGDIGTVYLAELIG------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF-LPTLYSQFTSDNLSCL 686 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN-IVkL~g~f~~~~~lyL 686 (992)
++.|..|-...+|++.... .++.|++|+..... .......+|.+++..+.... ..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777899987643 25789999976431 22234567888888885333 4466665542 36
Q ss_pred EEEecCCCChH
Q 001952 687 VMEYCPGGDLH 697 (992)
Q Consensus 687 VmEy~~GGSL~ 697 (992)
||||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0068 Score=65.31 Aligned_cols=132 Identities=20% Similarity=0.216 Sum_probs=76.1
Q ss_pred EccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeeccCCeEEEEEEecCCCC
Q 001952 617 LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTSDNLSCLVMEYCPGGD 695 (992)
Q Consensus 617 LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~~~~lyLVmEy~~GGS 695 (992)
+..|-...+|+... ++..+++|+..... ........+|..+|+.+....+ .+++.... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 45677888998864 45678889765321 1110134678889988864433 45554432 268999999876
Q ss_pred hHH--------------HHHhhc-----CCCCCHH-HHHHHHHHH---------HHHHHHHhh--------cCeeeeecC
Q 001952 696 LHV--------------LRQKQL-----GKCFSEP-AARFYVAEV---------LLALEYLHM--------LGVIYRDLK 738 (992)
Q Consensus 696 L~~--------------lLkk~~-----~~~Lse~-~i~~Ia~QI---------L~GL~YLHs--------~GIIHRDIK 738 (992)
+.. .+.+.. +.+++.. .+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 531 111111 1112211 111221111 111222211 248999999
Q ss_pred CceEEEccCCcEEEEecccc
Q 001952 739 PENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 739 PeNILLd~dg~VKLsDFGLA 758 (992)
|.|||++.++ +.|+||+.+
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a 173 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYA 173 (256)
T ss_pred cCcEEEeCCC-CEEEecccc
Confidence 9999999877 789999986
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.015 Score=67.82 Aligned_cols=80 Identities=19% Similarity=0.245 Sum_probs=55.0
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHH---H-hhcchhHHHHHHHHHHHcC---CCCccceeeeeccCCeEEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL---A-RRKKMPRAQTEREILRMLD---HPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l---~-~~~~~~~~~~EieILk~L~---HPNIVkL~g~f~~~~~lyL 686 (992)
.+.||.|.+..||++.+.+.++.|+||.-..... . ......+...|.+.|+.+. -.++++++.+ +.+..+|
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999865446899998531100 0 0123456677888888763 3457778776 3455789
Q ss_pred EEEecCCCC
Q 001952 687 VMEYCPGGD 695 (992)
Q Consensus 687 VmEy~~GGS 695 (992)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0001 Score=94.47 Aligned_cols=256 Identities=13% Similarity=0.022 Sum_probs=157.3
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCe-EEEEEEechhHHHh--hcchhHHHHHHHHHHHcCCCCccceeeeec--cCCe
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNC-LFAIKVMDNEFLAR--RKKMPRAQTEREILRMLDHPFLPTLYSQFT--SDNL 683 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~-~VAIKvIkk~~l~~--~~~~~~~~~EieILk~L~HPNIVkL~g~f~--~~~~ 683 (992)
..+++.--+|-|.+ +++++.+... .+.+|+.+.-.+.. +...+....|.+.++...|+++...+.-.. +...
T Consensus 1229 e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1229 EHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 34555544544443 4454433221 35666665332221 111233445555666778998887776554 3456
Q ss_pred EEEEEEecCCCChHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhhc---C--eeeeecCCceEEEccCCcEEEEecc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLG--KCFSEPAARFYVAEVLLALEYLHML---G--VIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~--~~Lse~~i~~Ia~QIL~GL~YLHs~---G--IIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
.|.+++|+.+|.+...+-+... ..++..-+.....+.+....-+|.. | .+|++||+-|.+|..+..++++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 7899999999999988765432 2344444544445557777777754 2 8999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
+.+.... .
T Consensus 1386 LdKIknp------------------------------------------------------------------------~ 1393 (2724)
T KOG1826|consen 1386 LDKIKNP------------------------------------------------------------------------V 1393 (2724)
T ss_pred cccccCc------------------------------------------------------------------------h
Confidence 9641100 0
Q ss_pred CCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
.......++++.|+.|++...-.++.++|+|.+|+.+|++--|..+|... -...+..++.....+.-+-..+.++-.+.
T Consensus 1394 ~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~f-lq~~Lkgiidn~tf~sIe~l~pgdaNve~ 1472 (2724)
T KOG1826|consen 1394 LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFF-LQPALKGIIDNHTFFSIEKLKPGDANVEA 1472 (2724)
T ss_pred HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHH-HHHHHcCcccccccccccccCCCcccHHH
Confidence 01122346788899999999888988899999999999999888877421 11111122222222211112234444555
Q ss_pred HHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
..+|-+.-..||. -...+.-+.|.
T Consensus 1473 ~~~Ll~K~~~rp~----q~isls~d~~a 1496 (2724)
T KOG1826|consen 1473 LHRLLWKYMERPG----QYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHhhhcch----hhhhccccccc
Confidence 5566666678888 66666655554
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.011 Score=65.52 Aligned_cols=137 Identities=12% Similarity=0.119 Sum_probs=74.2
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeee------eccCCeEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQ------FTSDNLSC 685 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~------f~~~~~ly 685 (992)
++.|+.|....+|+.... +| .+++|++... ....+..|+.++..|...+ +.+.+.. ....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~------~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFERL------TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEeccC------ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 456777888899998763 33 5889987511 1122334555555553212 3343321 22355678
Q ss_pred EEEEecCCCChH-----------HHHH---hhc-C--------CCCCH-HHHH------------HHHHH-HHHHHHHHh
Q 001952 686 LVMEYCPGGDLH-----------VLRQ---KQL-G--------KCFSE-PAAR------------FYVAE-VLLALEYLH 728 (992)
Q Consensus 686 LVmEy~~GGSL~-----------~lLk---k~~-~--------~~Lse-~~i~------------~Ia~Q-IL~GL~YLH 728 (992)
++|+|++|..+. ..+- ... + ..+.+ .... ..+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999887431 1111 000 0 00111 0100 01111 111222332
Q ss_pred -------hcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 729 -------MLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 729 -------s~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
..|+||+|+.|.|||++.+...-|+||+.+
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 237999999999999997666689999986
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0021 Score=72.71 Aligned_cols=134 Identities=22% Similarity=0.312 Sum_probs=91.7
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH------------Hhhc-------chhHHHHHHHHHHHcC-CCC
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL------------ARRK-------KMPRAQTEREILRMLD-HPF 670 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l------------~~~~-------~~~~~~~EieILk~L~-HPN 670 (992)
+.+.+.||-|.-+.||.+-+ +.|...++|+-+.... ..+. ..-...+|...|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56778899999999999977 4577888886432111 0000 0113456777788773 333
Q ss_pred -ccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc
Q 001952 671 -LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH 749 (992)
Q Consensus 671 -IVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~ 749 (992)
+.+.++ .+..|+|||++.|-.|....+- .+ ...+...+..-+--|..+|+||+|+.-=||++++++.
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~ 240 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV-----ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK 240 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec-----CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC
Confidence 334444 3456899999998888655322 12 2234444555566788999999999999999999999
Q ss_pred EEEEeccc
Q 001952 750 IMLTDFDL 757 (992)
Q Consensus 750 VKLsDFGL 757 (992)
++++||--
T Consensus 241 i~vIDFPQ 248 (465)
T KOG2268|consen 241 IVVIDFPQ 248 (465)
T ss_pred EEEeechH
Confidence 99999964
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.039 Score=62.49 Aligned_cols=140 Identities=11% Similarity=0.196 Sum_probs=80.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeeccCCeEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTSDNLSC 685 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~~~~ly 685 (992)
.+++ +.|..|=...+|++...+. +..|++|+..... ...-...+|..+++.+..-++ +++++++..+
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G---- 86 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DYVIDRERELQAIKYLSAAGFGAKLLGVFGNG---- 86 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc----CeEechHHHHHHHHHHHhcCCCCceeEEeCCc----
Confidence 3444 3454477788999876442 3378899875431 122233678889888865554 5677666322
Q ss_pred EEEEecCCCChHH--------------HHHhhcCCC------C-CHHHHHHHHHHH------------------------
Q 001952 686 LVMEYCPGGDLHV--------------LRQKQLGKC------F-SEPAARFYVAEV------------------------ 720 (992)
Q Consensus 686 LVmEy~~GGSL~~--------------lLkk~~~~~------L-se~~i~~Ia~QI------------------------ 720 (992)
+|.+|++|..|.. .+.+..... + .+..+..+..++
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899998876521 111111111 1 122232332221
Q ss_pred -HHHHHHHh-hc----CeeeeecCCceEEEcc-CCcEEEEecccc
Q 001952 721 -LLALEYLH-ML----GVIYRDLKPENILVRE-DGHIMLTDFDLS 758 (992)
Q Consensus 721 -L~GL~YLH-s~----GIIHRDIKPeNILLd~-dg~VKLsDFGLA 758 (992)
+..+..+. .. -++|.|+-+.|||++. ++.++|+||..|
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 11111111 11 2899999999999974 578999999986
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.045 Score=62.41 Aligned_cols=138 Identities=14% Similarity=0.173 Sum_probs=81.8
Q ss_pred EEEEEccCCceEEEEEEEcC----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeeccCCeEEEE
Q 001952 613 LLQKLGCGDIGTVYLAELIG----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTSDNLSCLV 687 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~~~~lyLV 687 (992)
-+..|-.|-.-.+|++.... .++.|++|+..... ..... ...|..+++.+..-++ .++++.+..+ .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 34456558888999987533 24679999886531 22222 3678889888854444 4666666433 58
Q ss_pred EEecCCCChHHH--------------HHhhcC-----C--CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 001952 688 MEYCPGGDLHVL--------------RQKQLG-----K--CFSEPAARFYVAEV-----------------LLALEYL-- 727 (992)
Q Consensus 688 mEy~~GGSL~~l--------------Lkk~~~-----~--~Lse~~i~~Ia~QI-----------------L~GL~YL-- 727 (992)
++|+++.+|... +.+... . ...+..+..+..++ ...+..|
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 999988776311 111100 0 11122333332221 1111111
Q ss_pred --h----hcCeeeeecCCceEEEcc-CCcEEEEecccc
Q 001952 728 --H----MLGVIYRDLKPENILVRE-DGHIMLTDFDLS 758 (992)
Q Consensus 728 --H----s~GIIHRDIKPeNILLd~-dg~VKLsDFGLA 758 (992)
. ...++|+|+++.|||++. ++.+.|+||..+
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 1 225999999999999986 468999999987
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.039 Score=61.05 Aligned_cols=28 Identities=32% Similarity=0.498 Sum_probs=24.2
Q ss_pred CeeeeecCCceEEEccCCc-EEEEecccc
Q 001952 731 GVIYRDLKPENILVREDGH-IMLTDFDLS 758 (992)
Q Consensus 731 GIIHRDIKPeNILLd~dg~-VKLsDFGLA 758 (992)
.+||+|+.|.|||++.++. .-|.||+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a 214 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEA 214 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence 4899999999999997454 579999986
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.082 Score=61.16 Aligned_cols=77 Identities=17% Similarity=0.185 Sum_probs=50.3
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHH----HhhcchhHHHHHHHHHHHcC--CC-CccceeeeeccCCeEEEEE
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL----ARRKKMPRAQTEREILRMLD--HP-FLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l----~~~~~~~~~~~EieILk~L~--HP-NIVkL~g~f~~~~~lyLVm 688 (992)
.||.|....||++...+.++.|+||.-..-.- ...-...+...|.+.|+... -| .++++|. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 47999999999999854446899997542211 11334456677888887763 34 4555553 3455567999
Q ss_pred EecCCC
Q 001952 689 EYCPGG 694 (992)
Q Consensus 689 Ey~~GG 694 (992)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.13 Score=56.41 Aligned_cols=28 Identities=29% Similarity=0.533 Sum_probs=24.9
Q ss_pred cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 730 ~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.++||+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47999999999999987 67899999975
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.31 E-value=0.072 Score=61.60 Aligned_cols=138 Identities=22% Similarity=0.280 Sum_probs=85.3
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH---------------------hhcchhHH--HHHHHHHHHcCCCC
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA---------------------RRKKMPRA--QTEREILRMLDHPF 670 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~---------------------~~~~~~~~--~~EieILk~L~HPN 670 (992)
-..|..|--+-||.|.- .+|..+|||+++-..+. ....+-.. ..|+.-|++|..-.
T Consensus 149 nGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34577788888999865 56777999987532110 00111122 34455566664433
Q ss_pred ccceeeeeccCCeEEEEEEecCCCChHH-HHHhhcCCCCCHHHHHHHHHHHHHHHHHH-hhcCeeeeecCCceEEEccCC
Q 001952 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLALEYL-HMLGVIYRDLKPENILVREDG 748 (992)
Q Consensus 671 IVkL~g~f~~~~~lyLVmEy~~GGSL~~-lLkk~~~~~Lse~~i~~Ia~QIL~GL~YL-Hs~GIIHRDIKPeNILLd~dg 748 (992)
|.- -.-..- ....|||+|+.+..... .|+ ...++...+..+-.|++.-+.-| |.+++||.||.-=|+|+. +|
T Consensus 228 IP~-PePIlL-k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 228 IPC-PEPILL-KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCC-CCceee-ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence 221 111111 12369999994333211 122 24566667777777877777766 467999999999999985 67
Q ss_pred cEEEEecccc
Q 001952 749 HIMLTDFDLS 758 (992)
Q Consensus 749 ~VKLsDFGLA 758 (992)
.+.|+|.+-+
T Consensus 302 ~lyiIDVSQS 311 (520)
T KOG2270|consen 302 KLYIIDVSQS 311 (520)
T ss_pred EEEEEEcccc
Confidence 8999999865
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.22 Score=55.78 Aligned_cols=76 Identities=20% Similarity=0.242 Sum_probs=48.8
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC---CCCccceeeeeccCCeEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD---HPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~---HPNIVkL~g~f~~~~~lyLV 687 (992)
.+-.+.|+.|....+|+.. .++..+.||+-.. .....+..|.+-|+.|. --.+++++++....+.-|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3445679999999999876 5677899998752 23456788888888883 44577999988777777999
Q ss_pred EEecCCC
Q 001952 688 MEYCPGG 694 (992)
Q Consensus 688 mEy~~GG 694 (992)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.032 Score=66.55 Aligned_cols=80 Identities=20% Similarity=0.203 Sum_probs=59.8
Q ss_pred ccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC-----------ccchHHHHHHHHHhccCCcCCcCCC
Q 001952 862 AAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS-----------PLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 862 ~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~-----------~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
+++|||++|.++.|+..|...+......+.+..+..-. ..+.. ..++..+.+++.+|+-..|..||.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~-~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l- 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYY-TDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL- 187 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhc-cCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc-
Confidence 38999999999999999999887665555554443211 11111 124556778999999999999998
Q ss_pred hHhHHHHHcCCCCCCC
Q 001952 931 QKGAAEIKQHPFFEGL 946 (992)
Q Consensus 931 ~~~aeEILkHPfF~~l 946 (992)
..++++|+-|.+.
T Consensus 188 ---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 ---PMELSKRCSFTEV 200 (725)
T ss_pred ---hhHHhcCccHHHH
Confidence 8899999988775
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.12 Score=60.07 Aligned_cols=81 Identities=17% Similarity=0.282 Sum_probs=49.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCC-e-----EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeecc
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTN-C-----LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTS 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg-~-----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~ 680 (992)
.+++.+. .|..|-...+|++...... . .|.+++... .....-...+|+++++.+...++ .++++.+..
T Consensus 50 ~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~ 124 (383)
T PTZ00384 50 PEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD 124 (383)
T ss_pred cccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC
Confidence 3344444 5555888999999764332 1 244444321 11222233678999999865544 567776643
Q ss_pred CCeEEEEEEecCCCChH
Q 001952 681 DNLSCLVMEYCPGGDLH 697 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~ 697 (992)
++|+||++|..|.
T Consensus 125 ----g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 ----FTIQEWVEGNTMG 137 (383)
T ss_pred ----EEEEEEeccccCC
Confidence 5999999998763
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.32 Score=54.26 Aligned_cols=28 Identities=14% Similarity=0.175 Sum_probs=26.5
Q ss_pred CeeeeecCCceEEEccCCcEEEEecccc
Q 001952 731 GVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 731 GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
++||+|+.+.|||++.++.+.|+||..+
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 6999999999999999999999999986
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.61 E-value=0.36 Score=56.80 Aligned_cols=77 Identities=21% Similarity=0.232 Sum_probs=52.8
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH----HhhcchhHHHHHHHHHHHcC---CCCccceeeeeccCCeEE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL----ARRKKMPRAQTEREILRMLD---HPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l----~~~~~~~~~~~EieILk~L~---HPNIVkL~g~f~~~~~ly 685 (992)
..+.||.|....||+.... +..|+||.-..... .......+...|.+.|+.+. -.++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999998873 34688997642111 01124555666777777664 247888988776 4467
Q ss_pred EEEEecCC
Q 001952 686 LVMEYCPG 693 (992)
Q Consensus 686 LVmEy~~G 693 (992)
|+|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999976
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.19 Score=58.93 Aligned_cols=78 Identities=19% Similarity=0.324 Sum_probs=52.0
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHH---HhhcchhHHHHHHHHHHHcC--CC-CccceeeeeccCCeEEEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL---ARRKKMPRAQTEREILRMLD--HP-FLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l---~~~~~~~~~~~EieILk~L~--HP-NIVkL~g~f~~~~~lyLV 687 (992)
++.||.|.-.-||++.+...++.|+||.-..-.- ...-...+...|.++|+... -| +++++|. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 6789999999999998843356799986432111 12334567778888888763 34 4556654 345556789
Q ss_pred EEecCC
Q 001952 688 MEYCPG 693 (992)
Q Consensus 688 mEy~~G 693 (992)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.21 Score=52.43 Aligned_cols=29 Identities=38% Similarity=0.626 Sum_probs=21.0
Q ss_pred CeeeeecCCceEEE-ccCCcEEEEeccccc
Q 001952 731 GVIYRDLKPENILV-REDGHIMLTDFDLSL 759 (992)
Q Consensus 731 GIIHRDIKPeNILL-d~dg~VKLsDFGLA~ 759 (992)
.++|+||.+.|||+ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 59999999999999 888999999999873
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.92 E-value=0.35 Score=55.16 Aligned_cols=146 Identities=11% Similarity=0.138 Sum_probs=80.4
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeeeeccCC--eEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQFTSDN--LSC 685 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~f~~~~--~ly 685 (992)
...+++.+..|---.+|..... ++.++++ ... ............+|..+|+.+.--. +...+++|.++. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 4445555533433345554442 6778888 321 1112233445567888888774323 344555555554 569
Q ss_pred EEEEecCCCCh---------H-HHHH--------hhc----------CC--CCCHHHHHHHHH--------------HHH
Q 001952 686 LVMEYCPGGDL---------H-VLRQ--------KQL----------GK--CFSEPAARFYVA--------------EVL 721 (992)
Q Consensus 686 LVmEy~~GGSL---------~-~lLk--------k~~----------~~--~Lse~~i~~Ia~--------------QIL 721 (992)
.||+|++|..+ . .+.. ... +. .+....+..+.. .+.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99999988322 1 1111 100 00 000011111111 122
Q ss_pred HHHHHHhhc--------CeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 722 LALEYLHML--------GVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 722 ~GL~YLHs~--------GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
.-..||+.+ .++|+|+.+.||+++.++-+-|.||+++.
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 334555543 39999999999999998889999999873
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.74 E-value=0.5 Score=56.05 Aligned_cols=79 Identities=13% Similarity=0.229 Sum_probs=50.4
Q ss_pred cCceEEEEEccCCceEEEEEEEcCC--------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeec
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGT--------NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFT 679 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~t--------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~ 679 (992)
++. -++.|..|=.-.+|++..... ++.|.+|+.-.. ...+-....|..+++.+..-+| .++++.+.
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~----te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~ 180 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKD----VDELYNPISEFEVYKTMSKYRIAPQLLNTFS 180 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCC----ccceeCHHHHHHHHHHHHHCCCCCceEEEeC
Confidence 344 456676777888999876422 467999987543 1122233568888888754444 36666553
Q ss_pred cCCeEEEEEEecCCCCh
Q 001952 680 SDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL 696 (992)
-+.|.||++|..|
T Consensus 181 ----gg~I~efi~g~~l 193 (442)
T PTZ00296 181 ----GGRIEEWLYGDPL 193 (442)
T ss_pred ----CCEEEEeeCCccC
Confidence 2468999988754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.22 E-value=0.19 Score=58.14 Aligned_cols=86 Identities=23% Similarity=0.267 Sum_probs=60.7
Q ss_pred CCCCccceeeee-ccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEE
Q 001952 667 DHPFLPTLYSQF-TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILV 744 (992)
Q Consensus 667 ~HPNIVkL~g~f-~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILL 744 (992)
..++..+++-+- .+..+.|++|++- |+.|... ....++++..++++.+.-|+-+... .+=|||+.-.||||
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 344444444333 3345678899987 7776433 1235677888888877666655543 68999999999999
Q ss_pred ccCCcEEEEecccccc
Q 001952 745 REDGHIMLTDFDLSLR 760 (992)
Q Consensus 745 d~dg~VKLsDFGLA~~ 760 (992)
+ +|++.|+||-+++.
T Consensus 356 d-~GnvtLIDfklsRl 370 (488)
T COG5072 356 D-EGNVTLIDFKLSRL 370 (488)
T ss_pred e-cCceEEEEeeeeec
Confidence 9 99999999999853
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=92.87 E-value=0.74 Score=57.09 Aligned_cols=86 Identities=15% Similarity=0.208 Sum_probs=64.9
Q ss_pred CCCccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC
Q 001952 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747 (992)
Q Consensus 668 HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d 747 (992)
+.||.++|++|...+.-++++|+.. .+-.+...-.....+.-..+.|+.||+.=-.-|...|+.--=|.++|+-|+.+
T Consensus 179 ~~~iP~v~~~~~~~~~~i~Lle~~~--~~~~l~~~w~~~~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv~~~ 256 (645)
T PRK14559 179 PTEIPKIHDAWQDGDLQVILLEDRS--HWQPLLDLWQDQTLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRVDED 256 (645)
T ss_pred cccCcchheeecCCCCcEEEeCCCC--CCchHHHHhhhcCCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheeeCCC
Confidence 4559999999998887888999863 34444333222335667888999999999999999999999999999999876
Q ss_pred CcEEEEec
Q 001952 748 GHIMLTDF 755 (992)
Q Consensus 748 g~VKLsDF 755 (992)
..+.|-.|
T Consensus 257 ~~~~l~~l 264 (645)
T PRK14559 257 QTLGLQQL 264 (645)
T ss_pred ceehHhhh
Confidence 65544433
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.73 E-value=1.8 Score=49.10 Aligned_cols=74 Identities=11% Similarity=-0.033 Sum_probs=43.0
Q ss_pred EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--cccee---e--eeccCCeEEEEE
Q 001952 616 KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLY---S--QFTSDNLSCLVM 688 (992)
Q Consensus 616 ~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~---g--~f~~~~~lyLVm 688 (992)
.|+ +.-..||+... .++..+++|+.+... .....+..|++++..|.... ++... | +...++..+.|+
T Consensus 33 ~l~-s~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~ 106 (325)
T PRK11768 33 ALN-SYENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALF 106 (325)
T ss_pred eec-cccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEE
Confidence 343 44567999865 345579999876321 12344566777776663211 22212 1 122356778899
Q ss_pred EecCCCC
Q 001952 689 EYCPGGD 695 (992)
Q Consensus 689 Ey~~GGS 695 (992)
++++|..
T Consensus 107 ~~~~G~~ 113 (325)
T PRK11768 107 PRRGGRA 113 (325)
T ss_pred eeeCCCC
Confidence 9998764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.54 E-value=0.88 Score=59.30 Aligned_cols=32 Identities=38% Similarity=0.442 Sum_probs=26.2
Q ss_pred cCeeeeecCCceEEEccCC--cEE-EEeccccccc
Q 001952 730 LGVIYRDLKPENILVREDG--HIM-LTDFDLSLRC 761 (992)
Q Consensus 730 ~GIIHRDIKPeNILLd~dg--~VK-LsDFGLA~~l 761 (992)
.++||+|+.+.|||++.++ .+. |+|||.+..-
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~~ 237 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVHA 237 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccccc
Confidence 4799999999999999775 454 9999987443
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=91.85 E-value=0.77 Score=50.58 Aligned_cols=76 Identities=25% Similarity=0.354 Sum_probs=52.4
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc---CCCCccceeeeeccCCeEEEEEEe
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L---~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
.+.+.-|..-..|...+ ....|.+|+=. +.....|..|+.-|..+ +--.+.+++.+....++.||||||
T Consensus 21 r~~v~gG~inea~~v~d--g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~ 92 (286)
T COG3001 21 REEVSGGDINEAWRLRD--GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEY 92 (286)
T ss_pred ccccCCccccceeEeec--CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEee
Confidence 34455555555665544 33468889754 33445677777766666 345678899999999999999999
Q ss_pred cCCCChH
Q 001952 691 CPGGDLH 697 (992)
Q Consensus 691 ~~GGSL~ 697 (992)
++-+.+.
T Consensus 93 L~~~~~d 99 (286)
T COG3001 93 LPTGPLD 99 (286)
T ss_pred ccCCCCC
Confidence 9886663
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=91.82 E-value=1 Score=49.50 Aligned_cols=74 Identities=19% Similarity=0.150 Sum_probs=45.6
Q ss_pred ccCCceEEEEEEEcC----C----CeEEEEEEechhHHHh--hcchhHHHHHHHHHHHcC-------------CCCccce
Q 001952 618 GCGDIGTVYLAELIG----T----NCLFAIKVMDNEFLAR--RKKMPRAQTEREILRMLD-------------HPFLPTL 674 (992)
Q Consensus 618 GsG~FGtVYlA~~~~----t----g~~VAIKvIkk~~l~~--~~~~~~~~~EieILk~L~-------------HPNIVkL 674 (992)
|.|-.|.+|++.... + ...++||......... -.....+.+|+.+.+.+- ...+.++
T Consensus 2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~ 81 (294)
T PF02958_consen 2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC 81 (294)
T ss_pred CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence 677788888886643 2 2468999886222111 123456778888766541 1345666
Q ss_pred eeeeccCCeEEEEEEec
Q 001952 675 YSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 675 ~g~f~~~~~lyLVmEy~ 691 (992)
+....+....+||||-+
T Consensus 82 ~~~~~~~~~~~lvlEDL 98 (294)
T PF02958_consen 82 YYADEDPGDEVLVLEDL 98 (294)
T ss_pred EEeccCCCceeeehhhh
Confidence 66655555678999876
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 992 | ||||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-35 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-35 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-28 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-15 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-28 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-28 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-22 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-22 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-28 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-28 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-15 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-28 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-28 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-15 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-28 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-15 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-28 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-28 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-15 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-15 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-15 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-15 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-21 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-15 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-15 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-15 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-27 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-19 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-15 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-22 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-15 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-15 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-15 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-18 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-15 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-27 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-15 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-26 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-19 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-26 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-26 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-15 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-26 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-26 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-26 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-26 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-26 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-26 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-26 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-26 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-20 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-26 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-19 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-26 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-26 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-15 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-26 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-26 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-26 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-26 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-26 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-26 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-26 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-26 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-26 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-26 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-26 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-26 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-26 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-26 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-26 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-26 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-26 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-19 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-25 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-25 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-25 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-25 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-25 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-25 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-25 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-20 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-20 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-25 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-19 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-20 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-25 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-20 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-20 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-21 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-21 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-23 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-16 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-22 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-21 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-20 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-20 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-20 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-19 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-18 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-18 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-18 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-18 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-16 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-16 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-04 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-13 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-12 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 8e-05 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-04 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-04 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 9e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-04 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-04 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 6e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 8e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 9e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 3e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-04 |
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 992 | |||
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-63 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-59 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 7e-47 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-58 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 9e-43 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 2e-55 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-45 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-55 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-43 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 5e-55 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-44 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-54 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 3e-47 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 4e-54 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-39 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-54 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-41 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-54 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-46 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-53 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-41 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-53 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 4e-42 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-53 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-46 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-53 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-42 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-53 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-40 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-53 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-44 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 8e-53 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 7e-44 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 5e-52 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-42 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-51 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-41 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-51 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-42 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-49 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-40 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-48 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-48 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 7e-41 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-47 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 8e-40 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 7e-47 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 5e-46 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-30 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-45 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-32 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-45 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-42 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-41 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-40 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-22 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-38 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-28 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-37 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-14 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 7e-37 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-25 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-36 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-19 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-36 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 5e-23 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-36 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-12 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-36 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-15 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-35 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-20 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-35 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-22 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 4e-14 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 5e-35 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-19 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-34 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-18 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-34 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 2e-17 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 7e-34 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 1e-19 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-34 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-19 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-34 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-33 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-18 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-33 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 2e-20 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-33 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-21 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-33 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-20 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-33 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-22 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-33 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 8e-18 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-33 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 6e-21 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 6e-33 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-22 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-32 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-21 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 1e-32 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-19 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-32 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-22 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 3e-32 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-20 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-32 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-20 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 7e-32 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 1e-22 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 7e-32 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 8e-20 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 7e-32 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 9e-22 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-32 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-21 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 9e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-12 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 9e-32 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-18 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-31 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-21 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-31 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-20 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-31 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-20 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-31 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-19 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-31 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-31 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 4e-20 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-31 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-16 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-31 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-17 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 6e-31 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-20 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 8e-31 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-15 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-30 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-19 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 3e-30 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 8e-21 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-30 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-20 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 5e-30 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-17 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-30 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-21 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 9e-30 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 8e-05 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-29 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 1e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-29 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-17 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-29 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-07 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-29 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-15 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 3e-29 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-29 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-19 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-29 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 6e-08 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-29 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-16 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-28 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-19 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-28 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-14 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-28 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-05 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-28 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-09 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 4e-28 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-12 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-28 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 4e-15 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 5e-28 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-09 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 6e-28 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-16 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 6e-28 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 8e-17 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-27 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 7e-07 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-27 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-09 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 3e-27 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-08 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-27 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-22 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 9e-27 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 5e-09 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-26 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-16 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-26 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-16 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-10 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-26 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-13 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-25 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-11 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-17 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-11 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-24 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 4e-22 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-24 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 4e-10 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 5e-10 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-23 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 5e-23 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-09 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-23 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-10 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-22 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 9e-22 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-10 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-21 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 8e-10 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-17 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 8e-06 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 8e-21 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-09 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 9e-21 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-10 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-20 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 9e-07 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-20 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-04 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-06 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-20 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-20 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-04 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-20 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 3e-10 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-20 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-06 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 6e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 6e-07 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-20 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-10 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-19 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-06 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 1e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 7e-08 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 3e-19 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-06 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-19 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 9e-08 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 4e-19 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 9e-04 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 5e-19 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-05 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-05 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 8e-19 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-05 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-06 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-19 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-06 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-18 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-10 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-18 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-06 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-18 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-06 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-18 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-06 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 4e-18 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-07 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-18 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 6e-18 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 7e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 5e-07 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 8e-18 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-06 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 1e-17 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 8e-08 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-17 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-06 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-17 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 3e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-17 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-06 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-17 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-06 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-16 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-07 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-16 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 1e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-16 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-04 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 9e-16 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-15 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-15 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-15 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 6e-15 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 4e-06 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 9e-15 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-14 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-14 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-06 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 2e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-08 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 2e-14 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-14 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-14 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-14 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-14 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-14 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-05 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 6e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 6e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-05 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 3e-13 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-13 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 5e-13 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 8e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 8e-13 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 5e-06 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 8e-13 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-12 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-12 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 8e-04 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-12 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-12 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-12 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-12 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 5e-12 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-12 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 5e-12 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-12 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 7e-12 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 8e-12 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 8e-12 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 9e-12 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-11 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-11 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-11 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-11 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 7e-11 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 6e-07 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-10 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 7e-07 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-10 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 3e-10 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-10 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-09 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-09 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-09 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-09 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-09 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-09 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-09 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 5e-09 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 9e-09 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-08 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-08 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-08 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-08 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-08 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-08 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-08 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 2e-05 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 1e-04 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-04 |
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-63
Identities = 68/352 (19%), Positives = 118/352 (33%), Gaps = 85/352 (24%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
F + LG G G V A + +AIK + + +K+ +E +L L+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLN 60
Query: 668 HPFLPTLYSQFTSDNLS-------------CLVMEYCPGGDLHVLRQKQLGKCFSEPAAR 714
H ++ Y+ + + MEYC G L+ L +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYW 119
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774
++L AL Y+H G+I+RDLKP NI + E ++ + DF L+ + S ++
Sbjct: 120 RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-------KNVHRSLDI 172
Query: 775 DPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834
S+ +
Sbjct: 173 LKLDSQNLPGSSDNLTSAI----------------------------------------- 191
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
GT Y+A E++ G GH +D ++ GI +E++Y G L
Sbjct: 192 ----------GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILK 239
Query: 894 NVVMQSLKFPD--SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ S++FP + +IR L+ +P R GA + +
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP----GARTLLNSGWL 287
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-59
Identities = 61/159 (38%), Positives = 86/159 (54%), Gaps = 6/159 (3%)
Query: 602 QYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE 661
Q F + LG G TV LA + T+ +AIK+++ + + K+P ER+
Sbjct: 23 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82
Query: 662 ILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAE 719
++ LDHPF LY F + L + Y G+L +R+ F E RFY AE
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKL-YFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAE 138
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++ ALEYLH G+I+RDLKPENIL+ ED HI +TDF +
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA 177
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-47
Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 4/133 (3%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889
L E AR+NSFVGT +Y++PE++ + + D W G +Y+L+ G PF+
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238
Query: 890 ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS--QKGAAEIKQHPFFEGLN 947
++ FP+ +ARDL+ LL+ + RLG +G +K HPFFE +
Sbjct: 239 LIFQKIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296
Query: 948 WALIRCAIPPELP 960
W + PP+L
Sbjct: 297 WENLHQQTPPKLT 309
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-58
Identities = 59/186 (31%), Positives = 102/186 (54%), Gaps = 3/186 (1%)
Query: 576 LSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNC 635
L S +++ ++W VRL+ + F +L+ +G G V + ++ T
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ 87
Query: 636 LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGG 694
++A+K+M+ + +R ++ + ER++L D ++ L+ F + L LVMEY GG
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL-YLVMEYYVGG 146
Query: 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTD 754
DL L K G+ ARFY+AE+++A++ +H LG ++RD+KP+NIL+ GHI L D
Sbjct: 147 DLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 755 FDLSLR 760
F L+
Sbjct: 206 FGSCLK 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-43
Identities = 58/181 (32%), Positives = 80/181 (44%), Gaps = 27/181 (14%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEG-------HGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889
RS VGT +YL+PEI++ G +G DWW G+F YE+ YG+TPF
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276
Query: 890 ETLANVV--MQSLKFPDSPL-ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946
ET +V + L P + +ARD I+ LL PE RLG + GA + + HPFF GL
Sbjct: 277 ETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLG-RGGAGDFRTHPFFFGL 334
Query: 947 NWALIRCAIPPELP-------------DFYDYGIQDMVPQK--SKYLECKATGEQLEFEL 991
+W +R ++PP P + S E G L F
Sbjct: 335 DWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVG 394
Query: 992 F 992
+
Sbjct: 395 Y 395
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-55
Identities = 63/156 (40%), Positives = 91/156 (58%), Gaps = 8/156 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
+ + F+ L+ LG G G V L T +A+K++ E + + ++ TE +L+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 666 LDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLL 722
HPFL L F T D L C VMEY GG+L H+ R++ F+E ARFY AE++
Sbjct: 62 TRHPFLTALKYAFQTHDRL-CFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVS 116
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
ALEYLH V+YRD+K EN+++ +DGHI +TDF L
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-45
Identities = 46/123 (37%), Positives = 75/123 (60%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ GR PF +E ++
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
M+ ++FP + +S +A+ L+ GLL K+P+ RLG A E+ +H FF +NW +++
Sbjct: 219 MEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276
Query: 955 IPP 957
+ P
Sbjct: 277 LLP 279
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-55
Identities = 62/155 (40%), Positives = 93/155 (60%), Gaps = 6/155 (3%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
L+ F +L+ LG G G V+L +A+KV+ E + R K++ ER +L +
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 666 LDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLA 723
+ HPF+ ++ F + + ++M+Y GG+L +LR+ Q F P A+FY AEV LA
Sbjct: 63 VTHPFIIRMWGTFQDAQQI-FMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLA 118
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LEYLH +IYRDLKPENIL+ ++GHI +TDF +
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 39/123 (31%), Positives = 70/123 (56%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ + GT +Y+APE++ + + ++DWW+FGI +YE+L G TPF S +T ++
Sbjct: 157 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNW-ALIRCA 954
L+FP P + +DL+ L+ ++ RLG+ + G ++K HP+F+ + W L+
Sbjct: 217 NAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 274
Query: 955 IPP 957
I
Sbjct: 275 IET 277
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 5e-55
Identities = 52/188 (27%), Positives = 93/188 (49%), Gaps = 5/188 (2%)
Query: 574 SNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGT 633
+L + ++ + +++ + + +++ +G G G V L T
Sbjct: 34 YDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST 93
Query: 634 NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCP 692
++A+K++ + +R ER+I+ + P++ L+ F L +VMEY P
Sbjct: 94 RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL-YMVMEYMP 152
Query: 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML 752
GGDL L E ARFY AEV+LAL+ +H +G I+RD+KP+N+L+ + GH+ L
Sbjct: 153 GGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 209
Query: 753 TDFDLSLR 760
DF ++
Sbjct: 210 ADFGTCMK 217
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-44
Identities = 59/177 (33%), Positives = 92/177 (51%), Gaps = 18/177 (10%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSG 887
+ + R ++ VGT +Y++PE++K +G +G DWW+ G+FLYE+L G TPF
Sbjct: 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 277
Query: 888 NEETLANVVM--QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
T + ++ SL FPD IS +A++LI L + E RLG + G EIK+H FF+
Sbjct: 278 LVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLG-RNGVEEIKRHLFFKN 335
Query: 946 LNWA--LIRCAIPPELPDF--------YDYGIQDMVPQKSKYLECKATGEQLEFELF 992
WA +R + P +PD +D +D +++ + G QL F F
Sbjct: 336 DQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGF 392
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 3e-54
Identities = 69/167 (41%), Positives = 101/167 (60%), Gaps = 12/167 (7%)
Query: 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMP 654
HV+ + F LL+ LG G G V+L + I L+A+KV+ L R ++
Sbjct: 13 HVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV- 71
Query: 655 RAQTEREILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEP 711
R + ER+IL ++HPF+ L+ F T L L++++ GGDL + ++ F+E
Sbjct: 72 RTKMERDILVEVNHPFIVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEV----MFTEE 126
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+FY+AE+ LAL++LH LG+IYRDLKPENIL+ E+GHI LTDF LS
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 3e-47
Identities = 48/123 (39%), Positives = 74/123 (60%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ ++ SF GT EY+APE++ GH + DWW+FG+ ++E+L G PF+G +ET+ ++
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
L P +S +A+ L+R L + P NRLG+ G EIK+H FF ++W L R
Sbjct: 240 KAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRRE 297
Query: 955 IPP 957
I P
Sbjct: 298 IHP 300
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 4e-54
Identities = 48/156 (30%), Positives = 90/156 (57%), Gaps = 4/156 (2%)
Query: 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL 663
+ HF +L+ +G G G V + + T ++A+K M+ + R ++ E +I+
Sbjct: 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 664 RMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
+ L+HPFL L+ F +++ +V++ GGDL Q+ F E + ++ E+++
Sbjct: 70 QGLEHPFLVNLWYSFQDEEDM-FMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVM 126
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
AL+YL +I+RD+KP+NIL+ E GH+ +TDF+++
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-39
Identities = 36/130 (27%), Positives = 62/130 (47%), Gaps = 12/130 (9%)
Query: 835 PTDARSNSFVGTHEYLAPEII---KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-- 889
P + + + GT Y+APE+ KG G+ AVDWW+ G+ YELL GR P+ +
Sbjct: 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 890 -ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
E + + +P S + L++ LL P+ R ++++ P+ +NW
Sbjct: 226 KEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINW 280
Query: 949 -ALIRCAIPP 957
A+ + + P
Sbjct: 281 DAVFQKRLIP 290
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-54
Identities = 65/157 (41%), Positives = 94/157 (59%), Gaps = 9/157 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-R 664
+GL+ F+LL+ +G G V L L T+ ++A+KV+ E + + + QTE+ + +
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 665 MLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVL 721
+HPFL L+S F T L V+EY GGDL H+ RQ+ E ARFY AE+
Sbjct: 66 ASNHPFLVGLHSCFQTESRL-FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEIS 120
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LAL YLH G+IYRDLK +N+L+ +GHI LTD+ +
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-41
Identities = 42/133 (31%), Positives = 77/133 (57%), Gaps = 14/133 (10%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-------- 888
+++F GT Y+APEI++GE +G +VDWW G+ ++E++ GR+PF G+
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
Query: 889 -EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS--QKGAAEIKQHPFFEG 945
+ ++ + ++ P S +S +A +++ L K+P+ RLG Q G A+I+ HPFF
Sbjct: 224 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
Query: 946 LNW-ALIRCAIPP 957
++W + + + P
Sbjct: 282 VDWDMMEQKQVVP 294
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 8e-54
Identities = 65/158 (41%), Positives = 93/158 (58%), Gaps = 9/158 (5%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL- 663
F+ L+ +G G G V LA +A+KV+ + + ++K+ +ER +L
Sbjct: 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 664 RMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEV 720
+ + HPFL L+ F T+D L V++Y GG+L H+ R++ CF EP ARFY AE+
Sbjct: 94 KNVKHPFLVGLHFSFQTADKL-YFVLDYINGGELFYHLQRER----CFLEPRARFYAAEI 148
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
AL YLH L ++YRDLKPENIL+ GHI+LTDF L
Sbjct: 149 ASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 7e-46
Identities = 48/122 (39%), Positives = 69/122 (56%), Gaps = 3/122 (2%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
++ +++F GT EYLAPE++ + + VDWW G LYE+LYG PF E N++
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW-ALIRCAI 955
+ L+ + I+ AR L+ GLL K+ RLG++ EIK H FF +NW LI I
Sbjct: 253 NKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKI 310
Query: 956 PP 957
P
Sbjct: 311 TP 312
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-53
Identities = 56/186 (30%), Positives = 101/186 (54%), Gaps = 3/186 (1%)
Query: 576 LSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNC 635
+ S ++ + W +++ + F +L+ +G G G V + +L +
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 636 LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGG 694
+FA+K+++ + +R + + ER++L D ++ TL+ F +NL LVM+Y GG
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL-YLVMDYYVGG 159
Query: 695 DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTD 754
DL L K + E ARFY+AE+++A++ +H L ++RD+KP+NIL+ +GHI L D
Sbjct: 160 DLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 755 FDLSLR 760
F L+
Sbjct: 219 FGSCLK 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-41
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 26/177 (14%)
Query: 837 DARSNSFVGTHEYLAPEIIKGE-----GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
+S+ VGT +Y++PEI++ +G DWW+ G+ +YE+LYG TPF ET
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289
Query: 892 LANVVM--QSLKFP-DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
++ + +FP +S A+DLIR L+ E+RLG Q G + K+HPFF G++W
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLG-QNGIEDFKKHPFFSGIDW 347
Query: 949 ALIRCAIPPELP-------------DFYDYGIQDMVPQKSKYLECKATGEQLEFELF 992
IR P +P D + +P + +G L F F
Sbjct: 348 DNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTA---FSGHHLPFVGF 401
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-53
Identities = 63/196 (32%), Positives = 103/196 (52%), Gaps = 11/196 (5%)
Query: 565 SSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGT 624
+++ + S + +WE + L F+ ++ LG G G
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQ-----NTAQLDQFDRIKTLGTGSFGR 56
Query: 625 VYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDNL 683
V L + + +A+K++D + + + K++ E+ IL+ ++ PFL L F + NL
Sbjct: 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116
Query: 684 SCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742
+VMEY GG++ LR+ FSEP ARFY A+++L EYLH L +IYRDLKPEN+
Sbjct: 117 -YMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172
Query: 743 LVREDGHIMLTDFDLS 758
L+ + G+I +TDF +
Sbjct: 173 LIDQQGYIQVTDFGFA 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-42
Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
R+ + GT E LAPEII +G+ AVDWW G+ +YE+ G PF + +V
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNW-ALIRCA 954
++FP S +DL+R LL + R G+ K G +IK H +F +W A+ +
Sbjct: 252 SGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309
Query: 955 IPP 957
+
Sbjct: 310 VEA 312
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 2e-53
Identities = 64/168 (38%), Positives = 87/168 (51%), Gaps = 12/168 (7%)
Query: 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKK-M 653
V I F LL+ LG G G V+ + T +FA+KV+ + R K
Sbjct: 6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT 65
Query: 654 PRAQTEREILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSE 710
+ ER IL + HPF+ L F T L L++EY GG+L + R+ F E
Sbjct: 66 AHTKAERNILEEVKHPFIVDLIYAFQTGGKL-YLILEYLSGGELFMQLEREGI----FME 120
Query: 711 PAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A FY+AE+ +AL +LH G+IYRDLKPENI++ GH+ LTDF L
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 45/123 (36%), Positives = 72/123 (58%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+++F GT EY+APEI+ GH AVDWW+ G +Y++L G PF G ++T+ ++
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
L P ++ +ARDL++ LL + +RLG+ A E++ HPFF +NW L+
Sbjct: 235 KCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARK 292
Query: 955 IPP 957
+ P
Sbjct: 293 VEP 295
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-53
Identities = 60/155 (38%), Positives = 85/155 (54%), Gaps = 5/155 (3%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-R 664
+ + F L + LG G G V+LAE TN FAIK + + + + E+ +L
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 665 MLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
+HPFL ++ F T +NL VMEY GGDL Q F A FY AE++L
Sbjct: 74 AWEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILG 130
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L++LH G++YRDLK +NIL+ +DGHI + DF +
Sbjct: 131 LQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-42
Identities = 51/122 (41%), Positives = 78/122 (63%), Gaps = 6/122 (4%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
DA++N+F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L G++PF G EE ++
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW-ALIRCAI 955
M + +P + +A+DL+ L ++EPE RLG +I+QHP F +NW L R I
Sbjct: 232 MDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKEI 286
Query: 956 PP 957
P
Sbjct: 287 DP 288
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-53
Identities = 67/200 (33%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 563 DYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDI 622
D ++ + + + M+ +A + LQ F+LL+ +G G
Sbjct: 13 DIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQ-------DFDLLRVIGRGSY 65
Query: 623 GTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLYSQF-TS 680
V L L T+ ++A++V+ E + + + QTE+ + + +HPFL L+S F T
Sbjct: 66 AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125
Query: 681 DNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLK 738
L V+EY GGDL H+ RQ+ E ARFY AE+ LAL YLH G+IYRDLK
Sbjct: 126 SRL-FFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLHERGIIYRDLK 180
Query: 739 PENILVREDGHIMLTDFDLS 758
+N+L+ +GHI LTD+ +
Sbjct: 181 LDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 42/133 (31%), Positives = 77/133 (57%), Gaps = 14/133 (10%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-------- 888
+++F GT Y+APEI++GE +G +VDWW G+ ++E++ GR+PF G+
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
Query: 889 -EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS--QKGAAEIKQHPFFEG 945
+ ++ + ++ P S +S +A +++ L K+P+ RLG Q G A+I+ HPFF
Sbjct: 267 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 946 LNW-ALIRCAIPP 957
++W + + + P
Sbjct: 325 VDWDMMEQKQVVP 337
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-53
Identities = 59/157 (37%), Positives = 87/157 (55%), Gaps = 9/157 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-R 664
+ L FN L LG G G V L+E GT+ L+A+K++ + + + + E+ +L
Sbjct: 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 665 MLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVL 721
PFL L+S F T D L VMEY GGDL H+ + + F EP A FY AE+
Sbjct: 77 PGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIA 131
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ L +L G+IYRDLK +N+++ +GHI + DF +
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-44
Identities = 47/123 (38%), Positives = 75/123 (60%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G +E +++
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
++ +P S +S +A + +GL+ K P RLG +G +IK+H FF ++W L R
Sbjct: 235 EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 292
Query: 955 IPP 957
I P
Sbjct: 293 IQP 295
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 8e-53
Identities = 61/157 (38%), Positives = 90/157 (57%), Gaps = 9/157 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-R 664
+G+ +F ++ LG G G V LA + T L+A+KV+ + + + + TE+ IL
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 665 MLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVL 721
+HPFL L+ F T D L VME+ GGDL H+ + + F E ARFY AE++
Sbjct: 80 ARNHPFLTQLFCCFQTPDRL-FFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEII 134
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
AL +LH G+IYRDLK +N+L+ +GH L DF +
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-44
Identities = 41/124 (33%), Positives = 66/124 (53%), Gaps = 5/124 (4%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ +F GT +Y+APEI++ +G AVDWW G+ LYE+L G PF+ ++ ++
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS--QKGAAEIKQHPFFEGLNW-ALIRC 953
+ +P + A +++ + K P RLGS Q G I +HPFF+ ++W L
Sbjct: 238 NDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHR 295
Query: 954 AIPP 957
I P
Sbjct: 296 QIEP 299
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-52
Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 565 SSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGT 624
S+ + S + ++ +G+ +F LL+ LG G G
Sbjct: 10 EEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGK 69
Query: 625 VYLAELI---GTNCLFAIKVMDNEFLARRKKM-PRAQTEREILRMLDH-PFLPTLYSQF- 678
V+L I T L+A+KV+ + ++ K +TER++L + PFL TL+ F
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129
Query: 679 TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736
T L L+++Y GG+L H+ ++++ F+E + YV E++LALE+LH LG+IYRD
Sbjct: 130 TETKL-HLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGIIYRD 184
Query: 737 LKPENILVREDGHIMLTDFDLS 758
+K ENIL+ +GH++LTDF LS
Sbjct: 185 IKLENILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-42
Identities = 51/129 (39%), Positives = 76/129 (58%), Gaps = 10/129 (7%)
Query: 837 DARSNSFVGTHEYLAPEIIKGE--GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA- 893
R+ F GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF G + + A
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 894 ---NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW- 948
++ +P +S A+DLI+ LL+K+P+ RLG + A EIK+H FF+ +NW
Sbjct: 274 ISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331
Query: 949 ALIRCAIPP 957
L +P
Sbjct: 332 DLAAKKVPA 340
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-51
Identities = 56/156 (35%), Positives = 88/156 (56%), Gaps = 4/156 (2%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
+G F + LG G G V+ ++ T L+A K ++ + L +RK A E++IL
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 666 LDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLL 722
+ F+ +L F T +L CLVM GGD+ H+ + F EP A FY A+++
Sbjct: 242 VHSRFIVSLAYAFETKTDL-CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LE+LH +IYRDLKPEN+L+ +DG++ ++D L+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-41
Identities = 39/127 (30%), Positives = 67/127 (52%), Gaps = 8/127 (6%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG----NEETL 892
++ + GT ++APE++ GE + +VD++ G+ LYE++ R PF+ G N+E
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 893 ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-AL 950
V+ Q++ +PD S ++D LL K+PE RLG ++ HP F ++W L
Sbjct: 403 QRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460
Query: 951 IRCAIPP 957
+ P
Sbjct: 461 EAGMLTP 467
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-51
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 13/215 (6%)
Query: 552 EFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGS----IG 607
F + +++++ D ++ + + + +
Sbjct: 87 TFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVT 146
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ F L+ LG G G V L + T +A+K++ E + + ++ TE +L+
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 668 HPFLPTLYSQF-TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLAL 724
HPFL L F T D L C VMEY GG+L H+ R+ + FSE ARFY AE++ AL
Sbjct: 207 HPFLTALKYSFQTHDRL-CFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSAL 261
Query: 725 EYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLS 758
+YLH V+YRDLK EN+++ +DGHI +TDF L
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-42
Identities = 47/123 (38%), Positives = 74/123 (60%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ GR PF +E+ ++
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 362
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
M+ ++FP + + +A+ L+ GLL K+P+ RLG + A EI QH FF G+ W +
Sbjct: 363 MEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKK 420
Query: 955 IPP 957
+ P
Sbjct: 421 LSP 423
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-49
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 2/159 (1%)
Query: 601 LQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTER 660
L+ + F + LG G G V ++ T ++A K ++ + + +RK A E+
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 661 EILRMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAE 719
+IL ++ F+ +L + T D L CLV+ GGDL F E A FY AE
Sbjct: 236 QILEKVNSRFVVSLAYAYETKDAL-CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ LE LH ++YRDLKPENIL+ + GHI ++D L+
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-40
Identities = 47/134 (35%), Positives = 66/134 (49%), Gaps = 9/134 (6%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG----NEE 890
P VGT Y+APE++K E + + DWW G LYE++ G++PF+ EE
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
Query: 891 TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNWA 949
V ++ + S QAR L LL K+P RLG A E+K+HP F+ LN+
Sbjct: 397 VERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454
Query: 950 LI--RCAIPPELPD 961
+ PP PD
Sbjct: 455 RLGAGMLEPPFKPD 468
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-48
Identities = 59/443 (13%), Positives = 107/443 (24%), Gaps = 112/443 (25%)
Query: 552 EFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQ-YGSIGLRH 610
F + + + ++ S + + W + R++ R
Sbjct: 15 YFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRT 74
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---- 666
LG D A T F + V + + + E LR+L
Sbjct: 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 134
Query: 667 ---------------------DHPFLPTLYSQFTSDNLSCLVMEY-CPGGDLHVL----- 699
+ + + Y +L
Sbjct: 135 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 194
Query: 700 RQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759
K A +V+ L LH G+++ L+P +I++ + G + LT F+ +
Sbjct: 195 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKA 819
R S F P
Sbjct: 255 RDGARVV----------------------------------SSVSRGFEP---------- 270
Query: 820 DPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYG 879
P+L A ++ + + D W G+ +Y +
Sbjct: 271 ---------PELEAR------------RATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 880 RTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939
P + F I R L+ G L E+RL + +
Sbjct: 310 DLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRL----LPLQAME 359
Query: 940 HPFFEGLNWALIRCAIPPELPDF 962
P +E L R + LP +
Sbjct: 360 TPEYEQL-----RTELSAALPLY 377
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-48
Identities = 66/303 (21%), Positives = 112/303 (36%), Gaps = 11/303 (3%)
Query: 460 QDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDSTVSNLTSVSAEVI 519
+ SE + + + + L + +
Sbjct: 194 DPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSR 253
Query: 520 STSVTTGIIEPDFIPNDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGS 579
+ + + + + ++ +GE+ G +
Sbjct: 254 NDFMGSLSFGISELQKAGVDGWFKL-LSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIG 312
Query: 580 SCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAI 639
P + + L FN L LG G G V L+E GT+ L+A+
Sbjct: 313 QGTKAPEEKTANTISKFDNNG-NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAV 371
Query: 640 KVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDL- 696
K++ + + + + E+ +L PFL L+S F T D L VMEY GGDL
Sbjct: 372 KILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLM 430
Query: 697 -HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
H+ + + F EP A FY AE+ + L +L G+IYRDLK +N+++ +GHI + DF
Sbjct: 431 YHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADF 486
Query: 756 DLS 758
+
Sbjct: 487 GMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 7e-41
Identities = 47/123 (38%), Positives = 75/123 (60%), Gaps = 4/123 (3%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G +E +++
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW-ALIRCA 954
++ +P S +S +A + +GL+ K P RLG +G +IK+H FF ++W L R
Sbjct: 556 EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKE 613
Query: 955 IPP 957
I P
Sbjct: 614 IQP 616
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 3e-47
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 12/233 (5%)
Query: 530 PDFIPNDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSA 589
+ + S+ + + Q Y NL G
Sbjct: 115 KELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQ----NLRGDVFQKFIESDK 170
Query: 590 DVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR 649
R+ ++V L + + F++ + +G G G VY T ++A+K +D + +
Sbjct: 171 FTRFCQWKNVELN-IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKM 229
Query: 650 RKKMPRAQTEREIL---RMLDHPFLPTLYSQF-TSDNLSCLVMEYCPGGDLHVLRQKQLG 705
++ A ER +L D PF+ + F T D L +++ GGDLH +
Sbjct: 230 KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL-SFILDLMNGGDLHYHLSQH-- 286
Query: 706 KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
FSE RFY AE++L LE++H V+YRDLKP NIL+ E GH+ ++D L+
Sbjct: 287 GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 8e-40
Identities = 43/130 (33%), Positives = 73/130 (56%), Gaps = 8/130 (6%)
Query: 834 EPTDARSNSFVGTHEYLAPEII-KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---E 889
+ + + ++ VGTH Y+APE++ KG + ++ DW++ G L++LL G +PF+
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 890 ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNW 948
E + +++ PDS S + R L+ GLL ++ RLG +GA E+K+ PFF L+W
Sbjct: 401 EIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458
Query: 949 -ALIRCAIPP 957
+ PP
Sbjct: 459 QMVFLQKYPP 468
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-47
Identities = 87/359 (24%), Positives = 138/359 (38%), Gaps = 104/359 (28%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPT 673
LG G V + T+ +A+K+++ + R ++ R E E+L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 674 LYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
L F ++ LV E GG + H+ +++ F+E A V +V AL++LH G
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLHNKG 131
Query: 732 VIYRDLKPENILVR---EDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNC 788
+ +RDLKPENIL + + + DFDL S + P +
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDL-------------GSGIKLNGDCSPIS---- 174
Query: 789 IQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848
P PC S E
Sbjct: 175 ------TPELLTPCGSA------------------------------------------E 186
Query: 849 YLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA---------- 893
Y+APE+++ + D W+ G+ LY LL G PF G +
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246
Query: 894 NVVMQS-----LKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
N++ +S +FPD IS A+DLI LL+++ + RL AA++ QHP+ +G
Sbjct: 247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL----SAAQVLQHPWVQG 301
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 2/159 (1%)
Query: 600 RLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE 659
+ + F++ + LG G G VYLA + A+KV+ L + + + E
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAE 719
EI L HP + +Y+ F L++E+ P G+L+ QK F E + ++ E
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEE 122
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ AL Y H VI+RD+KPEN+L+ G + + DF S
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 38/111 (34%), Positives = 52/111 (46%), Gaps = 6/111 (5%)
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL 892
R + GT +YL PE+I+G+ H VD W G+ YE L G PF + ET
Sbjct: 162 VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH 221
Query: 893 ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+V LKFP +S ++DLI LL P RL + +HP+
Sbjct: 222 RRIVNVDLKFPPF--LSDGSKDLISKLLRYHPPQRL----PLKGVMEHPWV 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 51/155 (32%), Positives = 73/155 (47%), Gaps = 2/155 (1%)
Query: 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL 663
L F + + LG G G VYLA + + A+KV+ L + + + E EI
Sbjct: 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
L HP + LY F L++EY P G ++ QK F E Y+ E+ A
Sbjct: 64 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 121
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L Y H VI+RD+KPEN+L+ G + + DF S
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+R GT +YL PE+I+G H VD W+ G+ YE L G+ PF+ + +E
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
Query: 891 TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
T + FPD ++ ARDLI LL P R + E+ +HP+
Sbjct: 215 TYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRPMLR----EVLEHPWI 261
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 84/376 (22%), Positives = 133/376 (35%), Gaps = 87/376 (23%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLD 667
+ + LG G G V T C A+K++ + L R A ++EI LR L
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNG-EANVKKEIQLLRRLR 64
Query: 668 HPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
H + L + +VMEYC G +L + F A Y +++ L
Sbjct: 65 HKNVIQLVDVLYNEEKQKM-YMVMEYCVCGMQEMLDSVPEKR-FPVCQAHGYFCQLIDGL 122
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCT 784
EYLH G++++D+KP N+L+ G + ++ +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGV--------------------------- 155
Query: 785 ESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844
+ + PF + TC+ SP F P++
Sbjct: 156 -AEALHPFAADDTCRTSQGSPAF--------------QP-----PEIAN----------- 184
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
G + G VD W+ G+ LY + G PF+G + N+ S P
Sbjct: 185 GLDTF----------SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG 234
Query: 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNWALIRCAIPPELPDFY 963
DL++G+L EP R +I+QH +F + A IPP
Sbjct: 235 D--CGPPLSDLLKGMLEYEPAKRF----SIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288
Query: 964 DYGIQDMVPQKSKYLE 979
+ +VP YLE
Sbjct: 289 RWRSMTVVP----YLE 300
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 79/367 (21%), Positives = 143/367 (38%), Gaps = 87/367 (23%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ ++ LL+ +G G+ V LA I T AIK++D L + + E I+++L+
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILN 72
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HP + L+ ++ L+MEY GG++ +++ ++ E AR +++ A++
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRM----KEKEARSKFRQIVSAVQ 128
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTE 785
Y H +++RDLK EN+L+ D +I + DF S + L +
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAF-------------- 173
Query: 786 SNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845
C +P + AA P+L
Sbjct: 174 ----------------CGAPPY--------------AA-----PELFQGK---------- 188
Query: 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS 905
+Y PE+ D W+ G+ LY L+ G PF G +E V+ K+
Sbjct: 189 --KYDGPEV----------DVWSLGVILYTLVSGSLPFDGQNLKELRERVL--RGKYRIP 234
Query: 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNWALIRCAIPPELPDFYD 964
+S +L++ L+ P R +I + + G ++ + PE D D
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRG----TLEQIMKDRWINAGHEEDELKPFVEPE-LDISD 289
Query: 965 YGIQDMV 971
D++
Sbjct: 290 QKRIDIM 296
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 75/384 (19%), Positives = 114/384 (29%), Gaps = 86/384 (22%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
+G + + L G VY A+ +G+ +A+K + +K E ++
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL---SNEEEKNRAIIQEVCFMK 80
Query: 665 ML-DHPFLPTLYSQF--------TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARF 715
L HP + S T L+ E C G + L++ + S
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 716 YVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773
+ A++++H +I+RDLK EN+L+ G I L
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL--------------------- 179
Query: 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833
D F AT + P +AQ R+L +
Sbjct: 180 CD----------------FGS---------------ATTISHYPDYSWSAQRRALVEEEI 208
Query: 834 EPTDARSNSFVGTHEYLAPEII---KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
T Y PEII G D W G LY L + + PF+
Sbjct: 209 T--------RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA--- 257
Query: 891 TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF-FEGLNWA 949
+V P LIR +L PE RL AE+
Sbjct: 258 -KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIAEVVHQLQEIAAARNV 312
Query: 950 LIRCAIPPELPDFYDYGIQDMVPQ 973
+ I L YG +
Sbjct: 313 NPKSPITELLEQNGGYGSATLSRG 336
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 42/155 (27%), Positives = 63/155 (40%), Gaps = 4/155 (2%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL- 663
S + F L +LG G G V+ L+A+K + F + + R E
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHE 111
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
++ HP L + + L E C G L + G E Y+ + LLA
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLA 169
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L +LH G+++ D+KP NI + G L DF L
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 21/108 (19%), Positives = 41/108 (37%), Gaps = 8/108 (7%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
T G Y+APE+++G +G A D ++ G+ + E+ E +
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH---GGEGWQQL 264
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
L + +S + R ++ +L +P+ R A + P
Sbjct: 265 RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRA----TAEALLALPVL 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 31/172 (18%), Positives = 68/172 (39%), Gaps = 23/172 (13%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQT--------- 658
+ + +++ L G + L E N +A+K + L +++ ++
Sbjct: 30 INDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 659 -----EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL------HVLRQKQLGKC 707
E +I+ + + + T T+ + ++ EY + + K
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 708 FSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ + VL + Y+H + +RD+KP NIL+ ++G + L+DF S
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 32/140 (22%), Positives = 57/140 (40%), Gaps = 24/140 (17%)
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGN-E 889
D + GT+E++ PE E +GA VD W+ GI LY + Y PF +
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 890 ETLANVVMQSLKFP-----------------DSPLISFQARDLIRGLLIKEPENRLGSQK 932
E N+ +++++P + +S + D ++ L K P R+ S+
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE- 318
Query: 933 GAAEIKQHPFFEGLNWALIR 952
+ +H + N +R
Sbjct: 319 ---DALKHEWLADTNIEDLR 335
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
S + L LG G V+ T LFAIKV +N + + E E+L+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLK 62
Query: 665 MLDHPFLPTLYSQF---TSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEV 720
L+H + L++ T+ + L+ME+CP G L VL + E + +V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 721 LLALEYLHMLGVIYRDLKPENILVR----EDGHIMLTDFDLS 758
+ + +L G+++R++KP NI+ LTDF +
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 26/138 (18%), Positives = 45/138 (32%), Gaps = 39/138 (28%)
Query: 841 NSFVGTHEYLAPEIIKG--------EGHGAAVDWWTFGIFLYELLYGRTPFKGSG----N 888
S GT EYL P++ + + +GA VD W+ G+ Y G PF+ N
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 889 EETLANVVMQ-------------------SLKFPDSPLISFQARD----LIRGLLIKEPE 925
+E + ++ S P S +S + ++ +L + E
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 926 NRLGSQKGAAEIKQHPFF 943
G +
Sbjct: 293 KCW----GFDQFFAETSD 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 3/152 (1%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ F + LG G VY AE I T AIK++D + + + + R Q E +I L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
HP + LY+ F N LV+E C G++ L+ + K FSE AR ++ +++ + Y
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLY 127
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LH G+++RDL N+L+ + +I + DF L+
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 36/99 (36%), Positives = 49/99 (49%), Gaps = 6/99 (6%)
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
GT Y++PEI HG D W+ G Y LL GR PF + TL VV+ + P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+S +A+DLI LL + P +RL + + HPF
Sbjct: 234 F--LSIEAKDLIHQLLRRNPADRL----SLSSVLDHPFM 266
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-36
Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 1/151 (0%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ + LQK+G G G L + + IK ++ ++ +++ ++ E +L +
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKERE-ESRREVAVLANMK 81
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
HP + F + +VM+YC GGDL Q G F E + ++ LAL+++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H +++RD+K +NI + +DG + L DF ++
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 28/113 (24%), Positives = 46/113 (40%), Gaps = 5/113 (4%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
V T + + +GT YL+PEI + + + D W G LYEL + F+ + +
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SMKN 232
Query: 892 LANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
L ++ P S S+ R L+ L + P +R I + F
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP----SVNSILEKGFIA 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-36
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 4/152 (2%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
R + + LG G + T +FA K++ L + + + E I R L
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
H + + F ++ +V+E C L + +++ K +EP AR+Y+ +++L +Y
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQY 130
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LH VI+RDLK N+ + ED + + DF L+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 36/116 (31%), Positives = 51/116 (43%), Gaps = 13/116 (11%)
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
GT Y+APE++ +GH VD W+ G +Y LL G+ PF+ S +ET + P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 236
Query: 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960
I+ A LI+ +L +P R E+ FF IP LP
Sbjct: 237 H--INPVAASLIQKMLQTDPTARP----TINELLNDEFFT-------SGYIPARLP 279
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-36
Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 9/161 (5%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
S + L LG G V+ T LFAIKV +N + + E E+L+
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLK 62
Query: 665 MLDHPFLPTLYS--QFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVL 721
L+H + L++ + T+ L+ME+CP G L VL + E + +V+
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 722 LALEYLHMLGVIYRDLKPENILVR----EDGHIMLTDFDLS 758
+ +L G+++R++KP NI+ LTDF +
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 23/124 (18%), Positives = 39/124 (31%), Gaps = 35/124 (28%)
Query: 841 NSFVGTHEYLAPEIIKG--------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL 892
S GT EYL P++ + + +GA VD W+ G+ Y G PF+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 893 ANVV--MQSLKFPD-------------------------SPLISFQARDLIRGLLIKEPE 925
V+ + + K S + ++ +L + E
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 926 NRLG 929
G
Sbjct: 293 KCWG 296
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 2/153 (1%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L +F + +K+G G VY A + A+K + L K E ++L+ L+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVL--RQKQLGKCFSEPAARFYVAEVLLALE 725
HP + Y+ F DN +V+E GDL + K+ + E Y ++ ALE
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++H V++RD+KP N+ + G + L D L
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 29/110 (26%), Positives = 46/110 (41%), Gaps = 8/110 (7%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG-SGNEETLAN 894
++S VGT Y++PE I G+ D W+ G LYE+ ++PF G N +L
Sbjct: 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248
Query: 895 VVMQSLKFPD--SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ Q +P S S + R L+ + +PE R +
Sbjct: 249 KIEQC-DYPPLPSDHYSEELRQLVNMCINPDPEKRP----DVTYVYDVAK 293
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 7/156 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLD 667
+ L + +G G V T FA+K++D + +RE I ML
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HP + L ++SD + +V E+ G DL ++++ G +SE A Y+ ++L AL
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 726 YLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
Y H +I+RD+KP +L+ + L F ++
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-20
Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 7/105 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
VGT ++APE++K E +G VD W G+ L+ LL G PF G+ E ++
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKY 249
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
K IS A+DL+R +L+ +P R+ E HP+
Sbjct: 250 KMNPRQWSHISESAKDLVRRMLMLDPAERI----TVYEALNHPWL 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 4/152 (2%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
R + + LG G + T +FA K++ L + + + E I R L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
H + + F ++ +V+E C L + +++ K +EP AR+Y+ +++L +Y
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQY 156
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LH VI+RDLK N+ + ED + + DF L+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 32/99 (32%), Positives = 47/99 (47%), Gaps = 6/99 (6%)
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
GT Y+APE++ +GH VD W+ G +Y LL G+ PF+ S +ET + P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 262
Query: 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
I+ A LI+ +L +P R E+ FF
Sbjct: 263 H--INPVAASLIQKMLQTDPTARP----TINELLNDEFF 295
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 36/180 (20%), Positives = 57/180 (31%), Gaps = 22/180 (12%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTN-----CLFAIKVMDNEFLARRKKMPRAQTER 660
+G + + LG G VY A N F +KV +
Sbjct: 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLM 118
Query: 661 EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLRQKQLGKCFSEPAARFYV 717
E L+ YS N S LV E G L L + K + +
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVR-----------EDGHIMLTDFDLSLRCSVSPT 766
+L +E +H +I+ D+KP+N ++ + L D S+ + P
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 4e-14
Identities = 16/126 (12%), Positives = 37/126 (29%), Gaps = 15/126 (11%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
P + T + E++ + +D++ +Y +L+G + E
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
Query: 895 VVMQSLKFPD------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ + L D + DL+R L K + ++ ++
Sbjct: 297 GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK---IRALRNRL 353
Query: 943 FEGLNW 948
L
Sbjct: 354 IVLLLE 359
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 10/160 (6%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ +L +G G G + K +D + +K +E +LR L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELK 63
Query: 668 HPFLPTLYSQF--TSDNLSCLVMEYCPGGDLHVL--RQKQLGKCFSEPAARFYVAEVLLA 723
HP + Y + ++ +VMEYC GGDL + + + + E + ++ LA
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 724 LEYLH-----MLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L+ H V++RDLKP N+ + ++ L DF L+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 8e-19
Identities = 25/112 (22%), Positives = 47/112 (41%), Gaps = 5/112 (4%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
+ + + +FVGT Y++PE + + D W+ G LYEL PF +++
Sbjct: 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKE 223
Query: 892 LANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
LA + + S + ++I +L + +R EI ++P
Sbjct: 224 LAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP----SVEEILENPLI 271
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 36/167 (21%), Positives = 64/167 (38%), Gaps = 23/167 (13%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
F ++ +G G G V+ A+ + IK + K A+ E + L LD
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK---YNNEK----AEREVKALAKLD 62
Query: 668 HPFLPTLYSQFTSDNLS----------------CLVMEYCPGGDLHVLRQKQLGKCFSEP 711
H + + + + ME+C G L +K+ G+ +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A ++ ++Y+H +I RDLKP NI + + + + DF L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 12/108 (11%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANV 895
D + GT Y++PE I + +G VD + G+ L ELL+ T F+ S
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-------KF 227
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
S + + + L++ LL K+PE+R +EI +
Sbjct: 228 FTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRP----NTSEILRTLTV 271
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 54/227 (23%), Positives = 91/227 (40%), Gaps = 12/227 (5%)
Query: 541 QPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVR 600
+ I E ++ SL D S ++N + + + +
Sbjct: 24 REIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDEL 83
Query: 601 LQYGSIG--LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKM---PR 655
+ + + ++ +G G V T FA+K+M+ + R
Sbjct: 84 PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVR 143
Query: 656 AQTERE--ILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEP 711
T RE ILR + HP + TL + S + LV + G+L L +K SE
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEK 200
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
R + +L A+ +LH +++RDLKPENIL+ ++ I L+DF S
Sbjct: 201 ETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 2e-17
Identities = 40/112 (35%), Positives = 50/112 (44%), Gaps = 12/112 (10%)
Query: 841 NSFVGTHEYLAPEIIKG------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
GT YLAPEI+K G+G VD W G+ L+ LL G PF L
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316
Query: 895 VVMQSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
++ +F S +DLI LL +PE RL A + QHPFFE
Sbjct: 317 IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL----TAEQALQHPFFE 364
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD----NEFLARRKKMPRAQTERE--IL 663
++ + LG G V T +A+K++D F A + R T +E IL
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 664 RMLD-HPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVL 721
R + HP + L + ++ LV + G+L L +K SE R + +L
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 134
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ LH L +++RDLKPENIL+ +D +I LTDF S
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 36/120 (30%), Positives = 52/120 (43%), Gaps = 12/120 (10%)
Query: 841 NSFVGTHEYLAPEIIKG------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
GT YLAPEII+ G+G VD W+ G+ +Y LL G PF L
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 895 VVMQSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952
++ + +F S +DL+ L+ +P+ R A E HPFF+ +R
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQQYVVEEVR 296
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 41/168 (24%), Positives = 74/168 (44%), Gaps = 9/168 (5%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
I +H+ +QKLG G V L E + +A+K + ++ AQ E ++ R
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL---CHEQQDREEAQREADMHR 81
Query: 665 MLDHPFLPTLYSQFTSDNLS----CLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVA 718
+ +HP + L + + + L++ + G L + R K G +E + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766
+ LE +H G +RDLKP NIL+ ++G +L D + +
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 24/121 (19%), Positives = 43/121 (35%), Gaps = 15/121 (12%)
Query: 842 SFVGTHEYLAPEIIKGEGH---GAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVM 897
+ T Y APE+ + H D W+ G LY +++G P+ +++A V
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 898 QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPP 957
L P SP S L+ ++ +P R + ++ P
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLSQLEA-------LQPPAPG 310
Query: 958 E 958
+
Sbjct: 311 Q 311
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 7/154 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F +KLG G G V+L E + IK ++ + + E E+L+ LDHP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEIEVLKSLDHP 80
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
+ ++ F + +VME C GG+L ++ + GK SE + +++ AL Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 728 HMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
H V+++DLKPENIL + I + DF L+
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+ GT Y+APE+ K + D W+ G+ +Y LL G PF G+ EE +
Sbjct: 184 TNAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242
Query: 901 KFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ ++ QA DL++ +L K+PE R AA++ H +F
Sbjct: 243 NYAVECRPLTPQAVDLLKQMLTKDPERRP----SAAQVLHHEWF 282
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 51/160 (31%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD-----NEFLARRKKMPRAQTEREILR 664
+ + + LG G G V LA T AIK++ +TE EIL+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLRQKQLGKCFSEPAARFYVAEVL 721
L+HP + + + F +++ +V+E GG+L V ++ E + Y ++L
Sbjct: 71 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQML 124
Query: 722 LALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
LA++YLH G+I+RDLKPEN+L+ ED I +TDF S
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 843 FVGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ- 898
GT YLAPE++ G+ AVD W+ G+ L+ L G PF + +L + +
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 899 SLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
F +S +A DL++ LL+ +P+ R E +HP+ +
Sbjct: 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEALRHPWLQD 280
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 50/154 (32%), Positives = 79/154 (51%), Gaps = 12/154 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F ++ LG G V+L + T LFA+K + R + + E +L+ + H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL---ENEIAVLKKIKHE 66
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
+ TL + S LVM+ GG+L +L + ++E A + +VL A++YL
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYL 122
Query: 728 HMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
H G+++RDLKPEN+L E+ IM+TDF LS
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 6/106 (5%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
+ GT Y+APE++ + + AVD W+ G+ Y LL G PF + + +
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225
Query: 902 FPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
F IS A+D I LL K+P R + HP+ +G
Sbjct: 226 FESPFWDDISESAKDFICHLLEKDPNERY----TCEKALSHPWIDG 267
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 11/153 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLD 667
+ + + LG G+ G V+ + + K + + K + ++E IL +
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV------KVKGTDQVLVKKEISILNIAR 59
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
H + L+ F S ++ E+ G D+ R +E YV +V AL++L
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 728 HMLGVIYRDLKPENILV--REDGHIMLTDFDLS 758
H + + D++PENI+ R I + +F +
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 6/100 (6%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
EY APE+ + + A D W+ G +Y LL G PF N++ + N++ F
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 904 DSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
+ IS +A D + LL+KE ++R+ A+E QHP
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHP 259
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-33
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 8/173 (4%)
Query: 599 VRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQT 658
V+ + + LG G G V L + T A+KV+ + ++
Sbjct: 17 VQHSTAIFS-DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 659 EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYV 717
E ++L+ LDHP + LY F LV E GG+L + + K FSE A +
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARII 132
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLSLRCSVSPTL 767
+VL + Y+H +++RDLKPEN+L+ +D +I + DF LS S +
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-20
Identities = 32/109 (29%), Positives = 48/109 (44%), Gaps = 7/109 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+GT Y+APE++ G + D W+ G+ LY LL G PF G+ + L V
Sbjct: 186 KDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947
F +S A+DLIR +L P R+ A + H + +
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLTYVPSMRI----SARDALDHEWIQTYT 289
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-ARRKKMPRAQTERE--ILRML 666
H+ + ++LG G V GT +A K + L + R+ + R + ERE ILR +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HP + TL+ F + L++E GG+L L +K + +E A ++ ++L +
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVH 122
Query: 726 YLHMLGVIYRDLKPENILV----REDGHIMLTDFDLS 758
YLH + + DLKPENI++ + I L DF ++
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 6/105 (5%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
GT E++APEI+ E G D W+ G+ Y LL G +PF G +ETL N+ + F
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 903 PDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+ S A+D IR LL+K+P+ R+ A+ +H + +
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRM----TIAQSLEHSWIKA 271
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-33
Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD-----NEFLARRKKMPRAQTEREILR 664
+ + + LG G G V LA T AI+++ +TE EIL+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLRQKQLGKCFSEPAARFYVAEVL 721
L+HP + + + F +++ +V+E GG+L V ++ E + Y ++L
Sbjct: 196 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKR-----LKEATCKLYFYQML 249
Query: 722 LALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
LA++YLH G+I+RDLKPEN+L+ ED I +TDF S
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 31/109 (28%), Positives = 51/109 (46%), Gaps = 10/109 (9%)
Query: 843 FVGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ- 898
GT YLAPE++ G+ AVD W+ G+ L+ L G PF + +L + +
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 899 SLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
F +S +A DL++ LL+ +P+ R E +HP+ +
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARF----TTEEALRHPWLQD 405
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 39/153 (25%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
++++ ++LG G V T FA K+++ + L + + + E I R L HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHP 65
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ L+ ++ LV + GG+L + + + +SE A + ++L ++ Y H
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCH 122
Query: 729 MLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
G+++R+LKPEN+L+ + + L DF L+
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+ F GT YL+PE++K + + VD W G+ LY LL G PF A + +
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 224
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+P ++ +A+ LI +L P+ R+ A + + P+
Sbjct: 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWICN 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-33
Identities = 50/191 (26%), Positives = 76/191 (39%), Gaps = 42/191 (21%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR--KKMPRAQTEREILRMLD 667
++L +G G G V +A T + AIK+M+ + + K + R +TE +++ L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL------------------------------- 696
HP + LY + + CLVME C GG L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 697 -------HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV--RED 747
++ L E + ++ AL YLH G+ +RD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 748 GHIMLTDFDLS 758
I L DF LS
Sbjct: 207 FEIKLVDFGLS 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 8/107 (7%)
Query: 841 NSFVGTHEYLAPEIIKGEGH--GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
+ GT ++APE++ G D W+ G+ L+ LL G PF G + +T++ V+ +
Sbjct: 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNK 291
Query: 899 SLKFPDSPL--ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
L F + +S ARDL+ LL + + R A QHP+
Sbjct: 292 KLCFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWI 334
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-32
Identities = 39/168 (23%), Positives = 80/168 (47%), Gaps = 11/168 (6%)
Query: 597 RHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRA 656
+ V ++ GS+ ++++L++LG G G V+ T +F K ++ + + +
Sbjct: 40 QPVEVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN- 97
Query: 657 QTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAAR 714
E I+ L HP L L+ F L++E+ GG+L + + SE
Sbjct: 98 --EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVI 152
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLSLR 760
Y+ + L+++H +++ D+KPENI+ ++ + + DF L+ +
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
T E+ APEI+ E G D W G+ Y LL G +PF G + ETL NV +F
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 904 DS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+ +S +A+D I+ LL KEP RL + +HP+ +G
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG 310
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTER-----EILR 664
+N++ LG G G V + T +A+KV++ + T E+L+
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN------KASAKNKDTSTILREVELLK 76
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLA 723
LDHP + L+ + +V E GG+L + ++ K FSE A + +V
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSG 133
Query: 724 LEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
+ Y+H +++RDLKPENIL+ +D I + DF LS
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 7/105 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+GT Y+APE+++G + D W+ G+ LY LL G PF G + L V
Sbjct: 181 KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
F IS A+DLIR +L P R+ A + +HP+
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWI 280
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 11/161 (6%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD-NEFLARRKKMPRAQTERE--ILRML 666
+++ ++LG G V T +A K + + A R+ + R + ERE ILR +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
H + TL+ + + L++E GG+L L QK+ SE A ++ ++L +
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 726 YLHMLGVIYRDLKPENILVR----EDGHIMLTDFDLSLRCS 762
YLH + + DLKPENI++ HI L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 40/105 (38%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
GT E++APEI+ E G D W+ G+ Y LL G +PF G +ETLAN+ S F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 903 PDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+ S A+D IR LL+KE RL E +HP+
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRL----TIQEALRHPWITP 278
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 53/153 (34%), Positives = 74/153 (48%), Gaps = 10/153 (6%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
++ L +G G G V +A GT A K + F+ + + E EI++ LDHP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHP 66
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ LY F + LVME C GG+L + K + F E A + +VL A+ Y H
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH 123
Query: 729 MLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
L V +RDLKPEN L D + L DF L+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 7/107 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+ VGT Y++P++++G +G D W+ G+ +Y LL G PF + E + + +
Sbjct: 166 RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
FP+ +S QA LIR LL K P+ R+ + + +H +FE
Sbjct: 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRI----TSLQALEHEWFEK 267
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+N++ LG G G V + T +A+KV++ + K E E+L+ LDHP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ L+ + +V E GG+L + ++ K FSE A + +V + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH 138
Query: 729 MLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
+++RDLKPENIL+ +D I + DF LS
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-20
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 7/107 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+GT Y+APE+++G + D W+ G+ LY LL G PF G + L V
Sbjct: 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
F IS A+DLIR +L P R+ A + +HP+ +
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRI----TATQCLEHPWIQK 282
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 11/161 (6%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-ARRKKMPRAQTERE--ILRML 666
+++ ++LG G V T +A K + + R+ + R ERE IL+ +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HP + TL+ + + L++E GG+L L +K + +E A ++ ++L +
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVY 128
Query: 726 YLHMLGVIYRDLKPENILVR----EDGHIMLTDFDLSLRCS 762
YLH L + + DLKPENI++ I + DF L+ +
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
GT E++APEI+ E G D W+ G+ Y LL G +PF G +ETLANV + +F
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 903 PDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947
D S A+D IR LL+K+P+ R+ + QHP+ + +
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKD 279
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-32
Identities = 38/153 (24%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L ++LG G V + +A +++ + L+ R + + E I R+L HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKHP 70
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+ L+ + + L+ + GG+L + + + +SE A + ++L A+ + H
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCH 127
Query: 729 MLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
+GV++R+LKPEN+L+ + + L DF L+
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-20
Identities = 33/105 (31%), Positives = 50/105 (47%), Gaps = 6/105 (5%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
F GT YL+PE+++ + +G VD W G+ LY LL G PF + + F
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF 232
Query: 903 PDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
P ++ +A+DLI +L P R+ AAE +HP+
Sbjct: 233 PSPEWDTVTPEAKDLINKMLTINPSKRI----TAAEALKHPWISH 273
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 59/188 (31%), Positives = 86/188 (45%), Gaps = 30/188 (15%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-------------- 655
+ L ++G G G V LA N +A+KV+ + L R+ PR
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 656 -------AQTEREI--LRMLDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
Q +EI L+ LDHP + L D+L +V E G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTL- 131
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
K SE ARFY +++ +EYLH +I+RD+KP N+LV EDGHI + DF +S
Sbjct: 132 --KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 764 SPTLLKSS 771
S LL ++
Sbjct: 190 SDALLSNT 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 7/113 (6%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEG---HGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+ +DA ++ VGT ++APE + G A+D W G+ LY ++G+ PF
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247
Query: 891 TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ + Q+L+FPD P I+ +DLI +L K PE+R+ EIK HP+
Sbjct: 248 LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI----VVPEIKLHPWV 296
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-ARRKKMPRAQTERE--ILRML 666
+++ ++LG G V T +A K + A R+ + R + ERE ILR +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLRQKQLGKCFSEPAARFYVAEVLLA 723
HP + TL+ + + L++E GG+L ++ SE A ++ ++L
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LSEEEATSFIKQILDG 127
Query: 724 LEYLHMLGVIYRDLKPENILVR----EDGHIMLTDFDLS 758
+ YLH + + DLKPENI++ HI L DF L+
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 40/105 (38%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
GT E++APEI+ E G D W+ G+ Y LL G +PF G +ETLAN+ S F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 903 PDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+ S A+D IR LL+KE RL E +HP+
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRL----TIQEALRHPWITP 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 31/151 (20%), Positives = 60/151 (39%), Gaps = 2/151 (1%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
F+ L+K+G G+ G+V+ C++AIK + + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVL--RQKQLGKCFSEPAARFYVAEVLLALE 725
H + +S + D+ + EYC GG L ++ F E + + +V L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFD 756
Y+H + +++ D+KP NI + +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEE 160
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 16/107 (14%), Positives = 40/107 (37%), Gaps = 17/107 (15%)
Query: 841 NSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
G +LA E+++ H D + + + + +G++
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR-NGDQ-------WHE 239
Query: 900 L---KFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ + P P ++S + +L++ ++ +PE R A + +H
Sbjct: 240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERR----PSAMALVKHSV 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 15/164 (9%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L F +Q LG G G V+ A+ +C +AIK + ++ + E + L L+
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLE 61
Query: 668 HPFLPTLYSQFTSDNLS------------CLVMEYCPGGDL-HVLRQKQLGKCFSEPAAR 714
HP + ++ + N + + M+ C +L + + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++ A+E+LH G+++RDLKP NI D + + DF L
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-18
Identities = 34/118 (28%), Positives = 48/118 (40%), Gaps = 9/118 (7%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
L P AR VGT Y++PE I G + VD ++ G+ L+ELLY PF
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV 234
Query: 891 TLANVVMQSLKFPDSPL-ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947
V KFP +++ +L P R A I ++ FE L+
Sbjct: 235 RTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERP----EAINIIENAVFEDLD 287
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 13/235 (5%)
Query: 535 NDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWE 594
+ D + K Q S+S + SN+D + ++ D+
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 595 A----IRHVRLQYGSIGLRHFNLLQK--LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA 648
R V + G++ + + + LG G G V+ E T A K++ +
Sbjct: 70 PAPFDHRIVTAKQGAVN-SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK 128
Query: 649 RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCF 708
++++ E ++ LDH L LY F S N LVMEY GG+L R
Sbjct: 129 DKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD-RIIDESYNL 184
Query: 709 SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLSLRC 761
+E ++ ++ + ++H + +++ DLKPENIL R+ I + DF L+ R
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 36/106 (33%), Positives = 53/106 (50%), Gaps = 6/106 (5%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
GT E+LAPE++ + D W+ G+ Y LL G +PF G + ETL N++
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 904 DS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947
D IS +A++ I LLIKE R+ A+E +HP+
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRI----SASEALKHPWLSDHK 350
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 9/184 (4%)
Query: 579 SSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFA 638
SS + D++ + + G + + ++KLG G G V L T+ A
Sbjct: 8 SSGRENLYFQGDLQATPGMFITSKKGHLS-EMYQRVKKLGSGAYGEVLLCRDKVTHVERA 66
Query: 639 IKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-H 697
IK++ + + E +L++LDHP + LY F LVME GG+L
Sbjct: 67 IKIIRKTSV-STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD 125
Query: 698 VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR---EDGHIMLTD 754
+ + F+E A + +VL + YLH +++RDLKPEN+L+ +D I + D
Sbjct: 126 EIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVD 182
Query: 755 FDLS 758
F LS
Sbjct: 183 FGLS 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-20
Identities = 32/126 (25%), Positives = 58/126 (46%), Gaps = 7/126 (5%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+GT Y+APE+++ + + D W+ G+ L+ LL G PF G ++E L V
Sbjct: 196 KERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY 254
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPE 958
F +S A+DLI+ +L + + R+ A + +HP+ + + P
Sbjct: 255 TFDSPEWKNVSEGAKDLIKQMLQFDSQRRI----SAQQALEHPWIKEMCSKKESGIELPS 310
Query: 959 LPDFYD 964
L + +
Sbjct: 311 LANAIE 316
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 49/233 (21%), Positives = 89/233 (38%), Gaps = 17/233 (7%)
Query: 535 NDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWE 594
N +S+P + + Y S ++ +
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRR--GYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQY 143
Query: 595 AIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP 654
+ V +++ + H+++ ++LG G G V+ T FA K F+ +
Sbjct: 144 YPQPVEIKHDHVL-DHYDIHEELGTGAFGVVHRVTERATGNNFAAK-----FVMTPHESD 197
Query: 655 RAQTERE--ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSE 710
+ +E + +L HP L L+ F DN ++ E+ GG+L V + SE
Sbjct: 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN---KMSE 254
Query: 711 PAARFYVAEVLLALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLSLRC 761
A Y+ +V L ++H ++ DLKPENI+ + + L DF L+
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 5e-20
Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 6/100 (6%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
GT E+ APE+ +G+ G D W+ G+ Y LL G +PF G ++ETL NV
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 904 DS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
DS IS +D IR LL+ +P R+ + +HP
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHP 412
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 41/150 (27%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPT 673
+ LG G +N FA+K++ ++ Q E L++ + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIIS------KRMEANTQKEITALKLCEGHPNIVK 70
Query: 674 LYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
L+ F + LVME GG+L + ++K FSE A + + +++ A+ ++H +G
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFSETEASYIMRKLVSAVSHMHDVG 126
Query: 732 VIYRDLKPENILVR---EDGHIMLTDFDLS 758
V++RDLKPEN+L ++ I + DF +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFA 156
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 13/121 (10%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG-------S 886
P + + T Y APE++ G+ + D W+ G+ LY +L G+ PF+ +
Sbjct: 160 PPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT 219
Query: 887 GNEETLANVVMQSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
E + + F +S +A+DLI+GLL +P RL + ++ + + +
Sbjct: 220 SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL----KMSGLRYNEWLQ 275
Query: 945 G 945
Sbjct: 276 D 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 43/164 (26%), Positives = 71/164 (43%), Gaps = 14/164 (8%)
Query: 600 RLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE 659
Q S+ R +++L+++G G V+ L ++AIK ++ L
Sbjct: 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN---LEEADNQTLDSYR 74
Query: 660 REI--LRMLDHPFLP--TLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAAR 714
EI L L LY +D +VME DL+ L++K K +
Sbjct: 75 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK---KSIDPWERK 130
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
Y +L A+ +H G+++ DLKP N L+ DG + L DF ++
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 29/120 (24%), Positives = 51/120 (42%), Gaps = 16/120 (13%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEG-----------HGAAVDWWTFGIFLYELLYGRTPFK 884
T +S VGT Y+ PE IK D W+ G LY + YG+TPF+
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 885 GSGNE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
N+ L ++ + + + +D+++ L ++P+ R+ E+ HP+
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYV 296
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE---RE--ILR 664
++++ ++LG G V T FA K+++ KK+ + RE I R
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICR 83
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLA 723
L HP + L+ ++ LV + GG+L + + + +SE A + ++L +
Sbjct: 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILES 140
Query: 724 LEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
+ Y H G+++R+LKPEN+L+ + + L DF L+
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 29/107 (27%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+ F GT YL+PE++K + + VD W G+ LY LL G PF A + +
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY 247
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+P ++ +A+ LI +L P+ R+ A + + P+
Sbjct: 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRI----TADQALKVPWICN 290
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 6/157 (3%)
Query: 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL 663
G + + H+ L LG G G V + E T A+K+++ + + + + + E + L
Sbjct: 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL 65
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVL 721
++ HP + LY ++ +VMEY GG+L ++ + ++ E AR ++L
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRV----EEMEARRLFQQIL 121
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A++Y H V++RDLKPEN+L+ + + DF LS
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 27/100 (27%), Positives = 42/100 (42%), Gaps = 7/100 (7%)
Query: 845 GTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
G+ Y APE+I G G VD W+ G+ LY LL G PF + P
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231
Query: 904 DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ ++ L+ +L +P R +I++H +F
Sbjct: 232 EY--LNRSVATLLMHMLQVDPLKRA----TIKDIREHEWF 265
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 14/168 (8%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLD 667
++L+Q LG G G V LA T A+K++D + R P ++EI +ML+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPE-NIKKEICINKMLN 63
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
H + Y N+ L +EYC GG+L + + EP A+ + +++ +
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPDAQRFFHQLMAGVV 119
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSS 771
YLH +G+ +RD+KPEN+L+ E ++ ++DF L+ R + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 7/115 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQ 898
N GT Y+APE++K H VD W+ GI L +L G P+ + + ++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNWALIR 952
I L+ +L++ P R+ +IK+ ++ + L R
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYNKPLKKGAKR 275
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 16/155 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F + +LG G VY + GT +A+KV+ + +TE +L L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-----KTVDKKIVRTEIGVLLRLSHP 108
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLH---VLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+ L F + LV+E GG+L V + +SE A V ++L A+ Y
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-----YSERDAADAVKQILEAVAY 163
Query: 727 LHMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
LH G+++RDLKPEN+L D + + DF LS
Sbjct: 164 LHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 7/108 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-S 899
+ GT Y APEI++G +G VD W+ GI Y LL G PF ++ + ++
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267
Query: 900 LKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
F +S A+DL+R L++ +P+ RL + QHP+ G
Sbjct: 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRL----TTFQALQHPWVTG 311
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-31
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 12/159 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ + ++LG G G V T AIK E + ++ R E +I++ L+HP
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRE--RWCLEIQIMKKLNHP 72
Query: 670 FLPTLY------SQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLL 722
+ + + ++L L MEYC GGDL L Q + E R ++++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLS 758
AL YLH +I+RDLKPENI+++ + D +
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 3e-15
Identities = 26/129 (20%), Positives = 51/129 (39%), Gaps = 26/129 (20%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-- 898
FVGT +YLAPE+++ + + VD+W+FG +E + G PF + V +
Sbjct: 181 TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 899 ------------SLKFPD--------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938
++KF S +++ + ++ +L+ R +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG----TDPQNP 296
Query: 939 QHPFFEGLN 947
F+ L+
Sbjct: 297 NVGCFQALD 305
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 18/174 (10%)
Query: 599 VRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--------MDNEFLARR 650
VR + G IG + ++KLG G G V L + + AIKV +
Sbjct: 27 VRKKEGKIG-ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 651 KKMPRAQTERE--ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKC 707
+ + E +L+ LDHP + L+ F LV E+ GG+L + +
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR---HK 142
Query: 708 FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
F E A + ++L + YLH +++RD+KPENIL+ +I + DF LS
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-19
Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 7/107 (6%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+GT Y+APE++K + + D W+ G+ +Y LL G PF G +++ + V
Sbjct: 206 RDRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264
Query: 901 KFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
F + IS +A++LI+ +L + R A E + +
Sbjct: 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRC----TAEEALNSRWIKK 307
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI-- 662
S+ R +++L+++G G V+ L ++AIK ++ L EI
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAY 60
Query: 663 LRMLDHPFLP--TLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAE 719
L L LY +D +VME DL+ L++K K + Y
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKK---KSIDPWERKSYWKN 116
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+L A+ +H G+++ DLKP N L+ DG + L DF ++
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 16/126 (12%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEG-----------HGAAVDWWTFGIFLYELLY 878
Q+ + T +S VGT Y+ PE IK D W+ G LY + Y
Sbjct: 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215
Query: 879 GRTPFKGSGNE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEI 937
G+TPF+ N+ L ++ + + + +D+++ L ++P+ R+ E+
Sbjct: 216 GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPEL 271
Query: 938 KQHPFF 943
HP+
Sbjct: 272 LAHPYV 277
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 48/156 (30%), Positives = 69/156 (44%), Gaps = 18/156 (11%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDH 668
+ + + +G G TN FA+K++D K E EIL R H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDPTEEIEILLRYGQH 75
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
P + TL + +V E GG+L +LRQK FSE A + + +EY
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTVEY 131
Query: 727 LHMLGVIYRDLKPENILVREDGH----IMLTDFDLS 758
LH GV++RDLKP NIL ++ I + DF +
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 9/108 (8%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---ETLANVVMQS 899
T ++APE+++ +G+ AA D W+ G+ LY +L G TPF ++ E LA +
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239
Query: 900 LKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+S A+DL+ +L +P RL AA + +HP+
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL----TAALVLRHPWIVH 283
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 14/168 (8%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLD 667
++L+Q LG G G V LA T A+K++D + R P ++EI +ML+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPE-NIKKEICINKMLN 63
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
H + Y N+ L +EYC GG+L + + EP A+ + +++ +
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM----PEPDAQRFFHQLMAGVV 119
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLLKSS 771
YLH +G+ +RD+KPEN+L+ E ++ ++DF L+ R + LL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 27/121 (22%), Positives = 49/121 (40%), Gaps = 7/121 (5%)
Query: 841 NSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQ 898
N GT Y+APE++K H VD W+ GI L +L G P+ + + ++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK 224
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNWALIRCAIPP 957
I L+ +L++ P R+ +IK+ ++ + L R +
Sbjct: 225 KTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYNKPLKKGAKRPRVTS 280
Query: 958 E 958
Sbjct: 281 G 281
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 10/156 (6%)
Query: 610 HFNLLQK-LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRML 666
+ L K LG G V T +A K + RR + RA+ E +L +
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK---KRRRGQDCRAEILHEIAVLELA 85
Query: 667 DH-PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
P + L+ + + + L++EY GG++ L +L + SE + ++L +
Sbjct: 86 KSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 726 YLHMLGVIYRDLKPENILV---REDGHIMLTDFDLS 758
YLH +++ DLKP+NIL+ G I + DF +S
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
+GT EYLAPEI+ + A D W GI Y LL +PF G N+ET N+ ++ +
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 903 PDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960
+ +S A D I+ LL+K PE R A H + + ++ +
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRP----TAEICLSHSWLQQWDFENLFHPEETSSS 308
Query: 961 D 961
Sbjct: 309 S 309
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-30
Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 3/148 (2%)
Query: 610 HFNLLQKLGCG--DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ LL +G G D+ TV LA T ++ ++ E + + Q E + ++ +
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE-ACSNEMVTFLQGELHVSKLFN 84
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
HP + + F +DN +V + G L +E A + + VL AL+Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDF 755
H +G ++R +K +IL+ DG + L+
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGL 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 26/150 (17%), Positives = 40/150 (26%), Gaps = 50/150 (33%)
Query: 840 SNSFVGTHEYLAPEIIK--GEGHGAAVDWWTFGIFLYELLYGRTPF-------------- 883
V +L+PE+++ +G+ A D ++ GI EL G PF
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 884 ------------------------------KGSGNEETLANVVMQSLKFPDSPLISFQAR 913
S T S P S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ L + P+ R A+ + H FF
Sbjct: 312 HFVEQCLQRNPDARP----SASTLLNHSFF 337
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD-----NEFLARRKKMPRAQTEREILR 664
++ + LG G G V+ A N +K + + K+ + E IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVME-YCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVL 721
++H + + F + LVME + G DL + R +L EP A + +++
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL----DEPLASYIFRQLV 140
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A+ YL + +I+RD+K ENI++ ED I L DF +
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 13/102 (12%)
Query: 843 FVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
F GT EY APE++ G G ++ W+ G+ LY L++ PF L V ++
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVEAAIH 242
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
P L+S + L+ GLL PE R ++ P+
Sbjct: 243 PP--YLVSKELMSLVSGLLQPVPERRT----TLEKLVTDPWV 278
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 46/224 (20%), Positives = 86/224 (38%), Gaps = 20/224 (8%)
Query: 554 SQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNL 613
QS + + + P ++ ++++ +I +
Sbjct: 7 GQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT 66
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLP 672
Q LG G G V T FA+K++ P+A+ E E+ R P +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARREVELHWRASQCPHIV 118
Query: 673 TLYSQF----TSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+ + +VME GG+L + + + F+E A + + A++Y
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQY 176
Query: 727 LHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCSVSPTL 767
LH + + +RD+KPEN+L R + + LTDF + + +L
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 220
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 30/107 (28%), Positives = 47/107 (43%), Gaps = 10/107 (9%)
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET----LANVV 896
+ T Y+APE++ E + + D W+ G+ +Y LL G PF + +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 897 MQSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
M +FP+ +S + + LIR LL EP R+ E HP
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHP 323
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 46/146 (31%), Positives = 78/146 (53%), Gaps = 4/146 (2%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ ++ +LG G G VY A+ T L A KV++ + +++ E EIL DHP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHP 76
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
++ L + D +++E+CPGG + + +L + +EP + ++L AL +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 730 LGVIYRDLKPENILVREDGHIMLTDF 755
+I+RDLK N+L+ +G I L DF
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 31/123 (25%), Positives = 49/123 (39%), Gaps = 28/123 (22%)
Query: 836 TDARSNSFVGTHEYLAPEII-----KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
T + +SF+GT ++APE++ K + D W+ GI L E+ P
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP-------- 221
Query: 891 TLANV-VMQSL---------KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ M+ L S + RD ++ L K PE R AA++ +H
Sbjct: 222 -HHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR----PSAAQLLEH 276
Query: 941 PFF 943
PF
Sbjct: 277 PFV 279
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 69/395 (17%), Positives = 120/395 (30%), Gaps = 98/395 (24%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML--- 666
+++++KLG G TV+L+ I A+KV + A E +L+ +
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNS 93
Query: 667 --DHP---FLPTLYSQFTSDNLS----CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYV 717
+ P + L F ++ C+V E G L K + P + +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 718 AEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776
+VL L+YLH +I+ D+KPENIL+ + + + S
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA---------- 202
Query: 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836
V +PK +++ A
Sbjct: 203 ----------------PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV 246
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE------ 890
+ T +Y + E++ G G+ D W+ +EL G F+ EE
Sbjct: 247 HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
Query: 891 ------------------------------------------TLANVVMQSLKFPDSPLI 908
L V+++ ++
Sbjct: 307 HIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAA 366
Query: 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
F D + +L PE R AAE +HP+
Sbjct: 367 GF--TDFLLPMLELIPEKRA----TAAECLRHPWL 395
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 36/154 (23%), Positives = 67/154 (43%), Gaps = 20/154 (12%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPT 673
Q LG G G V T A+K++ P+A+ E + P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLY--------DSPKARQEVDHHWQASGGPHIVC 86
Query: 674 LYSQFTSDNLSC----LVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
+ + + + ++ME GG+L + + + F+E A + ++ A+++L
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFL 144
Query: 728 HMLGVIYRDLKPENILV---REDGHIMLTDFDLS 758
H + +RD+KPEN+L +D + LTDF +
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 29/110 (26%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET----LANVVM 897
+ T Y+APE++ E + + D W+ G+ +Y LL G PF + + + +
Sbjct: 188 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 898 QSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
FP+ +S A+ LIR LL +P RL + HP+
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL----TITQFMNHPWINQ 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 42/152 (27%), Positives = 65/152 (42%), Gaps = 8/152 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L + +G G V A AIK ++ E + M E + + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQ-----LGKCFSEPAARFYVAEVLLA 723
+ + Y+ F + LVM+ GG + +++ E + EVL
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
LEYLH G I+RD+K NIL+ EDG + + DF
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 35/137 (25%), Positives = 52/137 (37%), Gaps = 28/137 (20%)
Query: 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIK-GEGHGAAVDWWTFGIFLYELLYGR 880
+A L + +FVGT ++APE+++ G+ D W+FGI EL G
Sbjct: 168 SAF---LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
Query: 881 TPF--------------KGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926
P+ + ET K+ R +I L K+PE
Sbjct: 225 APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY------GKSFRKMISLCLQKDPEK 278
Query: 927 RLGSQKGAAEIKQHPFF 943
R AAE+ +H FF
Sbjct: 279 RP----TAAELLRHKFF 291
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 47/155 (30%), Positives = 84/155 (54%), Gaps = 9/155 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
IG + + + LG G G V LA T A+K + + L + R + E L++
Sbjct: 8 IG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLA 723
L HP + LY T+ +V+EY GG+L +++ +K++ +E R + +++ A
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRM----TEDEGRRFFQQIICA 120
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EY H +++RDLKPEN+L+ ++ ++ + DF LS
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 7/100 (7%)
Query: 845 GTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
G+ Y APE+I G+ G VD W+ GI LY +L GR PF V P
Sbjct: 169 GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP 228
Query: 904 DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
D +S A+ LIR +++ +P R+ EI++ P+F
Sbjct: 229 DF--LSPGAQSLIRRMIVADPMQRI----TIQEIRRDPWF 262
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 44/205 (21%), Positives = 77/205 (37%), Gaps = 14/205 (6%)
Query: 559 SSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLG 618
S G + + + + + S+ R +++L+++G
Sbjct: 6 HSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIG 65
Query: 619 CGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLDHPFLP--TL 674
G V+ L ++AIK ++ L EI L L L
Sbjct: 66 SGGSSKVFQV-LNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 675 YSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
Y +D +VME DL+ L++K K + Y +L A+ +H G++
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 734 YRDLKPENILVREDGHIMLTDFDLS 758
+ DLKP N L+ DG + L DF ++
Sbjct: 178 HSDLKPANFLI-VDGMLKLIDFGIA 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 27/115 (23%), Positives = 49/115 (42%), Gaps = 16/115 (13%)
Query: 841 NSFVGTHEYLAPEIIKGEG-----------HGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889
+S VG Y+ PE IK D W+ G LY + YG+TPF+ N+
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 890 -ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
L ++ + + + +D+++ L ++P+ R+ E+ HP+
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI----SIPELLAHPYV 324
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
H+ L LG G G V + + T A+K+++ + + + + + E + L++ HP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
+ LY ++ + +VMEY GG+L ++ + +L E +R ++L ++Y
Sbjct: 77 HIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRL----DEKESRRLFQQILSGVDYC 132
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H V++RDLKPEN+L+ + + DF LS
Sbjct: 133 HRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 34/131 (25%), Positives = 51/131 (38%), Gaps = 13/131 (9%)
Query: 843 FVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
G+ Y APE+I G G VD W+ G+ LY LL G PF +
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY 234
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNWALIRCAIPPELP 960
P ++ L++ +L +P R +I++H +F + L L PE P
Sbjct: 235 TPQY--LNPSVISLLKHMLQVDPMKRA----TIKDIREHEWFKQDLPKYLF-----PEDP 283
Query: 961 DFYDYGIQDMV 971
+ I D
Sbjct: 284 SYSSTMIDDEA 294
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 45/146 (30%), Positives = 65/146 (44%), Gaps = 2/146 (1%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F+ L+++G G G VY A + + + AIK M +K E L+ L HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ ++ + LVMEYC G +L + K E L L YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 730 LGVIYRDLKPENILVREDGHIMLTDF 755
+I+RD+K NIL+ E G + L DF
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 31/118 (26%), Positives = 50/118 (42%), Gaps = 25/118 (21%)
Query: 838 ARSNSFVGTHEYLAPEII---KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
A +NSFVGT ++APE+I + VD W+ GI EL + P L N
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP---------LFN 255
Query: 895 V----VMQSLKFPDSPLI-----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ + + +SP + S R+ + L K P++R + + +H F
Sbjct: 256 MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR----PTSEVLLKHRFV 309
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 46/145 (31%), Positives = 69/145 (47%), Gaps = 6/145 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
F++L+KLG G G+VY A T + AIK + E + E I++ D P
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPH 85
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ Y + + +VMEYC G + + + K +E + L LEYLH +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDI-IRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 731 GVIYRDLKPENILVREDGHIMLTDF 755
I+RD+K NIL+ +GH L DF
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 23/119 (19%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
T A+ N+ +GT ++APE+I+ G+ D W+ GI E+ G+ P A+
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP---------YAD 227
Query: 895 V-VMQSL---------KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ M+++ F L S D ++ L+K PE R A ++ QHPF
Sbjct: 228 IHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR----ATATQLLQHPFV 282
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 46/225 (20%), Positives = 77/225 (34%), Gaps = 32/225 (14%)
Query: 537 SDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAI 596
S ++ + K+ S + T +++ L+ +V W
Sbjct: 7 SGQAHSLASLAKTWSSGSAKLQRL----GPETEDNEGVLLTEKLKPVDYEYREEVHW--- 59
Query: 597 RHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRA 656
++G G G V+ + T A+K + E
Sbjct: 60 --------------MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ 99
Query: 657 QTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFY 716
E L P + LY + ME GG L L ++ C E A +Y
Sbjct: 100 --ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYY 155
Query: 717 VAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLR 760
+ + L LEYLH +++ D+K +N+L+ DG L DF +L
Sbjct: 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 11/111 (9%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA-- 893
+ + GT ++APE++ G+ A VD W+ + +L G P+
Sbjct: 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW---TQYFRGPLC 265
Query: 894 -NVVMQSLKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ + + P + I+ L KEP +R A E+++
Sbjct: 266 LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHR----ASAMELRRKVG 312
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 16/167 (9%)
Query: 599 VRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQT 658
++++ +I + Q LG G G V T FA+K++ P+A+
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--------DCPKARR 59
Query: 659 EREIL-RMLDHPFLPTLYSQF----TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAA 713
E E+ R P + + + +VME GG+L Q + + F+E A
Sbjct: 60 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 119
Query: 714 RFYVAEVLLALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDL 757
+ + A++YLH + + +RD+KPEN+L + + LTDF
Sbjct: 120 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 27/102 (26%), Positives = 41/102 (40%), Gaps = 11/102 (10%)
Query: 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET----LANVVMQSLKFPDS 905
A E E + + D W+ G+ +Y LL G PF + + M +FP+
Sbjct: 166 FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 906 P--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
+S + + LIR LL EP R+ E HP+
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIMQ 262
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 44/147 (29%), Positives = 67/147 (45%), Gaps = 7/147 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F L+K+G G G V+ T + AIK++D E ++ Q E +L D P
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSP 80
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
++ Y + D ++MEY GG +L E + E+L L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH 136
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDF 755
I+RD+K N+L+ E G + L DF
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 23/122 (18%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889
QL T + N+FVGT ++APE+IK + + D W+ GI EL G P
Sbjct: 168 QLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP------- 218
Query: 890 ETLANV----VMQSLKFPDSPLI----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
+ + V+ + + P + S ++ + L KEP R A E+ +H
Sbjct: 219 --HSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP----TAKELLKHK 272
Query: 942 FF 943
F
Sbjct: 273 FI 274
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-28
Identities = 42/183 (22%), Positives = 66/183 (36%), Gaps = 20/183 (10%)
Query: 582 GNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV 641
G+ P + D E V +G F LG G GT+ + N A+K
Sbjct: 2 GSSPSLEQDDGDEETSVVI-----VGKISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKR 55
Query: 642 MDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLR 700
+ + A E ++LR D HP + + + +E C +
Sbjct: 56 IL------PECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVE 109
Query: 701 QKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH-----IMLTDF 755
QK + + L +LH L +++RDLKP NIL+ M++DF
Sbjct: 110 QK--DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167
Query: 756 DLS 758
L
Sbjct: 168 GLC 170
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-16
Identities = 27/117 (23%), Positives = 51/117 (43%), Gaps = 13/117 (11%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNE 889
+ +R + GT ++APE++ E VD ++ G Y ++ G PF +
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF--GKSL 234
Query: 890 ETLANVVMQSLKFP---DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ AN+++ + AR+LI ++ +P+ R A + +HPFF
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP----SAKHVLKHPFF 287
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLD 667
++ ++ +G G+ G L T L A+K ++ R +REI R L
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIE------RGAAIDENVQREIINHRSLR 74
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HP + + ++MEY GG+L + G+ FSE ARF+ ++L +
Sbjct: 75 HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA---GR-FSEDEARFFFQQLLSGVS 130
Query: 726 YLHMLGVIYRDLKPENILVRED--GHIMLTDFDLSLRCSVSPTLLKSS 771
Y H + + +RDLK EN L+ + + DF S + SV + KS+
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKST 177
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 8e-17
Identities = 38/140 (27%), Positives = 60/140 (42%), Gaps = 19/140 (13%)
Query: 842 SFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
S VGT Y+APE++ + G D W+ G+ LY +L G PF+ E +Q +
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPRDYRKTIQRI 234
Query: 901 K-----FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAI 955
PD IS + LI + + +P R+ EIK H +F +
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRI----SIPEIKTHSWF--------LKNL 282
Query: 956 PPELPDFYDYGIQDMVPQKS 975
P +L + + G Q P++
Sbjct: 283 PADLMNESNTGSQFQEPEQP 302
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 11/179 (6%)
Query: 587 MSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF 646
M++D ++ + L F L++ +G G G VY + T L AIKVMD
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT- 60
Query: 647 LARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSC------LVMEYCPGGDLHVL 699
+ + E +L+ H + T Y F N LVME+C G + L
Sbjct: 61 ---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117
Query: 700 RQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ G E + E+L L +LH VI+RD+K +N+L+ E+ + L DF +S
Sbjct: 118 IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 29/136 (21%), Positives = 52/136 (38%), Gaps = 35/136 (25%)
Query: 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE-----GHGAAVDWWTFGIFLYEL 876
+AQ+ T R N+F+GT ++APE+I + + D W+ GI E+
Sbjct: 176 SAQLDR--------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
Query: 877 LYGRTPFKGSGNEETLANV----VMQSLKFPDSPLI-----SFQARDLIRGLLIKEPENR 927
G P L ++ + + +P + S + + I L+K R
Sbjct: 228 AEGAPP---------LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 278
Query: 928 LGSQKGAAEIKQHPFF 943
++ +HPF
Sbjct: 279 ----PATEQLMKHPFI 290
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 47/145 (32%), Positives = 70/145 (48%), Gaps = 6/145 (4%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ +K+G G GTVY A + T AI+ M+ L ++ K E ++R +P
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ + + +VMEY GG L + + C E E L ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 731 GVIYRDLKPENILVREDGHIMLTDF 755
VI+RD+K +NIL+ DG + LTDF
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDF 160
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 33/132 (25%), Positives = 57/132 (43%), Gaps = 29/132 (21%)
Query: 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRT 881
AQI P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G
Sbjct: 163 CAQI--------TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 882 PFKGSGNEETLANVVMQSL---------KFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932
P+ NE +++L + + +S RD + L + E R
Sbjct: 215 PY---LNENP-----LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR----G 262
Query: 933 GAAEIKQHPFFE 944
A E+ QH F +
Sbjct: 263 SAKELLQHQFLK 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 44/146 (30%), Positives = 70/146 (47%), Gaps = 8/146 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ K+G G G V LA + A+K+MD L ++++ E I+R H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFN 103
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ +Y + ++ME+ GG L ++ Q +E VL AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHA 159
Query: 730 LGVIYRDLKPENILVREDGHIMLTDF 755
GVI+RD+K ++IL+ DG + L+DF
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDF 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 33/131 (25%), Positives = 57/131 (43%), Gaps = 29/131 (22%)
Query: 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRT 881
AQI + S VGT ++APE+I + VD W+ GI + E++ G
Sbjct: 188 CAQI--------SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 882 PFKGSGNEETLANVVMQSL---------KFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932
P+ ++ +Q++ K +S +S RD + +L+++P+ R
Sbjct: 240 PY---FSDSP-----VQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER----A 287
Query: 933 GAAEIKQHPFF 943
A E+ HPF
Sbjct: 288 TAQELLDHPFL 298
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 32/201 (15%), Positives = 54/201 (26%), Gaps = 32/201 (15%)
Query: 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML 666
G R L++ L GD V+L + FA+KV R ++ R L
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARL 119
Query: 667 DHPFLPTLYSQF--------------------------TSDNLSCLVMEYCPGGDLHVL- 699
+ + L+M DL +L
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLF 178
Query: 700 ----RQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
A A+++ L G+++ P+N+ + DG +ML D
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDV 238
Query: 756 DLSLRCSVSPTLLKSSSNMDP 776
+ P
Sbjct: 239 SALWKVGTRGPASSVPVTYAP 259
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 3e-22
Identities = 21/120 (17%), Positives = 33/120 (27%), Gaps = 13/120 (10%)
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGNE- 889
R + Y E + A++ W G+ +Y + PF
Sbjct: 241 LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 890 ------ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+L SL F + + LI L + RL E + P F
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPEF 356
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 5/158 (3%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTL 674
LG G G VY + AIK + + E + + L H +
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 675 YSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC-FSEPAARFYVAEVLLALEYLHMLGVI 733
F+ + + ME PGG L L + + G +E FY ++L L+YLH ++
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 734 YRDLKPENILV-REDGHIMLTDFDLSLRCSVSPTLLKS 770
+RD+K +N+L+ G + ++DF S R + ++
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 30/117 (25%), Positives = 48/117 (41%), Gaps = 21/117 (17%)
Query: 836 TDARSNSFVGTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
+ + +F GT +Y+APEII G+G A D W+ G + E+ G+ PF G
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---- 231
Query: 894 NVVMQSL----KFPDSPLI----SFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
++ F P I S +A+ I +P+ R A ++ F
Sbjct: 232 ---QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA----CANDLLVDEF 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 7/193 (3%)
Query: 592 RWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK 651
R EA + + G + F + +LG G+ G V+ + + A K++ E +
Sbjct: 16 RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 652 KMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEP 711
+ E ++L + P++ Y F SD + ME+ GG L + +K E
Sbjct: 76 N--QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQ 131
Query: 712 AARFYVAEVLLALEYLH-MLGVIYRDLKPENILVREDGHIMLTDFDLS--LRCSVSPTLL 768
V+ L YL +++RD+KP NILV G I L DF +S L S++ + +
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191
Query: 769 KSSSNMDPARVSG 781
+ S M P R+ G
Sbjct: 192 GTRSYMSPERLQG 204
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 21/71 (29%), Positives = 32/71 (45%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
D+ +NSFVGT Y++PE ++G + D W+ G+ L E+ GR P +E
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 896 VMQSLKFPDSP 906
Q
Sbjct: 243 GCQVEGDAAET 253
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 44/202 (21%), Positives = 82/202 (40%), Gaps = 15/202 (7%)
Query: 566 SSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTV 625
S+ + + G+ D+ + + + + + LG G G+V
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLES--QYQVGPLLGSGGFGSV 59
Query: 626 YLAELIGTNCLFAIKVMDNEFLARRKKMPR-AQTEREI--LRMLDHPFLP---TLYSQFT 679
Y + N AIK ++ + ++ ++P + E+ L+ + F L F
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFE 118
Query: 680 SDNLSCLVMEYC-PGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737
+ L++E P DL + ++ E AR + +VL A+ + H GV++RD+
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCGVLHRDI 175
Query: 738 KPENILV-REDGHIMLTDFDLS 758
K ENIL+ G + L DF
Sbjct: 176 KDENILIDLNRGELKLIDFGSG 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 36/147 (24%), Positives = 59/147 (40%), Gaps = 23/147 (15%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNE 889
A D F GT Y PE I+ HG + W+ GI LY+++ G PF+
Sbjct: 196 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--- 252
Query: 890 ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949
++ + F +S + + LIR L P +R EI+ HP+ + +
Sbjct: 253 ---EEIIRGQVFFR--QRVSSECQHLIRWCLALRPSDRP----TFEEIQNHPWMQDVL-- 301
Query: 950 LIRCAIPPELPDFYDYGIQDMVPQKSK 976
+P E + + + + P SK
Sbjct: 302 -----LPQETAEIH---LHSLSPGPSK 320
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 13/161 (8%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQT-EREI--LR 664
+ L LG G GTV+ + AIKV+ + + + T E+ L
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 665 MLD----HPFLPTLYSQFTSDNLSCLVMEY-CPGGDL-HVLRQKQLGKCFSEPAARFYVA 718
+ HP + L F + LV+E P DL + +K E +R +
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFG 146
Query: 719 EVLLALEYLHMLGVIYRDLKPENILV-REDGHIMLTDFDLS 758
+V+ A+++ H GV++RD+K ENIL+ G L DF
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 32/120 (26%), Positives = 45/120 (37%), Gaps = 14/120 (11%)
Query: 843 FVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
F GT Y PE I H W+ GI LY+++ G PF+ ++E L L
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFE--RDQEILEAE----LH 251
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNWALIRCAIPPELP 960
FP +S LIR L +P +R EI P+ + + P
Sbjct: 252 FPAH--VSPDCCALIRRCLAPKPSSRP----SLEEILLDPWMQTPAEDVPLNPSKGGPAP 305
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 33/157 (21%), Positives = 58/157 (36%), Gaps = 10/157 (6%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI-- 662
L ++G G G+V + + A+K + + + + Q ++
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST----VDEKEQKQLLMDLDV 73
Query: 663 -LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQ--KQLGKCFSEPAARFYVAE 719
+R D P++ Y + + ME + L E
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 720 VLLALEYLH-MLGVIYRDLKPENILVREDGHIMLTDF 755
+ AL +L L +I+RD+KP NIL+ G+I L DF
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 33/122 (27%), Positives = 47/122 (38%), Gaps = 15/122 (12%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAA----VDWWTFGIFLYELLYGRTPFKG 885
QLV + A++ G Y+APE I D W+ GI LYEL GR P+
Sbjct: 175 QLVD--SIAKTR-DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231
Query: 886 SGNE-ETLANVVMQ---SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941
+ + L VV L + S + + L K+ R E+ +HP
Sbjct: 232 WNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR----PKYKELLKHP 287
Query: 942 FF 943
F
Sbjct: 288 FI 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 40/162 (24%), Positives = 64/162 (39%), Gaps = 10/162 (6%)
Query: 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL 663
S R ++G G TVY T A + + L + + R + E E+L
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEML 79
Query: 664 RMLDHP----FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAE 719
+ L HP F + S LV E G L ++ K R + +
Sbjct: 80 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQ 137
Query: 720 VLLALEYLH--MLGVIYRDLKPENILV-REDGHIMLTDFDLS 758
+L L++LH +I+RDLK +NI + G + + D L+
Sbjct: 138 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 24/110 (21%), Positives = 51/110 (46%), Gaps = 8/110 (7%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+ + + +GT E++APE+ + E + +VD + FG+ + E+ P+ N +
Sbjct: 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241
Query: 896 VMQSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
V +K P S + + +++I G + + + R ++ H FF
Sbjct: 242 VTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFF 286
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 9/155 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--- 662
+ + +LG G G V + + + A+K + + + ++
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV----NSQEQKRLLMDLDIS 59
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQ-KQLGKCFSEPAARFYVAEVL 721
+R +D PF T Y + + ME +Q G+ E ++
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 722 LALEYLHM-LGVIYRDLKPENILVREDGHIMLTDF 755
ALE+LH L VI+RD+KP N+L+ G + + DF
Sbjct: 120 KALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 33/119 (27%), Positives = 46/119 (38%), Gaps = 12/119 (10%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAA----VDWWTFGIFLYELLYGRTPFKG 885
LV A+ + G Y+APE I E + D W+ GI + EL R P+
Sbjct: 159 YLVD--DVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215
Query: 886 SGNE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
G + L VV + + S + D L K + R E+ QHPFF
Sbjct: 216 WGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER----PTYPELMQHPFF 270
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 25/168 (14%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD- 667
+ LG G GTV A+K M A E ++L D
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRML------IDFCDIALMEIKLLTESDD 67
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGG--DLHVLRQK--QLGKCFSEPAARFYVAEVLLA 723
HP + Y T+D + +E C DL + + K E + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 724 LEYLHMLGVIYRDLKPENILV-------------REDGHIMLTDFDLS 758
+ +LH L +I+RDLKP+NILV E+ I+++DF L
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-17
Identities = 24/119 (20%), Positives = 48/119 (40%), Gaps = 19/119 (15%)
Query: 838 ARSNSFVGTHEYLAPEIIKGEGH-------GAAVDWWTFGIFLYELL-YGRTPFKGSGNE 889
N+ GT + APE+++ + ++D ++ G Y +L G+ PF
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF--GDKY 244
Query: 890 ETLANVVMQSLKFPDSPL-----ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+N++ + + +A DLI ++ +P R A ++ +HP F
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP----TAMKVLRHPLF 299
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 38/155 (24%), Positives = 62/155 (40%), Gaps = 10/155 (6%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI-- 662
+ L ++G G G V+ T + A+K M K + ++
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS----GNKEENKRILMDLDV 76
Query: 663 -LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
L+ D P++ + F ++ + ME + K++ E ++
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLK--KRMQGPIPERILGKMTVAIV 134
Query: 722 LALEYLH-MLGVIYRDLKPENILVREDGHIMLTDF 755
AL YL GVI+RD+KP NIL+ E G I L DF
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 29/121 (23%), Positives = 47/121 (38%), Gaps = 14/121 (11%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFK 884
+LV A+ + G Y+APE I + D W+ GI L EL G+ P+K
Sbjct: 174 RLVD--DKAK-DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYK 230
Query: 885 GSGNE-ETLANVV-MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ E L V+ + P S + ++ L K+ R ++ +H F
Sbjct: 231 NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR----PKYNKLLEHSF 286
Query: 943 F 943
Sbjct: 287 I 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 28/183 (15%), Positives = 53/183 (28%), Gaps = 31/183 (16%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR---- 664
R LG D A T F + V + + + E LR
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 665 ------------------MLDHPFLPTLYSQFTSDNLSCLVMEY----CPGGDLHVL--- 699
++ P + + ++ + +L
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 700 --RQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
K A +V+ L LH G+++ L+P +I++ + G + LT F+
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 758 SLR 760
+R
Sbjct: 258 LVR 260
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.4 bits (247), Expect = 4e-22
Identities = 23/126 (18%), Positives = 35/126 (27%), Gaps = 15/126 (11%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHG-----AAVDWWTFGIFLYELLYGRTPFKGSGN 888
+ E A ++ H A D WT G+ +Y + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 889 EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
+ F I R L+ G L E+RL + + P +E L
Sbjct: 323 LGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRL----LPLQAMETPEYEQLRT 372
Query: 949 ALIRCA 954
L
Sbjct: 373 ELSAAL 378
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-23
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 25/155 (16%)
Query: 613 LLQKLGCGDIGTVYLAE---LIGTNCLFAIKVM----DNEFLARRKKMPRAQTEREILRM 665
+ + G +G +YLA + G +K + D E A A ER+ L
Sbjct: 84 VKGCIAHGGLGWIYLALDRNVNGR--PVVLKGLVHSGDAEAQAM------AMAERQFLAE 135
Query: 666 LDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
+ HP + +++ + +VMEY G L + ++L A Y+ E+
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL----PVAEAIAYLLEI 191
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
L AL YLH +G++Y DLKPENI++ E+ + L D
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-10
Identities = 23/99 (23%), Positives = 35/99 (35%), Gaps = 14/99 (14%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
GT + APEI++ G A D +T G L L G +
Sbjct: 233 SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG---------RYVD 282
Query: 899 SLKFPDSPLISFQA-RDLIRGLLIKEPENRLGSQKGAAE 936
L D L ++ + L+R + +P R + A E
Sbjct: 283 GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTT---AEE 318
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 88/395 (22%), Positives = 139/395 (35%), Gaps = 123/395 (31%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI- 662
LR + L++KLG G G V+ + T + A+K N A+R T REI
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR-------TFREIM 60
Query: 663 -LR-MLDHPFLPTLYSQFTSDNLSC--LVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYV 717
L + H + L + +DN LV +Y DLH V+R L ++ V
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANIL----EPVHKQYVV 115
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPA 777
+++ ++YLH G+++RD+KP NIL+ + H+ + DF L +
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL-------------------S 156
Query: 778 RVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837
R P I + L TD
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDDDQPIL---------------------------TD 189
Query: 838 ARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSG--------- 887
+V T Y APEI+ G + +D W+ G L E+L G+ F GS
Sbjct: 190 -----YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244
Query: 888 ------NEETLANV-------VMQSLKFPD-----------------------SPLISFQ 911
+ E + ++ +++SLK + +
Sbjct: 245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEE 304
Query: 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946
A DL+ LL P R+ A + +HPF
Sbjct: 305 ALDLLDKLLQFNPNKRI----SANDALKHPFVSIF 335
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 42/158 (26%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
I + + + +G G G V A+ + AIK +++E + E L
Sbjct: 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESE-----SERKAFIVELRQLSR 57
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLAL 724
++HP + LY + + CLVMEY GG L+ VL + ++ A + + +
Sbjct: 58 VNHPNIVKLYG-ACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 725 EYLHML---GVIYRDLKPENILVREDGHIM-LTDFDLS 758
YLH + +I+RDLKP N+L+ G ++ + DF +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 1/87 (1%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG-SGNEETLANVVMQSL 900
+ G+ ++APE+ +G + D +++GI L+E++ R PF G + V
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT 221
Query: 901 KFPDSPLISFQARDLIRGLLIKEPENR 927
+ P + L+ K+P R
Sbjct: 222 RPPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 25/143 (17%), Positives = 46/143 (32%), Gaps = 4/143 (2%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
LL G + A + A+ +D + + + + L +D P +
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
+ + +V E+ GG L + S A + + A + H GV
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP----SPVGAIRAMQSLAAAADAAHRAGV 150
Query: 733 IYRDLKPENILVREDGHIMLTDF 755
P + V DG ++L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 18/97 (18%), Positives = 25/97 (25%), Gaps = 12/97 (12%)
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
+ + D G LY LL R P +G LA + P
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 904 DSP-----LISFQARDLIRGLLIKEPENRLGSQKGAA 935
P I FQ + + + R S
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNL 259
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 83/475 (17%), Positives = 133/475 (28%), Gaps = 145/475 (30%)
Query: 545 GKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYG 604
G + Q + + S S SS W+
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQI--------- 51
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF----LARRKKMPRAQTER 660
+ + +G G G V A + AIK + F +R R
Sbjct: 52 ---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-------ILR 101
Query: 661 EI--LRMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLH-VLRQKQLGKCFSEPA 712
EI L L+H + + ++ +V+E D + R +E
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY---LTELH 157
Query: 713 ARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
+ + +L+ ++Y+H G+++RDLKP N LV +D + + DF L
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL--------------- 202
Query: 773 NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832
AR ++ P R L V
Sbjct: 203 ----ART--------------VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELL----------YGRT 881
T Y APE+I + + A+D W+ G ELL R
Sbjct: 245 V------------TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292
Query: 882 P-FKGSG-----------------------------------NEETLANVVMQSLK---- 901
P F GS +EE + + + K
Sbjct: 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR 352
Query: 902 -FPDSPLISF---------QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946
FP A L++ +L+ P R+ E HPFF+ +
Sbjct: 353 IFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI----TINECLAHPFFKEV 403
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 16/150 (10%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREILRML 666
++ KLG G + TVYLAE N AIK + E L R ++ ++ L
Sbjct: 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ------L 68
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
H + ++ D+ LVMEY G L + S A + ++L ++
Sbjct: 69 SHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIK 125
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDF 755
+ H + +++RD+KP+NIL+ + + + DF
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 11/103 (10%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
++E + ++N +GT +Y +PE KGE D ++ GI LYE+L G PF G ET
Sbjct: 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG----ET 216
Query: 892 LANVVMQSL--KFPD-----SPLISFQARDLIRGLLIKEPENR 927
++ ++ + P+ I ++I K+ NR
Sbjct: 217 AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 3e-22
Identities = 77/411 (18%), Positives = 128/411 (31%), Gaps = 139/411 (33%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI- 662
++ + +G G G VYLA T AIK + ++ +R REI
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-------ILREIT 77
Query: 663 -LRMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLH-VLRQKQLGKCFSEPAARF 715
L L ++ LY D+L +V+E DL + + +E +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIF---LTEEHIKT 133
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMD 775
+ +LL ++H G+I+RDLKP N L+ +D + + DF L
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL------------------ 175
Query: 776 PARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835
AR ++N + + + QL
Sbjct: 176 -ARTINSEKDTNIVND----------------------LEENEEPGPHNKNLKKQL---- 208
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYG----------RTP-F 883
T V T Y APE+I + + ++D W+ G ELL R P F
Sbjct: 209 TS-----HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLF 263
Query: 884 KGSG--------------------------------NEETLANV-------VMQSLKFPD 904
GS E+ L N+ ++ P
Sbjct: 264 PGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF--PH 321
Query: 905 SPLISF---------QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946
I+ +L+ +L P R+ + HP+ + +
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRI----TIDQALDHPYLKDV 368
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 6/156 (3%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
I N+ +K+G G GTV+ AE G++ A+K++ + +++ E I++
Sbjct: 34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDV--AVKILMEQDFHA-ERVNEFLREVAIMKR 90
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLAL 724
L HP + T +V EY G L+ +L + + E +V +
Sbjct: 91 LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 725 EYLHMLG--VIYRDLKPENILVREDGHIMLTDFDLS 758
YLH +++R+LK N+LV + + + DF LS
Sbjct: 151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 25/92 (27%), Positives = 43/92 (46%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
T S S GT E++APE+++ E D ++FG+ L+EL + P+ + +A V
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
+ + ++ Q +I G EP R
Sbjct: 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 45/150 (30%), Positives = 64/150 (42%), Gaps = 16/150 (10%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREILRML 666
L + +G G +G VY AE + A+K+M D F R Q E L
Sbjct: 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR------MQREARTAGRL 91
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
P + ++ D + M G DL +LR++ + P A V ++ AL+
Sbjct: 92 QEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALD 148
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDF 755
H G +RD+KPENILV D L DF
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDF 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 8e-10
Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 11/105 (10%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
+ + + VGT Y+APE D + LYE L G P++G +
Sbjct: 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG----DQ 239
Query: 892 LANVVMQSLKFP------DSPLISFQARDLIRGLLIKEPENRLGS 930
L+ V+ + P I +I + K PE+R +
Sbjct: 240 LS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT 283
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 25/152 (16%), Positives = 48/152 (31%), Gaps = 2/152 (1%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L H +++ + + D L+ M + +
Sbjct: 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP-LSSPSPMDAPSVKIRRMDPFS 119
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA-ARFYVAEVLLALEY 726
+ + M+ C +L ++ E ++ A+E+
Sbjct: 120 TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LH G+++RDLKP NI D + + DF L
Sbjct: 180 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 8e-17
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 13/116 (11%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE--ET 891
P A VGT Y++PE I G + VD ++ G+ L+ELLY F + E
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFS-TQMERVRI 282
Query: 892 LANVVMQSLKFPDSPLISF-QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946
+ +V ++LKFP + Q +++ +L P R A +I ++ FE L
Sbjct: 283 ITDV--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIENAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 19/84 (22%), Positives = 33/84 (39%), Gaps = 2/84 (2%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L F +Q +G G G V+ A+ +C +AIK + R + E + L L+
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR--LPNRELAREKVMREVKALAKLE 62
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYC 691
HP + ++ + E
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMD 86
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 28/159 (17%), Positives = 59/159 (37%), Gaps = 9/159 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
I + N L KL G ++ G + +KV+ + RK E LR+
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRK-SRDFNEECPRLRI 63
Query: 666 LDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
HP + + + + L+ + P G L+ + + + A + ++
Sbjct: 64 FSHPNVLPVLGACQSPPAPHP-TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 723 ALEYLHMLG--VIYRDLKPENILVREDGHIMLTDFDLSL 759
+ +LH L + L ++++ ED ++ D+
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 3/91 (3%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGA---AVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV 896
S + ++APE ++ + + D W+F + L+EL+ PF N E V
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
++ L+ P IS L++ + ++P R
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 21/167 (12%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRA-QTEREILR 664
I L + +G G G VY A IG A+K ++ + + E ++
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA-EVLL 722
ML HP + L + CLVME+ GG L+ VL K++ P A ++
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRI-----PPDILVNWAVQIAR 116
Query: 723 ALEYLHMLG---VIYRDLKPENILVREDGHIM--------LTDFDLS 758
+ YLH +I+RDLK NIL+ + +TDF L+
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 24/86 (27%), Positives = 37/86 (43%)
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
S G + ++APE+I+ D W++G+ L+ELL G PF+G V M L
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA 232
Query: 902 FPDSPLISFQARDLIRGLLIKEPENR 927
P L+ +P +R
Sbjct: 233 LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 16/165 (9%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRA----QTERE 661
+ +++G G G V+ L+ + AIK + +M Q E
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEV 720
I+ L+HP + LY + +VME+ P GDL+ L K + ++
Sbjct: 76 IMSNLNHPNIVKLYG-LMHNPP-RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDI 131
Query: 721 LLALEYLHMLG--VIYRDLKPENILVREDG-----HIMLTDFDLS 758
L +EY+ +++RDL+ NI ++ + DF LS
Sbjct: 132 ALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 8/94 (8%)
Query: 840 SNSFVGTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGNEE--TLANV 895
+ +G +++APE I E + D ++F + LY +L G PF + + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 896 VMQSL--KFPDSPLISFQARDLIRGLLIKEPENR 927
+ L P+ R++I +P+ R
Sbjct: 243 REEGLRPTIPEDCPPRL--RNVIELCWSGDPKKR 274
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 29/181 (16%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRML 666
R LL+ +G G G V+ G N A+K+ F +R +K E E+ ML
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGEN--VAVKI----FSSRDEKS--WFRETELYNTVML 59
Query: 667 DHP----FLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA-EV 720
H F+ + + S L+ Y G L+ L+ L + + + +
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL-----DTVSCLRIVLSI 114
Query: 721 LLALEYLHML--------GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
L +LH+ + +RDLK +NILV+++G + D L++ S S L +
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 773 N 773
N
Sbjct: 175 N 175
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 29/133 (21%), Positives = 43/133 (32%), Gaps = 34/133 (25%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAA------VDWWTFGIFLYELLYGRTPFKGSGN 888
D +N VGT Y+APE++ VD W FG+ L+E+ +
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 889 ---------------EETLANVVMQSL--KFPDSPLISFQARDLIRGLLIKE-----PEN 926
E+ V + P+ L + L+KE P
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK--LMKECWYQNPSA 286
Query: 927 RLGSQKGAAEIKQ 939
RL A IK+
Sbjct: 287 RL----TALRIKK 295
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 43/156 (27%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
F L+KLG G TVY T A+K +D+E + P REI ++ L
Sbjct: 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-----EGTPS-TAIREISLMKEL 60
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVL----RQKQLGKCFSEPAARFYVAEVLL 722
H + LY ++N LV E+ DL + +++ ++L
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L + H +++RDLKP+N+L+ + G + L DF L+
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 29/139 (20%), Positives = 48/139 (34%), Gaps = 42/139 (30%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETL------- 892
+ E Y AP+++ G ++D W+ G L E++ G+ F G+ +EE L
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 893 -------------------------ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
+ Q L+ + D + GLL P+ R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 928 LGSQKGAAEIKQHPFFEGL 946
L A + HP+F
Sbjct: 286 L----SAKQALHHPWFAEY 300
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 46/199 (23%), Positives = 74/199 (37%), Gaps = 39/199 (19%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD----NEFLARRKKMPRAQTER 660
S+ L + LL+ +G G G VY L A+KV F+ E+
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANRQNFIN----------EK 56
Query: 661 EI--LRMLDHPFLPTLY------SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA 712
I + +++H + + LVMEY P G L S+
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEY-LLVMEYYPNGSLXKYLSLHT----SDWV 111
Query: 713 ARFYVA-EVLLALEYLHM---------LGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762
+ +A V L YLH + +RDL N+LV+ DG +++DF LS+R +
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 763 VSPTLLKSSSNMDPARVSG 781
+ + + G
Sbjct: 172 GNRLVRPGEEDNAAISEVG 190
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 7/76 (9%)
Query: 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKG-------EGHGAAVDWWTFGIFLY 874
+ ++ + D + S VGT Y+APE+++G E VD + G+ +
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
Query: 875 ELLYGRTPFKGSGNEE 890
E+ T +
Sbjct: 227 EIFMRCTDLFPGESVP 242
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 43/183 (23%), Positives = 72/183 (39%), Gaps = 19/183 (10%)
Query: 578 GSSCGNRPHMSADVR--WEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNC 635
+ H S D WE I + Q++G G GTVY + G
Sbjct: 2 KKGHHHHHHGSRDAADDWE-----------IPDGQITVGQRIGSGSFGTVYKGKWHGD-- 48
Query: 636 LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGD 695
A+K+++ +++ + E +LR H + T+ L +V ++C G
Sbjct: 49 -VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSS 105
Query: 696 LHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
L+ K F + ++YLH +I+RDLK NI + ED + + DF
Sbjct: 106 LYHHLHASETK-FEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 756 DLS 758
L+
Sbjct: 165 GLA 167
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 21/98 (21%), Positives = 43/98 (43%), Gaps = 7/98 (7%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGA---AVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
+ G+ ++APE+I+ + D + FGI LYEL+ G+ P+ N + +
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIK----EPENR 927
+V + PD + ++ L+ + + + R
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
F ++K+G G G VY A T + A+K +D E + +P REI L+ L
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE----TEGVPS-TAIREISLLKEL 59
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+HP + L ++N LV E+ DL P + Y+ ++L L +
Sbjct: 60 NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H V++RDLKP+N+L+ +G I L DF L+
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
+ L KLG G TVY + T+ L A+K +++E + P RE+ L+ L
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-----EGAPC-TAIREVSLLKDL 57
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
H + TL+ ++ LV EY DL G + + ++ ++L L Y
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY-LDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H V++RDLKP+N+L+ E G + L DF L+
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 6e-07
Identities = 35/151 (23%), Positives = 51/151 (33%), Gaps = 44/151 (29%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------ 887
+E Y P+I+ G +D W G YE+ GR F GS
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 888 ---NEETLANVV----MQSLKFPDSPLISFQ---------ARDLIRGLLIKEPENRLGSQ 931
EET ++ ++ +P + DL+ LL E NR+
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI--- 274
Query: 932 KGAAEIKQHPFFEGLNWALIRCAIPPELPDF 962
A + +HPFF L +LPD
Sbjct: 275 -SAEDAMKHPFFLSLG------ERIHKLPDT 298
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 9e-20
Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 20/154 (12%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREILRML 666
L + LG G + V+LA + + A+KV+ D F R ++ + L
Sbjct: 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAA------L 69
Query: 667 DHPFLPTLYSQFTSDNLSC----LVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVL 721
+HP + +Y ++ + +VMEY G L ++ + G + A +A+
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GP-MTPKRAIEVIADAC 126
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
AL + H G+I+RD+KP NI++ + + DF
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 27/101 (26%), Positives = 48/101 (47%), Gaps = 10/101 (9%)
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL 892
+ + ++ + +GT +YL+PE +G+ A D ++ G LYE+L G PF G ++
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSP 224
Query: 893 ANVVMQSLKFP------DSPLISFQARDLIRGLLIKEPENR 927
+V Q ++ +S ++ L K PENR
Sbjct: 225 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 45/152 (29%), Positives = 65/152 (42%), Gaps = 13/152 (8%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMPRAQTEREI--LRML 666
+ + K+G G G V+ T + AIK + + + + REI L+ L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-----DPVIKKIALREIRMLKQL 59
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HP L L F LV EYC + H L + Q G E + + L A+
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRG--VPEHLVKSITWQTLQAVN 116
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
+ H I+RD+KPENIL+ + I L DF
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 35/163 (21%), Positives = 54/163 (33%), Gaps = 46/163 (28%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------ 887
E Y +PE++ G+ G VD W G ELL G + G
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 888 ---NEETLANVV----MQSLKFPDS----------PLISFQARDLIRGLLIKEPENRLGS 930
+K PD P IS+ A L++G L +P RL
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL-- 277
Query: 931 QKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQ 973
++ HP+FE + +L +D +++ Q
Sbjct: 278 --TCEQLLHHPYFENIR-------EIEDLAKEHDKPAENLYFQ 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 36/184 (19%), Positives = 71/184 (38%), Gaps = 29/184 (15%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--L 663
+ +++++G G G V++ + G A+KV F + E EI
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKWRGEK--VAVKV----FFTTEEAS--WFRETEIYQT 85
Query: 664 RMLDHPFLPTLYSQFTSDNLS----CLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA 718
++ H + + S L+ +Y G L+ L+ L + + +A
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL-----DAKSMLKLA 140
Query: 719 -EVLLALEYLHML--------GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769
+ L +LH + +RDLK +NILV+++G + D L+++ +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 770 SSSN 773
N
Sbjct: 201 IPPN 204
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI-- 662
+ + +G G G+V A + AIK +E A+R RE+
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR-------AYRELLL 76
Query: 663 LRMLDHPFLPTLYSQFTSDNLSC------LVMEYCPGGDLH-VLRQKQLGKCFSEPAARF 715
L+ + H + L FT + LVM + DL ++ K FSE ++
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK-----FSEEKIQY 130
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
V ++L L+Y+H GV++RDLKP N+ V ED + + DF L+
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 7e-08
Identities = 42/146 (28%), Positives = 57/146 (39%), Gaps = 43/146 (29%)
Query: 838 ARSNS-----FVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG---- 887
AR +V T Y APE+I H VD W+ G + E+L G+T FKG
Sbjct: 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 888 -----------NEETLANV-------VMQSLKFPDSPLISF---------QARDLIRGLL 920
E + + +QSL P +P F QA DL+ +L
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSL--PQTPRKDFTQLFPRASPQAADLLEKML 290
Query: 921 IKEPENRLGSQKGAAEIKQHPFFEGL 946
+ + RL AA+ HPFFE
Sbjct: 291 ELDVDKRL----TAAQALTHPFFEPF 312
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.3 bits (220), Expect = 3e-19
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
+ L+K+G G GTV+ A+ T+ + A+K +D++ + +P REI L+ L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD----DEGVPS-SALREICLLKEL 58
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
H + L+ SD LV E+C DL + ++ ++L L +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H V++RDLKP+N+L+ +G + L +F L+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 8e-06
Identities = 31/137 (22%), Positives = 49/137 (35%), Gaps = 40/137 (29%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTP-FKGSGNEETLANVVMQ 898
+ E Y P+++ G ++D W+ G EL P F G+ ++ L + +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFR 217
Query: 899 SL------------KFPDS----------------PLISFQARDLIRGLLIKEPENRLGS 930
L K PD P ++ RDL++ LL P R+
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-- 275
Query: 931 QKGAAEIKQHPFFEGLN 947
A E QHP+F
Sbjct: 276 --SAEEALQHPYFSDFC 290
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 40/193 (20%), Positives = 73/193 (37%), Gaps = 21/193 (10%)
Query: 569 SNSDDSNLSGSSCGNRPHMSADVR--WEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVY 626
+ S LS S + ++ W+ I + + +G G G VY
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWD-----------IPFEQLEIGELIGKGRFGQVY 50
Query: 627 LAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686
G AI+++D E ++ + E R H + S +
Sbjct: 51 HGRWHGE---VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106
Query: 687 VMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR 745
+ C G L+ V+R R E++ + YLH G++++DLK +N+
Sbjct: 107 ITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY- 163
Query: 746 EDGHIMLTDFDLS 758
++G +++TDF L
Sbjct: 164 DNGKVVITDFGLF 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 11/94 (11%)
Query: 844 VGTHEYLAPEIIKGEGHGA---------AVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
G +LAPEII+ D + G YEL PFK E +
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW- 253
Query: 895 VVMQSLKFPDSPL-ISFQARDLIRGLLIKEPENR 927
+ +K S + + + D++ E E R
Sbjct: 254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 21/155 (13%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRML- 666
+ L++KLG G V+ A I N +K++ ++KK +REI L L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKK-----IKREIKILENLR 88
Query: 667 DHPFLPTLYSQF---TSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
P + TL S + LV E+ D L Q ++ RFY+ E+L A
Sbjct: 89 GGPNIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKA 142
Query: 724 LEYLHMLGVIYRDLKPENILV-REDGHIMLTDFDL 757
L+Y H +G+++RD+KP N+++ E + L D+ L
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 9e-04
Identities = 26/143 (18%), Positives = 48/143 (33%), Gaps = 41/143 (28%)
Query: 841 NSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTP-FKGSGNEETLANVV-- 896
N V + + PE++ ++D W+ G L +++ + P F G N + L +
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
Query: 897 ---------------------MQSL-KFPDSPLISF-----------QARDLIRGLLIKE 923
L + F +A D + LL +
Sbjct: 248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 307
Query: 924 PENRLGSQKGAAEIKQHPFFEGL 946
++RL A E +HP+F +
Sbjct: 308 HQSRL----TAREAMEHPYFYTV 326
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 32/146 (21%), Positives = 61/146 (41%), Gaps = 4/146 (2%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP 672
+ LG G G T + +K + ++ E +++R L+HP +
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF---LKEVKVMRCLEHPNVL 70
Query: 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGV 732
D + EY GG L + + + + + ++ + YLH + +
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 733 IYRDLKPENILVREDGHIMLTDFDLS 758
I+RDL N LVRE+ ++++ DF L+
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLA 155
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 15/51 (29%), Positives = 25/51 (49%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG 885
P + + VG ++APE+I G + VD ++FGI L E++
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 14/170 (8%)
Query: 604 GSIGLR---HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTER 660
GS+ LR + L +K+G G G +YL I AIK+ + K P+ E
Sbjct: 1 GSMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE-----CVKTKHPQLHIES 55
Query: 661 EILRMLDH-PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAE 719
+I +M+ +PT+ + + +VME G L L + FS +
Sbjct: 56 KIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQ 113
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLSLRCSVSPT 766
++ +EY+H I+RD+KP+N L+ + + DF L+ + + T
Sbjct: 114 MISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 51/209 (24%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 562 GDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRH----FNLLQKL 617
G +++ + S +S D + V G R + + +
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 618 GCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLY 675
G G G VY A+L + L AIK + D F R E +I+R LDH + L
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---------ELQIMRKLDHCNIVRLR 113
Query: 676 SQFTSDNLSC------LVMEYCPGGDLH-VLRQ-KQLGKCFSEPAARFYVAEVLLALEYL 727
F S LV++Y P ++ V R + + + Y+ ++ +L Y+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 728 HMLGVIYRDLKPENILVREDGHIM-LTDF 755
H G+ +RD+KP+N+L+ D ++ L DF
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 36/145 (24%), Positives = 51/145 (35%), Gaps = 32/145 (22%)
Query: 849 YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKG-SG--------------NEETL 892
Y APE+I G +++D W+ G L ELL G+ F G SG E +
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 893 A--NVVMQSLKFPDSPLISFQ----------ARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
N KFP + A L LL P RL E H
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAH 337
Query: 941 PFFEGLNWALIRCAIPPELPDFYDY 965
FF+ L ++ + P +++
Sbjct: 338 SFFDELRDPNVKLPNGRDTPALFNF 362
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 42/183 (22%), Positives = 71/183 (38%), Gaps = 27/183 (14%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--L 663
R L + +G G G V+ + G A+K+ F +R ++ E EI
Sbjct: 39 TIARTIVLQESIGKGRFGEVWRGKWRGEE--VAVKI----FSSREERS--WFREAEIYQT 90
Query: 664 RMLDHPFLPTLYSQFTSDNLS----CLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA 718
ML H + + DN + LV +Y G L L + + +
Sbjct: 91 VMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV----TVEGMIKLAL 146
Query: 719 EVLLALEYLHM--------LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770
L +LHM + +RDLK +NILV+++G + D L++R + +
Sbjct: 147 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206
Query: 771 SSN 773
+ N
Sbjct: 207 APN 209
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 8e-19
Identities = 50/151 (33%), Positives = 72/151 (47%), Gaps = 8/151 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
+ L LG G TVY A TN + AIK + + A+ + R REI L+ L
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAK-DGINR-TALREIKLLQEL 69
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
HP + L F + LV ++ DL V+ K + + Y+ L LEY
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
LH +++RDLKP N+L+ E+G + L DF L
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 3e-05
Identities = 36/149 (24%), Positives = 49/149 (32%), Gaps = 40/149 (26%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV--- 896
TH+ Y APE++ G G VD W G L ELL G + + L +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 897 ----------MQSL-------KFPDSPL------ISFQARDLIRGLLIKEPENRLGSQKG 933
M SL FP PL DLI+GL + P R+
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI----T 285
Query: 934 AAEIKQHPFFEGLNWALIRCAIPPELPDF 962
A + + +F +LP
Sbjct: 286 ATQALKMKYF----SNRPGPTPGCQLPRP 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-19
Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 11/152 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMPRAQTEREI--LRML 666
+ L +G G G V T + AIK + ++ KM + REI L+ L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-----DKMVKKIAMREIKLLKQL 81
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
H L L LV E+ + + + Y+ +++ + +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDD-LELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H +I+RD+KPENILV + G + L DF +
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 32/151 (21%), Positives = 46/151 (30%), Gaps = 44/151 (29%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFG-IFLYELLYGRTPFKGSG----------- 887
E Y APE++ G+ G AVD W G + E+ G F G
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV-TEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 888 ----NEETLANV----VMQSLKFPDS----------PLISFQARDLIRGLLIKEPENRLG 929
V ++ P+ P +S DL + L +P+ R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP- 299
Query: 930 SQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960
AE+ H FF+ EL
Sbjct: 300 ---FCAELLHHDFFQMDG---FAERFSQELQ 324
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 9e-19
Identities = 48/205 (23%), Positives = 90/205 (43%), Gaps = 30/205 (14%)
Query: 562 GDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGD 621
G ++ S + + L+ N+ + + Y + +G G
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAY--------TNCKVIGNGS 52
Query: 622 IGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679
G V+ A+L+ ++ AIK + D F R E +I+R++ HP + L + F
Sbjct: 53 FGVVFQAKLVESD-EVAIKKVLQDKRFKNR---------ELQIMRIVKHPNVVDLKAFFY 102
Query: 680 SDNLSC------LVMEYCPGGDLH-VLRQ-KQLGKCFSEPAARFYVAEVLLALEYLHMLG 731
S+ LV+EY P ++ R +L + + Y+ ++L +L Y+H +G
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 732 VIYRDLKPENILV-REDGHIMLTDF 755
+ +RD+KP+N+L+ G + L DF
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 41/145 (28%), Positives = 55/145 (37%), Gaps = 32/145 (22%)
Query: 849 YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKG-SG--------------NEETL 892
Y APE+I G + +D W+ G + EL+ G+ F G SG + E +
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 893 ANV--VMQSLKFPDSPLISFQ----------ARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ KFP F A DLI LL P RL A E H
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCH 322
Query: 941 PFFEGLNWALIRCAIPPELPDFYDY 965
PFF+ L R ELP +++
Sbjct: 323 PFFDELRTGEARMPNGRELPPLFNW 347
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 23/162 (14%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK---VMDNEFLARRKKMPRAQTEREI-- 662
F L LG G G V A T + AIK D A R T REI
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-------TLREIKI 62
Query: 663 LRMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLH-VLRQKQLGKCFSEPAARFY 716
L+ H + T+++ D+ ++ E DLH V+ + L S+ +++
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQML----SDDHIQYF 117
Query: 717 VAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ + L A++ LH VI+RDLKP N+L+ + + + DF L+
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 30/136 (22%), Positives = 49/136 (36%), Gaps = 39/136 (28%)
Query: 844 VGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGS---------------- 886
V T Y APE++ A+D W+ G L EL R F G
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 887 GNEETLANV-------VMQSLKFPDSPLISF---------QARDLIRGLLIKEPENRLGS 930
++ L + ++SL P P + DL++ +L+ +P R+
Sbjct: 243 HSDNDLRCIESPRAREYIKSL--PMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI-- 298
Query: 931 QKGAAEIKQHPFFEGL 946
A E +HP+ +
Sbjct: 299 --TAKEALEHPYLQTY 312
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 23/161 (14%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK---VMDNEFLARRKKMPRAQTEREI--L 663
+ L +G G G V A AIK +++ +R T REI L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-------TLREIKIL 79
Query: 664 RMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYV 717
H + + + + +V + DL+ +L+ + L S +++
Sbjct: 80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHL----SNDHICYFL 134
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++L L+Y+H V++RDLKP N+L+ + + DF L+
Sbjct: 135 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 30/135 (22%), Positives = 47/135 (34%), Gaps = 38/135 (28%)
Query: 844 VGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG--------------- 887
V T Y APEI+ ++D W+ G L E+L R F G
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 888 NEETLANV-------VMQSLKFPDSPLISF---------QARDLIRGLLIKEPENRLGSQ 931
++E L + + SL P + + +A DL+ +L P R+
Sbjct: 252 SQEDLNCIINLKARNYLLSL--PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI--- 306
Query: 932 KGAAEIKQHPFFEGL 946
+ HP+ E
Sbjct: 307 -EVEQALAHPYLEQY 320
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 85.6 bits (213), Expect = 2e-18
Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 14/153 (9%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
++ L+K+G G G VY A+ FA+K ++ E + +P T REI L+ L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKE----DEGIPS-TTIREISILKEL 57
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALE 725
H + LY + LV E+ DL +L + G A+ ++ ++L +
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQLLNGIA 114
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
Y H V++RDLKP+N+L+ +G + + DF L+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.4 bits (119), Expect = 2e-06
Identities = 26/135 (19%), Positives = 44/135 (32%), Gaps = 37/135 (27%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------ 887
THE Y AP+++ G +D W+ G E++ G F G
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 888 ---NEET------LANVVMQSLKFPDSPL------ISFQARDLIRGLLIKEPENRLGSQK 932
N + L + P + DL+ +L +P R+
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI---- 273
Query: 933 GAAEIKQHPFFEGLN 947
A + +H +F+ N
Sbjct: 274 TAKQALEHAYFKENN 288
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 26/164 (15%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI- 662
L+ + L+ +G G G V A AIK N+ A+R RE+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR-------AYRELV 76
Query: 663 -LRMLDHPFLPTLYSQFTSDNLSC------LVMEYCPGGDLH-VLRQKQLGKCFSEPAAR 714
++ ++H + L + FT +VME +L V++ +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME-----LDHERMS 130
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ + ++L +++LH G+I+RDLKP NI+V+ D + + DF L+
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 33/144 (22%), Positives = 54/144 (37%), Gaps = 44/144 (30%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG--------------- 887
+V T Y APE+I G G+ VD W+ G + E++ G F G+
Sbjct: 186 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 888 NEETLANV------VMQSL----------KFPD---------SPLISFQARDLIRGLLIK 922
E + + +++ FPD + L + QARDL+ +L+
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 923 EPENRLGSQKGAAEIKQHPFFEGL 946
+ R+ E QHP+
Sbjct: 306 DASKRI----SVDEALQHPYINVW 325
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 32/184 (17%), Positives = 67/184 (36%), Gaps = 25/184 (13%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
LL+ G G V+ A+L+ A+K+ F + K+ + + E L
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKI----FPIQDKQSWQNEYEVYSLPG 74
Query: 666 LDHPFLPTLY-SQFTSDNLS---CLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEV 720
+ H + ++ ++ L+ + G L L+ + S +
Sbjct: 75 MKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVV----SWNELCHIAETM 130
Query: 721 LLALEYLHM----------LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770
L YLH + +RD+K +N+L++ + + DF L+L+ + +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 771 SSNM 774
+
Sbjct: 191 HGQV 194
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-18
Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI-- 662
+ LQ +G G G V A T AIK +E A+R RE+
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-------AYRELRL 77
Query: 663 LRMLDHPFLPTLYSQFTSDNLSC------LVMEYCPGGDLH-VLRQKQLGKCFSEPAARF 715
L+ + H + L FT D LVM + G DL +++ ++L E +F
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKL----GEDRIQF 132
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
V ++L L Y+H G+I+RDLKP N+ V ED + + DF L+
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 37/146 (25%), Positives = 55/146 (37%), Gaps = 43/146 (29%)
Query: 838 ARSNS-----FVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG---- 887
AR +V T Y APE+I VD W+ G + E++ G+T FKGS
Sbjct: 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 888 -----------NEETLANV-------VMQSLKFPDSPLISF---------QARDLIRGLL 920
E + + M+ L P+ F A +L+ +L
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL--PELEKKDFASILTNASPLAVNLLEKML 292
Query: 921 IKEPENRLGSQKGAAEIKQHPFFEGL 946
+ + E R+ A E HP+FE L
Sbjct: 293 VLDAEQRV----TAGEALAHPYFESL 314
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 7e-18
Identities = 50/220 (22%), Positives = 89/220 (40%), Gaps = 29/220 (13%)
Query: 563 DYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIG---LRHFNLLQKLGC 619
D + D + S +MS + ++ G L+ + L+ +G
Sbjct: 15 DVKIAFCQGFDKQVDVSYIAKHYNMSKSKV--DNQFYSVEVGDSTFTVLKRYQNLKPIGS 72
Query: 620 GDIGTVYLAELIGTNCLFAIK----VMDNEFLARRKKMPRAQTEREI--LRMLDHPFLPT 673
G G V A + AIK N+ A+R RE+ ++ ++H + +
Sbjct: 73 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-------AYRELVLMKCVNHKNIIS 125
Query: 674 LYSQFTSDNLSC------LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
L + FT LVME +L + Q +L + + ++L +++L
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHER----MSYLLYQMLCGIKHL 180
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767
H G+I+RDLKP NI+V+ D + + DF L+ S +
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 5e-07
Identities = 32/144 (22%), Positives = 54/144 (37%), Gaps = 44/144 (30%)
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG--------------- 887
+V T Y APE+I G G+ VD W+ G + E++ + F G
Sbjct: 223 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 888 NEETLANV------VMQSL----------KFPD---------SPLISFQARDLIRGLLIK 922
E + + +++ FPD + L + QARDL+ +L+
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 923 EPENRLGSQKGAAEIKQHPFFEGL 946
+P R+ + QHP+
Sbjct: 343 DPAKRI----SVDDALQHPYINVW 362
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 8e-18
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 12/152 (7%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
+ L+K+G G G VY A+ + A+K +D E + +P REI L+ L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE----DEGIPS-TAIREISLLKEL 76
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
HP + +L S+ LV E+ DL + + + + Y+ ++L + +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKV-LDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H +++RDLKP+N+L+ DG + L DF L+
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 28/136 (20%), Positives = 46/136 (33%), Gaps = 38/136 (27%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------ 887
THE Y AP+++ G +VD W+ G E++ G+ F G
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 888 ---NEETLANVV----MQSLKFPDSPLISFQ---------ARDLIRGLLIKEPENRLGSQ 931
N V + F + DL+ +L +P R+
Sbjct: 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI--- 293
Query: 932 KGAAEIKQHPFFEGLN 947
A + HP+F+ L+
Sbjct: 294 -SARDAMNHPYFKDLD 308
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF----LARRKKMPRAQTEREI-- 662
+ L +G G G+V A T A+K + F A+R T RE+
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-------TYRELRL 81
Query: 663 LRMLDHPFLPTLYSQFTSDNLSC------LVMEYCPGGDLH-VLRQKQLGKCFSEPAARF 715
L+ + H + L FT LV G DL+ +++ ++L ++ +F
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKL----TDDHVQF 136
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ ++L L+Y+H +I+RDLKP N+ V ED + + DF L+
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 8e-08
Identities = 38/146 (26%), Positives = 56/146 (38%), Gaps = 43/146 (29%)
Query: 838 ARSNS-----FVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG---- 887
AR + +V T Y APEI+ H VD W+ G + ELL GRT F G+
Sbjct: 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
Query: 888 -----------NEETLANV-------VMQSLKFPDSPLISF---------QARDLIRGLL 920
E L + +QSL P ++F A DL+ +L
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNYIQSL--TQMPKMNFANVFIGANPLAVDLLEKML 296
Query: 921 IKEPENRLGSQKGAAEIKQHPFFEGL 946
+ + + R+ AA+ H +F
Sbjct: 297 VLDSDKRI----TAAQALAHAYFAQY 318
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 18/169 (10%)
Query: 604 GSIGLRH---FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQT 658
G +G + + ++G G GTVY A + A+K + N +P T
Sbjct: 1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG-GGLPI-ST 58
Query: 659 EREI-----LRMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLHVLRQKQLGKCF 708
RE+ L +HP + L + LV E+ DL K
Sbjct: 59 VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGL 117
Query: 709 SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
+ + + L L++LH +++RDLKPENILV G + L DF L
Sbjct: 118 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 26/129 (20%), Positives = 39/129 (30%), Gaps = 36/129 (27%)
Query: 846 THE-----YLAPEIIKGEGHGAAVDWWTFG-IFLYELLYGRTPFKGSG------------ 887
T Y APE++ + VD W+ G IF E+ + F G+
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF-AEMFRRKPLFCGNSEADQLGKIFDLI 235
Query: 888 ---NEETLANVV-MQSLKFPDSPLISFQ---------ARDLIRGLLIKEPENRLGSQKGA 934
E+ V + FP Q L+ +L P R+ A
Sbjct: 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI----SA 291
Query: 935 AEIKQHPFF 943
QH +
Sbjct: 292 FRALQHSYL 300
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 35/157 (22%), Positives = 65/157 (41%), Gaps = 13/157 (8%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH- 668
H+ + +++G G G ++ + N AIK RR P+ + E ++L
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGC 65
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+P +Y + LV++ G L L G+ FS ++L ++ +H
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIH 123
Query: 729 MLGVIYRDLKPENILVREDGH-----IMLTDFDLSLR 760
++YRD+KP+N L+ I + DF +
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 35/171 (20%), Positives = 58/171 (33%), Gaps = 21/171 (12%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGT--------NCLFAIKV------MDNE--FLARRKK 652
R + L + G +Y A T F++K+ + NE F R K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 653 MPRAQTEREILRMLDHPFLPTLY-SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEP 711
+ ++ L +PT D LV+ G L SE
Sbjct: 102 PLQVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLSLR 760
+ +L ALE+LH ++ ++ ENI V + + L + + R
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 17/156 (10%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI--LRML 666
+ + KLG G G VY A TN AIK +++E + +P RE+ L+ L
Sbjct: 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE----EEGVPG-TAIREVSLLKEL 90
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
H + L S ++ L+ EY DL K S + ++ +++ + +
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNF 147
Query: 727 LHMLGVIYRDLKPENILV-----REDGHIMLTDFDL 757
H ++RDLKP+N+L+ E + + DF L
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 30/135 (22%), Positives = 45/135 (33%), Gaps = 38/135 (28%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------ 887
THE Y PEI+ G H +VD W+ E+L F G
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 888 ---NEET------LANVVMQSLKFPDSPL-------ISFQARDLIRGLLIKEPENRLGSQ 931
++ T L + KF L + + DL+ +L +P R+
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI--- 311
Query: 932 KGAAEIKQHPFFEGL 946
A +HP+F
Sbjct: 312 -SAKNALEHPYFSHN 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 47/171 (27%), Positives = 72/171 (42%), Gaps = 32/171 (18%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNEFLARRKKMPRAQTEREI--L 663
+ L+ LGCG G V+ A + AIK V+ + + REI +
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-------ALREIKII 62
Query: 664 RMLDHPFLPTLYSQFTSDNLSC--------------LVMEYCPGGDLH-VLRQKQLGKCF 708
R LDH + ++ +V EY DL VL Q L
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPL---- 117
Query: 709 SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV-REDGHIMLTDFDLS 758
E AR ++ ++L L+Y+H V++RDLKP N+ + ED + + DF L+
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 26/132 (19%), Positives = 44/132 (33%), Gaps = 33/132 (25%)
Query: 844 VGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSG--------------- 887
+ T Y +P ++ + A+D W G E+L G+T F G+
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 888 NEETLANVVMQSLKF----PDSPLISF---------QARDLIRGLLIKEPENRLGSQKGA 934
+EE ++ + P +A D + +L P +RL A
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL----TA 300
Query: 935 AEIKQHPFFEGL 946
E HP+
Sbjct: 301 EEALSHPYMSIY 312
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 41/173 (23%), Positives = 67/173 (38%), Gaps = 18/173 (10%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP-----RAQ-TEREI 662
+ + + + G G V + AIK + N R + REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 663 --LRMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLH-VLRQKQLGKCFSEPAAR 714
L HP + L F LV E DL V+ +++ S +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRI--VISPQHIQ 137
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767
+++ +LL L LH GV++RDL P NIL+ ++ I + DF+L+ +
Sbjct: 138 YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 31/149 (20%), Positives = 52/149 (34%), Gaps = 46/149 (30%)
Query: 838 ARSNS-------FVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG-- 887
AR ++ +V Y APE++ VD W+ G + E+ + F+GS
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 888 -------------NEETLANV--------VMQSLKFPDSPLISF---------QARDLIR 917
E + + SL + P ++ A DLI
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL--SNVPARAWTAVVPTADPVALDLIA 298
Query: 918 GLLIKEPENRLGSQKGAAEIKQHPFFEGL 946
+L P+ R+ + +HP+FE L
Sbjct: 299 KMLEFNPQRRI----STEQALRHPYFESL 323
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 1e-16
Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 25/164 (15%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIK-VMDNEFLARRKKMPRAQTEREI--LR 664
+ F + + G G GTV L + T AIK V+ + R + + L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------ELQIMQDLA 74
Query: 665 MLDHP--------FLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQ-KQLGKCFSEPAAR 714
+L HP F D +VMEY P LH R + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDR-RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 715 FYVAEVLLALEYLHM--LGVIYRDLKPENILV-REDGHIMLTDF 755
++ +++ ++ LH+ + V +RD+KP N+LV DG + L DF
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 40/167 (23%), Positives = 59/167 (35%), Gaps = 43/167 (25%)
Query: 849 YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKG-SG--------------NEETL 892
Y APE+I G H AVD W+ G E++ G F+G + + E L
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 893 ANVVMQS----LKFPDSPLISFQ-------------ARDLIRGLLIKEPENRLGSQKGAA 935
+ + +S I + A DL+ LL PE R+
Sbjct: 257 RK--LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM----KPY 310
Query: 936 EIKQHPFFEGL---NWALIRCA-IPPELPDFYDYGIQDMVPQKSKYL 978
E HP+F+ L L +P +L F I+ M + L
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKL 357
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH- 668
+F + +K+GCG+ G + L + + TN AIK+ + + P+ E + L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLE-----PMKSRAPQLHLEYRFYKQLGSG 64
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+P +Y + +V+E G L L + FS +++ +EY+H
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH 122
Query: 729 MLGVIYRDLKPENILVREDGH-----IMLTDFDLS 758
+IYRD+KPEN L+ G+ I + DF L+
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-16
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 27/163 (16%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIK--VMDNE-----FLARRKKMPRAQTEREIL 663
+ L K+G G G V+ A T A+K +M+NE A R E +IL
Sbjct: 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR--------EIKIL 70
Query: 664 RMLDHPFLPTLYSQFTSDNLSC--------LVMEYCPGGDL-HVLRQKQLGKCFSEPAAR 714
++L H + L + LV ++C DL +L + F+ +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK--FTLSEIK 127
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
+ +L L Y+H +++RD+K N+L+ DG + L DF L
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 27/134 (20%), Positives = 43/134 (32%), Gaps = 40/134 (29%)
Query: 846 THE-----YLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------ 887
T+ Y PE++ GE G +D W G + E+ +G+
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245
Query: 888 ---NEETLANVV----MQSLKFPDSP-----------LISFQARDLIRGLLIKEPENRLG 929
E NV + L+ + A DLI LL+ +P R+
Sbjct: 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI- 304
Query: 930 SQKGAAEIKQHPFF 943
+ + H FF
Sbjct: 305 ---DSDDALNHDFF 315
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 9e-16
Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 13/154 (8%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE--RE--ILRM 665
L +++G G+ G V+ L N L A+K R P + + +E IL+
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC------RETLPPDLKAKFLQEARILKQ 168
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLAL 724
HP + L T +VME GGD LR + G V + +
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGM 226
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
EYL I+RDL N LV E + ++DF +S
Sbjct: 227 EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 43/158 (27%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIG----TNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
RH LQ+LG G+ G+V + T + A+K + + + + E EIL+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 97
Query: 665 MLDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEV 720
L H + NL L+MEY P G L L++ + Y +++
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQI 154
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EYL I+RDL NILV + + + DF L+
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 43/158 (27%), Positives = 68/158 (43%), Gaps = 14/158 (8%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIG----TNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
RH LQ+LG G+ G+V + T + A+K + + + + E EIL+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 66
Query: 665 MLDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEV 720
L H + NL L+MEY P G L L++ + Y +++
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQI 123
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EYL I+RDL NILV + + + DF L+
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 40/166 (24%), Positives = 64/166 (38%), Gaps = 31/166 (18%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTN----CLFAIKVM--------DNEFLARRKKMPRA 656
R+ ++ LG G G V L TN + A+K + + +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ-------- 82
Query: 657 QTEREILRMLDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPA 712
E +ILR L H + + +L LVMEY P G L L + +
Sbjct: 83 --EIDILRTLYHEHIIKYKGCCEDAGAASL-QLVMEYVPLGSLRDYLPRHSI----GLAQ 135
Query: 713 ARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ ++ + YLH I+RDL N+L+ D + + DF L+
Sbjct: 136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 44/160 (27%), Positives = 67/160 (41%), Gaps = 19/160 (11%)
Query: 611 FNLLQKLGCGDIGTVYLA-ELIGTNCLFAIKV--MDNEFLARRKKMPRAQTEREI----- 662
+ + ++G G G V+ A +L A+K + + MP T RE+
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG----EEGMP-LSTIREVAVLRH 67
Query: 663 LRMLDHPFLPTLYSQFTSDNLSC-----LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYV 717
L +HP + L+ T LV E+ DL K + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
++L L++LH V++RDLKP+NILV G I L DF L
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 4e-06
Identities = 30/149 (20%), Positives = 46/149 (30%), Gaps = 36/149 (24%)
Query: 846 THE-----YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG------------- 887
T Y APE++ + VD W+ G E+ + F+GS
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 888 --NEETLANVV-MQSLKFPDS---------PLISFQARDLIRGLLIKEPENRLGSQKGAA 935
EE V + F I +DL+ L P R+ A
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI----SAY 292
Query: 936 EIKQHPFFEGLNWALIRCAIPPELPDFYD 964
HP+F+ L + + LP +
Sbjct: 293 SALSHPYFQDLE--RCKENLDSHLPPSQN 319
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 9e-15
Identities = 47/176 (26%), Positives = 76/176 (43%), Gaps = 24/176 (13%)
Query: 616 KLGCGDIGTVYLA--ELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT 673
K+G G G VY A + + +A+K ++ ++ A E +LR L HP + +
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVIS 82
Query: 674 LYSQFTSDNLSC--LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV-------LLAL 724
L F S L+ +Y DL + + ++ + V L +
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 725 EYLHMLGVIYRDLKPENILVRED----GHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776
YLH V++RDLKP NILV + G + + D + R SP LK +++DP
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSP--LKPLADLDP 194
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 18/156 (11%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREIL 663
+ KLG G G VY + A+K + EFL E ++
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----------EAAVM 63
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLL 722
+ + HP L L T + ++ E+ G+L LR+ + S + ++
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISS 122
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A+EYL I+RDL N LV E+ + + DF LS
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 49/188 (26%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+ ++L + LG G G V I + FA+K + + R K R E +I+++LDH
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD--PRYKN--R---ELDIMKVLDH 59
Query: 669 PFLPTLYSQFTSDNLSC--------------------------------------LVMEY 690
+ L F + ++MEY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 691 CPGGDLH-VLRQ-KQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV-RED 747
P LH VL+ + G+ Y+ ++ A+ ++H LG+ +RD+KP+N+LV +D
Sbjct: 120 VPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKD 178
Query: 748 GHIMLTDF 755
+ L DF
Sbjct: 179 NTLKLCDF 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 30/135 (22%), Positives = 52/135 (38%), Gaps = 36/135 (26%)
Query: 842 SFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSG------------- 887
+++ + Y APE++ G ++D W+ G EL+ G+ F G
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 888 --NEETLANVVMQS----LKFPDSPLISFQ----------ARDLIRGLLIKEPENRLGSQ 931
+E + M ++FP ++ A DL+ +L EP+ R+
Sbjct: 260 TPTKEQMIR--MNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI--- 314
Query: 932 KGAAEIKQHPFFEGL 946
E HPFF+ L
Sbjct: 315 -NPYEAMAHPFFDHL 328
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 42/159 (26%), Positives = 61/159 (38%), Gaps = 24/159 (15%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV-----MDNEFLARRKKMPRAQTEREIL 663
+ LLQ +G G+ G V L + G A+K FLA E ++
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFLA----------EASVM 68
Query: 664 RMLDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAE 719
L H L L + +V EY G L LR + + +
Sbjct: 69 TQLRHSNLVQLLGVIVE--EKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLD 125
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
V A+EYL ++RDL N+LV ED ++DF L+
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 39/165 (23%), Positives = 68/165 (41%), Gaps = 29/165 (17%)
Query: 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-AQTEREILRML------ 666
++KLG G TV+LA+ + N A+K++ K A+ E ++L+ +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNT 78
Query: 667 --DHPFLP---TLYSQFTSDNLS----CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYV 717
D L F + +V E G +L L +K + +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS 137
Query: 718 AEVLLALEYLH-MLGVIYRDLKPENILVRE------DGHIMLTDF 755
++LL L+Y+H G+I+ D+KPEN+L+ I + D
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 25/158 (15%), Positives = 49/158 (31%), Gaps = 54/158 (34%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG------SGNE 889
D + + T EY +PE++ G G D W+ ++EL+ G F+ + ++
Sbjct: 188 YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 890 ETLA------------------------------------------NVVMQSLKFPDSPL 907
+ +A +V+ + KF
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945
D + +L +P R A + HP+ +
Sbjct: 308 KEI--SDFLSPMLQLDPRKRA----DAGGLVNHPWLKD 339
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DH 668
F L +K+G G G +YL I TN AIK+ + K P+ E +I R+L
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE-----NVKTKHPQLLYESKIYRILQGG 62
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+P + + + LVM+ G L L + S +++ +E++H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVH 120
Query: 729 MLGVIYRDLKPENILVREDGH---IMLTDFDLSLR 760
++RD+KP+N L+ + + DF L+ +
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 28/173 (16%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-- 666
+ L +K+G G G +YLA A V+ E ++ +E + + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE----YQENGPLFSELKFYQRVAK 92
Query: 667 -------------DHPFLPTLY----SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFS 709
D+ +P Y ++F + +VME G DL + Q G F
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS-GQNGT-FK 149
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLSLR 760
+ +L LEY+H ++ D+K N+L+ + + L D+ LS R
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 36/166 (21%), Positives = 61/166 (36%), Gaps = 29/166 (17%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELI----GTNCLFAIKVM--------DNEFLARRKKMPRA 656
R ++ LG G G V L T A+K + +
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK-------- 72
Query: 657 QTEREILRMLDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPA 712
E EILR L H + ++ + + L+ME+ P G L L + +
Sbjct: 73 --EIEILRNLYHENIVKYKGICTEDGGNGI-KLIMEFLPSGSLKEYLPKN--KNKINLKQ 127
Query: 713 ARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
Y ++ ++YL ++RDL N+LV + + + DF L+
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 16/155 (10%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREIL 663
+ KLG G G VY + A+K + EFL E ++
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----------EAAVM 270
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
+ + HP L L T + ++ E+ G+L ++ + S + ++ A
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+EYL I+R+L N LV E+ + + DF LS
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 36/173 (20%), Positives = 71/173 (41%), Gaps = 25/173 (14%)
Query: 609 RHFNLLQKLGCGDIGTVYLAEL-----IGTNCLFAIKVMDNE---------FLARRKKMP 654
+ + +G G G +YLA++ +G++ +KV ++ F R K
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 655 RAQTEREILRMLDHPFLPTLY----SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSE 710
+ Q R L + +P + + ++M+ G DL + + K FS
Sbjct: 95 QIQKWIR-TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSR 151
Query: 711 PAARFYVAEVLL-ALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLSLR 760
++ +L LEY+H ++ D+K N+L+ + + L D+ L+ R
Sbjct: 152 KTV-LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 43/163 (26%), Positives = 65/163 (39%), Gaps = 24/163 (14%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIG----TNCLFAIKVM-------DNEFLARRKKMPRAQ 657
RH + +LG G+ G+V L T L A+K + +F
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR--------- 73
Query: 658 TEREILRMLDHPFLPTLY--SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARF 715
E +IL+ L F+ S LVMEY P G L Q+ +
Sbjct: 74 -EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLL 131
Query: 716 YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
Y +++ +EYL ++RDL NILV + H+ + DF L+
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 45/168 (26%), Positives = 70/168 (41%), Gaps = 17/168 (10%)
Query: 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-A 656
+ +L+ +G G G V A + A+K++ N K+ R A
Sbjct: 86 SYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQA 140
Query: 657 QTEREILRML-------DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFS 709
E IL L + + FT N C+ E +L+ L +K + FS
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVI-HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFS 198
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH--IMLTDF 755
P R + +L L+ LH +I+ DLKPENIL+++ G I + DF
Sbjct: 199 LPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 21/60 (35%), Positives = 30/60 (50%), Gaps = 1/60 (1%)
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLI 908
Y APE+I G +G +D W+ G L ELL G G + LA +++ L P L+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA-CMIELLGMPSQKLL 323
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 6e-14
Identities = 42/158 (26%), Positives = 60/158 (37%), Gaps = 24/158 (15%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKV-----MDNEFLARRKKMPRAQTEREILR 664
LLQ +G G+ G V L + G A+K FLA E ++
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFLA----------EASVMT 241
Query: 665 MLDHPFLPTLY---SQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEV 720
L H L L + +V EY G L LR + + +V
Sbjct: 242 QLRHSNLVQLLGVIVE--EKGGLYIVTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDV 298
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A+EYL ++RDL N+LV ED ++DF L+
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 43/170 (25%), Positives = 69/170 (40%), Gaps = 19/170 (11%)
Query: 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-A 656
++ G + + + +G G G V A AIK++ N +K A
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQA 97
Query: 657 QTEREILRML------DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFS 709
Q E +L ++ ++ L F N CLV E +L+ +LR + S
Sbjct: 98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNF-RGVS 155
Query: 710 EPAARFYVAEVLLALEYLHM--LGVIYRDLKPENILVREDGH--IMLTDF 755
R + ++ AL +L L +I+ DLKPENIL+ I + DF
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 15/60 (25%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLI 908
Y +PE++ G + A+D W+ G L E+ G F G+ + + +++ L P + ++
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN-KIVEVLGIPPAHIL 282
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 41/150 (27%), Positives = 61/150 (40%), Gaps = 7/150 (4%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF---AIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
LL+KLG G G V E + A+K + + L++ + M E + LDH
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
L LY + + +V E P G L LR+ F Y +V + YL
Sbjct: 82 NLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLS 758
I+RDL N+L+ + + DF L
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 18/155 (11%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF----AIKVMDNEFLARRKKMPRAQTE--RE--ILR 664
++ LG G GTVY I AIK + R P+A E E ++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL------REATSPKANKEILDEAYVMA 72
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLA 723
+D+P + L + + L+ + P G L +R+ + ++
Sbjct: 73 SVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKG 129
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ YL +++RDL N+LV+ H+ +TDF L+
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 26/156 (16%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLF--AIKVM---------DNEFLARRKKMPRAQTEREIL 663
++LG G+ GTV + A+K++ +E LA E ++
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA----------EANVM 72
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLL 722
+ LD+P++ + +++ LVME G L+ L+Q + + V +V +
Sbjct: 73 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSM 128
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++YL ++RDL N+L+ + ++DF LS
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 20/157 (12%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREI 662
LL++LG G G V L + G + A+K++ ++EF E +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEFFQ----------EAQT 56
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVL 721
+ L HP L Y + + +V EY G L + LR GK +V
Sbjct: 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVC 114
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ +L I+RDL N LV D + ++DF ++
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 8e-13
Identities = 44/184 (23%), Positives = 80/184 (43%), Gaps = 16/184 (8%)
Query: 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPR-A 656
H + G + F +++K+G G G V L + I +A+KV+ N KK R A
Sbjct: 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSA 78
Query: 657 QTEREILRML------DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFS 709
+ E +IL+ + ++ + + +F + CL+ E G L+ ++ + F
Sbjct: 79 KIEADILKKIQNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFH 135
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769
+ Y E+L AL YL + + + DLKPENIL+ + + + +
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 770 SSSN 773
+ S
Sbjct: 196 TKST 199
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 31/140 (22%), Positives = 43/140 (30%), Gaps = 48/140 (34%)
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA--------------- 893
Y APE+I G + D W+FG L EL G F+ + E LA
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 894 -----------------------NVVMQSLKFPDS--PLISFQAR----DLIRGLLIKEP 924
+ S+K PL D + +L +P
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 925 ENRLGSQKGAAEIKQHPFFE 944
R AE+ +H F E
Sbjct: 345 TLRP----SPAELLKHKFLE 360
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 8e-13
Identities = 35/150 (23%), Positives = 65/150 (43%), Gaps = 8/150 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
L +KLG G G V++A + A+K M ++ + E +++ L H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMSVEAFL----AEANVMKTLQHD 243
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
L L++ T + + ++ E+ G L L+ + G P + A++ + ++
Sbjct: 244 KLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLS 758
I+RDL+ NILV + DF L+
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 33/158 (20%), Positives = 60/158 (37%), Gaps = 23/158 (14%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKV---------MDNE---FLARRKKMPRAQTER 660
+ +G G+ G VY L ++ + V + + FL E
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG----------EA 97
Query: 661 EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
I+ H + L + ++ EY G L +++ G+ FS + +
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGI 156
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++YL + ++RDL NILV + ++DF LS
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 1e-12
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
L KLG G G V++ G AIK + ++ + E ++++ L H
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHE 239
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
L LY+ + + + +V EY G L + + GK P A++ + Y+
Sbjct: 240 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ ++RDL+ NILV E+ + DF L+
Sbjct: 299 MNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 19/46 (41%), Positives = 21/46 (45%), Gaps = 1/46 (2%)
Query: 851 APEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANV 895
APE D W+FGI L EL GR P+ G N E L V
Sbjct: 349 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 20/157 (12%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREI 662
+Q++G G G V+L + + + AIK + + +F+ E E+
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----------EAEV 56
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVL 721
+ L HP L LY CLV E+ G L LR + F+ +V
Sbjct: 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVC 114
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ YL VI+RDL N LV E+ I ++DF ++
Sbjct: 115 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 22/157 (14%)
Query: 613 LLQKLGCGDIGTVYLAELI---GTNCLFAIKVM--------DNEFLARRKKMPRAQTERE 661
+ + +G GD G V L + AIK + +FL+ E
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS----------EAS 102
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
I+ DHP + L T L+ +V EY G L + G+ F+ + V
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVG 161
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ YL LG ++RDL N+LV + ++DF LS
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 3e-12
Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 24/155 (15%)
Query: 615 QKLGCGDIGTVYLAELIGTNCLF--AIKVM--------DNEFLARRKKMPRAQTEREILR 664
+LGCG+ G+V AIKV+ E + E +I+
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----------EAQIMH 391
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLA 723
LD+P++ L ++ L LVME GG LH L K + + +V +
Sbjct: 392 QLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMG 448
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++YL ++R+L N+L+ + ++DF LS
Sbjct: 449 MKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 38/158 (24%), Positives = 61/158 (38%), Gaps = 25/158 (15%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF---AIKVM--------DNEFLARRKKMPRAQTERE 661
L + +G G G V+ + AIK +FL E
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ----------EAL 68
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEV 720
+R DHP + L T + + ++ME C G+L L+ + + Y ++
Sbjct: 69 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQL 125
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
AL YL ++RD+ N+LV + + L DF LS
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 43/180 (23%), Positives = 71/180 (39%), Gaps = 34/180 (18%)
Query: 590 DVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLF--AIKVM----- 642
D + ++ L I +LGCG+ G+V AIKV+
Sbjct: 1 DKKLF-LKRDNLLIADI---------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE 50
Query: 643 ---DNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV- 698
E + E +I+ LD+P++ L ++ L LVME GG LH
Sbjct: 51 KADTEEMMR----------EAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKF 99
Query: 699 LRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L K + + +V + ++YL ++RDL N+L+ + ++DF LS
Sbjct: 100 LVGK--REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 37/156 (23%), Positives = 66/156 (42%), Gaps = 20/156 (12%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREIL 663
L+++LG G G V++ G + A+K + + FLA E ++
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLA----------EANLM 62
Query: 664 RMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLL 722
+ L H L LY+ T + + ++ EY G L L+ G + A++
Sbjct: 63 KQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAE 120
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ ++ I+RDL+ NILV + + DF L+
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 5e-12
Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 22/157 (14%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF----AIKVMDNEFLARRKKMPRAQTEREILR---- 664
L+ LG G GTV+ I IKV+ + Q+ + +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--------EDKSGRQSFQAVTDHMLA 68
Query: 665 --MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVL 721
LDH + L +L LV +Y P G L +RQ + + ++
Sbjct: 69 IGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIA 125
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ YL G+++R+L N+L++ + + DF ++
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 5e-12
Identities = 36/159 (22%), Positives = 68/159 (42%), Gaps = 14/159 (8%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF---AIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
L + LG G+ G+V A+L + F A+K++ + + E ++ DHP
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHP 85
Query: 670 FLPTLY------SQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAAR---FYVAE 719
+ L + +++ + GDLH L ++G+ + ++ +
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ +EYL I+RDL N ++ ED + + DF LS
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 39/158 (24%), Positives = 60/158 (37%), Gaps = 25/158 (15%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF---AIKVM--------DNEFLARRKKMPRAQTERE 661
L + LG G G VY A+K +F++ E
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS----------EAV 65
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEV 720
I++ LDHP + L + ++ME P G+L H L + Y ++
Sbjct: 66 IMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQI 122
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A+ YL + ++RD+ NILV + L DF LS
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 36/178 (20%), Positives = 66/178 (37%), Gaps = 28/178 (15%)
Query: 590 DVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLF----AIKVMDNE 645
++ + ++ LG G GTVY I AIK +
Sbjct: 6 QALLRILKETEFK----------KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--- 52
Query: 646 FLARRKKMPRAQT----EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LR 700
R P+A E ++ +D+P + L + + L+ + P G L +R
Sbjct: 53 ---REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVR 108
Query: 701 QKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ + ++ + YL +++RDL N+LV+ H+ +TDF L+
Sbjct: 109 EH--KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 8e-12
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
L KLG G G V++ G AIK + ++ + E ++++ L H
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHE 322
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
L LY+ + + + +V EY G L + + GK P A++ + Y+
Sbjct: 323 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ ++RDL+ NILV E+ + DF L+
Sbjct: 382 MNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 36/157 (22%), Positives = 59/157 (37%), Gaps = 22/157 (14%)
Query: 613 LLQKLGCGDIGTVYLAELIGT---NCLFAIKVM--------DNEFLARRKKMPRAQTERE 661
+ + +G G+ G V L AIK + +FL E
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG----------EAS 98
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
I+ DHP + L T +V EY G L +K + F+ + +
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIA 157
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++YL +G ++RDL NIL+ + ++DF L
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 1e-11
Identities = 51/253 (20%), Positives = 90/253 (35%), Gaps = 46/253 (18%)
Query: 518 VISTSVTTGIIEPDFIPNDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLS 577
+++ + + II P + S P + + +G S + S D + + +D+
Sbjct: 320 LVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY-- 377
Query: 578 GSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELI---GTN 634
M + +E R L + +G G G V+ +
Sbjct: 378 --------TMPSTRDYEIQRE-----------RIELGRCIGEGQFGDVHQGIYMSPENPA 418
Query: 635 CLFAIKVM--------DNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686
AIK +FL E +R DHP + L T + + +
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQ----------EALTMRQFDHPHIVKLIGVITENPV-WI 467
Query: 687 VMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR 745
+ME C G+L L+ + + Y ++ AL YL ++RD+ N+LV
Sbjct: 468 IMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS 525
Query: 746 EDGHIMLTDFDLS 758
+ + L DF LS
Sbjct: 526 SNDCVKLGDFGLS 538
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 37/173 (21%), Positives = 59/173 (34%), Gaps = 37/173 (21%)
Query: 613 LLQKLGCGDIGTVYLAELIGT-----NCLFAIKV-----MD---NEFLARRKKMPRAQTE 659
+++LG G VY L G AIK EF E
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH----------E 62
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA 718
+ L HP + L T D ++ YC GDLH L + V
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 719 EVLLALEYLHML-------------GVIYRDLKPENILVREDGHIMLTDFDLS 758
L +++H++ V+++DL N+LV + ++ ++D L
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 20/157 (12%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVM------DNEFLARRKKMPRAQTEREI 662
+ L++LG G G V + G + AIK++ ++EF+ E ++
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----------EAKV 72
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVL 721
+ L H L LY T ++ EY G L + LR+ F +V
Sbjct: 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVC 130
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
A+EYL ++RDL N LV + G + ++DF LS
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 34/167 (20%), Positives = 63/167 (37%), Gaps = 31/167 (18%)
Query: 613 LLQKLGCGDIGTVYLAELIGT-----NCLFAIKVM--------DNEFLARRKKMPRAQTE 659
+ ++LG G G VY G AIK + EFL E
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN----------E 78
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA 718
+++ + + L + + ++ME GDL LR + + A ++
Sbjct: 79 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138
Query: 719 EVLL-------ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+++ + YL+ ++RDL N +V ED + + DF ++
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 34/158 (21%), Positives = 66/158 (41%), Gaps = 13/158 (8%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF---AIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
L + LG G+ G+V L + A+K M + ++++ +E ++ HP
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 670 FLPTLY-----SQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAAR---FYVAEV 720
+ L +++ + GDLH L +L + ++ ++
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
L +EYL ++RDL N ++R+D + + DF LS
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 41/189 (21%), Positives = 63/189 (33%), Gaps = 41/189 (21%)
Query: 601 LQYGSIGLRHFN-----LLQKLGCGDIGTVYLAELIGT-----NCLFAIKVM-------D 643
+ I ++H L ++LG G G V+LAE L A+K +
Sbjct: 2 AMHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR 61
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQK 702
+F E E+L L H + Y + +V EY GDL+ LR
Sbjct: 62 KDFQR----------EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 703 QLGKCFSEPAARFYVAEVLLALEYLHM-------------LGVIYRDLKPENILVREDGH 749
L + LH+ ++RDL N LV +
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 171
Query: 750 IMLTDFDLS 758
+ + DF +S
Sbjct: 172 VKIGDFGMS 180
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 26/166 (15%), Positives = 53/166 (31%), Gaps = 21/166 (12%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLF-------AIKVMDNEFLARRKKMPRAQTERE 661
+ LG G ++ +KV+D +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FEAAS 64
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEV 720
++ L H L Y + + LV E+ G L L++ C + ++
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQL 122
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIM--------LTDFDLS 758
A+ +L +I+ ++ +NIL+ + L+D +S
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 34/167 (20%), Positives = 61/167 (36%), Gaps = 18/167 (10%)
Query: 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLA-ELIGTNCLFAIKVMDNEFLARRKKMPR- 655
H+ + G + ++ LG G G V + A+K++ N K
Sbjct: 8 HLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREA 62
Query: 656 AQTEREILRML-------DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKC 707
A+ E +L+ + + + F C+ E G + L++ +
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNF-QP 119
Query: 708 FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTD 754
+ P R ++ AL +LH + + DLKPENIL L +
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 34/140 (24%), Positives = 43/140 (30%), Gaps = 46/140 (32%)
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA--------------- 893
Y PE+I G D W+ G L+E G T F+ N E L
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264
Query: 894 -------------------------NVVMQSLK--FPDSPLISFQARDLIRGLLIKEPEN 926
+ LK L Q DL+R +L +P
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 927 RLGSQKGAAEIKQHPFFEGL 946
R+ AE HPFF GL
Sbjct: 325 RI----TLAEALLHPFFAGL 340
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 32/167 (19%), Positives = 62/167 (37%), Gaps = 18/167 (10%)
Query: 598 HVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNC-LFAIKVMDNEFLARRKKMPR- 655
H+ Q G + + ++ LG G G V A+K++ N +
Sbjct: 3 HLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEA 57
Query: 656 AQTEREILRML-------DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKC 707
A++E ++L L + + F C+V E G + +++
Sbjct: 58 ARSEIQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGF-LP 114
Query: 708 FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTD 754
F R ++ ++ +LH + + DLKPENIL + + +
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-07
Identities = 33/140 (23%), Positives = 46/140 (32%), Gaps = 46/140 (32%)
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA--------------- 893
Y APE+I G D W+ G L E G T F ++E LA
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 894 ------NVVMQSLKFPDS------------PLISF---------QARDLIRGLLIKEPEN 926
L + + PL F + DLI+ +L +P
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 927 RLGSQKGAAEIKQHPFFEGL 946
R+ E +HPFF+ L
Sbjct: 320 RI----TLREALKHPFFDLL 335
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 33/160 (20%), Positives = 64/160 (40%), Gaps = 25/160 (15%)
Query: 612 NLLQKLGCGDIGTVYLAELIGTNCLF---AIKVMD--------NEFLARRKKMPRAQTER 660
+ + +G G G VY L+ + A+K ++ ++FL E
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT----------EG 77
Query: 661 EILRMLDHPFLPTLYSQ-FTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA 718
I++ HP + +L S+ +V+ Y GDL +R + + +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGL 135
Query: 719 EVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+V ++YL ++RDL N ++ E + + DF L+
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 46/166 (27%), Positives = 62/166 (37%), Gaps = 38/166 (22%)
Query: 611 FNLLQKLGCGDIGTVYLAELI-GTNCLFAIKVMDN-------EFLARRKKMPRAQTEREI 662
F+ +G G G VY L G A+K EF +TE E
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRDGA--KVALKRRTPESSQGIEEF----------ETEIET 88
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEP--------A 712
L HP L +L N L+ +Y G+L H+ S A
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 713 ARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
AR L YLH +I+RD+K NIL+ E+ +TDF +S
Sbjct: 149 AR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 41/171 (23%), Positives = 60/171 (35%), Gaps = 35/171 (20%)
Query: 613 LLQKLGCGDIGTVYLAELIGT-----NCLFAIKVM-------DNEFLARRKKMPRAQTER 660
L +LG G G V+LAE L A+K + +F E
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR----------EA 94
Query: 661 EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARF---- 715
E+L ML H + + T +V EY GDL+ LR
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 716 --------YVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++V + YL L ++RDL N LV + + + DF +S
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 36/159 (22%), Positives = 60/159 (37%), Gaps = 25/159 (15%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLF---AIKVM--------DNEFLARRKKMPRAQTERE 661
+ +G G G VY E I AIK + FL E
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR----------EGL 74
Query: 662 ILRMLDHPFLPTLYSQFT-SDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAE 719
++R L+HP + L + L +++ Y GDL +R + + + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQ 132
Query: 720 VLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
V +EYL ++RDL N ++ E + + DF L+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 43/204 (21%), Positives = 74/204 (36%), Gaps = 56/204 (27%)
Query: 590 DVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVM-- 642
D +WE R L L + LG G+ G V A A+K++
Sbjct: 15 DPKWEFPRK-NLV----------LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 643 ------DNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL 696
+ L+ E +L+ ++HP + LY + D L++EY G L
Sbjct: 64 NASPSELRDLLS----------EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 697 H-VLRQKQLGKCFSEPAARF---------------------YVAEVLLALEYLHMLGVIY 734
LR+ + + + ++ ++YL + +++
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173
Query: 735 RDLKPENILVREDGHIMLTDFDLS 758
RDL NILV E + ++DF LS
Sbjct: 174 RDLAARNILVAEGRKMKISDFGLS 197
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 46/251 (18%), Positives = 87/251 (34%), Gaps = 43/251 (17%)
Query: 521 TSVTTGIIEPDFIPNDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSS 580
SV GI+ P P I + + + S + + + D +
Sbjct: 19 ASVAAGILVPRGSPGLDG----ICSIEELSTSLYKKAGSENLYFQGANTVHIDLS----- 69
Query: 581 CGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLF--- 637
P + V+ I L + + +G G G VY L+ +
Sbjct: 70 -ALNPELVQAVQHVVIGPSSLI--------VHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 638 AIKVM--------DNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQ-FTSDNLSCLVM 688
A+K + ++FL TE I++ HP + +L S+ +V+
Sbjct: 121 AVKSLNRITDIGEVSQFL----------TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170
Query: 689 EYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747
Y GDL +R + + + +V +++L ++RDL N ++ E
Sbjct: 171 PYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228
Query: 748 GHIMLTDFDLS 758
+ + DF L+
Sbjct: 229 FTVKVADFGLA 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 44/171 (25%), Positives = 61/171 (35%), Gaps = 35/171 (20%)
Query: 613 LLQKLGCGDIGTVYLAELI--GTNCLFAIKVM--------DNEFLARRKKMPRAQTEREI 662
+G G+ G V A + G AIK M +F E E+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG----------ELEV 78
Query: 663 LRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVAEV 720
L L HP + L L +EY P G+L LR+ ++ + A A
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 721 LLALEYLHML-------------GVIYRDLKPENILVREDGHIMLTDFDLS 758
L + + LH I+RDL NILV E+ + DF LS
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 36/181 (19%), Positives = 59/181 (32%), Gaps = 45/181 (24%)
Query: 613 LLQKLGCGDIGTVYLAELIG-----TNCLFAIKVM--------DNEFLARRKKMPRAQTE 659
++ +G G G V+ A G + A+K++ +F E
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ----------RE 100
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARFYVA 718
++ D+P + L CL+ EY GDL+ LR S +
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 719 EVLLAL---------------------EYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
+ + YL ++RDL N LV E+ + + DF L
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 758 S 758
S
Sbjct: 221 S 221
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 46/162 (28%), Positives = 67/162 (41%), Gaps = 28/162 (17%)
Query: 611 FNLLQKLGCGDIGTVYLAELI-GTNCLFAIKVMDN--------EFLARRKKMPRAQTERE 661
F+ LG G G VY L GT L A+K + +F QTE E
Sbjct: 32 FSNKNILGRGGFGKVYKGRLADGT--LVAVKRLKEERTQGGELQF----------QTEVE 79
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEV 720
++ M H L L + LV Y G + LR++ + + R +A +
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-L 138
Query: 721 LLA--LEYLH---MLGVIYRDLKPENILVREDGHIMLTDFDL 757
A L YLH +I+RD+K NIL+ E+ ++ DF L
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 51/250 (20%), Positives = 92/250 (36%), Gaps = 51/250 (20%)
Query: 539 RSQPIVGKTKSKGEFSQSSKSSLGDYSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRH 598
+ P+ + E S S S+ +T S ++ + + + D +WE R
Sbjct: 22 KRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRD 81
Query: 599 VRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG-------TNCLFAIKVM--------D 643
+L L + LG G G V +AE +G A+K++
Sbjct: 82 -KLT----------LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDL 130
Query: 644 NEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQ 701
++ ++ E E+++M+ H + L T D +++EY G+L LR
Sbjct: 131 SDLVS----------EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 180
Query: 702 KQLGKCFSEPAARFYVAEVLL-------------ALEYLHMLGVIYRDLKPENILVREDG 748
++ E + +EYL I+RDL N+LV E+
Sbjct: 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN 240
Query: 749 HIMLTDFDLS 758
+ + DF L+
Sbjct: 241 VMKIADFGLA 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 45/213 (21%), Positives = 73/213 (34%), Gaps = 57/213 (26%)
Query: 582 GNRPH------MSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG--- 632
GN + D +WE R+ RL + LG G G V A G
Sbjct: 1 GNNYVYIDPTQLPYDHKWEFPRN-RLS----------FGKTLGAGAFGKVVEATAYGLIK 49
Query: 633 --TNCLFAIKVM--------DNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSD 681
A+K++ ++ E ++L L +H + L T
Sbjct: 50 SDAAMTVAVKMLKPSAHLTEREALMS----------ELKVLSYLGNHMNIVNLLGACTIG 99
Query: 682 NLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYV---------------AEVLLALE 725
+ ++ EYC GDL + LR+K+ S+ + +V +
Sbjct: 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+L I+RDL NIL+ + DF L+
Sbjct: 160 FLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 5e-09
Identities = 34/194 (17%), Positives = 57/194 (29%), Gaps = 52/194 (26%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKV--MDNEFLARRKKMPRAQT---EREILRM 665
+K+G G G V+ T AIK+ ++ L + E I +
Sbjct: 22 LQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 666 L---------DHPFLPTLYS------------------------------QFTSDNLSCL 686
L L S F D+ +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 687 VMEYCPGG-DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH-MLGVIYRDLKPENILV 744
V+E+ GG DL + K S A+ + ++ +L L +RDL N+L+
Sbjct: 140 VLEFEFGGIDLE----QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 745 REDGHIMLTDFDLS 758
++ L
Sbjct: 196 KKTSLKKLHYTLNG 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 39/176 (22%), Positives = 68/176 (38%), Gaps = 40/176 (22%)
Query: 613 LLQKLGCGDIGTVYLAELIG-------TNCLFAIKVM--------DNEFLARRKKMPRAQ 657
L + LG G G V +AE +G A+K++ ++ ++
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS--------- 89
Query: 658 TEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAARF 715
E E+++M+ H + L T D +++EY G+L LR ++
Sbjct: 90 -EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 716 YVAEVLL-------------ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
E + +EYL I+RDL N+LV E+ + + DF L+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 37/168 (22%), Positives = 55/168 (32%), Gaps = 52/168 (30%)
Query: 616 KLGCGDIGTVYLAELIGTNCLFAIKVM-----------DNEFLARRKKMPRAQTEREILR 664
K+G G G VY + T A+K + +F E +++
Sbjct: 38 KMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQ----------EIKVMA 85
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDL--HVLRQKQ-------------LGKCFS 709
H L L + + CLV Y P G L + G
Sbjct: 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQG---- 141
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
AA + +LH I+RD+K NIL+ E ++DF L
Sbjct: 142 --AAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 38/177 (21%), Positives = 65/177 (36%), Gaps = 43/177 (24%)
Query: 613 LLQKLGCGDIGTVYLAELIG-----TNCLFAIKVM--------DNEFLARRKKMPRAQTE 659
L + LG G G V A+ G T A+K++ ++ E
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS----------E 80
Query: 660 REILRMLD-HPFLPTLY---SQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAAR 714
+IL + H + L ++ +++E+C G+L LR K+ + A
Sbjct: 81 LKILIHIGHHLNVVNLLGACTK--PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 715 FYVAEVL-------------LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ L +E+L I+RDL NIL+ E + + DF L+
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 33/167 (19%), Positives = 58/167 (34%), Gaps = 31/167 (18%)
Query: 613 LLQKLGCGDIGTVYLAELIG-----TNCLFAIKVM--------DNEFLARRKKMPRAQTE 659
L++ LG G G VY ++ G + A+K + + +FL E
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----------ME 83
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLR----QKQLGKCFSEPAAR 714
I+ +H + ++ME GGDL LR + +
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 143
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML---TDFDLS 758
++ +YL I+RD+ N L+ G + DF ++
Sbjct: 144 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 42/221 (19%), Positives = 73/221 (33%), Gaps = 47/221 (21%)
Query: 564 YSSSTSNSDDSNLSGSSCGNRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIG 623
Y + + + + + + +WE R+ LQ + LG G G
Sbjct: 12 YQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRN-NLQ----------FGKTLGAGAFG 60
Query: 624 TVYLAELIG-----TNCLFAIK-----VMDNE---FLARRKKMPRAQTEREILRMLD-HP 669
V A G A+K +E ++ E +I+ L H
Sbjct: 61 KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS----------ELKIMSHLGQHE 110
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARF-----------YV 717
+ L T ++ EYC GDL + LR+K A +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 718 AEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++V + +L I+RD+ N+L+ + DF L+
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 33/167 (19%), Positives = 59/167 (35%), Gaps = 31/167 (18%)
Query: 613 LLQKLGCGDIGTVYLAELIG-----TNCLFAIKVM--------DNEFLARRKKMPRAQTE 659
L++ LG G G VY ++ G + A+K + + +FL E
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL----------ME 124
Query: 660 REILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH-VLRQKQLGKCFSEPAAR---- 714
I+ +H + +++E GGDL LR+ + A
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLL 184
Query: 715 FYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML---TDFDLS 758
++ +YL I+RD+ N L+ G + DF ++
Sbjct: 185 HVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 49/202 (24%), Positives = 77/202 (38%), Gaps = 51/202 (25%)
Query: 587 MSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLF-------AI 639
+ D RWE R RL L + LG G G V LAE IG + A+
Sbjct: 58 LPEDPRWELPRD-RLV----------LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAV 106
Query: 640 KVM--------DNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEY 690
K++ ++ ++ E E+++M+ H + L T D +++EY
Sbjct: 107 KMLKSDATEKDLSDLIS----------EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEY 156
Query: 691 CPGGDLH----VLRQKQLGKCFSEPAARFYV----------AEVLLALEYLHMLGVIYRD 736
G+L R L ++ +V +EYL I+RD
Sbjct: 157 ASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRD 216
Query: 737 LKPENILVREDGHIMLTDFDLS 758
L N+LV ED + + DF L+
Sbjct: 217 LAARNVLVTEDNVMKIADFGLA 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 45/211 (21%), Positives = 70/211 (33%), Gaps = 56/211 (26%)
Query: 583 NRPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLF 637
+ D++WE R L+ + LG G G V A G +
Sbjct: 30 DFREYEYDLKWEFPRE-NLE----------FGKVLGSGAFGKVMNATAYGISKTGVSIQV 78
Query: 638 AIKVM--------DNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVM 688
A+K++ ++ E +++ L H + L T L+
Sbjct: 79 AVKMLKEKADSSEREALMS----------ELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128
Query: 689 EYCPGGDL-HVLRQK----QLGKCFSEPAARFYVAEVLLAL----------------EYL 727
EYC GDL + LR K + E R E L L E+L
Sbjct: 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 188
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++RDL N+LV + + DF L+
Sbjct: 189 EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 24/163 (14%), Positives = 53/163 (32%), Gaps = 26/163 (15%)
Query: 613 LLQKLGCGDIGTVYLAELI--GTNCLFAIKV---MDNEFLARRKKMPR------------ 655
+ + G V+ A+ + G A+K+ +EF + +
Sbjct: 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPK 110
Query: 656 ------AQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFS 709
+ E L + N L+ME+ +L +LG+
Sbjct: 111 EKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKN--VLLMEFIGEDELPAPTLVELGRELK 168
Query: 710 EPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIM 751
E +V+ ++ L+ +++ DL NI+ + + +
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDKVYFI 211
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 25/159 (15%), Positives = 52/159 (32%), Gaps = 30/159 (18%)
Query: 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD---NEFLA----------RRKKMPRAQT 658
+ + +G G V+ +K F +
Sbjct: 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 659 ERE--ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFY 716
E L+ L +P +Y+ + ++ME +L+ +R + +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRVRVENPDEVLDM------ 201
Query: 717 VAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755
+L + + G+++ DL N+LV E+ I + DF
Sbjct: 202 ---ILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 7e-04
Identities = 111/744 (14%), Positives = 209/744 (28%), Gaps = 253/744 (34%)
Query: 9 EIVEAGEEVNSVQNSRRTYRPSSGSSVMD--KDQKPRVLKLAYNESLEDDINQLFEAISL 66
I+ + + V+ T R + ++ +++ E L + L I
Sbjct: 53 HIIMSKDAVS------GTLR------LFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI-- 98
Query: 67 KNSTKGWGLSHEVGTSMSPVRKSDLKKPISVPHS-PRLGTSQPV-SLKQALRELSITKAS 124
K + + + +D + ++ RL QP L+QAL EL
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYND--NQVFAKYNVSRL---QPYLKLRQALLELR----- 148
Query: 125 EMAAMKRISKSTSSSVMSEAGRIKNLYNTKVVEPASGSGLLMDEGKGNMVEISLVPEESQ 184
KN+ +++ GS GK + +
Sbjct: 149 ---------------------PAKNV----LIDGVLGS------GKT-----WVALDVCL 172
Query: 185 LTSSQKMPPSLQVPKMKLINQSDNSSPQFTIPTLQN---AMGISQSANSSPLFAVPKRQN 241
Q ++ + L N +SP+ + LQ + + ++ S + R +
Sbjct: 173 SYKVQCKMDF-KIFWLNLKNC---NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 242 FSGTSKSAH-SSPQYAI----------PKMKNAAGTNQSVHYAPQFSVP-----TIQNAA 285
S Y K NA F++ T +
Sbjct: 229 SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA------------FNLSCKILLTTRFKQ 276
Query: 286 VTNQSAHSSPRFASSTIQNSTGTNKGAQSSSRLTVPTTDG--STGTNQRAHSSPRLAVPT 343
VT+ ++ S +S LT + R PR +
Sbjct: 277 VTD-FLSAATTTHISLDHHSMT----------LTPDEVKSLLLKYLDCRPQDLPREVL-- 323
Query: 344 QSGPQT-----ARMQDEIISTSTNVGTHAVKVEIAQKEKHVPAHPSSSDTVDLPEQ---- 394
+ P+ ++D ++T N + +K SS + ++ E
Sbjct: 324 TTNPRRLSIIAESIRDG-LATWDN-------WKHVNCDKLTTIIESSLNVLEPAEYRKMF 375
Query: 395 ------EKNVSAPSKLANRTSTVKSGRKGRLHAVPSSSSSNGSRV-TKISRNSPRVAKQV 447
+ P+ L L S + + ++ V
Sbjct: 376 DRLSVFPPSAHIPTIL--------------L-----------SLIWFDVIKSDVMVVVNK 410
Query: 448 LRKKGAVKKKVKQDSASSPCSSNFYSEVRSQLEPSSTQLICQRCHCALKNASNLPYQDST 507
L K V+K+ K+ + S P + Y E++ +LE + L H ++ + N+P +
Sbjct: 411 LHKYSLVEKQPKESTISIP---SIYLELKVKLE-NEYAL-----HRSIVDHYNIPKTFDS 461
Query: 508 VSNLTSVSAEVISTSVTTGIIEPDFIPNDSDRSQPIVGKTKSKGEFSQSSKSSLGDYSSS 567
D IP D F S +G + +
Sbjct: 462 ----------------------DDLIPPYLD------------QYFY----SHIGHHLKN 483
Query: 568 TSNSDDSNLSGSSCGNRPHMSADVRW-EA-IRHVRLQYGSIGLRHFNLLQKLGCGDIGTV 625
+ + L + D R+ E IRH + + G N LQ+L
Sbjct: 484 IEHPERMTLF-------RMVFLDFRFLEQKIRHDSTAWNASG-SILNTLQQL------KF 529
Query: 626 YLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685
Y I D ++ ER + +LD FLP + +
Sbjct: 530 YKPY---------ICDNDPKY------------ERLVNAILD--FLPKIEENLICSKYTD 566
Query: 686 LV---MEYCPGGDLHVLRQKQLGK 706
L+ + + KQ+ +
Sbjct: 567 LLRIALMA-EDEAIFEEAHKQVQR 589
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 32/161 (19%), Positives = 53/161 (32%), Gaps = 17/161 (10%)
Query: 613 LLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L + LG G G V A+ G T A+K++ + +E +IL +
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMSELKILIHIG 83
Query: 668 -HPFLPTLYSQFT-SDNLSCLVMEYCPGGDLHV-LRQKQLGKCFSEPAARFYVAEVLLAL 724
H + L T +++E+C G+L LR K+ Y +
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-------NEFVPYKTKGARFR 136
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765
+ +G I DLK + + F S
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 992 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.16 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.94 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.9 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.88 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.84 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.91 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.8 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.87 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=521.16 Aligned_cols=278 Identities=37% Similarity=0.675 Sum_probs=250.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++|||||+++++|++++.+|||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999987766667778899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 111 mEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~-- 186 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 186 (311)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT--
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC--
Confidence 9999999999999875 679999999999999999999999999999999999999999999999999986542100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......++||+
T Consensus 187 --------------------------------------------------------------------~~~~~~~~~GTp 198 (311)
T 4aw0_A 187 --------------------------------------------------------------------KQARANSFVGTA 198 (311)
T ss_dssp --------------------------------------------------------------------TCCCBCCCCSCG
T ss_pred --------------------------------------------------------------------CcccccCcccCc
Confidence 011234568999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++...+.+|. .++.++++||.+||..||++|
T Consensus 199 ~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp~~R 276 (311)
T 4aw0_A 199 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKR 276 (311)
T ss_dssp GGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSGGGS
T ss_pred ccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--ccCHHHHHHHHHHccCCHhHC
Confidence 999999999999999999999999999999999999999888999999888877765 489999999999999999999
Q ss_pred CCChH--hHHHHHcCCCCCCCchhhhhcCCCCCC
Q 001952 928 LGSQK--GAAEIKQHPFFEGLNWALIRCAIPPEL 959 (992)
Q Consensus 928 PT~~~--~aeEILkHPfF~~lnw~~lr~~~pp~l 959 (992)
|+..+ ...+|++||||+++||..++...||.+
T Consensus 277 ~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 277 LGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred cChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 99654 345689999999999999988877765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=506.46 Aligned_cols=278 Identities=41% Similarity=0.770 Sum_probs=237.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.+.++|++++.||+|+||+||+|++. .+++.||||++++..... .....+.+|+++|+.++|||||+++++|.+++
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34578999999999999999999874 467899999997653322 23446788999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999999999875 679999999999999999999999999999999999999999999999999984321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
. .......
T Consensus 178 ~------------------------------------------------------------------------~~~~~~~ 185 (304)
T 3ubd_A 178 D------------------------------------------------------------------------HEKKAYS 185 (304)
T ss_dssp ---------------------------------------------------------------------------CCCCS
T ss_pred C------------------------------------------------------------------------CCccccc
Confidence 0 0011234
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+.+..+....+.+|. .+++++++||.+||..
T Consensus 186 ~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~ 263 (304)
T 3ubd_A 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRMLFKR 263 (304)
T ss_dssp CCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred cccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccc
Confidence 68999999999999999999999999999999999999999999888999998887776664 5999999999999999
Q ss_pred CcCCcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCC
Q 001952 923 EPENRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELP 960 (992)
Q Consensus 923 DPekRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp 960 (992)
||++||++. ..++||++||||+++||..+ +...||.+|
T Consensus 264 dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 264 NPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp SGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 999999953 35789999999999999977 456677765
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-56 Score=495.67 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=228.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
...|+++++||+|+||+||+|.++.+|+.||||+++.. .......+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGG---GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999754 234456678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+...
T Consensus 150 mEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 223 (346)
T 4fih_A 150 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 223 (346)
T ss_dssp ECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence 999999999999876 46999999999999999999999999999999999999999999999999998543210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+||+
T Consensus 224 ---------------------------------------------------------------------~~~~~~~~GTp 234 (346)
T 4fih_A 224 ---------------------------------------------------------------------VPRRKSLVGTP 234 (346)
T ss_dssp ---------------------------------------------------------------------SCCBCCCCSCG
T ss_pred ---------------------------------------------------------------------CCcccccccCc
Confidence 01123568999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+..... .++....++.++++||.+||..||++
T Consensus 235 ~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 314 (346)
T 4fih_A 235 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 314 (346)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTT
T ss_pred CcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999999999999999999999999888888877765432 33444568999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~l 946 (992)
||+ ++|||+||||+..
T Consensus 315 R~t----a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 315 RAT----AAELLKHPFLAKA 330 (346)
T ss_dssp SCC----HHHHTTCGGGGGC
T ss_pred CcC----HHHHhcCHhhcCC
Confidence 999 9999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=500.82 Aligned_cols=261 Identities=26% Similarity=0.440 Sum_probs=225.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|++++.||+|+||+||+|++..+|+.||||+++..... ......+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999765332 23456789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|.+++....+..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--- 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH---
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC---
Confidence 99999999999998766667899999999999999999999999999999999999999999999999998443100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+||+
T Consensus 179 ---------------------------------------------------------------------~~~~~~~~GT~ 189 (350)
T 4b9d_A 179 ---------------------------------------------------------------------VELARACIGTP 189 (350)
T ss_dssp ---------------------------------------------------------------------HHHHHHHHSCC
T ss_pred ---------------------------------------------------------------------cccccccCCCc
Confidence 00123467999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+.+..++..... +.+..++.++++||.+||..||++|
T Consensus 190 ~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R 268 (350)
T 4b9d_A 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDR 268 (350)
T ss_dssp TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred cccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccCChhHC
Confidence 999999999999999999999999999999999999999888888888776543 3345689999999999999999999
Q ss_pred CCChHhHHHHHcCCCCCCC
Q 001952 928 LGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~l 946 (992)
|+ ++|||+||||+..
T Consensus 269 ~s----~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 269 PS----VNSILEKGFIAKR 283 (350)
T ss_dssp CC----HHHHHTSHHHHTT
T ss_pred cC----HHHHhcCHHhhcC
Confidence 99 9999999999763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-56 Score=478.22 Aligned_cols=256 Identities=32% Similarity=0.519 Sum_probs=215.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.+..+++.||||++++...........+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999876555555667889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||| +|+|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC----
Confidence 9999 78999888764 6799999999999999999999999999999999999999999999999999743210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+||+
T Consensus 165 ---------------------------------------------------------------------~~~~~~~~GT~ 175 (275)
T 3hyh_A 165 ---------------------------------------------------------------------GNFLKTSCGSP 175 (275)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ---------------------------------------------------------------------CCccCCeeECc
Confidence 00122457999
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|||||++.+..| +.++|||||||+||||+||+.||.+.+..+.+..+......+|. .++.++++||.+||+.||++
T Consensus 176 ~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~ 253 (275)
T 3hyh_A 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRMLIVNPLN 253 (275)
T ss_dssp TTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSSGGG
T ss_pred ccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCChhH
Confidence 9999999999886 68999999999999999999999998888888888777766654 58999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ 945 (992)
||| ++|+|+||||+.
T Consensus 254 R~s----~~eil~hpw~k~ 268 (275)
T 3hyh_A 254 RIS----IHEIMQDDWFKV 268 (275)
T ss_dssp SCC----HHHHHHCHHHHT
T ss_pred CcC----HHHHHcCccccc
Confidence 999 999999999963
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=498.77 Aligned_cols=257 Identities=28% Similarity=0.452 Sum_probs=228.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+.|++++.||+|+||.||+|.++.+|+.||||++... .......+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEST---TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999754 234456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|.++++. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+...
T Consensus 227 mEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--- 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 300 (423)
T ss_dssp EECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence 999999999999875 46999999999999999999999999999999999999999999999999998543210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+||+
T Consensus 301 ---------------------------------------------------------------------~~~~~~~~GTp 311 (423)
T 4fie_A 301 ---------------------------------------------------------------------VPRRKSLVGTP 311 (423)
T ss_dssp ---------------------------------------------------------------------CCCBCCCEECT
T ss_pred ---------------------------------------------------------------------CccccccccCc
Confidence 01124568999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+..... .++....++.++++||.+||..||++
T Consensus 312 ~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 391 (423)
T 4fie_A 312 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQ 391 (423)
T ss_dssp TTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTT
T ss_pred CcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhH
Confidence 99999999999999999999999999999999999999888888877765532 34444568999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~l 946 (992)
||+ ++|||+||||+..
T Consensus 392 R~t----a~ell~Hp~~~~~ 407 (423)
T 4fie_A 392 RAT----AAELLKHPFLAKA 407 (423)
T ss_dssp SCC----HHHHTTCGGGGGC
T ss_pred CcC----HHHHhcCHHhcCC
Confidence 999 9999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-54 Score=467.60 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=216.1
Q ss_pred cCc-eEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc----CCe
Q 001952 609 RHF-NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS----DNL 683 (992)
Q Consensus 609 ~~Y-eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~----~~~ 683 (992)
.+| ++.++||+|+||+||+|.+..+++.||||++...... ......+.+|+++|+.++|||||+++++|.. ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 7778899999999999999999999999999765332 2334678999999999999999999999864 456
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEc-cCCcEEEEecccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVR-EDGHIMLTDFDLSLR 760 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd-~dg~VKLsDFGLA~~ 760 (992)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|.+||+|||+|+.
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999875 67999999999999999999999998 99999999999998 478999999999742
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.. ....
T Consensus 182 ~~--------------------------------------------------------------------------~~~~ 187 (290)
T 3fpq_A 182 KR--------------------------------------------------------------------------ASFA 187 (290)
T ss_dssp CC--------------------------------------------------------------------------TTSB
T ss_pred CC--------------------------------------------------------------------------CCcc
Confidence 10 0012
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC-CCCccchHHHHHHHHHh
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF-PDSPLISFQARDLIRGL 919 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~-P~~~~vs~el~dLI~kc 919 (992)
...+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+......+...+...... ..+..+++++++||.+|
T Consensus 188 ~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~ 266 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266 (290)
T ss_dssp EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHH
T ss_pred CCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHH
Confidence 34579999999999876 59999999999999999999999998877766665555544332 22345778999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
|..||++||+ ++|||+||||++
T Consensus 267 L~~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 267 IRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp SCSSGGGSCC----HHHHHTSGGGC-
T ss_pred ccCChhHCcC----HHHHhcCccccC
Confidence 9999999999 999999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=510.31 Aligned_cols=278 Identities=32% Similarity=0.628 Sum_probs=238.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHH---HHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE---REILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~E---ieILk~L~HPNIVkL~g~f~~~ 681 (992)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+..+........+.+| +.+++.++|||||+|+++|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 4567899999999999999999999999999999999988766555555555555 4555667899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+|||||||+||+|..++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|..+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999999875 67999999999999999999999999999999999999999999999999998443
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. ....
T Consensus 343 ~~--------------------------------------------------------------------------~~~~ 348 (689)
T 3v5w_A 343 SK--------------------------------------------------------------------------KKPH 348 (689)
T ss_dssp SS--------------------------------------------------------------------------CCCC
T ss_pred CC--------------------------------------------------------------------------CCCC
Confidence 10 0123
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCc---hHHHHHHHhhccCCCCCccchHHHHHHHH
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---EETLANVVMQSLKFPDSPLISFQARDLIR 917 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---~e~L~~Iv~~~lk~P~~~~vs~el~dLI~ 917 (992)
..+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+.+. .+....+....+.+|. .++.++++||.
T Consensus 349 t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--~~S~~a~dLI~ 426 (689)
T 3v5w_A 349 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLE 426 (689)
T ss_dssp SCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT--TSCHHHHHHHH
T ss_pred CccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc--cCCHHHHHHHH
Confidence 4689999999999974 5799999999999999999999999986433 3444555555555554 59999999999
Q ss_pred HhccCCcCCcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCC
Q 001952 918 GLLIKEPENRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELP 960 (992)
Q Consensus 918 kcL~~DPekRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp 960 (992)
+||..||.+|++.. .+++||++||||+++||..+ +...||.+|
T Consensus 427 ~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P 472 (689)
T 3v5w_A 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 472 (689)
T ss_dssp HHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred HHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccC
Confidence 99999999999853 46899999999999999987 456788888
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=475.53 Aligned_cols=259 Identities=24% Similarity=0.327 Sum_probs=221.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.++||+|+||+||+|+++.+|+.||||+++.+. ...+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--------~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--------FRVEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--------CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--------hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997532 124699999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEeccccccccCCcc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~~~~~ 766 (992)
||||+||+|.++++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus 129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999875 5799999999999999999999999999999999999999887 699999999855421000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.........++||
T Consensus 207 -------------------------------------------------------------------~~~~~~~~~~~GT 219 (336)
T 4g3f_A 207 -------------------------------------------------------------------GKSLLTGDYIPGT 219 (336)
T ss_dssp --------------------------------------------------------------------------CCCCCC
T ss_pred -------------------------------------------------------------------ccceecCCccccC
Confidence 0000112346799
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-CCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP-DSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P-~~~~vs~el~dLI~kcL~~DPe 925 (992)
+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+.+..+......+. .++.+++++.+||.+||..||+
T Consensus 220 ~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 299 (336)
T 4g3f_A 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299 (336)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHh
Confidence 999999999999999999999999999999999999999888888888877654332 3346899999999999999999
Q ss_pred CcCCChHhHHHH-------------HcCCCCCCCc
Q 001952 926 NRLGSQKGAAEI-------------KQHPFFEGLN 947 (992)
Q Consensus 926 kRPT~~~~aeEI-------------LkHPfF~~ln 947 (992)
+||+ +.|| |+|||+.++.
T Consensus 300 ~R~s----a~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 300 HRAS----AMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp GSCC----HHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred HCcC----HHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 9999 6666 5799988754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-53 Score=477.81 Aligned_cols=267 Identities=26% Similarity=0.364 Sum_probs=223.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec------cCC
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT------SDN 682 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~------~~~ 682 (992)
++|++++.||+|+||+||+|.++.+|+.||||++++... .......+.+|+++|+.++|||||++++++. +.+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 689999999999999999999999999999999975432 1233456789999999999999999999875 346
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|||||||. |+|..++... +.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+++.+.
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 8999999995 6798888764 679999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
... .........
T Consensus 210 ~~~--------------------------------------------------------------------~~~~~~~~~ 221 (398)
T 4b99_A 210 TSP--------------------------------------------------------------------AEHQYFMTE 221 (398)
T ss_dssp --------------------------------------------------------------------------CCCCCS
T ss_pred cCc--------------------------------------------------------------------ccccccccc
Confidence 100 001122345
Q ss_pred cccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC-----------------
Q 001952 843 FVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD----------------- 904 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~----------------- 904 (992)
++||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+..+.+..|+.....++.
T Consensus 222 ~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~ 301 (398)
T 4b99_A 222 YVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS 301 (398)
T ss_dssp SCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHS
T ss_pred ceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc
Confidence 7899999999999886 4699999999999999999999999999998888887654322211
Q ss_pred ------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 905 ------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 905 ------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
.+.++.++.|||.+||.+||.+||| ++|+|+||||+.+.+...
T Consensus 302 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~p~~ 356 (398)
T 4b99_A 302 LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYHDPDD 356 (398)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTCCGGG
T ss_pred CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCCCCcc
Confidence 1236789999999999999999999 999999999998866543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=463.47 Aligned_cols=272 Identities=28% Similarity=0.422 Sum_probs=201.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----- 682 (992)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 357999999999999999999999999999999996432 2233457889999999999999999999987543
Q ss_pred -------eEEEEEEecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEe
Q 001952 683 -------LSCLVMEYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTD 754 (992)
Q Consensus 683 -------~lyLVmEy~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsD 754 (992)
++|||||||+||+|.+++..... ....+..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999986421 2245667899999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccC
Q 001952 755 FDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834 (992)
Q Consensus 755 FGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~ 834 (992)
||+|+.+......... ....
T Consensus 162 FGla~~~~~~~~~~~~------------------------------------------------------------~~~~ 181 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTV------------------------------------------------------------LTPM 181 (299)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred CccceecCCCcccccc------------------------------------------------------------cccc
Confidence 9998654321100000 0000
Q ss_pred CCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccCCC-CCccchHHH
Q 001952 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLKFP-DSPLISFQA 912 (992)
Q Consensus 835 ~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk~P-~~~~vs~el 912 (992)
......+..+||+.|||||++.+..|+.++|||||||+||||++ ||.+.... ..+..+ ....+| .....++.+
T Consensus 182 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~ 256 (299)
T 4g31_A 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCE 256 (299)
T ss_dssp ----------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH--HTTCCCHHHHHHCHHH
T ss_pred ccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH--hcCCCCCCCcccCHHH
Confidence 01122345689999999999999999999999999999999996 78653221 112222 222332 112345678
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
.+||.+||..||++||+ +.|||+||||++++|..
T Consensus 257 ~~li~~~L~~dP~~Rps----~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 257 YVMVQDMLSPSPMERPE----AINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHTSGGGCCC----
T ss_pred HHHHHHHcCCChhHCcC----HHHHhcCHhhCCCCCCC
Confidence 89999999999999999 99999999999999853
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=456.45 Aligned_cols=282 Identities=24% Similarity=0.349 Sum_probs=211.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCe
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ 683 (992)
.++|++++.||+|+||+||+|.++ .+++.||||++... .....+.+|+++|+.+ +|||||+++++|.+.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 468999999999999999999875 46789999998643 2345678899999998 69999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-CcEEEEecccccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLSLRCS 762 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-g~VKLsDFGLA~~l~ 762 (992)
+|||||||+||+|.+++. .+++..++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|+...
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~ 169 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH 169 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence 999999999999999874 38999999999999999999999999999999999999876 799999999986543
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
........ .... ......+. ................
T Consensus 170 ~~~~~~~~--------~~~~-------------~~~~~~~~-----------------------~~~~~~~~~~~~~~~~ 205 (361)
T 4f9c_A 170 DTKIELLK--------FVQS-------------EAQQERCS-----------------------QNKCSICLSRRQQVAP 205 (361)
T ss_dssp TCSCGGGG--------GC--------------------------------------------------------------
T ss_pred Cccccccc--------cccc-------------cccccccc-----------------------cccccccccccccccc
Confidence 21110000 0000 00000000 0000000011223456
Q ss_pred cccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhhc---------------------
Q 001952 843 FVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQS--------------------- 899 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~~--------------------- 899 (992)
.+||+.|||||++.+. .|+.++||||+||++|||++|+.||.... +.+++..|..-.
T Consensus 206 ~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~ 285 (361)
T 4f9c_A 206 RAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKE 285 (361)
T ss_dssp CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSC
T ss_pred cccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhcccccccccc
Confidence 7899999999999886 48999999999999999999999996544 445554443200
Q ss_pred -------------------------------cCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 900 -------------------------------LKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 900 -------------------------------lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
........++++++|||.+||..||++|+| ++|+|+||||++++
T Consensus 286 ~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 286 VPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFKDMS 360 (361)
T ss_dssp CCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGTTC-
T ss_pred CcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCC
Confidence 001112347889999999999999999999 99999999999876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=451.16 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=214.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
.+..++|.+.++||+|+||+||+|.+.+ +++.||||+++.. .......|.+|+++|++++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3456789999999999999999998753 5789999999754 2234467899999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhc-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQL-------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~-------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~ 746 (992)
+.+.+|||||||++|+|.++++... ..++++..++.|+.||+.||+|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 9999999999999999999987642 246899999999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhc
Q 001952 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIR 826 (992)
Q Consensus 747 dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~ 826 (992)
++.+||+|||+++.+....
T Consensus 194 ~~~~Ki~DFGla~~~~~~~------------------------------------------------------------- 212 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTD------------------------------------------------------------- 212 (329)
T ss_dssp TTEEEECCCC----------------------------------------------------------------------
T ss_pred CCcEEEcccccceeccCCC-------------------------------------------------------------
Confidence 9999999999985432100
Q ss_pred cCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCC
Q 001952 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDS 905 (992)
Q Consensus 827 ~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~ 905 (992)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+ ..++.+
T Consensus 213 ---------~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p 282 (329)
T 4aoj_A 213 ---------YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERP 282 (329)
T ss_dssp ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCC
T ss_pred ---------cceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCc
Confidence 0001123579999999999999999999999999999999999 99999998887777766543 445555
Q ss_pred ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
..+++++.+||.+||+.||++||+ +.||+++
T Consensus 283 ~~~~~~~~~li~~cl~~dP~~RPs----~~ei~~~ 313 (329)
T 4aoj_A 283 RACPPEVYAIMRGCWQREPQQRHS----IKDVHAR 313 (329)
T ss_dssp TTCCHHHHHHHHHHCCSSTTTSCC----HHHHHHH
T ss_pred ccccHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 679999999999999999999999 7777653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=447.65 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=216.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
.+..++|.+.+.||+|+||+||+|.+.. ++..||||+++... ......|.+|+++|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 3556789999999999999999998753 57889999997542 234467899999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhh-----------cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQ-----------LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG 748 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~-----------~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg 748 (992)
+++.+|||||||++|+|.++++.. ....+++..++.|+.||+.||+|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999763 235699999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccC
Q 001952 749 HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828 (992)
Q Consensus 749 ~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~ 828 (992)
.+||+|||+++.+.....
T Consensus 166 ~~Ki~DFGla~~~~~~~~-------------------------------------------------------------- 183 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------- 183 (299)
T ss_dssp CEEECCCSCHHHHTGGGC--------------------------------------------------------------
T ss_pred cEEECCcccceecCCCCc--------------------------------------------------------------
Confidence 999999999854321000
Q ss_pred CccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCcc
Q 001952 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPL 907 (992)
Q Consensus 829 ~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~ 907 (992)
........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+. .++.+..
T Consensus 184 --------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~~ 254 (299)
T 4asz_A 184 --------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPRT 254 (299)
T ss_dssp --------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCCTT
T ss_pred --------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCcc
Confidence 001123469999999999999999999999999999999999 999999988888777766543 3445567
Q ss_pred chHHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 908 vs~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
++.++.+||.+||+.||++||+ +.||+
T Consensus 255 ~~~~~~~li~~cl~~dP~~RPs----~~~i~ 281 (299)
T 4asz_A 255 CPQEVYELMLGCWQREPHMRKN----IKGIH 281 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHH
T ss_pred chHHHHHHHHHHcCCChhHCcC----HHHHH
Confidence 9999999999999999999999 77763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=446.84 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=219.1
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeee
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQ 677 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~ 677 (992)
..++...++++++.||+|+||+||+|.+.+ +++.||||+++... .......|.+|+.+|++++|||||+|+|+
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGV 97 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceE
Confidence 345677889999999999999999998743 57889999997542 23345678999999999999999999999
Q ss_pred eccCCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 678 FTSDNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 678 f~~~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
|.+++.+|||||||++|+|.+++.... ...+++..++.|+.||+.||+|||+++||||||||+|||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 999999999999999999999997532 245899999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 744 Ld~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
|+.++.+||+|||+++.+....
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~---------------------------------------------------------- 199 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAAD---------------------------------------------------------- 199 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGG----------------------------------------------------------
T ss_pred ECCCCCEEECCcccceeccCCC----------------------------------------------------------
Confidence 9999999999999985432100
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCC
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
........+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+.. ....
T Consensus 200 ------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~-~~~~ 266 (308)
T 4gt4_A 200 ------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN-RQVL 266 (308)
T ss_dssp ------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT-TCCC
T ss_pred ------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCC
Confidence 0011234579999999999999999999999999999999998 8999999887777766554 4455
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.+..++.++.+||.+||..||++||+ +.||+++
T Consensus 267 ~~p~~~~~~~~~li~~C~~~dP~~RPs----~~ei~~~ 300 (308)
T 4gt4_A 267 PCPDDCPAWVYALMIECWNEFPSRRPR----FKDIHSR 300 (308)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCcccchHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 666679999999999999999999999 6666543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=447.51 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=215.2
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
+++..++|++.++||+|+||+||+|.+.+ .||||+++.... .......|.+|+.+|++++|||||++++++.+ +.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 46778899999999999999999998743 489999874321 22345678999999999999999999998865 56
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||||||+||+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+|+....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 89999999999999999764 35699999999999999999999999999999999999999999999999999844311
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.. ........
T Consensus 185 ~~----------------------------------------------------------------------~~~~~~~~ 194 (307)
T 3omv_A 185 WS----------------------------------------------------------------------GSQQVEQP 194 (307)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred CC----------------------------------------------------------------------cceeeccc
Confidence 00 00112345
Q ss_pred ccCCCccChhhhcCC---CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC----CccchHHHHHHH
Q 001952 844 VGTHEYLAPEIIKGE---GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD----SPLISFQARDLI 916 (992)
Q Consensus 844 vGT~~Y~APEvL~g~---~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~----~~~vs~el~dLI 916 (992)
+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+..+.+..++......|. ...++.++.+||
T Consensus 195 ~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li 274 (307)
T 3omv_A 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLV 274 (307)
T ss_dssp CCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHH
T ss_pred ccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHH
Confidence 799999999999753 5899999999999999999999999998888877777776655443 345789999999
Q ss_pred HHhccCCcCCcCCChHhHH--HHHcCCC
Q 001952 917 RGLLIKEPENRLGSQKGAA--EIKQHPF 942 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~ae--EILkHPf 942 (992)
.+||+.||++||++...+. |+|+|+|
T Consensus 275 ~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 275 ADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 9999999999999554432 3466665
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=481.53 Aligned_cols=263 Identities=30% Similarity=0.451 Sum_probs=233.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.++.+|+.||||++..... .....+.+|+.+|+.++|||||+|+++|.+.+.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999975432 2235678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC--CcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED--GHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d--g~VKLsDFGLA~~l~~~~ 765 (992)
||||+||+|.+++... ...+++..++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+++.+...
T Consensus 233 ~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999988653 3569999999999999999999999999999999999999854 89999999998553210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
......+|
T Consensus 311 ------------------------------------------------------------------------~~~~~~~G 318 (573)
T 3uto_A 311 ------------------------------------------------------------------------QSVKVTTG 318 (573)
T ss_dssp ------------------------------------------------------------------------SEEEEECS
T ss_pred ------------------------------------------------------------------------CceeeeEE
Confidence 11234579
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccCC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIKE 923 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~D 923 (992)
|+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+....+.++.. ..++.++++||.+||..|
T Consensus 319 T~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 398 (573)
T 3uto_A 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD 398 (573)
T ss_dssp SGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSS
T ss_pred CccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999999999999988777666543 458999999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 924 PENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
|.+||+ +.|+|+||||+..+|...
T Consensus 399 p~~R~t----~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 399 PNTRMT----IHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp GGGSCC----HHHHHHSTTTSCCCCTTT
T ss_pred hhHCcC----HHHHhcCcCcCCCCCCCc
Confidence 999999 999999999999988654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=446.93 Aligned_cols=280 Identities=36% Similarity=0.727 Sum_probs=243.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++++.||+|+||+||+|.+..+++.||||++++...........+..|..+|..+ +||||++++++|.+.+.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4568999999999999999999999999999999999887666666777888999999988 799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999732110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........+
T Consensus 177 -----------------------------------------------------------------------~~~~~~~~~ 185 (353)
T 3txo_A 177 -----------------------------------------------------------------------NGVTTATFC 185 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------CCccccccC
Confidence 001123457
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++.....+|. .++.++.+||.+||..||
T Consensus 186 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dP 263 (353)
T 3txo_A 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLHEDATGILKSFMTKNP 263 (353)
T ss_dssp CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSG
T ss_pred CCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhhCH
Confidence 999999999999999999999999999999999999999999989999999888777765 489999999999999999
Q ss_pred CCcCCC--hHhHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 925 ENRLGS--QKGAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 925 ekRPT~--~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
.+||+. ..+++||++||||++++|..+ +...||..|.
T Consensus 264 ~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~ 304 (353)
T 3txo_A 264 TMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304 (353)
T ss_dssp GGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCC
Confidence 999995 234599999999999999977 4567777774
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=440.19 Aligned_cols=288 Identities=38% Similarity=0.714 Sum_probs=249.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++++.||+|+||+||+|.+..+++.||||++++...........+.+|+.+|+.++||||++++++|...+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 34679999999999999999999999999999999998876555667778899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||||++||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++.....
T Consensus 82 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 157 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--
Confidence 999999999999988765 5799999999999999999999999999999999999999999999999999732110
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+|
T Consensus 158 ----------------------------------------------------------------------~~~~~~~~~g 167 (337)
T 1o6l_A 158 ----------------------------------------------------------------------DGATMKTFCG 167 (337)
T ss_dssp ----------------------------------------------------------------------TTCCBCCCEE
T ss_pred ----------------------------------------------------------------------CCCccccccc
Confidence 0011234579
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||.
T Consensus 168 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~ 245 (337)
T 1o6l_A 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPK 245 (337)
T ss_dssp CGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTT
T ss_pred ChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHH
Confidence 99999999999999999999999999999999999999998888888888877777665 4899999999999999999
Q ss_pred CcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCCC---CCCCCCcc
Q 001952 926 NRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELPD---FYDYGIQD 969 (992)
Q Consensus 926 kRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~---~~d~~~~~ 969 (992)
+||+.. ..++||++||||.+++|..+ +...||..|. ..|...++
T Consensus 246 ~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~~d~~~f~ 295 (337)
T 1o6l_A 246 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFD 295 (337)
T ss_dssp TSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTCCTTSC
T ss_pred HhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCcchhhccc
Confidence 999321 12999999999999999977 4566777774 34444443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=434.01 Aligned_cols=276 Identities=36% Similarity=0.733 Sum_probs=245.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||.||+|.+..+++.||||++++...........+.+|+.+|+.++||||++++++|.+.+.+||
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 46789999999999999999999999999999999988766555667788899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 84 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~---- 157 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---- 157 (318)
T ss_dssp EECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS----
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC----
Confidence 99999999999999874 579999999999999999999999999999999999999999999999999974321
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
......+||
T Consensus 158 -----------------------------------------------------------------------~~~~~~~gt 166 (318)
T 1fot_A 158 -----------------------------------------------------------------------DVTYTLCGT 166 (318)
T ss_dssp -----------------------------------------------------------------------SCBCCCCSC
T ss_pred -----------------------------------------------------------------------CccccccCC
Confidence 001234699
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++...+.+|. .++.++.+||.+||..||.+
T Consensus 167 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dp~~ 244 (318)
T 1fot_A 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRDLSQ 244 (318)
T ss_dssp TTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTT
T ss_pred ccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhccCHHH
Confidence 9999999999999999999999999999999999999998888888888887777664 58999999999999999999
Q ss_pred cCCChH-hHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 927 RLGSQK-GAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 927 RPT~~~-~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
||+... .++||++||||++++|..+ +...+|..|.
T Consensus 245 R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~ 282 (318)
T 1fot_A 245 RLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 282 (318)
T ss_dssp CTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred cCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCC
Confidence 994322 4999999999999999977 4456666664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=437.40 Aligned_cols=286 Identities=36% Similarity=0.655 Sum_probs=251.9
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
....++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34578999999999999999999999999999999999877665666777889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++||+|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999743210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.....+
T Consensus 194 --------------------------------------------------------------------------~~~~~~ 199 (350)
T 1rdq_E 194 --------------------------------------------------------------------------RTWTLC 199 (350)
T ss_dssp --------------------------------------------------------------------------CBCCCE
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 012357
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||
T Consensus 200 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~dp 277 (350)
T 1rdq_E 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDL 277 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSCSCT
T ss_pred CCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999999998888888888887776664 589999999999999999
Q ss_pred CCcCCC-hHhHHHHHcCCCCCCCchhhh--hcCCCCCCCC---CCCCCCcc
Q 001952 925 ENRLGS-QKGAAEIKQHPFFEGLNWALI--RCAIPPELPD---FYDYGIQD 969 (992)
Q Consensus 925 ekRPT~-~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~---~~d~~~~~ 969 (992)
.+||+. ...++||++||||..++|..+ +...+|.+|+ ..|.+.++
T Consensus 278 ~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~f~ 328 (350)
T 1rdq_E 278 TKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFD 328 (350)
T ss_dssp TTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCTTSC
T ss_pred HhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCCcccccccc
Confidence 999984 345899999999999999877 4567777773 34444444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=447.32 Aligned_cols=288 Identities=36% Similarity=0.735 Sum_probs=242.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++++.||+|+||+||+|++..+++.||||++++...........+..|..+|..+ +||||++++++|.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 4578999999999999999999999999999999999877655556667788999999887 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999998875 5799999999999999999999999999999999999999999999999999732100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........+
T Consensus 206 -----------------------------------------------------------------------~~~~~~~~~ 214 (396)
T 4dc2_A 206 -----------------------------------------------------------------------PGDTTSTFC 214 (396)
T ss_dssp -----------------------------------------------------------------------TTCCBCCCC
T ss_pred -----------------------------------------------------------------------CCCcccccc
Confidence 001123467
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC---------chHHHHHHHhhccCCCCCccchHHHHHH
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG---------NEETLANVVMQSLKFPDSPLISFQARDL 915 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s---------~~e~L~~Iv~~~lk~P~~~~vs~el~dL 915 (992)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. .......+....+.+|. .++.++++|
T Consensus 215 gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~l 292 (396)
T 4dc2_A 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV 292 (396)
T ss_dssp BCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred CCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCCHHHHHH
Confidence 9999999999999999999999999999999999999996432 12344555566666665 489999999
Q ss_pred HHHhccCCcCCcCCCh--HhHHHHHcCCCCCCCchhhh--hcCCCCCCCC---CCCCCCcc
Q 001952 916 IRGLLIKEPENRLGSQ--KGAAEIKQHPFFEGLNWALI--RCAIPPELPD---FYDYGIQD 969 (992)
Q Consensus 916 I~kcL~~DPekRPT~~--~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~---~~d~~~~~ 969 (992)
|.+||..||.+||+.. .+++||++||||+++||..+ +...||.+|. .+|...+|
T Consensus 293 i~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd 353 (396)
T 4dc2_A 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFD 353 (396)
T ss_dssp HHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSC
T ss_pred HHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCCCccchhhcC
Confidence 9999999999999963 45799999999999999977 4567777773 34444444
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=448.77 Aligned_cols=261 Identities=21% Similarity=0.321 Sum_probs=222.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCC-----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC-CCccceeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH-PFLPTLYSQ 677 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg-----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H-PNIVkL~g~ 677 (992)
+++..++|++.+.||+|+||+||+|.+.+.+ +.||||+++.... ......+.+|+.+|.++.| ||||+|+++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 4567789999999999999999999987643 6899999975422 2334678899999999965 899999999
Q ss_pred ecc-CCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 678 FTS-DNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 678 f~~-~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
|.+ ++.+|||||||++|+|.++++... ...+++..++.|+.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 875 467899999999999999997642 24588999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
||+.++.+||+|||+|+.+.....
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~-------------------------------------------------------- 240 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPD-------------------------------------------------------- 240 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT--------------------------------------------------------
T ss_pred eeCCCCCEEECcchhhhhcccCCC--------------------------------------------------------
Confidence 999999999999999854321100
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
........||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+.+..++.....
T Consensus 241 --------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~ 306 (353)
T 4ase_A 241 --------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR 306 (353)
T ss_dssp --------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC
T ss_pred --------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 011234579999999999999999999999999999999998 99999998777777777777777
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
++.+..+++++.+||.+||+.||++||+ +.||++|
T Consensus 307 ~~~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 307 MRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 7777789999999999999999999999 8888876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=449.85 Aligned_cols=289 Identities=35% Similarity=0.627 Sum_probs=251.1
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..+..++|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34567899999999999999999999999999999999987666666667778999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||++||+|..++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+..
T Consensus 144 ~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 9999999999999999875 4689999999999999999999999999999999999999999999999999754321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.. .......
T Consensus 221 ~~-----------------------------------------------------------------------~~~~~~~ 229 (410)
T 3v8s_A 221 EG-----------------------------------------------------------------------MVRCDTA 229 (410)
T ss_dssp TS-----------------------------------------------------------------------EEECCSC
T ss_pred CC-----------------------------------------------------------------------cccccCC
Confidence 00 0012345
Q ss_pred ccCCCccChhhhcCCC----CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHHHHHH
Q 001952 844 VGTHEYLAPEIIKGEG----HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQARDLIR 917 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~----~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~dLI~ 917 (992)
+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+..+.+..++... +.+|....++.++++||.
T Consensus 230 ~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~ 309 (410)
T 3v8s_A 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309 (410)
T ss_dssp CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHH
T ss_pred cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHH
Confidence 7999999999998765 7899999999999999999999999998888888887653 566766679999999999
Q ss_pred HhccCCcCC--cCCChHhHHHHHcCCCCCCCchh--hhhcCCCCCCCC---CCCCCCccc
Q 001952 918 GLLIKEPEN--RLGSQKGAAEIKQHPFFEGLNWA--LIRCAIPPELPD---FYDYGIQDM 970 (992)
Q Consensus 918 kcL~~DPek--RPT~~~~aeEILkHPfF~~lnw~--~lr~~~pp~lp~---~~d~~~~~~ 970 (992)
+||..+|.+ |++ ++||++||||++++|. .++...||.+|+ ..|.+.+|-
T Consensus 310 ~lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~~~~d~~~fd~ 365 (410)
T 3v8s_A 310 AFLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDD 365 (410)
T ss_dssp HHSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCSSTTCCTTSCC
T ss_pred HHccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcCCCccchhhcCC
Confidence 999998988 999 9999999999999886 557788888883 445555543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=454.74 Aligned_cols=292 Identities=34% Similarity=0.616 Sum_probs=250.9
Q ss_pred ecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 602 QYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 602 ~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
....+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++||||++++++|.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 34456678999999999999999999999999999999999876555556666789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+|||||||+||+|..++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999999999863 357999999999999999999999999999999999999999999999999997543
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.... .....
T Consensus 226 ~~~~-----------------------------------------------------------------------~~~~~ 234 (437)
T 4aw2_A 226 MEDG-----------------------------------------------------------------------TVQSS 234 (437)
T ss_dssp CTTS-----------------------------------------------------------------------CEECC
T ss_pred ccCC-----------------------------------------------------------------------Ccccc
Confidence 2100 00122
Q ss_pred ccccCCCccChhhhc-----CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCC-ccchHHHH
Q 001952 842 SFVGTHEYLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDS-PLISFQAR 913 (992)
Q Consensus 842 s~vGT~~Y~APEvL~-----g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~-~~vs~el~ 913 (992)
..+||+.|+|||++. +..|+.++|||||||+||||++|+.||.+.+..+.+..++... +.+|.. ..++.+++
T Consensus 235 ~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~ 314 (437)
T 4aw2_A 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAK 314 (437)
T ss_dssp SCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHH
T ss_pred cccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHH
Confidence 357999999999997 4568999999999999999999999999998888888887643 444433 35899999
Q ss_pred HHHHHhccCCcCC--cCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCC---CCCCCCcc
Q 001952 914 DLIRGLLIKEPEN--RLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPD---FYDYGIQD 969 (992)
Q Consensus 914 dLI~kcL~~DPek--RPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~---~~d~~~~~ 969 (992)
+||++||..+|++ |++ ++||++||||+++||..++...+|.+|. ..|.+.+|
T Consensus 315 dLi~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~~~~~d~~~fd 371 (437)
T 4aw2_A 315 DLIRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFD 371 (437)
T ss_dssp HHHHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCCSSTTCCTTSC
T ss_pred HHHHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcCCCccchhhcC
Confidence 9999999998888 888 9999999999999999999888888884 33444444
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=439.42 Aligned_cols=284 Identities=38% Similarity=0.748 Sum_probs=239.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++++.||+|+||.||+|.+..+++.||||++++...........+..|..+|..+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4578999999999999999999999999999999999887655556677788999999877 999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++.....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999733110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........+
T Consensus 171 -----------------------------------------------------------------------~~~~~~~~~ 179 (345)
T 1xjd_A 171 -----------------------------------------------------------------------GDAKTNTFC 179 (345)
T ss_dssp -----------------------------------------------------------------------TTCCBCCCC
T ss_pred -----------------------------------------------------------------------CCCcccCCC
Confidence 001123457
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..||
T Consensus 180 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dp 257 (345)
T 1xjd_A 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREP 257 (345)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSG
T ss_pred CCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--ccCHHHHHHHHHHhcCCH
Confidence 999999999999999999999999999999999999999998888888888777666654 489999999999999999
Q ss_pred CCcCCChHhHH-HHHcCCCCCCCchhhh--hcCCCCCCCC---CCCCCCcc
Q 001952 925 ENRLGSQKGAA-EIKQHPFFEGLNWALI--RCAIPPELPD---FYDYGIQD 969 (992)
Q Consensus 925 ekRPT~~~~ae-EILkHPfF~~lnw~~l--r~~~pp~lp~---~~d~~~~~ 969 (992)
.+||+ +. +|++||||++++|..+ +...||..|. .+|.+.++
T Consensus 258 ~~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~~~d~~~f~ 304 (345)
T 1xjd_A 258 EKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFD 304 (345)
T ss_dssp GGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC----------------
T ss_pred hHcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcCCCCCCcchhhhcc
Confidence 99999 65 9999999999999987 4466777663 34444444
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=437.37 Aligned_cols=282 Identities=36% Similarity=0.697 Sum_probs=248.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++++.||+|+||.||+|.+..+++.||||++++...........+..|..+|..+ +||||++++++|...+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4568999999999999999999999999999999999887665566677888999999887 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999742110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........+
T Consensus 174 -----------------------------------------------------------------------~~~~~~~~~ 182 (353)
T 2i0e_A 174 -----------------------------------------------------------------------DGVTTKTFC 182 (353)
T ss_dssp -----------------------------------------------------------------------TTCCBCCCC
T ss_pred -----------------------------------------------------------------------CCccccccc
Confidence 001123457
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++...+.+|. .++.++.+||.+||..||
T Consensus 183 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP 260 (353)
T 2i0e_A 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHP 260 (353)
T ss_dssp SCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCT
T ss_pred CCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999999998888888888888777765 589999999999999999
Q ss_pred CCcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCCCCC
Q 001952 925 ENRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELPDFY 963 (992)
Q Consensus 925 ekRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~~~ 963 (992)
.+||++. ..+++|++||||+.++|..+ +...||..|...
T Consensus 261 ~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~ 302 (353)
T 2i0e_A 261 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAC 302 (353)
T ss_dssp TSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCC
Confidence 9999753 35899999999999999987 557788888543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=450.29 Aligned_cols=297 Identities=37% Similarity=0.665 Sum_probs=250.2
Q ss_pred eeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 600 RLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 600 ~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
.+....+..++|++++.||+|+||.||+|++..+++.||||++++...........+.+|+.+|..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34445567889999999999999999999999999999999998765555566677899999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
+.+.+||||||++||+|..++.+. +..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 999999999999999999999865 3579999999999999999999999999999999999999999999999999975
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+.... ...
T Consensus 211 ~~~~~~-----------------------------------------------------------------------~~~ 219 (412)
T 2vd5_A 211 KLRADG-----------------------------------------------------------------------TVR 219 (412)
T ss_dssp ECCTTS-----------------------------------------------------------------------CEE
T ss_pred eccCCC-----------------------------------------------------------------------ccc
Confidence 431100 001
Q ss_pred cCccccCCCccChhhhc-------CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCC-Cccch
Q 001952 840 SNSFVGTHEYLAPEIIK-------GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPD-SPLIS 909 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~-------g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~-~~~vs 909 (992)
....+||+.|+|||++. +..|+.++|||||||+||||++|+.||.+.+..+.+..++... +.+|. ...++
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 299 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCC
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCC
Confidence 12357999999999998 3568999999999999999999999999988888888887643 44443 24689
Q ss_pred HHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCC---CCCCCccc
Q 001952 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF---YDYGIQDM 970 (992)
Q Consensus 910 ~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~---~d~~~~~~ 970 (992)
.++++||.+||. +|.+|++ ...++||++||||+++||..++...||.+|.. .|...++.
T Consensus 300 ~~~~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~ 361 (412)
T 2vd5_A 300 EEARDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDL 361 (412)
T ss_dssp HHHHHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-----CCSSCC-
T ss_pred HHHHHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcCCCcccccccCc
Confidence 999999999999 9999963 22399999999999999999998888888843 34444443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=432.24 Aligned_cols=280 Identities=37% Similarity=0.746 Sum_probs=238.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|..+ +||||++++++|...+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4568999999999999999999999999999999999876544445566788999999988 899999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 86 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~- 162 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 162 (345)
T ss_dssp EEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence 9999999999999998875 5699999999999999999999999999999999999999999999999999732110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........+
T Consensus 163 -----------------------------------------------------------------------~~~~~~~~~ 171 (345)
T 3a8x_A 163 -----------------------------------------------------------------------PGDTTSTFC 171 (345)
T ss_dssp -----------------------------------------------------------------------TTCCBCCCC
T ss_pred -----------------------------------------------------------------------CCCcccccC
Confidence 001123457
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCC---------CchHHHHHHHhhccCCCCCccchHHHHHH
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS---------GNEETLANVVMQSLKFPDSPLISFQARDL 915 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~---------s~~e~L~~Iv~~~lk~P~~~~vs~el~dL 915 (992)
||+.|+|||++.+..++.++|||||||+||||++|+.||... .....+..+......+|. .++.++++|
T Consensus 172 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~l 249 (345)
T 3a8x_A 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASV 249 (345)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred CCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHHHHHH
Confidence 999999999999999999999999999999999999999752 222344555555555554 589999999
Q ss_pred HHHhccCCcCCcCCCh--HhHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 916 IRGLLIKEPENRLGSQ--KGAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 916 I~kcL~~DPekRPT~~--~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
|.+||..||.+||++. .+++||++||||++++|..+ +...||..|.
T Consensus 250 i~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~ 299 (345)
T 3a8x_A 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 299 (345)
T ss_dssp HHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999952 35799999999999999977 4566777764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=442.40 Aligned_cols=279 Identities=39% Similarity=0.719 Sum_probs=236.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHH-HHHcCCCCccceeeeeccCCeEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI-LRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieI-Lk~L~HPNIVkL~g~f~~~~~ly 685 (992)
..++|++++.||+|+||.||+|++..+++.||||++++...........+..|..+ ++.++||||++++++|.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 45789999999999999999999999999999999987654444445566677776 56789999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||||++||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||++.....
T Consensus 116 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999998875 5689999999999999999999999999999999999999999999999999743210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+|
T Consensus 192 ----------------------------------------------------------------------~~~~~~~~~g 201 (373)
T 2r5t_A 192 ----------------------------------------------------------------------HNSTTSTFCG 201 (373)
T ss_dssp ----------------------------------------------------------------------CCCCCCSBSC
T ss_pred ----------------------------------------------------------------------CCCccccccC
Confidence 0011234579
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..++...+.++. .++.++++||.+||..||.
T Consensus 202 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~lL~~dp~ 279 (373)
T 2r5t_A 202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGLLQKDRT 279 (373)
T ss_dssp CCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--SSCHHHHHHHHHHTCSSGG
T ss_pred CccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHcccCHH
Confidence 99999999999999999999999999999999999999998888888888887766654 5899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
+||+....+.+|++||||+++||..+ +...||..|.
T Consensus 280 ~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~ 317 (373)
T 2r5t_A 280 KRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPN 317 (373)
T ss_dssp GSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred hCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCC
Confidence 99998778899999999999999987 4567777773
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=440.98 Aligned_cols=281 Identities=38% Similarity=0.739 Sum_probs=233.3
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++||||++++++|...+.+
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34567899999999999999999999999999999999876554555566778899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
||||||+++++|..++... ..+++..++.|+.||+.||+|||+ +|||||||||+||||+.++.+||+|||++.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999988775 579999999999999999999998 8999999999999999999999999999732110
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
........
T Consensus 302 ------------------------------------------------------------------------~~~~~~~~ 309 (446)
T 4ejn_A 302 ------------------------------------------------------------------------DGATMKTF 309 (446)
T ss_dssp -----------------------------------------------------------------------------CCS
T ss_pred ------------------------------------------------------------------------CCcccccc
Confidence 00112345
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......+|. .++.++.+||.+||..|
T Consensus 310 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~d 387 (446)
T 4ejn_A 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSGLLKKD 387 (446)
T ss_dssp SSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred cCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccC
Confidence 7999999999999999999999999999999999999999998888888888877777665 48999999999999999
Q ss_pred cCCcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 924 PENRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 924 PekRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
|.+||+.. ..++|||+||||.+++|..+ +...||..|.
T Consensus 388 P~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~ 428 (446)
T 4ejn_A 388 PKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQ 428 (446)
T ss_dssp TTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred HHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCC
Confidence 99999110 12999999999999999876 4455666663
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=431.14 Aligned_cols=278 Identities=29% Similarity=0.630 Sum_probs=239.5
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
+.+..++|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 45667899999999999999999999999999999999988766666777889999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||+.||+|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.++|+|||++..+..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999999998864 5799999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.......
T Consensus 168 -------------------------------------------------------------------------~~~~~~~ 174 (384)
T 4fr4_A 168 -------------------------------------------------------------------------ETQITTM 174 (384)
T ss_dssp -------------------------------------------------------------------------TCCBCCC
T ss_pred -------------------------------------------------------------------------CCceecc
Confidence 0112345
Q ss_pred ccCCCccChhhhcC---CCCCccceeeehhhhhhhhccCCCCCCCCCc---hHHHHHHHhhccCCCCCccchHHHHHHHH
Q 001952 844 VGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---EETLANVVMQSLKFPDSPLISFQARDLIR 917 (992)
Q Consensus 844 vGT~~Y~APEvL~g---~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---~e~L~~Iv~~~lk~P~~~~vs~el~dLI~ 917 (992)
+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+... .+.+..+......+| ..++.++.+||.
T Consensus 175 ~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p--~~~s~~~~~li~ 252 (384)
T 4fr4_A 175 AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP--SAWSQEMVSLLK 252 (384)
T ss_dssp CSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC--TTSCHHHHHHHH
T ss_pred CCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC--CcCCHHHHHHHH
Confidence 79999999999974 4589999999999999999999999975432 334444444444444 358999999999
Q ss_pred HhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 918 GLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
+||..||.+||+. +++|++||||.+++|..+ +...||.+|.
T Consensus 253 ~lL~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~ 295 (384)
T 4fr4_A 253 KLLEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPN 295 (384)
T ss_dssp HHSCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCS
T ss_pred HHhcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCC
Confidence 9999999999984 789999999999999877 4566777774
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=459.11 Aligned_cols=281 Identities=36% Similarity=0.701 Sum_probs=249.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++++.||+|+||.||+|.+..+++.||||++++...........+..|..+|..+ +||||++++++|.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4578999999999999999999999999999999999987666666778888999999987 799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 494 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 494 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-
T ss_pred EEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-
Confidence 9999999999999999875 5699999999999999999999999999999999999999999999999999743210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........+
T Consensus 495 -----------------------------------------------------------------------~~~~~~~~~ 503 (674)
T 3pfq_A 495 -----------------------------------------------------------------------DGVTTKTFC 503 (674)
T ss_dssp -----------------------------------------------------------------------TTCCBCCCC
T ss_pred -----------------------------------------------------------------------CCccccccc
Confidence 001123467
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++...+.+|. .++.++.+||.+||..||
T Consensus 504 GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP 581 (674)
T 3pfq_A 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHP 581 (674)
T ss_dssp SCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT--TSCHHHHHHHHHHSCSSS
T ss_pred CCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999999999999999999888877775 499999999999999999
Q ss_pred CCcCCC-hHhHHHHHcCCCCCCCchhhh--hcCCCCCCCCC
Q 001952 925 ENRLGS-QKGAAEIKQHPFFEGLNWALI--RCAIPPELPDF 962 (992)
Q Consensus 925 ekRPT~-~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~~ 962 (992)
++||++ ..+++||++||||+++||..+ +...||..|+.
T Consensus 582 ~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~ 622 (674)
T 3pfq_A 582 GKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 622 (674)
T ss_dssp TTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBC
T ss_pred HHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcC
Confidence 999995 345799999999999999987 45778888843
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=416.82 Aligned_cols=279 Identities=38% Similarity=0.733 Sum_probs=231.2
Q ss_pred ccccCceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHH-hhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLA-RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~-~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
+..++|++++.||+|+||.||+|++. .+++.||||++++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 45678999999999999999999985 68899999999765322 223445678899999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+||||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999998865 56899999999999999999999999999999999999999999999999987321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... .....
T Consensus 172 ~~~------------------------------------------------------------------------~~~~~ 179 (327)
T 3a62_A 172 IHD------------------------------------------------------------------------GTVTH 179 (327)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ccC------------------------------------------------------------------------Ccccc
Confidence 100 00112
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
...||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.....+|. .++.++.+||.+||.
T Consensus 180 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~ 257 (327)
T 3a62_A 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP--YLTQEARDLLKKLLK 257 (327)
T ss_dssp TTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSC
T ss_pred ccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHHh
Confidence 356999999999999999999999999999999999999999998888888888877666654 589999999999999
Q ss_pred CCcCCcCCCh-HhHHHHHcCCCCCCCchhhh--hcCCCCCCC
Q 001952 922 KEPENRLGSQ-KGAAEIKQHPFFEGLNWALI--RCAIPPELP 960 (992)
Q Consensus 922 ~DPekRPT~~-~~aeEILkHPfF~~lnw~~l--r~~~pp~lp 960 (992)
.||.+||++. ..++|+++||||+.++|..+ +...+|..|
T Consensus 258 ~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p 299 (327)
T 3a62_A 258 RNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKP 299 (327)
T ss_dssp SCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred cCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCC
Confidence 9999999543 24999999999999999876 345566665
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=416.49 Aligned_cols=261 Identities=28% Similarity=0.488 Sum_probs=230.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|++++.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 3467899999999999999999999999999999999765322 234566789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999999998775 56999999999999999999999999999999999999999999999999997432110
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
......+|
T Consensus 168 ------------------------------------------------------------------------~~~~~~~g 175 (328)
T 3fe3_A 168 ------------------------------------------------------------------------GKLDAFCG 175 (328)
T ss_dssp ------------------------------------------------------------------------CGGGTTSS
T ss_pred ------------------------------------------------------------------------CccccccC
Confidence 01223569
Q ss_pred CCCccChhhhcCCCCC-ccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHG-AAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s-~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
|+.|+|||++.+..+. .++|||||||+||||++|+.||.+.+..+....+......+|. .++.++.+||.+||..||
T Consensus 176 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP 253 (328)
T 3fe3_A 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF--YMSTDCENLLKRFLVLNP 253 (328)
T ss_dssp SGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHCCSST
T ss_pred CcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHCCCCh
Confidence 9999999999998874 8999999999999999999999998888888888777766665 489999999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCCch
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~lnw 948 (992)
.+||+ ++|||+||||....+
T Consensus 254 ~~R~t----~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 254 IKRGT----LEQIMKDRWINAGHE 273 (328)
T ss_dssp TTSCC----HHHHTTCTTTTTTCT
T ss_pred hHCcC----HHHHhcCHhhcCCCc
Confidence 99999 999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=443.53 Aligned_cols=284 Identities=32% Similarity=0.618 Sum_probs=245.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||++++++|...+.+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999887666666677889999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
||||||++||+|..++.... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999999987643 3469999999999999999999999999999999999999999999999999974431
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. ......
T Consensus 341 ~~------------------------------------------------------------------------~~~~~~ 348 (543)
T 3c4z_A 341 AG------------------------------------------------------------------------QTKTKG 348 (543)
T ss_dssp TT------------------------------------------------------------------------CCCBCC
T ss_pred CC------------------------------------------------------------------------Cccccc
Confidence 10 001123
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc----hHHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN----EETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~----~e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
.+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+... .+....+......+| ..++.++.+||.+
T Consensus 349 ~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~ 426 (543)
T 3c4z_A 349 YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDFCEA 426 (543)
T ss_dssp CCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHH
T ss_pred ccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCHHHHHHHHH
Confidence 5799999999999999999999999999999999999999987532 455556665555555 3589999999999
Q ss_pred hccCCcCCcCCChH-hHHHHHcCCCCCCCchhhhh--cCCCCCCCCC
Q 001952 919 LLIKEPENRLGSQK-GAAEIKQHPFFEGLNWALIR--CAIPPELPDF 962 (992)
Q Consensus 919 cL~~DPekRPT~~~-~aeEILkHPfF~~lnw~~lr--~~~pp~lp~~ 962 (992)
||..||.+||++.. ++++|++||||+.++|..+. ...||.+|..
T Consensus 427 lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 427 LLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp HSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred hccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence 99999999998643 57999999999999999875 5677888753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=421.41 Aligned_cols=265 Identities=30% Similarity=0.471 Sum_probs=231.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---cchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---KKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.++|++++.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+|+.++||||++++++|.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4689999999999999999999999999999999976432211 1246788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC----cEEEEecccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLR 760 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg----~VKLsDFGLA~~ 760 (992)
||||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999998764 5799999999999999999999999999999999999998777 799999999744
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+... ...
T Consensus 169 ~~~~-------------------------------------------------------------------------~~~ 175 (361)
T 2yab_A 169 IEDG-------------------------------------------------------------------------VEF 175 (361)
T ss_dssp CCTT-------------------------------------------------------------------------CCC
T ss_pred cCCC-------------------------------------------------------------------------Ccc
Confidence 2100 011
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~k 918 (992)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+......++.. ..++.++++||.+
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 255 (361)
T 2yab_A 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRK 255 (361)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHH
T ss_pred ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHH
Confidence 23569999999999999999999999999999999999999999988888888887766655432 3578899999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
||..||.+||+ +.|+|+||||..++|...
T Consensus 256 ~L~~dP~~R~t----~~e~l~hp~~~~~~~~~~ 284 (361)
T 2yab_A 256 LLVKETRKRLT----IQEALRHPWITPVDTQQA 284 (361)
T ss_dssp HSCSSTTTSCC----HHHHHTSTTTSCSSHHHH
T ss_pred HCCCChhHCcC----HHHHhcCcCcCCCchhhh
Confidence 99999999999 999999999999998643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=403.57 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=225.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||+||+|.+..+++.||||++... .......+.+|+.+++.++||||++++++|...+.+||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGG---GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecc---cccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 357899999999999999999999999999999999754 23344667899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||++|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 169 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-- 169 (297)
T ss_dssp EEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc--
Confidence 9999999999999876 35899999999999999999999999999999999999999999999999997442110
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........||
T Consensus 170 ----------------------------------------------------------------------~~~~~~~~gt 179 (297)
T 3fxz_A 170 ----------------------------------------------------------------------QSKRSTMVGT 179 (297)
T ss_dssp ----------------------------------------------------------------------TCCBCCCCSC
T ss_pred ----------------------------------------------------------------------ccccCCccCC
Confidence 0012235699
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+..... .+..+..++..+.+||.+||..||+
T Consensus 180 ~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 259 (297)
T 3fxz_A 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 259 (297)
T ss_dssp GGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTT
T ss_pred cCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChh
Confidence 999999999999999999999999999999999999998877777666654433 3444556899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~l 946 (992)
+||+ +.|+|+||||+..
T Consensus 260 ~Rps----~~ell~h~~~~~~ 276 (297)
T 3fxz_A 260 KRGS----AKELLQHQFLKIA 276 (297)
T ss_dssp TSCC----HHHHTTCGGGGGC
T ss_pred HCcC----HHHHhhChhhccc
Confidence 9999 9999999999854
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=444.56 Aligned_cols=283 Identities=34% Similarity=0.570 Sum_probs=242.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..+..++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.
T Consensus 179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence 34667899999999999999999999999999999999988766666667788999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||++||+|..++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+..
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999999998875445699999999999999999999999999999999999999999999999999744210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
. ......
T Consensus 339 ~-------------------------------------------------------------------------~~~~~~ 345 (576)
T 2acx_A 339 G-------------------------------------------------------------------------QTIKGR 345 (576)
T ss_dssp T-------------------------------------------------------------------------CCEECC
T ss_pred C-------------------------------------------------------------------------cccccc
Confidence 0 011234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc----hHHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN----EETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~----~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
+||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+....+......++ ..++.++++||.+|
T Consensus 346 ~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI~~l 423 (576)
T 2acx_A 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCSQL 423 (576)
T ss_dssp CSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHH
T ss_pred CCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHh
Confidence 799999999999999999999999999999999999999987543 233344443344444 45899999999999
Q ss_pred ccCCcCCcCCChH-hHHHHHcCCCCCCCchhhhh--cCCCCCCCC
Q 001952 920 LIKEPENRLGSQK-GAAEIKQHPFFEGLNWALIR--CAIPPELPD 961 (992)
Q Consensus 920 L~~DPekRPT~~~-~aeEILkHPfF~~lnw~~lr--~~~pp~lp~ 961 (992)
|..||.+||++.. .++||++||||++++|..+. ...||..|.
T Consensus 424 L~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~ 468 (576)
T 2acx_A 424 LCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPD 468 (576)
T ss_dssp TCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred ccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCC
Confidence 9999999995432 49999999999999999875 456777774
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=413.10 Aligned_cols=250 Identities=23% Similarity=0.268 Sum_probs=190.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC----eE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----LS 684 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----~l 684 (992)
++|.+.+.||+|+||+||+|.+ +|+.||||+++.... .......|+..+..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 5688999999999999999988 578999999975421 1122334555667889999999999998654 68
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc--------CeeeeecCCceEEEccCCcEEEEecc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML--------GVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~--------GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
|||||||++|+|.++++. ..+++..+..|+.|++.||+|||++ +||||||||+||||+.++.+||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 999999999999999986 4689999999999999999999987 89999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
+++........ .
T Consensus 154 la~~~~~~~~~--------------------------------------------------------------------~ 165 (303)
T 3hmm_A 154 LAVRHDSATDT--------------------------------------------------------------------I 165 (303)
T ss_dssp TCEEEETTTTE--------------------------------------------------------------------E
T ss_pred CCccccCCCCc--------------------------------------------------------------------e
Confidence 98554211000 0
Q ss_pred CCCcCccccCCCccChhhhcCC------CCCccceeeehhhhhhhhccCCCCCCCCC--------------chHHHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGE------GHGAAVDWWTFGIFLYELLYGRTPFKGSG--------------NEETLANVV 896 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~------~~s~kSDIWSLGVlLyELLTGr~PF~g~s--------------~~e~L~~Iv 896 (992)
.......+||+.|||||++.+. .++.++|||||||+||||+||..||.... ..+.+...+
T Consensus 166 ~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 245 (303)
T 3hmm_A 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245 (303)
T ss_dssp SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHH
Confidence 0112345799999999999875 35779999999999999999977654211 223333333
Q ss_pred -hhccCCCCCc-----cchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 897 -MQSLKFPDSP-----LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 897 -~~~lk~P~~~-----~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
...+..+.+. .....+.+||.+||..||++||| +.||++
T Consensus 246 ~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~ 290 (303)
T 3hmm_A 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 3333322221 23457889999999999999999 666554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=414.93 Aligned_cols=274 Identities=23% Similarity=0.346 Sum_probs=222.8
Q ss_pred cccCceEEEEEccC--CceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 607 GLRHFNLLQKLGCG--DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 607 ~~~~Yeilr~LGsG--~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
..++|++++.||+| +||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||++++++|...+.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 35789999999999 9999999999999999999999765322 23456788899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+++++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999999998765677999999999999999999999999999999999999999999999999987443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
... ...........+
T Consensus 182 ~~~-----------------------------------------------------------------~~~~~~~~~~~~ 196 (389)
T 3gni_B 182 GQR-----------------------------------------------------------------QRVVHDFPKYSV 196 (389)
T ss_dssp TEE-----------------------------------------------------------------CSCBCCCCTTCT
T ss_pred ccc-----------------------------------------------------------------cccccccccccc
Confidence 000 000001122347
Q ss_pred cCCCccChhhhcC--CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC---------------------
Q 001952 845 GTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK--------------------- 901 (992)
Q Consensus 845 GT~~Y~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk--------------------- 901 (992)
||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..++.....
T Consensus 197 gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (389)
T 3gni_B 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSV 276 (389)
T ss_dssp TTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------------------
T ss_pred ccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccc
Confidence 8999999999998 57899999999999999999999999987776665544332211
Q ss_pred -----------------------CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 902 -----------------------FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 902 -----------------------~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
.+....++.++.+||.+||..||++||+ +.|+|+||||+.+.|..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 277 ANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp -----------------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---C
T ss_pred cccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhcc
Confidence 1122347788999999999999999999 99999999999988753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=404.91 Aligned_cols=265 Identities=29% Similarity=0.471 Sum_probs=229.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---cchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---KKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+|+.++||||++++++|...+.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999975432211 1346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC----cEEEEecccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLR 760 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg----~VKLsDFGLA~~ 760 (992)
||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 167 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence 9999999999999998764 5799999999999999999999999999999999999999887 799999999744
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+... ...
T Consensus 168 ~~~~-------------------------------------------------------------------------~~~ 174 (326)
T 2y0a_A 168 IDFG-------------------------------------------------------------------------NEF 174 (326)
T ss_dssp CCTT-------------------------------------------------------------------------SCC
T ss_pred CCCC-------------------------------------------------------------------------Ccc
Confidence 3110 001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~k 918 (992)
....||+.|+|||++.+..++.++|||||||++|||++|..||.+....+.+..+......++.. ..++..+.+||.+
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (326)
T 2y0a_A 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 254 (326)
T ss_dssp CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHH
T ss_pred ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHH
Confidence 23468999999999999999999999999999999999999999988888887776655554422 3478899999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
||..||.+||+ +.|+|+||||...+|...
T Consensus 255 ~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~~ 283 (326)
T 2y0a_A 255 LLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 283 (326)
T ss_dssp HSCSSGGGSCC----HHHHHHSTTTSCCSHHHH
T ss_pred HccCChhhCCC----HHHHhcCCCccCCcchhh
Confidence 99999999999 999999999999988643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=399.36 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=217.9
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
+...++|++++.||+|+||+||+|.+. +++.||||++..... .......+.+|+++|+.++||||+++++++.+++.+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 345689999999999999999999985 588999999975432 223346778999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||++ ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 95 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 95 TLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99999996 5777777654 356899999999999999999999999999999999999999999999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........
T Consensus 173 ------------------------------------------------------------------------~~~~~~~~ 180 (311)
T 3niz_A 173 ------------------------------------------------------------------------VRSYTHEV 180 (311)
T ss_dssp ------------------------------------------------------------------------CC---CCC
T ss_pred ------------------------------------------------------------------------cccccCCc
Confidence 00112346
Q ss_pred cCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC-------------------
Q 001952 845 GTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD------------------- 904 (992)
Q Consensus 845 GT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~------------------- 904 (992)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+.........
T Consensus 181 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (311)
T 3niz_A 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQV 260 (311)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCC
T ss_pred ccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccccc
Confidence 8999999999987 45899999999999999999999999988887777766542111100
Q ss_pred ---------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 905 ---------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 905 ---------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
.+.++.++.+||.+||..||.+||+ ++|+|+||||+++++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 261 FEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCTT
T ss_pred ccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCcc
Confidence 1235678999999999999999999 9999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=399.88 Aligned_cols=259 Identities=36% Similarity=0.576 Sum_probs=218.1
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh-----------------------hcchhHHHHHHHHH
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR-----------------------RKKMPRAQTEREIL 663 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~-----------------------~~~~~~~~~EieIL 663 (992)
..++|++.+.||+|+||.||+|.+..+++.||||++....... ......+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4578999999999999999999999999999999997543211 12346788999999
Q ss_pred HHcCCCCccceeeeecc--CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCce
Q 001952 664 RMLDHPFLPTLYSQFTS--DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPEN 741 (992)
Q Consensus 664 k~L~HPNIVkL~g~f~~--~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeN 741 (992)
+.++||||+++++++.+ .+.+||||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999986 6789999999999999876432 579999999999999999999999999999999999
Q ss_pred EEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCCh
Q 001952 742 ILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP 821 (992)
Q Consensus 742 ILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~ 821 (992)
||++.++.+||+|||++..+...
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------------------- 190 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGS--------------------------------------------------------- 190 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSS---------------------------------------------------------
T ss_pred EEECCCCCEEEecCCCccccccc---------------------------------------------------------
Confidence 99999999999999997443110
Q ss_pred hhhhccCCccccCCCCCCcCccccCCCccChhhhcCCC---CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh
Q 001952 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG---HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898 (992)
Q Consensus 822 ~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~---~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~ 898 (992)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+...
T Consensus 191 ---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 255 (298)
T 2zv2_A 191 ---------------DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQ 255 (298)
T ss_dssp ---------------SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ---------------cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcc
Confidence 00012346899999999998765 378899999999999999999999988777766677666
Q ss_pred ccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 899 ~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
...++....++.++.+||.+||..||++||+ +.|||+||||.
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~ 297 (298)
T 2zv2_A 256 ALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVT 297 (298)
T ss_dssp CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHH
T ss_pred cCCCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhcCcccc
Confidence 7777776779999999999999999999999 99999999985
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=394.12 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=211.9
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.+++.+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999975421 2233466789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+.+ +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 154 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---- 154 (292)
T ss_dssp ECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC----
T ss_pred ecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc----
Confidence 99965 555544432 367999999999999999999999999999999999999999999999999997443110
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........||+.
T Consensus 155 --------------------------------------------------------------------~~~~~~~~~t~~ 166 (292)
T 3o0g_A 155 --------------------------------------------------------------------VRCYSAEVVTLW 166 (292)
T ss_dssp --------------------------------------------------------------------CSCCCSCCSCGG
T ss_pred --------------------------------------------------------------------cccccCCccccC
Confidence 001123468999
Q ss_pred ccChhhhcCCC-CCccceeeehhhhhhhhccCCCCC-CCCCchHHHHHHHhhccCCC-----------------------
Q 001952 849 YLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPF-KGSGNEETLANVVMQSLKFP----------------------- 903 (992)
Q Consensus 849 Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF-~g~s~~e~L~~Iv~~~lk~P----------------------- 903 (992)
|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.+..+.......+
T Consensus 167 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T 3o0g_A 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246 (292)
T ss_dssp GCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTC
T ss_pred CcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCc
Confidence 99999998876 799999999999999999987775 45544555555543211110
Q ss_pred ----CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 904 ----DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 904 ----~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
..+.++.++++||.+||..||++||+ ++|+|+||||+++
T Consensus 247 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTC
T ss_pred chhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCcccccC
Confidence 11236789999999999999999999 9999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=392.37 Aligned_cols=261 Identities=34% Similarity=0.572 Sum_probs=229.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++.+.||+|+||.||+|.+..++..||||++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34578999999999999999999999999999999999876655555667789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 9999999999999998875 5689999999999999999999999999999999999999999999999998622110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 162 -------------------------------------------------------------------------~~~~~~~ 168 (279)
T 3fdn_A 162 -------------------------------------------------------------------------SRRTDLC 168 (279)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0012346
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++. .++.++.+||.+||..||
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p 246 (279)
T 3fdn_A 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHNP 246 (279)
T ss_dssp CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHCCSSG
T ss_pred CCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHhccCh
Confidence 899999999999999999999999999999999999999988877777777665555554 489999999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCCc
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~ln 947 (992)
.+||+ +.|||+||||....
T Consensus 247 ~~Rps----~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 247 SQRPM----LREVLEHPWITANS 265 (279)
T ss_dssp GGSCC----HHHHHHCHHHHHHC
T ss_pred hhCCC----HHHHhhCccccCCc
Confidence 99999 99999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=423.24 Aligned_cols=296 Identities=25% Similarity=0.330 Sum_probs=206.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec-----cCC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT-----SDN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~-----~~~ 682 (992)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||++++++|. ..+
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999986532 22234567889999999999999999999984 346
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||+ +++|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 68899888764 579999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
....... . . ...++ .....................
T Consensus 208 ~~~~~~~----~---------------~-----------~~~~~---------------~~~~~~~~~~~~~~~~~~~~~ 242 (458)
T 3rp9_A 208 YPENGNS----Q---------------L-----------PISPR---------------EDDMNLVTFPHTKNLKRQLTG 242 (458)
T ss_dssp SCTTCCC----C---------------C-----------C----------------------------------------
T ss_pred Ccccccc----c---------------c-----------ccCcc---------------ccccccccccccccccccccC
Confidence 2110000 0 0 00000 000000000000111223456
Q ss_pred cccCCCccChhhhc-CCCCCccceeeehhhhhhhhcc-----------CCCCCCCCCc--------------------hH
Q 001952 843 FVGTHEYLAPEIIK-GEGHGAAVDWWTFGIFLYELLY-----------GRTPFKGSGN--------------------EE 890 (992)
Q Consensus 843 ~vGT~~Y~APEvL~-g~~~s~kSDIWSLGVlLyELLT-----------Gr~PF~g~s~--------------------~e 890 (992)
.+||+.|+|||++. +..|+.++|||||||+||||++ |+++|.+.+. .+
T Consensus 243 ~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (458)
T 3rp9_A 243 HVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD 322 (458)
T ss_dssp --CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHH
T ss_pred CcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHH
Confidence 78999999999874 5669999999999999999998 7778876542 23
Q ss_pred HHHHHHhhcc--------------------CCC---------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCC
Q 001952 891 TLANVVMQSL--------------------KFP---------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941 (992)
Q Consensus 891 ~L~~Iv~~~l--------------------k~P---------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHP 941 (992)
.+..+..-.. .++ ..+.++.++.+||.+||..||++||| ++|+|+||
T Consensus 323 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----~~e~L~Hp 398 (458)
T 3rp9_A 323 QLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INECLAHP 398 (458)
T ss_dssp HHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSG
T ss_pred HHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC----HHHHhcCH
Confidence 3332221100 000 01235889999999999999999999 99999999
Q ss_pred CCCCCchhhhhcCCC
Q 001952 942 FFEGLNWALIRCAIP 956 (992)
Q Consensus 942 fF~~lnw~~lr~~~p 956 (992)
||++++|........
T Consensus 399 ~f~~~~~~~~e~~~~ 413 (458)
T 3rp9_A 399 FFKEVRIAEVETNAT 413 (458)
T ss_dssp GGTTTCCGGGCCCCS
T ss_pred hhhhcCCCccCCCCC
Confidence 999999998765443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=406.22 Aligned_cols=267 Identities=29% Similarity=0.418 Sum_probs=226.2
Q ss_pred hHhhheeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-----C
Q 001952 594 EAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-----H 668 (992)
Q Consensus 594 e~~~~~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-----H 668 (992)
+....+.+..+.+..++|++++.||+|+||.||+|.+..+++.||||++.... .....+..|+++|+.+. |
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h 95 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINN 95 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTG
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCC
Confidence 44556777788888899999999999999999999999999999999997431 23345677999999996 9
Q ss_pred CCccceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc--
Q 001952 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-- 746 (992)
Q Consensus 669 PNIVkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-- 746 (992)
|||+++++++...+.+||||||+ +++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174 (360)
T ss_dssp GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTT
T ss_pred CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccc
Confidence 99999999999999999999999 999999998765567999999999999999999999999999999999999975
Q ss_pred -----------------------CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCC
Q 001952 747 -----------------------DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCF 803 (992)
Q Consensus 747 -----------------------dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~ 803 (992)
++.+||+|||++....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~----------------------------------------- 213 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS----------------------------------------- 213 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-----------------------------------------
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecC-----------------------------------------
Confidence 7889999999974311
Q ss_pred CCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCC
Q 001952 804 SPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPF 883 (992)
Q Consensus 804 spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF 883 (992)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||
T Consensus 214 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 214 ----------------------------------DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp ----------------------------------SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred ----------------------------------CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 0012346899999999999999999999999999999999999999
Q ss_pred CCCCchHHHHHHHhhccCCCC--------------------------C------------------ccchHHHHHHHHHh
Q 001952 884 KGSGNEETLANVVMQSLKFPD--------------------------S------------------PLISFQARDLIRGL 919 (992)
Q Consensus 884 ~g~s~~e~L~~Iv~~~lk~P~--------------------------~------------------~~vs~el~dLI~kc 919 (992)
.+.+..+.+..+......+|. . ...+..+.+||.+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 988777776665443222221 0 00126778999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
|..||++||+ +.|+|+||||+
T Consensus 340 L~~dP~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 340 LQIDPTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp CCSSGGGSCC----HHHHTTSGGGC
T ss_pred hcCChhhCCC----HHHHhcCcccC
Confidence 9999999999 99999999996
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=411.61 Aligned_cols=285 Identities=27% Similarity=0.427 Sum_probs=213.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccC--C
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSD--N 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~--~ 682 (992)
...++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.+. ||||+++++++... .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 34679999999999999999999999999999999986432 22334466788999999997 99999999999754 4
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|||||||. ++|..++.. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.+.
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 7899999996 689888876 468999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
....... . .+..... .. ............
T Consensus 161 ~~~~~~~----------~---------~~~~~~~--------------~~------------------~~~~~~~~~~~~ 189 (388)
T 3oz6_A 161 NIRRVTN----------N---------IPLSINE--------------NT------------------ENFDDDQPILTD 189 (388)
T ss_dssp SCCCCCC----------C---------GGGCCC-----------------------------------------------
T ss_pred ccccccc----------c---------ccccccc--------------cc------------------cccccccccccC
Confidence 2110000 0 0000000 00 000001122345
Q ss_pred cccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC-----------------
Q 001952 843 FVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD----------------- 904 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~----------------- 904 (992)
.+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..++.. +..|.
T Consensus 190 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~ 268 (388)
T 3oz6_A 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV-IDFPSNEDVESIQSPFAKTMIE 268 (388)
T ss_dssp CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHH
T ss_pred CcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHH
Confidence 689999999999987 57899999999999999999999999999888888777532 22211
Q ss_pred -----------------------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 905 -----------------------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 905 -----------------------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
...++.++.+||.+||..||++||| ++|+|+||||..+.....
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~~~~~ 340 (388)
T 3oz6_A 269 SLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFHNPNE 340 (388)
T ss_dssp HHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTCCGGG
T ss_pred hCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhcCCcc
Confidence 1146789999999999999999999 999999999987754433
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.72 Aligned_cols=266 Identities=25% Similarity=0.350 Sum_probs=214.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH--hhcchhHHHHHHHHHHHc---CCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA--RRKKMPRAQTEREILRML---DHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~--~~~~~~~~~~EieILk~L---~HPNIVkL~g~f 678 (992)
|.+..++|++++.||+|+||+||+|.+..+++.||||++...... .......+.+|+.+++.+ +||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 345578999999999999999999999999999999998643211 111234566788777766 499999999999
Q ss_pred ccCC-----eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEE
Q 001952 679 TSDN-----LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLT 753 (992)
Q Consensus 679 ~~~~-----~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLs 753 (992)
.... .+++||||+. ++|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEe
Confidence 7654 5899999995 699999887655569999999999999999999999999999999999999999999999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|||++..+..
T Consensus 163 Dfg~a~~~~~---------------------------------------------------------------------- 172 (308)
T 3g33_A 163 DFGLARIYSY---------------------------------------------------------------------- 172 (308)
T ss_dssp SCSCTTTSTT----------------------------------------------------------------------
T ss_pred eCccccccCC----------------------------------------------------------------------
Confidence 9999743210
Q ss_pred CCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC---------
Q 001952 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--------- 904 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--------- 904 (992)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++......+.
T Consensus 173 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (308)
T 3g33_A 173 ---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSL 249 (308)
T ss_dssp ---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSS
T ss_pred ---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhc
Confidence 00112356899999999999999999999999999999999999999998888888777653221111
Q ss_pred ----------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 905 ----------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 905 ----------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.+.++.++.+||.+||..||++||+ +.|+|+||||+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 250 PRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKDE 304 (308)
T ss_dssp CGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC----
T ss_pred cccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCCC
Confidence 1246789999999999999999999 99999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=390.11 Aligned_cols=260 Identities=33% Similarity=0.568 Sum_probs=230.1
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+++++.++||||+++++++.+.+.+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 45578999999999999999999999999999999999876555555567789999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~- 166 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS- 166 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS-
T ss_pred EEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc-
Confidence 9999999999999998875 5689999999999999999999999999999999999999999999999998633210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 167 -------------------------------------------------------------------------~~~~~~~ 173 (284)
T 2vgo_A 167 -------------------------------------------------------------------------LRRRTMC 173 (284)
T ss_dssp -------------------------------------------------------------------------SCBCCCC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0012346
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
|++.|+|||++.+..++.++|||||||++|||++|..||......+....+......++ ..++.++.+||.+||..||
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p 251 (284)
T 2vgo_A 174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP--PFLSDGSKDLISKLLRYHP 251 (284)
T ss_dssp SCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--TTSCHHHHHHHHHHSCSSG
T ss_pred CCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC--CcCCHHHHHHHHHHhhcCH
Confidence 89999999999999999999999999999999999999998887777777776655554 3589999999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~l 946 (992)
.+||+ +.++++||||+..
T Consensus 252 ~~Rps----~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 252 PQRLP----LKGVMEHPWVKAN 269 (284)
T ss_dssp GGSCC----HHHHHTCHHHHHH
T ss_pred hhCCC----HHHHhhCHHHHhh
Confidence 99999 9999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=406.70 Aligned_cols=264 Identities=29% Similarity=0.484 Sum_probs=222.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh--cchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR--KKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~--~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+|+.++||||++++++|...+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4679999999999999999999999999999999976543322 13567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc---EEEEecccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLSLR 760 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~---VKLsDFGLA~~ 760 (992)
||||||+|++|.+++.... +..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 9999999999987765432 345899999999999999999999999999999999999986654 99999999744
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+... ....
T Consensus 183 ~~~~------------------------------------------------------------------------~~~~ 190 (351)
T 3c0i_A 183 LGES------------------------------------------------------------------------GLVA 190 (351)
T ss_dssp CCTT------------------------------------------------------------------------SCBC
T ss_pred ecCC------------------------------------------------------------------------Ceee
Confidence 3210 0011
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~k 918 (992)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||.+. ..+.+..+......++.. ..++.++.+||.+
T Consensus 191 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 269 (351)
T 3c0i_A 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRR 269 (351)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHH
T ss_pred cCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence 2346999999999999999999999999999999999999999875 445555665555444321 3478999999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
||..||++||+ +.|+|+||||+..++
T Consensus 270 ~L~~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 270 MLMLDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp HTCSSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred HCCCChhHCcC----HHHHhcChhhcCCcc
Confidence 99999999999 999999999998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=383.82 Aligned_cols=267 Identities=26% Similarity=0.469 Sum_probs=230.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 57899999999999999999999999999999999765322 23346678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc---EEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~---VKLsDFGLA~~l~~~ 764 (992)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999998888765 56899999999999999999999999999999999999986655 999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 162 -------------------------------------------------------------------------~~~~~~~ 168 (284)
T 3kk8_A 162 -------------------------------------------------------------------------EAWHGFA 168 (284)
T ss_dssp -------------------------------------------------------------------------CBCCCSC
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0012346
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++.. ..++.++.+||.+||..
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (284)
T 3kk8_A 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 248 (284)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred CCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHccc
Confidence 8999999999999999999999999999999999999999988888887777766655543 45889999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCchhhhhcC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLNWALIRCA 954 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~ 954 (992)
||++||+ +.|+|+||||...++......
T Consensus 249 dp~~Rps----~~~~l~h~~~~~~~~~~~~~~ 276 (284)
T 3kk8_A 249 NPKKRIT----ADQALKVPWICNRERVASAIH 276 (284)
T ss_dssp STTTSCC----HHHHTTSHHHHSCCCGGGSCC
T ss_pred ChhhCCC----HHHHhcCccccCChhHHhHhh
Confidence 9999999 999999999998876655443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=402.68 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=214.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||+||+|.+..+++.||||+++.... .......+.+|+.+|+.++||||+++++++...+.+||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 46789999999999999999999999999999999975422 22334556789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-----cCCcEEEEeccccccc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-----EDGHIMLTDFDLSLRC 761 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-----~dg~VKLsDFGLA~~l 761 (992)
||||++ ++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus 111 v~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 999996 5999988765 5699999999999999999999999999999999999994 4556999999998543
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... .....
T Consensus 188 ~~~------------------------------------------------------------------------~~~~~ 195 (329)
T 3gbz_A 188 GIP------------------------------------------------------------------------IRQFT 195 (329)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CCc------------------------------------------------------------------------ccccC
Confidence 210 00112
Q ss_pred ccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC---------------
Q 001952 842 SFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--------------- 905 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--------------- 905 (992)
...||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+.+..++......+..
T Consensus 196 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (329)
T 3gbz_A 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSF 275 (329)
T ss_dssp ----CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred CCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhh
Confidence 346899999999998854 7999999999999999999999999988888877776532211110
Q ss_pred -------------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 906 -------------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 906 -------------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
..++.++.+||.+||..||.+||+ ++|+|+||||++.+|.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 276 PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 116789999999999999999999 9999999999999985
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=404.65 Aligned_cols=257 Identities=25% Similarity=0.386 Sum_probs=225.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999999999999999997432 2234578999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc--CCcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE--DGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~--dg~VKLsDFGLA~~l~~~~ 765 (992)
|||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999998754 346899999999999999999999999999999999999997 789999999997443110
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.......|
T Consensus 158 ------------------------------------------------------------------------~~~~~~~g 165 (321)
T 1tki_A 158 ------------------------------------------------------------------------DNFRLLFT 165 (321)
T ss_dssp ------------------------------------------------------------------------CEEEEEES
T ss_pred ------------------------------------------------------------------------CccccccC
Confidence 01123468
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccCC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIKE 923 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~D 923 (992)
|+.|+|||++.+..++.++|||||||++|||++|..||.+....+.+..+......++.. ..++.++.+||.+||..|
T Consensus 166 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 245 (321)
T 1tki_A 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp CGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSS
T ss_pred ChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCC
Confidence 999999999999889999999999999999999999999988888888888776665532 357899999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCCC
Q 001952 924 PENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~l 946 (992)
|.+||+ +.|+|+||||+..
T Consensus 246 p~~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 246 RKSRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp GGGSCC----HHHHHHSHHHHSC
T ss_pred hhHCcC----HHHHhcChhhccC
Confidence 999999 9999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=398.34 Aligned_cols=265 Identities=26% Similarity=0.391 Sum_probs=207.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||||+++... .......+.+|+.+|+.++||||+++++++..++.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999997542 233446788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 688 MEYCPGGDLHVLRQKQL----GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~----~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
|||++ ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 69988887543 24589999999999999999999999999999999999999999999999999744311
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
. .......
T Consensus 161 ~------------------------------------------------------------------------~~~~~~~ 168 (317)
T 2pmi_A 161 P------------------------------------------------------------------------VNTFSSE 168 (317)
T ss_dssp C------------------------------------------------------------------------CCCCCCC
T ss_pred C------------------------------------------------------------------------cccCCCC
Confidence 0 0011234
Q ss_pred ccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-------------------
Q 001952 844 VGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP------------------- 903 (992)
Q Consensus 844 vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P------------------- 903 (992)
.||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......+
T Consensus 169 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T 2pmi_A 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQ 248 (317)
T ss_dssp CSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCC
T ss_pred cccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccccccc
Confidence 689999999999874 589999999999999999999999999888777776654211100
Q ss_pred -------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 904 -------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 904 -------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
....++.++.+||.+||..||++||+ +.|+|+||||.+..|...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHHAS 305 (317)
T ss_dssp CCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC---
T ss_pred ccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccchhh
Confidence 11246789999999999999999999 999999999999877644
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=409.28 Aligned_cols=259 Identities=26% Similarity=0.487 Sum_probs=226.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+.++||||+++++++.+.+..|||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999754322 23346788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VKLsDFGLA~~l~~~ 764 (992)
|||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~- 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 183 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT-
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC-
Confidence 9999999999888764 5689999999999999999999999999999999999998644 599999999743210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........
T Consensus 184 ------------------------------------------------------------------------~~~~~~~~ 191 (362)
T 2bdw_A 184 ------------------------------------------------------------------------SEAWHGFA 191 (362)
T ss_dssp ------------------------------------------------------------------------CCSCCCSC
T ss_pred ------------------------------------------------------------------------CcccccCC
Confidence 00112356
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......++.. ..++.++.+||.+||..
T Consensus 192 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 271 (362)
T 2bdw_A 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTV 271 (362)
T ss_dssp SCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCS
T ss_pred CCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCC
Confidence 9999999999999999999999999999999999999999988888888887777666544 35789999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||++||+ +.|+|+||||...
T Consensus 272 dP~~R~t----~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 272 NPKKRIT----ADQALKVPWICNR 291 (362)
T ss_dssp SGGGSCC----HHHHTTSHHHHTH
T ss_pred ChhhCcC----HHHHhcCcccCCC
Confidence 9999999 9999999999754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=390.70 Aligned_cols=259 Identities=24% Similarity=0.363 Sum_probs=213.9
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+|+.++||||+++++++...+.+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 6788999999975432 2334467789999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+.+ +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---- 153 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---- 153 (288)
T ss_dssp ECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc----
Confidence 99964 888888754 356899999999999999999999999999999999999999999999999997443100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........||+.
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~t~~ 165 (288)
T 1ob3_A 154 --------------------------------------------------------------------VRKYTHEIVTLW 165 (288)
T ss_dssp ----------------------------------------------------------------------------CCCT
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 001123468999
Q ss_pred ccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC------------------------
Q 001952 849 YLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP------------------------ 903 (992)
Q Consensus 849 Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P------------------------ 903 (992)
|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.......+
T Consensus 166 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T 1ob3_A 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245 (288)
T ss_dssp TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred ccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCcc
Confidence 9999999875 589999999999999999999999999887777766654211100
Q ss_pred ---CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 904 ---DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 904 ---~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
....++.++.+||.+||..||++||+ +.|+|+||||++.|
T Consensus 246 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 246 WESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKENN 288 (288)
T ss_dssp GGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC--
T ss_pred HHHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhcC
Confidence 01236889999999999999999999 99999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=406.84 Aligned_cols=274 Identities=40% Similarity=0.765 Sum_probs=222.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHH-hhcchhHHHHHHHHHHHc-CCCCccceeeeec
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLA-RRKKMPRAQTEREILRML-DHPFLPTLYSQFT 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~-~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~ 679 (992)
.+..++|++++.||+|+||.||+|++. .+++.||||+++..... .......+.+|+++|+.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345689999999999999999999984 47899999999754221 122335567799999999 6999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
..+.+||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999998875 569999999999999999999999999999999999999999999999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+... ....
T Consensus 208 ~~~~~-----------------------------------------------------------------------~~~~ 216 (355)
T 1vzo_A 208 EFVAD-----------------------------------------------------------------------ETER 216 (355)
T ss_dssp ECCGG-----------------------------------------------------------------------GGGG
T ss_pred ecccC-----------------------------------------------------------------------CCCc
Confidence 43100 0001
Q ss_pred cCccccCCCccChhhhcCC--CCCccceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhhccCCCCCccchHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKGE--GHGAAVDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQSLKFPDSPLISFQAR 913 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~--~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~~lk~P~~~~vs~el~ 913 (992)
....+||+.|+|||++.+. .++.++|||||||+||||++|+.||...... +....+......+ +..++..+.
T Consensus 217 ~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 294 (355)
T 1vzo_A 217 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAK 294 (355)
T ss_dssp GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTTSCHHHH
T ss_pred ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC--CcccCHHHH
Confidence 2235799999999999864 4789999999999999999999999754332 2333333333333 345889999
Q ss_pred HHHHHhccCCcCCcCCCh-HhHHHHHcCCCCCCCchhhhhc
Q 001952 914 DLIRGLLIKEPENRLGSQ-KGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~-~~aeEILkHPfF~~lnw~~lr~ 953 (992)
+||.+||..||.+||++. ..++|+++||||+.++|..+..
T Consensus 295 ~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~ 335 (355)
T 1vzo_A 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAA 335 (355)
T ss_dssp HHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhh
Confidence 999999999999999211 1299999999999999987743
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=401.59 Aligned_cols=262 Identities=26% Similarity=0.450 Sum_probs=219.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.+++..|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999864422 12235678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-- 159 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCC--
Confidence 9999999999887654 569999999999999999999999999999999999999999999999999975432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.........||+
T Consensus 160 --------------------------------------------------------------------~~~~~~~~~gt~ 171 (323)
T 3tki_A 160 --------------------------------------------------------------------RERLLNKMCGTL 171 (323)
T ss_dssp --------------------------------------------------------------------EECCBCSCCSCG
T ss_pred --------------------------------------------------------------------cccccCCCccCc
Confidence 001122357999
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
.|+|||++.+..+ +.++|||||||+||||++|+.||.+.... ..+..+.......+....++.++.+||.+||..||.
T Consensus 172 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 251 (323)
T 3tki_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 251 (323)
T ss_dssp GGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChh
Confidence 9999999998776 78899999999999999999999876554 333444444444444456899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCc
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ln 947 (992)
+||+ +.||++||||...-
T Consensus 252 ~R~t----~~eil~h~~~~~~~ 269 (323)
T 3tki_A 252 ARIT----IPDIKKDRWYNKPL 269 (323)
T ss_dssp TSCC----HHHHTTCTTTTCCC
T ss_pred hCcC----HHHHhhChhhcccc
Confidence 9999 99999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=395.42 Aligned_cols=266 Identities=30% Similarity=0.458 Sum_probs=229.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---cchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---KKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+|+.++||||+++++++...+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4679999999999999999999999999999999975422111 1346688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC----cEEEEecccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLR 760 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg----~VKLsDFGLA~~ 760 (992)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999998764 5689999999999999999999999999999999999999888 799999999743
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+... ...
T Consensus 169 ~~~~-------------------------------------------------------------------------~~~ 175 (321)
T 2a2a_A 169 IEDG-------------------------------------------------------------------------VEF 175 (321)
T ss_dssp CCTT-------------------------------------------------------------------------CCC
T ss_pred cCcc-------------------------------------------------------------------------ccc
Confidence 2100 001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~k 918 (992)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++.. ..++..+.+||.+
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 255 (321)
T 2a2a_A 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRK 255 (321)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHT
T ss_pred cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHH
Confidence 23468999999999999999999999999999999999999999988888877776655444321 3478899999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCCchhhhh
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr 952 (992)
||..||++||+ +.|+|+||||..++|....
T Consensus 256 ~l~~dp~~Rps----~~e~l~hp~~~~~~~~~~~ 285 (321)
T 2a2a_A 256 LLVKETRKRLT----IQEALRHPWITPVDNQQAM 285 (321)
T ss_dssp TSCSSTTTSCC----HHHHHHSTTTSCSSHHHHH
T ss_pred HcCCChhhCcC----HHHHhcCccccCCCccccc
Confidence 99999999999 9999999999999987543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=410.07 Aligned_cols=257 Identities=30% Similarity=0.510 Sum_probs=221.8
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++||||+++++++...+.+||
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 46799999999999999999999999999999999987766555666788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 99999 78888887765 5699999999999999999999999999999999999999999999999999743210
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.......+||
T Consensus 161 ----------------------------------------------------------------------~~~~~~~~gt 170 (336)
T 3h4j_B 161 ----------------------------------------------------------------------GNFLKTSCGS 170 (336)
T ss_dssp ----------------------------------------------------------------------SBTTCCCTTS
T ss_pred ----------------------------------------------------------------------CcccccccCC
Confidence 0011234699
Q ss_pred CCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+....+.+..+......+ +..++.++.+||.+||..||.
T Consensus 171 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~ 248 (336)
T 3h4j_B 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM--PDFLSPGAQSLIRRMIVADPM 248 (336)
T ss_dssp TTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC--CTTSCHHHHHHHHTTSCSSGG
T ss_pred cCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC--cccCCHHHHHHHHHHcCCChh
Confidence 99999999998876 789999999999999999999998765544443333222333 345899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ 945 (992)
+||+ ++||++||||..
T Consensus 249 ~Rpt----~~eil~hp~~~~ 264 (336)
T 3h4j_B 249 QRIT----IQEIRRDPWFNV 264 (336)
T ss_dssp GSCC----HHHHTTCHHHHT
T ss_pred HCcC----HHHHHhChhhcc
Confidence 9999 999999999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=383.76 Aligned_cols=267 Identities=29% Similarity=0.429 Sum_probs=225.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhH------HHhhcchhHHHHHHHHHHHcC-CCCccceeeeecc
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF------LARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTS 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~------l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~ 680 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .........+.+|+++|+.+. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999999999999999999996432 111233456789999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+..||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999998875 5689999999999999999999999999999999999999999999999998743
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+... ...
T Consensus 174 ~~~~-------------------------------------------------------------------------~~~ 180 (298)
T 1phk_A 174 LDPG-------------------------------------------------------------------------EKL 180 (298)
T ss_dssp CCTT-------------------------------------------------------------------------CCB
T ss_pred cCCC-------------------------------------------------------------------------ccc
Confidence 2100 001
Q ss_pred CccccCCCccChhhhc------CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHH
Q 001952 841 NSFVGTHEYLAPEIIK------GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQA 912 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~------g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el 912 (992)
....||+.|+|||++. ...++.++|||||||++|||++|+.||.+....+.+..+......++.. ..++.++
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 260 (298)
T 1phk_A 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 260 (298)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHH
Confidence 2246899999999986 4567899999999999999999999999888877777777766655433 4588999
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhc
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
.+||.+||..||.+||+ +.|+|+||||+...|..++.
T Consensus 261 ~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~~~ 297 (298)
T 1phk_A 261 KDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVRH 297 (298)
T ss_dssp HHHHHHHCCSSGGGSCC----HHHHTTSGGGCTTC------
T ss_pred HHHHHHHccCCcccCCC----HHHHHhChHhhhccchhhcc
Confidence 99999999999999999 99999999999999988764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=385.33 Aligned_cols=261 Identities=33% Similarity=0.593 Sum_probs=202.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++.+.+..|||
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 56899999999999999999999999999999999876555555567889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~--- 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--- 165 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC---
Confidence 9999999999998764 356899999999999999999999999999999999999999999999999997432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 166 ---------------------------------------------------------------------~~~~~~~~~~~ 176 (278)
T 3cok_A 166 ---------------------------------------------------------------------HEKHYTLCGTP 176 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------CCcceeccCCC
Confidence 00011246899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+.......+ ..++.++.+||.+||..||++|
T Consensus 177 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R 254 (278)
T 3cok_A 177 NYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLLRRNPADR 254 (278)
T ss_dssp ---------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC--TTSCHHHHHHHHHHSCSSGGGS
T ss_pred CcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc--cccCHHHHHHHHHHcccCHhhC
Confidence 99999999999899999999999999999999999988776666655544443333 4588999999999999999999
Q ss_pred CCChHhHHHHHcCCCCCCCc
Q 001952 928 LGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~ln 947 (992)
|+ +.++++||||....
T Consensus 255 ps----~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 255 LS----LSSVLDHPFMSRNS 270 (278)
T ss_dssp CC----HHHHTTSTTTC---
T ss_pred CC----HHHHhcCccccCCC
Confidence 99 99999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=399.93 Aligned_cols=270 Identities=30% Similarity=0.488 Sum_probs=224.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH--hhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA--RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~--~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
.++|++++.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+|+.++||||++++++|.+.+..|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46899999999999999999999999999999999865432 2344567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhc--------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 001952 686 LVMEYCPGGDLHVLRQKQL--------------------------------------GKCFSEPAARFYVAEVLLALEYL 727 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~--------------------------------------~~~Lse~~i~~Ia~QIL~GL~YL 727 (992)
|||||++|++|.+++.... ...+++..++.|+.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999875210 11235778889999999999999
Q ss_pred hhcCeeeeecCCceEEEccCC--cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCC
Q 001952 728 HMLGVIYRDLKPENILVREDG--HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSP 805 (992)
Q Consensus 728 Hs~GIIHRDIKPeNILLd~dg--~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~sp 805 (992)
|++||+||||||+|||++.++ .+||+|||++..+.....
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~--------------------------------------- 225 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN--------------------------------------- 225 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC---------------------------------------
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc---------------------------------------
Confidence 999999999999999998776 899999999854321000
Q ss_pred CcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcC--CCCCccceeeehhhhhhhhccCCCCC
Q 001952 806 RFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPF 883 (992)
Q Consensus 806 r~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF 883 (992)
..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||
T Consensus 226 -----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 276 (345)
T 3hko_A 226 -----------------------------GEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276 (345)
T ss_dssp -----------------------------C--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred -----------------------------cccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 00001123469999999999976 56899999999999999999999999
Q ss_pred CCCCchHHHHHHHhhccCCCCCc--cchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 884 KGSGNEETLANVVMQSLKFPDSP--LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 884 ~g~s~~e~L~~Iv~~~lk~P~~~--~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
.+....+.+..++.....++.+. .++.++.+||.+||..||.+||+ +.++|+||||+.+.|.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 277 PGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDK 340 (345)
T ss_dssp CCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSC
T ss_pred CCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHh
Confidence 99988888888887766555432 47899999999999999999999 9999999999987664
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=407.97 Aligned_cols=299 Identities=24% Similarity=0.425 Sum_probs=227.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec-------
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT------- 679 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~------- 679 (992)
..++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+++|+.++||||++++++|.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~-------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 4578999999999999999999999999999999986431 12246999999999999999999984
Q ss_pred -------------------------------cCCeEEEEEEecCCCChHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHH
Q 001952 680 -------------------------------SDNLSCLVMEYCPGGDLHVLRQK--QLGKCFSEPAARFYVAEVLLALEY 726 (992)
Q Consensus 680 -------------------------------~~~~lyLVmEy~~GGSL~~lLkk--~~~~~Lse~~i~~Ia~QIL~GL~Y 726 (992)
...+++|||||++ ++|..++.. ..+..+++..++.|+.||+.||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3345899999996 587776654 234679999999999999999999
Q ss_pred HhhcCeeeeecCCceEEEc-cCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCC
Q 001952 727 LHMLGVIYRDLKPENILVR-EDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSP 805 (992)
Q Consensus 727 LHs~GIIHRDIKPeNILLd-~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~sp 805 (992)
||++||+||||||+|||++ .++.+||+|||++..+...
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~----------------------------------------- 195 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS----------------------------------------- 195 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-----------------------------------------
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-----------------------------------------
Confidence 9999999999999999998 6889999999997543110
Q ss_pred CcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCC
Q 001952 806 RFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFK 884 (992)
Q Consensus 806 r~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~ 884 (992)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 196 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 196 --------------------------------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp --------------------------------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------------------------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 0112346899999999998764 8999999999999999999999999
Q ss_pred CCCchHHHHHHHhhcc-----------------CCC----------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHH
Q 001952 885 GSGNEETLANVVMQSL-----------------KFP----------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEI 937 (992)
Q Consensus 885 g~s~~e~L~~Iv~~~l-----------------k~P----------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEI 937 (992)
+.+..+.+..++.... .++ .+..++.++.+||.+||..||.+||+ +.|+
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~ 319 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN----PYEA 319 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHH
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC----HHHH
Confidence 9888888877764211 111 12236788999999999999999999 9999
Q ss_pred HcCCCCCCCchhhh-------h--cCCCCCCCCCCCCCCccccc-cchhhhhhhccccccccC
Q 001952 938 KQHPFFEGLNWALI-------R--CAIPPELPDFYDYGIQDMVP-QKSKYLECKATGEQLEFE 990 (992)
Q Consensus 938 LkHPfF~~lnw~~l-------r--~~~pp~lp~~~d~~~~~~~~-q~~~~~~~~~~~~~~~~~ 990 (992)
|+||||+.+.+... . ......+|..|++...++.. +.+-.-.+.-.+-..|||
T Consensus 320 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 382 (383)
T 3eb0_A 320 MAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFSPNYK 382 (383)
T ss_dssp HTSGGGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC-------
T ss_pred hcCHHHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhccccc
Confidence 99999998765211 1 11124577888888887765 444322333333344554
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=413.15 Aligned_cols=280 Identities=27% Similarity=0.442 Sum_probs=226.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc------C
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------D 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------~ 681 (992)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+++|+.++||||++++++|.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 357999999999999999999999999999999986431 123469999999999999999998843 2
Q ss_pred CeEEEEEEecCCCChHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-CcEEEEecccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQK--QLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLS 758 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk--~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-g~VKLsDFGLA 758 (992)
.+++|||||+++ +|..++.. .....+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 347799999965 56555442 224679999999999999999999999999999999999999955 67899999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
+.+... .
T Consensus 205 ~~~~~~-------------------------------------------------------------------------~ 211 (420)
T 1j1b_A 205 KQLVRG-------------------------------------------------------------------------E 211 (420)
T ss_dssp EECCTT-------------------------------------------------------------------------C
T ss_pred hhcccC-------------------------------------------------------------------------C
Confidence 543100 0
Q ss_pred CcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhh-----------------cc
Q 001952 839 RSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ-----------------SL 900 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~-----------------~l 900 (992)
.....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..++.. .+
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~ 291 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence 11235689999999999875 6899999999999999999999999998888877776542 11
Q ss_pred CCCC----------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCCCCCCccc
Q 001952 901 KFPD----------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDM 970 (992)
Q Consensus 901 k~P~----------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~d~~~~~~ 970 (992)
.++. ...++.++.+||.+||..||.+||+ +.|+|+||||+++.|...+......+|..+++...++
T Consensus 292 ~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (420)
T 1j1b_A 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQEL 367 (420)
T ss_dssp CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHH
T ss_pred ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHh
Confidence 2221 1236789999999999999999999 9999999999999888776555667777788766665
Q ss_pred cc
Q 001952 971 VP 972 (992)
Q Consensus 971 ~~ 972 (992)
..
T Consensus 368 ~~ 369 (420)
T 1j1b_A 368 SS 369 (420)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=390.45 Aligned_cols=264 Identities=30% Similarity=0.437 Sum_probs=215.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...+..|||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 4689999999999999999999999999999999864321 222345678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 155 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP--- 155 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc---
Confidence 9999999999887754 56999999999999999999999999999999999999999999999999997442100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 156 ---------------------------------------------------------------------~~~~~~~~~~~ 166 (311)
T 4agu_A 156 ---------------------------------------------------------------------SDYYDDEVATR 166 (311)
T ss_dssp -------------------------------------------------------------------------------G
T ss_pred ---------------------------------------------------------------------ccccCCCcCCc
Confidence 00112346899
Q ss_pred CccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-------------------cCCCCC--
Q 001952 848 EYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-------------------LKFPDS-- 905 (992)
Q Consensus 848 ~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-------------------lk~P~~-- 905 (992)
.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+.... ...+..
T Consensus 167 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 4agu_A 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPED 246 (311)
T ss_dssp GGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSS
T ss_pred cccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccc
Confidence 9999999987 567999999999999999999999999887776665543321 111111
Q ss_pred --------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 906 --------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 906 --------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
+.++.++.+||.+||..||.+||+ ++|+|+||||+++.|..
T Consensus 247 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 247 MEPLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREIE 295 (311)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC---
T ss_pred cchhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCHH
Confidence 246788999999999999999999 99999999999987654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=416.46 Aligned_cols=260 Identities=27% Similarity=0.495 Sum_probs=225.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+|+.++||||+++++++.+++..|||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997543222 2345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc---cCCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd---~dg~VKLsDFGLA~~l~~~ 764 (992)
|||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+...
T Consensus 89 ~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp ECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999888764 5699999999999999999999999999999999999998 4678999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........
T Consensus 167 ------------------------------------------------------------------------~~~~~~~~ 174 (444)
T 3soa_A 167 ------------------------------------------------------------------------QQAWFGFA 174 (444)
T ss_dssp ------------------------------------------------------------------------CCBCCCSC
T ss_pred ------------------------------------------------------------------------Cceeeccc
Confidence 00112357
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+..++.++|||||||+||+|++|..||.+.+..+.+..+......++.+ ..++.++.+||.+||..
T Consensus 175 gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 254 (444)
T 3soa_A 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTI 254 (444)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred CCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCC
Confidence 9999999999999999999999999999999999999999988888888888777666543 46899999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||.+||+ +.|+|+||||...
T Consensus 255 dP~~Rpt----a~e~L~hp~~~~~ 274 (444)
T 3soa_A 255 NPSKRIT----AAEALKHPWISHR 274 (444)
T ss_dssp STTTSCC----HHHHHHSCTTHHH
T ss_pred ChhHCCC----HHHHhcCccccCC
Confidence 9999999 9999999999653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=404.23 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=212.8
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.++||||+++++++...+.+||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG----AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS----TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC----ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence 457899999999999999999999999999999999753 2233567899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc--EEEEeccccccccCC
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH--IMLTDFDLSLRCSVS 764 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~--VKLsDFGLA~~l~~~ 764 (992)
||||+++|+|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 94 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 94 IMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 99999999999998765 56999999999999999999999999999999999999987765 99999998732110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......+
T Consensus 171 ------------------------------------------------------------------------~~~~~~~~ 178 (361)
T 3uc3_A 171 ------------------------------------------------------------------------HSQPKSTV 178 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------cCCCCCCc
Confidence 00112346
Q ss_pred cCCCccChhhhcCCCCCcc-ceeeehhhhhhhhccCCCCCCCCCch----HHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 845 GTHEYLAPEIIKGEGHGAA-VDWWTFGIFLYELLYGRTPFKGSGNE----ETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~k-SDIWSLGVlLyELLTGr~PF~g~s~~----e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
||+.|+|||++.+..++.+ +|||||||+||||++|+.||.+.... ..+..+......++....++.++.+||.+|
T Consensus 179 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 258 (361)
T 3uc3_A 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRI 258 (361)
T ss_dssp --CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHH
T ss_pred CCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHH
Confidence 9999999999999888655 89999999999999999999875543 444455555666676667899999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
|..||.+||+ +.||++||||..
T Consensus 259 L~~dP~~Rps----~~ell~hp~f~~ 280 (361)
T 3uc3_A 259 FVADPATRIS----IPEIKTHSWFLK 280 (361)
T ss_dssp SCSCTTTSCC----HHHHHTSHHHHT
T ss_pred ccCChhHCcC----HHHHHhCcchhc
Confidence 9999999999 999999999954
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=386.15 Aligned_cols=263 Identities=29% Similarity=0.484 Sum_probs=228.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++.+.+..|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999997654333344567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 92 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 168 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD- 168 (294)
T ss_dssp EEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST-
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC-
Confidence 999999999999988765 56899999999999999999999999999999999999999999999999997432100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........|
T Consensus 169 -----------------------------------------------------------------------~~~~~~~~~ 177 (294)
T 2rku_A 169 -----------------------------------------------------------------------GERKKVLCG 177 (294)
T ss_dssp -----------------------------------------------------------------------TCCBCCCCS
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 001123468
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+......++. .++..+.+||.+||..||+
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~ 255 (294)
T 2rku_A 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPT 255 (294)
T ss_dssp CCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGG
T ss_pred CCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc--ccCHHHHHHHHHHcccChh
Confidence 99999999999999999999999999999999999999988777777776666555543 5889999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCCch
Q 001952 926 NRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~lnw 948 (992)
+||+ ++|+++||||.....
T Consensus 256 ~Rps----~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 256 ARPT----INELLNDEFFTSGYI 274 (294)
T ss_dssp GSCC----GGGGGGSHHHHTSCC
T ss_pred hCcC----HHHHhhChheecCCc
Confidence 9999 999999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=397.54 Aligned_cols=264 Identities=30% Similarity=0.421 Sum_probs=214.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
++|++++.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++...+.+||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999999975432 122223457999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
||+. ++|..++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---- 153 (324)
T ss_dssp ECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence 9996 6888887764 356899999999999999999999999999999999999999999999999997432100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........||+.
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~t~~ 165 (324)
T 3mtl_A 154 --------------------------------------------------------------------TKTYDNEVVTLW 165 (324)
T ss_dssp -----------------------------------------------------------------------------CGG
T ss_pred --------------------------------------------------------------------ccccccccCccc
Confidence 001123468999
Q ss_pred ccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC-----------------------
Q 001952 849 YLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD----------------------- 904 (992)
Q Consensus 849 Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~----------------------- 904 (992)
|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.......+.
T Consensus 166 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (324)
T 3mtl_A 166 YRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAE 245 (324)
T ss_dssp GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCC
T ss_pred ccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccch
Confidence 999999987 56899999999999999999999999998887777766542211110
Q ss_pred -----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhh
Q 001952 905 -----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 905 -----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr 952 (992)
...++.++.+||.+||..||.+||+ ++|+|+||||.++.+....
T Consensus 246 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 246 ALLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGERIHK 294 (324)
T ss_dssp CHHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCSTTSS
T ss_pred hhhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhccccccc
Confidence 1236788999999999999999999 9999999999987755443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=381.90 Aligned_cols=256 Identities=34% Similarity=0.546 Sum_probs=223.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+++|+.++||||+++++++.+.+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 467999999999999999999999999999999997642 33456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE---ccCCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL---d~dg~VKLsDFGLA~~l~~~ 764 (992)
|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..+...
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 85 MELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 9999999999988765 568999999999999999999999999999999999999 78889999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 163 -------------------------------------------------------------------------~~~~~~~ 169 (277)
T 3f3z_A 163 -------------------------------------------------------------------------KMMRTKV 169 (277)
T ss_dssp -------------------------------------------------------------------------SCBCCCC
T ss_pred -------------------------------------------------------------------------cchhccC
Confidence 0112346
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+. ++.++|||||||++|||++|+.||.+....+.+..+......++.. ..++.++.+||.+||..
T Consensus 170 ~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (277)
T 3f3z_A 170 GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK 248 (277)
T ss_dssp SCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCS
T ss_pred CCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccC
Confidence 89999999998765 8999999999999999999999999988888888777766655542 24788999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||.+||+ +.++|+||||+..
T Consensus 249 dp~~R~s----~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 249 SPKQRIT----SLQALEHEWFEKQ 268 (277)
T ss_dssp STTTSCC----HHHHTTSHHHHHH
T ss_pred ChhhCcC----HHHHhcCHHHhcc
Confidence 9999999 9999999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=399.54 Aligned_cols=258 Identities=32% Similarity=0.489 Sum_probs=210.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+++|+.++||||++++++|...+.+||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 4578999999999999999999999999999999997542 23456789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEeccccccccC
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA~~l~~ 763 (992)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 126 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999999999988764 56899999999999999999999999999999999999975 88999999999743210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.......
T Consensus 204 -------------------------------------------------------------------------~~~~~~~ 210 (349)
T 2w4o_A 204 -------------------------------------------------------------------------QVLMKTV 210 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchH-HHHHHHhhccCCCC--CccchHHHHHHHHHhc
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE-TLANVVMQSLKFPD--SPLISFQARDLIRGLL 920 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e-~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL 920 (992)
.||+.|+|||++.+..++.++|||||||+||||++|..||.+....+ .+..+......++. ...++.++.+||.+||
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (349)
T 2w4o_A 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLI 290 (349)
T ss_dssp --CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTS
T ss_pred cCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHc
Confidence 68999999999999999999999999999999999999998776655 45555554443332 2458899999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
..||++||+ +.|+|+||||.+..+
T Consensus 291 ~~dP~~Rpt----~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 291 VLDPKKRLT----TFQALQHPWVTGKAA 314 (349)
T ss_dssp CSSGGGSCC----HHHHHHSTTTTSTTC
T ss_pred cCChhhCcC----HHHHhcCcccCCCcc
Confidence 999999999 999999999987654
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=379.95 Aligned_cols=262 Identities=28% Similarity=0.457 Sum_probs=220.6
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.+.+..++|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34566789999999999999999999999899999999998765555566678899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..||||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999998875 568999999999999999999999999999999999999999999999999873321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 163 ~~-------------------------------------------------------------------------~~~~~ 169 (276)
T 2h6d_A 163 DG-------------------------------------------------------------------------EFLRT 169 (276)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CC-------------------------------------------------------------------------cceec
Confidence 00 00112
Q ss_pred cccCCCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+....+.+..+......++ ..++.++.+||.+||.
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~ 247 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP--EYLNRSVATLLMHMLQ 247 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTC
T ss_pred ccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc--hhcCHHHHHHHHHHcc
Confidence 358899999999998776 6899999999999999999999988776666666655544444 3588999999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCC
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
.||.+||+ +.|+++||||+.
T Consensus 248 ~~p~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 248 VDPLKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp SSGGGSCC----HHHHHHSHHHHT
T ss_pred CChhhCCC----HHHHHhChhhcc
Confidence 99999999 999999999975
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=408.27 Aligned_cols=286 Identities=28% Similarity=0.466 Sum_probs=229.8
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-- 681 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-- 681 (992)
++....+|++++.||+|+||.||+|.+..+++ ||+|++.... ....+|+++|+.++||||++++++|...
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~-------~~~~~E~~il~~l~h~niv~l~~~~~~~~~ 106 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK-------RFKNRELQIMRIVKHPNVVDLKAFFYSNGD 106 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEESS
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc-------chHHHHHHHHHhCCCCCcceEEEEEEecCC
Confidence 33445689999999999999999999987776 7777775321 1123699999999999999999998543
Q ss_pred ----CeEEEEEEecCCCChHHHHH-hhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-cCCcEEEEec
Q 001952 682 ----NLSCLVMEYCPGGDLHVLRQ-KQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIMLTDF 755 (992)
Q Consensus 682 ----~~lyLVmEy~~GGSL~~lLk-k~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-~dg~VKLsDF 755 (992)
..+||||||++++.+..+.. ......+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+||
T Consensus 107 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 107 KKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 34889999997765544432 12246799999999999999999999999999999999999999 7999999999
Q ss_pred cccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 756 DLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 756 GLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
|++..+...
T Consensus 187 G~a~~~~~~----------------------------------------------------------------------- 195 (394)
T 4e7w_A 187 GSAKILIAG----------------------------------------------------------------------- 195 (394)
T ss_dssp TTCEECCTT-----------------------------------------------------------------------
T ss_pred CCcccccCC-----------------------------------------------------------------------
Confidence 997543110
Q ss_pred CCCCcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc---------------
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--------------- 899 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--------------- 899 (992)
......+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..++...
T Consensus 196 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 196 --EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp --CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred --CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 011234689999999999876 48999999999999999999999999988888877765421
Q ss_pred --cCCCC----------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCCCCCC
Q 001952 900 --LKFPD----------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGI 967 (992)
Q Consensus 900 --lk~P~----------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~d~~~ 967 (992)
..++. ...++.++.+||.+||..||.+||+ +.|+|+||||+++.|...+......+|..|++..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~ 349 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEARMPNGRELPPLFNWTK 349 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCH
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhccccccCCCCCCCCCcCCCCH
Confidence 11111 1236789999999999999999999 9999999999999998887777778888888876
Q ss_pred ccccccc
Q 001952 968 QDMVPQK 974 (992)
Q Consensus 968 ~~~~~q~ 974 (992)
.++...+
T Consensus 350 ~~~~~~~ 356 (394)
T 4e7w_A 350 EELSVRP 356 (394)
T ss_dssp HHHHTCG
T ss_pred HHhhcCH
Confidence 6654444
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=410.02 Aligned_cols=294 Identities=24% Similarity=0.328 Sum_probs=216.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----C
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-----N 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-----~ 682 (992)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++|+||+++++++... +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 478999999999999999999999999999999997532 2233446788999999999999999999999765 6
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||+ +++|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 799999999 56999988764 569999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
....... ....... ..+.............
T Consensus 181 ~~~~~~~----~~~~~~~----------------------------------------------~~~~~~~~~~~~~~~~ 210 (432)
T 3n9x_A 181 SEKDTNI----VNDLEEN----------------------------------------------EEPGPHNKNLKKQLTS 210 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccc----ccccccc----------------------------------------------ccccccccchhccccC
Confidence 2110000 0000000 0000000001122356
Q ss_pred cccCCCccChhhh-cCCCCCccceeeehhhhhhhhcc-----------CCCCCCCCCc-----------------hHHHH
Q 001952 843 FVGTHEYLAPEII-KGEGHGAAVDWWTFGIFLYELLY-----------GRTPFKGSGN-----------------EETLA 893 (992)
Q Consensus 843 ~vGT~~Y~APEvL-~g~~~s~kSDIWSLGVlLyELLT-----------Gr~PF~g~s~-----------------~e~L~ 893 (992)
.+||+.|+|||++ .+..++.++|||||||+||||++ |.++|.+.+. .+++.
T Consensus 211 ~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~ 290 (432)
T 3n9x_A 211 HVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLN 290 (432)
T ss_dssp CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHH
T ss_pred CCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHH
Confidence 7899999999987 45568999999999999999998 4455544431 23332
Q ss_pred HHHhhcc------------------------CCCC-----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCC
Q 001952 894 NVVMQSL------------------------KFPD-----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 894 ~Iv~~~l------------------------k~P~-----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~ 944 (992)
.++.... ..+. .+.++.++.+||.+||..||.+||+ ++|+|+||||+
T Consensus 291 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~ 366 (432)
T 3n9x_A 291 IIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDHPYLK 366 (432)
T ss_dssp HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTCGGGT
T ss_pred HHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcChhhh
Confidence 2221100 0000 0347889999999999999999999 99999999999
Q ss_pred CCchhhhhcCCCCCC
Q 001952 945 GLNWALIRCAIPPEL 959 (992)
Q Consensus 945 ~lnw~~lr~~~pp~l 959 (992)
+++|..........+
T Consensus 367 ~~~~~~~e~~~~~~~ 381 (432)
T 3n9x_A 367 DVRKKKLENFSTKKI 381 (432)
T ss_dssp TTCCTTTC---CCCC
T ss_pred hccCcccCcCCCCCC
Confidence 999987765444333
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=390.42 Aligned_cols=268 Identities=30% Similarity=0.460 Sum_probs=212.5
Q ss_pred ccCceEE-EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEE
Q 001952 608 LRHFNLL-QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 608 ~~~Yeil-r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ly 685 (992)
.+.|++. +.||+|+||.||+|.+..+++.||||++... .......+.+|+++|.++ +||||+++++++.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC---SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC---cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4578885 7899999999999999999999999999754 233456788999999885 7999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc---EEEEecccccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLSLRCS 762 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~---VKLsDFGLA~~l~ 762 (992)
|||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..+.
T Consensus 88 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999999998875 56899999999999999999999999999999999999998776 9999999974332
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
..... ..........
T Consensus 166 ~~~~~-----------------------------------------------------------------~~~~~~~~~~ 180 (316)
T 2ac3_A 166 LNGDC-----------------------------------------------------------------SPISTPELLT 180 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCcc-----------------------------------------------------------------cccccccccc
Confidence 10000 0000011123
Q ss_pred cccCCCccChhhhcC-----CCCCccceeeehhhhhhhhccCCCCCCCCCc---------------hHHHHHHHhhccCC
Q 001952 843 FVGTHEYLAPEIIKG-----EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---------------EETLANVVMQSLKF 902 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g-----~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---------------~e~L~~Iv~~~lk~ 902 (992)
.+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...+..+......+
T Consensus 181 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 260 (316)
T 2ac3_A 181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF 260 (316)
T ss_dssp -CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCC
T ss_pred ccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCccc
Confidence 469999999999986 4578999999999999999999999987543 22344444444444
Q ss_pred CCC--ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 903 PDS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 903 P~~--~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
+.. ..++.++.+||.+||..||.+||+ +.|+|+||||++..|.
T Consensus 261 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 261 PDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-----
T ss_pred CchhcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCCc
Confidence 432 347889999999999999999999 9999999999987664
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=416.41 Aligned_cols=256 Identities=28% Similarity=0.414 Sum_probs=210.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
.++|++++.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 579999999999999999999999999999999997542 2233456778999999999999999999999654
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+||||||+.++ |...+. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++...
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred CeEEEEEeCCCCC-HHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 4679999999654 555554 34899999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. .....
T Consensus 215 ~~-------------------------------------------------------------------------~~~~~ 221 (464)
T 3ttj_A 215 GT-------------------------------------------------------------------------SFMMT 221 (464)
T ss_dssp ---------------------------------------------------------------------------CCCC-
T ss_pred CC-------------------------------------------------------------------------CcccC
Confidence 10 01123
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC-------------------
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF------------------- 902 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~------------------- 902 (992)
..+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++......
T Consensus 222 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~ 301 (464)
T 3ttj_A 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 301 (464)
T ss_dssp ---CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTS
T ss_pred CCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcc
Confidence 4579999999999999999999999999999999999999999998888877765431110
Q ss_pred ---CCC------------------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 903 ---PDS------------------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 903 ---P~~------------------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
... ...+.++++||.+||..||++||| ++|+|+||||..+
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 302 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVW 362 (464)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGG
T ss_pred cccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhhc
Confidence 000 001567999999999999999999 9999999999853
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=397.06 Aligned_cols=268 Identities=27% Similarity=0.424 Sum_probs=227.4
Q ss_pred ccCceEE-EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEE
Q 001952 608 LRHFNLL-QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 608 ~~~Yeil-r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~ly 685 (992)
.++|.+. +.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.+ +||||+++++++...+.+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 4567777 889999999999999999999999999975422 223456788999999999 4699999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEecccccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLSLRCS 762 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA~~l~ 762 (992)
|||||+.+++|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||++. ++.++|+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999998886655577999999999999999999999999999999999999997 7899999999974431
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 186 ~~-------------------------------------------------------------------------~~~~~ 192 (327)
T 3lm5_A 186 HA-------------------------------------------------------------------------CELRE 192 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc-------------------------------------------------------------------------ccccc
Confidence 00 00122
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLL 920 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL 920 (992)
..||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++. ...++..+.+||.+||
T Consensus 193 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L 272 (327)
T 3lm5_A 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLL 272 (327)
T ss_dssp -CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred ccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHc
Confidence 46899999999999999999999999999999999999999998888887777665554443 2458899999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCCchhhhhc
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
..||++||+ +++||+||||+.++|..+..
T Consensus 273 ~~dP~~Rpt----~~~ll~h~~~~~~~~~~~~~ 301 (327)
T 3lm5_A 273 VKNPEKRPT----AEICLSHSWLQQWDFENLFH 301 (327)
T ss_dssp CSSGGGSCC----HHHHTTCGGGCCCCTTCC--
T ss_pred CCChhhCcC----HHHHhCCHhhcccccccccC
Confidence 999999999 99999999999999986643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=390.72 Aligned_cols=256 Identities=28% Similarity=0.454 Sum_probs=221.0
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
.|...+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+|+.++||||+++++++...+..|||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR---KQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT---TCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 478888999999999999999989999999999754 23445668899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccccc
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
|+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~----- 194 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD----- 194 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-----
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-----
Confidence 9999999998875 46999999999999999999999999999999999999999999999999997443110
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
........||+.|
T Consensus 195 -------------------------------------------------------------------~~~~~~~~gt~~y 207 (321)
T 2c30_A 195 -------------------------------------------------------------------VPKRKSLVGTPYW 207 (321)
T ss_dssp -------------------------------------------------------------------SCCBCCCCSCGGG
T ss_pred -------------------------------------------------------------------ccccccccCCccc
Confidence 0011234699999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcCCcC
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPENRL 928 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPekRP 928 (992)
+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+..... .+.....++.++.+||.+||..||++||
T Consensus 208 ~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 287 (321)
T 2c30_A 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287 (321)
T ss_dssp CCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred cCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999999999998877776666554332 2233345788999999999999999999
Q ss_pred CChHhHHHHHcCCCCCCCc
Q 001952 929 GSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 929 T~~~~aeEILkHPfF~~ln 947 (992)
+ +.|+|+||||....
T Consensus 288 s----~~ell~hp~~~~~~ 302 (321)
T 2c30_A 288 T----AQELLDHPFLLQTG 302 (321)
T ss_dssp C----HHHHHTSGGGGGCC
T ss_pred C----HHHHhcChhhccCC
Confidence 9 99999999998654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=406.09 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=225.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+|+.++||||++++++|.+.+.+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999975421 1234678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc--CCcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE--DGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~--dg~VKLsDFGLA~~l~~~~ 765 (992)
|||+.|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999988754 346899999999999999999999999999999999999974 567999999997443110
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.......|
T Consensus 205 ------------------------------------------------------------------------~~~~~~~g 212 (387)
T 1kob_A 205 ------------------------------------------------------------------------EIVKVTTA 212 (387)
T ss_dssp ------------------------------------------------------------------------SCEEEECS
T ss_pred ------------------------------------------------------------------------cceeeecc
Confidence 00122368
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccCC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~D 923 (992)
|+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..+......++. ...++.++.+||.+||..|
T Consensus 213 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 292 (387)
T 1kob_A 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 292 (387)
T ss_dssp SGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSS
T ss_pred CCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999999999999998888888777766554443 2358899999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCCCch
Q 001952 924 PENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~lnw 948 (992)
|.+||+ +.|+|+||||.+..+
T Consensus 293 P~~Rpt----~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 293 PRKRLT----VHDALEHPWLKGDHS 313 (387)
T ss_dssp GGGSCC----HHHHHTSTTTSSCCT
T ss_pred hhHCcC----HHHHhhCccccCCcc
Confidence 999999 999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=419.19 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=231.8
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.+.+..++|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+|+.++||||+++++++...+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 35566789999999999999999999999999999999998765555556678899999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999999998753 579999999999999999999999999999999999999999999999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 168 ~~-------------------------------------------------------------------------~~~~~ 174 (476)
T 2y94_A 168 DG-------------------------------------------------------------------------EFLRT 174 (476)
T ss_dssp TT-------------------------------------------------------------------------CCBCC
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 00 01123
Q ss_pred cccCCCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
.+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+.+....+..+.......| ..++.++.+||.+||.
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~~L~ 252 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP--QYLNPSVISLLKHMLQ 252 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC--TTCCHHHHHHHHHHTC
T ss_pred cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC--ccCCHHHHHHHHHHcC
Confidence 469999999999998876 7899999999999999999999999888888888777665554 3589999999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCC
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
.||.+||+ +.||++||||..
T Consensus 253 ~dP~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 253 VDPMKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp SSTTTSCC----HHHHHTCHHHHT
T ss_pred CCchhCcC----HHHHHhCHHhhh
Confidence 99999999 999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=382.93 Aligned_cols=266 Identities=29% Similarity=0.500 Sum_probs=225.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---cchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---KKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+|+.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 3579999999999999999999999999999999875432211 1356788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC----cEEEEecccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLR 760 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg----~VKLsDFGLA~~ 760 (992)
|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999998765 5689999999999999999999999999999999999999877 799999999743
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.... ...
T Consensus 162 ~~~~-------------------------------------------------------------------------~~~ 168 (283)
T 3bhy_A 162 IEAG-------------------------------------------------------------------------NEF 168 (283)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred ccCC-------------------------------------------------------------------------Ccc
Confidence 2100 001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~k 918 (992)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++. ...++..+.+||.+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 248 (283)
T 3bhy_A 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRR 248 (283)
T ss_dssp ---CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHT
T ss_pred cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHH
Confidence 2345899999999999999999999999999999999999999998877777776655444331 13478899999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCCchhhhh
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr 952 (992)
||..||.+||+ +.++|+||||+.+.|...+
T Consensus 249 ~l~~dp~~Rps----~~~~l~h~~~~~~~~~~~~ 278 (283)
T 3bhy_A 249 LLVKDPKRRMT----IAQSLEHSWIKAIRRRNVR 278 (283)
T ss_dssp TSCSSGGGSCC----HHHHHHCHHHHHHHHCCC-
T ss_pred HccCCHhHCcC----HHHHHhCHHHHHHHHHhhh
Confidence 99999999999 9999999999998876554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=394.71 Aligned_cols=272 Identities=22% Similarity=0.399 Sum_probs=231.9
Q ss_pred ecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcch--------------hHHHHHHHHHHHcC
Q 001952 602 QYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKM--------------PRAQTEREILRMLD 667 (992)
Q Consensus 602 ~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~--------------~~~~~EieILk~L~ 667 (992)
..+....++|++++.||+|+||.||+|.+ +++.||||++........... ..+.+|+.+|+.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34455678999999999999999999999 889999999987644332222 77899999999999
Q ss_pred CCCccceeeeeccCCeEEEEEEecCCCChHHH------HHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCc
Q 001952 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVL------RQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPE 740 (992)
Q Consensus 668 HPNIVkL~g~f~~~~~lyLVmEy~~GGSL~~l------Lkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPe 740 (992)
||||+++++++.+.+.+|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999987 555435779999999999999999999999 99999999999
Q ss_pred eEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCC
Q 001952 741 NILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKAD 820 (992)
Q Consensus 741 NILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~ 820 (992)
|||++.++.++|+|||++......
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------------------------------------------------------- 205 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------------------------------------------------------- 205 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT--------------------------------------------------------
T ss_pred hEEEcCCCcEEEeccccccccccc--------------------------------------------------------
Confidence 999999999999999997432100
Q ss_pred hhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC-CCCc-cceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHh
Q 001952 821 PAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE-GHGA-AVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVM 897 (992)
Q Consensus 821 ~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~-~~s~-kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~ 897 (992)
......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.+... .+.+..+..
T Consensus 206 ------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 206 ------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp ------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred ------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 11234589999999999988 5665 99999999999999999999998777 666666665
Q ss_pred hccCCCCC-----------------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhc
Q 001952 898 QSLKFPDS-----------------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 898 ~~lk~P~~-----------------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
....++.. ..++.++.+||.+||..||.+||+ +.|+++||||+..+|..+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHHHH
T ss_pred cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHHHH
Confidence 55555532 458899999999999999999999 99999999999999987754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=418.65 Aligned_cols=265 Identities=31% Similarity=0.453 Sum_probs=230.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++||||++++++|...+.+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997654433455677899999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE---ccCCcEEEEecccccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL---d~dg~VKLsDFGLA~~l~ 762 (992)
|||||+.+++|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||++..+.
T Consensus 103 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999888764 579999999999999999999999999999999999999 567899999999974432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 181 ~~-------------------------------------------------------------------------~~~~~ 187 (484)
T 3nyv_A 181 AS-------------------------------------------------------------------------KKMKD 187 (484)
T ss_dssp CC-------------------------------------------------------------------------CSHHH
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 10 01123
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLL 920 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL 920 (992)
.+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++. ...++.++++||.+||
T Consensus 188 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L 266 (484)
T 3nyv_A 188 KIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKML 266 (484)
T ss_dssp HTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHT
T ss_pred CCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHC
Confidence 469999999999987 5899999999999999999999999999888888888777665543 3468899999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
..||.+||+ +.|+|+||||+...+..
T Consensus 267 ~~dp~~R~s----~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 267 TYVPSMRIS----ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp CSSGGGSCC----HHHHHTSHHHHHHTC--
T ss_pred CCChhHCcC----HHHHhhChhhccccccc
Confidence 999999999 99999999998766543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=400.24 Aligned_cols=260 Identities=32% Similarity=0.429 Sum_probs=213.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999996532 1223346678999999999999999999999765
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+||||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3469999999 8999999876 46899999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ....
T Consensus 179 ~---------------------------------------------------------------------------~~~~ 183 (367)
T 1cm8_A 179 D---------------------------------------------------------------------------SEMT 183 (367)
T ss_dssp C---------------------------------------------------------------------------SSCC
T ss_pred c---------------------------------------------------------------------------cccC
Confidence 1 0012
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-----------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP----------------- 903 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P----------------- 903 (992)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++......+
T Consensus 184 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 263 (367)
T 1cm8_A 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263 (367)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHH
T ss_pred cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHH
Confidence 3468999999999988 6789999999999999999999999999888887777654321111
Q ss_pred ------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 904 ------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 904 ------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
....++.++.+||.+||..||.+||+ ++|+|+||||+.+.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~~~ 319 (367)
T 1cm8_A 264 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTED 319 (367)
T ss_dssp HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC----
T ss_pred hCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCCcc
Confidence 01246789999999999999999999 999999999999876654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=393.11 Aligned_cols=261 Identities=29% Similarity=0.493 Sum_probs=228.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++++.+.+.+||
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999976543334455678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 119 v~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-- 194 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 194 (335)
T ss_dssp EECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--
Confidence 99999999999988765 57999999999999999999999999999999999999999999999999997443110
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........||
T Consensus 195 ----------------------------------------------------------------------~~~~~~~~gt 204 (335)
T 2owb_A 195 ----------------------------------------------------------------------GERKKVLCGT 204 (335)
T ss_dssp ----------------------------------------------------------------------TCCBCCCCSC
T ss_pred ----------------------------------------------------------------------cccccccCCC
Confidence 0011234689
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.+..+......++. .++.++.+||.+||..||++
T Consensus 205 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~ 282 (335)
T 2owb_A 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTDPTA 282 (335)
T ss_dssp CSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHTCSSGGG
T ss_pred ccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHccCChhH
Confidence 9999999999999999999999999999999999999988777777777666655554 58899999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCc
Q 001952 927 RLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ln 947 (992)
||+ +.|+|+||||....
T Consensus 283 Rps----~~ell~~~~~~~~~ 299 (335)
T 2owb_A 283 RPT----INELLNDEFFTSGY 299 (335)
T ss_dssp SCC----GGGGGGSHHHHTSC
T ss_pred CcC----HHHHhcCccccCCC
Confidence 999 99999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=383.11 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=210.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeecc--CCe
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTS--DNL 683 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~--~~~ 683 (992)
..++|++++.||+|+||.||+|.+..+++.||||++... ....+.+|+.+|+.+. ||||+++++++.. ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 357899999999999999999999999999999999642 2356789999999997 9999999999987 678
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEecccccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLRCS 762 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l~ 762 (992)
.+|||||+.+++|..++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..+.
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999988753 78999999999999999999999999999999999999776 89999999974431
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. .....
T Consensus 183 ~~-------------------------------------------------------------------------~~~~~ 189 (330)
T 3nsz_A 183 PG-------------------------------------------------------------------------QEYNV 189 (330)
T ss_dssp TT-------------------------------------------------------------------------CCCCS
T ss_pred CC-------------------------------------------------------------------------Ccccc
Confidence 10 01123
Q ss_pred cccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhh-------------ccC------
Q 001952 843 FVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQ-------------SLK------ 901 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~-------------~lk------ 901 (992)
..||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ..+.+..+... ...
T Consensus 190 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (330)
T 3nsz_A 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 269 (330)
T ss_dssp CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHH
T ss_pred ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchh
Confidence 468899999999988 668999999999999999999999996443 33333332210 000
Q ss_pred ----------------CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 902 ----------------FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 902 ----------------~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
......++.++.+||.+||..||.+||+ ++|+|+||||+.+.|.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 270 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC--
T ss_pred hhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhccC
Confidence 0111237889999999999999999999 9999999999998875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=402.09 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=216.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyL 686 (992)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|+++|.++ +||||++++++|.+.+.+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-------~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-------CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-------CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 468999999999999999999999999999999997542 1235688888887 79999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC----CcEEEEecccccccc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED----GHIMLTDFDLSLRCS 762 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d----g~VKLsDFGLA~~l~ 762 (992)
||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||++..+.
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999988764 569999999999999999999999999999999999998533 359999999975431
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.. ......
T Consensus 172 ~~------------------------------------------------------------------------~~~~~~ 179 (342)
T 2qr7_A 172 AE------------------------------------------------------------------------NGLLMT 179 (342)
T ss_dssp CT------------------------------------------------------------------------TCCBCC
T ss_pred CC------------------------------------------------------------------------CCceec
Confidence 10 001123
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCC---CchHHHHHHHhhccCCCC--CccchHHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS---GNEETLANVVMQSLKFPD--SPLISFQARDLIR 917 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~---s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~ 917 (992)
.+||+.|+|||++.+..++.++|||||||+||||++|..||.+. ...+.+..+......++. ...++.++++||.
T Consensus 180 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~ 259 (342)
T 2qr7_A 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVS 259 (342)
T ss_dssp SSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHH
T ss_pred cCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHH
Confidence 46899999999999888999999999999999999999999863 334555666555555443 2458999999999
Q ss_pred HhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 918 GLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
+||..||++||+ +.++|+||||. +|..+
T Consensus 260 ~~L~~dP~~R~t----~~~il~hp~~~--~~~~~ 287 (342)
T 2qr7_A 260 KMLHVDPHQRLT----AALVLRHPWIV--HWDQL 287 (342)
T ss_dssp HHTCSSTTTSCC----HHHHTTSHHHH--TGGGS
T ss_pred HHCCCChhHCcC----HHHHhcCCeec--Ccccc
Confidence 999999999999 99999999995 46544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=393.79 Aligned_cols=271 Identities=28% Similarity=0.394 Sum_probs=219.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh--hcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR--RKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~--~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
.++|++++.||+|+||.||+|.+..+++.||||++....... ......+.+|+.+|+.++||||++++++|...+.+|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 578999999999999999999999999999999997543221 122456789999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||||+++ +|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 99999965 888877654 356899999999999999999999999999999999999999999999999997432100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........|
T Consensus 166 -----------------------------------------------------------------------~~~~~~~~~ 174 (346)
T 1ua2_A 166 -----------------------------------------------------------------------NRAYTHQVV 174 (346)
T ss_dssp -----------------------------------------------------------------------CCCCCCSCC
T ss_pred -----------------------------------------------------------------------cccCCcccc
Confidence 001123468
Q ss_pred CCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--------------------
Q 001952 846 THEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD-------------------- 904 (992)
Q Consensus 846 T~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~-------------------- 904 (992)
|+.|+|||++.+. .++.++|||||||++|||++|..||.+.+..+.+..++......+.
T Consensus 175 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (346)
T 1ua2_A 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 254 (346)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred cccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCC
Confidence 9999999999765 4799999999999999999999999998888888777653221110
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCC
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIP 956 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~p 956 (992)
...++.++.+||.+||..||.+||+ +.|+|+||||....|....+..+
T Consensus 255 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~~~~~~~~ 308 (346)
T 1ua2_A 255 IPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGPTPGCQLP 308 (346)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCCCCSSSSC
T ss_pred CChHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCCCCcccCC
Confidence 0235689999999999999999999 99999999999987776555444
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=405.72 Aligned_cols=258 Identities=31% Similarity=0.473 Sum_probs=218.5
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEec
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~ 691 (992)
...+.||+|+||.||+|.+..+++.||||+++.... .....+.+|+++|+.++||||+++++++...+.+||||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence 346789999999999999999999999999975422 23456789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE--ccCCcEEEEeccccccccCCccccc
Q 001952 692 PGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLSLRCSVSPTLLK 769 (992)
Q Consensus 692 ~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL--d~dg~VKLsDFGLA~~l~~~~~~~~ 769 (992)
++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 169 ~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~----- 242 (373)
T 2x4f_A 169 DGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR----- 242 (373)
T ss_dssp TTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-----
T ss_pred CCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-----
Confidence 999999887654 2468999999999999999999999999999999999999 56778999999997543110
Q ss_pred CCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCc
Q 001952 770 SSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY 849 (992)
Q Consensus 770 ~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y 849 (992)
......+||+.|
T Consensus 243 --------------------------------------------------------------------~~~~~~~gt~~y 254 (373)
T 2x4f_A 243 --------------------------------------------------------------------EKLKVNFGTPEF 254 (373)
T ss_dssp --------------------------------------------------------------------CBCCCCCSSCTT
T ss_pred --------------------------------------------------------------------cccccccCCCcE
Confidence 011223699999
Q ss_pred cChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccCCcCCc
Q 001952 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 850 ~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~DPekR 927 (992)
+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.....++.. ..++.++++||.+||..||.+|
T Consensus 255 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 334 (373)
T 2x4f_A 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWR 334 (373)
T ss_dssp CCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGS
T ss_pred eChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhC
Confidence 99999999999999999999999999999999999998888888888776555432 3578999999999999999999
Q ss_pred CCChHhHHHHHcCCCCCCCchhh
Q 001952 928 LGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~lnw~~ 950 (992)
|+ +.|+|+||||....|..
T Consensus 335 ps----~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 335 IS----ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp CC----HHHHHHSHHHHCHHHHH
T ss_pred CC----HHHHhcCcCcCCCchhh
Confidence 99 99999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=400.79 Aligned_cols=272 Identities=28% Similarity=0.428 Sum_probs=217.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN---- 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~---- 682 (992)
..++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3579999999999999999999999999999999997532 12233456789999999999999999999997654
Q ss_pred --eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 683 --LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 683 --~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+||||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999996 57777775 3489999999999999999999999999999999999999999999999999743
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
... ....
T Consensus 177 ~~~-------------------------------------------------------------------------~~~~ 183 (371)
T 2xrw_A 177 AGT-------------------------------------------------------------------------SFMM 183 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 210 0011
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-------------------
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK------------------- 901 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk------------------- 901 (992)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++.....
T Consensus 184 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (371)
T 2xrw_A 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVEN 263 (371)
T ss_dssp ------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHS
T ss_pred CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhh
Confidence 2346899999999999999999999999999999999999999998877777666542111
Q ss_pred ---C--------------CCC----ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCC
Q 001952 902 ---F--------------PDS----PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP 960 (992)
Q Consensus 902 ---~--------------P~~----~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp 960 (992)
+ +.. ..++.++++||.+||..||.+||| ++|+|+||||............+|.+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~~~~ 339 (371)
T 2xrw_A 264 RPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWYDPSEAEAPPPKIP 339 (371)
T ss_dssp SCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTCCHHHHTCCCCCCC
T ss_pred CccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhcCccccCCCCCCCC
Confidence 0 000 012568999999999999999999 999999999987666555555566665
Q ss_pred C
Q 001952 961 D 961 (992)
Q Consensus 961 ~ 961 (992)
.
T Consensus 340 ~ 340 (371)
T 2xrw_A 340 D 340 (371)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=380.89 Aligned_cols=258 Identities=32% Similarity=0.487 Sum_probs=216.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+++|+.++||||+++++++...+..|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 368999999999999999999999999999999997652 233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE---ccCCcEEEEecccccccc
Q 001952 688 MEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL---d~dg~VKLsDFGLA~~l~ 762 (992)
|||+++++|.+++... .+..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999887643 24679999999999999999999999999999999999999 456789999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
. ......
T Consensus 179 ~-------------------------------------------------------------------------~~~~~~ 185 (285)
T 3is5_A 179 S-------------------------------------------------------------------------DEHSTN 185 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-------------------------------------------------------------------------cccCcC
Confidence 0 001123
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC-ccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS-PLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~-~~vs~el~dLI~kcL~ 921 (992)
..||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+......++.. ..++.++.+||.+||.
T Consensus 186 ~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 264 (285)
T 3is5_A 186 AAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLT 264 (285)
T ss_dssp -CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTC
T ss_pred cccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHcc
Confidence 468999999999864 58999999999999999999999999887766666655544443322 3378899999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCC
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
.||.+||+ +.|+|+||||+.
T Consensus 265 ~dP~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 265 KDPERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp SCTTTSCC----HHHHHTSGGGGC
T ss_pred CChhhCcC----HHHHhcCHHhhc
Confidence 99999999 999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=399.64 Aligned_cols=270 Identities=27% Similarity=0.414 Sum_probs=225.2
Q ss_pred eeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 600 RLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 600 ~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
....+++..++|++++.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred hhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 34456777899999999999999999999999999999999997542 2233466889999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEecccc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.++.+||||||+++++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred ECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 999999999999999999999875 5689999999999999999999985 9999999999999999999999999987
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+.. .
T Consensus 180 ~~~~~--------------------------------------------------------------------------~ 185 (360)
T 3eqc_A 180 GQLID--------------------------------------------------------------------------S 185 (360)
T ss_dssp HHHHH--------------------------------------------------------------------------H
T ss_pred ccccc--------------------------------------------------------------------------c
Confidence 43210 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHH-------------------------
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA------------------------- 893 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~------------------------- 893 (992)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 0123468999999999999999999999999999999999999998765433221
Q ss_pred -----------------HHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 894 -----------------NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 894 -----------------~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
.+............++.++.+||.+||..||++||+ ++|+|+||||+..+|..+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHHSCC
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchHhhh
Confidence 111111111122347889999999999999999999 999999999998877654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=387.94 Aligned_cols=269 Identities=26% Similarity=0.399 Sum_probs=206.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----- 682 (992)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 468999999999999999999999999999999997432 2234467889999999999999999999885433
Q ss_pred ----------------------------------------------------eEEEEEEecCCCChHHHHHhhcC-CCCC
Q 001952 683 ----------------------------------------------------LSCLVMEYCPGGDLHVLRQKQLG-KCFS 709 (992)
Q Consensus 683 ----------------------------------------------------~lyLVmEy~~GGSL~~lLkk~~~-~~Ls 709 (992)
.+|||||||++++|.+++..... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999886422 2345
Q ss_pred HHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCC
Q 001952 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCI 789 (992)
Q Consensus 710 e~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~ 789 (992)
+..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+........
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~-------------------- 222 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT-------------------- 222 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcc--------------------
Confidence 667899999999999999999999999999999999999999999999865432100000
Q ss_pred CCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeeh
Q 001952 790 QPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTF 869 (992)
Q Consensus 790 ~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSL 869 (992)
. ..............||+.|+|||++.+..++.++|||||
T Consensus 223 ------------~----------------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 262 (332)
T 3qd2_B 223 ------------V----------------------------LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262 (332)
T ss_dssp -------------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHH
T ss_pred ------------c----------------------------cccccccccccccCCCcCccChHHhcCCCCcchhhHHHH
Confidence 0 000000112234579999999999999999999999999
Q ss_pred hhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC-CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 870 GIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD-SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 870 GVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~-~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||++|||++|..|+... ...+..+. ...++. ....+.++.+||.+||..||.+||+ +.|+|+||||+++
T Consensus 263 G~il~el~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 263 GLILFELLYSFSTQMER--VRIITDVR--NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHHSCCCCHHHH--HHHHHHHH--TTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTCCCC
T ss_pred HHHHHHHHHcCCChhHH--HHHHHHhh--ccCCCcccccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhhhcC
Confidence 99999999987765221 11111111 112221 1235678899999999999999999 9999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=386.57 Aligned_cols=267 Identities=28% Similarity=0.402 Sum_probs=221.7
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeecc-
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTS- 680 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~- 680 (992)
......++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC----cccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3344578999999999999999999999999999999998643 23346788999999999 89999999999976
Q ss_pred -----CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEec
Q 001952 681 -----DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755 (992)
Q Consensus 681 -----~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDF 755 (992)
.+.+||||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 568999999999999999998765567999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 756 DLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 756 GLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
|++..+...
T Consensus 174 g~~~~~~~~----------------------------------------------------------------------- 182 (326)
T 2x7f_A 174 GVSAQLDRT----------------------------------------------------------------------- 182 (326)
T ss_dssp TTTC----------------------------------------------------------------------------
T ss_pred cCceecCcC-----------------------------------------------------------------------
Confidence 987332100
Q ss_pred CCCCcCccccCCCccChhhhc-----CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 836 TDARSNSFVGTHEYLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~-----g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
........||+.|+|||++. +..++.++|||||||+||||++|..||.+......+..+............++.
T Consensus 183 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 2x7f_A 183 -VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 261 (326)
T ss_dssp ---------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCH
T ss_pred -ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCccccCH
Confidence 00112346899999999997 456899999999999999999999999888777666665554444334456889
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
.+.+||.+||..||.+||+ +.++++||||+...+.
T Consensus 262 ~l~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 262 KFQSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HHHHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTTH
T ss_pred HHHHHHHHHhccChhhCCC----HHHHhhChHHhhCccc
Confidence 9999999999999999999 9999999999887553
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=384.10 Aligned_cols=263 Identities=25% Similarity=0.334 Sum_probs=218.4
Q ss_pred eecccccccCceEEEEEccCCceEEEEEEE-cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC------Cccc
Q 001952 601 LQYGSIGLRHFNLLQKLGCGDIGTVYLAEL-IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP------FLPT 673 (992)
Q Consensus 601 ~~~gei~~~~Yeilr~LGsG~FGtVYlA~~-~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP------NIVk 673 (992)
.+.+....++|++++.||+|+||.||+|.+ ..+++.||||+++... .....+.+|+.+++.++|+ +|++
T Consensus 6 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~ 81 (339)
T 1z57_A 6 CQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81 (339)
T ss_dssp CSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred eecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence 345666678999999999999999999998 5678999999997532 2345677899999888655 4999
Q ss_pred eeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-------
Q 001952 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE------- 746 (992)
Q Consensus 674 L~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~------- 746 (992)
+++++...+.+||||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 82 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 160 (339)
T 1z57_A 82 MLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160 (339)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEecccccccc
Confidence 999999999999999999 999999988765557899999999999999999999999999999999999987
Q ss_pred ------------CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCcccccc
Q 001952 747 ------------DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKT 814 (992)
Q Consensus 747 ------------dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt 814 (992)
++.++|+|||++....
T Consensus 161 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~---------------------------------------------------- 188 (339)
T 1z57_A 161 NPKIKRDERTLINPDIKVVDFGSATYDD---------------------------------------------------- 188 (339)
T ss_dssp C----CEEEEESCCCEEECCCSSCEETT----------------------------------------------------
T ss_pred CCccccccccccCCCceEeeCcccccCc----------------------------------------------------
Confidence 6679999999873211
Q ss_pred CCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHH
Q 001952 815 RKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894 (992)
Q Consensus 815 ~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~ 894 (992)
.......||+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..
T Consensus 189 -----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 189 -----------------------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp -----------------------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred -----------------------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 001234689999999999999999999999999999999999999998877665554
Q ss_pred HHhhccCCC------------------------------------------CCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 895 VVMQSLKFP------------------------------------------DSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 895 Iv~~~lk~P------------------------------------------~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
+......+| .....+.++.+||.+||..||.+||+
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt--- 322 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT--- 322 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC---
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC---
Confidence 432211111 11234678999999999999999999
Q ss_pred hHHHHHcCCCCCCCc
Q 001952 933 GAAEIKQHPFFEGLN 947 (992)
Q Consensus 933 ~aeEILkHPfF~~ln 947 (992)
+.|+|+||||+.+.
T Consensus 323 -~~ell~hp~f~~~~ 336 (339)
T 1z57_A 323 -LREALKHPFFDLLK 336 (339)
T ss_dssp -HHHHTTSGGGGGGG
T ss_pred -HHHHhcCHHHHHHh
Confidence 99999999998764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=387.64 Aligned_cols=290 Identities=26% Similarity=0.350 Sum_probs=226.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD----- 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~----- 681 (992)
..++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 3578999999999999999999999999999999996421 223345677899999999999999999987654
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
...|+||||+. ++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 78999999995 689888876 46899999999999999999999999999999999999999999999999998554
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
........ ..........
T Consensus 163 ~~~~~~~~--------------------------------------------------------------~~~~~~~~~~ 180 (353)
T 2b9h_A 163 DESAADNS--------------------------------------------------------------EPTGQQSGMV 180 (353)
T ss_dssp C------------------------------------------------------------------------------C
T ss_pred cccccccc--------------------------------------------------------------Cccccccchh
Confidence 21100000 0000001123
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-------------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK------------------- 901 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk------------------- 901 (992)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+......
T Consensus 181 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (353)
T 2b9h_A 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYI 260 (353)
T ss_dssp CCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHH
T ss_pred hccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHh
Confidence 4579999999999875 67899999999999999999999999988766666554321110
Q ss_pred -----CCC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCCCCCCc
Q 001952 902 -----FPD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQ 968 (992)
Q Consensus 902 -----~P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~d~~~~ 968 (992)
.+. .+.++.++.+||.+||..||.+||+ +.|+|+||||+...|........+.-|..+++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (353)
T 2b9h_A 261 KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHY 334 (353)
T ss_dssp HTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGGCC
T ss_pred hcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCcccccccCCCCcceeeecch
Confidence 110 1247889999999999999999999 99999999999998876544433333445554443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=406.50 Aligned_cols=254 Identities=28% Similarity=0.448 Sum_probs=208.7
Q ss_pred ccCceEE-EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHH-HHcCCCCccceeeeecc----C
Q 001952 608 LRHFNLL-QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLYSQFTS----D 681 (992)
Q Consensus 608 ~~~Yeil-r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieIL-k~L~HPNIVkL~g~f~~----~ 681 (992)
.++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|++++ +..+||||++++++|.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 5678877 7899999999999999999999999999632 3456788887 45589999999998875 6
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEecccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLS 758 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA 758 (992)
+++|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67999999999999999998754457999999999999999999999999999999999999997 789999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..... ..
T Consensus 212 ~~~~~-------------------------------------------------------------------------~~ 218 (400)
T 1nxk_A 212 KETTS-------------------------------------------------------------------------HN 218 (400)
T ss_dssp EECC----------------------------------------------------------------------------
T ss_pred cccCC-------------------------------------------------------------------------CC
Confidence 43210 00
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchH----HHHHHHhhccCCCCC--ccchHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE----TLANVVMQSLKFPDS--PLISFQA 912 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e----~L~~Iv~~~lk~P~~--~~vs~el 912 (992)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..... ....+....+.++.. ..++.++
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 298 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 298 (400)
T ss_dssp --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHH
Confidence 1123568999999999999999999999999999999999999998765432 445555555555432 4589999
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.+||.+||..||++||+ +.|||+||||...
T Consensus 299 ~~li~~~L~~dP~~Rpt----~~eil~hp~~~~~ 328 (400)
T 1nxk_A 299 KMLIRNLLKTEPTQRMT----ITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHTTSCSSGGGSCC----HHHHHHSHHHHTT
T ss_pred HHHHHHHCCCChhHCcC----HHHHhcCccccCC
Confidence 99999999999999999 9999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=388.65 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=205.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHH-cCCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM-LDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~-L~HPNIVkL~g~f~~~~~l 684 (992)
+..++|++++.||+|+||+||+|.+..+++.||||++......... ......|+..+.. .+|+||++++++|.+++.+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 3446899999999999999999999999999999998643222222 2233445555444 4999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+ +++|..++... +..+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 133 ~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred EEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999999 78998887765 457999999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 211 -------------------------------------------------------------------------~~~~~~~ 217 (311)
T 3p1a_A 211 -------------------------------------------------------------------------GAGEVQE 217 (311)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred -------------------------------------------------------------------------CCCcccC
Confidence 0012235
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+ .++.++|||||||+||||++|..||.+... +..+............++.++.+||.+||..||
T Consensus 218 gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 293 (311)
T 3p1a_A 218 GDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP 293 (311)
T ss_dssp CCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred CCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCCCh
Confidence 8999999999987 689999999999999999999877765432 333322222111223478899999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~ 945 (992)
++||+ ++|+|+||||+.
T Consensus 294 ~~Rpt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 294 KLRAT----AEALLALPVLRQ 310 (311)
T ss_dssp TTSCC----HHHHHTSGGGSC
T ss_pred hhCcC----HHHHHhCccccC
Confidence 99999 999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=380.14 Aligned_cols=266 Identities=26% Similarity=0.422 Sum_probs=221.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh-hcchhHHHHHHHHHHHcCCCCccceeeee--ccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR-RKKMPRAQTEREILRMLDHPFLPTLYSQF--TSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~-~~~~~~~~~EieILk~L~HPNIVkL~g~f--~~~~~l 684 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++....... ......+.+|+.+|+.++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999999999999999998764332 23456788999999999999999999998 455689
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999766 777777655677999999999999999999999999999999999999999999999999997443100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. .........
T Consensus 163 ~----------------------------------------------------------------------~~~~~~~~~ 172 (305)
T 2wtk_C 163 A----------------------------------------------------------------------ADDTCRTSQ 172 (305)
T ss_dssp C----------------------------------------------------------------------SSCEECCCC
T ss_pred c----------------------------------------------------------------------cccccccCC
Confidence 0 000112345
Q ss_pred cCCCccChhhhcCCCC--CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGH--GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~--s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+... +.++|||||||++|||++|+.||.+.+..+.+..+......++ ..++..+.+||.+||..
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--~~~~~~l~~li~~~l~~ 250 (305)
T 2wtk_C 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP--GDCGPPLSDLLKGMLEY 250 (305)
T ss_dssp SCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC--SSSCHHHHHHHHHHTCS
T ss_pred CCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC--CccCHHHHHHHHHHccC
Confidence 8999999999987543 7899999999999999999999998877777777666555444 35899999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
||.+||+ +.|+++||||+......
T Consensus 251 dp~~Rps----~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 251 EPAKRFS----IRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp STTTSCC----HHHHHHSHHHHSCCCC-
T ss_pred ChhhCCC----HHHHhcCcccccCCCCc
Confidence 9999999 99999999999876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=411.42 Aligned_cols=259 Identities=32% Similarity=0.492 Sum_probs=224.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+++|+.++||||+++++++...+.+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4689999999999999999999999999999999976532 233456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc---cCCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd---~dg~VKLsDFGLA~~l~~~ 764 (992)
|||+.+++|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+|||++..+...
T Consensus 100 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999888765 5699999999999999999999999999999999999995 4567999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
......+
T Consensus 178 -------------------------------------------------------------------------~~~~~~~ 184 (486)
T 3mwu_A 178 -------------------------------------------------------------------------TKMKDRI 184 (486)
T ss_dssp -----------------------------------------------------------------------------CCT
T ss_pred -------------------------------------------------------------------------CccCCCc
Confidence 0112346
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+. ++.++|||||||++|+|++|+.||.+.+..+.+..+......++. ...++.++++||.+||..
T Consensus 185 gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 263 (486)
T 3mwu_A 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263 (486)
T ss_dssp TGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCS
T ss_pred CCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCC
Confidence 99999999999874 899999999999999999999999999888888888777655443 345889999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
||.+||+ +.++|+||||+...
T Consensus 264 dp~~R~t----~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 264 HPSLRIT----ATQCLEHPWIQKYS 284 (486)
T ss_dssp STTTSCC----HHHHHHCHHHHHTC
T ss_pred ChhhCcC----HHHHhcCHhhccCc
Confidence 9999999 99999999998654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=383.07 Aligned_cols=256 Identities=31% Similarity=0.485 Sum_probs=221.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+|+.++||||+++++++...+.+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 468999999999999999999999999999999997542 12235678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE---ccCCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL---d~dg~VKLsDFGLA~~l~~~ 764 (992)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 85 MQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp ECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999999999988765 568999999999999999999999999999999999999 7888999999998632100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 162 -------------------------------------------------------------------------~~~~~~~ 168 (304)
T 2jam_A 162 -------------------------------------------------------------------------GIMSTAC 168 (304)
T ss_dssp -------------------------------------------------------------------------BTTHHHH
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0012246
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+......++. ...++.++.+||.+||..
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (304)
T 2jam_A 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEK 248 (304)
T ss_dssp SCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCS
T ss_pred CCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCC
Confidence 899999999999999999999999999999999999999988877777777766554432 345889999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||.+||+ +.|+|+||||++.
T Consensus 249 dp~~Rps----~~~~l~h~~~~~~ 268 (304)
T 2jam_A 249 DPNERYT----CEKALSHPWIDGN 268 (304)
T ss_dssp STTTSCC----HHHHHTSHHHHSS
T ss_pred ChhHCcC----HHHHhcCccccCC
Confidence 9999999 9999999999764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=374.57 Aligned_cols=261 Identities=26% Similarity=0.456 Sum_probs=219.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR--AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG--CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc--chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 468999999999999999999999999999999997542 123346788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 159 (276)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc--
Confidence 9999999999887653 568999999999999999999999999999999999999999999999999974431100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.........||+
T Consensus 160 --------------------------------------------------------------------~~~~~~~~~~~~ 171 (276)
T 2yex_A 160 --------------------------------------------------------------------RERLLNKMCGTL 171 (276)
T ss_dssp --------------------------------------------------------------------EECCBCCCCSCG
T ss_pred --------------------------------------------------------------------chhcccCCcccc
Confidence 000112346899
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
.|+|||++.+..+ +.++|||||||++|||++|+.||.+.... ..+..+.......+....++.++.+||.+||..||.
T Consensus 172 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 251 (276)
T 2yex_A 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 251 (276)
T ss_dssp GGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCch
Confidence 9999999988775 78899999999999999999999876554 334444444334444456889999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~l 946 (992)
+||+ +.|+++||||+..
T Consensus 252 ~Rps----~~~il~~~~~~~~ 268 (276)
T 2yex_A 252 ARIT----IPDIKKDRWYNKP 268 (276)
T ss_dssp TSCC----HHHHTTCTTTTCC
T ss_pred hCCC----HHHHhcCccccCh
Confidence 9999 9999999999865
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=411.73 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=221.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.+..++..||||++...... ......+.+|+.+|+.++||||++++++|.+.+.+|||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999765332 23356788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA~~l~~~ 764 (992)
||||++|+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||++..+...
T Consensus 115 ~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 115 MECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999888765 56999999999999999999999999999999999999975 445999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
......+
T Consensus 193 -------------------------------------------------------------------------~~~~~~~ 199 (494)
T 3lij_A 193 -------------------------------------------------------------------------KKMKERL 199 (494)
T ss_dssp -------------------------------------------------------------------------BCBCCCC
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0112346
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+.+..+......++.+ ..++.++++||.+||..
T Consensus 200 gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 278 (494)
T 3lij_A 200 GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278 (494)
T ss_dssp SCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCS
T ss_pred CCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCC
Confidence 9999999999874 58999999999999999999999999998888888887776665543 35889999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
||.+||+ +.|+|+||||+...+.
T Consensus 279 dp~~R~s----~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 279 DSQRRIS----AQQALEHPWIKEMCSK 301 (494)
T ss_dssp STTTSCC----HHHHHTCHHHHHHHHH
T ss_pred ChhhCcc----HHHHhcCcccccCccc
Confidence 9999999 9999999999876544
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=393.85 Aligned_cols=261 Identities=25% Similarity=0.360 Sum_probs=211.0
Q ss_pred eecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC--------CCCcc
Q 001952 601 LQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD--------HPFLP 672 (992)
Q Consensus 601 ~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~--------HPNIV 672 (992)
+..+.+..++|++++.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|+.+. |+||+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 4455666789999999999999999999999999999999997532 23456788999999885 78899
Q ss_pred ceeeeec----cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccC
Q 001952 673 TLYSQFT----SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVRED 747 (992)
Q Consensus 673 kL~g~f~----~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~d 747 (992)
+++++|. ....+||||||+ +++|..++.......+++..++.|+.||+.||+|||++ |||||||||+||||+.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999987 567899999999 66666666554446799999999999999999999998 99999999999999977
Q ss_pred C-------------------------------------------------cEEEEeccccccccCCcccccCCCCCCCCc
Q 001952 748 G-------------------------------------------------HIMLTDFDLSLRCSVSPTLLKSSSNMDPAR 778 (992)
Q Consensus 748 g-------------------------------------------------~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r 778 (992)
+ .++|+|||++....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~---------------- 247 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH---------------- 247 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT----------------
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc----------------
Confidence 6 68888888863321
Q ss_pred cCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC
Q 001952 779 VSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE 858 (992)
Q Consensus 779 ~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~ 858 (992)
......+||+.|+|||++.+.
T Consensus 248 -----------------------------------------------------------~~~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 248 -----------------------------------------------------------KHFTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp -----------------------------------------------------------BCSCSCCSCGGGCCHHHHHTS
T ss_pred -----------------------------------------------------------ccCccCCCCCcccCChhhcCC
Confidence 112234689999999999999
Q ss_pred CCCccceeeehhhhhhhhccCCCCCCCCCc------hHHHHHHHhhccCC------------------------------
Q 001952 859 GHGAAVDWWTFGIFLYELLYGRTPFKGSGN------EETLANVVMQSLKF------------------------------ 902 (992)
Q Consensus 859 ~~s~kSDIWSLGVlLyELLTGr~PF~g~s~------~e~L~~Iv~~~lk~------------------------------ 902 (992)
.++.++|||||||+||||++|+.||.+.+. .+.+..+.......
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 999999999999999999999999986543 22333322211111
Q ss_pred ----------CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 903 ----------PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 903 ----------P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
.....++.++.+||.+||..||++||+ ++|||+||||.+
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 112234567899999999999999999 999999999974
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=393.92 Aligned_cols=258 Identities=28% Similarity=0.367 Sum_probs=221.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+.|++++.||+|+||.||+|.+..+++.||||++.............+.+|+++|+.++||||+++++++...+..|||
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45699999999999999999999999999999999654322334456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~----- 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA----- 205 (348)
T ss_dssp EECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-----
T ss_pred EecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-----
Confidence 99996 6777777644 3679999999999999999999999999999999999999999999999999873211
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
......||+
T Consensus 206 -----------------------------------------------------------------------~~~~~~gt~ 214 (348)
T 1u5q_A 206 -----------------------------------------------------------------------PANSFVGTP 214 (348)
T ss_dssp -----------------------------------------------------------------------SBCCCCSCG
T ss_pred -----------------------------------------------------------------------CCCcccCCc
Confidence 011246899
Q ss_pred CccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 848 EYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 848 ~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
.|+|||++. +..++.++|||||||+||||++|+.||.+.+..+.+..+............++..+.+||.+||..||
T Consensus 215 ~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 294 (348)
T 1u5q_A 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIP 294 (348)
T ss_dssp GGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred ceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCh
Confidence 999999996 45689999999999999999999999998887777777766555444445689999999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCCc
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~ln 947 (992)
++||+ ++++|+||||....
T Consensus 295 ~~Rps----~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 295 QDRPT----SEVLLKHRFVLRER 313 (348)
T ss_dssp GGSCC----HHHHTTCHHHHSCC
T ss_pred hhCcC----HHHHhhChhhhccC
Confidence 99999 99999999997643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=388.17 Aligned_cols=266 Identities=26% Similarity=0.348 Sum_probs=217.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------- 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------- 680 (992)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 5789999999999999999999999999999999865421 22334567889999999999999999999876
Q ss_pred -CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 681 -DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 681 -~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
.+.+||||||+.+ +|...+... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 4578999999964 776666544 3569999999999999999999999999999999999999999999999999985
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..... .....
T Consensus 173 ~~~~~~~--------------------------------------------------------------------~~~~~ 184 (351)
T 3mi9_A 173 AFSLAKN--------------------------------------------------------------------SQPNR 184 (351)
T ss_dssp ECCCCSS--------------------------------------------------------------------SSCCC
T ss_pred ccccccc--------------------------------------------------------------------ccccc
Confidence 4321100 00111
Q ss_pred cCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--cc---------
Q 001952 840 SNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PL--------- 907 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~--------- 907 (992)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+......++.. +.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 264 (351)
T 3mi9_A 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 264 (351)
T ss_dssp CCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTS
T ss_pred cCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcc
Confidence 2345789999999999874 57999999999999999999999999988877777665433222211 00
Q ss_pred -------------------chHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 908 -------------------ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 908 -------------------vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
.+.++.+||.+||..||++||+ ++|+|+||||....+
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 265 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSDPM 320 (351)
T ss_dssp SCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSSSC
T ss_pred cccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCCCC
Confidence 2567899999999999999999 999999999987554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=384.27 Aligned_cols=269 Identities=26% Similarity=0.341 Sum_probs=221.2
Q ss_pred eeecccccccCceEEEEEccCCceEEEEEEEcCCC-eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC------cc
Q 001952 600 RLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF------LP 672 (992)
Q Consensus 600 ~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg-~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN------IV 672 (992)
....+....++|++++.||+|+||.||+|.+..++ +.||||+++... .....+.+|+.+|+.+.|++ ++
T Consensus 10 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred ccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 34456666789999999999999999999998776 799999997532 23356678999999887655 89
Q ss_pred ceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE--------
Q 001952 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV-------- 744 (992)
Q Consensus 673 kL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL-------- 744 (992)
.+++++...+.+||||||+ +++|.+++.......+++..++.|+.||+.||+|||++||+||||||+|||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 86 LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp CEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEE
T ss_pred EeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccc
Confidence 9999999999999999999 6777777666544679999999999999999999999999999999999999
Q ss_pred -----------ccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccc
Q 001952 745 -----------REDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAK 813 (992)
Q Consensus 745 -----------d~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~k 813 (992)
+.++.+||+|||++....
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~--------------------------------------------------- 193 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDH--------------------------------------------------- 193 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETT---------------------------------------------------
T ss_pred ccccccccccccCCCcEEEeecCcccccc---------------------------------------------------
Confidence 567899999999873311
Q ss_pred cCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHH
Q 001952 814 TRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893 (992)
Q Consensus 814 t~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~ 893 (992)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.+.
T Consensus 194 ------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 194 ------------------------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp ------------------------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ------------------------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 00123468999999999999999999999999999999999999999887766655
Q ss_pred HHHhhccCCC------------------------------------------CCccchHHHHHHHHHhccCCcCCcCCCh
Q 001952 894 NVVMQSLKFP------------------------------------------DSPLISFQARDLIRGLLIKEPENRLGSQ 931 (992)
Q Consensus 894 ~Iv~~~lk~P------------------------------------------~~~~vs~el~dLI~kcL~~DPekRPT~~ 931 (992)
.+......+| .....+.++.+||.+||..||++||+
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt-- 327 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT-- 327 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC--
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC--
Confidence 4433221111 11223568899999999999999999
Q ss_pred HhHHHHHcCCCCCCCchhhhh
Q 001952 932 KGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 932 ~~aeEILkHPfF~~lnw~~lr 952 (992)
+.|+|+||||.+++|....
T Consensus 328 --~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 328 --LAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp --HHHHTTSGGGGGCCHHHHC
T ss_pred --HHHHhcChhhcCCChhhcc
Confidence 9999999999999987553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=378.58 Aligned_cols=263 Identities=28% Similarity=0.474 Sum_probs=221.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 457899999999999999999999999999999999754 33456778899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 94 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 170 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-- 170 (302)
T ss_dssp EEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--
T ss_pred EEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999999988764 356999999999999999999999999999999999999999999999999986321100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........||
T Consensus 171 ----------------------------------------------------------------------~~~~~~~~~~ 180 (302)
T 2j7t_A 171 ----------------------------------------------------------------------LQKRDSFIGT 180 (302)
T ss_dssp ----------------------------------------------------------------------HHC-----CC
T ss_pred ----------------------------------------------------------------------ccccccccCC
Confidence 0001234689
Q ss_pred CCccChhhhc-----CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-CCCCccchHHHHHHHHHhc
Q 001952 847 HEYLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-FPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 847 ~~Y~APEvL~-----g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-~P~~~~vs~el~dLI~kcL 920 (992)
+.|+|||++. +..++.++|||||||++|||++|..||...+....+..+...... ......++.++.+||.+||
T Consensus 181 ~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 260 (302)
T 2j7t_A 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIAL 260 (302)
T ss_dssp GGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHS
T ss_pred hhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHc
Confidence 9999999984 567899999999999999999999999988777766666554332 2234557889999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
..||.+||+ +.++++||||..+.|.
T Consensus 261 ~~dp~~Rps----~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 261 DKNPETRPS----AAQLLEHPFVSSITSN 285 (302)
T ss_dssp CSCTTTSCC----HHHHTTSTTTTTCCCC
T ss_pred ccChhhCCC----HHHHhcChHHhhhccc
Confidence 999999999 9999999999998875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=393.83 Aligned_cols=259 Identities=32% Similarity=0.482 Sum_probs=221.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhH-----HHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF-----LARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSD 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~-----l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~ 681 (992)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .........+.+|+.+|+.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 467999999999999999999999899999999986532 11122345678999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+..||||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++..+
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999998865 56999999999999999999999999999999999999999999999999987443
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... ....
T Consensus 251 ~~~-------------------------------------------------------------------------~~~~ 257 (365)
T 2y7j_A 251 EPG-------------------------------------------------------------------------EKLR 257 (365)
T ss_dssp CTT-------------------------------------------------------------------------CCBC
T ss_pred CCC-------------------------------------------------------------------------cccc
Confidence 110 0112
Q ss_pred ccccCCCccChhhhcCC------CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHH
Q 001952 842 SFVGTHEYLAPEIIKGE------GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQAR 913 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~------~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~ 913 (992)
...||+.|+|||++.+. .++.++|||||||+||||++|+.||.+......+..+......++.+ ..++.++.
T Consensus 258 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 337 (365)
T 2y7j_A 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK 337 (365)
T ss_dssp CCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHH
T ss_pred cCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHH
Confidence 34689999999999743 57899999999999999999999999887777777777665554422 34788899
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
+||.+||..||++||+ +.|+|+||||+.
T Consensus 338 ~li~~~L~~dP~~Rps----~~ell~hp~f~r 365 (365)
T 2y7j_A 338 DLISRLLQVDPEARLT----AEQALQHPFFER 365 (365)
T ss_dssp HHHHHHSCSSTTTSCC----HHHHHHSGGGCC
T ss_pred HHHHHHcCCChhHCcC----HHHHhcCcccCC
Confidence 9999999999999999 999999999973
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=409.94 Aligned_cols=260 Identities=29% Similarity=0.432 Sum_probs=222.1
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh----------cchhHHHHHHHHHHHcCCCCccceee
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR----------KKMPRAQTEREILRMLDHPFLPTLYS 676 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~----------~~~~~~~~EieILk~L~HPNIVkL~g 676 (992)
..++|.+++.||+|+||+||+|.+..+++.||||++........ .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999999999999999999976533211 34567889999999999999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEEEE
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLT 753 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VKLs 753 (992)
+|.+.+.+|||||||+||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999888765 5699999999999999999999999999999999999999776 69999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|||++..+...
T Consensus 192 Dfg~a~~~~~~--------------------------------------------------------------------- 202 (504)
T 3q5i_A 192 DFGLSSFFSKD--------------------------------------------------------------------- 202 (504)
T ss_dssp CCTTCEECCTT---------------------------------------------------------------------
T ss_pred ECCCCEEcCCC---------------------------------------------------------------------
Confidence 99997443110
Q ss_pred CCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHH
Q 001952 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQ 911 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~e 911 (992)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....+.++.. ..++.+
T Consensus 203 ----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (504)
T 3q5i_A 203 ----YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDE 277 (504)
T ss_dssp ----SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred ----CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHH
Confidence 01123469999999999875 58999999999999999999999999998888888887766555422 357899
Q ss_pred HHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+++||.+||..||.+||+ ++|+|+||||+..
T Consensus 278 ~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 278 AKELIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp HHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred HHHHHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 999999999999999999 9999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=377.04 Aligned_cols=263 Identities=25% Similarity=0.338 Sum_probs=206.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..++|++++.||+|+||.||+|.+..+++.||||++...... ......+.++..+++.++||||+++++++...+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 34568999999999999999999999999999999999754221 22233344555567888999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
||||||++ ++|.+++... .+..+++..++.|+.||+.||+|||++ ||+||||||+|||++.++.++|+|||++..+
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 5887776542 246799999999999999999999998 9999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... ....
T Consensus 161 ~~~-------------------------------------------------------------------------~~~~ 167 (290)
T 3fme_A 161 VDD-------------------------------------------------------------------------VAKD 167 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 100 0011
Q ss_pred ccccCCCccChhhh----cCCCCCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 842 SFVGTHEYLAPEII----KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 842 s~vGT~~Y~APEvL----~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
...||+.|+|||++ .+..++.++|||||||++|||++|+.||.... ....+...+...........++.++.+||
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 247 (290)
T 3fme_A 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFT 247 (290)
T ss_dssp --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHH
T ss_pred ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHH
Confidence 23589999999997 45678999999999999999999999998743 34455555544444333446899999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.+||..||++||+ +.|+++||||+..
T Consensus 248 ~~~l~~~p~~Rpt----~~e~l~hp~f~~~ 273 (290)
T 3fme_A 248 SQCLKKNSKERPT----YPELMQHPFFTLH 273 (290)
T ss_dssp HHHTCSSGGGSCC----HHHHTTSHHHHHH
T ss_pred HHHhhcChhhCcC----HHHHHhCcccccC
Confidence 9999999999999 9999999999753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=389.05 Aligned_cols=277 Identities=28% Similarity=0.408 Sum_probs=211.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN---- 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~---- 682 (992)
..++|++.+.||+|+||.||+|.+..+++.||||++... ......+..++..|..++||||++++++|...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD----PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECC----TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC----ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 357899999999999999999999999999999998643 233455677888899999999999999986433
Q ss_pred ---eEEEEEEecCCCChHHHHHh--hcCCCCCHHHHHHHHHHHHHHHHHHh--hcCeeeeecCCceEEEcc-CCcEEEEe
Q 001952 683 ---LSCLVMEYCPGGDLHVLRQK--QLGKCFSEPAARFYVAEVLLALEYLH--MLGVIYRDLKPENILVRE-DGHIMLTD 754 (992)
Q Consensus 683 ---~lyLVmEy~~GGSL~~lLkk--~~~~~Lse~~i~~Ia~QIL~GL~YLH--s~GIIHRDIKPeNILLd~-dg~VKLsD 754 (992)
.+||||||+++ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEee
Confidence 38899999976 54443332 12356889999999999999999999 999999999999999996 89999999
Q ss_pred ccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccC
Q 001952 755 FDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834 (992)
Q Consensus 755 FGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~ 834 (992)
||++..+...
T Consensus 176 fg~a~~~~~~---------------------------------------------------------------------- 185 (360)
T 3e3p_A 176 FGSAKKLSPS---------------------------------------------------------------------- 185 (360)
T ss_dssp CTTCBCCCTT----------------------------------------------------------------------
T ss_pred CCCceecCCC----------------------------------------------------------------------
Confidence 9997432100
Q ss_pred CCCCCcCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC-----------
Q 001952 835 PTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF----------- 902 (992)
Q Consensus 835 ~~~~~s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~----------- 902 (992)
.......||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+..+.+..++......
T Consensus 186 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3e3p_A 186 ---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS 262 (360)
T ss_dssp ---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred ---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence 0112346899999999997765 8999999999999999999999999988877777765421111
Q ss_pred -------------------CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCC-CC
Q 001952 903 -------------------PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELP-DF 962 (992)
Q Consensus 903 -------------------P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp-~~ 962 (992)
.....++.++.+||.+||..||.+||+ +.|+|+||||+++.+........+.+| +.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~ 338 (360)
T 3e3p_A 263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDPATKLPNNKDLPEDL 338 (360)
T ss_dssp CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCTTCCCTTSCCCCGGG
T ss_pred hhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCccccCCCCCCCCcHH
Confidence 011125678999999999999999999 999999999999887776666666666 33
Q ss_pred CCC
Q 001952 963 YDY 965 (992)
Q Consensus 963 ~d~ 965 (992)
+.+
T Consensus 339 ~~~ 341 (360)
T 3e3p_A 339 FRF 341 (360)
T ss_dssp GCC
T ss_pred HHc
Confidence 333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=369.74 Aligned_cols=254 Identities=20% Similarity=0.321 Sum_probs=208.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyL 686 (992)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.++..+ +||||+++++++.+.+.+||
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 46899999999999999999999999999999998753211 22345678899999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC----------------
Q 001952 687 VMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---------------- 748 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---------------- 748 (992)
||||+++++|.+++.... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 999999999999987643 25689999999999999999999999999999999999998544
Q ss_pred ---cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhh
Q 001952 749 ---HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQI 825 (992)
Q Consensus 749 ---~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i 825 (992)
.++|+|||++.....
T Consensus 169 ~~~~~kl~Dfg~~~~~~~-------------------------------------------------------------- 186 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISS-------------------------------------------------------------- 186 (289)
T ss_dssp -CCCEEECCCTTCEETTC--------------------------------------------------------------
T ss_pred CceEEEEcccccccccCC--------------------------------------------------------------
Confidence 799999998743210
Q ss_pred ccCCccccCCCCCCcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC
Q 001952 826 RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904 (992)
Q Consensus 826 ~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~ 904 (992)
.....||+.|+|||++.+. .++.++|||||||++|||++|..++.... .+..+..... ...
T Consensus 187 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~-~~~ 248 (289)
T 1x8b_A 187 --------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRL-PRI 248 (289)
T ss_dssp --------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCC-CCC
T ss_pred --------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCC-CCC
Confidence 0112489999999999876 56789999999999999999998875442 3333333322 223
Q ss_pred CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 905 ~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+..++.++.+||.+||..||++||+ +.|+++||||.+.
T Consensus 249 ~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 249 PQVLSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred CcccCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 3468999999999999999999999 9999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=400.64 Aligned_cols=256 Identities=27% Similarity=0.368 Sum_probs=215.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc------CCCCccceeeeecc
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML------DHPFLPTLYSQFTS 680 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L------~HPNIVkL~g~f~~ 680 (992)
...+|++++.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+|+.+ +|+||+++++++..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 4568999999999999999999999999999999997542 2234566788888777 57799999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc--EEEEecccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH--IMLTDFDLS 758 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~--VKLsDFGLA 758 (992)
.+.+||||||+ +++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++. +||+|||++
T Consensus 171 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999999999 579999888765567999999999999999999999999999999999999999887 999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
.... .
T Consensus 250 ~~~~---------------------------------------------------------------------------~ 254 (429)
T 3kvw_A 250 CYEH---------------------------------------------------------------------------Q 254 (429)
T ss_dssp EETT---------------------------------------------------------------------------C
T ss_pred eecC---------------------------------------------------------------------------C
Confidence 3211 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC---------------
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP--------------- 903 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P--------------- 903 (992)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++......+
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~ 334 (429)
T 3kvw_A 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334 (429)
T ss_dssp CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBC
T ss_pred cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccC
Confidence 11234689999999999999999999999999999999999999999888877776654211000
Q ss_pred ----------------------------------C--------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCC
Q 001952 904 ----------------------------------D--------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941 (992)
Q Consensus 904 ----------------------------------~--------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHP 941 (992)
. ....+.++.+||.+||..||++||| ++|+|+||
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----a~e~L~Hp 410 (429)
T 3kvw_A 335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----PGQALRHP 410 (429)
T ss_dssp TTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----HHHHHTST
T ss_pred CCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----HHHHhCCh
Confidence 0 0113678999999999999999999 99999999
Q ss_pred CCCCC
Q 001952 942 FFEGL 946 (992)
Q Consensus 942 fF~~l 946 (992)
||+..
T Consensus 411 w~~~~ 415 (429)
T 3kvw_A 411 WLRRR 415 (429)
T ss_dssp TTC--
T ss_pred hhccC
Confidence 99864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=380.59 Aligned_cols=273 Identities=28% Similarity=0.377 Sum_probs=200.9
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++...+..
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 3557899999999999999999999988999999999875422 23455678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhh------cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQ------LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~------~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999999988742 2356899999999999999999999999999999999999999999999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+...... ....
T Consensus 169 ~~~~~~~~~-------------------------------------------------------------------~~~~ 181 (303)
T 2vwi_A 169 AFLATGGDI-------------------------------------------------------------------TRNK 181 (303)
T ss_dssp HHCC----------------------------------------------------------------------------
T ss_pred heeccCCCc-------------------------------------------------------------------cchh
Confidence 543210000 0001
Q ss_pred CcCccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC--------CCccch
Q 001952 839 RSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP--------DSPLIS 909 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P--------~~~~vs 909 (992)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+........... ....++
T Consensus 182 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (303)
T 2vwi_A 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYG 261 (303)
T ss_dssp ------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCC
T ss_pred hhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhh
Confidence 1123468999999999976 5689999999999999999999999998877766655544332111 123477
Q ss_pred HHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 910 ~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
.++.+||.+||..||.+||+ +.++++||||+...+..
T Consensus 262 ~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 262 KSFRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKNKE 298 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCC----HHHHHTSTTC-------
T ss_pred HHHHHHHHHHccCChhhCcC----HHHHhhChhhhcCCCCc
Confidence 89999999999999999999 99999999999877654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=375.59 Aligned_cols=258 Identities=23% Similarity=0.388 Sum_probs=215.6
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc----CC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS----DN 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~----~~ 682 (992)
....|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+|+.++||||++++++|.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 345689999999999999999999999999999999754322 2345678899999999999999999998864 46
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEc-cCCcEEEEeccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVR-EDGHIMLTDFDLSL 759 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd-~dg~VKLsDFGLA~ 759 (992)
.+||||||+++++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ .++.++|+|||++.
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 789999999999999999875 56899999999999999999999999 99999999999998 78899999999873
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.... ..
T Consensus 181 ~~~~--------------------------------------------------------------------------~~ 186 (290)
T 1t4h_A 181 LKRA--------------------------------------------------------------------------SF 186 (290)
T ss_dssp GCCT--------------------------------------------------------------------------TS
T ss_pred cccc--------------------------------------------------------------------------cc
Confidence 2110 00
Q ss_pred cCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC-CCCccchHHHHHHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF-PDSPLISFQARDLIRG 918 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~-P~~~~vs~el~dLI~k 918 (992)
.....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+...... .....++.++.+||.+
T Consensus 187 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 265 (290)
T 1t4h_A 187 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265 (290)
T ss_dssp BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHH
Confidence 123468999999998875 48999999999999999999999999876666655555443322 2233467899999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||..||.+||+ +.|+|+||||++-
T Consensus 266 ~l~~dp~~Rps----~~ell~h~~f~~~ 289 (290)
T 1t4h_A 266 CIRQNKDERYS----IKDLLNHAFFQEE 289 (290)
T ss_dssp HSCSSGGGSCC----HHHHHTSGGGC--
T ss_pred HccCChhhCCC----HHHHhhCcccccC
Confidence 99999999999 9999999999863
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=391.07 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=217.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC----
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN---- 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~---- 682 (992)
..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999999999999999998654444444567889999999999999999999987544
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..||||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 359999999999999999865 569999999999999999999999999999999999999999999999999974432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... .......
T Consensus 168 ~~~~---------------------------------------------------------------------~~~~~~~ 178 (311)
T 3ork_A 168 DSGN---------------------------------------------------------------------SVTQTAA 178 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc---------------------------------------------------------------------ccccccc
Confidence 1000 0001123
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLL 920 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL 920 (992)
..||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+....++......+. ...++.++.+||.+||
T Consensus 179 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 258 (311)
T 3ork_A 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKAL 258 (311)
T ss_dssp ---CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHT
T ss_pred cCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHH
Confidence 56999999999999999999999999999999999999999988777776666655433321 2347889999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
..||++||+ +.+++.|+|++.
T Consensus 259 ~~dP~~R~~----~~~~l~~~l~~~ 279 (311)
T 3ork_A 259 AKNPENRYQ----TAAEMRADLVRV 279 (311)
T ss_dssp CSSGGGSCS----SHHHHHHHHHHH
T ss_pred hcCHhhChh----hHHHHHHHHHHH
Confidence 999999999 888888887754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=388.46 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=216.0
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC-----Ce
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-----NL 683 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-----~~ 683 (992)
.+|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+++|+.++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 68999999999999999999999999999999997432 223346678999999999999999999998654 47
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
.|+||||+. ++|..++.. ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 105 ~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 899999995 689888875 4699999999999999999999999999999999999999999999999999754321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ........
T Consensus 181 ~~~---------------------------------------------------------------------~~~~~~~~ 191 (364)
T 3qyz_A 181 DHD---------------------------------------------------------------------HTGFLTEY 191 (364)
T ss_dssp GGC---------------------------------------------------------------------BCCTTCCC
T ss_pred CCC---------------------------------------------------------------------cccccccc
Confidence 000 00112335
Q ss_pred ccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-------------------
Q 001952 844 VGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP------------------- 903 (992)
Q Consensus 844 vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P------------------- 903 (992)
+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..++......+
T Consensus 192 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (364)
T 3qyz_A 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271 (364)
T ss_dssp CSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred ccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhc
Confidence 799999999987654 589999999999999999999999999888887777653211111
Q ss_pred -C---------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 904 -D---------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 904 -~---------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
. ...++.++.+||.+||..||.+||+ +.|+|+||||+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 272 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 320 (364)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred CCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhc
Confidence 0 1236788999999999999999999 9999999999986
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=391.84 Aligned_cols=254 Identities=28% Similarity=0.497 Sum_probs=196.5
Q ss_pred cCceEE---EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeE
Q 001952 609 RHFNLL---QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 609 ~~Yeil---r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~l 684 (992)
++|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+|+.+. ||||+++++++.+.+..
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 345554 6799999999999999999999999999753 2345678999999997 99999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEEEEeccccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLTDFDLSLRC 761 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VKLsDFGLA~~l 761 (992)
||||||+++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999998874 6799999999999999999999999999999999999998766 8999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... .....
T Consensus 160 ~~~------------------------------------------------------------------------~~~~~ 167 (325)
T 3kn6_A 160 PPD------------------------------------------------------------------------NQPLK 167 (325)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCC------------------------------------------------------------------------CCccc
Confidence 100 00112
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc-------hHHHHHHHhhccCCCCC--ccchHHH
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-------EETLANVVMQSLKFPDS--PLISFQA 912 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-------~e~L~~Iv~~~lk~P~~--~~vs~el 912 (992)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .+.+..+......++.. ..++.++
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 247 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA 247 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHH
Confidence 34689999999999999999999999999999999999999986433 34455555444444332 2478999
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
++||.+||..||.+||+ +.|+++||||+..
T Consensus 248 ~~li~~~L~~dP~~Rpt----~~ell~h~w~~~~ 277 (325)
T 3kn6_A 248 KDLIQGLLTVDPNKRLK----MSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHCCCTTTCCC----TTTSTTCGGGCTT
T ss_pred HHHHHHHCCCChhHCCC----HHHHhcChhhccC
Confidence 99999999999999999 9999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=393.05 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=217.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh-----cchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR-----KKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~-----~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.++|++++.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+|+.++||||++++++|...+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4689999999999999999999999999999999976532211 13345678999999999999999999999999
Q ss_pred eEEEEEEecCCC-ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 683 LSCLVMEYCPGG-DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 683 ~lyLVmEy~~GG-SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
.++|||||+.+| +|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 999999999776 999998764 56999999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. .....
T Consensus 181 ~~-------------------------------------------------------------------------~~~~~ 187 (335)
T 3dls_A 181 ER-------------------------------------------------------------------------GKLFY 187 (335)
T ss_dssp CT-------------------------------------------------------------------------TCCBC
T ss_pred CC-------------------------------------------------------------------------CCcee
Confidence 10 00112
Q ss_pred ccccCCCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .+..... .+..++.++.+||.+||
T Consensus 188 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~--~~~~~~~~l~~li~~~L 259 (335)
T 3dls_A 188 TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIH--PPYLVSKELMSLVSGLL 259 (335)
T ss_dssp EECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCC--CSSCCCHHHHHHHHHHT
T ss_pred ccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccC--CCcccCHHHHHHHHHHc
Confidence 3568999999999998887 8899999999999999999999976321 1222222 23358999999999999
Q ss_pred cCCcCCcCCChHhHHHHHcCCCCCC------CchhhhhcC
Q 001952 921 IKEPENRLGSQKGAAEIKQHPFFEG------LNWALIRCA 954 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkHPfF~~------lnw~~lr~~ 954 (992)
..||++||+ +.++++||||.. ++|..+...
T Consensus 260 ~~dP~~Rps----~~ell~hp~~~~~~~~~~~~~~~~~~~ 295 (335)
T 3dls_A 260 QPVPERRTT----LEKLVTDPWVTQPVNLADYTWEEVFRV 295 (335)
T ss_dssp CSSGGGSCC----HHHHHHCTTTTCCCCGGGCCHHHHC--
T ss_pred cCChhhCcC----HHHHhcCccccCCccccccCHHHHhhh
Confidence 999999999 999999999965 567655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=390.79 Aligned_cols=265 Identities=26% Similarity=0.372 Sum_probs=219.7
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++...+.+||
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 35789999999999999999999999999999999864321 12233456789999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++++|..++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 102 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 99999999998876653 56999999999999999999999999999999999999999999999999997432110
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........||
T Consensus 178 ----------------------------------------------------------------------~~~~~~~~~t 187 (331)
T 4aaa_A 178 ----------------------------------------------------------------------GEVYDDEVAT 187 (331)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred ----------------------------------------------------------------------ccccCCCcCC
Confidence 0011234689
Q ss_pred CCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-------------------CCCC--
Q 001952 847 HEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-------------------KFPD-- 904 (992)
Q Consensus 847 ~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-------------------k~P~-- 904 (992)
+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..++.... .++.
T Consensus 188 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (331)
T 4aaa_A 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIK 267 (331)
T ss_dssp CTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCS
T ss_pred ccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccc
Confidence 999999999886 689999999999999999999999999887777766543211 1111
Q ss_pred --------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 905 --------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 905 --------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
.+.++.++.+||.+||..||++||+ +.|+|+||||+..+|..
T Consensus 268 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 317 (331)
T 4aaa_A 268 EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFAE 317 (331)
T ss_dssp SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHHH
T ss_pred ccchhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChhh
Confidence 1246889999999999999999999 99999999999887753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=377.92 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=215.2
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
|.+..++|++++.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 45557899999999999999999999999999999999864432333445678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+..
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999999999875 5799999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
. ........
T Consensus 164 ~-----------------------------------------------------------------------~~~~~~~~ 172 (294)
T 4eqm_A 164 T-----------------------------------------------------------------------SLTQTNHV 172 (294)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-----------------------------------------------------------------------cccccCcc
Confidence 0 00011234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC---CCccchHHHHHHHHHhc
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP---DSPLISFQARDLIRGLL 920 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P---~~~~vs~el~dLI~kcL 920 (992)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.....+....... ....++..+.++|.+||
T Consensus 173 ~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 252 (294)
T 4eqm_A 173 LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252 (294)
T ss_dssp --CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHS
T ss_pred ccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHh
Confidence 699999999999999999999999999999999999999998877766666554433211 22457899999999999
Q ss_pred cCCcCCcCCChHhHHHHH
Q 001952 921 IKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEIL 938 (992)
..||.+||+....+.+.|
T Consensus 253 ~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 253 EKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CSSGGGSCSSHHHHHHHH
T ss_pred cCCHhHccccHHHHHHHH
Confidence 999999997433333333
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=391.77 Aligned_cols=261 Identities=31% Similarity=0.421 Sum_probs=217.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE---
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS--- 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l--- 684 (992)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 478999999999999999999999999999999997542 1223346778999999999999999999999877654
Q ss_pred ---EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 685 ---CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 685 ---yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
||||||+. ++|..++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999995 68877653 45899999999999999999999999999999999999999999999999997321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ....
T Consensus 195 ~---------------------------------------------------------------------------~~~~ 199 (371)
T 4exu_A 195 D---------------------------------------------------------------------------AEMT 199 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c---------------------------------------------------------------------------cCcC
Confidence 1 0012
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC------------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF------------------ 902 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~------------------ 902 (992)
...||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..++......
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (371)
T 4exu_A 200 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 279 (371)
T ss_dssp CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHH
T ss_pred CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhh
Confidence 3468999999999988 678999999999999999999999999988777777665421111
Q ss_pred -----CC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhc
Q 001952 903 -----PD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 903 -----P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
+. .+.++.++.+||.+||..||++||+ +.|+|+||||+.+.+.....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~~~~ 337 (371)
T 4exu_A 280 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEEET 337 (371)
T ss_dssp HSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGGCC
T ss_pred ccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCccccc
Confidence 00 1236789999999999999999999 99999999999887665543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=378.31 Aligned_cols=263 Identities=27% Similarity=0.379 Sum_probs=219.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEc-CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc---CCCCccceeeeec----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELI-GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPTLYSQFT---- 679 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~-~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L---~HPNIVkL~g~f~---- 679 (992)
.++|++++.||+|+||.||+|.+. .+++.||||++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 478999999999999999999995 67899999999754221 22234566788877766 8999999999987
Q ss_pred -cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 680 -SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 680 -~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
....++|||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678899999996 69999988765566999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
...... .
T Consensus 168 ~~~~~~-------------------------------------------------------------------------~ 174 (326)
T 1blx_A 168 RIYSFQ-------------------------------------------------------------------------M 174 (326)
T ss_dssp CCCCGG-------------------------------------------------------------------------G
T ss_pred ccccCC-------------------------------------------------------------------------C
Confidence 332100 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-----CC----------
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-----FP---------- 903 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-----~P---------- 903 (992)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..++..... ++
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 254 (326)
T 1blx_A 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 254 (326)
T ss_dssp GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhh
Confidence 112346899999999999999999999999999999999999999998888777776642110 00
Q ss_pred ----------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 904 ----------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 904 ----------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
....++..+.+||.+||..||++||+ +.|+|+||||+.++|.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 255 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERC 306 (326)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCC
T ss_pred cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchh
Confidence 11347889999999999999999999 9999999999998864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=376.47 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=218.6
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+|+.++||||+++++++...+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 3467899999999999999999999999999999999753 34567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
|||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 101 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp EEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred EEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 999999999999998743 467999999999999999999999999999999999999999999999999997432100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........|
T Consensus 179 -----------------------------------------------------------------------~~~~~~~~~ 187 (314)
T 3com_A 179 -----------------------------------------------------------------------MAKRNTVIG 187 (314)
T ss_dssp -----------------------------------------------------------------------BSCBCCCCS
T ss_pred -----------------------------------------------------------------------ccccCccCC
Confidence 001123468
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DP 924 (992)
|+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+..... .+.....++.++.+||.+||..||
T Consensus 188 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 267 (314)
T 3com_A 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSP 267 (314)
T ss_dssp CGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCT
T ss_pred CCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999999999999988776655544433322 233344578999999999999999
Q ss_pred CCcCCChHhHHHHHcCCCCCCCchh
Q 001952 925 ENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 925 ekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
.+||+ +.++|+||||....+.
T Consensus 268 ~~Rpt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 268 EQRAT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp TTSCC----HHHHTTSHHHHTCCCG
T ss_pred hhCcC----HHHHHhCHHHhcCCcc
Confidence 99999 9999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=378.35 Aligned_cols=264 Identities=27% Similarity=0.385 Sum_probs=211.6
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec-------
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT------- 679 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~------- 679 (992)
..++|++++.||+|+||.||+|.+..+++.||||++... .......+.+|+.+|+.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 357899999999999999999999999999999998643 2334567789999999999999999999873
Q ss_pred -------cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-cCCcEE
Q 001952 680 -------SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIM 751 (992)
Q Consensus 680 -------~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-~dg~VK 751 (992)
..+.+||||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+|
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 4578899999996 699988864 5689999999999999999999999999999999999997 567999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++.......
T Consensus 162 l~Dfg~~~~~~~~~------------------------------------------------------------------ 175 (320)
T 2i6l_A 162 IGDFGLARIMDPHY------------------------------------------------------------------ 175 (320)
T ss_dssp ECCCTTCBCC----------------------------------------------------------------------
T ss_pred EccCccccccCCCc------------------------------------------------------------------
Confidence 99999974321000
Q ss_pred ccCCCCCCcCccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC--------
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF-------- 902 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~-------- 902 (992)
..........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..++......
T Consensus 176 ---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (320)
T 2i6l_A 176 ---SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQEL 252 (320)
T ss_dssp -------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHH
T ss_pred ---ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhh
Confidence 00011123467899999999876 678999999999999999999999999988777776665432110
Q ss_pred --------------CC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 903 --------------PD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 903 --------------P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
+. ...++.++.+||.+||..||.+||+ +.|+|+||||+..+|+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 253 LSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC--
T ss_pred hhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCcc
Confidence 10 1247889999999999999999999 99999999999988765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=389.93 Aligned_cols=259 Identities=20% Similarity=0.324 Sum_probs=216.1
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYS 676 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g 676 (992)
.+..++|++.+.||+|+||.||+|.+.+ ++..||||+++... .......+.+|+++|+.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4557899999999999999999998753 45689999997542 223456788999999999 8999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
+|...+.+||||||+++|+|.+++.... ...+++..++.++.||+.||+|||++|||||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998653 13578999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
||+.++.+||+|||++..+.....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~-------------------------------------------------------- 258 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDY-------------------------------------------------------- 258 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCT--------------------------------------------------------
T ss_pred EECCCCCEEEccccCCcccCcccc--------------------------------------------------------
Confidence 999999999999999754321000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ....
T Consensus 259 --------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~ 323 (370)
T 2psq_A 259 --------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHR 323 (370)
T ss_dssp --------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCC
T ss_pred --------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCC
Confidence 001122357889999999999999999999999999999999 999999887766665543 4444
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+.+..++.++.+||.+||..||++||+ +.|++++
T Consensus 324 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~ 358 (370)
T 2psq_A 324 MDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 358 (370)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 4455568999999999999999999999 7777653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=387.88 Aligned_cols=261 Identities=26% Similarity=0.422 Sum_probs=213.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC--CCccceeeeeccCCe
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH--PFLPTLYSQFTSDNL 683 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H--PNIVkL~g~f~~~~~ 683 (992)
+..++|++++.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+|+.+.| +||+++++++..++.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 4567899999999999999999988 4688999999975421 22334678899999999976 999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||||+ .+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+..
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9999995 588999998874 6799999999999999999999999999999999999997 67899999999743311
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.. ........
T Consensus 160 ~~----------------------------------------------------------------------~~~~~~~~ 169 (343)
T 3dbq_A 160 DT----------------------------------------------------------------------TSVVKDSQ 169 (343)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc----------------------------------------------------------------------ccccCCCC
Confidence 00 00011234
Q ss_pred ccCCCccChhhhcC-----------CCCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccCCCCCccchHH
Q 001952 844 VGTHEYLAPEIIKG-----------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLKFPDSPLISFQ 911 (992)
Q Consensus 844 vGT~~Y~APEvL~g-----------~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk~P~~~~vs~e 911 (992)
+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.... ..+..++........+...+.+
T Consensus 170 ~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T 3dbq_A 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKD 249 (343)
T ss_dssp CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHH
T ss_pred cCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHH
Confidence 69999999999975 66889999999999999999999999875443 4455555555555555567889
Q ss_pred HHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+.+||.+||..||.+||+ +.|+|+||||+..
T Consensus 250 l~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 250 LQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 280 (343)
T ss_dssp HHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSC
T ss_pred HHHHHHHHcCCChhHCCC----HHHHHhCcccccc
Confidence 999999999999999999 9999999999753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=402.83 Aligned_cols=263 Identities=30% Similarity=0.482 Sum_probs=209.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH-----hhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA-----RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~-----~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+|+.++||||+++++++.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 57899999999999999999999999999999999764321 12223457899999999999999999999854 5
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEEEEeccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIMLTDFDLSL 759 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VKLsDFGLA~ 759 (992)
.+||||||+++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 589999999999998877653 6799999999999999999999999999999999999997544 59999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+.. ...
T Consensus 291 ~~~~-------------------------------------------------------------------------~~~ 297 (419)
T 3i6u_A 291 ILGE-------------------------------------------------------------------------TSL 297 (419)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred ecCC-------------------------------------------------------------------------Ccc
Confidence 3210 001
Q ss_pred cCccccCCCccChhhhcC---CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh-hccCCCC--CccchHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM-QSLKFPD--SPLISFQAR 913 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g---~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~-~~lk~P~--~~~vs~el~ 913 (992)
....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+......+...+. ....+.. ...++.++.
T Consensus 298 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 377 (419)
T 3i6u_A 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 377 (419)
T ss_dssp -------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHH
T ss_pred ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHH
Confidence 123569999999999864 5678899999999999999999999987655444433333 3322221 134788999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhh
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWAL 950 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~ 950 (992)
+||.+||..||.+||+ ++|+|+||||+..+|..
T Consensus 378 ~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~~ 410 (419)
T 3i6u_A 378 DLVKKLLVVDPKARFT----TEEALRHPWLQDEDMKR 410 (419)
T ss_dssp HHHHHHSCSSTTTSCC----HHHHHHSGGGCCHHHHH
T ss_pred HHHHHHccCChhHCcC----HHHHhCCcccCChhHHH
Confidence 9999999999999999 99999999999988754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=394.79 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=204.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD------ 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~------ 681 (992)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 478999999999999999999999999999999996532 1223345678999999999999999999998653
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..+||||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 6689999999 8899888775 46999999999999999999999999999999999999999999999999997321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ....
T Consensus 183 ~---------------------------------------------------------------------------~~~~ 187 (367)
T 2fst_X 183 A---------------------------------------------------------------------------DEMT 187 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c---------------------------------------------------------------------------ccCC
Confidence 1 0012
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-------------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK------------------- 901 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk------------------- 901 (992)
..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.....
T Consensus 188 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 267 (367)
T 2fst_X 188 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 267 (367)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHH
T ss_pred CcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHh
Confidence 3578999999999987 67899999999999999999999999998887777766542111
Q ss_pred ----CCC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 902 ----FPD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 902 ----~P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
.+. ...++.++.+||.+||..||.+||+ ++|+|+||||+.+.+..-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~~~~ 323 (367)
T 2fst_X 268 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHDPDD 323 (367)
T ss_dssp TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCGGG
T ss_pred ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccCCCC
Confidence 010 0235678999999999999999999 999999999998766543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=382.59 Aligned_cols=262 Identities=31% Similarity=0.500 Sum_probs=212.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH-----hhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA-----RRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~-----~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+++|+.++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46899999999999999999999999999999999754321 1223345789999999999999999999987665
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc---EEEEeccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDLSL 759 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~---VKLsDFGLA~ 759 (992)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 89999999999999988754 57999999999999999999999999999999999999987664 9999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
..... ..
T Consensus 166 ~~~~~-------------------------------------------------------------------------~~ 172 (322)
T 2ycf_A 166 ILGET-------------------------------------------------------------------------SL 172 (322)
T ss_dssp ECCCC-------------------------------------------------------------------------HH
T ss_pred ecccc-------------------------------------------------------------------------cc
Confidence 32100 00
Q ss_pred cCccccCCCccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHH-hhccCCCC--CccchHHHH
Q 001952 840 SNSFVGTHEYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV-MQSLKFPD--SPLISFQAR 913 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv-~~~lk~P~--~~~vs~el~ 913 (992)
.....||+.|+|||++. +..++.++|||||||++|||++|..||.+......+...+ .....+.. ...++.++.
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (322)
T 2ycf_A 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL 252 (322)
T ss_dssp HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHH
Confidence 12346899999999985 4568899999999999999999999998765543333333 33222211 134788999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
+||.+||..||++||+ +.++|+||||+..+|.
T Consensus 253 ~li~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 253 DLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHHHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred HHHHHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 9999999999999999 9999999999998874
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=384.82 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=218.3
Q ss_pred cccccCceEEEEEccCCceEEEEEEE-----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAEL-----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~-----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
++..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+++|..+ +||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 45678999999999999999999984 4566899999997542 223345688999999999 799999999998
Q ss_pred ccCC-eEEEEEEecCCCChHHHHHhhcC----------------------------------------------------
Q 001952 679 TSDN-LSCLVMEYCPGGDLHVLRQKQLG---------------------------------------------------- 705 (992)
Q Consensus 679 ~~~~-~lyLVmEy~~GGSL~~lLkk~~~---------------------------------------------------- 705 (992)
...+ .+|+||||+++|+|.+++.....
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8754 58999999999999999886432
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCCC
Q 001952 706 ------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSN 773 (992)
Q Consensus 706 ------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~ 773 (992)
..+++..++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++..+....
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~-------- 247 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-------- 247 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT--------
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccc--------
Confidence 128899999999999999999999999999999999999999999999999974321100
Q ss_pred CCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChh
Q 001952 774 MDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPE 853 (992)
Q Consensus 774 ~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APE 853 (992)
.........||+.|+|||
T Consensus 248 --------------------------------------------------------------~~~~~~~~~~t~~y~aPE 265 (359)
T 3vhe_A 248 --------------------------------------------------------------DYVRKGDARLPLKWMAPE 265 (359)
T ss_dssp --------------------------------------------------------------TCEEC--CEECGGGCCHH
T ss_pred --------------------------------------------------------------cchhccccCCCceeEChh
Confidence 000112346889999999
Q ss_pred hhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChH
Q 001952 854 IIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK 932 (992)
Q Consensus 854 vL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~ 932 (992)
++.+..++.++|||||||++|||++ |..||.+....+.+...+......+.+..++.++.+||.+||..||.+||+
T Consensus 266 ~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps--- 342 (359)
T 3vhe_A 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT--- 342 (359)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC---
T ss_pred hhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---
Confidence 9999999999999999999999998 999999888777777777776666666779999999999999999999999
Q ss_pred hHHHHHcC
Q 001952 933 GAAEIKQH 940 (992)
Q Consensus 933 ~aeEILkH 940 (992)
+.|+++|
T Consensus 343 -~~ell~~ 349 (359)
T 3vhe_A 343 -FSELVEH 349 (359)
T ss_dssp -HHHHHHH
T ss_pred -HHHHHHH
Confidence 8888776
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=390.39 Aligned_cols=266 Identities=26% Similarity=0.362 Sum_probs=217.9
Q ss_pred eeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CC-----Ccc
Q 001952 599 VRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HP-----FLP 672 (992)
Q Consensus 599 ~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HP-----NIV 672 (992)
+.+..+....++|++.+.||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.+. |+ +|+
T Consensus 44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv 119 (382)
T 2vx3_A 44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIV 119 (382)
T ss_dssp BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBC
T ss_pred EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEE
Confidence 344556666889999999999999999999999999999999997532 23455677888888875 54 499
Q ss_pred ceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCeeeeecCCceEEEc--cCC
Q 001952 673 TLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH--MLGVIYRDLKPENILVR--EDG 748 (992)
Q Consensus 673 kL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH--s~GIIHRDIKPeNILLd--~dg 748 (992)
++++++...+.+||||||+. ++|.+++.......+++..++.++.||+.||.||| +.|||||||||+||||+ .++
T Consensus 120 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~ 198 (382)
T 2vx3_A 120 HLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS 198 (382)
T ss_dssp CEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred EeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence 99999999999999999995 69999988765567999999999999999999999 57999999999999995 477
Q ss_pred cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccC
Q 001952 749 HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828 (992)
Q Consensus 749 ~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~ 828 (992)
.+||+|||++.....
T Consensus 199 ~~kL~DFG~a~~~~~----------------------------------------------------------------- 213 (382)
T 2vx3_A 199 AIKIVDFGSSCQLGQ----------------------------------------------------------------- 213 (382)
T ss_dssp CEEECCCTTCEETTC-----------------------------------------------------------------
T ss_pred cEEEEeccCceeccc-----------------------------------------------------------------
Confidence 899999999743210
Q ss_pred CccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-----
Q 001952 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP----- 903 (992)
Q Consensus 829 ~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P----- 903 (992)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++......+
T Consensus 214 ----------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 214 ----------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp ----------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ----------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 01234689999999999999999999999999999999999999999888887777664321111
Q ss_pred -------------C-------------------Cc-------------------------cchHHHHHHHHHhccCCcCC
Q 001952 904 -------------D-------------------SP-------------------------LISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 904 -------------~-------------------~~-------------------------~vs~el~dLI~kcL~~DPek 926 (992)
. .. ....++.+||.+||..||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 0 00 01147899999999999999
Q ss_pred cCCChHhHHHHHcCCCCCCCch
Q 001952 927 RLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~lnw 948 (992)
||| ++|+|+||||++..|
T Consensus 364 Rpt----a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 364 RIQ----PYYALQHSFFKKTAD 381 (382)
T ss_dssp SCC----HHHHTTSGGGCC---
T ss_pred CCC----HHHHhcCcccccCCC
Confidence 999 999999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=377.69 Aligned_cols=257 Identities=24% Similarity=0.369 Sum_probs=211.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC--e
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN--L 683 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~--~ 683 (992)
...++|++.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+++|+.++||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 34578999999999999999999999999999999997643 2234566789999999999999999999987654 7
Q ss_pred EEEEEEecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE----ccCCcEEEEecccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV----REDGHIMLTDFDLS 758 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL----d~dg~VKLsDFGLA 758 (992)
+||||||+++++|.+++..... ..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999886532 348999999999999999999999999999999999999 77788999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+... .
T Consensus 164 ~~~~~~-------------------------------------------------------------------------~ 170 (319)
T 4euu_A 164 RELEDD-------------------------------------------------------------------------E 170 (319)
T ss_dssp EECCTT-------------------------------------------------------------------------C
T ss_pred eecCCC-------------------------------------------------------------------------C
Confidence 443110 0
Q ss_pred CcCccccCCCccChhhhc--------CCCCCccceeeehhhhhhhhccCCCCCCCCCc----hHHHHHHHhhcc------
Q 001952 839 RSNSFVGTHEYLAPEIIK--------GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN----EETLANVVMQSL------ 900 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~--------g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~----~e~L~~Iv~~~l------ 900 (992)
......||+.|+|||++. +..++.++|||||||+||||++|+.||..... .+.+..++....
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~ 250 (319)
T 4euu_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250 (319)
T ss_dssp CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEE
T ss_pred ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchh
Confidence 112346899999999997 56789999999999999999999999975433 344555544332
Q ss_pred -------------CCCC----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCC
Q 001952 901 -------------KFPD----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941 (992)
Q Consensus 901 -------------k~P~----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHP 941 (992)
.++. ...++..+.+||.+||..||++||+ ++|+|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred hhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 1111 1235678899999999999999999 99999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=377.51 Aligned_cols=279 Identities=20% Similarity=0.282 Sum_probs=206.6
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCe---EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNC---LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~---~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
...+..++|++.+.||+|+||.||+|.+..++. .||||+++..... ......+.+|+++|+.++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 345567899999999999999999999877665 7999999764322 234567889999999999999999999998
Q ss_pred cCCeE------EEEEEecCCCChHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc
Q 001952 680 SDNLS------CLVMEYCPGGDLHVLRQKQLG----KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH 749 (992)
Q Consensus 680 ~~~~l------yLVmEy~~GGSL~~lLkk~~~----~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~ 749 (992)
..+.. |+||||+.+++|.+++..... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 76655 999999999999998875432 25899999999999999999999999999999999999999999
Q ss_pred EEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCC
Q 001952 750 IMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLP 829 (992)
Q Consensus 750 VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~ 829 (992)
+||+|||++..+.....
T Consensus 176 ~kl~Dfg~a~~~~~~~~--------------------------------------------------------------- 192 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDY--------------------------------------------------------------- 192 (323)
T ss_dssp EEECCCCC------------------------------------------------------------------------
T ss_pred EEEeecccccccccccc---------------------------------------------------------------
Confidence 99999999744311000
Q ss_pred ccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccc
Q 001952 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLI 908 (992)
Q Consensus 830 ~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~v 908 (992)
........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+.... ..+....+
T Consensus 193 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 264 (323)
T 3qup_A 193 -------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQPPEC 264 (323)
T ss_dssp ---------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTC
T ss_pred -------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCCCcc
Confidence 001122346888999999999999999999999999999999 999999988877777665443 34445568
Q ss_pred hHHHHHHHHHhccCCcCCcCCChH---hHHHHHcCCCCCCCchhhhhc
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQK---GAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~---~aeEILkHPfF~~lnw~~lr~ 953 (992)
+.++.+||.+||..||++||++.. .+++++.|+|+....+.-+..
T Consensus 265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~ 312 (323)
T 3qup_A 265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYI 312 (323)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------------
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCC
Confidence 999999999999999999999654 478889999999887765543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=373.68 Aligned_cols=261 Identities=31% Similarity=0.477 Sum_probs=223.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+++|+.++||||+++++++...+.+|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4689999999999999999999999999999999975432 223456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC---CcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED---GHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d---g~VKLsDFGLA~~l~~~ 764 (992)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 100 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 100 GELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 9999999999888765 568999999999999999999999999999999999999754 46999999987432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 178 -------------------------------------------------------------------------~~~~~~~ 184 (287)
T 2wei_A 178 -------------------------------------------------------------------------TKMKDRI 184 (287)
T ss_dssp -------------------------------------------------------------------------SSCSCHH
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0012345
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~ 922 (992)
||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++. ...++.++.+||.+||..
T Consensus 185 ~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 263 (287)
T 2wei_A 185 GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263 (287)
T ss_dssp HHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCS
T ss_pred CcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHccc
Confidence 88999999999765 899999999999999999999999998877777777666554432 245789999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
||++||+ +.|+|+||||++.+|.
T Consensus 264 dp~~Rps----~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 264 HPSLRIT----ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp SGGGSCC----HHHHHHSHHHHHHCCC
T ss_pred ChhhCcC----HHHHhcCHHHhccccC
Confidence 9999999 9999999999887664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=400.28 Aligned_cols=263 Identities=19% Similarity=0.218 Sum_probs=199.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc--CCCCccceee-------ee
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML--DHPFLPTLYS-------QF 678 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L--~HPNIVkL~g-------~f 678 (992)
..+|.+.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.+ +||||++++. ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 45699999999999999999999999999999999875433344456677886555544 6999887553 33
Q ss_pred ccC-----------------CeEEEEEEecCCCChHHHHHhhcCCCCCHHHH------HHHHHHHHHHHHHHhhcCeeee
Q 001952 679 TSD-----------------NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAA------RFYVAEVLLALEYLHMLGVIYR 735 (992)
Q Consensus 679 ~~~-----------------~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i------~~Ia~QIL~GL~YLHs~GIIHR 735 (992)
... ..+||||||++ ++|.+++.... ..+.+..+ +.++.||+.||+|||++|||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 222 34899999997 89999988652 33455555 6777999999999999999999
Q ss_pred ecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccC
Q 001952 736 DLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTR 815 (992)
Q Consensus 736 DIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~ 815 (992)
||||+||||+.+|.+||+|||++.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~---------------------------------------------------- 246 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGT---------------------------------------------------- 246 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTC----------------------------------------------------
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCC----------------------------------------------------
Confidence 9999999999999999999999743210
Q ss_pred CCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcC--CCCCccceeeehhhhhhhhccCCCCCCCCCchHH--
Q 001952 816 KPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET-- 891 (992)
Q Consensus 816 ~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~-- 891 (992)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+......
T Consensus 247 -----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 303 (371)
T 3q60_A 247 -----------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303 (371)
T ss_dssp -----------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC
T ss_pred -----------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc
Confidence 0112356799999999988 6789999999999999999999999987633211
Q ss_pred HH-----HHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 892 LA-----NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 892 L~-----~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
+. ......+.++....++.++.+||.+||..||++||+ +.++|+||||++++|...
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHHH
T ss_pred hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHHh
Confidence 10 011123344444578999999999999999999999 999999999999988643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=371.81 Aligned_cols=256 Identities=29% Similarity=0.410 Sum_probs=220.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+.|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++...+.+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 467999999999999999999999999999999997542 233457789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 99 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--- 172 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--- 172 (303)
T ss_dssp EECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT---
T ss_pred EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc---
Confidence 999999999999865 56899999999999999999999999999999999999999999999999997443110
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 173 ---------------------------------------------------------------------~~~~~~~~~~~ 183 (303)
T 3a7i_A 173 ---------------------------------------------------------------------QIKRNTFVGTP 183 (303)
T ss_dssp ---------------------------------------------------------------------BCCBCCCCSCG
T ss_pred ---------------------------------------------------------------------ccccCccCCCc
Confidence 00112346899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||++.+..++.++|||||||++|||++|+.||......+.+..+... ........++..+.+||.+||..||.+|
T Consensus 184 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~R 262 (303)
T 3a7i_A 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEGNYSKPLKEFVEACLNKEPSFR 262 (303)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-CCCCCCSSCCHHHHHHHHHHCCSSGGGS
T ss_pred CccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-CCCCCccccCHHHHHHHHHHcCCChhhC
Confidence 999999999999999999999999999999999999887766655554433 2223334688999999999999999999
Q ss_pred CCChHhHHHHHcCCCCCC
Q 001952 928 LGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 928 PT~~~~aeEILkHPfF~~ 945 (992)
|+ +.++++||||..
T Consensus 263 ps----~~~ll~~~~~~~ 276 (303)
T 3a7i_A 263 PT----AKELLKHKFILR 276 (303)
T ss_dssp CC----HHHHTTCHHHHH
T ss_pred cC----HHHHhhChhhhc
Confidence 99 999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=393.46 Aligned_cols=262 Identities=26% Similarity=0.417 Sum_probs=215.0
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC--CCCccceeeeeccCCeE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD--HPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~--HPNIVkL~g~f~~~~~l 684 (992)
...+|++++.||+|+||.||+|.+.. ++.||||++..... .......+.+|+.+|+.+. |+||+++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34579999999999999999998865 88999999975422 2234567889999999996 59999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||| +.+++|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+ ++.+||+|||++..+...
T Consensus 132 ~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 99999 5589999998874 5789999999999999999999999999999999999995 689999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ........+
T Consensus 208 ~----------------------------------------------------------------------~~~~~~~~~ 217 (390)
T 2zmd_A 208 T----------------------------------------------------------------------TSVVKDSQV 217 (390)
T ss_dssp ----------------------------------------------------------------------------CCSC
T ss_pred C----------------------------------------------------------------------ccccCCCCC
Confidence 0 000112346
Q ss_pred cCCCccChhhhcC-----------CCCCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhccCCCCCccchHHH
Q 001952 845 GTHEYLAPEIIKG-----------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQSLKFPDSPLISFQA 912 (992)
Q Consensus 845 GT~~Y~APEvL~g-----------~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~lk~P~~~~vs~el 912 (992)
||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+... ...+..++.....++.+...+.++
T Consensus 218 gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (390)
T 2zmd_A 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297 (390)
T ss_dssp CCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHH
T ss_pred cCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHH
Confidence 9999999999976 3688999999999999999999999987644 355666665555555555678899
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
.+||.+||..||.+||+ +.|+|+||||+....
T Consensus 298 ~~li~~~L~~dP~~Rps----~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 298 QDVLKCCLKRDPKQRIS----IPELLAHPYVQIQTH 329 (390)
T ss_dssp HHHHHHHTCSSTTTSCC----HHHHHTSHHHHSCC-
T ss_pred HHHHHHHcccChhhCCC----HHHHhhCcCccccCc
Confidence 99999999999999999 999999999986543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=382.27 Aligned_cols=260 Identities=31% Similarity=0.421 Sum_probs=215.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL---- 683 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~---- 683 (992)
.++|.+.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999997532 122334567899999999999999999999987654
Q ss_pred --EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 684 --SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 684 --lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+|+||||+. ++|..++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999995 68876653 35899999999999999999999999999999999999999999999999986321
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ....
T Consensus 177 ~---------------------------------------------------------------------------~~~~ 181 (353)
T 3coi_A 177 D---------------------------------------------------------------------------AEMT 181 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C---------------------------------------------------------------------------CCcc
Confidence 1 0012
Q ss_pred ccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC-------------------
Q 001952 842 SFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK------------------- 901 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk------------------- 901 (992)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..++.....
T Consensus 182 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (353)
T 3coi_A 182 GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQ 261 (353)
T ss_dssp --CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHH
T ss_pred ccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHH
Confidence 3468999999999987 67899999999999999999999999988877766665432110
Q ss_pred ---------C-CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhh
Q 001952 902 ---------F-PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIR 952 (992)
Q Consensus 902 ---------~-P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr 952 (992)
+ .....++.++.+||.+||..||++||+ ++++|+||||+.+.+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~~~~ 318 (353)
T 3coi_A 262 SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPEEE 318 (353)
T ss_dssp TSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGGGC
T ss_pred hCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccCcccc
Confidence 0 111346889999999999999999999 9999999999988766543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=378.02 Aligned_cols=260 Identities=18% Similarity=0.289 Sum_probs=219.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
++..++|++.+.||+|+||.||+|.+. +++..||||++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 456789999999999999999999973 467789999997542 234456789999999999 899999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeec
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLG---------------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~---------------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDI 737 (992)
...+.+||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999886432 23789999999999999999999999999999
Q ss_pred CCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCC
Q 001952 738 KPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKP 817 (992)
Q Consensus 738 KPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~ 817 (992)
||+|||++.++.++|+|||++..+....
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~---------------------------------------------------- 226 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDS---------------------------------------------------- 226 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCT----------------------------------------------------
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCc----------------------------------------------------
Confidence 9999999999999999999974331100
Q ss_pred CCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHH
Q 001952 818 KADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVV 896 (992)
Q Consensus 818 ~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv 896 (992)
.........||+.|+|||++.+..++.++|||||||+||||+| |..||.+......+..++
T Consensus 227 ------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 288 (344)
T 1rjb_A 227 ------------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288 (344)
T ss_dssp ------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred ------------------cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHH
Confidence 0001123457889999999999999999999999999999998 999999988777777777
Q ss_pred hhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 897 ~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
......+.+..++.++.+||.+||..||.+||+ +.+|++|
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 328 (344)
T 1rjb_A 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 328 (344)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 777777666778999999999999999999999 7888765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=403.41 Aligned_cols=251 Identities=20% Similarity=0.219 Sum_probs=201.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHH---HHHHcCCCCcccee-------ee
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE---ILRMLDHPFLPTLY-------SQ 677 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~Eie---ILk~L~HPNIVkL~-------g~ 677 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+. +|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998899999999997543333445567889995 45555899999999 55
Q ss_pred eccCC-----------------eEEEEEEecCCCChHHHHHhhcCCCCC-------HHHHHHHHHHHHHHHHHHhhcCee
Q 001952 678 FTSDN-----------------LSCLVMEYCPGGDLHVLRQKQLGKCFS-------EPAARFYVAEVLLALEYLHMLGVI 733 (992)
Q Consensus 678 f~~~~-----------------~lyLVmEy~~GGSL~~lLkk~~~~~Ls-------e~~i~~Ia~QIL~GL~YLHs~GII 733 (992)
+...+ ..||||||+ +|+|.+++.... .++ +..++.|+.||+.||+|||++|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 228 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 228 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 55443 389999999 789999988642 233 478888999999999999999999
Q ss_pred eeecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccc
Q 001952 734 YRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAK 813 (992)
Q Consensus 734 HRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~k 813 (992)
||||||+||||+.++.+||+|||++....
T Consensus 229 HrDikp~NIll~~~~~~kL~DFG~a~~~~--------------------------------------------------- 257 (377)
T 3byv_A 229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDG--------------------------------------------------- 257 (377)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETT---------------------------------------------------
T ss_pred cCCCCHHHEEEcCCCCEEEEechhheecC---------------------------------------------------
Confidence 99999999999999999999999974311
Q ss_pred cCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCC-----------CCCccceeeehhhhhhhhccCCCC
Q 001952 814 TRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGE-----------GHGAAVDWWTFGIFLYELLYGRTP 882 (992)
Q Consensus 814 t~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~-----------~~s~kSDIWSLGVlLyELLTGr~P 882 (992)
.......| +.|+|||++.+. .++.++|||||||+||||++|+.|
T Consensus 258 ------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~P 312 (377)
T 3byv_A 258 ------------------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312 (377)
T ss_dssp ------------------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCC
T ss_pred ------------------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCC
Confidence 01123457 899999999988 899999999999999999999999
Q ss_pred CCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 883 FKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 883 F~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
|.+....+.+..+. .....++.++.+||.+||..||++||+ +.|+|+||||+++.
T Consensus 313 f~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 313 ITKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLR 367 (377)
T ss_dssp C------CCSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHHH
T ss_pred Ccccccccchhhhh------hhccCCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHHH
Confidence 98765443332222 122458899999999999999999999 99999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=376.57 Aligned_cols=257 Identities=26% Similarity=0.349 Sum_probs=212.5
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..+..++|++.+.||+|+||+||+|.+ ++..||||++..... .......+.+|+++|+.++||||+++++++...+.
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 445678999999999999999999987 577899999875422 12334678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCcEEEEecccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
+||||||+++++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999876421 23899999999999999999999999 99999999999999999999999999732
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
.... ....
T Consensus 189 ~~~~------------------------------------------------------------------------~~~~ 196 (309)
T 3p86_A 189 KAST------------------------------------------------------------------------FLSS 196 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc------------------------------------------------------------------------cccc
Confidence 1100 0011
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.........+..++.++.+||.+||
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 276 (309)
T 3p86_A 197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276 (309)
T ss_dssp -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHc
Confidence 23468999999999999999999999999999999999999999888777777665555555556679999999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||.+||+ +.+|++
T Consensus 277 ~~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 277 TNEPWKRPS----FATIMD 291 (309)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 777765
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=363.86 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=209.8
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh-hcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR-RKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~-~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
++..++|++.+.||+|+||.||+|.+. +..||||++....... ......+.+|+++++.++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 355789999999999999999999984 7789999997543222 3345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeeeecCCceEEEcc--------CCcEEE
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG---VIYRDLKPENILVRE--------DGHIML 752 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G---IIHRDIKPeNILLd~--------dg~VKL 752 (992)
.|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.++|
T Consensus 81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 9999999999999998864 57999999999999999999999999 999999999999986 778999
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++.....
T Consensus 158 ~Dfg~~~~~~~--------------------------------------------------------------------- 168 (271)
T 3dtc_A 158 TDFGLAREWHR--------------------------------------------------------------------- 168 (271)
T ss_dssp CCCCC---------------------------------------------------------------------------
T ss_pred ccCCccccccc---------------------------------------------------------------------
Confidence 99999733210
Q ss_pred cCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHH
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQA 912 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el 912 (992)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.......+.+..++.++
T Consensus 169 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (271)
T 3dtc_A 169 -----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF 243 (271)
T ss_dssp ------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred -----ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHH
Confidence 001123589999999999999999999999999999999999999999888777777777777777677789999
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+||.+||..||.+||+ +.|+++|
T Consensus 244 ~~li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 244 AKLMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhcCCcccCcC----HHHHHHH
Confidence 99999999999999999 7777764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=366.87 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=218.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec--cCCeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT--SDNLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~--~~~~ly 685 (992)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+|+.++||||+++++++. ..+.+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 56899999999999999999999999999999999754321 233467889999999999999999999874 567899
Q ss_pred EEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC-----eeeeecCCceEEEccCCcEEEEecccc
Q 001952 686 LVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLG-----VIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~G-----IIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||+.| |+||||||+|||++.++.++|+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 9999999999999987642 345899999999999999999999999 999999999999999999999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
....... .
T Consensus 164 ~~~~~~~------------------------------------------------------------------------~ 171 (279)
T 2w5a_A 164 RILNHDT------------------------------------------------------------------------S 171 (279)
T ss_dssp HHC---C------------------------------------------------------------------------H
T ss_pred eeecccc------------------------------------------------------------------------c
Confidence 4321000 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+..... ...+..++.++.+||.+
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~li~~ 250 (279)
T 2w5a_A 172 FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPYRYSDELNEIITR 250 (279)
T ss_dssp HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-CCCCTTSCHHHHHHHHH
T ss_pred cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc-ccCCcccCHHHHHHHHH
Confidence 01124689999999999999999999999999999999999999998876666666554433 23334588999999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
||..||.+||+ +.||++|+||.+
T Consensus 251 ~l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 251 MLNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp HTCSSGGGSCC----HHHHHTSTTCCG
T ss_pred HcCCCcccCCC----HHHHHhChhhhh
Confidence 99999999999 999999999975
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=378.99 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=215.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCC---eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTN---CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg---~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
.++..++|++.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.+|+.++||||+++++++..
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3456789999999999999999999997554 459999997542 22334568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+.+||||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred CCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999999998754 35699999999999999999999999999999999999999999999999999854
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+..... .....
T Consensus 201 ~~~~~~---------------------------------------------------------------------~~~~~ 211 (325)
T 3kul_A 201 LEDDPD---------------------------------------------------------------------AAYTT 211 (325)
T ss_dssp CC-------------------------------------------------------------------------CCEEC
T ss_pred cccCcc---------------------------------------------------------------------ceeec
Confidence 321100 00001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
....+|+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+. .....+.+..++.++.+||.+|
T Consensus 212 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 290 (325)
T 3kul_A 212 TGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPMGCPHALHQLMLDC 290 (325)
T ss_dssp C---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCCCcCHHHHHHHHHH
Confidence 12346888999999999999999999999999999999 999999887777666654 4455566667899999999999
Q ss_pred ccCCcCCcCCChHhHHHHHc
Q 001952 920 LIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILk 939 (992)
|..||++||+ +.+|++
T Consensus 291 l~~dp~~Rps----~~eil~ 306 (325)
T 3kul_A 291 WHKDRAQRPR----FSQIVS 306 (325)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred ccCChhhCcC----HHHHHH
Confidence 9999999999 666554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=391.37 Aligned_cols=265 Identities=26% Similarity=0.326 Sum_probs=197.7
Q ss_pred cCceE-EEEEccCCceEEEEEEEc--CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee--ccCCe
Q 001952 609 RHFNL-LQKLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF--TSDNL 683 (992)
Q Consensus 609 ~~Yei-lr~LGsG~FGtVYlA~~~--~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f--~~~~~ 683 (992)
+.|++ .++||+|+||+||+|.+. .+++.||||++... .....+.+|+.+|+.++||||++++++| .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 45665 457999999999999976 46889999999743 2334678899999999999999999999 45788
Q ss_pred EEEEEEecCCCChHHHHHhhc-------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE----ccCCcEEE
Q 001952 684 SCLVMEYCPGGDLHVLRQKQL-------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV----REDGHIML 752 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~-------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL----d~dg~VKL 752 (992)
+||||||+. ++|..++.... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 57776665321 1248999999999999999999999999999999999999 67789999
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++..+.....
T Consensus 174 ~Dfg~a~~~~~~~~------------------------------------------------------------------ 187 (405)
T 3rgf_A 174 ADMGFARLFNSPLK------------------------------------------------------------------ 187 (405)
T ss_dssp CCTTCCC-------------------------------------------------------------------------
T ss_pred EECCCceecCCCCc------------------------------------------------------------------
Confidence 99999854321000
Q ss_pred cCCCCCCcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCc---------hHHHHHHHhhccCC
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGN---------EETLANVVMQSLKF 902 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---------~e~L~~Iv~~~lk~ 902 (992)
........+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+... .+.+..++......
T Consensus 188 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p 264 (405)
T 3rgf_A 188 ---PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 264 (405)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCC
T ss_pred ---ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCC
Confidence 00112345799999999999885 489999999999999999999999976543 24454443321111
Q ss_pred CCC------------------------------------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 903 PDS------------------------------------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 903 P~~------------------------------------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
+.. ...+.++.+||.+||..||.+||| ++|+|+||||.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp~f~~~ 340 (405)
T 3rgf_A 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYFLED 340 (405)
T ss_dssp CTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTSS
T ss_pred ChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhccC
Confidence 100 012567899999999999999999 9999999999988
Q ss_pred chhhhh
Q 001952 947 NWALIR 952 (992)
Q Consensus 947 nw~~lr 952 (992)
.|....
T Consensus 341 ~~~~~~ 346 (405)
T 3rgf_A 341 PLPTSD 346 (405)
T ss_dssp SCCCSS
T ss_pred CCCccc
Confidence 776443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=380.87 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=210.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH--------hhcchhHHHHHHHHHHHcCCCCccceeee
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA--------RRKKMPRAQTEREILRMLDHPFLPTLYSQ 677 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~--------~~~~~~~~~~EieILk~L~HPNIVkL~g~ 677 (992)
...++|++.+.||+|+||.||+|.+.. ++.||||++...... .......+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346899999999999999999998854 889999998643211 11223678899999999999999999999
Q ss_pred ec-----cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEE
Q 001952 678 FT-----SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIML 752 (992)
Q Consensus 678 f~-----~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKL 752 (992)
+. ....+||||||+. ++|..++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 84 3457899999996 6787777653 357999999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++.....
T Consensus 176 ~Dfg~~~~~~~--------------------------------------------------------------------- 186 (362)
T 3pg1_A 176 CDFNLAREDTA--------------------------------------------------------------------- 186 (362)
T ss_dssp CCTTC---------------------------------------------------------------------------
T ss_pred EecCccccccc---------------------------------------------------------------------
Confidence 99999732110
Q ss_pred cCCCCCCcCccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC---------
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF--------- 902 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~--------- 902 (992)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..++......
T Consensus 187 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 262 (362)
T 3pg1_A 187 ----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFS 262 (362)
T ss_dssp -------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTS
T ss_pred ----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhcc
Confidence 001123468999999999987 678999999999999999999999999988777777665421111
Q ss_pred ---------------CC------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 903 ---------------PD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 903 ---------------P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
+. .+.++..+.+||.+||..||.+||+ +.|+|+||||+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 263 SPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESLF 324 (362)
T ss_dssp CHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTTC
T ss_pred chhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhcc
Confidence 00 1235778999999999999999999 99999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.72 Aligned_cols=260 Identities=20% Similarity=0.288 Sum_probs=220.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEE-----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAEL-----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~-----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
++..++|++.+.||+|+||.||+|.+ ..+++.||||++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 45568999999999999999999986 3467899999997542 122346788999999999 999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcC----------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLG----------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~----------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
...+..||||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 999999999999999999999886532 2489999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|++.++.++|+|||++........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------------- 200 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSN-------------------------------------------------------- 200 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTT--------------------------------------------------------
T ss_pred EEcCCCCEEEcccccccccccccc--------------------------------------------------------
Confidence 999999999999999743211000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+......+..++.....
T Consensus 201 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~ 266 (313)
T 1t46_A 201 --------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR 266 (313)
T ss_dssp --------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC
T ss_pred --------------ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCC
Confidence 000122457889999999999999999999999999999999 99999988877777777777766
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
......++.++.+||.+||..||.+||+ +.|++++
T Consensus 267 ~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 267 MLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 6666678999999999999999999999 7777754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=362.01 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=215.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++++.||+|+||.||+|.+. ++..||+|++.... .....+.+|+++|+.++||||+++++++.+.+..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 80 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc----cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence 345689999999999999999999986 46779999997542 2335688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999998764 356899999999999999999999999999999999999999999999999997432110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ........
T Consensus 160 ~-----------------------------------------------------------------------~~~~~~~~ 168 (269)
T 4hcu_A 160 Q-----------------------------------------------------------------------YTSSTGTK 168 (269)
T ss_dssp H-----------------------------------------------------------------------HHSTTSTT
T ss_pred c-----------------------------------------------------------------------cccccCcc
Confidence 0 00011234
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... .....+..++.++.+||.+||..|
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~ 247 (269)
T 4hcu_A 169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWRER 247 (269)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHHHHccCC
Confidence 6788999999999999999999999999999999 99999988777766665543 444445568999999999999999
Q ss_pred cCCcCCChHhHHHHHcC
Q 001952 924 PENRLGSQKGAAEIKQH 940 (992)
Q Consensus 924 PekRPT~~~~aeEILkH 940 (992)
|++||+ +.++++|
T Consensus 248 p~~Rps----~~~ll~~ 260 (269)
T 4hcu_A 248 PEDRPA----FSRLLRQ 260 (269)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred cccCcC----HHHHHHH
Confidence 999999 7777765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=360.99 Aligned_cols=252 Identities=20% Similarity=0.315 Sum_probs=216.5
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC--
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD-- 681 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~-- 681 (992)
..+..++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+|+.++||||+++++++...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3456789999999999999999999984 778999999754211 23345688999999999999999999999876
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCcEEEEeccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
+..++||||+++++|.+++.......+++..++.|+.||+.||.|||++| |+||||||+|||++.++.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78899999999999999998765456999999999999999999999999 9999999999999999999999999852
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.. .
T Consensus 162 ~~-----------------------------------------------------------------------------~ 164 (271)
T 3kmu_A 162 SF-----------------------------------------------------------------------------Q 164 (271)
T ss_dssp TT-----------------------------------------------------------------------------S
T ss_pred ee-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cCccccCCCccChhhhcCCCCCc---cceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGA---AVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~---kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
.....||+.|+|||++.+..++. ++|||||||++|||++|+.||.+....+....+.........+..++.++.+||
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 244 (271)
T 3kmu_A 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLM 244 (271)
T ss_dssp CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHH
T ss_pred ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 11235789999999999876544 799999999999999999999998888887777777766666667999999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHc
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILk 939 (992)
.+||..||++||+ +.++++
T Consensus 245 ~~~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 245 KICMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHcCCChhhCcC----HHHHHH
Confidence 9999999999999 777664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.58 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=212.4
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|.....||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++...+..++
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 345566667899999999999999999999999998753 23345678899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-CCcEEEEeccccccccCC
Q 001952 687 VMEYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-DGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-dg~VKLsDFGLA~~l~~~ 764 (992)
||||+++++|.+++....+ ..+++..++.++.||+.||.|||++||+|+||||+|||++. ++.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 9999999999999886532 35678899999999999999999999999999999999987 899999999997442100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
........
T Consensus 177 ------------------------------------------------------------------------~~~~~~~~ 184 (295)
T 2clq_A 177 ------------------------------------------------------------------------NPCTETFT 184 (295)
T ss_dssp ----------------------------------------------------------------------------CCCC
T ss_pred ------------------------------------------------------------------------CCcccccC
Confidence 00012346
Q ss_pred cCCCccChhhhcCCC--CCccceeeehhhhhhhhccCCCCCCCCCchHH-HHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 845 GTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGNEET-LANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 845 GT~~Y~APEvL~g~~--~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~-L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ +............+..++.++.+||.+||.
T Consensus 185 ~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 264 (295)
T 2clq_A 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFE 264 (295)
T ss_dssp CCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTC
T ss_pred CCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHcc
Confidence 899999999998754 78999999999999999999999986544332 222222222333345689999999999999
Q ss_pred CCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 922 KEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
.||++||+ +.++|+||||+...
T Consensus 265 ~dp~~Rps----~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 265 PDPDKRAC----ANDLLVDEFLKVSS 286 (295)
T ss_dssp SSTTTSCC----HHHHHTSGGGCC--
T ss_pred CChhhCCC----HHHHhcChhhhhcc
Confidence 99999999 99999999998654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=388.81 Aligned_cols=275 Identities=18% Similarity=0.248 Sum_probs=223.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEE-----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAEL-----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~-----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
++..++|++++.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45678999999999999999999994 4467889999996431 1223346788999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---cEE
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLG-----KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG---HIM 751 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~-----~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg---~VK 751 (992)
..+..||||||+++|+|.+++..... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999999987532 3588999999999999999999999999999999999999555 599
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++..+....
T Consensus 225 L~DFG~a~~~~~~~------------------------------------------------------------------ 238 (367)
T 3l9p_A 225 IGDFGMARDIYRAG------------------------------------------------------------------ 238 (367)
T ss_dssp ECCCHHHHHHHHHS------------------------------------------------------------------
T ss_pred ECCCcccccccccc------------------------------------------------------------------
Confidence 99999985431100
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
.........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+... ...+....++.
T Consensus 239 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~ 313 (367)
T 3l9p_A 239 ----YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPG 313 (367)
T ss_dssp ----SCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCH
T ss_pred ----ccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCccCCH
Confidence 0011223468999999999999999999999999999999998 99999988777766665543 33444456899
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCC
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIP 956 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~p 956 (992)
.+.+||.+||..||++||+ +.+|++|.++..-+...+....|
T Consensus 314 ~l~~li~~~l~~dP~~Rps----~~eil~~l~~~~~~~~~~~~~~p 355 (367)
T 3l9p_A 314 PVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDVINTALP 355 (367)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHHHTCCCC
T ss_pred HHHHHHHHHcCCCHhHCcC----HHHHHHHHHHHhhChhhccCCCc
Confidence 9999999999999999999 99999987665544444444333
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=362.49 Aligned_cols=256 Identities=18% Similarity=0.248 Sum_probs=208.6
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCC
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDN 682 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~ 682 (992)
+.+..++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.+ +|+||+++++++....
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC-----CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 345567899999999999999999999999999999998643 2335578899999999 7999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc-----EEEEeccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH-----IMLTDFDL 757 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~-----VKLsDFGL 757 (992)
..||||||+ +++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++. ++|+|||+
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 999999999 99999999864 356999999999999999999999999999999999999987776 99999999
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+..+...... .....
T Consensus 158 ~~~~~~~~~~-----------------------------------------------------------------~~~~~ 172 (298)
T 1csn_A 158 VKFYRDPVTK-----------------------------------------------------------------QHIPY 172 (298)
T ss_dssp CEESBCTTTC-----------------------------------------------------------------CBCCC
T ss_pred cccccccccc-----------------------------------------------------------------ccccc
Confidence 8543211000 00000
Q ss_pred CCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC---chHHHHHHHhhccCCCC---CccchHH
Q 001952 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG---NEETLANVVMQSLKFPD---SPLISFQ 911 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s---~~e~L~~Iv~~~lk~P~---~~~vs~e 911 (992)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..+.......+. ...++.+
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 1csn_A 173 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 252 (298)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHH
T ss_pred cCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHH
Confidence 11234579999999999999999999999999999999999999998753 33444444333322221 1247889
Q ss_pred HHHHHHHhccCCcCCcCCCh
Q 001952 912 ARDLIRGLLIKEPENRLGSQ 931 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~ 931 (992)
+.+||.+||..||++||++.
T Consensus 253 l~~li~~~l~~dp~~RP~~~ 272 (298)
T 1csn_A 253 FYKYMHYARNLAFDATPDYD 272 (298)
T ss_dssp HHHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHHHHhcCCcccCCCHH
Confidence 99999999999999999943
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=373.87 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=216.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
..+..++|++++.||+|+||.||+|.+.+ +++.||||+++... .......+.+|+.+|+.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 34567899999999999999999999973 55899999997542 223346788999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeee
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQL----------------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~----------------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRD 736 (992)
...+.+||||||+++++|.+++.... ...+++..++.|+.||+.||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999988642 15689999999999999999999999999999
Q ss_pred cCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCC
Q 001952 737 LKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRK 816 (992)
Q Consensus 737 IKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~ 816 (992)
|||+|||++.++.+||+|||++..+.....
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------- 229 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADY-------------------------------------------------- 229 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGC--------------------------------------------------
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCcc--------------------------------------------------
Confidence 999999999999999999999754321000
Q ss_pred CCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHH
Q 001952 817 PKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANV 895 (992)
Q Consensus 817 ~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~I 895 (992)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+
T Consensus 230 --------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 289 (343)
T 1luf_A 230 --------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 289 (343)
T ss_dssp --------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred --------------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHH
Confidence 001122357899999999999999999999999999999999 99999988777776665
Q ss_pred HhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 896 v~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..... .+.+..++.++.+||.+||..||++||+ +.++++
T Consensus 290 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~ 328 (343)
T 1luf_A 290 RDGNI-LACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 328 (343)
T ss_dssp HTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred hCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 54433 3334568999999999999999999999 666664
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=368.80 Aligned_cols=260 Identities=21% Similarity=0.315 Sum_probs=216.5
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
.++..++|.+.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+++|+.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3556789999999999999999999884 455899999997542 233456788999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeee
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLG----------------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~----------------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRD 736 (992)
...+..|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999986432 2388999999999999999999999999999
Q ss_pred cCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCC
Q 001952 737 LKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRK 816 (992)
Q Consensus 737 IKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~ 816 (992)
|||+|||++.++.++|+|||++........
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------------------- 205 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDS-------------------------------------------------- 205 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSC--------------------------------------------------
T ss_pred cchheEEEcCCCCEEEcccccccccccccc--------------------------------------------------
Confidence 999999999999999999999754321000
Q ss_pred CCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHH
Q 001952 817 PKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANV 895 (992)
Q Consensus 817 ~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~I 895 (992)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+
T Consensus 206 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 265 (314)
T 2ivs_A 206 --------------------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265 (314)
T ss_dssp --------------------EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred --------------------ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHh
Confidence 000112347889999999999989999999999999999999 99999988776665544
Q ss_pred HhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 896 v~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
. .....+.+..++.++.+||.+||..||++||+ +.||+++
T Consensus 266 ~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 266 K-TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred h-cCCcCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 3 34444445568999999999999999999999 7777654
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=380.97 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=208.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-----------CCCccce
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-----------HPFLPTL 674 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-----------HPNIVkL 674 (992)
+..++|++++.||+|+||.||+|.+..+++.||||++..... ....+.+|+.+|+.+. |+||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 456799999999999999999999999999999999975422 2345678898888875 8999999
Q ss_pred eeeeccCC----eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEcc---
Q 001952 675 YSQFTSDN----LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVRE--- 746 (992)
Q Consensus 675 ~g~f~~~~----~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~--- 746 (992)
++++...+ .+++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99997654 789999999 99999999876566799999999999999999999998 9999999999999953
Q ss_pred ---CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 747 ---DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 747 ---dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
.+.+||+|||++.....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~------------------------------------------------------------ 190 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE------------------------------------------------------------ 190 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB------------------------------------------------------------
T ss_pred CcCcceEEEcccccccccCC------------------------------------------------------------
Confidence 34799999999743210
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC------chHHHHHHHh
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG------NEETLANVVM 897 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s------~~e~L~~Iv~ 897 (992)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..++.
T Consensus 191 ---------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (373)
T 1q8y_A 191 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255 (373)
T ss_dssp ---------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred ---------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHH
Confidence 0122368999999999999999999999999999999999999998654 2233333322
Q ss_pred hccC----------------------------------------CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHH
Q 001952 898 QSLK----------------------------------------FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEI 937 (992)
Q Consensus 898 ~~lk----------------------------------------~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEI 937 (992)
.... +.....++.++.+||.+||..||++||+ ++||
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~el 331 (373)
T 1q8y_A 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGL 331 (373)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHH
T ss_pred hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC----HHHH
Confidence 1111 1122346778999999999999999999 9999
Q ss_pred HcCCCCCCC
Q 001952 938 KQHPFFEGL 946 (992)
Q Consensus 938 LkHPfF~~l 946 (992)
|+||||++.
T Consensus 332 l~hp~f~~~ 340 (373)
T 1q8y_A 332 VNHPWLKDT 340 (373)
T ss_dssp HTCGGGTTC
T ss_pred hhChhhhcc
Confidence 999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=364.80 Aligned_cols=274 Identities=25% Similarity=0.403 Sum_probs=209.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------- 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------- 680 (992)
.++|++++.||+|+||.||+|.+..+++.||||++... ......+.+|+.+|+.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 35799999999999999999999999999999999643 2334678899999999999999999998754
Q ss_pred ------CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEe
Q 001952 681 ------DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTD 754 (992)
Q Consensus 681 ------~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsD 754 (992)
.+.+|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence 45789999999999999999864 34678899999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccC
Q 001952 755 FDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE 834 (992)
Q Consensus 755 FGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~ 834 (992)
||++............ ......
T Consensus 160 fg~~~~~~~~~~~~~~----------------------------------------------------------~~~~~~ 181 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKL----------------------------------------------------------DSQNLP 181 (303)
T ss_dssp CCCCSCTTC-----------------------------------------------------------------------
T ss_pred Ccchhhcccccchhcc----------------------------------------------------------cccccc
Confidence 9997543211000000 000000
Q ss_pred CCCCCcCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhhccCCCC--CccchH
Q 001952 835 PTDARSNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQSLKFPD--SPLISF 910 (992)
Q Consensus 835 ~~~~~s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~~lk~P~--~~~vs~ 910 (992)
..........||+.|+|||++.+. .++.++|||||||++|||++ ||.... ..+.+..+......++. ...++.
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (303)
T 1zy4_A 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMK 258 (303)
T ss_dssp ------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSH
T ss_pred ccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchH
Confidence 001122345799999999999875 68999999999999999998 565332 22333333333333332 234677
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
.+.+||.+||..||.+||+ +.++++||||....+...
T Consensus 259 ~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~ 295 (303)
T 1zy4_A 259 VEKKIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQDEV 295 (303)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHHHH
T ss_pred HHHHHHHHHHhcCcccCcC----HHHHhCCCCcCCCChHHH
Confidence 8999999999999999999 999999999998877643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=372.38 Aligned_cols=270 Identities=21% Similarity=0.300 Sum_probs=214.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyL 686 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+|+.+ +||||+++++++...+..||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK-----SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT-----CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc-----cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 47899999999999999999999999999999998743 2334678999999999 99999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc-----EEEEeccccccc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH-----IMLTDFDLSLRC 761 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~-----VKLsDFGLA~~l 761 (992)
||||+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||++.++. ++|+|||++..+
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 99999998864 467999999999999999999999999999999999999998887 999999998553
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
...... .........
T Consensus 161 ~~~~~~-----------------------------------------------------------------~~~~~~~~~ 175 (330)
T 2izr_A 161 IDPETK-----------------------------------------------------------------KHIPYREHK 175 (330)
T ss_dssp BCTTTC-----------------------------------------------------------------CBCCCCCCC
T ss_pred ecCCCC-----------------------------------------------------------------ccccccccC
Confidence 211000 000001123
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch---HHHHHHHhhccCCCCC---ccchHHHHHH
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---ETLANVVMQSLKFPDS---PLISFQARDL 915 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~---e~L~~Iv~~~lk~P~~---~~vs~el~dL 915 (992)
...||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... +.+..+.......+.. ..++ ++.+|
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~l 254 (330)
T 2izr_A 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATY 254 (330)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHH
T ss_pred CcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHH
Confidence 467999999999999999999999999999999999999999885433 3344443333333211 1245 89999
Q ss_pred HHHhccCCcCCcCCChHhHH---HHH---cCCCCCCCchhh
Q 001952 916 IRGLLIKEPENRLGSQKGAA---EIK---QHPFFEGLNWAL 950 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~ae---EIL---kHPfF~~lnw~~ 950 (992)
|..||..||.+||++..... +++ ...+...++|..
T Consensus 255 i~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 255 LRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred HHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 99999999999999433221 111 245566788873
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=372.04 Aligned_cols=264 Identities=20% Similarity=0.279 Sum_probs=210.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|.+.+.||+|+||+||+|.+..+++.||+|++... .......+.+|+++|+.++||||+++++++.+++..|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4567999999999999999999999999999999988543 2334567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+++++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 84 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999864 3569999999999999999999999999999999999999999999999999986542111
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.... + . ...............|
T Consensus 163 ~~~~-----------~------------------------------~-----------------~~~~~~~~~~~~~~~g 184 (310)
T 3s95_A 163 TQPE-----------G------------------------------L-----------------RSLKKPDRKKRYTVVG 184 (310)
T ss_dssp ---------------------------------------------------------------------------CCCCS
T ss_pred cccc-----------c------------------------------c-----------------ccccccccccccccCC
Confidence 0000 0 0 0000001112234679
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchH-----HHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE-----TLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e-----~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
|+.|+|||++.+..++.++|||||||+||||++|..||....... ........ ..+..++.++.+||.+||
T Consensus 185 t~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l 260 (310)
T 3s95_A 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPITVRCC 260 (310)
T ss_dssp CGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHHHHHHT
T ss_pred CcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHHHHHHc
Confidence 999999999999999999999999999999999999987533211 11111111 122347788999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||++||+ +.++++
T Consensus 261 ~~dP~~Rps----~~~l~~ 275 (310)
T 3s95_A 261 DLDPEKRPS----FVKLEH 275 (310)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 777765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=364.60 Aligned_cols=250 Identities=19% Similarity=0.253 Sum_probs=208.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCC-------eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTN-------CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQ 677 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg-------~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~ 677 (992)
++..++|.+.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+|+.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456789999999999999999999988766 57999999754 23445678899999999999999999999
Q ss_pred eccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc--------
Q 001952 678 FTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH-------- 749 (992)
Q Consensus 678 f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~-------- 749 (992)
+...+..||||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999999999999865 244899999999999999999999999999999999999998887
Q ss_pred EEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCC
Q 001952 750 IMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLP 829 (992)
Q Consensus 750 VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~ 829 (992)
++|+|||++....
T Consensus 160 ~kl~Dfg~~~~~~------------------------------------------------------------------- 172 (289)
T 4fvq_A 160 IKLSDPGISITVL------------------------------------------------------------------- 172 (289)
T ss_dssp EEECCCCSCTTTS-------------------------------------------------------------------
T ss_pred eeeccCccccccc-------------------------------------------------------------------
Confidence 9999999863210
Q ss_pred ccccCCCCCCcCccccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccc
Q 001952 830 QLVAEPTDARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLI 908 (992)
Q Consensus 830 ~~~a~~~~~~s~s~vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~v 908 (992)
......||+.|+|||++.+ ..++.++|||||||++|||++|..|+..................++. .+
T Consensus 173 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 241 (289)
T 4fvq_A 173 ---------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA--PK 241 (289)
T ss_dssp ---------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--CS
T ss_pred ---------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC--CC
Confidence 0012357888999999998 67899999999999999999965555444444444444444444443 36
Q ss_pred hHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.++.+||.+||..||.+||+ +.++++|
T Consensus 242 ~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 242 AAELANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp SCTTHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 788999999999999999999 8888765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=372.17 Aligned_cols=271 Identities=20% Similarity=0.255 Sum_probs=221.8
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
.++..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 3456789999999999999999999886 357889999997542 122345678999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcE
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQL--------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHI 750 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~--------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~V 750 (992)
...+..||||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 99999999999999999999987532 1457899999999999999999999999999999999999999999
Q ss_pred EEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCc
Q 001952 751 MLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQ 830 (992)
Q Consensus 751 KLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~ 830 (992)
+|+|||++........
T Consensus 178 kl~Dfg~~~~~~~~~~---------------------------------------------------------------- 193 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDY---------------------------------------------------------------- 193 (322)
T ss_dssp EECCTTCCCGGGGGGC----------------------------------------------------------------
T ss_pred EECcCccccccccccc----------------------------------------------------------------
Confidence 9999999743211000
Q ss_pred cccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccch
Q 001952 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLIS 909 (992)
Q Consensus 831 ~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs 909 (992)
........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+..... .+....++
T Consensus 194 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 266 (322)
T 1p4o_A 194 ------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPDNCP 266 (322)
T ss_dssp ------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCTTCC
T ss_pred ------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CCCCCCCC
Confidence 001122357889999999999999999999999999999999 8999998877766666554433 33445689
Q ss_pred HHHHHHHHHhccCCcCCcCCChHhHHHHHcC------CCCCCCchhhh
Q 001952 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQH------PFFEGLNWALI 951 (992)
Q Consensus 910 ~el~dLI~kcL~~DPekRPT~~~~aeEILkH------PfF~~lnw~~l 951 (992)
.++.+||.+||..||.+||+ +.|+++| +||..++|...
T Consensus 267 ~~l~~li~~~l~~dp~~Rps----~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 267 DMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred HHHHHHHHHHcCCCcccCcC----HHHHHHHHHHhhccCCcccccccc
Confidence 99999999999999999999 6666554 77776665543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=362.98 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=219.8
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
.+++..++|++.+.||+|+||.||+|.+..++..||||++... ......+.+|+++|+.++||||+++++++...+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3456678999999999999999999999999999999999753 233466789999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|+||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999999999987656679999999999999999999999999999999999999999999999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
... ......
T Consensus 163 ~~~-----------------------------------------------------------------------~~~~~~ 171 (288)
T 3kfa_A 163 GDT-----------------------------------------------------------------------YTAHAG 171 (288)
T ss_dssp SSS-----------------------------------------------------------------------SEEETT
T ss_pred CCc-----------------------------------------------------------------------cccccC
Confidence 100 001122
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+....... +......+.+..++.++.+||.+||.
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (288)
T 3kfa_A 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQ 250 (288)
T ss_dssp EEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHHhC
Confidence 357889999999999999999999999999999999 9999988766655544 44445555556789999999999999
Q ss_pred CCcCCcCCChHhHHHHHc
Q 001952 922 KEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILk 939 (992)
.||.+||+ +.++++
T Consensus 251 ~dp~~Rps----~~~~~~ 264 (288)
T 3kfa_A 251 WNPSDRPS----FAEIHQ 264 (288)
T ss_dssp SSGGGSCC----HHHHHH
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 666654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=357.88 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=214.8
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..++|++++.||+|+||.||+|.+. ++..||||++.... .....+.+|+++|+.++||||+++++++...+..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS----MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT----BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC----CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 355789999999999999999999875 56779999997542 2335678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999998765 346899999999999999999999999999999999999999999999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. .......
T Consensus 158 ~~-----------------------------------------------------------------------~~~~~~~ 166 (268)
T 3sxs_A 158 QY-----------------------------------------------------------------------VSSVGTK 166 (268)
T ss_dssp CE-----------------------------------------------------------------------EECCSCC
T ss_pred hh-----------------------------------------------------------------------hcccCCC
Confidence 00 0011234
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+... .....+..++.++.+||.+||..|
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~ 245 (268)
T 3sxs_A 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYRPHLASDTIYQIMYSCWHEL 245 (268)
T ss_dssp CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHTTCSS
T ss_pred cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC-CCCCCCCcChHHHHHHHHHHcCCC
Confidence 6788999999999889999999999999999999 99999988777766665443 333444568899999999999999
Q ss_pred cCCcCCChHhHHHHHcC
Q 001952 924 PENRLGSQKGAAEIKQH 940 (992)
Q Consensus 924 PekRPT~~~~aeEILkH 940 (992)
|.+||+ +.++++|
T Consensus 246 p~~Rps----~~~ll~~ 258 (268)
T 3sxs_A 246 PEKRPT----FQQLLSS 258 (268)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred hhhCcC----HHHHHHH
Confidence 999999 8888765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=370.98 Aligned_cols=259 Identities=19% Similarity=0.288 Sum_probs=220.0
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCe-----EEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNC-----LFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~-----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
++..++|++.+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4557899999999999999999999977654 79999997542 123346688999999999 899999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhc------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQL------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE 746 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~ 746 (992)
...+.+||||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 99999999999999999999987542 346899999999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhc
Q 001952 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIR 826 (992)
Q Consensus 747 dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~ 826 (992)
++.++|+|||++..+....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~------------------------------------------------------------- 218 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDS------------------------------------------------------------- 218 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCT-------------------------------------------------------------
T ss_pred CCeEEECcccccccccccc-------------------------------------------------------------
Confidence 9999999999974321100
Q ss_pred cCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCC
Q 001952 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDS 905 (992)
Q Consensus 827 ~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~ 905 (992)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..++......+.+
T Consensus 219 ---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 289 (333)
T 2i1m_A 219 ---------NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 289 (333)
T ss_dssp ---------TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC
T ss_pred ---------ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC
Confidence 0000122357889999999999999999999999999999999 999999887777777777777776666
Q ss_pred ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..++.++.+||.+||..||.+||+ +.++++
T Consensus 290 ~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~ 319 (333)
T 2i1m_A 290 AFAPKNIYSIMQACWALEPTHRPT----FQQICS 319 (333)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCHHHHHHHHHHhccChhhCcC----HHHHHH
Confidence 778999999999999999999999 777765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=360.67 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=212.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|++++.||+|+||.||+|.+. ++..||||++.... .....+.+|+++|+.++|+||+++++++...+.+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC----CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 456789999999999999999999885 56789999997542 2335678999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999999998764 246999999999999999999999999999999999999999999999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ........
T Consensus 174 ~-----------------------------------------------------------------------~~~~~~~~ 182 (283)
T 3gen_A 174 E-----------------------------------------------------------------------YTSSVGSK 182 (283)
T ss_dssp H-----------------------------------------------------------------------HHSTTSTT
T ss_pred c-----------------------------------------------------------------------cccccCCc
Confidence 0 00011234
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. ......+..++..+.+||.+||..|
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~ 261 (283)
T 3gen_A 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIMYSCWHEK 261 (283)
T ss_dssp SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhc-ccCCCCCCcCCHHHHHHHHHHccCC
Confidence 6788999999999999999999999999999998 9999998877766666544 3444445568899999999999999
Q ss_pred cCCcCCChHhHHHHHcC
Q 001952 924 PENRLGSQKGAAEIKQH 940 (992)
Q Consensus 924 PekRPT~~~~aeEILkH 940 (992)
|.+||+ +.++++|
T Consensus 262 p~~Rps----~~~ll~~ 274 (283)
T 3gen_A 262 ADERPT----FKILLSN 274 (283)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred hhHCcC----HHHHHHH
Confidence 999999 7777765
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=373.42 Aligned_cols=259 Identities=26% Similarity=0.382 Sum_probs=215.8
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---cchhHHHHHHHHHHHcC--CCCccceeee
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---KKMPRAQTEREILRMLD--HPFLPTLYSQ 677 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---~~~~~~~~EieILk~L~--HPNIVkL~g~ 677 (992)
.++...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.+|+.+. |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 344557899999999999999999999999999999999976532211 12245678999999996 5999999999
Q ss_pred eccCCeEEEEEEecCC-CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-cCCcEEEEec
Q 001952 678 FTSDNLSCLVMEYCPG-GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIMLTDF 755 (992)
Q Consensus 678 f~~~~~lyLVmEy~~G-GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-~dg~VKLsDF 755 (992)
+...+..++||||+.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 9999999999999976 8999998875 5789999999999999999999999999999999999999 7899999999
Q ss_pred cccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCC
Q 001952 756 DLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835 (992)
Q Consensus 756 GLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~ 835 (992)
|++..+..
T Consensus 195 g~~~~~~~------------------------------------------------------------------------ 202 (320)
T 3a99_A 195 GSGALLKD------------------------------------------------------------------------ 202 (320)
T ss_dssp TTCEECCS------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 99743210
Q ss_pred CCCCcCccccCCCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHH
Q 001952 836 TDARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 836 ~~~~s~s~vGT~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
.......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... .+......++ ..++.++.+
T Consensus 203 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--~~~~~~~~~ 272 (320)
T 3a99_A 203 --TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQH 272 (320)
T ss_dssp --SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--SCCCHHHHH
T ss_pred --ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--ccCCHHHHH
Confidence 00122458999999999988776 788999999999999999999997531 2333333333 458999999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
||.+||..||++||+ ++||++||||+...+.
T Consensus 273 li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 273 LIRWCLALRPSDRPT----FEEIQNHPWMQDVLLP 303 (320)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHTSGGGSSCCCH
T ss_pred HHHHHccCChhhCcC----HHHHhcCHhhcCccCc
Confidence 999999999999999 9999999999988654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=365.33 Aligned_cols=258 Identities=23% Similarity=0.291 Sum_probs=208.0
Q ss_pred cccccCceEEEEEccCCceEEEEEE----EcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAE----LIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~----~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
.+..++|++++.||+|+||.||+|. +..+++.||||++... .......+.+|+++|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999998 4568899999999754 23334678899999999999999999999854
Q ss_pred --CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 681 --DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 681 --~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
...+||||||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 456899999999999999988652 45899999999999999999999999999999999999999999999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+..... ...
T Consensus 162 ~~~~~~~~---------------------------------------------------------------------~~~ 172 (295)
T 3ugc_A 162 KVLPQDKE---------------------------------------------------------------------FFK 172 (295)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccccCCcc---------------------------------------------------------------------eee
Confidence 44321000 000
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch---------------HHHHHHHhhccCCC
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---------------ETLANVVMQSLKFP 903 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~---------------e~L~~Iv~~~lk~P 903 (992)
......||..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 3ugc_A 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 252 (295)
T ss_dssp ---CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC
T ss_pred eccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCC
Confidence 011234778899999999999999999999999999999999998643111 12223334445566
Q ss_pred CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 904 DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 904 ~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.+..++.++.+||.+||..||++||+ +.|+++
T Consensus 253 ~~~~~~~~l~~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 253 RPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CCcCcCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 66678999999999999999999999 666654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=382.39 Aligned_cols=257 Identities=25% Similarity=0.338 Sum_probs=215.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.+..++|.+.+.||+|+||.||+|.+..+++.||||+++... .......+.+|+.+|+.++||||+++++++...+.+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 456789999999999999999999999899999999997542 122335678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+++|+|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999999998764 346899999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. ........
T Consensus 267 ~~----------------------------------------------------------------------~~~~~~~~ 276 (377)
T 3cbl_A 267 VY----------------------------------------------------------------------AASGGLRQ 276 (377)
T ss_dssp EE----------------------------------------------------------------------ECCSSCCE
T ss_pred ce----------------------------------------------------------------------eecCCCCC
Confidence 00 00011123
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
++..|+|||++.+..++.++|||||||+||||++ |..||.+....+.... +.....++.+..++.++.+||.+||..|
T Consensus 277 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~d 355 (377)
T 3cbl_A 277 VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRLPCPELCPDAVFRLMEQCWAYE 355 (377)
T ss_dssp EEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence 6778999999999999999999999999999998 9999998776655544 4455566666678999999999999999
Q ss_pred cCCcCCChHhHHHHHc
Q 001952 924 PENRLGSQKGAAEIKQ 939 (992)
Q Consensus 924 PekRPT~~~~aeEILk 939 (992)
|++||+ +.+|++
T Consensus 356 P~~Rps----~~~i~~ 367 (377)
T 3cbl_A 356 PGQRPS----FSTIYQ 367 (377)
T ss_dssp GGGSCC----HHHHHH
T ss_pred chhCcC----HHHHHH
Confidence 999999 666653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=376.33 Aligned_cols=259 Identities=23% Similarity=0.334 Sum_probs=216.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC-------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT-------NCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYS 676 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t-------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g 676 (992)
++..++|.+.+.||+|+||.||+|.+.+. +..||||++.... .......+.+|+++|+.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 45567999999999999999999997643 3579999997542 233456788999999999 9999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLG--------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~~--------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
++...+.+||||||+++++|.+++..... ..+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 99999999999999999999999987531 3589999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
||+.++.+||+|||++..+.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~-------------------------------------------------------- 246 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDY-------------------------------------------------------- 246 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCT--------------------------------------------------------
T ss_pred EEcCCCcEEEcccCcccccccccc--------------------------------------------------------
Confidence 999999999999999743211000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+ .....
T Consensus 247 --------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~ 311 (382)
T 3tt0_A 247 --------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGHR 311 (382)
T ss_dssp --------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HTTCC
T ss_pred --------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCC
Confidence 001122357889999999999999999999999999999999 99999887666555444 44445
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
...+..++.++.+||.+||..||++||+ +.||+++
T Consensus 312 ~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 312 MDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp CCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 5555678999999999999999999999 7777764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=366.21 Aligned_cols=260 Identities=22% Similarity=0.321 Sum_probs=216.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
.+..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+.+|..+ +||||+++++++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 100 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 100 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence 355789999999999999999999864 467899999997542 223345688999999999 799999999998
Q ss_pred ccCC-eEEEEEEecCCCChHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 679 TSDN-LSCLVMEYCPGGDLHVLRQKQLG--------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 679 ~~~~-~lyLVmEy~~GGSL~~lLkk~~~--------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
...+ .+|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 180 (316)
T 2xir_A 101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180 (316)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 7654 58999999999999999986532 12789999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 744 Ld~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
++.++.++|+|||++..+....
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~---------------------------------------------------------- 202 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDP---------------------------------------------------------- 202 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCT----------------------------------------------------------
T ss_pred ECCCCCEEECCCccccccccCc----------------------------------------------------------
Confidence 9999999999999974321100
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCC
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+...+......
T Consensus 203 ------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~ 270 (316)
T 2xir_A 203 ------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 270 (316)
T ss_dssp ------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred ------------cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccC
Confidence 0001123457899999999999999999999999999999998 999999877666666666665555
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.+..++.++.+||.+||..||.+||+ +.|+++|
T Consensus 271 ~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 271 RAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 556678999999999999999999999 8888776
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=359.35 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=209.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH----hhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA----RRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~----~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
.+..++|++.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 34568999999999999999999999999999999998643211 11233678899999999999999999999977
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCc-----EEEE
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGH-----IMLT 753 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~-----VKLs 753 (992)
.. +|||||+++++|.+++... ...+++..++.++.||+.||+|||++| |+||||||+|||++.++. ++|+
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CC--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 65 6999999999998887654 357999999999999999999999999 999999999999988776 9999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|||++....
T Consensus 172 Dfg~~~~~~----------------------------------------------------------------------- 180 (287)
T 4f0f_A 172 DFGLSQQSV----------------------------------------------------------------------- 180 (287)
T ss_dssp CCTTCBCCS-----------------------------------------------------------------------
T ss_pred CCCcccccc-----------------------------------------------------------------------
Confidence 999863210
Q ss_pred CCCCCCcCccccCCCccChhhhc--CCCCCccceeeehhhhhhhhccCCCCCCCCCchHH--HHHHHhhccCCCCCccch
Q 001952 834 EPTDARSNSFVGTHEYLAPEIIK--GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET--LANVVMQSLKFPDSPLIS 909 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL~--g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~--L~~Iv~~~lk~P~~~~vs 909 (992)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+.........+..++
T Consensus 181 ----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (287)
T 4f0f_A 181 ----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCP 256 (287)
T ss_dssp ----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSC
T ss_pred ----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCcccC
Confidence 0012346899999999994 44578999999999999999999999987655433 444444555555556789
Q ss_pred HHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 910 ~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.++.+||.+||..||.+||+ +.|+++
T Consensus 257 ~~l~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 257 PRLRNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 99999999999999999999 777664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=370.89 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=206.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeE----EEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCL----FAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~----VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
+..++|++++.||+|+||+||+|.+..+++. ||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4467899999999999999999999877765 4777775432 234456789999999999999999999999876
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
. .++||||+.+|+|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.+||+|||++..+
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 78999999999999998764 356999999999999999999999999999999999999999999999999998553
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
..... .....
T Consensus 168 ~~~~~----------------------------------------------------------------------~~~~~ 177 (327)
T 3poz_A 168 GAEEK----------------------------------------------------------------------EYHAE 177 (327)
T ss_dssp TTTCC---------------------------------------------------------------------------
T ss_pred cCCcc----------------------------------------------------------------------ccccc
Confidence 21100 00112
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.. .++......+.+..++.++.+||.+||
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l 256 (327)
T 3poz_A 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMVKCW 256 (327)
T ss_dssp --CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTTBCHHHHHHHHHHT
T ss_pred CCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 2357889999999999999999999999999999999 99999887665544 445555566666779999999999999
Q ss_pred cCCcCCcCCChHhHHHHHcC
Q 001952 921 IKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkH 940 (992)
..||.+||+ +.+++++
T Consensus 257 ~~~p~~Rps----~~ell~~ 272 (327)
T 3poz_A 257 MIDADSRPK----FRELIIE 272 (327)
T ss_dssp CSCGGGSCC----HHHHHHH
T ss_pred CCChhhCCC----HHHHHHH
Confidence 999999999 6666654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=371.43 Aligned_cols=257 Identities=18% Similarity=0.246 Sum_probs=209.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeE----EEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCL----FAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~----VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
.+..++|++++.||+|+||.||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34568999999999999999999999888776 7777775431 2334456778999999999999999999886
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
++..++||||+.+|+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 55689999999999999998764 24689999999999999999999999999999999999999999999999999854
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+.... .....
T Consensus 165 ~~~~~----------------------------------------------------------------------~~~~~ 174 (325)
T 3kex_A 165 LPPDD----------------------------------------------------------------------KQLLY 174 (325)
T ss_dssp SCCCT----------------------------------------------------------------------TCCC-
T ss_pred cCccc----------------------------------------------------------------------ccccc
Confidence 32100 00011
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
....||..|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+. .....+.+..++.++.+||.+|
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~ 253 (325)
T 3kex_A 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE-KGERLAQPQICTIDVYMVMVKC 253 (325)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH-TTCBCCCCTTBCTTTTHHHHHH
T ss_pred cCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH-cCCCCCCCCcCcHHHHHHHHHH
Confidence 23467889999999999999999999999999999999 999999877666555544 3444444556888999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcC
Q 001952 920 LIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkH 940 (992)
|..||.+||+ +.++++|
T Consensus 254 l~~dp~~Rps----~~el~~~ 270 (325)
T 3kex_A 254 WMIDENIRPT----FKELANE 270 (325)
T ss_dssp TCSCTTTSCC----HHHHHHH
T ss_pred cCCChhhCcC----HHHHHHH
Confidence 9999999999 6666554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=359.70 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=210.3
Q ss_pred cccccCceEEEEEccCCceEEEEEE----EcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAE----LIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~----~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
.+..++|++++.||+|+||.||+|. +..+++.||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 4456789999999999999999998 45688999999997543 33455778899999999999999999999987
Q ss_pred C--CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 681 D--NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 681 ~--~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
. +.+|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 6 6789999999999999998665 356999999999999999999999999999999999999999999999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+...... ..
T Consensus 174 ~~~~~~~~~---------------------------------------------------------------------~~ 184 (302)
T 4e5w_A 174 KAIETDKEY---------------------------------------------------------------------YT 184 (302)
T ss_dssp EECCTTCCE---------------------------------------------------------------------EE
T ss_pred ccccCCCcc---------------------------------------------------------------------ee
Confidence 543211000 00
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCC--------------CCchHHHHHHHhhccCCCC
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG--------------SGNEETLANVVMQSLKFPD 904 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g--------------~s~~e~L~~Iv~~~lk~P~ 904 (992)
......||..|+|||++.+..++.++|||||||++|||++|..|+.. ......+...+......+.
T Consensus 185 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (302)
T 4e5w_A 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPC 264 (302)
T ss_dssp CCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCC
T ss_pred ccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCC
Confidence 11234588899999999999999999999999999999999987632 2222333444455556666
Q ss_pred CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 905 ~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
+..++.++.+||.+||..||.+||+ +.++++
T Consensus 265 ~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 265 PPNCPDEVYQLMRKCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 6679999999999999999999999 666654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=359.83 Aligned_cols=256 Identities=25% Similarity=0.356 Sum_probs=205.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
++..++|++.+.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+|+.++||||+++++++. +
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 45578999999999999999999998653 5679999987532 2233466889999999999999999999985 5
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 6789999999999999998764 346899999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.... .....
T Consensus 167 ~~~~-----------------------------------------------------------------------~~~~~ 175 (281)
T 1mp8_A 167 EDST-----------------------------------------------------------------------YYKAS 175 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cccc-----------------------------------------------------------------------ccccc
Confidence 1100 00011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+... ...+.+..++.++.+||.+||
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l 254 (281)
T 1mp8_A 176 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKCW 254 (281)
T ss_dssp ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHc
Confidence 2346788999999999999999999999999999997 99999988777777665543 334455568999999999999
Q ss_pred cCCcCCcCCChHhHHHHHcC
Q 001952 921 IKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkH 940 (992)
..||++||+ +.|++++
T Consensus 255 ~~~p~~Rps----~~~l~~~ 270 (281)
T 1mp8_A 255 AYDPSRRPR----FTELKAQ 270 (281)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred cCChhhCcC----HHHHHHH
Confidence 999999999 7776653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=366.04 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=203.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---cchhHHHHHHHHHHHc----CCCCccceeeee
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---KKMPRAQTEREILRML----DHPFLPTLYSQF 678 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---~~~~~~~~EieILk~L----~HPNIVkL~g~f 678 (992)
...++|++.+.||+|+||.||+|.+..+++.||||++........ .....+.+|+.++..+ +|+||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 345789999999999999999999999999999999975432111 1233456799999998 899999999999
Q ss_pred ccCCeEEEEEEe-cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc-cCCcEEEEecc
Q 001952 679 TSDNLSCLVMEY-CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR-EDGHIMLTDFD 756 (992)
Q Consensus 679 ~~~~~lyLVmEy-~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd-~dg~VKLsDFG 756 (992)
...+..++|||| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg 185 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence 999999999999 7899999998875 5699999999999999999999999999999999999999 88999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++..+..
T Consensus 186 ~~~~~~~------------------------------------------------------------------------- 192 (312)
T 2iwi_A 186 SGALLHD------------------------------------------------------------------------- 192 (312)
T ss_dssp SCEECCS-------------------------------------------------------------------------
T ss_pred hhhhccc-------------------------------------------------------------------------
Confidence 9743210
Q ss_pred CCCcCccccCCCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDL 915 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dL 915 (992)
.......||..|+|||++.+..+ +.++|||||||++|||++|+.||... ..+......++ ..++.++.+|
T Consensus 193 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~--~~~~~~~~~l 263 (312)
T 2iwi_A 193 -EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFP--AHVSPDCCAL 263 (312)
T ss_dssp -SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCC--TTSCHHHHHH
T ss_pred -CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCc--ccCCHHHHHH
Confidence 00123458999999999987776 45899999999999999999999753 22333444444 3589999999
Q ss_pred HHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
|.+||..||++||+ ++|+++||||+...
T Consensus 264 i~~~l~~~p~~Rps----~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 264 IRRCLAPKPSSRPS----LEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHTCSSTTTSCC----HHHHHHSTTTCC--
T ss_pred HHHHccCChhhCcC----HHHHhcChhhcCch
Confidence 99999999999999 99999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=354.53 Aligned_cols=273 Identities=18% Similarity=0.253 Sum_probs=210.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee-ccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f-~~~~~lyL 686 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.+.|++++..+.++ ...+..+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc-----ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 47899999999999999999999999999999987643 2234578899999999988877666655 67788999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE---ccCCcEEEEeccccccccC
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL---d~dg~VKLsDFGLA~~l~~ 763 (992)
||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99999 99999998754 3569999999999999999999999999999999999999 7899999999999855321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
..... ..........
T Consensus 161 ~~~~~-----------------------------------------------------------------~~~~~~~~~~ 175 (296)
T 4hgt_A 161 ARTHQ-----------------------------------------------------------------HIPYRENKNL 175 (296)
T ss_dssp TTTCC-----------------------------------------------------------------BCCCCCSCCC
T ss_pred cccCc-----------------------------------------------------------------cCCCCccccc
Confidence 10000 0000112345
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc---hHHHHHHHhhccCCCCC---ccchHHHHHHHH
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---EETLANVVMQSLKFPDS---PLISFQARDLIR 917 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---~e~L~~Iv~~~lk~P~~---~~vs~el~dLI~ 917 (992)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+.......+.. ..++.++.+||.
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (296)
T 4hgt_A 176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN 255 (296)
T ss_dssp CSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred CCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHH
Confidence 799999999999999999999999999999999999999987543 24444444444333311 346889999999
Q ss_pred HhccCCcCCcCCChHhHHHH---H---cCCCCCCCchhhhh
Q 001952 918 GLLIKEPENRLGSQKGAAEI---K---QHPFFEGLNWALIR 952 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEI---L---kHPfF~~lnw~~lr 952 (992)
+||..||++||++...++.+ + ...|...++|..++
T Consensus 256 ~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 296 (296)
T 4hgt_A 256 FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296 (296)
T ss_dssp HHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGCC
T ss_pred HHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhcC
Confidence 99999999999943322211 1 14566667777653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=351.40 Aligned_cols=253 Identities=23% Similarity=0.348 Sum_probs=213.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++.+.||+|+||.||+|.+. +++.||+|++.... .....+.+|+++++.++||||+++++++...+..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTT----BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 45689999999999999999999986 56789999997542 23356889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999999998765 3568999999999999999999999999999999999999999999999999974321000
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........|
T Consensus 159 -----------------------------------------------------------------------~~~~~~~~~ 167 (267)
T 3t9t_A 159 -----------------------------------------------------------------------YTSSTGTKF 167 (267)
T ss_dssp -----------------------------------------------------------------------HHSTTSTTC
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 000112357
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
|..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... .....+..++.++.+||.+||..||
T Consensus 168 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p 246 (267)
T 3t9t_A 168 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWRERP 246 (267)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred cccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC-CcCCCCccCcHHHHHHHHHHccCCh
Confidence 788999999999999999999999999999999 99999988776666665443 3344445688999999999999999
Q ss_pred CCcCCChHhHHHHHcC
Q 001952 925 ENRLGSQKGAAEIKQH 940 (992)
Q Consensus 925 ekRPT~~~~aeEILkH 940 (992)
++||+ +.+++++
T Consensus 247 ~~Rps----~~~ll~~ 258 (267)
T 3t9t_A 247 EDRPA----FSRLLRQ 258 (267)
T ss_dssp GGSCC----HHHHHHH
T ss_pred hhCcC----HHHHHHH
Confidence 99999 7777654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=363.30 Aligned_cols=262 Identities=25% Similarity=0.369 Sum_probs=200.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|++++.||+|+||.||+|.+..+++.||||++...... ......+..+..+++.++||||+++++++...+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 4468999999999999999999999999999999999754221 122233445556788889999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|||||+ ++.+..+.... ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++..+...
T Consensus 101 lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999 66666665543 46799999999999999999999995 9999999999999999999999999987332100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......
T Consensus 179 -------------------------------------------------------------------------~~~~~~~ 185 (318)
T 2dyl_A 179 -------------------------------------------------------------------------KAKDRSA 185 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0011235
Q ss_pred cCCCccChhhhc-----CCCCCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhcc-CCCCCccchHHHHHHHH
Q 001952 845 GTHEYLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQSL-KFPDSPLISFQARDLIR 917 (992)
Q Consensus 845 GT~~Y~APEvL~-----g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~ 917 (992)
||+.|+|||++. +..++.++|||||||+||||++|+.||..... .+.+..+..... .++....++.++.+||.
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 265 (318)
T 2dyl_A 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265 (318)
T ss_dssp -CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHH
T ss_pred CCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHH
Confidence 899999999995 45688999999999999999999999987543 445555544332 23444458899999999
Q ss_pred HhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 918 GLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 918 kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
+||..||.+||+ +++|++||||+..+
T Consensus 266 ~~l~~dp~~Rps----~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 266 DCLTKDHRKRPK----YNKLLEHSFIKRYE 291 (318)
T ss_dssp HHTCSCTTTSCC----HHHHTTSHHHHHHH
T ss_pred HHccCChhHCcC----HHHHhhCHHHHhcc
Confidence 999999999999 99999999998653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=365.20 Aligned_cols=268 Identities=26% Similarity=0.422 Sum_probs=214.7
Q ss_pred eeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC--CCCccceeee
Q 001952 600 RLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD--HPFLPTLYSQ 677 (992)
Q Consensus 600 ~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~--HPNIVkL~g~ 677 (992)
.++...+..++|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+|+.+. |+||++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 34445566788999999999999999999885 588999999964321 1234567889999999997 5999999999
Q ss_pred eccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccc
Q 001952 678 FTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757 (992)
Q Consensus 678 f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGL 757 (992)
+...+.+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~ 172 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGI 172 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSS
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccc
Confidence 999999999999 4589999998864 5789999999999999999999999999999999999996 58999999999
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+..+.... ..
T Consensus 173 ~~~~~~~~----------------------------------------------------------------------~~ 182 (313)
T 3cek_A 173 ANQMQPDT----------------------------------------------------------------------TS 182 (313)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred cccccCcc----------------------------------------------------------------------cc
Confidence 74321100 00
Q ss_pred CCcCccccCCCccChhhhcC-----------CCCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhccCCCCC
Q 001952 838 ARSNSFVGTHEYLAPEIIKG-----------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSLKFPDS 905 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g-----------~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~lk~P~~ 905 (992)
.......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ..+..++........+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 01123468999999999986 46788999999999999999999999876443 4444555444444444
Q ss_pred ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
...+.++.+||.+||..||.+||+ +.|+|+||||+...
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~~~~~~ 300 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQT 300 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHCC-
T ss_pred ccchHHHHHHHHHHccCCcccCcC----HHHHhcCccccCCC
Confidence 557889999999999999999999 99999999998653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=360.02 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=204.4
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
+....++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++||||+++++++...+.
T Consensus 27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 106 (310)
T 2wqm_A 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 106 (310)
T ss_dssp TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence 34456789999999999999999999999999999999975332233445678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
.|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999999988753 2456899999999999999999999999999999999999999999999999987432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
... .....
T Consensus 187 ~~~------------------------------------------------------------------------~~~~~ 194 (310)
T 2wqm_A 187 SSK------------------------------------------------------------------------TTAAH 194 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCC------------------------------------------------------------------------Ccccc
Confidence 100 00012
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc-h-HHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN-E-ETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~-e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.+... . .....+............++.++.+||.+|
T Consensus 195 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 274 (310)
T 2wqm_A 195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274 (310)
T ss_dssp ----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHH
T ss_pred ccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHH
Confidence 34689999999999999999999999999999999999999976532 2 233333322222222345889999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcC
Q 001952 920 LIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkH 940 (992)
|..||.+||+ +.+++++
T Consensus 275 l~~dp~~Rps----~~~il~~ 291 (310)
T 2wqm_A 275 INPDPEKRPD----VTYVYDV 291 (310)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCChhhCCC----HHHHHHH
Confidence 9999999999 7777753
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=374.77 Aligned_cols=253 Identities=25% Similarity=0.394 Sum_probs=184.9
Q ss_pred ccCceEEE-EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc----CC
Q 001952 608 LRHFNLLQ-KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS----DN 682 (992)
Q Consensus 608 ~~~Yeilr-~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~----~~ 682 (992)
.++|.+++ .||+|+||.||+|.+..+++.||||++.... .........++.++||||+++++++.. ..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 57899965 6999999999999999999999999996431 111223344677899999999999875 55
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEeccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLSL 759 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA~ 759 (992)
.+||||||++||+|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||++. ++.++|+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999998765567999999999999999999999999999999999999986 4559999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.... ..
T Consensus 180 ~~~~--------------------------------------------------------------------------~~ 185 (336)
T 3fhr_A 180 ETTQ--------------------------------------------------------------------------NA 185 (336)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred eccc--------------------------------------------------------------------------cc
Confidence 3210 00
Q ss_pred cCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHH----HHHHhhccCC--CCCccchHHHH
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL----ANVVMQSLKF--PDSPLISFQAR 913 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L----~~Iv~~~lk~--P~~~~vs~el~ 913 (992)
.....||+.|+|||++.+..++.++|||||||+||+|++|+.||.+....... ..+......+ +....++.++.
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (336)
T 3fhr_A 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAK 265 (336)
T ss_dssp ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHH
T ss_pred cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHH
Confidence 12245799999999999888999999999999999999999999876544332 2222222222 23346899999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
+||.+||..||.+||+ +.|+|+||||..
T Consensus 266 ~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 266 QLIRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHCCCChhHCcC----HHHHhcCccccc
Confidence 9999999999999999 999999999976
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=359.24 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=208.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcC-CC--eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIG-TN--CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~-tg--~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
+..++|++++.||+|+||.||+|.+.. ++ ..||||+++............+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 94 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP 94 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC
Confidence 346789999999999999999998643 22 368999997654444455678899999999999999999999998765
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred -ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 89999999999999988765 2468999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... .......
T Consensus 173 ~~~~---------------------------------------------------------------------~~~~~~~ 183 (291)
T 1u46_A 173 QNDD---------------------------------------------------------------------HYVMQEH 183 (291)
T ss_dssp C-CC---------------------------------------------------------------------EEEC---
T ss_pred cccc---------------------------------------------------------------------chhhhcc
Confidence 1000 0000122
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..+|..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.+..+......++....++.++.+||.+||.
T Consensus 184 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 263 (291)
T 1u46_A 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 263 (291)
T ss_dssp --CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHcc
Confidence 357888999999999889999999999999999999 9999999888888888777766777777799999999999999
Q ss_pred CCcCCcCCChHhHHHHHc
Q 001952 922 KEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILk 939 (992)
.||++||+ +.++++
T Consensus 264 ~~p~~Rps----~~~l~~ 277 (291)
T 1u46_A 264 HKPEDRPT----FVALRD 277 (291)
T ss_dssp SSGGGSCC----HHHHHH
T ss_pred CCcccCcC----HHHHHH
Confidence 99999999 777775
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=369.11 Aligned_cols=272 Identities=17% Similarity=0.226 Sum_probs=216.5
Q ss_pred cccccCceEEEEEccCCceEEEEEE-----EcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAE-----LIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~-----~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~ 679 (992)
++..++|++++.||+|+||.||+|. ...+++.||||++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3556899999999999999999998 45678899999996432 1233456788999999999999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEE
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLG-----KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIM 751 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~-----~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VK 751 (992)
..+..||||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.++
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999999987532 34889999999999999999999999999999999999994 44699
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++........
T Consensus 184 l~Dfg~~~~~~~~~~----------------------------------------------------------------- 198 (327)
T 2yfx_A 184 IGDFGMARDIYRASY----------------------------------------------------------------- 198 (327)
T ss_dssp ECCCHHHHHHHC--------------------------------------------------------------------
T ss_pred ECccccccccccccc-----------------------------------------------------------------
Confidence 999999744321000
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+... ........++.
T Consensus 199 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 272 (327)
T 2yfx_A 199 -----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPG 272 (327)
T ss_dssp --------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCH
T ss_pred -----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC-CCCCCCCCCCH
Confidence 001123467899999999999999999999999999999998 99999887766666555443 33344456899
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhc
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
.+.+||.+||..||.+||+ +.+|++|.|+...+......
T Consensus 273 ~l~~li~~~l~~dp~~Rps----~~~ll~~l~~~~~~~~~~~~ 311 (327)
T 2yfx_A 273 PVYRIMTQCWQHQPEDRPN----FAIILERIEYCTQDPDVINT 311 (327)
T ss_dssp HHHHHHHHHTCSSGGGSCC----HHHHHHHHHHHHHCHHHHTC
T ss_pred HHHHHHHHHhcCChhhCcC----HHHHHHHHHHHhcCHHHhcc
Confidence 9999999999999999999 99999987765443333333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.87 Aligned_cols=256 Identities=24% Similarity=0.321 Sum_probs=212.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEE--EEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLF--AIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~V--AIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~ 681 (992)
.+..++|++.+.||+|+||.||+|.+..++..+ |||.+.... .......+.+|+++|+.+ +||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 98 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 98 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence 355689999999999999999999998888765 999886432 234456788999999999 899999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d 747 (992)
+.+||||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 178 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCC
Confidence 99999999999999999987642 2468999999999999999999999999999999999999999
Q ss_pred CcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhcc
Q 001952 748 GHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827 (992)
Q Consensus 748 g~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~ 827 (992)
+.++|+|||++.....
T Consensus 179 ~~~kL~Dfg~~~~~~~---------------------------------------------------------------- 194 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEV---------------------------------------------------------------- 194 (327)
T ss_dssp GCEEECCTTCEESSCE----------------------------------------------------------------
T ss_pred CeEEEcccCcCccccc----------------------------------------------------------------
Confidence 9999999998732110
Q ss_pred CCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCc
Q 001952 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSP 906 (992)
Q Consensus 828 ~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~ 906 (992)
........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+. .......+.
T Consensus 195 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~ 264 (327)
T 1fvr_A 195 ---------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRLEKPL 264 (327)
T ss_dssp ---------ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG-GTCCCCCCT
T ss_pred ---------cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh-cCCCCCCCC
Confidence 000112346788999999999989999999999999999998 999999887666555543 444444555
Q ss_pred cchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 907 LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 907 ~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.++.++.+||.+||..||.+||+ +.+++++
T Consensus 265 ~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 265 NCDDEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 68999999999999999999999 7777765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=353.89 Aligned_cols=255 Identities=19% Similarity=0.208 Sum_probs=205.8
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCe---EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE-E
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNC---LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS-C 685 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~---~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l-y 685 (992)
.|.+.+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+|+.++||||+++++++...+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 56777999999999999998765544 79999987532 223456788999999999999999999999876655 9
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
+||||+.+++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999998763 4668999999999999999999999999999999999999999999999999974321100
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
. ..........|
T Consensus 179 ~--------------------------------------------------------------------~~~~~~~~~~~ 190 (298)
T 3pls_A 179 Y--------------------------------------------------------------------YSVQQHRHARL 190 (298)
T ss_dssp G--------------------------------------------------------------------GCSCCSSCTTC
T ss_pred c--------------------------------------------------------------------cccccCcCCCC
Confidence 0 00011223468
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||.+.+..++.++|||||||++|||++|..||........+...+......+.+..++.++.+||.+||..||.
T Consensus 191 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 270 (298)
T 3pls_A 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPA 270 (298)
T ss_dssp GGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChh
Confidence 89999999999999999999999999999999955554444444444444555555666667899999999999999999
Q ss_pred CcCCChHhHHHHHc
Q 001952 926 NRLGSQKGAAEIKQ 939 (992)
Q Consensus 926 kRPT~~~~aeEILk 939 (992)
+||+ +.++++
T Consensus 271 ~Rps----~~~ll~ 280 (298)
T 3pls_A 271 VRPT----FRVLVG 280 (298)
T ss_dssp GSCC----HHHHHH
T ss_pred hCcC----HHHHHH
Confidence 9999 666654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.81 Aligned_cols=248 Identities=27% Similarity=0.344 Sum_probs=201.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 57899999999999999999999999999999999865443444457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--- 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE--- 187 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc---
Confidence 9999999999998875 56999999999999999999999999999999999999999999999999987332100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.........||+
T Consensus 188 --------------------------------------------------------------------~~~~~~~~~~~~ 199 (309)
T 2h34_A 188 --------------------------------------------------------------------KLTQLGNTVGTL 199 (309)
T ss_dssp -----------------------------------------------------------------------------CCG
T ss_pred --------------------------------------------------------------------ccccccccCCCc
Confidence 000112346899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC--CCccchHHHHHHHHHhccCCcC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP--DSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P--~~~~vs~el~dLI~kcL~~DPe 925 (992)
.|+|||++.+..++.++|||||||++|||++|+.||.+.... .+...+......+ ....++.++.+||.+||..||+
T Consensus 200 ~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 278 (309)
T 2h34_A 200 YYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPE 278 (309)
T ss_dssp GGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGG
T ss_pred CccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHH
Confidence 999999999999999999999999999999999999876544 3333333332221 2345788999999999999999
Q ss_pred CcCC
Q 001952 926 NRLG 929 (992)
Q Consensus 926 kRPT 929 (992)
+||+
T Consensus 279 ~Rp~ 282 (309)
T 2h34_A 279 DRYV 282 (309)
T ss_dssp GSCS
T ss_pred HHHH
Confidence 9994
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=364.68 Aligned_cols=259 Identities=20% Similarity=0.317 Sum_probs=213.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc-------CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI-------GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYS 676 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~-------~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g 676 (992)
.+..++|++.+.||+|+||.||+|.+. .+++.||||++.... .......+.+|+++|+.+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 355689999999999999999999986 356789999997542 223456788999999999 8999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQLG--------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~~--------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
++...+.+||||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 99999999999999999999999986531 2488999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|++.++.+||+|||++........
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~-------------------------------------------------------- 212 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDY-------------------------------------------------------- 212 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSS--------------------------------------------------------
T ss_pred EEcCCCCEEEcccccccccccccc--------------------------------------------------------
Confidence 999999999999999754321000
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+. ....
T Consensus 213 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-~~~~ 277 (334)
T 2pvf_A 213 --------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK-EGHR 277 (334)
T ss_dssp --------------EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCC
T ss_pred --------------ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHh-cCCC
Confidence 000112347888999999999889999999999999999999 999999876666555443 3444
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+.+..++.++.+||.+||..||.+||+ +.|++++
T Consensus 278 ~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 278 MDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 4445568999999999999999999999 7777654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=389.98 Aligned_cols=256 Identities=21% Similarity=0.297 Sum_probs=219.0
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.++...+|++.+.||+|+||.||+|.+..++..||||+++.. ......+.+|+.+|+.++||||+++++++...+.
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc----ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 345677899999999999999999999998999999999753 2345678899999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||+++|+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+..
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999876556789999999999999999999999999999999999999999999999999754311
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ......
T Consensus 371 ~~~-----------------------------------------------------------------------~~~~~~ 379 (495)
T 1opk_A 371 DTY-----------------------------------------------------------------------TAHAGA 379 (495)
T ss_dssp CCE-----------------------------------------------------------------------ECCTTC
T ss_pred Cce-----------------------------------------------------------------------eecCCC
Confidence 000 001123
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.+|..|+|||++.+..++.++|||||||+||||++ |..||.+.+..+.+.. +......+.+..++.++.+||.+||..
T Consensus 380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~ 458 (495)
T 1opk_A 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMERPEGCPEKVYELMRACWQW 458 (495)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCCCCCCHHHHHHHHHHcCc
Confidence 46788999999999999999999999999999999 9999998876665544 445556666667899999999999999
Q ss_pred CcCCcCCChHhHHHHHc
Q 001952 923 EPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 923 DPekRPT~~~~aeEILk 939 (992)
||++||+ +.+|++
T Consensus 459 dP~~RPs----~~el~~ 471 (495)
T 1opk_A 459 NPSDRPS----FAEIHQ 471 (495)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhHCcC----HHHHHH
Confidence 9999999 566553
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=379.98 Aligned_cols=248 Identities=22% Similarity=0.348 Sum_probs=212.2
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN- 682 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~- 682 (992)
..+..++|++++.||+|+||.||+|.+. ++.||||+++.. .....+.+|+.+|+.++||||+++++++...+
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC-----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc-----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 4567889999999999999999999884 678999999753 24567899999999999999999999987654
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||+++|+|.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++....
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999987654557999999999999999999999999999999999999999999999999974211
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
. ....
T Consensus 341 ~---------------------------------------------------------------------------~~~~ 345 (450)
T 1k9a_A 341 S---------------------------------------------------------------------------TQDT 345 (450)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c---------------------------------------------------------------------------cccC
Confidence 0 0011
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ....++.+..++.++.+||.+||.
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~ 424 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYDVMKNCWH 424 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcC
Confidence 246788999999999999999999999999999998 999999887777666554 445555666799999999999999
Q ss_pred CCcCCcCCChHhHHHHH
Q 001952 922 KEPENRLGSQKGAAEIK 938 (992)
Q Consensus 922 ~DPekRPT~~~~aeEIL 938 (992)
.||++||+ +.+|+
T Consensus 425 ~dp~~Rpt----~~~l~ 437 (450)
T 1k9a_A 425 LDAATRPT----FLQLR 437 (450)
T ss_dssp SSGGGSCC----HHHHH
T ss_pred CChhHCcC----HHHHH
Confidence 99999999 55554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=370.16 Aligned_cols=265 Identities=24% Similarity=0.339 Sum_probs=193.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHH-HHHHcCCCCccceeeeeccCCe
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE-ILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~Eie-ILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.+..++|++++.||+|+||.||+|.+..+++.||||++..... ......+..|+. +++.++||||+++++++...+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 4567899999999999999999999999999999999975321 122234455555 6777899999999999999999
Q ss_pred EEEEEEecCCCChHHHHHh---hcCCCCCHHHHHHHHHHHHHHHHHHhhc-CeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQK---QLGKCFSEPAARFYVAEVLLALEYLHML-GVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk---~~~~~Lse~~i~~Ia~QIL~GL~YLHs~-GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
.||||||+.+ +|.+++.. .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~ 174 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG 174 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence 9999999964 77776653 2246789999999999999999999998 99999999999999999999999999974
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+... ..
T Consensus 175 ~~~~~-------------------------------------------------------------------------~~ 181 (327)
T 3aln_A 175 QLVDS-------------------------------------------------------------------------IA 181 (327)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ecccc-------------------------------------------------------------------------cc
Confidence 32100 00
Q ss_pred cCccccCCCccChhhh----cCCCCCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhhcc-CCC--CCccchHH
Q 001952 840 SNSFVGTHEYLAPEII----KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQSL-KFP--DSPLISFQ 911 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL----~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~~l-k~P--~~~~vs~e 911 (992)
.....||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.... +.+..++.... .++ ....++.+
T Consensus 182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3aln_A 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPS 261 (327)
T ss_dssp ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHH
T ss_pred cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHH
Confidence 1123589999999999 4566899999999999999999999999875432 22222222111 111 12347899
Q ss_pred HHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
+.+||.+||..||++||+ +.+|++||||...++.
T Consensus 262 l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~~ 295 (327)
T 3aln_A 262 FINFVNLCLTKDESKRPK----YKELLKHPFILMYEER 295 (327)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHS
T ss_pred HHHHHHHHhhCChhhCcC----HHHHHhChHHHHhHhh
Confidence 999999999999999999 9999999999877654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=376.97 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=204.0
Q ss_pred cccccCceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
++...+|.+.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.+|+.++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 455678999999999999999999886 467789999997542 223346788999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+||||||+++++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999999999764 356899999999999999999999999999999999999999999999999997443
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
..... ......
T Consensus 198 ~~~~~---------------------------------------------------------------------~~~~~~ 208 (373)
T 2qol_A 198 EDDPE---------------------------------------------------------------------AAYTTR 208 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCc---------------------------------------------------------------------cceecc
Confidence 21000 000011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+ ......+....++.++.+||.+||
T Consensus 209 ~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl 287 (373)
T 2qol_A 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPPPMDCPAALYQLMLDCW 287 (373)
T ss_dssp -----CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-HTTEECCCCTTCBHHHHHHHHHHT
T ss_pred CCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCccccHHHHHHHHHHh
Confidence 1236788999999999999999999999999999998 99999988766665554 444555556678999999999999
Q ss_pred cCCcCCcCCChH
Q 001952 921 IKEPENRLGSQK 932 (992)
Q Consensus 921 ~~DPekRPT~~~ 932 (992)
..||.+||++..
T Consensus 288 ~~dp~~RPs~~~ 299 (373)
T 2qol_A 288 QKDRNNRPKFEQ 299 (373)
T ss_dssp CSSGGGSCCHHH
T ss_pred CcChhhCcCHHH
Confidence 999999999433
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=370.79 Aligned_cols=280 Identities=16% Similarity=0.196 Sum_probs=206.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCC-----CeEEEEEEechhHHH--------hhcchhHHHHHHHHHHHcCCCCcc
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT-----NCLFAIKVMDNEFLA--------RRKKMPRAQTEREILRMLDHPFLP 672 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~t-----g~~VAIKvIkk~~l~--------~~~~~~~~~~EieILk~L~HPNIV 672 (992)
+..++|++.+.||+|+||.||+|.+..+ ++.||||++...... .......+..|+..+..++|+||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456999999999999999999998764 578999998643211 111122344566667778899999
Q ss_pred ceeeeeccC----CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc--c
Q 001952 673 TLYSQFTSD----NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR--E 746 (992)
Q Consensus 673 kL~g~f~~~----~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd--~ 746 (992)
++++++... .++||||||+ |++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+ .
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 999998764 5689999999 99999998864 46799999999999999999999999999999999999999 8
Q ss_pred CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhc
Q 001952 747 DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIR 826 (992)
Q Consensus 747 dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~ 826 (992)
++.+||+|||++..+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~----------------------------------------------------------- 210 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVH----------------------------------------------------------- 210 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCC-----------------------------------------------------------
T ss_pred CCeEEEEECCcceecccCCcc-----------------------------------------------------------
Confidence 899999999998554211000
Q ss_pred cCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC---
Q 001952 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP--- 903 (992)
Q Consensus 827 ~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P--- 903 (992)
............||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+...........
T Consensus 211 ------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 284 (364)
T 3op5_A 211 ------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIAS 284 (364)
T ss_dssp ------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHH
T ss_pred ------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHH
Confidence 00001112345699999999999999999999999999999999999999986443333322221111000
Q ss_pred ------CCccchHHHHHHHHHhccCCcCCcCCChHhHHH---HH---cCCCCCCCchhhhh
Q 001952 904 ------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAE---IK---QHPFFEGLNWALIR 952 (992)
Q Consensus 904 ------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeE---IL---kHPfF~~lnw~~lr 952 (992)
....++.++.+||..||..||.+||++...... ++ ...+...++|....
T Consensus 285 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 285 LMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 113468899999999999999999995433221 11 24556666776443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=352.72 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=206.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------- 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------- 680 (992)
..+|++++.||+|+||.||+|.+..+++.||||++... ...+.+|+++|+.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC-------SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 46899999999999999999999989999999999643 1345789999999999999999998854
Q ss_pred ---------CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 681 ---------DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 681 ---------~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999876567899999999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++..+...
T Consensus 163 l~Dfg~~~~~~~~------------------------------------------------------------------- 175 (284)
T 2a19_B 163 IGDFGLVTSLKND------------------------------------------------------------------- 175 (284)
T ss_dssp ECCCTTCEESSCC-------------------------------------------------------------------
T ss_pred ECcchhheecccc-------------------------------------------------------------------
Confidence 9999997442110
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQ 911 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~e 911 (992)
.......||+.|+|||++.+..++.++|||||||++|||++|..||... ......+... .+ ...++.+
T Consensus 176 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--~~--~~~~~~~ 243 (284)
T 2a19_B 176 ------GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--II--SDIFDKK 243 (284)
T ss_dssp ------SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--CC--CTTSCHH
T ss_pred ------ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--cc--cccCCHH
Confidence 0012235899999999999999999999999999999999999887532 1222222211 12 2357889
Q ss_pred HHHHHHHhccCCcCCcCCChHhHHHHHcCCCC
Q 001952 912 ARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 912 l~dLI~kcL~~DPekRPT~~~~aeEILkHPfF 943 (992)
+.+||.+||..||.+||+ +.|+++|.++
T Consensus 244 ~~~li~~~l~~dp~~Rps----~~e~l~~l~~ 271 (284)
T 2a19_B 244 EKTLLQKLLSKKPEDRPN----TSEILRTLTV 271 (284)
T ss_dssp HHHHHHHHTCSSGGGSCC----HHHHHHHHHH
T ss_pred HHHHHHHHccCChhhCcC----HHHHHHHHHH
Confidence 999999999999999999 9999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.56 Aligned_cols=268 Identities=22% Similarity=0.323 Sum_probs=212.2
Q ss_pred ccccCceEEEEEccCCceEEEEEEE----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec--
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAEL----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT-- 679 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~-- 679 (992)
+..++|++++.||+|+||.||+|.+ ..+++.||||++.... ......+.+|+++|+.++|+||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 4467999999999999999999984 5688999999997542 233456889999999999999999999886
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
..+.+||||||+++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence 5677999999999999999988643 458999999999999999999999999999999999999999999999999985
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+...... ...
T Consensus 176 ~~~~~~~~---------------------------------------------------------------------~~~ 186 (327)
T 3lxl_A 176 LLPLDKDY---------------------------------------------------------------------YVV 186 (327)
T ss_dssp ECCTTCSE---------------------------------------------------------------------EEC
T ss_pred ecccCCcc---------------------------------------------------------------------cee
Confidence 43210000 001
Q ss_pred cCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc--------------hHHHHHHHhhccCCCCC
Q 001952 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN--------------EETLANVVMQSLKFPDS 905 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~--------------~e~L~~Iv~~~lk~P~~ 905 (992)
.....||..|+|||++.+..++.++|||||||++|+|++|..||..... ...+...+......+.+
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (327)
T 3lxl_A 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAP 266 (327)
T ss_dssp SSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCC
T ss_pred eccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCC
Confidence 1223588899999999999999999999999999999999999865322 12333444555566666
Q ss_pred ccchHHHHHHHHHhccCCcCCcCCChHhHHHH---HcCCCCCCCchhh
Q 001952 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEI---KQHPFFEGLNWAL 950 (992)
Q Consensus 906 ~~vs~el~dLI~kcL~~DPekRPT~~~~aeEI---LkHPfF~~lnw~~ 950 (992)
..++.++.+||.+||..||.+||+ +.|+ |+..|.....|..
T Consensus 267 ~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 267 PACPAEVHELMKLCWAPSPQDRPS----FSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHC---------
T ss_pred CcccHHHHHHHHHHcCCChhhCcC----HHHHHHHHHHHHhhhcCccc
Confidence 779999999999999999999999 6666 4444555444443
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=352.47 Aligned_cols=256 Identities=22% Similarity=0.319 Sum_probs=210.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC---CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~---tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
.+..++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|+.++||||+++++++.++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 3456899999999999999999998754 34569999997542 122346788999999999999999999998754
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 568999999999999998765 356899999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.... .....
T Consensus 164 ~~~~-----------------------------------------------------------------------~~~~~ 172 (281)
T 3cc6_A 164 EDED-----------------------------------------------------------------------YYKAS 172 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc-----------------------------------------------------------------------ccccc
Confidence 1100 00011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. .....+.+..++..+.+||.+||
T Consensus 173 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 251 (281)
T 3cc6_A 173 VTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPDLCPPVLYTLMTRCW 251 (281)
T ss_dssp CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 2346888999999999999999999999999999998 999998877766665543 33445555668999999999999
Q ss_pred cCCcCCcCCChHhHHHHHcC
Q 001952 921 IKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkH 940 (992)
..||++||+ +.|++++
T Consensus 252 ~~~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 252 DYDPSDRPR----FTELVCS 267 (281)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred cCCchhCcC----HHHHHHH
Confidence 999999999 7777754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=366.48 Aligned_cols=251 Identities=22% Similarity=0.289 Sum_probs=198.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC---
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN--- 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~--- 682 (992)
+..++|++++.||+|+||+||+|.+. ++.||||++.... ........|+.+|+.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 45679999999999999999999885 7899999997542 22234456888899999999999999998643
Q ss_pred -eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc----------CeeeeecCCceEEEccCCcEE
Q 001952 683 -LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML----------GVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 683 -~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~----------GIIHRDIKPeNILLd~dg~VK 751 (992)
.+||||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred ceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 47999999999999999976 4589999999999999999999999 999999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++..+.....
T Consensus 172 L~DFg~a~~~~~~~~----------------------------------------------------------------- 186 (322)
T 3soc_A 172 IADFGLALKFEAGKS----------------------------------------------------------------- 186 (322)
T ss_dssp ECCCTTCEEECTTSC-----------------------------------------------------------------
T ss_pred EccCCcccccccccC-----------------------------------------------------------------
Confidence 999999854321000
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCC-----CCCccceeeehhhhhhhhccCCCCCCCCCc---------------hHH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGE-----GHGAAVDWWTFGIFLYELLYGRTPFKGSGN---------------EET 891 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~-----~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---------------~e~ 891 (992)
........||+.|+|||++.+. .++.++|||||||+||||++|+.||.+... ...
T Consensus 187 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 187 -----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp -----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred -----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 0011234699999999999874 456788999999999999999999976432 222
Q ss_pred HHHHHhhccCCCCCc------cchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 892 LANVVMQSLKFPDSP------LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 892 L~~Iv~~~lk~P~~~------~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
+...+......+... ..+.++.+||.+||..||++||+ +.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 222222222222211 23456999999999999999999 666654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=348.92 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=203.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee-ccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f-~~~~~lyL 686 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.+.|++++..+.++ ...+..||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC-----SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC-----cchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 57899999999999999999999999999999998643 2335688999999999988876666555 56788899
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE---ccCCcEEEEeccccccccC
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL---d~dg~VKLsDFGLA~~l~~ 763 (992)
||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+..
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 99999998754 3579999999999999999999999999999999999999 4888999999999854321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
..... ..........
T Consensus 161 ~~~~~-----------------------------------------------------------------~~~~~~~~~~ 175 (296)
T 3uzp_A 161 ARTHQ-----------------------------------------------------------------HIPYRENKNL 175 (296)
T ss_dssp TTTCC-----------------------------------------------------------------BCCCCCSCCC
T ss_pred ccccc-----------------------------------------------------------------cccccccccc
Confidence 10000 0000112345
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC---chHHHHHHHhhccCCCC---CccchHHHHHHHH
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG---NEETLANVVMQSLKFPD---SPLISFQARDLIR 917 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s---~~e~L~~Iv~~~lk~P~---~~~vs~el~dLI~ 917 (992)
.||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..+.......+. ...++.++.+||.
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (296)
T 3uzp_A 176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN 255 (296)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHH
T ss_pred ccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHH
Confidence 79999999999999999999999999999999999999998743 33445555444444331 1347889999999
Q ss_pred HhccCCcCCcCCC
Q 001952 918 GLLIKEPENRLGS 930 (992)
Q Consensus 918 kcL~~DPekRPT~ 930 (992)
+||..||.+||++
T Consensus 256 ~~l~~dp~~Rps~ 268 (296)
T 3uzp_A 256 FCRSLRFDDKPDY 268 (296)
T ss_dssp HHHTSCTTCCCCH
T ss_pred HHHhcCcCcCCCH
Confidence 9999999999993
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=351.27 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=211.4
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.++..++|++++.||+|+||.||+|.+. ++..||||++... ......+.+|+++|+.++||||+++++++.. +.
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCC----cccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 4556789999999999999999999875 5678999999753 2234678899999999999999999998864 56
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
.|+||||+++++|.+++....+..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 89999999999999998765434689999999999999999999999999999999999999999999999999744321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ......
T Consensus 162 ~~~-----------------------------------------------------------------------~~~~~~ 170 (279)
T 1qpc_A 162 NEY-----------------------------------------------------------------------TAREGA 170 (279)
T ss_dssp SCE-----------------------------------------------------------------------ECCTTC
T ss_pred ccc-----------------------------------------------------------------------ccccCC
Confidence 000 001123
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+. .......+..++.++.+||.+||..
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 249 (279)
T 1qpc_A 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKE 249 (279)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh-cccCCCCcccccHHHHHHHHHHhcc
Confidence 46788999999998889999999999999999999 999999887766665554 3344444556899999999999999
Q ss_pred CcCCcCCChHhHHHHHc
Q 001952 923 EPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 923 DPekRPT~~~~aeEILk 939 (992)
||++||+ +.++++
T Consensus 250 ~p~~Rps----~~~l~~ 262 (279)
T 1qpc_A 250 RPEDRPT----FDYLRS 262 (279)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCCC----HHHHHH
Confidence 9999999 666654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=382.34 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=213.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..++|++.+.||+|+||.||+|.+. .+..||||+++.. ......+.+|+.+|+.++||||+++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTT----SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCC----CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 456789999999999999999999985 4678999999753 234567899999999999999999999986 6678
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+++|+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999999998654456889999999999999999999999999999999999999999999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. .......
T Consensus 338 ~~-----------------------------------------------------------------------~~~~~~~ 346 (454)
T 1qcf_A 338 EY-----------------------------------------------------------------------TAREGAK 346 (454)
T ss_dssp HH-----------------------------------------------------------------------HTTCSSS
T ss_pred ce-----------------------------------------------------------------------eccCCCc
Confidence 00 0011224
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ....++.+..++.++.+||.+||..|
T Consensus 347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~d 425 (454)
T 1qcf_A 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENCPEELYNIMMRCWKNR 425 (454)
T ss_dssp SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6788999999999999999999999999999999 999999887777666544 45566666779999999999999999
Q ss_pred cCCcCCChHhHHHHH
Q 001952 924 PENRLGSQKGAAEIK 938 (992)
Q Consensus 924 PekRPT~~~~aeEIL 938 (992)
|++||+ +++|+
T Consensus 426 p~~RPt----~~~i~ 436 (454)
T 1qcf_A 426 PEERPT----FEYIQ 436 (454)
T ss_dssp GGGSCC----HHHHH
T ss_pred hhHCcC----HHHHH
Confidence 999999 55554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=354.45 Aligned_cols=257 Identities=22% Similarity=0.296 Sum_probs=208.9
Q ss_pred cccccCceEEE-EEccCCceEEEEEEE--cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQ-KLGCGDIGTVYLAEL--IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr-~LGsG~FGtVYlA~~--~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
.+..++|.+.+ .||+|+||.||+|.+ ..+++.||||++..... .......+.+|+.+++.++||||+++++++ ..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~ 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EA 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence 45567899998 999999999999955 56678999999976421 223356788999999999999999999999 56
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 7789999999999999999874 56999999999999999999999999999999999999999999999999997543
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
...... .....
T Consensus 168 ~~~~~~---------------------------------------------------------------------~~~~~ 178 (291)
T 1xbb_A 168 RADENY---------------------------------------------------------------------YKAQT 178 (291)
T ss_dssp CTTCSE---------------------------------------------------------------------EEC--
T ss_pred ccCCCc---------------------------------------------------------------------ccccc
Confidence 210000 00011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+. .....+.+..++.++.+||.+||
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 257 (291)
T 1xbb_A 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCW 257 (291)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHc
Confidence 2346788999999999889999999999999999999 999999877666555544 33334444568999999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||.+||+ +.++++
T Consensus 258 ~~dp~~Rps----~~~l~~ 272 (291)
T 1xbb_A 258 TYDVENRPG----FAAVEL 272 (291)
T ss_dssp CSSTTTSCC----HHHHHH
T ss_pred CCChhhCcC----HHHHHH
Confidence 999999999 666554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=353.18 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=212.1
Q ss_pred ccccCceEEE-EEccCCceEEEEEEEc--CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQ-KLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr-~LGsG~FGtVYlA~~~--~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
+..++|.+.+ .||+|+||.||+|.+. .++..||||+++... .......+.+|+++|+.++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 4567888887 9999999999999864 467889999997542 223456788999999999999999999999 556
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 799999999999999998653 3569999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
..... ......
T Consensus 162 ~~~~~---------------------------------------------------------------------~~~~~~ 172 (287)
T 1u59_A 162 ADDSY---------------------------------------------------------------------YTARSA 172 (287)
T ss_dssp TCSCE---------------------------------------------------------------------ECCCCS
T ss_pred cCcce---------------------------------------------------------------------eecccc
Confidence 10000 000112
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+.. ....+.+..++.++.+||.+||.
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~~l~ 251 (287)
T 1u59_A 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWI 251 (287)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTC
T ss_pred ccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-CCcCCCCCCcCHHHHHHHHHHcC
Confidence 347889999999998889999999999999999998 9999998877776655544 33334445689999999999999
Q ss_pred CCcCCcCCChHhHHHHHcC
Q 001952 922 KEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkH 940 (992)
.||.+||+ +.++++|
T Consensus 252 ~~p~~Rps----~~~l~~~ 266 (287)
T 1u59_A 252 YKWEDRPD----FLTVEQR 266 (287)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CChhhCcC----HHHHHHH
Confidence 99999999 7787765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=356.64 Aligned_cols=259 Identities=23% Similarity=0.344 Sum_probs=203.0
Q ss_pred eecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 601 LQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 601 ~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
...+++..++|++.+.||+|+||.||+|.+.. .||||+++.... .......+.+|+.+|+.++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 34567778999999999999999999997643 499999874321 223446788999999999999999999965 4
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 56689999999999999988654 35689999999999999999999999999999999999999999999999999743
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
..... .....
T Consensus 170 ~~~~~----------------------------------------------------------------------~~~~~ 179 (289)
T 3og7_A 170 KSRWS----------------------------------------------------------------------GSHQF 179 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc----------------------------------------------------------------------ccccc
Confidence 21000 00011
Q ss_pred CccccCCCccChhhhc---CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC----CccchHHHH
Q 001952 841 NSFVGTHEYLAPEIIK---GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD----SPLISFQAR 913 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~---g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~----~~~vs~el~ 913 (992)
....||+.|+|||++. +..++.++|||||||++|||++|+.||.+....+.+..++......+. ...++.++.
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 259 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMK 259 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHH
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHH
Confidence 2346899999999997 566889999999999999999999999988777777666655443332 235788999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
+||.+||..||.+||+ +.++++
T Consensus 260 ~li~~~l~~~p~~Rps----~~ell~ 281 (289)
T 3og7_A 260 RLMAECLKKKRDERPS----FPRILA 281 (289)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHccCChhhCCC----HHHHHH
Confidence 9999999999999999 666654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=353.34 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=198.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHH--cCCCCccceeeeecc--
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM--LDHPFLPTLYSQFTS-- 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~--L~HPNIVkL~g~f~~-- 680 (992)
....++|++++.||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34568999999999999999999988 6889999999753 22345667777777 799999999998643
Q ss_pred --CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--------hcCeeeeecCCceEEEccCCcE
Q 001952 681 --DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH--------MLGVIYRDLKPENILVREDGHI 750 (992)
Q Consensus 681 --~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH--------s~GIIHRDIKPeNILLd~dg~V 750 (992)
...+||||||+++|+|.++++. ..+++..++.++.||+.||+||| +.||+||||||+|||++.++.+
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred CCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCE
Confidence 4568999999999999999864 56999999999999999999999 9999999999999999999999
Q ss_pred EEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCc
Q 001952 751 MLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQ 830 (992)
Q Consensus 751 KLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~ 830 (992)
||+|||++.........
T Consensus 153 kl~Dfg~a~~~~~~~~~--------------------------------------------------------------- 169 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQ--------------------------------------------------------------- 169 (301)
T ss_dssp EECCCTTCEEEETTTTE---------------------------------------------------------------
T ss_pred EEeeCCCeeeccccccc---------------------------------------------------------------
Confidence 99999997543211000
Q ss_pred cccCCCCCCcCccccCCCccChhhhcCC------CCCccceeeehhhhhhhhccC----------CCCCCCCC----chH
Q 001952 831 LVAEPTDARSNSFVGTHEYLAPEIIKGE------GHGAAVDWWTFGIFLYELLYG----------RTPFKGSG----NEE 890 (992)
Q Consensus 831 ~~a~~~~~~s~s~vGT~~Y~APEvL~g~------~~s~kSDIWSLGVlLyELLTG----------r~PF~g~s----~~e 890 (992)
.........||+.|+|||++.+. .++.++|||||||++|||++| ..||.... ...
T Consensus 170 -----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~ 244 (301)
T 3q4u_A 170 -----LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244 (301)
T ss_dssp -----EECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred -----ccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchh
Confidence 00011234799999999999887 345799999999999999999 88886532 234
Q ss_pred HHHHHHhhccCCCCC------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 891 TLANVVMQSLKFPDS------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 891 ~L~~Iv~~~lk~P~~------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.+...+......+.. ..++.++.+||.+||..||.+||+ +.||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 444443332222221 125678999999999999999999 667664
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=364.08 Aligned_cols=255 Identities=20% Similarity=0.316 Sum_probs=208.2
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEE----EEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLF----AIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~V----AIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
+..++|++++.||+|+||.||+|.+..+++.+ |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC--SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc--cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 44689999999999999999999998887765 66665432 1234456788999999999999999999999876
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
. .++||||+.+++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 78999999999999998865 356999999999999999999999999999999999999999999999999997443
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
..... .....
T Consensus 168 ~~~~~----------------------------------------------------------------------~~~~~ 177 (327)
T 3lzb_A 168 GAEEK----------------------------------------------------------------------EYHAE 177 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCccc----------------------------------------------------------------------ccccc
Confidence 21000 00011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+... ++.....++.+..++.++.+||.+||
T Consensus 178 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l 256 (327)
T 3lzb_A 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQPPICTIDVYMIMRKCW 256 (327)
T ss_dssp --CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-HHHTTCCCCCCTTBCHHHHHHHHHHT
T ss_pred CCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-HHHcCCCCCCCccCCHHHHHHHHHHc
Confidence 2347889999999999999999999999999999999 999998876665554 44555566666779999999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||.+||+ +.|+++
T Consensus 257 ~~dp~~Rps----~~ell~ 271 (327)
T 3lzb_A 257 MIDADSRPK----FRELII 271 (327)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CCChhHCcC----HHHHHH
Confidence 999999999 666665
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.63 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=210.1
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCC----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTN----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
++..++|.+.+.||+|+||.||+|.+..++ ..||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 456789999999999999999999886543 469999997542 12234567899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+..||||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999998764 35789999999999999999999999999999999999999999999999999744
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+..... .....
T Consensus 197 ~~~~~~---------------------------------------------------------------------~~~~~ 207 (333)
T 1mqb_A 197 LEDDPE---------------------------------------------------------------------ATYTT 207 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hccccc---------------------------------------------------------------------ccccc
Confidence 321000 00001
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
....+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. ....++....++.++.+||.+|
T Consensus 208 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~ 286 (333)
T 1mqb_A 208 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DGFRLPTPMDCPSAIYQLMMQC 286 (333)
T ss_dssp ---CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTCBHHHHHHHHHH
T ss_pred CCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-CCCcCCCcccCCHHHHHHHHHH
Confidence 12346788999999999999999999999999999999 999998877766665544 4445555667899999999999
Q ss_pred ccCCcCCcCCChHhHHHHHc
Q 001952 920 LIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILk 939 (992)
|..||.+||+ +.++++
T Consensus 287 l~~~p~~Rps----~~~l~~ 302 (333)
T 1mqb_A 287 WQQERARRPK----FADIVS 302 (333)
T ss_dssp TCSSTTTSCC----HHHHHH
T ss_pred cCCChhhCcC----HHHHHH
Confidence 9999999999 666554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=368.83 Aligned_cols=262 Identities=23% Similarity=0.241 Sum_probs=207.8
Q ss_pred ecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 602 QYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 602 ~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
.......++|++.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|+++|+.++||||+++++++...
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 34455678999999999999999999975 4688999999976532 22334688999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHhhc---CeeeeecCCceEEEccCCcEEEEecc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLG--KCFSEPAARFYVAEVLLALEYLHML---GVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~--~~Lse~~i~~Ia~QIL~GL~YLHs~---GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
+..+|||||+++++|.+++..... ..+++..++.|+.||+.||+|||++ ||+||||||+|||++.++.++|+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 999999999999999999886532 3489999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++..+....
T Consensus 180 ~~~~~~~~~----------------------------------------------------------------------- 188 (326)
T 3uim_A 180 LAKLMDYKD----------------------------------------------------------------------- 188 (326)
T ss_dssp SCEECCSSS-----------------------------------------------------------------------
T ss_pred cccccCccc-----------------------------------------------------------------------
Confidence 975432100
Q ss_pred CCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCC----CCchHHHHHHHhhccC-----------
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKG----SGNEETLANVVMQSLK----------- 901 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g----~s~~e~L~~Iv~~~lk----------- 901 (992)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.. ......+..++.....
T Consensus 189 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 3uim_A 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD 268 (326)
T ss_dssp SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTT
T ss_pred ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChh
Confidence 0011234589999999999999999999999999999999999999952 1111122222221111
Q ss_pred --CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCC
Q 001952 902 --FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHP 941 (992)
Q Consensus 902 --~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHP 941 (992)
.......+.++.+||.+||..||.+||+ +.||++|-
T Consensus 269 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L 306 (326)
T 3uim_A 269 LQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRML 306 (326)
T ss_dssp CTTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHH
T ss_pred hccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHh
Confidence 1112234578999999999999999999 78887763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=356.17 Aligned_cols=261 Identities=19% Similarity=0.267 Sum_probs=207.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcC---CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~---tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
..+..++|.+.+.||+|+||.||+|.+.. ++..||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34567899999999999999999998865 566899999975421 12334668899999999999999999999976
Q ss_pred CC-----eEEEEEEecCCCChHHHHHhh----cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEE
Q 001952 681 DN-----LSCLVMEYCPGGDLHVLRQKQ----LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIM 751 (992)
Q Consensus 681 ~~-----~lyLVmEy~~GGSL~~lLkk~----~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VK 751 (992)
.+ ..|+||||+++++|..++... ....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 54 459999999999999988532 235689999999999999999999999999999999999999999999
Q ss_pred EEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcc
Q 001952 752 LTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQL 831 (992)
Q Consensus 752 LsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~ 831 (992)
|+|||++..+.....
T Consensus 188 l~Dfg~~~~~~~~~~----------------------------------------------------------------- 202 (313)
T 3brb_A 188 VADFGLSKKIYSGDY----------------------------------------------------------------- 202 (313)
T ss_dssp ECSCSCC-------------------------------------------------------------------------
T ss_pred EeecCcceecccccc-----------------------------------------------------------------
Confidence 999999743311000
Q ss_pred ccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 832 ~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
........+++.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+... ...+.+..++.
T Consensus 203 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 276 (313)
T 3brb_A 203 -----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-HRLKQPEDCLD 276 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCBTTCCH
T ss_pred -----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC-CCCCCCccccH
Confidence 000122357889999999999999999999999999999999 99999988777777665543 33444456889
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
++.+||.+||..||.+||+ +.+++++
T Consensus 277 ~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 277 ELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp HHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999999999 7777754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.18 Aligned_cols=266 Identities=24% Similarity=0.365 Sum_probs=208.5
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec----c
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT----S 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~----~ 680 (992)
.+..++|++++.||+|+||.||+|.+..+++.||||++... .......+.+|+++++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 34567899999999999999999999999999999998643 2234467789999999999999999999986 3
Q ss_pred CCeEEEEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
....|+||||+.+++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 45789999999999999988763 2467999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
......... . ... ....
T Consensus 182 ~~~~~~~~~-----------------------------------------------------~-~~~---------~~~~ 198 (317)
T 2buj_A 182 NQACIHVEG-----------------------------------------------------S-RQA---------LTLQ 198 (317)
T ss_dssp EESCEEEES-----------------------------------------------------H-HHH---------HHHH
T ss_pred hhccccccc-----------------------------------------------------c-ccc---------cccc
Confidence 432110000 0 000 0000
Q ss_pred CcCccccCCCccChhhhcCCC---CCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhhccCCCCCccchHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEG---HGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQSLKFPDSPLISFQARD 914 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~---~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~~lk~P~~~~vs~el~d 914 (992)
......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... ..+.+...+.....++....++.++.+
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 278 (317)
T 2buj_A 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ 278 (317)
T ss_dssp HHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHH
T ss_pred ccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHH
Confidence 012345799999999998664 6899999999999999999999996411 111222333445556666678999999
Q ss_pred HHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 915 LIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 915 LI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
||.+||..||.+||+ +.+++++
T Consensus 279 li~~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 279 LLNSMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHhhcChhhCCC----HHHHHHH
Confidence 999999999999999 8888765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.76 Aligned_cols=257 Identities=24% Similarity=0.242 Sum_probs=207.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
...++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 3568999999999999999999986 46889999998754 2234567889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 686 LVMEYCPGGDLHVLRQKQL--GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~--~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999999998876542 23589999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.. ........
T Consensus 192 ~~----------------------------------------------------------------------~~~~~~~~ 201 (321)
T 2qkw_B 192 LD----------------------------------------------------------------------QTHLSTVV 201 (321)
T ss_dssp SS----------------------------------------------------------------------CCCCBCCC
T ss_pred cc----------------------------------------------------------------------cccccccc
Confidence 00 00011234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHH--HH----H-hh--------ccCCCCCccc
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA--NV----V-MQ--------SLKFPDSPLI 908 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~--~I----v-~~--------~lk~P~~~~v 908 (992)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+... .+ . .. .........+
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (321)
T 2qkw_B 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES 281 (321)
T ss_dssp EEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHH
T ss_pred CCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHH
Confidence 68999999999999999999999999999999999999998654332111 10 0 01 0111122345
Q ss_pred hHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.++.+||.+||..||++||+ +.|+++|
T Consensus 282 ~~~l~~li~~~l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 282 LRKFGDTAVKCLALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp HHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 678999999999999999999 7787765
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.37 Aligned_cols=257 Identities=18% Similarity=0.245 Sum_probs=206.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee-ccCC
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF-TSDN 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f-~~~~ 682 (992)
...+|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+|+.++||||+++++++ ..++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 345799999999999999999987543 3468999987531 223456788999999999999999999985 4567
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..|+||||+++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccc
Confidence 889999999999999998764 3568999999999999999999999999999999999999999999999999974432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... ........
T Consensus 180 ~~~~--------------------------------------------------------------------~~~~~~~~ 191 (298)
T 3f66_A 180 DKEY--------------------------------------------------------------------YSVHNKTG 191 (298)
T ss_dssp CGGG--------------------------------------------------------------------CBC-----
T ss_pred ccch--------------------------------------------------------------------hccccccC
Confidence 1000 00011123
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.... ....+..++..+.+||.+||.
T Consensus 192 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~ 270 (298)
T 3f66_A 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKCWH 270 (298)
T ss_dssp CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHcC
Confidence 457899999999999999999999999999999999 677777776666665554433 334445689999999999999
Q ss_pred CCcCCcCCChHhHHHHHc
Q 001952 922 KEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILk 939 (992)
.||.+||+ +.|+++
T Consensus 271 ~~p~~Rps----~~ell~ 284 (298)
T 3f66_A 271 PKAEMRPS----FSELVS 284 (298)
T ss_dssp SSGGGSCC----HHHHHH
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 666654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=353.84 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=203.4
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++.+.||+|+||.||+|.+. ++.||||++... .....+.+|+.+|+.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999884 678999999643 234567899999999999999999998874 479
Q ss_pred EEEEecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhh---cCeeeeecCCceEEEccCCc-EEEEecccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHM---LGVIYRDLKPENILVREDGH-IMLTDFDLSLR 760 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs---~GIIHRDIKPeNILLd~dg~-VKLsDFGLA~~ 760 (992)
|||||+++++|.+++..... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999886422 247889999999999999999999 89999999999999998886 79999998632
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
... ..
T Consensus 156 ~~~---------------------------------------------------------------------------~~ 160 (307)
T 2eva_A 156 IQT---------------------------------------------------------------------------HM 160 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc---------------------------------------------------------------------------cc
Confidence 110 01
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchH-HHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE-TLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e-~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+......+....++..+.+||.+|
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 240 (307)
T 2eva_A 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRC 240 (307)
T ss_dssp ----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHH
T ss_pred ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHH
Confidence 12358999999999999999999999999999999999999998654332 22222333334444456889999999999
Q ss_pred ccCCcCCcCCChHhHHHHHc-----CCCCCCCch
Q 001952 920 LIKEPENRLGSQKGAAEIKQ-----HPFFEGLNW 948 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILk-----HPfF~~lnw 948 (992)
|..||++||+ +.++++ ..+|.+.+.
T Consensus 241 l~~dp~~Rps----~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 241 WSKDPSQRPS----MEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp TCSSGGGSCC----HHHHHHHHHHHGGGCCCTTS
T ss_pred hcCChhhCcC----HHHHHHHHHHHHHhccCCCC
Confidence 9999999999 666655 345555443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=350.99 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=204.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-CCe
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-DNL 683 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-~~~ 683 (992)
.+..++|++.+.||+|+||.||+|.+ .++.||||+++.. .....+.+|+.+++.++||||+++++++.. .+.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 45678999999999999999999988 4788999999743 244678899999999999999999998754 457
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 89999999999999998865434488999999999999999999999999999999999999999999999998632110
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.....
T Consensus 170 ---------------------------------------------------------------------------~~~~~ 174 (278)
T 1byg_A 170 ---------------------------------------------------------------------------TQDTG 174 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00112
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+. ..........++..+.+||.+||..
T Consensus 175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 253 (278)
T 1byg_A 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-KGYKMDAPDGCPPAVYEVMKNCWHL 253 (278)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-TTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCcccCCHHHHHHHHHHhcC
Confidence 46788999999999999999999999999999998 999998877666665543 3344445556899999999999999
Q ss_pred CcCCcCCChHhHHHHHc
Q 001952 923 EPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 923 DPekRPT~~~~aeEILk 939 (992)
||.+||+ +.++++
T Consensus 254 ~p~~Rps----~~~l~~ 266 (278)
T 1byg_A 254 DAAMRPS----FLQLRE 266 (278)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhhCCC----HHHHHH
Confidence 9999999 666654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=376.53 Aligned_cols=251 Identities=25% Similarity=0.383 Sum_probs=204.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC--e
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN--L 683 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~--~ 683 (992)
...++|.+.+.||+|+||+||+|.+..+++.||||++.... .......+.+|+++|+.++||||+++++++...+ .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 44678999999999999999999999999999999997643 2234566789999999999999999999987654 7
Q ss_pred EEEEEEecCCCChHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE----ccCCcEEEEecccc
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLG-KCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV----REDGHIMLTDFDLS 758 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~-~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL----d~dg~VKLsDFGLA 758 (992)
.||||||+++++|.+++..... ..+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999876432 348999999999999999999999999999999999999 77778999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+... .
T Consensus 164 ~~~~~~-------------------------------------------------------------------------~ 170 (396)
T 4eut_A 164 RELEDD-------------------------------------------------------------------------E 170 (396)
T ss_dssp EECCCG-------------------------------------------------------------------------G
T ss_pred eEccCC-------------------------------------------------------------------------C
Confidence 443110 0
Q ss_pred CcCccccCCCccChhhhcC--------CCCCccceeeehhhhhhhhccCCCCCCCC----CchHHHHHHHhhccC-----
Q 001952 839 RSNSFVGTHEYLAPEIIKG--------EGHGAAVDWWTFGIFLYELLYGRTPFKGS----GNEETLANVVMQSLK----- 901 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g--------~~~s~kSDIWSLGVlLyELLTGr~PF~g~----s~~e~L~~Iv~~~lk----- 901 (992)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+.+..++.....
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~ 250 (396)
T 4eut_A 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250 (396)
T ss_dssp GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEE
T ss_pred ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchh
Confidence 1123468999999999976 45788999999999999999999999753 334555555543221
Q ss_pred --------------CCC----CccchHHHHHHHHHhccCCcCCcCCCh
Q 001952 902 --------------FPD----SPLISFQARDLIRGLLIKEPENRLGSQ 931 (992)
Q Consensus 902 --------------~P~----~~~vs~el~dLI~kcL~~DPekRPT~~ 931 (992)
++. ...++..+.+||.+||..||++||++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~ 298 (396)
T 4eut_A 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298 (396)
T ss_dssp EECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHH
T ss_pred heeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHH
Confidence 111 123567889999999999999999943
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=377.87 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=211.0
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+.+|+.++||||+++++++.. +.+
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 4567889999999999999999999865 4569999997542 234568899999999999999999999876 678
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+++|+|.+++....+..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999999998655567999999999999999999999999999999999999999999999999997432100
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ........
T Consensus 334 ~-----------------------------------------------------------------------~~~~~~~~ 342 (452)
T 1fmk_A 334 E-----------------------------------------------------------------------YTARQGAK 342 (452)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-----------------------------------------------------------------------eecccCCc
Confidence 0 00011234
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+ ......+.+..++..+.+||.+||..|
T Consensus 343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~d 421 (452)
T 1fmk_A 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRKE 421 (452)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTSCHHHHHHHHHHTCSS
T ss_pred ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6788999999999999999999999999999999 99999988777766654 445556666679999999999999999
Q ss_pred cCCcCCChHhHHHHHc
Q 001952 924 PENRLGSQKGAAEIKQ 939 (992)
Q Consensus 924 PekRPT~~~~aeEILk 939 (992)
|++||+ +++|++
T Consensus 422 P~~Rpt----~~~l~~ 433 (452)
T 1fmk_A 422 PEERPT----FEYLQA 433 (452)
T ss_dssp GGGSCC----HHHHHH
T ss_pred hhhCcC----HHHHHH
Confidence 999999 666654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=364.71 Aligned_cols=263 Identities=19% Similarity=0.231 Sum_probs=199.8
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC---CCeEEEEEEechhHH--------HhhcchhHHHHHHHHHHHcCCCCccc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG---TNCLFAIKVMDNEFL--------ARRKKMPRAQTEREILRMLDHPFLPT 673 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~---tg~~VAIKvIkk~~l--------~~~~~~~~~~~EieILk~L~HPNIVk 673 (992)
.+..++|++.+.||+|+||.||+|.+.. ++..||||++..... ........+.+|+.+++.++||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 3446789999999999999999999987 788999999864321 11122344677888999999999999
Q ss_pred eeeeecc----CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-
Q 001952 674 LYSQFTS----DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG- 748 (992)
Q Consensus 674 L~g~f~~----~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg- 748 (992)
+++++.. ...+||||||+ +++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence 9999987 78899999999 99999998765 3799999999999999999999999999999999999999887
Q ss_pred -cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhcc
Q 001952 749 -HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRS 827 (992)
Q Consensus 749 -~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~ 827 (992)
.+||+|||++..+......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~------------------------------------------------------------ 209 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNH------------------------------------------------------------ 209 (345)
T ss_dssp TSEEECCCTTCEESSGGGCC------------------------------------------------------------
T ss_pred CcEEEEeCCCceeccccccc------------------------------------------------------------
Confidence 9999999998554211000
Q ss_pred CCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhh-ccCCCC-
Q 001952 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQ-SLKFPD- 904 (992)
Q Consensus 828 ~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~-~lk~P~- 904 (992)
............||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+...... ...++.
T Consensus 210 -----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 284 (345)
T 2v62_A 210 -----KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQS 284 (345)
T ss_dssp -----CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHH
T ss_pred -----ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHH
Confidence 0000111234579999999999999999999999999999999999999996532 22222222111 111111
Q ss_pred ------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 905 ------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 905 ------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
...++.++.+||.+||..||++||+ +.+|++
T Consensus 285 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 321 (345)
T 2v62_A 285 VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN----YQALKK 321 (345)
T ss_dssp HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred HHhhccccccHHHHHHHHHHHhhcCcccCCC----HHHHHH
Confidence 1157889999999999999999999 666654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.15 Aligned_cols=263 Identities=26% Similarity=0.328 Sum_probs=189.1
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeee------
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQF------ 678 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f------ 678 (992)
+...+|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+|+.+. ||||+++++++
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 4456899999999999999999999999999999998543 2233456788999999996 99999999998
Q ss_pred --ccCCeEEEEEEecCCCChHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEccCCcEEEE
Q 001952 679 --TSDNLSCLVMEYCPGGDLHVLRQKQ-LGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVREDGHIMLT 753 (992)
Q Consensus 679 --~~~~~lyLVmEy~~GGSL~~lLkk~-~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd~dg~VKLs 753 (992)
.....+|+||||+ +|+|.+++... ....+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 3445689999999 57888877653 2356999999999999999999999999 9999999999999999999999
Q ss_pred eccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCcccc
Q 001952 754 DFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVA 833 (992)
Q Consensus 754 DFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a 833 (992)
|||++..+......... . ..
T Consensus 181 Dfg~~~~~~~~~~~~~~-----------------------------------------~-------------------~~ 200 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWS-----------------------------------------A-------------------QR 200 (337)
T ss_dssp CCTTCBCCSSCC--------------------------------------------------------------------
T ss_pred cCccceeccccCccccc-----------------------------------------c-------------------cc
Confidence 99998543211100000 0 00
Q ss_pred CCCCCCcCccccCCCccChhhh---cCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchH
Q 001952 834 EPTDARSNSFVGTHEYLAPEII---KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISF 910 (992)
Q Consensus 834 ~~~~~~s~s~vGT~~Y~APEvL---~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~ 910 (992)
...........||+.|+|||++ .+..++.++|||||||+||||++|+.||.+..... ++......+....++.
T Consensus 201 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 276 (337)
T 3ll6_A 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQYT 276 (337)
T ss_dssp -----------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCSSG
T ss_pred cccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----hhcCcccCCcccccch
Confidence 0000112245689999999999 56678999999999999999999999997654433 3334445555556778
Q ss_pred HHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 911 QARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 911 el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+.+||.+||..||.+||+ +.|+++|
T Consensus 277 ~~~~li~~~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 277 VFHSLIRAMLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp GGHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 8999999999999999999 8888876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=377.82 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=200.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~l 684 (992)
+...+|.+.+.||+|+||+||.. ...+++.||||++.... ...+.+|+.+|+.+ +||||+++++++.+.+.+
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 93 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC------FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQ 93 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTT------EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred EccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence 34557999999999999997643 34578899999996432 23356899999999 799999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---C--CcEEEEeccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---D--GHIMLTDFDLSL 759 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---d--g~VKLsDFGLA~ 759 (992)
|||||||. |+|.+++.... ..+.+..++.|+.||+.||+|||++|||||||||+||||+. + ..++|+|||++.
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 99999995 69999987653 34556667889999999999999999999999999999953 2 258899999985
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..... ....
T Consensus 172 ~~~~~~~---------------------------------------------------------------------~~~~ 182 (432)
T 3p23_A 172 KLAVGRH---------------------------------------------------------------------SFSR 182 (432)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred eccCCCc---------------------------------------------------------------------ceee
Confidence 4321000 0011
Q ss_pred cCccccCCCccChhhhcC---CCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCC---CCCccchHHH
Q 001952 840 SNSFVGTHEYLAPEIIKG---EGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKF---PDSPLISFQA 912 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g---~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~---P~~~~vs~el 912 (992)
.....||+.|+|||++.+ ..++.++|||||||+||||++ |..||......... . ....... ......+..+
T Consensus 183 ~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 260 (432)
T 3p23_A 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-I-LLGACSLDCLHPEKHEDVIA 260 (432)
T ss_dssp ---CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-H-HTTCCCCTTSCTTCHHHHHH
T ss_pred ccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-H-HhccCCccccCccccccHHH
Confidence 223569999999999984 567889999999999999999 99999655433322 2 2222211 1123356778
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
.+||.+||..||.+||+ +.|+++||||..++|.
T Consensus 261 ~~li~~~L~~dP~~Rps----~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 261 RELIEKMIAMDPQKRPS----AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp HHHHHHHSCSSGGGSCC----HHHHHTSTTTCCHHHH
T ss_pred HHHHHHHHhCCHhhCCC----HHHHHhCccccChHHH
Confidence 99999999999999999 9999999999999884
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=361.88 Aligned_cols=252 Identities=17% Similarity=0.171 Sum_probs=201.0
Q ss_pred cccccCceEEEEEccCCceEEEEE-----EEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC---CCCccceee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLA-----ELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD---HPFLPTLYS 676 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA-----~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~---HPNIVkL~g 676 (992)
.+..++|.+.+.||+|+||+||+| .+..+++.||||++... ....+..|+++++.++ |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 345688999999999999999999 46678899999999743 2345678888888887 999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-------
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQ---LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE------- 746 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~---~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~------- 746 (992)
++...+..||||||+++|+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 999999999999999999999998753 2357999999999999999999999999999999999999998
Q ss_pred ----CCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 747 ----DGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 747 ----dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
++.+||+|||++..+....
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~--------------------------------------------------------- 237 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFP--------------------------------------------------------- 237 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSC---------------------------------------------------------
T ss_pred cccccCCEEEeeCchhhhhhccC---------------------------------------------------------
Confidence 8999999999985432100
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
........+||+.|+|||++.+..|+.++|||||||+||||+||+.||......... . ...+
T Consensus 238 -------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~--~~~~ 299 (365)
T 3e7e_A 238 -------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---P--EGLF 299 (365)
T ss_dssp -------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---E--CSCC
T ss_pred -------------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---e--chhc
Confidence 001123457999999999999999999999999999999999999999654321100 0 0111
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
.. ...++.+.+++..||..+|.+|+.....+.+.|
T Consensus 300 ~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 300 RR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp TT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred cc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 11 125678899999999999999988544444433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=384.70 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=213.7
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.++..++|++.+.||+|+||.||+|.+.. +..||||+++... .....+.+|+++|+.++|+||+++++++.+ +.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence 34567889999999999999999999865 4569999997542 234568899999999999999999999876 67
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||+.+|+|.+++....+..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+..
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 89999999999999999865556799999999999999999999999999999999999999999999999999743210
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ......
T Consensus 416 ~~~-----------------------------------------------------------------------~~~~~~ 424 (535)
T 2h8h_A 416 NEY-----------------------------------------------------------------------TARQGA 424 (535)
T ss_dssp HHH-----------------------------------------------------------------------HTTCST
T ss_pred Cce-----------------------------------------------------------------------ecccCC
Confidence 000 001123
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+ .....++.+..++.++.+||.+||..
T Consensus 425 ~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~ 503 (535)
T 2h8h_A 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPECPESLHDLMCQCWRK 503 (535)
T ss_dssp TSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 46788999999999999999999999999999999 99999988777766654 44555666667899999999999999
Q ss_pred CcCCcCCChHhHHHHHc
Q 001952 923 EPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 923 DPekRPT~~~~aeEILk 939 (992)
||++||+ +++|++
T Consensus 504 dP~~RPt----~~~l~~ 516 (535)
T 2h8h_A 504 EPEERPT----FEYLQA 516 (535)
T ss_dssp SGGGSCC----HHHHHH
T ss_pred ChhHCcC----HHHHHH
Confidence 9999999 666554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=361.14 Aligned_cols=249 Identities=18% Similarity=0.232 Sum_probs=198.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcC--------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccc------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIG--------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT------ 673 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~--------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVk------ 673 (992)
.++|++.+.||+|+||.||+|.+.. .++.||||++... ..+.+|+++|+.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 4789999999999999999999987 4889999998743 35788999999999999988
Q ss_pred ---------eeeeecc-CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 674 ---------LYSQFTS-DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 674 ---------L~g~f~~-~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
+++++.. ++.+||||||+ +++|.+++.......+++..++.|+.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5566654 78899999999 999999998764567999999999999999999999999999999999999
Q ss_pred EccCC--cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCCh
Q 001952 744 VREDG--HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADP 821 (992)
Q Consensus 744 Ld~dg--~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~ 821 (992)
++.++ .++|+|||++..+......
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~------------------------------------------------------ 217 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKH------------------------------------------------------ 217 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCC------------------------------------------------------
T ss_pred EcCCCCceEEEecCcceeeccCCCcc------------------------------------------------------
Confidence 99998 8999999998543211000
Q ss_pred hhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCC-chHHHHHHHhh--
Q 001952 822 AAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG-NEETLANVVMQ-- 898 (992)
Q Consensus 822 ~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s-~~e~L~~Iv~~-- 898 (992)
............||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+......
T Consensus 218 -----------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 286 (352)
T 2jii_A 218 -----------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFV 286 (352)
T ss_dssp -----------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH
T ss_pred -----------ccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhcc
Confidence 0000111233579999999999999999999999999999999999999998764 33333333221
Q ss_pred --ccCCCC----CccchHHHHHHHHHhccCCcCCcCCC
Q 001952 899 --SLKFPD----SPLISFQARDLIRGLLIKEPENRLGS 930 (992)
Q Consensus 899 --~lk~P~----~~~vs~el~dLI~kcL~~DPekRPT~ 930 (992)
...+.. ...++.++.+||.+||..||.+||++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 324 (352)
T 2jii_A 287 DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY 324 (352)
T ss_dssp HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence 111111 12368999999999999999999993
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=349.67 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=196.3
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc--CCCCccceeeeeccC---
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML--DHPFLPTLYSQFTSD--- 681 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L--~HPNIVkL~g~f~~~--- 681 (992)
..++|++++.||+|+||.||+|.+. ++.||||++.... ...+..|.+++..+ +||||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 106 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence 3578999999999999999999884 7899999986432 22344566666554 899999999999876
Q ss_pred -CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc--------CeeeeecCCceEEEccCCcEEE
Q 001952 682 -NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML--------GVIYRDLKPENILVREDGHIML 752 (992)
Q Consensus 682 -~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~--------GIIHRDIKPeNILLd~dg~VKL 752 (992)
..+||||||+++++|.++++. ..+++..++.++.||+.||.|||.+ |||||||||+|||++.++.+||
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999976 4689999999999999999999998 9999999999999999999999
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++..+......
T Consensus 184 ~Dfg~a~~~~~~~~~----------------------------------------------------------------- 198 (337)
T 3mdy_A 184 ADLGLAVKFISDTNE----------------------------------------------------------------- 198 (337)
T ss_dssp CCCTTCEECC----------------------------------------------------------------------
T ss_pred EeCCCceeecccccc-----------------------------------------------------------------
Confidence 999998543210000
Q ss_pred cCCCCCCcCccccCCCccChhhhcCCCCCcc------ceeeehhhhhhhhccC----------CCCCCCCC----chHHH
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKGEGHGAA------VDWWTFGIFLYELLYG----------RTPFKGSG----NEETL 892 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~k------SDIWSLGVlLyELLTG----------r~PF~g~s----~~e~L 892 (992)
.........||+.|+|||++.+..++.. +|||||||+||||++| +.||.... ....+
T Consensus 199 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 275 (337)
T 3mdy_A 199 ---VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275 (337)
T ss_dssp -------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ---ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhh
Confidence 0001123479999999999998876655 9999999999999999 77776532 22333
Q ss_pred HHHHhh-ccCCCCC-----ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 893 ANVVMQ-SLKFPDS-----PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 893 ~~Iv~~-~lk~P~~-----~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
...+.. ......+ ..++.++.+||.+||..||.+||+ +.|+++|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 333322 2222221 246678999999999999999999 7777765
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.84 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=205.9
Q ss_pred cCceEEEEEccCCceEEEEEEEc----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CC
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELI----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DN 682 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~ 682 (992)
+.|++++.||+|+||+||++.+. .+++.||||++.... .......+.+|+++|+.++||||+++++++.+ ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 34599999999999999888653 478899999997542 22335668899999999999999999999986 46
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||+++++|.+++... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 889999999999999998763 58999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
..... ......
T Consensus 186 ~~~~~---------------------------------------------------------------------~~~~~~ 196 (318)
T 3lxp_A 186 EGHEY---------------------------------------------------------------------YRVRED 196 (318)
T ss_dssp TTCSE---------------------------------------------------------------------EEC---
T ss_pred ccccc---------------------------------------------------------------------cccccC
Confidence 11000 001122
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch--------------HHHHHHHhhccCCCCCccc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE--------------ETLANVVMQSLKFPDSPLI 908 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~--------------e~L~~Iv~~~lk~P~~~~v 908 (992)
..||..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+.+..+
T Consensus 197 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (318)
T 3lxp_A 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKC 276 (318)
T ss_dssp CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccc
Confidence 35788899999999999999999999999999999999999753211 1233344455566666778
Q ss_pred hHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 909 SFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 909 s~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
+.++.+||.+||..||.+||+ +.|+++
T Consensus 277 ~~~l~~li~~~l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 277 PAEVYHLMKNCWETEASFRPT----FENLIP 303 (318)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 999999999999999999999 666664
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=375.99 Aligned_cols=276 Identities=20% Similarity=0.276 Sum_probs=218.0
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC-CCccceeeeeccCCeEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH-PFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H-PNIVkL~g~f~~~~~ly 685 (992)
..++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+++++.+.| ++|..+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT-----CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc-----cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999998643 233457889999999987 55666666777888999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEE---ccCCcEEEEecccccccc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILL---d~dg~VKLsDFGLA~~l~ 762 (992)
|||||+ +++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||++..+.
T Consensus 80 lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999999 99999998754 3579999999999999999999999999999999999999 688999999999986542
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
...... .........
T Consensus 158 ~~~~~~-----------------------------------------------------------------~~~~~~~~~ 172 (483)
T 3sv0_A 158 DTSTHQ-----------------------------------------------------------------HIPYRENKN 172 (483)
T ss_dssp CTTTCC-----------------------------------------------------------------BCCCCCCCC
T ss_pred CCcccc-----------------------------------------------------------------ccccccccc
Confidence 110000 000011234
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc---hHHHHHHHhhccCCCC---CccchHHHHHHH
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN---EETLANVVMQSLKFPD---SPLISFQARDLI 916 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~---~e~L~~Iv~~~lk~P~---~~~vs~el~dLI 916 (992)
..||+.|+|||++.+..++.++|||||||+||||++|+.||.+... .+.+..+......... ...++.++.+||
T Consensus 173 ~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li 252 (483)
T 3sv0_A 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYF 252 (483)
T ss_dssp CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHH
T ss_pred cCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHH
Confidence 5799999999999999999999999999999999999999987554 2333333333222111 124688999999
Q ss_pred HHhccCCcCCcCCChHhH---HHH---HcCCCCCCCchhhhhcC
Q 001952 917 RGLLIKEPENRLGSQKGA---AEI---KQHPFFEGLNWALIRCA 954 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~a---eEI---LkHPfF~~lnw~~lr~~ 954 (992)
..||..||++||++.... .++ +.++|+..+||..++..
T Consensus 253 ~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~ 296 (483)
T 3sv0_A 253 HYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (483)
T ss_dssp HHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-
T ss_pred HHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccc
Confidence 999999999999965332 222 34899999999988653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=352.39 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=189.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHH--HHHcCCCCccceeeeec---
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREI--LRMLDHPFLPTLYSQFT--- 679 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieI--Lk~L~HPNIVkL~g~f~--- 679 (992)
.+..++|++++.||+|+||.||+|.+ +++.||||++.... ...+..|.++ +..++|+||+++++++.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 45678999999999999999999977 67899999997532 1223344444 44589999999997543
Q ss_pred --cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc---------CeeeeecCCceEEEccCC
Q 001952 680 --SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML---------GVIYRDLKPENILVREDG 748 (992)
Q Consensus 680 --~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~---------GIIHRDIKPeNILLd~dg 748 (992)
....+||||||+++|+|.+++... .+++..++.++.||+.||.|||+. |||||||||+||||+.++
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC
Confidence 344679999999999999999763 468899999999999999999999 999999999999999999
Q ss_pred cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccC
Q 001952 749 HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828 (992)
Q Consensus 749 ~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~ 828 (992)
.+||+|||++..+.......
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~------------------------------------------------------------ 177 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVR------------------------------------------------------------ 177 (336)
T ss_dssp CEEECCCTTCEECSSSSCC-------------------------------------------------------------
T ss_pred cEEEeeccceeecccccccC------------------------------------------------------------
Confidence 99999999986543111000
Q ss_pred CccccCCCCCCcCccccCCCccChhhhcC-------CCCCccceeeehhhhhhhhccCCCCCCCCCc-------------
Q 001952 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKG-------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGN------------- 888 (992)
Q Consensus 829 ~~~~a~~~~~~s~s~vGT~~Y~APEvL~g-------~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~------------- 888 (992)
............||+.|+|||++.+ ..++.++|||||||+||||++|..||.....
T Consensus 178 ----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~ 253 (336)
T 3g2f_A 178 ----PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253 (336)
T ss_dssp ------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHC
T ss_pred ----ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccC
Confidence 0000111234579999999999987 3456789999999999999999777643221
Q ss_pred ----hHHHHHHHhhcc---CCC----CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHH
Q 001952 889 ----EETLANVVMQSL---KFP----DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIK 938 (992)
Q Consensus 889 ----~e~L~~Iv~~~l---k~P----~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEIL 938 (992)
.+.+...+.... .++ ....++.++.+||.+||..||++||+ +.|++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l 310 (336)
T 3g2f_A 254 NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAE 310 (336)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHH
T ss_pred CCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHH
Confidence 122222222221 111 11235668999999999999999999 55553
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=353.35 Aligned_cols=258 Identities=23% Similarity=0.297 Sum_probs=207.9
Q ss_pred cccccCceEEEEEccCCceEEEEEEE----cCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAEL----IGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~----~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
.+..++|++++.||+|+||.||+|.+ ..+++.||||++... .......+.+|+++|+.++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 34567899999999999999999984 567899999999753 23345678899999999999999999999876
Q ss_pred CC--eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 681 DN--LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 681 ~~--~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.+ .++|||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 44 789999999999999998865 356899999999999999999999999999999999999999999999999997
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
......... ..
T Consensus 193 ~~~~~~~~~---------------------------------------------------------------------~~ 203 (326)
T 2w1i_A 193 KVLPQDKEY---------------------------------------------------------------------YK 203 (326)
T ss_dssp EECCSSCSE---------------------------------------------------------------------EE
T ss_pred hhccccccc---------------------------------------------------------------------cc
Confidence 543211000 00
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCc------------h---HHHHHHHhhccCCC
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN------------E---ETLANVVMQSLKFP 903 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~------------~---e~L~~Iv~~~lk~P 903 (992)
......++..|+|||++.+..++.++|||||||+||||++|..||..... . ..+...+......+
T Consensus 204 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (326)
T 2w1i_A 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP 283 (326)
T ss_dssp CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC
T ss_pred cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC
Confidence 01123477889999999999899999999999999999999999864210 0 11223334444555
Q ss_pred CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 904 DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 904 ~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.+..++.++.+||.+||..||++||+ +.||++
T Consensus 284 ~~~~~~~~l~~li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 284 RPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CCCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 56678999999999999999999999 666654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=369.24 Aligned_cols=257 Identities=26% Similarity=0.350 Sum_probs=196.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyL 686 (992)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++.... ...+.+|+.+|+.+ +||||+++++++.+.+.+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 3456667889999999998764 4578999999986532 23567899999876 89999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCC-----CCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC-------------C
Q 001952 687 VMEYCPGGDLHVLRQKQLGKC-----FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED-------------G 748 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~-----Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d-------------g 748 (992)
|||||. |+|.+++....... ..+..++.++.||+.||+|||++|||||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999994 69999987642111 1233467899999999999999999999999999999754 4
Q ss_pred cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccC
Q 001952 749 HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828 (992)
Q Consensus 749 ~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~ 828 (992)
.+||+|||++..+......
T Consensus 166 ~~kL~DFG~a~~~~~~~~~------------------------------------------------------------- 184 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSS------------------------------------------------------------- 184 (434)
T ss_dssp EEEECCCTTCEECCC-----------------------------------------------------------------
T ss_pred EEEEcccccceecCCCCcc-------------------------------------------------------------
Confidence 8999999998543210000
Q ss_pred CccccCCCCCCcCccccCCCccChhhhcC-------CCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhcc
Q 001952 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKG-------EGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSL 900 (992)
Q Consensus 829 ~~~~a~~~~~~s~s~vGT~~Y~APEvL~g-------~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~l 900 (992)
.........||+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+....+ ..++....
T Consensus 185 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~ 255 (434)
T 2rio_A 185 -------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIF 255 (434)
T ss_dssp -----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCC
T ss_pred -------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCC
Confidence 0001123469999999999976 568999999999999999999 999997654443 34444443
Q ss_pred CCCCC-----ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 901 KFPDS-----PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 901 k~P~~-----~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.++.. ..++.++.+||.+||..||.+||+ +.++++||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 256 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred CcccccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 33322 235688999999999999999999 9999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=365.40 Aligned_cols=256 Identities=17% Similarity=0.248 Sum_probs=201.4
Q ss_pred cCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec-cCCeE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT-SDNLS 684 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~-~~~~l 684 (992)
..|.+.+.||+|+||.||+|.+..+ +..||||.++.. ........+.+|+.+|+.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 4588899999999999999987543 346899998642 12234567889999999999999999999865 45688
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999999754 356889999999999999999999999999999999999999999999999997443110
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.. ..........
T Consensus 246 ~~--------------------------------------------------------------------~~~~~~~~~~ 257 (373)
T 3c1x_A 246 EF--------------------------------------------------------------------DSVHNKTGAK 257 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc--------------------------------------------------------------------ccccccCCCC
Confidence 00 0000112335
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
||+.|+|||++.+..++.++|||||||+||||++ |.+||.+.+..+....+... .....+..++..+.+||.+||..|
T Consensus 258 ~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~-~~~~~p~~~~~~l~~li~~cl~~d 336 (373)
T 3c1x_A 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLYEVMLKCWHPK 336 (373)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred CcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCC
Confidence 7889999999999999999999999999999999 78888887776666555443 334445568999999999999999
Q ss_pred cCCcCCChHhHHHHHcC
Q 001952 924 PENRLGSQKGAAEIKQH 940 (992)
Q Consensus 924 PekRPT~~~~aeEILkH 940 (992)
|++||+ +.|++++
T Consensus 337 p~~RPs----~~ell~~ 349 (373)
T 3c1x_A 337 AEMRPS----FSELVSR 349 (373)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred hhhCcC----HHHHHHH
Confidence 999999 6666653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.95 Aligned_cols=233 Identities=29% Similarity=0.473 Sum_probs=190.5
Q ss_pred ccCceEE-EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHH-HHcCCCCccceeeeecc----C
Q 001952 608 LRHFNLL-QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREIL-RMLDHPFLPTLYSQFTS----D 681 (992)
Q Consensus 608 ~~~Yeil-r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieIL-k~L~HPNIVkL~g~f~~----~ 681 (992)
.++|.++ +.||+|+||.||+|.+..+++.||||++... ..+.+|++++ +.++||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678887 7899999999999999999999999999642 3456788887 66699999999999876 6
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEecccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLS 758 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA 758 (992)
..+||||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998865567999999999999999999999999999999999999998 788999999986
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
....
T Consensus 168 ~~~~---------------------------------------------------------------------------- 171 (299)
T 3m2w_A 168 KETT---------------------------------------------------------------------------- 171 (299)
T ss_dssp EECT----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHH----hhccCCCCC--ccchHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV----MQSLKFPDS--PLISFQA 912 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv----~~~lk~P~~--~~vs~el 912 (992)
+..++.++|||||||+||||++|+.||.+.........+. .....++.. ..++.++
T Consensus 172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T 3m2w_A 172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 233 (299)
T ss_dssp ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHH
T ss_pred ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHH
Confidence 1235678999999999999999999998765433221111 111111111 3478899
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.+||.+||..||.+||+ +.|+|+||||...
T Consensus 234 ~~li~~~l~~dP~~Rps----~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 234 KMLIRNLLKTEPTQRMT----ITEFMNHPWIMQS 263 (299)
T ss_dssp HHHHHHHTCSSTTTSCC----HHHHHTSHHHHTG
T ss_pred HHHHHHHcccChhhCCC----HHHHhcChhhccc
Confidence 99999999999999999 9999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.78 Aligned_cols=260 Identities=21% Similarity=0.255 Sum_probs=208.1
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
..++..++|++.+.||+|+||.||+|.+.+ .||+|+++.... .......+.+|+.+++.++|+||+++++++...+
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 345667899999999999999999998854 399999875421 2233456678999999999999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ++.++|+|||++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 999999999999999998764 34689999999999999999999999999999999999998 6799999999974321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... .........
T Consensus 181 ~~~~-------------------------------------------------------------------~~~~~~~~~ 193 (319)
T 2y4i_B 181 VLQA-------------------------------------------------------------------GRREDKLRI 193 (319)
T ss_dssp --------------------------------------------------------------------------CCSCBC
T ss_pred cccc-------------------------------------------------------------------ccccccccc
Confidence 1000 000111223
Q ss_pred cccCCCccChhhhcC---------CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHH
Q 001952 843 FVGTHEYLAPEIIKG---------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQAR 913 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g---------~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~ 913 (992)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+............++.++.
T Consensus 194 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 273 (319)
T 2y4i_B 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEIS 273 (319)
T ss_dssp CSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHH
T ss_pred CCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHH
Confidence 458999999999975 34789999999999999999999999988777666665554433333345788999
Q ss_pred HHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 914 DLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 914 dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
+||.+||..||++||+ +.++++
T Consensus 274 ~li~~~l~~~p~~Rpt----~~~l~~ 295 (319)
T 2y4i_B 274 DILLFCWAFEQEERPT----FTKLMD 295 (319)
T ss_dssp HHHHHHHCSSTTTSCC----HHHHHH
T ss_pred HHHHHHhcCChhhCcC----HHHHHH
Confidence 9999999999999999 777765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=383.18 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=205.3
Q ss_pred ccccCceEEE-EEccCCceEEEEEEEc--CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQ-KLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr-~LGsG~FGtVYlA~~~--~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
+..++|.+.+ .||+|+||.||+|.+. .++..||||+++... .......+.+|+++|+.++|||||++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 3455666666 8999999999999876 356789999997541 23345678999999999999999999999976 5
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||+++|+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 699999999999999998754 4569999999999999999999999999999999999999999999999999974432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
..... ......
T Consensus 488 ~~~~~---------------------------------------------------------------------~~~~~~ 498 (613)
T 2ozo_A 488 ADDSY---------------------------------------------------------------------YTARSA 498 (613)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCce---------------------------------------------------------------------eeeccC
Confidence 10000 000112
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ....+.+..++.++.+||.+||.
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl~ 577 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWI 577 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHTTC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCCcCCHHHHHHHHHHcC
Confidence 236788999999999999999999999999999998 9999999888777766543 44455556689999999999999
Q ss_pred CCcCCcCC
Q 001952 922 KEPENRLG 929 (992)
Q Consensus 922 ~DPekRPT 929 (992)
.||++||+
T Consensus 578 ~dP~~RPs 585 (613)
T 2ozo_A 578 YKWEDRPD 585 (613)
T ss_dssp SSTTTSCC
T ss_pred CChhHCcC
Confidence 99999999
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.76 Aligned_cols=253 Identities=21% Similarity=0.238 Sum_probs=199.7
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH-HhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-ARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVME 689 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l-~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmE 689 (992)
|...+.||+|+||.||+|.+ +++.||||++..... ........+.+|+.+|+.++||||+++++++...+..|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 34458899999999999987 577899999864321 122335678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 690 YCPGGDLHVLRQKQL-GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 690 y~~GGSL~~lLkk~~-~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--- 187 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--- 187 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS---
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc---
Confidence 999999999987532 3568999999999999999999999999999999999999999999999999974321100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
.........||+.
T Consensus 188 -------------------------------------------------------------------~~~~~~~~~g~~~ 200 (307)
T 2nru_A 188 -------------------------------------------------------------------QTVMTSRIVGTTA 200 (307)
T ss_dssp -------------------------------------------------------------------SCEECSSCCSCGG
T ss_pred -------------------------------------------------------------------ccccccccCCCcC
Confidence 0001123468999
Q ss_pred ccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh---h-c---------cCCCCCccchHHHHHH
Q 001952 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM---Q-S---------LKFPDSPLISFQARDL 915 (992)
Q Consensus 849 Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~---~-~---------lk~P~~~~vs~el~dL 915 (992)
|+|||++.+. ++.++|||||||++|+|++|..||.+......+..+.. . . ........++..+.+|
T Consensus 201 y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 279 (307)
T 2nru_A 201 YMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV 279 (307)
T ss_dssp GCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHH
T ss_pred cCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHH
Confidence 9999998764 78999999999999999999999987554332222211 1 0 0011223456789999
Q ss_pred HHHhccCCcCCcCCChHhHHHHHcC
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEILkH 940 (992)
|.+||..||.+||+ +.+++++
T Consensus 280 i~~cl~~~p~~Rps----~~~l~~~ 300 (307)
T 2nru_A 280 ASQCLHEKKNKRPD----IKKVQQL 300 (307)
T ss_dssp HHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHcCCCcccCcC----HHHHHHH
Confidence 99999999999999 7777653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=383.79 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=204.1
Q ss_pred CceEE-EEEccCCceEEEEEEEc--CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 610 HFNLL-QKLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 610 ~Yeil-r~LGsG~FGtVYlA~~~--~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
.+.+. +.||+|+||.||+|.+. .+++.||||+++... ........+.+|+++|+.++|||||++++++.. +.++|
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 47999999999999654 567899999998652 223345678999999999999999999999864 56899
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+.....
T Consensus 447 v~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred EEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 99999999999999764 6799999999999999999999999999999999999999999999999999854321100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
. ........||
T Consensus 525 ~---------------------------------------------------------------------~~~~~~~~~t 535 (635)
T 4fl3_A 525 Y---------------------------------------------------------------------YKAQTHGKWP 535 (635)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred c---------------------------------------------------------------------cccccCCCCc
Confidence 0 0011223478
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+. .....+.+..++.++.+||.+||..||+
T Consensus 536 ~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~ 614 (635)
T 4fl3_A 536 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-KGERMGCPAGCPREMYDLMNLCWTYDVE 614 (635)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSTT
T ss_pred eeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHHcCCCHh
Confidence 89999999999999999999999999999998 999999887776665544 4445555567899999999999999999
Q ss_pred CcCCChHhHHHHH
Q 001952 926 NRLGSQKGAAEIK 938 (992)
Q Consensus 926 kRPT~~~~aeEIL 938 (992)
+||+ +++|+
T Consensus 615 ~RPs----~~~l~ 623 (635)
T 4fl3_A 615 NRPG----FAAVE 623 (635)
T ss_dssp TSCC----HHHHH
T ss_pred HCcC----HHHHH
Confidence 9999 55554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=347.44 Aligned_cols=251 Identities=24% Similarity=0.296 Sum_probs=199.9
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHH--cCCCCccceeeeeccCC--
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM--LDHPFLPTLYSQFTSDN-- 682 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~--L~HPNIVkL~g~f~~~~-- 682 (992)
..++|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++...+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 356899999999999999999988 5889999999743 23456788999888 78999999999998775
Q ss_pred --eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh--------hcCeeeeecCCceEEEccCCcEEE
Q 001952 683 --LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH--------MLGVIYRDLKPENILVREDGHIML 752 (992)
Q Consensus 683 --~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH--------s~GIIHRDIKPeNILLd~dg~VKL 752 (992)
.+|+||||+++++|.+++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++.++|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL 188 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred cceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence 89999999999999999976 46899999999999999999999 899999999999999999999999
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++.........
T Consensus 189 ~Dfg~~~~~~~~~~~----------------------------------------------------------------- 203 (342)
T 1b6c_B 189 ADLGLAVRHDSATDT----------------------------------------------------------------- 203 (342)
T ss_dssp CCCTTCEEEETTTTE-----------------------------------------------------------------
T ss_pred EECCCceeccccccc-----------------------------------------------------------------
Confidence 999997543211000
Q ss_pred cCCCCCCcCccccCCCccChhhhcCCC------CCccceeeehhhhhhhhccC----------CCCCCCCC----chHHH
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKGEG------HGAAVDWWTFGIFLYELLYG----------RTPFKGSG----NEETL 892 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g~~------~s~kSDIWSLGVlLyELLTG----------r~PF~g~s----~~e~L 892 (992)
.........||+.|+|||++.+.. ++.++|||||||+||||++| ..||.... ..+.+
T Consensus 204 ---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 280 (342)
T 1b6c_B 204 ---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280 (342)
T ss_dssp ---EEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ---cccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHH
Confidence 000112346999999999998763 33689999999999999999 78987643 22333
Q ss_pred HHHHh-hccCCCCC-----ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 893 ANVVM-QSLKFPDS-----PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 893 ~~Iv~-~~lk~P~~-----~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
...+. .......+ ..++..+.+||.+||..||++||+ +.++++|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 33332 22222221 134568999999999999999999 7777765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=361.76 Aligned_cols=246 Identities=20% Similarity=0.236 Sum_probs=190.6
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH-----hhcchhHHHHHHHHHHHcC--------------
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA-----RRKKMPRAQTEREILRMLD-------------- 667 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~-----~~~~~~~~~~EieILk~L~-------------- 667 (992)
..++|++++.||+|+||+||+|.+ +++.||||++...... .......+.+|+.+|+.++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 457899999999999999999998 6799999999754221 1223467889999999886
Q ss_pred ------------CCCccceeeeecc-------------CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHH
Q 001952 668 ------------HPFLPTLYSQFTS-------------DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722 (992)
Q Consensus 668 ------------HPNIVkL~g~f~~-------------~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~ 722 (992)
||||++++++|.. .+.+||||||+++|+|.+.+.+ ..+++..++.|+.||+.
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence 5555555555554 7899999999999976554433 46899999999999999
Q ss_pred HHHHHh-hcCeeeeecCCceEEEccCC--------------------cEEEEeccccccccCCcccccCCCCCCCCccCC
Q 001952 723 ALEYLH-MLGVIYRDLKPENILVREDG--------------------HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSG 781 (992)
Q Consensus 723 GL~YLH-s~GIIHRDIKPeNILLd~dg--------------------~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sg 781 (992)
||+||| ++|||||||||+||||+.++ .+||+|||+++...
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~------------------- 233 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER------------------- 233 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE-------------------
T ss_pred HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC-------------------
Confidence 999999 99999999999999999887 89999999974321
Q ss_pred CCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCC
Q 001952 782 PCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHG 861 (992)
Q Consensus 782 p~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s 861 (992)
....+||+.|+|||++.+.. +
T Consensus 234 ----------------------------------------------------------~~~~~gt~~y~aPE~~~g~~-~ 254 (336)
T 2vuw_A 234 ----------------------------------------------------------DGIVVFCDVSMDEDLFTGDG-D 254 (336)
T ss_dssp ----------------------------------------------------------TTEEECCCCTTCSGGGCCCS-S
T ss_pred ----------------------------------------------------------CCcEEEeecccChhhhcCCC-c
Confidence 01237999999999999876 8
Q ss_pred ccceeeehhhh-hhhhccCCCCCCCCCchHHHHHHHhhccCCCC------CccchHHHHHHHHHhccCCcCCcCCChHhH
Q 001952 862 AAVDWWTFGIF-LYELLYGRTPFKGSGNEETLANVVMQSLKFPD------SPLISFQARDLIRGLLIKEPENRLGSQKGA 934 (992)
Q Consensus 862 ~kSDIWSLGVl-LyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~------~~~vs~el~dLI~kcL~~DPekRPT~~~~a 934 (992)
.++||||||++ .+++++|..||.+......+...+.....+.. ...++.++++||.+||.+| + +
T Consensus 255 ~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s----a 325 (336)
T 2vuw_A 255 YQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S----A 325 (336)
T ss_dssp HHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S----H
T ss_pred cceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C----H
Confidence 99999998777 78899999999542111112111211111111 1247889999999999987 7 9
Q ss_pred HHHH-cCCCCC
Q 001952 935 AEIK-QHPFFE 944 (992)
Q Consensus 935 eEIL-kHPfF~ 944 (992)
+|+| +||||+
T Consensus 326 ~e~l~~Hp~f~ 336 (336)
T 2vuw_A 326 TDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHCGGGC
T ss_pred HHHHhcCCCcC
Confidence 9999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=370.19 Aligned_cols=255 Identities=20% Similarity=0.188 Sum_probs=198.1
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC-CCcccee----------
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH-PFLPTLY---------- 675 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H-PNIVkL~---------- 675 (992)
...+|.+.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.+.| .|+..+.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568899999999999999999999999999999984433344556778999999999977 3221111
Q ss_pred -----------eeecc-----CCeEEEEEEecCCCChHHHHHhh-----cCCCCCHHHHHHHHHHHHHHHHHHhhcCeee
Q 001952 676 -----------SQFTS-----DNLSCLVMEYCPGGDLHVLRQKQ-----LGKCFSEPAARFYVAEVLLALEYLHMLGVIY 734 (992)
Q Consensus 676 -----------g~f~~-----~~~lyLVmEy~~GGSL~~lLkk~-----~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIH 734 (992)
.++.. ...++++|+++ +++|.++++.. ....+++..++.++.||+.||+|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11111 22467788876 89999888522 2345778889999999999999999999999
Q ss_pred eecCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCcccccc
Q 001952 735 RDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKT 814 (992)
Q Consensus 735 RDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt 814 (992)
|||||+||||+.++.+||+|||++.....
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~--------------------------------------------------- 263 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA--------------------------------------------------- 263 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTE---------------------------------------------------
T ss_pred CCcccceEEEecCCeEEEEeccceeecCC---------------------------------------------------
Confidence 99999999999999999999999743210
Q ss_pred CCCCCChhhhhccCCccccCCCCCCcCccccCCCccChhhh----------cCCCCCccceeeehhhhhhhhccCCCCCC
Q 001952 815 RKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEII----------KGEGHGAAVDWWTFGIFLYELLYGRTPFK 884 (992)
Q Consensus 815 ~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL----------~g~~~s~kSDIWSLGVlLyELLTGr~PF~ 884 (992)
.....+| +.|+|||++ .+..++.++|||||||+||||++|+.||.
T Consensus 264 ------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~ 318 (413)
T 3dzo_A 264 ------------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318 (413)
T ss_dssp ------------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred ------------------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 0123467 899999999 55557889999999999999999999998
Q ss_pred CCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 885 GSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 885 g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
+.+..+.+..+ +.....++.++.+||.+||..||++||+ +.++++||||+.+..
T Consensus 319 ~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 319 DDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRT 372 (413)
T ss_dssp TTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHH
T ss_pred CcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHHH
Confidence 76554433332 2222357899999999999999999999 999999999998754
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=374.39 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=209.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
++..++|++.+.||+|+||.||+|.+..+ +..||||++.... .......+.+|+.+|+.++||||+++++++. +
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34567899999999999999999998643 4679999987532 2233467889999999999999999999985 4
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+||||||+++|+|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 5689999999999999998864 346899999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.... .....
T Consensus 542 ~~~~-----------------------------------------------------------------------~~~~~ 550 (656)
T 2j0j_A 542 EDST-----------------------------------------------------------------------YYKAS 550 (656)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCCc-----------------------------------------------------------------------ceecc
Confidence 1000 00011
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+... ...+.+..++..+.+||.+||
T Consensus 551 ~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~l 629 (656)
T 2j0j_A 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTKCW 629 (656)
T ss_dssp ---CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCCccccHHHHHHHHHHc
Confidence 2346789999999999999999999999999999997 99999988777777665543 344455568999999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||.+||+ +.+|++
T Consensus 630 ~~dP~~RPs----~~el~~ 644 (656)
T 2j0j_A 630 AYDPSRRPR----FTELKA 644 (656)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred CCChhHCcC----HHHHHH
Confidence 999999999 666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.67 Aligned_cols=230 Identities=19% Similarity=0.163 Sum_probs=188.2
Q ss_pred eccc-ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 602 QYGS-IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 602 ~~ge-i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
..|. +..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++..
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 3454 556789999999999999999999999999999999986543333445678899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+..||||||++|++|.++++.. .....+..|+.||+.||+|||++||+||||||+||||+.+|.++|+++|.
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--- 175 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--- 175 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---
T ss_pred CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---
Confidence 99999999999999999998642 45667888999999999999999999999999999999999999885542
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
T Consensus 176 -------------------------------------------------------------------------------- 175 (286)
T 3uqc_A 176 -------------------------------------------------------------------------------- 175 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHH---HHHhhccCCC--CCccchHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA---NVVMQSLKFP--DSPLISFQARDL 915 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~---~Iv~~~lk~P--~~~~vs~el~dL 915 (992)
++ .++.++|||||||+||||+||+.||.+.+..+.+. ..+......+ ....++.++.+|
T Consensus 176 ---------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (286)
T 3uqc_A 176 ---------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239 (286)
T ss_dssp ---------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred ---------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence 22 26789999999999999999999999876543221 1111111110 113478899999
Q ss_pred HHHhccCCcCCcCCChHhHHHHHc
Q 001952 916 IRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 916 I~kcL~~DPekRPT~~~~aeEILk 939 (992)
|.+||..||.+| + +.|+++
T Consensus 240 i~~~l~~dP~~R-s----~~el~~ 258 (286)
T 3uqc_A 240 AARSVQGDGGIR-S----ASTLLN 258 (286)
T ss_dssp HHHHHCTTSSCC-C----HHHHHH
T ss_pred HHHHcccCCccC-C----HHHHHH
Confidence 999999999999 8 666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=386.94 Aligned_cols=265 Identities=27% Similarity=0.394 Sum_probs=208.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc------C
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------D 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------~ 681 (992)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+++|+.++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999987532 22334668899999999999999999998765 6
Q ss_pred CeEEEEEEecCCCChHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCc---EEEEeccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQL-GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGH---IMLTDFDL 757 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~-~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~---VKLsDFGL 757 (992)
+..||||||++|++|.+++.... ...+++..++.|+.||+.||+|||++||+||||||+|||++.++. ++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 77899999999999999988643 236899999999999999999999999999999999999997764 99999999
Q ss_pred cccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCC
Q 001952 758 SLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTD 837 (992)
Q Consensus 758 A~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~ 837 (992)
+..... .
T Consensus 171 a~~~~~-------------------------------------------------------------------------~ 177 (676)
T 3qa8_A 171 AKELDQ-------------------------------------------------------------------------G 177 (676)
T ss_dssp CCBTTS-------------------------------------------------------------------------C
T ss_pred cccccc-------------------------------------------------------------------------c
Confidence 743210 0
Q ss_pred CCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH--------------HhhccCC-
Q 001952 838 ARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV--------------VMQSLKF- 902 (992)
Q Consensus 838 ~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I--------------v~~~lk~- 902 (992)
.......||+.|+|||++.+..++.++|||||||++|||++|..||.+......+... ..+...+
T Consensus 178 ~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~ 257 (676)
T 3qa8_A 178 ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFS 257 (676)
T ss_dssp CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCC
T ss_pred cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccc
Confidence 0112346899999999999999999999999999999999999999765332221100 0011111
Q ss_pred ---C----CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 903 ---P----DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 903 ---P----~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
+ ....++..+.+||.+||..||++||+ +.++|+||||+.++.-.-
T Consensus 258 ~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 258 SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQALDSILS 309 (676)
T ss_dssp SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHHHHHHC
T ss_pred cccCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHHHHHHh
Confidence 1 12336789999999999999999999 899999999998764433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=374.40 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=197.1
Q ss_pred cccccccCceEEEEEccCCceEEEEEEEcC-CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 603 YGSIGLRHFNLLQKLGCGDIGTVYLAELIG-TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 603 ~gei~~~~Yeilr~LGsG~FGtVYlA~~~~-tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
.+.+..++|++++.||+|+||.||+|.+.. +++.||||++.... .......+.+|+.+|+.++||||++++++|...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 345556899999999999999999999976 78999999986431 223345678999999999999999999999876
Q ss_pred Ce-----EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecc
Q 001952 682 NL-----SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 682 ~~-----lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
+. .||||||++|++|.+++.. .+++..++.|+.||+.||.|||++|||||||||+||||+.+ .+||+|||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecc
Confidence 55 7999999999999887653 68999999999999999999999999999999999999975 89999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++.....
T Consensus 227 ~a~~~~~------------------------------------------------------------------------- 233 (681)
T 2pzi_A 227 AVSRINS------------------------------------------------------------------------- 233 (681)
T ss_dssp TCEETTC-------------------------------------------------------------------------
T ss_pred cchhccc-------------------------------------------------------------------------
Confidence 9743210
Q ss_pred CCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLI 916 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI 916 (992)
.....||+.|+|||++.+.. +.++|||||||+||||++|..||.+...... ........++..+.+||
T Consensus 234 ---~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li 301 (681)
T 2pzi_A 234 ---FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL--------PEDDPVLKTYDSYGRLL 301 (681)
T ss_dssp ---CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC--------CTTCHHHHHCHHHHHHH
T ss_pred ---CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc--------cccccccccCHHHHHHH
Confidence 02346999999999998764 8999999999999999999998875321100 00000012456899999
Q ss_pred HHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
.+||..||.+||+ ..+++.|+|+.-
T Consensus 302 ~~~l~~dP~~R~~----~~~~l~~~l~~~ 326 (681)
T 2pzi_A 302 RRAIDPDPRQRFT----TAEEMSAQLTGV 326 (681)
T ss_dssp HHHTCSSGGGSCS----SHHHHHHHHHHH
T ss_pred hhhccCChhhCCC----HHHHHHHHHHHH
Confidence 9999999999999 566666766643
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=298.78 Aligned_cols=191 Identities=15% Similarity=0.110 Sum_probs=134.5
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHH-------HhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCCeEEE
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-------ARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l-------~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~~lyL 686 (992)
..++.|++|.+..++..-.|+.|++|++.+... ........+.+|+++|+++ .|+||+++++++++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 347788888887777767788899999965321 1223446789999999999 69999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
|||||+|++|.+++... +++++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+...
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-- 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-- 392 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence 99999999999999874 566653 58899999999999999999999999999999999999999998442100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.......+||
T Consensus 393 ----------------------------------------------------------------------~~~~~t~vGT 402 (569)
T 4azs_A 393 ----------------------------------------------------------------------CSWPTNLVQS 402 (569)
T ss_dssp -----------------------------------------------------------------------CCSHHHHHH
T ss_pred ----------------------------------------------------------------------CccccCceec
Confidence 0112346899
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPF 883 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF 883 (992)
+.|||||++.+. +...+|+|++|+++++|+++..+|
T Consensus 403 p~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 403 FFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp HHHHHHHHC------------------CCCCTTHHHH
T ss_pred hhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 999999999875 567899999999999998765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.2e-26 Score=264.42 Aligned_cols=194 Identities=18% Similarity=0.159 Sum_probs=143.6
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEechh-----HHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNE-----FLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~-----~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
...+.||+|+||.||+|.+ .++.+++|.+... ..........+.+|+++|+.++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 3356899999999999954 5667889876432 11222334568999999999999999966666667777899
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||++|++|.+++.. ++.|+.||+.||+|||++|||||||||+|||++. .+||+|||+++.......
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999998764 5679999999999999999999999999999998 999999999855321000
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
. ...+ ......+.||
T Consensus 485 ~------------------------------------------------------~~~~-----------~~~~~~~~GT 499 (540)
T 3en9_A 485 K------------------------------------------------------AVDL-----------IVFKKAVLST 499 (540)
T ss_dssp H------------------------------------------------------HHHH-----------HHHHHHHHHH
T ss_pred c------------------------------------------------------ccch-----------hhhhhhhcCC
Confidence 0 0000 0011346799
Q ss_pred CCccChhhhcC--CCCCccceeeehhhhhhhhccCCCCCC
Q 001952 847 HEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFK 884 (992)
Q Consensus 847 ~~Y~APEvL~g--~~~s~kSDIWSLGVlLyELLTGr~PF~ 884 (992)
+.|||||++.+ ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 500 ~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 500 HHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 99999999987 567888999999988888877766653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-23 Score=224.01 Aligned_cols=135 Identities=16% Similarity=0.131 Sum_probs=109.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---------------cchhHHHHHHHHHHHcCCCCccc
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---------------KKMPRAQTEREILRMLDHPFLPT 673 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---------------~~~~~~~~EieILk~L~HPNIVk 673 (992)
..|.+.+.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+++|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3456669999999999999999 8899999999974321111 12356789999999998 5 67
Q ss_pred eeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEE
Q 001952 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLT 753 (992)
Q Consensus 674 L~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLs 753 (992)
+++++.. +..||||||++|++|.+ +. ......++.||+.||.|||++|||||||||+|||++ +|.++|+
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~ 234 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWII 234 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEEC
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEE
Confidence 7765544 55699999999999976 21 123557999999999999999999999999999999 9999999
Q ss_pred ecccc
Q 001952 754 DFDLS 758 (992)
Q Consensus 754 DFGLA 758 (992)
|||++
T Consensus 235 DFG~a 239 (282)
T 1zar_A 235 DFPQS 239 (282)
T ss_dssp CCTTC
T ss_pred ECCCC
Confidence 99986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=191.64 Aligned_cols=139 Identities=17% Similarity=0.168 Sum_probs=107.7
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeE--EEEEEechhHHHhh---------------------cchhHHHHHHHHHHHcC
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCL--FAIKVMDNEFLARR---------------------KKMPRAQTEREILRMLD 667 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~--VAIKvIkk~~l~~~---------------------~~~~~~~~EieILk~L~ 667 (992)
|.+.+.||+|+||.||+|.+..+|+. ||||+++....... .....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999778888 99999754311100 01135788999999998
Q ss_pred CCCc--cceeeeeccCCeEEEEEEecCC-C----ChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh-hcCeeeeecCC
Q 001952 668 HPFL--PTLYSQFTSDNLSCLVMEYCPG-G----DLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH-MLGVIYRDLKP 739 (992)
Q Consensus 668 HPNI--VkL~g~f~~~~~lyLVmEy~~G-G----SL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLH-s~GIIHRDIKP 739 (992)
|++| +.++++ +..||||||+.+ | .|.++... +++..+..++.||+.||.||| .+|||||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8864 444432 356899999932 3 67665432 235567889999999999999 99999999999
Q ss_pred ceEEEccCCcEEEEecccccc
Q 001952 740 ENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 740 eNILLd~dg~VKLsDFGLA~~ 760 (992)
+|||++. .++|+|||++..
T Consensus 200 ~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp TSEEESS--SEEECCCTTCEE
T ss_pred HHEEEcC--cEEEEECccccc
Confidence 9999998 899999999844
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=8.7e-17 Score=182.23 Aligned_cols=137 Identities=17% Similarity=0.217 Sum_probs=96.0
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh------hc-----chhH--------HHHHHHHHHHcCCCCc
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR------RK-----KMPR--------AQTEREILRMLDHPFL 671 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~------~~-----~~~~--------~~~EieILk~L~HPNI 671 (992)
|.+.+.||.|+||.||+|.+ .+|+.||||+++...... +. .... ..+|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 89999999999999999987 468899999986421100 00 0001 1245555555543333
Q ss_pred cceeeeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC---
Q 001952 672 PTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG--- 748 (992)
Q Consensus 672 VkL~g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg--- 748 (992)
.-. ..+... ..+|||||++|+.|..+. .......++.||+.+|.|||++|||||||||.||||+.+|
T Consensus 176 ~vp-~p~~~~-~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVP-EPIAQS-RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCC-CEEEEE-TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCC-eeeecc-CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 211 111111 237999999998885432 1223466889999999999999999999999999999877
Q ss_pred -------cEEEEecccc
Q 001952 749 -------HIMLTDFDLS 758 (992)
Q Consensus 749 -------~VKLsDFGLA 758 (992)
.+.|+||+-+
T Consensus 246 d~~~~~~~~~iID~~Q~ 262 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQM 262 (397)
T ss_dssp CTTSEEEEEEECCCTTC
T ss_pred cccccccceEEEEeCCc
Confidence 3899999965
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-11 Score=129.30 Aligned_cols=139 Identities=17% Similarity=0.156 Sum_probs=111.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyL 686 (992)
+..|.+...++.|+++.||++.. .+..+++|+...... .....+.+|+.+|+.+. +..+.++++++...+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 35688889999999999999975 357899999875321 22345788999999984 6778899999998899999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM------------------------------------- 729 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs------------------------------------- 729 (992)
||||++|.+|..... +......++.+++.+|..||.
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999876521 122344678899999999998
Q ss_pred ----------------------cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 730 ----------------------LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 730 ----------------------~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
..++|+|++|.|||++.++.+.|+||+.+
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 45999999999999987666779999986
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.16 E-value=7.3e-11 Score=121.19 Aligned_cols=134 Identities=19% Similarity=0.113 Sum_probs=98.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeeeeccCCeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQFTSDNLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~f~~~~~ly 685 (992)
...|.+....+.|.++.||++.. .+|..+++|+.... ....+..|+.+|+.+.+.+ +.++++++..++..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34566544444566799999965 45677999997642 2245678999999885444 567888888888899
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG---------------------------------- 731 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G---------------------------------- 731 (992)
+||||++|.+|. + . ... ...++.+++..|..||...
T Consensus 92 ~v~e~i~G~~l~-~-~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 92 LLLGEVPGQDLL-S-S-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EEEECCSSEETT-T-S-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEEEecCCcccC-c-C-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 999999998884 1 1 111 2246667777777777643
Q ss_pred ------------------------eeeeecCCceEEEccCCcEEEEecccc
Q 001952 732 ------------------------VIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 732 ------------------------IIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
++|+|++|.|||++.++.+.|+|||.+
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999987766779999986
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=9.3e-10 Score=120.67 Aligned_cols=141 Identities=12% Similarity=0.169 Sum_probs=105.0
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEec--hhHHHhhcchhHHHHHHHHHHHcC--CCCccceeeeeccC---Ce
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD--NEFLARRKKMPRAQTEREILRMLD--HPFLPTLYSQFTSD---NL 683 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIk--k~~l~~~~~~~~~~~EieILk~L~--HPNIVkL~g~f~~~---~~ 683 (992)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+|+.+. +..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 345678999999999998763 3578889876 33211 12245678999999997 45578899888766 45
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM---------------------------------- 729 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs---------------------------------- 729 (992)
.|+||||++|..+.+. ....++......++.+++..|..||.
T Consensus 116 ~~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp CEEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred eEEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 8999999999887431 11346778888899999999999997
Q ss_pred ------------------------cCeeeeecCCceEEEccCC--cEEEEeccccc
Q 001952 730 ------------------------LGVIYRDLKPENILVREDG--HIMLTDFDLSL 759 (992)
Q Consensus 730 ------------------------~GIIHRDIKPeNILLd~dg--~VKLsDFGLA~ 759 (992)
.++||+|+++.|||++.++ .+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 3599999999999999765 36899999874
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=6.9e-10 Score=119.16 Aligned_cols=132 Identities=17% Similarity=0.153 Sum_probs=95.7
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCC--ccceeeeeccCC---eEEEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPF--LPTLYSQFTSDN---LSCLV 687 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPN--IVkL~g~f~~~~---~lyLV 687 (992)
++.|+.|.+..||++. ..+++|+.... .....+.+|.++|+.+ .+.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3458999999999863 35889987543 2235678899999888 3333 445555544333 34899
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-------------------------------------- 729 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-------------------------------------- 729 (992)
|++++|..|...... .++......++.+++..|..||.
T Consensus 95 m~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 95 FTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 999999988653322 35667777778888888888875
Q ss_pred --------------------cCeeeeecCCceEEEcc--CCcEEEEeccccc
Q 001952 730 --------------------LGVIYRDLKPENILVRE--DGHIMLTDFDLSL 759 (992)
Q Consensus 730 --------------------~GIIHRDIKPeNILLd~--dg~VKLsDFGLA~ 759 (992)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 13799999999999998 5568899999863
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.3e-06 Score=91.29 Aligned_cols=131 Identities=18% Similarity=0.139 Sum_probs=91.9
Q ss_pred EEccCCce-EEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEEEEEecCC
Q 001952 616 KLGCGDIG-TVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 616 ~LGsG~FG-tVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyLVmEy~~G 693 (992)
.+..|..| .||+......+..+++|+-... ....+..|..+|+.+. +--+.++++++.+.+..|||||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445544 6999877777778999987643 2345678999998884 33367889999889999999999999
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML------------------------------------------- 730 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~------------------------------------------- 730 (992)
.++....... ......++.++...|..||..
T Consensus 105 ~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 105 KTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 8876654321 111222333444444444421
Q ss_pred ---------------CeeeeecCCceEEEccCCcEEEEecccc
Q 001952 731 ---------------GVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 731 ---------------GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.++|+|+.+.|||++.++.+-|+||+.+
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 2799999999999998777789999986
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.4e-06 Score=94.23 Aligned_cols=132 Identities=17% Similarity=0.127 Sum_probs=89.1
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC---Cccceeeeec-cCCeEEEEEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP---FLPTLYSQFT-SDNLSCLVME 689 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP---NIVkL~g~f~-~~~~lyLVmE 689 (992)
++.++.|....||+. +..+++|+.... .....+..|.++|+.+.+. .+.+++.++. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456888999999988 356888986432 2235678999999999653 2567776664 4566789999
Q ss_pred ecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 001952 690 YCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM---------------------------------------- 729 (992)
Q Consensus 690 y~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs---------------------------------------- 729 (992)
|++|..|....- ..++......++.++...|..||.
T Consensus 94 ~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 999988865311 112333333344444444444332
Q ss_pred --------------------cCeeeeecCCceEEEcc---CCc-EEEEeccccc
Q 001952 730 --------------------LGVIYRDLKPENILVRE---DGH-IMLTDFDLSL 759 (992)
Q Consensus 730 --------------------~GIIHRDIKPeNILLd~---dg~-VKLsDFGLA~ 759 (992)
..++|+|++|.|||++. ++. +.|+||+.+.
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 14699999999999997 344 5899999863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=4.4e-06 Score=91.14 Aligned_cols=85 Identities=12% Similarity=0.060 Sum_probs=56.6
Q ss_pred eEEEEE-ccCCceEEEEEEEc--C----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-C--CCccceeeeeccC
Q 001952 612 NLLQKL-GCGDIGTVYLAELI--G----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-H--PFLPTLYSQFTSD 681 (992)
Q Consensus 612 eilr~L-GsG~FGtVYlA~~~--~----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-H--PNIVkL~g~f~~~ 681 (992)
..++.| +.|....+|+.... . ++..+++|+..............+..|+.+|+.+. + -.+.+++.++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345678 88999999998763 1 25678999875431000001245678888888874 2 3567888877654
Q ss_pred ---CeEEEEEEecCCCCh
Q 001952 682 ---NLSCLVMEYCPGGDL 696 (992)
Q Consensus 682 ---~~lyLVmEy~~GGSL 696 (992)
+..|+||||++|..+
T Consensus 103 ~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TTTSSCEEEEECCCCBCC
T ss_pred CccCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=8.4e-06 Score=90.63 Aligned_cols=80 Identities=19% Similarity=0.189 Sum_probs=51.4
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH-Hh---hcchhHHHHHHHHHHHcCC--C-CccceeeeeccCCeEE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-AR---RKKMPRAQTEREILRMLDH--P-FLPTLYSQFTSDNLSC 685 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l-~~---~~~~~~~~~EieILk~L~H--P-NIVkL~g~f~~~~~ly 685 (992)
.++.||.|.++.||++.+..+++.++||....... .. .....++..|.++|+.+.. + .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997655677899998653210 00 1234566789999988742 3 34466644 344568
Q ss_pred EEEEecCCC
Q 001952 686 LVMEYCPGG 694 (992)
Q Consensus 686 LVmEy~~GG 694 (992)
|||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=4.2e-05 Score=81.73 Aligned_cols=137 Identities=13% Similarity=0.128 Sum_probs=77.8
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC--CCCccceee------eeccCCeE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD--HPFLPTLYS------QFTSDNLS 684 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~--HPNIVkL~g------~f~~~~~l 684 (992)
-++.|+.|..+.||++... ++ .+++|+..... ..+..|..+++.+. .-.+++++. +....+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD-SG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET-TE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC-CC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456776778999999763 33 48999987421 22334555555442 113444443 12346678
Q ss_pred EEEEEecCCCChH---------------HHHHhhcCC--C---------CCHHH--------------------------
Q 001952 685 CLVMEYCPGGDLH---------------VLRQKQLGK--C---------FSEPA-------------------------- 712 (992)
Q Consensus 685 yLVmEy~~GGSL~---------------~lLkk~~~~--~---------Lse~~-------------------------- 712 (992)
++||+|++|..+. .+-...... + ..+..
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986531 111111100 0 01111
Q ss_pred -----HHHHHHHHHHHHHHHhh-------------cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 713 -----ARFYVAEVLLALEYLHM-------------LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 713 -----i~~Ia~QIL~GL~YLHs-------------~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
...+..++..++++|+. .++||+|+.+.|||++.++.+.|+||+.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 01111223445666652 47999999999999988889999999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00048 Score=77.49 Aligned_cols=77 Identities=19% Similarity=0.266 Sum_probs=46.3
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHH--Hh--hcchhHHHHHHHHHHHc---CCCCccceeeeeccCCeEE
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL--AR--RKKMPRAQTEREILRML---DHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l--~~--~~~~~~~~~EieILk~L---~HPNIVkL~g~f~~~~~ly 685 (992)
-++.||.|..+.||++.. ++..++||....... .. .........|.+++..+ ....+++++.+. .+..+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 457899999999999954 456799994321100 00 00112223344444332 334577777765 45678
Q ss_pred EEEEec-CC
Q 001952 686 LVMEYC-PG 693 (992)
Q Consensus 686 LVmEy~-~G 693 (992)
+||||+ +|
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 77
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0012 Score=70.11 Aligned_cols=81 Identities=16% Similarity=0.094 Sum_probs=57.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCC---CccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP---FLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HP---NIVkL~g~f~~~~~l 684 (992)
.....-++.+|.|..+.||+... .+|+.|++|+.... .......+..|...|+.|.-. -+++++++. .-
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~---~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDD---APALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTT---CCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCC---CcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence 34566678899999999999987 46788999987533 122334578899999988422 345555542 23
Q ss_pred EEEEEecCCCCh
Q 001952 685 CLVMEYCPGGDL 696 (992)
Q Consensus 685 yLVmEy~~GGSL 696 (992)
++||||++++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 789999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00093 Score=73.35 Aligned_cols=77 Identities=18% Similarity=0.196 Sum_probs=60.2
Q ss_pred eEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC---CCCccceeeeeccCCeEEEEE
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD---HPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~---HPNIVkL~g~f~~~~~lyLVm 688 (992)
.-++.|+.|.+..+|+... ++..+++|+.... ....+..|.+.|+.|. ...+++++.+....+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 4467899999999999875 4567889987642 2345778888888873 356889998888788899999
Q ss_pred EecCCCCh
Q 001952 689 EYCPGGDL 696 (992)
Q Consensus 689 Ey~~GGSL 696 (992)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00049 Score=73.59 Aligned_cols=71 Identities=11% Similarity=0.065 Sum_probs=45.8
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeeccCCeEEEEEEec-
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTSDNLSCLVMEYC- 691 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~~~~lyLVmEy~- 691 (992)
++.|+.|....+|++ ..+++|+..... ........|..+++.+...++ .++++++.+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~----~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT----EEYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc----cceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecC
Confidence 678989999999998 348899886431 111223568877777742233 566655433 347899999
Q ss_pred CCCCh
Q 001952 692 PGGDL 696 (992)
Q Consensus 692 ~GGSL 696 (992)
+|..|
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66555
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0014 Score=70.10 Aligned_cols=142 Identities=14% Similarity=0.102 Sum_probs=80.1
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeee------eccC
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQ------FTSD 681 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~------f~~~ 681 (992)
...-++.|+.|....+|++... ++ .+++|+.... .....+..|+.+++.+...+ +.+++.. ....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-----CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3345677888988999999763 33 5889998642 12234566777777763222 3344422 1224
Q ss_pred CeEEEEEEecCCCChH-----H------H---HHhhc---CCC----CC---HHHHHH------------HHHHHHHHHH
Q 001952 682 NLSCLVMEYCPGGDLH-----V------L---RQKQL---GKC----FS---EPAARF------------YVAEVLLALE 725 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~-----~------l---Lkk~~---~~~----Ls---e~~i~~------------Ia~QIL~GL~ 725 (992)
+..+++|+|++|..+. . . ++... ... .. |..... +...+...++
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 5678999999886531 0 0 11110 001 01 111000 0011334455
Q ss_pred HHhh-------cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 726 YLHM-------LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 726 YLHs-------~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
+|+. .++||+|+.+.|||++.++.+.|+||+.+
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 5552 36999999999999997766689999986
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0019 Score=73.58 Aligned_cols=75 Identities=21% Similarity=0.314 Sum_probs=50.6
Q ss_pred EEEEEccCCceEEEEEEEcC-------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC-ccceeeeeccCCeE
Q 001952 613 LLQKLGCGDIGTVYLAELIG-------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF-LPTLYSQFTSDNLS 684 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~-------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN-IVkL~g~f~~~~~l 684 (992)
-++.|+.|-...||++.... .+..+++|+.... .....+..|..+++.+...+ .+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678888899999998753 2467999988431 11134457888888874333 4677776643
Q ss_pred EEEEEecCCCCh
Q 001952 685 CLVMEYCPGGDL 696 (992)
Q Consensus 685 yLVmEy~~GGSL 696 (992)
.+||||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999987443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0028 Score=68.48 Aligned_cols=137 Identities=11% Similarity=0.038 Sum_probs=71.5
Q ss_pred EEEEccCCceE-EEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC--CCccceeeeeccCCeEEEEEEe
Q 001952 614 LQKLGCGDIGT-VYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH--PFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 614 lr~LGsG~FGt-VYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H--PNIVkL~g~f~~~~~lyLVmEy 690 (992)
++.|+.|.... +|+... .++..+++|...... ...+..|+.+++.+.. -.+.+++.+....+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34566565554 667643 225567787654321 0233456777776632 23567776644333 789999
Q ss_pred cCCCChHHHHHhhc---------------------C---CCCCHHHHH-------HHH-------------HHHHHHHHH
Q 001952 691 CPGGDLHVLRQKQL---------------------G---KCFSEPAAR-------FYV-------------AEVLLALEY 726 (992)
Q Consensus 691 ~~GGSL~~lLkk~~---------------------~---~~Lse~~i~-------~Ia-------------~QIL~GL~Y 726 (992)
+.+..+..++.... . ..+...... .+. ..+...++.
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 97766654432110 0 012221110 000 011122233
Q ss_pred H------hhcCeeeeecCCceEEEccC----CcEEEEeccccc
Q 001952 727 L------HMLGVIYRDLKPENILVRED----GHIMLTDFDLSL 759 (992)
Q Consensus 727 L------Hs~GIIHRDIKPeNILLd~d----g~VKLsDFGLA~ 759 (992)
| +...+||+|+.+.|||++.+ +.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 3 23469999999999999874 689999999873
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0018 Score=71.24 Aligned_cols=75 Identities=13% Similarity=0.235 Sum_probs=45.9
Q ss_pred EEEEccCCceEEEEEEEcCC--------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC-ccceeeeeccCCeE
Q 001952 614 LQKLGCGDIGTVYLAELIGT--------NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF-LPTLYSQFTSDNLS 684 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~t--------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN-IVkL~g~f~~~~~l 684 (992)
+..|+.|....+|++...+. +..+++|+..... ........|..+|+.+...+ +.++++.+. -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV----DELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG----GGTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc----cceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 45788888899999987531 2578999876431 11122367888888774333 457776552 2
Q ss_pred EEEEEecCCCCh
Q 001952 685 CLVMEYCPGGDL 696 (992)
Q Consensus 685 yLVmEy~~GGSL 696 (992)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0064 Score=70.16 Aligned_cols=76 Identities=17% Similarity=0.256 Sum_probs=50.4
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc-cceeeeeccCCeEEEEEEec
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL-PTLYSQFTSDNLSCLVMEYC 691 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI-VkL~g~f~~~~~lyLVmEy~ 691 (992)
-++.|+.|-...+|++...+.+..+++|+.... ....-....|..+|+.|...++ .++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~----~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPK----TDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-----CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCC----hhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 456788888999999988554578899987532 1111122579999998865444 57877763 2 2599999
Q ss_pred CCCCh
Q 001952 692 PGGDL 696 (992)
Q Consensus 692 ~GGSL 696 (992)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0068 Score=64.97 Aligned_cols=75 Identities=13% Similarity=0.060 Sum_probs=47.1
Q ss_pred EEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCC--ccceeee-----eccCCeEEEE
Q 001952 615 QKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF--LPTLYSQ-----FTSDNLSCLV 687 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPN--IVkL~g~-----f~~~~~lyLV 687 (992)
..|+ |....||++.. .+|+.+++|+..... .....+..|..+++.+.... +++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~----~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC----CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998765 345579999986321 12234566788777774222 4444443 1224567899
Q ss_pred EEecCCCC
Q 001952 688 MEYCPGGD 695 (992)
Q Consensus 688 mEy~~GGS 695 (992)
|+|++|..
T Consensus 106 ~~~i~G~~ 113 (328)
T 1zyl_A 106 FPSVGGRQ 113 (328)
T ss_dssp EECCCCEE
T ss_pred EEecCCCC
Confidence 99998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0024 Score=72.02 Aligned_cols=143 Identities=16% Similarity=0.200 Sum_probs=84.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcC-------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeec
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIG-------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFT 679 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~-------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~ 679 (992)
.+.+.+ +.|..|-...+|++.... .++.|++|+.... ......+.+|..+++.+. +.-..++++++.
T Consensus 50 ~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 50 PEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp GGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred cCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 344543 567668888899997742 3467999986431 122344567888888774 333467777765
Q ss_pred cCCeEEEEEEecCCCChH--------------HHHHhhc------CCCCC--HHHHHHHHHHHHH---------------
Q 001952 680 SDNLSCLVMEYCPGGDLH--------------VLRQKQL------GKCFS--EPAARFYVAEVLL--------------- 722 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~--------------~lLkk~~------~~~Ls--e~~i~~Ia~QIL~--------------- 722 (992)
+ .+||||++|..|. ..+.+.. +.... +..+..|..++..
T Consensus 125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp T----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred C----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 4 2999999886552 1111111 11122 3455555544422
Q ss_pred ----HHHHHh----h----cCeeeeecCCceEEEccC----CcEEEEeccccc
Q 001952 723 ----ALEYLH----M----LGVIYRDLKPENILVRED----GHIMLTDFDLSL 759 (992)
Q Consensus 723 ----GL~YLH----s----~GIIHRDIKPeNILLd~d----g~VKLsDFGLA~ 759 (992)
.++.|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 1 249999999999999876 789999999873
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.099 Score=57.22 Aligned_cols=28 Identities=25% Similarity=0.419 Sum_probs=26.0
Q ss_pred CeeeeecCCceEEEccCCcEEEEecccc
Q 001952 731 GVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 731 GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.++|+|+.+.|||++.++.+.|+||+.+
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~ 234 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEP 234 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCC
Confidence 5999999999999998888999999876
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.21 E-value=0.055 Score=57.25 Aligned_cols=60 Identities=17% Similarity=0.020 Sum_probs=44.7
Q ss_pred CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEe
Q 001952 694 GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTD 754 (992)
Q Consensus 694 GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsD 754 (992)
-+|.++++.. +.+++++++|.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|-+.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 4788888865 6899999999999999999877621 1112333456889999998877653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.80 E-value=0.16 Score=58.11 Aligned_cols=76 Identities=13% Similarity=0.308 Sum_probs=49.9
Q ss_pred EEEEEccCCceEEEEEEEcCC-------CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeE
Q 001952 613 LLQKLGCGDIGTVYLAELIGT-------NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~t-------g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~l 684 (992)
-++.|..|-...+|++..... +..|++|+.... ....-...+|..+++.+. +.-..++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~----t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH----VGKFYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC----C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC----cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 345677788889999987521 567999987532 112223357888888774 333567776443 2
Q ss_pred EEEEEecCCCCh
Q 001952 685 CLVMEYCPGGDL 696 (992)
Q Consensus 685 yLVmEy~~GGSL 696 (992)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 789999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.87 E-value=0.32 Score=54.51 Aligned_cols=28 Identities=36% Similarity=0.508 Sum_probs=24.4
Q ss_pred eeeeecCCceEEE------ccCCcEEEEeccccc
Q 001952 732 VIYRDLKPENILV------REDGHIMLTDFDLSL 759 (992)
Q Consensus 732 IIHRDIKPeNILL------d~dg~VKLsDFGLA~ 759 (992)
++|+|+.+.|||+ +.++.+.|+||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 7899999999999 456679999999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 992 | ||||
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-56 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-23 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-35 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-23 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-41 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-24 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-40 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-25 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-40 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-22 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-18 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-27 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-36 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-22 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-26 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-16 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-15 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-17 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-12 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-21 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-23 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-18 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-12 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-32 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-15 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-32 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-14 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-15 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-14 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-16 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-13 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-16 |
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 193 bits (491), Expect = 4e-56
Identities = 70/344 (20%), Positives = 115/344 (33%), Gaps = 82/344 (23%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKK------MPRAQTEREIL 663
++ + LG G V T +A+K++D E +IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 664 RML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
R + HP + L + ++ LV + G+L ++ SE R + +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGP 782
+ LH L +++RDLKPENIL+ +D +I LTDF S + G
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-----------------PGE 164
Query: 783 CTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842
C P + +P + + P + S
Sbjct: 165 KLREVCGTPSYL---------APEIIECSMNDNHPGYGKEVDMWST-------------- 201
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
G+ +Y LL G PF L ++ + +F
Sbjct: 202 ---------------------------GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 903 --PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
P+ S +DL+ L+ +P+ R A E HPFF+
Sbjct: 235 GSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 6e-56
Identities = 95/358 (26%), Positives = 152/358 (42%), Gaps = 79/358 (22%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
+ + F+ L+ LG G G V L T +A+K++ E + + ++ TE +L+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
HPFL L F + + C VMEY GG+L ++ + F+E ARFY AE++ ALE
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTE 785
YLH V+YRD+K EN+++ +DGHI +TDF L
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGL---------------------------- 151
Query: 786 SNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845
C + T + C +P +L A L ++ E
Sbjct: 152 --CKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYE----------- 197
Query: 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS 905
++ GR PF +E ++M+ ++FP +
Sbjct: 198 ------------------------------MMCGRLPFYNQDHERLFELILMEEIRFPRT 227
Query: 906 PLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNWALI--RCAIPPELP 960
+S +A+ L+ GLL K+P+ RLG A E+ +H FF +NW + + +PP P
Sbjct: 228 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-52
Identities = 66/346 (19%), Positives = 109/346 (31%), Gaps = 53/346 (15%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F + +LG G+ G V+ + + A K++ E + + E ++L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSP 64
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH- 728
++ Y F SD + ME+ GG L + +K E V+ L YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE 122
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNC 788
+++RD+KP NILV G I L DF +S ++ S
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS------------------GQLIDSMANSFV 164
Query: 789 IQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAE------PTDARSNS 842
+ P + + I S+ + E P
Sbjct: 165 GTRSYMSPERL---------------QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA- 208
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
E + EG A YG E L +V +
Sbjct: 209 ----KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK 264
Query: 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
S + S + +D + LIK P R ++ H F + +
Sbjct: 265 LPSGVFSLEFQDFVNKCLIKNPAERA----DLKQLMVHAFIKRSDA 306
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 7e-45
Identities = 49/161 (30%), Positives = 80/161 (49%), Gaps = 4/161 (2%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ ++ +LG G G VY A+ T+ L A KV+D + +++ E +IL DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHP 69
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L F +N +++E+C GG + + + + +E + + L AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770
+I+RDLK NIL DG I L DF +S + + + S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (243), Expect = 8e-23
Identities = 27/116 (23%), Positives = 45/116 (38%), Gaps = 10/116 (8%)
Query: 834 EPTDARSNSFVGTHEYLAPEII-----KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGN 888
T R +SF+GT ++APE++ K + D W+ GI L E+ P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220
Query: 889 EETLANVVM-QSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
L + + S +D ++ L K + R +++ QHPF
Sbjct: 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFV 272
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-43
Identities = 62/163 (38%), Positives = 88/163 (53%), Gaps = 2/163 (1%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
F + LG G TV LA + T+ +AIK+++ + + K+P ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
F LY F D + Y G+L +K F E RFY AE++ ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
G+I+RDLKPENIL+ ED HI +TDF + S +++S
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 42/129 (32%), Positives = 67/129 (51%), Gaps = 4/129 (3%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
E AR+NSFVGT +Y++PE++ + + D W G +Y+L+ G PF+
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK--GAAEIKQHPFFEGLNWALI 951
++ FP+ +ARDL+ LL+ + RLG ++ G +K HPFFE + W +
Sbjct: 221 KIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
Query: 952 RCAIPPELP 960
PP+L
Sbjct: 279 HQQTPPKLT 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 56/176 (31%), Positives = 82/176 (46%), Gaps = 4/176 (2%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L F + + LG G G VYLA + + A+KV+ L + + + E EI L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
HP + LY F L++EY P G ++ QK F E Y+ E+ AL Y
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYC 122
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC--SVSPTLLKSSSNMDPARVSG 781
H VI+RD+KPEN+L+ G + + DF S+ S TL + + P + G
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEG 178
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-28
Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 6/113 (5%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
+R + GT +YL PE+I+G H VD W+ G+ YE L G+ PF+ + +E
Sbjct: 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 891 TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
T + FPD ++ ARDLI LL P R E+ +HP+
Sbjct: 212 TYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRP----MLREVLEHPWI 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (394), Expect = 1e-42
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 2/173 (1%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+ F+ L+++G G G VY A + + + AIK M +K E L+ L H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
P + ++ + LVMEYC G +L + K E L L YLH
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 132
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSG 781
+I+RD+K NIL+ E G + L DF + + + + + + M P +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILA 185
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.9 bits (246), Expect = 4e-23
Identities = 29/108 (26%), Positives = 44/108 (40%), Gaps = 7/108 (6%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHG---AAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+NSFVGT ++APE+I G VD W+ GI EL + P L ++
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
S S R+ + L K P++R + + +H F
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFV 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-42
Identities = 68/368 (18%), Positives = 117/368 (31%), Gaps = 64/368 (17%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ + +G G G VY A+L + L AIK + + E +I+R LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHCN 74
Query: 671 LPTLYSQFTSDNLS------CLVMEYCPGGDLHVLRQ-KQLGKCFSEPAARFYVAEVLLA 723
+ L F S LV++Y P V R + + + Y+ ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIM-LTDFDLSLRCSVSPTLLKSSSNMDPARVSGP 782
L Y+H G+ +RD+KP+N+L+ D ++ L DF + + G
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----------------RGE 177
Query: 783 CTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842
S + P + + S ++AE +
Sbjct: 178 PNVSYICSRYYRAPELIF--------------GATDYTSSIDVWSAGCVLAELLLGQPIF 223
Query: 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF 902
+ EIIK G + E +
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIRE--------------MNPNYTEFKFPQIKAHPWTK 269
Query: 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF 962
P +A L LL P RL E H FF+ L ++ + P
Sbjct: 270 VFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRDTPAL 325
Query: 963 YDYGIQDM 970
+++ Q++
Sbjct: 326 FNFTTQEL 333
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-41
Identities = 63/347 (18%), Positives = 105/347 (30%), Gaps = 55/347 (15%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTERE--ILRMLDHPF 670
L LG G TVY A TN + AIK + + K RE +L+ L HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 671 LPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHML 730
+ L F + LV ++ +++ + + Y+ L LEYLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 731 GVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQ 790
+++RDLKP N+L+ E+G + L DF L+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR------------------------ 155
Query: 791 PFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEY- 849
+ + + ++ ++AE R G +
Sbjct: 156 ------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE-LLLRVPFLPGDSDLD 208
Query: 850 LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLIS 909
I + G W + + P +
Sbjct: 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI---------------FSAAG 253
Query: 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIP 956
DLI+GL + P R+ A + + +F C +P
Sbjct: 254 DDLLDLIQGLFLFNPCARI----TATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 4e-41
Identities = 65/337 (19%), Positives = 112/337 (33%), Gaps = 52/337 (15%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
++ + L+K+G G GTV+ A+ T+ + A+K + + A E +L+ L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-SALREICLLKELK 59
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
H + L+ SD LV E+C + ++ ++L L +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFC 117
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESN 787
H V++RDLKP+N+L+ +G + L +F L+ +
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--------------------- 156
Query: 788 CIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847
+ + P + + S + AE +A F G
Sbjct: 157 ---------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 848 EY-LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSP 906
I + G W + Y P S P
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV--------------VP 253
Query: 907 LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
++ RDL++ LL P R+ A E QHP+F
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYF 286
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 151 bits (382), Expect = 1e-40
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 7/162 (4%)
Query: 599 VRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQT 658
V +++ + L H+++ ++LG G G V+ T FA K + + ++ +
Sbjct: 17 VEIKHDHV-LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE---TVRK 72
Query: 659 EREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVA 718
E + + +L HP L L+ F DN ++ E+ GG+L + K SE A Y+
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMR 131
Query: 719 EVLLALEYLHMLGVIYRDLKPENILV--REDGHIMLTDFDLS 758
+V L ++H ++ DLKPENI+ + + L DF L+
Sbjct: 132 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 112 bits (280), Expect = 3e-27
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 10/140 (7%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
GT E+ APE+ +G+ G D W+ G+ Y LL G +PF G ++ETL NV
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
Query: 899 SLKFPDS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIP 956
DS IS +D IR LL+ +P R+ + +HP+ N
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNAP----GRD 292
Query: 957 PELPDFYDYGIQDMVPQKSK 976
++P I+D + K
Sbjct: 293 SQIPSSRYTKIRDSIKTKYD 312
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (376), Expect = 2e-40
Identities = 45/325 (13%), Positives = 86/325 (26%), Gaps = 74/325 (22%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH- 668
H+ + +++G G G ++ + N AIK RR P+ + E ++L
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGC 60
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+P +Y + LV++ +L G+ FS ++L ++ +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH 118
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNC 788
++YRD+KP+ N R +
Sbjct: 119 EKSLVYRDIKPD--------------------------------NFLIGRPNSKNANMIY 146
Query: 789 IQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848
+ F + + P + GT
Sbjct: 147 VVDFGM----------------------------VKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 849 YLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPL- 907
Y++ G D G L G P++G K +PL
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 908 -----ISFQARDLIRGLLIKEPENR 927
+ + +
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 45/149 (30%), Positives = 78/149 (52%), Gaps = 4/149 (2%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
++L+Q LG G G V LA T A+K++D + + + E I +ML+H
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLNHE 63
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ Y N+ L +EYC GG+L + EP A+ + +++ + YLH
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
+G+ +RD+KPEN+L+ E ++ ++DF L+
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLA 150
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 26/116 (22%), Positives = 47/116 (40%), Gaps = 6/116 (5%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKG-SG 887
+ N GT Y+APE++K H VD W+ GI L +L G P+ S
Sbjct: 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211
Query: 888 NEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ + ++ + I L+ +L++ P R+ +IK+ ++
Sbjct: 212 SCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWY 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (378), Expect = 4e-40
Identities = 39/173 (22%), Positives = 80/173 (46%), Gaps = 7/173 (4%)
Query: 592 RWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK 651
+ + V ++ GS+ ++++L++LG G G V+ T +F K ++ + +
Sbjct: 13 KKYVPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 652 KMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEP 711
+ E I+ L HP L L+ F L++E+ GG+L + SE
Sbjct: 72 ---TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEA 127
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILVR--EDGHIMLTDFDLSLRCS 762
Y+ + L+++H +++ D+KPENI+ + + + DF L+ + +
Sbjct: 128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 107 bits (268), Expect = 1e-25
Identities = 41/125 (32%), Positives = 59/125 (47%), Gaps = 7/125 (5%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
D T E+ APEI+ E G D W G+ Y LL G +PF G + ETL NV
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 896 VMQSLKFPDS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRC 953
+F + +S +A+D I+ LL KEP RL + +HP+ +G + + +
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKG-DHSNLTS 295
Query: 954 AIPPE 958
IP
Sbjct: 296 RIPSS 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-40
Identities = 64/342 (18%), Positives = 110/342 (32%), Gaps = 52/342 (15%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L K+G G G V+ A T A+K + E + A E +IL++L H
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHE 69
Query: 670 FLPTLYSQFTS--------DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
+ L + LV ++C +L F+ + + +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLL 127
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSG 781
L Y+H +++RD+K N+L+ DG + L DF L AR
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-------------------ARAFS 168
Query: 782 PCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841
S + + + P + P + ++AE RS
Sbjct: 169 LAKNSQPNRYTNR-------VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW-TRSP 220
Query: 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK 901
G E +I G E+ ++ E + +
Sbjct: 221 IMQGNTEQHQLALIS----------QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKD 270
Query: 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ + A DLI LL+ +P R+ + + H FF
Sbjct: 271 RLKAYVRDPYALDLIDKLLVLDPAQRI----DSDDALNHDFF 308
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 1e-39
Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 5/164 (3%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
+ + F++ + +G G G VY T ++A+K +D + + ++ A ER +L +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 666 L---DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
+ D PF+ + F + + +++ GGDLH + FSE RFY AE++L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIIL 118
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766
LE++H V+YRDLKP NIL+ E GH+ ++D L+ S
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (274), Expect = 2e-26
Identities = 40/131 (30%), Positives = 74/131 (56%), Gaps = 5/131 (3%)
Query: 836 TDARSNSFVGTHEYLAPEII-KGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA- 893
+ + ++ VGTH Y+APE++ KG + ++ DW++ G L++LL G +PF+ ++
Sbjct: 158 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHPFFEGLNWALI- 951
+ + ++ S + R L+ GLL ++ RLG +GA E+K+ PFF L+W ++
Sbjct: 218 DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVF 277
Query: 952 -RCAIPPELPD 961
+ PP +P
Sbjct: 278 LQKYPPPLIPP 288
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-39
Identities = 74/359 (20%), Positives = 123/359 (34%), Gaps = 64/359 (17%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ LQ +G G G V A T AIK + F + RA E +L+ + H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAYRELRLLKHMRHE 77
Query: 670 FLPTLYSQFTSDNLS------CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLA 723
+ L FT D LVM + +++ ++L E +F V ++L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL----GEDRIQFLVYQMLKG 133
Query: 724 LEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPC 783
L Y+H G+I+RDLKP N+ V ED + + DF L AR +
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL-------------------ARQADSE 174
Query: 784 TESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843
+ + P + + I S+ ++AE ++
Sbjct: 175 MTGYVVTRWYRAPEVIL--------------NWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP 903
H EI+K G A + P + ++
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI----------- 269
Query: 904 DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF 962
S A +L+ +L+ + E R+ A E HP+FE L+ P++ +
Sbjct: 270 -LTNASPLAVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHDT----EDEPQVQKY 319
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 40/169 (23%), Positives = 72/169 (42%), Gaps = 10/169 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ +L +G G G + K +D + +K +E +LR L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELKHPN 64
Query: 671 LPTLYSQFT--SDNLSCLVMEYCPGGDL--HVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+ Y + ++ +VMEYC GGDL + + + + E + ++ LAL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 727 LHMLG-----VIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770
H V++RDLKP N+ + ++ L DF L+ + + K+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.6 bits (240), Expect = 1e-22
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 5/109 (4%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
+ + +FVGT Y++PE + + D W+ G LYEL PF +E
Sbjct: 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 224
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPF 942
+ + S + ++I +L + +R EI ++P
Sbjct: 225 KIREGKFRRIPYR-YSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-39
Identities = 55/335 (16%), Positives = 102/335 (30%), Gaps = 81/335 (24%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
I + L++LG G G V + G AIK++ ++ E +++
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSED----EFIEEAKVMMN 55
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
L H L LY T ++ EY G L ++ + F +V A+E
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAME 114
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTE 785
YL ++RDL N LV + G + ++DF LS + + + G
Sbjct: 115 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS----------RYVLDDEYTSSVGSKFP 164
Query: 786 SNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845
P + K + I + L+ E
Sbjct: 165 VRWSPPEVL--------------------MYSKFSSKSDIWAFGVLMWE----------- 193
Query: 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS 905
++ G + P++ N ET ++ Q L+
Sbjct: 194 --------------------IYSLG---------KMPYERFTNSETAEHIA-QGLRLYRP 223
Query: 906 PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
L S + ++ ++ + R + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERP----TFKILLSN 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (365), Expect = 9e-39
Identities = 61/151 (40%), Positives = 90/151 (59%), Gaps = 2/151 (1%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
L+ F +L+ LG G G V+L +A+KV+ E + R K++ ER +L ++
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
HPF+ ++ F ++M+Y GG+L L +K + F P A+FY AEV LALEYL
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYL 120
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
H +IYRDLKPENIL+ ++GHI +TDF +
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 8e-30
Identities = 45/144 (31%), Positives = 76/144 (52%), Gaps = 5/144 (3%)
Query: 820 DPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYG 879
D I+ A+ + + GT +Y+APE++ + + ++DWW+FGI +YE+L G
Sbjct: 138 DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197
Query: 880 RTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIK 938
TPF S +T ++ L+FP P + +DL+ L+ ++ RLG+ Q G ++K
Sbjct: 198 YTPFYDSNTMKTYEKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
Query: 939 QHPFFEGLNWA--LIRCAIPPELP 960
HP+F+ + W L R P P
Sbjct: 256 NHPWFKEVVWEKLLSRNIETPYEP 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-38
Identities = 65/372 (17%), Positives = 112/372 (30%), Gaps = 56/372 (15%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L +G G G V A AIK + + R E +IL H
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHE 66
Query: 670 FLPTLYSQFTSDNLS-----CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
+ + + + LV +L+ + L S +++ ++L L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL----SNDHICYFLYQILRGL 122
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCT 784
+Y+H V++RDLKP N+L+ + + DF L ARV+ P
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL-------------------ARVADPDH 163
Query: 785 ESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844
+ + + + I S+ ++AE R
Sbjct: 164 DHTG--------FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
+ I+ G + D P K L
Sbjct: 216 KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRL------------ 263
Query: 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYD 964
P +A DL+ +L P R+ + HP+ E + E P +D
Sbjct: 264 FPNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLE--QYYDPSDEPIAEAPFKFD 317
Query: 965 YGIQDMVPQKSK 976
+ D+ +K K
Sbjct: 318 MELDDLPKEKLK 329
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 4e-38
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 6/162 (3%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
+ + +K+G G GTVY A + T AI+ M+ + +++ E ++R +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
P + + + +VMEY GG L + + C E E L ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH 133
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770
VI+RD+K +NIL+ DG + LTDF + + + +
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 1e-25
Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 5/111 (4%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
P ++ ++ VGT ++APE++ + +G VD W+ GI E++ G P+ L
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 894 NVVMQ-SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ + + + +S RD + L + E R A E+ QH F
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG----SAKELLQHQFL 273
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (356), Expect = 5e-38
Identities = 59/337 (17%), Positives = 110/337 (32%), Gaps = 52/337 (15%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ ++ L+K+G G G VY A+ FA+K + E E IL+ L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELK 58
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
H + LY + LV E+ +L + A+ ++ ++L + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYC 116
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESN 787
H V++RDLKP+N+L+ +G + + DF L+ +
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP----------------------- 153
Query: 788 CIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847
+ + K I S+ + AE + +
Sbjct: 154 -------VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206
Query: 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPL 907
I + G + +W L + T ++ E L
Sbjct: 207 ADQLMRIFRILGTPNSKNWPNV-TELPKYDPNFTVYEPLPWESFL-------------KG 252
Query: 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
+ DL+ +L +P R+ A + +H +F+
Sbjct: 253 LDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 72/341 (21%), Positives = 115/341 (33%), Gaps = 52/341 (15%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD 667
+ +F ++K+G G G VY A T + A+K + + A E +L+ L+
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-TAIREISLLKELN 59
Query: 668 HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYL 727
HP + L ++N LV E+ + L P + Y+ ++L L +
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG-IPLPLIKSYLFQLLQGLAFC 118
Query: 728 HMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESN 787
H V++RDLKP+N+L+ +G I L DF L+ V
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--------------------- 157
Query: 788 CIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847
T + + A I SL + AE R F G
Sbjct: 158 ---------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAE-MVTRRALFPGDS 207
Query: 848 EY-LAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSP 906
E I + G V W + P + + VV P
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPG-----VTSMPDYKPSFPKWARQDFSKVV---------P 253
Query: 907 LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947
+ R L+ +L +P R+ A HPFF+ +
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 37/149 (24%), Positives = 65/149 (43%), Gaps = 6/149 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ Q++G G GTVY + G A+K+++ +++ + E +LR H
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHV 64
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ T+ L +V ++C G L+ K F + ++YLH
Sbjct: 65 NILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHA 122
Query: 730 LGVIYRDLKPENILVREDGHIMLTDFDLS 758
+I+RDLK NI + ED + + DF L+
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLA 151
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.7 bits (204), Expect = 7e-18
Identities = 24/112 (21%), Positives = 44/112 (39%), Gaps = 11/112 (9%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHG---AAVDWWTFGIFLYELLYGRTPFKGSGNEETL 892
+ G+ ++APE+I+ + D + FGI LYEL+ G+ P+ N + +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 893 ANVVMQSLKFPD----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+V + PD + L+ L K+ + R +I
Sbjct: 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP----LFPQILAS 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 57/152 (37%), Positives = 82/152 (53%), Gaps = 3/152 (1%)
Query: 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM-L 666
+ F L + LG G G V+LAE TN FAIK + + + + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
+HPFL ++ F + VMEY GGDL Q F A FY AE++L L++
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQF 118
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
LH G++YRDLK +NIL+ +DGHI + DF +
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-33
Identities = 50/130 (38%), Positives = 79/130 (60%), Gaps = 7/130 (5%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
DA++N+F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L G++PF G EE
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 894 NVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI-- 951
++ M + +P + +A+DL+ L ++EPE RLG +I+QHP F +NW +
Sbjct: 214 SIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELER 268
Query: 952 RCAIPPELPD 961
+ PP P
Sbjct: 269 KEIDPPFRPK 278
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 6e-37
Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 5/156 (3%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMPRAQTEREI 662
IG + LL+KLG G G V E G A+K + + L++ + M E
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 663 LRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLL 722
+ LDH L LY + + +V E P G L +K G F Y +V
Sbjct: 65 MHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAE 122
Query: 723 ALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ YL I+RDL N+L+ + + DF L
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (206), Expect = 4e-18
Identities = 20/95 (21%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETL 892
+ + APE +K A D W FG+ L+E+ YG+ P+ G + L
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
Query: 893 ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
+ + + P +++ +PE+R
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 9e-37
Identities = 60/170 (35%), Positives = 96/170 (56%), Gaps = 7/170 (4%)
Query: 592 RWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK 651
+WE Q L F+ ++ LG G G V L + + +A+K++D + + + K
Sbjct: 29 KWETPSQNTAQ-----LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 652 KMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEP 711
++ E+ IL+ ++ PFL L F ++ +VMEY GG++ ++ FSEP
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEP 141
Query: 712 AARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761
ARFY A+++L EYLH L +IYRDLKPEN+L+ + G+I +TDF + R
Sbjct: 142 HARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (276), Expect = 9e-27
Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 5/136 (3%)
Query: 832 VAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEET 891
A+ R+ + GT E LAPEII +G+ AVDWW G+ +YE+ G PF +
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 892 LANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNWAL 950
+V ++FP S +DL+R LL + R G+ K G +IK H +F +W
Sbjct: 247 YEKIVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 951 I--RCAIPPELPDFYD 964
I R P +P F
Sbjct: 305 IYQRKVEAPFIPKFKG 320
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 137 bits (346), Expect = 1e-36
Identities = 39/167 (23%), Positives = 75/167 (44%), Gaps = 6/167 (3%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L + LG G + V+LA + + A+KV+ + R + E + L+HP
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67
Query: 670 FLPTLYSQFTSDN----LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
+ +Y ++ L +VMEY G L + + + A +A+ AL
Sbjct: 68 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALN 125
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
+ H G+I+RD+KP NI++ + + DF ++ + S + ++
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 95.6 bits (237), Expect = 3e-22
Identities = 30/106 (28%), Positives = 50/106 (47%), Gaps = 5/106 (4%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+ ++ + +GT +YL+PE +G+ A D ++ G LYE+L G PF G
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226
Query: 896 VMQSLKFPDS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939
V + P + +S ++ L K PENR + AAE++
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT---AAEMRA 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 58/348 (16%), Positives = 105/348 (30%), Gaps = 63/348 (18%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNC-LFAIKVMDNEFLARRKKMPRAQTEREILRML-- 666
+ + ++G G G V+ A + A+K + + + E +LR L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIREVAVLRHLET 66
Query: 667 -DHPFLPTLYSQFTS-----DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
+HP + L+ T + LV E+ L + + + ++
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQL 125
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVS 780
L L++LH V++RDLKP+NILV G I L DF L+ S
Sbjct: 126 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF----------------- 168
Query: 781 GPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840
+ + + + + S+ + AE +
Sbjct: 169 --------------QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKP 213
Query: 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL 900
+ +I+ G DW + + ++
Sbjct: 214 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIE-------------- 259
Query: 901 KFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
I +DL+ L P R+ A HP+F+ L
Sbjct: 260 --KFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 46/195 (23%), Positives = 79/195 (40%), Gaps = 16/195 (8%)
Query: 605 SIGL----RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTER 660
++G+ R ++G G TVY T A + + L + ++ R + E
Sbjct: 1 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEA 59
Query: 661 EILRMLDHPFLPTLYSQFTS----DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFY 716
E+L+ L HP + Y + S LV E G L ++ K R +
Sbjct: 60 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSW 117
Query: 717 VAEVLLALEYLHMLG--VIYRDLKPENILVR-EDGHIMLTDFDLS--LRCSVSPTLLKSS 771
++L L++LH +I+RDLK +NI + G + + D L+ R S + ++ +
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP 177
Query: 772 SNMDPARVSGPCTES 786
M P ES
Sbjct: 178 EFMAPEMYEEKYDES 192
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (267), Expect = 4e-26
Identities = 22/115 (19%), Positives = 50/115 (43%), Gaps = 6/115 (5%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
L + + + +GT E++APE+ + + +VD + FG+ + E+ P+ N
Sbjct: 161 LATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219
Query: 891 TLANVVMQSLKFPDSP-LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
+ V +K + + +++I G + + + R ++ H FF+
Sbjct: 220 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 44/251 (17%), Positives = 84/251 (33%), Gaps = 26/251 (10%)
Query: 584 RPHMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMD 643
+P + WE + L+++LG G G V++ G A+K +
Sbjct: 1 KPW--WEDEWE-----------VPRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK 46
Query: 644 NEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
++ E +++ L H L LY+ T + + ++ EY G L +
Sbjct: 47 QGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTP 101
Query: 704 LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763
G + A++ + ++ I+RDL+ NILV + + DF L+
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA----- 156
Query: 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823
L++ + P + T + +S L T P
Sbjct: 157 --RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 824 QIRSLPQLVAE 834
+ Q +
Sbjct: 215 TNPEVIQNLER 225
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 2e-15
Identities = 27/119 (22%), Positives = 47/119 (39%), Gaps = 8/119 (6%)
Query: 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGS 886
L +L+ + ++ APE I D W+FGI L E++ +GR P+ G
Sbjct: 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
Query: 887 GNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ--HPFF 943
N E + N+ + + + L+R + PE+R ++ FF
Sbjct: 215 TNPEVIQNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDRP----TFDYLRSVLEDFF 268
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 8e-36
Identities = 63/166 (37%), Positives = 99/166 (59%), Gaps = 7/166 (4%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARRKKMP-RAQTERE 661
+G+ +F LL+ LG G G V+L I T L+A+KV+ + ++ K +TER+
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 662 ILRMLDH-PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEV 720
+L + PFL TL+ F ++ L+++Y GG+L ++ + F+E + YV E+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEI 138
Query: 721 LLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766
+LALE+LH LG+IYRD+K ENIL+ +GH++LTDF LS T
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 7e-27
Identities = 54/137 (39%), Positives = 79/137 (57%), Gaps = 6/137 (4%)
Query: 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKG--EGHGAAVDWWTFGIFLYELLYGRTPFK 884
L + R+ F GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF
Sbjct: 174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233
Query: 885 GSGNEETLANVVMQSLKF--PDSPLISFQARDLIRGLLIKEPENRLGS-QKGAAEIKQHP 941
G + + A + + LK P +S A+DLI+ LL+K+P+ RLG + A EIK+H
Sbjct: 234 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 293
Query: 942 FFEGLNW-ALIRCAIPP 957
FF+ +NW L +P
Sbjct: 294 FFQKINWDDLAAKKVPA 310
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-35
Identities = 38/161 (23%), Positives = 66/161 (40%), Gaps = 6/161 (3%)
Query: 616 KLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT 673
+LGCG+ G+V AIKV+ + E +I+ LD+P++
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
L ++ L LVME GG LH + + + +V + ++YL +
Sbjct: 74 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFV 131
Query: 734 YRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774
+RDL N+L+ + ++DF LS + + S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.4 bits (195), Expect = 1e-16
Identities = 21/112 (18%), Positives = 45/112 (40%), Gaps = 3/112 (2%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETL 892
+ ++ ++ APE I + D W++G+ ++E L YG+ P+K E +
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222
Query: 893 ANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFE 944
A + Q + P + L+ I + E+R + + ++
Sbjct: 223 AF-IEQGKRMECPPECPPELYALMSDCWIYKWEDRP-DFLTVEQRMRACYYS 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (341), Expect = 1e-35
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
++ LG G V LAE T L AIK + + L ++ + E +L + HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHP 67
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L + S L+M+ GG+L ++ ++E A + +VL A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 125
Query: 730 LGVIYRDLKPENILVR---EDGHIMLTDFDLS 758
LG+++RDLKPEN+L ED IM++DF LS
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (277), Expect = 3e-27
Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 8/135 (5%)
Query: 834 EPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA 893
E + ++ GT Y+APE++ + + AVD W+ G+ Y LL G PF + +
Sbjct: 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 219
Query: 894 NVVMQSLKF--PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA-- 949
++ +F P IS A+D IR L+ K+PE R + QHP+ G
Sbjct: 220 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF----TCEQALQHPWIAGDTALDK 275
Query: 950 LIRCAIPPELPDFYD 964
I ++ ++ +
Sbjct: 276 NIHQSVSEQIKKNFA 290
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 1e-35
Identities = 34/157 (21%), Positives = 65/157 (41%), Gaps = 6/157 (3%)
Query: 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTN---CLFAIKVMDNEFLARRKKMPRAQTERE 661
I + + Q +G G+ G V L AIK + + + ++++ +E
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEAS 79
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
I+ DHP + L T ++ E+ G L ++ G+ + + +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQLVGMLRGIA 138
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
++YL + ++RDL NILV + ++DF LS
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 75.2 bits (184), Expect = 4e-15
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 2/103 (1%)
Query: 826 RSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFK 884
R L ++PT + + APE I+ +A D W++GI ++E++ YG P+
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235
Query: 885 GSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
N++ + N + Q + P L+ K+ +R
Sbjct: 236 DMTNQD-VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (337), Expect = 1e-35
Identities = 40/162 (24%), Positives = 66/162 (40%), Gaps = 8/162 (4%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
+ ++ LLQ +G G+ G V L + G A+K + N+ A+ E ++
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATAQA-----FLAEASVMTQ 56
Query: 666 LDHPFLPTLYSQFTSDNLS-CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
L H L L + +V EY G L + + + +V A+
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 116
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766
EYL ++RDL N+LV ED ++DF L+ S +
Sbjct: 117 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 158
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.3 bits (195), Expect = 9e-17
Identities = 16/105 (15%), Positives = 42/105 (40%), Gaps = 6/105 (5%)
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANV 895
+ ++ ++ APE ++ + D W+FGI L+E+ +GR P+ ++ +
Sbjct: 154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR- 212
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
V + K ++++ + R ++++
Sbjct: 213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP----SFLQLREQ 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-35
Identities = 48/378 (12%), Positives = 100/378 (26%), Gaps = 113/378 (29%)
Query: 590 DVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-----CLFAIKVMDN 644
D++WE + + LG G G V A G + A+K++
Sbjct: 29 DLKWE-----------FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77
Query: 645 EFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ 703
+ + ++ +E +++ L H + L T L+ EYC GDL + +
Sbjct: 78 KADSSERE--ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 135
Query: 704 LGK---------------------CFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742
K + + +V +E+L ++RDL N+
Sbjct: 136 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195
Query: 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPC 802
LV + + DF L+ + + P +
Sbjct: 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK-----------------------W 232
Query: 803 FSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGA 862
+P L + + + S L+ E
Sbjct: 233 MAPESL------FEGIYTIKSDVWSYGILLWE---------------------------- 258
Query: 863 AVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922
++ G+ Y G + ++ K + + +++
Sbjct: 259 ---IFSLGVNPYP---------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAF 306
Query: 923 EPENRLGSQKGAAEIKQH 940
+ R +
Sbjct: 307 DSRKRP----SFPNLTSF 320
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 4e-35
Identities = 36/195 (18%), Positives = 71/195 (36%), Gaps = 10/195 (5%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
+ + KLG G G VY + A+K + + + E +++
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKE 69
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
+ HP L L T + ++ E+ G+L ++ + S + ++ A+E
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVS----- 780
YL I+RDL N LV E+ + + DF LS + + + +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 781 -GPCTESNCIQPFCI 794
+ + + F +
Sbjct: 190 YNKFSIKSDVWAFGV 204
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.1 bits (163), Expect = 2e-12
Identities = 15/97 (15%), Positives = 32/97 (32%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEE 890
L+ T ++ APE + D W FG+ L+E+ +
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
Query: 891 TLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
+ ++ + + + +L+R P +R
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 18/169 (10%)
Query: 599 VRLQYGSIGLRHFNLLQK-LGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQ 657
++++ +I + + + + LG G G V T FA+K++ + P+A+
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKAR 52
Query: 658 TEREIL-RMLDHPFLPTLY----SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPA 712
E E+ R P + + + + +VME GG+L Q + + F+E
Sbjct: 53 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 713 ARFYVAEVLLALEYLHMLGVIYRDLKPENILV---REDGHIMLTDFDLS 758
A + + A++YLH + + +RD+KPEN+L R + + LTDF +
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 7e-21
Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 10/115 (8%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
+ + T Y+APE++ E + + D W+ G+ +Y LL G PF +
Sbjct: 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 895 VVMQ------SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF 943
+ + P+ +S + + LIR LL EP R+ E HP+
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWI 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 6/161 (3%)
Query: 616 KLGCGDIGTVYLAELI--GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPT 673
+LG G+ GTV A+K++ NE K E +++ LD+P++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPYIVR 72
Query: 674 LYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVI 733
+ +++ LVME G L+ Q+ + + V +V + ++YL +
Sbjct: 73 MIGICEAESW-MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 734 YRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774
+RDL N+L+ + ++DF LS K+ ++
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.0 bits (220), Expect = 5e-20
Identities = 21/110 (19%), Positives = 43/110 (39%), Gaps = 3/110 (2%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNEETLANVVMQ 898
++ APE I + D W+FG+ ++E YG+ P++G E A + +
Sbjct: 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEK 225
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
+ + DL+ + ENR ++ +++ +N
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRP-GFAAVELRLRNYYYDVVNE 274
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-34
Identities = 32/151 (21%), Positives = 62/151 (41%), Gaps = 7/151 (4%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ + + LG G+ G V+ + + K + + + + E IL + H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIARHR 61
Query: 670 FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM 729
+ L+ F S ++ E+ G D+ +E YV +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 730 LGVIYRDLKPENILV--REDGHIMLTDFDLS 758
+ + D++PENI+ R I + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 1e-23
Identities = 35/120 (29%), Positives = 57/120 (47%), Gaps = 10/120 (8%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
EY APE+ + + A D W+ G +Y LL G PF N++ + N++
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218
Query: 899 SLKFPDSPL--ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF----EGLNWALIR 952
F + IS +A D + LL+KE ++R+ A+E QHP+ E ++ +IR
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLKQKIERVSTKVIR 274
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-34
Identities = 41/152 (26%), Positives = 62/152 (40%), Gaps = 6/152 (3%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
I +Q++G G G V+L + + AIK + ++ E E++
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEE----DFIEEAEVMMK 56
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
L HP L LY CLV E+ G L + Q F+ +V +
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMA 115
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDL 757
YL VI+RDL N LV E+ I ++DF +
Sbjct: 116 YLEEACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.8 bits (204), Expect = 6e-18
Identities = 14/113 (12%), Positives = 40/113 (35%), Gaps = 4/113 (3%)
Query: 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG 887
+ + V + S ++ +PE+ + + D W+FG+ ++E+ +
Sbjct: 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 888 NEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ + + + L S ++ + PE+R + + +
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRP----AFSRLLRQ 255
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-34
Identities = 40/153 (26%), Positives = 67/153 (43%), Gaps = 6/153 (3%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
I L KLG G G V++ GT AIK + ++ E ++++
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE----AFLQEAQVMKK 68
Query: 666 LDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALE 725
L H L LY+ + + + +V EY G L + + GK P A++ +
Sbjct: 69 LRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127
Query: 726 YLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
Y+ + ++RDL+ NILV E+ + DF L+
Sbjct: 128 YVERMNYVHRDLRAANILVGENLVCKVADFGLA 160
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 1e-17
Identities = 24/121 (19%), Positives = 38/121 (31%), Gaps = 6/121 (4%)
Query: 828 LPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG 887
L +L+ + ++ APE D W+FGI L EL
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218
Query: 888 NEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ--HPFFEG 945
+ + V + + P P DL+ KEPE R ++ +F
Sbjct: 219 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP----TFEYLQAFLEDYFTS 274
Query: 946 L 946
Sbjct: 275 T 275
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-33
Identities = 60/360 (16%), Positives = 112/360 (31%), Gaps = 58/360 (16%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L +G G G+V A T A+K + F + R E +L+ + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKHMKHE 77
Query: 670 FLPTLYSQFTS-----DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
+ L FT + ++ + G DL+ + + Q ++ +F + ++L L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGL 134
Query: 725 EYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCT 784
+Y+H +I+RDLKP N+ V ED + + DF L+
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------------- 168
Query: 785 ESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844
+ + + + I S+ ++AE R+
Sbjct: 169 -------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD 904
H I++ G A N +
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV------------ 269
Query: 905 SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYD 964
+ A DL+ +L+ + + R+ AA+ H +F + P F
Sbjct: 270 FIGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYFAQYHDPDDEPVADPYDQSFES 325
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-33
Identities = 39/220 (17%), Positives = 69/220 (31%), Gaps = 35/220 (15%)
Query: 586 HMSADVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIK 640
+ D +WE + + LG G G V A G A+K
Sbjct: 11 QLPYDHKWE-----------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVK 59
Query: 641 VMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVL 699
++ A + +E ++L L +H + L T + ++ EYC GDL
Sbjct: 60 MLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
Query: 700 RQKQLGKC----------------FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743
+++ + +V + +L I+RDL NIL
Sbjct: 118 LRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177
Query: 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPC 783
+ + DF L+ + + P + P
Sbjct: 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPE 217
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.6 bits (159), Expect = 6e-12
Identities = 18/99 (18%), Positives = 40/99 (40%), Gaps = 1/99 (1%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGN 888
+ + + +++APE I + D W++GIFL+EL G +P+ G
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 889 EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
+ ++ + + + D+++ +P R
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 9/180 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMP---RAQTEREILRML 666
+ + LG G G+VY + N AIK ++ + ++ ++P R E +L+ +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 667 D--HPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
+ L F + L++E + G E AR + +VL A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAV 123
Query: 725 EYLHMLGVIYRDLKPENILVRED-GHIMLTDFDLS--LRCSVSPTLLKSSSNMDPARVSG 781
+ H GV++RD+K ENIL+ + G + L DF L+ +V + P +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 7e-23
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 13/112 (11%)
Query: 836 TDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
D F GT Y PE I+ HG + W+ GI LY+++ G PF+
Sbjct: 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EE 215
Query: 895 VVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946
++ + F +S + + LIR L P +R EI+ HP+ + +
Sbjct: 216 IIRGQVFFRQR--VSSECQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-32
Identities = 39/177 (22%), Positives = 68/177 (38%), Gaps = 14/177 (7%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTN---CLFAIKVMDNEFLARRKKMPRAQTEREILRML 666
L + +G G G V+ + AIK N ++ + E +R
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMRQF 65
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
DHP + L T + + ++ME C G+L Q + + Y ++ AL Y
Sbjct: 66 DHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 727 LHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPC 783
L ++RD+ N+LV + + L DF LS ++ S+ ++ P
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-------RYMEDSTYYKASKGKLPI 173
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 2e-15
Identities = 20/114 (17%), Positives = 40/114 (35%), Gaps = 4/114 (3%)
Query: 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGS 886
L + + + T +++ +++APE I +A D W FG+ ++E+L
Sbjct: 153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212
Query: 887 GNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ + + P P L+ +P R E+K
Sbjct: 213 VKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP----RFTELKAQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-32
Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 9/165 (5%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-ARRKKMPRAQTERE--ILRML 666
+++ ++LG G V T +A K + + R+ + R ERE IL+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 667 DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEY 726
HP + TL+ + + L++E GG+L ++ + +E A ++ ++L + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 727 LHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLRCSVSPTL 767
LH L + + DLKPENI++ + I + DF L+ +
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 43/129 (33%), Positives = 63/129 (48%), Gaps = 8/129 (6%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
+ GT E++APEI+ E G D W+ G+ Y LL G +PF G +ETLAN
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227
Query: 895 VVMQSLKFPDS--PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW--AL 950
V + +F D S A+D IR LL+K+P+ R+ + QHP+ + + AL
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQQAL 283
Query: 951 IRCAIPPEL 959
P+
Sbjct: 284 SSAWSHPQF 292
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (311), Expect = 7e-32
Identities = 48/347 (13%), Positives = 104/347 (29%), Gaps = 78/347 (22%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHP 669
+ L +K+G G G +YL I AIK+ + K P+ E +I +M+
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGG 62
Query: 670 -FLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
+PT+ + + +VME + + FS +++ +EY+H
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH 120
Query: 729 MLGVIYRDLKPENILVREDGH---IMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTE 785
I+RD+KP+N L+ + + DF L+ + + T
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART------------------- 161
Query: 786 SNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845
+ + R+ + SL
Sbjct: 162 ----HQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESL----------------- 199
Query: 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS 905
G + ++ G ++ L T + + + + P
Sbjct: 200 ---------------GYVLMYFNLGSLPWQGLKAATKR------QKYERISEKKMSTPIE 238
Query: 906 PL---ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNW 948
L + + +++ ++ ++ F +G ++
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQGFSY 284
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (309), Expect = 2e-31
Identities = 40/201 (19%), Positives = 67/201 (33%), Gaps = 29/201 (14%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
+ ++ +G G G V+ A G + A+K++ E A + Q E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMA 71
Query: 665 MLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQ--------------------- 703
D+P + L CL+ EY GDL+ +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 704 -LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762
S +V + YL ++RDL N LV E+ + + DF LS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 763 VSPTLLKSSSNMDPARVSGPC 783
+ ++ P R P
Sbjct: 192 SADYYKADGNDAIPIRWMPPE 212
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.4 bits (174), Expect = 5e-14
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 2/99 (2%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGN 888
+ + + ++ PE I + D W +G+ L+E+ YG P+ G +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 889 EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
EE + V ++ + +L+R K P +R
Sbjct: 249 EEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADR 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 8e-31
Identities = 36/193 (18%), Positives = 68/193 (35%), Gaps = 11/193 (5%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEF--LARRKKMPRAQTEREILRMLDH 668
F ++ LG G GTVY I I V E K E ++ +D+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 669 PFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLH 728
P + L + + L+ + P G L ++ + ++ + YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 729 MLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPAR-------VSG 781
+++RDL N+LV+ H+ +TDF L+ + P + +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 782 PCTESNCIQPFCI 794
T + + + +
Sbjct: 189 IYTHQSDVWSYGV 201
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 2e-14
Identities = 18/98 (18%), Positives = 47/98 (47%), Gaps = 2/98 (2%)
Query: 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGNE 889
L AE + + +++A E I + D W++G+ ++EL+ +G P+ G
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220
Query: 890 ETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
E +++++ + + P P+ + ++ + + ++R
Sbjct: 221 E-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSR 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-30
Identities = 56/363 (15%), Positives = 102/363 (28%), Gaps = 107/363 (29%)
Query: 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH 668
R L + +G G G V+ + G A+K+ + R ++ + E ML H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGE--EVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 669 PFLPTLYSQFTSDNLS----CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLAL 724
+ + DN + LV +Y G L + + L
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGL 113
Query: 725 EYLHM--------LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDP 776
+LHM + +RDLK +NILV+++G + D L++R + + + N
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN--- 170
Query: 777 ARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836
G +P L + + ++ A I
Sbjct: 171 -HRVGT-----------------KRYMAPEVLDDSINMKHFESFKRADI----------- 201
Query: 837 DARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSG--------- 887
+ G+ +E+ +
Sbjct: 202 ------------------------------YAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 888 -----NEETLANVVMQSLKFPD------SPLISFQARDLIRGLLIKEPENRLGSQKGAAE 936
+ E + VV + P+ S ++R RL A
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL----TALR 287
Query: 937 IKQ 939
IK+
Sbjct: 288 IKK 290
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 38/168 (22%), Positives = 57/168 (33%), Gaps = 15/168 (8%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM 665
+ +G G+ G V A + + + A + E E+L
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 666 L-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQK--------------QLGKCFSE 710
L HP + L L +EY P G+L +K S
Sbjct: 67 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 711 PAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ A+V ++YL I+RDL NILV E+ + DF LS
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 3e-15
Identities = 16/106 (15%), Positives = 34/106 (32%), Gaps = 4/106 (3%)
Query: 835 PTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
+ ++A E + + D W++G+ L+E++ L
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 895 VVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ Q + + DL+R ++P R A+I
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP----SFAQILVS 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 50/211 (23%), Positives = 81/211 (38%), Gaps = 35/211 (16%)
Query: 590 DVRWEAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTN-------CLFAIKVM 642
D RWE + L + LG G G V LAE IG + A+K++
Sbjct: 5 DPRWE-----------LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML 53
Query: 643 DNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQ 701
++ A K + +E E+++M+ H + L T D +++EY G+L Q
Sbjct: 54 KSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ 111
Query: 702 KQLGKC--------------FSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED 747
+ S +V +EYL I+RDL N+LV ED
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 748 GHIMLTDFDLSLRCSVSPTLLKSSSNMDPAR 778
+ + DF L+ K+++ P +
Sbjct: 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.4 bits (179), Expect = 1e-14
Identities = 18/99 (18%), Positives = 41/99 (41%), Gaps = 2/99 (2%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGN 888
+ ++ + +++APE + + D W+FG+ L+E+ G +P+ G
Sbjct: 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243
Query: 889 EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927
EE L ++ + + + + ++R P R
Sbjct: 244 EE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 6e-29
Identities = 55/376 (14%), Positives = 120/376 (31%), Gaps = 53/376 (14%)
Query: 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPF 670
+ L++KLG G TV+LA+ + N A+K++ + + A+ E ++L+ ++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLLQRVNDAD 70
Query: 671 LPTL--------------YSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFY 716
++ + + +++ G +L L +K + +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 717 VAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMD 775
++LL L+Y+H G+I+ D+KPEN+L+ + + +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE-NLIQIKIADLGNACWYDEHYTNS 189
Query: 776 PARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEP 835
E C +S L T
Sbjct: 190 IQTREYRSPE----VLLGAPWGCGADIWSTACLIFELITGDF-----------------L 228
Query: 836 TDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV 895
+ + +II+ G + G + R + +
Sbjct: 229 FEPDEGHSYTKDDDHIAQIIELLGELPS-YLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 287
Query: 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFF-EGLNWALIRCA 954
+ + K+ S + + D + +L +P R A + HP+ + L IR
Sbjct: 288 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA----DAGGLVNHPWLKDTLGMEEIRVP 343
Query: 955 IPP------ELPDFYD 964
++P +++
Sbjct: 344 DRELYGSGSDIPGWFE 359
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 4e-28
Identities = 35/173 (20%), Positives = 65/173 (37%), Gaps = 7/173 (4%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTN----CLFAIKVMDNEFLARRKKMPRAQTERE 661
I + +G G+ G VY L ++ AIK + + +++ E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAG 61
Query: 662 ILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
I+ H + L + ++ EY G L +++ FS + +
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIA 120
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNM 774
++YL + ++RDL NILV + ++DF LS P ++S
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 1e-14
Identities = 15/88 (17%), Positives = 30/88 (34%)
Query: 840 SNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS 899
++ + APE I +A D W+FGI ++E++ + + +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 900 LKFPDSPLISFQARDLIRGLLIKEPENR 927
+ P L+ +E R
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 2e-27
Identities = 38/169 (22%), Positives = 75/169 (44%), Gaps = 10/169 (5%)
Query: 594 EAIRHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLARR 650
+A++HV + S+ + HFN + +G G G VY L+ G A+K ++
Sbjct: 15 QAVQHVVIGPSSLIV-HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDI 69
Query: 651 KKMPRAQTEREILRMLDHPFLPTLY-SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFS 709
++ + TE I++ HP + +L S+ +V+ Y GDL + + +
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPT 128
Query: 710 EPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ +V +++L ++RDL N ++ E + + DF L+
Sbjct: 129 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 2e-16
Identities = 15/102 (14%), Positives = 35/102 (34%), Gaps = 4/102 (3%)
Query: 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQ 898
+++A E ++ + D W+FG+ L+EL+ P N + ++Q
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 899 SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+ +++ + E R +E+
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRP----SFSELVSR 287
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 3e-27
Identities = 36/190 (18%), Positives = 66/190 (34%), Gaps = 23/190 (12%)
Query: 610 HFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILR 664
L + LG G G V A+ G T A+K++ + +E +IL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 71
Query: 665 MLDHPFLPTLY--SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKC--------------F 708
+ H + +++E+C G+L + + +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 709 SEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768
+ Y +V +E+L I+RDL NIL+ E + + DF L+ P +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 769 KSSSNMDPAR 778
+ P +
Sbjct: 192 RKGDARLPLK 201
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.9 bits (170), Expect = 2e-13
Identities = 20/112 (17%), Positives = 42/112 (37%), Gaps = 5/112 (4%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYG-RTPFKGSGN 888
+ +P R +++APE I + D W+FG+ L+E+ +P+ G
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242
Query: 889 EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940
+E + + + + + + EP R +E+ +H
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP----TFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-27
Identities = 35/191 (18%), Positives = 65/191 (34%), Gaps = 15/191 (7%)
Query: 606 IGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTER 660
+ + ++LG G G VY G AIK ++ R + E
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEA 74
Query: 661 EILRMLDHPFLPTLYSQFTSDNLSCLVMEYCPGGDLH--------VLRQKQLGKCFSEPA 712
+++ + + L + + ++ME GDL + + S
Sbjct: 75 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 713 ARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772
E+ + YL+ ++RDL N +V ED + + DF ++ + K
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 773 NMDPARVSGPC 783
+ P R P
Sbjct: 195 GLLPVRWMSPE 205
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 3e-13
Identities = 24/121 (19%), Positives = 47/121 (38%), Gaps = 4/121 (3%)
Query: 830 QLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELL-YGRTPFKGSGN 888
+ + + +++PE +K D W+FG+ L+E+ P++G N
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 889 EETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ--HPFFEGL 946
E+ L V+ L +L+R P+ R + + IK+ P F +
Sbjct: 242 EQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
Query: 947 N 947
+
Sbjct: 301 S 301
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 7e-18
Identities = 20/157 (12%), Positives = 42/157 (26%), Gaps = 22/157 (14%)
Query: 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKM-------PRAQTEREILRM 665
+ + +G G V+ +K + +K
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 666 LDHPFLPTLYSQFTSDNL----SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVL 721
+ L L + ++ME + + +L
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE---------LYRVRVENPDEVLDMIL 113
Query: 722 LALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758
+ + G+++ DL N+LV + I + DF S
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 149
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 80.7 bits (198), Expect = 7e-17
Identities = 24/150 (16%), Positives = 50/150 (33%), Gaps = 41/150 (27%)
Query: 836 TDARSNSFVGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLAN 894
N V + + PE++ + + ++D W+ G L +++ + PF +
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 895 VVMQSLKFP------------------------------------DSPLISFQARDLIRG 918
+ + L + L+S +A D +
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948
LL + ++RL A E +HP+F +
Sbjct: 302 LLRYDHQSRL----TAREAMEHPYFYTVVK 327
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.6 bits (195), Expect = 2e-16
Identities = 38/182 (20%), Positives = 63/182 (34%), Gaps = 48/182 (26%)
Query: 833 AEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETL 892
T +V T Y APE+I G G+ VD W+ G + E++ + F G +
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227
Query: 893 ANVV---------------------------MQSLKFPD-------------SPLISFQA 912
V+ L FP + L + QA
Sbjct: 228 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQA 287
Query: 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDF----YDYGIQ 968
RDL+ +L+ +P R+ + QHP+ A PP++ D ++ I+
Sbjct: 288 RDLLSKMLVIDPAKRI----SVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIE 343
Query: 969 DM 970
+
Sbjct: 344 EW 345
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 992 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.34 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.65 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.42 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.38 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-57 Score=491.16 Aligned_cols=279 Identities=37% Similarity=0.667 Sum_probs=247.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.+..+++.||||++.+...........+.+|+++|++++||||++++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999877666666778899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.+....
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-- 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 162 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC--
Confidence 9999999999988875 679999999999999999999999999999999999999999999999999985432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........+||+
T Consensus 163 --------------------------------------------------------------------~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 163 --------------------------------------------------------------------KQARANSFVGTA 174 (288)
T ss_dssp ---------------------------------------------------------------------------CCCCG
T ss_pred --------------------------------------------------------------------cccccccccCCc
Confidence 011123457999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .+++++++||.+||..||.+|
T Consensus 175 ~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~~R 252 (288)
T d1uu3a_ 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLDATKR 252 (288)
T ss_dssp GGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--TCCHHHHHHHHTTSCSSGGGS
T ss_pred cccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhHC
Confidence 999999999999999999999999999999999999998888888888887776664 589999999999999999999
Q ss_pred CCChH--hHHHHHcCCCCCCCchhhhhcCCCCCCC
Q 001952 928 LGSQK--GAAEIKQHPFFEGLNWALIRCAIPPELP 960 (992)
Q Consensus 928 PT~~~--~aeEILkHPfF~~lnw~~lr~~~pp~lp 960 (992)
||+.+ ...+|++||||+++||..++...||.+|
T Consensus 253 ~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 253 LGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred cCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 99543 2345899999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=490.05 Aligned_cols=279 Identities=38% Similarity=0.738 Sum_probs=249.3
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45689999999999999999999999999999999999877666677788999999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCc
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~ 765 (992)
||||||+||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 82 iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-- 157 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-- 157 (337)
T ss_dssp EEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred cceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--
Confidence 999999999999998875 6799999999999999999999999999999999999999999999999999743210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........+|
T Consensus 158 ----------------------------------------------------------------------~~~~~~~~~G 167 (337)
T d1o6la_ 158 ----------------------------------------------------------------------DGATMKTFCG 167 (337)
T ss_dssp ----------------------------------------------------------------------TTCCBCCCEE
T ss_pred ----------------------------------------------------------------------CCccccccee
Confidence 0011234689
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+....+.+|. .++.++++||.+||.+||.
T Consensus 168 T~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~ 245 (337)
T d1o6la_ 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPK 245 (337)
T ss_dssp CGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTT
T ss_pred CHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHhhccCCch
Confidence 99999999999999999999999999999999999999999988888888888777765 4999999999999999999
Q ss_pred CcCCChH-hHHHHHcCCCCCCCchhhh--hcCCCCCCC
Q 001952 926 NRLGSQK-GAAEIKQHPFFEGLNWALI--RCAIPPELP 960 (992)
Q Consensus 926 kRPT~~~-~aeEILkHPfF~~lnw~~l--r~~~pp~lp 960 (992)
+|++... .++||++||||++++|..+ +...||..|
T Consensus 246 ~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P 283 (337)
T d1o6la_ 246 QRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKP 283 (337)
T ss_dssp TSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred hhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCC
Confidence 9996432 3899999999999999977 445666666
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-55 Score=484.93 Aligned_cols=278 Identities=36% Similarity=0.674 Sum_probs=247.1
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
.+++|++++.||+|+||.||+|.++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|...+.+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35799999999999999999999999999999999987766666777889999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+.||+|..++... +.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.+..
T Consensus 119 v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 99999999999988775 5799999999999999999999999999999999999999999999999999854310
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
......||
T Consensus 194 ------------------------------------------------------------------------~~~~~~Gt 201 (350)
T d1rdqe_ 194 ------------------------------------------------------------------------RTWTLCGT 201 (350)
T ss_dssp ------------------------------------------------------------------------CBCCCEEC
T ss_pred ------------------------------------------------------------------------ccccccCc
Confidence 01235799
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+.|||||++.+..|+.++|||||||+||||+||+.||.+.+....+..+......+|. .++.++.+||.+||..||.+
T Consensus 202 ~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~k 279 (350)
T d1rdqe_ 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQVDLTK 279 (350)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSCSCTTT
T ss_pred cccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHhhhCHHh
Confidence 9999999999999999999999999999999999999998888888888877766654 58999999999999999999
Q ss_pred cCC-ChHhHHHHHcCCCCCCCchhhhh--cCCCCCCCCCC
Q 001952 927 RLG-SQKGAAEIKQHPFFEGLNWALIR--CAIPPELPDFY 963 (992)
Q Consensus 927 RPT-~~~~aeEILkHPfF~~lnw~~lr--~~~pp~lp~~~ 963 (992)
|+. .+..++|||+||||+++||..+. ...+|.+|...
T Consensus 280 R~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~ 319 (350)
T d1rdqe_ 280 RFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp CTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred ccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCC
Confidence 962 22349999999999999998763 45677777543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=469.29 Aligned_cols=257 Identities=34% Similarity=0.587 Sum_probs=232.6
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
..++|++++.||+|+||+||+|.++.+++.||||++.+...........+.+|+++|+.++|||||++++++.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999987766666677788999999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
|||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 99999999999998875 5699999999999999999999999999999999999999999999999999733210
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
.......||
T Consensus 159 -----------------------------------------------------------------------~~~~~~~Gt 167 (263)
T d2j4za1 159 -----------------------------------------------------------------------SRRTTLCGT 167 (263)
T ss_dssp -----------------------------------------------------------------------CCCEETTEE
T ss_pred -----------------------------------------------------------------------CcccccCCC
Confidence 011234699
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+....+.+|. .++.++++||.+||..||++
T Consensus 168 ~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~ 245 (263)
T d2j4za1 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKHNPSQ 245 (263)
T ss_dssp GGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSSGGG
T ss_pred CcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCCHhH
Confidence 9999999999999999999999999999999999999998888888888777666654 58999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ 945 (992)
||| ++|+|+||||.+
T Consensus 246 R~t----~~eil~hp~~~~ 260 (263)
T d2j4za1 246 RPM----LREVLEHPWITA 260 (263)
T ss_dssp SCC----HHHHHTCHHHHH
T ss_pred CcC----HHHHHcCcCcCC
Confidence 999 999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-55 Score=477.70 Aligned_cols=275 Identities=37% Similarity=0.736 Sum_probs=245.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 57899999999999999999999999999999999887666667778899999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++.+..
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999999888764 6789999999999999999999999999999999999999999999999999744210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.....+||+
T Consensus 157 -----------------------------------------------------------------------~~~~~~Gt~ 165 (316)
T d1fota_ 157 -----------------------------------------------------------------------VTYTLCGTP 165 (316)
T ss_dssp -----------------------------------------------------------------------CBCCCCSCT
T ss_pred -----------------------------------------------------------------------ccccccCcc
Confidence 012357999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||++.+..|+.++|||||||+||||+||+.||.+.+..+.+..+......+|. .++.++++||.+||..||.+|
T Consensus 166 ~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dp~~R 243 (316)
T d1fota_ 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRDLSQR 243 (316)
T ss_dssp TTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTTC
T ss_pred cccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhhCHHhc
Confidence 999999999999999999999999999999999999999888888888887766654 589999999999999999999
Q ss_pred CCC-hHhHHHHHcCCCCCCCchhhh--hcCCCCCCCC
Q 001952 928 LGS-QKGAAEIKQHPFFEGLNWALI--RCAIPPELPD 961 (992)
Q Consensus 928 PT~-~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp~ 961 (992)
++. +..+++||+||||++++|..+ +...+|..|.
T Consensus 244 ~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~ 280 (316)
T d1fota_ 244 LGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPP 280 (316)
T ss_dssp TTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCC
T ss_pred cccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCC
Confidence 732 224999999999999999976 4556666663
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=466.05 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=226.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.+..+|+.||||+++.. .....+.+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGG---GCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecc---cChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 45799999999999999999999999999999999754 233456789999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|..++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+...
T Consensus 96 mEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~--- 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (293)
T ss_dssp EECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred EEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc---
Confidence 999999999998775 46999999999999999999999999999999999999999999999999998543210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+||+
T Consensus 170 ---------------------------------------------------------------------~~~~~~~~gt~ 180 (293)
T d1yhwa1 170 ---------------------------------------------------------------------QSKRSTMVGTP 180 (293)
T ss_dssp ---------------------------------------------------------------------TCCBCCCCSCG
T ss_pred ---------------------------------------------------------------------cccccccccCC
Confidence 01123457999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+..... .++.+..++.++++||.+||..||++
T Consensus 181 ~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 260 (293)
T d1yhwa1 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260 (293)
T ss_dssp GGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTT
T ss_pred CccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhH
Confidence 99999999999999999999999999999999999999888887777765543 34455678999999999999999999
Q ss_pred cCCChHhHHHHHcCCCCCC
Q 001952 927 RLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 927 RPT~~~~aeEILkHPfF~~ 945 (992)
||+ ++|+|+||||+.
T Consensus 261 R~s----~~eil~Hp~~~~ 275 (293)
T d1yhwa1 261 RGS----AKELLQHQFLKI 275 (293)
T ss_dssp SCC----HHHHTTCGGGGG
T ss_pred CcC----HHHHhcCHhhCC
Confidence 999 999999999974
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=470.06 Aligned_cols=273 Identities=39% Similarity=0.762 Sum_probs=236.8
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHH-HcCCCCccceeeeeccCCeEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILR-MLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk-~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
++|++++.||+|+||+||+|.+..+++.||||++++...........+..|..++. .++|||||+++++|.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999998776655666677777877765 68999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++......
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--- 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT---
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc---
Confidence 9999999999999875 56899999999999999999999999999999999999999999999999997432110
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 157 ---------------------------------------------------------------------~~~~~~~~gt~ 167 (320)
T d1xjda_ 157 ---------------------------------------------------------------------DAKTNTFCGTP 167 (320)
T ss_dssp ---------------------------------------------------------------------TCCBCCCCSCG
T ss_pred ---------------------------------------------------------------------cccccccCCCC
Confidence 01122357999
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+....+.+|. .++.++.+||.+||..||++|
T Consensus 168 ~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~dP~~R 245 (320)
T d1xjda_ 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEKR 245 (320)
T ss_dssp GGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGGS
T ss_pred CcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHhcccCCCCC
Confidence 999999999999999999999999999999999999999888888888777666554 589999999999999999999
Q ss_pred CCChHhHH-HHHcCCCCCCCchhhhh--cCCCCCCCC
Q 001952 928 LGSQKGAA-EIKQHPFFEGLNWALIR--CAIPPELPD 961 (992)
Q Consensus 928 PT~~~~ae-EILkHPfF~~lnw~~lr--~~~pp~lp~ 961 (992)
|+ +. |+++||||++++|..+. ...||..|+
T Consensus 246 ~s----~~~~l~~hpff~~~~~~~l~~~~~~pp~~p~ 278 (320)
T d1xjda_ 246 LG----VRGDIRQHPLFREINWEELERKEIDPPFRPK 278 (320)
T ss_dssp BT----TBSCGGGSGGGTTCCHHHHHTTCSCC-----
T ss_pred cC----HHHHHHhCchhccCCHHHHHhcCCCCCCCCC
Confidence 99 64 89999999999998763 445566663
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=462.82 Aligned_cols=260 Identities=27% Similarity=0.446 Sum_probs=218.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.++.+|+.||||+++.... ......+.+|+++|+.++|||||++++++.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999999999999999975432 22345688999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||++..+....
T Consensus 82 mEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~-- 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN-- 157 (271)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT--
T ss_pred EeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC--
Confidence 9999999999988653 579999999999999999999999999999999999999999999999999985432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........+||+
T Consensus 158 --------------------------------------------------------------------~~~~~~~~~GT~ 169 (271)
T d1nvra_ 158 --------------------------------------------------------------------RERLLNKMCGTL 169 (271)
T ss_dssp --------------------------------------------------------------------EECCBCCCCSCG
T ss_pred --------------------------------------------------------------------ccccccceeeCc
Confidence 001123467999
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHH-HHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLA-NVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~-~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
.|||||++.+..+ +.++|||||||+||||+||+.||.+........ .+.......+....++.++.+||.+||..||+
T Consensus 170 ~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 249 (271)
T d1nvra_ 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPS 249 (271)
T ss_dssp GGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTT
T ss_pred CccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChh
Confidence 9999999998876 678999999999999999999998765544433 33333333444456899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ 945 (992)
+||| ++|+|+||||+.
T Consensus 250 ~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 250 ARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp TSCC----HHHHTTCTTTTC
T ss_pred HCcC----HHHHhcCHhhCc
Confidence 9999 999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.9e-53 Score=472.55 Aligned_cols=278 Identities=31% Similarity=0.597 Sum_probs=230.2
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHH---HHHHHHcCCCCccceeeeeccCCe
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTE---REILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~E---ieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
.+++|++++.||+|+||.||+|++..+|+.||||++.+...........+.+| +.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 36799999999999999999999999999999999987655544444444444 566667789999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||||||+||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 99999999999999999875 6789999999999999999999999999999999999999999999999999744310
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
......
T Consensus 160 --------------------------------------------------------------------------~~~~~~ 165 (364)
T d1omwa3 160 --------------------------------------------------------------------------KKPHAS 165 (364)
T ss_dssp --------------------------------------------------------------------------SCCCSC
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 011234
Q ss_pred ccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHH-hhccCCCCCccchHHHHHHHHHhcc
Q 001952 844 VGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVV-MQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 844 vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv-~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
+||+.|+|||++.+ ..|+.++|||||||+||||+||+.||.+....+...... ........+..+++++++||.+||.
T Consensus 166 ~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 245 (364)
T d1omwa3 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 245 (364)
T ss_dssp CSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTC
T ss_pred ccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcc
Confidence 69999999999975 568999999999999999999999998765443322111 1122233344689999999999999
Q ss_pred CCcCCcCCC-hHhHHHHHcCCCCCCCchhhh--hcCCCCCCC
Q 001952 922 KEPENRLGS-QKGAAEIKQHPFFEGLNWALI--RCAIPPELP 960 (992)
Q Consensus 922 ~DPekRPT~-~~~aeEILkHPfF~~lnw~~l--r~~~pp~lp 960 (992)
.||.+||++ ...++|||+||||+++||..+ +...||.+|
T Consensus 246 ~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p 287 (364)
T d1omwa3 246 RDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287 (364)
T ss_dssp SSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred cCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCC
Confidence 999999995 345899999999999999866 445666676
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=457.71 Aligned_cols=265 Identities=29% Similarity=0.471 Sum_probs=227.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhh---cchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARR---KKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~---~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
.++|++++.||+|+||+||+|.++.+|+.||||++++...... .....+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3579999999999999999999999999999999975432221 2346788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC----cEEEEecccccc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG----HIMLTDFDLSLR 760 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg----~VKLsDFGLA~~ 760 (992)
|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.++ .+||+|||++..
T Consensus 89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999999875 5799999999999999999999999999999999999999776 499999999754
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+... ...
T Consensus 167 ~~~~-------------------------------------------------------------------------~~~ 173 (293)
T d1jksa_ 167 IDFG-------------------------------------------------------------------------NEF 173 (293)
T ss_dssp CTTS-------------------------------------------------------------------------CBC
T ss_pred cCCC-------------------------------------------------------------------------ccc
Confidence 3210 112
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRG 918 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~k 918 (992)
....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++.. ..++.++++||.+
T Consensus 174 ~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 253 (293)
T d1jksa_ 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRR 253 (293)
T ss_dssp SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHH
Confidence 23468999999999999999999999999999999999999999998888888887766655432 3578999999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
||..||++||+ ++|||+||||+..+|...
T Consensus 254 ~L~~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 254 LLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp TSCSSGGGSCC----HHHHHHSTTTCC------
T ss_pred HccCChhHCcC----HHHHhcCcccCCCChhHh
Confidence 99999999999 999999999999998754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=472.45 Aligned_cols=264 Identities=27% Similarity=0.408 Sum_probs=220.5
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEE
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSC 685 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ly 685 (992)
+..++|++++.||+|+||+||+|.+..+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 44678999999999999999999999999999999997542 2233457889999999999999999999999999999
Q ss_pred EEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 686 LVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+||+|.+++.+. ..+++..++.++.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|..+..
T Consensus 81 iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~- 157 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID- 157 (322)
T ss_dssp EEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred EEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC-
Confidence 999999999999999875 569999999999999999999997 5999999999999999999999999999854210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
......+
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (322)
T d1s9ja_ 158 -------------------------------------------------------------------------SMANSFV 164 (322)
T ss_dssp -------------------------------------------------------------------------HTC---C
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0112458
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH-----------------------------
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV----------------------------- 895 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I----------------------------- 895 (992)
||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+.....
T Consensus 165 GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T d1s9ja_ 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244 (322)
T ss_dssp CSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------------
T ss_pred CCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccccc
Confidence 999999999999999999999999999999999999999876543221110
Q ss_pred -------------HhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 896 -------------VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 896 -------------v~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
............++.++++||.+||..||.+||| ++|+|+||||++.+|..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp -CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHHSCC
T ss_pred ccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCcccc
Confidence 0000000011236789999999999999999999 999999999998877544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=459.80 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=225.7
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
+.|++++.||+|+||+||+|.+..+++.||||+++.. .......+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 4689999999999999999999999999999999754 2344567889999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|||+||+|..++... ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||++......
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 999999999987754 367999999999999999999999999999999999999999999999999997432100
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
........||+.
T Consensus 164 --------------------------------------------------------------------~~~~~~~~Gt~~ 175 (288)
T d2jfla1 164 --------------------------------------------------------------------IQRRDSFIGTPY 175 (288)
T ss_dssp --------------------------------------------------------------------HHHHTCCCSCCT
T ss_pred --------------------------------------------------------------------cccccccccccc
Confidence 001123579999
Q ss_pred ccChhhhc-----CCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhcc-CCCCCccchHHHHHHHHHhccC
Q 001952 849 YLAPEIIK-----GEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSL-KFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 849 Y~APEvL~-----g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~l-k~P~~~~vs~el~dLI~kcL~~ 922 (992)
|+|||++. +..|+.++|||||||+||||+||+.||.+.+..+.+..+..... .++.+..++.++++||.+||..
T Consensus 176 y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~ 255 (288)
T d2jfla1 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEK 255 (288)
T ss_dssp TCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCS
T ss_pred cCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccC
Confidence 99999995 44578999999999999999999999999988888888877654 3344456899999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~l 946 (992)
||++||| ++|||+||||+.-
T Consensus 256 dp~~R~t----~~ell~hp~~~~~ 275 (288)
T d2jfla1 256 NVDARWT----TSQLLQHPFVTVD 275 (288)
T ss_dssp STTTSCC----HHHHTTSGGGCCC
T ss_pred ChhHCcC----HHHHhcCcccCCC
Confidence 9999999 9999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.8e-53 Score=469.27 Aligned_cols=265 Identities=30% Similarity=0.448 Sum_probs=232.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|++++.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999975432 2345678999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc--cCCcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR--EDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd--~dg~VKLsDFGLA~~l~~~~ 765 (992)
||||+||+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||++..+...
T Consensus 102 mE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 9999999999988654 35699999999999999999999999999999999999996 4678999999998543210
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.......|
T Consensus 180 ------------------------------------------------------------------------~~~~~~~g 187 (350)
T d1koaa2 180 ------------------------------------------------------------------------QSVKVTTG 187 (350)
T ss_dssp ------------------------------------------------------------------------SCEEEECS
T ss_pred ------------------------------------------------------------------------cccceecC
Confidence 11224579
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccCC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIKE 923 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~D 923 (992)
|+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+......++.. ..++.++++||.+||..|
T Consensus 188 T~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 267 (350)
T d1koaa2 188 TAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD 267 (350)
T ss_dssp CTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSS
T ss_pred cccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999998888898888777665543 458899999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCCCchhhhhc
Q 001952 924 PENRLGSQKGAAEIKQHPFFEGLNWALIRC 953 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~lnw~~lr~ 953 (992)
|++||| ++|||+||||...+|.....
T Consensus 268 P~~R~t----~~eil~hp~~~~~~~~~~~~ 293 (350)
T d1koaa2 268 PNTRMT----IHQALEHPWLTPGNAPGRDS 293 (350)
T ss_dssp GGGSCC----HHHHHHSTTTSCTTCCSCCC
T ss_pred hhHCcC----HHHHhcCcccCCCCCCCchh
Confidence 999999 99999999999988765433
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-53 Score=460.37 Aligned_cols=257 Identities=33% Similarity=0.508 Sum_probs=214.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.+.|++++.||+|+||+||+|.++.+++.||||++.+..... ....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997654332 235577899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc---cCCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR---EDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd---~dg~VKLsDFGLA~~l~~~ 764 (992)
||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||+. .++.+||+|||++.....
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 9999999999998764 6799999999999999999999999999999999999995 578999999999743210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.......+
T Consensus 163 ------------------------------------------------------------------------~~~~~~~~ 170 (307)
T d1a06a_ 163 ------------------------------------------------------------------------GSVLSTAC 170 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------CCeeeeee
Confidence 01122357
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHHHHHHHHhccC
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQARDLIRGLLIK 922 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el~dLI~kcL~~ 922 (992)
||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+.+..+......++. ...+++++.+||.+||..
T Consensus 171 GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 250 (307)
T d1a06a_ 171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEK 250 (307)
T ss_dssp --CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred eCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccC
Confidence 999999999999999999999999999999999999999998888888888877665543 356899999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~~ 945 (992)
||++||| ++|+|+||||++
T Consensus 251 dP~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 251 DPEKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp SGGGSCC----HHHHHHSTTTTS
T ss_pred CHhHCcC----HHHHhcCHhhCC
Confidence 9999999 999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-53 Score=462.78 Aligned_cols=255 Identities=29% Similarity=0.389 Sum_probs=226.1
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVM 688 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVm 688 (992)
+.|++++.||+|+||+||+|.+..+++.||||++.............+.+|+++|+.++|||||+++++|.+++.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999999999999999997654444455667899999999999999999999999999999999
Q ss_pred EecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccc
Q 001952 689 EYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLL 768 (992)
Q Consensus 689 Ey~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~ 768 (992)
|||.+|+|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||++....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC------
Confidence 999999997766543 679999999999999999999999999999999999999999999999999973321
Q ss_pred cCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCC
Q 001952 769 KSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHE 848 (992)
Q Consensus 769 ~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~ 848 (992)
......||+.
T Consensus 167 ----------------------------------------------------------------------~~~~~~GT~~ 176 (309)
T d1u5ra_ 167 ----------------------------------------------------------------------PANSFVGTPY 176 (309)
T ss_dssp ----------------------------------------------------------------------SBCCCCSCGG
T ss_pred ----------------------------------------------------------------------CCCccccCcc
Confidence 0123469999
Q ss_pred ccChhhhcC---CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 849 YLAPEIIKG---EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 849 Y~APEvL~g---~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
|||||++.+ ..|+.++|||||||+||||++|+.||.+.+..+.+..+............+++++++||.+||..||.
T Consensus 177 Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 256 (309)
T d1u5ra_ 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQ 256 (309)
T ss_dssp GCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChh
Confidence 999999975 35889999999999999999999999998888888888877666655667899999999999999999
Q ss_pred CcCCChHhHHHHHcCCCCCC
Q 001952 926 NRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 926 kRPT~~~~aeEILkHPfF~~ 945 (992)
+||| ++|||+||||..
T Consensus 257 ~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 257 DRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp GSCC----HHHHTTCHHHHS
T ss_pred HCcC----HHHHHhCHHhcC
Confidence 9999 999999999965
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=451.10 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=213.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc--CCeEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS--DNLSC 685 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~--~~~ly 685 (992)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+++|++++|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 36899999999999999999999999999999999765332 2335678899999999999999999999864 56789
Q ss_pred EEEEecCCCChHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHhhcC-----eeeeecCCceEEEccCCcEEEEecccc
Q 001952 686 LVMEYCPGGDLHVLRQKQ--LGKCFSEPAARFYVAEVLLALEYLHMLG-----VIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 686 LVmEy~~GGSL~~lLkk~--~~~~Lse~~i~~Ia~QIL~GL~YLHs~G-----IIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
||||||+||+|.+++.+. ....+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||++
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 999999999999988653 3467999999999999999999999976 999999999999999999999999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..+... ..
T Consensus 162 ~~~~~~------------------------------------------------------------------------~~ 169 (269)
T d2java1 162 RILNHD------------------------------------------------------------------------TS 169 (269)
T ss_dssp HHC-----------------------------------------------------------------------------
T ss_pred eecccC------------------------------------------------------------------------CC
Confidence 543210 00
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRG 918 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~k 918 (992)
.....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.+..+.+..+...... +.+..+++++.+||.+
T Consensus 170 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~li~~ 248 (269)
T d2java1 170 FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEIITR 248 (269)
T ss_dssp ------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHH
T ss_pred ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHHHHHHHHH
Confidence 112457999999999999999999999999999999999999999998887777777665543 2334689999999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF 943 (992)
||..||.+||+ ++|||+|||+
T Consensus 249 ~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 249 MLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp HTCSSGGGSCC----HHHHHTSTTC
T ss_pred HcCCChhHCcC----HHHHHhCCcC
Confidence 99999999999 9999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.4e-52 Score=463.88 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=227.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
.++|++++.||+|+||+||+|.+..+|+.||||+++..... ....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999764322 234678899999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEc--cCCcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVR--EDGHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd--~dg~VKLsDFGLA~~l~~~~ 765 (992)
||||+||+|.+++... +..+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||++..+..
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-- 181 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-- 181 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT--
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC--
Confidence 9999999998876643 35699999999999999999999999999999999999998 678999999999854321
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
........|
T Consensus 182 -----------------------------------------------------------------------~~~~~~~~g 190 (352)
T d1koba_ 182 -----------------------------------------------------------------------DEIVKVTTA 190 (352)
T ss_dssp -----------------------------------------------------------------------TSCEEEECS
T ss_pred -----------------------------------------------------------------------CCceeeccC
Confidence 011223568
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccCC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIKE 923 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~D 923 (992)
|+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+..+.+..+......++.. ..++.++++||.+||..|
T Consensus 191 t~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 270 (352)
T d1koba_ 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 270 (352)
T ss_dssp SGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSS
T ss_pred cccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999998888888888777665532 468999999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCCC
Q 001952 924 PENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~l 946 (992)
|.+||+ +.|+|+||||++.
T Consensus 271 p~~R~s----~~eil~Hp~~~~~ 289 (352)
T d1koba_ 271 PRKRLT----VHDALEHPWLKGD 289 (352)
T ss_dssp GGGSCC----HHHHHTSTTTSSC
T ss_pred hhHCcC----HHHHhcCHhhCCC
Confidence 999999 9999999999874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-52 Score=444.28 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=213.4
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc----CCeEEE
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS----DNLSCL 686 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~----~~~lyL 686 (992)
|++.+.||+|+||+||+|.+..+++.||+|++...... ......+.+|+++|++++|||||+++++|.. ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 46778899999999999999999999999999765332 2334678899999999999999999999864 456899
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--eeeeecCCceEEEc-cCCcEEEEeccccccccC
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLG--VIYRDLKPENILVR-EDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~G--IIHRDIKPeNILLd-~dg~VKLsDFGLA~~l~~ 763 (992)
|||||++|+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||++....
T Consensus 90 vmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred EEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-
Confidence 99999999999999875 57999999999999999999999998 99999999999997 57899999999973211
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.......
T Consensus 167 -------------------------------------------------------------------------~~~~~~~ 173 (270)
T d1t4ha_ 167 -------------------------------------------------------------------------ASFAKAV 173 (270)
T ss_dssp -------------------------------------------------------------------------TTSBEES
T ss_pred -------------------------------------------------------------------------CCccCCc
Confidence 0011245
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC-CCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF-PDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~-P~~~~vs~el~dLI~kcL~~ 922 (992)
+||+.|||||++.+ .++.++|||||||+||||++|+.||.+....+.+...+...... .....+++++.+||.+||..
T Consensus 174 ~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~ 252 (270)
T d1t4ha_ 174 IGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQ 252 (270)
T ss_dssp CSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred ccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccC
Confidence 79999999999876 59999999999999999999999998877666655555444332 22344788999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFFE 944 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF~ 944 (992)
||++||| ++|||+||||+
T Consensus 253 dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 253 NKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp SGGGSCC----HHHHHTSGGGC
T ss_pred CHhHCcC----HHHHhCCcccC
Confidence 9999999 99999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6e-51 Score=436.49 Aligned_cols=260 Identities=30% Similarity=0.434 Sum_probs=226.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHH------hhcchhHHHHHHHHHHHcC-CCCccceeeeecc
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLA------RRKKMPRAQTEREILRMLD-HPFLPTLYSQFTS 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~------~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~ 680 (992)
.++|++++.||+|+||+||+|++..+++.||||++.+.... .......+.+|+.+|+.++ ||||++++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999999999999999998654211 1223346789999999997 9999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
++.+|||||||+||+|.++++.+ ..+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++..
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 99999999999999999999875 5799999999999999999999999999999999999999999999999999754
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
... ....
T Consensus 160 ~~~-------------------------------------------------------------------------~~~~ 166 (277)
T d1phka_ 160 LDP-------------------------------------------------------------------------GEKL 166 (277)
T ss_dssp CCT-------------------------------------------------------------------------TCCB
T ss_pred ccC-------------------------------------------------------------------------CCce
Confidence 321 0011
Q ss_pred CccccCCCccChhhhcC------CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC--CccchHHH
Q 001952 841 NSFVGTHEYLAPEIIKG------EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD--SPLISFQA 912 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g------~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~--~~~vs~el 912 (992)
....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+......++. ...+++++
T Consensus 167 ~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 246 (277)
T d1phka_ 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTV 246 (277)
T ss_dssp CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHH
T ss_pred eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHH
Confidence 23579999999999974 34688999999999999999999999999888888888877665543 34689999
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
++||.+||..||.+||+ ++|||+||||++.
T Consensus 247 ~~li~~~L~~~p~~R~s----~~eil~h~~~~~~ 276 (277)
T d1phka_ 247 KDLVSRFLVVQPQKRYT----AEEALAHPFFQQY 276 (277)
T ss_dssp HHHHHHHCCSSGGGSCC----HHHHTTSGGGCTT
T ss_pred HHHHHHHccCChhHCcC----HHHHHcCHHHHHh
Confidence 99999999999999999 9999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=439.61 Aligned_cols=257 Identities=27% Similarity=0.367 Sum_probs=212.2
Q ss_pred EEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh--hcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEe
Q 001952 613 LLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR--RKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEY 690 (992)
Q Consensus 613 ilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~--~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy 690 (992)
.+++||+|+||+||+|.+..+|+.||||+++...... ......+.+|+.+|+.++|||||+++++|..++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 5689999999999999999999999999997543222 12345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccC
Q 001952 691 CPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKS 770 (992)
Q Consensus 691 ~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~ 770 (992)
+.++++..+... ...+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC------
Confidence 988877766543 367999999999999999999999999999999999999999999999999997432110
Q ss_pred CCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCcc
Q 001952 771 SSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYL 850 (992)
Q Consensus 771 ~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~ 850 (992)
.......+||+.|+
T Consensus 154 ------------------------------------------------------------------~~~~~~~~gt~~y~ 167 (299)
T d1ua2a_ 154 ------------------------------------------------------------------NRAYTHQVVTRWYR 167 (299)
T ss_dssp ------------------------------------------------------------------CCCCCCSCCCCTTC
T ss_pred ------------------------------------------------------------------cccccceecChhhc
Confidence 01112357999999
Q ss_pred ChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC--------------------C-----
Q 001952 851 APEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP--------------------D----- 904 (992)
Q Consensus 851 APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P--------------------~----- 904 (992)
|||++.+. .|+.++|||||||++|||++|..||.+.+..+.+..+.......+ .
T Consensus 168 aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
T d1ua2a_ 168 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH 247 (299)
T ss_dssp CHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHH
T ss_pred cHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHH
Confidence 99999765 579999999999999999999999999988888887764321110 0
Q ss_pred -CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 905 -SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 905 -~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
...++.++.+||.+||..||++||| ++|+|+||||+..-
T Consensus 248 ~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 248 IFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRP 287 (299)
T ss_dssp HCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSS
T ss_pred hcccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCCC
Confidence 0235789999999999999999999 99999999998654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=448.28 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=226.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|++++.||+|+||+||+|.+..+++.||||+++..... ...+.+|+++|+.++|||||+++++|.+++.+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999764322 24578999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccC--CcEEEEeccccccccCCc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRED--GHIMLTDFDLSLRCSVSP 765 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~d--g~VKLsDFGLA~~l~~~~ 765 (992)
||||+||+|.+++... +..+++..++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||++..+...
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999998764 3469999999999999999999999999999999999999854 47999999997443110
Q ss_pred ccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcccc
Q 001952 766 TLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVG 845 (992)
Q Consensus 766 ~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vG 845 (992)
.......|
T Consensus 158 ------------------------------------------------------------------------~~~~~~~~ 165 (321)
T d1tkia_ 158 ------------------------------------------------------------------------DNFRLLFT 165 (321)
T ss_dssp ------------------------------------------------------------------------CEEEEEES
T ss_pred ------------------------------------------------------------------------Cccccccc
Confidence 01123468
Q ss_pred CCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC--ccchHHHHHHHHHhccCC
Q 001952 846 THEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS--PLISFQARDLIRGLLIKE 923 (992)
Q Consensus 846 T~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~--~~vs~el~dLI~kcL~~D 923 (992)
|+.|+|||.+.+..|+.++|||||||+||||++|+.||.+.+..+.+..+....+.++.. ..++.++++||.+||..|
T Consensus 166 t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 245 (321)
T d1tkia_ 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp CGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSS
T ss_pred ccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999999889999988877766542 347899999999999999
Q ss_pred cCCcCCChHhHHHHHcCCCCCC
Q 001952 924 PENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 924 PekRPT~~~~aeEILkHPfF~~ 945 (992)
|.+||+ ++|+|+||||++
T Consensus 246 p~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 246 RKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp GGGSCC----HHHHHHSHHHHS
T ss_pred hhHCcC----HHHHhcCHhhcc
Confidence 999999 999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=434.17 Aligned_cols=262 Identities=28% Similarity=0.414 Sum_probs=217.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|++++.||+|+||+||+|.+..+++.||||+++.... .......+.+|+++|++++|||||+++++|.+++.+|||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999999999999999999999999976532 234457788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+.+ .+..++.......+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--- 155 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--- 155 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC---
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC---
Confidence 999955 5555555444577999999999999999999999999999999999999999999999999998543210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 156 ---------------------------------------------------------------------~~~~~~~~gt~ 166 (298)
T d1gz8a_ 156 ---------------------------------------------------------------------VRTYTHEVVTL 166 (298)
T ss_dssp ---------------------------------------------------------------------SBCTTCCBCCC
T ss_pred ---------------------------------------------------------------------cccceeecccc
Confidence 01122347999
Q ss_pred CccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC----------------------
Q 001952 848 EYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD---------------------- 904 (992)
Q Consensus 848 ~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~---------------------- 904 (992)
.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 167 ~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T d1gz8a_ 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246 (298)
T ss_dssp TTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCC
T ss_pred eeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccccccc
Confidence 9999999887764 89999999999999999999999998888877776543211110
Q ss_pred -----CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 905 -----SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 905 -----~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
...++.++++||.+||..||++||| +.|||+||||++++
T Consensus 247 ~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDVT 290 (298)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTCC
T ss_pred chhhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccCC
Confidence 0235688999999999999999999 99999999998874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-50 Score=434.69 Aligned_cols=257 Identities=20% Similarity=0.254 Sum_probs=223.6
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
+++..++|++.+.||+|+||+||+|.+..+++.||||+++.. ......+.+|+.+|+.++|||||+++++|.+++.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 456678999999999999999999999999999999999754 2345678999999999999999999999999999
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||||||++|+|..++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999999876667899999999999999999999999999999999999999999999999999743211
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.. .......
T Consensus 168 ~~-----------------------------------------------------------------------~~~~~~~ 176 (287)
T d1opja_ 168 DT-----------------------------------------------------------------------YTAHAGA 176 (287)
T ss_dssp SS-----------------------------------------------------------------------SEEETTE
T ss_pred CC-----------------------------------------------------------------------ceeeccc
Confidence 00 0011233
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKE 923 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~D 923 (992)
.||+.|+|||++.+..|+.++|||||||+||||++|..||........+..++.....++.+..++.++.+||.+||..|
T Consensus 177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~d 256 (287)
T d1opja_ 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWN 256 (287)
T ss_dssp EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCC
Confidence 58899999999999999999999999999999999877776666666666777777777777789999999999999999
Q ss_pred cCCcCCChHhHHHHHc
Q 001952 924 PENRLGSQKGAAEIKQ 939 (992)
Q Consensus 924 PekRPT~~~~aeEILk 939 (992)
|++||+ ++||++
T Consensus 257 P~~Rps----~~ei~~ 268 (287)
T d1opja_ 257 PSDRPS----FAEIHQ 268 (287)
T ss_dssp GGGSCC----HHHHHH
T ss_pred HhHCcC----HHHHHH
Confidence 999999 777764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=429.62 Aligned_cols=262 Identities=26% Similarity=0.347 Sum_probs=215.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCC-CeEEEEEEechhHHHhhcchhHHHHHHHHHHHc---CCCCccceeeeec----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGT-NCLFAIKVMDNEFLARRKKMPRAQTEREILRML---DHPFLPTLYSQFT---- 679 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~t-g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L---~HPNIVkL~g~f~---- 679 (992)
.++|++++.||+|+||+||+|.+..+ ++.||||+++..... ......+.+|+.+|+.+ +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47899999999999999999999765 678999999754322 22334566788877766 7999999999985
Q ss_pred -cCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 680 -SDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 680 -~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
....+|++|||+.++.+..... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3457899999998777654443 33567999999999999999999999999999999999999999999999999986
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
..... ..
T Consensus 164 ~~~~~-------------------------------------------------------------------------~~ 170 (305)
T d1blxa_ 164 RIYSF-------------------------------------------------------------------------QM 170 (305)
T ss_dssp CCCCG-------------------------------------------------------------------------GG
T ss_pred hhhcc-------------------------------------------------------------------------cc
Confidence 32110 01
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCC----------------
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKF---------------- 902 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~---------------- 902 (992)
......||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++......
T Consensus 171 ~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 250 (305)
T d1blxa_ 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250 (305)
T ss_dssp GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGS
T ss_pred cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhh
Confidence 1234579999999999999999999999999999999999999999998888887775421110
Q ss_pred ---------CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 903 ---------PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 903 ---------P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
.....++.++.+||.+||..||++||| +.|+|+||||+++++
T Consensus 251 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLER 301 (305)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred ccccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchh
Confidence 011346789999999999999999999 999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-50 Score=437.24 Aligned_cols=260 Identities=18% Similarity=0.286 Sum_probs=221.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCe-----EEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNC-----LFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~-----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
++..++|++.+.||+|+||+||+|.+.+.++ .||+|.+.... .......+.+|+.+|.++ +|||||+++++|
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 4566899999999999999999999876543 69999986542 234456788999999998 899999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhcC---------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeeeeec
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQLG---------------------KCFSEPAARFYVAEVLLALEYLHMLGVIYRDL 737 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~~---------------------~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDI 737 (992)
.+.+.+|||||||++|+|.++++.... ..+++..++.|+.||+.||+|||++|||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 999999999999999999999876431 35889999999999999999999999999999
Q ss_pred CCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCC
Q 001952 738 KPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKP 817 (992)
Q Consensus 738 KPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~ 817 (992)
||+|||++.++.+||+|||+++......
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~---------------------------------------------------- 218 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDS---------------------------------------------------- 218 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCT----------------------------------------------------
T ss_pred chhccccccCCeEEEeeccccccccCCC----------------------------------------------------
Confidence 9999999999999999999984432100
Q ss_pred CCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHH
Q 001952 818 KADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVV 896 (992)
Q Consensus 818 ~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv 896 (992)
.........||+.|||||++.+..++.++|||||||+||||+| |+.||.+.+..+.+..++
T Consensus 219 ------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~ 280 (325)
T d1rjba_ 219 ------------------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280 (325)
T ss_dssp ------------------TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred ------------------ceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 0001123568999999999999999999999999999999998 899999988888888888
Q ss_pred hhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 897 MQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 897 ~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.....++.+..++.++++||.+||..||++||| ++||++|
T Consensus 281 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 281 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 888888777789999999999999999999999 8888875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=427.07 Aligned_cols=252 Identities=27% Similarity=0.404 Sum_probs=213.1
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhc---chhHHHHHHHHHHHcC--CCCccceeeeeccCC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRK---KMPRAQTEREILRMLD--HPFLPTLYSQFTSDN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~---~~~~~~~EieILk~L~--HPNIVkL~g~f~~~~ 682 (992)
.++|++.+.||+|+||+||+|.+..+|+.||||++++....... ...++.+|+.+|+.++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999999999999999999765432211 1234568999999996 899999999999999
Q ss_pred eEEEEEEecCC-CChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-CCcEEEEecccccc
Q 001952 683 LSCLVMEYCPG-GDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-DGHIMLTDFDLSLR 760 (992)
Q Consensus 683 ~lyLVmEy~~G-GSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-dg~VKLsDFGLA~~ 760 (992)
.+|+||||+.+ +++..++... ..+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||++..
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred eEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 99999999976 5777887765 67999999999999999999999999999999999999985 57999999999743
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
... ...
T Consensus 161 ~~~--------------------------------------------------------------------------~~~ 166 (273)
T d1xwsa_ 161 LKD--------------------------------------------------------------------------TVY 166 (273)
T ss_dssp CCS--------------------------------------------------------------------------SCB
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 210 012
Q ss_pred CccccCCCccChhhhcCCCC-CccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHh
Q 001952 841 NSFVGTHEYLAPEIIKGEGH-GAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGL 919 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~-s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kc 919 (992)
....||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+. ..+......++. .++.++++||.+|
T Consensus 167 ~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~--~~s~~~~~li~~~ 238 (273)
T d1xwsa_ 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQ--RVSSECQHLIRWC 238 (273)
T ss_dssp CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSS--CCCHHHHHHHHHH
T ss_pred cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCC--CCCHHHHHHHHHH
Confidence 24579999999999988765 67899999999999999999999763 234445555443 5899999999999
Q ss_pred ccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 920 LIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 920 L~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
|..||++||| ++|||+||||+.+-
T Consensus 239 L~~dp~~R~s----~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 239 LALRPSDRPT----FEEIQNHPWMQDVL 262 (273)
T ss_dssp TCSSGGGSCC----HHHHHTSGGGSSCC
T ss_pred ccCCHhHCcC----HHHHhcCHhhCCCC
Confidence 9999999999 99999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=426.93 Aligned_cols=260 Identities=21% Similarity=0.307 Sum_probs=215.7
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
+++..++|++++.||+|+||+||+|.+. +++.||||+++.. ......+.+|+++|++++|||||++++++.+ +.
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC----cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 3466789999999999999999999985 5678999999753 2334578999999999999999999998765 56
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||||||+++|+|.+++....+..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC
Confidence 79999999999999887665555799999999999999999999999999999999999999999999999999855321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ......
T Consensus 162 ~~~-----------------------------------------------------------------------~~~~~~ 170 (272)
T d1qpca_ 162 NEY-----------------------------------------------------------------------TAREGA 170 (272)
T ss_dssp SCE-----------------------------------------------------------------------ECCTTC
T ss_pred Ccc-----------------------------------------------------------------------cccccc
Confidence 100 011234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCC-CCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGR-TPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr-~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.||+.|+|||++.+..++.++|||||||+||||+||. +||......+.+.. +......+.+..++.++.+||.+||..
T Consensus 171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~~li~~cl~~ 249 (272)
T d1qpca_ 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCPEELYQLMRLCWKE 249 (272)
T ss_dssp CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcCCCCCcccChHHHHHHHHHHcCC
Confidence 6899999999999999999999999999999999954 55555555455444 445556666667999999999999999
Q ss_pred CcCCcCCChHhHHHHHc--CCCCCC
Q 001952 923 EPENRLGSQKGAAEIKQ--HPFFEG 945 (992)
Q Consensus 923 DPekRPT~~~~aeEILk--HPfF~~ 945 (992)
||++||| ++||++ |+||.+
T Consensus 250 ~P~~Rpt----~~ei~~~L~~~fts 270 (272)
T d1qpca_ 250 RPEDRPT----FDYLRSVLEDFFTA 270 (272)
T ss_dssp SGGGSCC----HHHHHHHHHHHHHH
T ss_pred CHhHCcC----HHHHHHHhhhhhhc
Confidence 9999999 788876 667753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=443.98 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=209.8
Q ss_pred ccCceEEE-EEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHH-cCCCCccceeeeecc----C
Q 001952 608 LRHFNLLQ-KLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRM-LDHPFLPTLYSQFTS----D 681 (992)
Q Consensus 608 ~~~Yeilr-~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~-L~HPNIVkL~g~f~~----~ 681 (992)
.++|+++. .||+|+||+||+|.+..+++.||||+++.. ..+.+|++++.+ ++|||||+++++|.+ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57899885 599999999999999999999999999642 346789988654 589999999999865 5
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEecccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLS 758 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA 758 (992)
..+|||||||+||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+|||++. .+.+||+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 67899999999999999998765567999999999999999999999999999999999999985 557999999998
Q ss_pred ccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCC
Q 001952 759 LRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDA 838 (992)
Q Consensus 759 ~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~ 838 (992)
+.+... .
T Consensus 162 ~~~~~~-------------------------------------------------------------------------~ 168 (335)
T d2ozaa1 162 KETTSH-------------------------------------------------------------------------N 168 (335)
T ss_dssp EECCCC-------------------------------------------------------------------------C
T ss_pred eeccCC-------------------------------------------------------------------------C
Confidence 543210 0
Q ss_pred CcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHh----hccCCCCC--ccchHHH
Q 001952 839 RSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVM----QSLKFPDS--PLISFQA 912 (992)
Q Consensus 839 ~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~----~~lk~P~~--~~vs~el 912 (992)
.....+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+....+..+.. ....+|.. ..++.++
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 248 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHH
T ss_pred ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHH
Confidence 11234699999999999999999999999999999999999999988766555444332 23334432 3478899
Q ss_pred HHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 913 RDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 913 ~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
++||.+||..||++||+ +.|||+||||..
T Consensus 249 ~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 249 KMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 99999999999999999 999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=433.49 Aligned_cols=281 Identities=27% Similarity=0.437 Sum_probs=224.1
Q ss_pred CceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc------CCe
Q 001952 610 HFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------DNL 683 (992)
Q Consensus 610 ~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------~~~ 683 (992)
+|+.+++||+|+||+||+|++..+|+.||||++.... ..+.+|+++|++++|+||++++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-------hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 6999999999999999999999999999999997531 123479999999999999999999843 346
Q ss_pred EEEEEEecCCCChHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEEEeccccccc
Q 001952 684 SCLVMEYCPGGDLHVLRQK-QLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIMLTDFDLSLRC 761 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk-~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKLsDFGLA~~l 761 (992)
+|||||||+++.+..+... .....+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||++..+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 8999999976655544432 2346799999999999999999999999999999999999999765 8999999997443
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. .....
T Consensus 174 ~~-------------------------------------------------------------------------~~~~~ 180 (350)
T d1q5ka_ 174 VR-------------------------------------------------------------------------GEPNV 180 (350)
T ss_dssp CT-------------------------------------------------------------------------TSCCC
T ss_pred cC-------------------------------------------------------------------------Ccccc
Confidence 11 01122
Q ss_pred ccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc-----------------cCCC
Q 001952 842 SFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS-----------------LKFP 903 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~-----------------lk~P 903 (992)
..+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..++... ..++
T Consensus 181 ~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~ 260 (350)
T d1q5ka_ 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 260 (350)
T ss_dssp SCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCC
T ss_pred cccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcccc
Confidence 35799999999998764 68999999999999999999999999988888777765321 1111
Q ss_pred ----------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCCCCCCCCCCcccccc
Q 001952 904 ----------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPELPDFYDYGIQDMVPQ 973 (992)
Q Consensus 904 ----------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~lp~~~d~~~~~~~~q 973 (992)
....+++++.+||.+||..||++||| +.|+|+||||+++.....+.......+..+++...++...
T Consensus 261 ~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~ 336 (350)
T d1q5ka_ 261 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336 (350)
T ss_dssp CCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTC
T ss_pred ccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCC
Confidence 11346889999999999999999999 9999999999987655544444445566666666555443
Q ss_pred c
Q 001952 974 K 974 (992)
Q Consensus 974 ~ 974 (992)
.
T Consensus 337 ~ 337 (350)
T d1q5ka_ 337 P 337 (350)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-49 Score=423.31 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=210.3
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC----e
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----L 683 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----~ 683 (992)
.++|++.+.||+|+||+||+|.+..+|+.||||+++............+.+|+++|+.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998665444455667899999999999999999999987643 4
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||||||+|++|..++... +.+++..++.|+.||+.||+|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999888765 6799999999999999999999999999999999999999999999999998643211
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.. .........
T Consensus 164 ~~---------------------------------------------------------------------~~~~~~~~~ 174 (277)
T d1o6ya_ 164 SG---------------------------------------------------------------------NSVTQTAAV 174 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc---------------------------------------------------------------------ccccccccc
Confidence 00 001122346
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC--CCccchHHHHHHHHHhcc
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP--DSPLISFQARDLIRGLLI 921 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P--~~~~vs~el~dLI~kcL~ 921 (992)
+||+.|+|||++.+..++.++|||||||+||||+||+.||.+.+..+.+..++.....++ ....++.++.+||.+||.
T Consensus 175 ~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~ 254 (277)
T d1o6ya_ 175 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALA 254 (277)
T ss_dssp ----TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTC
T ss_pred cCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHcc
Confidence 799999999999999999999999999999999999999999888888888877655443 234589999999999999
Q ss_pred CCcCCcCC
Q 001952 922 KEPENRLG 929 (992)
Q Consensus 922 ~DPekRPT 929 (992)
.||.+||+
T Consensus 255 ~dp~~R~~ 262 (277)
T d1o6ya_ 255 KNPENRYQ 262 (277)
T ss_dssp SSGGGSCS
T ss_pred CCHhHCHh
Confidence 99999995
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=416.89 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=206.7
Q ss_pred cccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEE
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyL 686 (992)
+-++|++++.||+|+||+||+|.+. ++..||||+++.. ......+.+|+++|+.++|||||++++++..++.+||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 3568999999999999999999985 5678999999753 2334568899999999999999999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPT 766 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~ 766 (992)
||||+++|+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+....
T Consensus 78 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp EEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 99999999999988764 3568999999999999999999999999999999999999999999999999974431100
Q ss_pred cccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccC
Q 001952 767 LLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGT 846 (992)
Q Consensus 767 ~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT 846 (992)
........||
T Consensus 156 ----------------------------------------------------------------------~~~~~~~~gt 165 (263)
T d1sm2a_ 156 ----------------------------------------------------------------------YTSSTGTKFP 165 (263)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ----------------------------------------------------------------------ceeecceecC
Confidence 0011234689
Q ss_pred CCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcC
Q 001952 847 HEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPE 925 (992)
Q Consensus 847 ~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPe 925 (992)
+.|+|||++.+..|+.++|||||||+||||+| |.+||.+.+..+.+..+ ......+.+..++.++.+||.+||..||+
T Consensus 166 ~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~li~~cl~~~p~ 244 (263)
T d1sm2a_ 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-STGFRLYKPRLASTHVYQIMNHCWKERPE 244 (263)
T ss_dssp TTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH-HHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred cccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH-HhcCCCCCccccCHHHHHHHHHHccCCHh
Confidence 99999999999999999999999999999999 56666666555555554 44555556667899999999999999999
Q ss_pred CcCCChHhHHHHHcC
Q 001952 926 NRLGSQKGAAEIKQH 940 (992)
Q Consensus 926 kRPT~~~~aeEILkH 940 (992)
+||+ ++||++|
T Consensus 245 ~Rps----~~~il~~ 255 (263)
T d1sm2a_ 245 DRPA----FSRLLRQ 255 (263)
T ss_dssp GSCC----HHHHHHH
T ss_pred HCcC----HHHHHHH
Confidence 9999 8888775
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.3e-49 Score=420.23 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=215.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|++++.||+|+||+||+|.+. +|+.||||+++.... .......+.+|+.+|+.++||||++++++|..++..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 368999999999999999999985 788999999976532 234467889999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+.++.+..+.... +.+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC---
Confidence 9999777776665543 67999999999999999999999999999999999999999999999999997543210
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........|++
T Consensus 154 ---------------------------------------------------------------------~~~~~~~~~~~ 164 (286)
T d1ob3a_ 154 ---------------------------------------------------------------------VRKYTHEIVTL 164 (286)
T ss_dssp -----------------------------------------------------------------------------CCC
T ss_pred ---------------------------------------------------------------------ccccceecccc
Confidence 01122346899
Q ss_pred CccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-----------------------
Q 001952 848 EYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP----------------------- 903 (992)
Q Consensus 848 ~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P----------------------- 903 (992)
.|+|||.+.+. .++.++|||||||+||||++|+.||.+.+..+.+..+........
T Consensus 165 ~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T d1ob3a_ 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244 (286)
T ss_dssp TTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCC
T ss_pred hhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCc
Confidence 99999999865 469999999999999999999999999888777776653211100
Q ss_pred ----CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 904 ----DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 904 ----~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
....++.+++|||++||..||++||| +.|||+||||++
T Consensus 245 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 245 PWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp CGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred chhhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 11336789999999999999999999 999999999974
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=424.73 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=212.3
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
+++..++|++.+.||+|+||+||+|++.+ .||||+++.... .......+.+|+++|++++|||||++++++.+ +.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence 35677899999999999999999997643 599999975422 23445678899999999999999999998754 56
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||||||++|+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+..
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 89999999999999998764 35699999999999999999999999999999999999999999999999999744311
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
.. ........
T Consensus 157 ~~----------------------------------------------------------------------~~~~~~~~ 166 (276)
T d1uwha_ 157 WS----------------------------------------------------------------------GSHQFEQL 166 (276)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred cC----------------------------------------------------------------------Cccccccc
Confidence 00 00112345
Q ss_pred ccCCCccChhhhcCC---CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCC----CccchHHHHHHH
Q 001952 844 VGTHEYLAPEIIKGE---GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPD----SPLISFQARDLI 916 (992)
Q Consensus 844 vGT~~Y~APEvL~g~---~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~----~~~vs~el~dLI 916 (992)
.||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+....+..++......|. ...++.++.+||
T Consensus 167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li 246 (276)
T d1uwha_ 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLM 246 (276)
T ss_dssp CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHH
T ss_pred ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHH
Confidence 799999999999753 4789999999999999999999999998888777777766654442 335788999999
Q ss_pred HHhccCCcCCcCCChHhHHHHHcC
Q 001952 917 RGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~~aeEILkH 940 (992)
.+||..||++||| +.||+++
T Consensus 247 ~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 247 AECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp HHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999 7888765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-49 Score=426.25 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=207.7
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCe---EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNC---LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~---~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
++..++|++.+.||+|+||+||+|.++.+++ .||||.+.... .......+.+|+++|++++|||||++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4567899999999999999999999976654 68999886532 223345789999999999999999999999999
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+|||||||++|+|..++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 9999999999999999988764 356899999999999999999999999999999999999999999999999998543
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
...... .......
T Consensus 179 ~~~~~~-------------------------------------------------------------------~~~~~~~ 191 (299)
T d1jpaa_ 179 EDDTSD-------------------------------------------------------------------PTYTSAL 191 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCCCc-------------------------------------------------------------------ceeeecc
Confidence 211000 0001112
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..++.++|||||||+||||+| |+.||.+....+.+..+ .....++.+..++.++.+||.+||
T Consensus 192 ~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~cl 270 (299)
T d1jpaa_ 192 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLPPPMDCPSALHQLMLDCW 270 (299)
T ss_dssp ----CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred cccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHc
Confidence 3468999999999999999999999999999999998 89999988777766654 445566666679999999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||++||+ +.||++
T Consensus 271 ~~~P~~RPs----~~ei~~ 285 (299)
T d1jpaa_ 271 QKDRNHRPK----FGQIVN 285 (299)
T ss_dssp CSSTTTSCC----HHHHHH
T ss_pred CCCHhHCcC----HHHHHH
Confidence 999999999 555443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=430.82 Aligned_cols=284 Identities=39% Similarity=0.730 Sum_probs=232.8
Q ss_pred ccccCceEEEEEccCCceEEEEEEEc---CCCeEEEEEEechhHHH-hhcchhHHHHHHHHHHHcCC-CCccceeeeecc
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELI---GTNCLFAIKVMDNEFLA-RRKKMPRAQTEREILRMLDH-PFLPTLYSQFTS 680 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~---~tg~~VAIKvIkk~~l~-~~~~~~~~~~EieILk~L~H-PNIVkL~g~f~~ 680 (992)
+.+++|++++.||+|+||+||+|.+. .+|+.||||++++.... .......+.+|+++|++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 35688999999999999999999874 46899999999754322 22345667889999999976 899999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+.+|+||||+.+|+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.++|+|||+++.
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999998876 5678999999999999999999999999999999999999999999999999854
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+.... ....
T Consensus 179 ~~~~~-----------------------------------------------------------------------~~~~ 187 (322)
T d1vzoa_ 179 FVADE-----------------------------------------------------------------------TERA 187 (322)
T ss_dssp CCGGG-----------------------------------------------------------------------GGGG
T ss_pred hcccc-----------------------------------------------------------------------cccc
Confidence 32110 0112
Q ss_pred CccccCCCccChhhhcCCC--CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhc--cCCCCCccchHHHHHHH
Q 001952 841 NSFVGTHEYLAPEIIKGEG--HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQS--LKFPDSPLISFQARDLI 916 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~--~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~--lk~P~~~~vs~el~dLI 916 (992)
....|++.|++||.+.+.. ++.++|||||||+||||++|+.||.+.+..+....+.... ..++.+..++.++.+||
T Consensus 188 ~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 267 (322)
T d1vzoa_ 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 267 (322)
T ss_dssp CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHH
Confidence 2356899999999998754 6889999999999999999999998876655544444332 23333446899999999
Q ss_pred HHhccCCcCCcCCChH-hHHHHHcCCCCCCCchhhh--hcCCCCCCCCC
Q 001952 917 RGLLIKEPENRLGSQK-GAAEIKQHPFFEGLNWALI--RCAIPPELPDF 962 (992)
Q Consensus 917 ~kcL~~DPekRPT~~~-~aeEILkHPfF~~lnw~~l--r~~~pp~lp~~ 962 (992)
.+||..||++||++.. .++|||+||||++++|..+ +...+|.+|..
T Consensus 268 ~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~ 316 (322)
T d1vzoa_ 268 QRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 316 (322)
T ss_dssp HHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCC
Confidence 9999999999996532 4899999999999999876 34666666743
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=428.28 Aligned_cols=260 Identities=32% Similarity=0.424 Sum_probs=211.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----- 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----- 682 (992)
.++|++++.||+|+||+||+|.+..+|+.||||+++.... .......+.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5789999999999999999999999999999999975422 2334567889999999999999999999997654
Q ss_pred -eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 683 -LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 683 -~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
++||||||+ +.+|..+.+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7788877664 56999999999999999999999999999999999999999999999999997432
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
. ...+
T Consensus 172 ~---------------------------------------------------------------------------~~~~ 176 (346)
T d1cm8a_ 172 D---------------------------------------------------------------------------SEMT 176 (346)
T ss_dssp C---------------------------------------------------------------------------SSCC
T ss_pred C---------------------------------------------------------------------------Cccc
Confidence 1 0112
Q ss_pred ccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC-----------------
Q 001952 842 SFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP----------------- 903 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P----------------- 903 (992)
..+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..+.......+
T Consensus 177 ~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (346)
T d1cm8a_ 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256 (346)
T ss_dssp SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHH
T ss_pred cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhc
Confidence 35799999999999875 568999999999999999999999999887777665543221111
Q ss_pred ------------CCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhh
Q 001952 904 ------------DSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALI 951 (992)
Q Consensus 904 ------------~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~l 951 (992)
....+++++.+||.+||..||.+||| +.|||+||||+.+++...
T Consensus 257 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDTED 312 (346)
T ss_dssp HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC----
T ss_pred cCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCCccc
Confidence 11246789999999999999999999 999999999999886553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=420.25 Aligned_cols=256 Identities=22% Similarity=0.304 Sum_probs=208.6
Q ss_pred EEEccCCceEEEEEEEcC--CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEEEEecC
Q 001952 615 QKLGCGDIGTVYLAELIG--TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 615 r~LGsG~FGtVYlA~~~~--tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLVmEy~~ 692 (992)
++||+|+||+||+|.+.. +++.||||+++.... .......+.+|+++|++++|||||+++++|.. +..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 469999999999998753 567899999975432 23345678999999999999999999999865 45789999999
Q ss_pred CCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCcccccCCC
Q 001952 693 GGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSS 772 (992)
Q Consensus 693 GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s 772 (992)
+|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 91 ~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~----- 163 (277)
T d1xbba_ 91 LGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----- 163 (277)
T ss_dssp TEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-----
T ss_pred CCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-----
Confidence 99999998864 67999999999999999999999999999999999999999999999999998543211000
Q ss_pred CCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCCCccCh
Q 001952 773 NMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAP 852 (992)
Q Consensus 773 ~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~AP 852 (992)
........||+.|+||
T Consensus 164 ----------------------------------------------------------------~~~~~~~~gt~~y~AP 179 (277)
T d1xbba_ 164 ----------------------------------------------------------------YKAQTHGKWPVKWYAP 179 (277)
T ss_dssp ----------------------------------------------------------------EEC----CCCGGGCCH
T ss_pred ----------------------------------------------------------------cccccccCCCceecCc
Confidence 0011234689999999
Q ss_pred hhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCcCCCh
Q 001952 853 EIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQ 931 (992)
Q Consensus 853 EvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~ 931 (992)
|++.+..++.++|||||||+||||+| |+.||.+.+..+....+ .....++.+..++.++.+||.+||..||++||+
T Consensus 180 E~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs-- 256 (277)
T d1xbba_ 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPG-- 256 (277)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCC--
T ss_pred hhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcC--
Confidence 99999999999999999999999998 99999988776665554 444555556679999999999999999999999
Q ss_pred HhHHHH---HcCCCCCCCch
Q 001952 932 KGAAEI---KQHPFFEGLNW 948 (992)
Q Consensus 932 ~~aeEI---LkHPfF~~lnw 948 (992)
+++| |+|+|++-+|+
T Consensus 257 --~~~i~~~L~~~~~~~~~e 274 (277)
T d1xbba_ 257 --FAAVELRLRNYYYDVVNE 274 (277)
T ss_dssp --HHHHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHhhCHHhhcCCC
Confidence 5554 67877765544
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-48 Score=413.24 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=209.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCC----eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTN----CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS 680 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg----~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~ 680 (992)
++..++|++.++||+|+||.||+|.++.++ ..||||+++.... ......+.+|+++|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 456678999999999999999999987654 5799999975432 2234568899999999999999999999999
Q ss_pred CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccc
Q 001952 681 DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLR 760 (992)
Q Consensus 681 ~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~ 760 (992)
.+.+++|||||.+++|.+++... ...+++..++.|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 99999999999999999887654 36799999999999999999999999999999999999999999999999999854
Q ss_pred ccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCc
Q 001952 761 CSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARS 840 (992)
Q Consensus 761 l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s 840 (992)
+..... .....
T Consensus 160 ~~~~~~---------------------------------------------------------------------~~~~~ 170 (283)
T d1mqba_ 160 LEDDPE---------------------------------------------------------------------ATYTT 170 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCCc---------------------------------------------------------------------cceEe
Confidence 321000 00011
Q ss_pred CccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 841 NSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 841 ~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
....||+.|+|||++.+..++.++|||||||+||||++|..||........+...+......+.+..++.++.+||.+||
T Consensus 171 ~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl 250 (283)
T d1mqba_ 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCW 250 (283)
T ss_dssp ---CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHT
T ss_pred ccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHC
Confidence 23458999999999999999999999999999999999655554444444445556666677777779999999999999
Q ss_pred cCCcCCcCCChHhHHHHHc
Q 001952 921 IKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILk 939 (992)
..||++||+ +.||++
T Consensus 251 ~~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 251 QQERARRPK----FADIVS 265 (283)
T ss_dssp CSSTTTSCC----HHHHHH
T ss_pred cCCHhHCcC----HHHHHH
Confidence 999999999 666654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6e-48 Score=418.09 Aligned_cols=263 Identities=25% Similarity=0.426 Sum_probs=212.9
Q ss_pred hheeeecccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCcccee
Q 001952 597 RHVRLQYGSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLY 675 (992)
Q Consensus 597 ~~~~~~~gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~ 675 (992)
+.....++. .++|++++.||+|+||+||+|++..+++.||||+++.. ....+.+|+++|+.+. ||||++++
T Consensus 25 ~~~~~~~~~--~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~ 96 (328)
T d3bqca1 25 ESHVVEWGN--QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLA 96 (328)
T ss_dssp GGCCCCCCC--GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEE
T ss_pred hhcccCCCC--CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEE
Confidence 333444443 46899999999999999999999999999999999743 2456789999999995 99999999
Q ss_pred eeecc--CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC-cEEE
Q 001952 676 SQFTS--DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG-HIML 752 (992)
Q Consensus 676 g~f~~--~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg-~VKL 752 (992)
++|.. ...+|+|||||.+++|..+. +.+++..++.++.||+.||+|||++|||||||||+||||+.++ .++|
T Consensus 97 ~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl 171 (328)
T d3bqca1 97 DIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171 (328)
T ss_dssp EEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeee
Confidence 99874 46799999999999996552 4589999999999999999999999999999999999998655 6999
Q ss_pred EeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccc
Q 001952 753 TDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLV 832 (992)
Q Consensus 753 sDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~ 832 (992)
+|||++..+...
T Consensus 172 ~DFG~a~~~~~~-------------------------------------------------------------------- 183 (328)
T d3bqca1 172 IDWGLAEFYHPG-------------------------------------------------------------------- 183 (328)
T ss_dssp CCGGGCEECCTT--------------------------------------------------------------------
T ss_pred cccccceeccCC--------------------------------------------------------------------
Confidence 999997443110
Q ss_pred cCCCCCCcCccccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCch-HHHHHHHhh------------
Q 001952 833 AEPTDARSNSFVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNE-ETLANVVMQ------------ 898 (992)
Q Consensus 833 a~~~~~~s~s~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~-e~L~~Iv~~------------ 898 (992)
......+||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...... +....+...
T Consensus 184 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 184 -----QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp -----CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred -----CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 0122346899999999998764 799999999999999999999999865543 222222110
Q ss_pred -----------------------ccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchh
Q 001952 899 -----------------------SLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWA 949 (992)
Q Consensus 899 -----------------------~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~ 949 (992)
....+....++.+++|||++||..||.+||| ++|||+||||+.+.|.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCCC
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 0001112346789999999999999999999 9999999999999984
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=418.04 Aligned_cols=263 Identities=25% Similarity=0.342 Sum_probs=212.5
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-------
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS------- 680 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~------- 680 (992)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+++|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5799999999999999999999999999999999976532 23455678899999999999999999998854
Q ss_pred -CCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccc
Q 001952 681 -DNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSL 759 (992)
Q Consensus 681 -~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~ 759 (992)
.+++|+||||+.++.+..+... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 4568999999977766544333 4678999999999999999999999999999999999999999999999999985
Q ss_pred cccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCC
Q 001952 760 RCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDAR 839 (992)
Q Consensus 760 ~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~ 839 (992)
.+..... .....
T Consensus 166 ~~~~~~~--------------------------------------------------------------------~~~~~ 177 (318)
T d3blha1 166 AFSLAKN--------------------------------------------------------------------SQPNR 177 (318)
T ss_dssp ECCC-------------------------------------------------------------------------CCC
T ss_pred ecccccc--------------------------------------------------------------------ccccc
Confidence 4321000 00111
Q ss_pred cCccccCCCccChhhhcCC-CCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCC-------------
Q 001952 840 SNSFVGTHEYLAPEIIKGE-GHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDS------------- 905 (992)
Q Consensus 840 s~s~vGT~~Y~APEvL~g~-~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~------------- 905 (992)
....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+..+......++..
T Consensus 178 ~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T d3blha1 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257 (318)
T ss_dssp CCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-----
T ss_pred ccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhh
Confidence 2345799999999999876 68999999999999999999999999988877777665433222211
Q ss_pred -----------------ccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCC
Q 001952 906 -----------------PLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEG 945 (992)
Q Consensus 906 -----------------~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ 945 (992)
...+.+++|||.+||..||++||| ++|+|+||||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~ 310 (318)
T d3blha1 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWS 310 (318)
T ss_dssp --CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSS
T ss_pred hcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhcc
Confidence 012557889999999999999999 999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=419.46 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=214.3
Q ss_pred cccCceEEEE-EccCCceEEEEEEEcC--CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 607 GLRHFNLLQK-LGCGDIGTVYLAELIG--TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 607 ~~~~Yeilr~-LGsG~FGtVYlA~~~~--tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..++|.+.+. ||+|+||+||+|.++. ++..||||+++... .......+.+|+++|++++|||||++++++.. +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 3467888885 9999999999998754 45689999997542 22345678999999999999999999999865 46
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+|||||||++|+|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+..
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 89999999999999987643 35799999999999999999999999999999999999999999999999999865421
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ........
T Consensus 162 ~~~---------------------------------------------------------------------~~~~~~~~ 172 (285)
T d1u59a_ 162 DDS---------------------------------------------------------------------YYTARSAG 172 (285)
T ss_dssp CSC---------------------------------------------------------------------EECCCCSS
T ss_pred ccc---------------------------------------------------------------------cccccccc
Confidence 100 00011234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.||+.|+|||++.+..++.++|||||||+||||+| |+.||.+.+..+.+..+. ....++.+..++.++.+||.+||..
T Consensus 173 ~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~ 251 (285)
T d1u59a_ 173 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-QGKRMECPPECPPELYALMSDCWIY 251 (285)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred ccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCHHHHHHHHHHcCC
Confidence 58999999999999999999999999999999998 999999988777766554 4444555567999999999999999
Q ss_pred CcCCcCCChHhHHHHHcCCCC
Q 001952 923 EPENRLGSQKGAAEIKQHPFF 943 (992)
Q Consensus 923 DPekRPT~~~~aeEILkHPfF 943 (992)
||++||++. .+.+.|+|+|+
T Consensus 252 ~p~~RPs~~-~i~~~L~~~~~ 271 (285)
T d1u59a_ 252 KWEDRPDFL-TVEQRMRACYY 271 (285)
T ss_dssp SGGGSCCHH-HHHHHHHHHHH
T ss_pred CHhHCcCHH-HHHHHHHHHHH
Confidence 999999933 23344677765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=416.73 Aligned_cols=261 Identities=24% Similarity=0.286 Sum_probs=214.6
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeE
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLS 684 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~l 684 (992)
++..++|++.+.||+|+||+||+|.+..+ +.||||+++... .....+.+|+.+|++++|||||++++++.+ +.+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 45678999999999999999999998655 569999997542 234678999999999999999999999865 567
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCC
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~ 764 (992)
||||||+++|+|..++.......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999999998887655567999999999999999999999999999999999999999999999999997443210
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
. ........
T Consensus 167 ~-----------------------------------------------------------------------~~~~~~~~ 175 (285)
T d1fmka3 167 E-----------------------------------------------------------------------YTARQGAK 175 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C-----------------------------------------------------------------------ceeecccc
Confidence 0 00112346
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCc
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEP 924 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DP 924 (992)
||+.|+|||++.+..++.++|||||||+||||++|..||........+...+......+.+..++.++.+||.+||+.||
T Consensus 176 gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP 255 (285)
T d1fmka3 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 255 (285)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred ccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCH
Confidence 89999999999999999999999999999999996555544444444444455566667777899999999999999999
Q ss_pred CCcCCChHhHHHHHc--CCCCCCC
Q 001952 925 ENRLGSQKGAAEIKQ--HPFFEGL 946 (992)
Q Consensus 925 ekRPT~~~~aeEILk--HPfF~~l 946 (992)
++||+ +++|+. |+||...
T Consensus 256 ~~Rps----~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 256 EERPT----FEYLQAFLEDYFTST 275 (285)
T ss_dssp GGSCC----HHHHHHHHHTTTSCS
T ss_pred hHCcC----HHHHHHHHhhhhcCC
Confidence 99999 888776 7888764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=408.63 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=215.4
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
+++|++++.||+|+||+||+|.+..+++.||||+++... ........+.+|+.+|+.++||||++++++|.+.+..++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997543 2234456788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||++.+++|..++... +.+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-- 155 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-- 155 (292)
T ss_dssp EECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--
T ss_pred eeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--
Confidence 9999999998887654 678999999999999999999999999999999999999999999999999985432100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.......+++
T Consensus 156 ----------------------------------------------------------------------~~~~~~~~~~ 165 (292)
T d1unla_ 156 ----------------------------------------------------------------------RCYSAEVVTL 165 (292)
T ss_dssp ----------------------------------------------------------------------SCCCSCCSCG
T ss_pred ----------------------------------------------------------------------ccceeecccc
Confidence 0111235778
Q ss_pred CccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCc-hHHHHHHHhhccCC-----------------------
Q 001952 848 EYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGN-EETLANVVMQSLKF----------------------- 902 (992)
Q Consensus 848 ~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~-~e~L~~Iv~~~lk~----------------------- 902 (992)
.|+|||++.+.. ++.++|||||||++|||++|+.||....+ .+.+..+.......
T Consensus 166 ~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T d1unla_ 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245 (292)
T ss_dssp GGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTT
T ss_pred chhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccccccccc
Confidence 899999998765 69999999999999999999998765444 44444433211110
Q ss_pred ----CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCC
Q 001952 903 ----PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGL 946 (992)
Q Consensus 903 ----P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~l 946 (992)
.....++.++++||.+||+.||.+||| ++|+|+||||+++
T Consensus 246 ~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSSC
T ss_pred chhhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcCC
Confidence 011235788999999999999999999 9999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=410.53 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=216.6
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCeEEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNLSCLV 687 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~lyLV 687 (992)
-++|++++.||+|+||+||+|+++ +++.||||+++... .....+.+|+.++++++||||++++++|.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 468999999999999999999984 77889999998642 2345788999999999999999999999999999999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
|||+++|+|..++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-- 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-- 154 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS--
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC--
Confidence 99999999998876543 568899999999999999999999999999999999999999999999999974321100
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
........||+
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~t~ 165 (258)
T d1k2pa_ 155 ---------------------------------------------------------------------YTSSVGSKFPV 165 (258)
T ss_dssp ---------------------------------------------------------------------CCCCCCSCCCG
T ss_pred ---------------------------------------------------------------------ceeecccCCCC
Confidence 00112346899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCC
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPEN 926 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPek 926 (992)
.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+....+. .....+.+..++.++.+||.+||..||++
T Consensus 166 ~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~-~~~~~~~p~~~~~~l~~li~~cl~~dP~~ 244 (258)
T d1k2pa_ 166 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADE 244 (258)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGG
T ss_pred CcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH-hCCCCCCcccccHHHHHHHHHHccCCHhH
Confidence 9999999999999999999999999999998 899999988777776665 44556666779999999999999999999
Q ss_pred cCCChHhHHHHHcC
Q 001952 927 RLGSQKGAAEIKQH 940 (992)
Q Consensus 927 RPT~~~~aeEILkH 940 (992)
||+ +.||++|
T Consensus 245 RPt----~~eil~~ 254 (258)
T d1k2pa_ 245 RPT----FKILLSN 254 (258)
T ss_dssp SCC----HHHHHHH
T ss_pred CcC----HHHHHHH
Confidence 999 7777766
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=407.67 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=209.1
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccC
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSD 681 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~ 681 (992)
++..++|++.+.||+|+||.||+|.+..+ +..||||.++... .......+.+|+++|+.++|||||++++++. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 46678999999999999999999988654 4568999986532 2334467889999999999999999999996 4
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
+.+||||||+++|+|..++... ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999999999887654 357899999999999999999999999999999999999999999999999997443
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.... .....
T Consensus 159 ~~~~-----------------------------------------------------------------------~~~~~ 167 (273)
T d1mp8a_ 159 EDST-----------------------------------------------------------------------YYKAS 167 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCc-----------------------------------------------------------------------ceecc
Confidence 2100 00112
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhc
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLL 920 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL 920 (992)
...||+.|+|||++.+..++.++|||||||+||||++ |.+||.+.+..+.+..+.. ....+.+..++.++.+||.+||
T Consensus 168 ~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~cl 246 (273)
T d1mp8a_ 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMPPNCPPTLYSLMTKCW 246 (273)
T ss_dssp ---CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-TCCCCCCTTCCHHHHHHHHHHT
T ss_pred ceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHc
Confidence 3458999999999999999999999999999999998 8999999888888777654 3445556679999999999999
Q ss_pred cCCcCCcCCChHhHHHHHcC
Q 001952 921 IKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 921 ~~DPekRPT~~~~aeEILkH 940 (992)
..||++||+ +.||++|
T Consensus 247 ~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 247 AYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred CCCHhHCcC----HHHHHHH
Confidence 999999999 8888765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=410.20 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=209.2
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQF 678 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f 678 (992)
++..++|++++.||+|+||.||+|.+.. +++.||||+++... .......+..|..++.++ +|+||+.+++++
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 3556889999999999999999999865 34789999997543 223345667777777766 689999999987
Q ss_pred cc-CCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 679 TS-DNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 679 ~~-~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
.. ++.+|+|||||++|+|.++++... ...+++..++.|+.||+.||.|||++|||||||||+|||
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NIL 166 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 166 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcccee
Confidence 65 457899999999999999987542 235889999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 744 Ld~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
|+.++.+||+|||+++.+....
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~---------------------------------------------------------- 188 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDP---------------------------------------------------------- 188 (299)
T ss_dssp ECGGGCEEECC------CCSCT----------------------------------------------------------
T ss_pred ECCCCcEEEccCcchhhccccc----------------------------------------------------------
Confidence 9999999999999985432100
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccC-CCCCCCCCchHHHHHHHhhccCC
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYG-RTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTG-r~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
.........||+.|+|||++.+..++.++|||||||++|||+|| ..||.+....+.+..++.....+
T Consensus 189 ------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~ 256 (299)
T d1ywna1 189 ------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 256 (299)
T ss_dssp ------------TSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCC
T ss_pred ------------cccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 00112345799999999999999999999999999999999986 57888887777777777777777
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+.+..+++++.+||.+||..||++||+ ++||++|
T Consensus 257 ~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 257 RAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 777779999999999999999999999 8888876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=420.50 Aligned_cols=269 Identities=28% Similarity=0.401 Sum_probs=210.9
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeec------cC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFT------SD 681 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~------~~ 681 (992)
.++|++++.||+|+||+||+|.+..+|+.||||++..... .......+.+|+.+|+.++|||||+++++|. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4789999999999999999999999999999999976532 2334457889999999999999999999995 34
Q ss_pred CeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccc
Q 001952 682 NLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRC 761 (992)
Q Consensus 682 ~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l 761 (992)
.++|||||||.++.+.. +. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++...
T Consensus 95 ~~~~iv~Ey~~~~l~~~-~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQV-IQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp CEEEEEEECCSEEHHHH-HT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred ceeEEEEeccchHHHHh-hh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 78999999996655543 32 45899999999999999999999999999999999999999999999999986332
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
.. .....
T Consensus 170 ~~-------------------------------------------------------------------------~~~~~ 176 (355)
T d2b1pa1 170 GT-------------------------------------------------------------------------SFMMT 176 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 10 01123
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC--------------------
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK-------------------- 901 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk-------------------- 901 (992)
..+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+....+..++.....
T Consensus 177 ~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (355)
T d2b1pa1 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENR 256 (355)
T ss_dssp ----CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTS
T ss_pred cccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcC
Confidence 457899999999999999999999999999999999999999988777666655432111
Q ss_pred --CCC------------------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCchhhhhcCCCCCC
Q 001952 902 --FPD------------------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNWALIRCAIPPEL 959 (992)
Q Consensus 902 --~P~------------------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw~~lr~~~pp~l 959 (992)
... ...++.++++||++||..||++||| |+|||+||||++.-|..-....+|.+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~~~~~~~~~~~~~~ 330 (355)
T d2b1pa1 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVWYDPAEVEAPPPQI 330 (355)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGGCCHHHHTCCCC--
T ss_pred ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCCCCcccccCCCCCC
Confidence 000 0124668899999999999999999 99999999999865544444444433
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=410.31 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=210.0
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCC---CeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGT---NCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~t---g~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~ 682 (992)
+..++|++++.||+|+||+||+|.+... ...||||++++...........+.+|+.+|+.++|||||++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 3457899999999999999999987543 34789999987665555666789999999999999999999999976 4
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.++|||||+++|+|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999998877653 569999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.... .......
T Consensus 163 ~~~~---------------------------------------------------------------------~~~~~~~ 173 (273)
T d1u46a_ 163 QNDD---------------------------------------------------------------------HYVMQEH 173 (273)
T ss_dssp C-CC---------------------------------------------------------------------EEEC---
T ss_pred cCCC---------------------------------------------------------------------cceecCc
Confidence 1100 0001223
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..||..|+|||++.+..++.++|||||||+||||+| |+.||.+.+..+.+..+......++.+..++.++.+||.+||.
T Consensus 174 ~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~ 253 (273)
T d1u46a_ 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWA 253 (273)
T ss_dssp --CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcC
Confidence 457889999999999999999999999999999998 8999999999999888888888887777899999999999999
Q ss_pred CCcCCcCCChHhHHHHH
Q 001952 922 KEPENRLGSQKGAAEIK 938 (992)
Q Consensus 922 ~DPekRPT~~~~aeEIL 938 (992)
.||++||+ +.||+
T Consensus 254 ~dp~~RPt----~~ei~ 266 (273)
T d1u46a_ 254 HKPEDRPT----FVALR 266 (273)
T ss_dssp SSGGGSCC----HHHHH
T ss_pred CChhHCcC----HHHHH
Confidence 99999999 66664
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=412.10 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=209.0
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCe----EEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCCe
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNC----LFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDNL 683 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~----~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~~ 683 (992)
..+|++++.||+|+||+||+|.+..+|+ .||+|.++... .......+.+|+++|++++|||||+++++|.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3579999999999999999999988776 57888886432 334456789999999999999999999999865 5
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
.+++|||+.+++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 67889999999998887764 46799999999999999999999999999999999999999999999999999855321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... .......
T Consensus 164 ~~~----------------------------------------------------------------------~~~~~~~ 173 (317)
T d1xkka_ 164 EEK----------------------------------------------------------------------EYHAEGG 173 (317)
T ss_dssp TCC-----------------------------------------------------------------------------
T ss_pred ccc----------------------------------------------------------------------ccccccc
Confidence 100 0011234
Q ss_pred ccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccC
Q 001952 844 VGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIK 922 (992)
Q Consensus 844 vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~ 922 (992)
.||+.|+|||++.+..++.++|||||||+||||+| |..||.+.+..+.. .++.....++.+..++.++.+||.+||..
T Consensus 174 ~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 252 (317)
T d1xkka_ 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPICTIDVYMIMVKCWMI 252 (317)
T ss_dssp -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred ccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCcccCHHHHHHHHHhCCC
Confidence 68999999999999999999999999999999998 89999887766654 44555666666678999999999999999
Q ss_pred CcCCcCCChHhHHHHHcC
Q 001952 923 EPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 923 DPekRPT~~~~aeEILkH 940 (992)
||.+||+ +.||++|
T Consensus 253 dP~~RPs----~~eil~~ 266 (317)
T d1xkka_ 253 DADSRPK----FRELIIE 266 (317)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred ChhhCcC----HHHHHHH
Confidence 9999999 8888877
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-47 Score=415.65 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=209.0
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC-----e
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN-----L 683 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~-----~ 683 (992)
++|++++.||+|+||+||+|.+..+|+.||||++++.. .......+.+|+++|+.++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997532 2233457789999999999999999999986543 3
Q ss_pred EEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccC
Q 001952 684 SCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSV 763 (992)
Q Consensus 684 lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~ 763 (992)
+||+ +|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++..+..
T Consensus 86 ~~l~-~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEE-EeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 4555 55669999999875 4699999999999999999999999999999999999999999999999999854321
Q ss_pred CcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCcc
Q 001952 764 SPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSF 843 (992)
Q Consensus 764 ~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~ 843 (992)
... ........
T Consensus 162 ~~~---------------------------------------------------------------------~~~~~~~~ 172 (345)
T d1pmea_ 162 DHD---------------------------------------------------------------------HTGFLTEY 172 (345)
T ss_dssp GGC---------------------------------------------------------------------BCCTTCCC
T ss_pred CCc---------------------------------------------------------------------cceeeccc
Confidence 000 00112345
Q ss_pred ccCCCccChhhhcC-CCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccC--------------------C
Q 001952 844 VGTHEYLAPEIIKG-EGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLK--------------------F 902 (992)
Q Consensus 844 vGT~~Y~APEvL~g-~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk--------------------~ 902 (992)
+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+.+..+........... .
T Consensus 173 ~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (345)
T d1pmea_ 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 252 (345)
T ss_dssp CSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred cccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccC
Confidence 79999999999854 56789999999999999999999999988766665554321111 1
Q ss_pred CC---------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCch
Q 001952 903 PD---------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLNW 948 (992)
Q Consensus 903 P~---------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~lnw 948 (992)
+. .+.++.++++||.+||..||.+||+ +.|+|+||||+...-
T Consensus 253 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 253 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQYYD 303 (345)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTTCC
T ss_pred CccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccCCC
Confidence 10 1235678999999999999999999 999999999986643
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=416.29 Aligned_cols=257 Identities=26% Similarity=0.380 Sum_probs=211.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-----CC
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-----DN 682 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-----~~ 682 (992)
.++|++++.||+|+||+||+|++..+|+.||||++.+... .......+.+|+++|+.++|||||+++++|.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3689999999999999999999999999999999975432 22334567899999999999999999999853 23
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
..+++|+|+.||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+|++|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 34566777789999999864 469999999999999999999999999999999999999999999999999863211
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
.....
T Consensus 173 ---------------------------------------------------------------------------~~~~~ 177 (348)
T d2gfsa1 173 ---------------------------------------------------------------------------DEMTG 177 (348)
T ss_dssp ---------------------------------------------------------------------------GGGSS
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01123
Q ss_pred cccCCCccChhhhcCCC-CCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCC------------------
Q 001952 843 FVGTHEYLAPEIIKGEG-HGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFP------------------ 903 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~-~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P------------------ 903 (992)
..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.......+
T Consensus 178 ~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (348)
T d2gfsa1 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257 (348)
T ss_dssp SCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTT
T ss_pred ccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhh
Confidence 46999999999988765 58999999999999999999999999887777766654322211
Q ss_pred -----C------CccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcCCCCCCCc
Q 001952 904 -----D------SPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQHPFFEGLN 947 (992)
Q Consensus 904 -----~------~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkHPfF~~ln 947 (992)
. ...++.++++||.+||..||.+||| +.|||+||||+++.
T Consensus 258 ~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYH 308 (348)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTC
T ss_pred cccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCCC
Confidence 0 1236788999999999999999999 99999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=403.72 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=215.5
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
.++..++|++++.||+|+||+||+|++.+ +++.||||+++... .......+.+|+++|+.++||||++++++|
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 45567899999999999999999999864 56789999997542 223346789999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhc----------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeee
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQL----------------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRD 736 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~----------------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRD 736 (992)
...+..++||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999987532 13478999999999999999999999999999
Q ss_pred cCCceEEEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCC
Q 001952 737 LKPENILVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRK 816 (992)
Q Consensus 737 IKPeNILLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~ 816 (992)
|||+||||+.++.+||+|||+++.+....
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~--------------------------------------------------- 194 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSAD--------------------------------------------------- 194 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGG---------------------------------------------------
T ss_pred EcccceEECCCCcEEEccchhheeccCCc---------------------------------------------------
Confidence 99999999999999999999985432100
Q ss_pred CCCChhhhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCC-CCCCCCCchHHHHHH
Q 001952 817 PKADPAAQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGR-TPFKGSGNEETLANV 895 (992)
Q Consensus 817 ~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr-~PF~g~s~~e~L~~I 895 (992)
.........||+.|+|||++.+..|+.++|||||||+||||++|. .||.+.+..+.+..+
T Consensus 195 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v 255 (301)
T d1lufa_ 195 -------------------YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255 (301)
T ss_dssp -------------------CBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred -------------------cccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHH
Confidence 001123456899999999999999999999999999999999985 678888777777665
Q ss_pred HhhccCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 896 VMQSLKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 896 v~~~lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..+ ...+.+..++.++.+||.+||+.||++||+ +.||++
T Consensus 256 ~~~-~~~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 256 RDG-NILACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HcC-CCCCCCccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 544 344555678999999999999999999999 666643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=406.96 Aligned_cols=255 Identities=24% Similarity=0.306 Sum_probs=211.7
Q ss_pred ccccCceEEEEEccCCceEEEEEEEcCCCeE--EEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeeccCC
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELIGTNCL--FAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFTSDN 682 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~--VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~~~~ 682 (992)
++.++|++.+.||+|+||+||+|.+..++.. ||||.++... .......+.+|+++|.++ +|||||+++++|.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5678999999999999999999999888764 6777765332 233456789999999998 7999999999999999
Q ss_pred eEEEEEEecCCCChHHHHHhh--------------cCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCC
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQ--------------LGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDG 748 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~--------------~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg 748 (992)
.+||||||+++|+|.++++.. ....+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998753 236789999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccC
Q 001952 749 HIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSL 828 (992)
Q Consensus 749 ~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~ 828 (992)
.+||+|||+++.....
T Consensus 165 ~~kl~DfG~a~~~~~~---------------------------------------------------------------- 180 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---------------------------------------------------------------- 180 (309)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred ceEEcccccccccccc----------------------------------------------------------------
Confidence 9999999997432100
Q ss_pred CccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCC-CCCCCCCchHHHHHHHhhccCCCCCcc
Q 001952 829 PQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGR-TPFKGSGNEETLANVVMQSLKFPDSPL 907 (992)
Q Consensus 829 ~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr-~PF~g~s~~e~L~~Iv~~~lk~P~~~~ 907 (992)
.......||..|+|||.+.+..++.++|||||||++|||++|. +||.+.+..+.+..+ .....++.+..
T Consensus 181 ---------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i-~~~~~~~~~~~ 250 (309)
T d1fvra_ 181 ---------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEKPLN 250 (309)
T ss_dssp ---------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-GGTCCCCCCTT
T ss_pred ---------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH-HhcCCCCCCcc
Confidence 0011235899999999999999999999999999999999965 578777666666554 44455666667
Q ss_pred chHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 908 ISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 908 vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
+++++.+||.+||..||++||+ +.||++|
T Consensus 251 ~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 251 CDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 9999999999999999999999 8888876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=399.77 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=208.4
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-CC
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-DN 682 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-~~ 682 (992)
+++..++|++++.||+|+||.||+|.+. |..||||+++.+ ...+.+.+|+++|++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 3567889999999999999999999984 678999999753 344678899999999999999999999865 46
Q ss_pred eEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEecccccccc
Q 001952 683 LSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCS 762 (992)
Q Consensus 683 ~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~ 762 (992)
.+||||||+++|+|.+++.......+++..++.|+.||+.||.|||+.+||||||||+|||++.+|.+||+|||++....
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 78999999999999999876544568999999999999999999999999999999999999999999999999873321
Q ss_pred CCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCc
Q 001952 763 VSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNS 842 (992)
Q Consensus 763 ~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s 842 (992)
. ....
T Consensus 155 ~---------------------------------------------------------------------------~~~~ 159 (262)
T d1byga_ 155 S---------------------------------------------------------------------------TQDT 159 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C---------------------------------------------------------------------------CCcc
Confidence 0 0112
Q ss_pred cccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhcc
Q 001952 843 FVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLI 921 (992)
Q Consensus 843 ~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~ 921 (992)
..+|..|+|||++.+..++.++|||||||++|||+| |++||.+....+.+..+ .....++.+..++.++.+||.+||.
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~li~~cl~ 238 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAVYEVMKNCWH 238 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH-TTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHHHHHcc
Confidence 347889999999999999999999999999999998 78888887666666554 4455566666789999999999999
Q ss_pred CCcCCcCCChHhHHHHHcC
Q 001952 922 KEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 922 ~DPekRPT~~~~aeEILkH 940 (992)
.||++||+ +.+|+++
T Consensus 239 ~dP~~Rps----~~~l~~~ 253 (262)
T d1byga_ 239 LDAAMRPS----FLQLREQ 253 (262)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred cCHhHCcC----HHHHHHH
Confidence 99999999 6666653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=401.14 Aligned_cols=258 Identities=20% Similarity=0.292 Sum_probs=219.9
Q ss_pred ccccCceEEEEEccCCceEEEEEEEc-----CCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceeeeec
Q 001952 606 IGLRHFNLLQKLGCGDIGTVYLAELI-----GTNCLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYSQFT 679 (992)
Q Consensus 606 i~~~~Yeilr~LGsG~FGtVYlA~~~-----~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g~f~ 679 (992)
+..++|++.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.++..+ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 55689999999999999999999874 456789999997543 223345688999999999 6999999999999
Q ss_pred cCCeEEEEEEecCCCChHHHHHhhc----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEE
Q 001952 680 SDNLSCLVMEYCPGGDLHVLRQKQL----------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENIL 743 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~lLkk~~----------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNIL 743 (992)
+.+.+|||||||++|+|.++++... ...+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999987642 135889999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhh
Q 001952 744 VREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAA 823 (992)
Q Consensus 744 Ld~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~ 823 (992)
++.++.++|+|||+++.+.....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~--------------------------------------------------------- 200 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN--------------------------------------------------------- 200 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT---------------------------------------------------------
T ss_pred ccccCcccccccchheeccCCCc---------------------------------------------------------
Confidence 99999999999999743321000
Q ss_pred hhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccCC
Q 001952 824 QIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLKF 902 (992)
Q Consensus 824 ~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk~ 902 (992)
........||+.|+|||++.+..++.++|||||||+||||+| |.+||.+.+..+.+..++......
T Consensus 201 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~ 267 (311)
T d1t46a_ 201 -------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM 267 (311)
T ss_dssp -------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC
T ss_pred -------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 011123579999999999999999999999999999999998 677787877878888888888877
Q ss_pred CCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 903 PDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 903 P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
..+..++.++.+||.+||..||.+||+ +++|++
T Consensus 268 ~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 268 LSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 777789999999999999999999999 666664
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=397.56 Aligned_cols=258 Identities=23% Similarity=0.347 Sum_probs=211.4
Q ss_pred cccccCceEEEEEccCCceEEEEEEEcCCC-------eEEEEEEechhHHHhhcchhHHHHHHHHHHHc-CCCCccceee
Q 001952 605 SIGLRHFNLLQKLGCGDIGTVYLAELIGTN-------CLFAIKVMDNEFLARRKKMPRAQTEREILRML-DHPFLPTLYS 676 (992)
Q Consensus 605 ei~~~~Yeilr~LGsG~FGtVYlA~~~~tg-------~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L-~HPNIVkL~g 676 (992)
++..++|++++.||+|+||.||+|++..++ ..||||+++.+. .......+.+|..++.++ +|||||++++
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 356789999999999999999999886654 479999997653 223346678888888888 8999999999
Q ss_pred eeccCCeEEEEEEecCCCChHHHHHhhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceE
Q 001952 677 QFTSDNLSCLVMEYCPGGDLHVLRQKQL--------------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENI 742 (992)
Q Consensus 677 ~f~~~~~lyLVmEy~~GGSL~~lLkk~~--------------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNI 742 (992)
+|.+++.+|+|||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 9999999999999999999999997542 24589999999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChh
Q 001952 743 LVREDGHIMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPA 822 (992)
Q Consensus 743 LLd~dg~VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~ 822 (992)
|++.++.+||+|||++..+....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~--------------------------------------------------------- 189 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHID--------------------------------------------------------- 189 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCC---------------------------------------------------------
T ss_pred eecCCCCeEeccchhhccccccc---------------------------------------------------------
Confidence 99999999999999974432100
Q ss_pred hhhccCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhcc-CCCCCCCCCchHHHHHHHhhccC
Q 001952 823 AQIRSLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLY-GRTPFKGSGNEETLANVVMQSLK 901 (992)
Q Consensus 823 ~~i~~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLT-Gr~PF~g~s~~e~L~~Iv~~~lk 901 (992)
.........||+.|+|||++.+..|+.++|||||||+||||++ |+.||.+.+..+.+. .+.....
T Consensus 190 -------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~-~i~~~~~ 255 (299)
T d1fgka_ 190 -------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK-LLKEGHR 255 (299)
T ss_dssp -------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHHTTCC
T ss_pred -------------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH-HHHcCCC
Confidence 0111234568999999999999999999999999999999998 788998776665554 4555666
Q ss_pred CCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 902 FPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 902 ~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
++.+..++.++.+||.+||+.||.+||+ +.||++
T Consensus 256 ~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 256 MDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp CCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 6777789999999999999999999999 777765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=399.99 Aligned_cols=270 Identities=20% Similarity=0.245 Sum_probs=220.6
Q ss_pred ccccccCceEEEEEccCCceEEEEEEEcC-----CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeee
Q 001952 604 GSIGLRHFNLLQKLGCGDIGTVYLAELIG-----TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQF 678 (992)
Q Consensus 604 gei~~~~Yeilr~LGsG~FGtVYlA~~~~-----tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f 678 (992)
+++..++|++.+.||+|+||+||+|.+.+ .+..||||+++... .......+.+|+++|++++||||+++++++
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 35667899999999999999999998863 35789999997542 223345688999999999999999999999
Q ss_pred ccCCeEEEEEEecCCCChHHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcE
Q 001952 679 TSDNLSCLVMEYCPGGDLHVLRQKQL--------GKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHI 750 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL~~lLkk~~--------~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~V 750 (992)
..++.++|||||+++|+|..++.... -..+++..+..|+.||+.||.|||+++||||||||+||||+.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 99999999999999999999876432 1346889999999999999999999999999999999999999999
Q ss_pred EEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCc
Q 001952 751 MLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQ 830 (992)
Q Consensus 751 KLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~ 830 (992)
||+|||+++.+....
T Consensus 173 Kl~DFGla~~~~~~~----------------------------------------------------------------- 187 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETD----------------------------------------------------------------- 187 (308)
T ss_dssp EECCTTCCCGGGGGG-----------------------------------------------------------------
T ss_pred EEeecccceeccCCc-----------------------------------------------------------------
Confidence 999999985432110
Q ss_pred cccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccC-CCCCCCCCchHHHHHHHhhccCCCCCccch
Q 001952 831 LVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYG-RTPFKGSGNEETLANVVMQSLKFPDSPLIS 909 (992)
Q Consensus 831 ~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTG-r~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs 909 (992)
.........||+.|+|||.+.+..++.++|||||||+||||+|| ..||.+.+..+.+..+... ..++.+..++
T Consensus 188 -----~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~-~~~~~p~~~~ 261 (308)
T d1p4oa_ 188 -----YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKPDNCP 261 (308)
T ss_dssp -----CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCC
T ss_pred -----ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhC-CCCCCcccch
Confidence 00112234689999999999999999999999999999999997 5888888877777776654 3455556789
Q ss_pred HHHHHHHHHhccCCcCCcCCChHhHHHHHc--CCCCCCC
Q 001952 910 FQARDLIRGLLIKEPENRLGSQKGAAEIKQ--HPFFEGL 946 (992)
Q Consensus 910 ~el~dLI~kcL~~DPekRPT~~~~aeEILk--HPfF~~l 946 (992)
..+.+||.+||+.||++||++...+..|.+ +|+|+++
T Consensus 262 ~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 262 DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 999999999999999999994333333322 6666543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=393.34 Aligned_cols=254 Identities=17% Similarity=0.234 Sum_probs=203.1
Q ss_pred eEEEEEccCCceEEEEEEEcCCC---eEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeecc-CCeEEEE
Q 001952 612 NLLQKLGCGDIGTVYLAELIGTN---CLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTS-DNLSCLV 687 (992)
Q Consensus 612 eilr~LGsG~FGtVYlA~~~~tg---~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~-~~~lyLV 687 (992)
.+.++||+|+||+||+|.+..++ ..||||+++.. ........+.+|+++|++++||||+++++++.. ++.+++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 33678999999999999986543 36899998643 133445778999999999999999999999765 5689999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEeccccccccCCccc
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDFDLSLRCSVSPTL 767 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDFGLA~~l~~~~~~ 767 (992)
||||++|+|.+++... ...+++..++.++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.+......
T Consensus 108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999999988764 356778889999999999999999999999999999999999999999999998543211000
Q ss_pred ccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccccCC
Q 001952 768 LKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFVGTH 847 (992)
Q Consensus 768 ~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~vGT~ 847 (992)
.........||.
T Consensus 187 --------------------------------------------------------------------~~~~~~~~~gt~ 198 (311)
T d1r0pa_ 187 --------------------------------------------------------------------SVHNKTGAKLPV 198 (311)
T ss_dssp --------------------------------------------------------------------CTTCTTCSSCCG
T ss_pred --------------------------------------------------------------------cceecccccccc
Confidence 001112346899
Q ss_pred CccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHHHhhccCCCCCccchHHHHHHHHHhccCCcCCc
Q 001952 848 EYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANVVMQSLKFPDSPLISFQARDLIRGLLIKEPENR 927 (992)
Q Consensus 848 ~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~Iv~~~lk~P~~~~vs~el~dLI~kcL~~DPekR 927 (992)
.|+|||++.+..++.++|||||||+||||+||..||........+...+.....++.+..+++++.+||.+||..||++|
T Consensus 199 ~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~R 278 (311)
T d1r0pa_ 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278 (311)
T ss_dssp GGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred cccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHC
Confidence 99999999999999999999999999999998777765544433334444455666667789999999999999999999
Q ss_pred CCChHhHHHHHcC
Q 001952 928 LGSQKGAAEIKQH 940 (992)
Q Consensus 928 PT~~~~aeEILkH 940 (992)
|+ +.||++|
T Consensus 279 Ps----~~ei~~~ 287 (311)
T d1r0pa_ 279 PS----FSELVSR 287 (311)
T ss_dssp CC----HHHHHHH
T ss_pred cC----HHHHHHH
Confidence 99 7777765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-44 Score=387.65 Aligned_cols=273 Identities=19% Similarity=0.255 Sum_probs=206.2
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCcc-ceeeeeccCCeEEEE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLP-TLYSQFTSDNLSCLV 687 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIV-kL~g~f~~~~~lyLV 687 (992)
++|++++.||+|+||+||+|.+..+|+.||||++... .....+..|+++++.++|+|++ .+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC-----TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh-----ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999998753 2234578899999999877655 555566788899999
Q ss_pred EEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc---CCcEEEEeccccccccCC
Q 001952 688 MEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE---DGHIMLTDFDLSLRCSVS 764 (992)
Q Consensus 688 mEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~---dg~VKLsDFGLA~~l~~~ 764 (992)
|||+ +++|...+... ...+++..++.++.||+.||+|||++|||||||||+|||++. +..++|+|||++..+...
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 66666655543 467999999999999999999999999999999999999863 457999999998654311
Q ss_pred cccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcCccc
Q 001952 765 PTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSNSFV 844 (992)
Q Consensus 765 ~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~s~v 844 (992)
.... ..........+
T Consensus 160 ~~~~-----------------------------------------------------------------~~~~~~~~~~~ 174 (299)
T d1ckia_ 160 RTHQ-----------------------------------------------------------------HIPYRENKNLT 174 (299)
T ss_dssp TTCC-----------------------------------------------------------------BCCCCBCCSCC
T ss_pred cccc-----------------------------------------------------------------ceeccccCCcC
Confidence 1000 00011223567
Q ss_pred cCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCchHHHHHH---HhhccCCCC---CccchHHHHHHHHH
Q 001952 845 GTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNEETLANV---VMQSLKFPD---SPLISFQARDLIRG 918 (992)
Q Consensus 845 GT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~e~L~~I---v~~~lk~P~---~~~vs~el~dLI~k 918 (992)
||+.|+|||++.+..++.++|||||||++|||+||+.||.+.........+ .......+. ...++.++.+||.+
T Consensus 175 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~ 254 (299)
T d1ckia_ 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNF 254 (299)
T ss_dssp CCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHH
T ss_pred CCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHH
Confidence 999999999999999999999999999999999999999876554433322 222222221 23478999999999
Q ss_pred hccCCcCCcCCChHhHHHHHcCCCC-------CCCchhhhhcC
Q 001952 919 LLIKEPENRLGSQKGAAEIKQHPFF-------EGLNWALIRCA 954 (992)
Q Consensus 919 cL~~DPekRPT~~~~aeEILkHPfF-------~~lnw~~lr~~ 954 (992)
||..||++||++. .+.++|+|+|. ..+||..++..
T Consensus 255 cl~~~p~~RP~~~-~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~ 296 (299)
T d1ckia_ 255 CRSLRFDDKPDYS-YLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296 (299)
T ss_dssp HHHSCTTCCCCHH-HHHHHHHHHHHHHTCCCSCCCHHHHGGGT
T ss_pred HccCChhHCcCHH-HHHHHHHHHHHHcCCCCCCCcCchhhcCC
Confidence 9999999999942 33456666543 23567666643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.3e-43 Score=373.77 Aligned_cols=252 Identities=18% Similarity=0.242 Sum_probs=203.8
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC-CCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH-PFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H-PNIVkL~g~f~~~~~lyL 686 (992)
.++|++++.||+|+||+||+|.+..+|+.||||++... .....+.+|++.++.+.| +||+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC-----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc-----cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 46899999999999999999999999999999998643 223456789999999965 899999999999999999
Q ss_pred EEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEcc-----CCcEEEEeccccccc
Q 001952 687 VMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVRE-----DGHIMLTDFDLSLRC 761 (992)
Q Consensus 687 VmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~-----dg~VKLsDFGLA~~l 761 (992)
||||+ +++|..++... +..+++..++.++.|++.||+|||++|||||||||+|||++. ++.++|+|||+++.+
T Consensus 79 vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99999 89999887654 467999999999999999999999999999999999999974 578999999998654
Q ss_pred cCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCCCCCcC
Q 001952 762 SVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPTDARSN 841 (992)
Q Consensus 762 ~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~~~~s~ 841 (992)
...... .........
T Consensus 157 ~~~~~~-----------------------------------------------------------------~~~~~~~~~ 171 (293)
T d1csna_ 157 RDPVTK-----------------------------------------------------------------QHIPYREKK 171 (293)
T ss_dssp BCTTTC-----------------------------------------------------------------CBCCCCCCC
T ss_pred ccCccc-----------------------------------------------------------------cceeecccC
Confidence 211000 000011123
Q ss_pred ccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch---HHHHHHHhhccCCCC---CccchHHHHHH
Q 001952 842 SFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE---ETLANVVMQSLKFPD---SPLISFQARDL 915 (992)
Q Consensus 842 s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~---e~L~~Iv~~~lk~P~---~~~vs~el~dL 915 (992)
..+||+.|||||++.+..++.++|||||||++|||+||+.||.+.... +.+..+.......+. ...++.++.+|
T Consensus 172 ~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~i 251 (293)
T d1csna_ 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKY 251 (293)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred ceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHH
Confidence 468999999999999999999999999999999999999999865433 333333332222211 13478899999
Q ss_pred HHHhccCCcCCcCCCh
Q 001952 916 IRGLLIKEPENRLGSQ 931 (992)
Q Consensus 916 I~kcL~~DPekRPT~~ 931 (992)
+..|+..+|++||+++
T Consensus 252 i~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 252 MHYARNLAFDATPDYD 267 (293)
T ss_dssp HHHHHHCCTTCCCCHH
T ss_pred HHHHhcCCcccCcCHH
Confidence 9999999999999854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-43 Score=378.73 Aligned_cols=250 Identities=23% Similarity=0.264 Sum_probs=189.6
Q ss_pred cCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCccceeeeeccCC----eE
Q 001952 609 RHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFLPTLYSQFTSDN----LS 684 (992)
Q Consensus 609 ~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNIVkL~g~f~~~~----~l 684 (992)
++|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+..+..++|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5788999999999999999987 578999999975421 1112233444556789999999999997543 68
Q ss_pred EEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh--------cCeeeeecCCceEEEccCCcEEEEecc
Q 001952 685 CLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM--------LGVIYRDLKPENILVREDGHIMLTDFD 756 (992)
Q Consensus 685 yLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs--------~GIIHRDIKPeNILLd~dg~VKLsDFG 756 (992)
|||||||++|+|..++++ ..+++..++.++.|++.||.|||. +|||||||||+||||+.++.+||+|||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999999986 368999999999999999999996 589999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhccCCccccCCC
Q 001952 757 LSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIRSLPQLVAEPT 836 (992)
Q Consensus 757 LA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~~~~~~~a~~~ 836 (992)
++..+...... .
T Consensus 154 l~~~~~~~~~~--------------------------------------------------------------------~ 165 (303)
T d1vjya_ 154 LAVRHDSATDT--------------------------------------------------------------------I 165 (303)
T ss_dssp TCEEEETTTTE--------------------------------------------------------------------E
T ss_pred ccccccCCCcc--------------------------------------------------------------------e
Confidence 98654211100 0
Q ss_pred CCCcCccccCCCccChhhhcCCC------CCccceeeehhhhhhhhccCCCCCCCCC--------------chHHHHHHH
Q 001952 837 DARSNSFVGTHEYLAPEIIKGEG------HGAAVDWWTFGIFLYELLYGRTPFKGSG--------------NEETLANVV 896 (992)
Q Consensus 837 ~~~s~s~vGT~~Y~APEvL~g~~------~s~kSDIWSLGVlLyELLTGr~PF~g~s--------------~~e~L~~Iv 896 (992)
.......+||+.|+|||++.+.. ++.++|||||||+||||+||..||.... ..+.+...+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T d1vjya_ 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245 (303)
T ss_dssp CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHH
Confidence 01123457999999999998753 4678999999999999999988774321 223333333
Q ss_pred hh-ccCCCCCc-----cchHHHHHHHHHhccCCcCCcCCChHhHHHHHc
Q 001952 897 MQ-SLKFPDSP-----LISFQARDLIRGLLIKEPENRLGSQKGAAEIKQ 939 (992)
Q Consensus 897 ~~-~lk~P~~~-----~vs~el~dLI~kcL~~DPekRPT~~~~aeEILk 939 (992)
.. ..+.+.+. .....+.+||.+||..||++||+ +.||++
T Consensus 246 ~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~ 290 (303)
T d1vjya_ 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKK 290 (303)
T ss_dssp TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHH
T ss_pred hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHH
Confidence 22 22222111 13346889999999999999999 666654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-41 Score=369.57 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=197.7
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-----------CCCccceee
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-----------HPFLPTLYS 676 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-----------HPNIVkL~g 676 (992)
.++|+++++||+|+||+||+|++..+|+.||||+++++... ...+.+|+.+|+.+. |+||+++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 35699999999999999999999999999999999865322 245677888888774 578999999
Q ss_pred eecc--CCeEEEEEEecCCCCh-HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeeeecCCceEEEccCCc---
Q 001952 677 QFTS--DNLSCLVMEYCPGGDL-HVLRQKQLGKCFSEPAARFYVAEVLLALEYLHM-LGVIYRDLKPENILVREDGH--- 749 (992)
Q Consensus 677 ~f~~--~~~lyLVmEy~~GGSL-~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs-~GIIHRDIKPeNILLd~dg~--- 749 (992)
++.. ....+++|+++..+.+ ..+........+++..++.++.||+.||+|||+ +||+||||||+||||+.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 8864 4567777777655544 333344445678999999999999999999997 89999999999999986653
Q ss_pred ---EEEEeccccccccCCcccccCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCCcCccccccCCCCCChhhhhc
Q 001952 750 ---IMLTDFDLSLRCSVSPTLLKSSSNMDPARVSGPCTESNCIQPFCIEPTCQVPCFSPRFLPATAKTRKPKADPAAQIR 826 (992)
Q Consensus 750 ---VKLsDFGLA~~l~~~~~~~~~~s~~~~~r~sgp~~~s~~~~p~~~~~~~~~~~~spr~~~~~~kt~~~~~~~~~~i~ 826 (992)
++|+|||.+....
T Consensus 168 ~~~~kl~dfg~s~~~~---------------------------------------------------------------- 183 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYD---------------------------------------------------------------- 183 (362)
T ss_dssp EEEEEECCCTTCEETT----------------------------------------------------------------
T ss_pred cceeeEeecccccccc----------------------------------------------------------------
Confidence 9999999873321
Q ss_pred cCCccccCCCCCCcCccccCCCccChhhhcCCCCCccceeeehhhhhhhhccCCCCCCCCCch------HHHHHHHhhc-
Q 001952 827 SLPQLVAEPTDARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGIFLYELLYGRTPFKGSGNE------ETLANVVMQS- 899 (992)
Q Consensus 827 ~~~~~~a~~~~~~s~s~vGT~~Y~APEvL~g~~~s~kSDIWSLGVlLyELLTGr~PF~g~s~~------e~L~~Iv~~~- 899 (992)
......+||+.|+|||++.+..++.++|||||||+++||++|+.||...... +.+...+...
T Consensus 184 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 184 -----------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp -----------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred -----------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 0112346999999999999999999999999999999999999999754321 1222111100
Q ss_pred ---------------------------------------cCCCCCccchHHHHHHHHHhccCCcCCcCCChHhHHHHHcC
Q 001952 900 ---------------------------------------LKFPDSPLISFQARDLIRGLLIKEPENRLGSQKGAAEIKQH 940 (992)
Q Consensus 900 ---------------------------------------lk~P~~~~vs~el~dLI~kcL~~DPekRPT~~~~aeEILkH 940 (992)
..+......+.++.|||.+||..||.+||| ++|+|+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~L~H 328 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGLVNH 328 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHHHTC
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC----HHHHhcC
Confidence 001111235678999999999999999999 9999999
Q ss_pred CCCCCCc
Q 001952 941 PFFEGLN 947 (992)
Q Consensus 941 PfF~~ln 947 (992)
|||++..
T Consensus 329 p~f~~~~ 335 (362)
T d1q8ya_ 329 PWLKDTL 335 (362)
T ss_dssp GGGTTCT
T ss_pred cccCCCC
Confidence 9999654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=6e-23 Score=205.32 Aligned_cols=135 Identities=19% Similarity=0.177 Sum_probs=105.5
Q ss_pred ceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHh---------------hcchhHHHHHHHHHHHcCCCCcccee
Q 001952 611 FNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLAR---------------RKKMPRAQTEREILRMLDHPFLPTLY 675 (992)
Q Consensus 611 Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~---------------~~~~~~~~~EieILk~L~HPNIVkL~ 675 (992)
+.+.++||+|+||+||+|.+ .+|+.||||+++...... ......+..|...|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 45788999999999999988 468899999876432110 01123345688889999999999988
Q ss_pred eeeccCCeEEEEEEecCCCChHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhhcCeeeeecCCceEEEccCCcEEEEec
Q 001952 676 SQFTSDNLSCLVMEYCPGGDLHVLRQKQLGKCFSEPAARFYVAEVLLALEYLHMLGVIYRDLKPENILVREDGHIMLTDF 755 (992)
Q Consensus 676 g~f~~~~~lyLVmEy~~GGSL~~lLkk~~~~~Lse~~i~~Ia~QIL~GL~YLHs~GIIHRDIKPeNILLd~dg~VKLsDF 755 (992)
++.. .+|+|||+++..+.. ++...+..++.||+.+|+|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 7642 379999998766532 4555677899999999999999999999999999999965 4889999
Q ss_pred ccccc
Q 001952 756 DLSLR 760 (992)
Q Consensus 756 GLA~~ 760 (992)
|++..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 98743
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.34 E-value=1.4e-06 Score=87.92 Aligned_cols=86 Identities=15% Similarity=0.143 Sum_probs=61.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeeeccCCeEEE
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f~~~~~lyL 686 (992)
...|+..+..+-++...||+... ++..+++|+.... .......+.+|..+|..+. +--+.+++.++..++..|+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~---~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSR---YKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGG---GTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCC---cccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 35677766655455678998753 5556888987644 2223445678888888774 4346788888888899999
Q ss_pred EEEecCCCChHH
Q 001952 687 VMEYCPGGDLHV 698 (992)
Q Consensus 687 VmEy~~GGSL~~ 698 (992)
||++++|..+..
T Consensus 88 v~~~l~G~~~~~ 99 (263)
T d1j7la_ 88 LMSEADGVLCSE 99 (263)
T ss_dssp EEECCSSEEHHH
T ss_pred EEEecccccccc
Confidence 999999987743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=3e-05 Score=77.56 Aligned_cols=136 Identities=15% Similarity=0.037 Sum_probs=83.1
Q ss_pred EEccCCc-eEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCC--CCccceeeeeccCCeEEEEEEecC
Q 001952 616 KLGCGDI-GTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDH--PFLPTLYSQFTSDNLSCLVMEYCP 692 (992)
Q Consensus 616 ~LGsG~F-GtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~H--PNIVkL~g~f~~~~~lyLVmEy~~ 692 (992)
.+..|.. +.||+... .++..+++|+.... ....+..|...|+.+.. --+.+++.+..+++..++||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~------~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc------CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455553 67999876 44666888986532 23446778888887743 236778888888888999999998
Q ss_pred CCChHH--------------HHHhhc-----CCCCC--HHHHHH-----H---------------HHHHHHHHHHHhhc-
Q 001952 693 GGDLHV--------------LRQKQL-----GKCFS--EPAARF-----Y---------------VAEVLLALEYLHML- 730 (992)
Q Consensus 693 GGSL~~--------------lLkk~~-----~~~Ls--e~~i~~-----I---------------a~QIL~GL~YLHs~- 730 (992)
|..+.. ++.+.. ..++. ...... + ...+...+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 876521 111110 00111 000000 0 00111223333322
Q ss_pred ------CeeeeecCCceEEEccCCcEEEEecccc
Q 001952 731 ------GVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 731 ------GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
.+||+|+.|.|||++.++.+-|+||+.+
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 3899999999999998777789999986
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=6.1e-05 Score=82.01 Aligned_cols=81 Identities=19% Similarity=0.169 Sum_probs=51.4
Q ss_pred EEEEccCCceEEEEEEEcCCCeEEEEEEechhHH-H---hhcchhHHHHHHHHHHHcC-C--CCccceeeeeccCCeEEE
Q 001952 614 LQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFL-A---RRKKMPRAQTEREILRMLD-H--PFLPTLYSQFTSDNLSCL 686 (992)
Q Consensus 614 lr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l-~---~~~~~~~~~~EieILk~L~-H--PNIVkL~g~f~~~~~lyL 686 (992)
.+.||.|....||++.+..+++.|+||.-..... . ......+...|.+.|+.+. + ..+++++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 5679999999999998877788899996542110 0 1123445667888887763 2 3456666543 445579
Q ss_pred EEEecCCCCh
Q 001952 687 VMEYCPGGDL 696 (992)
Q Consensus 687 VmEy~~GGSL 696 (992)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999977543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.65 E-value=0.0034 Score=67.51 Aligned_cols=80 Identities=23% Similarity=0.359 Sum_probs=53.5
Q ss_pred cccCceEEEEEccCCceEEEEEEEcC-------CCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcC-CCCccceeeee
Q 001952 607 GLRHFNLLQKLGCGDIGTVYLAELIG-------TNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLD-HPFLPTLYSQF 678 (992)
Q Consensus 607 ~~~~Yeilr~LGsG~FGtVYlA~~~~-------tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~-HPNIVkL~g~f 678 (992)
..+++++ +.|+.|-.-.+|++.... ..+.|.+++.-.. .......+|..+++.+. +.-..++++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-----~~~idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----ETESHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-----chhhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3445554 578778888999998753 2356788886521 12233467888888874 44456888877
Q ss_pred ccCCeEEEEEEecCCCCh
Q 001952 679 TSDNLSCLVMEYCPGGDL 696 (992)
Q Consensus 679 ~~~~~lyLVmEy~~GGSL 696 (992)
.+ .+||||++|..|
T Consensus 115 ~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPL 128 (395)
T ss_dssp TT----EEEECCCCEEEC
T ss_pred CC----ceEEEEeccccC
Confidence 53 589999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.42 E-value=0.0043 Score=65.02 Aligned_cols=70 Identities=14% Similarity=0.088 Sum_probs=44.5
Q ss_pred CceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc--ccee-----eeeccCCeEEEEEEecCC
Q 001952 621 DIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL--PTLY-----SQFTSDNLSCLVMEYCPG 693 (992)
Q Consensus 621 ~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI--VkL~-----g~f~~~~~lyLVmEy~~G 693 (992)
.--.||++.. .+|..|++|+.+.. ......+..|...|..|....| +..+ ..+..++..+.++++++|
T Consensus 34 ~EN~vy~v~~-~dg~~~VlK~~rp~----~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 34 YENRVYQFQD-EDRRRFVVKFYRPE----RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSSEEEEECC-TTCCCEEEEEECTT----TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ccceeEEEEc-CCCCEEEEEEeCCC----CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 3458999977 56778999998753 2233456778888777742222 1111 123456678999999977
Q ss_pred CC
Q 001952 694 GD 695 (992)
Q Consensus 694 GS 695 (992)
..
T Consensus 109 ~~ 110 (325)
T d1zyla1 109 RQ 110 (325)
T ss_dssp EE
T ss_pred cC
Confidence 44
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.38 E-value=0.012 Score=60.51 Aligned_cols=144 Identities=14% Similarity=0.085 Sum_probs=77.2
Q ss_pred ccCceEEEEEccCCceEEEEEEEcCCCeEEEEEEechhHHHhhcchhHHHHHHHHHHHcCCCCc--cceee------eec
Q 001952 608 LRHFNLLQKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKMPRAQTEREILRMLDHPFL--PTLYS------QFT 679 (992)
Q Consensus 608 ~~~Yeilr~LGsG~FGtVYlA~~~~tg~~VAIKvIkk~~l~~~~~~~~~~~EieILk~L~HPNI--VkL~g------~f~ 679 (992)
++...-++.|..|---+.|+.... +| .|++|++... .....+..|+++|..+...++ ...+. +..
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~-----~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC-----CCHHHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 445555666778888889998764 34 4899998643 122345567777777632221 11111 112
Q ss_pred cCCeEEEEEEecCCCChHH-----H---------HHhhc---CC----CC------------------CHHHHHHHHHHH
Q 001952 680 SDNLSCLVMEYCPGGDLHV-----L---------RQKQL---GK----CF------------------SEPAARFYVAEV 720 (992)
Q Consensus 680 ~~~~lyLVmEy~~GGSL~~-----l---------Lkk~~---~~----~L------------------se~~i~~Ia~QI 720 (992)
.....+.++.++.|..... . ++... .. .. ........+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 3455677787776643310 0 00000 00 00 001112222233
Q ss_pred HHHHHHHhh----cCeeeeecCCceEEEccCCcEEEEecccc
Q 001952 721 LLALEYLHM----LGVIYRDLKPENILVREDGHIMLTDFDLS 758 (992)
Q Consensus 721 L~GL~YLHs----~GIIHRDIKPeNILLd~dg~VKLsDFGLA 758 (992)
...+.-.+. .|+||+|+.++|||++.+...-|.||+.+
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 333333332 37999999999999998887889999986
|